Citrus Sinensis ID: 046240

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760---
Protein Sequence
MERTYGLRLIAVPLSHCLLLYLVVAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELYK
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHcccccccccccccccccccccccEEEEcccccccccEEEcccccEEEcccccccccccccEEEcccccccccccccccccHHHHHccccccEEEccccccEEcccccccccccccEEEccccEEcccccccccccccccccccccccccccccccccHHHHcccccccEEEEEccEEEEcccccccccccccEEccccccccccccHHHHcccccccccEEcccccccccccccccccccccccccccccccccccccHHHHccccccEEccccccccccccHHHHcccccccccccccccccccHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEccccccccccHHHHHHHHHcccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEcccccccccccccccccEEcccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHcccccccccccccccccccccEEEEEEccccccEEEEEcccccccccccHHHccccccEEEEEccccccccccccccccHHHHHccccccEEEEccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEEEEEcccccccccccHHHHccccccEEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEEcccccccccccccccccccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHccccHccEEEcccccEEEEEEcccccEEEEEEcccccccccccHHHHHHHHcHcccccHHHHHEEEcccccEEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEccccHHHHHHccHHHHEcccccccEEEEEccccccccccHEEEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHHHHHccccEEccHHHccccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccHHHHcc
Coil and Loop (DISEMBL)
MERTYGLRLIAVPLSHCLLLYLVVAAAATSNITTDQQALLALEAHisydptnllaqnwtsntsVCNWIGITCDVNSHRVTAlnisslnlqgeipheigylpsltKLALGYnslvgnnslsgslpsridlalpnVKALSLAYnrfsgtiqspitnasKLTILElggnsfsgfipntignlrnIEWLGLVIGLignplngilpssIVNLSISLERLYisncsitgnipqvMGNLSIFLLLDLElnkltgpipvtfgrlqnskldtlslcgnsfsgsipscidignLKVVVEINLsrnnfsgdipatigglkdvqnislpynrlegpipesfgyLTSLEIldlsnnkiSGFILISLEKLLYLKKLNLSFNklegeiprggpfanftaksfmgneklcglphlqvpqckhqtrpksskKMILLVIVLPLSAALIAVVVLALKYkstrrgkstglsnggillsqatkrrlpyqdlsratnrfgrdnligiGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEympngsldifLYSSTCMLDIFQRLNIMIDVASALEYlnfrhttpiihcdlkssnvlldEDMIAHLSDFGIakllsgedqsmtQTQTLATIgymapeygierkvstrsdiYSYGIMLIETftrkkpadKMFAAELSLKHWVNGLLPVSLMEVVNKtllsppekdfaaKEQCVLSIFSLAMECTmelpekrinakccnFVLCEQFVSNSSELYK
Flexible Loop (DISEMBL)
MERTYGLRLIAVPLSHCLLLYLVVAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYkstrrgkstglsnggillsqatkrrlpyqdlsratnrfgrdnlIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEqfvsnsselyk
Low Complexity Region (SEG)
MERTYGLRLIAVPLSHClllylvvaaaaTSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLAlgynslvgnnslsgslPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGfilislekllylkklnlsfnkleGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMillvivlplsaaliavvvlalKYKSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELYK
Disordered region (IsUnstruct)
****YGLRLIAVPLSHCLLLYLVVAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQC**********KMILLVIVLPLSAALIAVVVLALKYKSTR******LSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED*SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV********
Disordered Region (DISOPRED)
********LIAVPLSHCLLLYLVVAAAA***ITTDQQALLALEAHISY*********WTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPH********************LVIVLPLSAALIAVVVLALKY********************ATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED***TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC************
Disordered Region (DISEMBL)
MERTYGLRLIAVPLSHCLLLYLVVAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVP**********SKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV********
Disordered Region (DISPRO)
***TYGLRLIAVPLSHCLLLYLVVAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGK*****NGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV********
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MERTYGLRLIAVPLSHCLLLYLVVAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELYK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	763	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.863	0.652	0.357	1e-101
C0LGT6	1031	LRR receptor-like serine/	no	no	0.806	0.596	0.332	4e-98
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.874	0.534	0.319	2e-92
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.859	0.523	0.324	2e-90
Q9SD62	1025	Putative receptor-like pr	no	no	0.809	0.602	0.375	2e-88
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.867	0.675	0.315	4e-87
Q9FL28	1173	LRR receptor-like serine/	no	no	0.829	0.539	0.306	3e-83
Q9SGP2	996	Receptor-like protein kin	no	no	0.851	0.652	0.327	2e-79
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.833	0.533	0.324	8e-78
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.791	0.500	0.318	2e-76

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  371 bits (953), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 264/739 (35%), Positives = 392/739 (53%), Gaps = 80/739 (10%)

Query: 82   LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLAL-------PNV 134
            L ++  NL G IP   G +P+L  L L  NSL       GS  SR DL           +
Sbjct: 288  LGMNENNLTGSIP-TFGNVPNLKLLFLHTNSL-------GSDSSR-DLEFLTSLTNCTQL 338

Query: 135  KALSLAYNRFSGTIQSPITN-ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL------ 187
            + L +  NR  G +   I N ++KL  L+LGG   SG IP  IGNL N++ L L      
Sbjct: 339  ETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLS 398

Query: 188  --------------VIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS 233
                           + L  N L+G +P+ I N+++ LE L +SN    G +P  +GN S
Sbjct: 399  GPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTM-LETLDLSNNGFEGIVPTSLGNCS 457

Query: 234  IFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS 293
              L L +  NKL G IP+   ++Q  +L  L + GNS  GS+P   DIG L+ +  ++L 
Sbjct: 458  HLLELWIGDNKLNGTIPLEIMKIQ--QLLRLDMSGNSLIGSLPQ--DIGALQNLGTLSLG 513

Query: 294  RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISL 353
             N  SG +P T+G    ++++ L  N   G IP+  G L  ++ +DLSNN +SG I    
Sbjct: 514  DNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYF 572

Query: 354  EKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG-LPHLQVPQC-------- 404
                 L+ LNLSFN LEG++P  G F N T  S +GN  LCG +   Q+  C        
Sbjct: 573  ASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVV 632

Query: 405  -KHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQATKR 463
             KH +R K     + + I L L   + +V ++ L+    +R K+   +N      +    
Sbjct: 633  KKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLR----KRKKNKETNNPTPSTLEVLHE 688

Query: 464  RLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVEC 522
            ++ Y DL  ATN F   N++G GSFG VYKA L  +   VA+KV + +   AMKSF  EC
Sbjct: 689  KISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAEC 748

Query: 523  EVMKNIRHRNLVKIISGCSNDDF-----KALVLEYMPNGSLDIFLYSSTC--------ML 569
            E +K+IRHRNLVK+++ CS+ DF     +AL+ E+MPNGSLD++L+             L
Sbjct: 749  ESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTL 808

Query: 570  DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
             + +RLNI IDVAS L+YL+     PI HCDLK SNVLLD+D+ AH+SDFG+A+LL   D
Sbjct: 809  TLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFD 868

Query: 630  Q-----SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE 684
            +      ++      TIGY APEYG+  + S   D+YS+GI+L+E FT K+P +++F   
Sbjct: 869  EESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGN 928

Query: 685  LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
             +L  +    LP  ++++V++++L    +      +C+  +F + + C  E P  R+   
Sbjct: 929  FTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATS 988

Query: 745  CCNFVLCEQFVSNSSELYK 763
                ++ ++ +S     +K
Sbjct: 989  ----IVVKELISIRERFFK 1003

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  359 bits (922), Expect = 4e-98,   Method: Compositional matrix adjust.
 Identities = 260/783 (33%), Positives = 378/783 (48%), Gaps = 168/783 (21%)

Query: 78  RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGN------------------NSL 119
           ++  L++S  NL G  P  +G L SL KL   YN + G                   NS 
Sbjct: 170 KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSF 229

Query: 120 SGSLPSRIDLALPNVKALSLAYNRFSGTIQSP-------------------------ITN 154
           SG  P  +   + ++++LSLA N FSG +++                          + N
Sbjct: 230 SGGFPPAL-YNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLAN 288

Query: 155 ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL--------------VIGLIGN------ 194
            S L   ++  N  SG IP + G LRN+ WLG+               IG + N      
Sbjct: 289 ISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEY 348

Query: 195 ------PLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGP 248
                  L G LP+SI NLS +L  L++    I+G IP  +GNL     L LE N L+G 
Sbjct: 349 LDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGE 408

Query: 249 IPVTFGRLQN----------------------SKLDTLSLCGNSFSGSIPSCI------- 279
           +PV+FG+L N                      ++L  L L  NSF G IP  +       
Sbjct: 409 LPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLL 468

Query: 280 ---------------------------------------DIGNLKVVVEINLSRNNFSGD 300
                                                  ++G L+++V +  S N  SG 
Sbjct: 469 DLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528

Query: 301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLK 360
           +P  IGG   ++ + +  N  +G IP+    L SL+ +D SNN +SG I   L  L  L+
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587

Query: 361 KLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG-LPHLQVPQCKHQTRPK-----SSK 414
            LNLS NK EG +P  G F N TA S  GN  +CG +  +Q+  C  Q  P+     S +
Sbjct: 588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647

Query: 415 KMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQAT---KRRLPYQDLS 471
           K ++  I + +++ L+ ++V +L +   R+ K+   S+G    S        ++ Y++L 
Sbjct: 648 KKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNA-SDGNPSDSTTLGMFHEKVSYEELH 706

Query: 472 RATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRH 530
            AT+RF   NLIG G+FG V+K  L  +   VA+KV +     A KSF  ECE  K IRH
Sbjct: 707 SATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRH 766

Query: 531 RNLVKIISGCSN-----DDFKALVLEYMPNGSLDIFLY--------SSTCMLDIFQRLNI 577
           RNLVK+I+ CS+     +DF+ALV E+MP GSLD++L           +  L   ++LNI
Sbjct: 767 RNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNI 826

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ-----SM 632
            IDVASALEYL+     P+ HCD+K SN+LLD+D+ AH+SDFG+A+LL   D+       
Sbjct: 827 AIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQF 886

Query: 633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN 692
           +      TIGY APEYG+  + S + D+YS+GI+L+E F+ KKP D+ FA + +L  +  
Sbjct: 887 SSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK 946

Query: 693 GLL 695
            +L
Sbjct: 947 SIL 949

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  340 bits (872), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 245/768 (31%), Positives = 398/768 (51%), Gaps = 101/768 (13%)

Query: 75   NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
            N H++  L+++   L G IP   G+L  L +L L YN     NSL G+LP  + ++L N+
Sbjct: 502  NCHQLNILDLADNQLSGSIPSSFGFLKGLEQLML-YN-----NSLQGNLPDSL-ISLRNL 554

Query: 135  KALSLAYNRFSGTIQS-----------------------PITNASKLTILELGGNSFSGF 171
              ++L++NR +GTI                          + N+  L  L LG N  +G 
Sbjct: 555  TRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGK 614

Query: 172  IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGN 231
            IP T+G +R +     ++ +  N L G +P  +V L   L  + ++N  ++G IP  +G 
Sbjct: 615  IPWTLGKIRELS----LLDMSSNALTGTIPLQLV-LCKKLTHIDLNNNFLSGPIPPWLGK 669

Query: 232  LSIF------------------------LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLC 267
            LS                          L+L L+ N L G IP   G L    L+ L+L 
Sbjct: 670  LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNL--GALNVLNLD 727

Query: 268  GNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN-ISLPYNRLEGPIP 326
             N FSGS+P  +  G L  + E+ LSRN+ +G+IP  IG L+D+Q+ + L YN   G IP
Sbjct: 728  KNQFSGSLPQAM--GKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIP 785

Query: 327  ESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKS 386
             + G L+ LE LDLS+N+++G +  S+  +  L  LN+SFN L G++ +   F+ + A S
Sbjct: 786  STIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADS 843

Query: 387  FMGNEKLCGLPHLQVPQCKHQTRPK--SSKKMILLVIVLPLSAALIAVVVLALKYKS--- 441
            F+GN  LCG P  +  + +   + +  S++ ++++  +  L+A  + ++V+AL +K    
Sbjct: 844  FLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHD 903

Query: 442  ------------TRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFG 489
                        T    S+  ++  +  + A+K  + ++D+  AT+    + +IG G  G
Sbjct: 904  FFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSG 963

Query: 490  YVYKAELDDGIEVAIK-VFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFK 546
             VYKAEL++G  VA+K +  ++   + KSF  E + +  IRHR+LVK++  CS+  +   
Sbjct: 964  KVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLN 1023

Query: 547  ALVLEYMPNGSLDIFLYSSTC-------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
             L+ EYM NGS+  +L+           +LD   RL I + +A  +EYL+     PI+H 
Sbjct: 1024 LLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHR 1083

Query: 600  DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL--ATIGYMAPEYGIERKVSTR 657
            D+KSSNVLLD +M AHL DFG+AK+L+    + T + T    + GY+APEY    K + +
Sbjct: 1084 DIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEK 1143

Query: 658  SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA 717
            SD+YS GI+L+E  T K P D +F AE+ +  WV   L V+        L+ P  K    
Sbjct: 1144 SDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVA--GSARDKLIDPKLKPLLP 1201

Query: 718  -KEQCVLSIFSLAMECTMELPEKRINAK-CCNFVLCEQFVSNSSELYK 763
             +E     +  +A++CT   P++R +++  C+ +L     +N +  YK
Sbjct: 1202 FEEDAACQVLEIALQCTKTSPQERPSSRQACDSLL--HVYNNRTAGYK 1247

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  334 bits (856), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 246/758 (32%), Positives = 392/758 (51%), Gaps = 102/758 (13%)

Query: 75   NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
            N H++T ++++   L G IP   G+L +L         ++ NNSL G+LP  + + L N+
Sbjct: 503  NCHQMTVIDLADNQLSGSIPSSFGFLTALELF------MIYNNSLQGNLPDSL-INLKNL 555

Query: 135  KALSLAYNRFSGTIQSPITNAS------------------------KLTILELGGNSFSG 170
              ++ + N+F+G+I SP+  +S                         L  L LG N F+G
Sbjct: 556  TRINFSSNKFNGSI-SPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTG 614

Query: 171  FIPNTIGNLRNIEWL--------GLV------------IGLIGNPLNGILPSSIVNLSIS 210
             IP T G +  +  L        G++            I L  N L+G++P+ +  L + 
Sbjct: 615  RIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPL- 673

Query: 211  LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNS 270
            L  L +S+    G++P  + +L+  L L L+ N L G IP   G LQ   L+ L+L  N 
Sbjct: 674  LGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQ--ALNALNLEENQ 731

Query: 271  FSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN-ISLPYNRLEGPIPESF 329
             SG +PS I  G L  + E+ LSRN  +G+IP  IG L+D+Q+ + L YN   G IP + 
Sbjct: 732  LSGPLPSTI--GKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTI 789

Query: 330  GYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMG 389
              L  LE LDLS+N++ G +   +  +  L  LNLS+N LEG++ +   F+ + A +F+G
Sbjct: 790  STLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVG 847

Query: 390  NEKLCGLP--HLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTR---- 443
            N  LCG P  H      K+Q R  S K ++++  +  L+A  + V+V+ L +K       
Sbjct: 848  NAGLCGSPLSHCNRAGSKNQ-RSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFK 906

Query: 444  --RG------------KSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFG 489
              RG            ++   SNGG       K  + + D+  AT+    + +IG G  G
Sbjct: 907  KVRGGNSAFSSNSSSSQAPLFSNGG------AKSDIKWDDIMEATHYLNEEFMIGSGGSG 960

Query: 490  YVYKAELDDGIEVAIK-VFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFK 546
             VYKAEL +G  +A+K +  ++   + KSF  E + +  IRHR+LVK++  CS+  D   
Sbjct: 961  KVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLN 1020

Query: 547  ALVLEYMPNGSLDIFLYSSTC-----MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
             L+ EYM NGS+  +L+++       +L    RL I + +A  +EYL++    PI+H D+
Sbjct: 1021 LLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDI 1080

Query: 602  KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL--ATIGYMAPEYGIERKVSTRSD 659
            KSSNVLLD ++ AHL DFG+AK+L+G   + T++ T+   + GY+APEY    K + +SD
Sbjct: 1081 KSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSD 1140

Query: 660  IYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL---PVSLMEVVNKTLLSPPEKDFA 716
            +YS GI+L+E  T K P + MF  E  +  WV  +L   P S  E   K + S  +    
Sbjct: 1141 VYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGS--EAREKLIDSELKSLLP 1198

Query: 717  AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF 754
             +E+    +  +A++CT   P++R +++  +  L   F
Sbjct: 1199 CEEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNVF 1236

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  327 bits (838), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 247/657 (37%), Positives = 354/657 (53%), Gaps = 39/657 (5%)

Query: 114  VGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIP 173
            VG N L G LP  I      +  LSL  N  SG+I   I N   L  L+LG N  +G +P
Sbjct: 359  VGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLP 418

Query: 174  NTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS 233
             ++G L  +      + L  N L+G +PSS+ N+S  L  LY+ N S  G+IP  +G+ S
Sbjct: 419  PSLGELSELRK----VLLYSNGLSGEIPSSLGNIS-GLTYLYLLNNSFEGSIPSSLGSCS 473

Query: 234  IFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS 293
              L L+L  NKL G IP     L +  L  L++  N   G  P   DIG LK ++ +++S
Sbjct: 474  YLLDLNLGTNKLNGSIPHELMELPS--LVVLNVSFNLLVG--PLRQDIGKLKFLLALDVS 529

Query: 294  RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISL 353
             N  SG IP T+     ++ + L  N   GPIP+  G LT L  LDLS N +SG I   +
Sbjct: 530  YNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYM 588

Query: 354  EKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG-LPHLQVPQCKHQ--TRP 410
                 L+ LNLS N  +G +P  G F N +A S  GN  LCG +P LQ+  C  +   R 
Sbjct: 589  ANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRH 648

Query: 411  KSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLS----QATKRRLP 466
             S +K+I + +   ++A L+  + +        R KS   +N     S    ++   ++ 
Sbjct: 649  SSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKIS 708

Query: 467  YQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECAR-AMKSFEVECEV 524
            Y +L + T  F   NLIG G+FG V+K  L      VAIKV +  C R A KSF  ECE 
Sbjct: 709  YDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAECEA 767

Query: 525  MKNIRHRNLVKIISGCSN-----DDFKALVLEYMPNGSLDIFLY--------SSTCMLDI 571
            +  IRHRNLVK+++ CS+     +DF+ALV E+MPNG+LD++L+        + +  L +
Sbjct: 768  LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGL 827

Query: 572  FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
            F RLNI IDVASAL YL+     PI HCD+K SN+LLD+D+ AH+SDFG+A+LL   D+ 
Sbjct: 828  FARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRD 887

Query: 632  MTQTQ-----TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS 686
                Q        TIGY APEYG+    S   D+YS+GI+L+E FT K+P +K+F   L+
Sbjct: 888  TFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLT 947

Query: 687  LKHWV-NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN 742
            L  +  + L     +++ ++T+L           +C+  +F + + C+ E P  RI+
Sbjct: 948  LHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRIS 1004

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  323 bits (828), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 252/798 (31%), Positives = 393/798 (49%), Gaps = 136/798 (17%)

Query: 68  IGITCDVNSHRVTALNISSLNLQGEIPHEIG-YLPSLTKLALGYNSLVG----------- 115
           + + C+ +S  +  +++S+ +L GEIP     +L  L  L L  N L G           
Sbjct: 157 VQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTN 216

Query: 116 -------NNSLSGSLPSRIDLALPNVKALSLAYNRF----SGTIQSP----ITNASKLTI 160
                  +N LSG LPS++   +P ++ L L+YN F    + T   P    + N+S L  
Sbjct: 217 LKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQE 276

Query: 161 LELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSI----------- 209
           LEL GNS  G I +++   R++    + I L  N ++G +P  I NL             
Sbjct: 277 LELAGNSLGGEITSSV---RHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLL 333

Query: 210 ------------SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQ 257
                        LER+Y+SN  +TG IP  +G++    LLD+  N L+G IP +FG L 
Sbjct: 334 SGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNL- 392

Query: 258 NSKLDTLSLCGNSFSGSIPS----CIDI-----------GNLKVVV---------EINLS 293
            S+L  L L GN  SG++P     CI++           G + V V          +NLS
Sbjct: 393 -SQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLS 451

Query: 294 RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISL 353
            N+ SG IP  +  +  V ++ L  N L G IP   G   +LE L+LS N  S  +  SL
Sbjct: 452 SNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSL 511

Query: 354 EKLLYLKKLNLSFNKLEGEIPRG------------------------GPFANFTAKSFMG 389
            +L YLK+L++SFN+L G IP                          G F+  T +SF+G
Sbjct: 512 GQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLG 571

Query: 390 NEKLCG-LPHLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKST 448
           +  LCG +  +Q  + KH+        ++ L+     +  ++ V    L  +S R GK+ 
Sbjct: 572 DSLLCGSIKGMQACKKKHKYPSVLLPVLLSLI-----ATPVLCVFGYPLVQRS-RFGKNL 625

Query: 449 GLSNGGILLSQATKR-------RLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE 501
            +     +  +  +        R+ YQ L  AT  F   +LIG G FG+VYK  L +  +
Sbjct: 626 TVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTK 685

Query: 502 VAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDI 560
           VA+KV   + A     SF+ EC+++K  RHRNL++II+ CS   F ALVL  MPNGSL+ 
Sbjct: 686 VAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLER 745

Query: 561 FLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS 617
            LY    S+  LD+ Q +NI  DVA  + YL+      ++HCDLK SN+LLD++M A ++
Sbjct: 746 HLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVT 805

Query: 618 DFGIAKLLSGEDQSMTQTQTLA----------TIGYMAPEYGIERKVSTRSDIYSYGIML 667
           DFGI++L+ G +++++   +++          ++GY+APEYG+ ++ ST  D+YS+G++L
Sbjct: 806 DFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 865

Query: 668 IETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL-----LSPPEKDFAAKEQCV 722
           +E  + ++P D +     SL  ++    P SL  ++ + L        PEK      + +
Sbjct: 866 LEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVI 925

Query: 723 LSIFSLAMECTMELPEKR 740
           L +  L + CT   P  R
Sbjct: 926 LEMIELGLVCTQYNPSTR 943

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  310 bits (794), Expect = 3e-83,   Method: Compositional matrix adjust.
 Identities = 232/757 (30%), Positives = 379/757 (50%), Gaps = 124/757 (16%)

Query: 82   LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
            L++S   + GEIP   G + +LT ++      +G N  +G +P  I     N++ LS+A 
Sbjct: 413  LDLSHNQMTGEIPRGFGRM-NLTFIS------IGRNHFTGEIPDDI-FNCSNLETLSVAD 464

Query: 142  NRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILP 201
            N  +GT++  I    KL IL++  NS +G IP  IGNL+++     ++ L  N   G +P
Sbjct: 465  NNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLN----ILYLHSNGFTGRIP 520

Query: 202  SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKL 261
              + NL++ L+ L + +  + G IP+ M ++ +  +LDL  NK +G IP  F +L++  L
Sbjct: 521  REMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLES--L 577

Query: 262  DTLSLCGNSFSGSIPSCI------------------------------------------ 279
              LSL GN F+GSIP+ +                                          
Sbjct: 578  TYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLL 637

Query: 280  ------DIGNLKVVVEINLSRNNFSGDIPATIGGLKDV------QN-------------- 313
                  ++G L++V EI+LS N FSG IP ++   K+V      QN              
Sbjct: 638  TGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGM 697

Query: 314  -----ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNK 368
                 ++L  N   G IP+SFG +T L  LDLS+N ++G I  SL  L  LK L L+ N 
Sbjct: 698  DMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNN 757

Query: 369  LEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMILLVIVL----- 423
            L+G +P  G F N  A   MGN  LCG      P    Q     SK+  +++I+L     
Sbjct: 758  LKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAA 817

Query: 424  --PLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQATK-RRLPYQDLSRATNRFGRD 480
               +   ++ +     K K       + L +    L  A K +R   ++L +AT+ F   
Sbjct: 818  LLLVLLLVLILTCCKKKEKKIENSSESSLPD----LDSALKLKRFEPKELEQATDSFNSA 873

Query: 481  NLIGIGSFGYVYKAELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIIS 538
            N+IG  S   VYK +L+DG  +A+KV +  +  A + K F  E + +  ++HRNLVKI+ 
Sbjct: 874  NIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILG 933

Query: 539  -GCSNDDFKALVLEYMPNGSLDIFLYSSTCML-DIFQRLNIMIDVASALEYLNFRHTTPI 596
                +   KALVL +M NG+L+  ++ S   +  + +++++ + +AS ++YL+  +  PI
Sbjct: 934  FAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPI 993

Query: 597  IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA---TIGYMAPEYGIERK 653
            +HCDLK +N+LLD D +AH+SDFG A++L   +   T   T A   TIGY+APE+   RK
Sbjct: 994  VHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRK 1053

Query: 654  VSTRSDIYSYGIMLIETFTRKKPA--DKMFAAELSLKHWV--------NGLLPVSLMEVV 703
            V+T++D++S+GI+++E  T+++P   +   + +++L+  V         G++ V  ME+ 
Sbjct: 1054 VTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELG 1113

Query: 704  NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
            +  +          +E+ +     L + CT   PE R
Sbjct: 1114 DSIV-------SLKQEEAIEDFLKLCLFCTSSRPEDR 1143

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  297 bits (761), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 231/706 (32%), Positives = 353/706 (50%), Gaps = 56/706 (7%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALS 138
           + +LN+   NL+GE+P  I   P+L      Y   +  N L+G LP  + L  P ++ L 
Sbjct: 302 LESLNLYENNLEGELPASIALSPNL------YEIRIFGNRLTGGLPKDLGLNSP-LRWLD 354

Query: 139 LAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG 198
           ++ N FSG + + +    +L  L +  NSFSG IP ++ + R++      I L  N  +G
Sbjct: 355 VSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLT----RIRLAYNRFSG 410

Query: 199 ILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN 258
            +P+    L   +  L + N S +G I + +G  S   LL L  N+ TG +P   G L N
Sbjct: 411 SVPTGFWGLP-HVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDN 469

Query: 259 SKLDTLSLCGNSFSGSIP-SCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLP 317
             L+ LS  GN FSGS+P S + +G L     ++L  N FSG++ + I   K +  ++L 
Sbjct: 470 --LNQLSASGNKFSGSLPDSLMSLGELGT---LDLHGNQFSGELTSGIKSWKKLNELNLA 524

Query: 318 YNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGG 377
            N   G IP+  G L+ L  LDLS N  SG I +SL+ L  L +LNLS+N+L G++P   
Sbjct: 525 DNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSL-KLNQLNLSYNRLSGDLPPS- 582

Query: 378 PFANFTAKSFMGNEKLCG-LPHLQVPQCKHQTRPKSSKKMILL--VIVLPLSAALIAVVV 434
              +    SF+GN  LCG +  L    C  +   K    + LL  + VL     L  V  
Sbjct: 583 LAKDMYKNSFIGNPGLCGDIKGL----CGSENEAKKRGYVWLLRSIFVLAAMVLLAGVAW 638

Query: 435 LALKYKSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA 494
              KY++ ++ ++   S   ++    +  +L + +          DN+IG G+ G VYK 
Sbjct: 639 FYFKYRTFKKARAMERSKWTLM----SFHKLGFSE-HEILESLDEDNVIGAGASGKVYKV 693

Query: 495 ELDDGIEVAIKVFHQECARAM---------------KSFEVECEVMKNIRHRNLVKIISG 539
            L +G  VA+K       +                 ++FE E E +  IRH+N+VK+   
Sbjct: 694 VLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCC 753

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
           CS  D K LV EYMPNGSL   L+SS   ML    R  I++D A  L YL+     PI+H
Sbjct: 754 CSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVH 813

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTR 657
            D+KS+N+L+D D  A ++DFG+AK +    ++      +A + GY+APEY    +V+ +
Sbjct: 814 RDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEK 873

Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA 717
           SDIYS+G++++E  TRK+P D     E  L  WV   L    +E V       P+ D   
Sbjct: 874 SDIYSFGVVILEIVTRKRPVDPEL-GEKDLVKWVCSTLDQKGIEHVID-----PKLDSCF 927

Query: 718 KEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELYK 763
           KE+ +  I ++ + CT  LP  R + +    +L E    +   L+K
Sbjct: 928 KEE-ISKILNVGLLCTSPLPINRPSMRRVVKMLQEIGGGDEDSLHK 972

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  292 bits (747), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 233/717 (32%), Positives = 365/717 (50%), Gaps = 81/717 (11%)

Query: 78   RVTALNISSLN---LQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
            ++T+L++ +LN    QG+IP E+G   SLT L LG      +N+L G +P +I  AL  +
Sbjct: 494  KLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLG------SNNLQGQIPDKIT-ALAQL 546

Query: 135  KALSLAYNRFSGTIQSP------------ITNASKLTILELGGNSFSGFIPNTIGNLRNI 182
            + L L+YN  SG+I S             ++      I +L  N  SG IP  +G     
Sbjct: 547  QCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELG----- 601

Query: 183  EWLGLV-IGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLE 241
            E L LV I L  N L+G +P+S+  L+ +L  L +S  ++TG+IP+ MGN      L+L 
Sbjct: 602  ECLVLVEISLSNNHLSGEIPASLSRLT-NLTILDLSGNALTGSIPKEMGNSLKLQGLNLA 660

Query: 242  LNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDI 301
             N+L G IP +FG L    L  L+L  N   G +P+   +GNLK +  ++LS NN SG++
Sbjct: 661  NNQLNGHIPESFGLL--GSLVKLNLTKNKLDGPVPA--SLGNLKELTHMDLSFNNLSGEL 716

Query: 302  PATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKK 361
             + +  ++ +  + +  N+  G IP   G LT LE LD+S N +SG I   +  L  L+ 
Sbjct: 717  SSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEF 776

Query: 362  LNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQ-TRPKSSKKMILLV 420
            LNL+ N L GE+P  G   + +     GN++LCG   +    CK + T+ +S+  +  L+
Sbjct: 777  LNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCG--RVVGSDCKIEGTKLRSAWGIAGLM 834

Query: 421  IVLPLSAALIAVVVLALK-YKSTRRGKS------------TGLSNGGILLSQATKRRLPY 467
            +   +   ++ V V +L+ +  T+R K              G  +  +     ++ R P 
Sbjct: 835  LGFTI---IVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPL 891

Query: 468  Q----------------DLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC 511
                             D+  AT+ F + N+IG G FG VYKA L     VA+K   +  
Sbjct: 892  SINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAK 951

Query: 512  ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI 571
             +  + F  E E +  ++H NLV ++  CS  + K LV EYM NGSLD +L + T ML++
Sbjct: 952  TQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEV 1011

Query: 572  F---QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
                +RL I +  A  L +L+      IIH D+K+SN+LLD D    ++DFG+A+L+S  
Sbjct: 1012 LDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISA- 1070

Query: 629  DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--S 686
             +S   T    T GY+ PEYG   + +T+ D+YS+G++L+E  T K+P    F      +
Sbjct: 1071 CESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGN 1130

Query: 687  LKHW-VNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN 742
            L  W +  +     ++V++  L+S       A +   L +  +AM C  E P KR N
Sbjct: 1131 LVGWAIQKINQGKAVDVIDPLLVS------VALKNSQLRLLQIAMLCLAETPAKRPN 1181

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  287 bits (735), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 227/712 (31%), Positives = 336/712 (47%), Gaps = 108/712 (15%)

Query: 89   LQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTI 148
            L GEIP E+ YL +L  L L +N L      +G +P+ +      +  +SL+ N+ SG I
Sbjct: 487  LSGEIPQELMYLQALENLILDFNDL------TGPIPASLS-NCTKLNWISLSNNQLSGEI 539

Query: 149  QSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIV--- 205
             + +   S L IL+LG NS SG IP  +GN +++ WL L      N LNG +P  +    
Sbjct: 540  PASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNT----NFLNGSIPPPLFKQS 595

Query: 206  -NLSISL----ERLYISN-----CSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGR 255
             N++++L      +YI N     C   GN+ +  G      +   +L++++   P  F R
Sbjct: 596  GNIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGG------IRQEQLDRISTRHPCNFTR 649

Query: 256  L----------QNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI 305
            +           N  +  L L  N   GSIP   ++G +  +  +NL  N+ SG IP  +
Sbjct: 650  VYRGITQPTFNHNGSMIFLDLSYNKLEGSIPK--ELGAMYYLSILNLGHNDLSGMIPQQL 707

Query: 306  GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLS 365
            GGLK+V  + L YNR  G IP S   LT L  +DLSNN +SG                  
Sbjct: 708  GGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGM----------------- 750

Query: 366  FNKLEGEIPRGGPFANFTAKSFMGNEKLCG----LPHLQVPQCKHQTRPKSSKKMILLV- 420
                   IP   PF  F    F  N  LCG    LP    P+       KS ++   L  
Sbjct: 751  -------IPESAPFDTFPDYRF-ANNSLCGYPLPLPCSSGPKSDANQHQKSHRRQASLAG 802

Query: 421  -IVLPLSAALIAV---VVLALKYKSTRRGKSTGL------------SNGGILLSQATK-- 462
             + + L  +L  +   +++A++ K  RR K   L            +N     + A +  
Sbjct: 803  SVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAWKFTSAREAL 862

Query: 463  -----------RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC 511
                       R+L + DL  ATN F  D+L+G G FG VYKA+L DG  VAIK      
Sbjct: 863  SINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVS 922

Query: 512  ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS---STCM 568
             +  + F  E E +  I+HRNLV ++  C   + + LV EYM  GSL+  L+    +   
Sbjct: 923  GQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIK 982

Query: 569  LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
            L+   R  I I  A  L +L+      IIH D+KSSNVLLDE++ A +SDFG+A+L+S  
Sbjct: 983  LNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAM 1042

Query: 629  DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
            D  ++ +    T GY+ PEY    + ST+ D+YSYG++L+E  T K+P D     + +L 
Sbjct: 1043 DTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLV 1102

Query: 689  HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
             WV       + +V ++ LL    K+ A+ E  +L    +A  C  +   KR
Sbjct: 1103 GWVKLHAKGKITDVFDRELL----KEDASIEIELLQHLKVACACLDDRHWKR 1150

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	763
224116832	1061	predicted protein [Populus trichocarpa]	0.871	0.626	0.456	1e-173
359485453	1202	PREDICTED: probable LRR receptor-like se	0.851	0.540	0.460	1e-168
255572272	1089	serine-threonine protein kinase, plant-t	0.867	0.607	0.447	1e-165
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.855	0.459	0.450	1e-165
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.853	0.447	0.442	1e-165
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.847	0.618	0.444	1e-163
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.853	0.571	0.451	1e-162
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.871	0.551	0.440	1e-162
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.853	0.529	0.443	1e-161
224139658	1019	predicted protein [Populus trichocarpa]	0.853	0.638	0.433	1e-160

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  615 bits (1587), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 356/779 (45%), Positives = 463/779 (59%), Gaps = 114/779 (14%)

Query: 75   NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGN------------------ 116
            N   +  +++ + NL G IP+E+G L +L +L LG+N++ G+                  
Sbjct: 257  NCTYLMEIHVENNNLTGVIPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAY 316

Query: 117  NSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTI 176
            N LSG LPS   L LPN++ L L  N  SG I   I NASKL +L+L  NSFSG IP+ +
Sbjct: 317  NYLSGHLPSNTGLGLPNLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLL 376

Query: 177  GNLRNIEWLGLVIGLI---------------------------GNPLNGILPSSIVNLSI 209
            GNLRN++ L L   ++                           GNPL G LP SI NLS 
Sbjct: 377  GNLRNLQKLNLAENILTSKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSA 436

Query: 210  SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN----------- 258
            SLE LY  +C I GNIP+ +GNLS  + L L+ N+LTG IP   GRL++           
Sbjct: 437  SLEELYAFDCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKL 496

Query: 259  -----------SKLDTLSLCGNSFSGSIPSC----------------------------- 278
                        +L  L L  N FSGS+P+C                             
Sbjct: 497  QGHIPNEICHLERLSYLYLLENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKD 556

Query: 279  ----------------IDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLE 322
                            ++IGNLKVV  I+ S N  SGDIP +I  L+++ + SL  NR++
Sbjct: 557  LLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQ 616

Query: 323  GPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANF 382
            GPIP SFG L SLE LDLS N +SG I  SLEKL++LK  N+SFN+L+GEI  GGPFANF
Sbjct: 617  GPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANF 676

Query: 383  TAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKST 442
            + +SFM NE LCG   +QVP CK  +  + SK+    VI   + A    ++VLAL     
Sbjct: 677  SFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIF 736

Query: 443  RRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEV 502
            RR     LS     L  AT R++ Y +L RAT  F   NL+G GS G VYK  L DG+ +
Sbjct: 737  RRSHKRKLSTQEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCI 796

Query: 503  AIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL 562
            A+KVFH +    +  F+ ECEV++ +RHRNLVKIIS C N DFKAL+LE++P+GSL+ +L
Sbjct: 797  AVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWL 856

Query: 563  YSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA 622
            YS    LDI QRLNIMIDVASALEYL+   T P++HCDLK SNVL++EDM+AH+SDFGI+
Sbjct: 857  YSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGIS 916

Query: 623  KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFA 682
            +LL GE  ++TQT TLATIGYMAPEYG+E  VS + D+YSYGI L+ETFTRKKP D MF 
Sbjct: 917  RLL-GEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFG 975

Query: 683  AELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI 741
             E+SLK+WV   LP ++ EV++  LL   E+ F AK+ C+ SI +LA+EC+ +LP +RI
Sbjct: 976  GEMSLKNWVKQSLPKAITEVIDANLLI-EEEHFVAKKDCITSILNLALECSADLPGERI 1033

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  600 bits (1547), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 353/767 (46%), Positives = 455/767 (59%), Gaps = 117/767 (15%)

Query: 91   GEIPHEIGYLPSLTKLALGYNSLVG------------------NNSLSGSLPSRIDLALP 132
            G IP E+G L +L  L+L  N+L G                   N LSGSLPS I   LP
Sbjct: 421  GNIPKELGNLVNLQFLSLNVNNLTGIVPEAIFNISKLQVLSLAGNHLSGSLPSSIGSWLP 480

Query: 133  NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL----- 187
            N++ L +  N FSG I   I+N S L  L++  N F G +P  +GNLR ++ LGL     
Sbjct: 481  NLEQLLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQL 540

Query: 188  ----------------------VIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNI 225
                                   + +  NPL G++P+S+ NLSISLE +Y S+C + G I
Sbjct: 541  TNEHSASELAFLTSLTNCIFLRTLSISDNPLKGMIPNSLGNLSISLEIIYASDCQLRGTI 600

Query: 226  PQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN----------------------SKLDT 263
            P  + NL+  + L L+ N LTG IP  FGRLQ                       + L  
Sbjct: 601  PTGISNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAF 660

Query: 264  LSLCGNSFSGSIPSC--------------------------------------------- 278
            L L  N  SG+IPSC                                             
Sbjct: 661  LDLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQL 720

Query: 279  -IDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEI 337
             + +GN+K +V ++LS+N FSG+IP+TI  L+++  + L +N+L+G IP +FG L SLE 
Sbjct: 721  PLQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLES 780

Query: 338  LDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP 397
            LDLS N +SG I  SLE L YL+ LN+SFNKL+GEIP GGPFANFTA+SF+ N  LCG P
Sbjct: 781  LDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAP 840

Query: 398  HLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILL 457
              QV  C+  +R K++K ++L  IV PLS +L  ++++ L  +  RR   +       L 
Sbjct: 841  RFQVMACEKDSR-KNTKSLLLKCIV-PLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLS 898

Query: 458  SQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKS 517
                 R +P+Q+L  ATN FG DNLIG GS G VYK  L DG+ VA+KVF+ E   A KS
Sbjct: 899  LPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKS 958

Query: 518  FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
            FEVECEVM+NIRHRNL KIIS CSN DFKALVLEYMPNGSL+ +LYS    LD  QRL I
Sbjct: 959  FEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKI 1018

Query: 578  MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            MIDVAS LEYL+  ++ P++HCDLK SNVLLD+DM+AH+SDFGIAKLL G  + M +T+T
Sbjct: 1019 MIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMG-SEFMKRTKT 1077

Query: 638  LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV 697
            L T+GYMAPEYG E  VST+ DIYSYGI+L+ETF RKKP D+MF  EL+LK WV      
Sbjct: 1078 LGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESSTN- 1136

Query: 698  SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
            ++MEV++  LL+  ++ FA K  C  SI +LA++CT+E PEKRIN K
Sbjct: 1137 NIMEVIDANLLTEEDESFALKRACFSSIMTLALDCTVEPPEKRINTK 1183

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  588 bits (1517), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 354/791 (44%), Positives = 462/791 (58%), Gaps = 129/791 (16%)

Query: 75   NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGN------------------ 116
            N  ++  L++   NL G IP EIG L +L  + L +N+L G+                  
Sbjct: 286  NLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTS 345

Query: 117  NSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTI 176
            N+L G+LP+ + L LPN+  L L  N+ SG I S I+NASKLTILEL  NSF+GFIP+++
Sbjct: 346  NNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSL 405

Query: 177  GNLRNIEWLGLVIGLIG---------------------------NPLNGILPSSIVNLSI 209
            G+LRN++ L L   L+                            NPL+G LP S+ NLS 
Sbjct: 406  GDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSN 465

Query: 210  SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSK--------- 260
            SLE    S+  I G++ + +GNLS    L+L  N LTG IP T G L++ +         
Sbjct: 466  SLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDL 525

Query: 261  -------------LDTLSLCGNSFSGSIPSCI---------------------------- 279
                         L  L L GN  SGSIP+C                             
Sbjct: 526  DGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLK 585

Query: 280  ------------------DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRL 321
                              +I NL+ V  IN+S+N  SG+IP +IGGL+D+  + L  N+L
Sbjct: 586  DILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKL 645

Query: 322  EGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFAN 381
            +GPIP+S G + SLE LDLS+N +SG I  SL+ LLYLK  N+SFN L+GEIP GG F+N
Sbjct: 646  QGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSN 705

Query: 382  FTAKSFMGNEKLCGLPHLQVPQCK----HQTRPKSSKKMILLVIVLPLSAALIAVVVLA- 436
            F+A+SF+GNE LCG   LQV  CK      T    SK  I+L  VLP  A + AV VLA 
Sbjct: 706  FSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSK--IVLRYVLP--AIVFAVFVLAF 761

Query: 437  ---LKYKSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYK 493
               LK    R+ K    S     L+  T RR+ Y +L  ATN F   N +G+GSFG VYK
Sbjct: 762  VIMLKRYCERKAK---FSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYK 818

Query: 494  AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM 553
              L DG  +A KVF+ +  RA KSF+ ECEV++N+RHRNLVKII+ CS  +FKALVLE+M
Sbjct: 819  GTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFM 878

Query: 554  PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
            PN SL+ +LYS    L+  QRLNIM+DVAS LEYL+  +T P+ HCD+K SNVLL+EDM+
Sbjct: 879  PNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMV 938

Query: 614  AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR 673
            A L+DFGI+KLL GE+ S+ QT TLATIGYMAPEYG E  VS R D+YSYG++L+ETFT+
Sbjct: 939  AFLADFGISKLL-GEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQ 997

Query: 674  KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECT 733
            KKP DKMF  +LSLK WV   L   + +V++  LL   E   AAK+ C++SI  LA++C+
Sbjct: 998  KKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQCS 1057

Query: 734  MELPEKRINAK 744
             +LP  RI+ K
Sbjct: 1058 ADLPHDRIDMK 1068

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  588 bits (1516), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 347/770 (45%), Positives = 450/770 (58%), Gaps = 117/770 (15%)

Query: 88   NLQGEIPHEIGYLPSLTKLALGYNSLVG------------------NNSLSGSLPSRIDL 129
            N+QG IP+E+G L +L  L L  N+L G                   N  SGSLPS I  
Sbjct: 419  NIQGNIPNELGNLINLQNLKLSVNNLTGIIPEAIFNISKLQTLXLAQNHFSGSLPSSIGT 478

Query: 130  ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL-- 187
             LP+++ L++  N FSG I   I+N S+LT+L++  N F+G +P  +GNLR +E+L L  
Sbjct: 479  QLPDLEGLAIGXNEFSGIIPMSISNMSELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGF 538

Query: 188  ----------VIGLI---------------GNPLNGILPSSIVNLSISLERLYISNCSIT 222
                       +G +                NPL GILP+S+ NLSISLE    S C   
Sbjct: 539  NQLTDEHSTSEVGFLTSLTNCKFLRRLWIEDNPLKGILPNSLGNLSISLESFDASACQFK 598

Query: 223  GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN----------------------SK 260
            G IP  +GNL   + L L  N LTG IP++FG LQ                         
Sbjct: 599  GTIPTGIGNLINLIDLRLNDNDLTGLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRN 658

Query: 261  LDTLSLCGNSFSGSIPSC------------------------------------------ 278
            L  L L  N  SG+IP C                                          
Sbjct: 659  LGYLDLSSNKLSGTIPGCFGNLTALRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLN 718

Query: 279  ----IDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTS 334
                +++GN+K ++ ++LS+N FSG+IP+TI  L+++  + L +N+L+G +P +FG L S
Sbjct: 719  CQLPLEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVS 778

Query: 335  LEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLC 394
            LE LDLS N  SG I  SLE L YLK LN+SFNKL+GEIP  GPFANFTA+SF+ N  LC
Sbjct: 779  LEYLDLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALC 838

Query: 395  GLPHLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGG 454
            G P  QV  C+   R  +  K +LL  ++PLS +L  ++++ L     RR   +      
Sbjct: 839  GAPRFQVMACEKDARRNT--KSLLLKCIVPLSVSLSTMILVVLFTLWKRRQTESESPVQV 896

Query: 455  ILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARA 514
             LL     R + +Q+L  AT+ FG +NLIG GS G VYK  L DG+ VA+KVF+ E   A
Sbjct: 897  DLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGA 956

Query: 515  MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR 574
             KSFEVECEVM+NIRHRNL KIIS CSN DFKALVLEYMPN SL+ +LYS    LD  QR
Sbjct: 957  FKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQR 1016

Query: 575  LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ 634
            L IMIDVAS LEYL+  ++ P++HCDLK SNVLLD+DM+AH+SDFGIAKLL G  + M +
Sbjct: 1017 LKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGS-EFMKR 1075

Query: 635  TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
            T+TL TIGYMAPEYG E  VST+ D YSYGI+L+E F RKKP D+MF  EL+LK WV   
Sbjct: 1076 TKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFVRKKPTDEMFVEELTLKSWVES- 1134

Query: 695  LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
               ++MEV++  LL+  ++ FA K+ C  SI +LA++CT+E PEKRIN K
Sbjct: 1135 SANNIMEVIDANLLTEEDESFALKQACFSSIMTLALDCTIEPPEKRINMK 1184

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  587 bits (1514), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 342/773 (44%), Positives = 456/773 (58%), Gaps = 122/773 (15%)

Query: 88   NLQGEIPHEIGYLPSLTKLALGYNSLVG------------------NNSLSGSLPSRIDL 129
            N+QG IP+E+G L +L  L L  N+L G                   N  SGSLPS +  
Sbjct: 673  NIQGNIPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGT 732

Query: 130  ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL-- 187
             LP+++ L++  N FSG I   I+N S+LT L++  N F+G +P  +GNLR +E+L L  
Sbjct: 733  QLPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGS 792

Query: 188  -------------------------VIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT 222
                                      + +  NPL GILP+S+ NLSISLE    S C   
Sbjct: 793  NQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPNSLGNLSISLESFDASACQFR 852

Query: 223  GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGN------------- 269
            G IP  +GNL+  + L+L  N LTG IP T G+L+  KL  L + GN             
Sbjct: 853  GTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLK--KLQELGIAGNRLRGSIPNDLCRL 910

Query: 270  -----------SFSGSIPSCI--------------------------------------- 279
                         +GSIPSC+                                       
Sbjct: 911  KNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNF 970

Query: 280  -------DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYL 332
                   ++GN+K +  ++LS+N  SG IP T+G L++++++SL  NRL+GPIP  FG L
Sbjct: 971  LTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDL 1030

Query: 333  TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEK 392
             SL+ LDLS N +SG I  SL+ L YLK LN+SFNKL+GEIP GGPF NFTA+SF+ NE 
Sbjct: 1031 LSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEA 1090

Query: 393  LCGLPHLQVPQCKHQTRPKSSK-KMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLS 451
            LCG PH QV  C   TR +S + K+ +L  +LP   ++I +VV  + +   RR K+  + 
Sbjct: 1091 LCGAPHFQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLW--IRRRKNLEVP 1148

Query: 452  NGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC 511
                     +  ++ +Q L  ATN FG DNLIG GS   VYK  L +G+ VA+KVF+ E 
Sbjct: 1149 TPIDSWLPGSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEF 1208

Query: 512  ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI 571
              A +SF+ ECEVM++IRHRNLVKII+ CSN DFKALVLEYMP GSLD +LYS    LD+
Sbjct: 1209 QGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDL 1268

Query: 572  FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
             QRLNIMIDVASALEYL+    + ++HCDLK +N+LLD+DM+AH+ DFGIA+LL+ E +S
Sbjct: 1269 IQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLT-ETES 1327

Query: 632  MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV 691
            M QT+TL TIGYMAPEYG +  VST+ D++SYGIML+E F RKKP D+MF  +L+LK WV
Sbjct: 1328 MQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV 1387

Query: 692  NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
              L   S++EVV+  LL   ++DFA K  C+ SI +LA+ CT + PE+RI+ K
Sbjct: 1388 ESLAD-SMIEVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEERIDMK 1439

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  581 bits (1498), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 347/781 (44%), Positives = 450/781 (57%), Gaps = 134/781 (17%)

Query: 91   GEIPHEIGYLPSLTKLALGYNSLVGN----------------------------NSLSGS 122
            G IP EIG L  L ++ L  NSL+G+                            N LSGS
Sbjct: 258  GSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLSFNISKLQTLGLVQNHLSGS 317

Query: 123  LPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNI 182
            LPS I   LP+++ L +  N FSGTI   I+N SKLT+L L  NSF+G +P  + NL  +
Sbjct: 318  LPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKL 377

Query: 183  EWLGLV------------IGLIG---------------NPLNGILPSSIVNLSISLERLY 215
            ++L L             +G +                NPL G LP+S+ NL I+LE   
Sbjct: 378  QFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNLWIGYNPLTGTLPNSLGNLPIALEIFI 437

Query: 216  ISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGN------ 269
             S C   G IP  +GNL+  + LDL  N LTG IP T G+LQ  KL  LS+ GN      
Sbjct: 438  ASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQ--KLQALSIVGNRIRGSI 495

Query: 270  ------------------SFSGSIPSCI-------------------------------- 279
                                SGSIPSC                                 
Sbjct: 496  PNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLV 555

Query: 280  --------------DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPI 325
                          ++GN+K +  ++LS+N  SG IP+ +G L+++  +SL  N+L+GPI
Sbjct: 556  LNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPI 615

Query: 326  PESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAK 385
            P  FG L SLE LDLS N +SG I  +LE L+YLK LN+SFNKL+GEIP GGPF  FTA+
Sbjct: 616  PVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAE 675

Query: 386  SFMGNEKLCGLPHLQVPQCKHQTRPKS--SKKMILLVIVLPLSAALIAVVVLALKYKSTR 443
            SFM NE LCG PH QV  C    R +S  +K  IL  I+LP+ + +  VV + L     R
Sbjct: 676  SFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLW---IR 732

Query: 444  RGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVA 503
            R  +  +          T  ++ +Q L  ATN FG DNLIG GS G VYK  L +G+ VA
Sbjct: 733  RRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVA 792

Query: 504  IKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY 563
            IKVF+ E   A++SF  ECEVM+ IRHRNLV+II+ CSN DFKALVL+YMPNGSL+  LY
Sbjct: 793  IKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKLLY 852

Query: 564  SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK 623
            S    LD+ QRLNIMIDVASALEYL+   ++ ++HCDLK SNVLLD+DM+AH++DFGIAK
Sbjct: 853  SHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAK 912

Query: 624  LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA 683
            LL+ E +SM QT+TL+TIGYMAPE+G    VST+SD+YSYGI+L+E F RKKP D+MF  
Sbjct: 913  LLT-ETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFTG 971

Query: 684  ELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA 743
            +L+LK WV   L  S+++VV+  LL   ++D A K  C+ SI +LA+ CT + PE+RI+ 
Sbjct: 972  DLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTTDSPEERIDM 1030

Query: 744  K 744
            K
Sbjct: 1031 K 1031

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  578 bits (1489), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 348/771 (45%), Positives = 444/771 (57%), Gaps = 120/771 (15%)

Query: 89   LQGEIPHEIGYLPSLTKLALGYNSLVGN------------------NSLSGSLPSRIDLA 130
            L G IP   G L +L  L LG N+L G                   N LSGSLPS I   
Sbjct: 360  LIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTW 419

Query: 131  LPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLV-- 188
            LP+++ L +A N FSG I   I+N SKLT+L L  NSF+G +P  +GNL  ++ L L   
Sbjct: 420  LPDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGN 479

Query: 189  ----------IGL--------------IGN-PLNGILPSSIVNLSISLERLYISNCSITG 223
                      +G               IGN P  G LP+S+ NL I+LE    S C   G
Sbjct: 480  QLTDEHVASEVGFLTSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRG 539

Query: 224  NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN----------------------SKL 261
             IP  +GNL+  + LDL  N LTG IP T G+LQ                         L
Sbjct: 540  TIPTGIGNLTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDL 599

Query: 262  DTLSLCGNSFSGSIPSCI------------------------------------------ 279
              L L  N  SGSIPSC                                           
Sbjct: 600  GYLFLSSNKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTG 659

Query: 280  ----DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL 335
                ++GN+K +  ++LS+N  SG IP+ +G L+ +  +SL  NRL+GPIP  FG L SL
Sbjct: 660  NLPPEVGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSL 719

Query: 336  EILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG 395
            E LDLS N +SG I  SLE L+YLK LN+S NKL+GEIP GGPF NFTA+SFM NE LCG
Sbjct: 720  ESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCG 779

Query: 396  LPHLQVPQCKHQTRPKS--SKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNG 453
             PH QV  C    R +S  +K  IL  I+LP+ + +  VV + L     RR  +  +   
Sbjct: 780  APHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLW---IRRRDNMEIPTP 836

Query: 454  GILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR 513
                   T  ++ +Q L  ATN FG DNLIG GS G VYK  L +G+ VAIKVF+ E   
Sbjct: 837  IDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQG 896

Query: 514  AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQ 573
            A++SF+ ECEVM+ IRHRNLV+II+ CSN DFKALVLEYMPNGSL+ +LYS    LD+ Q
Sbjct: 897  ALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQ 956

Query: 574  RLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT 633
            RLNIMIDVASALEYL+   ++ ++HCDLK +NVLLD+DM+AH++DFGI KLL+ + +SM 
Sbjct: 957  RLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQ 1015

Query: 634  QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
            QT+TL TIGYMAPE+G +  VST+SD+YSYGI+L+E F+RKKP D+MF   L+LK WV  
Sbjct: 1016 QTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWVES 1075

Query: 694  LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
             L  S+++VV+  LL   ++D A K  C+ SI +LA+ CT   PEKR+N K
Sbjct: 1076 -LSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTNSPEKRLNMK 1125

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  578 bits (1489), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 346/785 (44%), Positives = 451/785 (57%), Gaps = 120/785 (15%)

Query: 75   NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG------------------N 116
            N  ++  +++ S +L G IP   G L +L  L LG N L G                   
Sbjct: 411  NLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTVPEAIFNISELQNLALVQ 470

Query: 117  NSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTI 176
            N LSGSLPS I   LP+++ L +  N FSGTI   I+N SKLT+L L  NSF+G +P  +
Sbjct: 471  NHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDL 530

Query: 177  GNLRNIEWLGLV------------IGLIG---------------NPLNGILPSSIVNLSI 209
             NL  +++L L             +G +                NPL G LP+S+ NL I
Sbjct: 531  CNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPLKGTLPNSLGNLPI 590

Query: 210  SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN----------- 258
            +LE      C   G IP  +GNL+  + LDL  N LTG IP T GRLQ            
Sbjct: 591  ALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKLQRLHIAGNRI 650

Query: 259  -----------SKLDTLSLCGNSFSGSIPSCI---------------------------- 279
                         L  L L  N  SGS PSC                             
Sbjct: 651  RGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLR 710

Query: 280  ------------------DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRL 321
                              ++GN+K +  ++LS+N  SG IP+ +G L+ +  +SL  NRL
Sbjct: 711  DLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYLITLSLSQNRL 770

Query: 322  EGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFAN 381
            +GPI   FG L SLE LDLS+N +SG I  SLE L+YLK LN+SFNKL+GEIP GGPF  
Sbjct: 771  QGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVK 830

Query: 382  FTAKSFMGNEKLCGLPHLQVPQCKHQTRPKS--SKKMILLVIVLPLSAALIAVVVLALKY 439
            FTA+SFM NE LCG PH QV  C    R +S  +K  IL  I+LP+ + +  VV + L  
Sbjct: 831  FTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWI 890

Query: 440  KSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDG 499
            +     +     +  +L    T  ++ +Q L  ATN FG DNLIG GS G VYK  L +G
Sbjct: 891  RRRDNMEIPTPIDSWLL---GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNG 947

Query: 500  IEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLD 559
            + VAIKVF+ E   A++SF+ ECEVM+ IRHRNLV+II+ CSN DFKALVLEYMPNGSL+
Sbjct: 948  LNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLE 1007

Query: 560  IFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF 619
             +LYS    LD+ QRLNIMIDVASALEYL+   ++ ++HCDLK SNVLLD+DM+AH++DF
Sbjct: 1008 KWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADF 1067

Query: 620  GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK 679
            GIAKLL+ E +SM QT+TL TIGYMAPE+G    VST+SD+YSYGI+L+E F RKKP D+
Sbjct: 1068 GIAKLLT-ETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDE 1126

Query: 680  MFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEK 739
            MF  +L+LK WV   L  S+++VV+  LL   ++D A K  C+ SI +LA+ CT + P++
Sbjct: 1127 MFTGDLTLKTWVES-LSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTTDSPKE 1185

Query: 740  RINAK 744
            RI+ K
Sbjct: 1186 RIDMK 1190

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  575 bits (1481), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 342/771 (44%), Positives = 443/771 (57%), Gaps = 120/771 (15%)

Query: 89   LQGEIPHEIGYLPSLTKLALGYNSLVGN------------------NSLSGSLPSRIDLA 130
            L G IP   G L +L  L LG N+L G                   N LSGSLPS I   
Sbjct: 449  LIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTW 508

Query: 131  LPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLV-- 188
            L +++ L +A N FSG I   I+N SKLT+L L  NSF+G +P  +GNL  ++ L L   
Sbjct: 509  LSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGN 568

Query: 189  ----------IGLI---------------GNPLNGILPSSIVNLSISLERLYISNCSITG 223
                      +G +                NP  G LP+S+ NL I+LE    S C   G
Sbjct: 569  QLTDEHVASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRG 628

Query: 224  NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN----------------------SKL 261
             IP  +GNL+  + LDL  N LTG IP T GRL+                         L
Sbjct: 629  TIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNL 688

Query: 262  DTLSLCGNSFSGSIPSCI------------------------------------------ 279
              L L  N  SGSIPSC                                           
Sbjct: 689  GYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTG 748

Query: 280  ----DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL 335
                ++GN+K +  ++LS+N  SG IP  +G  +++  +SL  N+L+GPIP  FG L SL
Sbjct: 749  NLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSL 808

Query: 336  EILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG 395
            E LDLS N +SG I  SLE L+YLK LN+S NKL+GEIP GGPF NFTA+SFM NE LCG
Sbjct: 809  ESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCG 868

Query: 396  LPHLQVPQCKHQTRPKS--SKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNG 453
             PH QV  C    R +S  +K  IL  I+LP+ + +  VV + L     RR  +  +   
Sbjct: 869  APHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLW---IRRRDNMEIPTP 925

Query: 454  GILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR 513
                   T  ++ +Q L  ATN FG DNLIG GS G VYK  L +G+ VAIKVF+ E   
Sbjct: 926  IDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQG 985

Query: 514  AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQ 573
            A++SF+ ECEVM+ IRHRNLV+II+ CSN DFKALVLEYMPNGSL+ +LYS    LD+ Q
Sbjct: 986  ALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQ 1045

Query: 574  RLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT 633
            RLNIMIDVASALEYL+   ++ ++HCDLK +NVLLD+DM+AH++DFGI KLL+ + +SM 
Sbjct: 1046 RLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQ 1104

Query: 634  QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
            QT+TL TIGYMAPE+G +  VST+SD+YSYGI+L+E F+RKKP D+MF  +L+LK WV  
Sbjct: 1105 QTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWVES 1164

Query: 694  LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
             L  S+++VV+  LL   ++D A K  C+ SI +LA+ CT + PE+R+N K
Sbjct: 1165 -LSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTDSPEERLNMK 1214

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  572 bits (1473), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 333/768 (43%), Positives = 443/768 (57%), Gaps = 117/768 (15%)

Query: 88  NLQGEIPHEIGYLPSLTKLALGYNSLVGN------------------NSLSGSLPSRIDL 129
           N  G IP E+G+LP L  L LG N L G+                  N+LSGS+P    +
Sbjct: 230 NFTGVIPEELGFLPMLEVLNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSI 289

Query: 130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLV- 188
            LPN++ L L  N  +G++   + N S+L IL+L  N  +G +    GNLR ++ L L  
Sbjct: 290 DLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQS 349

Query: 189 --------------------------IGLIGNPLNGILPSSIVNLSISLERLYISNCSIT 222
                                     + +  NPL+G+LP+S+ NLS  L + Y+    + 
Sbjct: 350 NSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLK 409

Query: 223 GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN----------------------SK 260
           GNIP  +GNLS  ++L LE N L GPIP T G L+                        +
Sbjct: 410 GNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARR 469

Query: 261 LDTLSLCGNSFSGSIPSCI----------------------------------------- 279
           L  ++L  N  SG IPSCI                                         
Sbjct: 470 LVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLY 529

Query: 280 -----DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTS 334
                 +G ++  + I LS N  SG+IP+TIG L+++   SL  N  +G IPE+FG L S
Sbjct: 530 GSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVS 589

Query: 335 LEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLC 394
           LE+LDLS N +SG I  SLE L YL+  ++SFN L+GEIPRGGPFANFTA+SF+ N+ LC
Sbjct: 590 LELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLC 649

Query: 395 GLPHLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVV-LALKYKSTRRGKSTGLSNG 453
           G   LQVP C  ++R  S  K  LL   LP  A+++ VV  + L     RR +   +   
Sbjct: 650 GPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEA 709

Query: 454 GILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR 513
             L   A +RR+ Y +L  ATN F   NL+GIGSFG VY+  L DG+ VA+K+F+ +  R
Sbjct: 710 --LPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQR 767

Query: 514 AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQ 573
           A +SF+ ECE+M+NIRHRNLVKII  CSN DFKALVLEYMP GSL+ +LYS    LDI Q
Sbjct: 768 AFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQ 827

Query: 574 RLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT 633
           R+NIMIDVASALEYL+  + +P++HCDLK SNVLLDEDM+AH+ DFGIAKLL GE++S  
Sbjct: 828 RVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GENESFA 886

Query: 634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           QT+TLATIGYMAPEYG++  VST+ D+YS+GIML+E  TRK+P D+MF  E+SLK  V  
Sbjct: 887 QTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKE 946

Query: 694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI 741
            LP S++++V+  +L+  +     KE CV SI  LA++C  E P +R+
Sbjct: 947 SLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESPGERM 994

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	763
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.391	0.296	0.399	8.1e-91
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.785	0.584	0.353	3.1e-90
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.554	0.419	0.351	1e-55
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.630	0.469	0.330	1.3e-50
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.630	0.466	0.313	2.3e-50
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.363	0.282	0.375	4e-80
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.553	0.337	0.315	4.2e-43
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.416	0.254	0.342	1.3e-75
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.846	0.550	0.301	2.6e-75
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.701	0.529	0.355	1.4e-73

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 590 (212.7 bits), Expect = 8.1e-91, Sum P(2) = 8.1e-91
 Identities = 127/318 (39%), Positives = 190/318 (59%)

Query:   443 RRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIE 501
             +R K+   +N      +    ++ Y DL  ATN F   N++G GSFG VYKA L  +   
Sbjct:   668 KRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKV 727

Query:   502 VAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF-----KALVLEYMPNG 556
             VA+KV + +   AMKSF  ECE +K+IRHRNLVK+++ CS+ DF     +AL+ E+MPNG
Sbjct:   728 VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNG 787

Query:   557 SLDIFLYSSTC--------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL 608
             SLD++L+             L + +RLNI IDVAS L+YL+     PI HCDLK SNVLL
Sbjct:   788 SLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLL 847

Query:   609 DEDMIAHLSDFGIAKLLSGEDQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSY 663
             D+D+ AH+SDFG+A+LL   D+      ++      TIGY APEYG+  + S   D+YS+
Sbjct:   848 DDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSF 907

Query:   664 GIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVL 723
             GI+L+E FT K+P +++F    +L  +    LP  ++++V++++L    +      +C+ 
Sbjct:   908 GILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLT 967

Query:   724 SIFSLAMECTMELPEKRI 741
              +F + + C  E P  R+
Sbjct:   968 MVFEVGLRCCEESPMNRL 985

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
 Identities = 224/633 (35%), Positives = 334/633 (52%)

Query:    98 GYLPSLTKLAXXXXXXXXXXXXXXXXPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK 157
             G++  LT  +                P+       ++  L+L  N+ +G+I   I N   
Sbjct:   342 GFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIG 401

Query:   158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
             L  L L  N+F G +P+++G L+N   LG+++    N L+G +P +I NL+  L  L + 
Sbjct:   402 LQHLYLCNNNFRGSLPSSLGRLKN---LGILLAYENN-LSGSIPLAIGNLT-ELNILLLG 456

Query:   218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPS 277
                 +G IP  + NL+  L L L  N L+GPIP     +Q   +  +++  N+  GSIP 
Sbjct:   457 TNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSI-MINVSKNNLEGSIPQ 515

Query:   278 CIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEI 337
               +IG+LK +VE +   N  SG IP T+G  + ++ + L  N L G IP + G L  LE 
Sbjct:   516 --EIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLET 573

Query:   338 LDLSNNKISGXXXXXXXXXXXXXXXXXXXXXXXGEIPRGGPFANFTAKSFMGNEKLCG-L 396
             LDLS+N +SG                       GE+P  G FA  +  S  GN KLCG +
Sbjct:   574 LDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGI 633

Query:   397 PHLQVPQCKH--QTRPKSSKKMXXXXXXXXXXXXXXXXXXXXXKYKSTRRGKSTGLSNGG 454
             P L +P+C    + R K    +                      +K T++G  +  S  G
Sbjct:   634 PDLHLPRCCPLLENR-KHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKG 692

Query:   455 ILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARA 514
               L       + Y  L +AT+ F   NL+G GSFG VYK +L+    VA+KV   E  +A
Sbjct:   693 HPL-------VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKA 745

Query:   515 MKSFEVECEVMKNIRHRNLVKIISGCSN-----DDFKALVLEYMPNGSLDIFLYSSTC-- 567
             +KSF  ECE ++N+RHRNLVKI++ CS+     +DFKA+V ++MPNGSL+ +++  T   
Sbjct:   746 LKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQ 805

Query:   568 ----MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK 623
                  L++ +R+ I++DVA AL+YL+     P++HCD+KSSNVLLD DM+AH+ DFG+A+
Sbjct:   806 ADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLAR 865

Query:   624 LL-SGED---QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK 679
             +L  G     QS +    + TIGY APEYG+    ST  DIYSYGI+++E  T K+P D 
Sbjct:   866 ILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDS 925

Query:   680 MFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
              F  +L L+ +V   L   + +VV+  L+   E
Sbjct:   926 TFRPDLGLRQYVELGLHGRVTDVVDTKLILDSE 958

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 582 (209.9 bits), Expect = 1.0e-55, P = 1.0e-55
 Identities = 163/464 (35%), Positives = 235/464 (50%)

Query:   133 NVKALSLAYNRFSGTIQSPITNAS-KLTILELGGNSFSGFIPNTIGNLRNIEWL------ 185
             ++  LS++YNR  G + + I N S +LT+L L GN   G IP+ IGNL  ++ L      
Sbjct:   338 HLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNL 397

Query:   186 ---------GLVIGL-----IGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGN 231
                      G ++GL       N  +G +PS I NL+  L +LY+SN S  G +P  +G+
Sbjct:   398 LTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLT-QLVKLYLSNNSFEGIVPPSLGD 456

Query:   232 LSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEIN 291
              S  L L +  NKL G IP     +Q   L  L++  NS SGS+P+  DIG L+ +VE+ 
Sbjct:   457 CSHMLDLQIGYNKLNGTIPKEI--MQIPTLVHLNMESNSLSGSLPN--DIGRLQNLVELL 512

Query:   292 LSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGXXXX 351
             L  NN SG +P T+G    ++ I L  N  +G IP+  G L  ++ +DLSNN +SG    
Sbjct:   513 LGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSISE 571

Query:   352 XXXXXXXXXXXXXXXXXXXGEIPRGGPFANFTAKSFMGNEKLCG-LPHLQVPQCKHQ--- 407
                                G +P  G F N T  S  GN+ LCG +  L++  C  Q   
Sbjct:   572 YFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPP 631

Query:   408 --TRPKSSKKMXXXXXXXXXXXXXXXXXXXXXKYKSTRRGKSTGLSNGGILLSQATKRRL 465
               TR  S  K                       +K  +R  +  ++N      +    +L
Sbjct:   632 VETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFK--KRKNNQKINNSAPFTLEIFHEKL 689

Query:   466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEV 524
              Y DL  AT+ F   N++G GSFG V+KA L  +   VA+KV + +   AMKSF  ECE 
Sbjct:   690 SYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECES 749

Query:   525 MKNIRHRNLVKIISGCSNDDF-----KALVLEYMPNGSLDIFLY 563
             +K+IRHRNLVK+++ C++ DF     +AL+ E+MPNGSLD +L+
Sbjct:   750 LKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLH 793

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 535 (193.4 bits), Expect = 1.3e-50, P = 1.3e-50
 Identities = 173/524 (33%), Positives = 246/524 (46%)

Query:    75 NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLAXXXXXXXXXXXXXXXXPSRIDLALPNV 134
             N   +  L+I S +L G+IP   G L +L  L                    +      +
Sbjct:   296 NISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNC-SQL 354

Query:   135 KALSLAYNRFSGTIQSPITNAS-KLTILELGGNSFSGFIPNTIGNLRNIEWL----GLVI 189
             + L++ +N+  G +   I N S +LT L LGGN  SG IP+ IGNL +++ L     L+ 
Sbjct:   355 QYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLT 414

Query:   190 G----------------LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS 233
             G                L  N L+G +PSS+ N+S  L  LY+ N S  G+IP  +G+ S
Sbjct:   415 GKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNIS-GLTYLYLLNNSFEGSIPSSLGSCS 473

Query:   234 IFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS 293
               L L+L  NKL G IP     L +  L  L++  N   G +    DIG LK ++ +++S
Sbjct:   474 YLLDLNLGTNKLNGSIPHELMELPS--LVVLNVSFNLLVGPLRQ--DIGKLKFLLALDVS 529

Query:   294 RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGXXXXXX 353
              N  SG IP T+     ++ + L  N   GPIP+  G LT L  LDLS N +SG      
Sbjct:   530 YNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYM 588

Query:   354 XXXXXXXXXXXXXXXXXGEIPRGGPFANFTAKSFMGNEKLCG-LPHLQVPQCKHQT--RP 410
                              G +P  G F N +A S  GN  LCG +P LQ+  C  +   R 
Sbjct:   589 ANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRH 648

Query:   411 KSSKKMXXXXXXXXXXXXXXXXXXXXXKYKSTRRGKSTGLSNGGILLS----QATKRRLP 466
              S +K+                           R KS   +N     S    ++   ++ 
Sbjct:   649 SSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKIS 708

Query:   467 YQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE-VAIKVFHQECAR-AMKSFEVECEV 524
             Y +L + T  F   NLIG G+FG V+K  L    + VAIKV +  C R A KSF  ECE 
Sbjct:   709 YDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAECEA 767

Query:   525 MKNIRHRNLVKIISGCSN-----DDFKALVLEYMPNGSLDIFLY 563
             +  IRHRNLVK+++ CS+     +DF+ALV E+MPNG+LD++L+
Sbjct:   768 LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 533 (192.7 bits), Expect = 2.3e-50, P = 2.3e-50
 Identities = 164/523 (31%), Positives = 238/523 (45%)

Query:    75 NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLAXXXXXXXXXXXXXXXXPSRIDLALPNV 134
             N   +   +ISS  L G IP   G L +L  L                    +      +
Sbjct:   288 NISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAV-ANCTQL 346

Query:   135 KALSLAYNRFSGTIQSPITNASK-LTILELGGNSFSGFIPNTIGNLRNIEWLGL------ 187
             + L + YNR  G + + I N S  LT L LG N  SG IP+ IGNL +++ L L      
Sbjct:   347 EYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLS 406

Query:   188 --------------VIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS 233
                           V+ L  N ++G +PS   N++  L++L++++ S  G IPQ +G   
Sbjct:   407 GELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMT-RLQKLHLNSNSFHGRIPQSLGRCR 465

Query:   234 IFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS 293
               L L ++ N+L G IP     LQ   L  + L  N  +G  P   ++G L+++V +  S
Sbjct:   466 YLLDLWMDTNRLNGTIPQEI--LQIPSLAYIDLSNNFLTGHFPE--EVGKLELLVGLGAS 521

Query:   294 RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGXXXXXX 353
              N  SG +P  IGG   ++ + +  N  +G IP+    L SL+ +D SNN +SG      
Sbjct:   522 YNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYL 580

Query:   354 XXXXXXXXXXXXXXXXXGEIPRGGPFANFTAKSFMGNEKLCG-LPHLQVPQCKHQTRPKS 412
                              G +P  G F N TA S  GN  +CG +  +Q+  C  Q  P+ 
Sbjct:   581 ASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRK 640

Query:   413 SKKMXXXXXXXXXXXXXXXXXXXXXKYKST----RRGKSTGLSNGGILLSQAT---KRRL 465
              K +                        S     +R K    S+G    S        ++
Sbjct:   641 RKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKV 700

Query:   466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEV 524
              Y++L  AT+RF   NLIG G+FG V+K  L  +   VA+KV +     A KSF  ECE 
Sbjct:   701 SYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECET 760

Query:   525 MKNIRHRNLVKIISGCSN-----DDFKALVLEYMPNGSLDIFL 562
              K IRHRNLVK+I+ CS+     +DF+ALV E+MP GSLD++L
Sbjct:   761 FKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL 803

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 509 (184.2 bits), Expect = 4.0e-80, Sum P(2) = 4.0e-80
 Identities = 111/296 (37%), Positives = 173/296 (58%)

Query:   464 RLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMK-SFEVEC 522
             R+ YQ L  AT  F   +LIG G FG+VYK  L +  +VA+KV   + A     SF+ EC
Sbjct:   648 RISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKREC 707

Query:   523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMI 579
             +++K  RHRNL++II+ CS   F ALVL  MPNGSL+  LY    S+  LD+ Q +NI  
Sbjct:   708 QILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICS 767

Query:   580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
             DVA  + YL+      ++HCDLK SN+LLD++M A ++DFGI++L+ G +++++   +++
Sbjct:   768 DVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVS 827

Query:   640 ----------TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH 689
                       ++GY+APEYG+ ++ ST  D+YS+G++L+E  + ++P D +     SL  
Sbjct:   828 FGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHE 887

Query:   690 WVNGLLPVSLMEVVNKTLL--SP---PEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
             ++    P SL  ++ + L    P   PEK      + +L +  L + CT   P  R
Sbjct:   888 FMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTR 943

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 482 (174.7 bits), Expect = 4.2e-43, P = 4.2e-43
 Identities = 142/450 (31%), Positives = 219/450 (48%)

Query:   133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLI 192
             N+  L L  N+F+G I       S+L++L++  NS SG IP  +G  + +      I L 
Sbjct:   601 NLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTH----IDLN 656

Query:   193 GNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVT 252
              N L+G++P+ +  L + L  L +S+    G++P  + +L+  L L L+ N L G IP  
Sbjct:   657 NNYLSGVIPTWLGKLPL-LGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQE 715

Query:   253 FGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQ 312
              G LQ   L+ L+L  N  SG +PS I  G L  + E+ LSRN  +G+IP  IG L+D+Q
Sbjct:   716 IGNLQ--ALNALNLEENQLSGPLPSTI--GKLSKLFELRLSRNALTGEIPVEIGQLQDLQ 771

Query:   313 N-ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGXXXXXXXXXXXXXXXXXXXXXXXG 371
             + + L YN   G IP +   L  LE LDLS+N++ G                       G
Sbjct:   772 SALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEG 831

Query:   372 EIPRGGPFANFTAKSFMGNEKLCGLP--HLQVPQCKHQTR--PKSSKKMXXXXXXXXXXX 427
             ++ +   F+ + A +F+GN  LCG P  H      K+Q    PK+   +           
Sbjct:   832 KLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIAL 889

Query:   428 XXXXXXXXXXK----YKSTRRGKSTGLSNGGI----LLSQA-TKRRLPYQDLSRATNRFG 478
                       +    +K  R G S   SN       L S    K  + + D+  AT+   
Sbjct:   890 MVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLN 949

Query:   479 RDNLIGIGSFGYVYKAELDDGIEVAIK-VFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
              + +IG G  G VYKAEL +G  +A+K +  ++   + KSF  E + +  IRHR+LVK++
Sbjct:   950 EEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLM 1009

Query:   538 SGCSN--DDFKALVLEYMPNGSLDIFLYSS 565
               CS+  D    L+ EYM NGS+  +L+++
Sbjct:  1010 GYCSSKADGLNLLIYEYMANGSVWDWLHAN 1039

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 476 (172.6 bits), Expect = 1.3e-75, Sum P(2) = 1.3e-75
 Identities = 115/336 (34%), Positives = 185/336 (55%)

Query:   442 TRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE 501
             T    S+  ++  +  + A+K  + ++D+  AT+    + +IG G  G VYKAEL++G  
Sbjct:   916 TSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGET 975

Query:   502 VAIK-VFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFKALVLEYMPNGSL 558
             VA+K +  ++   + KSF  E + +  IRHR+LVK++  CS+  +    L+ EYM NGS+
Sbjct:   976 VAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSI 1035

Query:   559 DIFLYSSTC-------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED 611
               +L+           +LD   RL I + +A  +EYL+     PI+H D+KSSNVLLD +
Sbjct:  1036 WDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSN 1095

Query:   612 MIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             M AHL DFG+AK+L+    + T + T    + GY+APEY    K + +SD+YS GI+L+E
Sbjct:  1096 MEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLME 1155

Query:   670 TFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA-KEQCVLSIFSL 728
               T K P D +F AE+ +  WV   L V+        L+ P  K     +E     +  +
Sbjct:  1156 IVTGKMPTDSVFGAEMDMVRWVETHLEVA--GSARDKLIDPKLKPLLPFEEDAACQVLEI 1213

Query:   729 AMECTMELPEKRINAK-CCNFVLCEQFVSNSSELYK 763
             A++CT   P++R +++  C+ +L     +N +  YK
Sbjct:  1214 ALQCTKTSPQERPSSRQACDSLL--HVYNNRTAGYK 1247

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 765 (274.4 bits), Expect = 2.6e-75, P = 2.6e-75
 Identities = 205/681 (30%), Positives = 333/681 (48%)

Query:    78 RVTALNISSLNLQGEIPHEIGYLPSLTKLAXXXXXXXXXXXXXXXXPSRIDLALPNVKAL 137
             ++  L +S  +L G IP EIG L  L  L                 P  +   L  ++ L
Sbjct:   480 KLRILQVSYNSLTGPIPREIGNLKDLNIL------YLHSNGFTGRIPREMS-NLTLLQGL 532

Query:   138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN 197
              +  N   G I   + +   L++L+L  N FSG IP     L ++ +L L     GN  N
Sbjct:   533 RMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQ----GNKFN 588

Query:   198 GILPSSIVNLSISLERLYISNCSITGNIP-QVMGNL-SIFLLLDLELNKLTGPIPVTFGR 255
             G +P+S+ +LS+ L    IS+  +TG IP +++ +L ++ L L+   N LTG IP   G+
Sbjct:   589 GSIPASLKSLSL-LNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGK 647

Query:   256 LQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNI 314
             L+   +  + L  N FSGSIP  +     K V  ++ S+NN SG IP  +  G+  + ++
Sbjct:   648 LE--MVQEIDLSNNLFSGSIPRSLQA--CKNVFTLDFSQNNLSGHIPDEVFQGMDMIISL 703

Query:   315 SLPYNRLEGPIPESFGYLTSLEILDLSNNKISGXXXXXXXXXXXXXXXXXXXXXXXGEIP 374
             +L  N   G IP+SFG +T L  LDLS+N ++G                       G +P
Sbjct:   704 NLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVP 763

Query:   375 RGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMXXXXXXXXXXXXXXXXXX 434
               G F N  A   MGN  LCG      P C  + +     K                   
Sbjct:   764 ESGVFKNINASDLMGNTDLCGSKKPLKP-CTIKQKSSHFSKRTRVILIILGSAAALLLVL 822

Query:   435 XXXKYKSTRRGKSTGLSNGGIL----LSQATK-RRLPYQDLSRATNRFGRDNLIGIGSFG 489
                   +  + K   + N        L  A K +R   ++L +AT+ F   N+IG  S  
Sbjct:   823 LLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLS 882

Query:   490 YVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIIS-GCSNDDFK 546
              VYK +L+DG  +A+KV + +   A + K F  E + +  ++HRNLVKI+     +   K
Sbjct:   883 TVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTK 942

Query:   547 ALVLEYMPNGSLDIFLYSSTCML-DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSN 605
             ALVL +M NG+L+  ++ S   +  + +++++ + +AS ++YL+  +  PI+HCDLK +N
Sbjct:   943 ALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPAN 1002

Query:   606 VLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA---TIGYMAPEYGIERKVSTRSDIYS 662
             +LLD D +AH+SDFG A++L   +   T   T A   TIGY+APE+   RKV+T++D++S
Sbjct:  1003 ILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFS 1062

Query:   663 YGIMLIETFTRKKPA--DKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK-E 719
             +GI+++E  T+++P   +   + +++L+  V   +      +V    +   +   + K E
Sbjct:  1063 FGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQE 1122

Query:   720 QCVLSIFSLAMECTMELPEKR 740
             + +     L + CT   PE R
Sbjct:  1123 EAIEDFLKLCLFCTSSRPEDR 1143

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 743 (266.6 bits), Expect = 1.4e-73, P = 1.4e-73
 Identities = 202/568 (35%), Positives = 292/568 (51%)

Query:    96 EIGYLPSLTKLAXXXXXXXXXXXXXXXXPSRIDLALPNVKALSLAYNRFSGTIQSPITNA 155
             ++ ++ SLT                   P+ I      + +L+L  N F G+I   I N 
Sbjct:   326 DLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNL 385

Query:   156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLY 215
               L  L+LG N  +G +P ++G L     LGL + L  N ++G +PS I NL+  LE LY
Sbjct:   386 IGLQRLQLGKNMLTGPLPTSLGKLLR---LGL-LSLYSNRMSGEIPSFIGNLT-QLEILY 440

Query:   216 ISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSI 275
             +SN S  G +P  +G  S  L L +  NKL G IP     +Q   L  LS+ GNS SGS+
Sbjct:   441 LSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEI--MQIPTLVNLSMEGNSLSGSL 498

Query:   276 PSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL 335
             P+  DIG+L+ +V+++L  N FSG +P T+G    ++ + L  N  +G IP   G L  +
Sbjct:   499 PN--DIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGV 555

Query:   336 EILDLSNNKISGXXXXXXXXXXXXXXXXXXXXXXXGEIPRGGPFANFTAKSFMGNEKLCG 395
               +DLSNN +SG                       G++P  G F N T     GN+ LCG
Sbjct:   556 RRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCG 615

Query:   396 -LPHLQVPQCKHQTRP---KSS---KKMXXXXXXXXXXXXXXXXXXXXXKYKSTRRGKST 448
              +  L++  C  Q  P   K S   KK+                      +   RR K+ 
Sbjct:   616 GIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRR-KNQ 674

Query:   449 GLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE-VAIKVF 507
               +N      +    ++ Y DL  ATN F   N++G GSFG V+KA L    + VA+KV 
Sbjct:   675 QTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVL 734

Query:   508 HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF-----KALVLEYMPNGSLDIFL 562
             + +   AMKSF  ECE +K+ RHRNLVK+++ C++ DF     +AL+ EY+PNGS+D++L
Sbjct:   735 NMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWL 794

Query:   563 YSSTC--------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
             +             L + +RLNI+IDVAS L+YL+     PI HCDLK SNVLL++D+ A
Sbjct:   795 HPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTA 854

Query:   615 HLSDFGIAKLLSGEDQSMTQTQTLATIG 642
             H+SDFG+A+LL   D+     Q L++ G
Sbjct:   855 HVSDFGLARLLLKFDKESFLNQ-LSSAG 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	763
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-53
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-43
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-32
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-27
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-27
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-26
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-22
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-19
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-08
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	6e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
pfam03109	117	pfam03109, ABC1, ABC1 family	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  197 bits (502), Expect = 9e-53
 Identities = 177/643 (27%), Positives = 294/643 (45%), Gaps = 66/643 (10%)

Query: 78  RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL 137
           ++ +L++S  +L GEIP  +  L +L  L L       +N+ +G +P  +  +LP ++ L
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLF------SNNFTGKIPVALT-SLPRLQVL 337

Query: 138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN 197
            L  N+FSG I   +   + LT+L+L  N+ +G IP  + +  N+  L L      N L 
Sbjct: 338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL----FSNSLE 393

Query: 198 GILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVT----- 252
           G +P S+     SL R+ + + S +G +P     L +   LD+  N L G I        
Sbjct: 394 GEIPKSLGACR-SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452

Query: 253 ------------FGRLQNS----KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNN 296
                       FG L +S    +L+ L L  N FSG++P    +G+L  ++++ LS N 
Sbjct: 453 SLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPR--KLGSLSELMQLKLSENK 510

Query: 297 FSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKL 356
            SG+IP  +   K + ++ L +N+L G IP SF  +  L  LDLS N++SG I  +L  +
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570

Query: 357 LYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQ-VPQCKHQTRPKSSKK 415
             L ++N+S N L G +P  G F    A +  GN  LCG      +P CK   R + +  
Sbjct: 571 ESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK---RVRKTPS 627

Query: 416 MILLVIVLPLSAALIAVVVLALKYKSTRRG-------KSTGLSNGGILLSQATKRRLPYQ 468
               +     +  ++A+V     +   R            G        S+ +K  +   
Sbjct: 628 WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKS-ITIN 686

Query: 469 DLSRATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKN 527
           D+  +      +N+I  G  G  YK + + +G++  +K    E          E   M  
Sbjct: 687 DILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVK----EINDVNSIPSSEIADMGK 739

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           ++H N+VK+I  C ++    L+ EY+   +L   L +    L   +R  I I +A AL +
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRF 795

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           L+ R +  ++  +L    +++D     HL        LS      T T+   +  Y+APE
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPE 848

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW 690
               + ++ +SDIY +G++LIE  T K PAD  F    S+  W
Sbjct: 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW 891

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  183 bits (467), Expect = 3e-48
 Identities = 134/369 (36%), Positives = 198/369 (53%), Gaps = 28/369 (7%)

Query: 39  LLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIG 98
           LL+ ++ I+ DP   L+ NW S+  VC W GITC+ NS RV ++++S  N+ G+I   I 
Sbjct: 34  LLSFKSSIN-DPLKYLS-NWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIF 90

Query: 99  YLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKL 158
            LP +  + L       NN LSG +P  I     +++ L+L+ N F+G+I  P  +   L
Sbjct: 91  RLPYIQTINLS------NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI--PRGSIPNL 142

Query: 159 TILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISN 218
             L+L  N  SG IPN IG+  +++    V+ L GN L G +P+S+ NL+ SLE L +++
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLK----VLDLGGNVLVGKIPNSLTNLT-SLEFLTLAS 197

Query: 219 CSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSC 278
             + G IP+ +G +     + L  N L+G IP   G L  + L+ L L  N+ +G IPS 
Sbjct: 198 NQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL--TSLNHLDLVYNNLTGPIPS- 254

Query: 279 IDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEIL 338
             +GNLK +  + L +N  SG IP +I  L+ + ++ L  N L G IPE    L +LEIL
Sbjct: 255 -SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313

Query: 339 DLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPFANFTAKSFMGN------- 390
            L +N  +G I ++L  L  L+ L L  NK  GEIP+  G   N T      N       
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373

Query: 391 EKLCGLPHL 399
           E LC   +L
Sbjct: 374 EGLCSSGNL 382

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (415), Expect = 1e-45
 Identities = 75/266 (28%), Positives = 133/266 (50%), Gaps = 33/266 (12%)

Query: 483 IGIGSFGYVYKAELDD-----GIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG VYK +L        +EVA+K   ++ +   ++ F  E  +M+ + H N+VK+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
           +  C+ ++   +V+EYM  G L  +L  +   L +   L+  + +A  +EYL    +   
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL---ESKNF 123

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           IH DL + N L+ E+++  +SDFG+++ L  +D    +      I +MAPE   E K ++
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGKFTS 182

Query: 657 RSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLME-VVNKTLLSPPEKD 714
           +SD++S+G++L E FT  ++P   M   E              ++E + N   L  P   
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEE--------------VLEYLKNGYRLPQPPN- 227

Query: 715 FAAKEQCVLSIFSLAMECTMELPEKR 740
                 C   ++ L ++C  E PE R
Sbjct: 228 ------CPPELYDLMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  163 bits (414), Expect = 2e-45
 Identities = 78/270 (28%), Positives = 119/270 (44%), Gaps = 28/270 (10%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV----ECEVMKNIRHRNLVKII 537
           +G GSFG VYKA     G  VA+K+  +         +     E  +++ + H N+V++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               + D   LV+EY   G L  +L      L   +   I + +   LEYL   H+  II
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYL---HSNGII 120

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE-YGIERKVST 656
           H DLK  N+LLDE+ +  ++DFG+AK L     S+T T    T  YMAPE          
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGP 178

Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFA 716
           + D++S G++L E  T K P               +G   +  ++++ + L  P E D  
Sbjct: 179 KVDVWSLGVILYELLTGKPP--------------FSGENILDQLQLIRRILGPPLEFDEP 224

Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCC 746
                      L  +C  + P KR  A+  
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (400), Expect = 5e-44
 Identities = 68/191 (35%), Positives = 103/191 (53%), Gaps = 9/191 (4%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           +G G FG VY A     G +VAIK+  +E  +  ++    E E++K + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +++   LV+EY   GSL   L  +   L   + L I++ +   LEYL   H+  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRD 117

Query: 601 LKSSNVLLDED-MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRS 658
           LK  N+LLD D     L+DFG++KLL+ +   +       T  YMAPE  + +   S +S
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKS 175

Query: 659 DIYSYGIMLIE 669
           DI+S G++L E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  158 bits (402), Expect = 7e-44
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 42/271 (15%)

Query: 483 IGIGSFGYVYKAELDD-----GIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG VYK  L         +VA+K   +  +    + F  E  +MK + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
           +  C+  +   +V EYMP G L  FL      L +   L + + +A  +EYL  ++    
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN---F 123

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           +H DL + N L+ E+++  +SDFG+++ +  +D    +      I +MAPE   + K ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNKT----LLS 709
           +SD++S+G++L E FT                    G  P   +S  EV+        L 
Sbjct: 184 KSDVWSFGVLLWEIFTL-------------------GEQPYPGMSNEEVLELLEDGYRLP 224

Query: 710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
            PE        C   ++ L ++C    PE R
Sbjct: 225 RPEN-------CPDELYELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (398), Expect = 3e-43
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 34/267 (12%)

Query: 483 IGIGSFGYVYKAELDDG-----IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG VYK  L        +EVA+K   ++   + ++ F  E  +M+ + H N+VK+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFL-YSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +  C+ ++   +V+EYMP G L  +L  +    L +   L+  + +A  +EYL    +  
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKN 123

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
            IH DL + N L+ E+++  +SDFG+++ L  +D           I +MAPE   E K +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEGKFT 182

Query: 656 TRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVV-NKTLLSPPEK 713
           ++SD++S+G++L E FT  ++P   M  AE              ++E +     L  P  
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAE--------------VLEYLKKGYRLPKP-- 226

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKR 740
                  C   ++ L ++C  E PE R
Sbjct: 227 -----PNCPPELYKLMLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  151 bits (383), Expect = 3e-41
 Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 39/277 (14%)

Query: 481 NLIGIGSFGYVYKAELDDG----IEVAIKVFHQECAR--AMKSFEVECEVMKNIRHRNLV 534
             +G G+FG VYK +L        EVA+K    E A     K F  E  VMK + H N+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--------QRLNIMIDVASALE 586
           +++  C+ ++   LVLEYM  G L  +L  S  +              L+  I +A  +E
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YL    +   +H DL + N L+ ED++  +SDFG+++ +  +D    +T     I +MAP
Sbjct: 120 YL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNK 705
           E   +   +++SD++S+G++L E FT    P   +   E+ L++   G           K
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEYLRKGYRL-------PK 228

Query: 706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN 742
               P E            ++ L + C    PE R  
Sbjct: 229 PEYCPDE------------LYELMLSCWQLDPEDRPT 253

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  150 bits (382), Expect = 4e-41
 Identities = 80/266 (30%), Positives = 121/266 (45%), Gaps = 26/266 (9%)

Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIKVFH-QECARAMKSFEVECEVMKNIRHRNLVKIIS 538
             +G GSFG VY A +   G  VAIKV   ++  +  +    E +++K ++H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              ++D   LV+EY   G L   L      L   +    +  + SALEYL   H+  I+H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYL---HSKGIVH 120

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            DLK  N+LLDED    L+DFG+A+ L   ++  T   T     YMAPE  + +      
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAPEVLLGKGYGKAV 177

Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK 718
           DI+S G++L E  T K P    F  +  L      +          +  +SP  KD    
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI-- 231

Query: 719 EQCVLSIFSLAMECTMELPEKRINAK 744
            +       L  +     PEKR+ A+
Sbjct: 232 RKL------LVKD-----PEKRLTAE 246

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (324), Expect = 3e-33
 Identities = 76/259 (29%), Positives = 116/259 (44%), Gaps = 46/259 (17%)

Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIKV--FHQECARAMKSFEVECEVMKNIRHRNLVKII 537
            L+G GSFG VY A + D G  +A+K      +    +++ E E  ++ +++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 538 SGCSNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNI------MIDVASALEYL 588
            G   D+ K    + LEY+  GSL     SS  +L  F +L           +   L YL
Sbjct: 66  -GSERDEEKNTLNIFLEYVSGGSL-----SS--LLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H+  I+H D+K +N+L+D D +  L+DFG AK L   +          T  +MAPE 
Sbjct: 118 ---HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 649 GIERKVSTR-SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL 707
            I  +   R +DI+S G  +IE  T K P             W     P++ +  +  + 
Sbjct: 175 -IRGEEYGRAADIWSLGCTVIEMATGKPP-------------WSELGNPMAALYKIGSSG 220

Query: 708 LSP--PE------KDFAAK 718
             P  PE      KDF  K
Sbjct: 221 EPPEIPEHLSEEAKDFLRK 239

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  126 bits (317), Expect = 3e-32
 Identities = 84/284 (29%), Positives = 134/284 (47%), Gaps = 46/284 (16%)

Query: 483 IGIGSFGYVYKAEL------DDGIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVK 535
           +G G+FG V+  E       +D   VA+K   +  +  A K FE E E++ N +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYS------------STCM-LDIFQRLNIMIDVA 582
               C+  D   +V EYM +G L+ FL S            S    L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           S + YL  +H    +H DL + N L+  D++  + DFG+++ +   D       T+  I 
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLME 701
           +M PE  + RK +T SD++S+G++L E FT  K+P             W  GL    ++E
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------WY-GLSNEEVIE 235

Query: 702 VVNK-TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
            + +  LL  P         C   ++ + + C    P++RIN K
Sbjct: 236 CITQGRLLQRP-------RTCPSEVYDIMLGCWKRDPQQRINIK 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  122 bits (308), Expect = 4e-31
 Identities = 70/266 (26%), Positives = 126/266 (47%), Gaps = 27/266 (10%)

Query: 477 FGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           F  +  +G G FG V++    + + VAIK+   +     + F+ E + +K +RH++L+ +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTP 595
            + CS  +   ++ E M  GSL  FL S    +L +   +++   VA  + YL  ++   
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--- 124

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
            IH DL + N+L+ ED++  ++DFG+A+L+  ++     +       + APE       S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 656 TRSDIYSYGIMLIETFTRKK-PADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD 714
           T+SD++S+GI+L E FT  + P   M   E+  +      +P             P +  
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP------------CPAK-- 228

Query: 715 FAAKEQCVLSIFSLAMECTMELPEKR 740
                 C   I+ + +EC    PE R
Sbjct: 229 ------CPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 6e-31
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 32/261 (12%)

Query: 482 LIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
            IG G FG V   +   G +VA+K    + + A ++F  E  VM  +RH NLV+++    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 542 NDDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
             +   +V EYM  GSL  +L S    ++ + Q+L   +DV   +EYL  ++    +H D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + NVL+ ED++A +SDFG+AK     + S  Q      + + APE   E+K ST+SD+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 661 YSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
           +S+GI+L E ++  + P  ++   ++ + H   G      ME         PE       
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDV-VPHVEKGY----RME--------APEG------ 223

Query: 720 QCVLSIFSLAMECTMELPEKR 740
            C   ++ +  +C    P KR
Sbjct: 224 -CPPEVYKVMKDCWELDPAKR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  118 bits (298), Expect = 8e-30
 Identities = 69/203 (33%), Positives = 95/203 (46%), Gaps = 23/203 (11%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG G FG VYKA     G EVAIKV   E     +    E +++K  +H N+VK      
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN------IMIDVASALEYLNFRHTT 594
             D   +V+E+   GSL D+       +    Q L       +  ++   LEYL   H+ 
Sbjct: 68  KKDELWIVMEFCSGGSLKDL-------LKSTNQTLTESQIAYVCKELLKGLEYL---HSN 117

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IIH D+K++N+LL  D    L DFG++  LS      T    + T  +MAPE  I  K 
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEV-INGKP 173

Query: 655 -STRSDIYSYGIMLIETFTRKKP 676
              ++DI+S GI  IE    K P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 71/205 (34%), Positives = 102/205 (49%), Gaps = 21/205 (10%)

Query: 481 NLIGIGSFGYVYKAE-LDDGIEVAIK--VFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +LIG G+FG VYK   L+ G  VAIK     +    A+KS   E +++KN++H N+VK I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 538 SGCSNDDFKALVLEYMPNGSL-DIF-----LYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
                 D   ++LEY  NGSL  I         S   + ++Q       V   L YL   
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGLAYL--- 115

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   +IH D+K++N+L  +D +  L+DFG+A  L+   +       + T  +MAPE    
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEM 173

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
              ST SDI+S G  +IE  T   P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  120 bits (300), Expect = 3e-29
 Identities = 81/277 (29%), Positives = 128/277 (46%), Gaps = 27/277 (9%)

Query: 482 LIGIGSFGYVYKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRH-RNLVKII 537
            +G GSFG VY A   D   VA+KV     +  ++ ++ F  E +++ ++ H  N+VK+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFL--YSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
               ++    LV+EY+  GSL+  L        L   + L I+  + SALEYL   H+  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKG 121

Query: 596 IIHCDLKSSNVLLDED-MIAHLSDFGIAKLLSGEDQSMTQTQTLA----TIGYMAPEY-- 648
           IIH D+K  N+LLD D  +  L DFG+AKLL     + +     +    T GYMAPE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 649 -GIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL 707
                  S+ SDI+S GI L E  T   P +    +  + +          ++E+   +L
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI------ILELPTPSL 235

Query: 708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
            SP        E    +   L  +   + P+ R+++ 
Sbjct: 236 ASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSS 270

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (288), Expect = 3e-28
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 14/206 (6%)

Query: 481 NLIGIGSFGYVYKAELD-----DGIEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
             +G G FG V     D      G +VA+K  +          FE E E+++ + H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 535 KIISGCSNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           K   G           L++EY+P+GSL  +L      +++ + L     +   ++YL  +
Sbjct: 70  KYK-GVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT-QTQTLATIGYMAPEYGI 650
                IH DL + N+L++ + +  +SDFG+AK+L  +      +    + I + APE   
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
             K S+ SD++S+G+ L E FT   P
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  113 bits (285), Expect = 5e-28
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 23/225 (10%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFH------QECARAMKSFEVECEVMKNI 528
           ++     IG GSFG VY      DG    +K         +E   A+     E +++K +
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKL 56

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF---QRLNIMIDVASAL 585
            H N++K            +V+EY   G L   +         F   Q L+  + +  AL
Sbjct: 57  NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
           +YL+ R    I+H D+K  N+ L  + +  L DFGI+K+LS     + +T  + T  Y++
Sbjct: 117 KYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLS 171

Query: 646 PEYGIERKVSTRSDIYSYGIMLIETFTRKKP--ADKMFAAELSLK 688
           PE    +  + +SDI+S G +L E  T K P   + +   EL+LK
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LELALK 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 2e-27
 Identities = 67/195 (34%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 482 LIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVKIISGC 540
            IG G+FG VYK  L    EVA+K         +K  F  E E++K   H N+VK+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
                  +V+E +P GSL  FL      L + + L + +D A+ +EYL  ++    IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHRD 118

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTR 657
           L + N L+ E+ +  +SDFG+++   G   +++       I + APE   YG   + ++ 
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG---RYTSE 175

Query: 658 SDIYSYGIMLIETFT 672
           SD++SYGI+L ETF+
Sbjct: 176 SDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (281), Expect = 2e-27
 Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 58/287 (20%)

Query: 483 IGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVK 535
           +G G+FG VYK EL           VAIK   +     ++  F  E E+M +++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMID 580
           ++  C+ +    ++ EY+ +G L  FL  ++                 LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           +A+ +EYL+  H    +H DL + N L+ E +   +SDFG+++ +   D    Q+++L  
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP---V 697
           + +M PE  +  K +T SDI+S+G++L E F+                    GL P    
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY-------------------GLQPYYGF 230

Query: 698 SLMEVVN----KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           S  EV+     + LL  P       E C   +++L +EC  E+P +R
Sbjct: 231 SNQEVIEMIRSRQLLPCP-------EDCPARVYALMIECWNEIPARR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 72/264 (27%), Positives = 128/264 (48%), Gaps = 35/264 (13%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   +    + ++F  E ++MK +RH  LV++ + CS 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID----VASALEYLNFRHTTPIIH 598
           ++   +V EYM  GSL  FL S         RL  ++D    +A  + YL  R+    IH
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            DL + N+L+ E+++  ++DFG+A+L+  +D+   +      I + APE     + + +S
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185

Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                    G +P   M   N+ +L   E+ +   
Sbjct: 186 DVWSFGILLTEIVTY-------------------GRVPYPGM--TNREVLEQVERGYRMP 224

Query: 717 AKEQCVLSIFSLAMECTMELPEKR 740
               C   ++ L ++C  + PE+R
Sbjct: 225 RPPNCPEELYDLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  110 bits (275), Expect = 7e-27
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 36/261 (13%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V + E   G +VA+K    +C    ++F  E  VM  + H+NLV+++    +
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    +V+E M  G+L  FL +    ++ + Q L   +DVA  +EYL    +  ++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDL 126

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIY 661
            + N+L+ ED +A +SDFG+A++      SM    +   + + APE    +K S++SD++
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181

Query: 662 SYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL-LSPPEKDFAAKE 719
           SYG++L E F+  + P  KM   E+               E V K   + PP       E
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMSLKEVK--------------ECVEKGYRMEPP-------E 220

Query: 720 QCVLSIFSLAMECTMELPEKR 740
            C   ++ L   C    P+KR
Sbjct: 221 GCPADVYVLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  110 bits (277), Expect = 7e-27
 Identities = 76/284 (26%), Positives = 132/284 (46%), Gaps = 45/284 (15%)

Query: 483 IGIGSFGYVYKAE------LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG V+ AE        D + VA+K        A K F+ E E++ N++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYS---------------STCMLDIFQRLNIMIDV 581
              C + D   +V EYM +G L+ FL +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           AS + YL  +H    +H DL + N L+  +++  + DFG+++ +   D       T+  I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME 701
            +M PE  + RK +T SD++S+G++L E FT  K            + W   L    ++E
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQ-LSNTEVIE 236

Query: 702 VVNK-TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
            + +  +L  P         C   ++ + + C    P++R+N K
Sbjct: 237 CITQGRVLERPRV-------CPKEVYDIMLGCWQREPQQRLNIK 273

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  109 bits (276), Expect = 1e-26
 Identities = 70/190 (36%), Positives = 99/190 (52%), Gaps = 11/190 (5%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG G+ G VYKA +   G EVAIK          +    E  +MK+ +H N+V       
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
             D   +V+EYM  GSL DI   +   M +  Q   +  +V   LEYL   H+  +IH D
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEP-QIAYVCREVLQGLEYL---HSQNVIHRD 141

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRSD 659
           +KS N+LL +D    L+DFG A  L+ +++S   +  + T  +MAPE  I+RK    + D
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSV-VGTPYWMAPEV-IKRKDYGPKVD 198

Query: 660 IYSYGIMLIE 669
           I+S GIM IE
Sbjct: 199 IWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  107 bits (268), Expect = 9e-26
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 23/213 (10%)

Query: 483 IGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG V+ AE        D + VA+K   +    A + F+ E E++  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYS--------------STCMLDIFQRLNIMIDVA 582
              C+      +V EYM +G L+ FL S              +   L + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           S + YL   H    +H DL + N L+ + ++  + DFG+++ +   D      +T+  I 
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKK 675
           +M PE  + RK +T SDI+S+G++L E FT  K
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 3e-25
 Identities = 72/265 (27%), Positives = 124/265 (46%), Gaps = 31/265 (11%)

Query: 483 IGIGSFGYVYKA----ELDD-GIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG VYK     E +   I VAIKV  +E +  A K    E  VM ++ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
           +  C +     L+ + MP G L  ++ +    +     LN  + +A  + YL  +    +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---L 130

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           +H DL + NVL+       ++DFG+AKLL  +++          I +MA E  + R  + 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 657 RSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF 715
           +SD++SYG+ + E  T   KP + + A E+             L+E   + L  PP    
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-----------DLLEKGER-LPQPP---- 234

Query: 716 AAKEQCVLSIFSLAMECTMELPEKR 740
                C + ++ + ++C M   E R
Sbjct: 235 ----ICTIDVYMVLVKCWMIDAESR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 5e-25
 Identities = 74/262 (28%), Positives = 120/262 (45%), Gaps = 32/262 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+  +    I+VAIK+   E A +   F  E +VM  + H NLV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                +V EYM NG L  +L      L     L++  DV  A+EYL   +    IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE-SNG--FIHRDLA 127

Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ ED +  +SDFG+A+ +  +DQ  +   T   + +  PE     + S++SD++S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186

Query: 663 YGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEKDFAAK 718
           +G+++ E F+  K         +  + + N        EVV        L  P       
Sbjct: 187 FGVLMWEVFSEGK---------MPYERFSNS-------EVVESVSAGYRLYRP------- 223

Query: 719 EQCVLSIFSLAMECTMELPEKR 740
           +     ++++   C  E PE R
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 7e-25
 Identities = 59/191 (30%), Positives = 102/191 (53%), Gaps = 6/191 (3%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V++   ++   VA+K          K F  E ++MK +RH  L+++ + C+ 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           ++   +V E M  GSL  +L       L + Q +++   VAS + YL  ++    IH DL
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIY 661
            + NVL+ E+ I  ++DFG+A+++  ED    +      I + APE  +  + S +SD++
Sbjct: 130 AARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188

Query: 662 SYGIMLIETFT 672
           S+GI+L E  T
Sbjct: 189 SFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 8e-25
 Identities = 75/235 (31%), Positives = 102/235 (43%), Gaps = 29/235 (12%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           +G GSFG V    + D G   A+KV  ++     K  E    E  ++  I H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
               ++   LVLEY P G L   L       +   R     ++  ALEYL   H+  II+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYL---HSLGIIY 116

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTR 657
            DLK  N+LLD D    L+DFG+AK LS E     +T T   T  Y+APE  + +     
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
            D +S G++L E  T K P    F AE                E+  K L  P  
Sbjct: 174 VDWWSLGVLLYEMLTGKPP----FYAE-------------DRKEIYEKILKDPLR 211

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 69/193 (35%), Positives = 102/193 (52%), Gaps = 15/193 (7%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V   +   G +VA+K    +     ++F  E  VM  +RH NLV+++ G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL-GVIV 69

Query: 543 DDFKAL--VLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
           ++   L  V EYM  GSL  +L S    +L     L   +DV  A+EYL        +H 
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHR 126

Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           DL + NVL+ ED +A +SDFG+ K     + S TQ      + + APE   E+K ST+SD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181

Query: 660 IYSYGIMLIETFT 672
           ++S+GI+L E ++
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  103 bits (258), Expect = 2e-24
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 21/211 (9%)

Query: 483 IGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG V+ AE        D I VA+K        A K F  E E++ N++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYS------------STCMLDIFQRLNIMIDVASA 584
              C   D   +V EYM +G L+ FL +                L   Q L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           + YL  +H    +H DL + N L+ E+++  + DFG+++ +   D       T+  I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRKK 675
            PE  + RK +T SD++S G++L E FT  K
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  101 bits (253), Expect = 5e-24
 Identities = 74/262 (28%), Positives = 130/262 (49%), Gaps = 32/262 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +    VAIK   +    + ++F  E +VMK +RH  LV++ +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    +V EYM  GSL  FL       L + Q +++   +AS + Y+   +    +H DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +++N+L+ E+++  ++DFG+A+L+  ED   T  Q     I + APE  +  + + +SD+
Sbjct: 129 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L E  T+                   G +P   M  VN+ +L   E+ +     
Sbjct: 187 WSFGILLTELTTK-------------------GRVPYPGM--VNREVLDQVERGYRMPCP 225

Query: 719 EQCVLSIFSLAMECTMELPEKR 740
            +C  S+  L  +C  + PE+R
Sbjct: 226 PECPESLHDLMCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 6e-24
 Identities = 80/267 (29%), Positives = 122/267 (45%), Gaps = 36/267 (13%)

Query: 483 IGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKII 537
           +G G+FG V    Y  +    +EVA+K   QE   A K  F  E  VM  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFL--YSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C  +    LV+E  P G L  +L       + D+     +   VA  + YL  +H   
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKH--- 115

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +H DL + NVLL     A +SDFG+++ L +G D     T     + + APE     K 
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 655 STRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK 713
           S++SD++SYG+ L E F+   KP  +M  AE+           ++++E   + L  P E 
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV-----------IAMLE-SGERLPRPEE- 222

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKR 740
                  C   I+S+ + C    PE R
Sbjct: 223 -------CPQEIYSIMLSCWKYRPEDR 242

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (253), Expect = 8e-24
 Identities = 68/245 (27%), Positives = 108/245 (44%), Gaps = 31/245 (12%)

Query: 483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECARAM-KSFEVECEVMKNIRHRNLVKIISGC 540
           +G GS G VYK      G   A+K  H +      K    E + +++     +VK    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 541 SNDDFK----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL-NFRHTTP 595
               +K    ++VLEYM  GSL   L     + +      I   +   L+YL   RH   
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLHTKRH--- 120

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEYGIERKV 654
           IIH D+K SN+L++      ++DFGI+K+L   + ++ Q  T + T+ YM+PE       
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGESY 177

Query: 655 STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT-LLSPPEK 713
           S  +DI+S G+ L+E    K P    F        +        LM+ +      S P +
Sbjct: 178 SYAADIWSLGLTLLECALGKFP----FLPPGQPSFF-------ELMQAICDGPPPSLPAE 226

Query: 714 DFAAK 718
           +F+ +
Sbjct: 227 EFSPE 231

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  100 bits (251), Expect = 8e-24
 Identities = 76/267 (28%), Positives = 124/267 (46%), Gaps = 38/267 (14%)

Query: 482 LIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVKIISGC 540
           L+G G+FG V+K  L D   VA+K   ++  + +K  F  E  ++K   H N+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +      +V+E +P G    FL      L   Q +   +D A+ + YL  ++    IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC---IHRD 118

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPE---YGIERKVS 655
           L + N L+ E+ +  +SDFG+++    ED  +  +  L    I + APE   YG   + S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYG---RYS 172

Query: 656 TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF 715
           + SD++SYGI+L ETF+                    G+ P   M   N+      EK +
Sbjct: 173 SESDVWSYGILLWETFSL-------------------GVCPYPGM--TNQQAREQVEKGY 211

Query: 716 --AAKEQCVLSIFSLAMECTMELPEKR 740
             +  ++C   ++ +   C    PE R
Sbjct: 212 RMSCPQKCPDDVYKVMQRCWDYKPENR 238

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  100 bits (250), Expect = 2e-23
 Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 7/194 (3%)

Query: 481 NLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           + +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
           C+ +    ++ E+M  G+L  +L       ++    L +   ++SA+EYL  ++    IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            DL + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +S
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 659 DIYSYGIMLIETFT 672
           D++++G++L E  T
Sbjct: 187 DVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.1 bits (244), Expect = 9e-23
 Identities = 58/193 (30%), Positives = 101/193 (52%), Gaps = 5/193 (2%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V+     +  +VAIK   +E A + + F  E +VM  + H  LV++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                LV E+M +G L  +L +          L + +DV   + YL    ++ +IH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLA 127

Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ E+ +  +SDFG+ + +  +DQ  + T T   + + +PE     K S++SD++S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 663 YGIMLIETFTRKK 675
           +G+++ E F+  K
Sbjct: 187 FGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 96.9 bits (241), Expect = 3e-22
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 6/207 (2%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+  +E + +   F  E +VM  + H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                +V EYM NG L  +L          Q L +  DV   + YL  +     IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLA 127

Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+D+     +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SD+++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 663 YGIMLIETFTR-KKPADKMFAAELSLK 688
           +G+++ E ++  K P ++   +E   K
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 96.6 bits (240), Expect = 3e-22
 Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 34/268 (12%)

Query: 483 IGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVKII 537
           +G G+FG V    YK      I+VAIKV   E  ++++     E E+M  + +  +V++I
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
             C  +    LV+E    G L+ FL      + +   + +M  V+  ++YL  ++    +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FV 117

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIERKVS 655
           H DL + NVLL     A +SDFG++K L G D S  + ++     + + APE    RK S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 656 TRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD 714
           +RSD++SYGI + E F+  +KP  KM   E+           +S +E   K L  P E  
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----------MSFIE-QGKRLDCPAE-- 222

Query: 715 FAAKEQCVLSIFSLAMECTMELPEKRIN 742
                 C   +++L  +C +   E R N
Sbjct: 223 ------CPPEMYALMKDCWIYKWEDRPN 244

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 79/308 (25%), Positives = 136/308 (44%), Gaps = 54/308 (17%)

Query: 472 RATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKS-FEVECEV 524
           R    + RD  IG G+FG V++A        +    VA+K+  +E +  M++ F+ E  +
Sbjct: 4   RNNIEYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSST------------------ 566
           M    H N+VK++  C+      L+ EYM  G L+ FL   +                  
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 567 ---CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK 623
                L   ++L I   VA+ + YL+ R     +H DL + N L+ E+M+  ++DFG+++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK-KPADKMFA 682
            +   D           I +M PE     + +T SD+++YG++L E F+   +P   M A
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-A 237

Query: 683 AELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN 742
            E  + +  +G             +LS P       + C L +++L   C  +LP  R +
Sbjct: 238 HEEVIYYVRDG------------NVLSCP-------DNCPLELYNLMRLCWSKLPSDRPS 278

Query: 743 AKCCNFVL 750
               N +L
Sbjct: 279 FASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 29/252 (11%)

Query: 481 NLIGIGSFGYVYKAELDDGIEV-AIKVFH-QEC--ARAMKSFEVECEVMKNIRHRNLVKI 536
            +IG G+FG V   +  D  ++ A+K  + Q+C    ++++   E  +++ + H  LV +
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                +++   LV++ +  G L   L       +   +   + ++  ALEYL   H+  I
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYL---HSKGI 121

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           IH D+K  N+LLDE    H++DF IA  ++ +  +   T T  T GYMAPE    +  S 
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSV 178

Query: 657 RSDIYSYGIMLIETFTRKKP-------------ADKMFAAELSLKHWVNGLLPVSLMEVV 703
             D +S G+   E    K+P             A +  A  L    W         ++ +
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW-----STEAIDAI 233

Query: 704 NKTLLSPPEKDF 715
           NK L   P+K  
Sbjct: 234 NKLLERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 78/270 (28%), Positives = 116/270 (42%), Gaps = 29/270 (10%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           IG+G+   VY A  L +  +VAIK    E C  ++     E + M    H N+VK  +  
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 541 SNDDFKALVLEYMPNGS-LDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              D   LV+ Y+  GS LDI   S     LD      ++ +V   LEYL   H+   IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIH 125

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLL--SGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
            D+K+ N+LL ED    ++DFG++  L   G+     +   + T  +MAPE   +     
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 657 -RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK-- 713
            ++DI+S+GI  IE  T   P  K                    M+V+  TL + P    
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPP-----------------MKVLMLTLQNDPPSLE 228

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKRINA 743
             A  ++   S   +   C  + P KR  A
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTA 258

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.1 bits (239), Expect = 6e-22
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 22/211 (10%)

Query: 481 NLIGIGSFGYVY----KAELDDG---IEVAIKVFHQECARAMKS-FEVECEVMKNIRHRN 532
           N +G G+FG VY       L  G   I VA+K   +      K  F  E  +M N  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS------TCMLDIFQRLNIMIDVASALE 586
           +VK++  C  ++ + +++E M  G L  +L  +        +L + + L+I +DVA    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDE-----DMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           YL   H    IH DL + N L+ E     D +  + DFG+A+ +   D    + + L  +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            +MAPE  ++ K +T+SD++S+G+++ E  T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.4 bits (238), Expect = 7e-22
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 34/209 (16%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
            +G GS+G VYKA   + G  VAIKV        ++    E  ++K      +VK     
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN----------IMIDVASALEYLNF 590
             +    +V+EY   GS+           DI +  N          I+      LEYL  
Sbjct: 68  FKNTDLWIVMEYCGAGSV----------SDIMKITNKTLTEEEIAAILYQTLKGLEYL-- 115

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPE 647
            H+   IH D+K+ N+LL+E+  A L+DFG++  L+    +M +  T+  IG   +MAPE
Sbjct: 116 -HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGTPFWMAPE 169

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
              E   + ++DI+S GI  IE    K P
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 72/262 (27%), Positives = 130/262 (49%), Gaps = 32/262 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   +    + +SF  E ++MK +RH  LV++ +  S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    +V EYM  GSL  FL       L +   +++   VA+ + Y+   +    IH DL
Sbjct: 73  EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 128

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +S+N+L+ + ++  ++DFG+A+L+  ED   T  Q     I + APE  +  + + +SD+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L E  T+                   G +P   M   N+ +L   E+ +     
Sbjct: 187 WSFGILLTELVTK-------------------GRVPYPGMN--NREVLEQVERGYRMPCP 225

Query: 719 EQCVLSIFSLAMECTMELPEKR 740
           + C +S+  L ++C  + PE+R
Sbjct: 226 QDCPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 12/209 (5%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKV--FHQECARAMKSFEVECEVMKNIRHRN 532
           R+ R N IG G+FG VY A  LD G  +A+K         + +K    E +V++ ++H N
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           LVK      + +   + +EY   G+L+  L        I     I +     LE L + H
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLH 116

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM-TQTQTLA-TIGYMAPEYGI 650
           +  I+H D+K +N+ LD + +  L DFG A  L     +M  + Q+LA T  YMAPE   
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 651 ERKVSTR---SDIYSYGIMLIETFTRKKP 676
             K       +DI+S G +++E  T K+P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 35/227 (15%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH-----QECARAMKSFEVECEVM-KNI 528
           +FG+  +IG GSF  V  A E +   E AIK+       +E  + +K  ++E EV+ +  
Sbjct: 4   KFGK--IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE--KKVKYVKIEKEVLTRLN 59

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            H  ++K+     +++    VLEY PNG L  ++      LD         ++  ALEYL
Sbjct: 60  GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYL 118

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG------ 642
              H+  IIH DLK  N+LLD+DM   ++DFG AK+L   + S    +  AT        
Sbjct: 119 ---HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEK 174

Query: 643 -------------YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
                        Y++PE   E+     SD+++ G ++ +  T K P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 44/280 (15%)

Query: 483 IGIGSFGYVYKAEL-----DDGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G  +FG +YK  L     D    VAIK        +    F+ E  +M  + H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSST----------------CMLDIFQRLNIMID 580
           +   + +    ++ EY+  G L  FL   +                  LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           +A+ +EYL+       +H DL + N+L+ E +   +SD G+++ +   D    Q ++L  
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I +M PE  +  K S+ SDI+S+G++L E F+              L+ +  G     ++
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS------------FGLQPYY-GFSNQEVI 236

Query: 701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           E+V K  L P        E C   ++SL  EC  E P +R
Sbjct: 237 EMVRKRQLLP------CSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 14/202 (6%)

Query: 479 RDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNL 533
            + +IG G FG V +  L       I+VAIK      +   +  F  E  +M    H N+
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL---NF 590
           +++    +      ++ EYM NGSLD FL  +     + Q + ++  +AS ++YL   N+
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
                 +H DL + N+L++ +++  +SDFG+++ L   + + T       I + APE   
Sbjct: 128 ------VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 651 ERKVSTRSDIYSYGIMLIETFT 672
            RK ++ SD++S+GI++ E  +
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 13/206 (6%)

Query: 479 RDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH-----QECARAMKSFEVECEVMKNIRHRN 532
           R  L+G G+FG VY   ++D G E+A+K         E  + + + E E +++KN++H  
Sbjct: 6   RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65

Query: 533 LVKIISGCSNDDFK-ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           +V+   GC  DD   ++ +EYMP GS+   L +   + +   R      +   +EYL   
Sbjct: 66  IVQYY-GCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYL--- 120

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGI 650
           H+  I+H D+K +N+L D      L DFG +K L     S T  +++  T  +M+PE   
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
                 ++D++S G  ++E  T K P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 28/235 (11%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG VYKA+  + G+  A K+   E    ++ F VE +++   +H N+V +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
            ++   +++E+   G+LD  +      L   Q   +   +  AL +L   H+  +IH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDL 129

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-----ERKVST 656
           K+ N+LL  D    L+DFG++       Q   +   + T  +MAPE        +     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP 711
           ++DI+S GI LIE    + P  ++                 + M V+ K L S P
Sbjct: 188 KADIWSLGITLIELAQMEPPHHEL-----------------NPMRVLLKILKSEP 225

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.3 bits (229), Expect = 9e-21
 Identities = 66/276 (23%), Positives = 128/276 (46%), Gaps = 36/276 (13%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVF---HQECARAMKSFEVECEVMKN 527
           +   +  +IG G FG V++  L       + VAIK     + E  R  + F  E  +M  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQ 62

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
             H N++++    +      ++ EYM NG+LD +L         +Q + ++  +A+ ++Y
Sbjct: 63  FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKY 122

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG--YMA 645
           L+       +H DL + N+L++ ++   +SDFG++++L  +D   T T +   I   + A
Sbjct: 123 LS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTA 178

Query: 646 PEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVN 704
           PE    RK ++ SD++S+GI++ E  +  ++P   M   E              +M+ +N
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------------VMKAIN 224

Query: 705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
                P   D      C  +++ L ++C  +   +R
Sbjct: 225 DGFRLPAPMD------CPSAVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 13/201 (6%)

Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRN 532
           + +IG G FG V    L       I VAIK     + E  R  + F  E  +M    H N
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPN 66

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           ++ +    +      +V EYM NGSLD FL        + Q + ++  +AS ++YL+   
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS--- 123

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLATIGYMAPEYGIE 651
               +H DL + N+L++ +++  +SDFG++++L  + + + T       I + APE    
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 652 RKVSTRSDIYSYGIMLIETFT 672
           RK ++ SD++SYGI++ E  +
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 20/209 (9%)

Query: 482 LIGIGSFGYVYKAEL--DDG--IEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVK 535
           ++G G FG V + +L  DDG  ++VA+K    +      ++ F  E   MK+  H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 536 IISGC----SNDDFKA--LVLEYMPNGSLDIFL-YSSTCMLDIF---QRL-NIMIDVASA 584
           +I  C    S        ++L +M +G L  FL YS    L      Q L   M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           +EYL+ R+    IH DL + N +L EDM   ++DFG++K +   D           + ++
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTR 673
           A E   +R  +++SD++++G+ + E  TR
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.1 bits (226), Expect = 4e-20
 Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 21/268 (7%)

Query: 483 IGIGSFG----YVYKAELDD-GIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKI 536
           +G G FG    Y Y    D  G  VA+K   +EC +   S ++ E  ++K + H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 537 ISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
              CS    K   L++EY+P GSL  +L      L++ Q L     +   + YL+ +H  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH-- 127

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERK 653
             IH DL + NVLLD D +  + DFG+AK +  G +    +    + + + A E   E K
Sbjct: 128 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 654 VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP-VSLMEVVNKTLLSPPE 712
            S  SD++S+G+ L E  T              +     G +  V L+E++ + +  P  
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP 246

Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKR 740
           K+      C   ++ L   C     + R
Sbjct: 247 KN------CPQEVYILMKNCWETEAKFR 268

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 74/294 (25%), Positives = 117/294 (39%), Gaps = 57/294 (19%)

Query: 482 LIGIGSFGYVYKAE----LDDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKI 536
            +G GSFG V + E        I VA+K    +  +  M  F  E  +M ++ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 537 ISGCSNDDFKALVLEYMPNGSL---------DIFLYSSTCMLDIFQRLNIMIDVASALEY 587
             G        +V E  P GSL           FL S+ C        +  + +A+ + Y
Sbjct: 62  Y-GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLC--------DYAVQIANGMRY 112

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAP 646
           L  +     IH DL + N+LL  D    + DFG+ + L   ED  + +        + AP
Sbjct: 113 LESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNK 705
           E    R  S  SD++ +G+ L E FT  ++P             W  GL    +++ ++K
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP-------------WA-GLSGSQILKKIDK 215

Query: 706 TL--LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV-LCEQFVS 756
               L  P       E C   I+++ ++C    P  R       F  L E    
Sbjct: 216 EGERLERP-------EACPQDIYNVMLQCWAHNPADR-----PTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.9 bits (223), Expect = 6e-20
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 9/204 (4%)

Query: 478 GRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           G   ++G G++G VY A +L   + +AIK   +  +R ++    E  +   ++HRN+V+ 
Sbjct: 11  GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
           +   S + F  + +E +P GSL   L S    L   ++  I+      LE L + H   I
Sbjct: 71  LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIIFYTKQILEGLKYLHDNQI 129

Query: 597 IHCDLKSSNVLLDE-DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE---R 652
           +H D+K  NVL++    +  +SDFG +K L+G +   T+T T  T+ YMAPE  I+   R
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEV-IDKGPR 186

Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
                +DI+S G  ++E  T K P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 90.4 bits (224), Expect = 1e-19
 Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 51/281 (18%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKSFEVECEVMKNIRH 530
           F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K    E  VM ++ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR----------LNIMID 580
            ++ +++  C     + L+ + MP G          C+LD  +           LN  + 
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 117

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  +++          
Sbjct: 118 IAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSL 699
           I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S           S+
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SI 223

Query: 700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           +E   + L  PP         C + ++ + ++C M   + R
Sbjct: 224 LE-KGERLPQPP--------ICTIDVYMIMVKCWMIDADSR 255

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 479 RDNL-----IGIGSFGYVYKAELDD------GIEVAIKVFHQECA--RAMKSFEVECEVM 525
           R+ +     +G GSFG VY+              VAIK  + E A  R    F  E  VM
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNEASVM 63

Query: 526 KNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS------STCMLDIFQRLNIM- 578
           K     ++V+++   S      +V+E M  G L  +L S      +   L        + 
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 579 --IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
              ++A  + YL  +     +H DL + N ++ ED+   + DFG+ + +   D      +
Sbjct: 124 MAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            L  + +MAPE   +   +T+SD++S+G++L E  T
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 93.3 bits (232), Expect = 1e-19
 Identities = 53/154 (34%), Positives = 78/154 (50%), Gaps = 9/154 (5%)

Query: 286 VVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKI 345
            +  + L      G IP  I  L+ +Q+I+L  N + G IP S G +TSLE+LDLS N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 346 SGFILISLEKLLYLKKLNLSFNKLEGEIPR--GGPFANFTAKSFMGNEKLCGLPHLQVPQ 403
           +G I  SL +L  L+ LNL+ N L G +P   GG   +  + +F  N  LCG+P L    
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RA 536

Query: 404 CKHQTRPKSSKKMILLVIVLPLSAALIAVVVLAL 437
           C        +K    + I   +S A + +V+ A+
Sbjct: 537 CG-PHLSVGAK----IGIAFGVSVAFLFLVICAM 565

Length = 623

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 71/274 (25%), Positives = 123/274 (44%), Gaps = 48/274 (17%)

Query: 483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKIISGC 540
           IG G+FG V+   L  D   VA+K   +     +K+ F  E  ++K   H N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +      +V+E +  G    FL +    L + + + ++ + A+ +EYL  +H    IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI--GYMAPE---YGIERKVS 655
           L + N L+ E  +  +SDFG+++    ED     T  +  I   + APE   YG   + S
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYG---RYS 174

Query: 656 TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM------EVVNKTL-L 708
           + SD++S+GI+L E F+                    G +P + +      E + + + L
Sbjct: 175 SESDVWSFGILLWEAFSL-------------------GAVPYANLSNQQTREAIEQGVRL 215

Query: 709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN 742
             P       E C  +++ L   C    P +R +
Sbjct: 216 PCP-------ELCPDAVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 482 LIGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
            +G G+FG V     D      G  VA+K      A  ++ FE E E++K+++H N+VK 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 537 ISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
              C +   +   LV+EY+P GSL  +L      LD  + L     +   +EYL  +   
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR-- 128

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERK 653
             +H DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K
Sbjct: 129 -YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187

Query: 654 VSTRSDIYSYGIMLIETFT 672
            S  SD++S+G++L E FT
Sbjct: 188 FSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 11/201 (5%)

Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLV 534
           + +IG G FG V +  L       I VAIK        +  + F  E  +M    H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +    +      ++ E+M NG+LD FL  +     + Q + ++  +A+ ++YL+     
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EM 125

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA---TIGYMAPEYGIE 651
             +H DL + N+L++ +++  +SDFG+++ L  +    T T +L     I + APE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 652 RKVSTRSDIYSYGIMLIETFT 672
           RK ++ SD++SYGI++ E  +
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 18/216 (8%)

Query: 479 RDNLIGIGSFGYVYKA-ELDDGIEVAIK------VFHQECARA---MKSFEVECEVMKNI 528
           +  LIG GSFG VY       G  +A+K      V      R    + +   E  ++K +
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
           +H N+V+ +    + D   + LEY+P GS+   L         F+   +   V   L+ L
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGL 119

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT----LATIGYM 644
           N+ H   IIH D+K +N+L+D      +SDFGI+K L     S            ++ +M
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKM 680
           APE   +   + ++DI+S G +++E  T K P    
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 18/207 (8%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE-----VECEVMKNIRHRNLVKI 536
           IG GSFG V K     DG  +  K   +     M   E      E  +++ ++H N+V+ 
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWK---EIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 537 ISGCSNDDFKAL--VLEYMPNGSLDIFL---YSSTCMLDIFQRLNIMIDVASALEYLNFR 591
                +   + L  V+EY   G L   +         ++      I+  +  AL   + R
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 592 H--TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
                 ++H DLK +N+ LD +    L DFG+AK+L G D S  +T  + T  YM+PE  
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSPEQL 182

Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP 676
                  +SDI+S G ++ E      P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 70/259 (27%), Positives = 118/259 (45%), Gaps = 26/259 (10%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+  +    I+VAIK    E A + + F  E +VM  + H  LV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                +V E+M NG L  +L      L     L++  DV   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLA 127

Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+    +  +SDFG+ + +  +D+  + +     + +  PE     K S++SD++S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 663 YGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQC 721
           +G+++ E FT  K P +K                  S  EVV   ++S   + +  K   
Sbjct: 187 FGVLMWEVFTEGKMPFEKK-----------------SNYEVV--EMISRGFRLYRPKLAS 227

Query: 722 VLSIFSLAMECTMELPEKR 740
            ++++ +   C  E PE R
Sbjct: 228 -MTVYEVMYSCWHEKPEGR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 31/224 (13%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL------DDGIEVAIKVFHQECA-RAMKSFEVECEV 524
             RD L     +G G+FG V KAE       ++   VA+K+   +   + +     E E+
Sbjct: 9   LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM 68

Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YSSTCMLDIFQR 574
           MK I +H+N++ ++  C+ +    +V+EY  +G+L  FL          S        + 
Sbjct: 69  MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 575 L------NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L      +    VA  +E+L  +     IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185

Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 69/262 (26%), Positives = 128/262 (48%), Gaps = 32/262 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VAIK   +      ++F  E ++MK +RH  LV + +  S 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL-EYLNFRHTTPIIHCDL 601
           +    +V E+M  GSL  FL         + +L  ++D+A+ + + + +      IH DL
Sbjct: 73  EPI-YIVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +++N+L+ ++++  ++DFG+A+L+  ED   T  Q     I + APE  +  + + +SD+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L E  T+                   G +P   M  VN+ +L   E+ +     
Sbjct: 187 WSFGILLTELVTK-------------------GRVPYPGM--VNREVLEQVERGYRMPCP 225

Query: 719 EQCVLSIFSLAMECTMELPEKR 740
           + C  S+  L   C  + P++R
Sbjct: 226 QGCPESLHELMKLCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 87.6 bits (217), Expect = 4e-19
 Identities = 68/273 (24%), Positives = 132/273 (48%), Gaps = 41/273 (15%)

Query: 479 RDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           R+ L     +G G FG V+    +   +VAIK   ++ + + ++F  E  +MK ++H  L
Sbjct: 5   RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRL 63

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-LDIFQRLNIMIDVASALEYLNFRH 592
           V++ +  + +    ++ EYM NGSL  FL +   + L I + +++   +A  + ++  ++
Sbjct: 64  VRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YG 649
               IH DL+++N+L+ E +   ++DFG+A+L+  +++   +      I + APE   YG
Sbjct: 123 Y---IHRDLRAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYG 178

Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS 709
                + +SD++S+GI+L E  T                    G +P   M   N  ++ 
Sbjct: 179 T---FTIKSDVWSFGILLTEIVTY-------------------GRIPYPGM--TNPEVIQ 214

Query: 710 PPEKDF--AAKEQCVLSIFSLAMECTMELPEKR 740
             E+ +     + C   ++ L   C  E PE+R
Sbjct: 215 NLERGYRMPRPDNCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 87.7 bits (217), Expect = 5e-19
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 25/278 (8%)

Query: 479 RDNLIGIGSFGYV----YKAELDD-GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRN 532
           RD  +G G FG V    Y  E D+ G +VA+K    E     +   + E E+++N+ H N
Sbjct: 10  RD--LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67

Query: 533 LVKIISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
           +VK    C+ D      L++E++P+GSL  +L  +   +++ Q+L   + +   ++YL  
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYG 649
           R     +H DL + NVL++ +    + DFG+ K +  + +  T    L + + + APE  
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS-LMEVVN--KT 706
           I+ K    SD++S+G+ L E  T            L +    +G + V+ L+ V+   K 
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244

Query: 707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           L  PP         C   ++ L  +C    P KR   +
Sbjct: 245 LPRPPN--------CPEEVYQLMRKCWEFQPSKRTTFQ 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 30/218 (13%)

Query: 479 RDNL-----IGIGSFGYVYKAEL----DDGIE--VAIKVFHQECARAMKS-FEVECEVMK 526
           RD++     +G G+FG VY+        D +E  VA+K   + C+   +S F +E  +M 
Sbjct: 5   RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS 64

Query: 527 NIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNI 577
              H+N+V++I        + ++LE M  G L  FL          SS  M D+   L  
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFC 121

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQ 634
             DVA   +YL   H    IH D+ + N LL       +A ++DFG+A+ +         
Sbjct: 122 ARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178

Query: 635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            + +  I +M PE  ++   ++++D++S+G++L E F+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 59/196 (30%), Positives = 86/196 (43%), Gaps = 8/196 (4%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAM-KSFEVECEVMKNIRHRNLVKIISGC 540
           +G G+ G V K      G  +A+K    E   A+ K    E +++       +V      
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            N+   ++ +EYM  GSLD  L      +       I + V   L YL       IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL--HEKHKIIHRD 126

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           +K SN+L++      L DFG++  L     S+ +T    T  YMAPE       S +SDI
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 661 YSYGIMLIETFTRKKP 676
           +S G+ LIE  T + P
Sbjct: 183 WSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 66/230 (28%), Positives = 118/230 (51%), Gaps = 27/230 (11%)

Query: 480 DNLIGIGSFGYVYKAELD-DGIEV--AIKVFHQECARA-MKSFEVECEVMKNI-RHRNLV 534
           +++IG G+FG V +A +  DG+++  AIK+  +  +    + F  E EV+  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------LDIFQRLNIMI 579
            ++  C N  +  + +EY P G+L  FL  S  +               L   Q L    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
           DVA+ ++YL+ +     IH DL + NVL+ E++ + ++DFG+++   GE+  + +T    
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
            + +MA E       +T+SD++S+G++L E  +    P   M  AEL  K
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 87.8 bits (217), Expect = 1e-18
 Identities = 69/232 (29%), Positives = 114/232 (49%), Gaps = 30/232 (12%)

Query: 466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMK 516
           P  +LSR     G+   +G G FG V  AE         +  + VA+K+   +   + + 
Sbjct: 5   PKWELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS 62

Query: 517 SFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YS-S 565
               E E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L         YS  
Sbjct: 63  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122

Query: 566 TCMLD----IFQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG 620
           TC L      F+ L +    VA  +EYL    +   IH DL + NVL+ ED +  ++DFG
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           +A+ +   D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 63/224 (28%), Positives = 111/224 (49%), Gaps = 23/224 (10%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVF--HQECARAMKSFEVECEVMKNIRHRN 532
           ++ +  ++G G+FG V+      D   V IK     Q       + + EC+V+K + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY----- 587
           +++       D    +V+EY P G+L  +         I +R N ++D  + L +     
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQIL 111

Query: 588 --LNFRHTTPIIHCDLKSSNVLLDE-DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
             L+  HT  I+H DLK+ N+LLD+  M+  + DFGI+K+LS + ++ T    + T  Y+
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYI 168

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
           +PE    +  + +SDI++ G +L E  + K+  +      L LK
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 13/214 (6%)

Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIK-VFHQECARAMKSFEV-ECEVMKNIRHRNLVKII 537
           N IG GSFG V+K     D    A+K +   +  R  +   + E  V+  +    +++  
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTT 594
               +     +V+EY  NG L   L          D   R  I I +      L   H+ 
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG-----LAHLHSK 120

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            I+H D+KS N+ LD      + D G+AKLLS  D +      + T  Y++PE   ++  
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 655 STRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
           + +SD+++ G++L E  T K P D      L LK
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 29/201 (14%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG G++G VYKA ++  G  VAIKV   E     +  + E  ++K  RH N+V       
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID---VA----SALEYLNFRHTT 594
             D   +V+EY   GSL           DI+Q     +    +A      L+ L + H T
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEYGIE 651
             IH D+K +N+LL ED    L+DFG++  L+    ++ + ++   IG   +MAPE    
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSF--IGTPYWMAPEVAAV 175

Query: 652 RKVS---TRSDIYSYGIMLIE 669
            +      + DI++ GI  IE
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 10/203 (4%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G VY A ++  G EVAIK  + +     +    E  VM+  +H N+V
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 535 KIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
             +      D   +V+EY+  GSL D+   + TCM D  Q   +  +   ALE+L   H+
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCM-DEGQIAAVCRECLQALEFL---HS 133

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             +IH D+KS N+LL  D    L+DFG    ++ E     ++  + T  +MAPE    + 
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKA 191

Query: 654 VSTRSDIYSYGIMLIETFTRKKP 676
              + DI+S GIM IE    + P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 33/224 (14%)

Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 17  RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 76

Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL-----------YSSTC----M 568
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L           Y+ T      
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 569 LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L     ++    VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 137 LSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193

Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 13/204 (6%)

Query: 480 DNLIGIGSFGYVYKA----ELDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLV 534
              IG G FG VY+       ++ I VA+K      + +++  F  E  +M+   H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           K+I   + ++   +V+E  P G L  +L  +   LD+   +     +++AL YL    + 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ESK 126

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM-TQTQTLATIGYMAPEYGIERK 653
             +H D+ + NVL+       L DFG+++ L  ED+S    ++    I +MAPE    R+
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRR 184

Query: 654 VSTRSDIYSYGIMLIETFTR-KKP 676
            ++ SD++ +G+ + E      KP
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 7e-18
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECAR------AMKSFEVECEVMKNIRHRNLVK 535
           IG G++G VYKA     G  VA+K    E  +      A++    E ++++ +RH N+V+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62

Query: 536 II----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           +     S      +  +V EYM +  L   L S        Q    M  +   L+YL   
Sbjct: 63  LKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL--- 116

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE--YG 649
           H+  I+H D+K SN+L++ D +  L+DFG+A+  +    S   T  + T+ Y  PE   G
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLG 175

Query: 650 IERKVSTRSDIYSYGIMLIETFTRK 674
              +     D++S G +L E F  K
Sbjct: 176 -ATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 84.7 bits (209), Expect = 7e-18
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 25/219 (11%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG VYKA+  + G   A KV   +    ++ + VE E++    H  +VK++    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDI---FQRLNIMIDVASALEYLNFRHTTPIIH 598
            D    +++E+ P G++D        ML++        I +     LE L + H+  IIH
Sbjct: 80  WDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIA----KLLSGEDQSMTQTQTLATIGYMAPEYGI---- 650
            DLK+ NVLL  D    L+DFG++    K L   D        + T  +MAPE  +    
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD------SFIGTPYWMAPEVVMCETM 187

Query: 651 -ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
            +     ++DI+S GI LIE    + P  ++    + LK
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.0 bits (210), Expect = 7e-18
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 33/226 (14%)

Query: 477 FGRDNLI-----GIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L+     G G FG V +AE         D  + VA+K+       + +     E 
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68

Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY---------------SST 566
           E+MK I +H+N++ ++  C+ +    +++EY   G+L  FL                   
Sbjct: 69  ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128

Query: 567 CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
             L     ++    VA  +EYL  R     IH DL + NVL+ ED +  ++DFG+A+ + 
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     +     + +MAPE   +R  + +SD++S+GI++ E FT
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 15/208 (7%)

Query: 479 RDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH-----QECARAMKSFEVECEVMKNIRHRN 532
           R  L+G G+FG VY   ++D G E+A K         E ++ + + E E +++KN++H  
Sbjct: 6   RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65

Query: 533 LVKIISGCSNDDFK---ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           +V+   GC  D  +    + +EYMP GS+   L +   + +   R          LE ++
Sbjct: 66  IVQYY-GCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY----TRQILEGMS 120

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY-MAPEY 648
           + H+  I+H D+K +N+L D      L DFG +K L     S T  +++    Y M+PE 
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKP 676
                   ++D++S G  ++E  T K P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.3 bits (208), Expect = 1e-17
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 11/214 (5%)

Query: 479 RDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRN 532
           R  ++G G+FG VYK   + +G    I VAIK+ ++    +A   F  E  +M ++ H +
Sbjct: 11  RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 70

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           LV+++  C +   + LV + MP+G L  +++     +     LN  + +A  + YL  R 
Sbjct: 71  LVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
              ++H DL + NVL+       ++DFG+A+LL G+++          I +MA E    R
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 653 KVSTRSDIYSYGIMLIETFT-RKKPADKMFAAEL 685
           K + +SD++SYG+ + E  T   KP D +   E+
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVF-----HQECARAMKSFEVECEVMKNIRHRNLVK 535
           L+G GSFG VY+   LDDG   A+K        Q    A+K  E E  ++  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
            +     +D   + LE +P GSL   L                  +   LEYL+ R+T  
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT-- 123

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEYGIER 652
            +H D+K +N+L+D + +  L+DFG+AK      Q +  +   +  G   +MAPE  I +
Sbjct: 124 -VHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEV-IAQ 175

Query: 653 K--VSTRSDIYSYGIMLIETFTRKKP 676
           +      +DI+S G  ++E  T K P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 56/198 (28%), Positives = 107/198 (54%), Gaps = 14/198 (7%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    ++  +VA+K   +    ++++F  E  +MK ++H  LV++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-NIMIDVASALEYLNFRHTTPIIHCDL 601
           ++   ++ EYM  GSL  FL S      +  +L +    +A  + Y+  ++    IH DL
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 129

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++NVL+ E ++  ++DFG+A+++  ED   T  +     I + APE   +G     + +
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFG---SFTIK 184

Query: 658 SDIYSYGIMLIETFTRKK 675
           SD++S+GI+L E  T  K
Sbjct: 185 SDVWSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 25/215 (11%)

Query: 479 RDNLIGIGSFGYVYKA-ELDDGIEVAIKVF---------HQECARAM-KSFEVECEVMKN 527
           +  LIG G++G VY A  +  G  +A+K           H    + M K+   E E +K+
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 528 IRHRNLVKIISGCSN-DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALE 586
           + H N+V+ + G    +++ ++ LEY+P GS+     S       F+   +       LE
Sbjct: 65  LDHLNIVQYL-GFETTEEYLSIFLEYVPGGSIG----SCLRTYGRFEEQLVRFFTEQVLE 119

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL---LSGEDQSMTQTQTLATIGY 643
            L + H+  I+H DLK+ N+L+D D I  +SDFGI+K    +   DQ+M+      ++ +
Sbjct: 120 GLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFW 176

Query: 644 MAPE--YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           MAPE  +   +  S + DI+S G +++E F  ++P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 482 LIGIGSFGYVYKAEL----DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVK 535
           ++G G FG V +A+L        +VA+K+   +   +  ++ F  E   MK   H N++K
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 536 IISGCSNDDFKA------LVLEYMPNGSLDIFLYSSTCMLDIFQ-----RLNIMIDVASA 584
           +I        K       ++L +M +G L  FL  S    + F       +  MID+AS 
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           +EYL+ ++    IH DL + N +L+E+M   ++DFG++K +   D       +   + ++
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTR 673
           A E   +   +T SD++++G+ + E  TR
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 67/229 (29%), Positives = 116/229 (50%), Gaps = 27/229 (11%)

Query: 481 NLIGIGSFGYVYKAEL-DDGI--EVAIKVFHQECARA-MKSFEVECEVMKNI-RHRNLVK 535
           ++IG G+FG V KA +  DG+  + AIK   +  ++   + F  E EV+  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFL---------------YSSTCMLDIFQRLNIMID 580
           ++  C +  +  L +EY P+G+L  FL                S+   L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  ++YL+ +     IH DL + N+L+ E+ +A ++DFG+++   G++  + +T     
Sbjct: 133 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           + +MA E       +T SD++SYG++L E  +    P   M  AEL  K
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 33/226 (14%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 12  FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71

Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL-----------YSSTCMLD 570
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L           Y    + D
Sbjct: 72  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131

Query: 571 ---IFQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    VA  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 31/222 (13%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVF------HQECARAMKSFEVECEVMKNIRHRNLV 534
            +G GS+G VYK + L D    A+K         +E   A+     E  ++ ++ H N++
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN----EIRILASVNHPNII 62

Query: 535 KIISGCSNDDF-----KALVLEYMPNGSLDIFLYSSTCMLDIFQR---LNIMIDVASALE 586
                   + F       +V+EY P G L   +        +        I I +   L+
Sbjct: 63  -----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L   H   I+H DLKS+N+LL  + +  + D GI+K+L    ++M +TQ   T  YMAP
Sbjct: 118 AL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYMAP 170

Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
           E    R  S +SDI+S G +L E  T   P +     +L  K
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)

Query: 463 RRLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKA------ELDDGIEVAIKVFHQEC 511
            +LPY DL      F R+NL     +G G+FG V +A      + D  ++VA+K+  +  
Sbjct: 22  TQLPY-DLKW---EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPT 76

Query: 512 ARA--MKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS-STC 567
           A +   ++   E ++M ++  H N+V ++  C+      ++ EY   G L  FL      
Sbjct: 77  AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES 136

Query: 568 MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG 627
            L +   L+    VA  + +L  ++    IH DL + NVLL    I  + DFG+A+ +  
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMN 193

Query: 628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           +   + +      + +MAPE       +  SD++SYGI+L E F+
Sbjct: 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 27/226 (11%)

Query: 481 NLIGIGSFGYVYKAELD-DGIEV--AIKVFHQECARA-MKSFEVECEVMKNI-RHRNLVK 535
           ++IG G+FG V KA +  DG+ +  AIK   +  ++   + F  E EV+  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------LDIFQRLNIMID 580
           ++  C +  +  L +EY P+G+L  FL  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  ++YL+ +     IH DL + N+L+ E+ +A ++DFG+++   G++  + +T     
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAEL 685
           + +MA E       +T SD++SYG++L E  +    P   M  AEL
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 220

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 15/207 (7%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRN 532
             F     IG GSFG VYKA +      VAIKV   E A   ++  + E + +   R   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 533 LVKIISGCSNDDFK-ALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
           + K   G      K  +++EY   GS LD+        LD      I+ +V   LEYL  
Sbjct: 61  ITKYY-GSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYL-- 114

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYG 649
            H    IH D+K++N+LL E+    L+DFG++  L+    +M++  T   T  +MAPE  
Sbjct: 115 -HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNTFVGTPFWMAPEVI 170

Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP 676
            +     ++DI+S GI  IE    + P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 29/212 (13%)

Query: 483 IGIGSFGYVYKAEL--DDGI-EVAIKVFHQE-CARA-MKSFEVECEVMKNIRHRNLVKII 537
           +G G FG V + +L  DD I +VA+K      C R+ M+ F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 538 SGC----SNDDFKA--LVLEYMPNGSLDIFL----------YSSTCMLDIFQRLNIMIDV 581
             C     ++ + +  ++L +M +G L  FL          Y  T ML  F     M D+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-----MTDI 121

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           AS +EYL+   +   IH DL + N +L+E+M   ++DFG++K +   D           +
Sbjct: 122 ASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTR 673
            ++A E   +R  +T+SD++S+G+ + E  TR
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 479 RDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECARAMKSFEVECE---VMKNIRH 530
           +  L+G G FG V+K   + +G    I VAIK       R  ++F+   +    M ++ H
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDH 68

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             +V+++  C     + LV +  P GSL   +      LD  + LN  + +A  + YL  
Sbjct: 69  AYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE- 126

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H   ++H +L + N+LL  D I  ++DFG+A LL  +D+    ++    I +MA E  +
Sbjct: 127 EHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 651 ERKVSTRSDIYSYGIMLIETFT 672
             + + +SD++SYG+ + E  +
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 21/217 (9%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG VYKA+  + G+  A KV   +    ++ + VE +++ +  H N+VK++    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVASALEYLNFRHTTPIIH 598
            ++   +++E+   G++D        ML++ + L    I +     LE LN+ H   IIH
Sbjct: 73  YENNLWILIEFCAGGAVD------AVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGI-----E 651
            DLK+ N+L   D    L+DFG+    S ++    Q +   + T  +MAPE  +     +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
           R    ++D++S GI LIE    + P  ++    + LK
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 69/301 (22%), Positives = 132/301 (43%), Gaps = 60/301 (19%)

Query: 469 DLSRATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKS-FEVE 521
           +++ +T RF  +  +G   FG VYK  L      +    VAIK    +    ++  F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR------- 574
             +   ++H N+V ++   + +   +++  Y  +  L  FL   +   D+          
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 575 --------LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
                   ++I+  +A+ +E+L+  H   ++H DL + NVL+ + +   +SD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS 686
             D       +L  I +M+PE  +  K S  SDI+SYG++L E F+              
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY------------- 222

Query: 687 LKHWVNGLLPV------SLMEVV-NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEK 739
                 GL P        ++E++ N+ +L  P       + C   +++L +EC  E P +
Sbjct: 223 ------GLQPYCGYSNQDVIEMIRNRQVLPCP-------DDCPAWVYTLMLECWNEFPSR 269

Query: 740 R 740
           R
Sbjct: 270 R 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 19/212 (8%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH-----QECARAMKSFEVECEVMKNIR 529
           R G+  L+G G+FG VY   + D G E+A+K         E ++ + + E E +++KN+ 
Sbjct: 5   RLGK--LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 530 HRNLVKIISGCSNDDFK---ALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASAL 585
           H  +V+   GC  D  +   ++ +E+MP GS+   L S   + + + ++    I     L
Sbjct: 63  HERIVQYY-GCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----L 116

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY-M 644
           E +++ H+  I+H D+K +N+L D      L DFG +K L     S T  +++    Y M
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           +PE         ++DI+S G  ++E  T K P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 54/213 (25%), Positives = 103/213 (48%), Gaps = 16/213 (7%)

Query: 479 RDNLIGIGSFGYVYKAELDDGIEVAIK--VFHQE----CARAMKSFEVECEVMKNIRHRN 532
           +  ++G G++G VY    + G  +A+K             +  +  + E +++K+++H N
Sbjct: 4   KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFR 591
           +V+ +  C +D+  ++ +E++P GS+   L     + +  F +    I     L+ + + 
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI-----LDGVAYL 118

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG----YMAPE 647
           H   ++H D+K +NV+L  + I  L DFG A+ L+      T +  L ++     +MAPE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKPADKM 680
              E     +SDI+S G  + E  T K P   M
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 11/204 (5%)

Query: 481 NLIGIGSFGYVYKAELDDG----IEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLVK 535
            +IG G FG VY   L D     I  A+K  ++      ++ F  E  +MK+  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 536 IISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++  C   +   LV L YM +G L  F+ S T    +   +   + VA  +EYL  +   
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK-- 118

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAK-LLSGEDQSMTQ-TQTLATIGYMAPEYGIER 652
             +H DL + N +LDE     ++DFG+A+ +   E  S+   T     + +MA E    +
Sbjct: 119 -FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
           K +T+SD++S+G++L E  TR  P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 36/220 (16%)

Query: 483 IGIGSFGYVYKAELDDGIE---------------VAIKVFHQECAR-AMKSFEVECEVMK 526
           +G G FG V+  E +   E               VA+K+   +  + A   F  E ++M 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 527 NIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL-----YSSTCM------LDIFQRL 575
            +++ N+++++  C +DD   ++ EYM NG L+ FL      S+         + I   L
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 576 NIMIDVASALEYL---NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM 632
            + + +AS ++YL   NF      +H DL + N L+       ++DFG+++ L   D   
Sbjct: 133 YMAVQIASGMKYLASLNF------VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            Q + +  I +MA E  +  K +T SD++++G+ L E FT
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.8 bits (198), Expect = 3e-16
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 28/211 (13%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE---------CARAMKSFEVECEVMK 526
           + +   +G G++G VYKA +   G  VA+K    +           R     E+    +K
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-----EISL--LK 53

Query: 527 NIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALE 586
            ++H N+VK++     +    LV EY     L  +L      L      +IM  +   L 
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           Y    H+  I+H DLK  N+L++ D +  L+DFG+A+      ++   T  + T+ Y AP
Sbjct: 113 YC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAP 167

Query: 647 EYGI---ERKVSTRSDIYSYGIMLIETFTRK 674
           E  I    +  ST  DI+S G +  E  T K
Sbjct: 168 E--ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 29/199 (14%)

Query: 483 IGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           +G GSFG V         +  A+K+  +     +K  E    E  ++++IRH  LV +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI------DVASALEYLNFRH 592
              +D    LV+EY+P G  ++F +     L    R    +       V  ALEYL   H
Sbjct: 69  SFQDDSNLYLVMEYVPGG--ELFSH-----LRKSGRFPEPVARFYAAQVVLALEYL---H 118

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIE 651
           +  I++ DLK  N+LLD D    ++DFG AK + G      +T TL  T  Y+APE  I 
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAPEI-IL 171

Query: 652 RKVSTRS-DIYSYGIMLIE 669
            K   ++ D ++ GI++ E
Sbjct: 172 SKGYGKAVDWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRHR 531
                  IG GS G V  A +   G +VA+K       R  +  E+   E  +M++ +H 
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHP 76

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
           N+V++ S     D   +V+E++  G+L DI  ++    ++  Q   + + V  AL +L  
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFL-- 131

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY-MAPEYG 649
            H   +IH D+KS ++LL  D    LSDFG    +S E   + + ++L    Y MAPE  
Sbjct: 132 -HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEV- 186

Query: 650 IERK-VSTRSDIYSYGIMLIE 669
           I R    T  DI+S GIM+IE
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 19/212 (8%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVF-----HQECARAMKSFEVECEVMKNIR 529
           R G+  L+G G+FG VY   + D G E+A+K        QE ++ + + E E +++KN+R
Sbjct: 5   RLGK--LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 530 HRNLVKIISGCSNDDFK---ALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASAL 585
           H  +V+   GC  D  +   ++ +EYMP GS+   L +   + + + +R    I     L
Sbjct: 63  HDRIVQYY-GCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI-----L 116

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY-M 644
           + +++ H+  I+H D+K +N+L D      L DFG +K +     S T  +++    Y M
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           +PE         ++D++S    ++E  T K P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 23/220 (10%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV----ECEVM 525
            R  ++F     IG G++G VYKA + D G  VA+K    +  +  + F +    E +++
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 526 KNIRHRNLVKIISGCSND----DFKA------LVLEYMPNGSLDIFLYSSTCMLDIFQRL 575
           + + HRN+V +    ++     DFK       LV EYM +   D+     + ++  F   
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVH-FSED 116

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
           +I   +   LE LN+ H    +H D+K SN+LL+      L+DFG+A+L + E+     T
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YT 175

Query: 636 QTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRK 674
             + T+ Y  PE  + E +     D++S G +L E FT+K
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 39/231 (16%)

Query: 483 IGIGSFGYVYKAELDDGIE-----------------VAIKVFHQECAR-AMKSFEVECEV 524
           +G G FG V+  E D   +                 VA+KV   + +  A + F  E ++
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY------SSTCM----LDIFQR 574
           +  +   N+ +++  C+ D    +++EYM NG L+ FL       S        L     
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 575 LNIMIDVASALEYL---NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           L +   +AS + YL   NF      +H DL + N L+ ++    ++DFG+++ L   D  
Sbjct: 133 LYMATQIASGMRYLESLNF------VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT--RKKPADKM 680
             Q +    I +MA E  +  K +T+SD++++G+ L E  T  R++P + +
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 78.6 bits (193), Expect = 8e-16
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 8/202 (3%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G VY A ++  G EVAI+  + +     +    E  VM+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
             +      D   +V+EY+  GSL   + + TCM D  Q   +  +   ALE+L   H+ 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSN 135

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +IH D+KS N+LL  D    L+DFG    ++ E     ++  + T  +MAPE    +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAY 193

Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + DI+S GIM IE    + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 8/202 (3%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G VY A ++  G EVAIK  + +     +    E  VM+  ++ N+V
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
             +      D   +V+EY+  GSL   + + TCM        I       L+ L+F H+ 
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM----DEGQIAAVCRECLQALDFLHSN 134

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +IH D+KS N+LL  D    L+DFG    ++ E QS   T  + T  +MAPE    +  
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAY 192

Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + DI+S GIM IE    + P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 62/221 (28%), Positives = 116/221 (52%), Gaps = 24/221 (10%)

Query: 480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +  +G G FG V+ A  +   +VA+K   +  + ++++F  E  VMK ++H  LVK+ + 
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID----VASALEYLNFRHTTP 595
            + +    ++ E+M  GSL  FL S        Q L  +ID    +A  + ++  R+   
Sbjct: 70  VTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRN--- 122

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIE 651
            IH DL+++N+L+   ++  ++DFG+A+++  ED   T  +     I + APE   +G  
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFG-- 178

Query: 652 RKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAEL--SLKH 689
              + +SD++S+GI+L+E  T  + P   M   E+  +L+ 
Sbjct: 179 -SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.1 bits (189), Expect = 2e-15
 Identities = 68/202 (33%), Positives = 101/202 (50%), Gaps = 8/202 (3%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G V+ A ++  G EVAIK  + +     +    E  VMK +++ N+V
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
             +      D   +V+EY+  GSL   + + TCM D  Q   +  +   ALE+L   H  
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCM-DEAQIAAVCRECLQALEFL---HAN 134

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +IH D+KS NVLL  D    L+DFG    ++ E QS   T  + T  +MAPE    +  
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAY 192

Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + DI+S GIM IE    + P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 16/211 (7%)

Query: 472 RATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR---AMKSFEVECEVMKN 527
           R+   F + N IG G++G VY+A +   G  VA+K    +  R    + S   E  ++ N
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLN 62

Query: 528 IRHRNLV---KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
           +RH N+V   +++ G   D    LV+EY     L   L +        Q   +M+ +   
Sbjct: 63  LRHPNIVELKEVVVGKHLDSI-FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           L+YL   H   IIH DLK SN+LL +     ++DFG+A+      + M  T  + T+ Y 
Sbjct: 121 LQYL---HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYR 175

Query: 645 APEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
           APE  +     T + D+++ G +L E    K
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 28/214 (13%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVA---IKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           IG G F  VYKA  L DG  VA   +++F    A+A +    E +++K + H N++K ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID----------VASALEYL 588
               ++   +VLE    G L       + M+  F++   +I           + SALE++
Sbjct: 70  SFIENNELNIVLELADAGDL-------SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H+  I+H D+K +NV +    +  L D G+ +  S   ++      + T  YM+PE 
Sbjct: 123 ---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPER 177

Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKP--ADKM 680
             E   + +SDI+S G +L E    + P   DKM
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 71/266 (26%), Positives = 121/266 (45%), Gaps = 31/266 (11%)

Query: 482 LIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           ++G G+FG VYK   + DG    I VAIKV  +  + +A K    E  VM  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           ++  C     + LV + MP G L  ++  +   +     LN  + +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVR 129

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           ++H DL + NVL+       ++DFG+A+LL  ++           I +MA E  + R+ +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 656 TRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD 714
            +SD++SYG+ + E  T   KP D + A E+             L+E   + L  PP   
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-----------DLLE-KGERLPQPP--- 234

Query: 715 FAAKEQCVLSIFSLAMECTMELPEKR 740
                 C + ++ + ++C M   E R
Sbjct: 235 -----ICTIDVYMIMVKCWMIDSECR 255

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.3 bits (193), Expect = 8e-15
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 18/215 (8%)

Query: 497 DDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKII-SGCSNDDFKALVLEY 552
             G EVAIK+      E       F  E  +   + H N+V ++ SG +       V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---D 609
           +P  +L   L ++   L   +   +M+ V   L+ L   H   I+H DLK  N+++    
Sbjct: 61  VPGRTLREVL-AADGALPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTG 116

Query: 610 EDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IG---YMAPEYGIERKVSTRSDIYSYG 664
               A + DFGI  LL G   +   T T  T  +G   Y APE      V+  SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 665 IMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSL 699
           ++ +E  T ++       AE+  +      + VSL
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQL--SPVDVSL 209

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 15/207 (7%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIK-VFHQECARAMKSFEV----ECEVMKNIR 529
           R+ +   +G G++  VYKA   + G  VAIK +   E   A          E ++++ ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H N++ ++    +     LV E+M    L+  +   + +L      + M+     LEYL 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL- 118

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE-- 647
             H+  I+H DLK +N+L+  D +  L+DFG+A+     ++ MT  Q + T  Y APE  
Sbjct: 119 --HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAPELL 174

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRK 674
           +G  R      D++S G +  E   R 
Sbjct: 175 FG-ARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 20/201 (9%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ------ECARAMKSFEVECEVMKNIRHRNLVK 535
           IG G++G VYKA +   G  VAIK              A++    E +++K + H N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           ++    +     LV E+M +  L   +      L      + +  +   L +    H+  
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC---HSHG 118

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE--YGIERK 653
           I+H DLK  N+L++ + +  L+DFG+A+           T  + T  Y APE   G ++ 
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLG-DKG 175

Query: 654 VSTRSDIYSYGIMLIETFTRK 674
            ST  DI+S G +  E  +R+
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 66/247 (26%), Positives = 119/247 (48%), Gaps = 15/247 (6%)

Query: 483 IGIGSFG--YVYKAELDDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G+FG   +Y+   DD + V  +V     + +  +    E  ++  ++H N++   + 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 540 CSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
             +D+   + +EY   G+L D  +     + +    L  +  + SA+ Y+   H   I+H
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILH 124

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K+ N+ L +  +  L DFGI+K+L G + SM +T  + T  YM+PE     K + +S
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQGVKYNFKS 182

Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLK----HWVNGLLPVS--LMEVVNKTLLSPPE 712
           DI++ G +L E  T K+  D      L +K    ++   +   S  L+ +V+  L   PE
Sbjct: 183 DIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPE 242

Query: 713 KDFAAKE 719
           K   A E
Sbjct: 243 KRPTADE 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 37/205 (18%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH---------QECARAMKSFEVECEVMKNIRHRN 532
           IG G+ G V+KA + + G  VA+K             +  R       E + ++  +H  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-------EIKALQACQHPY 60

Query: 533 LVKII------SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALE 586
           +VK++      SG        LV+EYMP   L   L      L   Q  + M  +   + 
Sbjct: 61  VVKLLDVFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           Y+   H   I+H DLK +N+L+  D +  ++DFG+A+L S E+     +  +AT  Y AP
Sbjct: 114 YM---HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAP 169

Query: 647 E--YGIERKVSTRSDIYSYGIMLIE 669
           E  YG  RK     D+++ G +  E
Sbjct: 170 ELLYG-ARKYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 55/232 (23%), Positives = 105/232 (45%), Gaps = 42/232 (18%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL-----------------DDGIEVAIKVFHQECAR- 513
           F R  L     +G G FG V+  E                  +  + VA+K+  ++  + 
Sbjct: 2   FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61

Query: 514 AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL----------Y 563
           A   F  E ++M  ++  N++++++ C   D   ++ EYM NG L+ FL           
Sbjct: 62  ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 564 SSTCMLDIFQRLNIMIDVASALEYL---NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG 620
           +    +     + +   +AS ++YL   NF      +H DL + N L+ ++    ++DFG
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNF------VHRDLATRNCLVGKNYTIKIADFG 175

Query: 621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           +++ L   D    Q + +  I +M+ E  +  K +T SD++++G+ L E  T
Sbjct: 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 24/216 (11%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL----DDGIE--VAIKVF-HQECARAMKSFEVECEV 524
           F R NL     +G G FG V+ A+     ++G E  V +K     +       F  E ++
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM--------LDIFQRLN 576
            + + H+N+V+++  C   +   ++LEY   G L  FL ++           L   Q++ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 577 IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           +   +A  +++L        +H DL + N L+       +S   ++K +   +    +  
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-N 177

Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            L  + ++APE   E   ST+SD++S+G+++ E FT
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 45/291 (15%)

Query: 401 VPQCKHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQA 460
           +P     T     ++   L + LP     +AV  L L   S+    S+  S  G     A
Sbjct: 12  LPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVP-LPLPPPSSSSSSSSSSSASG----SA 66

Query: 461 TKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMK 516
                   +L R        N IG G+ G VYK      G   A+KV    H++  R  +
Sbjct: 67  PSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--R 117

Query: 517 SFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN 576
               E E+++++ H N+VK      ++    ++LE+M  GSL+      T + D     +
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-----GTHIADEQFLAD 172

Query: 577 IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-T 635
           +   + S + YL+ RH   I+H D+K SN+L++      ++DFG++++L+   Q+M    
Sbjct: 173 VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA---QTMDPCN 226

Query: 636 QTLATIGYMAPEYGIERKVST----------RSDIYSYGIMLIETFTRKKP 676
            ++ TI YM+PE     +++T            DI+S G+ ++E +  + P
Sbjct: 227 SSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 53/223 (23%), Positives = 101/223 (45%), Gaps = 33/223 (14%)

Query: 480 DNLIGIGSFGYVYKAE------LDDGIEVAIKVFHQECARA-MKSFEVECEVMKNIRHRN 532
              +G G FG V KA             VA+K+  +  + + ++    E  ++K + H +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-----------------------L 569
           ++K+   CS D    L++EY   GSL  FL  S  +                       L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
            +   ++    ++  ++YL       ++H DL + NVL+ E     +SDFG+++ +  ED
Sbjct: 125 TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + +++    + +MA E   +   +T+SD++S+G++L E  T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 23/208 (11%)

Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIKVFH-QECARAMKSFEV-ECEVMKNIR---HRNLV 534
             IG G++G VYKA +L+ G  VA+K          +    + E  ++K +    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 535 KIISGCSNDDFK-----ALVLEYMPNGSLDIFLYSSTCM---LDIFQRLNIMIDVASALE 586
           +++  C            LV E++     D+  Y S C    L      ++M  +   ++
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           +L   H+  I+H DLK  N+L+  D    ++DFG+A++ S E   M  T  + T+ Y AP
Sbjct: 122 FL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWYRAP 175

Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRK 674
           E  ++   +T  D++S G +  E F R+
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 13/208 (6%)

Query: 477 FGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFH-QECARAMKSFEVECEVMKNIRHRNL 533
           F +   IG GSFG V+K  +D+  +  VAIK+   +E    ++  + E  V+       +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 534 VKIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            K            +++EY+  GS LD+         D FQ   ++ ++   L+YL   H
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYL---H 118

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +   IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   + 
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQS 176

Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKM 680
              +++DI+S GI  IE    + P   M
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 70/253 (27%), Positives = 109/253 (43%), Gaps = 31/253 (12%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAM-KSFEVECEVMKNIRHRNLVKIISGC 540
           +G G+ G V K + +  G  +A KV H     ++ K    E ++M   R   +V      
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 541 SNDDFKALVLEYMPNGSLD-IFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
            N++   + +E+M  GSLD I+       ++I  +  I + V   L YL   H   I+H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHR 128

Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
           D+K SN+L++      L DFG+    SGE   S+  T  + T  YM+PE     K + +S
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGV----SGELINSIADT-FVGTSTYMSPERIQGGKYTVKS 183

Query: 659 DIYSYGIMLIETFTRKKP------ADKMFAAELS----LKHWVN--------GLLPVSLM 700
           D++S GI +IE    K P       D      +     L+  V            P  L 
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243

Query: 701 EVVNKTLLSPPEK 713
           + V+  LL  P +
Sbjct: 244 DFVDACLLKDPTE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIRH 530
           + R  LIG G++G VY+   +  G  VA+K+ + +        +V     E  ++  +R 
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQ 58

Query: 531 RNLVKIIS--GCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
                I    G      +  +++EY   GS+   + +   + + +  + I+ +V  AL+Y
Sbjct: 59  SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-PIAEKYISV-IIREVLVALKY 116

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY-MAP 646
           +   H   +IH D+K++N+L+       L DFG+A LL+   Q+ ++  T     Y MAP
Sbjct: 117 I---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAP 170

Query: 647 EYGIE-RKVSTRSDIYSYGIMLIETFTRKKP 676
           E   E +   T++DI+S GI + E  T   P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 20/175 (11%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQ--ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           ++G G++G V K      G  VAIK F +  +     K+   E +V++ +RH N+V +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCM------LDIFQRLNIMIDVASALEYLNFRH 592
                    LV EY+    L++   S   +        I+Q L        A+ Y    H
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ-------AIAYC---H 117

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           +  IIH D+K  N+L+ E  +  L DFG A+ L     S   T  +AT  Y APE
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 66/234 (28%), Positives = 96/234 (41%), Gaps = 36/234 (15%)

Query: 470 LSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI 528
           L   T  F    +IG G++G VYKA     G  VAIK+         +  + E  +++  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59

Query: 529 -RHRNLVKIISGC-------SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN---- 576
             H N+     G         NDD   LV+E    GS+   L          +RL     
Sbjct: 60  SNHPNIATF-YGAFIKKNPPGNDDQLWLVMELCGGGSV-TDLVKGL--RKKGKRLKEEWI 115

Query: 577 --IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ 634
             I+ +    L YL+      +IH D+K  N+LL ++    L DFG++  L   D ++ +
Sbjct: 116 AYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGR 169

Query: 635 TQTLATIG---YMAPE-----YGIERKVSTRSDIYSYGIMLIETFTRKKPADKM 680
             T   IG   +MAPE        +     RSD++S GI  IE    K P   M
Sbjct: 170 RNT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 14/204 (6%)

Query: 477 FGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFH-QECARAMKSFEVECEVMKNIRHRNL 533
           F +   IG GSFG V+K  +D+  +  VAIK+   +E    ++  + E  V+       +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 534 VKIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            K       D    +++EY+  GS LD+        LD  Q   I+ ++   L+YL   H
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYL---H 118

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +   IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   + 
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQS 176

Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
              +++DI+S GI  IE   + +P
Sbjct: 177 AYDSKADIWSLGITAIE-LAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 22/201 (10%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQ-ECARAMKSFEV-ECEVMKNIRHRNLVKIIS 538
           L+G GS+G V K +  + G  VAIK F + E  + +K   + E  ++K +RH NLV +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
                    LV E++ +  LD  L      LD  +    +  +   +E+    H+  IIH
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFC---HSHNIIH 123

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE-------YGIE 651
            D+K  N+L+ +  +  L DFG A+ L+   +    T  +AT  Y APE       YG  
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYG-- 179

Query: 652 RKVSTRSDIYSYGIMLIETFT 672
           R V    DI++ G ++ E  T
Sbjct: 180 RAV----DIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 483 IGIGSFGYVYKAELDDGIE-VAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           IG GSFG VY A      E VAIK       ++ + ++    E   ++ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY-K 81

Query: 539 GCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDI----FQRLNIMIDVASALEYLNFRHT 593
           GC   +  A LV+EY         L S++ +L++     Q + I      AL+ L + H+
Sbjct: 82  GCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI--- 650
              IH D+K+ N+LL E     L+DFG A L+S  +        + T  +MAPE  +   
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMD 187

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFA 682
           E +   + D++S GI  IE   RK P   M A
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 72.3 bits (178), Expect = 7e-14
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)

Query: 483 IGIGSFGYVYKAELD-DGIEVAIKV--FHQECARAM-KSFEVECEVMKNIRHRNLVKIIS 538
           I  G++G V+ A+    G   AIKV        +        E +++   +   +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
                    LV+EY+P G L   L +   + +   R   + ++  ALEYL   H+  IIH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR-IYIAEIVLALEYL---HSNGIIH 116

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ------TQTLATIGYMAPEYGIER 652
            DLK  N+L+D +    L+DFG++K+     Q           + + T  Y+APE  + +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 653 KVSTRSDIYSYGIMLIETFT 672
             S   D +S G +L E   
Sbjct: 177 GHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARA----MKSFEVECEVMKNIRHRNLVKIIS 538
           IG G FG V   E   G+  A  V  +  A A       F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCML------DIFQRLNIMIDVASALEYLNFRH 592
            C       LVLE+ P G L  +L S+  M+      D+ QR+    +VAS L +L   H
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWL---H 117

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
               IH DL   N  L  D+   + D+G+A     ED  +T+      + ++APE    R
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 653 -------KVSTRSDIYSYGIMLIETFT 672
                    + +S+I+S G+ + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 20/208 (9%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQ------ECARAMKSFEVECEVMKNIRHRNLV 534
            +G G+F   Y+A ++  G  +A+K          E    +++   E  +M  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR---LNIMIDVASALEYLNFR 591
           +++     D    L +E+M  GS+   L         F+    +N    +   L YL   
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYL--- 119

Query: 592 HTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLS--GEDQSMTQTQTLATIGYMAPEY 648
           H   IIH D+K +N+L+D       ++DFG A  L+  G      Q Q L TI +MAPE 
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKP 676
               +     D++S G ++IE  T K P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 57/237 (24%), Positives = 113/237 (47%), Gaps = 41/237 (17%)

Query: 469 DLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE-----------------VAIKVFHQEC 511
              R    F ++ L G G FG V+  E+ +  +                 VA+K+   + 
Sbjct: 1   KFPRGHLLF-KEKL-GEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA 58

Query: 512 AR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS------ 564
            + A   F  E +++  ++  N+++++  C ++D   ++ EYM NG L+ FL S      
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118

Query: 565 ----------STCMLDI-FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM 612
                     + C+  I +  L ++ + +AS ++YL+   +   +H DL + N L+ E++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENL 175

Query: 613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
              ++DFG+++ L   D    Q + +  I +MA E  +  K +T SD++++G+ L E
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 12/205 (5%)

Query: 476 RFGRDNL--IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN 532
           R   D+   IG GS G V  A E   G +VA+K       +  +    E  +M++  H N
Sbjct: 21  REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           +V + +     D   +V+E++  G+L DI  ++    ++  Q   + + V  AL YL   
Sbjct: 81  VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYL--- 134

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   +IH D+KS ++LL  D    LSDFG    +S E     +   + T  +MAPE    
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISR 192

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
               T  DI+S GIM+IE    + P
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 28/220 (12%)

Query: 477 FGRDNLIGIGSFGYVYKAE-LDDGIEVAIK---VFHQECARAMKSFEVECEVMKNIRHRN 532
           F  +  IG G F  VY+A  L DG+ VA+K   +F    A+A      E +++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI----------DVA 582
           ++K  +    D+   +VLE    G L       + M+  F++   +I           + 
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDL-------SRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           SALE++   H+  ++H D+K +NV +    +  L D G+ +  S   ++      + T  
Sbjct: 117 SALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPY 171

Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP--ADKM 680
           YM+PE   E   + +SDI+S G +L E    + P   DKM
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRN 532
             R   +G G+FG V+   +       A+KV        +K  +    E  V+K + H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFL-----YSSTCMLDIFQRLNIMIDVASALEY 587
           ++++     +  F  +++EY+P G L  +L     +S++  L  F    I+     ALEY
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL--FYASEIV----CALEY 116

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAP 646
           L   H+  I++ DLK  N+LLD++    L+DFG AK L        +T TL  T  Y+AP
Sbjct: 117 L---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWTLCGTPEYLAP 167

Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFTRKKP 676
           E  I+ K   ++ D ++ GI++ E      P
Sbjct: 168 EV-IQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 53/222 (23%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFH-----QECARAMKSFEVECEVMKNIRHRNLVK 535
            IG G+ G VYK      G  +A+K        +E  R +   +V   V+K+     +VK
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV---VLKSHDCPYIVK 78

Query: 536 IISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLN----------IMIDVASA 584
              G    D    + +E M           STC+  + +R+           + + +  A
Sbjct: 79  CY-GYFITDSDVFICMELM-----------STCLDKLLKRIQGPIPEDILGKMTVAIVKA 126

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           L YL  +H   +IH D+K SN+LLD      L DFGI+  L     S  +T++     YM
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYM 181

Query: 645 APE----------YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           APE          Y I      R+D++S GI L+E  T + P
Sbjct: 182 APERIDPPDPNPKYDI------RADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 72/256 (28%), Positives = 117/256 (45%), Gaps = 35/256 (13%)

Query: 463 RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVE 521
           RR P +D       F     IG G++G VYKA  ++ G   AIKV   E        + E
Sbjct: 4   RRNPQED-------FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQE 56

Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMID 580
             +MK+ +H N+V         D   + +E+   GSL DI  Y  T  L   Q   +  +
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDI--YHVTGPLSESQIAYVSRE 114

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LA 639
               L YL   H+   +H D+K +N+LL ++    L+DFG++  ++    ++ + ++ + 
Sbjct: 115 TLQGLYYL---HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA---TIAKRKSFIG 168

Query: 640 TIGYMAPEY-GIERK--VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP 696
           T  +MAPE   +ERK   +   DI++ GI  IE    + P   MF            L P
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP---MF-----------DLHP 214

Query: 697 VSLMEVVNKTLLSPPE 712
           +  + ++ K+   PP+
Sbjct: 215 MRALFLMTKSNFQPPK 230

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIK---VFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           IG G F  VY+A  L D   VA+K   +F    A+A +    E +++K + H N++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI----------DVASALEYL 588
               D+   +VLE    G L       + M+  F++   +I           + SA+E++
Sbjct: 70  SFIEDNELNIVLELADAGDL-------SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H+  ++H D+K +NV +    +  L D G+ +  S +  +      + T  YM+PE 
Sbjct: 123 ---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPER 177

Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKP--ADKM 680
             E   + +SDI+S G +L E    + P   DKM
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.9 bits (172), Expect = 8e-13
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 37/215 (17%)

Query: 481 NLIGIGSFGYVYKAE-LDDGIEVAIK----VFH--QECARAMKSFEVECEVMKNIRHRNL 533
             IG G++G V  A     G +VAIK    VF    +  R ++    E ++++++RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 534 VK---IISGCSNDDFKAL--VLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEY 587
           +    I+   S +DF  +  V E M    L   + S      D  Q    +  +   L+Y
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY--FLYQILRGLKY 118

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIGYMAP 646
           L   H+  +IH DLK SN+L++ +    + DFG+A+ +  ++      T+ + T  Y AP
Sbjct: 119 L---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175

Query: 647 E-------YGIERKVSTRSDIYSYGIMLIETFTRK 674
           E       Y      +   DI+S G +  E  TRK
Sbjct: 176 ELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 8e-13
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 49/236 (20%)

Query: 482 LIGIGSFGYVYKAELDDGIE----VAIKVFHQ-ECARAMKSF---EVECEVMKNIRHRNL 533
           ++G G +G V++     G +     A+KV  +    R  K     + E  +++ ++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 534 VKIISGCSNDDFKALVLEYMPNGSL-------DIFLYSSTCMLDIFQRLNIMIDVASALE 586
           V +I          L+LEY+  G L        IF+  + C          + +++ ALE
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY--------LSEISLALE 114

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           +L   H   II+ DLK  N+LLD      L+DFG+ K  S  + ++T T    TI YMAP
Sbjct: 115 HL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHT-FCGTIEYMAP 169

Query: 647 EYGIERKVSTRS------DIYSYGIMLIETFT---------RKKPADKMFAAELSL 687
           E      +  RS      D +S G ++ +  T         RKK  DK+   +L+L
Sbjct: 170 E------ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 41/215 (19%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV---------ECEVMKNIRHRN 532
           IG G++G V  A +   G +VAIK       +   +F+V         E +++++ +H N
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 533 LVKI--ISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
           ++ I  I      DFK   +V++ M +    I         +  +    +  +   L+Y+
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYF--LYQLLRGLKYI 123

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL--SGEDQSMTQTQTLATIGYMAP 646
              H+  +IH DLK SN+L++ED    + DFG+A+ L  S  +     T+ +AT  Y AP
Sbjct: 124 ---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Query: 647 E-------YGIERKVSTRSDIYSYGIMLIETFTRK 674
           E       Y      +T  D++S G +  E   R+
Sbjct: 181 ELLLSLPEY------TTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 58/170 (34%), Positives = 79/170 (46%), Gaps = 11/170 (6%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARA---MKSFEVECEVM-KNIRHRNLVKII 537
           IG GSFG V  A+   DG   A+KV  ++        K    E  V+ KN++H  LV + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
                 D    VL+Y+  G L   L       +   R     ++ASAL YL   H+  II
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYL---HSLNII 118

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           + DLK  N+LLD      L+DFG+ K   G + S T +    T  Y+APE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)

Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYS---------STCMLDIFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S               + + + +  ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEV-----MKNIRHRNLVKI 536
           IG+G++G VYKA +   G  VA+K    +            EV     ++   H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 537 ISGC----SNDDFK-ALVLEYMPNGSLDIFLYSSTCM---LDIFQRLNIMIDVASALEYL 588
           +  C    ++ + K  LV E++     D+  Y        L      ++M      L++L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H   I+H DLK  N+L+       L+DFG+A++ S +   M  T  + T+ Y APE 
Sbjct: 125 ---HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEV 178

Query: 649 GIERKVSTRSDIYSYGIMLIETFTRK 674
            ++   +T  D++S G +  E F RK
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 12/222 (5%)

Query: 483 IGIGSFGYVYKAELD-DGIEVAIKV--FHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG GSFG +Y A+   D     IK     +   +  ++ + E  ++  ++H N+V   + 
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 540 CSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              +    +V+EY   G L          +    Q L+  + ++  L+++   H   I+H
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI---HDRKILH 124

Query: 599 CDLKSSNVLLDED-MIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVST 656
            D+KS N+ L ++ M+A L DFGIA+ L   + SM    T   T  Y++PE    R  + 
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS 698
           ++DI+S G +L E  T K P +     +L LK       P+S
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 33/224 (14%)

Query: 477 FGRDNL-----IGIGSFGYVYKA-ELDDGIEVAIKVFHQEC-ARAMKSFEVECE-VMKNI 528
           F  ++L     IG G+FG V K      G  +A+K        +  K   ++ + VM++ 
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA----SA 584
               +VK       +    + +E M + SLD F      +L       I+  +A     A
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           L YL  +    IIH D+K SN+LLD +    L DFGI+  L     S+ +T+      YM
Sbjct: 120 LNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYM 174

Query: 645 APE---------YGIERKVSTRSDIYSYGIMLIETFTRKKPADK 679
           APE         Y +      RSD++S GI L E  T K P  K
Sbjct: 175 APERIDPSARDGYDV------RSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 12/197 (6%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A E   G +VA+K+      +  +    E  +M++ +H+N+V++     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
             +   +++E++  G+L DI    S   L+  Q   +   V  AL YL   H+  +IH D
Sbjct: 89  VGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYL---HSQGVIHRD 142

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY-MAPEYGIERKVSTRSD 659
           +KS ++LL  D    LSDFG    +S   + + + ++L    Y MAPE        T  D
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 660 IYSYGIMLIETFTRKKP 676
           I+S GIM+IE    + P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 22/206 (10%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARA----MKSFEVECEVMKNIRHRNLVKIIS 538
           IG G FG V   E++ G   A  V  +    A       F  E +  ++++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSS------TCMLDIFQRLNIMIDVASALEYLNFRH 592
            C+      LV+E+ P G L  +L S       T      QR+    ++A  L +L   H
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHL---H 117

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE- 651
               IH DL   N LL  D+   + D+G++     ED  +T  Q    + ++APE   E 
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 652 ------RKVSTRSDIYSYGIMLIETF 671
                    +  S+++S G+ + E F
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 15/198 (7%)

Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLV 534
           + ++G G FG + +  L       + VAI      C  +  + F  E   +    H N+V
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++    +  +   +V EYM NG+LD FL      L   Q + ++  +AS ++YL+     
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EM 126

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL---ATIGYMAPEYGIE 651
             +H  L +  VL++ D++  +S F   +    ED+S     T+   + + + APE    
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 652 RKVSTRSDIYSYGIMLIE 669
              S+ SD++S+GI++ E
Sbjct: 183 HHFSSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 11/202 (5%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNLVKIISG 539
           IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+VK++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              ++   LV E++     D+  +     L       I   +   L+ L F H+  ++H 
Sbjct: 68  IHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124

Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRS 658
           DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  K  ST  
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAV 182

Query: 659 DIYSYGIMLIETFTRKK--PAD 678
           DI+S G +  E  TR+   P D
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 59/212 (27%), Positives = 109/212 (51%), Gaps = 14/212 (6%)

Query: 483 IGIGSFGYVYKA--ELDDGIE-VAIKVFHQECARAMKSFEV--ECEVMKNIRHRNLVKII 537
           +G G+FG V K   ++    + VA+K+   +        E+  E  VM+ + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
             C  + +  LV+E    G L+ FL  +  + +      ++  V+  ++YL     T  +
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYL---EETNFV 117

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIERKVS 655
           H DL + NVLL     A +SDFG++K L G D++  + +T     + + APE     K S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 656 TRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
           ++SD++S+G+++ E F+  +KP   M   E++
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 66/227 (29%), Positives = 107/227 (47%), Gaps = 28/227 (12%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           IG GSFG VY A ++ +   VAIK       ++ + ++    E   ++ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY-R 81

Query: 539 GCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDI----FQRLNIMIDVASALEYLNFRHT 593
           GC   +  A LV+EY         L S++ +L++     Q + I      AL+ L + H+
Sbjct: 82  GCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI--- 650
             +IH D+K+ N+LL E  +  L DFG A +++  +        + T  +MAPE  +   
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMD 187

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV 697
           E +   + D++S GI  IE   RK P   M A   +L H      P 
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA 233

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 39/212 (18%)

Query: 483 IGIGSFGYVYKAEL-DDGIEVAIK------VFHQECARAMKSFEVECEVMKNIRHRNLVK 535
           +G+G FG V   ++       A+K      +        + S   E E+++   H  +VK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID---------VASALE 586
           +     +  +  +++EY   G L            I +   +  +         V  A E
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFE 107

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMA 645
           YL   H   II+ DLK  N+LLD +    L DFG AK L    +S  +T T   T  Y+A
Sbjct: 108 YL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVA 160

Query: 646 PEYGIERKVSTRS-DIYSYGIMLIETFTRKKP 676
           PE  I  K    S D +S GI+L E  T + P
Sbjct: 161 PEI-ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 19/227 (8%)

Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYS---------STCMLDIFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S               + + + +  ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H DL + N ++  D    + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV----ECEVMKNIR 529
           +++ +   IG G+FG V+KA        VA+K    E     + F +    E ++++ ++
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLK 69

Query: 530 HRNLVKIISGCSN-----DDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
           H N+V +I  C       + +K    LV E+  +  L   L +      + +   +M  +
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK--LLSGEDQSMTQTQTLA 639
            + L Y+   H   I+H D+K++N+L+ +D I  L+DFG+A+   LS   +    T  + 
Sbjct: 129 LNGLYYI---HRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 640 TIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTR 673
           T+ Y  PE  + ER      D++  G ++ E +TR
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 14/155 (9%)

Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLN-- 576
           E E+ K+ +   +VK      ++      + +EY   GSLD  +Y    +     R+   
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKK--VKKRGGRIGEK 105

Query: 577 IMIDVA-SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQ 634
           ++  +A S L+ L++ H+  IIH D+K SN+LL       L DFG+    SGE   S+  
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAG 161

Query: 635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           T T  T  YMAPE    +  S  SD++S G+ L+E
Sbjct: 162 TFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 36/213 (16%)

Query: 482 LIGIGSFGYVY----KAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVK 535
           ++G GSFG V+        D G   A+KV  +     R     ++E +++  + H  +VK
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN--IMI----------DVAS 583
           +      +    L+L+++  G             D+F RL+  +M           ++A 
Sbjct: 63  LHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELAL 109

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           AL++L   H+  II+ DLK  N+LLDE+    L+DFG++K     D          T+ Y
Sbjct: 110 ALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEY 164

Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           MAPE    R  +  +D +S+G+++ E  T   P
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 61/193 (31%), Positives = 88/193 (45%), Gaps = 11/193 (5%)

Query: 482 LIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVM-KNIRHRNLVKI 536
           +IG GSFG V  A+   DG   A+KV  ++     +       E  V+ KN++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                  +    VL+Y+  G L   L    C L+   R     +VASA+ YL   H+  I
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYL---HSLNI 117

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           I+ DLK  N+LLD      L+DFG+ K   G +   T +    T  Y+APE   +     
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 657 RSDIYSYGIMLIE 669
             D +  G +L E
Sbjct: 176 TVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 483 IGIGSFGYVYKAELDDGIE-VAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           IG GSFG VY A      E VA+K       +  + ++    E + ++ ++H N ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY-K 87

Query: 539 GCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDI----FQRLNIMIDVASALEYLNFRHT 593
           GC   +  A LV+EY         L S++ +L++     Q + I      AL+ L + H+
Sbjct: 88  GCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI--- 650
             +IH D+K+ N+LL E     L+DFG A   S  +        + T  +MAPE  +   
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPYWMAPEVILAMD 193

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFA 682
           E +   + D++S GI  IE   RK P   M A
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVM-KNI-----RHRNLV 534
           ++G GSFG V  AEL    EV AIKV  ++    ++  +V+C +  K I     +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +       D    V+EY+  G L +F    +   D  +      +V  AL +L   H  
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFL---HRH 115

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +I+ DLK  N+LLD +    L+DFG+ K   G    +T T    T  Y+APE   E + 
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 655 STRSDIYSYGIMLIETFTRKKP 676
               D ++ G+++ E    + P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 11/203 (5%)

Query: 477 FGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFH-QECARAMKSFEVECEVMKNIRHRNLV 534
           F +   IG GSFG VYK   +   EV AIK+   +E    ++  + E  V+       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 535 KIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +            +++EY+  GS LD+        L+      I+ ++   L+YL   H+
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYL---HS 119

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
              IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   +  
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 654 VSTRSDIYSYGIMLIETFTRKKP 676
              ++DI+S GI  IE    + P
Sbjct: 178 YDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 27/212 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           IG GSFG VY A      EV AIK       ++ + ++    E + ++ I+H N ++   
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY-K 91

Query: 539 GCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS----ALEYLNFRHT 593
           GC   +  A LV+EY         L S++ +L++ ++    +++A+    AL+ L + H+
Sbjct: 92  GCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI--- 650
             +IH D+K+ N+LL E     L+DFG A + S  +        + T  +MAPE  +   
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPEVILAMD 197

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFA 682
           E +   + D++S GI  IE   RK P   M A
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 33/215 (15%)

Query: 476 RFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFH--QECARAMKSFEVECEVMKNIR 529
           ++ +   IG GSFG   KA L    +DG +  IK  +  +   +  +    E  V+ N++
Sbjct: 1   KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57

Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIF---------LYSSTCMLDIFQRLNIMID 580
           H N+V+       +    +V++Y   G  D++         L+    +LD F      + 
Sbjct: 58  HPNIVQYQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWF------VQ 109

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LA 639
           +  AL+++   H   I+H D+KS N+ L +D    L DFGIA++L   + ++   +T + 
Sbjct: 110 ICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIG 163

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           T  Y++PE    R  + +SDI++ G +L E  T K
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.0 bits (159), Expect = 3e-11
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 33/217 (15%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR------AMKSFEVECEVMKNIRHRNLVK 535
           +G G+FG VYKA ++  G  VA+K       +      A++    E +++K ++H N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 536 II------SGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           +I         S     +  +V  YM +  L   L + +  L   Q    M+ +   LE 
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQL---LEG 127

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ---------TQTL 638
           +N+ H   I+H D+K++N+L+D   I  ++DFG+A+   G   +            T  +
Sbjct: 128 INYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187

Query: 639 ATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRK 674
            T  Y  PE  + ER+ +T  DI+  G +  E FTR+
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 11/107 (10%)

Query: 577 IMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
           I + +  ALEYL   H+   +IH D+K SNVL++ +    L DFGI+  L     S+ +T
Sbjct: 108 IAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKT 161

Query: 636 QTLATIGYMAPEY----GIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
                  YMAPE       ++    +SD++S GI +IE  T + P D
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 19/216 (8%)

Query: 483 IGIGSFGYVYKAELDDGIE-VAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIIS 538
           +G G +G V+ A+  D  E VA+K   +     +   +    E +++   +   LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI--MIDVASALEYLNFRHTTPI 596
              +D++  L +EY+P G     L +   + +   R  +  M +   AL      H    
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL------HELGY 122

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           IH DLK  N L+D      L+DFG++K +     S+     + +  YMAPE    +    
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDF 177

Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHW 690
             D +S G ML E      P       E   +LK+W
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 10/199 (5%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKII 537
           L+G G+FG V    E   G   A+K+  +E   A         E  V+KN RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
                 D    V+EY+  G L   L       +   R     ++ SAL+YL   H+  I+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYL---HSGKIV 117

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           + DLK  N++LD+D    ++DFG+ K   G   + T      T  Y+APE   +      
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 658 SDIYSYGIMLIETFTRKKP 676
            D +  G+++ E    + P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDGIEVAIK--VFHQECARAMKSFEV----ECEVMKNIR 529
           + + N I  G++G VY+A +   G  VA+K     +E     + F +    E  ++  ++
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE----KEGFPITSLREINILLKLQ 62

Query: 530 HRNLVK---IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALE 586
           H N+V    ++ G SN D   +V+EY+ +  L   + +        +   +M+ + S + 
Sbjct: 63  HPNIVTVKEVVVG-SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           +L   H   I+H DLK+SN+LL+   I  + DFG+A+      +    TQ + T+ Y AP
Sbjct: 121 HL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRAP 175

Query: 647 E--YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           E   G  ++ ST  D++S G +  E    KKP
Sbjct: 176 ELLLG-AKEYSTAIDMWSVGCIFAE-LLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)

Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A +   G  VA+K       +  +    E  +M++ +H N+V++ +   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTTPII 597
             D   +V+E++  G+L DI  ++         R+N   I     + L+ L+  H   +I
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHT---------RMNEEQIAAVCLAVLKALSVLHAQGVI 138

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+KS ++LL  D    LSDFG    +S E     +   + T  +MAPE          
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPE 196

Query: 658 SDIYSYGIMLIETFTRKKP 676
            DI+S GIM+IE    + P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 61/193 (31%), Positives = 89/193 (46%), Gaps = 11/193 (5%)

Query: 482 LIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVM-KNIRHRNLVKI 536
           +IG GSFG V  A+   DG   A+KV  ++     +  K    E  V+ KN++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                  +    VL+++  G L   L       +   R     ++ASAL YL   H+  I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYL---HSINI 117

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           ++ DLK  N+LLD      L+DFG+ K   G  QS T T    T  Y+APE   ++    
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 657 RSDIYSYGIMLIE 669
             D +  G +L E
Sbjct: 176 TVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 7e-11
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 37/214 (17%)

Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIRHRNLV 534
           + IG G++G V  A     G++VAIK      HQ  C R ++    E ++++  +H N++
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66

Query: 535 KI---ISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLD-------IFQRLNIMIDVA 582
            I   I   S + F    +V E M     D++    T  L        ++Q L       
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYFLYQILR------ 117

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTLATI 641
             L+Y+   H+  ++H DLK SN+LL+ +    + DFG+A++     D +   T+ +AT 
Sbjct: 118 -GLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 642 GYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
            Y APE  +  K  T++ DI+S G +L E  + +
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 10/197 (5%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G GS+G V       DG +  IK  +   A  R  K+ E E +++  ++H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 540 CSNDD-FKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPII 597
              +D    +V+ +   G L   L      +L   Q +   + +A AL+YL+ +H   I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H DLK+ NV L    I  + D GIA++L  E+Q    +  + T  YM+PE    +  + +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 658 SDIYSYGIMLIETFTRK 674
           SD+++ G  + E  T K
Sbjct: 183 SDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 50/254 (19%)

Query: 476 RFGRDNLIGIGSFGYV-YKAELDDGIEVAIKVF------HQECARAMKSFEVECEVMKNI 528
           ++    ++G G+ G V     + DG   A+KV         +  RA    EV C  + N 
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA--QAEVCC--LLNC 88

Query: 529 RHRNLVKIISGCSNDDFK------------ALVLEYMPNGSLDIFLYSSTCMLDIFQRLN 576
              ++VK    C  D  K            ALVL+Y   G L   + S       F+   
Sbjct: 89  DFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144

Query: 577 ---IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT 633
              + I V  A+ +++ +H   +IH D+KS+N+LL  + +  L DFG +K+ +       
Sbjct: 145 AGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201

Query: 634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
                 T  Y+APE    +  S ++D++S G++L E  T K+P D               
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-------------- 247

Query: 694 LLPVSLMEVVNKTL 707
               ++ EV++KTL
Sbjct: 248 ---ENMEEVMHKTL 258

Length = 496

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 55/177 (31%), Positives = 81/177 (45%), Gaps = 27/177 (15%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF-HQECARAMKSFEV-ECEVMKNIRHRNLVKIISG 539
           IG GS+G V+K    + G  VAIK F   E    +K   + E  ++K ++H NLV +I  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-- 66

Query: 540 CSNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQR----LNIMIDVASALEYLNF 590
              + F+      LV EY  +  L+         L+   R      I   +   L+ +NF
Sbjct: 67  ---EVFRRKRKLHLVFEYCDHTVLN--------ELEKNPRGVPEHLIKKIIWQTLQAVNF 115

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
            H    IH D+K  N+L+ +     L DFG A++L+G       T  +AT  Y APE
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 42/236 (17%)

Query: 481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKI 536
             +G GSFG V  A+    G   AIK   +     MK  +    E  ++  + H  +V +
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS--------ALEYL 588
           +    +++    +LE++  G L   L  +    +         DVA         A EYL
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN---------DVAKFYHAELVLAFEYL 134

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPE 647
              H+  II+ DLK  N+LLD      ++DFG AK +        +T TL  T  Y+APE
Sbjct: 135 ---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP------DRTFTLCGTPEYLAPE 185

Query: 648 YGIERKVSTRS-DIYSYGIMLIETFTRKKP---------ADKMFAAELSLKHWVNG 693
             I+ K   ++ D ++ G++L E      P          +K+ A  L   +W +G
Sbjct: 186 V-IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240

Length = 329

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 11/199 (5%)

Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           +G G FG V   ++   G   A K   ++  +  K  +    E ++++ +  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
                D   LV+  M  G L   +Y+         + +     +   LE+L   H   I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIV 117

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           + DLK  NVLLD+     +SD G+A  L G            T GYMAPE          
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 658 SDIYSYGIMLIETFTRKKP 676
            D ++ G  L E    + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQEC------ARAMKSFEVECEVMKNIRHRNLVK 535
           IG G++G VYKA +   G  VA+K    E       + A++    E  ++K + H N+V+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           ++    +++   LV E++    LD+  Y  +  L       I   +   L+ + + H+  
Sbjct: 63  LLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKV 654
           ++H DLK  N+L+D +    L+DFG+A+      +  T T  + T+ Y APE  +  R+ 
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQY 177

Query: 655 STRSDIYSYGIMLIETFTRK 674
           ST  DI+S G +  E   R+
Sbjct: 178 STPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 482 LIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKN------IRHRNLV 534
           ++G GSFG V+ AEL       AIK   ++    +   +VEC +++         H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHT 593
            +       +    V+EY+  G  D+  +  +C   D+ +      ++   L++L   H+
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGG--DLMFHIQSCHKFDLPRATFYAAEIICGLQFL---HS 114

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTLATIGYMAPEYGIER 652
             I++ DLK  N+LLD D    ++DFG+ K  + G+ ++ T      T  Y+APE  + +
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAPEILLGQ 171

Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
           K +T  D +S+G++L E    + P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVMKN------IRHRNLV 534
           ++G GSFG V  AEL    E  AIK   ++    ++  +VEC +++         H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPFLT 59

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +       +    V+EY+  G L +F   S+   D  +      ++   L++L   H  
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDL-MFHIQSSGRFDEARARFYAAEIICGLQFL---HKK 115

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTLATIGYMAPEYGIERK 653
            II+ DLK  NVLLD+D    ++DFG+ K  ++GE ++ T      T  Y+APE    +K
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST---FCGTPDYIAPEILKGQK 172

Query: 654 VSTRSDIYSYGIMLIETFTRKKP 676
            +   D +S+G++L E    + P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 64/256 (25%), Positives = 111/256 (43%), Gaps = 35/256 (13%)

Query: 463 RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVE 521
           RR P  D             +G G++G VYKA  L  G   A+K+   E        + E
Sbjct: 4   RRNPQHDYELIQR-------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQE 56

Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMID 580
             ++K  +H N+V       + +   + +EY   GSL DI+  +          L I   
Sbjct: 57  IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP-----LSELQIAYV 111

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LA 639
               L+ L + H+   +H D+K +N+LL ++    L+DFG+A  ++    ++ + ++ + 
Sbjct: 112 CRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIG 168

Query: 640 TIGYMAPEYGIERK---VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP 696
           T  +MAPE     K    +   DI++ GI  IE    + P   MF            L P
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP---MF-----------DLHP 214

Query: 697 VSLMEVVNKTLLSPPE 712
           +  + +++K+   PP+
Sbjct: 215 MRALFLMSKSNFQPPK 230

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 4e-10
 Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 11/164 (6%)

Query: 516 KSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQ-- 573
           K+   E +++K I HR ++ +I        K+ V   MP    D+F Y     +D     
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTY-----VDRSGPL 182

Query: 574 RLNIMIDVASAL-EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM 632
            L   I +   L E L + H   IIH D+K+ N+ LDE   A L DFG A  L     + 
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Query: 633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
                  T+   +PE         ++DI+S G++L E   +   
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 27/211 (12%)

Query: 482 LIGIGSFGYVYKAEL----DDGIEVAIKVFHQECARAMKSFEVEC-----EVMKNIRHRN 532
           ++G G++G V+        D G   A+KV  Q+ A   K+  VE       V++++R   
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVL-QKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 533 -LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI---DVASALEYL 588
            LV +      +    L+L+Y+  G +   LY      D F    +     ++  ALE+L
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHL 121

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H   I++ D+K  N+LLD +    L+DFG++K    E++  T +    TI YMAPE 
Sbjct: 122 ---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPE- 176

Query: 649 GIERKVSTRS---DIYSYGIMLIETFTRKKP 676
            I R         D +S GI++ E  T   P
Sbjct: 177 -IIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 11/212 (5%)

Query: 477 FGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNLV 534
           F R + +G G+ G V K +    G+ +A K+ H E   A+++  + E +V+       +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-LDIFQRLNIMIDVASALEYLNFRHT 593
                  +D   ++ +E+M  GSLD  L  +  +  +I  +++I   V   L YL  +H 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ 124

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE      
Sbjct: 125 --IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQGTH 178

Query: 654 VSTRSDIYSYGIMLIETFTRKKPADKMFAAEL 685
            S +SDI+S G+ L+E    + P     A EL
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 54/199 (27%), Positives = 84/199 (42%), Gaps = 10/199 (5%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKII 537
           L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
                 D    V+EY   G L   L       +   R     ++ SALEYL   H+  ++
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL---HSRDVV 117

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           + D+K  N++LD+D    ++DFG+ K   G     T      T  Y+APE   +      
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 658 SDIYSYGIMLIETFTRKKP 676
            D +  G+++ E    + P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 11/214 (5%)

Query: 477 FGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNLV 534
           F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFRHT 593
                  +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +H 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 124

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE      
Sbjct: 125 --IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQGTH 178

Query: 654 VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL 687
            S +SDI+S G+ L+E    + P     A EL L
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 60.5 bits (147), Expect = 7e-10
 Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 18/205 (8%)

Query: 490 YVYKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKI----ISGCSN 542
            +YK   ++  EV I+ F   H+     +   E E + ++ I   N++KI    I    +
Sbjct: 35  SIYKGIFNNK-EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               +L+LEY   G L   L      L    +L++ ID    L  L      P  + +L 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY--GIERKVSTRSDI 660
           S + L+ E+    +   G+ K+LS         + +  + Y + +    I  + + + DI
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILS-----SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205

Query: 661 YSYGIMLIETFTRKKPADKMFAAEL 685
           YS G++L E FT K P + +   E+
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTKEI 230

Length = 283

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)

Query: 483 IGIGSFGYVYKAEL----DDGIEVAIKVFHQ----ECARAMKSFEVECEVMKNIRHRN-L 533
           +G G++G V+        D G   A+KV  +    + A+  +    E +V++ +R    L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V +      D    L+L+Y+  G L   LY      +   R+ I  ++  AL++L   H 
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHL---HQ 123

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY--GIE 651
             II+ D+K  N+LLD +    L+DFG++K    E++    +    TI YMAPE   G  
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGS 182

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
                  D +S G++  E  T   P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 15/197 (7%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNLVKIISGC 540
           +G G++  VYK      G  VA+K  H +      S  + E  +MK ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSST----CMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
             ++   LV EYM     D+  Y  T      LD     +    +   L+ + F H   +
Sbjct: 68  HTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRV 121

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVS 655
           +H DLK  N+L+++     L+DFG+A+   G   + T +  + T+ Y AP+  +  R  S
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAF-GIPVN-TFSNEVVTLWYRAPDVLLGSRTYS 179

Query: 656 TRSDIYSYGIMLIETFT 672
           T  DI+S G ++ E  T
Sbjct: 180 TSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.8 bits (150), Expect = 9e-10
 Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 3/96 (3%)

Query: 184 WLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELN 243
           W    +GL    L G +P+ I  L   L+ + +S  SI GNIP  +G+++   +LDL  N
Sbjct: 418 WFIDGLGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476

Query: 244 KLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI 279
              G IP + G+L  + L  L+L GNS SG +P+ +
Sbjct: 477 SFNGSIPESLGQL--TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 31/93 (33%), Positives = 54/93 (58%), Gaps = 4/93 (4%)

Query: 238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF 297
           L L+   L G IP    +L+   L +++L GNS  G+IP    +G++  +  ++LS N+F
Sbjct: 423 LGLDNQGLRGFIPNDISKLR--HLQSINLSGNSIRGNIP--PSLGSITSLEVLDLSYNSF 478

Query: 298 SGDIPATIGGLKDVQNISLPYNRLEGPIPESFG 330
           +G IP ++G L  ++ ++L  N L G +P + G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 1e-09
 Identities = 39/116 (33%), Positives = 59/116 (50%), Gaps = 13/116 (11%)

Query: 67  WIGITCDVNSHR----VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLS-G 121
           W G  C  +S +    +  L + +  L+G IP++I  L  L  + L  NS+ GN   S G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 122 SLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIG 177
           S+ S        ++ L L+YN F+G+I   +   + L IL L GNS SG +P  +G
Sbjct: 464 SITS--------LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 3/104 (2%)

Query: 569 LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L     L+    VA  +E+L  ++    +H DL + NVLL +  I  + DFG+A+ +  +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNC---VHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
              +++  T   + +MAPE   +   +T SD++SYGI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVEC-EVMKNI-----RHRNLV 534
           ++G GSFG V  AEL    E+ A+KV  ++    ++  +VEC    K +     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++ S     D    V+EY+  G L +F    +   D  +      ++   L++L   H  
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDL-MFHIQRSGRFDEPRARFYAAEIVLGLQFL---HER 115

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERK 653
            II+ DLK  NVLLD +    ++DFG+ K       +   T T   T  Y+APE    + 
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSYQP 172

Query: 654 VSTRSDIYSYGIMLIETFTRKKPAD 678
                D ++ G++L E    + P +
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 48/208 (23%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 500 IEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLD 559
           + V +KV   +   ++  FE    +M  + H++LVK+   C  D+   +V EY+  G LD
Sbjct: 31  VSVVLKVLGSDHRDSLAFFET-ASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLD 88

Query: 560 IFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-------M 612
           +FL+     + +  +L++   +ASAL YL       ++H ++   N+L+           
Sbjct: 89  VFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVP 145

Query: 613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY--GIERKVSTRSDIYSYGIMLIET 670
              LSD GI   +      +++ + +  I ++APE     +  ++  +D +S+G  L+E 
Sbjct: 146 FIKLSDPGIPITV------LSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Query: 671 FTR-KKPADKMFAAELSLKHWVNGLLPV 697
            +  ++P   + ++E    +     LP+
Sbjct: 200 CSNGEEPLSTLSSSEKERFYQDQHRLPM 227

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)

Query: 481 NLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAM--KSFEVECEVMKNIRHRNLVKII 537
           + +G G++G V  A     G +VAIK   +    A+  K    E  ++K++ H N++ ++
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 538 S----GCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLN---IMIDVASALEYL 588
                  S +DF+   LV   M  G+ D+            Q+L+   I   V   L  L
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM--GA-DLNNIVKC------QKLSDDHIQFLVYQILRGL 131

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
            + H+  IIH DLK SN+ ++ED    + DFG+A+    E   M  T  +AT  Y APE 
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---M--TGYVATRWYRAPEI 186

Query: 649 GIERKVSTRS-DIYSYGIMLIETFTRK 674
            +      ++ DI+S G ++ E  T K
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 59/193 (30%), Positives = 88/193 (45%), Gaps = 11/193 (5%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQEC---ARAMKSFEVECEVM-KNIRHRNLVKI 536
           +IG GSFG V  A    +    A+KV  ++     +  K    E  V+ KN++H  LV +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                  D    VL+Y+  G L   L    C L+   R     ++ASAL YL   H+  I
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYL---HSLNI 117

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           ++ DLK  N+LLD      L+DFG+ K     + + T +    T  Y+APE   ++    
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 657 RSDIYSYGIMLIE 669
             D +  G +L E
Sbjct: 176 TVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 482 LIGIGSFGYVYKAELDDGIE-VAIKVFHQECARAMKSFEVECEVMKN----IRHRN--LV 534
           ++G GSFG V  AEL    E  A+K   ++    +   +VEC +++     +   N  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVV--LIDDDVECTMVEKRVLALAWENPFLT 59

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +       +    V+E++  G L +F        D+++      ++   L++L   H+ 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDL-MFHIQDKGRFDLYRATFYAAEIVCGLQFL---HSK 115

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTLATIGYMAPEYGIERK 653
            II+ DLK  NV+LD D    ++DFG+ K  + G++++ T      T  Y+APE     K
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAPEILQGLK 172

Query: 654 VSTRSDIYSYGIMLIETFTRKKP 676
            +   D +S+G++L E    + P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 32/211 (15%)

Query: 483 IGIGSFGYVYKA-ELDDGIE-VAIK-VFHQECARAMKSFEV-ECEVMKNIR---HRNLVK 535
           IG G++G V+KA +L +G   VA+K V  Q     M    + E  V++++    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 536 IISGC--SNDDFKA---LVLEYMPNGSLDIFL-------YSSTCMLDIFQRLNIMIDVAS 583
           +   C  S  D +    LV E++ +  L  +L         +  + D+  +L        
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL-------- 119

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
            L  L+F H+  ++H DLK  N+L+       L+DFG+A++ S +   M  T  + T+ Y
Sbjct: 120 -LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWY 175

Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            APE  ++   +T  D++S G +  E F RK
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 33/226 (14%)

Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDG--IEVAIKVFHQECARAMKSFE 519
           K ++ Y+D       F     +G GSFG V  A   +     VAIK F  E ++ +K  +
Sbjct: 24  KNKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF--EKSKIIKQKQ 74

Query: 520 V-----ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---LDI 571
           V     E +++  I H   V +     ++ +  LVLE++  G    FL  +      +  
Sbjct: 75  VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC 134

Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           F    I++      EYL    +  I++ DLK  N+LLD+D    ++DFG AK++      
Sbjct: 135 FYAAQIVL----IFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----- 182

Query: 632 MTQTQTL-ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
            T+T TL  T  Y+APE  +       +D ++ GI + E      P
Sbjct: 183 -TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 50/223 (22%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV---------ECE 523
           TNR+     +G+G+FG V  A +   G  VAIK       + MK F           E +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61

Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN------- 576
           ++K++RH N++       +D F +      P    DI+  +     D+ + L        
Sbjct: 62  LLKHLRHENII-----SLSDIFIS------P--LEDIYFVTELLGTDLHRLLTSRPLEKQ 108

Query: 577 ----IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM 632
                +  +   L+Y+   H+  ++H DLK SN+L++E+    + DFG+A++   +D  M
Sbjct: 109 FIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM 162

Query: 633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRK 674
             T  ++T  Y APE  +  +K     DI+S G +  E    K
Sbjct: 163 --TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 40/250 (16%)

Query: 483 IGIGSFGYV-YKAELDDGIEVAIKVFH---QECARAMKSFEVECEVMKNIRHRNLVKII- 537
           +G G++G V    +   G +VAIK  +   Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81

Query: 538 ---SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFR 591
                 S D F    L  MP      F+ +    L   ++L+   I   V   L+ L + 
Sbjct: 82  VFTPDLSLDRFHDFYL-VMP------FMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   IIH DLK  N+ ++ED    + DFG+A+    E      T  + T  Y APE  + 
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILN 189

Query: 652 RKVSTRS-DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP 710
               T++ DI+S G ++ E  T K     +F     L           LME++  T    
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGK----PLFKGHDHLDQ---------LMEIMKVT--GT 234

Query: 711 PEKDFAAKEQ 720
           P K+F  K Q
Sbjct: 235 PSKEFVQKLQ 244

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 33/119 (27%), Positives = 61/119 (51%), Gaps = 3/119 (2%)

Query: 554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
           P  +    L + +  L     +     VA+ +E+L  ++    +H DL + NVL+ E  +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVLICEGKL 277

Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   +++  T   + +MAPE       +T SD++S+GI+L E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  +E+L  R     IH DL + N+LL E+ +  + DFG+A+ +  +   + +      
Sbjct: 182 VARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + +MAPE   ++  +T+SD++S+G++L E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH---QECARAMKSFEVECEVMKNIRHR 531
           R+     +G G++G V  A +   G +VAIK      Q    A +++  E  ++K+++H 
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHE 74

Query: 532 NLVKII----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           N++ ++    S  S D+F+   L  MP    D+       M        +   V   L  
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYL-VMPYMQTDL----QKIMGHPLSEDKVQYLVYQMLCG 129

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           L + H+  IIH DLK  N+ ++ED    + DFG+A+    E      T  + T  Y APE
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE 184

Query: 648 YGIERKVSTRS-DIYSYGIMLIETFTRK 674
             +      ++ DI+S G ++ E  T K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 41/121 (33%), Positives = 62/121 (51%), Gaps = 9/121 (7%)

Query: 550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD 609
           +E+M  GSLD  L  +  + +      I I V   L YL  +H   I+H D+K SN+L++
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134

Query: 610 EDMIAHLSDFGIAKLLSGE-DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLI 668
                 L DFG+    SG+   SM  +  + T  YM+PE       + +SDI+S G+ L+
Sbjct: 135 SRGEIKLCDFGV----SGQLIDSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189

Query: 669 E 669
           E
Sbjct: 190 E 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.4 bits (142), Expect = 4e-09
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 44/216 (20%)

Query: 483 IGIGSFGYVYKAELD--DGIEVAIK-VFH--QECARAMKSFEVECEVM-----KNIRHRN 532
           +G G++G V+KA +D      VA+K +F   +    A ++F    E+M      +  H N
Sbjct: 15  LGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFR---EIMFLQELGD--HPN 68

Query: 533 LVKIISGCSNDDFKA-------LVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVA 582
           +VK++     +  KA       LV EYM     +  L++   +  + D+ +R  IM  + 
Sbjct: 69  IVKLL-----NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLL 117

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS---GEDQSMTQTQTLA 639
            AL+Y+   H+  +IH DLK SN+LL+ D    L+DFG+A+ LS      ++   T  +A
Sbjct: 118 KALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 640 TIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRK 674
           T  Y APE  +   + +   D++S G +L E    K
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 60/251 (23%), Positives = 107/251 (42%), Gaps = 26/251 (10%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARA---MKSFEVECEVMKNIRHR-NLVKII 537
           I  G+FG VY A+    G   AIKV  +    A   + + + E  +M        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               + D+  LV+EY+  G     + +   + + + +   + +V   +E L   H   II
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDL---HQRGII 119

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+K  N+L+D+     L+DFG+++        +   + + T  Y+APE  +       
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDDKM 173

Query: 658 SDIYSYGIMLIETFTRKKP-----ADKMFAAELSLK-HW----VNGLLPVSLMEVVNKTL 707
           SD +S G ++ E      P      D +F   LS + +W         P ++ +++N+ L
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAV-DLINRLL 232

Query: 708 LSPPEKDFAAK 718
              P K   A 
Sbjct: 233 CMDPAKRLGAN 243

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 26/223 (11%)

Query: 482 LIGIGSFGYVYKAEL----DDGIEVAIKVFHQ----ECARAMKSFEVECEVMKNIRHRN- 532
           ++G G++G V+        D G   A+KV  +    + A+  +    E +V+++IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI---DVASALEYLN 589
           LV +      D    L+L+Y+  G L    ++     + F+   + I   ++  ALE+L 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVLALEHL- 121

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY- 648
             H   II+ D+K  N+LLD +    L+DFG++K    ED+         TI YMAP+  
Sbjct: 122 --HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIV 178

Query: 649 -GIERKVSTRSDIYSYGIMLIETFTRKKP----ADKMFAAELS 686
            G +       D +S G+++ E  T   P     +K   AE+S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 6e-09
 Identities = 53/219 (24%), Positives = 84/219 (38%), Gaps = 35/219 (15%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKS---FEVECEVMKNIRHRNLVKII 537
           +IG G+FG V+   + D G   A+KV  +              E +++ +     +VK+ 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               +++   LV+EYMP G L   L       +   R  I  ++  AL+ +   H    I
Sbjct: 68  YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSV---HKLGFI 123

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAK------------LLSGEDQSMTQTQ--------- 636
           H D+K  N+L+D D    L+DFG+ K              S                   
Sbjct: 124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183

Query: 637 ------TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
                 T+ T  Y+APE           D +S G++L E
Sbjct: 184 RVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.8 bits (140), Expect = 7e-09
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 46/216 (21%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIK----VF--HQECARAMKSFEVECEVMKNIRHRNLVK 535
           IG G++G V  A   +   +VAIK     F    +  R ++    E ++++++ H N++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 536 ---IISGCSNDDFKA--LVLEYMPNGSLDIFLYSST-----CMLDIFQRLNIMIDVASAL 585
              I+     + F    +V E M      I   S T     C   ++Q L         L
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GL 121

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
           +Y+   H+  ++H DLK SN+LL+ +    + DFG+A+  S +   M  T+ + T  Y A
Sbjct: 122 KYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYRA 176

Query: 646 PE-------YGIERKVSTRSDIYSYGIMLIETFTRK 674
           PE       Y       T  D++S G +  E   RK
Sbjct: 177 PELLLNCSEYT------TAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  +E+L  R     IH DL + N+LL E+ +  + DFG+A+ +  +   + +      
Sbjct: 188 VAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)

Query: 483 IGIGSFGYVYKAELDDGIE-VAIKV--FHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G++G VYKA      E +A+K     QE      +   E  ++K ++H N+V++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--SALEYLNFRHTTPII 597
             ++    LV EY+    LD+  +  +     F +   +I       L  + + H+  ++
Sbjct: 70  VHSEKRLYLVFEYL---DLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124

Query: 598 HCDLKSSNVLLDEDMIA-HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVS 655
           H DLK  N+L+D    A  L+DFG+A+      +  T T  + T+ Y APE  +  R  S
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYS 182

Query: 656 TRSDIYSYGIMLIETFTRKK--PAD 678
           T  DI+S G +  E   +K   P D
Sbjct: 183 TPVDIWSVGCIFAEMVNQKPLFPGD 207

Length = 294

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 19/198 (9%)

Query: 483 IGIGSFGYVY-----KAELDDGIEVAIKVFHQECARAMKSFE-----VECEVMKNIRHRN 532
           +G GSFG VY     KA  ++     +KV  +     +   E      E +++  + H  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEE----RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +VK  +     D   ++ EY     LD  L              +       L  +++ H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLATIGYMAPEYGIE 651
              I+H DLK+ N+ L  +++  + DFG+++LL G  D + T T    T  YM+PE    
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEALKH 179

Query: 652 RKVSTRSDIYSYGIMLIE 669
           +   ++SDI+S G +L E
Sbjct: 180 QGYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 3/92 (3%)

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  +E+L  R     IH DL + N+LL E+ +  + DFG+A+ +  +   + +      
Sbjct: 183 VARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + +MAPE   ++  +T+SD++S+G++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 51/192 (26%), Positives = 94/192 (48%), Gaps = 13/192 (6%)

Query: 483 IGIGSFGYVYK--AELDDGIEV--AIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++  V+K  ++L + +     I++ H+E A      EV   ++K+++H N+V +  
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS--LLKDLKHANIVTLHD 71

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
               D    LV EY+     D+  Y   C  +I    N+ I +   L  L + H   ++H
Sbjct: 72  IVHTDKSLTLVFEYLDK---DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLH 127

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTR 657
            DLK  N+L++E     L+DFG+A+  S   +  T +  + T+ Y  P+  +   + ST+
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQ 185

Query: 658 SDIYSYGIMLIE 669
            D++  G +  E
Sbjct: 186 IDMWGVGCIFFE 197

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECA-RAMKSFEV-ECEVMKNIRHRNLVKIISG 539
           IG G++G VYK      G  VA+K    E     + S  + E  ++K ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS----ALEYLNFRHTTP 595
              +    L+ E++   S+D+  Y  +  L   Q ++  + V S     L+ + F H+  
Sbjct: 68  LMQESRLYLIFEFL---SMDLKKYLDS--LPKGQYMDAEL-VKSYLYQILQGILFCHSRR 121

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE--YGIERK 653
           ++H DLK  N+L+D   +  L+DFG+A+      +    T  + T+ Y APE   G  R 
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPR- 178

Query: 654 VSTRSDIYSYGIMLIETFTRK 674
            ST  DI+S G +  E  T+K
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 32/213 (15%)

Query: 483 IGIGSFGYVYKA---ELDDGIEVAIKVFHQECARAMKSFEVEC-EVM--KNIRHRNLVKI 536
           IG G++G VYKA      DG E AIK F  +  +     +  C E+   + ++H N+V +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 537 ISGCSNDDFKA--LVLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFR 591
           +        K+  L+ +Y  +    I  +        +      +++  + + + YL   
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL--- 124

Query: 592 HTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIA-------KLLSGEDQSMTQTQTLAT 640
           H+  ++H DLK +N+L+     E  +  + D G+A       K L+  D        + T
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD------PVVVT 178

Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFT 672
           I Y APE  +  +  T++ DI++ G +  E  T
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 56.4 bits (137), Expect = 2e-08
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 50/214 (23%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVEC----EVMKNIR----HRNL 533
           +G G+FG VY A   + G  VAIK   ++      S+E EC    EV K++R    H N+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKK----FYSWE-ECMNLREV-KSLRKLNEHPNI 60

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-------NIMIDVASALE 586
           VK+      +D    V EYM     +  LY    M D   +        +I+  +   L 
Sbjct: 61  VKLKEVFRENDELYFVFEYM-----EGNLYQL--MKDRKGKPFSESVIRSIIYQILQGLA 113

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM-TQTQTLATIGYMA 645
           ++   H     H DLK  N+L+    +  ++DFG+A+    E +S    T  ++T  Y A
Sbjct: 114 HI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRA 166

Query: 646 PEYGIERKVSTRS-------DIYSYGIMLIETFT 672
           PE      +  RS       DI++ G ++ E +T
Sbjct: 167 PE------ILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 31/203 (15%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNLVKIISGC 540
           +G GS+  VYK     +G  VA+KV   +    +    + E  ++K ++H N+V +    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 541 SNDDFKALVLEYM-----------PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
              +    V EYM           P G     L+     L +FQ L         L Y++
Sbjct: 73  HTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLR-------GLAYIH 120

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
            +H   I+H DLK  N+L+       L+DFG+A+  S   Q  T +  + T+ Y  P+  
Sbjct: 121 GQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVL 175

Query: 650 I-ERKVSTRSDIYSYGIMLIETF 671
           +     S+  DI+  G + IE  
Sbjct: 176 LGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 35/224 (15%)

Query: 480 DNLIGIGSFGYVYKAE-LDDGIEVAIK-VFHQECARAMKS-----------FEV--ECEV 524
              +G G++G V KA     G  VAIK V   E +  +             F    E ++
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
           M  I+H N++ ++      DF  LV++ M +    +        L   Q   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV--DRKIRLTESQVKCILLQILNG 131

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK-----LLSGE--DQSMTQ--- 634
           L  L   H    +H DL  +N+ ++   I  ++DFG+A+       S         Q   
Sbjct: 132 LNVL---HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 635 --TQTLATIGYMAPE--YGIERKVSTRSDIYSYGIMLIETFTRK 674
             T  + T+ Y APE   G E K     D++S G +  E  T K
Sbjct: 189 EMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 20/217 (9%)

Query: 482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVM-KNI-----RHRNLV 534
           ++G GSFG V  A L + G   A+KV  ++    ++  +VEC +  K I      H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLT 59

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++       D    V+E++  G L +F    +   D  +      ++ SAL +L   H  
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEITSALMFL---HDK 115

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            II+ DLK  NVLLD +    L+DFG+ K   G     T +    T  Y+APE   E   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173

Query: 655 STRSDIYSYGIMLIETFTRKKP-----ADKMFAAELS 686
               D ++ G++L E      P      D +F A L+
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 19/237 (8%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIE-VAIKVFH--QECARAMKSFEVECEVMKNIRHR 531
           N+F    ++G G++G V K    +  E VAIK F   +E     ++   E ++++ ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           N+V++           LV EY+    L++       +     R  I       ++ +++ 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWC 116

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K  N+L+  + +  L DFG A+ LS E  +   T+ +AT  Y +PE  + 
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLG 175

Query: 652 RKVSTRSDIYSYGIMLIE------TFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV 702
                  D++S G +L E       F  +   D++F  +  L     G LP   M++
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL-----GPLPAEQMKL 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 28/208 (13%)

Query: 483 IGIGSFGYVYKA---ELDDG-----IEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           +G G+F  ++K    E+ D       EV +KV  +      +SF     +M  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
                C   D   +V EY+  GSLD +L  +  +++I  +L +   +A AL +L  +   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG-- 120

Query: 595 PIIHCDLKSSNVLL--DEDMIA------HLSDFGIA-KLLSGEDQSMTQTQTLATIGYMA 645
            + H ++ + NVLL  +ED          LSD GI+  +L  E         L  I ++ 
Sbjct: 121 -LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-------ILLERIPWVP 172

Query: 646 PEYGIE-RKVSTRSDIYSYGIMLIETFT 672
           PE     + +S  +D +S+G  L E F+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 481 NLIGIGSFGYVYKAELDDGI-----EVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRN 532
           +L+  G+FG ++   L D       EV +K       E    +     E  ++  + H+N
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLYGLSHQN 69

Query: 533 LVKIISGCSNDDFKALVLE-YMPNGSLDIFLYS-------STCMLDIFQRLNIMIDVASA 584
           ++ I+  C  D     VL  YM  G+L +FL         +   L   Q +++ I +A  
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           + YL   H   +IH D+ + N ++DE++   ++D  +++ L   D           + +M
Sbjct: 130 MSYL---HKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFT 672
           A E  + ++ S+ SD++S+G++L E  T
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKII-- 537
           ++G G++G VYK   +  G   AIKV         +  ++E  ++K    HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 538 ----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
               S   +DD   LV+E+   GS+   + ++    +  +   I       L  L   H 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA 139

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEYGI-- 650
             +IH D+K  NVLL E+    L DFG++  L   D+++ +  T + T  +MAPE     
Sbjct: 140 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 651 ERKVST---RSDIYSYGIMLIE 669
           E   +T   RSDI+S GI  IE
Sbjct: 197 ENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 46/226 (20%)

Query: 469 DLSRATNR-FGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMK 526
           D++R+ N+ +   N+IG GSFG VY+A  +D   +VAIK   Q+     +    E  +MK
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMK 114

Query: 527 NIRHRNLVKIISGCSNDDFKA--------LVLEYMP-------------NGSLDIFLYSS 565
           N+ H N++ +      + FK         +V+E++P             N +L +FL   
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK- 173

Query: 566 TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKL 624
              L  +Q       +  AL Y+   H+  I H DLK  N+L+D +     L DFG AK 
Sbjct: 174 ---LYSYQ-------LCRALAYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220

Query: 625 LSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIE 669
           L    +S++    + +  Y APE  +     +T  D++S G ++ E
Sbjct: 221 LLAGQRSVSY---ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263

Length = 440

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 3/104 (2%)

Query: 569 LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           LD    L+    VA  + +L  ++    IH DL + N+LL    I  + DFG+A+ +  +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
              + +      + +MAPE       +  SD++SYGI+L E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 15/196 (7%)

Query: 483 IGIGSFGYVYK--AELDDGIEVA---IKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G++  V+K  ++L + + VA   I++ H+E A      EV   ++KN++H N+V + 
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVS--LLKNLKHANIVTLH 69

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
                +    LV EY+ +   D+  Y   C  ++    N+ I +   L  L++ H   I+
Sbjct: 70  DIIHTERCLTLVFEYLDS---DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKIL 125

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVST 656
           H DLK  N+L++E     L+DFG+A+  S   +  T +  + T+ Y  P+  +   + ST
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 657 RSDIYSYGIMLIETFT 672
             D++  G +L E  T
Sbjct: 184 PIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 21/202 (10%)

Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGC 540
           IG G++G VYK     DG   A+K+     +   +  E E  +++++  H N+VK     
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 541 SNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRH 592
              D        LVLE    GS+   +     +L   QRL+   I   +  AL  L   H
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY---- 648
              IIH D+K +N+LL  +    L DFG++  L+     + +  ++ T  +MAPE     
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEVIACE 203

Query: 649 -GIERKVSTRSDIYSYGIMLIE 669
              +     R D++S GI  IE
Sbjct: 204 QQYDYSYDARCDVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 2/158 (1%)

Query: 519 EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM 578
           E+ C  +    H  +VK      +DD   L++EY   G L+  +         FQ   + 
Sbjct: 115 ELHC--LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
           +     +  L+  H+  ++H DLKS+N+ L    I  L DFG +K  S        +   
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
            T  Y+APE    ++ S ++D++S G++L E  T  +P
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 21/223 (9%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAM-KSFEVECEVMKNIRHRNLVKIISGC 540
           +G G+ G VYKA  L     +A+KV   +    + K    E E++       ++      
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
             ++  ++  E+M  GSLD++      +L       I + V   L YL    +  I+H D
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRD 120

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           +K SN+L++      L DFG++  L     S+ +T  + T  YMAPE     +    SD+
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERISGEQYGIHSDV 176

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV 703
           +S GI  +E    + P  ++   + S       L+P+ L++ +
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGS-------LMPLQLLQCI 212

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 63/255 (24%), Positives = 109/255 (42%), Gaps = 29/255 (11%)

Query: 483 IGIGSFGYVYKAELDDGIEV-AIKVFHQE--CARAMKSFEVE---CE-----VMKNIRHR 531
           +G G FG V  AE     E+ AIK   +    AR     EVE   CE        + RH 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD----EVESLMCEKRIFETANSERHP 62

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
            LV + +    +D    V+EY   G L + +++     D+F     +   A  +  L + 
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYL 117

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGI 650
           H   I++ DLK  N+LLD +    ++DFG+ K   G      +T T   T  ++APE   
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPEVLT 174

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP-----ADKMFAAELSLKHWVNGLLPVSLMEVVNK 705
           E   +   D +  G+++ E    + P      +++F + ++ +      L    + ++ +
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR 234

Query: 706 TLLSPPEKDFAAKEQ 720
            L   PE+   + E+
Sbjct: 235 LLRRNPERRLGSGEK 249

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 10/200 (5%)

Query: 483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           +G G FG V   ++   G   A K  +++  +  K +E   VE  ++  +  R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
                    LV+  M  G L   +Y+       F         A  +  L   H   II+
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVST 656
            DLK  NVLLD D    +SD G+A +L  G+    ++T+  A T G+MAPE     +   
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQ----SKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 657 RSDIYSYGIMLIETFTRKKP 676
             D ++ G+ L E    + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 39/130 (30%), Positives = 60/130 (46%), Gaps = 7/130 (5%)

Query: 548 LVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNV 606
           LV+  M  G L   +Y+     L++ + ++    +   + +L   H+  I++ D+K  NV
Sbjct: 70  LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENV 126

Query: 607 LLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIM 666
           LLD+     LSD G+A  L       T TQ   T GYMAPE   E   S   D ++ G  
Sbjct: 127 LLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCS 183

Query: 667 LIETFTRKKP 676
           + E    + P
Sbjct: 184 IYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 15/196 (7%)

Query: 483 IGIGSFGYVYK--AELDDGIEVA---IKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G++  VYK  ++L D + VA   I++ H+E A      EV   ++K+++H N+V + 
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVS--LLKDLKHANIVTLH 70

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
                +    LV EY+     D+  Y   C  +     N+ + +   L  LN+ H   ++
Sbjct: 71  DIIHTEKSLTLVFEYLDK---DLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVL 126

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVST 656
           H DLK  N+L++E     L+DFG+A+  S    + T +  + T+ Y  P+  +     ST
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKS--IPTKTYSNEVVTLWYRPPDILLGSTDYST 184

Query: 657 RSDIYSYGIMLIETFT 672
           + D++  G +  E  T
Sbjct: 185 QIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 39/216 (18%)

Query: 480 DNLIGIGSFGYVYK-AELDDGIEVAIK----VFHQ--ECARAMKSFEVECEVMKNIRHRN 532
           D  IG G+FG V+   +  DG  VA+K    VF     C R  +  ++ C      +H N
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLC----FFKHDN 60

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIF--LYSSTCML--DIF------QRL---NIMI 579
              ++S           L+ +    +D F  +Y  T ++  D+       Q L   ++ +
Sbjct: 61  ---VLS----------ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV 107

Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            +   L  L + H+  I+H D+K  N+L++ + +  + DFG+A+ +   D+S   TQ + 
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVV 166

Query: 640 TIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRK 674
           T  Y APE  +  R  ++  DI+S G +  E   R+
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 7/157 (4%)

Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMI 579
           E ++++ +  R +V +       D   LVL  M  G L   +Y       +  + +    
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
           ++   LE L   H   I++ DLK  N+LLD+     +SD G+A  +  E Q++     + 
Sbjct: 110 EICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTI--KGRVG 163

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           T+GYMAPE     + +   D ++ G +L E    + P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.3 bits (133), Expect = 5e-08
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 11/153 (7%)

Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM--LDIFQRLNI 577
           +E  +++N+ H +++++     +     +VL   P+ S D++ Y +     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
              +   L YL   H   IIH D+K+ N+ +++     + D G A+        +    T
Sbjct: 163 EKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219

Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIET 670
           + T    APE     K ++++DI+S GI+L E 
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 20/175 (11%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIRHRNLVK 535
           L+G G+FG V    E   G   A+K+  +E   A    EV     E  V++N RH  L  
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKD--EVAHTLTESRVLQNTRHPFLTA 59

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM-IDVASALEYLNFRHTT 594
           +       D    V+EY   G L  F + S   +    R      ++ SAL YL   H+ 
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYL---HSC 114

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL--ATIGYMAPE 647
            +++ DLK  N++LD+D    ++DFG+ K    E  S   T      T  Y+APE
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 6e-08
 Identities = 31/104 (29%), Positives = 57/104 (54%), Gaps = 3/104 (2%)

Query: 569 LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           LD+   L     VA  +++L  ++    IH D+ + NVLL +  +A + DFG+A+ +  +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
              + +      + +MAPE   +   + +SD++SYGI+L E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 48.9 bits (117), Expect = 6e-08
 Identities = 16/41 (39%), Positives = 28/41 (68%), Gaps = 2/41 (4%)

Query: 34 TDQQALLALEAHISYDPTNLLAQNWTSNTSV-CNWIGITCD 73
           D+ ALLA ++ ++ DP+  L+ +W  ++S  C+W G+TCD
Sbjct: 3  DDRDALLAFKSSLNGDPSGALS-SWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.2 bits (133), Expect = 9e-08
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 4/95 (4%)

Query: 214 LYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSG 273
           L + N  + G IP  +  L     ++L  N + G IP + G +  + L+ L L  NSF+G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI--TSLEVLDLSYNSFNG 480

Query: 274 SIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGL 308
           SIP    +G L  +  +NL+ N+ SG +PA +GG 
Sbjct: 481 SIPE--SLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.3 bits (130), Expect = 9e-08
 Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 9/199 (4%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKII 537
           L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
                 D    V+EY   G L   L       +   R     ++ SAL+YL+      ++
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHSEKN--VV 118

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           + DLK  N++LD+D    ++DFG+ K   G     T      T  Y+APE   +      
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 658 SDIYSYGIMLIETFTRKKP 676
            D +  G+++ E    + P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.2 bits (133), Expect = 1e-07
 Identities = 40/113 (35%), Positives = 59/113 (52%), Gaps = 10/113 (8%)

Query: 161 LELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCS 220
           L L      GFIPN I  LR+++     I L GN + G +P S+ +++ SLE L +S  S
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQ----SINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNS 477

Query: 221 ITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFG-----RLQNSKLDTLSLCG 268
             G+IP+ +G L+   +L+L  N L+G +P   G     R   +  D   LCG
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530

Length = 623

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 21/191 (10%)

Query: 487 SFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK 546
             GY Y+ E    I+V +KV          +F     +M+ + H+++V +   C  D   
Sbjct: 24  DDGYSYEKE----IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79

Query: 547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNV 606
            +V E++  G LD+F++  + +L    +  +   +ASAL YL  +    ++H ++ + N+
Sbjct: 80  IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNI 136

Query: 607 LLDEDMI-------AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRS 658
           LL  + I         LSD GI   +      +++ + +  I ++APE   + K  S  +
Sbjct: 137 LLAREGIDGECGPFIKLSDPGIPITV------LSRQECVERIPWIAPECVEDSKNLSIAA 190

Query: 659 DIYSYGIMLIE 669
           D +S+G  L E
Sbjct: 191 DKWSFGTTLWE 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 21/211 (9%)

Query: 482 LIGIGSFGYVYKAELDDG---------IEVAIKVFHQECARAMKSFE---VECEVMK-NI 528
            +G G+FG VYK    +          I V    F ++     KS      E  ++K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRL-NIMIDVASAL 585
           RH N+V+       +D   +V++ +    L     S       F  +R+ NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            YL+      I+H DL  +N++L ED    ++DFG+AK     +  +  T  + TI Y  
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL--TSVVGTILYSC 181

Query: 646 PEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           PE         ++D++++G +L +  T + P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 31/112 (27%), Positives = 58/112 (51%), Gaps = 9/112 (8%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
           N  L G +P+ I   L ++++++L+ N   G I   + + + L +L+L  NSF+G IP +
Sbjct: 427 NQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISN----CSITG 223
           +G L ++  L L     GN L+G +P+++    +       ++    C I G
Sbjct: 486 LGQLTSLRILNLN----GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533

Length = 623

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 12/204 (5%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI--ISG 539
           +G GS G V+ A + D    VA+K       +++K    E ++++ + H N+VK+  + G
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 540 CSNDDFKALVLEYMPNGSLDIFL-YSSTCMLDIFQRLNIMIDVASALEY-----LNFRHT 593
            S  D    V       S+ I   Y  T + ++ ++  +  + A    Y     L + H+
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS 132

Query: 594 TPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGE-DQSMTQTQTLATIGYMAPEYGIE 651
             ++H DLK +NV ++ ED++  + DFG+A+++          ++ L T  Y +P   + 
Sbjct: 133 ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192

Query: 652 RKVSTRS-DIYSYGIMLIETFTRK 674
               T++ D+++ G +  E  T K
Sbjct: 193 PNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 36/214 (16%)

Query: 483 IGIGSFGYVYKA---ELDDGIEVAIK----VFHQE--CARAMKSFEVECEVMKNIR-HRN 532
           +G G++G V  A   E  +   VAIK    VF ++    RA++    E +++++ R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 533 LVKIISG--CSNDDFKALVL-EYMPNGSLDIFLYSSTCMLD------IFQRLNIMIDVAS 583
           +  +         +F  L L E +    L   + S   + D      I+Q L        
Sbjct: 64  ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL-------C 116

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG--EDQSMTQTQTLATI 641
            L+Y+   H+  ++H DLK  N+L++ D    + DFG+A+  S    + +   T+ +AT 
Sbjct: 117 GLKYI---HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 642 GYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
            Y APE  +  +  T++ D++S G +L E   RK
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 477 FGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVMKN----IRHR 531
           F    ++G GSFG V  AE     E+ AIK+  ++    ++  +VEC +++     ++ +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDK 59

Query: 532 N--LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
              L ++ S     D    V+EY+  G L   +Y     +  F+    +   A     L 
Sbjct: 60  PPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQ-QVGKFKEPQAVFYAAEISVGLF 115

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK--LLSGEDQSMTQTQTLATIGYMAPE 647
           F H   II+ DLK  NV+LD +    ++DFG+ K  ++ G    +T      T  Y+APE
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAPE 171

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
               +      D ++YG++L E    + P D
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 15/199 (7%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGC 540
           IG G++G V+K     +G + A+K+         +  E E  ++K +  H N+VK     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 541 SNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
              D K      LVLE    GS+   +       +  +   I   +  AL  L   H   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY-GIERKV 654
            IH D+K +N+LL  +    L DFG++  L+     + +  ++ T  +MAPE    E+++
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 655 ST----RSDIYSYGIMLIE 669
            +    R D++S GI  IE
Sbjct: 203 DSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 24/173 (13%)

Query: 476 RFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSF---EVECEVMKNIRHR 531
            F +  L+G G  G V+   L    ++ A+KV  ++             E E++  + H 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM-IDVAS------- 583
            L  + +    + +  LV++Y P G L   L          Q    +  +VA        
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQR--------QPGKCLSEEVARFYAAEVL 113

Query: 584 -ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
            ALEYL   H   I++ DLK  N+LL E     LSDF ++K    E   +++ 
Sbjct: 114 LALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 13/206 (6%)

Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRHRN 532
           F +  ++G G FG V   ++   G   A K   ++  +  K   +   E ++++ +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFR 591
           +V +       D   LVL  M  G L   +Y+   M +  F+    +   A  L  L   
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDL 118

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTLATIGYMAPEYGI 650
           H    ++ DLK  N+LLD+     +SD G+A K+  GE    +    + T+GYMAPE   
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLN 174

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
            ++ +   D +  G ++ E    + P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 35/207 (16%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH---QECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++    
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVI---- 79

Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                    L+  + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 80  --------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 131

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 186

Query: 647 EYGIE-RKVSTRSDIYSYGIMLIETFT 672
           E  +     +   DI+S G ++ E  T
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 35/211 (16%)

Query: 476 RFGRDNLIGIGSFGYVYKAELDD--GIEVAIKVF---HQECARAMKSFEVECEVMKNIRH 530
           R+ +   IG G+ G V  A  D   GI VA+K      Q    A +++  E  ++K + H
Sbjct: 22  RYQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNH 79

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASALE 586
           +N++ +++             + P  SL    D++L       ++ Q +++ +D    + 
Sbjct: 80  KNIISLLN------------VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD-HERMS 126

Query: 587 YLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
           YL ++        H+  IIH DLK SN+++  D    + DFG+A+       +   T  +
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYV 183

Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            T  Y APE  +        DI+S G ++ E
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECE-VMKNI-----RHRNLV 534
           ++G GSFG V  AE     E+ AIK+  ++    ++  +VEC  V K +     +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-----FQRLNIMIDVASALEYLN 589
           ++ S     D    V+EY+  G L         M  I     F+  + +   A     L 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---------MYHIQQVGKFKEPHAVFYAAEIAIGLF 115

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEY 648
           F H+  II+ DLK  NV+LD +    ++DFG+ K      ++   T+T   T  Y+APE 
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEI 172

Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
              +      D +++G++L E    + P D
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 51.3 bits (122), Expect = 6e-07
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 20/202 (9%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           L+G G++G VYK   +  G   AIKV         +  + E  ++K   H   +    G 
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 541 -------SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
                    DD   LV+E+   GS+   + ++    +  +   I       L  L+  H 
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ 129

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEY---- 648
             +IH D+K  NVLL E+    L DFG++  L   D+++ +  T + T  +MAPE     
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 649 -GIERKVSTRSDIYSYGIMLIE 669
              +     +SD++S GI  IE
Sbjct: 187 ENPDATYDFKSDLWSLGITAIE 208

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.9 bits (127), Expect = 6e-07
 Identities = 64/283 (22%), Positives = 115/283 (40%), Gaps = 43/283 (15%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKII 537
           LIG G  G VY A +      VA+K   +   E     K F  E ++  ++ H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR-----------LNIMIDVASALE 586
           S CS+ D     + Y+   +L   L  S    +   +           L+I   + + +E
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLL-KSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ---------------S 631
           Y+   H+  ++H DLK  N+LL       + D+G A     E++               S
Sbjct: 128 YV---HSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 632 MTQT-QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW 690
           MT   + + T  YMAPE  +    S  +DIY+ G++L +  T   P  +    ++S +  
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDV 244

Query: 691 VNGL--------LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSI 725
           +           +P  L ++  K L   P + +++ ++    +
Sbjct: 245 ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287

Length = 932

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 32/204 (15%)

Query: 483 IGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG G+FG VY+    D   + A+KV  ++   A K      EV   I  RN++ + +   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNIL-VRTLLD 53

Query: 542 NDDFKA-------------LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI-DVASALEY 587
              F               LV +YM  G L   L       +   R    I ++  ALE+
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEH 111

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTLATIGYMAP 646
           L   H   I++ DLK  N+LLD      L DFG++K  L+    + T      T  Y+AP
Sbjct: 112 L---HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAP 165

Query: 647 EYGIERKVSTRS-DIYSYGIMLIE 669
           E  ++ K  T+  D +S G+++ E
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 8e-07
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 44/208 (21%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIK-VFHQECARAMKSFEV-ECEVMKNIRHRNLVKIISG 539
           IG G++G V+KA   +    VA+K V   +    + S  + E  ++K ++H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 540 CSNDDFKALVLEYMP----------NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
             +D    LV EY            NG +D           +FQ           L+ L 
Sbjct: 68  LHSDKKLTLVFEYCDQDLKKYFDSCNGDID----PEIVKSFMFQ----------LLKGLA 113

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-------KLLSGEDQSMTQTQTLATIG 642
           F H+  ++H DLK  N+L++++    L+DFG+A       +  S E         + T+ 
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE---------VVTLW 164

Query: 643 YMAPEYGIERKV-STRSDIYSYGIMLIE 669
           Y  P+     K+ ST  D++S G +  E
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAE 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 9e-07
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 32/218 (14%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ------ECARAMKSFEVECEVMKNI 528
           R+    +IG GS+G V  A +   G +VAIK  +       +  R ++    E ++++ +
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLL 56

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA---- 584
           RH ++V+I         K ++L        DI++       D+ Q +    D+       
Sbjct: 57  RHPDIVEI---------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF 107

Query: 585 -----LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTL 638
                L  L + HT  + H DLK  N+L + D    + DFG+A++  +    ++  T  +
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 639 ATIGYMAPEY--GIERKVSTRSDIYSYGIMLIETFTRK 674
           AT  Y APE       K +   DI+S G +  E  T K
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 39/218 (17%)

Query: 476 RFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVFH---QECARAMKSFEVECEVMKNIR 529
           R+     +G G++G V   Y   L    +VA+K      Q    A +++  E  ++K+++
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHMK 72

Query: 530 HRNLVKIIS----GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-----FQRL---NI 577
           H N++ ++       S ++F             +++L ++    D+      Q+L   ++
Sbjct: 73  HENVIGLLDVFTPATSIENFN------------EVYLVTNLMGADLNNIVKCQKLSDEHV 120

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
              +   L  L + H+  IIH DLK SNV ++ED    + DFG+A+     D  M  T  
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGY 175

Query: 638 LATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRK 674
           +AT  Y APE  +     +   DI+S G ++ E    K
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 14/156 (8%)

Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY-SSTCMLDIFQRLNIMI 579
           E  +++ I H +++++    + + F  L+L   P    D++ Y ++   + I   L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL- 638
            V  A++YL   H   IIH D+K+ N+ ++      L DFG A         +   +   
Sbjct: 190 SVLRAIQYL---HENRIIHRDIKAENIFINHPGDVCLGDFGAACF----PVDINANKYYG 242

Query: 639 --ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
              TI   APE           DI+S GI+L E  T
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 1e-06
 Identities = 19/59 (32%), Positives = 32/59 (54%)

Query: 311 VQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
           ++++ L  NRL      +F  L +L++LDLS N ++     +   L  L+ L+LS N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 39/131 (29%), Positives = 57/131 (43%), Gaps = 6/131 (4%)

Query: 548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL 607
           LV+EY+  G L   +     + +   R       A     LNF H   II+ DLK  NVL
Sbjct: 73  LVIEYVNGGDLMFHMQRQRKLPEEHARFY----AAEICIALNFLHERGIIYRDLKLDNVL 128

Query: 608 LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
           LD D    L+D+G+ K   G     T +    T  Y+APE     +     D ++ G+++
Sbjct: 129 LDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLM 186

Query: 668 IETFTRKKPAD 678
            E    + P D
Sbjct: 187 FEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 26/218 (11%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKS---FEVECEVMKNIRH 530
             F   +L+G G FG V    E   G   A+KV  +    A ++   FE E +++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             + ++     + D   LV+EY P G L   L       D F        +A  +  ++ 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHS 117

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE--- 647
            H    +H D+K  NVL+D      L+DFG A  L+  ++ +     + T  Y+APE   
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPEVLT 176

Query: 648 ---------YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
                    YG+E       D +S G++  E    + P
Sbjct: 177 TMNGDGKGTYGVE------CDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 22/205 (10%)

Query: 482 LIGIGSFG--YVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           ++G GSFG   + +    D      ++   + + A++    E  ++  ++H N+V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 540 CSNDDFKALVLEYMPNGSL-------DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
              D    +V+EY   G L          L+    +L  F ++ + +            H
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV---------QHIH 117

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEYGIE 651
              ++H D+KS N+ L ++    L DFG A+LL+          T + T  Y+ PE    
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT---SPGAYACTYVGTPYYVPPEIWEN 174

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
              + +SDI+S G +L E  T K P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 37/210 (17%)

Query: 483 IGIGSFGYV---YKAELDDGIEVAIKVFH---QECARAMKSFEVECEVMKNIRHRNLVKI 536
           IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK + H+N++ +
Sbjct: 25  IGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 537 ISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR- 591
           ++             + P  SL    D++L       ++ Q + + +D    + YL ++ 
Sbjct: 82  LN------------VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYLLYQM 128

Query: 592 -------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
                  H+  IIH DLK SN+++  D    + DFG+A+       S   T  + T  Y 
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 185

Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           APE  +        DI+S G ++ E    K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 57/191 (29%), Positives = 83/191 (43%), Gaps = 22/191 (11%)

Query: 80  TALNISSLNLQG----EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVK 135
              N+  L+L       +P  +  LP+L  L L +N L         LP  +   L N+ 
Sbjct: 138 LKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-------DLPKLL-SNLSNLN 189

Query: 136 ALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNP 195
            L L+ N+ S  +   I   S L  L+L  NS    I   + +L N++ L   + L  N 
Sbjct: 190 NLDLSGNKIS-DLPPEIELLSALEELDLSNNS----IIELLSSLSNLKNL-SGLELSNNK 243

Query: 196 LNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGR 255
           L   LP SI NLS +LE L +SN  I+       G+L+    LDL  N L+  +P+    
Sbjct: 244 LED-LPESIGNLS-NLETLDLSNNQISSISSL--GSLTNLRELDLSGNSLSNALPLIALL 299

Query: 256 LQNSKLDTLSL 266
           L   +L    L
Sbjct: 300 LLLLELLLNLL 310

Length = 394

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 64/296 (21%), Positives = 112/296 (37%), Gaps = 61/296 (20%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRN 532
           F +   +GIG+FG V  A ++D     A+K   ++       +   + E +++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +VK+     + D    V++Y+P G +   L       ++  R  I  ++  A+E +   H
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESV---H 118

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIA------------------------------ 622
               IH D+K  N+L+D D    L+DFG+                               
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 623 ---------KLLSGEDQSMTQTQT------LATIGYMAPEYGIERKVSTRSDIYSYGIML 667
                    +L + E ++  Q Q       + T  Y+APE  + +  +   D +S G++L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 668 IETFTRKKPADKMFAAELSLK--HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQC 721
            E    + P       E  LK  +W N L       +  +  LSP   D   K  C
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTL------HIPPQVKLSPEAVDLITKLCC 288

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 19/206 (9%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECE-VMKNI-----RHRNLV 534
           ++G GSFG V  AE     E+ AIK+  ++    ++  +VEC  V K +     +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++ S     D    V+EY+  G L   +Y     +  F+  + +   A     L F H+ 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAK--LLSGEDQSMTQTQTLATIGYMAPEYGIER 652
            II+ DLK  NV+LD +    ++DFG+ K  +  G    +T      T  Y+APE    +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAPEIIAYQ 176

Query: 653 KVSTRSDIYSYGIMLIETFTRKKPAD 678
                 D +++G++L E    + P +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 31/201 (15%)

Query: 483 IGIGSFGYVYKAELD-DGIEVAIKVFH-QECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           +G GS+  VYK +   +G  VA+KV   QE      +   E  ++K ++H N+V +    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 541 SNDDFKALVLEYM-----------PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
              +   LV EY+           P G     L+     L +FQ L         L Y++
Sbjct: 73  HTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKLFLFQLLR-------GLSYIH 120

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
            R+   I+H DLK  N+L+ +     L+DFG+A+  S    S T +  + T+ Y  P+  
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPDVL 175

Query: 650 I-ERKVSTRSDIYSYGIMLIE 669
           +   + ST  D++  G + +E
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVE 196

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 60/225 (26%)

Query: 467 YQDLSRATNRFGRDNLIGIGSFGYVYKAELDD---GIEVAIKVFH---QECARAMKSFEV 520
           YQ+L            IG G+ G V  A   D   G  VAIK      Q    A +++  
Sbjct: 18  YQNLK----------PIGSGAQGIVCAA--YDTVTGQNVAIKKLSRPFQNVTHAKRAYR- 64

Query: 521 ECEVMKNIRHRNLVKIISGC----SNDDFKA--LVLEYMP-------NGSLD-----IFL 562
           E  +MK + H+N++ +++      S ++F+   LV+E M           LD       L
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL 124

Query: 563 YSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA 622
           Y   C                 +++L   H+  IIH DLK SN+++  D    + DFG+A
Sbjct: 125 YQMLC----------------GIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165

Query: 623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYG-IM 666
           +  +G    M  T  + T  Y APE  +        DI+S G IM
Sbjct: 166 R-TAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 48.4 bits (115), Expect = 8e-06
 Identities = 87/303 (28%), Positives = 139/303 (45%), Gaps = 27/303 (8%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG----NNSLSGSLPSRIDLALPNVKAL 137
            +  S N   E+     Y  +   + L +          N L+ +L S   L LP+  + 
Sbjct: 9   KSALSSNTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSR 68

Query: 138 SLAYNRFS-GTIQSP-----ITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGL 191
            L+ +  S   I S      + N   L  L+L  N     I + +  L N+      + L
Sbjct: 69  LLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLT----SLDL 123

Query: 192 IGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPV 251
             N +  I P  I  L  +L+ L +S+  I  ++P  + NL     LDL  N L+    +
Sbjct: 124 DNNNITDI-PPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD---L 178

Query: 252 TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDV 311
                  S L+ L L GN  S  +P   +I  L  + E++LS N+   ++ +++  LK++
Sbjct: 179 PKLLSNLSNLNNLDLSGNKIS-DLPP--EIELLSALEELDLSNNSII-ELLSSLSNLKNL 234

Query: 312 QNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG 371
             + L  N+LE  +PES G L++LE LDLSNN+IS   + SL  L  L++L+LS N L  
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSN 291

Query: 372 EIP 374
            +P
Sbjct: 292 ALP 294

Length = 394

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 17/203 (8%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARA----MKSFEVECEVMKNIRHRNLVKIIS 538
           IG G FG V  +E+     VA  V  +  A A       F  + +  + ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCML---DIFQRLNIMIDVASALEYLNFRHTTP 595
            C       LV EY   G L  +L           +     +  ++A+ + ++   H   
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHN 119

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER--- 652
            +H DL   N  L  D+   + D+GI      ED   T+      + ++APE   E    
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 653 ----KVSTRSDIYSYGIMLIETF 671
               + +  S++++ G+ L E F
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 64/261 (24%), Positives = 106/261 (40%), Gaps = 38/261 (14%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG- 539
           +IG G FG VY   + D G   A+K   ++  + MK  E        +  R ++ ++S  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIMLSLVSTG 54

Query: 540 ------CSNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
                 C    F        +L+ M  G L   L        +F    +       +  L
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGL 110

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H   +++ DLK +N+LLDE     +SD G+A   S +        ++ T GYMAPE 
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEV 166

Query: 649 GIERKVS--TRSDIYSYGIMLIE------TFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
            +++  +  + +D +S G ML +       F + K  DK     ++L   VN  LP S  
Sbjct: 167 -LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELPDSFS 223

Query: 701 EVVNKTLLSPPEKDFAAKEQC 721
             +   L    ++D + +  C
Sbjct: 224 PELKSLLEGLLQRDVSKRLGC 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 62/253 (24%), Positives = 112/253 (44%), Gaps = 21/253 (8%)

Query: 433 VVLALKYKSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVY 492
           +VL L + + R+ K+  + N    L++  K     + L      +    +IG G+FG V 
Sbjct: 6   LVLDLDFPALRKNKN--IDN---FLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ 60

Query: 493 KAELDDGIEV-AIKVFHQ-ECARAMKS--FEVECEVMKNIRHRNLVKIISGCSNDDFKAL 548
                   +V A+K+  + E  +   S  F  E ++M       +V++     +D +  +
Sbjct: 61  LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120

Query: 549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL 608
           V+EYMP G L + L S+  + + + +       A  +  L+  H+  +IH D+K  N+LL
Sbjct: 121 VMEYMPGGDL-VNLMSNYDVPEKWAKFY----TAEVVLALDAIHSMGLIHRDVKPDNMLL 175

Query: 609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEY----GIERKVSTRSDIYSY 663
           D+     L+DFG    +  ++  M +  T + T  Y++PE     G +       D +S 
Sbjct: 176 DKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233

Query: 664 GIMLIETFTRKKP 676
           G+ L E      P
Sbjct: 234 GVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 14/217 (6%)

Query: 468 QDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQ-ECARAMKS--FEVECE 523
           +DL      +    +IG G+FG V         +V A+K+  + E  +   S  F  E +
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
           +M       +V++     +D +  +V+EYMP G L + L S+  + + + R     +V  
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVL 153

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           AL+ +   H+   IH D+K  N+LLD+     L+DFG    ++ E      T  + T  Y
Sbjct: 154 ALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDY 209

Query: 644 MAPEY----GIERKVSTRSDIYSYGIMLIETFTRKKP 676
           ++PE     G +       D +S G+ L E      P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 9/161 (5%)

Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMI 579
           E  +++ +  R +V +       D   LVL  M  G L   +Y+      D  + +    
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTL 638
           ++   LE L       I++ DLK  N+LLD+     +SD G+A ++  GE    T    +
Sbjct: 110 ELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRV 162

Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK 679
            T+GYMAPE     K +   D +  G ++ E    + P  K
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 7/157 (4%)

Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID 580
           E ++++ +  R +V +       D   LVL  M  G L   +Y+       F     +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFY 107

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTLA 639
            A     L   H   I++ DLK  N+LLD+     +SD G+A ++  GE    T    + 
Sbjct: 108 AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVG 163

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           T+GYMAPE     + +   D +  G ++ E    K P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 5/101 (4%)

Query: 134 VKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIG 193
           +  L L      G I + I+    L  + L GNS  G IP ++G++ ++E    V+ L  
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE----VLDLSY 475

Query: 194 NPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSI 234
           N  NG +P S+  L+ SL  L ++  S++G +P  +G   +
Sbjct: 476 NSFNGSIPESLGQLT-SLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 42/196 (21%), Positives = 79/196 (40%), Gaps = 26/196 (13%)

Query: 486 GSFGYVYKAELDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSND 543
               ++ K +      VA+K  + +      +K  + E    + ++H N++  ++    D
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVASALEYLNFRHTTPIIHCD 600
               +V   M  GS +  L +     +    L    I+ DV +AL+Y+   H+   IH  
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYI---HSKGFIHRS 126

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-----TQTLATIGYMAPE------YG 649
           +K+S++LL  D    LS    +  +    +           ++  + +++PE       G
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186

Query: 650 IERKVSTRSDIYSYGI 665
              K    SDIYS GI
Sbjct: 187 YNEK----SDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 11/202 (5%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSF---EVECEVMKNI-RHRNLVKI 536
           +IG GS+  V    L     + A+KV  +E     +     + E  V +    H  LV +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
            S    +     V+EY+  G L   +     + +   R     +++ AL YL   H   I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYL---HERGI 117

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           I+ DLK  NVLLD +    L+D+G+ K   G     T +    T  Y+APE         
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D ++ G+++ E    + P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 6/93 (6%)

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           LNF H   II+ DLK  NVLLD +    L+D+G+ K   G     T +    T  Y+APE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166

Query: 648 Y--GIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
              G +   S   D ++ G+++ E    + P D
Sbjct: 167 ILRGEDYGFSV--DWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 65/274 (23%), Positives = 101/274 (36%), Gaps = 81/274 (29%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKN-IRH----RNL---- 533
           IGIG+FG V      D   +           AMK+      +M+N   H    R++    
Sbjct: 9   IGIGAFGEVCLVRKVDTNAL----------YAMKTLRKADVLMRNQAAHVKAERDILAEA 58

Query: 534 -----VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQ----RLNIMIDVASA 584
                VK+     + D    V++Y+P G +   L      L IF+    R  I  ++  A
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIA-ELTCA 113

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI----------------------- 621
           +E +   H    IH D+K  N+L+D D    L+DFG+                       
Sbjct: 114 IESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 622 ------------AKLLSGEDQSMTQTQT------LATIGYMAPEYGIERKVSTRS-DIYS 662
                        +L   E +   Q Q       + T  Y+APE  + R   T+  D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV-LLRTGYTQLCDWWS 229

Query: 663 YGIMLIETFTRKKP--ADKMFAAELSLKHWVNGL 694
            G++L E    + P  AD     +L + +W   L
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 50/214 (23%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVK---IISG 539
           +G G++G VYK            V H+     M   E+  E +   +   ++    I+  
Sbjct: 9   LGKGNYGSVYK------------VLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHK 55

Query: 540 CSND---DFKA---------LVLEYMPNGSLDIFLY---SSTCMLDIFQRLNIMIDVASA 584
             +    DF           + +EYM  GSLD  LY    +T  +       I   V   
Sbjct: 56  AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKG 114

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG-- 642
           L++L   H   IIH D+K +NVL++ +    L DFG++  L     S+ +T     IG  
Sbjct: 115 LKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTN----IGCQ 165

Query: 643 -YMAPEY---GIERKVST---RSDIYSYGIMLIE 669
            YMAPE    G   +  T   +SD++S G+ ++E
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 35/204 (17%)

Query: 483 IGIGSFGYVYKAELDDGIE--VAIKVFH---QECARAMKSFEVECEVMKNIRHRNLVKII 537
           IG G+ G V  A  D  +E  VAIK      Q    A +++  E  +MK + H+N++ ++
Sbjct: 32  IGSGAQGIVCAA-YDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLL 89

Query: 538 SGCSNDDFKALVLEYMPNGSLDIF--LYSSTCMLD--IFQRLNIMIDVASALEYLNFR-- 591
           +             + P  SL+ F  +Y    ++D  + Q + + +D    + YL ++  
Sbjct: 90  N------------VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYLLYQML 136

Query: 592 ------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
                 H+  IIH DLK SN+++  D    + DFG+A+       S   T  + T  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRA 193

Query: 646 PEYGIERKVSTRSDIYSYGIMLIE 669
           PE  +        DI+S G ++ E
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGE 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.2 bits (108), Expect = 6e-05
 Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 38/216 (17%)

Query: 486 GSFG--YVYKAELDDGIEVAIKVFHQECARAMKSFEVECEV---MKNIRHRNLVKIISGC 540
           G FG   V K +         K+F Q+  +A     +E  V   MK+  + N +K+    
Sbjct: 27  GKFGKVSVLKHKPTQ------KLFVQKIIKAKNFNAIEPMVHQLMKD--NPNFIKLYYSV 78

Query: 541 SNDDFKALVLEYMPNGSL------DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           +      L+++Y+ +G L      +  L  +     I Q       +  AL  L   H  
Sbjct: 79  TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ-------LVEALNDL---HKH 128

Query: 595 PIIHCDLKSSNVLLDEDMI-AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
            IIH D+K  NVL D      +L D+G+ K+            TL    Y +PE  I+  
Sbjct: 129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI---IGTPSCYDGTLD---YFSPE-KIKGH 181

Query: 654 VSTRS-DIYSYGIMLIETFTRKKPADKMFAAELSLK 688
               S D ++ G++  E  T K P  +    EL L+
Sbjct: 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217

Length = 267

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 34/215 (15%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG G++G VYKA + + G  VA+K       +     + E      +R  +L++++S   
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSES- 60

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV----------ASALEYLNFR 591
               + L +E++   +    LY     LD    L   +D           A  ++   ++
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLD--SDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 592 --------HTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
                   H   ++H DLK  N+L+D+   +  ++D G+ +  S   +S   T  + T+ 
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLW 176

Query: 643 YMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKP 676
           Y APE  +     ST  DI+S G +  E  +RK+P
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAE-MSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG- 539
           +IG G FG VY   + D G   A+K   ++  + MK  E        +  R ++ ++S  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIMLSLVSTG 54

Query: 540 ------CSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
                 C +  F      + +L+ M  G L   L        +F    +    A  +  L
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGL 110

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H   +++ DLK +N+LLDE     +SD G+A   S +        ++ T GYMAPE 
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEV 166

Query: 649 GIERKVS--TRSDIYSYGIMLIETFTRKKP 676
            +++ V+  + +D +S G ML +      P
Sbjct: 167 -LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 39/170 (22%), Positives = 73/170 (42%), Gaps = 17/170 (10%)

Query: 512 ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE--------YMPNGSLDIFLY 563
           +RA    E E   +  + H N++KI     ++    ++ +        +M + + D   +
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---W 260

Query: 564 SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK 623
               +L   Q   IM  +  A+EY+   H   +IH D+K  N+ L+ D    L DFG A 
Sbjct: 261 KDRPLL--KQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFLNCDGKIVLGDFGTAM 315

Query: 624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR 673
               E ++      + T+   +PE          +DI+S G++L++  + 
Sbjct: 316 PFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 31/204 (15%)

Query: 483 IGIGSFGYVYKA--ELDDGIEVAIKVF---HQECA--RAMKSFEVECEVMKNIRHRNLVK 535
           +G GS+  VYK   +L   + VA+K     H+E A   A++    E  ++K+++H N+V 
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIR----EASLLKDLKHANIVT 67

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +           LV EY+     D+  Y   C        N+ + +   L  L + H   
Sbjct: 68  LHDIIHTKKTLTLVFEYLDT---DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR 123

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP-------EY 648
           ++H DLK  N+L+ E     L+DFG+A+  S    S T +  + T+ Y  P       EY
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKS--VPSKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 649 GIERKVSTRSDIYSYGIMLIETFT 672
                 ST  D++  G +  E  T
Sbjct: 182 ------STSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 35/181 (19%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIR-HRNLVKII-- 537
           IG G+F  V KA     G   AIK   +      +   + E + ++ +  H N++++I  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 538 -----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------NIMIDVASALE 586
                +G       ALV E M     D+ LY    +    + L      + M  +  +L+
Sbjct: 67  LFDRKTGRL-----ALVFELM-----DMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           ++   H   I H D+K  N+L+ +D++  L+DFG  +   G       T+ ++T  Y AP
Sbjct: 115 HM---HRNGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAP 167

Query: 647 E 647
           E
Sbjct: 168 E 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 29/139 (20%), Positives = 59/139 (42%), Gaps = 19/139 (13%)

Query: 491 VYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV--KIISGCSNDDFKAL 548
           VY     D  +  +K+       A +  EV   +++ +  + L   K+++   +D +  L
Sbjct: 14  VYLLGTKDE-DYVLKINPSREKGADREREVA--ILQLLARKGLPVPKVLASGESDGWSYL 70

Query: 549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI---IHCDLKSSN 605
           ++E++   +LD         +   ++ +I   +A  L  L   H  P+    H DL   N
Sbjct: 71  LMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKL---HQLPLLVLCHGDLHPGN 119

Query: 606 VLLDEDMIAHLSDFGIAKL 624
           +L+D+  I  + D+  A  
Sbjct: 120 ILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLVKIIS-GC 540
           +G G++G+VYKA+  DG +       Q E      S   E  +++ ++H N++ +     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 541 SNDDFKA-LVLEYMPNGSLDI--FLYSSTCMLDIFQRLNIMID--VASALEYLNFRHTTP 595
           S+ D K  L+ +Y  +    I  F  +S       Q    M+   +   L+ +++ H   
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 596 IIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQ-TLATIGYMAPEYGI 650
           ++H DLK +N+L+     E     ++D G A+L +   + +      + T  Y APE  +
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188

Query: 651 ERKVSTRS-DIYSYGIMLIETFTRK 674
             +  T++ DI++ G +  E  T +
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 7/90 (7%)

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLD--EDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           SA++Y+   H   IIH D+K+ NVL++  ED+   L DFG A    G   +        T
Sbjct: 271 SAIDYI---HGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGT 325

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIET 670
           +   APE       +   DI+S G+++ E 
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355

Length = 461

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 16/99 (16%)

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK---------LLSGEDQSMTQ 634
           ALEYL   H   I+H DLK  N+L+       L+DFG++K         L  G  +  T+
Sbjct: 113 ALEYL---HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 635 ----TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
                Q   T  Y+APE  + +      D ++ GI+L E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 39/217 (17%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFH--QECARAMKS-FEVECEVMKNIRHRNLVKII 537
           +IG G+FG V   +L +  +V A+K+ +  +   RA  + F  E +V+ N  ++ +  + 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFL--YSSTCMLDI----FQRLNIMIDVASALEYLNFR 591
               +++   LV++Y   G L   L  +      D+       + I ID    L Y    
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFG-IAKLLSGEDQSMTQTQTLATIGYMAPE--- 647
                +H D+K  N+L+D +    L+DFG   KL+  ED ++  +  + T  Y++PE   
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQ 176

Query: 648 --------YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
                   YG E       D +S G+ + E    + P
Sbjct: 177 AMEDGKGKYGPE------CDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 65/256 (25%), Positives = 109/256 (42%), Gaps = 35/256 (13%)

Query: 430 IAVVVLALKYKSTRRGKSTG--LSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGS 487
           +  +V      + R+ K+    LS       + TK R+  +D       F    +IG G+
Sbjct: 3   VTALVYDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAED-------FDVIKVIGRGA 55

Query: 488 FGYVYKAELDDGIEV-AIKVFHQ-ECARAMKS--FEVECEVMKNIRHRNLVKIISGCSND 543
           FG V         +V A+K+  + E  +   S  F  E ++M +     +V++     +D
Sbjct: 56  FGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115

Query: 544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKS 603
            +  +V+EYMP G L + L S+  + + + R     +V  AL+ +   H+   IH D+K 
Sbjct: 116 KYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTA-EVVLALDAI---HSMGFIHRDVKP 170

Query: 604 SNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE----------YGIERK 653
            N+LLD+     L+DFG    +         T  + T  Y++PE          YG E  
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRE-- 227

Query: 654 VSTRSDIYSYGIMLIE 669
                D +S G+ L E
Sbjct: 228 ----CDWWSVGVFLYE 239

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 16/201 (7%)

Query: 483 IGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEV-----ECEVMKNIRHRNLVKI 536
           IG GSFG V +    D   + A+K   +  A  +   EV     E  V+  +    +V +
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                + +   LVL ++  G L   L       D+ +      ++  ALE L   H   +
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENL---HKFNV 114

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           I+ DLK  N+LLD      L DFG+ KL +  +D++ T      T  Y+APE  +    +
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPELLLGHGYT 171

Query: 656 TRSDIYSYGIMLIETFTRKKP 676
              D ++ G++L E  T   P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLVKIIS-GC 540
           +G G++G+VYKA+  DG +       Q E      S   E  +++ ++H N++ +     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 541 SNDDFKA-LVLEYMPNGSLDI--FLYSSTCMLDIFQRLNIMID--VASALEYLNFRHTTP 595
           S+ D K  L+ +Y  +    I  F  +S       Q    M+   +   L+ +++ H   
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 596 IIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQ-TLATIGYMAPEYGI 650
           ++H DLK +N+L+     E     ++D G A+L +   + +      + T  Y APE  +
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188

Query: 651 ERKVSTRS-DIYSYGIMLIETFTRK 674
             +  T++ DI++ G +  E  T +
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 9/119 (7%)

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK--LLSGEDQSMT 633
           NIM D+ + LEY+   H   I H D+K  N+++D +   ++ D+GIA   ++ G+    +
Sbjct: 130 NIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186

Query: 634 QTQT---LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH 689
           + Q      T+ Y   +      V+ R D+ S G  +++    K P  K F    +L H
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW-KGFGHNGNLIH 244

Length = 294

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 8/149 (5%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRN 532
           F +   +GIG+FG V  A ++D     A+K   ++       +   + E +++    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +V++     + D    V++Y+P G +   L       +   R  I  ++  A+E +   H
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA-ELTCAVESV---H 118

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGI 621
               IH D+K  N+L+D D    L+DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 27/183 (14%)

Query: 500 IEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG 556
           + V +KV    H++ A A   FE    +M  + H +L  +   C       +V E++ +G
Sbjct: 45  LRVVLKVLDPSHRDIALAF--FET-ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101

Query: 557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH- 615
            LD+ L      + +  ++ +   +ASAL YL  ++   ++H ++ + N+LL    +A  
Sbjct: 102 PLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158

Query: 616 ------LSDFGIA-KLLSGEDQSMTQTQTLATIGYMAPE--YGIERKVSTRSDIYSYGIM 666
                 LSD G++   LS E++       +  I ++APE   G    +ST +D +S+G  
Sbjct: 159 TSPFIKLSDPGVSFTALSREER-------VERIPWIAPECVPGGN-SLSTAADKWSFGTT 210

Query: 667 LIE 669
           L+E
Sbjct: 211 LLE 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 0.002
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 40/245 (16%)

Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL--VLEYMPNGSLDIFLYSSTCMLD 570
           R      +E  VM+ ++H+N+V+ I    N   + L  ++E+   G L   +     M  
Sbjct: 54  REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG 113

Query: 571 IFQR---LNIMIDVASALEYLNFRHTTP----IIHCDLKSSNVLLDEDM----------- 612
             +    ++I   +  AL Y +     P    ++H DLK  N+ L   +           
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173

Query: 613 ------IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS--TRSDIYSYG 664
                 IA + DFG++K +  E  SM  +  + T  Y +PE  +    S   +SD+++ G
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIE--SMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 665 IMLIETFTRKKPADKM--FAAELS-LKHWVNGLLPV----SLMEVVNKTLLSPPEKDFAA 717
            ++ E  + K P  K   F+  +S LK   +  LP+      + ++ K LL+   K+  +
Sbjct: 231 CIIYELCSGKTPFHKANNFSQLISELKRGPD--LPIKGKSKELNILIKNLLNLSAKERPS 288

Query: 718 KEQCV 722
             QC+
Sbjct: 289 ALQCL 293

Length = 1021

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 38.0 bits (89), Expect = 0.002
 Identities = 13/35 (37%), Positives = 19/35 (54%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKS 517
           I   S   V++A L DG EVA+KV      + ++S
Sbjct: 19  IAAASIAQVHRAVLKDGEEVAVKVQRPGVKKRIRS 53

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 30/81 (37%), Positives = 45/81 (55%), Gaps = 12/81 (14%)

Query: 548 LVLEYMPNGS----LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKS 603
           LV+EY+  G     L I+ Y    M      +  + +VA AL+YL+ RH   IIH DLK 
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEM-----AVKYISEVALALDYLH-RHG--IIHRDLKP 132

Query: 604 SNVLLDEDMIAHLSDFGIAKL 624
            N+L+  +    L+DFG++K+
Sbjct: 133 DNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.9 bits (93), Expect = 0.004
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 16/212 (7%)

Query: 499 GIEVAIKVFHQE-CARAMKSF-EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG 556
           G  V ++  + E C   M +F + E  V K   H N+V   +    D+   +V  +M  G
Sbjct: 25  GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84

Query: 557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
           S    +   T  +D    L I   +   L+ L++ H    +H  +K+S++L+  D   +L
Sbjct: 85  SAKDLI--CTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL 142

Query: 617 SDFGIAKLLS----GEDQSMTQ---TQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIML 667
           S  G+   LS    G+   +       ++  + +++PE   +  +    +SDIYS GI  
Sbjct: 143 S--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 200

Query: 668 IETFTRKKPADKMFAAELSLKHWVNGLLPVSL 699
            E      P   M A ++ L+  +NG +P  L
Sbjct: 201 CELANGHVPFKDMPATQMLLEK-LNGTVPCLL 231

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	763
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.88
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.87
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.84
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
PRK10345	210	hypothetical protein; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.72
smart00090	237	RIO RIO-like kinase.	99.69
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.58
PLN03150	623	hypothetical protein; Provisional	99.57
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.52
PLN03150	623	hypothetical protein; Provisional	99.51
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.46
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.36
KOG1243	690	consensus Protein kinase [General function predict	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.3
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.28
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.18
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.16
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.15
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.15
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.11
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.11
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.1
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.08
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.05
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.05
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.04
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.95
KOG3087	229	consensus Serine/threonine protein kinase [General	98.94
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.88
COG4248	637	Uncharacterized protein with protein kinase and he	98.87
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.83
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.81
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.76
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.69
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.66
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.64
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.63
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.63
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.55
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.43
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.42
PRK09902	216	hypothetical protein; Provisional	98.37

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-83  Score=785.18  Aligned_cols=701  Identities=30%  Similarity=0.488  Sum_probs=439.7

Q ss_pred             HHHHhhcCCChhhHHHHHHHHHhccCCCCcccccCCCCCCCCCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCC
Q 046240           23 VVAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPS  102 (763)
Q Consensus        23 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~  102 (763)
                      ++....+...+.|..||++||+.+. +|.+.+. +|..+.+||.|.||+|+. .++|+.|+|++|++++.+|..|..+++
T Consensus        18 ~~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~-~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~   94 (968)
T PLN00113         18 FLFLNFSMLHAEELELLLSFKSSIN-DPLKYLS-NWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPY   94 (968)
T ss_pred             HHHHHccCCCHHHHHHHHHHHHhCC-CCcccCC-CCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCC
Confidence            3333344446789999999999985 7877775 898888999999999984 568999999999999888888888888


Q ss_pred             CCEEEcCCCcccC-------------------CCccccCcc----------------------ccccccCCCccEEEccc
Q 046240          103 LTKLALGYNSLVG-------------------NNSLSGSLP----------------------SRIDLALPNVKALSLAY  141 (763)
Q Consensus       103 L~~L~L~~n~l~~-------------------~~~~~~~lp----------------------~~~~~~l~~L~~L~L~~  141 (763)
                      |+.|+|++|++++                   .|.+++.+|                      ..+ .++++|++|+|++
T Consensus        95 L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~-~~l~~L~~L~L~~  173 (968)
T PLN00113         95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDI-GSFSSLKVLDLGG  173 (968)
T ss_pred             CCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHH-hcCCCCCEEECcc
Confidence            8888888887752                   122222222                      222 2344444444444


Q ss_pred             ccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcc
Q 046240          142 NRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSI  221 (763)
Q Consensus       142 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l  221 (763)
                      |.+++.+|..|.++++|++|+|++|++++.+|..|+++++|+.|+    +++|++++.+|..+.++. +|++|+|++|++
T Consensus       174 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~----L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l  248 (968)
T PLN00113        174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY----LGYNNLSGEIPYEIGGLT-SLNHLDLVYNNL  248 (968)
T ss_pred             CcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEE----CcCCccCCcCChhHhcCC-CCCEEECcCcee
Confidence            444444444444445555555555555444555555555555555    566777777777777776 788888888877


Q ss_pred             ccccccccCCccccceeecccccccCCCCccccccCC-------------------------------------------
Q 046240          222 TGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN-------------------------------------------  258 (763)
Q Consensus       222 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-------------------------------------------  258 (763)
                      ++.+|..|+++++|++|+|++|++++.+|..+.++++                                           
T Consensus       249 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~  328 (968)
T PLN00113        249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL  328 (968)
T ss_pred             ccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH
Confidence            7666666655555555555555544433322221111                                           


Q ss_pred             ---------------------------CCccEEEecCCccccCCCCcc--------------------------------
Q 046240          259 ---------------------------SKLDTLSLCGNSFSGSIPSCI--------------------------------  279 (763)
Q Consensus       259 ---------------------------~~L~~L~L~~N~l~~~~p~~~--------------------------------  279 (763)
                                                 .+|+.|++++|++++.+|...                                
T Consensus       329 ~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~  408 (968)
T PLN00113        329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR  408 (968)
T ss_pred             hcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCE
Confidence                                       012222222222211111000                                


Q ss_pred             --------------cccc-----------------------------------------------CCcccEEEccccccc
Q 046240          280 --------------DIGN-----------------------------------------------LKVVVEINLSRNNFS  298 (763)
Q Consensus       280 --------------~~~~-----------------------------------------------l~~L~~L~Ls~N~l~  298 (763)
                                    .+..                                               .++|+.|++++|+++
T Consensus       409 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~  488 (968)
T PLN00113        409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFS  488 (968)
T ss_pred             EECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccC
Confidence                          0000                                               012334444445554


Q ss_pred             ccCCcc------------------------cCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhh
Q 046240          299 GDIPAT------------------------IGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE  354 (763)
Q Consensus       299 ~~~p~~------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  354 (763)
                      +..|..                        +.++++|+.|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+.
T Consensus       489 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  568 (968)
T PLN00113        489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG  568 (968)
T ss_pred             CccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHh
Confidence            444544                        44455555555555555555555555555555555555555555555555


Q ss_pred             hhccCceEEcccccCCCCCCCCCCccccccccccCCCcccCCC-CCCCCCCCCCCCCCCCcceeeeeeehhhHHHHHHHH
Q 046240          355 KLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP-HLQVPQCKHQTRPKSSKKMILLVIVLPLSAALIAVV  433 (763)
Q Consensus       355 ~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p-~~~~~~c~~~~~~~~~~~~~vi~~~~~~~~~l~~~v  433 (763)
                      .+++|+.|++++|++++.+|..+.+..+....+.+|+.+|+.+ ....++|....   +....+++++++.+++++++++
T Consensus       569 ~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~---~~~~~~~~~~~~~~~~~~~~~~  645 (968)
T PLN00113        569 NVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR---KTPSWWFYITCTLGAFLVLALV  645 (968)
T ss_pred             cCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc---ccceeeeehhHHHHHHHHHHHH
Confidence            5556666666666666666665555666666677777777643 22345664321   1112222222222222222222


Q ss_pred             HH-HhhhccccCC--CCCCCCCCcccc---cccccCCCChHHHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEE
Q 046240          434 VL-ALKYKSTRRG--KSTGLSNGGILL---SQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKV  506 (763)
Q Consensus       434 ~~-~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~  506 (763)
                      ++ +++++++++.  +......+....   .......+.+++   ....|...+.||+|+||.||+|.. .+++.||||+
T Consensus       646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~  722 (968)
T PLN00113        646 AFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE  722 (968)
T ss_pred             HHHHHHHHhhhcccccccccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEE
Confidence            22 2222222111  111111110000   000111223333   345677889999999999999976 5789999999


Q ss_pred             eehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHH
Q 046240          507 FHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALE  586 (763)
Q Consensus       507 ~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~  586 (763)
                      +.....    ....|++++++++||||++++++|.+.+..++||||+++|+|.++++.    ++|..+..|+.|+|+|++
T Consensus       723 ~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~  794 (968)
T PLN00113        723 INDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALR  794 (968)
T ss_pred             ccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHH
Confidence            864322    123468899999999999999999999999999999999999999963    789999999999999999


Q ss_pred             HHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHH
Q 046240          587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIM  666 (763)
Q Consensus       587 ~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~  666 (763)
                      |||..++++|+|||+||+||+++.++.+++. ||.......      .....++..|+|||++.+..++.++|||||||+
T Consensus       795 yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvv  867 (968)
T PLN00113        795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLI  867 (968)
T ss_pred             HhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHH
Confidence            9976668899999999999999999888876 665543321      122367899999999999999999999999999


Q ss_pred             HHHHHcCCCCCchhhhhhhhhhhhhcccCCh-hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHH
Q 046240          667 LIETFTRKKPADKMFAAELSLKHWVNGLLPV-SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKC  745 (763)
Q Consensus       667 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  745 (763)
                      +|||+||+.||+...........|....... ....+++..+.....    .......++.+++.+||+.+|++||+|+|
T Consensus       868 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e  943 (968)
T PLN00113        868 LIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS----VNQNEIVEVMNLALHCTATDPTARPCAND  943 (968)
T ss_pred             HHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC----ccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence            9999999999965443333444444332222 233334433322211    11234667899999999999999999999


Q ss_pred             HHHHHhhccccC
Q 046240          746 CNFVLCEQFVSN  757 (763)
Q Consensus       746 v~~~L~~~~~~~  757 (763)
                      |+++|+++.+..
T Consensus       944 vl~~L~~~~~~~  955 (968)
T PLN00113        944 VLKTLESASRSS  955 (968)
T ss_pred             HHHHHHHhhccc
Confidence            999999887753

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-50  Score=427.54  Aligned_cols=290  Identities=40%  Similarity=0.612  Sum_probs=245.3

Q ss_pred             ccCCCChHHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeee
Q 046240          461 TKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC  540 (763)
Q Consensus       461 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  540 (763)
                      ..+.+++.++..||++|...+.||+|+||.||+|..++|+.||||++.....+..++|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999988765432145699999999999999999999999


Q ss_pred             ecCC-ceEEEEEccCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          541 SNDD-FKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       541 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                      .+.+ +.+||||||++|+|+++++.... .++|.+|++||.++|+||+|||+...++||||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9999 59999999999999999998776 899999999999999999999987778899999999999999999999999


Q ss_pred             ecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhh-hhhhhhhhhhcccCCh
Q 046240          619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMF-AAELSLKHWVNGLLPV  697 (763)
Q Consensus       619 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~~  697 (763)
                      ||+|+..+......... ..||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... .....+..|+......
T Consensus       221 FGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCccccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            99997654311111111 179999999999999999999999999999999999999887643 3344477776555544


Q ss_pred             -hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          698 -SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       698 -~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                       .+.+++|+.+.......    ......+..++..|++.+|++||+|.+|+++|+.+..
T Consensus       300 ~~~~eiiD~~l~~~~~~~----~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPD----EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cchhheeCCCccCCCCCh----HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence             67888888876311110    0346779999999999999999999999999965543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=369.97  Aligned_cols=251  Identities=25%  Similarity=0.305  Sum_probs=210.5

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC-ceEEEEEcc
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-FKALVLEYM  553 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  553 (763)
                      .+..+.||+|..|+||++.++ +++.+|+|++... .....+++.+|++++++.+||+||.+||.|.... ...++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344578999999999999775 6888999999544 3445788999999999999999999999999988 599999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++|+|+.++...+ .++....-+|+.+|++||.|||  ++++||||||||+|||++..|.|||||||.++.+...    .
T Consensus       161 DgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~  233 (364)
T KOG0581|consen  161 DGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I  233 (364)
T ss_pred             CCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence            9999999997653 5889999999999999999996  3588999999999999999999999999999887432    3


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....+||..|||||.+.+..|+.++||||||++++|+.+|+.||....            ..+..+.++++.-+...|..
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~------------~~~~~~~~Ll~~Iv~~ppP~  301 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN------------PPYLDIFELLCAIVDEPPPR  301 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC------------CCCCCHHHHHHHHhcCCCCC
Confidence            356789999999999999999999999999999999999999987641            11123344444444433322


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      -+..  .+..++.+++..|++.||.+||++.|+++
T Consensus       302 lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 LPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2211  46888999999999999999999999985

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=385.58  Aligned_cols=256  Identities=30%  Similarity=0.456  Sum_probs=211.4

Q ss_pred             cCcCceecccCCceEEEEEecCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCC-ceEEEEEcc
Q 046240          477 FGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-FKALVLEYM  553 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  553 (763)
                      ....+.+|+|+||+||+|.++....||||++.....  ...+.|.+|+.+|++++|||||+++|+|.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            344566999999999999998555599999976532  22668999999999999999999999999988 799999999


Q ss_pred             CCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCCEEecCCC-cEEEeeecCceecCCCCC
Q 046240          554 PNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTP-IIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       554 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~-ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~  630 (763)
                      ++|+|..+++. ....+++..++.+|.+||+||.||   |+.+ ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999988 356899999999999999999999   7777 99999999999999997 99999999998764322 


Q ss_pred             ccccccccccccccCccccC--CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          631 SMTQTQTLATIGYMAPEYGI--ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                       ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||..........             .++.... 
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~-------------~v~~~~~-  263 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS-------------AVVVGGL-  263 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH-------------HHHhcCC-
Confidence             2334468999999999999  5699999999999999999999999998854422111             1111111 


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                           |+..+..+...+..++..||+.||+.||++.+++..|+.+...
T Consensus       264 -----Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  264 -----RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             -----CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence                 1111222677899999999999999999999999999866553

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=380.80  Aligned_cols=257  Identities=31%  Similarity=0.496  Sum_probs=217.5

Q ss_pred             ccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          476 RFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      .+..++.||+|.||.||.|.++....||+|.++... ...+.|.+|+++|++++|+|||+++|+|..++..|||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            344568899999999999999988899999997642 2357788999999999999999999999999999999999999


Q ss_pred             CChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          556 GSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       556 g~L~~~l~~-~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      |+|.+++.. .+..+...+.+.++.|||+|++||   +++++|||||.++||||+++..+||+|||+|+... ++.....
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~  361 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTAS  361 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccC-CCceeec
Confidence            999999987 455789999999999999999999   89999999999999999999999999999999544 3333334


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....-+..|.|||.+..+.++.|||||||||+||||+| |+.||..+...+                 ++.. +.  ...
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----------------v~~~-le--~Gy  421 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----------------VLEL-LE--RGY  421 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------------HHHH-Hh--ccC
Confidence            44455788999999999999999999999999999999 999988754332                 1111 11  122


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      |...++.|+..+.++|..||+.+|++|||++.+...+++.....
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            34445568999999999999999999999999988888776643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=360.62  Aligned_cols=262  Identities=28%  Similarity=0.405  Sum_probs=211.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ..+|...+.||+|+||+||+|++. ++..||||.+...  .....+.+..|+.+|+.++|||||++++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888889999999999999775 6899999999766  4556777899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC------CcEEEeeecCcee
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED------MIAHLSDFGIAKL  624 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~------~~~kl~Dfgla~~  624 (763)
                      |||+||+|..+++..+ .++......++.|+|.||++|   |+++||||||||+|||++..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999998875 588899999999999999999   88999999999999999764      4689999999999


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh--------hcccCC
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW--------VNGLLP  696 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~--------~~~~~~  696 (763)
                      +.+..   .....+|++.|||||++..++|+.|+|+||.|+++|||++|+.||+.....+.....-        ......
T Consensus       165 L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s  241 (429)
T KOG0595|consen  165 LQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS  241 (429)
T ss_pred             CCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence            86332   2345689999999999999999999999999999999999999998654443322111        111122


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ....+++-..+.+++..+...       ...+....+...|.+|+.+.++-..
T Consensus       242 ~~~~~Ll~~ll~~~~~~~~~~-------~~~~~~~~l~~~p~~~~~~~~~~~~  287 (429)
T KOG0595|consen  242 NPLRELLISLLQRNPKDRISF-------EDFFDHPFLAANPQDRADAFELESR  287 (429)
T ss_pred             CchhhhhhHHHhcCccccCch-------HHhhhhhhcccCcccccCccccccc
Confidence            344566666666665544332       2345566677788888877665433

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-44  Score=342.52  Aligned_cols=258  Identities=24%  Similarity=0.295  Sum_probs=206.8

Q ss_pred             hccCcCceecccCCceEEEE-EecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEe-eeecCCc-eEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIIS-GCSNDDF-KALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  549 (763)
                      .+|.+.++||+|.||+||++ +..+|..||.|.++-.  .....++...|+.+|++++|||||++++ -+.++.. .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            35777889999999999999 6678999999988743  3456678899999999999999999998 4555554 8999


Q ss_pred             EEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          550 LEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      ||||++|+|..++..   ..+.++...++++..|++.||.++|+.-.+ -|+||||||.||+++.+|.||++|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999864   344789999999999999999999542222 3899999999999999999999999999998


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ....  ......+||++||+||.+.+..|+.|+||||+||++|||+.-++||.+..-.              .+..-+. 
T Consensus       179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~--------------~L~~KI~-  241 (375)
T KOG0591|consen  179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL--------------SLCKKIE-  241 (375)
T ss_pred             cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH--------------HHHHHHH-
Confidence            6433  2345679999999999999999999999999999999999999999773110              1111111 


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                        ..+.  .+-..+.....+.+++..|+..||+.||+.-..++.+...
T Consensus       242 --qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  242 --QGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             --cCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence              1111  1111234467799999999999999999976666666553

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-43  Score=368.00  Aligned_cols=247  Identities=26%  Similarity=0.330  Sum_probs=209.5

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .+|...+.||+|||+.+|.++. .+|+.||+|++.+..   ....+...+||++-++++|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999976 889999999998642   345677889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+|+.++|.+++. .++++++.++..+..||+.||.||   |+.+|+|||||..|+|++++.++||+|||+|..+..++.
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999988 456899999999999999999999   899999999999999999999999999999998864432


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        .....+||+.|+|||++....++..+||||+||+||-|+.|++||+...-.+                 ..++.-..+
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-----------------ty~~Ik~~~  234 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-----------------TYNKIKLNE  234 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-----------------HHHHHHhcC
Confidence              2234689999999999999999999999999999999999999998743221                 111111111


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..    .+.....+..+++...++.+|.+|||+++|+.
T Consensus       235 Y~----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 YS----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cc----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11    11123445678999999999999999999985

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-43  Score=353.54  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=202.1

Q ss_pred             HHhccCcCceecccCCceEEEE-EecCCceEEEEEeehhhHH-------HHHHHHHHHHHHHhCCCCccceEEeeeecCC
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR-------AMKSFEVECEVMKNIRHRNLVKIISGCSNDD  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  544 (763)
                      ..+.|.+.+.+|+|+||.|-+| ...+|+.||||++++....       ......+|+++|++++|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3467888999999999999999 5568999999999755211       2234579999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC---CcEEEeeecC
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED---MIAHLSDFGI  621 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~---~~~kl~Dfgl  621 (763)
                      ..||||||++||.|.+++-.+. .+....-..+++|++.|+.||   |++||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999987665 366667788999999999999   89999999999999999765   7899999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCC---CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChh
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV---STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      |+.....   ......+||+.|.|||++.+..+   ..++|+||+||++|-+++|.+||+........-.          
T Consensus       326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----------  392 (475)
T KOG0615|consen  326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----------  392 (475)
T ss_pred             hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----------
Confidence            9987522   23455789999999999876543   3478999999999999999999987543321111          


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ++........|    ..-....++..+++.+++..||++||++.|+++
T Consensus       393 --QI~~G~y~f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 --QILKGRYAFGP----LQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             --HHhcCcccccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence              11111111111    122234567889999999999999999999985

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.9e-43  Score=381.20  Aligned_cols=260  Identities=30%  Similarity=0.485  Sum_probs=218.0

Q ss_pred             hccCcCceecccCCceEEEEEec------CCceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      .+....+.||+|+||+||+|...      +.+.||||.++..... ..++|++|++++..++|||||+++|.|.+++-.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34445678999999999999653      3567999999877554 7889999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          548 LVLEYMPNGSLDIFLYSST-------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      +|+|||..|+|.+|+....             .+++..+.+.||.|||.|++||   -++.+|||||.++|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCcccccchhhhhceeccceEE
Confidence            9999999999999996421             1378899999999999999999   67779999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcc
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  693 (763)
                      ||+|||+++.+-..+.+.......-.++|||||.+..++++.+||||||||+|||++| |+.||.+....+.        
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV--------  714 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV--------  714 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--------
Confidence            9999999997655555555555667899999999999999999999999999999999 9999887543321        


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                           +..+-...+       .+.++.|+.++.++|..||+..|++||+++||-..|+...+..
T Consensus       715 -----Ie~i~~g~l-------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  715 -----IECIRAGQL-------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             -----HHHHHcCCc-------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence                 111111112       3345568899999999999999999999999999998766543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=360.78  Aligned_cols=267  Identities=26%  Similarity=0.388  Sum_probs=217.2

Q ss_pred             HHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          468 QDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       468 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ++.+...+++.+.+.||+|.||+||+|.|..  .||||++...  ..+..+.|+.|+.++++-+|.||+-++|||..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            3344445667788999999999999998873  6999999754  34567899999999999999999999999999988


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                       .||+.+|+|.+|+.+++..+..++..+...||.|||+|+.||   |.++|||||||+.|||+.++++|||+|||++..-
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             999999999999999998888899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      .............|...|||||++.   ..+|++.+||||||+++|||+||..||.....+..-+. .-++....+    
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-VGrG~l~pd----  613 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-VGRGYLMPD----  613 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-ecccccCcc----
Confidence            3332223344566888999999865   35789999999999999999999999984322221110 011111111    


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                                 .......|..++.+++..||..++++||.+.+|+.+|++++.+
T Consensus       614 -----------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  614 -----------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             -----------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                       1112234677899999999999999999999999999888773

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.4e-42  Score=329.33  Aligned_cols=267  Identities=22%  Similarity=0.282  Sum_probs=208.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      +.|+...++|+|+||+||+++.+ +|+.||||++....  +...+-..+|+.+|++++|||+|.++.+|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46788889999999999999765 69999999996442  3446677899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      ||+..-|++.-+.. ...+.....++++|+++|+.|+   |++++|||||||+|||++.+|.+|+||||.|+.+...+  
T Consensus        82 ~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--  155 (396)
T KOG0593|consen   82 YCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--  155 (396)
T ss_pred             ecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence            99986666654433 3478888999999999999999   89999999999999999999999999999999886432  


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh-h-hhhhhcccCChhHHHHHHhhc-
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL-S-LKHWVNGLLPVSLMEVVNKTL-  707 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~i~~~l-  707 (763)
                      ...+.++.|.||+|||.+.+ .+|+..+||||.||++.||++|.+-|-+..+-+. . .+.... .+.+.-.++...-- 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG-~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG-NLIPRHQSIFSSNPF  234 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc-ccCHHHHHHhccCCc
Confidence            24567889999999999887 7899999999999999999999998866433221 1 222222 23333333332211 


Q ss_pred             -----CCCccccHHHH---HHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 -----LSPPEKDFAAK---EQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 -----~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                           ...++...+..   ......+.+++..|++.||++|++-++++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                 01111111111   122446899999999999999999999873

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=336.08  Aligned_cols=202  Identities=30%  Similarity=0.411  Sum_probs=179.5

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|++.++||+|+||+||.++. ++++.+|+|++++..   ..+.+....|..+|.+++||+||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46899999999999999999955 468899999998663   23467788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +||+.||.|...+++.+ .++.....-.+..|+.||.||   |+++||||||||+|||+|.+|+++|+|||+++.....+
T Consensus       104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            99999999999998665 577777777889999999999   89999999999999999999999999999998643222


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhh
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMF  681 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~  681 (763)
                        ..+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||....
T Consensus       180 --~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  180 --DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             --CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence              23445799999999999999999999999999999999999999998744

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=347.59  Aligned_cols=270  Identities=20%  Similarity=0.224  Sum_probs=214.1

Q ss_pred             HHhccCcCceecccCCceEEEEE-ecCCceEEEEEeehhhH-HHHHHHHHHHHHHHhCC-CCccceEEeeeecCC-ceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIR-HRNLVKIISGCSNDD-FKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l  548 (763)
                      ..++|...+.||.|.||.||+|+ ..+|..||||++++... .+...-.||+..|++++ ||||+++.+++.+.+ ..|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            35789999999999999999995 45789999999976532 23344478999999998 999999999999888 9999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |||||++ +|++++..+++.++...+..|+.||.+||+|+   |.+|++|||+||+|||+.....+||+|||+|+.+.. 
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-  162 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-  162 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEeccccccccccc-
Confidence            9999977 89999998888999999999999999999999   899999999999999999889999999999998742 


Q ss_pred             CCccccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhh--hhhhcccCCh---hHHHH
Q 046240          629 DQSMTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL--KHWVNGLLPV---SLMEV  702 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~--~~~~~~~~~~---~~~~~  702 (763)
                        ....+.++.|.||+|||++. .+-|+.+.||||+||+++|+.+-++-|-+..+.+.-.  -+..+.....   ...++
T Consensus       163 --kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  163 --KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             --CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence              33567889999999999865 6789999999999999999999998886644332221  1212111111   11223


Q ss_pred             HHhhcCCCccccH----HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          703 VNKTLLSPPEKDF----AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       703 i~~~l~~~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ...+-.+-|....    ..-..+..+..+++..|+.+||++||||.++++.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            3333222222211    1112356778999999999999999999999874

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.3e-41  Score=317.50  Aligned_cols=267  Identities=25%  Similarity=0.362  Sum_probs=210.7

Q ss_pred             hccCcCceecccCCceEEEE-EecCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|...+++|+|.||.||+| +..+|+.||||+++....  +......+||+.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            47888899999999999999 556899999999975532  234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |++. +|+.+++.+...+...++.+++.++.+|++|+   |.+.|+||||||.|+|++++|.+||+|||+|+.+...+..
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9976 89999998888899999999999999999999   8999999999999999999999999999999998755443


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh-------cccCCh--hHHH
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV-------NGLLPV--SLME  701 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~--~~~~  701 (763)
                        .+..+.|.+|+|||.+.+ ..|+..+||||.||++.||+-|.+-|.+..+-+ ++....       ...+|+  .+-+
T Consensus       158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHHcCCCCcccCcccccccc
Confidence              334488999999998876 579999999999999999999987776643322 222211       111111  1111


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .+.-.....+..+ .....+.+...+++..++.++|.+|+++.|++++
T Consensus       235 Y~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111111111111 1222345667999999999999999999999864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=331.68  Aligned_cols=261  Identities=27%  Similarity=0.341  Sum_probs=210.6

Q ss_pred             HhccCcCceecccCCceEEEE-EecCCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .+.|+..+.||.|..++||+| +.+.+..||||++.-+ +....+.+++|+..++.++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            467999999999999999999 5567899999999865 34457889999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||.+|++.+++...- ..+++..+..|.+++++||.||   |++|.||||||+.|||++++|.|||+|||.+..+...+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999987632 2588899999999999999999   899999999999999999999999999998766543322


Q ss_pred             -cccc-ccccccccccCccccC--CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          631 -SMTQ-TQTLATIGYMAPEYGI--ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       631 -~~~~-~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                       .... ...+||++|||||++.  ...|+.|+||||||++..|+.+|..||.........+..... ..|-....     
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn-~pp~~~t~-----  255 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN-DPPTLLTS-----  255 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CCCCcccc-----
Confidence             1222 5668999999999854  357999999999999999999999999885443332222211 11110000     


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                           ..+..........+.+++..|+..||++|||++++++
T Consensus       256 -----~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  256 -----GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             -----cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                 1122223334557899999999999999999999985

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-40  Score=341.75  Aligned_cols=269  Identities=26%  Similarity=0.337  Sum_probs=210.9

Q ss_pred             HhccCcCceecccCCceEEEE-EecCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  548 (763)
                      .+.|+..++||+|.||.||+| +..+|+.||+|++..+.  .+......+||.+|++++||||+++.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            456788899999999999999 55689999999987554  34456678999999999999999999998776  68999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |+|||+. +|.-++...+-.++..++..++.|+++||+|+   |+++|+|||||.+|||+|.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999987 78888887777899999999999999999999   8999999999999999999999999999999998654


Q ss_pred             CCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh--cccCChhHHHHHH-
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV--NGLLPVSLMEVVN-  704 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~i~-  704 (763)
                      .. ...+..+.|.||+|||++.+ ..|+.++|+||.||||.||++|++.|.+...-+ ++...+  -+-..+......+ 
T Consensus       272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccccC
Confidence            43 34677889999999998876 579999999999999999999999998743322 222221  1111111111000 


Q ss_pred             --hhcCCCc-c-cc--HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 --KTLLSPP-E-KD--FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 --~~l~~~~-~-~~--~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        -...+.. . .+  .+.........++++...+..||++|.||.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              0000000 0 01  1122334557789999999999999999999885

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=349.02  Aligned_cols=249  Identities=27%  Similarity=0.327  Sum_probs=211.2

Q ss_pred             hccCcCceecccCCceEEEE-EecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      ..|.....||+|+.|.||.| +..+++.||||++........+-+..|+.+|+..+|+|||++++.|...++.++||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            46777789999999999999 56678999999998777666777899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      +||+|.+++....  +++.++..|+.++++||+||   |.++|+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999987654  88999999999999999999   899999999999999999999999999999988764443  3


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....+||++|||||+.....|++|+||||||++++||+-|++||-....                ++.+..-+.  +...
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----------------lrAlyLIa~--ng~P  487 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----------------LRALYLIAT--NGTP  487 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----------------HHHHHHHhh--cCCC
Confidence            4557899999999999999999999999999999999999999875211                111111111  1111


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +....+.....+.+++.+|+..||++||++.|+++
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            22223345678999999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=339.00  Aligned_cols=253  Identities=30%  Similarity=0.386  Sum_probs=202.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC--ceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD--FKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  551 (763)
                      .+|...+.||+|+||+||++... +|...|||..........+.+.+|+.+|++++|||||+++|.....+  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677899999999999999665 58999999887653333677899999999999999999999865555  5889999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-CCcEEEeeecCceecCCC-C
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHLSDFGIAKLLSGE-D  629 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~-~  629 (763)
                      |+++|+|.+++...+..++...+...+.||++||+||   |+++||||||||+|||++. ++.+||+|||+++..... .
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            9999999999988765789999999999999999999   8999999999999999999 799999999999877531 1


Q ss_pred             CccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchh-hhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          630 QSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKM-FAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .........||+.|||||+...+ ....++||||+||++.||+||++||... ......+.....             . 
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-------------~-  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE-------------D-  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc-------------C-
Confidence            12233457899999999998853 3345999999999999999999999873 111111111100             0 


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                       ..|.    .++....+..+++..|+..+|++||||+++++-
T Consensus       240 -~~P~----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  240 -SLPE----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             -CCCC----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence             1111    112245668899999999999999999999974

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=376.81  Aligned_cols=263  Identities=26%  Similarity=0.422  Sum_probs=219.7

Q ss_pred             HhccCcCceecccCCceEEEEEecC--Cc----eEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD--GI----EVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .+..+..+.||+|+||.||.|...+  |.    .||||.+.+.. .+...+|.+|..+|+.++|||||+++|+|......
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3455667889999999999997653  33    49999987663 56788999999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeec
Q 046240          547 ALVLEYMPNGSLDIFLYSS------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG  620 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfg  620 (763)
                      ++++|||++|+|..+++..      ...+...+.+.++.+||+|+.||   +++++|||||.++|+|+++...|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999886      55788899999999999999999   78889999999999999999999999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhH
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSL  699 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  699 (763)
                      +|+.+-..+..+......-...|||||.+..+.++.|+|||||||++||++| |..||......+               
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---------------  912 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---------------  912 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------------
Confidence            9996654444444333345678999999999999999999999999999999 999998743322               


Q ss_pred             HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCcc
Q 046240          700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSS  759 (763)
Q Consensus       700 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~  759 (763)
                        ++..-+...   |...+..|++.+.++|..||+.+|++||++..+++.+..++.....
T Consensus       913 --v~~~~~~gg---RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  913 --VLLDVLEGG---RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             --HHHHHHhCC---ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence              111111111   4444556889999999999999999999999999998887776533

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=341.81  Aligned_cols=251  Identities=27%  Similarity=0.369  Sum_probs=201.5

Q ss_pred             HHhccCcCceecccCCceEEEEE-ecCCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  547 (763)
                      ...+|..++.||.|+|++|++|+ ..+++.+|||++.+..   +...+...+|-++|.++ .||.|++++..|+++..+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            34689999999999999999995 4579999999997653   23345567899999999 8999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      .|+||+++|+|-++|...+ .++.......+.+|..|++||   |+.|||||||||+|||+|+++++||+|||.|+.+++
T Consensus       151 FvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999999998765 688888889999999999999   999999999999999999999999999999999864


Q ss_pred             CCCc---------ccc--ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC
Q 046240          628 EDQS---------MTQ--TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       628 ~~~~---------~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      ....         ...  ..++||..|.+||++.+...++.+|+|+|||++|+|+.|++||.+... ...+         
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliF---------  296 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIF---------  296 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHH---------
Confidence            3221         111  458999999999999999999999999999999999999999987432 1111         


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         +.+++-.....+.        .++...+++.+.+..||.+|++..++.+
T Consensus       297 ---qkI~~l~y~fp~~--------fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  297 ---QKIQALDYEFPEG--------FPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ---HHHHHhcccCCCC--------CCHHHHHHHHHHHccCccccccHHHHhh
Confidence               1111111111111        1234566666777777777777766543

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=329.23  Aligned_cols=273  Identities=29%  Similarity=0.366  Sum_probs=214.6

Q ss_pred             CcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC--CCCccceEEeeeecCC----ceEEEEE
Q 046240          478 GRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGCSNDD----FKALVLE  551 (763)
Q Consensus       478 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~~~lv~e  551 (763)
                      ...+.||+|+||.||+|.+.+ +.||||++...   ..+.+..|-+|++..  +|+||++++++-....    +++||+|
T Consensus       213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            345789999999999999974 89999999753   456777788887764  8999999999876555    8899999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~------h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      |.+.|+|.+++..+.  ++|....+|+..+++||+|||..      |+++|+|||||++||||.+|+++.|+|||+|.++
T Consensus       289 fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  289 FHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             eccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            999999999998765  89999999999999999999975      6778999999999999999999999999999998


Q ss_pred             CCCCCccccccccccccccCccccCCCCC------CcchhHHHHHHHHHHHHcCCCCCch-hhhhh-hhhhhhhcccCC-
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKV------STRSDIYSYGIMLIETFTRKKPADK-MFAAE-LSLKHWVNGLLP-  696 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~------~~~~Dv~slGv~l~elltg~~p~~~-~~~~~-~~~~~~~~~~~~-  696 (763)
                      .+..........+||.+|||||++.+..-      -.+.||||+|.+||||+++..-+.. ...+. .-+..-++.... 
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            76655555566899999999999876432      1368999999999999997654431 11111 011111222222 


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      +++++++-+.-.+..-.........+..+.+.+..||++||+.|.|+..|-+.+.++...
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            356666655555444444444455678899999999999999999999999988766543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-41  Score=360.33  Aligned_cols=273  Identities=24%  Similarity=0.439  Sum_probs=227.2

Q ss_pred             cCCCChHHHHHHH---------hccCcCceecccCCceEEEEEec----CCceEEEEEeehhh-HHHHHHHHHHHHHHHh
Q 046240          462 KRRLPYQDLSRAT---------NRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQEC-ARAMKSFEVECEVMKN  527 (763)
Q Consensus       462 ~~~~~~~~~~~~~---------~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~  527 (763)
                      ...++|+|-..|-         ....+.++||.|.||.||+|+++    ....||||.++... ++...+|..|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            4456777655443         34456789999999999999775    23569999998664 4567889999999999


Q ss_pred             CCCCccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 046240          528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL  607 (763)
Q Consensus       528 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIl  607 (763)
                      +.||||+++.|+.....-.+||+|||++|+|+.|++.+++.+.+.+...+.++||.|++||   .+.++|||||.++|||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNIL  763 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhhee
Confidence            9999999999999999999999999999999999999888899999999999999999999   8899999999999999


Q ss_pred             ecCCCcEEEeeecCceecCCCCC-ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhh
Q 046240          608 LDEDMIAHLSDFGIAKLLSGEDQ-SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAEL  685 (763)
Q Consensus       608 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~  685 (763)
                      |+.+..+|++|||+++.+.++.. ...+..-.-..+|-|||.+..++++.++||||||++|||.++ |.+||-++...+ 
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-  842 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-  842 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-
Confidence            99999999999999998754431 222222233678999999999999999999999999999998 999987754322 


Q ss_pred             hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          686 SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       686 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                                   ....+..-.      |.+.+-+|+..+.++|..||+.|-.+||.+.+++..|.+.++++
T Consensus       843 -------------VIkaIe~gy------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  843 -------------VIKAIEQGY------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             -------------HHHHHHhcc------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence                         112222221      22333467889999999999999999999999999999988875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-39  Score=350.30  Aligned_cols=261  Identities=24%  Similarity=0.422  Sum_probs=204.4

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCC-
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDD-  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  544 (763)
                      .++|.+.+.||+|+||.||+|..      .+++.||+|++.... ....+.+.+|+.+++++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            56899999999999999999964      235689999987432 23456788999999999 8999999999887654 


Q ss_pred             ceEEEEEccCCCChhhhhccCC----------------------------------------------------------
Q 046240          545 FKALVLEYMPNGSLDIFLYSST----------------------------------------------------------  566 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  566 (763)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5789999999999998886421                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccc
Q 046240          567 ---CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY  643 (763)
Q Consensus       567 ---~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y  643 (763)
                         ..+++.....++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               2366778889999999999999   7889999999999999999999999999999875433222222334467889


Q ss_pred             cCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHH
Q 046240          644 MAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCV  722 (763)
Q Consensus       644 ~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~  722 (763)
                      +|||++.+..++.++|||||||++|||++ |..||...........            .+.+......+       ..+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~------------~~~~~~~~~~~-------~~~~  303 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ------------RLKDGTRMRAP-------ENAT  303 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH------------HHhcCCCCCCC-------CCCC
Confidence            99999999999999999999999999997 9999876321111000            01110000111       1234


Q ss_pred             HHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          723 LSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       723 ~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ..+.+++.+||+.+|++||++.+++++|++++.+
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            5688999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.2e-39  Score=334.18  Aligned_cols=246  Identities=28%  Similarity=0.377  Sum_probs=207.2

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.  .+.+.+.+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888899999999999999654 6889999998754  34567789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+.| +|..++...+ .++..++..|+.++..||.||   |+.+|.|||+||+|||++.++.+|+||||+|+.+....  
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence            9988 9999998765 588999999999999999999   89999999999999999999999999999999876422  


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ...+...||+.|||||+..+++|+..+|+||+||++||+++|++||-..                 .+.+++...+..++
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----------------si~~Lv~~I~~d~v  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----------------SITQLVKSILKDPV  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------------HHHHHHHHHhcCCC
Confidence            2345667999999999999999999999999999999999999998652                 22333433333332


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....    .....+..++...+..||.+|.+..+++.
T Consensus       218 ~~p~----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 KPPS----TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCcc----cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            2211    23556778888888999999999888763

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.9e-38  Score=334.53  Aligned_cols=263  Identities=23%  Similarity=0.390  Sum_probs=202.2

Q ss_pred             HhccCcCceecccCCceEEEEEecC-----------------CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD-----------------GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVK  535 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  535 (763)
                      .++|.+.+.||+|+||.||++.+++                 +..||+|++.... ......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999997532                 3469999987543 334567889999999999999999


Q ss_pred             EEeeeecCCceEEEEEccCCCChhhhhccCC------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 046240          536 IISGCSNDDFKALVLEYMPNGSLDIFLYSST------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPII  597 (763)
Q Consensus       536 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~iv  597 (763)
                      +++++...+..++||||+++|+|.+++....                  ..+++.....++.|++.||.||   |+.+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH---HHCCcc
Confidence            9999999999999999999999999885421                  2367788899999999999999   788999


Q ss_pred             eCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc--CCC
Q 046240          598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT--RKK  675 (763)
Q Consensus       598 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~  675 (763)
                      ||||||+||+++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999987643332222233456788999999988899999999999999999987  567


Q ss_pred             CCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          676 PADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       676 p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      ||........  ..        ...+............+   ...++..+.+++.+||+.+|++||++.+|.+.|++
T Consensus       241 p~~~~~~~~~--~~--------~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQV--IE--------NAGEFFRDQGRQVYLFR---PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHHH--HH--------HHHHHhhhccccccccC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            7765322111  00        00111111000000000   01235578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=334.19  Aligned_cols=248  Identities=24%  Similarity=0.329  Sum_probs=203.6

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh----hH-HHHHHHHHHHHHHHhCC-CCccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE----CA-RAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  545 (763)
                      ...+|..++.||+|.||+|+.|.. .+|..||+|++.+.    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456899999999999999999955 57899999977654    11 23456778999999998 9999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCcee
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKL  624 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~  624 (763)
                      .++||||+.||.|.+++.. ...+.......++.|++.|++|+   |+++|+||||||+||++|.+ +.+||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999988 44678889999999999999999   89999999999999999999 9999999999998


Q ss_pred             cCCCCCccccccccccccccCccccCCCC-CC-cchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERK-VS-TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      ..  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+.......              ..-
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--------------~~k  234 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--------------YRK  234 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH--------------HHH
Confidence            74  1222345678999999999999877 86 789999999999999999999987322111              000


Q ss_pred             HHhhcCCCccccHHHHHHH-HHHHHHHHHHccccCcCCCCCHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQC-VLSIFSLAMECTMELPEKRINAKCCN  747 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~Rps~~~v~  747 (763)
                      +.+.-..-|.       .+ ..++..++.+|+..+|.+|+++.+++
T Consensus       235 i~~~~~~~p~-------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  235 IRKGEFKIPS-------YLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HhcCCccCCC-------CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1111111111       11 44578999999999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=329.36  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=195.8

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ..++|+....||+|+||.||.|+. .+|..+|+|++++..   ....+..+.|-.+|....+|.||+++..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            347899999999999999999965 479999999998663   2346678889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||++||++..++...+ .++.....-.+.+++-|+..+   |+.|||||||||+|+|||..|++||+|||++.-+...
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999998765 466666666777777788888   8999999999999999999999999999998533110


Q ss_pred             ---------------------CCcc-----cc-------------------ccccccccccCccccCCCCCCcchhHHHH
Q 046240          629 ---------------------DQSM-----TQ-------------------TQTLATIGYMAPEYGIERKVSTRSDIYSY  663 (763)
Q Consensus       629 ---------------------~~~~-----~~-------------------~~~~g~~~y~aPE~~~~~~~~~~~Dv~sl  663 (763)
                                           ....     ..                   ...+|||.|||||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                 0000     00                   13469999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC
Q 046240          664 GIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI  741 (763)
Q Consensus       664 Gv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp  741 (763)
                      |||+|||+.|.+||......+.  .+..|.             ..+....+.+      +..+..++|.+|+. ||++|.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-------------~~l~fP~~~~------~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWR-------------ETLKFPEEVD------LSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-------------hhccCCCcCc------ccHHHHHHHHHHhc-CHHHhc
Confidence            9999999999999987443221  122221             1222222222      23556788998888 999998


Q ss_pred             C
Q 046240          742 N  742 (763)
Q Consensus       742 s  742 (763)
                      .
T Consensus       435 G  435 (550)
T KOG0605|consen  435 G  435 (550)
T ss_pred             C
Confidence            7

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.4e-38  Score=340.86  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=203.8

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  545 (763)
                      .++|++.+.||+|+||.||+|..      .++..||||+++... ....+.+.+|+.+++.+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788999999999999999953      245689999986432 33456788999999999 89999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-----------------------------------------------------------
Q 046240          546 KALVLEYMPNGSLDIFLYSST-----------------------------------------------------------  566 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  566 (763)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999998885421                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          567 ---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       567 ---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                                     ..+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.+......
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           1467888899999999999999   7889999999999999999999999999999876433222


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......             ...+.+.......
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------------~~~~~~~~~~~~~  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------------KFYKMIKEGYRML  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------------HHHHHHHhCccCC
Confidence            22222345678999999999999999999999999999998 888886532211             1111122111100


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .      ......++.+++..||+.+|++||++.+|++.|++.
T Consensus       338 ~------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 S------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             C------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0      011245688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=314.20  Aligned_cols=270  Identities=25%  Similarity=0.260  Sum_probs=207.7

Q ss_pred             HHhccCcCceecccCCceEEEEE-ecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeec-----CC
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSN-----DD  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~  544 (763)
                      ...+|...+.||+|+||.|+.|. ..+|+.||||++...  .....++..+|+++++.++|+||+.+.+.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            44566667899999999999995 457999999998733  34467788999999999999999999998865     35


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..|+|+|+| +.+|...++.+. .++.....-+.+|+++||+|+   |+.+|+||||||+|++++.+...||+|||+|+.
T Consensus       100 DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEeccccceee
Confidence            789999999 458999887654 477788888999999999999   999999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhh-hhhhhhhhhcccCCh-----
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFA-AELSLKHWVNGLLPV-----  697 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~-----  697 (763)
                      .+........+..+.|.+|.|||++. ...|+.+.||||.||++.||++|++-|-+... ....+..-.-+..++     
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            86443333457788999999999865 67899999999999999999999998866322 111111112222222     


Q ss_pred             ----hHHHHHHhhcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 ----SLMEVVNKTLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ----~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          .++..+...- ..+...+. ..........+++.+++..||.+|+|++|+++
T Consensus       255 i~s~~ar~yi~slp-~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  255 IRSEKARPYIKSLP-QIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             hccHHHHHHHHhCC-CCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                2223222222 22222211 11223446789999999999999999999985

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=331.05  Aligned_cols=265  Identities=25%  Similarity=0.447  Sum_probs=219.6

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .+...+.++||+|-||.|..+....+.+||||.++..... ..++|.+|+++|.+++||||++++|+|..++-.++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            4566788999999999999999988899999999876544 458999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTCML-DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~-~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |++|+|.+++..+..+. +......|+.|||.|++||   .+.++||||+.++|+|+|.++++||+|||+++-+-..+..
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999998765433 5556678999999999999   8899999999999999999999999999999976555555


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc--CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT--RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ......+-++.|||||.+.-++++.++|||+||+++||+++  ...||+...++...  +        ...++.+.   .
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv--e--------n~~~~~~~---~  760 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV--E--------NAGEFFRD---Q  760 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH--H--------hhhhhcCC---C
Confidence            56666677899999999999999999999999999999987  78899876544321  0        11111111   1


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      ....-...+..|+..+.+++.+||..+-++||+++++...|++..
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            111122334457888999999999999999999999998887653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=328.06  Aligned_cols=248  Identities=28%  Similarity=0.346  Sum_probs=207.3

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..|...+.||+|.||.||+|.. .+++.||+|++.-+. ....+++.+|+.++.+++++||.++|+.|..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577779999999999999954 578999999998654 34567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      |.||++.+.+.... .++...+..|..++..|+.|+   |.++.+|||||+.||++..+|.||++|||.+..+.....  
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999999997654 347777888999999999999   889999999999999999999999999999987754333  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      .....+||+.|||||++....|+.|+||||||++.+||.+|.+|+.........  ..+.                +...
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--flIp----------------k~~P  228 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--FLIP----------------KSAP  228 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--Eecc----------------CCCC
Confidence            225688999999999999889999999999999999999999999875432110  0011                1111


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        +.....+...+.+++..|++.+|+.||+|.++++
T Consensus       229 --P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 --PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence              1111245667899999999999999999999985

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-38  Score=301.01  Aligned_cols=230  Identities=27%  Similarity=0.358  Sum_probs=194.0

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|+..+.+|.|+||+|..++.+ +|..+|+|++++..-   +..+...+|..+|+.+.||+++++++.|.+.+..||||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56888899999999999999765 688999999986632   34566788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||++||-|..+++..+ .++.....-+|.+|+.|++||   |+.+|++|||||+|||+|.+|.+||+|||.|+.+.+.  
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence            9999999999998765 578888888999999999999   8899999999999999999999999999999987532  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh------hcccCChhHHHHHH
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW------VNGLLPVSLMEVVN  704 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~i~  704 (763)
                         +-..+||+.|+|||.+....++.++|.|||||++|||+.|.+||....... .....      .+...+..+.+++.
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-iY~KI~~~~v~fP~~fs~~~kdLl~  273 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-IYEKILEGKVKFPSYFSSDAKDLLK  273 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-HHHHHHhCcccCCcccCHHHHHHHH
Confidence               334689999999999999999999999999999999999999998754321 11222      23334456777777


Q ss_pred             hhcCCCcccc
Q 046240          705 KTLLSPPEKD  714 (763)
Q Consensus       705 ~~l~~~~~~~  714 (763)
                      +.+..+...|
T Consensus       274 ~LL~vD~t~R  283 (355)
T KOG0616|consen  274 KLLQVDLTKR  283 (355)
T ss_pred             HHHhhhhHhh
Confidence            7776654444

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-37  Score=325.50  Aligned_cols=245  Identities=24%  Similarity=0.280  Sum_probs=197.1

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeec----CCceEEEEEc
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSN----DDFKALVLEY  552 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  552 (763)
                      ...||+|++|.||+|.. +|+.||||++.....   ...+.+.+|+.++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999988 588999999875432   224678899999999999999999999876    3467899999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++|+|.+++.... .+++.....++.+++.|+.||   |+ .+++||||||+||++++++.+||+|||+++.+....  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNL---YKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHH---HhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999997644 688899999999999999999   54 478899999999999999999999999988654221  


Q ss_pred             cccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          632 MTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||........                 .......
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-----------------~~~i~~~  237 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-----------------YDLIINK  237 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-----------------HHHHHhc
Confidence               23457889999999876  6899999999999999999999999986432211                 1111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .....  .+..+...+.+++.+||+.||++|||++++++.|++.
T Consensus       238 ~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        238 NNSLK--LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCCCC--CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11100  0112356789999999999999999999999998765

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=337.38  Aligned_cols=263  Identities=26%  Similarity=0.364  Sum_probs=211.8

Q ss_pred             HHHHHhccCcCceecccCCceEEEEEecC--C---ceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeee
Q 046240          470 LSRATNRFGRDNLIGIGSFGYVYKAELDD--G---IEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCS  541 (763)
Q Consensus       470 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  541 (763)
                      .+...++....++||+|+||.||+|.+..  +   ..||||..+..   ......++.+|++++++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33344566667999999999999996642  2   23899998852   2456788999999999999999999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       542 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                      ...-.++|||+|.||+|.+++......++..++..++.+.|+||+||   |+++++||||.++|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            99999999999999999999998776799999999999999999999   899999999999999999999999999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHH
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLM  700 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  700 (763)
                      ++.-.  ..........-+..|+|||.+..+.++.++|||||||++||+++ |..||.+......              .
T Consensus       309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v--------------~  372 (474)
T KOG0194|consen  309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV--------------K  372 (474)
T ss_pred             ccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH--------------H
Confidence            87532  11111112245788999999999999999999999999999999 8999987543321              1


Q ss_pred             HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       701 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ..+...-.+.+.     ....+..+..++..||..+|++||+|.++.+.++.....
T Consensus       373 ~kI~~~~~r~~~-----~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  373 AKIVKNGYRMPI-----PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             HHHHhcCccCCC-----CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            111110000111     012356688899999999999999999999999877655

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-37  Score=338.29  Aligned_cols=260  Identities=23%  Similarity=0.405  Sum_probs=204.2

Q ss_pred             HHhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCC
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDD  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  544 (763)
                      ..++|.+.+.||+|+||.||+|...      ++..||+|++.... ......+.+|+++++.+ +||||++++++|...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3468999999999999999998642      34579999987542 33456788999999999 8999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCC----------------------------------------------------------
Q 046240          545 FKALVLEYMPNGSLDIFLYSST----------------------------------------------------------  566 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  566 (763)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999998875321                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          567 -----------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       567 -----------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                                 ..+++.....++.|+++||.||   |+++|+||||||+||++++++.+||+|||+++.+..........
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       1367788899999999999999   78999999999999999999999999999998764332211222


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcccc
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD  714 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  714 (763)
                      ...++..|+|||++.+..++.++|||||||++|||++ |+.||........             ....+...... ... 
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-------------~~~~~~~~~~~-~~~-  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-------------FYKMVKRGYQM-SRP-  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-------------HHHHHHcccCc-cCC-
Confidence            2335678999999988899999999999999999997 9999876322111             11111111100 000 


Q ss_pred             HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          715 FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       715 ~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                          .....++.+++..||+.+|++||++.+|+++|++++
T Consensus       338 ----~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 ----DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                012456889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=331.85  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=203.2

Q ss_pred             CCChHHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecC
Q 046240          464 RLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND  543 (763)
Q Consensus       464 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  543 (763)
                      .++++++..       .+-+|+|+.|.||.|++. ++.||||+++.-       -+.+|+-|++++||||+.+.|+|...
T Consensus       120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  120 EIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             cCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC
Confidence            456665543       467999999999999998 578999976422       24578899999999999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      ..+|||||||..|.|..++...+ .+.-.....+..+||.|+.||   |.+.|||||||+-||||..+..|||+|||-++
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEeeccceEEeccccchH
Confidence            99999999999999999998765 456666778999999999999   88899999999999999999999999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      .....   .+.-.+.||..|||||++...+.++|+|||||||+||||+||..||.+.....     .+.+.-..      
T Consensus       261 e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwGVGsN------  326 (904)
T KOG4721|consen  261 ELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWGVGSN------  326 (904)
T ss_pred             hhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEeccCC------
Confidence            76433   13345789999999999999999999999999999999999999998743221     11111000      


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                              ......+..|++.+.=++..||+..|..||++++++.-|.
T Consensus       327 --------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  327 --------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             --------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence                    0112233456788999999999999999999999998765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-37  Score=321.69  Aligned_cols=256  Identities=23%  Similarity=0.382  Sum_probs=204.8

Q ss_pred             HhccCcCceecccCCceEEEEEec----CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357888999999999999999653    35689999987553 2334678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++......+++.....++.|++.|++||   |+++++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999977655789999999999999999999   7889999999999999999999999999987653211


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      . ........++..|+|||.+.+..++.++|||||||++||+++ |..||.......              ..+.+....
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------------~~~~~~~~~  225 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------------VIKAVEDGF  225 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------------HHHHHHCCC
Confidence            1 111122335678999999999999999999999999999875 999987642211              111111110


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      . .+     ....++..+.+++..||+.+|++||+++++.+.|...
T Consensus       226 ~-~~-----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 R-LP-----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             C-CC-----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0 01     1122456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-38  Score=325.47  Aligned_cols=249  Identities=34%  Similarity=0.523  Sum_probs=194.9

Q ss_pred             cCceecccCCceEEEEEec-----CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          479 RDNLIGIGSFGYVYKAELD-----DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       479 ~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..+.||.|.||.||+|.+.     .+..|+||.+... .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999776     3568999999654 234478899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++|+|.+++... ...+++..+..|+.|+++||+||   |+.+++||||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999887 55789999999999999999999   6778999999999999999999999999999876332222


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      ...........|+|||.+.+..++.++||||||+++||+++ |+.||.......              ..+.+.+.-.. 
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--------------~~~~~~~~~~~-  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--------------IIEKLKQGQRL-  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--------------HHHHHHTTEET-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------ccccccccccc-
Confidence            23344557788999999988889999999999999999999 788876642221              11111111110 


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                           .....+...+.+++..||+.+|++||++.++++.|
T Consensus       225 -----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 -----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 11112356688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.5e-37  Score=316.29  Aligned_cols=252  Identities=25%  Similarity=0.390  Sum_probs=203.2

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      ++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688889999999999999998888899999876432 224568889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +|+|.+++......+++..+..++.+++.||+||   |+.+++||||||+||+++.++.+||+|||.++....... ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence            9999999876555688999999999999999999   788999999999999999999999999999886532221 112


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....++..|+|||...+..++.++||||||+++|||++ |+.||........ ...            +........+. 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-~~~------------i~~~~~~~~~~-  224 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-VEM------------ISRGFRLYRPK-  224 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH------------HHCCCCCCCCC-
Confidence            23345678999999988889999999999999999999 8999876322111 011            11000000111 


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                            .....+.+++.+||+.+|++||+++++++.|.
T Consensus       225 ------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  12446899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.6e-37  Score=335.81  Aligned_cols=260  Identities=23%  Similarity=0.395  Sum_probs=206.2

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~  545 (763)
                      .++|.+.+.||+|+||.||+|...      .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            568889999999999999999652      23479999997542 334567889999999996 9999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-----------------------------------------------------------
Q 046240          546 KALVLEYMPNGSLDIFLYSST-----------------------------------------------------------  566 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  566 (763)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998875421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC
Q 046240          567 ------------------------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE  610 (763)
Q Consensus       567 ------------------------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~  610 (763)
                                                          ..+++..+..++.|+++|++||   |+.+|+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHhEEEeC
Confidence                                                1367778889999999999999   7889999999999999999


Q ss_pred             CCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhh
Q 046240          611 DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKH  689 (763)
Q Consensus       611 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~  689 (763)
                      ++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||........    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999987643332222333456788999999988899999999999999999997 9999875322111    


Q ss_pred             hhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          690 WVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       690 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                               ....+.....  +    .....+...+.+++.+||+.+|++||++.+|.++|++.++
T Consensus       349 ---------~~~~~~~~~~--~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 ---------FYNKIKSGYR--M----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ---------HHHHHhcCCC--C----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                     1111111100  0    0111235678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.1e-37  Score=328.47  Aligned_cols=259  Identities=25%  Similarity=0.408  Sum_probs=206.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCc----eEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGI----EVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .+|+..+.||+|+||.||+|.+. +++    .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56899999999999999999753 333    48999986442 34456788999999999999999999999765 5679


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |+||+++|+|.+++......+++.....++.|+++||+||   |+.+|+||||||+||++++++.+||+|||+++.+...
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999987666688999999999999999999   7899999999999999999999999999999876533


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..........++..|+|||++.+..++.++|||||||++|||++ |..||.......              ..+++....
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--------------~~~~~~~~~  228 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------ISSILEKGE  228 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------------HHHHHhCCC
Confidence            32222223334678999999999999999999999999999998 999987632211              111111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      . .+..     ..+...+.+++..||..+|++||++.+++..+..+..+.
T Consensus       229 ~-~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         229 R-LPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             C-CCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            1 1111     123456889999999999999999999999998777654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=295.85  Aligned_cols=262  Identities=22%  Similarity=0.264  Sum_probs=210.3

Q ss_pred             HHHhccCcCceecccCCceEEEEE-ecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecC-----Cc
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND-----DF  545 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  545 (763)
                      ...+||.+.+.+|+|||+.||.+. ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+     .+
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            345789999999999999999995 567889999999877667788889999999999999999999988543     35


Q ss_pred             eEEEEEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--CeEeCCCCCCCEEecCCCcEEEeeec
Q 046240          546 KALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTT--PIIHCDLKSSNVLLDEDMIAHLSDFG  620 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~--~ivH~dlk~~NIll~~~~~~kl~Dfg  620 (763)
                      .|++++|...|+|.+.+..   ++..++..+.++|+.++++||++|   |+.  +++||||||.||++.+.+.+++.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~l---H~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEAL---HEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHH---hccCCcccccCCCcceeEecCCCceEEEecc
Confidence            8999999999999988865   344789999999999999999999   554  49999999999999999999999999


Q ss_pred             CceecCCCCCc-------cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh
Q 046240          621 IAKLLSGEDQS-------MTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW  690 (763)
Q Consensus       621 la~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~  690 (763)
                      .++..+-.-..       ........|..|+|||.+.   +...++++|||||||++|+|+.|..||+.....+.++...
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            98765311111       0113445799999999875   5678999999999999999999999999876644433322


Q ss_pred             hcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          691 VNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       691 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      +..           ..+......+      ..+.+.+++..|++.||.+||++.+++..+...
T Consensus       255 v~n-----------~q~s~P~~~~------yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  255 VQN-----------AQISIPNSSR------YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             eec-----------cccccCCCCC------ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            111           1111111122      256789999999999999999999999887654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-36  Score=326.00  Aligned_cols=264  Identities=25%  Similarity=0.312  Sum_probs=204.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|++.+.||+|+||.||++... +|..||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999665 68899999987542 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+++++|.+++.... .+++.....++.|++.||.||   |+ .+|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYL---REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---hhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999987644 578889999999999999999   54 46999999999999999999999999998765322  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccC---------------
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL---------------  695 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---------------  695 (763)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||........  ........               
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL--EAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhcccccccccCCccccCccc
Confidence              12335689999999999999999999999999999999999999965332211  11100000               


Q ss_pred             ----------------ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          696 ----------------PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       696 ----------------~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                                      .....+..+......+.....  .....++.+++.+||+.+|++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN--GVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCC--ccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                            001111222111111111000  1124568999999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.7e-37  Score=323.82  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             cCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      |...+.||+|+||+||+|.. .+|+.||+|.+.....   .....+.+|++++++++|++|+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999965 5789999999875432   2234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++|+|..++... ...+++.....++.|++.||+||   |+.+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            9999998887543 23588999999999999999999   88999999999999999999999999999998764222  


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......              ..+.+...+....
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------------~~~~~~~~~~~~~  221 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--------------KREEVDRRVKEDQ  221 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--------------hHHHHHHHhhccc
Confidence             2234568999999999999999999999999999999999999997632111              0011111111111


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                      ..   ........+.+++..||+.+|++||+     ++++++
T Consensus       222 ~~---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EE---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cc---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            00   00112456889999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=304.04  Aligned_cols=266  Identities=26%  Similarity=0.288  Sum_probs=202.6

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeec--CCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  548 (763)
                      -++|+..+.|++|.||.||+|.. ++++.||+|+++.+..  +..-...+||.+|.+++|||||.+-.+..-  -+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            46788889999999999999954 5789999999875432  223345789999999999999999887753  457999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |||||+. +|..++..-..++...+..-+..|+++|++||   |...|+|||||++|+|+...|.+||+|||+|+.+...
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999987 89999988777888999999999999999999   8899999999999999999999999999999988644


Q ss_pred             CCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh-------cccCChhHH
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV-------NGLLPVSLM  700 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~  700 (763)
                      .  ...+..+.|.||+|||++.+ ..|+.+.|+||+|||+.||+++++-|.+.....+ +...+       ...+|. +.
T Consensus       231 ~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtPte~iwpg-~~  306 (419)
T KOG0663|consen  231 L--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTPSEAIWPG-YS  306 (419)
T ss_pred             c--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCCccccCCC-cc
Confidence            2  34567789999999998876 5699999999999999999999999876433221 11111       001111 00


Q ss_pred             H--HHH-hhcCCCccc----cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 E--VVN-KTLLSPPEK----DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ~--~i~-~~l~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +  .+. -.....|..    ++... ...+.=++++...+.+||++|.||.|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhc
Confidence            0  000 000011100    01000 02245678999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.2e-37  Score=320.92  Aligned_cols=255  Identities=30%  Similarity=0.532  Sum_probs=205.9

Q ss_pred             hccCcCceecccCCceEEEEEecC------CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDD------GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      ++|+..+.||+|+||.||+|....      ...||+|.+.... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468888999999999999997542      2579999986443 334567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC
Q 046240          548 LVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM  612 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~  612 (763)
                      ++|||+++++|.+++....               ..+++.....++.|++.||+||   |+.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccccceEEEcCCC
Confidence            9999999999999986531               3477888999999999999999   788999999999999999999


Q ss_pred             cEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhh
Q 046240          613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWV  691 (763)
Q Consensus       613 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~  691 (763)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+       
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999987543332223344556888999999988899999999999999999998 999987533211       


Q ss_pred             cccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          692 NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       692 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                             ..+.+......      .....++.++.+++..||+.+|++||++.+|++.|++
T Consensus       235 -------~~~~i~~~~~~------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 -------VIEMIRSRQLL------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -------HHHHHHcCCcC------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                   11111111110      0112346779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=329.30  Aligned_cols=202  Identities=27%  Similarity=0.341  Sum_probs=176.6

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  548 (763)
                      -++|...++||+|.||+|+++... +++.+|||++++..   ..+.+..+.|..|+... +||.+++++.+|+..++.|.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            468999999999999999999665 68899999998763   34566777888888877 59999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+.||++..+++.  ..++.....-+|..|+.||.||   |+++||+||||.+|||+|.+|++||+|||+++.--  
T Consensus       447 vmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--  519 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--  519 (694)
T ss_pred             EEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence            9999999995444443  3588888888999999999999   89999999999999999999999999999998632  


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhh
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFA  682 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~  682 (763)
                      .....++..+||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+...
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE  573 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE  573 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            223355678999999999999999999999999999999999999999987443

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=314.61  Aligned_cols=257  Identities=25%  Similarity=0.432  Sum_probs=207.9

Q ss_pred             HhccCcCceecccCCceEEEEEec----CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|++.+.||+|+||+||+|.+.    +...||+|+++... ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            357889999999999999999764    24579999987543 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++++|.+++......+++..+..++.|++.|++||   |+.+|+||||||+||++++++.++|+|||+++.+...
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999977655789999999999999999999   7899999999999999999999999999999887522


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..........++..|+|||...+..++.++||||||+++|||++ |..||.......              ..+.+....
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~  225 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------------VIKAVEDGY  225 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------------HHHHHHcCC
Confidence            22222223345678999999998899999999999999999998 999986532221              111111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .. +.     ...++..+.+++.+|++.+|++||++.+|++.|.++
T Consensus       226 ~~-~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 RL-PP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC-CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10 10     112355689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.4e-37  Score=329.43  Aligned_cols=262  Identities=25%  Similarity=0.410  Sum_probs=205.3

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC-C
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND-D  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  544 (763)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+.+|+++++++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999532      35789999987442 23345678899999999 899999999988654 5


Q ss_pred             ceEEEEEccCCCChhhhhccCC----------------------------------------------------------
Q 046240          545 FKALVLEYMPNGSLDIFLYSST----------------------------------------------------------  566 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  566 (763)
                      ..++++||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999998885421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccccccccc
Q 046240          567 --CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM  644 (763)
Q Consensus       567 --~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~  644 (763)
                        ..+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              2578889999999999999999   78899999999999999999999999999998764333222233345677899


Q ss_pred             CccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHH
Q 046240          645 APEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVL  723 (763)
Q Consensus       645 aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~  723 (763)
                      |||++.+..++.++|||||||++|||++ |..||......+             .....+.......      ..+....
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------------~~~~~~~~~~~~~------~~~~~~~  303 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------------EFCRRLKEGTRMR------APEYATP  303 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------------HHHHHHhccCCCC------CCccCCH
Confidence            9999999999999999999999999998 999986522111             1111111111000      0112345


Q ss_pred             HHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          724 SIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       724 ~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ++.+++.+||+.+|++||++.++++.|+.+++++
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~~  337 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN  337 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcC
Confidence            6899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=311.76  Aligned_cols=277  Identities=26%  Similarity=0.363  Sum_probs=212.0

Q ss_pred             HHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC--CCCccceEEeeeecCC----ce
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGCSNDD----FK  546 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~~  546 (763)
                      ...+....+.||+|.||.||+|.++ |..||||++...   +++.+.+|.++++.+  +|+||+.+++.-..+.    +.
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            3467788899999999999999998 789999999743   345667788888764  9999999998775443    67


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----HTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                      +||++|.+.|||.+++.+..  ++....++++..+|.||+|||..     -++.|.|||||+.||||..++.+.|+|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r~t--v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRNT--VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEeeecccCCcHHHHHhhcc--CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            89999999999999998754  89999999999999999999853     356799999999999999999999999999


Q ss_pred             ceecCCCCC--ccccccccccccccCccccCCCC----CC--cchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcc
Q 046240          622 AKLLSGEDQ--SMTQTQTLATIGYMAPEYGIERK----VS--TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       622 a~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~----~~--~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~  693 (763)
                      |........  ....+..+||.+|||||++....    +.  ..+||||||.++||+.-+..--+....-......+++.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            988754422  33456789999999999986532    11  36899999999999976543211111111112222332


Q ss_pred             cCCh-hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          694 LLPV-SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       694 ~~~~-~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      ..+. ++++++.-.-.+......+....++..+.++|..||..+|..|.|+-.+-+.|.++.+
T Consensus       443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            2222 4555554333333333344445668899999999999999999999999999998874

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=322.66  Aligned_cols=244  Identities=24%  Similarity=0.308  Sum_probs=199.0

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999665 68999999997542   233556788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++...+ .++......++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999987654 578888999999999999999   7899999999999999999999999999998865321  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                         .....|++.|+|||++.+..++.++|||||||++|||++|+.||........             ...+...... .
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-------------~~~i~~~~~~-~  217 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-------------YEKILAGKLE-F  217 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhCCcC-C
Confidence               1234689999999999988899999999999999999999999976322110             1111111111 1


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                      +.       .....+.+++.+|++.||++||+     ++++++
T Consensus       218 ~~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         218 PR-------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             Cc-------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            11       11345789999999999999995     777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.2e-37  Score=318.81  Aligned_cols=259  Identities=24%  Similarity=0.356  Sum_probs=205.7

Q ss_pred             hccCcCceecccCCceEEEEEec-CCc----eEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGI----EVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|+..+.||+|+||+||+|.+. +++    .|++|.+.... ......+..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            56888899999999999999763 344    47888875432 2334667788889999999999999998864 45788


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ++||+++|+|.+++......+++.....++.|++.||+||   |+++++||||||+||++++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999987666789999999999999999999   7889999999999999999999999999999876443


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..........++..|+|||+..++.++.++|||||||++||+++ |..||.......              ..+++.+..
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------------~~~~~~~~~  228 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--------------VPDLLEKGE  228 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------------HHHHHHCCC
Confidence            33223334557788999999988899999999999999999998 999987642211              112222111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ....      ...+...+.+++.+||..+|++||++.|+++.+..+.++.
T Consensus       229 ~~~~------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         229 RLAQ------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             cCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            1000      0112445788999999999999999999999998877765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-36  Score=318.61  Aligned_cols=260  Identities=30%  Similarity=0.488  Sum_probs=209.2

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            35788899999999999999964      234569999987655555678899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEE
Q 046240          548 LVLEYMPNGSLDIFLYSST------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH  615 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~k  615 (763)
                      +||||+++++|.+++....            ..+++..+..++.|++.||+||   |+++++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999986432            2488999999999999999999   788999999999999999999999


Q ss_pred             EeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhccc
Q 046240          616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGL  694 (763)
Q Consensus       616 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  694 (763)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ......  
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-~~~i~~--  237 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-IECITQ--  237 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHc--
Confidence            999999986643332222233446788999999988899999999999999999999 8999865432211 111111  


Q ss_pred             CChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                                ......+.       .+...+.+++.+|++.+|.+||++.+|.+.|+.+..+
T Consensus       238 ----------~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         238 ----------GRVLQRPR-------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             ----------CCcCCCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                      00000011       1245689999999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.6e-37  Score=326.21  Aligned_cols=241  Identities=24%  Similarity=0.310  Sum_probs=194.7

Q ss_pred             ceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCC
Q 046240          481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      +.||+|+||.||++.. .+|+.||+|++....   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999965 478999999998653   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccc
Q 046240          557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ  636 (763)
Q Consensus       557 ~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  636 (763)
                      +|.+++.... .+++.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9998887543 678899999999999999999   78899999999999999999999999999987542211  12234


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHH
Q 046240          637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFA  716 (763)
Q Consensus       637 ~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  716 (763)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||........              .+.+   .......   
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--------------~~~~---~~~~~~~---  214 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--------------FELI---LMEEIRF---  214 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--------------HHHH---HcCCCCC---
Confidence            5689999999999999999999999999999999999999965322111              0111   1111100   


Q ss_pred             HHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          717 AKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       717 ~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                       ......++.+++..|++.||++||     ++.++++
T Consensus       215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence             011245678999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.6e-37  Score=317.21  Aligned_cols=256  Identities=28%  Similarity=0.482  Sum_probs=210.5

Q ss_pred             HHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      +...+|...+.||.|+||.||+|...+++.||+|++..........+..|+++++.++||||+++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567899999999999999999888899999999987665556778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+++++|.+++... ...+++.....++.++++|+.||   |+++++||||||+||++++++.+||+|||.+........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999764 33688999999999999999999   788999999999999999999999999999977643221


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        ......++..|+|||...+..++.++||||||+++|||++ |+.||......+              ..+.+..... 
T Consensus       160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~~-  222 (261)
T cd05148         160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------------VYDQITAGYR-  222 (261)
T ss_pred             --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--------------HHHHHHhCCc-
Confidence              1123345778999999988899999999999999999998 899986633211              1111111100 


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      .+.     ...+...+.+++.+|++.+|++|||++++++.|+.
T Consensus       223 ~~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 MPC-----PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            010     11235668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-37  Score=328.92  Aligned_cols=251  Identities=24%  Similarity=0.317  Sum_probs=202.7

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....   .....+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999765 588999999986532   24566788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997544 578888999999999999999   788999999999999999999999999999986532   


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChhHHHHHHhhcC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                        ......|++.|+|||++.+..++.++|||||||++|||++|..||........  ....|.             ..+.
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------------~~~~  218 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-------------ETLQ  218 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-------------cccc
Confidence              22345689999999999988999999999999999999999999976332211  011110             0000


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                       .+.... .......++.+++.+|+..+|++||++.++++.
T Consensus       219 -~~~~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 -RPVYDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -CCCCCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             111000 001234568899999999999999999999853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.1e-37  Score=321.67  Aligned_cols=269  Identities=21%  Similarity=0.248  Sum_probs=203.2

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|++.+.||+|+||+||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999775 68899999987542  2334667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |++++.+..+... ...+++..+..++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            9999877765543 33588889999999999999999   788999999999999999999999999999987643221 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh-hhhhhcccCChhHHHHHHhh--cC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS-LKHWVNGLLPVSLMEVVNKT--LL  708 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~--l~  708 (763)
                      .......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ......+..+..........  ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            1223456899999999999888999999999999999999999999764322111 11111111222111111000  00


Q ss_pred             --CCccc-c-----HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 --SPPEK-D-----FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 --~~~~~-~-----~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ..+.. .     ..........+.+++.+|++.+|++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              00000 0     0011123557899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-36  Score=318.63  Aligned_cols=259  Identities=29%  Similarity=0.475  Sum_probs=208.9

Q ss_pred             hccCcCceecccCCceEEEEEec------CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .+|...+.||+|+||.||+|...      ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999642      356799999876655556778999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc
Q 046240          549 VLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI  613 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~  613 (763)
                      ||||+++++|.+++....               ..+++..+..++.|++.|++||   |+++++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccCcceEEEccCCc
Confidence            999999999999986532               2478899999999999999999   7899999999999999999999


Q ss_pred             EEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhc
Q 046240          614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVN  692 (763)
Q Consensus       614 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~  692 (763)
                      ++|+|||+++...............++..|+|||+..+..++.++|||||||++|||+| |+.||........       
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-------  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence            99999999976543322222334456788999999998999999999999999999999 9999865332211       


Q ss_pred             ccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          693 GLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       693 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                             .+.+...   .....   ...++..+.+++.+||+.+|++||++.+|+++|+++...
T Consensus       235 -------~~~~~~~---~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 -------IECITQG---RVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -------HHHHhCC---CCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                   0111110   00000   011345688999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-38  Score=326.64  Aligned_cols=264  Identities=25%  Similarity=0.415  Sum_probs=221.0

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEecC---C--ceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeec
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAELDD---G--IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSN  542 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  542 (763)
                      +.....+.....++||.|-||.||+|.+.+   |  -.||||..+.++ ....+.|..|..+|+.++||||++++|+|.+
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            344455566677889999999999996643   2  358999998764 3457889999999999999999999999987


Q ss_pred             CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      . -.++|||.++-|-|..+++.....++.......+.||..||+||   |+...|||||..+||||.+..-||++|||++
T Consensus       463 ~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  463 Q-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             c-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchh
Confidence            6 46899999999999999998887899999999999999999999   8999999999999999999999999999999


Q ss_pred             eecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      +.+..+..... +...-++-|||||.+.-++++.++|||.|||++||+++ |..||.+....+.-.              
T Consensus       539 R~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------------  603 (974)
T KOG4257|consen  539 RYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------------  603 (974)
T ss_pred             hhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------------
Confidence            99875544332 33345778999999999999999999999999999999 999998743322110              


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                            .-....|.+.++.|+..+..++.+||.++|.+||++.++...|..+++.+
T Consensus       604 ------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  604 ------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             ------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence                  11123345556678889999999999999999999999999998888743

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-36  Score=316.78  Aligned_cols=256  Identities=31%  Similarity=0.499  Sum_probs=205.3

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|.+.+.||+|+||.||+|...      +++.||+|.+...... ..+.+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            356888899999999999999663      3478999998755333 457889999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc
Q 046240          547 ALVLEYMPNGSLDIFLYSST-------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI  613 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~  613 (763)
                      ++||||+++++|.+++...+             ..+++.....++.|++.|+.||   |+++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccccccceEEEcCCCe
Confidence            99999999999999986532             2467888999999999999999   7889999999999999999999


Q ss_pred             EEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhc
Q 046240          614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVN  692 (763)
Q Consensus       614 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~  692 (763)
                      +||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........       
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-------  233 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-------  233 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence            99999999986533322222233446788999999999999999999999999999999 9999865332211       


Q ss_pred             ccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          693 GLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       693 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                             .+.+.......+.      ......+.+++.+||..+|++||++.||++.|++
T Consensus       234 -------~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 -------IECITQGRLLQRP------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -------HHHHHcCCcCCCC------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                   1111111100111      1235568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=340.63  Aligned_cols=251  Identities=21%  Similarity=0.249  Sum_probs=201.7

Q ss_pred             hccCcCceecccCCceEEEEEec-C-CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-D-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            34888999999999999999554 4 678999977655445556778899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          553 MPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       553 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +++|+|.+++..   ....+++.....++.|++.||.|+   |+++|+||||||+||+++.++.+||+|||+++.+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999988754   233578889999999999999999   78899999999999999999999999999998765332


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 ++...+..
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----------------~~~~~~~~  286 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----------------IMQQVLYG  286 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhC
Confidence            2222344568999999999999999999999999999999999999997532211                 11111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....   ....+...+.+++..|+..+|++||++.++++
T Consensus       287 ~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        287 KYDP---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1100   00112456889999999999999999999864

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-36  Score=311.99  Aligned_cols=249  Identities=25%  Similarity=0.402  Sum_probs=198.6

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      +.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999664 78999999876442 33456788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccc
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL  638 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  638 (763)
                      .+++......+++.....++.|+++||.||   |+.+++||||||+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999976555688999999999999999999   78999999999999999999999999999987653221111111222


Q ss_pred             ccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHH
Q 046240          639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA  717 (763)
Q Consensus       639 g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  717 (763)
                      .+..|+|||.+.++.++.++|||||||++|||++ |..||.......              ....+.......      .
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------------~~~~~~~~~~~~------~  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAIEQGVRLP------C  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--------------HHHHHHcCCCCC------C
Confidence            3567999999998889999999999999999998 888886532211              111111111100      0


Q ss_pred             HHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          718 KEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       718 ~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      ...+...+.+++.+|++.+|++||++.++.++|++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            11234568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9e-37  Score=320.39  Aligned_cols=268  Identities=21%  Similarity=0.265  Sum_probs=200.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|...+.||+|+||+||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46889999999999999999664 68899999986432 22344677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++ +|.+++......+++.....++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence            985 88888876555678889999999999999999   789999999999999999999999999999976532221  


Q ss_pred             ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHH-----H
Q 046240          633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVV-----N  704 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i-----~  704 (763)
                      ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+..  .........++.+.++.     .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2233567899999998765 56899999999999999999999999764322211  11111111111111100     0


Q ss_pred             hhcCCCcc-cc-HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLSPPE-KD-FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~-~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ........ .. .........+..+++.+|+..||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000 00 0000112446789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=313.92  Aligned_cols=254  Identities=27%  Similarity=0.457  Sum_probs=205.8

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45788899999999999999988778899999987543 23466888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++.... ..+++.....++.+++.|+.||   |+.+++||||||+||++++++.+||+|||+++.+..... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999987643 4689999999999999999999   788999999999999999999999999999987652211 1


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      .......+..|+|||+..+..++.++||||||+++|||+| |+.||.......              ....+.+.... +
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------------~~~~~~~~~~~-~  224 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--------------VLQQVDQGYRM-P  224 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------------HHHHHHcCCCC-C
Confidence            1122223467999999998899999999999999999999 999987632211              11111111100 0


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      .     ...+...+.+++.+|++.+|++||++.++.+.|++
T Consensus       225 ~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 C-----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             C-----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0     11235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-36  Score=315.87  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             HHhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ++++|+..+.||+|+||.||+|...      ++..||+|++.... ......+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999998653      35679999986432 2345568899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEE
Q 046240          546 KALVLEYMPNGSLDIFLYSST---------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL  616 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl  616 (763)
                      .++||||+++++|.+++....         ...++..+..++.|+++|+.||   |+.+++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986522         2357788899999999999999   7889999999999999999999999


Q ss_pred             eeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccC
Q 046240          617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLL  695 (763)
Q Consensus       617 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  695 (763)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ..       
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~-~~-------  232 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-LR-------  232 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HH-------
Confidence            99999876543222222223345778999999998899999999999999999999 7888865322110 00       


Q ss_pred             ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       696 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                           .+........+       ..++..+.+++.+|++.+|++||++.|+++.|++
T Consensus       233 -----~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 -----FVMEGGLLDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -----HHHcCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                 01111111111       1234568999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-36  Score=315.17  Aligned_cols=254  Identities=25%  Similarity=0.430  Sum_probs=206.0

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            467899999999999999999888888999998865432 3567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++... ...+++..+..++.++++|++||   |+.+++||||||+||+++.++.++|+|||+++....... .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999998653 34678889999999999999999   778999999999999999999999999999987643221 1


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||+.....++.++|||||||++|||+| |..||........              ...+..... .+
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--------------~~~~~~~~~-~~  224 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV--------------MSALQRGYR-MP  224 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH--------------HHHHHcCCC-CC
Confidence            1223345678999999988889999999999999999999 9999865322111              111111111 11


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      .     ...+..++.+++.+|+..+|++||+++++.+.|+.
T Consensus       225 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 R-----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             C-----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1     01234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=323.85  Aligned_cols=250  Identities=25%  Similarity=0.334  Sum_probs=209.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc-eEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF-KALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  550 (763)
                      ++|..++.+|+|+||.++..+++ +++.+++|.+.-..  ........+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999654 67899999886442  3345577899999999999999999999999998 99999


Q ss_pred             EccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +|++||++.+.+.... ..++...+.+++.|++.|+.||   |+..|+|||||+.|||++.++.|||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999997765 5789999999999999999999   78899999999999999999999999999999986544


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      .  .....+||+.||.||.+.+.+|+.|+||||+||++|||++-+++|....-...             ...+.......
T Consensus       161 ~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-------------i~ki~~~~~~P  225 (426)
T KOG0589|consen  161 S--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-------------ILKINRGLYSP  225 (426)
T ss_pred             h--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-------------HHHHhhccCCC
Confidence            2  23457899999999999999999999999999999999999999987432221             11122211111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .|.       ....++..++..|++.+|+.||++.+++.+
T Consensus       226 lp~-------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPS-------MYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCc-------cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            111       235678999999999999999999999976

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.5e-37  Score=328.19  Aligned_cols=268  Identities=22%  Similarity=0.238  Sum_probs=197.2

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC-----CceE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND-----DFKA  547 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  547 (763)
                      +|++.+.||+|+||.||+|.. .+|+.||||++....  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            578889999999999999965 478999999987432  23345678999999999999999999988543     2479


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||++ ++|.+++.... .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 58888876543 588999999999999999999   788999999999999999999999999999986532


Q ss_pred             CCC-ccccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChh----
Q 046240          628 EDQ-SMTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVS----  698 (763)
Q Consensus       628 ~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~----  698 (763)
                      ... ........|+..|+|||++.+  ..++.++|||||||++|||+||+.||........  ..........+..    
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            221 112234578999999998765  6789999999999999999999999975332111  0111111111111    


Q ss_pred             ----HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 ----LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ----~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          ..+.+.......+.............+.+++.+|++.+|++||+++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                11111111111111100000112346789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-37  Score=287.44  Aligned_cols=247  Identities=24%  Similarity=0.305  Sum_probs=206.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      -++|++++.+|+|.||.||.|+.+ ++-.||+|++.+..   .+...++++|+++-+.++||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            468999999999999999999665 67789999997652   33567899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          550 LEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      +||.++|.+...+.... ..++......+..|+|.|+.|+   |.++|+||||||+|+|++..+..||+|||.+..-+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998543 3578888889999999999999   89999999999999999999999999999987643  


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                        .......+||..|.|||...+..++..+|+|++|++.||++.|.+||......+              ...-+.+.-.
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--------------tYkrI~k~~~  239 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--------------TYKRIRKVDL  239 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--------------HHHHHHHccc
Confidence              123344689999999999999999999999999999999999999998754222              1111222222


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..|.       .......+++..|+..+|.+|.+..||++
T Consensus       240 ~~p~-------~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  240 KFPS-------TISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             cCCc-------ccChhHHHHHHHHhccCccccccHHHHhh
Confidence            2232       12445689999999999999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=323.00  Aligned_cols=243  Identities=23%  Similarity=0.260  Sum_probs=193.8

Q ss_pred             ecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          483 IGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       483 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999665 68899999997542   23456678899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccc
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL  638 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  638 (763)
                      .+++.... .+++.....++.|+++||.||   |+++|+||||||+||+++.++.+||+|||+++......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99987644 588899999999999999999   78999999999999999999999999999987643221  1223456


Q ss_pred             ccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHH
Q 046240          639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK  718 (763)
Q Consensus       639 g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  718 (763)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.......                 .....+......    .
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-----------------~~~~~~~~~~~~----~  213 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-----------------MYRKILQEPLRF----P  213 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-----------------HHHHHHcCCCCC----C
Confidence            8999999999999999999999999999999999999997532211                 111111111110    0


Q ss_pred             HHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       719 ~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      ......+.+++.+|++.+|++||++.++.+.+..
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            1124567899999999999999875544444433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.7e-36  Score=311.17  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=203.3

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      ++|.+.+.||+|+||+||.|...++..||+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4678889999999999999988777789999887442 224568899999999999999999999999889999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +|+|.+++......+++..+..++.|++.|++||   |+.+++|+||||+||+++.++.+||+|||.++...... ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence            9999999976555689999999999999999999   78899999999999999999999999999988654322 1122


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....++..|+|||+..+..++.++|||||||++|||++ |..||.......              ..+.+..... .+..
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~~-~~~~  223 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------------TVEKVSQGLR-LYRP  223 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------------HHHHHhcCCC-CCCC
Confidence            23345678999999988889999999999999999999 999986533211              0111111100 0000


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                           ......+.+++..||+.+|++||++.++++.|+
T Consensus       224 -----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 -----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 012457899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-36  Score=325.67  Aligned_cols=243  Identities=22%  Similarity=0.273  Sum_probs=197.7

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999765 68899999997543   223456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++.... .++......++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999999987654 577888888999999999999   78899999999999999999999999999998764221 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                          ....|++.|+|||++.+..++.++|||||||++|||++|..||........ .            ..+..... ..
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~------------~~i~~~~~-~~  234 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-Y------------EKILAGRL-KF  234 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-H------------HHHhcCCc-CC
Confidence                234689999999999998999999999999999999999999965321110 0            11111110 00


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCN  747 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~  747 (763)
                      +.       .....+.+++..|++.||++||+     +++++
T Consensus       235 p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        235 PN-------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             CC-------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            11       12345789999999999999997     45555

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.2e-36  Score=321.63  Aligned_cols=264  Identities=25%  Similarity=0.332  Sum_probs=202.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|++.+.||+|+||.||++... ++..+|+|++.... ......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999765 68889999887542 3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++++|.+++.... .++......++.+++.|+.|||  +..+++||||||+||+++.++.+||+|||++..+...   
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence            999999999987643 5788888999999999999994  2357999999999999999999999999998765321   


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc----ccC------------
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN----GLL------------  695 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~----~~~------------  695 (763)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||.........  ....    ...            
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccCcccCCc
Confidence             123346899999999999889999999999999999999999998753221110  0000    000            


Q ss_pred             ------------C-hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          696 ------------P-VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       696 ------------~-~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                                  + .....+.+......+.....  .....++.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS--GVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCC--CCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                        0 01111111111111110000  012356889999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-36  Score=315.54  Aligned_cols=269  Identities=27%  Similarity=0.408  Sum_probs=205.9

Q ss_pred             hcc-CcCceecccCCceEEEEEe-----cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--Cc
Q 046240          475 NRF-GRDNLIGIGSFGYVYKAEL-----DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DF  545 (763)
Q Consensus       475 ~~~-~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  545 (763)
                      ++| ...+.||+|+||+||.+..     .+++.||+|++.... ......+.+|++++++++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 7889999999999988643     357889999987543 23456788999999999999999999988654  35


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++||||+++++|.+++...  .+++..+..++.|+++|+.||   |+.+|+||||||+||++++++.+||+|||+++.+
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            78999999999999998764  389999999999999999999   7889999999999999999999999999999876


Q ss_pred             CCCCCcc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccC-ChhHHHHH
Q 046240          626 SGEDQSM-TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL-PVSLMEVV  703 (763)
Q Consensus       626 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~i  703 (763)
                      ....... ......++..|+|||...+..++.++||||||+++|||+||..|+...............+.. .....+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            4322211 112234567799999998888999999999999999999999998653322111111111111 11222233


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      +......      ....++..+.+++..||+.+|++||++++++++|+++.
T Consensus       238 ~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRLP------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCCC------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2222111      11223567999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.8e-36  Score=316.12  Aligned_cols=259  Identities=25%  Similarity=0.412  Sum_probs=206.5

Q ss_pred             ccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      +|.+.+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4678899999999999999653      23578999887543 2345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 046240          549 VLEYMPNGSLDIFLYSST-----------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSN  605 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~N  605 (763)
                      |+||+++++|.+++....                       ..+++.....++.|++.|++||   |+.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---HHCCeehhhhhhhe
Confidence            999999999999875321                       2477889999999999999999   78899999999999


Q ss_pred             EEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhh
Q 046240          606 VLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAE  684 (763)
Q Consensus       606 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~  684 (763)
                      |++++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543322222233345678999999988889999999999999999999 99998653211 


Q ss_pred             hhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       685 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                                   ...+.+.+.......      ..+..++.+++..|++.+|++||++.++++.|++++.++
T Consensus       237 -------------~~~~~~~~~~~~~~~------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~~  290 (290)
T cd05045         237 -------------RLFNLLKTGYRMERP------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS  290 (290)
T ss_pred             -------------HHHHHHhCCCCCCCC------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhcC
Confidence                         222222222211111      123456889999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-36  Score=321.35  Aligned_cols=269  Identities=22%  Similarity=0.278  Sum_probs=198.5

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999765 688999999864422 223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |++ +++.+++......++...+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            996 577777766555688889999999999999999   78999999999999999999999999999987643222  


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc--ccCCh-hHHHH-----
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN--GLLPV-SLMEV-----  702 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~--~~~~~-~~~~~-----  702 (763)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|..||.........+.....  +.... .....     
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            12234568999999998765 46889999999999999999999999764322211111110  00000 00000     


Q ss_pred             -HHhhc-CCCccccHH--HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 -VNKTL-LSPPEKDFA--AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 -i~~~l-~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ..... ...+..-..  ........+.+++..|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00000 000000000  00011245779999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-37  Score=326.79  Aligned_cols=246  Identities=26%  Similarity=0.294  Sum_probs=199.6

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .-|..++.||.|+.|.|-.|++ .+|+.+|||++.+..   ......+++||-+|+.+.||||+++|+++.+..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3467789999999999999966 589999999997652   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|-|.+++..++ .++..+..+.+.||..|+.|+   |..+|+||||||+|+|+|..+.+||+|||+|..-.++. 
T Consensus        92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            9999999999998766 578888999999999999999   77889999999999999999999999999998753322 


Q ss_pred             ccccccccccccccCccccCCCCCC-cchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVS-TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        -....+|+++|.|||+..+.+|. .++||||.|||||.++||+.||++.+..                 .++.+-...
T Consensus       167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-----------------~LLlKV~~G  227 (786)
T KOG0588|consen  167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-----------------VLLLKVQRG  227 (786)
T ss_pred             --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-----------------HHHHHHHcC
Confidence              23446899999999999999885 6899999999999999999999964322                 222222111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+.    +.....+..+++.+++..||++|.|++||.+
T Consensus       228 ~f~M----Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  228 VFEM----PSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             cccC----CCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            1111    1222445667777777777777777777765

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.4e-36  Score=313.42  Aligned_cols=267  Identities=26%  Similarity=0.391  Sum_probs=205.8

Q ss_pred             hccCcCceecccCCceEEEEEe-----cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec--CCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-----DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  547 (763)
                      .+|.+.+.||+|+||.||++..     .++..||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688899999999999999964     2578999999876655566788999999999999999999998754  34688


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +|+||+++++|.+++......+++.....++.|+++||+||   |+++++||||||+||++++++.+||+|||+++.+..
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999999976555689999999999999999999   788999999999999999999999999999987643


Q ss_pred             CCCcc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccC--Ch---hHHH
Q 046240          628 EDQSM-TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL--PV---SLME  701 (763)
Q Consensus       628 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--~~---~~~~  701 (763)
                      ..... ......++..|+|||+..+..++.++|||||||++|||++|..|+.......   ........  +.   .+.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF---MRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh---hhhcccccccccchHHHHH
Confidence            32211 1122234556999999988889999999999999999999887764422111   11111110  01   1112


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .+.....      ......+...+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGR------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            2211111      011122356789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3e-36  Score=321.51  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=193.6

Q ss_pred             ceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCC
Q 046240          481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      +.||+|+||.||++.. .+|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4689999999999965 478999999998653   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccc
Q 046240          557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ  636 (763)
Q Consensus       557 ~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  636 (763)
                      +|..++.... .+++.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9988886543 578899999999999999999   78899999999999999999999999999987532211  12234


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHH
Q 046240          637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFA  716 (763)
Q Consensus       637 ~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  716 (763)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||........ .            ..+...... .+.    
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~------------~~~~~~~~~-~p~----  216 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-F------------ELILMEEIR-FPR----  216 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-H------------HHHhcCCCC-CCC----
Confidence            5689999999999999999999999999999999999999975322211 0            011111110 111    


Q ss_pred             HHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          717 AKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       717 ~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                         .....+.+++..|++.+|++||     ++.++++
T Consensus       217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 ---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence               1245678999999999999998     7777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.8e-36  Score=315.97  Aligned_cols=255  Identities=29%  Similarity=0.460  Sum_probs=202.0

Q ss_pred             hccCcCceecccCCceEEEEEe-----cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-----DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|++.+.||+|+||+||+|..     .+++.||+|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677889999999999999964     256789999987432 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC
Q 046240          549 VLEYMPNGSLDIFLYSS----------------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM  612 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~  612 (763)
                      ||||+++++|.+++...                ...+++.+...++.+++.||+||   |+++++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeehhccccceEEEcCCC
Confidence            99999999999988532                12467888899999999999999   788999999999999999999


Q ss_pred             cEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhh
Q 046240          613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWV  691 (763)
Q Consensus       613 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~  691 (763)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......        
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--------  233 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------  233 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999987643332222233445778999999988889999999999999999999 88898653211        


Q ss_pred             cccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          692 NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       692 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                            ...+.+.......      ..+.+...+.+++..|++.+|++||++.++.+.|..
T Consensus       234 ------~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 ------EVIEMVRKRQLLP------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ------HHHHHHHcCCcCC------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                  1111111111000      011234568899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.9e-36  Score=312.21  Aligned_cols=255  Identities=25%  Similarity=0.427  Sum_probs=204.7

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .+|...+.||+|+||.||+|... .++.||+|++.... .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999654 58899999987543 33567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++.... ..+++..+..++.|+++||+||   |+.+++||||||+||++++++.+||+|||.+......... 
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            9999999986533 3588999999999999999999   7889999999999999999999999999999876432211 


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||+..+..++.++|||||||++|||++ |..||.......              ..+.+........
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------------~~~~~~~~~~~~~  226 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------VYELLEKGYRMER  226 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------------HHHHHHCCCCCCC
Confidence            1122234668999999988899999999999999999998 899986532211              1111111111110


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                            .+.++..+.+++.+|++.+|++||++.++.++|++++
T Consensus       227 ------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         227 ------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             ------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                  1123567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-36  Score=317.69  Aligned_cols=263  Identities=25%  Similarity=0.405  Sum_probs=201.4

Q ss_pred             HhccCcCceecccCCceEEEEEecC---------------CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD---------------GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKII  537 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  537 (763)
                      .++|++.+.||+|+||.||++....               ...||+|.++... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578999999999999999986532               2358999987542 33456788999999999999999999


Q ss_pred             eeeecCCceEEEEEccCCCChhhhhccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCE
Q 046240          538 SGCSNDDFKALVLEYMPNGSLDIFLYSST-----------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNV  606 (763)
Q Consensus       538 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NI  606 (763)
                      +++...+..++||||+++++|.+++....           ..+++..+..++.++++|++||   |+.+++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---HhcCeeccccChhhE
Confidence            99999999999999999999999885432           1367888999999999999999   788999999999999


Q ss_pred             EecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc--CCCCCchhhhhh
Q 046240          607 LLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT--RKKPADKMFAAE  684 (763)
Q Consensus       607 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~~  684 (763)
                      ++++++.+||+|||++................++..|+|||+..++.++.++|||||||+++||++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976543322222233445778999999988889999999999999999998  667776532211


Q ss_pred             hhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       685 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      . ...         ..+.............   ....+..+.+++.+|++.+|++||++++|++.|++
T Consensus       241 ~-~~~---------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 V-IEN---------TGEFFRNQGRQIYLSQ---TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             H-HHH---------HHHhhhhccccccCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            1 000         0000000000000000   00124578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=335.43  Aligned_cols=261  Identities=26%  Similarity=0.293  Sum_probs=207.9

Q ss_pred             HHhccCcCceecccCCceEEEEEecCC-ceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEe-eeec------C
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDDG-IEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIIS-GCSN------D  543 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------~  543 (763)
                      ...++++.+.|.+|||+.||.|....+ ..||+|++-...+...+.+++||++|+.++ |+|||.+++ ....      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            456778889999999999999977655 999999987777777889999999999996 999999999 3321      1


Q ss_pred             CceEEEEEccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          544 DFKALVLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      -+.+|.||||.||.|-+++... ...++..++++|+.++++|+++||+ .+.+|||||||-+|||++.++..||||||.|
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            3677999999999999998743 2248999999999999999999976 4678999999999999999999999999998


Q ss_pred             eecCCCCCcc-------ccccccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc
Q 046240          623 KLLSGEDQSM-------TQTQTLATIGYMAPEYG---IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN  692 (763)
Q Consensus       623 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~  692 (763)
                      +-.-..-...       ......-|+.|+|||.+   .+..+++|+|||||||+||-++....||+.......       
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-------  266 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-------  266 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-------
Confidence            6432111000       01234579999999965   478899999999999999999999999987322111       


Q ss_pred             ccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          693 GLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       693 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                                +.......+..      .....+.+||..|++++|++||++.+|+..+.++..+.
T Consensus       267 ----------lng~Y~~P~~p------~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  267 ----------LNGNYSFPPFP------NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ----------EeccccCCCCc------cHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                      01011111111      23667899999999999999999999999999887764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=304.45  Aligned_cols=270  Identities=24%  Similarity=0.268  Sum_probs=203.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCc-cceEEeeeecCC-----
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRN-LVKIISGCSNDD-----  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-----  544 (763)
                      ...|...++||+|+||+||+|+. .+|+.||+|++.-...  +......+|+.++++++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34566678899999999999955 5789999999875533  34566789999999999999 999999998877     


Q ss_pred             -ceEEEEEccCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeec
Q 046240          545 -FKALVLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG  620 (763)
Q Consensus       545 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfg  620 (763)
                       ..++|+||++. +|..++....   ..++...+..++.|+++||+|+   |+++|+||||||+||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccc
Confidence             78899999966 8888887654   3467788999999999999999   89999999999999999999999999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh-cccCC-h
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV-NGLLP-V  697 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~-~~~~~-~  697 (763)
                      +|+.+.-+.  ...+..++|.+|+|||++.+. .|+...||||+||+++||++++.-|.+.........-+- -+... .
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            999764222  235677899999999998876 799999999999999999999988876544222211110 01110 0


Q ss_pred             h---HHHHHHhhcC--CCccccHHH--HHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          698 S---LMEVVNKTLL--SPPEKDFAA--KEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       698 ~---~~~~i~~~l~--~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .   .....+-...  ..+..+.-.  .........+++.+|++++|+.|.|++.+++.
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            0   1111111100  000000000  01112367899999999999999999999875

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-36  Score=323.74  Aligned_cols=245  Identities=23%  Similarity=0.276  Sum_probs=198.4

Q ss_pred             HhccCcCceecccCCceEEEEEec-C-CceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-D-GIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|.+.+.||+|+||.||+|... + +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            357889999999999999999654 3 3689999987542   2334567889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999987654 578889999999999999999   7889999999999999999999999999999876421


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                           .....||+.|+|||++.+..++.++|||||||++|||++|..||........             ...+......
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------------~~~i~~~~~~  246 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------------YQKILEGIIY  246 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------------HHHHhcCCCC
Confidence                 1235689999999999888899999999999999999999999976322110             0111111111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                       .+.       .....+.+++.+|++.+|++|+     +++++++
T Consensus       247 -~p~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        247 -FPK-------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -CCC-------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence             111       1134467899999999999995     7877764

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-36  Score=317.07  Aligned_cols=264  Identities=24%  Similarity=0.441  Sum_probs=209.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeec
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSN  542 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  542 (763)
                      ..++|.+.+.||+|+||.||+|...        ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            4578889999999999999999641        34579999987542 33456788999999999 89999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL  607 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIl  607 (763)
                      ....++||||+++|+|.+++....               ..+++..+..++.|+++||.||   |+.+++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HHCCeeecccccceEE
Confidence            999999999999999999986532               2467888999999999999999   7889999999999999


Q ss_pred             ecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhh
Q 046240          608 LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELS  686 (763)
Q Consensus       608 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~  686 (763)
                      +++++.+||+|||.++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||.......  
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--  247 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  247 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence            99999999999999987653332222233445678999999988889999999999999999999 788875432111  


Q ss_pred             hhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCcc
Q 046240          687 LKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSS  759 (763)
Q Consensus       687 ~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~  759 (763)
                                  ..+.+...   .....   ...+...+.+++.+||+.+|++||++.++++.|++++...++
T Consensus       248 ------------~~~~~~~~---~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         248 ------------LFKLLKEG---HRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             ------------HHHHHHcC---CcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence                        11111111   00000   112356788999999999999999999999999988776554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=311.62  Aligned_cols=251  Identities=28%  Similarity=0.418  Sum_probs=201.8

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      .+|++.+.||+|+||.||+|...++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            45788899999999999999887778899999864321 23467789999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|.+++......+++.....++.|+++|++||   |+.+++||||||+||++++++.+||+|||.++....... ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence            9999999976555789999999999999999999   788999999999999999999999999999886532211 111


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....++..|+|||...+..++.++||||||+++||+++ |+.||........              .+.+..... .+..
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------------~~~~~~~~~-~~~~  223 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--------------VESVSAGYR-LYRP  223 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--------------HHHHHcCCc-CCCC
Confidence            22234567999999998899999999999999999999 8999875322111              001111100 0000


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                           ..++.++.+++.+|+..+|++||++.+++++|
T Consensus       224 -----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         224 -----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 11355789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.7e-36  Score=311.19  Aligned_cols=260  Identities=26%  Similarity=0.402  Sum_probs=206.8

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCc----eEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGI----EVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      .++|+..+.||+|+||+||+|.+ .+|+    .||+|++... .....+.+.+|+.+++.+.||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            35788899999999999999965 3444    4899998644 233456788999999999999999999999754 577


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +++||+++|+|.+++......+++.....++.|+++||+||   |+++++||||||+||++++++.+||+|||+++.+..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999999987655789999999999999999999   789999999999999999999999999999987643


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...........++..|+|||...+..++.++|||||||++|||++ |..||+......              ....+...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------------~~~~~~~~  227 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------------IPDLLEKG  227 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------------HHHHHHCC
Confidence            322222223345678999999988899999999999999999998 899987532211              11122211


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ... +.     ...+...+.+++..||+.||++||++.++++.+.++.++.
T Consensus       228 ~~~-~~-----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         228 ERL-PQ-----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CcC-CC-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            110 10     0123456889999999999999999999999998887764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-37  Score=308.74  Aligned_cols=261  Identities=26%  Similarity=0.315  Sum_probs=194.5

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC-----ceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-----FKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  548 (763)
                      -.|...+++|+|+||.||+|... +++.||||+...+..    .--+|.++|+.++|||||++..+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35677899999999999999664 578999998865422    2236899999999999999998885432     3458


Q ss_pred             EEEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCcee
Q 046240          549 VLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKL  624 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~  624 (763)
                      |||||+. +|.++++.   .+..++...+.-+.+|+.+||+||   |+.+|+||||||+|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999987 88888874   234577778888999999999999   77999999999999999977 8999999999999


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh---hHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV---SLM  700 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~  700 (763)
                      +.....   ......|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+... ..++...+.-.-.+   ++.
T Consensus       176 L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  176 LVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHHh
Confidence            864443   244567899999998876 5799999999999999999999999987432 22333332211111   111


Q ss_pred             HH-------HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 EV-------VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ~~-------i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+       ....+...+..+. .......+..+++.+++.++|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~-~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKV-FFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceee-cccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            11       0011111111110 11123556899999999999999999999885

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.4e-36  Score=314.78  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=203.9

Q ss_pred             hccCcCceecccCCceEEEEEec------CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .+|...+.||+|+||.||++...      ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56778899999999999999532      456899999876655667789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          549 VLEYMPNGSLDIFLYSST--------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      ||||+++++|.+++....              ..+++..+..++.|++.|++||   |+.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeecccccHhhEEEcCCCCE
Confidence            999999999999986542              2478889999999999999999   78899999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcc
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  693 (763)
                      ||+|||+++.+.............+++.|+|||+..+..++.++|||||||++|||++ |..||........        
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------  233 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--------  233 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--------
Confidence            9999999976543222222223345678999999998999999999999999999999 8999865332211        


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                            .+.+.....  ...    ...++..+.+++..||+.||++||++.+|.+.|+
T Consensus       234 ------~~~~~~~~~--~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 ------IECITQGRE--LER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ------HHHHHcCcc--CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                  011111100  000    0123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.9e-36  Score=326.10  Aligned_cols=202  Identities=23%  Similarity=0.342  Sum_probs=174.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|+..+.||+|+||+||+|... +++.||+|++....   ......+.+|+.++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999654 68899999997543   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++.... .++......++.|++.||+||   |+.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999987644 588899999999999999999   889999999999999999999999999999876532110


Q ss_pred             c---------------------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 046240          631 S---------------------------------MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPA  677 (763)
Q Consensus       631 ~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~  677 (763)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999999999999999999999999999999999


Q ss_pred             chh
Q 046240          678 DKM  680 (763)
Q Consensus       678 ~~~  680 (763)
                      ...
T Consensus       237 ~~~  239 (363)
T cd05628         237 CSE  239 (363)
T ss_pred             CCC
Confidence            763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=327.63  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=192.5

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45666789999999999999654 78999999986542 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|....     ..+......++.|+++||+||   |+.+|+||||||+||++++++.+||+|||+++.+.....  
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            9999986532     245667788999999999999   788999999999999999999999999999987642211  


Q ss_pred             ccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          633 TQTQTLATIGYMAPEYGIE-----RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ......|+..|+|||++..     ...+.++|||||||++|||++|+.||......              ....+.....
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------------~~~~~~~~~~  289 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--------------DWASLMCAIC  289 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--------------cHHHHHHHHh
Confidence            1234578999999998743     33456899999999999999999999732111              0111111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ...+..   ....+..++.+++..||+.+|++||++.|+++.
T Consensus       290 ~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 MSQPPE---APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111110   011234568999999999999999999999863

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.6e-36  Score=320.61  Aligned_cols=241  Identities=25%  Similarity=0.314  Sum_probs=193.8

Q ss_pred             ceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCC
Q 046240          481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      +.||+|+||.||++.. .+|+.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999965 468999999997653   234566788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccc
Q 046240          557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ  636 (763)
Q Consensus       557 ~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  636 (763)
                      +|..++.... .+++.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9988886543 588999999999999999999   78999999999999999999999999999987532211  12234


Q ss_pred             ccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHH
Q 046240          637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFA  716 (763)
Q Consensus       637 ~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  716 (763)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||........                 ...........   
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-----------------~~~~~~~~~~~---  214 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----------------FELILMEDIKF---  214 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-----------------HHHhccCCccC---
Confidence            5689999999999988999999999999999999999999965322110                 01111111100   


Q ss_pred             HHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          717 AKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       717 ~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                       +......+.+++.+|+..+|++||     ++.++++
T Consensus       215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence             011244578999999999999997     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.6e-36  Score=309.82  Aligned_cols=257  Identities=23%  Similarity=0.334  Sum_probs=205.3

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||.||+|... +++.||||.+...   .......+.+|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999654 7899999987532   2334567888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      ||+++++|..++..   ....++......++.|+++||+||   |+.+++||||||+||+++.++.++|+|||.+..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   233578888999999999999999   789999999999999999999999999999887643


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.||.........            ..+.+... 
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~------------~~~~~~~~-  223 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS------------LCQKIEQC-  223 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH------------HHHHHhcC-
Confidence            221  122346888999999998888999999999999999999999998653211111            11111110 


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                       ..+..   ..+.....+.+++.+||+.+|++||++.+|++.++++
T Consensus       224 -~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         224 -DYPPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -CCCCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             01111   1122356689999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.7e-37  Score=326.73  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=200.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||+||++... +|+.||+|+++....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999654 789999999986532   24566788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++......+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999987655789999999999999999999   789999999999999999999999999999987643322


Q ss_pred             ccccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          631 SMTQTQTLATIGYMAPEYGI------ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      . ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........             ...+..
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------------~~~i~~  223 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------------YNNIMN  223 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------------HHHHHc
Confidence            1 223356899999999876      45678999999999999999999999975322111             111111


Q ss_pred             hh-cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KT-LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~-l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .. ....+..     ......+.+++..|++ +|++||++.++++
T Consensus       224 ~~~~~~~~~~-----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         224 FQRFLKFPED-----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCccCCCCC-----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            10 0011111     0124457889999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.5e-36  Score=336.18  Aligned_cols=254  Identities=25%  Similarity=0.312  Sum_probs=202.3

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC-----
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-----  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  544 (763)
                      ..++|.+.+.||+|+||+||+|.. .+|+.||||++...  .......+.+|+.++..++|+||+++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            457899999999999999999954 57899999998654  2344567788999999999999999988775432     


Q ss_pred             ---ceEEEEEccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          545 ---FKALVLEYMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       545 ---~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                         ..++||||+++|+|.+++...   ...++......++.|++.||.|+   |+++|+||||||+||+++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence               367999999999999988643   23678889999999999999999   789999999999999999999999999


Q ss_pred             ecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChh
Q 046240          619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       619 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      ||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||......               
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---------------  251 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---------------  251 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---------------
Confidence            99998765332222234457899999999999999999999999999999999999999753221               


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                        +++.+.+......   ....+..++.+++..||+.+|++||++.++++.
T Consensus       252 --~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 --EVMHKTLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence              1111111111100   011234568899999999999999999999763

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=303.15  Aligned_cols=201  Identities=25%  Similarity=0.384  Sum_probs=181.2

Q ss_pred             HhccCcCceecccCCceEEEEE-ecCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ..+|++.+.+|+|.||+|-+|. ...|+.||||.++++.   .++.-.+++||+||+.++||||+.+|.+|...+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            5688899999999999999994 4689999999987653   44566789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||..+|.|++++...+ .++..+..+++.||..|+.|+   |+++++|||||.+|||+|.++.+||+|||++..+....
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999997755 588899999999999999999   89999999999999999999999999999998875332


Q ss_pred             CccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhh
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMF  681 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~  681 (763)
                         ....++|++-|.+||+..+.+| ++.+|-||+||+||-++.|..||++..
T Consensus       208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D  257 (668)
T KOG0611|consen  208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD  257 (668)
T ss_pred             ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence               3456889999999999999888 578999999999999999999999843

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-35  Score=323.62  Aligned_cols=262  Identities=21%  Similarity=0.236  Sum_probs=198.0

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .+|.+.+.||+|+||.||++.. .+++.||+|+..      ...+.+|++++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            5799999999999999999955 578899999743      234678999999999999999999999999999999998


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      . ++|..++.... .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~  239 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NK  239 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-cc
Confidence            5 57877776543 578899999999999999999   788999999999999999999999999999975432111 12


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhh------hhhhhhhhhc--c----cCCh----
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFA------AELSLKHWVN--G----LLPV----  697 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~------~~~~~~~~~~--~----~~~~----  697 (763)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+.....      ....+.....  +    ..+.    
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            2345799999999999999999999999999999999999988643211      1111111110  0    0111    


Q ss_pred             hHHHHH---HhhcCCCccccH--HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 SLMEVV---NKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ~~~~~i---~~~l~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...+..   .+.....+..++  ........++.+++.+|++.||++|||++|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            111111   111112222221  111234567899999999999999999999985

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=328.58  Aligned_cols=251  Identities=21%  Similarity=0.313  Sum_probs=196.7

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|+..+.||+|+||+||+|... +|+.||||++....   ......+.+|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999664 68999999997542   233456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++.... .++......++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999987654 588899999999999999999   788999999999999999999999999999876532111


Q ss_pred             cc------------------------------------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCC
Q 046240          631 SM------------------------------------TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK  674 (763)
Q Consensus       631 ~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~  674 (763)
                      ..                                    ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    001235899999999999899999999999999999999999


Q ss_pred             CCCchhhhhhhhhhhhhcccCChhHHHHHHhh-cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC---HHHHHH
Q 046240          675 KPADKMFAAELSLKHWVNGLLPVSLMEVVNKT-LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN---AKCCNF  748 (763)
Q Consensus       675 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps---~~~v~~  748 (763)
                      .||........ ..            .++... -...+...     .....+.+++..|+. +|++|++   +.++++
T Consensus       237 ~Pf~~~~~~~~-~~------------~i~~~~~~~~~~~~~-----~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQET-YR------------KIINWKETLQFPDEV-----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHHHH-HH------------HHHcCCCccCCCCCC-----CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99976432211 00            011000 00001100     113456778888886 8999998   777764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.5e-36  Score=319.28  Aligned_cols=238  Identities=25%  Similarity=0.347  Sum_probs=189.1

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHH---HhCCCCccceEEeeeecCCceEEE
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVM---KNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      |.+.+.||+|+||.||+|... +|+.||||+++...   ....+.+.+|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999654 68999999997553   22344566666655   456799999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|..++...  .+++.....++.|++.||.||   |+.+|+||||||+||++++++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999998888653  489999999999999999999   78999999999999999999999999999987542221


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        .......|++.|+|||++.+..++.++|||||||++|||++|+.||........             ...+...... 
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-------------~~~i~~~~~~-  219 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-------------FDSIVNDEVR-  219 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhCCCC-
Confidence              122345689999999999999999999999999999999999999976332111             0111111111 


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCC
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN  742 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps  742 (763)
                      .+.       .....+.+++.+|++.||++||+
T Consensus       220 ~p~-------~~~~~~~~li~~~L~~dP~~R~~  245 (324)
T cd05589         220 YPR-------FLSREAISIMRRLLRRNPERRLG  245 (324)
T ss_pred             CCC-------CCCHHHHHHHHHHhhcCHhHcCC
Confidence            111       12455789999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=329.39  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=202.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||+||+|... +|+.||+|++.....   .....+..|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999765 789999999976532   34566888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC-
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED-  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-  629 (763)
                      ||+++++|.+++... ..++......++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998765 4688899999999999999999   78999999999999999999999999999998764332 


Q ss_pred             --------------------------CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhh
Q 046240          630 --------------------------QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA  683 (763)
Q Consensus       630 --------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~  683 (763)
                                                .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001223456899999999999999999999999999999999999999764322


Q ss_pred             hhhhhhhhcccCChhHHHHHH--hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC-HHHHHH
Q 046240          684 ELSLKHWVNGLLPVSLMEVVN--KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-AKCCNF  748 (763)
Q Consensus       684 ~~~~~~~~~~~~~~~~~~~i~--~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-~~~v~~  748 (763)
                      ..             ...+..  ..+. .+...     .....+.+++..|+. +|++||+ ++++++
T Consensus       237 ~~-------------~~~i~~~~~~~~-~p~~~-----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         237 ET-------------YNKIINWKESLR-FPPDP-----PVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HH-------------HHHHhccCCccc-CCCCC-----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            11             011111  0111 11111     124567899999997 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.6e-36  Score=318.50  Aligned_cols=241  Identities=24%  Similarity=0.332  Sum_probs=192.5

Q ss_pred             ceecccCCceEEEEEe----cCCceEEEEEeehhh----HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          481 NLIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +.||+|+||.||++..    .+++.||+|++....    ......+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999965    357899999997542    12345677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++.... .+.......++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999987644 567788888999999999999   788999999999999999999999999999875432221  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||........             ...+....... +.
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-------------~~~~~~~~~~~-~~  221 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-------------IDKILKGKLNL-PP  221 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-------------HHHHHcCCCCC-CC
Confidence            22335689999999999988899999999999999999999999976332110             11111111111 11


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                             .....+.+++.+|++.+|++||     ++.++++
T Consensus       222 -------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         222 -------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                   1244578999999999999999     6777654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.2e-36  Score=314.05  Aligned_cols=267  Identities=23%  Similarity=0.298  Sum_probs=195.3

Q ss_pred             hccCcCceecccCCceEEEEEe-c-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhC---CCCccceEEeeee-----c
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-D-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNI---RHRNLVKIISGCS-----N  542 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~  542 (763)
                      ++|++.+.||+|+||+||+|.. . +++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3788999999999999999975 3 468899998864321  2234456677777765   6999999999885     2


Q ss_pred             CCceEEEEEccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                      ....++||||++ ++|.+++... ...+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            446899999997 5888887653 23578899999999999999999   789999999999999999999999999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhH
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSL  699 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~  699 (763)
                      ++.....   .......|++.|+|||++.+..++.++|||||||++|||++|++||.........  .........+...
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            9876432   1233456899999999998889999999999999999999999999764322111  1111111111111


Q ss_pred             HH---HHHhhcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 ME---VVNKTLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 ~~---~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   +........+..... ........+.+++.+|++.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00   001111111111111 11123456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4e-36  Score=318.63  Aligned_cols=262  Identities=26%  Similarity=0.426  Sum_probs=207.1

Q ss_pred             HhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      .++|.+.+.||+|+||.||+|...        ++..+|+|.+.... ......+.+|+++++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999652        23579999987542 33456788899999999 799999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          544 DFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.||+||   |+.+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHHheEE
Confidence            99999999999999999986532               2478889999999999999999   78899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||......    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----  249 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  249 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence            9999999999999876543221111222234568999999988889999999999999999998 88888642211    


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                                ...+.+.....  ..    ....+..++.+++..|++.+|++||++.+|++.|.+++....
T Consensus       250 ----------~~~~~~~~~~~--~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         250 ----------ELFKLLKEGHR--MD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             ----------HHHHHHHcCCC--CC----CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence                      11111111110  00    111235578899999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8e-36  Score=314.67  Aligned_cols=262  Identities=24%  Similarity=0.418  Sum_probs=204.0

Q ss_pred             HhccCcCceecccCCceEEEEEecC-----------------CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD-----------------GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVK  535 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  535 (763)
                      ..+|++.+.||+|+||.||+|...+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999986542                 2458999987543 344677889999999999999999


Q ss_pred             EEeeeecCCceEEEEEccCCCChhhhhccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 046240          536 IISGCSNDDFKALVLEYMPNGSLDIFLYSST----------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSN  605 (763)
Q Consensus       536 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~N  605 (763)
                      +++++..++..++|+||+++++|..++....          ..+++.....++.|++.||+||   |+.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---HHcCccccccchhc
Confidence            9999999999999999999999999986543          2578999999999999999999   78899999999999


Q ss_pred             EEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc--CCCCCchhhhh
Q 046240          606 VLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT--RKKPADKMFAA  683 (763)
Q Consensus       606 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~  683 (763)
                      |+++.++.++|+|||+++...............++..|+|||+..+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999886543332222334456788999999988889999999999999999998  67787653221


Q ss_pred             hhhhhhhhcccCChhHHHHHHhhcCC-CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          684 ELSLKHWVNGLLPVSLMEVVNKTLLS-PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       684 ~~~~~~~~~~~~~~~~~~~i~~~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      .. +.            .. ...... ...........++.++.+++..|++.+|++||++.+|++.|++
T Consensus       241 ~~-~~------------~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 QV-IE------------NA-GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HH-HH------------HH-HhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            11 00            00 000000 0000000011224578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.1e-36  Score=327.94  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=194.0

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .|...+.||+|+||+||+|.. .+++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999965 468899999997542   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++|+|.+++.... .+++.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.+......
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987654 578888888999999999999   7899999999999999999999999999997643110000


Q ss_pred             ---------------------------------------------cccccccccccccCccccCCCCCCcchhHHHHHHH
Q 046240          632 ---------------------------------------------MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIM  666 (763)
Q Consensus       632 ---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~  666 (763)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123469999999999998899999999999999


Q ss_pred             HHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH-hhcCCCccccHHHHHHHHHHHHHHHHH--ccccCcCCCCCH
Q 046240          667 LIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN-KTLLSPPEKDFAAKEQCVLSIFSLAME--CTMELPEKRINA  743 (763)
Q Consensus       667 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~-~~l~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~Rps~  743 (763)
                      +|||++|+.||...........             ++. ......+..     .....+..+++.+  |+..+|..||++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~-------------i~~~~~~~~~~~~-----~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLK-------------VINWENTLHIPPQ-----VKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHH-------------HHccccccCCCCC-----CCCCHHHHHHHHHHccCcccccCCCCH
Confidence            9999999999976432221110             110 000000100     0112345666665  666677779999


Q ss_pred             HHHHH
Q 046240          744 KCCNF  748 (763)
Q Consensus       744 ~~v~~  748 (763)
                      .++++
T Consensus       300 ~~~l~  304 (381)
T cd05626         300 DDIKA  304 (381)
T ss_pred             HHHhc
Confidence            99875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.1e-36  Score=317.29  Aligned_cols=260  Identities=28%  Similarity=0.460  Sum_probs=206.3

Q ss_pred             HHHhccCcCceecccCCceEEEEEec------CCceEEEEEeehh-hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQE-CARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      ...++|+..+.||+|+||.||++...      ....+|+|.+... .......+.+|+++++++ +|+||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34567889999999999999999764      2367999988754 233456688999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          544 DFKALVLEYMPNGSLDIFLYSS---------------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      +..++||||+++|+|..++...               ...+++..++.++.|++.|++||   |+.+|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCccccccceeeEEE
Confidence            9999999999999999998532               23578899999999999999999   78899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||.++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||.......   
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  242 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  242 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence            9999999999999987653322222222345678999999988899999999999999999998 999986532211   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                                 ..+.+......  ..    ...+...+.+++.+|++.+|++|||+.++++.|..++
T Consensus       243 -----------~~~~~~~~~~~--~~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 -----------LFKLLKEGYRM--EK----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----------HHHHHHcCCcC--CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                       11111111100  00    0112456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.5e-36  Score=313.93  Aligned_cols=261  Identities=22%  Similarity=0.347  Sum_probs=207.9

Q ss_pred             HHhccCcCceecccCCceEEEEEecC-----CceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeec-CCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDD-----GIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSN-DDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  545 (763)
                      ..++|...+.||+|+||.||+|...+     +..|++|++... .....+.+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35788999999999999999997765     688999988644 23446778899999999999999999998766 467


Q ss_pred             eEEEEEccCCCChhhhhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          546 KALVLEYMPNGSLDIFLYSST-------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                      .++++||+++++|.+++....       ..+++..+..++.+++.||+||   |+.+++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999986532       3588999999999999999999   788999999999999999999999999


Q ss_pred             ecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCCh
Q 046240          619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPV  697 (763)
Q Consensus       619 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  697 (763)
                      ||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||.......  .          
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----------  228 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--M----------  228 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--H----------
Confidence            999987643332222233446778999999988889999999999999999999 999987632211  1          


Q ss_pred             hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          698 SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       698 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                        ...+..... .+.     ...++..+.+++.+||..+|++||++.++++.|+.+..+
T Consensus       229 --~~~~~~~~~-~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         229 --AAYLKDGYR-LAQ-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             --HHHHHcCCC-CCC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence              111111110 000     111345689999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-35  Score=313.51  Aligned_cols=258  Identities=25%  Similarity=0.401  Sum_probs=205.3

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  545 (763)
                      .++|...+.||+|+||.||+|..      .++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            46799999999999999999964      135579999887542 33456788999999999 79999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          546 KALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      .++||||+++|+|.+++.... ..+++.+...++.+++.|++||   |+.+++|+||||+||+++.++.++++|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999987543 2479999999999999999999   788999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      +.............++..|+|||++.+..++.++|||||||++|||++ |..||.......             ...+.+
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------------~~~~~~  257 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------------KFYKLI  257 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------------HHHHHH
Confidence            643322112223345778999999998899999999999999999998 999986532211             111111


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .........      ......+.+++.+|+..+|++||++.++++.|++.
T Consensus       258 ~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         258 KEGYRMAQP------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcCCcCCCC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111110000      01134688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-35  Score=307.93  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=203.6

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|.+.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            357899999999999999999887777899999875322 23568889999999999999999998754 5679999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++|+|.+++... ...+++..+..++.++++||+|+   |+.+++||||||+||++++++.+||+|||.++.+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            999999999753 23578899999999999999999   789999999999999999999999999999987643322 1


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||+..+..++.++|||||||++|||+| |..||........              .+.+..   ..+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--------------~~~~~~---~~~  221 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVER---GYR  221 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--------------HHHHhc---CCC
Confidence            2223446778999999988899999999999999999999 8888865332211              010110   000


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      .   .....++..+.+++.+|++.+|++||++.+++++|++.+
T Consensus       222 ~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         222 M---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             C---CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            0   001123567899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-35  Score=307.45  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=196.7

Q ss_pred             cCcCceecccCCceEEEEEecC-Cc--eEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC------Cc
Q 046240          477 FGRDNLIGIGSFGYVYKAELDD-GI--EVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSND------DF  545 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  545 (763)
                      |.+++.||+|+||.||+|...+ +.  .||+|.++..  .....+.+.+|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999997754 32  6899987643  234467788999999999999999999987432      25


Q ss_pred             eEEEEEccCCCChhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeec
Q 046240          546 KALVLEYMPNGSLDIFLYS-----STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG  620 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfg  620 (763)
                      .++|+||+++|+|..++..     ....+++.....++.|++.||+||   |+++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999888742     223578899999999999999999   77899999999999999999999999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhH
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSL  699 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  699 (763)
                      +++.+.............++..|+|||+..+..++.++|||||||++|||++ |+.||.......              .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------------~  223 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--------------I  223 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------------H
Confidence            9987643322222223345778999999999999999999999999999999 788886532211              0


Q ss_pred             HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       700 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .+.+..   ......   ...+...+.+++.+||+.+|++||++.++++.|+++
T Consensus       224 ~~~~~~---~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         224 YDYLRQ---GNRLKQ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHHc---CCCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111111   000000   012345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=318.56  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=218.3

Q ss_pred             HHhccCcCceecccCCceEEEEEecC-CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ...+..+.++||-|.||.||.|.|.. .-.||||.++.+ .-..++|..|+.+|+.++|||+|+++|+|..+.-.|||+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34456778899999999999998863 557999998755 3457889999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||..|+|.++++... ..++....+.+|.||+.|++||   ..+++|||||.++|.||.++-.|||+|||+++++.++..
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence            999999999998743 3677778889999999999999   788999999999999999999999999999999865433


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      . ......-.+-|.|||-+....++.|+|||+|||+|||+.| |-.||-+....              .+.+++.+-   
T Consensus       421 T-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------------qVY~LLEkg---  482 (1157)
T KOG4278|consen  421 T-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QVYGLLEKG---  482 (1157)
T ss_pred             e-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------------HHHHHHhcc---
Confidence            2 2233334778999999999999999999999999999999 88888663221              123333322   


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                         .|...++.|+..+.++|..||++.|.+||+++|+-+.++-++++++
T Consensus       483 ---yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  483 ---YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             ---ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence               2233455688999999999999999999999999999998887753

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.1e-36  Score=310.01  Aligned_cols=256  Identities=25%  Similarity=0.446  Sum_probs=203.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CC---ceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DG---IEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .+|.+.+.||+|+||.||+|... ++   ..||+|++... .....+.+..|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35778899999999999999764 33   36999998754 234467789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++......+++.++..++.|++.|++||   |+.+++||||||+||+++.++.+|++|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999987666789999999999999999999   78899999999999999999999999999987654322


Q ss_pred             Ccccccc-c--cccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          630 QSMTQTQ-T--LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       630 ~~~~~~~-~--~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ....... .  ..+..|+|||+..+..++.++|||||||++||+++ |..||.......              ..+.+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------------~~~~i~~  226 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------------VINAIEQ  226 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------------HHHHHHc
Confidence            2111111 1  12457999999998999999999999999999987 999986532211              1111111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .. ..+     ....++..+.+++..||..+|++||++.+|+..|+++
T Consensus       227 ~~-~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 DY-RLP-----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CC-cCC-----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10 001     0112355688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-35  Score=309.11  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=201.8

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            567889999999999999999664      35679999886443 33456788899999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC---cEEEe
Q 046240          547 ALVLEYMPNGSLDIFLYSST------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM---IAHLS  617 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~---~~kl~  617 (763)
                      ++||||+++++|.+++...+      ..+++..+..++.||+.|++||   |+++++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999986543      2578999999999999999999   788999999999999998654   69999


Q ss_pred             eecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCC
Q 046240          618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       618 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      |||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||.......            
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------------  229 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------------  229 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------------
Confidence            9999987632222112222334568999999998899999999999999999997 999987633221            


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                        ..+.+........      ...++..+.+++.+|++.+|++||++.+|++.|.+
T Consensus       230 --~~~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         230 --VMEFVTGGGRLDP------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             --HHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence              1111111100000      01124568899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-35  Score=304.89  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=199.0

Q ss_pred             ceecccCCceEEEEEecCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCChh
Q 046240          481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLD  559 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  559 (763)
                      ++||+|+||.||+|...+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999988888999999987543 233456889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccc
Q 046240          560 IFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA  639 (763)
Q Consensus       560 ~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  639 (763)
                      +++......+++.....++.+++.++.|+   |+++++||||||+||+++.++.+|++|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            99876655688999999999999999999   789999999999999999999999999999876432211 11122334


Q ss_pred             cccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHH
Q 046240          640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK  718 (763)
Q Consensus       640 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  718 (763)
                      +..|+|||+..+..++.++||||||+++||+++ |..||........              ...+.+......      .
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~------~  216 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--------------REQVEKGYRMSC------P  216 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--------------HHHHHcCCCCCC------C
Confidence            677999999988899999999999999999999 9999865422211              011111100000      0


Q ss_pred             HHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       719 ~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      ..+...+.+++.+|+..+|++||++.+++++|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            112457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=304.54  Aligned_cols=253  Identities=28%  Similarity=0.345  Sum_probs=196.8

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--------------HHHHHHHHHHHHHHhCCCCccceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--------------RAMKSFEVECEVMKNIRHRNLVKII  537 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~  537 (763)
                      .-++|++.+.||+|.||.|-+|.. .+++.||||++.+..-              ...+..++||.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            347899999999999999999955 5799999999974321              0135778999999999999999999


Q ss_pred             eeeecC--CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEE
Q 046240          538 SGCSND--DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH  615 (763)
Q Consensus       538 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~k  615 (763)
                      .+..+.  +..|||+|||..|.+...=.. ...+...+..++..++..||+||   |.++||||||||+|+|++++|+||
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCCCcEE
Confidence            999654  589999999999887543222 11388899999999999999999   889999999999999999999999


Q ss_pred             EeeecCceecCCCC---CccccccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh
Q 046240          616 LSDFGIAKLLSGED---QSMTQTQTLATIGYMAPEYGIERK----VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK  688 (763)
Q Consensus       616 l~Dfgla~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~  688 (763)
                      |+|||.+.......   ........+||+.|+|||...++.    .+.+.||||+||+||-|+.|+.||.+.+.-+.   
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l---  327 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL---  327 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH---
Confidence            99999998773221   111223478999999999876632    35688999999999999999999987432221   


Q ss_pred             hhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       689 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                                ...++...+.-...      .+..+++.+++.+++..||++|.+..+|..
T Consensus       328 ----------~~KIvn~pL~fP~~------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  328 ----------FDKIVNDPLEFPEN------PEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             ----------HHHHhcCcccCCCc------ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence                      12222222222111      123556789999999999999999988864

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=306.92  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=200.1

Q ss_pred             cCcCceecccCCceEEEEEecC----CceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc-----
Q 046240          477 FGRDNLIGIGSFGYVYKAELDD----GIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF-----  545 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  545 (763)
                      |.+.+.||+|+||.||+|....    +..||+|+++..  .......+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999997642    367999998743  23345678899999999999999999998866554     


Q ss_pred             -eEEEEEccCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeee
Q 046240          546 -KALVLEYMPNGSLDIFLYSS-----TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       546 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                       .++|+||+++|+|..++...     ...+++.....++.|++.||.||   |+.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999887442     22578889999999999999999   7889999999999999999999999999


Q ss_pred             cCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChh
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      |+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||.......              
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--------------  223 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------------  223 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence            99987653332222223345678999999988899999999999999999999 888886532211              


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      ..+.+..   .....   ....+...+.+++.+|++.+|++||++.++++.|++.
T Consensus       224 ~~~~~~~---~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         224 IYDYLRH---GNRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHHHc---CCCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111111   10000   0112356789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-35  Score=310.87  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=204.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999543      24579999876442 2234467889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEE
Q 046240          546 KALVLEYMPNGSLDIFLYSST---------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL  616 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl  616 (763)
                      .++||||+++|+|.+++....         ...++.....++.|++.||.||   |+++|+||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986421         2346677889999999999999   7889999999999999999999999


Q ss_pred             eeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccC
Q 046240          617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLL  695 (763)
Q Consensus       617 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  695 (763)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........  .       
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~--~-------  231 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV--L-------  231 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-------
Confidence            99999886543222222223345678999999988899999999999999999999 7888865322110  0       


Q ss_pred             ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       696 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                          ..+.+......+       +.+...+.+++..|++.+|++||++.++++.+++.+..
T Consensus       232 ----~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         232 ----KFVMDGGYLDQP-------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             ----HHHHcCCCCCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence                011111011111       12245789999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-35  Score=311.33  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=200.8

Q ss_pred             hccCcCceecccCCceEEEEEec------CCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      .+|...+.||+|+||.||+|...      +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34667789999999999999653      357899999875432 23466888999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC
Q 046240          548 LVLEYMPNGSLDIFLYSS---------------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM  612 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~  612 (763)
                      +++||+++++|..++...               ...+++..+..++.|+++||.|+   |+++++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCccccccchhheEecCCC
Confidence            999999999999987421               12477888899999999999999   788999999999999999999


Q ss_pred             cEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhh
Q 046240          613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWV  691 (763)
Q Consensus       613 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~  691 (763)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......       
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------  234 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999887643322222233456788999999988889999999999999999998 888886532211       


Q ss_pred             cccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          692 NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       692 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                                ++.........   .....+...+.+++..|++.+|++||++++|++.|+
T Consensus       235 ----------~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         235 ----------VIEMIRNRQVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             ----------HHHHHHcCCcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence                      11111111100   001234566899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.2e-36  Score=325.30  Aligned_cols=252  Identities=20%  Similarity=0.255  Sum_probs=198.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ..++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999664 68899999997542   2234557789999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++...  .++......++.|++.||+||   |+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999998654  367778888999999999999   7889999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIER----KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      .. .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......             ....+..
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------------~~~~i~~  261 (370)
T cd05596         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------------TYSKIMD  261 (370)
T ss_pred             Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------------HHHHHHc
Confidence            21 122345699999999987643    47889999999999999999999997632211             0111111


Q ss_pred             hhc-CCCccccHHHHHHHHHHHHHHHHHccccCcCC--CCCHHHHHH
Q 046240          705 KTL-LSPPEKDFAAKEQCVLSIFSLAMECTMELPEK--RINAKCCNF  748 (763)
Q Consensus       705 ~~l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~v~~  748 (763)
                      ..- ...+..     .....++.+++..|+..+|++  ||++.++++
T Consensus       262 ~~~~~~~~~~-----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         262 HKNSLTFPDD-----IEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCcCCCCCc-----CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            100 001110     012456788999999988887  999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-35  Score=306.02  Aligned_cols=248  Identities=29%  Similarity=0.458  Sum_probs=196.8

Q ss_pred             ecccCCceEEEEEec---CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          483 IGIGSFGYVYKAELD---DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       483 lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            899999999999654   35579999987553 2335678899999999999999999998854 578999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc-cccccc
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS-MTQTQT  637 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~  637 (763)
                      .+++......+++..+..++.|+++|+.||   |+++++||||||+||+++.++.+||+|||++..+...... ......
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999976555789999999999999999999   7889999999999999999999999999999865433221 111222


Q ss_pred             cccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHH
Q 046240          638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFA  716 (763)
Q Consensus       638 ~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~  716 (763)
                      .++..|+|||+.....++.++|||||||++||+++ |..||.......              ....+.+.....      
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~~~~------  218 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------------VMSFIEQGKRLD------  218 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------------HHHHHHCCCCCC------
Confidence            34578999999888889999999999999999997 999987643221              111111111100      


Q ss_pred             HHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       717 ~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      ....+..++.+++..||..+|++||++.+|.+.|+..+
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            01123567889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=327.55  Aligned_cols=202  Identities=24%  Similarity=0.348  Sum_probs=172.6

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||+||++.. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999965 478999999987542   234566788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++...+ .++......++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999987543 578888888999999999999   889999999999999999999999999999864321100


Q ss_pred             c-----------c----------------------------------ccccccccccccCccccCCCCCCcchhHHHHHH
Q 046240          631 S-----------M----------------------------------TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGI  665 (763)
Q Consensus       631 ~-----------~----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv  665 (763)
                      .           .                                  ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0           0                                  001246899999999999999999999999999


Q ss_pred             HHHHHHcCCCCCchh
Q 046240          666 MLIETFTRKKPADKM  680 (763)
Q Consensus       666 ~l~elltg~~p~~~~  680 (763)
                      ++|||++|..||...
T Consensus       237 il~elltG~~Pf~~~  251 (377)
T cd05629         237 IMFECLIGWPPFCSE  251 (377)
T ss_pred             hhhhhhcCCCCCCCC
Confidence            999999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-35  Score=318.53  Aligned_cols=260  Identities=22%  Similarity=0.391  Sum_probs=202.5

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC-C
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND-D  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  544 (763)
                      .++|.+.+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46899999999999999999963      357889999987542 23456688899999999 689999999988654 4


Q ss_pred             ceEEEEEccCCCChhhhhccCC----------------------------------------------------------
Q 046240          545 FKALVLEYMPNGSLDIFLYSST----------------------------------------------------------  566 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  566 (763)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999886421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccc
Q 046240          567 --------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL  638 (763)
Q Consensus       567 --------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  638 (763)
                              ..+++.....++.|+++||+||   |+++|+||||||+||++++++.+||+|||+++.+.............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    1357778889999999999999   78999999999999999999999999999998753322222222334


Q ss_pred             ccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC-CCccccHH
Q 046240          639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL-SPPEKDFA  716 (763)
Q Consensus       639 g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~~~~~~~~  716 (763)
                      ++..|+|||...+..++.++||||||+++|||++ |..||.......             .....+..... ..+.    
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~~~~----  305 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------------EFCRRLKEGTRMRAPD----  305 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------------HHHHHHhccCCCCCCC----
Confidence            5678999999988899999999999999999997 899986532111             11111111110 0111    


Q ss_pred             HHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       717 ~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                         ....++.+++..||+.+|++||++.++++.|+.+++.
T Consensus       306 ---~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         306 ---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence               1234688999999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-35  Score=308.04  Aligned_cols=258  Identities=24%  Similarity=0.463  Sum_probs=205.5

Q ss_pred             HhccCcCceecccCCceEEEEEec-CC---ceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DG---IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|.+.... ....+.+..|++++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356788899999999999999764 33   379999886542 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++++|.+++......+++.....++.+++.|++||   |+.+++||||||+||++++++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999977656789999999999999999999   7889999999999999999999999999999876432


Q ss_pred             CCcc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          629 DQSM-TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       629 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      .... .......+..|+|||++....++.++|||||||++|||++ |+.||.......              ....+...
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--------------~~~~i~~~  226 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------------VMKAINDG  226 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------------HHHHHhcC
Confidence            2111 1112223567999999988889999999999999999998 999986532211              11111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      . ..+.     ...+...+.+++.+|++.+|++||++.+|++.|.+++
T Consensus       227 ~-~~~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         227 F-RLPA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             C-CCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            1 1111     1123566899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-35  Score=323.55  Aligned_cols=261  Identities=22%  Similarity=0.381  Sum_probs=204.7

Q ss_pred             HHHhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCC-CCccceEEeeeecC
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIR-HRNLVKIISGCSND  543 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  543 (763)
                      ...++|.+.+.||+|+||.||+|.+.      .++.||+|+++... ....+.+.+|++++.++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34567888999999999999999753      34679999997542 233456889999999997 99999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCC---------------------------------------------------------
Q 046240          544 DFKALVLEYMPNGSLDIFLYSST---------------------------------------------------------  566 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  566 (763)
                      +..++|+||+++|+|.++++..+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999886421                                                         


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCE
Q 046240          567 ----------------------------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNV  606 (763)
Q Consensus       567 ----------------------------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NI  606 (763)
                                                              ..+++.....++.|++.||+||   |+++++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCcCcccCCcceE
Confidence                                                    1356677888999999999999   789999999999999


Q ss_pred             EecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhh
Q 046240          607 LLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAEL  685 (763)
Q Consensus       607 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~  685 (763)
                      ++++++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            999999999999999987533222112223456788999999988889999999999999999998 8899865322111


Q ss_pred             hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          686 SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       686 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                                   ..+.+.......      ....+...+.+++.+||..+|++||++++|++.|+..+
T Consensus       351 -------------~~~~~~~~~~~~------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 -------------FYNAIKRGYRMA------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -------------HHHHHHcCCCCC------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                         111111111000      00112456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.4e-35  Score=307.92  Aligned_cols=256  Identities=25%  Similarity=0.447  Sum_probs=204.5

Q ss_pred             hccCcCceecccCCceEEEEEec----CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .+|.+.+.||+|+||.||+|...    .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888999999999999999653    23479999886542 33456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++......+++.+...++.|++.|++||   |+.+++||||||+||+++.++.++++|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999987666789999999999999999999   78899999999999999999999999999998764332


Q ss_pred             Ccc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          630 QSM-TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       630 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ... ......++..|+|||+..+..++.++|||||||++||+++ |..||........  ..            .+.+..
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--~~------------~~~~~~  226 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--IK------------AIEEGY  226 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--HH------------HHhCCC
Confidence            211 1122233568999999998899999999999999999887 9999865322110  00            111100


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                       ..+.     ...++..+.+++.+|++.+|++||++.++++.|.++
T Consensus       227 -~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 -RLPA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -cCCC-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             0010     112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-35  Score=307.19  Aligned_cols=253  Identities=27%  Similarity=0.480  Sum_probs=202.3

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            357888999999999999999888888999999875432 2456889999999999999999999885 45688999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++.... ..+++..+..++.+++.|++||   |+.+++||||||+||++++++.++|+|||.+..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            9999999987532 3588999999999999999999   7788999999999999999999999999999876432211 


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||+..+..++.++||||||+++|||++ |..||.......              ..+.+...... +
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~~~-~  223 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--------------VLEQVERGYRM-P  223 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------------HHHHHHcCCCC-C
Confidence            1222345678999999988889999999999999999999 889986532211              11111111000 0


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                           ........+.+++.+|+..+|++|||++++.+.|++
T Consensus       224 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 -----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 011234568999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.4e-35  Score=312.85  Aligned_cols=262  Identities=23%  Similarity=0.395  Sum_probs=201.2

Q ss_pred             hccCcCceecccCCceEEEEEec-----------------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-----------------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKI  536 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l  536 (763)
                      ++|++.+.||+|+||.||++...                 ++..||+|++.... ......+.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999998432                 24468999987542 3345678899999999999999999


Q ss_pred             EeeeecCCceEEEEEccCCCChhhhhccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCE
Q 046240          537 ISGCSNDDFKALVLEYMPNGSLDIFLYSST----------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNV  606 (763)
Q Consensus       537 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NI  606 (763)
                      ++++...+..++||||+++++|.+++....          ..+++.....++.|++.|++||   |+.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---HHCCeecccCChheE
Confidence            999999999999999999999999986532          1366778999999999999999   788999999999999


Q ss_pred             EecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc--CCCCCchhhhhh
Q 046240          607 LLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT--RKKPADKMFAAE  684 (763)
Q Consensus       607 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt--g~~p~~~~~~~~  684 (763)
                      +++.++.++|+|||+++.+.............++..|+|||...++.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986643322222222345678999998888889999999999999999998  778886532211


Q ss_pred             hhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       685 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      . ..         ...+............   ....+...+.+++..||+.+|++||++.+|++.|++
T Consensus       242 ~-~~---------~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 V-IE---------NTGEFFRDQGRQVYLP---KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H-HH---------HHHHHHhhccccccCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1 00         0001111100000000   001234678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-35  Score=318.80  Aligned_cols=251  Identities=25%  Similarity=0.311  Sum_probs=195.7

Q ss_pred             ccCcCceecccCCceEEEEEe----cCCceEEEEEeehhh----HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCce
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  546 (763)
                      +|++.+.||+|+||.||++..    .+++.||+|++....    ....+.+..|+++++++ +||+|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999865    357899999997542    22345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++|+|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999886543 578889999999999999999   78899999999999999999999999999998653


Q ss_pred             CCCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ..... ......||..|+|||++.+. .++.++|||||||++|||+||+.||.......             ....+..+
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------------~~~~~~~~  222 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-------------TQSEVSRR  222 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-------------CHHHHHHH
Confidence            22221 22345689999999998764 47889999999999999999999996422110             00111111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      .....+...    ......+.+++.+|++.||++||     +++++++
T Consensus       223 ~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ILKCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HhcCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            111111111    11244578999999999999999     5556653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.8e-35  Score=308.60  Aligned_cols=246  Identities=24%  Similarity=0.290  Sum_probs=193.8

Q ss_pred             ecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       483 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ||+|+||.||++... +|+.||+|++.....   .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999664 689999999875321   1234556799999999999999999999999999999999999999


Q ss_pred             hhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccc
Q 046240          559 DIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT  637 (763)
Q Consensus       559 ~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  637 (763)
                      ..++.... ..+++.....++.|++.|++||   |+.+++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            88876533 3588889999999999999999   78999999999999999999999999999988764322   22335


Q ss_pred             cccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHH
Q 046240          638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA  717 (763)
Q Consensus       638 ~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  717 (763)
                      .|+..|+|||++.+..++.++||||+||++|||++|+.||........             ..++..+.........   
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~~~~~---  218 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-------------KEELKRRTLEDEVKFE---  218 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-------------HHHHHHHhhccccccc---
Confidence            689999999999888899999999999999999999999875321110             0111111111111100   


Q ss_pred             HHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          718 KEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       718 ~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                      ......++.+++..|++.+|++||+++|+++.+
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            012345688999999999999999998776544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4e-35  Score=303.38  Aligned_cols=240  Identities=23%  Similarity=0.329  Sum_probs=190.7

Q ss_pred             ceecccCCceEEEEEecC-------------CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          481 NLIGIGSFGYVYKAELDD-------------GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      +.||+|+||.||+|...+             ...|++|++..........+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2358999887655555667888999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc-------EEEeeec
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI-------AHLSDFG  620 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~-------~kl~Dfg  620 (763)
                      +||||+++|+|..++......+++..+..++.|+++|++||   |+++|+||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999999876666789999999999999999999   8899999999999999987654       8999999


Q ss_pred             CceecCCCCCccccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHH-cCCCCCchhhhhhhhhhhhhcccCChh
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETF-TRKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      ++.....      .....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+.             
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------------  218 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------------  218 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------------
Confidence            9875431      12345788899999876 567899999999999999998 58888765321110             


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                       .......... ..       ....++.+++.+||+.||++||++.++++.|+
T Consensus       219 -~~~~~~~~~~-~~-------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 -ERFYEGQCML-VT-------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -HHHHhcCccC-CC-------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             0000000000 00       01345789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-35  Score=309.19  Aligned_cols=270  Identities=24%  Similarity=0.400  Sum_probs=204.8

Q ss_pred             ccCcCceecccCCceEEEEEe-----cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-----DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKA  547 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  547 (763)
                      -|.+.+.||+|+||.||.+..     .++..||+|.++... ......+.+|+++++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999964     357889999987443 33456788999999999999999999998775  5688


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||+++++|.+++......+++..+..++.+++.||+||   |+++++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            99999999999999876555689999999999999999999   789999999999999999999999999999987643


Q ss_pred             CCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC-hhHHHHHHh
Q 046240          628 EDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP-VSLMEVVNK  705 (763)
Q Consensus       628 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~  705 (763)
                      .... .......++..|+|||+..+..++.++|||||||++|||+|++.|................+... ....+.+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            2221 11223456778999999988889999999999999999999887654321111000000000000 111111111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      ... .+     ....++..+.+++.+|++.+|++||++.++++.++.++
T Consensus       242 ~~~-~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         242 GKR-LP-----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             Ccc-CC-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            111 11     11124567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-35  Score=307.94  Aligned_cols=258  Identities=25%  Similarity=0.327  Sum_probs=206.1

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|.. .+++.+|||.+...   .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999975 57899999987643   2234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      ||+++++|.+++..   ....+++.....++.++++|+.||   |+.+++|+||||+||+++.++.++++|||.+..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863   233578999999999999999999   789999999999999999999999999999876643


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ...  ......++..|+|||+..+..++.++||||||+++|||++|..||...........            ..+... 
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------------~~~~~~-  223 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC------------KKIEQC-  223 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh------------hhhhcC-
Confidence            221  12234688899999999888899999999999999999999999865321111100            001100 


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      . .+...   .......+.+++.+|++.+|++|||+.+|++++++..
T Consensus       224 ~-~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 D-YPPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             C-CCCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0 01100   1123567899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-35  Score=302.93  Aligned_cols=248  Identities=25%  Similarity=0.307  Sum_probs=202.9

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|...+.||+|++|.||+|... +++.|++|.+...  .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777899999999999999764 6899999998743  234566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++++|.+++... ...+++.....++.+++.|+.||   |+.+++||||||+||++++++.++|+|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999998764 34688899999999999999999   788999999999999999999999999999887643221 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......++..|+|||+..+..++.++|||||||++|||++|+.||........                 ..+......
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~~  218 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-----------------ILKIIRGVF  218 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHcCCC
Confidence             12334678899999999988899999999999999999999999976432111                 111111110


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   ........+.+++.+||+.+|++||++.++++
T Consensus       219 ~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         219 PP---VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CC---CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            00   00123556899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-35  Score=314.65  Aligned_cols=240  Identities=26%  Similarity=0.322  Sum_probs=189.2

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... +++.||+|+++....   ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 678899999986531   2334455677777654 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .++......++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99998887644 578888999999999999999   78899999999999999999999999999998643222  1233


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........                 ........+... 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-----------------~~~i~~~~~~~~-  216 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-----------------FDSILNDRPHFP-  216 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHcCCCCCC-
Confidence            45689999999999988999999999999999999999999976332111                 111111111100 


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHH-HHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAK-CCN  747 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~v~  747 (763)
                         ..+...+.+++..|++.+|++||++. ++.
T Consensus       217 ---~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 ---RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ---CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               11244578999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.9e-36  Score=309.01  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=200.3

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999975 57889999998755434455678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++.... .+++..+..++.|+++|+.||   |+.+|+|||+||+||+++.++.++|+|||++..+.....  
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence            99999999886543 578899999999999999999   788999999999999999999999999999987642211  


Q ss_pred             ccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          633 TQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ......++..|+|||.+.   ...++.++|||||||++|||++|+.||.......... .+...            .. .
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~~------------~~-~  227 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKS------------NF-Q  227 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeecC------------CC-C
Confidence            123346888999999874   4557889999999999999999999986532111100 00000            00 0


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .+.  ..........+.+++.+|+..+|++||+++++++.
T Consensus       228 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         228 PPK--LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCC--CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            000  00011124568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=311.94  Aligned_cols=250  Identities=23%  Similarity=0.303  Sum_probs=198.5

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .|+..+.||+|+||+||++.. .+++.||+|++.....   .....+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999965 4689999999875422   223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+++|+|.+++... ...+++.....++.|++.|+.||   |+.+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            99999999888653 23688999999999999999999   78899999999999999999999999999998764222 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ..         .....+....   
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~---------~~~~~~~~~~---  221 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-RE---------EVERRVKEDQ---  221 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HH---------HHHHHhhhcc---
Confidence              12234689999999999888999999999999999999999999975321110 00         0111111110   


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      ...    .......+.+++..|++.||++||     +++++++
T Consensus       222 ~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 EEY----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ccc----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            000    111345688999999999999999     7778754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-35  Score=340.40  Aligned_cols=261  Identities=24%  Similarity=0.318  Sum_probs=202.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47899999999999999999664 68999999987532   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeec
Q 046240          551 EYMPNGSLDIFLYSS----------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG  620 (763)
Q Consensus       551 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfg  620 (763)
                      ||++||+|.+++...          ....++.....++.|+++||+||   |+++|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988641          12345677889999999999999   78899999999999999999999999999


Q ss_pred             CceecCCCCCc----------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh
Q 046240          621 IAKLLSGEDQS----------------MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE  684 (763)
Q Consensus       621 la~~~~~~~~~----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~  684 (763)
                      +++........                .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99876211100                01123468999999999999999999999999999999999999997632211


Q ss_pred             hhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC-CHHHHHHHHhhcccc
Q 046240          685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-NAKCCNFVLCEQFVS  756 (763)
Q Consensus       685 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~v~~~L~~~~~~  756 (763)
                      .....                 ....+.. .......+..+.+++.+|++.+|++|| +++++.+.|+..++.
T Consensus       239 i~~~~-----------------~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISYRD-----------------VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhhh-----------------hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            11000                 0000000 000112345678999999999999996 567777777766554

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.9e-35  Score=309.07  Aligned_cols=256  Identities=29%  Similarity=0.486  Sum_probs=202.9

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|+..+.||+|+||.||+|...      ++..||+|++.... ......+.+|++++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999753      46789999987543 33456788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 046240          547 ALVLEYMPNGSLDIFLYSST---------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSN  605 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~N  605 (763)
                      ++|+||+++|+|.+++....                     ..+++..++.++.|++.||.||   |+++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---H~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCeecccccHhh
Confidence            99999999999999986321                     2467888899999999999999   78899999999999


Q ss_pred             EEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhh
Q 046240          606 VLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAE  684 (763)
Q Consensus       606 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~  684 (763)
                      |++++++.++|+|||.+..+..............+..|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876543222212223345677999999988899999999999999999998 888886532221


Q ss_pred             hhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       685 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      .             ...+.+......+       +.++.++.+++.+|++.+|++||++.|+++.|++
T Consensus       241 ~-------------~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 V-------------IYYVRDGNVLSCP-------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H-------------HHHHhcCCCCCCC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            0             0111111111001       1235678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.4e-35  Score=312.90  Aligned_cols=257  Identities=27%  Similarity=0.436  Sum_probs=201.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCc--eEEEEEeehh-hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGI--EVAIKVFHQE-CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57888999999999999999765 333  4788888643 233456788999999999 799999999999999999999


Q ss_pred             EEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          550 LEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      +||+++++|.+++....               ..+++.....++.|++.|++||   |+++|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCcCCcceEEECCCCeE
Confidence            99999999999986432               2477889999999999999999   78899999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcc
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  693 (763)
                      ||+|||++......   ........+..|+|||+..+..++.++|||||||++|||++ |..||........        
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~--------  227 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL--------  227 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence            99999998643211   11111223557999999988889999999999999999998 9999865322110        


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                            .+.+........      ...+...+.+++.+|++.+|.+||+++++++.|..+.++.
T Consensus       228 ------~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         228 ------YEKLPQGYRMEK------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             ------HHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                  111111110000      1123456889999999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-35  Score=307.18  Aligned_cols=259  Identities=24%  Similarity=0.372  Sum_probs=205.7

Q ss_pred             HhccCcCceecccCCceEEEEEecC----CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD----GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|...+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.++++++||||+++++++.. +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3567888999999999999997543    3468999887554 3455678899999999999999999998875 45789


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++++|.+++......+++..+..++.+++.|++||   |+.+++||||||+||+++.++.+|++|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            9999999999999977555689999999999999999999   7889999999999999999999999999999876433


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ... ......++..|+|||.+....++.++|||||||++||+++ |..||......... ..             +....
T Consensus       161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~-------------~~~~~  225 (270)
T cd05056         161 SYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GR-------------IENGE  225 (270)
T ss_pred             cce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HH-------------HHcCC
Confidence            221 1223334568999999888889999999999999999996 99998764322211 00             00000


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                       ..+     ....++..+.+++.+|+.++|++||++.++++.|.+...++
T Consensus       226 -~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         226 -RLP-----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             -cCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence             000     01123557899999999999999999999999998876554

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-35  Score=317.42  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=193.0

Q ss_pred             ceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCC
Q 046240          481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      +.||+|+||.||++.. .+|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999965 478999999998653   223456678999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       557 ~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      +|..++.... .+++.....++.|++.||.||   |+ .+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9998886544 588999999999999999999   65 7999999999999999999999999999875432211  223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||........              .+.+...-...+.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--------------~~~i~~~~~~~p~---  217 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--------------FELILMEEIRFPR---  217 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--------------HHHHhcCCCCCCC---
Confidence            35689999999999999999999999999999999999999965322111              1111100001111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                          ....++.+++..|++.||++|+     ++.++++
T Consensus       218 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         218 ----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                1244578999999999999997     8888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.8e-35  Score=315.13  Aligned_cols=236  Identities=25%  Similarity=0.301  Sum_probs=189.0

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999764 68899999997643   22345667788888877 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .++......++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            99998887654 588899999999999999999   78899999999999999999999999999987542221  1223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........                 ............ 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----------------~~~i~~~~~~~~-  216 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-----------------FEAILNDEVVYP-  216 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-----------------HHHHhcCCCCCC-
Confidence            45689999999999988999999999999999999999999976432211                 011111111000 


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                         ......+.+++..|++.||++||++
T Consensus       217 ---~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 ---TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ---CCCCHHHHHHHHHHcccCHHHCCCC
Confidence               0124457899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=9.1e-36  Score=325.65  Aligned_cols=201  Identities=22%  Similarity=0.349  Sum_probs=171.7

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      +|+..+.||+|+||+||+|.. .+++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999965 468899999997543   2345678889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC-
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ-  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-  630 (763)
                      |+++|+|.+++...+ .++......++.|++.||+||   |+.+|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999987653 577888888999999999999   788999999999999999999999999999754310000 


Q ss_pred             --------------------------------------------ccccccccccccccCccccCCCCCCcchhHHHHHHH
Q 046240          631 --------------------------------------------SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIM  666 (763)
Q Consensus       631 --------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~  666 (763)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999999999999999999999


Q ss_pred             HHHHHcCCCCCchh
Q 046240          667 LIETFTRKKPADKM  680 (763)
Q Consensus       667 l~elltg~~p~~~~  680 (763)
                      +|||++|+.||...
T Consensus       238 l~elltG~~Pf~~~  251 (382)
T cd05625         238 LYEMLVGQPPFLAQ  251 (382)
T ss_pred             HHHHHhCCCCCCCC
Confidence            99999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-35  Score=306.43  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=204.1

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            467889999999999999999654      24689999986442 33456788899999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEe
Q 046240          547 ALVLEYMPNGSLDIFLYSST---------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS  617 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~  617 (763)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.||.||   |+.+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986422         2367888999999999999999   78899999999999999999999999


Q ss_pred             eecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCC
Q 046240          618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       618 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      |||+++.+.............++..|+|||...+..++.++|||||||++||++| |..||.......            
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------------  229 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------------  229 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------------
Confidence            9999886643332222334456788999999988889999999999999999998 899986532211            


Q ss_pred             hhHHHHHH-hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          697 VSLMEVVN-KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       697 ~~~~~~i~-~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                        ..+.+. ......+.       .+...+.+++..|++.+|++|||+.++++.|++
T Consensus       230 --~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         230 --VLKFVIDGGHLDLPE-------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             --HHHHHhcCCCCCCCC-------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence              111111 10001111       125678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-35  Score=312.17  Aligned_cols=249  Identities=28%  Similarity=0.315  Sum_probs=202.0

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788899999999999999965 478899999987654444567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++...  .+++.+...++.|++.|++||   |+.+|+||||||+||+++.++.+||+|||++........  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999998653  478889999999999999999   788999999999999999999999999999876543221  1


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      .....+++.|+|||.+.+..++.++|||||||++|||++|+.||............+                ....+..
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~----------------~~~~~~~  236 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------TNGTPEL  236 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh----------------cCCCCCC
Confidence            233468899999999988889999999999999999999999996533211100000                0000000


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        .........+.+++.+|+..+|++||++.++++
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence              001122456789999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.4e-35  Score=302.33  Aligned_cols=258  Identities=25%  Similarity=0.326  Sum_probs=207.0

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999776 7899999988632   2233567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      ||+++++|..++..   ....+++..+..++.+++.|+.||   |+.+++||||+|+||+++.++.++|+|||.+..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999988854   233578899999999999999999   789999999999999999999999999999876542


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ...  ......++..|+|||...+..++.++|||||||++|||++|+.||......               ..++.+...
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~~~~~  221 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------------LYSLCKKIE  221 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---------------HHHHHhhhh
Confidence            221  123346788999999998888999999999999999999999998653211               111111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      ......  .........+.+++..|+..+|++||++.+|+++++++.
T Consensus       222 ~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 KCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            100000  001123557889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-35  Score=316.95  Aligned_cols=238  Identities=30%  Similarity=0.343  Sum_probs=187.8

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHH-HHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECE-VMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||+||+|... +|+.||+|++.....   .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999764 789999999975432   22334445544 56778999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99998887643 578888899999999999999   78899999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||........             ...+........+.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------------~~~i~~~~~~~~~~---  218 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-------------YDNILNKPLRLKPN---  218 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-------------HHHHHcCCCCCCCC---
Confidence            45689999999999999999999999999999999999999976322110             11111111111111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAKC  745 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  745 (763)
                           ....+.+++.+|++.+|++||++.+
T Consensus       219 -----~~~~~~~li~~~l~~~p~~R~~~~~  243 (323)
T cd05575         219 -----ISVSARHLLEGLLQKDRTKRLGAKD  243 (323)
T ss_pred             -----CCHHHHHHHHHHhhcCHHhCCCCCC
Confidence                 2445789999999999999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.6e-35  Score=314.71  Aligned_cols=241  Identities=25%  Similarity=0.305  Sum_probs=191.9

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCC-CccceEEeeeecCCceEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRH-RNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  550 (763)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|++++..++| ++|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999665 57899999998653   2344567789999999976 56888999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|..++.... .+++.....++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            9999999998886544 578889999999999999999   78899999999999999999999999999987532111 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                       .......||+.|+|||++.+..++.++||||+||++|||+||+.||........ ..            .+.... ...
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~------------~i~~~~-~~~  220 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQ------------SIMEHN-VSY  220 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HH------------HHHcCC-CCC
Confidence             122345689999999999999999999999999999999999999976332211 00            111100 000


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      +.       .....+.+++.+|+..+|++|++.
T Consensus       221 ~~-------~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         221 PK-------SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CC-------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence            11       123457899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.8e-35  Score=315.40  Aligned_cols=241  Identities=25%  Similarity=0.325  Sum_probs=191.7

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999665 57899999998653   23345567788888876 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .+++.....++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            99998886543 578889999999999999999   788999999999999999999999999999876432221  223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||........ ..            .+...... .+.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~------------~i~~~~~~-~p~---  217 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-FE------------SILHDDVL-YPV---  217 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-HH------------HHHcCCCC-CCC---
Confidence            45689999999999988999999999999999999999999976432211 11            11111000 011   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCC-------CHHHHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRI-------NAKCCNF  748 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rp-------s~~~v~~  748 (763)
                          .+..++.+++..|++.+|++||       ++.++++
T Consensus       218 ----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         218 ----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                1234578999999999999999       6666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.3e-35  Score=307.15  Aligned_cols=244  Identities=24%  Similarity=0.282  Sum_probs=192.2

Q ss_pred             ecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       483 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ||+|+||+||++... +|+.||+|++.....   ...+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999654 788999999875432   2235667899999999999999999999999999999999999999


Q ss_pred             hhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          559 DIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       559 ~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      ..++..   ....+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||.+..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            887743   233588999999999999999999   788999999999999999999999999999987643222  223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.......             ...++..........   
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-------------~~~~~~~~~~~~~~~---  219 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-------------ENKELKQRILNDSVT---  219 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-------------hHHHHHHhhcccCCC---
Confidence            3568999999999999999999999999999999999999997532110             001111111111100   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                       ........+.+++..|++.+|++||     +++++++
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         220 -YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence             0112345688999999999999999     5666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-35  Score=302.22  Aligned_cols=248  Identities=31%  Similarity=0.458  Sum_probs=199.5

Q ss_pred             ceecccCCceEEEEEecCCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCChh
Q 046240          481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLD  559 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  559 (763)
                      ++||+|+||.||++...+++.||+|.+..... ...+.+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999877799999998875432 34567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccc
Q 046240          560 IFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA  639 (763)
Q Consensus       560 ~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  639 (763)
                      +++......+++.....++.++++++.||   |+.+++||||||+||+++.++.+||+|||.+.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99976555678889999999999999999   788999999999999999999999999999876532221111122234


Q ss_pred             cccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHH
Q 046240          640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK  718 (763)
Q Consensus       640 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  718 (763)
                      +..|+|||++.++.++.++|||||||++|||+| |..||.......              ..+.+.....      ....
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------------~~~~~~~~~~------~~~~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------------TRERIESGYR------MPAP  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------------HHHHHhcCCC------CCCC
Confidence            667999999988899999999999999999999 888886543211              1111111100      0001


Q ss_pred             HHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       719 ~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      ..+...+.+++.+|+..+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            123557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=316.57  Aligned_cols=245  Identities=27%  Similarity=0.318  Sum_probs=203.4

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ..|.-.+-||.|+||.||-|.. .+.+.||||++.-.   .....+++..|+..|++++|||++.+-|||..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3466678899999999999954 57789999998633   3345688999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |||-| +-.+++.-..+++....+..|+.+.++||+||   |+.+.||||||+.|||+++.|.||++|||.|..+.+.  
T Consensus       106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--  179 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--  179 (948)
T ss_pred             HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence            99955 77888877777888999999999999999999   8899999999999999999999999999999887643  


Q ss_pred             ccccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          631 SMTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                          ..++||++|||||++.   .+.|+-|+||||+|++-.|+.-.++|+..++..........+               
T Consensus       180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN---------------  240 (948)
T KOG0577|consen  180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------------  240 (948)
T ss_pred             ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc---------------
Confidence                4578999999999854   689999999999999999999999998876544322111110               


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ..|-   -....+.+.+..++..|++..|.+|||.+++++
T Consensus       241 -esPt---Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 -ESPT---LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CCCC---CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             1111   012234677899999999999999999998875

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-35  Score=302.94  Aligned_cols=249  Identities=27%  Similarity=0.356  Sum_probs=204.4

Q ss_pred             hccCcCceecccCCceEEEEEecC-CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      ++|+..+.||+|+||.||+|...+ ++.|++|.+.....  .+.+.+|++++++++||||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999997764 78999999876533  678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++......+++.....++.++++|+.||   |+.+++||||+|+||++++++.+||+|||++........  .
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~  155 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K  155 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence            99999999976666789999999999999999999   788999999999999999999999999999887643221  2


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.||...........              +..    ....
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------------~~~----~~~~  217 (256)
T cd06612         156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------------IPN----KPPP  217 (256)
T ss_pred             cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------------hcc----CCCC
Confidence            2334578899999999888999999999999999999999999875322111000              000    0000


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...........+.+++.+|++.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            11111223456889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.9e-36  Score=323.03  Aligned_cols=252  Identities=20%  Similarity=0.238  Sum_probs=195.0

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ..++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++..++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3578999999999999999999765 68899999987532   2234567789999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++...  .++......++.|++.||+||   |+++|+||||||+||++++++.+||+|||+++.+...
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999998654  378888899999999999999   7889999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIER----KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      .. .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||........             ...+++
T Consensus       196 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------------~~~i~~  261 (370)
T cd05621         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------------YSKIMD  261 (370)
T ss_pred             Cc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------------HHHHHh
Confidence            21 122345699999999988653    378899999999999999999999976322111             111221


Q ss_pred             hhcC-CCccccHHHHHHHHHHHHHHHHHccccCcC--CCCCHHHHHH
Q 046240          705 KTLL-SPPEKDFAAKEQCVLSIFSLAMECTMELPE--KRINAKCCNF  748 (763)
Q Consensus       705 ~~l~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~--~Rps~~~v~~  748 (763)
                      .... ..+..     ......+.+++..|+..+|.  .||++.++++
T Consensus       262 ~~~~~~~p~~-----~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         262 HKNSLNFPED-----VEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             CCcccCCCCc-----ccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            1100 00110     11234466777788864443  3788888775

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.2e-35  Score=312.41  Aligned_cols=240  Identities=25%  Similarity=0.363  Sum_probs=190.0

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||+||+|... +++.||+|+++...   .........|..+++.. +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999765 57899999998653   22344566778888764 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            99999987543 578889999999999999999   788999999999999999999999999999875321111  223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||........              .+.+..   ..+... 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--------------~~~i~~---~~~~~~-  216 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--------------FQSIRM---DNPCYP-  216 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH--------------HHHHHh---CCCCCC-
Confidence            45689999999999998999999999999999999999999976322110              011110   011100 


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHH-HHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAK-CCN  747 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~v~  747 (763)
                         ......+.+++.+|++.+|++||++. ++.
T Consensus       217 ---~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 ---RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ---ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence               01234578999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.1e-35  Score=313.11  Aligned_cols=241  Identities=25%  Similarity=0.305  Sum_probs=193.4

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||+||+|... +++.||+|++....   ......+.+|+++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999665 57899999998653   23345667888899888 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .+++.....++.|++.||+||   |+.+|+||||||+||++++++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            99998887653 588999999999999999999   789999999999999999999999999999875322111  223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||........ .            ..+...... .+    
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-~------------~~i~~~~~~-~~----  216 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-F------------QSILEDEVR-YP----  216 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-H------------HHHHcCCCC-CC----
Confidence            34689999999999999999999999999999999999999975332111 0            011111110 01    


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCH-----HHHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINA-----KCCNF  748 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~-----~~v~~  748 (763)
                         ......+.+++.+|++.||++||++     .++++
T Consensus       217 ---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 ---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence               1124567899999999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=303.75  Aligned_cols=251  Identities=25%  Similarity=0.347  Sum_probs=200.7

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-----HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-----ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|...+.||+|++|.||+|.. .+++.||+|.+....     ....+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688899999999999999965 468999999886431     1234568889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |+||+++++|.+++.... .++......++.+++.|+.||   |+.+++||||+|+||++++++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999886543 578888899999999999999   7889999999999999999999999999999865432


Q ss_pred             CCcc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSM-TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .... ......++..|+|||+..+..++.++||||||+++|||++|+.||.........             ........
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------------~~~~~~~~  224 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-------------FKIATQPT  224 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-------------HHHhccCC
Confidence            2111 113345788999999999888999999999999999999999998753221110             00000000


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        .+    .....+...+.+++..||..+|++||++.++++
T Consensus       225 --~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         225 --NP----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             --CC----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence              00    011123456889999999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.5e-35  Score=304.39  Aligned_cols=239  Identities=22%  Similarity=0.321  Sum_probs=189.1

Q ss_pred             eecccCCceEEEEEecC-------------------------CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceE
Q 046240          482 LIGIGSFGYVYKAELDD-------------------------GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI  536 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  536 (763)
                      .||+|+||.||+|....                         ...|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999996421                         23589999876655555678889999999999999999


Q ss_pred             EeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC----
Q 046240          537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM----  612 (763)
Q Consensus       537 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~----  612 (763)
                      ++++......++||||+++|+|..++......+++..+..++.|+++||+||   |+++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYL---EDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999876555788999999999999999999   788999999999999997643    


Q ss_pred             ---cEEEeeecCceecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHH-cCCCCCchhhhhhhhh
Q 046240          613 ---IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETF-TRKKPADKMFAAELSL  687 (763)
Q Consensus       613 ---~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell-tg~~p~~~~~~~~~~~  687 (763)
                         .+|++|||.+......      ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.......   
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---  229 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---  229 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence               4799999987653211      22356788999998765 56899999999999999995 6999986532211   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                                 .......... .+..       ....+.+++.+||+.+|++||++.++++.|.
T Consensus       230 -----------~~~~~~~~~~-~~~~-------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 -----------KERFYEKKHR-LPEP-------SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----------HHHHHHhccC-CCCC-------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                       1111111111 1111       1235789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-35  Score=305.29  Aligned_cols=259  Identities=27%  Similarity=0.412  Sum_probs=207.3

Q ss_pred             hccCcCceecccCCceEEEEEec-CCc----eEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGI----EVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .+|...+.||+|+||.||+|... +|.    .||+|.+.... ......+.+|++++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            57888899999999999999754 333    58999886553 3345678899999999999999999999987 78899


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |+||+++|+|.+++......+++.....++.|+++|++||   |+.+++||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            9999999999999987666689999999999999999999   7799999999999999999999999999999876533


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..........++..|+|||......++.++|+||||+++||+++ |+.||.......              ..+.+....
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~  228 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------------IPDLLEKGE  228 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------------HHHHHhCCC
Confidence            22222222234568999999988899999999999999999999 999987632211              111111110


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      . .+.     ...+...+.+++.+||..+|++||++.++++.+.+...+.
T Consensus       229 ~-~~~-----~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         229 R-LPQ-----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             C-CCC-----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            0 000     0112446889999999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-35  Score=303.35  Aligned_cols=248  Identities=31%  Similarity=0.506  Sum_probs=203.1

Q ss_pred             ceecccCCceEEEEEecC----CceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELDD----GIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|....    +..|++|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999997653    788999998765433 367888999999999999999999999999999999999999


Q ss_pred             CChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          556 GSLDIFLYSS--------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       556 g~L~~~l~~~--------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      ++|.+++...        ...+++.....++.|+++|++||   |+++++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875        35789999999999999999999   889999999999999999999999999999988754


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...........++..|+|||......++.++||||+|+++|||++ |..||.......              ..+.+.. 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------------~~~~~~~-  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--------------VLEYLRK-  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--------------HHHHHHc-
Confidence            332223344567889999999988889999999999999999999 699987642111              1111111 


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                        ..   +......+...+.+++..|++.+|++||++.++++.|+
T Consensus       223 --~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --GY---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CC---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              00   00111123567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-35  Score=303.50  Aligned_cols=247  Identities=25%  Similarity=0.395  Sum_probs=195.7

Q ss_pred             eecccCCceEEEEEec---CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCC
Q 046240          482 LIGIGSFGYVYKAELD---DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      .||+|+||.||+|.+.   +++.||+|+++...  ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999653   57889999986432  334567889999999999999999999885 45678999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc-ccc
Q 046240          557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM-TQT  635 (763)
Q Consensus       557 ~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~  635 (763)
                      +|.+++.... .+++.....++.|++.|++||   |+++++||||||+||++++++.+||+|||+++.+....... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999986543 588899999999999999999   78899999999999999999999999999998764332211 112


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcccc
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD  714 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  714 (763)
                      ...++..|+|||.+....++.++|||||||++|||++ |+.||.......              ..+.+.+.....    
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------------~~~~i~~~~~~~----  218 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------------VTQMIESGERME----  218 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHCCCCCC----
Confidence            2234578999999888889999999999999999998 999997643221              111122111100    


Q ss_pred             HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          715 FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       715 ~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                        .+..+..++.+++..||+.+|++||++.+|.+.|+..
T Consensus       219 --~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 --CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              0112355688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.4e-36  Score=326.28  Aligned_cols=202  Identities=22%  Similarity=0.329  Sum_probs=172.1

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999654 68999999987542   1234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC-
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ-  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-  630 (763)
                      |+++|+|.+++...+ .++......++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||++..+..... 
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            999999999987654 577888888999999999999   788999999999999999999999999999753310000 


Q ss_pred             ----------------------------------------ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHH
Q 046240          631 ----------------------------------------SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIET  670 (763)
Q Consensus       631 ----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~el  670 (763)
                                                              ........||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0001134689999999999999999999999999999999


Q ss_pred             HcCCCCCchhh
Q 046240          671 FTRKKPADKMF  681 (763)
Q Consensus       671 ltg~~p~~~~~  681 (763)
                      ++|+.||....
T Consensus       238 l~G~~Pf~~~~  248 (376)
T cd05598         238 LVGQPPFLADT  248 (376)
T ss_pred             hhCCCCCCCCC
Confidence            99999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.6e-35  Score=314.20  Aligned_cols=261  Identities=26%  Similarity=0.440  Sum_probs=205.6

Q ss_pred             HhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      ..+|.+.+.||+|+||.||+|...        .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            457899999999999999999642        12368999887542 33456788999999999 799999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          544 DFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      +..++++||+++|+|.+++....               ..+++..+..++.|+++||+||   |+++++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEE
Confidence            99999999999999999986421               2478889999999999999999   78899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            9999999999999987643322222222334567999999999999999999999999999998 888886532111   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                                 ....+.......   .   ...+...+.+++.+|++.+|++||++.++++.|.++....
T Consensus       245 -----------~~~~~~~~~~~~---~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         245 -----------LFKLLKEGHRMD---K---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -----------HHHHHHcCCCCC---C---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                       111111111000   0   1123456889999999999999999999999999887544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.8e-35  Score=304.31  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=203.3

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|.+.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++||||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467889999999999999999988889999999875432 2457888999999999999999999874 45789999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++... +..+++.+...++.+++.||+||   |+.+++||||||+||++++++.++|+|||++........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            999999988653 33688899999999999999999   789999999999999999999999999999987642221 1


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||++....++.++||||||+++||+++ |+.||.......              ..+.+..... .+
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~~-~~  223 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--------------VIQNLERGYR-MP  223 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--------------HHHHHHcCCC-CC
Confidence            2223345678999999988889999999999999999999 999997533211              1111111100 00


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                           .......++.+++.+|+..+|++||+++++.+.|+.
T Consensus       224 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 -----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 011224568999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-35  Score=302.35  Aligned_cols=249  Identities=32%  Similarity=0.490  Sum_probs=204.4

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|...+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999876 78999999976644 4677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++.... ..+++.....++.|++.|+.||   |+.+++||||||+||+++.++.+||+|||.++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999987644 2689999999999999999999   789999999999999999999999999999987632211  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                         ....+..|+|||++....++.++||||||+++||+++ |..||.......              ..+.+.+...  .
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~~--~  218 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------VVPHVEKGYR--M  218 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--------------HHHHHhcCCC--C
Confidence               2234667999999988889999999999999999997 999986532211              1111111100  0


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      .    ....++..+.+++.+|+..+|++||++.+++++|+.
T Consensus       219 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 E----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             C----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            0    011235678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.7e-35  Score=308.32  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=199.6

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      -|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3567788999999999999765 578899999876555566778899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|..++......+++..+..++.|+++||.||   |+.+++||||||+||+++.++.+||+|||++.......  ...
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~  160 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR  160 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence            9999998876555789999999999999999999   78899999999999999999999999999987653221  122


Q ss_pred             ccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          635 TQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ....++..|+|||++.     +..++.++|||||||++|||++|+.||........ ......               ..
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~---------------~~  224 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK---------------SE  224 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhh---------------cC
Confidence            3456889999999873     45678899999999999999999999875332111 011000               00


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+..  .........+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 PPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  001112456889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.5e-35  Score=308.31  Aligned_cols=251  Identities=27%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +.|++.+.||+|+||.||+|... +++.|++|++........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999765 58899999997666566778889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|..++......+++..+..++.|++.++.||   |+.+++||||||+||+++.++.+||+|||.+.......  ..
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cc
Confidence            99999988876555689999999999999999999   78999999999999999999999999999987643211  12


Q ss_pred             cccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          634 QTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .....++..|+|||++.     ...++.++|||||||++|||++|..||........ .......               
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~---------------  230 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKS---------------  230 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHHHhcC---------------
Confidence            23345788999999874     34568899999999999999999999865322111 1111100               


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+.  ..........+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 EPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000  0001122446889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-35  Score=309.69  Aligned_cols=270  Identities=25%  Similarity=0.413  Sum_probs=208.4

Q ss_pred             hccCcCceecccCCceEEEEEec-----CCceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeec--CCce
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-----DGIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFK  546 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  546 (763)
                      +.|...+.||+|+||.||+|...     +++.||+|++...... ..+.+.+|+++++.+.||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999753     3678999999755432 46788999999999999999999999877  5578


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++++|.+++......+++..+..++.|++.||+||   |+.+++||||||+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999987655689999999999999999999   78899999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcc-cCChhHHHHHH
Q 046240          627 GEDQSM-TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG-LLPVSLMEVVN  704 (763)
Q Consensus       627 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~i~  704 (763)
                      ...... ......++..|+|||...+..++.++||||||++++||+||+.|+................ .......+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            322211 1122345667999999988899999999999999999999999986532221110000000 00111222222


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      ....      ......+..++.+++.+|++.+|++||++.||+++|..+
T Consensus       241 ~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGER------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCCc------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111      111123456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-35  Score=313.50  Aligned_cols=260  Identities=27%  Similarity=0.454  Sum_probs=204.1

Q ss_pred             HhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      .++|.+.+.||+|+||.||+|...        ....||+|.+.... ......+.+|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            468889999999999999999642        24579999887442 33456788899999999 699999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          544 DFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      +..++||||+++|+|.+++....               ..+++.....++.|++.||.||   |+.+++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeeccccceeEEE
Confidence            99999999999999999986532               2478889999999999999999   78899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987643222111222234567999999988899999999999999999999 888886532211   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                                 ..+.+.....  ...    ...+..++.+++.+|++.+|++||++.++++.|.++...
T Consensus       245 -----------~~~~~~~~~~--~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         245 -----------LFKLLREGHR--MDK----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             -----------HHHHHHcCCC--CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                       1111111100  000    112345688999999999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3e-35  Score=313.98  Aligned_cols=241  Identities=24%  Similarity=0.306  Sum_probs=192.3

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      +|.+.+.||+|+||.||+|... +++.||+|++.....   .....+..|..++... +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999665 678999999986532   2334566788888877 5899999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|..++.... .+++..+..++.|++.||+||   |+.+|+||||||+||++++++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            9999999998886543 578889999999999999999   78899999999999999999999999999987543221 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                       .......||+.|+|||++.+..++.++|||||||++|||+||+.||........ .            ..+...... .
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~------------~~i~~~~~~-~  220 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-F------------QSIMEHNVA-Y  220 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-H------------HHHHhCCCC-C
Confidence             122345689999999999999999999999999999999999999976432211 0            111111111 1


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      +.       ....++.+++.+|++.+|++|++.
T Consensus       221 p~-------~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         221 PK-------SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CC-------cCCHHHHHHHHHHcccCHHhcCCC
Confidence            11       124457899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.4e-36  Score=317.28  Aligned_cols=238  Identities=26%  Similarity=0.356  Sum_probs=191.9

Q ss_pred             ceecccCCceEEEEEe----cCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          481 NLIGIGSFGYVYKAEL----DDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+.+|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999854    3688999999986532  234556789999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +|+|.+++.... .+++.....++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            999999886543 588999999999999999999   78899999999999999999999999999987653221  122


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD  714 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  714 (763)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||........ .            ..+..... ..+.  
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~------------~~i~~~~~-~~p~--  219 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-M------------TMILKAKL-GMPQ--  219 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-H------------HHHHcCCC-CCCC--
Confidence            345689999999999888899999999999999999999999976332111 0            11111111 1111  


Q ss_pred             HHHHHHHHHHHHHHHHHccccCcCCCCCHHH
Q 046240          715 FAAKEQCVLSIFSLAMECTMELPEKRINAKC  745 (763)
Q Consensus       715 ~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  745 (763)
                           .....+.+++..|++.||++||++.+
T Consensus       220 -----~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 -----FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -----CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                 12445789999999999999999665

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-35  Score=301.64  Aligned_cols=253  Identities=28%  Similarity=0.358  Sum_probs=204.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      ++|+..+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999664 67889999998665556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++......++......++.|++.|+.||   |+.+++||||+|+||++++++.+||+|||.+........  .
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~  157 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--K  157 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--c
Confidence            99999999877645688999999999999999999   788999999999999999999999999999876542211  1


Q ss_pred             cccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          634 QTQTLATIGYMAPEYGIER---KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .....++..|+|||...+.   .++.++|||||||++|||+||+.||............             ..... ..
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-------------~~~~~-~~  223 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-------------SKSNF-PP  223 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------HhccC-CC
Confidence            2334678899999998776   8899999999999999999999998763322111000             00000 00


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.  .........++.+++.+|+..+|++||++.+|+.
T Consensus       224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00  0111223456899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.9e-35  Score=305.68  Aligned_cols=255  Identities=26%  Similarity=0.376  Sum_probs=201.0

Q ss_pred             HHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          471 SRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       471 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      +.+++.+.....||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            44566666778999999999999965 46788999998766555667889999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-CCcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYSSTCML--DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~  626 (763)
                      +||+++++|.+++......+  +...+..++.|+++|++||   |+.+|+||||||+||+++. ++.++|+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999997654445  7788889999999999999   7889999999999999986 6799999999987654


Q ss_pred             CCCCccccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIER--KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ....  ......++..|+|||++.+.  .++.++||||||+++|||++|+.||.........  .+.            .
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~------------~  224 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFK------------V  224 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhh------------h
Confidence            3221  22234578899999987654  3788999999999999999999998653211100  000            0


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......+..    +..+..++.+++.+|++.+|++||++.++++
T Consensus       225 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         225 GMFKIHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhccCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            000011111    1123456889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=309.08  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=203.8

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|++.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467888999999999999999764 6889999999766555667888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++...+..+++.....++.|++.|+.||   |+.+|+||||||+||+++.++.++|+|||.+........  
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence            999999999877666789999999999999999999   788999999999999999999999999999876532221  


Q ss_pred             ccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          633 TQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ......++..|+|||++.     ...++.++|||||||++|||++|+.||........ ...+..               
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---------------  222 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LLKILK---------------  222 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HHHHhc---------------
Confidence            223456888999999864     34577899999999999999999999876422111 111110               


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       . ..........+...+.+++..||+.+|++||++.++++
T Consensus       223 -~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         223 -S-EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             -C-CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence             0 00001111223456889999999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.7e-35  Score=302.64  Aligned_cols=252  Identities=26%  Similarity=0.446  Sum_probs=200.9

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      ++|.+.+.||+|++|.||+|...++..||+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688889999999999999988777789999876432 22456788999999999999999999875 456889999999


Q ss_pred             CCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          555 NGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       555 ~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      +++|.+++.... ..+++..+..++.++++||.||   |+.+++||||||+||++++++.++|+|||.++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999997643 3578999999999999999999   788999999999999999999999999999987643221 11


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      .....++..|+|||+..+..++.++|||||||++|||+| |..||........              .+.+.....  +.
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--------------~~~~~~~~~--~~  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--------------LEQVERGYR--MP  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcCCC--CC
Confidence            223345678999999988899999999999999999999 8999876332211              011111000  00


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                          .....+..+.+++.+|+..+|++||++++|.+.|++
T Consensus       224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 ----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                011235668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.1e-35  Score=302.52  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=199.8

Q ss_pred             ceecccCCceEEEEEecC--C--ceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELDD--G--IEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  3  3699999986654 556788999999999999999999999988 889999999999


Q ss_pred             CChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc-cc
Q 046240          556 GSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS-MT  633 (763)
Q Consensus       556 g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~  633 (763)
                      ++|.+++.... ..+++.....++.|+++||+||   |+++++||||||+||+++.++.+||+|||+++.+...... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997754 4689999999999999999999   7899999999999999999999999999999877532221 11


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      .....++..|+|||+..+..++.++|||||||++|||++ |+.||........              .+.+.......+ 
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--------------~~~~~~~~~~~~-  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--------------LKKIDKEGERLE-  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHhcCCcCC-
Confidence            223456788999999988899999999999999999999 9999865322211              001111000000 


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                          ..+..+..+.+++.+|++.+|++||++.++++.|.+
T Consensus       222 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         222 ----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence                011235678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-35  Score=312.45  Aligned_cols=240  Identities=24%  Similarity=0.324  Sum_probs=189.7

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... +|+.||+|+++...   .........|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999765 68899999998653   12345566778888765 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .++......++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            99998886643 578889999999999999999   78899999999999999999999999999987532111  1223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||........              .+.+.......+.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~--------------~~~~~~~~~~~~~---  217 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL--------------FESIRVDTPHYPR---  217 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--------------HHHHHhCCCCCCC---
Confidence            45689999999999999999999999999999999999999975322110              1111110000111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHH-HHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAK-CCN  747 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~v~  747 (763)
                          ....++.+++.+|++.||++||++. ++.
T Consensus       218 ----~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 ----WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                1234578999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.8e-35  Score=311.41  Aligned_cols=268  Identities=19%  Similarity=0.256  Sum_probs=199.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|...+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999665 678899999874432 2334567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++ ++.+++......+++.....++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            986 78777766555678889999999999999999   789999999999999999999999999999876532221  


Q ss_pred             ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHH------
Q 046240          633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVV------  703 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i------  703 (763)
                      ......++..|+|||++.+ ..++.++|||||||++|||+||+.||.........  .........+..+..+.      
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            1223467899999998764 56889999999999999999999999764322111  11111111111111110      


Q ss_pred             HhhcCC-CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLS-PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +..... .+..-.........++.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000 000000111123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-35  Score=311.43  Aligned_cols=260  Identities=27%  Similarity=0.426  Sum_probs=204.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCc----eEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGI----EVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      .++|+..+.||+|+||.||+|... +|.    .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            456788899999999999999653 444    57889886543 23344678899999999999999999998754 467


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +++||+++|+|.+++......+++.....++.|++.||.||   |+++|+||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999999877655688999999999999999999   788999999999999999999999999999987653


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...........++..|+|||+..+..++.++|||||||++|||++ |+.||.......              ..+++...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--------------~~~~~~~~  227 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------------IPDLLEKG  227 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHCC
Confidence            332222233445778999999988899999999999999999998 899986532111              11111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .. .+..     ..+...+.+++..||..+|++||+++++++.++++..++
T Consensus       228 ~~-~~~~-----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         228 ER-LPQP-----PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CC-CCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            10 0100     112446789999999999999999999999999877664

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=318.86  Aligned_cols=248  Identities=24%  Similarity=0.400  Sum_probs=205.8

Q ss_pred             cCceecccCCceEEEEEec--CCc--eEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          479 RDNLIGIGSFGYVYKAELD--DGI--EVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       479 ~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      ..+.||+|.||.|++|.|.  +|+  .||||.+...... ...+|.+|+.+|-+++|||++++||...+ .-..||||.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4578999999999999775  343  5899999766433 67889999999999999999999999987 5678999999


Q ss_pred             CCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~-~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++|+|.+.++. ....+-......++.|||.|+.||   ..++.|||||.++|+++.....|||+|||+.+.+...+...
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            99999999987 444677788889999999999999   88999999999999999999999999999999887555433


Q ss_pred             c-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          633 T-QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       633 ~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      . .....-.+.|+|||.+....++.++|||+|||++|||+| |+.||-+.....              +-+.+|      
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------------IL~~iD------  329 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------------ILKNID------  329 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------------HHHhcc------
Confidence            3 334456788999999999999999999999999999999 889987643211              111222      


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                      ..+|....+.|.+.|.+++..||...|++||++.++.+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            2233344456899999999999999999999999998543

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-35  Score=320.56  Aligned_cols=206  Identities=24%  Similarity=0.309  Sum_probs=175.4

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD  544 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  544 (763)
                      ++....++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++..++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445689999999999999999999665 68899999987532   223455778999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..++||||+++|+|.+++...  .++......++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++.
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            999999999999999998654  377888888999999999999   789999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCCC----CCCcchhHHHHHHHHHHHHcCCCCCchh
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIER----KVSTRSDIYSYGIMLIETFTRKKPADKM  680 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slGv~l~elltg~~p~~~~  680 (763)
                      +..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            643221 122345799999999987653    3788999999999999999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-35  Score=312.60  Aligned_cols=257  Identities=30%  Similarity=0.450  Sum_probs=201.5

Q ss_pred             hccCcCceecccCCceEEEEEec-CCc--eEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGI--EVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.+.... ......+.+|++++.++ +||||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57888899999999999999764 444  46777776432 33456788899999999 899999999999999999999


Q ss_pred             EEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          550 LEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      +||+++++|.+++....               ..+++..+..++.|+++|++||   |+++++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEecCCCcE
Confidence            99999999999986432               2478889999999999999999   78999999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcc
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  693 (763)
                      ||+|||+++....   .........+..|+|||+..+..++.++|||||||++|||+| |..||........        
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------  232 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------  232 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--------
Confidence            9999999864321   111122234667999999988889999999999999999998 9999865322110        


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                            .+.+.....  ...    .......+.+++.+|++.+|++||++.++++++.++++..
T Consensus       233 ------~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         233 ------YEKLPQGYR--LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             ------HHHHhcCCc--CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                  000100000  000    0112446789999999999999999999999998887765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.9e-35  Score=318.10  Aligned_cols=267  Identities=22%  Similarity=0.282  Sum_probs=197.9

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC-----ceE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-----FKA  547 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  547 (763)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++...  .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999965 57899999988643  2234567889999999999999999999998776     789


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +|+||+.+ +|..++.... .+++..+..++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~~-~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQS-DLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeecccc-CHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            99999974 6777765433 588999999999999999999   788999999999999999999999999999987543


Q ss_pred             CCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChhHHHH--
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVSLMEV--  702 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~--  702 (763)
                      ... .......++..|+|||++.+. .++.++||||+||++|||++|+.||........  .............+...  
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            221 222345678999999988764 578999999999999999999999976432211  01111111111111110  


Q ss_pred             -HHhhcCCCccccHH------HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 -VNKTLLSPPEKDFA------AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 -i~~~l~~~~~~~~~------~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ....+...+.....      .......++.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence             11111111111000      00112456889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.6e-35  Score=316.38  Aligned_cols=243  Identities=28%  Similarity=0.332  Sum_probs=190.5

Q ss_pred             ceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHH-HHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECE-VMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|.. .+|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4689999999999965 478999999997542   123344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .+++.....++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            99988886543 588899999999999999999   78999999999999999999999999999987532111  1223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||.......             ....+....+...+.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------------~~~~~~~~~~~~~~~---  218 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-------------MYDNILHKPLVLRPG---  218 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-------------HHHHHHcCCccCCCC---
Confidence            4568999999999999999999999999999999999999997532211             011111111111111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                           ....+.+++.+|++.+|++||++++.++.+
T Consensus       219 -----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         219 -----ASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             -----CCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence                 134577899999999999999987544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.7e-35  Score=313.96  Aligned_cols=245  Identities=23%  Similarity=0.287  Sum_probs=190.3

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... +++.||+|+++...   ......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999664 68899999998653   22345678899999998 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++...+ .+++..+..++.|++.||.||   |+++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            99988886543 589999999999999999999   78999999999999999999999999999987532111  1223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||+........     .........+.+.......|.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~p~---  226 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-----DQNTEDYLFQVILEKQIRIPR---  226 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc-----cccchHHHHHHHHcCCCCCCC---
Confidence            456899999999999999999999999999999999999999642111000     000001111111111111111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                          .....+.+++.+|++.+|++||++
T Consensus       227 ----~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         227 ----SLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcCCC
Confidence                124567899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=318.33  Aligned_cols=244  Identities=26%  Similarity=0.376  Sum_probs=203.2

Q ss_pred             eecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCChhh
Q 046240          482 LIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDI  560 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  560 (763)
                      ++|+|.||+||.|+.. +...+|||.+.....+..+-+..||..-++++|.|||+++|.+.++++.-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            5999999999999654 566799999987777777888999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec-CCCcEEEeeecCceecCCCCCccccccc
Q 046240          561 FLYSSTCML--DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMTQTQT  637 (763)
Q Consensus       561 ~l~~~~~~~--~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~  637 (763)
                      .++.+-+++  +..+.--...||++||.||   |...|||||||-+||||+ -.|.+||+|||-++.+.+-+  ..+..+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence            999887766  6677777899999999999   888899999999999996 46899999999999875433  244557


Q ss_pred             cccccccCccccCCC--CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          638 LATIGYMAPEYGIER--KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       638 ~g~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      .||..|||||++..+  .|+.++|||||||++.||.||++||-........+              +--.+....|..  
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------------FkVGmyKvHP~i--  800 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------------FKVGMYKVHPPI--  800 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------------hhhcceecCCCC--
Confidence            799999999998864  58899999999999999999999997643322111              111222233332  


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ++....+...++.+|+.+||.+||++.++++
T Consensus       801 --Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 --PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             --cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence              3445667889999999999999999999986

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7e-35  Score=316.00  Aligned_cols=265  Identities=22%  Similarity=0.243  Sum_probs=196.2

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC-----
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-----  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  544 (763)
                      ..++|...+.||+|+||.||++.. .+|+.||+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999965 46899999998643  2234566788999999999999999999986543     


Q ss_pred             -ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          545 -FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       545 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                       ..++||||+++ ++...+..   .++...+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             47999999976 45555432   367888889999999999999   78899999999999999999999999999997


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc--CChhH--
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL--LPVSL--  699 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~--  699 (763)
                      .....   .......+|..|+|||.+.+..++.++|||||||++|||++|+.||........ ........  .+...  
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHHH
Confidence            64321   122345689999999999999999999999999999999999999976432211 11111100  00000  


Q ss_pred             --HHHHHhhcCCCcccc---H-------------HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 --MEVVNKTLLSPPEKD---F-------------AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 --~~~i~~~l~~~~~~~---~-------------~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ...+.......+...   .             .........+.+++.+|+..||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence              011111111111000   0             000112356789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=287.72  Aligned_cols=201  Identities=24%  Similarity=0.395  Sum_probs=173.1

Q ss_pred             HHhccCcCceecccCCceEEEE-EecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++.|++-+.||+|.|+.||+. ...+|+.+|+|++.-.  .....+.+.+|+.|.+.++||||+++.+.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4567888899999999999998 4568999999987533  234567889999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~  626 (763)
                      +|+|+|+.|..-+-.. ...+.....+...||+++|.|.   |.++|||||+||+|+++.+   ..-+|++|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999986555332 2456677888999999999999   8999999999999999953   3468999999999886


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKM  680 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~  680 (763)
                      +   .......+||++|||||++...+|+..+|||+-||+||-++.|..||.+.
T Consensus       165 ~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~  215 (355)
T KOG0033|consen  165 D---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  215 (355)
T ss_pred             C---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence            2   22345688999999999999999999999999999999999999999773

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.9e-35  Score=314.57  Aligned_cols=245  Identities=24%  Similarity=0.298  Sum_probs=189.3

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... +++.||+|++....   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 68899999998642   23345677888888877 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .+++.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            99988876543 588899999999999999999   788999999999999999999999999999875322111  223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.........     .........+.+......-|.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-----~~~~~~~~~~~i~~~~~~~p~---  226 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQNTEDYLFQVILEKQIRIPR---  226 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc-----ccccHHHHHHHHhcCCCCCCC---
Confidence            456899999999999999999999999999999999999999642111000     000000111111111111111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                          .....+.+++.+|++.||++||++
T Consensus       227 ----~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 ----SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ----CCCHHHHHHHHHHhcCCHHHcCCC
Confidence                124567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-35  Score=306.54  Aligned_cols=252  Identities=31%  Similarity=0.444  Sum_probs=198.5

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHH--HHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARA--MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      |+.++.||+|+||+||++... +++.||+|++.......  .....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999999765 56789999998664332  223456999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++.. ...++...+..++.|+++||++|   |+.+++|+||||+||++++++.++|+|||.+..+.  .....
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN  154 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred             ccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--ccccc
Confidence            99999999983 23589999999999999999999   67899999999999999999999999999998652  12223


Q ss_pred             cccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          634 QTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      .....++..|+|||+.. +..++.++||||+|+++|+|++|..||........              ...+.+.......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--------------~~~~~~~~~~~~~  220 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--------------LEIIEKILKRPLP  220 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--------------HHHHHHHHHTHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhh--------------hhhhhhccccccc
Confidence            44567899999999988 88899999999999999999999999987511110              0001111100000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ............+.+++..|++.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000001267899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-35  Score=313.76  Aligned_cols=244  Identities=28%  Similarity=0.296  Sum_probs=189.8

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHH-HHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVEC-EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||+||+|... +++.||+|++.....   .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46899999999999665 678899999975431   2223344444 456778999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .+.......++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            99999887644 467778888999999999999   78999999999999999999999999999987542211  1223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||........             ...+........+.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~i~~~~~~~~~~---  218 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------------YDNILNKPLQLKPN---  218 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-------------HHHHHhCCcCCCCC---
Confidence            45689999999999999999999999999999999999999975332110             11111111111111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                           ....+.+++.+|++.+|++||++.+.+.++.
T Consensus       219 -----~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         219 -----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             -----CCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence                 2445789999999999999999876554443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.2e-35  Score=303.38  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=189.9

Q ss_pred             ceecccCCceEEEEEecC---CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCC
Q 046240          481 NLIGIGSFGYVYKAELDD---GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      +.||+|+||.||+|...+   +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999997643   4579999886543 233457888999999999999999999999999999999999999


Q ss_pred             ChhhhhccCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          557 SLDIFLYSST----CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       557 ~L~~~l~~~~----~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +|.+++....    ...++.....++.|++.|++||   |+.+++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986532    2456777788999999999999   78899999999999999999999999999987643332222


Q ss_pred             ccccccccccccCccccCCC-------CCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          633 TQTQTLATIGYMAPEYGIER-------KVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ......++..|+|||+..+.       .++.++|||||||++|||++ |..||............             +.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-------------~~  224 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-------------VR  224 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------------hh
Confidence            22344577889999987532       35789999999999999996 99999764322211000             00


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      ......+..  .........+.+++..|+ .+|++||++++|++.|+
T Consensus       225 ~~~~~~~~~--~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         225 EQQLKLPKP--RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cccCCCCCC--ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            000000000  000112345788999999 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-35  Score=301.45  Aligned_cols=255  Identities=27%  Similarity=0.486  Sum_probs=205.7

Q ss_pred             HHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..++|.+.+.||+|+||.||+|..++++.||||.+..... ..+.+.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3568999999999999999999888888999999875432 346788999999999999999999999998999999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++++|.+++.... ..+++..+..++.+++.|+.||   |+.+++|+||||+||++++++.+|++|||.++.+..... 
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence            99999999997643 4688999999999999999999   788999999999999999999999999999987643211 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      ........+..|+|||...+..++.++||||+||+++|+++ |+.||....... ....             +...... 
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~-------------~~~~~~~-  223 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQ-------------VERGYRM-  223 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHH-------------HHcCCCC-
Confidence            11122334568999999998889999999999999999999 999986532211 1111             1111000 


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      +.     ....+..+.+++.+|+..+|++||+++++.+.|+.
T Consensus       224 ~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PR-----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CC-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            00     01124568999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.9e-35  Score=303.50  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=197.1

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999965 57889999998654 233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|..+.     .+++.....++.|++.|+.||   |+.+|+|+||||+||+++.++.++|+|||++..+...    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997553     357788889999999999999   7889999999999999999999999999999865322    


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||..........       .+....+.+..   ..+.
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~~~~~---~~~~  218 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVD---EDPP  218 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------chHHHHHHHhc---cCCC
Confidence            1233568999999999998899999999999999999999999997633221100       00111111110   0100


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ...  ......++.+++.+|++.+|++||+++++++.
T Consensus       219 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000  00123457899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8e-35  Score=301.26  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=193.9

Q ss_pred             ceecccCCceEEEEEec----CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeee-cCCceEEEEEccC
Q 046240          481 NLIGIGSFGYVYKAELD----DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCS-NDDFKALVLEYMP  554 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  554 (763)
                      +.||+|+||.||+|...    ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999653    2457999988543 2344567888999999999999999999775 4556889999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc--c
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS--M  632 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~  632 (763)
                      +++|.+++.......++.....++.++++|+.||   |+.+++||||||+||++++++.+||+|||+++.+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999976555567888889999999999999   7889999999999999999999999999998765322111  1


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcC-CCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||+..+..++.++|||||||++|||++| .+||.......                 +........+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-----------------~~~~~~~~~~  220 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-----------------ITVYLLQGRR  220 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HHHHHhcCCC
Confidence            11223456789999999888999999999999999999995 55554422111                 1111111100


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      .   ...+.++..+.+++..||+.+|++||++.++++.|++.+.
T Consensus       221 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         221 L---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             C---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            0   0011224568899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=320.96  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=217.2

Q ss_pred             cCcCceecccCCceEEEEEe-cCC----ceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDG----IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ....++||+|+||+||+|.+ +.|    -+||+|++.... .+...++..|+.+|.+++|||+++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34468899999999999944 444    368999987553 345678899999999999999999999998776 88999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      +|++.|+|.++++..+..+.....+.+..|||+||.||   |.+.+|||||.++||||.+-..+||+|||+++....+..
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            99999999999998888899999999999999999999   789999999999999999999999999999999876665


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ........-.+.|||-|.+....|+.++|||||||++||++| |..|+++...++              +.+++.     
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------------I~dlle-----  914 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------------IPDLLE-----  914 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------------hhHHHh-----
Confidence            555444455788999999999999999999999999999999 999998854332              222222     


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      . ..|.+.++.|...+..++.+||..|++.||+++++...+.++.++.
T Consensus       915 ~-geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  915 K-GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             c-cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            1 1234455567888999999999999999999999999998887764

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.5e-35  Score=309.47  Aligned_cols=249  Identities=29%  Similarity=0.337  Sum_probs=202.2

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .+|+..+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688899999999999999964 578999999987554444567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|..++...  .+++.++..++.+++.|++||   |+.+++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999988654  478999999999999999999   788999999999999999999999999999876543322  1


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||............              ..  ...+. 
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--------------~~--~~~~~-  234 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------AT--NGTPE-  234 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------Hh--cCCcc-
Confidence            23346888999999998888999999999999999999999999764322111000              00  00000 


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ..........+.+++.+||..+|++||++.++++
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             0001122446789999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-35  Score=309.45  Aligned_cols=250  Identities=27%  Similarity=0.319  Sum_probs=202.8

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36899999999999999999965 57899999998765444456788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++...  .+++.++..++.+++.||.||   |+.+++||||||+||+++.++.++|+|||.+........  
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--  170 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence            9999999998653  478889999999999999999   788999999999999999999999999999887543322  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......+++.|+|||...+..++.++|||||||++|++++|..||............+.                ...+.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~----------------~~~~~  234 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----------------NGTPE  234 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc----------------CCCCC
Confidence            12334688899999999988899999999999999999999999965322111000000                00000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ..........+.+++.+|++.+|++||+++++++
T Consensus       235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0001122455789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-34  Score=306.97  Aligned_cols=263  Identities=25%  Similarity=0.307  Sum_probs=203.2

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999654 68889999886542 33456688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++++|.+++... ..+++.....++.|+++||.||   |+ .+++||||||+||++++++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH---HhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999765 3578889999999999999999   54 58999999999999999999999999998765322   


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccC----------------
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL----------------  695 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----------------  695 (763)
                       ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......  ...+.....                
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccCCC
Confidence             1233568899999999888889999999999999999999999986432211  111111000                


Q ss_pred             -----ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          696 -----PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       696 -----~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                           +....++.+......+...+  .+....++.+++.+|+..+|++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00112222222221111100  01134568999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-35  Score=303.07  Aligned_cols=249  Identities=30%  Similarity=0.462  Sum_probs=194.5

Q ss_pred             ceecccCCceEEEEEec-CCc--eEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGI--EVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... ++.  .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999765 343  57888887432 34456788999999999 799999999999999999999999999


Q ss_pred             CChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeec
Q 046240          556 GSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG  620 (763)
Q Consensus       556 g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfg  620 (763)
                      |+|.+++....               ..+++.+...++.|++.|++||   |+.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432               2467889999999999999999   78899999999999999999999999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhH
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSL  699 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  699 (763)
                      ++.....   .........+..|+|||+.....++.++|||||||++|||++ |..||........              
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--------------  220 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------------  220 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH--------------
Confidence            9863221   111112233567999999988889999999999999999997 9999865322110              


Q ss_pred             HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       700 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      .+.+.....  ...    ...+...+.+++.+|++.+|.+||++.++++.|.++++
T Consensus       221 ~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         221 YEKLPQGYR--LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             HHHHhCCCC--CCC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence            001111000  000    01124568899999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-35  Score=293.12  Aligned_cols=207  Identities=27%  Similarity=0.360  Sum_probs=176.5

Q ss_pred             HhccCcCceecccCCceEEEEEecC-CceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      -+.|+..+.||+|.-|+||++...+ +..+|+|++.+..   .....+...|.+||+.++||.++.+|+.++.++..|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3456777899999999999998764 5889999998764   23456678899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC-
Q 046240          550 LEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG-  627 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~-  627 (763)
                      ||||+||+|....+.+. +.++...+.-.+..|+-||+||   |..|||+|||||+||||.++|++.|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999887653 4788888888899999999999   899999999999999999999999999998743310 


Q ss_pred             --------------------------------CCC---------------------ccccccccccccccCccccCCCCC
Q 046240          628 --------------------------------EDQ---------------------SMTQTQTLATIGYMAPEYGIERKV  654 (763)
Q Consensus       628 --------------------------------~~~---------------------~~~~~~~~g~~~y~aPE~~~~~~~  654 (763)
                                                      ...                     ...+...+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                     011234578999999999999999


Q ss_pred             CcchhHHHHHHHHHHHHcCCCCCchhhhh
Q 046240          655 STRSDIYSYGIMLIETFTRKKPADKMFAA  683 (763)
Q Consensus       655 ~~~~Dv~slGv~l~elltg~~p~~~~~~~  683 (763)
                      +.++|.|+|||++|||+.|..||.+....
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~  341 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK  341 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch
Confidence            99999999999999999999999885543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.1e-35  Score=305.45  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=205.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999654 68899999886542 33457788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|..++...+ .+++.....++.+++.++.|||  +..+++||||+|+||++++++.++|+|||++......    
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----  157 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----  157 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence            99999999886543 5889999999999999999995  2457999999999999999999999999998754321    


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||++.+..++.++|||||||++||+++|..||........      ....+....+.+.......+.
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD------GQDDPMGILDLLQQIVQEPPP  231 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh------hhhhhhHHHHHHHHHhhccCC
Confidence            11234689999999999888999999999999999999999999986433211      001111222333333222111


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      . .. ...+...+.+++.+|++.+|++||++.|+++.
T Consensus       232 ~-~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         232 R-LP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             C-CC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1 10 11235578899999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-35  Score=321.27  Aligned_cols=265  Identities=20%  Similarity=0.175  Sum_probs=196.6

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..+|.+.+.||+|+||.||+|... .++.||||...      ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347899999999999999999765 57889999643      23356799999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +. ++|..++......+++..+..++.|+++||.||   |+++|+||||||+|||++.++.+||+|||+++.+.......
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 688888766555789999999999999999999   78899999999999999999999999999998764332222


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhh---------hhhhhhhhcc---cCCh---
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA---------ELSLKHWVNG---LLPV---  697 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~---------~~~~~~~~~~---~~~~---  697 (763)
                      ......||..|+|||++.+..++.++|||||||++|||++|..|+......         ..........   ..+.   
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            223456999999999999999999999999999999999987664321110         0011111100   0111   


Q ss_pred             -hHHHHHHhhcC--CCcc-ccH--HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 -SLMEVVNKTLL--SPPE-KDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 -~~~~~i~~~l~--~~~~-~~~--~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       .+.........  ..+. .+.  .........+.+++.+|++.||++|||+.|+++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence             11111111000  0000 000  000112336789999999999999999999986

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.9e-35  Score=299.46  Aligned_cols=252  Identities=26%  Similarity=0.426  Sum_probs=202.3

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      .+|+..+.||+|+||.||+|...++..+|+|.+..... ....+.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46778899999999999999887788999998864422 23568889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|.+++......+++.....++.+++.+++||   |+.+++||||||+||+++.++.+||+|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            9999999876655688999999999999999999   78899999999999999999999999999988653221 1112


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....++..|+|||+..+..++.++||||||+++|||++ |..||........              .+.+.+.... ...
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--------------~~~~~~~~~~-~~~  223 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV--------------VETINAGFRL-YKP  223 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--------------HHHHhCCCCC-CCC
Confidence            23345678999999988889999999999999999998 9999875322110              0011110000 000


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      +     .....+.+++.+||+.+|++||++.+++++|.
T Consensus       224 ~-----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         224 R-----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             C-----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            1     12456899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-34  Score=299.58  Aligned_cols=249  Identities=29%  Similarity=0.413  Sum_probs=196.6

Q ss_pred             ceecccCCceEEEEEec-C---CceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-D---GIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... .   +..||+|.+..... ...+.+.+|+++++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46899999999999653 2   36899999875532 34567889999999999999999999876 4568999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc-c
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT-Q  634 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~  634 (763)
                      ++|.+++.... .+++..+..++.|+++|++||   |..+++||||||+||+++.++.+||+|||.++.+........ .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997654 688999999999999999999   788999999999999999999999999999987643322111 1


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....++..|+|||...+..++.++|||||||++|||++ |..||.......  ...+            +...   .+..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~------------~~~~---~~~~  218 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAM------------LESG---ERLP  218 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHH------------HHcC---CcCC
Confidence            12223567999999988899999999999999999998 999987643211  1111            1110   0000


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                         ....++..+.+++.+|+..+|++||++.++++.|+...
T Consensus       219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence               01123456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.6e-35  Score=299.95  Aligned_cols=248  Identities=29%  Similarity=0.422  Sum_probs=199.0

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeee-cCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS-NDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  553 (763)
                      ++|...+.||+|+||.||++... |..||+|.+....  ..+.+.+|+.++++++|+|++++++++. .++..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            57888999999999999999765 7789999886442  3456889999999999999999999764 556789999999


Q ss_pred             CCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++..... .+++.....++.+++.||+||   |+++++||||||+||++++++.+|++|||+++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            99999999876443 478899999999999999999   78999999999999999999999999999987653221   


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                        ....++..|+|||+..+..++.++|||||||++|||++ |+.||.......              ....+.+....  
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~~~--  218 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------VVPRVEKGYKM--  218 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHhcCCCC--
Confidence              12334568999999988889999999999999999998 999986532111              01111111100  


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .    ....++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       219 ~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 D----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            0    0112356788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.2e-35  Score=299.55  Aligned_cols=249  Identities=22%  Similarity=0.272  Sum_probs=200.7

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999654 6889999998643 2344567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++... ...++......++.+++.|+.||   |+.+++|+||||+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999888653 33578889999999999999999   889999999999999999999999999999987643222  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||+..+..++.++||||||+++|+|++|..||........                 +.........
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~~~  218 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-----------------ILKVCQGSYK  218 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----------------HHHHhcCCCC
Confidence            22335688899999999888899999999999999999999999975321111                 0000000000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .   ........+.+++.+||+.+|++||++.+++..
T Consensus       219 ~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 P---LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C---CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0   001124457899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.2e-35  Score=323.85  Aligned_cols=263  Identities=24%  Similarity=0.316  Sum_probs=190.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecC--------C
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND--------D  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~  544 (763)
                      ..+|.+.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            46799999999999999999966 468899999886432    2335699999999999999999876432        2


Q ss_pred             ceEEEEEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeec
Q 046240          545 FKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFG  620 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfg  620 (763)
                      ..++||||+++ ++.+++..   ....+++.....++.|+++||+||   |+.+|+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46789999986 56555532   334688999999999999999999   788999999999999999664 79999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc--ccCCh
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN--GLLPV  697 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~--~~~~~  697 (763)
                      +++.+.....   .....+++.|+|||++.+ ..++.++|||||||++|||++|.+||........ +.....  +..+.
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-LVRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCH
Confidence            9987643221   223567999999998765 4689999999999999999999999976432211 111111  11111


Q ss_pred             hHHHHHHhhcC--CCccc-----cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 SLMEVVNKTLL--SPPEK-----DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ~~~~~i~~~l~--~~~~~-----~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...........  ..+..     +...+.....++.+++.+|+..+|++|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            10000000000  00000     00001112457889999999999999999999983

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-35  Score=319.81  Aligned_cols=202  Identities=23%  Similarity=0.348  Sum_probs=173.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++..++||+|+++++++...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999664 68999999997542   223556788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++...+ .++......++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999987644 578888999999999999999   789999999999999999999999999999875432110


Q ss_pred             c---------------------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 046240          631 S---------------------------------MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPA  677 (763)
Q Consensus       631 ~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~  677 (763)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0011346899999999999999999999999999999999999999


Q ss_pred             chh
Q 046240          678 DKM  680 (763)
Q Consensus       678 ~~~  680 (763)
                      ...
T Consensus       237 ~~~  239 (360)
T cd05627         237 CSE  239 (360)
T ss_pred             CCC
Confidence            764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-34  Score=309.31  Aligned_cols=241  Identities=25%  Similarity=0.308  Sum_probs=191.9

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  550 (763)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++....   ....+.+..|..+++.+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467789999999999999965 468899999998653   223456778888888885 577888999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|..++.... .+++.....++.|++.||+||   |+++|+||||||+||++++++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999999886544 588999999999999999999   788999999999999999999999999999875432211


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||........             ...+...... .
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------------~~~i~~~~~~-~  220 (323)
T cd05615         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-------------FQSIMEHNVS-Y  220 (323)
T ss_pred             --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhCCCC-C
Confidence              22335689999999999988999999999999999999999999976432111             1111111111 1


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      +.       .....+.+++.+|++.+|++|++.
T Consensus       221 p~-------~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 PK-------SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             Cc-------cCCHHHHHHHHHHcccCHhhCCCC
Confidence            11       123457889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.8e-35  Score=311.10  Aligned_cols=237  Identities=27%  Similarity=0.332  Sum_probs=185.9

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHH-HHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECE-VMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|... +++.||+|++.....   .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 688999999975432   22334455544 57888999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      ++|...+.... .++......++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99988876543 577888888999999999999   78899999999999999999999999999987532111  1223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||........             ...+........+.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~i~~~~~~~~~~---  218 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-------------YDNILHKPLQLPGG---  218 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-------------HHHHhcCCCCCCCC---
Confidence            45689999999999988999999999999999999999999976321110             01111111111111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAK  744 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  744 (763)
                           ....+.+++.+|++.+|++||++.
T Consensus       219 -----~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 -----KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -----CCHHHHHHHHHHccCCHhhcCCCC
Confidence                 134578999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-34  Score=301.05  Aligned_cols=251  Identities=26%  Similarity=0.354  Sum_probs=188.0

Q ss_pred             eecccCCceEEEEEecC---CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCC
Q 046240          482 LIGIGSFGYVYKAELDD---GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGS  557 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  557 (763)
                      .||+|+||.||+|...+   ...+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996543   3568888775432 2345667889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          558 LDIFLYSSTC----MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       558 L~~~l~~~~~----~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      |.+++.....    ..++.....++.|++.|++||   |+.+|+||||||+||++++++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999876432    245677889999999999999   788999999999999999999999999999876433222112


Q ss_pred             cccccccccccCccccC-------CCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          634 QTQTLATIGYMAPEYGI-------ERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .....++..|+|||+..       ...++.++|||||||++|||++ |..||........ ..            ..+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~------------~~~~~  225 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LK------------QVVRE  225 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HH------------HHhhc
Confidence            23345677899999853       3456889999999999999999 7888865432211 11            11110


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      .....+.  +.....+...+.+++..|+ .||++||++++|++.|.
T Consensus       226 ~~~~~~~--~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         226 QDIKLPK--PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCccCCC--CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0000000  0111123456778888998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-34  Score=298.93  Aligned_cols=238  Identities=25%  Similarity=0.388  Sum_probs=189.9

Q ss_pred             ceecccCCceEEEEEecCCc-----------eEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          481 NLIGIGSFGYVYKAELDDGI-----------EVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      +.||+|+||.||+|...+..           .|++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999775432           5788877654332 5778899999999999999999999988 778999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-------cEEEeeecCc
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-------IAHLSDFGIA  622 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-------~~kl~Dfgla  622 (763)
                      |||+++|+|.+++......+++..+..++.|++.||+||   |+++|+||||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999987655688999999999999999999   789999999999999999887       7999999998


Q ss_pred             eecCCCCCccccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIER--KVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSL  699 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  699 (763)
                      .....      .....++..|+|||++.+.  .++.++|||||||++||+++ |..|+.......  ...+         
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~---------  218 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERF---------  218 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHH---------
Confidence            86532      2234567789999998776  78999999999999999999 577776532111  0000         


Q ss_pred             HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       700 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                         ... ....+...       ...+.+++.+|+..+|++||++.+|++.|.
T Consensus       219 ---~~~-~~~~~~~~-------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 ---YQD-QHRLPMPD-------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---Hhc-CCCCCCCC-------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               000 00011111       156889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-35  Score=322.04  Aligned_cols=266  Identities=21%  Similarity=0.210  Sum_probs=198.7

Q ss_pred             HhccCcCceecccCCceEEEEEec---CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD---DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ..+|.+.+.||+|+||.||++...   .++.||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999653   4578999987643     23467999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |++. ++|.+++.. ...+++..+..++.|++.||.||   |+++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9986 577777743 34689999999999999999999   788999999999999999999999999999987654333


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhh--hhhhhhhhc------ccCCh----h
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA--ELSLKHWVN------GLLPV----S  698 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~--~~~~~~~~~------~~~~~----~  698 (763)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...+.....      ...+.    .
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            33334567999999999999999999999999999999999999998653211  111111110      00111    0


Q ss_pred             HHHHHHhhcC-CCccc---cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          699 LMEVVNKTLL-SPPEK---DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       699 ~~~~i~~~l~-~~~~~---~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .......... ..+..   ...........+.+++.+|+..+|++||++.|+++.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1111111100 00000   000011123467889999999999999999999864

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-34  Score=303.98  Aligned_cols=249  Identities=22%  Similarity=0.295  Sum_probs=196.6

Q ss_pred             cCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      |+..+.||+|+||+||+|.. .+++.||+|.+.....   .....+.+|++++++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778999999999999966 4788999999875421   2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++++|.+++.... ..+++.....++.|++.||.||   |+.+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886532 3689999999999999999999   78999999999999999999999999999987654221  


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......|+..|+|||++.+..++.++|+|||||++|||++|..||........ .             +.+........
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~-------------~~~~~~~~~~~  221 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-R-------------EEVDRRVLETE  221 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-H-------------HHHHHhhhccc
Confidence             12234689999999999888999999999999999999999999975322110 0             01111111110


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                      ..   ........+.+++..|++.+|++||+     +.++++
T Consensus       222 ~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 EV---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             cc---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            00   00112445789999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.8e-35  Score=300.22  Aligned_cols=240  Identities=25%  Similarity=0.337  Sum_probs=190.0

Q ss_pred             ceecccCCceEEEEEecC--------CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          481 NLIGIGSFGYVYKAELDD--------GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +.||+|+||.||+|....        ..+||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999996532        335888888665555566788899999999999999999999998999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc--------EEEeeecCcee
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI--------AHLSDFGIAKL  624 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~--------~kl~Dfgla~~  624 (763)
                      +++|+|..++...+..+++.....++.|++.|++||   |+++|+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999987665789999999999999999999   7899999999999999987765        69999998865


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCC-CCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRK-KPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      ...      .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+.......              ...+
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------------~~~~  217 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------------KLQF  217 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------------HHHH
Confidence            432      123457888999999876 45789999999999999999985 5554322111              0011


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      ..... ..+.       .....+.+++.+||+.+|++||++++++++|+
T Consensus       218 ~~~~~-~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 YEDRH-QLPA-------PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHccc-cCCC-------CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11100 0111       01345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-34  Score=299.10  Aligned_cols=253  Identities=24%  Similarity=0.436  Sum_probs=203.0

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|...+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46788999999999999999988778889999887542 234678889999999999999999999887 7789999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++... ....++..+..++.+++.||.||   |+.+++||||||+||+++.++.+||+|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            999999998763 33578889999999999999999   778999999999999999999999999999987643221 1


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||++....++.++|+|||||++||++| |..||.......  ...            .+....   .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~------------~~~~~~---~  221 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR------------ALERGY---R  221 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHH------------HHhCCC---C
Confidence            2223345678999999988889999999999999999999 899987532211  111            111100   0


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      ...   .......+.+++.+|++.+|++||++.++.++|+.
T Consensus       222 ~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 MPR---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCC---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            000   01124568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.9e-35  Score=302.22  Aligned_cols=252  Identities=25%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      ++|...+.||+|+||.||+|.. .+++.||+|+++.........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            5777889999999999999965 468899999987654444566788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++...+ .++..+...++.|++.|+.||   |+.+++|+||||+||+++.++.+||+|||++.......  ..
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence            9999999886544 588999999999999999999   77899999999999999999999999999987653221  12


Q ss_pred             cccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          634 QTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .....|+..|+|||++.   ...++.++|||||||++|||++|..||................             .. .
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-------------~~-~  228 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-------------FQ-P  228 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-------------CC-C
Confidence            23456899999999874   4568899999999999999999999986532211100000000             00 0


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +..  .....+...+.+++.+|+..+|++||+++++++
T Consensus       229 ~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         229 PKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             Ccc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000  000012345789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.3e-35  Score=302.40  Aligned_cols=249  Identities=29%  Similarity=0.481  Sum_probs=195.9

Q ss_pred             ceecccCCceEEEEEecC-------CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          481 NLIGIGSFGYVYKAELDD-------GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +.||+|+||.||+|...+       ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997642       2579999876442 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-----cEEEeeecC
Q 046240          553 MPNGSLDIFLYSS------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-----IAHLSDFGI  621 (763)
Q Consensus       553 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-----~~kl~Dfgl  621 (763)
                      +++++|.+++...      ...+++..+..++.|++.|++||   |+.+++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      22478889999999999999999   788999999999999999877     899999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHH
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLM  700 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  700 (763)
                      ++...............++..|+|||++.+..++.++|||||||++|||+| |+.||........  .            
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~--~------------  223 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--L------------  223 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH--H------------
Confidence            876543322222233445788999999999999999999999999999998 9999865322110  0            


Q ss_pred             HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       701 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      ..+....      +.......+..+.+++.+||..+|++||++.++++.|++
T Consensus       224 ~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         224 QHVTAGG------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHhcCC------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0111000      000111235568899999999999999999999998864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=301.36  Aligned_cols=248  Identities=27%  Similarity=0.315  Sum_probs=202.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|+..+.||.|++|.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999664 68899999987543 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++...  .+++.....++.|++.|+.||   |+.+++||||+|+||++++++.++|+|||+++.+....  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999998765  588999999999999999999   78899999999999999999999999999998875332  1


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||++.+..++.++|||||||++|||+||+.||........              ...+.....  +.
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--------------~~~~~~~~~--~~  217 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--------------LFLIPKNNP--PS  217 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--------------HHHhhhcCC--CC
Confidence            22345678899999999988899999999999999999999999975332111              011111111  11


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...   ......+.+++..|+..+|++||+++++++
T Consensus       218 ~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             Ccc---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            000   003456889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=310.69  Aligned_cols=202  Identities=23%  Similarity=0.313  Sum_probs=173.7

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999764 68999999997532   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++......++...+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999999976555688889999999999999999   889999999999999999999999999999877643222


Q ss_pred             ccccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCchh
Q 046240          631 SMTQTQTLATIGYMAPEYGIE-----RKVSTRSDIYSYGIMLIETFTRKKPADKM  680 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~  680 (763)
                       .......||+.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence             12233468999999998763     45788999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.3e-34  Score=295.58  Aligned_cols=249  Identities=23%  Similarity=0.297  Sum_probs=202.6

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|+..+.||.|+||.||.+.. .+++.+++|.+...  .....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999854 46889999988643  234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++++|.+++... ...+++.....++.|+++++.||   |+.+++||||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 34688999999999999999999   788999999999999999999999999999987643321 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......++..|+|||+..+..++.++||||||+++|||++|..||.......             ...++........ 
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------------~~~~~~~~~~~~~-  221 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------------LVVKIVQGNYTPV-  221 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-------------HHHHHHcCCCCCC-
Confidence             2234568899999999988888999999999999999999999986532211             1111111111100 


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                            .......+.+++.+|+..+|++||++.++++.
T Consensus       222 ------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                  01234568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-34  Score=299.70  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=200.0

Q ss_pred             ccCcCceecccCCceEEEEEecCCceEEEEEeehhh------HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC------ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      +|...+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999988889999999886321      23345688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +||+++++|.+++.... .+++..+..++.|++.|++||   |+.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997643 578888899999999999999   78899999999999999999999999999987653211


Q ss_pred             C----ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          630 Q----SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       630 ~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .    ........++..|+|||+..+..++.++|||||||++|||++|+.||..........             .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-------------~~~~~  223 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-------------YIGAH  223 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-------------Hhhhc
Confidence            1    111223468899999999998889999999999999999999999997532211100             00000


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      . ...+..    ......++.+++.+|++.+|++||++.++++
T Consensus       224 ~-~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         224 R-GLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             c-CCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0 000110    0112456789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.7e-34  Score=299.92  Aligned_cols=248  Identities=26%  Similarity=0.335  Sum_probs=202.2

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..|+..+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999764 68899999987542 34567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++...  .++..+...++.+++.|++|+   |+.+++|+||+|+||+++.++.++++|||++........  
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            9999999988653  478888999999999999999   789999999999999999999999999999977643221  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||.........              ..+..   ..+ 
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------------~~~~~---~~~-  218 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--------------FLIPK---NNP-  218 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--------------hhhhc---CCC-
Confidence            223346788999999998888999999999999999999999998753322110              00000   000 


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                        ......+...+.+++..||+.+|++||++.++++.
T Consensus       219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 --PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence              11122345678899999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=308.19  Aligned_cols=251  Identities=24%  Similarity=0.296  Sum_probs=207.3

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHH---HHHHHHHHHHHHHhCC-CCccceEEeeeecCCceE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR---AMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  547 (763)
                      ..+.|+..+.||+|.||.||++... +|+.+|+|++.+....   ......+|+.+|+++. |||||.+++.|......+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567888999999999999999766 5999999999766432   3468899999999998 999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC----CcEEEeeecCce
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED----MIAHLSDFGIAK  623 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~  623 (763)
                      +|||++.||.|.+.+...  .++......++.|++++++|+   |+.+|+|||+||+|+|+...    +.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999998776  288899999999999999999   88999999999999999643    579999999999


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      ....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... .            +.
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~------------i~  251 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A------------IL  251 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H------------HH
Confidence            8764   234456789999999999999999999999999999999999999998754332211 1            11


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....    ......-+.......+++..++..||.+|+++.++++
T Consensus       252 ~~~~----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  252 RGDF----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             cCCC----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1111    1101111123556788999999999999999999987

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.6e-35  Score=315.34  Aligned_cols=267  Identities=22%  Similarity=0.213  Sum_probs=196.6

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC------
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSND------  543 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  543 (763)
                      ..++|...+.||+|+||.||++.. ..++.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999965 46889999998743  223456677899999999999999999988543      


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      ...++||||+++ ++...+..   .+++..+..++.|+++||.||   |+++|+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            357999999976 55555532   377888889999999999999   78999999999999999999999999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCCh----
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPV----  697 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~----  697 (763)
                      .....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||.........  .........++    
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            65322   1223456899999999999989999999999999999999999999753221110  00001111111    


Q ss_pred             ---hHHHHHHhhcCCC----c----c----ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          698 ---SLMEVVNKTLLSP----P----E----KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       698 ---~~~~~i~~~l~~~----~----~----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                         .....+...-...    +    .    ............+.+++.+|++.||++|||+.|+++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               1111111100000    0    0    0000001123467899999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=311.87  Aligned_cols=267  Identities=23%  Similarity=0.261  Sum_probs=196.7

Q ss_pred             HHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecC----
Q 046240          471 SRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSND----  543 (763)
Q Consensus       471 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  543 (763)
                      ....++|...+.||+|+||.||+|.. .+++.||||++.....  ...+.+.+|++++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34568899999999999999999965 5788999999875422  2345677899999999999999999987543    


Q ss_pred             --CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          544 --DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       544 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                        ...++++|++ +++|..++...  .++...+..++.|+++||.||   |+.+|+||||||+||++++++.+||+|||+
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence              3568999988 77888877543  488999999999999999999   788999999999999999999999999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChh
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVS  698 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~  698 (763)
                      ++.....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........  ..........+..
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9875422     233568999999999876 5789999999999999999999999965322111  1111111111110


Q ss_pred             HHHH----HHhh---cCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 LMEV----VNKT---LLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ~~~~----i~~~---l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...+    ..+.   +...+..... ........+.+++.+|+..||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1000    0000   1111111000 00112335789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-34  Score=306.24  Aligned_cols=268  Identities=20%  Similarity=0.243  Sum_probs=200.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57889999999999999999664 68899999986442 22334567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++ ++|..++......+++.....++.|+++||+||   |+.+|+||||||+||++++++.+||+|||++........  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            97 488888876555688999999999999999999   789999999999999999999999999999876432221  


Q ss_pred             ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHHHhhcCC
Q 046240          633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........  ............+..+....-..
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            1223457889999998765 45788999999999999999999999764332111  11111111111111111110000


Q ss_pred             ---Ccccc----HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 ---PPEKD----FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ---~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         .+...    ..........+.+++.+|++.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               01000    0011123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-34  Score=303.72  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=198.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999765 7899999988654 233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSS--TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      +++++|..++...  ...+++.....++.++++|+.|||  ++.+++||||||+||+++.++.+||+|||.+..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999988764  226899999999999999999995  2468999999999999999999999999998765322  


Q ss_pred             ccccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          631 SMTQTQTLATIGYMAPEYGIER------KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                        ......++..|+|||++.+.      .++.++|||||||++|||++|+.||.......              ....+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------------~~~~~~  220 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--------------IFAQLS  220 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--------------HHHHHH
Confidence              12234578899999987543      35789999999999999999999986522111              001111


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......+...   ...+...+.+++.+|+..+|++||++.++++
T Consensus       221 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         221 AIVDGDPPTL---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHhhcCCCCC---CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1111111111   1124566889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.1e-35  Score=303.88  Aligned_cols=248  Identities=26%  Similarity=0.332  Sum_probs=199.8

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            3466678899999999999965 467899999987442 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++...  .+++..+..++.++++|+.||   |+++++|+||+|+||++++++.++++|||++..+.....  
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06642          84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence            9999999988653  478889999999999999999   789999999999999999999999999999887643221  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.|+........  ..            .+....  .+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~------------~~~~~~--~~~  220 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LF------------LIPKNS--PPT  220 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hh------------hhhcCC--CCC
Confidence            22334578899999999988899999999999999999999999865322110  00            000000  000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                          ....+...+.+++.+|++.+|++||++.++++.
T Consensus       221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 ----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                011234568899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-36  Score=312.46  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=206.6

Q ss_pred             hccCcCceecccCCceEEEEEecC-CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +-|.++.-+|.|+||.||+|...+ +...|.|++........+++.-||+||..++||+||++++.|...+.++|..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            345566779999999999997664 4556788887777778899999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      .||.++.++-.-+..+...++..+++|++.||.||   |+++|||||||+.|||++-+|.++++|||.+.....  ....
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK  186 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence            99999999887777899999999999999999999   899999999999999999999999999999765321  1123


Q ss_pred             cccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          634 QTQTLATIGYMAPEYG-----IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      ...+.||++|||||+.     ...+|+.++||||||++|.||..+.+|.........                 +-+.-.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-----------------llKiaK  249 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----------------LLKIAK  249 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-----------------HHHHhh
Confidence            4567899999999975     467899999999999999999999999766432221                 111111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..|. ....+..+...+.+++.+|+..+|..||+++++++
T Consensus       250 SePP-TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  250 SEPP-TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCCC-cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1111 12223345677999999999999999999999875

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2e-34  Score=308.04  Aligned_cols=244  Identities=24%  Similarity=0.284  Sum_probs=190.1

Q ss_pred             ceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||+||+|... +++.||+|++....   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999664 67899999998653   23345678899999888 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99988876543 588999999999999999999   78899999999999999999999999999987532211  1223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.........       .......+.+.......|.   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-------~~~~~~~~~~~~~~~~~p~---  224 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-------NTEDYLFQVILEKPIRIPR---  224 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-------ccHHHHHHHHHhCCCCCCC---
Confidence            456899999999999999999999999999999999999999642211000       0000111111111111111   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAK  744 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  744 (763)
                          .....+.+++.+|+..||++||++.
T Consensus       225 ----~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         225 ----FLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcCCCC
Confidence                1234578999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.3e-34  Score=301.61  Aligned_cols=250  Identities=22%  Similarity=0.302  Sum_probs=197.6

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .|+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++|++|+++++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999654 78999999987542   1223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+++++|.+++.... ..++......++.|++.||.||   |+.+|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999998885432 3588889999999999999999   78999999999999999999999999999987654222 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .         .....++...-...
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~---------~~~~~~~~~~~~~~  224 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-R---------EEVERLVKEVQEEY  224 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-H---------HHHHhhhhhhhhhc
Confidence              11234689999999999998999999999999999999999999975321100 0         00011111000000


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                             .......+.+++..|++.+|++||+     +.|+++
T Consensus       225 -------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 -------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                   0112445789999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-34  Score=299.99  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=198.6

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---------HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---------ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      +|.+.+.||+|++|.||+|.. .+++.||+|.+....         ....+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999965 468899999886331         1223568889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++|+||+++++|..++.... .++......++.|++.|++||   |+.+++||||+|+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997643 578888899999999999999   7889999999999999999999999999998876


Q ss_pred             CCCCCc----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          626 SGEDQS----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       626 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      ......    .......++..|+|||.+.+..++.++|||||||++|||++|+.||........             ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------------~~~  223 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------------IFK  223 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-------------HHH
Confidence            422111    111223578899999999888899999999999999999999999976322111             001


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +..   ...+..    .......+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~---~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 IGE---NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             Hhc---cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111   001110    1123456889999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=293.70  Aligned_cols=247  Identities=27%  Similarity=0.357  Sum_probs=208.8

Q ss_pred             cCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      |.+++++|+|+||.||+|.+ .+|+.||||.+.-+  .+.+++..|+.++++++.|++|++||.|.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            55678999999999999955 57999999988644  4578889999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+..++++..++.+...++..|....+.||+||   |...-+|||||+.|||++.+|.+|++|||.|..+.+  .-....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YL---H~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYL---HDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHH---HHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            999999998888999999999999999999999   555679999999999999999999999999976532  122345


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...||+.|||||++..-.|+.++||||+|++..||.-|++||.+......-+                  ++-..|...+
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------------MIPT~PPPTF  249 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------------MIPTKPPPTF  249 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------------eccCCCCCCC
Confidence            5679999999999999999999999999999999999999998743321100                  1112233334


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..++....++.+++..|+-..|++|-|+.++++
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            445667888999999999999999999887765

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-34  Score=315.05  Aligned_cols=265  Identities=22%  Similarity=0.206  Sum_probs=196.6

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC------
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND------  543 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  543 (763)
                      ..++|...+.||+|+||.||++... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999654 68899999987532  23456678899999999999999999987543      


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      ...|+||||+++ ++...+..   .+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999976 56665543   367888899999999999999   88999999999999999999999999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc--CChhHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL--LPVSLME  701 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~  701 (763)
                      .....   .......++..|+|||++.+..++.++|||||||++|||++|+.||........ ........  .......
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence            65322   122345689999999999999999999999999999999999999976432211 11111110  0011111


Q ss_pred             H----HHhhcCCCccc-c---------------HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 V----VNKTLLSPPEK-D---------------FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~----i~~~l~~~~~~-~---------------~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .    +.......+.. .               ..........+.+++.+|++.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1    11111000100 0               0000011346789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.9e-34  Score=298.92  Aligned_cols=253  Identities=25%  Similarity=0.297  Sum_probs=204.2

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|+..+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999765 68999999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++++|.+++......++......++.|+++|++||   |+ .+++||||||+||++++++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            999999999987645788889999999999999999   78 8999999999999999999999999999876532111 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                         ....++..|+|||+..+..++.++||||||+++|+|++|+.||.......            ....+.+.......+
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~  221 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP------------DGIFELLQYIVNEPP  221 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc------------ccHHHHHHHHhcCCC
Confidence               12567889999999998899999999999999999999999987642211            111222222222211


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .....  ......+.+++..|+..+|++||++.++++
T Consensus       222 ~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 PRLPS--GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCCh--hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            11111  114566899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5e-34  Score=294.37  Aligned_cols=250  Identities=30%  Similarity=0.540  Sum_probs=200.6

Q ss_pred             cCcCceecccCCceEEEEEecC-----CceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          477 FGRDNLIGIGSFGYVYKAELDD-----GIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      |++.+.||.|+||.||++...+     +..||+|++...... ..+.+..|+.+++.++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999997753     378999998755432 5678889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCM-LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      ||+++++|.+++...... +++.....++.|++.|++||   |+.+++||||||+||++++++.++++|||.++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765443 89999999999999999999   88899999999999999999999999999998765432


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .... ....++..|+|||...+..++.++||||+|++++||++ |..||.......              ..+.+.....
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~~  222 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--------------VLEYLKKGYR  222 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHhcCCC
Confidence            2211 12336789999999988889999999999999999999 788876522111              1111111110


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                      . +.     .......+.+++.+|+..+|++|||+.++++.|
T Consensus       223 ~-~~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 L-PK-----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C-CC-----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0 00     011355689999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.7e-35  Score=303.17  Aligned_cols=251  Identities=24%  Similarity=0.299  Sum_probs=196.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecC------C
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSND------D  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~  544 (763)
                      +++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            5677888999999999999999654 68899999986543 2345678899999998 699999999998653      4


Q ss_pred             ceEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          545 FKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      ..++||||+++++|.+++.... ..+++.....++.|++.|++||   |+++|+||||||+||++++++.++|+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6789999999999999987643 3678899999999999999999   77899999999999999999999999999988


Q ss_pred             ecCCCCCccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChh
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      ......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||...........          
T Consensus       160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----------  227 (272)
T cd06637         160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----------  227 (272)
T ss_pred             eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----------
Confidence            653221  1223456889999999875     34678899999999999999999999865322111100          


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          ..........     ...+...+.+++.+||..+|++||++.++++
T Consensus       228 ----~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         228 ----IPRNPAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ----HhcCCCCCCC-----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                0000000000     0112456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.7e-34  Score=307.27  Aligned_cols=266  Identities=22%  Similarity=0.264  Sum_probs=194.4

Q ss_pred             cCceeccc--CCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          479 RDNLIGIG--SFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       479 ~~~~lg~G--~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +.++||+|  +|++||++.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  6789999965 578999999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++|+|.+++... ...+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.++++||+.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998653 23588999999999999999999   78899999999999999999999999998654332111100


Q ss_pred             -----ccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh-------h
Q 046240          633 -----TQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV-------S  698 (763)
Q Consensus       633 -----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~  698 (763)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .....+.       .
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccchh
Confidence                 1122356778999999875  46899999999999999999999999764322211111 1111110       0


Q ss_pred             HHHHHHhhcCC---------------Cc-c---ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 LMEVVNKTLLS---------------PP-E---KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ~~~~i~~~l~~---------------~~-~---~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..++..+....               .+ .   ............+.+++..|++.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00000000000               00 0   000011123457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3e-34  Score=321.52  Aligned_cols=273  Identities=22%  Similarity=0.237  Sum_probs=195.3

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCC------CccceEEeeee
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRH------RNLVKIISGCS  541 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~  541 (763)
                      ++....++|.+.+.||+|+||+||+|.. .+++.||||+++... ........|+++++.++|      ++++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3344568899999999999999999965 467889999986432 223445667777777654      45888999887


Q ss_pred             cC-CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCC-------
Q 046240          542 ND-DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDM-------  612 (763)
Q Consensus       542 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~-------  612 (763)
                      .. .+.++|||++ +++|.+++...+ .+++..+..|+.|++.||.||   |+ .+||||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yL---H~~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYF---HTELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhcCCeecCCCCHHHEEEecCCccccccc
Confidence            65 5788999988 667887776543 588999999999999999999   54 6999999999999998765       


Q ss_pred             ---------cEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhh
Q 046240          613 ---------IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA  683 (763)
Q Consensus       613 ---------~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~  683 (763)
                               .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     499999998764321     223467899999999999999999999999999999999999999764321


Q ss_pred             hh-hhhhhhcccCChhH---------HHHHHhhcCCCccccH-----------HHHHHHHHHHHHHHHHccccCcCCCCC
Q 046240          684 EL-SLKHWVNGLLPVSL---------MEVVNKTLLSPPEKDF-----------AAKEQCVLSIFSLAMECTMELPEKRIN  742 (763)
Q Consensus       684 ~~-~~~~~~~~~~~~~~---------~~~i~~~l~~~~~~~~-----------~~~~~~~~~l~~l~~~cl~~~P~~Rps  742 (763)
                      +. .......+..+..+         .++.+......+....           .........+.+++..|++.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            11 11111111222211         1111111100000000           000011345789999999999999999


Q ss_pred             HHHHHH--HHhh
Q 046240          743 AKCCNF--VLCE  752 (763)
Q Consensus       743 ~~~v~~--~L~~  752 (763)
                      ++|+++  .+.+
T Consensus       432 a~e~L~Hp~~~~  443 (467)
T PTZ00284        432 ARQMTTHPYVLK  443 (467)
T ss_pred             HHHHhcCccccc
Confidence            999986  4444

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-34  Score=303.86  Aligned_cols=266  Identities=25%  Similarity=0.287  Sum_probs=191.5

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhC---CCCccceEEeeeec-----CC
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNI---RHRNLVKIISGCSN-----DD  544 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~  544 (763)
                      +|++.+.||+|+||+||+|... +++.||+|.+.....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888899999999999999654 689999998864321  1223455677766655   79999999998854     24


Q ss_pred             ceEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          545 FKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      ..++||||+++ +|..++.... ..+++..+..++.|++.||.||   |+.+++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999985 7877776532 3588999999999999999999   78899999999999999999999999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLME  701 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~  701 (763)
                      ......   ......++..|+|||++.+..++.++||||+||++|||++|++||.........  ............+..
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            764221   223346789999999998889999999999999999999999998654322111  111110000000000


Q ss_pred             HH---HhhcCCCcccc-HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VV---NKTLLSPPEKD-FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i---~~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   ........... ..........+.+++.+|++.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00   00000000000 0011123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.4e-34  Score=293.95  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=201.3

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|+..+.||+|+||.+|++.. .+|+.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            578899999999999999955 468999999987542  33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++++|.+++.... ..+++.....++.|++.|+.||   |+.+++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999886543 3578889999999999999999   788999999999999999999999999999987643221 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......++..|+|||+..+..++.++|||||||+++||++|+.||......                 +.+.+.+....
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----------------~~~~~~~~~~~  218 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----------------NLVLKIIRGSY  218 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----------------HHHHHHhcCCC
Confidence             122345788899999998888999999999999999999999998653221                 11111111111


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   ....+...+.+++.+|++.+|++||++.+|++
T Consensus       219 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         219 PP---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CC---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            10   01123456899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-34  Score=300.20  Aligned_cols=267  Identities=22%  Similarity=0.265  Sum_probs=196.3

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|+..+.||+|++|.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999764 68999999986432  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSST--CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ++ ++|.+++....  ..+++..+..++.|+++||.||   |+.+++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 57877775422  4688999999999999999999   78899999999999999999999999999987653221 


Q ss_pred             ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh--hhhcccCChhH---HHHH-
Q 046240          631 SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK--HWVNGLLPVSL---MEVV-  703 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~---~~~i-  703 (763)
                       .......++..|+|||++.+ ..++.++|||||||++|||+||+.||...........  ...........   ...- 
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             12233457889999998765 4578899999999999999999999975332211110  00000000000   0000 


Q ss_pred             -HhhcCCCcccc-HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 -NKTLLSPPEKD-FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 -~~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ........... .........++.+++.+|+..||++|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00000000000 0001113456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-34  Score=310.01  Aligned_cols=201  Identities=22%  Similarity=0.300  Sum_probs=173.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||++... +++.||+|++....   ......+..|+.++..++|++|+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999765 67889999987532   223455788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|..++......+++.....++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999987555688888999999999999999   789999999999999999999999999999987643222


Q ss_pred             ccccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          631 SMTQTQTLATIGYMAPEYGIE-----RKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                       .......|++.|+|||++.+     +.++.++|||||||++|||++|+.||..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence             12233568999999998765     5678899999999999999999999965

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.5e-34  Score=297.39  Aligned_cols=254  Identities=26%  Similarity=0.366  Sum_probs=197.6

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh----------HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC----------ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD  544 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  544 (763)
                      +|...+.||+|+||.||+|.. .+|+.||+|.++...          ....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477789999999999999965 468999999875321          112346788999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..++||||+++++|.+++.... .+++..+..++.|++.|+.||   |+.+++||||+|+||+++.++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987653 688889999999999999999   788999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERK--VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      ..............++..|+|||......  ++.++||||||+++||+++|..||.........             .++
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------------~~~  224 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM-------------FKL  224 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH-------------HHh
Confidence            54222111223345788999999877644  789999999999999999999998653221110             000


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......  +.........+...+.+++..|+..+|++||++.+|++
T Consensus       225 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         225 GNKRSA--PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             hccccC--CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            000000  00000011123567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-34  Score=303.54  Aligned_cols=267  Identities=21%  Similarity=0.227  Sum_probs=196.6

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|+..+.||+|+||.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999664 68999999986432  12235677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++ +|.+++......+++.....++.|+++||.||   |+.+++||||||+||+++.++.+||+|||+++.+.....  
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            975 77777765555689999999999999999999   788999999999999999999999999999886542221  


Q ss_pred             ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcc--cCChh-HH---HHHHh
Q 046240          633 TQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG--LLPVS-LM---EVVNK  705 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~-~~---~~i~~  705 (763)
                      ......++..|+|||++.+. .++.++|||||||++|||+||..|+.........+......  ..+.. ..   +..+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            22334578899999987664 47899999999999999999998864322221111111100  00110 00   00000


Q ss_pred             hcCCCccccH---HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDF---AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..........   ........++.+++.+|++.+|++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000000   001123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-34  Score=304.12  Aligned_cols=249  Identities=25%  Similarity=0.285  Sum_probs=198.7

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      .|.....||+|+||.||++... ++..||||++........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444567999999999999654 688999999876555556778899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|.+++...  .+++.....++.|++.|+.||   |+.+|+||||||+||++++++.++|+|||++........  ..
T Consensus       103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  175 (292)
T cd06658         103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR  175 (292)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence            99999988553  478899999999999999999   788999999999999999999999999999876532221  12


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD  714 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  714 (763)
                      ....++..|+|||+..+..++.++||||||+++|||++|+.||........ .             ..+.......... 
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~-------------~~~~~~~~~~~~~-  240 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-M-------------RRIRDNLPPRVKD-  240 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H-------------HHHHhcCCCcccc-
Confidence            335688999999999888899999999999999999999999865322110 0             0111111111000 


Q ss_pred             HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          715 FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       715 ~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                         .......+.+++..|+..+|++||+++++++.
T Consensus       241 ---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 ---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               01124457889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.9e-34  Score=299.37  Aligned_cols=255  Identities=23%  Similarity=0.380  Sum_probs=202.3

Q ss_pred             hccCcCceecccCCceEEEEEec------CCceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      ++|...+.||+|+||.||+|...      +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999753      3467999988654333 4567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeee
Q 046240          548 LVLEYMPNGSLDIFLYSST--------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987543        1578999999999999999999   7889999999999999999999999999


Q ss_pred             cCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChh
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      |++....... ........++..|+|||.+.+..++.++||||||+++||+++ |..||........ .           
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-~-----------  228 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-L-----------  228 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-H-----------
Confidence            9987543221 112233456778999999888888999999999999999999 7888865322110 0           


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                       ............      ...++..+.+++.+|++.+|++||++.+++++|.+
T Consensus       229 -~~~~~~~~~~~~------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         229 -NRLQAGKLELPV------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -HHHHcCCcCCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence             001001110000      11234578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-34  Score=303.00  Aligned_cols=260  Identities=23%  Similarity=0.290  Sum_probs=199.5

Q ss_pred             ChHHHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeee--
Q 046240          466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCS--  541 (763)
Q Consensus       466 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--  541 (763)
                      .++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3455566788999999999999999999965 468899999876432 2235677899999999 6999999999884  


Q ss_pred             ---cCCceEEEEEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEE
Q 046240          542 ---NDDFKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH  615 (763)
Q Consensus       542 ---~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~k  615 (763)
                         .++..++||||+++++|.+++..   ....+++..+..++.|+++|+.||   |+.+++||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEEECCCCCEE
Confidence               34568999999999999988753   233578888999999999999999   788999999999999999999999


Q ss_pred             EeeecCceecCCCCCccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh
Q 046240          616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW  690 (763)
Q Consensus       616 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~  690 (763)
                      |+|||+++.+.....  ......|+..|+|||++.     +..++.++|||||||++|||++|+.||........ ....
T Consensus       165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~  241 (286)
T cd06638         165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKI  241 (286)
T ss_pred             EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhc
Confidence            999999887643221  223346889999999875     34578899999999999999999999865322110 0000


Q ss_pred             hcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          691 VNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       691 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .                 ............+...+.+++.+|++.+|++||++.|+++.
T Consensus       242 ~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 P-----------------RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             c-----------------ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0                 00000000001123458899999999999999999999863

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-34  Score=308.68  Aligned_cols=202  Identities=22%  Similarity=0.295  Sum_probs=172.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||++... +++.||+|++.+..   ......+..|+.++..++|++|+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999765 57889999987532   223445788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++......+++.....++.|++.|+.||   |+.+|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999977555688888999999999999999   788999999999999999999999999999876532221


Q ss_pred             ccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchh
Q 046240          631 SMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKM  680 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~  680 (763)
                       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence             1223457899999999875     346788999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-35  Score=302.53  Aligned_cols=253  Identities=21%  Similarity=0.271  Sum_probs=201.9

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ...|++.+.||+||.+.||++...+.+.+|+|++...  ..+....|..|+..|.+++ |.+|+++++|-..++..||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3568899999999999999999988888998876432  3456788999999999995 999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||= ..+|..++.......+...+..+..|++.|+.++   |+.||||.||||.|+|+-. |.+||+|||+|..+..+..
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence            975 4489999988766555346778999999999999   8899999999999999864 5899999999999887766


Q ss_pred             ccccccccccccccCccccCCC-----------CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhH
Q 046240          631 SMTQTQTLATIGYMAPEYGIER-----------KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSL  699 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  699 (763)
                      ......-+||+.||+||.+...           .++.++||||+||+||+|+.|+.||.........+.....+.     
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~-----  589 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN-----  589 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC-----
Confidence            6666778899999999976432           256789999999999999999999987433222222211110     


Q ss_pred             HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                                 .+..+.... ...++.++|..|+..||.+||+..++++
T Consensus       590 -----------~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  590 -----------HEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -----------ccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                       111111000 0223899999999999999999999986

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.8e-34  Score=308.40  Aligned_cols=195  Identities=28%  Similarity=0.388  Sum_probs=168.2

Q ss_pred             hccCcCceecccCCceEEEE-EecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-C-----CccceEEeeeecCCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-H-----RNLVKIISGCSNDDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~  547 (763)
                      .+|++.+.||+|.||.|-+| +..+++.||||+++... ....+...|+.+|..++ |     -|+|++++||...++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            38999999999999999999 45679999999997653 33455677999999996 4     38999999999999999


Q ss_pred             EEEEccCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC--CcEEEeeecCcee
Q 046240          548 LVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED--MIAHLSDFGIAKL  624 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~  624 (763)
                      ||+|.+.. +|++++..... .++...+..++.||+.||.+|   |+.+|||+||||+|||+.+-  ..+||+|||.|+.
T Consensus       265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            99998854 99999987543 688999999999999999999   78999999999999999643  4799999999997


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      ....-.     ...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            642221     34567889999999999999999999999999999999877755

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.3e-34  Score=303.89  Aligned_cols=194  Identities=23%  Similarity=0.332  Sum_probs=157.9

Q ss_pred             CceecccCCceEEEEEec---CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec--CCceEEEEEccC
Q 046240          480 DNLIGIGSFGYVYKAELD---DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFKALVLEYMP  554 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  554 (763)
                      +++||+|+||+||+|...   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999754   46789999986442  22456789999999999999999998854  456889999986


Q ss_pred             CCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe----cCCCcEEEeeecCc
Q 046240          555 NGSLDIFLYSS--------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIA  622 (763)
Q Consensus       555 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla  622 (763)
                      + +|..++...        ...++......++.|++.||.||   |+.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 776665421        12478888999999999999999   78999999999999999    45678999999999


Q ss_pred             eecCCCCCc-cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          623 KLLSGEDQS-MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       623 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      +.+...... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            876432221 12234578999999998876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4e-34  Score=296.74  Aligned_cols=254  Identities=28%  Similarity=0.335  Sum_probs=202.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|++.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999754 68899999986432 23567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSST--CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      +++++|.+++....  ..+++.....++.|++.|++||   |+.+++||||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987632  3578999999999999999999   789999999999999999999999999999877653332


Q ss_pred             cc--ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          631 SM--TQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       631 ~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..  ......++..|+|||++... .++.++|||||||++|||++|+.||........ ......               
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~---------------  221 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQ---------------  221 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhc---------------
Confidence            21  22334688999999998776 789999999999999999999999976422111 111111               


Q ss_pred             CCCcc-ccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPE-KDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~-~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ..+. .... ........+.+++..|++.+|++||++.++++
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         222 -NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             -CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             0110 0000 01123566889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-34  Score=311.76  Aligned_cols=263  Identities=20%  Similarity=0.217  Sum_probs=193.9

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ...+|.+.+.||+|+||.||+|... +++.||+|+....      ....|+.++++++||||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999765 5778999975432      23468999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+. ++|.+++......+++..+..++.|++.||.||   |+++|+||||||+||+++.++.+||+|||+++......  
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            995 578888776666789999999999999999999   78899999999999999999999999999987532111  


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC-chhhhh--------hhhhhhhhc------ccCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPA-DKMFAA--------ELSLKHWVN------GLLP  696 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~-~~~~~~--------~~~~~~~~~------~~~~  696 (763)
                       ......||..|+|||++.+..++.++|||||||++|||+++..|+ ......        ...+.....      ...+
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence             223356899999999999999999999999999999999965554 321110        001111100      0011


Q ss_pred             h-----hHHHHHH-hhcCCCccccHHHH--HHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 V-----SLMEVVN-KTLLSPPEKDFAAK--EQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~-----~~~~~i~-~~l~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .     ....+++ ....+.+..+....  ........+++.+|++.||++|||+.||++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            0     0111111 11111111111111  112345667999999999999999999875

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.9e-34  Score=292.38  Aligned_cols=246  Identities=31%  Similarity=0.506  Sum_probs=197.9

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      ++|.+.+.||+|+||.||++.. +++.||+|.+....  ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999975 57889999986543  235678899999999999999999998765 4799999999


Q ss_pred             CCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          555 NGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       555 ~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      +++|.+++.... ..+++..+..++.|++.|+.||   |+.+++||||||+||+++.++.+||+|||.+......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999987643 3578899999999999999999   7899999999999999999999999999998764321     


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......+..|+|||++.+..++.++|||||||++|||++ |+.||.......              ..+.+.+.....+ 
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~-  218 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--------------VKECVEKGYRMEP-  218 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------------HHHHHhCCCCCCC-
Confidence            112234567999999988899999999999999999998 999986532211              1111111111111 


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                           ...++..+.+++.+|++.+|++||+++++++.|++
T Consensus       219 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 -----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                 11235668899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.5e-34  Score=295.20  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=193.1

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehh-----hHHHHHHHHHHHHHHHhCCCCccceEEeeeec--CCceE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE-----CARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFKA  547 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  547 (763)
                      +|...+.||+|+||.||+|.. .+++.||+|++...     ..+....+.+|++++++++||||+++++++..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            688899999999999999965 46889999987532     12345678899999999999999999998865  35678


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +++||+++++|.+++.... .+++.....++.|++.||+||   |+.+++||||||+||+++.++.+||+|||+++....
T Consensus        83 l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            9999999999999987644 478888899999999999999   788999999999999999999999999999876532


Q ss_pred             CCC-ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          628 EDQ-SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       628 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ... ........++..|+|||++.+..++.++|||||||++||+++|+.||........             ..+...  
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-------------~~~~~~--  223 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-------------IFKIAT--  223 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-------------HHHHhc--
Confidence            111 1111234578899999999988899999999999999999999999875321110             010000  


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....+..    +......+.+++ .||..+|++||+++||++
T Consensus       224 ~~~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 QPTNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            0001111    111233455555 788999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.8e-34  Score=304.15  Aligned_cols=247  Identities=24%  Similarity=0.283  Sum_probs=197.2

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      |.....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334567999999999999654 6899999998754444456788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      ++|..++...  .+++..+..++.|++.||.||   |+.+++||||||+||+++.++.+||+|||++..+.....  ...
T Consensus       103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         103 GALTDIVSQT--RLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            9999887553  478999999999999999999   788999999999999999999999999999876532221  223


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||........ ....             .........   
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~-------------~~~~~~~~~---  238 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKRL-------------RDSPPPKLK---  238 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-------------hccCCCCcc---
Confidence            35688999999999888899999999999999999999999875322111 1110             000000000   


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ........+.+++..|++.+|++||++.++++
T Consensus       239 -~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         239 -NAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             -ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence             00112345789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.6e-34  Score=301.84  Aligned_cols=258  Identities=23%  Similarity=0.290  Sum_probs=202.2

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|...+.||+|+||.||++... +++.||+|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999665 57899999987553   233557788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|.+++...+ .+++.....++.++++|++||   |+.+++||||||+||+++.++.+|++|||.++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997654 578888889999999999999   788999999999999999999999999999864211000


Q ss_pred             -------------ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh
Q 046240          631 -------------SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV  697 (763)
Q Consensus       631 -------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  697 (763)
                                   ........++..|+|||++.+..++.++|+|||||++|||++|..||........            
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~------------  224 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------------  224 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------------
Confidence                         0011123578889999999888899999999999999999999999865321110            


Q ss_pred             hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          698 SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       698 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                       .......... .+...    ......+.+++.+|++.+|++||++.++.+.++...
T Consensus       225 -~~~~~~~~~~-~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         225 -FGQVISDDIE-WPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             -HHHHHhcccC-CCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence             0111111000 11110    123456899999999999999999888877777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.4e-33  Score=291.03  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=198.4

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC-CceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND-DFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  551 (763)
                      +|++.+.||+|++|.||++... +++.||+|++....  ....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999654 57899999987542  33456788899999999999999999987644 46789999


Q ss_pred             ccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+++++|.+++... ...+++.+...++.+++.|+++|   |+.+++||||||+||+++.++.++|+|||++..+.....
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999988763 33589999999999999999999   788999999999999999999999999999987642221


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......+++.|+|||+..+..++.++||||||++++||++|+.||........             ...+....+...
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-------------~~~~~~~~~~~~  222 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-------------VYRIIEGKLPPM  222 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-------------HHHHHhcCCCCC
Confidence              22334678899999999999999999999999999999999999875322111             011111111010


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +       ......+.+++.+|++.+|++||++.++++
T Consensus       223 ~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 P-------KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             c-------cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1       112456889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.5e-34  Score=299.70  Aligned_cols=267  Identities=23%  Similarity=0.304  Sum_probs=201.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|+..+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999765 68999999886432  1233567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |++++.+..++.... .+++..+..++.|++.||+||   |+.+++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999998888775433 589999999999999999999   789999999999999999999999999999987643321 


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHHHh---
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVVNK---  705 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~---  705 (763)
                       ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+..  .........+. ..+..+.   
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  233 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-HQQIFSTNQF  233 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH-Hhhhcccccc
Confidence             1223457889999998765 56789999999999999999999999754322111  11111111111 0111000   


Q ss_pred             ---hcCCCccccHH---HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 ---TLLSPPEKDFA---AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ---~l~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         .....+.....   ........+.+++.+|++.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence               00000100000   01122456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-35  Score=309.79  Aligned_cols=243  Identities=24%  Similarity=0.393  Sum_probs=200.3

Q ss_pred             CceecccCCceEEEEEe-cCCceEEEEEeehh----hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc--eEEEEEc
Q 046240          480 DNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE----CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF--KALVLEY  552 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~  552 (763)
                      ...||+|+|-+||+|.. .+|..||--.++..    .....+.|..|+.+|+.++||||+++|+++.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            46799999999999954 46888875444322    23445789999999999999999999999987664  7789999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +..|+|..|..+.+ ..+......++.||++||.|||. |.++|+|||||-+||||+.+ |.|||+|.|+|+.+...   
T Consensus       125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---  199 (632)
T ss_pred             ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence            99999999998765 47788899999999999999987 78999999999999999764 89999999999987422   


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......||+.|||||... ..|++.+||||||++|+||+|+..||........-.+....+..|..+..+-        
T Consensus       200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~--------  269 (632)
T KOG0584|consen  200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK--------  269 (632)
T ss_pred             -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC--------
Confidence             223368999999999765 8899999999999999999999999998766665555555555554433221        


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                                ..++.+++.+|+.. .++|||+.|+++
T Consensus       270 ----------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  270 ----------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                      23477999999999 999999999985

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.6e-34  Score=297.98  Aligned_cols=268  Identities=22%  Similarity=0.227  Sum_probs=202.1

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5788899999999999999764 68999999987543  33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      + +++|.+++......+++..+..++.|+++||+||   |+.+++|+||||+||+++.++.++|+|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 9999999876666789999999999999999999   788999999999999999999999999999987643321 1


Q ss_pred             ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHH------HH
Q 046240          633 TQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLME------VV  703 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~------~i  703 (763)
                      ......++..|+|||.+.+. .++.++||||+||+++||++|.+||.........  .........+....+      .-
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            22345688999999987654 4689999999999999999998887653321111  001111000000000      00


Q ss_pred             HhhcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ............ .........+.+++.+|++.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000000000000 000122467899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-33  Score=292.84  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=198.6

Q ss_pred             ccCcCceecccCCceEEEEEecC--CceEEEEEeehh----------hHHHHHHHHHHHHHHHh-CCCCccceEEeeeec
Q 046240          476 RFGRDNLIGIGSFGYVYKAELDD--GIEVAIKVFHQE----------CARAMKSFEVECEVMKN-IRHRNLVKIISGCSN  542 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  542 (763)
                      .|++.+.||+|+||.||+|....  ++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788999999999999997754  688999987532          12234556778888875 699999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          543 DDFKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRH-TTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h-~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                      .+..++||||+++++|.+++..   ....+++..+..++.|++.++.||   | ..+++||||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL---HKEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHh---ccCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999888743   334688889999999999999999   6 47899999999999999999999999


Q ss_pred             ecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChh
Q 046240          619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       619 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      ||.+.......   ......++..|+|||...+..++.++||||||+++|||++|+.||........             
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-------------  221 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-------------  221 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-------------
Confidence            99998764332   22345688899999999988899999999999999999999999865321110             


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      ...+........+.      ......+.+++.+||+.+|++||++.||.+++.
T Consensus       222 ~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         222 ATKIVEAVYEPLPE------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHHhhccCCcCCc------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            01111111110011      112456889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.6e-34  Score=301.31  Aligned_cols=251  Identities=27%  Similarity=0.313  Sum_probs=202.5

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            36889999999999999999965 46889999998654444456788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++...  .+++..+..++.+++.|+.||   |+.+++||||||+||+++.++.++|+|||++..+.....  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            9999999998754  378889999999999999999   788999999999999999999999999999876543322  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||.+.+..++.++|||||||++||+++|+.||.............                  ..+.
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------------------~~~~  232 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------------TNGT  232 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------------------cCCC
Confidence            2233468889999999988889999999999999999999999997632211100000                  0000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ......+.....+.+++.+||..+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0011111234568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1e-33  Score=293.93  Aligned_cols=251  Identities=22%  Similarity=0.329  Sum_probs=184.6

Q ss_pred             eecccCCceEEEEEecCC---ceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCC
Q 046240          482 LIGIGSFGYVYKAELDDG---IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGS  557 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  557 (763)
                      .||+|+||+||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999965433   346677665432 3345678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          558 LDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       558 L~~~l~~~~---~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      |.+++....   ...+......++.|+++||+||   |+.+++||||||+||+++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999987532   2456667788999999999999   7789999999999999999999999999998643222111122


Q ss_pred             ccccccccccCccccCC-------CCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          635 TQTLATIGYMAPEYGIE-------RKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ....++..|+|||+...       ..++.++|||||||++|||++ |..||........ .            ..++...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~------------~~~~~~~  225 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-L------------NHVIKDQ  225 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH-H------------HHHHhhc
Confidence            34567889999998742       345789999999999999997 5678764322111 1            1111110


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      ....+  ++.........+.+++..|| .+|++||++++|++.|.
T Consensus       226 ~~~~~--~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         226 QVKLF--KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccccC--CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            00000  00001112445778899999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.2e-34  Score=299.65  Aligned_cols=266  Identities=23%  Similarity=0.286  Sum_probs=199.1

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-----HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-----RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      +|...+.||+|+||.||+|... +|+.||+|++.....     .....+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999764 689999999875432     2345567899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+ +++|.+++......+++..+..++.|+++||.||   |+.+++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 8899999977554689999999999999999999   78899999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh---cccCChhHHHHH--
Q 046240          630 QSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV---NGLLPVSLMEVV--  703 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~i--  703 (763)
                      .  ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||........ .....   ............  
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcccc
Confidence            1  2223356788999998754 5678999999999999999999877765322111 11111   000000100000  


Q ss_pred             -Hhh--cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 -NKT--LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 -~~~--l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       +..  ....+.............+.+++.+|++.+|++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence             000  000000000011122457889999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.8e-34  Score=293.45  Aligned_cols=247  Identities=25%  Similarity=0.322  Sum_probs=199.1

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-----HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-----ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ....+.+.+|+++++.++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999775 78999999886432     23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +||+++++|.+++.... .+++.....++.|+++|++||   |+.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987653 578899999999999999999   78899999999999999999999999999988754322


Q ss_pred             CccccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERK-VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                         ......++..|+|||...... ++.++|+|||||++|||++|+.||......... .            .+. .. .
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~------------~~~-~~-~  218 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-F------------KIG-RS-K  218 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-H------------HHH-hc-c
Confidence               223456888999999887666 899999999999999999999998764311110 0            000 00 0


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+..    .......+.+++.+|++.+|++||++.++++
T Consensus       219 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 ELPPI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cCCCc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            00000    1112456789999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.1e-34  Score=300.84  Aligned_cols=260  Identities=25%  Similarity=0.309  Sum_probs=200.4

Q ss_pred             CChHHHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeec
Q 046240          465 LPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSN  542 (763)
Q Consensus       465 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  542 (763)
                      ++.+++..+.++|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34455555678999999999999999999966 568899999986432 2235667899999998 79999999999865


Q ss_pred             C-----CceEEEEEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          543 D-----DFKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       543 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      .     +..++|+||+++++|.+++..   ....+++.....++.|++.||+||   |+.+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999988753   234678899999999999999999   78899999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCC-----CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhh
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-----KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH  689 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~  689 (763)
                      ||+|||++........  ......++..|+|||.+...     .++.++|||||||++|||++|+.||........ ...
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~  244 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFK  244 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHH
Confidence            9999999886542221  12234678899999987543     368899999999999999999999876432111 111


Q ss_pred             hhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          690 WVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       690 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +...                 +.......+.....+.+++.+|++.+|++||++.++++
T Consensus       245 ~~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         245 IPRN-----------------PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HhcC-----------------CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1100                 00000001122446889999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-35  Score=277.00  Aligned_cols=248  Identities=23%  Similarity=0.253  Sum_probs=197.1

Q ss_pred             CcCceecccCCceEEEEEec-CCceEEEEEeehh-hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccC
Q 046240          478 GRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE-CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       478 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      .....+|+|..|.||++++. +|...|||.+.+. +..+.+++...+.++..- .+|.||+.+|||..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34566999999999999776 5889999999765 344566777778777766 48999999999999999999999884


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      . ..+.++.....++++...-++...+..||.||.+.  ++|+|||+||+|||+|+.|.+|+||||++.++-+.   ...
T Consensus       175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kAh  248 (391)
T KOG0983|consen  175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KAH  248 (391)
T ss_pred             H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc---ccc
Confidence            3 56666666666788888889999999999999754  57999999999999999999999999999877432   234


Q ss_pred             ccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          635 TQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      +...|.+.|||||.+.   ...|+.++||||||+.++|+.||+.||.....+...+......                .|
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~----------------eP  312 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE----------------EP  312 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc----------------CC
Confidence            4567999999999886   3578899999999999999999999998865554433333321                11


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ........+...+.+++..|+..|+.+||...++++
T Consensus       313 -P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  313 -PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence             111111124567899999999999999999988875

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.9e-34  Score=328.39  Aligned_cols=256  Identities=21%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             HHHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeec--CC
Q 046240          470 LSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DD  544 (763)
Q Consensus       470 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  544 (763)
                      .....++|.+.+.||+|+||+||+|... ++..||+|++...  .......+..|+.++++++||||++++++|..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            3345578999999999999999999664 6778999988643  23345678899999999999999999998854  35


Q ss_pred             ceEEEEEccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEeCCCCCCCEEecC-------
Q 046240          545 FKALVLEYMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRH----TTPIIHCDLKSSNVLLDE-------  610 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h----~~~ivH~dlk~~NIll~~-------  610 (763)
                      ..|+||||+++|+|..++...   ...+++..++.|+.||+.||.|||...    .++||||||||+|||++.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            689999999999999988652   236899999999999999999996422    256999999999999964       


Q ss_pred             ----------CCcEEEeeecCceecCCCCCccccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCc
Q 046240          611 ----------DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPAD  678 (763)
Q Consensus       611 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~  678 (763)
                                .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||++|||+||+.||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      2358999999998764222   1234568999999998754  458899999999999999999999996


Q ss_pred             hhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          679 KMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       679 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......                .++.. +...+....   ......+.+++..||..+|++||++.++++
T Consensus       245 ~~~~~~----------------qli~~-lk~~p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANNFS----------------QLISE-LKRGPDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCcHH----------------HHHHH-HhcCCCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            532111                11111 111111100   012456889999999999999999999983

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=309.43  Aligned_cols=236  Identities=22%  Similarity=0.262  Sum_probs=182.5

Q ss_pred             ecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhC---CCCccceEEeeeecCCceEEEEEccCC
Q 046240          483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNI---RHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       483 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      ||+|+||+||+|... +++.||+|++.....   ........|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999664 689999999975422   2233445566777665   699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|..++.... .++......++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            99998886543 588899999999999999999   78899999999999999999999999999987542221  1223


Q ss_pred             cccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcccc
Q 046240          636 QTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD  714 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  714 (763)
                      ...||..|+|||++.+. .++.++|||||||++|||++|+.||........ .            ..+.... ...+.. 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~------------~~i~~~~-~~~~~~-  219 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-Y------------RNIAFGK-VRFPKN-  219 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-H------------HHHHcCC-CCCCCc-
Confidence            45689999999988654 579999999999999999999999876322111 0            0111000 011111 


Q ss_pred             HHHHHHHHHHHHHHHHHccccCcCCCCCHH
Q 046240          715 FAAKEQCVLSIFSLAMECTMELPEKRINAK  744 (763)
Q Consensus       715 ~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~  744 (763)
                           .....+.+++.+|++.+|++||++.
T Consensus       220 -----~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         220 -----VLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             -----cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence                 1244578999999999999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.7e-33  Score=298.40  Aligned_cols=247  Identities=27%  Similarity=0.300  Sum_probs=196.5

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|...+.||+|+||+||+|... +++.||+|++...   .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999999664 6899999988633   223446788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +||+++ ++.+++......+++..+..++.|++.||.||   |+.+++||||+|+||+++.++.++|+|||++...... 
T Consensus        94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            999974 66666655445689999999999999999999   7889999999999999999999999999998765322 


Q ss_pred             CccccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          630 QSMTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                           ....++..|+|||++.   ...++.++||||||+++|||+||..||...........             +.   
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-------------~~---  227 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------------IA---  227 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-------------Hh---
Confidence                 2345788899999874   46688999999999999999999999876432211000             00   


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ....+...   ...+...+.+++.+||..+|++||++.++++.
T Consensus       228 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         228 QNDSPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             cCCCCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00011100   11235578999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.7e-34  Score=299.74  Aligned_cols=270  Identities=23%  Similarity=0.274  Sum_probs=196.9

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++++|...+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+++++.++|+||+++++++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            356899999999999999999965 4688999999864422 22345678999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+. +++.+++......+++.....++.|+++||+||   |+.+|+|+||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9996 566666655444577888889999999999999   788999999999999999999999999999876432221


Q ss_pred             ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc-ccCCh-hH-HHHH---
Q 046240          631 SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN-GLLPV-SL-MEVV---  703 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~-~~-~~~i---  703 (763)
                        ......++..|+|||++.+ ..++.++|||||||++|||++|..||.........+..... ...+. .. ..+.   
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              1233457889999998875 45788999999999999999999999764432222221110 00010 00 0000   


Q ss_pred             ---HhhcCCCccccHHH---HHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 ---NKTLLSPPEKDFAA---KEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ---~~~l~~~~~~~~~~---~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         .......+......   .......+.+++.+|+..||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               00000000000000   0011346789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=294.18  Aligned_cols=248  Identities=21%  Similarity=0.269  Sum_probs=199.0

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ..-|...+.||+|.|+.|-.|++- +|.+||||++.+..  .-....+.+|+..|+.++|||||++|.+...+...|+|.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            345778899999999999999554 79999999997653  234566788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec-CCCcEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |.-++|+|.++|......+...-..+.+.||+.|+.|.   |+..+|||||||+||.+- .-|-||++|||++..+.++.
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YC---HqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYC---HQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHH---hhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            99999999999988777788888999999999999999   566699999999999774 56899999999998876443


Q ss_pred             CccccccccccccccCccccCCCCCC-cchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVS-TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                         ..+..+|+..|-|||++.+..|+ +++||||+||+||-++.|+.||+...+.+..             ..++|-.  
T Consensus       174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-------------TmImDCK--  235 (864)
T KOG4717|consen  174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-------------TMIMDCK--  235 (864)
T ss_pred             ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-------------hhhhccc--
Confidence               34557899999999999999886 5899999999999999999999876544321             1111111  


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                            +..+.....++.+++..|+..||.+|-+.++|+.
T Consensus       236 ------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 ------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                  1112223445666777777777777777776653

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.9e-34  Score=299.44  Aligned_cols=267  Identities=24%  Similarity=0.298  Sum_probs=200.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999775 58999999876432  1234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |++++++..+..... .+++.....++.|+++|++||   |+.+++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999999988775543 488999999999999999999   778999999999999999999999999999887643321 


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChhHHHHH-----
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVSLMEVV-----  703 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~i-----  703 (763)
                       ......++..|+|||+..+ ..++.++||||||+++|||++|+.||........  ....+.. ..........     
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG-NLIPRHQEIFQKNPL  233 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC-CCchhhHHHhccchH
Confidence             2233457889999998765 4578899999999999999999999864322111  1111111 1111111111     


Q ss_pred             -HhhcCCCcccc---HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 -NKTLLSPPEKD---FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 -~~~l~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ...........   ..........+.+++..||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             11111000000   0001123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-33  Score=293.85  Aligned_cols=254  Identities=26%  Similarity=0.448  Sum_probs=196.5

Q ss_pred             cCcCceecccCCceEEEEEec----CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC------
Q 046240          477 FGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------  544 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  544 (763)
                      |.+.+.||+|+||.||+|...    +++.||||++...  .....+.+.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999653    4688999998754  2334567889999999999999999999885432      


Q ss_pred             ceEEEEEccCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeee
Q 046240          545 FKALVLEYMPNGSLDIFLYSS-----TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                      ..++++||+++|+|..++...     ...+++.....++.|++.|++||   |+.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhEEEcCCCCEEECcc
Confidence            347889999999998876432     12468888999999999999999   7889999999999999999999999999


Q ss_pred             cCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChh
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      |.++...............++..|++||......++.++|||||||++|||++ |+.||........  ..+        
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~--~~~--------  227 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI--YNY--------  227 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH--HHH--------
Confidence            99987643222222223345678999999988889999999999999999999 8888865332111  110        


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                         +........+       ..+...+.+++.+|++.+|++||++.++++.|+++
T Consensus       228 ---~~~~~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 ---LIKGNRLKQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ---HHcCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               0000000000       11245789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=294.82  Aligned_cols=252  Identities=25%  Similarity=0.310  Sum_probs=199.0

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCC------
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDD------  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------  544 (763)
                      .+++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++++ .|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4688999999999999999999764 678999999875543 346788999999999 7999999999996544      


Q ss_pred             ceEEEEEccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          545 FKALVLEYMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                      ..++||||+++++|.+++...   ...+++..+..++.|+++||.||   |+.+++||||+|+||++++++.+||+|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999988653   24688999999999999999999   889999999999999999999999999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIE-----RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      +.......  .......++..|+|||++..     ..++.++|||||||+++||++|+.||........ ..        
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~--------  228 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LF--------  228 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HH--------
Confidence            87654221  12234568899999998653     3567899999999999999999999975322111 11        


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          ++..     .+.............+.+++.+|+..||++|||+.++++
T Consensus       229 ----~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         229 ----KIPR-----NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ----Hhhc-----cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                1110     011111111223557889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.6e-33  Score=292.04  Aligned_cols=250  Identities=23%  Similarity=0.280  Sum_probs=194.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehh-----hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC--Cce
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE-----CARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFK  546 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  546 (763)
                      ++|.+.+.||+|+||.||.|... +++.||+|.+...     .....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999664 6889999987532     123456788899999999999999999998764  467


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++++|.+++.... .+++.....++.+++.||+||   |+.+++|+||||+||+++.++.++|+|||.++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999986543 478888899999999999999   78899999999999999999999999999988653


Q ss_pred             CCCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          627 GEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       627 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ..... .......++..|+|||+..+..++.++|||||||++|||++|+.||......... ..            ....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~------------~~~~  224 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-FK------------IATQ  224 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-HH------------HhcC
Confidence            22111 1122345888999999998888999999999999999999999998753211110 00            0000


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ...+..    +......+.+++.+|+. +|++||+++++++
T Consensus       225 --~~~~~~----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 --PTNPVL----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --CCCCCC----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              001111    11224457788888884 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-34  Score=272.77  Aligned_cols=252  Identities=25%  Similarity=0.329  Sum_probs=200.4

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--------HHHHHHHHHHHHHHHhC-CCCccceEEeeeec
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--------ARAMKSFEVECEVMKNI-RHRNLVKIISGCSN  542 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  542 (763)
                      .-..|...+.+|.|..++|-+... .+|+.+|+|++....        ....+.-.+|+.+|+++ .||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            345678888999999999988855 478899999886321        22345567899999999 69999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      +...++|+|.|+.|-|.+++...- .++.....+|+.|+.+|++||   |.++||||||||+|||+|++..+||+|||.+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEecccee
Confidence            999999999999999999997643 577888899999999999999   8999999999999999999999999999999


Q ss_pred             eecCCCCCccccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGI------ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      +.+.++.   .....+||++|+|||.+.      ...|+..+|+||.||+||-++.|.+||-.-.. -.-++....+.+ 
T Consensus       171 ~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-mlMLR~ImeGky-  245 (411)
T KOG0599|consen  171 CQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-MLMLRMIMEGKY-  245 (411)
T ss_pred             eccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-HHHHHHHHhccc-
Confidence            9886443   345678999999999753      35688899999999999999999999865211 111111111111 


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                                     .-+-+.=.+......+++.+|++.||.+|.|++|+++
T Consensus       246 ---------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  246 ---------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ---------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                           1111111223456788999999999999999999884

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=297.51  Aligned_cols=268  Identities=23%  Similarity=0.266  Sum_probs=197.5

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999765 688999999865432 1234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++ +|.+++......+++.....++.|+++||.||   |+.+++||||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            985 89888876555788999999999999999999   788999999999999999999999999999875432111  


Q ss_pred             ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh---cccCChhHHHHHHhh--
Q 046240          633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV---NGLLPVSLMEVVNKT--  706 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~--  706 (763)
                      ......++..|+|||+..+ ..++.++||||+||++|||++|+.||..............   ....+.....+....  
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1122346788999998765 5578999999999999999999999965432111111111   110111111111000  


Q ss_pred             -cCCCccc-cHHHHH---HH--HHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 -LLSPPEK-DFAAKE---QC--VLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 -l~~~~~~-~~~~~~---~~--~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ....+.. .....+   ..  .....+++.+|++.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             0000000 000000   01  156789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-33  Score=291.43  Aligned_cols=252  Identities=28%  Similarity=0.351  Sum_probs=200.7

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|...+.||+|+||.||+|... +++.|++|+++....  ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999654 788999999875533  3567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++.... .+++.....++.++++|++||   |+.+++|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987653 478888999999999999999   78899999999999999999999999999998765333221


Q ss_pred             c--cccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          633 T--QTQTLATIGYMAPEYGIERK---VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       633 ~--~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .  .....++..|+|||++.+..   ++.++||||||+++||+++|+.||............ .            .  .
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-~------------~--~  221 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-V------------G--A  221 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH-H------------h--c
Confidence            1  12346788999999988766   889999999999999999999999753211110000 0            0  0


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...+..  .........+.+++.+|++.+|++||++.+++.
T Consensus       222 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 GHKPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000  001112455789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-33  Score=293.38  Aligned_cols=248  Identities=27%  Similarity=0.357  Sum_probs=200.0

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +-|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3467788999999999999965 468899999886432 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++...  .+++.....++.+++.++.||   |+.+++|+||+|+||+++.++.++|+|||++..+.....  
T Consensus        84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            9999999988653  478999999999999999999   889999999999999999999999999999876643221  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||+..+..++.++|||||||++|||++|..||.......              ....+...  ..+.
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------------~~~~~~~~--~~~~  220 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------------VLFLIPKN--NPPT  220 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------------HHHHHhcC--CCCC
Confidence            1223467889999999988888999999999999999999999987532211              00111000  0000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                          ........+.+++.+|++.+|++||++.++++.
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 ----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                011224567899999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-33  Score=287.94  Aligned_cols=249  Identities=31%  Similarity=0.390  Sum_probs=203.9

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      +|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++||+++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999775 788999999976654556788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|.+++......+++..+..++.++++++.+|   |+.+++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            9999999877645689999999999999999999   789999999999999999999999999999887653321   2


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD  714 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  714 (763)
                      ....++..|+|||+..+..++.++||||||+++++|++|+.||..........              ......  .+.. 
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~--~~~~-  217 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--------------KIATNG--PPGL-  217 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH--------------HHHhcC--CCCc-
Confidence            34568889999999988889999999999999999999999987642111100              000000  0000 


Q ss_pred             HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          715 FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       715 ~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       .........+.+++..|++.+|++||++.++++
T Consensus       218 -~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         218 -RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             000112456889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-36  Score=309.71  Aligned_cols=313  Identities=22%  Similarity=0.238  Sum_probs=253.0

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCC
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNA  155 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l  155 (763)
                      .+|++.|+|.+|.|+.+-.++++.++.|++||||.|.|+       .||...|..-.++++|+|++|+|+.+-.+.|.++
T Consensus       124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-------~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~l  196 (873)
T KOG4194|consen  124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-------EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSL  196 (873)
T ss_pred             ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-------cccCCCCCCCCCceEEeecccccccccccccccc
Confidence            367888888888888777888888888888888888886       7777777666778888888888887777788888


Q ss_pred             CCCCeeeecCcccccccccccCCCCchhhhhhh--------------------hhccCCcccccCCcccccccccccEEE
Q 046240          156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLV--------------------IGLIGNPLNGILPSSIVNLSISLERLY  215 (763)
Q Consensus       156 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~--------------------~~l~~n~l~~~~p~~~~~l~~~L~~L~  215 (763)
                      .+|.+|.|++|+|+...+..|..|++|+.|+|.                    +.|..|.+...-...|.++. ++++|+
T Consensus       197 nsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~-kme~l~  275 (873)
T KOG4194|consen  197 NSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLE-KMEHLN  275 (873)
T ss_pred             chheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeec-ccceee
Confidence            888888888888887777788888888888741                    33556666655556666776 788888


Q ss_pred             eecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccc
Q 046240          216 ISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN  295 (763)
Q Consensus       216 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N  295 (763)
                      |+.|+++..-.+++-+|+.|+.|+||+|.|..+-++.+.-.+.  |++|+|++|+|+..-++  .|..|..|++|+|++|
T Consensus       276 L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk--L~~LdLs~N~i~~l~~~--sf~~L~~Le~LnLs~N  351 (873)
T KOG4194|consen  276 LETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK--LKELDLSSNRITRLDEG--SFRVLSQLEELNLSHN  351 (873)
T ss_pred             cccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc--ceeEeccccccccCChh--HHHHHHHhhhhccccc
Confidence            8888888777778888888888888888888778888777765  88899999988855555  7888888899999999


Q ss_pred             cccccCCcccCCCcCccEEEccCccccCcccc---cccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCC
Q 046240          296 NFSGDIPATIGGLKDVQNISLPYNRLEGPIPE---SFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGE  372 (763)
Q Consensus       296 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  372 (763)
                      .++.+...+|.++++|+.|||++|.|+..+.+   .|.+|++|+.|+|.+|+|..+.-.+|.++..|+.|||.+|.|-..
T Consensus       352 si~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSI  431 (873)
T KOG4194|consen  352 SIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASI  431 (873)
T ss_pred             chHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceee
Confidence            98888888889999999999999998876654   577899999999999999998889999999999999999999877


Q ss_pred             CCCCCCccccccccccCCCcccCCCCCC
Q 046240          373 IPRGGPFANFTAKSFMGNEKLCGLPHLQ  400 (763)
Q Consensus       373 ~p~~~~~~~l~~~~~~~n~~~c~~p~~~  400 (763)
                      -|....-.++..+-+.....+|+|.-.+
T Consensus       432 q~nAFe~m~Lk~Lv~nSssflCDCql~W  459 (873)
T KOG4194|consen  432 QPNAFEPMELKELVMNSSSFLCDCQLKW  459 (873)
T ss_pred             cccccccchhhhhhhcccceEEeccHHH
Confidence            7765333377778888888999987433

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=299.67  Aligned_cols=252  Identities=26%  Similarity=0.327  Sum_probs=200.2

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|...+.||+|+||+||+|... +++.||+|.+.....   ...+.+..|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999765 589999999875431   24567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      ||+.+++|.+++... ...+++.....++.|+++||+||   |+.+++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998754 24688899999999999999999   78899999999999999999999999999987653221


Q ss_pred             Cc---------------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhh
Q 046240          630 QS---------------------------MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFA  682 (763)
Q Consensus       630 ~~---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~  682 (763)
                      ..                           .......|+..|+|||+..+..++.++||||||+++|||++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011133578899999999988899999999999999999999999976432


Q ss_pred             hhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC----HHHHHH
Q 046240          683 AELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN----AKCCNF  748 (763)
Q Consensus       683 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps----~~~v~~  748 (763)
                      ...             ..++..........      ......+.+++.+|+..+|++||+    ++++++
T Consensus       238 ~~~-------------~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DET-------------FSNILKKEVTFPGS------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHH-------------HHHHhcCCccCCCc------cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211             11111111111111      113567899999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.2e-34  Score=296.75  Aligned_cols=258  Identities=24%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             ChHHHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeec-
Q 046240          466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSN-  542 (763)
Q Consensus       466 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  542 (763)
                      +..++....+.|++.+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.+++++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4455555678899999999999999999966 468899999986543 2345678899999998 69999999999853 


Q ss_pred             -----CCceEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEE
Q 046240          543 -----DDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL  616 (763)
Q Consensus       543 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl  616 (763)
                           ....+++|||+++|+|.+++.... ..+++..+..++.|++.|+.||   |+.+++||||+|+||++++++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEE
Confidence                 457899999999999999886533 3577888889999999999999   7889999999999999999999999


Q ss_pred             eeecCceecCCCCCccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh
Q 046240          617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV  691 (763)
Q Consensus       617 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~  691 (763)
                      +|||++........  ......++..|+|||.+.     ...++.++|||||||++|||++|..||.........     
T Consensus       163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----  235 (282)
T cd06636         163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----  235 (282)
T ss_pred             eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence            99999876532111  223356889999999875     356788999999999999999999998653221110     


Q ss_pred             cccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          692 NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       692 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                              .. +.+...  +..   ....+...+.+++..||+.+|++||++.|+++
T Consensus       236 --------~~-~~~~~~--~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 --------FL-IPRNPP--PKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --------hh-HhhCCC--CCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                    00 000000  000   01123557899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-33  Score=288.82  Aligned_cols=247  Identities=26%  Similarity=0.408  Sum_probs=199.2

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|+..+.||+|+||.||++.. .+++.+|+|++...  .....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999965 46889999998644  233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~  630 (763)
                      +++++|.+++.... ..+++..+..++.+++++++||   |+++++||||+|+||+++++ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997643 3578899999999999999999   78899999999999999855 468999999998764322 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........             ...+........
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~  221 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-------------VLKIMSGTFAPI  221 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH-------------HHHHHhcCCCCC
Confidence              12234678899999999888899999999999999999999999865322111             111111111100


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +       ..+...+.+++..||+.+|++||++.++++
T Consensus       222 ~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 S-------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             C-------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1       113456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-33  Score=295.26  Aligned_cols=248  Identities=26%  Similarity=0.300  Sum_probs=198.7

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      +|...+.||+|++|.||++.. .+++.|++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455568999999999999965 4788999999875544455668899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|.+++...  .+++.....++.|++.|++||   |+.+++||||+|+||+++.++.++++|||.+........  ..
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            99999998763  478889999999999999999   788999999999999999999999999998875532211  12


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD  714 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  714 (763)
                      ....|+..|+|||...+..++.++|||||||++|||++|+.||........              ...+.....  +...
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~--------------~~~~~~~~~--~~~~  236 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--------------MKRIRDNLP--PKLK  236 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH--------------HHHHHhcCC--CCCc
Confidence            234588999999999888899999999999999999999999865221110              000111100  0000


Q ss_pred             HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          715 FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       715 ~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ........+.+++.+|++.+|++||++.++++
T Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              00112456899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-33  Score=299.12  Aligned_cols=194  Identities=23%  Similarity=0.335  Sum_probs=157.3

Q ss_pred             CceecccCCceEEEEEec---CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec--CCceEEEEEccC
Q 046240          480 DNLIGIGSFGYVYKAELD---DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFKALVLEYMP  554 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  554 (763)
                      +.+||+|+||+||+|...   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999764   45789999886542  23456789999999999999999998853  457889999987


Q ss_pred             CCChhhhhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe----cCCCcEEEeeecCc
Q 046240          555 NGSLDIFLYS--------STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIA  622 (763)
Q Consensus       555 ~g~L~~~l~~--------~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla  622 (763)
                      + +|.+++..        ....+++..+..++.|+++||.||   |+.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            6 66665532        112478888999999999999999   78999999999999999    56679999999999


Q ss_pred             eecCCCCCc-cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          623 KLLSGEDQS-MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       623 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      +.+...... .......+|..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            876433221 12234568999999998876 4579999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-33  Score=295.00  Aligned_cols=255  Identities=24%  Similarity=0.272  Sum_probs=197.7

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  550 (763)
                      ++|...+.||.|++|.||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4678889999999999999976 468899999987542 23456788999999999999999999998654  4689999


Q ss_pred             EccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      ||+++++|.+++..   ....++......++.|+++||.||   |+.+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887643   233578888999999999999999   789999999999999999999999999999876532


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhh---hhhhhhhhcccCChhHHHHHH
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA---ELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ..    .....++..|+|||...+..++.++||||+||++|||++|+.||......   ......+......        
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  225 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--------  225 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--------
Confidence            21    12345788899999998889999999999999999999999999764210   0011111110000        


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+...+..    .......+.+++.+|++.+|++||++.|+++
T Consensus       226 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 PELKDEPGN----GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhhccCCCC----CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            000011110    0112456899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.6e-33  Score=289.10  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=200.1

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeec--CCceEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFKALVL  550 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  550 (763)
                      +|++.+.||.|+||.||++.. .+++.||+|++...  .....+.+..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999965 47889999998643  23445678889999999999999999998754  44678999


Q ss_pred             EccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          551 EYMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRH--TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       551 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      ||+++++|.+++...   ...+++.....++.++++|+.|||..+  +.+++||||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   346889999999999999999994332  899999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .....  ......++..|+|||+..+..++.++||||||+++++|++|+.||.......              ..+.+..
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~  224 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--------------LASKIKE  224 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--------------HHHHHhc
Confidence            43322  1233468899999999998889999999999999999999999997643111              1111111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .....      ........+.+++.+|++.+|++||++.+|++
T Consensus       225 ~~~~~------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 GKFRR------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CCCCC------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            11100      01123457899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.1e-33  Score=289.58  Aligned_cols=251  Identities=27%  Similarity=0.331  Sum_probs=204.6

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +|++.+.||+|++|.||+|... +++.|++|++..... .....+.+|+.++++++|+|++++++++...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6788899999999999999776 589999999876533 44677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++... ..++......++.|+++|++||   |+ .+++||||+|+||+++.++.++|+|||.+......... 
T Consensus        82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            999999999765 3588999999999999999999   88 99999999999999999999999999999876432221 


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                       .....++..|+|||...+..++.++||||||+++|||+||+.||......              ...+.+.........
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--------------~~~~~~~~~~~~~~~  221 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--------------SFFELMQAICDGPPP  221 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--------------CHHHHHHHHhcCCCC
Confidence             12345788999999999889999999999999999999999998764320              001111111111100


Q ss_pred             ccHHHHHH-HHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          713 KDFAAKEQ-CVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       713 ~~~~~~~~-~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .   .... ....+.+++..|++.+|++||++.++++.
T Consensus       222 ~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 S---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             C---CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0   0011 35678999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.8e-33  Score=295.17  Aligned_cols=252  Identities=29%  Similarity=0.350  Sum_probs=204.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++.|+..+.+|+|++|.||+|... +++.|++|++..... ..+.+.+|+++++.++|+|++++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999776 688999999976543 45678889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++++|.+++......+++..+..++.++++||+||   |+.+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            9999999999987644689999999999999999999   789999999999999999999999999999876542221 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ..            .+.......  
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~------------~~~~~~~~~--  235 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LF------------LITTKGIPP--  235 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HH------------HHHhcCCCC--
Confidence             11233578899999999888899999999999999999999999875322111 00            111111100  


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         ......+...+.+++..|++.+|.+||++.++++
T Consensus       236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         236 ---LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ---CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               0111123556889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.3e-33  Score=290.17  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=199.3

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh------HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC------ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      +|+..+.||+|++|.||+|.. .+++.||+|++....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999965 578999999986432      1235678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeecCceecCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSG  627 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~  627 (763)
                      |+||+++++|.+++.... .+++.....++.|++.||.||   |+.+++|+||+|+||+++.++ .+||+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987543 578889999999999999999   788999999999999998775 699999999887643


Q ss_pred             CCCc--cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          628 EDQS--MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       628 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ....  .......++..|+|||+..+..++.++||||+|++++|+++|..||........              ...+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~  222 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--------------LALIFK  222 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--------------HHHHHH
Confidence            3211  112234678899999999888899999999999999999999999864211100              001111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .......  ....+.....+.+++.+|+..+|++||++.++++
T Consensus       223 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         223 IASATTA--PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HhccCCC--CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0000000  0111223556889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.8e-33  Score=293.25  Aligned_cols=243  Identities=25%  Similarity=0.304  Sum_probs=197.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|...+.||+|+||.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999664 68999999987542   234566888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|.+++.... .++...+..++.|+++||.||   |+.+++||||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987653 588889999999999999999   7899999999999999999999999999998876432  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                         .....+++.|+|||...+...+.++||||||+++|||++|+.||....... ..            ..+..    ..
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~------------~~~~~----~~  214 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IY------------EKILE----GK  214 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HH------------HHHhc----CC
Confidence               223468899999999988888999999999999999999999987533111 00            11110    01


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCN  747 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~  747 (763)
                      ...    .......+.+++.+||..+|++||     +++|++
T Consensus       215 ~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         215 VRF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ccC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            000    001144678999999999999999     566665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-33  Score=294.56  Aligned_cols=249  Identities=24%  Similarity=0.299  Sum_probs=191.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHH-HHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEV-MKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|+.+ ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999765 68999999987542 2233445556665 566689999999999999999999999


Q ss_pred             ccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          552 YMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       552 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      |++ |+|.+++..   ....+++.....++.|++.|++||   |++ +++||||||+||+++.++.+||+|||.+..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 577776643   234688999999999999999999   666 899999999999999999999999999886532


Q ss_pred             CCCccccccccccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIE----RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      ..   ......++..|+|||.+.+    ..++.++|+|||||++|||++|+.||.........            ....+
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------------~~~~~  221 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ------------LKQVV  221 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH------------HHHHH
Confidence            11   2233467889999998764    45688999999999999999999998653211111            11111


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .......+..      ....++.+++..|+..+|++||++.++++
T Consensus       222 ~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         222 EEPSPQLPAE------KFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             hcCCCCCCcc------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111111      13456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.3e-33  Score=294.06  Aligned_cols=267  Identities=24%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|+..+.||.|++|.||+|... +|+.||||++....  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999664 68999999886442  22335688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +. ++|..++... ...+++.....++.|+++|++||   |+.+++||||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 5788877653 34688999999999999999999   788999999999999999999999999999876532221 


Q ss_pred             cccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh--hhhcccCCh---hHHHHHHh
Q 046240          632 MTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK--HWVNGLLPV---SLMEVVNK  705 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~--~~~~~~~~~---~~~~~i~~  705 (763)
                       ......++..|+|||+..+. .++.++|||||||++|||+||+.||...........  .........   ....+...
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             12334568899999987654 468899999999999999999999865332211111  111110000   00000000


Q ss_pred             h--cCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 T--LLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~--l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .  ......... ........++.+++.+|++.||++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0  000000000 001112345789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=293.68  Aligned_cols=266  Identities=23%  Similarity=0.269  Sum_probs=196.2

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      |+..+.||.|++|.||+|... +|+.||+|++....  ......+.+|++++++++|||++++++++..++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999654 79999999987443  222356788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      + ++|.+++.... ..+++..+..++.|+++||+||   |+.+++||||+|+||+++.++.++|+|||.+..+.....  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 58888886543 3589999999999999999999   678999999999999999999999999999976532221  


Q ss_pred             ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh--hhhcccCChhH------HHHH
Q 046240          633 TQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK--HWVNGLLPVSL------MEVV  703 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~------~~~i  703 (763)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||...........  .......+..+      .+..
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            12233568899999987654 578999999999999999999999975432211111  11100000000      0000


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .....................+.+++.+|++.+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000000111122356889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.8e-33  Score=294.82  Aligned_cols=268  Identities=24%  Similarity=0.251  Sum_probs=198.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  549 (763)
                      ++|+..+.||+|+||.||+|... +++.||+|.++....  .....+.+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999765 688999999874422  2234567899999999999999999998777  899999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +||+++ +|.+++......+++.....++.|++.||+||   |+.+++||||||+||+++.++.+||+|||+++.+....
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 88888876555689999999999999999999   78899999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHHH--
Q 046240          630 QSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVVN--  704 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~--  704 (763)
                      .  ......++..|+|||.+.+. .++.++|+||||+++|||++|..||.........  .........+..+..+..  
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            1  22334578899999987654 4688999999999999999999999754322111  111111111111110000  


Q ss_pred             ----hhcCCCcccc--HHHHHH-HHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 ----KTLLSPPEKD--FAAKEQ-CVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ----~~l~~~~~~~--~~~~~~-~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          .........+  ...... ....+.+++..|++.+|++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                0000000000  000000 2456789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=292.76  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=197.7

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehh-hHHHHHHHHHHHHHHHhCC---CCccceEEeeeecCCceEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIR---HRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .|+..+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999975 57899999998644 2334567788999999996   999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|.+++...  .+++.....++.++++|+.||   |+.+++||||+|+||++++++.++|+|||++..+.....
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998654  588999999999999999999   788999999999999999999999999999987653331


Q ss_pred             ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        ......|+..|+|||...+ ..++.++|||||||++|||++|..||.........  ..            +...  .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~------------~~~~--~  218 (277)
T cd06917         157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--ML------------IPKS--K  218 (277)
T ss_pred             --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--hc------------cccC--C
Confidence              2233468889999998765 45689999999999999999999999753221100  00            0000  0


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+....   +....++.+++..|++.+|++||++.++++
T Consensus       219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            010000   013456889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-33  Score=295.56  Aligned_cols=253  Identities=28%  Similarity=0.296  Sum_probs=191.9

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999654 68999999986542 234567888999999996 99999999999999999999999


Q ss_pred             cCCCChhhh---hcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          553 MPNGSLDIF---LYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       553 ~~~g~L~~~---l~~-~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ++. ++..+   +.. ....+++.....++.++++||+|||  ++.+++||||||+||+++.++.+||+|||+++.+...
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            865 44433   222 2346888999999999999999995  3468999999999999999999999999998765322


Q ss_pred             CCccccccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIER---KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .   ......++..|+|||++.+.   .++.++|||||||++|||++|+.||.................           
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------  227 (288)
T cd06616         162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD-----------  227 (288)
T ss_pred             C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC-----------
Confidence            1   11234578899999998765   689999999999999999999999876431111111111000           


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                          .+.........+..++.+++..|++.+|++||++.+|++.
T Consensus       228 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 ----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ----CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0110001111235578999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-33  Score=291.33  Aligned_cols=247  Identities=24%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      +|.+.+.||.|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999765 68999999997543   2346778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++++|..++... ..++......++.++++||.||   |+.+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998765 4688899999999999999999   78899999999999999999999999999988754322  


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......++..|+|||...+..++.++|+||||+++|+|++|..||.......           ..........   ..+
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~---~~~  219 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----------RDQIRAKQET---ADV  219 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----------HHHHHHHhcc---ccc
Confidence             2234567889999999988889999999999999999999999987643210           0011111111   001


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCH--HHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINA--KCCN  747 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~--~~v~  747 (763)
                      .    ........+.+++.+||+.+|.+||++  +|++
T Consensus       220 ~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 L----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             c----CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1    011234678899999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=294.37  Aligned_cols=268  Identities=23%  Similarity=0.313  Sum_probs=201.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|+..+.||+|+||.||+|... +++.||+|+++...  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999765 68899999886542  2234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |++++.+..+.... ..++......++.+++.|+.||   |+.+++||||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99987777665443 3588999999999999999999   788999999999999999999999999999887653332 


Q ss_pred             cccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHHHh--h
Q 046240          632 MTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVVNK--T  706 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~--~  706 (763)
                      .......++..|+|||+..+. .++.++||||||+++|||++|+.||.........  ...... ..+.........  .
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG-PLPPSHQELFSSNPR  234 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHhhhcccCcc
Confidence            122335678899999998877 8899999999999999999999998753222111  111111 111111100000  0


Q ss_pred             cCC----CccccHH----HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLS----PPEKDFA----AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~----~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...    .......    ....+..++.+++.+||..+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000    0000000    01122567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=330.80  Aligned_cols=258  Identities=28%  Similarity=0.343  Sum_probs=204.4

Q ss_pred             HhccCcCceecccCCceEEEEE-ecCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      +-++....+||.|.||.||.|. .++|...|+|-+....  ....+.+.+|..++..++|||+|++||+-..++..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4577788899999999999995 5678899999776432  234566788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |||++|+|.+.++..+ ..+......+..|++.|++||   |+.|||||||||.||+++.+|.+|.+|||.|..+.+...
T Consensus      1314 EyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999998754 456666667899999999999   889999999999999999999999999999998754422


Q ss_pred             c--cccccccccccccCccccCCC---CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          631 S--MTQTQTLATIGYMAPEYGIER---KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       631 ~--~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .  .......||+.|||||++.+.   ....+.||||+||++.||+||++||.....+-.-+-....+..|+        
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq-------- 1461 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ-------- 1461 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC--------
Confidence            2  223467899999999998753   355689999999999999999999987544332222222222221        


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                                 .++....+=.+++..|+..||++|+++.|+++   ..+.+.
T Consensus      1462 -----------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle---~~f~~~ 1499 (1509)
T KOG4645|consen 1462 -----------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE---HAFGKS 1499 (1509)
T ss_pred             -----------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH---hhcccc
Confidence                       11123445578999999999999999887765   455443

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4e-33  Score=299.64  Aligned_cols=271  Identities=25%  Similarity=0.298  Sum_probs=199.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecC--Cce
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNI-RHRNLVKIISGCSND--DFK  546 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~  546 (763)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578889999999999999999765 6889999988542  223345567899999999 999999999998654  368


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++ +|..++...  .+++.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            999999974 888888654  578889999999999999999   78899999999999999999999999999998764


Q ss_pred             CCCCc---cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHH
Q 046240          627 GEDQS---MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLM  700 (763)
Q Consensus       627 ~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~  700 (763)
                      .....   .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.........  ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            33221   12234568899999998754 56788999999999999999999999653322111  11111111111111


Q ss_pred             ----HHHHhhcC---CCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          701 ----EVVNKTLL---SPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       701 ----~~i~~~l~---~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                          ...+..+.   ........ .......++.+++..|++.+|++||++.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                11111111   11111111 111135678999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-32  Score=293.39  Aligned_cols=246  Identities=26%  Similarity=0.306  Sum_probs=195.6

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .|...+.||+|+||.||+|.. .++..||+|++...   .......+.+|++++++++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            367788999999999999965 46889999998643   22344678889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++ ++.+.+......+++.++..++.+++.|+.||   |+.+++||||+|+||+++.++.+||+|||++.....    
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            9975 77777665555689999999999999999999   788999999999999999999999999999875432    


Q ss_pred             cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          632 MTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                        .....++..|+|||++.   .+.++.++|||||||++|||++|+.||........             ...+......
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------------~~~~~~~~~~  242 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNESP  242 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHhccCC
Confidence              12345788999999873   46788999999999999999999999865322111             1111111110


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                      ..+      .......+.+++.+|++.+|++||++.++++..
T Consensus       243 ~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 TLQ------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CCC------CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            000      112245688999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.2e-33  Score=286.73  Aligned_cols=248  Identities=24%  Similarity=0.338  Sum_probs=198.4

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|...+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999665 68899999987542  23445678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~  630 (763)
                      +++++|.+++.... ..+++.....++.++++|+.||   |+.+++|+||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999986543 2578999999999999999999   788999999999999999875 569999999877643221


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......|+..|+|||+..+..++.++||||||++++||++|..||.........             .+.........
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~~  222 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV-------------LKICQGYFAPI  222 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-------------HHHhcccCCCC
Confidence              122345888999999998888999999999999999999999998753221111             11111111100


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +       ......+.+++.+|+..+|++||++.++++
T Consensus       223 ~-------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 S-------PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             C-------CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0       012346889999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.7e-33  Score=300.98  Aligned_cols=265  Identities=23%  Similarity=0.248  Sum_probs=197.2

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC------
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSND------  543 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  543 (763)
                      ..++|+..+.||+|+||.||+|.. .+|+.||+|++...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999965 47899999998643  223345677899999999999999999988643      


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      ...++||||+++ +|.+.+...   ++......++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||.++
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            357999999965 777776542   78888899999999999999   78899999999999999999999999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc--ccCChhHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN--GLLPVSLME  701 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~  701 (763)
                      ......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ......  +..+..+.+
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence            754221   12334578899999999999999999999999999999999999975332111 111110  111111111


Q ss_pred             HHHhh----cCCCcccc---H--------------HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VVNKT----LLSPPEKD---F--------------AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i~~~----l~~~~~~~---~--------------~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+...    ....+..+   .              .........+.+++.+|++.||++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111    11111000   0              000112456789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=281.52  Aligned_cols=263  Identities=23%  Similarity=0.304  Sum_probs=218.6

Q ss_pred             HHHHHHHhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeee
Q 046240          468 QDLSRATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGC  540 (763)
Q Consensus       468 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~  540 (763)
                      +++....+|++....+-+|.||.||.|.+.      +.+.|.+|.++... +-....+..|...+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            456666778888888999999999999543      45678888776543 33456788899999999999999999998


Q ss_pred             ecC-CceEEEEEccCCCChhhhhcc-----C--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC
Q 046240          541 SND-DFKALVLEYMPNGSLDIFLYS-----S--TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM  612 (763)
Q Consensus       541 ~~~-~~~~lv~e~~~~g~L~~~l~~-----~--~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~  612 (763)
                      .++ +..+.+|.++..|+|..++..     .  .+.+...+...++.|++.|++||   |+.+|||.||.++|.++|+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhhe
Confidence            655 578899999999999999972     1  22567778889999999999999   889999999999999999999


Q ss_pred             cEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhh
Q 046240          613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWV  691 (763)
Q Consensus       613 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~  691 (763)
                      .+||+|=.+++.+-+.+.+.-......+..||+||.+....|+.++|||||||+||||+| |+.||......+       
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------  506 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------  506 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------
Confidence            999999999999888888887788889999999999999999999999999999999999 999987643221       


Q ss_pred             cccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          692 NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       692 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                             +...    +.  ...|...+..|+++++.+|.-||..+|++||+++++..-|.+.
T Consensus       507 -------m~~y----lk--dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  507 -------MEHY----LK--DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             -------HHHH----Hh--ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                   1111    11  1223444556899999999999999999999999999887654

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-34  Score=287.17  Aligned_cols=200  Identities=25%  Similarity=0.356  Sum_probs=177.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .+.|..-++||+|+||.||-.+.+ +|+.+|.|.+.+...   ........|-.+|++++.+.||.+-..|+..+..|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356788899999999999999654 799999998865532   2345567899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          550 LEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      +..|.||+|..+|...+ ..++.....-.|.+|+.||++|   |...||.||+||+|||+|+.|+++|+|.|+|..++..
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999987754 3688888889999999999999   8999999999999999999999999999999998654


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      ..   ....+||.+|||||++.++.|+...|.||+||++|||+.|+.||..
T Consensus       341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            43   3456899999999999999999999999999999999999999976

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-33  Score=291.54  Aligned_cols=267  Identities=25%  Similarity=0.289  Sum_probs=199.0

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceEEEEE
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKALVLE  551 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  551 (763)
                      |++.+.||+|+||.||+|... +++.+|+|++....  ......+.+|++++++++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999765 58899999998653  23345678899999999999999999999888  89999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++ +|..++......+++.....++.|+++|++||   |+.+++|+||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 88888876645789999999999999999999   678999999999999999999999999999987643321 


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHH---HH-HH
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLM---EV-VN  704 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~---~~-i~  704 (763)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........  .........+....   ++ ..
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            12233456888999997654 46789999999999999999999999764322110  11111110000000   00 00


Q ss_pred             hhcCCCccccH---H-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLSPPEKDF---A-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~~~~---~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...........   . ....+...+.+++.+|++.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00000000000   0 00112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8e-33  Score=285.27  Aligned_cols=251  Identities=27%  Similarity=0.350  Sum_probs=203.8

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKALVL  550 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  550 (763)
                      +|...+.||+|++|.||+|... +++.|++|++....  ....+.+.+|++++++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999776 78999999987553  24567788999999999999999999999988  8899999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|.+++.... .+++..+..++.+++++++||   |+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999987654 689999999999999999999   779999999999999999999999999999988754332


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      ........++..|+|||...+..++.++||||||+++++|++|..||...........            .+..   ...
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------------~~~~---~~~  221 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY------------KIGS---SGE  221 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH------------hccc---cCC
Confidence            1123345688899999999888899999999999999999999999876431110000            0000   000


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .   ....+.....+.+++.+|+..+|++||++.++++
T Consensus       222 ~---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 P---PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             C---cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            0   0011122567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.6e-34  Score=318.41  Aligned_cols=256  Identities=26%  Similarity=0.323  Sum_probs=192.2

Q ss_pred             HHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeec------
Q 046240          471 SRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSN------  542 (763)
Q Consensus       471 ~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  542 (763)
                      .+-..+|++.+.||+||||.||+++.. ||+.||||++.... ......+.+|++.+++++|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678999999999999999999776 89999999997553 3445678899999999999999999843310      


Q ss_pred             -----------------------------------------------------------C--------------------
Q 046240          543 -----------------------------------------------------------D--------------------  543 (763)
Q Consensus       543 -----------------------------------------------------------~--------------------  543 (763)
                                                                                 .                    
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                       0                    


Q ss_pred             ----------------------------------CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046240          544 ----------------------------------DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN  589 (763)
Q Consensus       544 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh  589 (763)
                                                        ...||-||||+...+.+++.++...-.....+++..+|++||+|+ 
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI-  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI-  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH-
Confidence                                              123678899998888888876543224567788999999999999 


Q ss_pred             hcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC----------------CCCCccccccccccccccCccccCCC-
Q 046240          590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS----------------GEDQSMTQTQTLATIGYMAPEYGIER-  652 (763)
Q Consensus       590 ~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~~~~-  652 (763)
                        |++|||||||||.|||+|+++.|||+|||+|+...                ........+..+||.-|+|||++.+. 
T Consensus       714 --H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  714 --HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             --HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence              89999999999999999999999999999998721                00111234677899999999998764 


Q ss_pred             --CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHH
Q 046240          653 --KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAM  730 (763)
Q Consensus       653 --~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~  730 (763)
                        .|+.|+|+||+||+++||+.   ||...-.....+...-.+.+|.+ .++.               ...+..=.+++.
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~---------------~~~~~~e~slI~  852 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFF---------------DPEHPEEASLIR  852 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-cccc---------------cccchHHHHHHH
Confidence              49999999999999999995   45542222211222112222222 1000               111233468899


Q ss_pred             HccccCcCCCCCHHHHHH
Q 046240          731 ECTMELPEKRINAKCCNF  748 (763)
Q Consensus       731 ~cl~~~P~~Rps~~~v~~  748 (763)
                      +++++||.+||||.|+++
T Consensus       853 ~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHhcCCCccCCCHHHHhh
Confidence            999999999999999986

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=288.76  Aligned_cols=266  Identities=23%  Similarity=0.255  Sum_probs=201.7

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      |...+.||+|++|.||+|... +++.+++|++.....  .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999664 788999999875432  24567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++ ++.+++......+++..+..++.++++|+.||   |+.+++|+||||+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            76 78777766555789999999999999999999   78899999999999999999999999999998765332  12


Q ss_pred             cccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChh---HHHHHHhhc
Q 046240          634 QTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVS---LMEVVNKTL  707 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~---~~~~i~~~l  707 (763)
                      .....++..|+|||.+.+. .++.++||||||+++|+|+||+.||.........  .........+..   ..+......
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2234578899999988766 7899999999999999999999998654322111  111111111111   111111111


Q ss_pred             CC----CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LS----PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..    ..............++.+++..|++.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00    011111122345678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-33  Score=285.68  Aligned_cols=248  Identities=24%  Similarity=0.310  Sum_probs=191.7

Q ss_pred             ceecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHHHHHH-hCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVECEVMK-NIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||.||+|.. .+|+.||+|++.....   .....+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999966 4688999999865321   22233445554444 45899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      ++|..++.... .++...+..++.|+++||.||   |+.+++||||+|+||++++++.+||+|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999987643 578889999999999999999   788999999999999999999999999999876432      22


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...++..|+|||...+..++.++||||||+++|||++|..||........ .            ..+.........    
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~------------~~~~~~~~~~~~----  214 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-F------------DNILSRRINWPE----  214 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-H------------HHHHhcccCCCC----
Confidence            34578899999998888889999999999999999999999975322111 0            011111111110    


Q ss_pred             HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       716 ~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      .....+...+.+++.+|+..+|++||++.++.+.+....-
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence            1111245678999999999999999998877776665443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-33  Score=298.51  Aligned_cols=270  Identities=21%  Similarity=0.250  Sum_probs=197.8

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecC-----Cce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSND-----DFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  546 (763)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999965 578999999986432 23345677899999999999999999887544     357


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++|+||+++ ++..++...  .+++.....++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            999999975 777776543  488899999999999999999   78899999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh--hhhhhhhcccCChhHHHH
Q 046240          627 GEDQS-MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE--LSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       627 ~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~  702 (763)
                      ..... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ...........++....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32211 11233568899999998654 568899999999999999999999996532211  111111111111222221


Q ss_pred             HHhh-------cCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          703 VNKT-------LLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       703 i~~~-------l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .+..       ....+..... .......++.+++.+|++.+|++||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111       0011111100 011224568899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-32  Score=287.80  Aligned_cols=263  Identities=21%  Similarity=0.240  Sum_probs=193.6

Q ss_pred             cCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCC-CCccceEEeeeecC--CceEEEEE
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIR-HRNLVKIISGCSND--DFKALVLE  551 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  551 (763)
                      |...+.||+|+||.||+|.. .+++.||+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56778999999999999965 468899999987542 122233457888899885 99999999999887  88999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++ ++.+.+......+++..+..++.|++.||+||   |+.+++||||+|+||+++. +.+||+|||+++....... 
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            9975 77777765545689999999999999999999   7889999999999999999 9999999999987643221 


Q ss_pred             cccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChhHHHHHHhhcC
Q 046240          632 MTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                        .....++..|+|||+.. +..++.++|||||||++|||++|..||......+.  ...... +..++.+.......-.
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVL-GTPDAEVLKKFRKSRH  231 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHc-CCCCHHHHHhhccccc
Confidence              12345788999999764 45678899999999999999999999976432211  111111 1111111111111000


Q ss_pred             CC---ccc----cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SP---PEK----DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~---~~~----~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   +..    -..........+.+++.+|++.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00   000    00111234678999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.5e-33  Score=290.12  Aligned_cols=267  Identities=22%  Similarity=0.262  Sum_probs=198.5

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +|+..+.||.|++|.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999775 688999999875432 23456678999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          554 PNGSLDIFLYSST--CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       554 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      ++ +|.+++....  ..+++..+..++.|+++||.||   |+.+++||||||+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 7887776543  3589999999999999999999   788999999999999999999999999999876532211 


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhh--hhhhcccCChhHHHHHHhh-c
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL--KHWVNGLLPVSLMEVVNKT-L  707 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~-l  707 (763)
                       ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+...  ........+..+..+.... .
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             1233457889999998765 457889999999999999999999997643222111  1111111111111111100 0


Q ss_pred             -CCCcccc----HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 -LSPPEKD----FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 -~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ...+...    ..........+.+++..|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             0000000    0011123456889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=318.92  Aligned_cols=261  Identities=27%  Similarity=0.452  Sum_probs=210.3

Q ss_pred             HHhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeec
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSN  542 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  542 (763)
                      ..++..+.+.+|+|+||.|++|...        ....||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3445566679999999999999643        14579999987553 34677889999999999 69999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL  607 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIl  607 (763)
                      ++..++|.||+..|+|..+++..+               ..+...+.+.++.|||.|++||   ++.++|||||.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhhhhEE
Confidence            999999999999999999998766               3488889999999999999999   8889999999999999


Q ss_pred             ecCCCcEEEeeecCceecCCCCCcccc-ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhh
Q 046240          608 LDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAEL  685 (763)
Q Consensus       608 l~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~  685 (763)
                      +.++..+||+|||+|+.....+..... ....-...|||||.+....++.|+|||||||+|||++| |..||.+....  
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--  528 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--  528 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence            999999999999999976544333211 11113556999999999999999999999999999999 89998652111  


Q ss_pred             hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          686 SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       686 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                                    .+++. .+.  ...|...++.|..++.++|..||+.+|++||++.++.+.+..++.
T Consensus       529 --------------~~l~~-~l~--~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  529 --------------EELLE-FLK--EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             --------------HHHHH-HHh--cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence                          11111 111  112233344567889999999999999999999999999988654

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-32  Score=283.81  Aligned_cols=248  Identities=26%  Similarity=0.357  Sum_probs=202.9

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|...+.||+|+||.||++... +++.|++|++....  ....+.+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999665 68899999987543  24566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          553 MPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       553 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +++++|.+++...   ...+++.....++.++++|+.||   |+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999998764   25789999999999999999999   78899999999999999999999999999998764332


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        .......++..|+|||...+..++.++||||+|+++++|++|+.||........             ...........
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~  222 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL-------------ALKILKGQYPP  222 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH-------------HHHHhcCCCCC
Confidence              122334688899999998888899999999999999999999999876321110             01111111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.       .+...+.+++..|+..+|++||++.++++
T Consensus       223 ~~~-------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 IPS-------QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111       23456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=8.9e-33  Score=293.46  Aligned_cols=270  Identities=24%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCC------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  544 (763)
                      -++|...+.||+|+||.||+|... +++.||||++.....  .....+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999664 689999998864321  12334567999999999999999999986554      


Q ss_pred             --ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          545 --FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       545 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                        ..++||||+.+ ++...+......+++.....++.|++.||+||   |+.+++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              45999999975 77777766555689999999999999999999   7789999999999999999999999999999


Q ss_pred             eecCCCCCc--cccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh-hhhhhhcccCChh
Q 046240          623 KLLSGEDQS--MTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL-SLKHWVNGLLPVS  698 (763)
Q Consensus       623 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~  698 (763)
                      ..+......  .......++..|+|||++.+. .++.++||||||+++|||++|..||........ .......+..+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            876432211  112334578899999987654 478899999999999999999999876432211 1111111111111


Q ss_pred             H------HHHHHhhcCCCccccHHHHH-----HHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 L------MEVVNKTLLSPPEKDFAAKE-----QCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ~------~~~i~~~l~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .      .+..+. .............     .....+.+++..|+..+|++||+++++++
T Consensus       247 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKK-MELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhh-ccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0      000010 0000000000000     01245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-32  Score=290.27  Aligned_cols=267  Identities=24%  Similarity=0.275  Sum_probs=193.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|+..+.||+|++|+||+|... +|+.||+|.+....  ....+.+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999765 78899999886432  2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-CCcEEEeeecCceecCCCC
Q 046240          552 YMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       552 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~  629 (763)
                      |+++ ++.+++... ....++.....++.|++.||+||   |+++++||||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9965 676666443 22467788889999999999999   7889999999999999985 5679999999997653221


Q ss_pred             CccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhh--hhcccCChhH------H
Q 046240          630 QSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH--WVNGLLPVSL------M  700 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~------~  700 (763)
                        .......++..|+|||++.+ ..++.++||||+||++|||+||+.||............  .........+      .
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence              11233457889999998765 45789999999999999999999999754322211111  0000000000      0


Q ss_pred             HHHHhhcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 EVVNKTLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.... ....+.... ........++.+++.+|++.+|++||++.++++
T Consensus       236 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSA-FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhh-cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000 000000000 001112456789999999999999999999986

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-33  Score=294.64  Aligned_cols=269  Identities=22%  Similarity=0.289  Sum_probs=194.5

Q ss_pred             ccCcCceecccCCceEEEEEec---CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD---DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKA  547 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  547 (763)
                      +|.+.+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.++++++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999764   47899999987632   23345677899999999999999999999888  7899


Q ss_pred             EEEEccCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC----CCcEEEeee
Q 046240          548 LVLEYMPNGSLDIFLYSS----TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE----DMIAHLSDF  619 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~----~~~~kl~Df  619 (763)
                      +||||+++ ++.+++...    ...++......++.|++.|+.||   |+.+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 555554321    12578888999999999999999   7889999999999999999    899999999


Q ss_pred             cCceecCCCCC-ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh--------hhhhh
Q 046240          620 GIAKLLSGEDQ-SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE--------LSLKH  689 (763)
Q Consensus       620 gla~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~--------~~~~~  689 (763)
                      |+++.+..... ........++..|+|||+..+ ..++.++|||||||+++||++|+.||.......        ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643222 122234567889999998765 457899999999999999999999997543221        01111


Q ss_pred             hhccc---CChhH---------HHHHHhh-cCCCccccHHH--HH--HHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          690 WVNGL---LPVSL---------MEVVNKT-LLSPPEKDFAA--KE--QCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       690 ~~~~~---~~~~~---------~~~i~~~-l~~~~~~~~~~--~~--~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .....   .+...         ....+.. ....+......  ..  .....+.+++.+|++.+|++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11000   00000         0000000 00000000000  00  22456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-32  Score=290.90  Aligned_cols=268  Identities=22%  Similarity=0.240  Sum_probs=194.3

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCC-CCccceEEeeeecCCc-----
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDF-----  545 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  545 (763)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999764 689999998865432  22356788999999995 6999999999977665     


Q ss_pred             eEEEEEccCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-CCcEEEeeec
Q 046240          546 KALVLEYMPNGSLDIFLYSS----TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHLSDFG  620 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-~~~~kl~Dfg  620 (763)
                      .++||||+++ ++.+++...    ...+++.....++.||++||.||   |+++++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 787777543    23578999999999999999999   7889999999999999998 8899999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh--hhhcccCCh
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK--HWVNGLLPV  697 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~--~~~~~~~~~  697 (763)
                      .++.+.....  ......+++.|+|||++.+ ..++.++||||||+++|||++|..||...........  .........
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9886532211  1223456888999998764 4578999999999999999999999875332211111  100000000


Q ss_pred             ---hHHHHHHhh-c-CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 ---SLMEVVNKT-L-LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ---~~~~~i~~~-l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         ...+..+.. . ...+............++.+++..|+.++|++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               000000000 0 00000000111123566899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.1e-33  Score=297.78  Aligned_cols=270  Identities=24%  Similarity=0.282  Sum_probs=199.4

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeec----CCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSN----DDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  546 (763)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            47899999999999999999965 468999999987542  2234567789999999999999999988753    3468


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++|+||+. ++|..++.... .+++.....++.|+++||.||   |+.+++||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999996 58888886544 489999999999999999999   77899999999999999999999999999997764


Q ss_pred             CCCCc--cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh-hhhhhhcccCChhHH--
Q 046240          627 GEDQS--MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL-SLKHWVNGLLPVSLM--  700 (763)
Q Consensus       627 ~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~--  700 (763)
                      .....  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .......+..+....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211  11123468899999998765 5688999999999999999999999976432111 111111111111111  


Q ss_pred             ---HHHHhhcCCCc---cccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 ---EVVNKTLLSPP---EKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ---~~i~~~l~~~~---~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         +.+.+.....+   ..... ........+.+++..|++.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               11111111111   11110 11223567899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.5e-33  Score=291.48  Aligned_cols=244  Identities=25%  Similarity=0.288  Sum_probs=195.6

Q ss_pred             CceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          480 DNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ...||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46799999999999966 47899999998654444566788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccc
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL  638 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  638 (763)
                      .+++...  .+++.....++.|++.+++||   |+.+++||||+|+||++++++.++|+|||.+........  ......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence            9987543  478889999999999999999   778999999999999999999999999999876542211  123346


Q ss_pred             ccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHH
Q 046240          639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK  718 (763)
Q Consensus       639 g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  718 (763)
                      ++..|+|||+..+..++.++|+||||+++|||++|..||........              ...+...+......    .
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--------------~~~~~~~~~~~~~~----~  239 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------------MKMIRDNLPPKLKN----L  239 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------------HHHHHhhCCcccCC----c
Confidence            78899999998888889999999999999999999999875321110              01111111100000    0


Q ss_pred             HHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          719 EQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       719 ~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......+.+++.+|++.+|.+||++.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            112345788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.2e-33  Score=292.23  Aligned_cols=272  Identities=24%  Similarity=0.295  Sum_probs=199.4

Q ss_pred             HHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCC----
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDD----  544 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  544 (763)
                      ...++|++.+.||+|+||.||+|... +|+.||+|+++....  .....+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999775 688999999875432  23356678999999999999999999987654    


Q ss_pred             ------ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          545 ------FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       545 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                            ..++|+||+++ ++...+......+++.....++.|++.||+||   |+.+|+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999987 66666665544689999999999999999999   788999999999999999999999999


Q ss_pred             ecCceecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccC
Q 046240          619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLL  695 (763)
Q Consensus       619 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~  695 (763)
                      ||.+..+..... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........  .+........
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999987643321 12223346788999998754 4578899999999999999999999975332111  1111111111


Q ss_pred             ChhHHHHHHhhcCC----Cccc-c--HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          696 PVSLMEVVNKTLLS----PPEK-D--FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       696 ~~~~~~~i~~~l~~----~~~~-~--~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +....++.......    .... +  ..........+.+++..|++.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111111000000    0000 0  0011123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8e-33  Score=291.19  Aligned_cols=259  Identities=19%  Similarity=0.189  Sum_probs=183.9

Q ss_pred             HhccCcCceecccCCceEEEEEecC----CceEEEEEeehhhHH---H--------HHHHHHHHHHHHhCCCCccceEEe
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD----GIEVAIKVFHQECAR---A--------MKSFEVECEVMKNIRHRNLVKIIS  538 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~~~~---~--------~~~~~~e~~~l~~l~h~niv~l~~  538 (763)
                      .++|.+.+.||+|+||+||+|...+    +..+|+|+.......   .        ......+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999997654    456677754322110   0        011223344556678999999999


Q ss_pred             eeecCC----ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          539 GCSNDD----FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       539 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      ++....    ..++++|++.. ++.+.+... ...++.....++.|+++||+||   |+.+|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCcE
Confidence            775543    34677887644 455554432 2356778889999999999999   78899999999999999999999


Q ss_pred             EEeeecCceecCCCCCc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhh
Q 046240          615 HLSDFGIAKLLSGEDQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH  689 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~  689 (763)
                      +|+|||+|+.+......     .......||+.|+|||+..+..++.++|||||||++|||++|+.||............
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999876432211     1122346899999999999999999999999999999999999999864222111110


Q ss_pred             hhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          690 WVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       690 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                              ...+++.+.......     ...+...+.+++..|++.+|++||++.++.+.+
T Consensus       246 --------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 --------AKCDFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             --------hHHHHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                    001111111111100     112356689999999999999999999999876

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.8e-32  Score=293.35  Aligned_cols=265  Identities=21%  Similarity=0.272  Sum_probs=192.6

Q ss_pred             ceeccc--CCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIG--SFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G--~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      ..||+|  +||+||++.. .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  8999999966 47999999998643  233457788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc-
Q 046240          556 GSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT-  633 (763)
Q Consensus       556 g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-  633 (763)
                      +++.+++.... ..+++.....++.|++.||+||   |+.+++||||||+||+++.++.++++||+.+........... 
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999887542 2578888899999999999999   788999999999999999999999999986543321111100 


Q ss_pred             ----cccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccC--------ChhH
Q 046240          634 ----QTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL--------PVSL  699 (763)
Q Consensus       634 ----~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~  699 (763)
                          .....++..|+|||++.+  ..++.++|||||||++|||++|+.||..................        +...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                111234667999999876  35789999999999999999999999764332221111110000        0000


Q ss_pred             HHHH-----------Hhhc-------CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 MEVV-----------NKTL-------LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 ~~~i-----------~~~l-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....           ....       ......+......+...+.+++.+|+..||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0000           0000       00011112223345678999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.6e-33  Score=293.04  Aligned_cols=269  Identities=25%  Similarity=0.271  Sum_probs=196.5

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  548 (763)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999664 689999999874422  1223456799999999999999999998755  46899


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++ +|.+++......+++.....++.|+++|++||   |+.+++||||||+||++++++.+||+|||.+..+...
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999975 78888776555789999999999999999999   7889999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHHHh
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~  705 (763)
                      ..  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.........  ...............+...
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            21  2223345788999998765 55789999999999999999999999754322111  1111110000000000000


Q ss_pred             h------cCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 T------LLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~------l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .      +...+..... ........+.+++..|++.||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0      0000000000 00112456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.3e-32  Score=282.83  Aligned_cols=242  Identities=26%  Similarity=0.334  Sum_probs=193.3

Q ss_pred             ecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          483 IGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       483 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ||.|++|.||++... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999765 58899999987542   23456788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccc
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL  638 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  638 (763)
                      .+++.... .++...+..++.|+++||+||   |+.+++|+||+|+||+++.++.++|+|||.++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997653 478889999999999999999   78999999999999999999999999999998764322   122346


Q ss_pred             ccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHH
Q 046240          639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK  718 (763)
Q Consensus       639 g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  718 (763)
                      ++..|+|||.+.+..++.++|+||+|+++|||++|..||.......               .++.........  ....+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~--~~~~~  216 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---------------MEIYNDILKGNG--KLEFP  216 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---------------HHHHHHHhccCC--CCCCC
Confidence            7889999999888889999999999999999999999997643110               111111110000  00011


Q ss_pred             HHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          719 EQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       719 ~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                      ......+.+++.+||..+|++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            112457899999999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.9e-32  Score=284.13  Aligned_cols=249  Identities=20%  Similarity=0.206  Sum_probs=192.6

Q ss_pred             HHHHHHHhccCcCcee--cccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          468 QDLSRATNRFGRDNLI--GIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       468 ~~~~~~~~~~~~~~~l--g~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      .+.....++|.+.+.+  |+|+||.||++.. .++..+|+|.+.......     .|+.....+ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            4445556778887777  9999999999965 468889999987542111     122222222 799999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeecCc
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIA  622 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla  622 (763)
                      +..++||||+++++|.+++.... .+++.....++.|+++|+.||   |+.+++||||||+||+++.++ .++|+|||.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            99999999999999999997654 689999999999999999999   788999999999999999988 9999999998


Q ss_pred             eecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      +.....      ....++..|+|||++.+..++.++|||||||++|||++|+.||............+            
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------  219 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL------------  219 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH------------
Confidence            865322      22457889999999998899999999999999999999999997543222111111            


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC-HHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-AKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-~~~v~~  748 (763)
                      .... .....    ........+.+++..|++.+|++||+ ++++++
T Consensus       220 ~~~~-~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        220 LKRQ-QKKLP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHhh-cccCC----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1111 11100    01123556889999999999999996 588764

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-32  Score=290.64  Aligned_cols=252  Identities=25%  Similarity=0.272  Sum_probs=193.8

Q ss_pred             HhccCcCceecccCCceEEEEEecC-CceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++|++.+.||+|+||.||+|...+ ++.||||+++... ......+..|+.++.+. .||||+++++++......++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3568889999999999999998764 8999999987542 22345566677777766 4999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      ||+++ ++..++......+++..+..++.++++|++||   |+ .+|+||||+|+||++++++.+||+|||.+..+....
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYL---KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            99854 67766655445788999999999999999999   54 589999999999999999999999999987654222


Q ss_pred             CccccccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERK----VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .   .....++..|+|||++.+..    ++.++||||||+++|||++|+.||..............            ..
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------~~  234 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL------------QE  234 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh------------cC
Confidence            1   12335788999999987543    78899999999999999999999875322211111111            11


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .....+..     ..+..++.+++.+|++.+|++||++.++++.
T Consensus       235 ~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         235 EPPSLPPN-----EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCC-----CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10000000     0234568999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-32  Score=285.30  Aligned_cols=250  Identities=27%  Similarity=0.340  Sum_probs=198.4

Q ss_pred             ecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       483 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ||.|+||.||++... +|+.|++|++.....   ...+.+.+|++++++++||||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999776 589999999875432   3456788899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC------cc
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ------SM  632 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------~~  632 (763)
                      .+++.... .+++..+..++.|+++||+||   |+.+++||||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987654 588999999999999999999   788999999999999999999999999999876432211      11


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......++..|+|||.......+.++||||||+++||+++|..||........                 ..........
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~~~  219 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----------------FQNILNGKIE  219 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HHHHhcCCcC
Confidence            22344578899999998888899999999999999999999999875332111                 1111110000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      . + ........+.+++.+|++.+|++||++.++.+.++....
T Consensus       220 ~-~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~  260 (265)
T cd05579         220 W-P-EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF  260 (265)
T ss_pred             C-C-ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence            0 0 000124568999999999999999999777777665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.9e-32  Score=291.50  Aligned_cols=265  Identities=21%  Similarity=0.244  Sum_probs=191.3

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCC
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGS  557 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  557 (763)
                      ++.+|.|+++.||++.. +++.||+|++...  .....+.+.+|+++++.++||||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34445555555555544 6899999998754  33456778999999999999999999999999999999999999999


Q ss_pred             hhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc-----
Q 046240          558 LDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS-----  631 (763)
Q Consensus       558 L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-----  631 (763)
                      +.+++... ...++......++.|+++||+||   |+.+|+||||||+||+++.++.+|++|||.+..+......     
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99998753 23578888999999999999999   7889999999999999999999999999998765322211     


Q ss_pred             cccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhH----HHHHHh
Q 046240          632 MTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSL----MEVVNK  705 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~i~~  705 (763)
                      .......++..|+|||++..  ..++.++|||||||++|||++|+.||............ ..+..+...    ......
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhcC
Confidence            11233456788999998865  45889999999999999999999999764322211111 111100000    000000


Q ss_pred             hcCC------Ccc----ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          706 TLLS------PPE----KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       706 ~l~~------~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ....      .+.    ............+.+++..||..+|++||++.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0000      000    0001112234578899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=281.99  Aligned_cols=247  Identities=31%  Similarity=0.390  Sum_probs=201.4

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|+..+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++++++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999665 678999999875532  4567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++... ..+++..+..++.|++.++.||   |+.+++||||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998765 3689999999999999999999   7889999999999999999999999999999876533321 


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                       .....++..|+|||...+..++.++||||+|++++||++|..||.........             .....   ...+.
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~-------------~~~~~---~~~~~  218 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL-------------FRIVQ---DDHPP  218 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-------------HHHhc---cCCCC
Confidence             23356788999999988878899999999999999999999998653211100             00000   00111


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .    .......+.+++.+|+..+|++||++.+++.
T Consensus       219 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 L----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             C----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            0    1112456889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-33  Score=269.83  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             ChHHHHHHHhccCcCceecccCCceEEEE-EecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          466 PYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       466 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      .++|+...++     +.+|+|+|+.|-.+ ...+|+++|||++.+...-...+..+|++++.+. .|+||++++++|.++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3577777775     68999999999988 5678999999999877655677888999999999 499999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC---cEEEeeec
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM---IAHLSDFG  620 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~---~~kl~Dfg  620 (763)
                      ...|+|||.|.||+|...|+... .++..+...+..+||.||.+|   |.+||.||||||+|||...-.   -+|||||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999887654 588889999999999999999   899999999999999996544   47999998


Q ss_pred             CceecCCCC-----CccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh
Q 046240          621 IAKLLSGED-----QSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW  690 (763)
Q Consensus       621 la~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~  690 (763)
                      +..-+....     ........+|+..|||||+..     ...|+.++|.||+||++|-|++|.+||.+.-.+.-   .|
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GW  301 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GW  301 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---Cc
Confidence            865432111     112224567899999999642     34688999999999999999999999987543322   12


Q ss_pred             hcccCChhHHHHHHhhcCC----CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          691 VNGLLPVSLMEVVNKTLLS----PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       691 ~~~~~~~~~~~~i~~~l~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      -++..=...++.+-..+..    -|+++..   ....+-.+++...+..||.+|.++.++++
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWa---hIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWA---HISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCCcCChhhhH---HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            2222211222222222211    1222211   22445667777778899999999988876

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-32  Score=295.62  Aligned_cols=268  Identities=22%  Similarity=0.256  Sum_probs=198.9

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC-----Cc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSND-----DF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  545 (763)
                      .++|.+.+.||+|+||+||+|.. .+++.||||.+...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45789999999999999999965 47899999998643  222345667899999999999999999988644     35


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++|+||+. ++|.+++.... .++......++.|++.||.||   |+.+++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999996 57888876543 588999999999999999999   7889999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh--hhhhhhhcccCCh-----
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE--LSLKHWVNGLLPV-----  697 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~-----  697 (763)
                      .....  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||.......  ...........+.     
T Consensus       159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         159 SEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             CCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            43221  2233457889999998764 568899999999999999999999996532211  1111111111111     


Q ss_pred             ---hHHHHHHhhcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          698 ---SLMEVVNKTLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       698 ---~~~~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                         ...+.+. .....+.... .....+...+.+++.+|++.+|++||+++++++-
T Consensus       237 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         237 RNEKARRYIR-SLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CchhhhHHHH-hcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence               1111111 1111111111 1112345678999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3e-32  Score=280.75  Aligned_cols=246  Identities=25%  Similarity=0.309  Sum_probs=200.6

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|++.+.||+|+||.||++.. .+++.+|+|++....  ......+.+|++++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999955 478899999987542  23456677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          553 MPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       553 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      +++++|..++...   ...+++.....++.++++|++||   |+.+++||||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652   23578889999999999999999   8899999999999999999999999999999876433 


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                         ......++..|+|||...+..++.++|+||||+++|||++|+.||........              ...+.   ..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--------------~~~~~---~~  216 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--------------RYKVQ---RG  216 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------------HHHHh---cC
Confidence               22234578899999999998999999999999999999999999976432211              00011   01


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....   ........+.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         217 KYPP---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCC---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1000   11133566899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.9e-32  Score=292.78  Aligned_cols=269  Identities=24%  Similarity=0.274  Sum_probs=199.3

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeec-CC
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSN-DD  544 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  544 (763)
                      ++...+++|+..+.||.|+||.||+|.. .+++.||+|++....  ....+.+.+|+++++.++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            3445678999999999999999999964 478999999876432  2234667889999999999999999999865 55


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..++|+||+ +++|..++...  .++......++.|+++||.||   |+.+++||||+|+||++++++.++|+|||.+..
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            789999998 55888887643  367788888999999999999   788999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh--hhhhhhhcccCChhH--
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE--LSLKHWVNGLLPVSL--  699 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~--  699 (763)
                      ....     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.......  ......... .+++.  
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~  231 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT-PPDDVIN  231 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CCHHHHH
Confidence            4321     123456888999998765 578999999999999999999999996533211  111111111 11111  


Q ss_pred             -------HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          700 -------MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       700 -------~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                             .+++...-...+.............+.+++.+|++.+|++||++.+++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   11111111111110001111234678999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-32  Score=286.31  Aligned_cols=243  Identities=24%  Similarity=0.283  Sum_probs=190.6

Q ss_pred             ecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       483 lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ||+|+||+||++.. .+|+.||+|++....   ......+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999965 468899999987542   12344567899999999999999999999999999999999999999


Q ss_pred             hhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccc
Q 046240          559 DIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT  637 (763)
Q Consensus       559 ~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  637 (763)
                      .+++.... ..+++..+..++.|++.|+.||   |+.+++||||+|+||++++++.++|+|||.+.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99987643 3588999999999999999999   78899999999999999999999999999987654211   22334


Q ss_pred             cccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHH
Q 046240          638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA  717 (763)
Q Consensus       638 ~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~  717 (763)
                      .++..|+|||+..+..++.++|||||||++|||++|+.||........             ..++..........    .
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~~~----~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-------------KEELKRRTLEMAVE----Y  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-------------HHHHHhcccccccc----C
Confidence            578899999998888899999999999999999999999865322100             00111111111100    1


Q ss_pred             HHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          718 KEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       718 ~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      .......+.+++.+|++.+|++||     ++.++++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            112245688999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.7e-32  Score=288.19  Aligned_cols=246  Identities=26%  Similarity=0.335  Sum_probs=194.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      +.|...+.||+|+||.||+|... +++.||+|.+...   .....+.+.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777788999999999999764 6788999988632   2234456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+. |++.+.+......+++..+..++.+++.|+.||   |+.+++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9997 577777655455688999999999999999999   7889999999999999999999999999998765422  


Q ss_pred             ccccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          631 SMTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                          ....++..|+|||++.   ...++.++|||||||++|||++|..||......... ..            +.....
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~------------~~~~~~  231 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YH------------IAQNES  231 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HH------------HhhcCC
Confidence                2345788999999864   356788999999999999999999998653221110 01            110000


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                         +...   .......+.+++.+||+.+|++||++.++++.
T Consensus       232 ---~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 ---PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence               1000   11234568899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.1e-32  Score=286.64  Aligned_cols=243  Identities=26%  Similarity=0.313  Sum_probs=192.0

Q ss_pred             cCcCceecccCCceEEEEEe-cCCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      |...+.||+|+||+||+|.. .+|+.|++|++...   .......+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999965 46889999998643   223445678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +.+ ++.+++......+++.++..++.|++.++.||   |+.+++||||+|+||+++.++.+||+|||.+....      
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------  172 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------  172 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence            964 67777765555689999999999999999999   77899999999999999999999999999886432      


Q ss_pred             ccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          633 TQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ......++..|+|||++.   ...++.++|||||||++|||++|..||..........             .....   .
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-------------~~~~~---~  236 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------HIAQN---D  236 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------HHHhc---C
Confidence            112346888999999874   4668889999999999999999999987643211110             00000   0


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+...   .......+.+++.+|++.+|++||++.++++
T Consensus       237 ~~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         237 SPTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            01100   0112345789999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-32  Score=293.25  Aligned_cols=269  Identities=22%  Similarity=0.239  Sum_probs=202.8

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC-----ceE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-----FKA  547 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  547 (763)
                      +|.+.+.||+|++|.||+|... +++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999765 58999999987543  334567889999999999999999999987765     789


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||+++ +|.+++.... .+++..+..++.++++||+||   |+.+|+||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99999984 7888886654 688999999999999999999   788999999999999999999999999999987653


Q ss_pred             CCCc-cccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCC-------
Q 046240          628 EDQS-MTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLP-------  696 (763)
Q Consensus       628 ~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~-------  696 (763)
                      .... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.........  .........+       
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            3210 122345678899999998877 8899999999999999999999999764322110  1111111011       


Q ss_pred             -hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          697 -VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       697 -~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                       ....+.+...-...+.............+.+++..||+.+|++||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             11111111100000000000111235678999999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-32  Score=285.76  Aligned_cols=241  Identities=23%  Similarity=0.259  Sum_probs=184.1

Q ss_pred             eecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHh---CCCCccceEEeeeecCCceEEEEEccC
Q 046240          482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKN---IRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      .||+|+||.||++.. .+++.||+|.+....   ......+.+|..+++.   .+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999966 468899999886432   1112233444444333   479999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|.+++.... .+++.....++.|++.||+||   |+.+|+||||||+||++++++.++++|||++.......    .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999998887544 589999999999999999999   78899999999999999999999999999987653221    1


Q ss_pred             ccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....|+..|+|||... +..++.++|||||||++|||++|..||.........           ......   ...... 
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----------~~~~~~---~~~~~~-  217 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----------EIDRMT---LTVNVE-  217 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-----------HHHHHh---hcCCcC-
Confidence            2346899999999876 456899999999999999999999999753211100           000000   001111 


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                         ..+.....+.+++.+|++.+|++||     +++++++
T Consensus       218 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         218 ---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence               1112355688999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=273.76  Aligned_cols=260  Identities=27%  Similarity=0.292  Sum_probs=200.4

Q ss_pred             CCCChHHHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH-HHHHHHHHHHHHHHhC-CCCccceEEee
Q 046240          463 RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA-RAMKSFEVECEVMKNI-RHRNLVKIISG  539 (763)
Q Consensus       463 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~  539 (763)
                      ..|+.++++..       ..||.|+||+|++..+ +.|+..|||++..... .+.+++..|.+...+- ++||||++||.
T Consensus        59 ~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            34554555433       5699999999999965 4799999999986643 5667788888766655 79999999999


Q ss_pred             eecCCceEEEEEccCCCChhhhhc---c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEE
Q 046240          540 CSNDDFKALVLEYMPNGSLDIFLY---S-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH  615 (763)
Q Consensus       540 ~~~~~~~~lv~e~~~~g~L~~~l~---~-~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~k  615 (763)
                      +-.++..++.||.|+- +++.+-.   . +...+++...-+|+.-..+||.||.  ....|+|||+||+|||+|..|.+|
T Consensus       132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK--~~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK--EELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH--HHhhhhhccCChhheEEecCCCEe
Confidence            9999999999999965 6554432   2 2335777778888888999999997  455799999999999999999999


Q ss_pred             EeeecCceecCCCCCccccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcc
Q 046240          616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       616 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~  693 (763)
                      +||||++..+.   .+...+...|...|||||.+..  ..|+.++||||+|++|+|+.||..||..+..-..++...+.+
T Consensus       209 LCDFGIcGqLv---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g  285 (361)
T KOG1006|consen  209 LCDFGICGQLV---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG  285 (361)
T ss_pred             eecccchHhHH---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence            99999987653   2334456789999999998863  458999999999999999999999999877655555555444


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ..|.         +..+.+.     -.....+..++..|+..|-..||...++.++
T Consensus       286 dpp~---------l~~~~~~-----~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  286 DPPI---------LLFDKEC-----VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCCe---------ecCcccc-----cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            3332         1111110     0124468899999999999999999998764

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-32  Score=307.37  Aligned_cols=271  Identities=19%  Similarity=0.185  Sum_probs=188.2

Q ss_pred             HHhccCcCceecccCCceEEEEEecC--CceEEEEE--------------eeh---hhHHHHHHHHHHHHHHHhCCCCcc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDD--GIEVAIKV--------------FHQ---ECARAMKSFEVECEVMKNIRHRNL  533 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~e~~~l~~l~h~ni  533 (763)
                      ..++|.+.+.||+|+||+||++..+.  +..+++|.              +.+   ........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999986532  22222221              111   111234567899999999999999


Q ss_pred             ceEEeeeecCCceEEEEEccCCCChhhhhccCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec
Q 046240          534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSST----CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD  609 (763)
Q Consensus       534 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~  609 (763)
                      +++++++...+..|+|+|++.+ ++..++....    ..........++.|++.||.||   |+++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEC
Confidence            9999999999999999999865 5666554321    1223456678999999999999   788999999999999999


Q ss_pred             CCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCC-CCchhh-hhhhhh
Q 046240          610 EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKK-PADKMF-AAELSL  687 (763)
Q Consensus       610 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~-p~~~~~-~~~~~~  687 (763)
                      .++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|.. |+.... .....+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999876533221 2234578999999999999999999999999999999999875 443221 111111


Q ss_pred             hhhh------cccCCh---hHHHHHHhhcC-CCccccHH--HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          688 KHWV------NGLLPV---SLMEVVNKTLL-SPPEKDFA--AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       688 ~~~~------~~~~~~---~~~~~i~~~l~-~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....      ....+.   .+.+.+...-. ..+..-..  ........+.+++.+|++.||++||++.|+++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1111      111121   22222221111 11110000  00112345778899999999999999999986

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-32  Score=292.64  Aligned_cols=266  Identities=23%  Similarity=0.245  Sum_probs=196.9

Q ss_pred             HHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC----
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD----  544 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  544 (763)
                      ...++|.+.+.||+|+||.||+|.. .+|+.||||++....  ......+.+|++++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3567899999999999999999964 578999999986432  233456788999999999999999999986553    


Q ss_pred             --ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          545 --FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       545 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                        ..++||||+ +++|..++...  .+++..+..++.|+++|++||   |+.+|+||||||+||+++.++.+|++|||.+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence              358999998 67888887643  488999999999999999999   7889999999999999999999999999998


Q ss_pred             eecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh-hcccCChhHH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW-VNGLLPVSLM  700 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~  700 (763)
                      ......     .....++..|+|||.+.+ ..++.++|+||+||++|++++|..||............. .....+..+.
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            765321     123457889999998765 458899999999999999999999997533211111100 0011111111


Q ss_pred             ---------HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 ---------EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ---------~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                               ..+...-...+..-......+...+.+++.+|++.+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                     111110000000000111223456889999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=298.70  Aligned_cols=199  Identities=33%  Similarity=0.487  Sum_probs=169.9

Q ss_pred             cCcCceecccCCceEEEEE-ecCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC------ceEE
Q 046240          477 FGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------FKAL  548 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~l  548 (763)
                      +...+.+|+|+||.||+|+ ..+|+.||||.+.... ....+..-+|++++++++|||||++++.-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4456789999999999998 4589999999987643 234556678999999999999999998875543      6789


Q ss_pred             EEEccCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec--CCC--cEEEeeecCc
Q 046240          549 VLEYMPNGSLDIFLYSST--CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD--EDM--IAHLSDFGIA  622 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~--~~~--~~kl~Dfgla  622 (763)
                      |||||.||+|...+.+..  +.++....+.+...++.||.||   |..+|+||||||.||++-  ++|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999998743  3689999999999999999999   789999999999999983  333  4799999999


Q ss_pred             eecCCCCCccccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhh
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMF  681 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~  681 (763)
                      +.++++.   .....+||..|++||... .+.|+..+|.|||||++||++||..||....
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9886443   445688999999999988 4889999999999999999999999997643

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-32  Score=280.89  Aligned_cols=250  Identities=22%  Similarity=0.290  Sum_probs=195.9

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehh-----hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC--Cce
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE-----CARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFK  546 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  546 (763)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|++...     .......+.+|++++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999965 46899999987532     223456788999999999999999999998664  467


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++|+||+++++|.+++.... .+++.....++.+++.|+.||   |+.+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987544 478888999999999999999   78899999999999999999999999999998653


Q ss_pred             CCCC-ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          627 GEDQ-SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       627 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .... ........++..|+|||++.+..++.++|||||||++||+++|+.||.......                .+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~  221 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----------------AIFKI  221 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----------------HHHHH
Confidence            2111 111123458899999999988889999999999999999999999987532211                11111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ........   .+......+.+++.+|+. .|..||++.++++
T Consensus       222 ~~~~~~~~---~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         222 ATQPTKPM---LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HcCCCCCC---CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            11111110   111234568899999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-32  Score=282.27  Aligned_cols=264  Identities=25%  Similarity=0.295  Sum_probs=193.8

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhC---CCCccceEEeeeecCCc-----
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNI---RHRNLVKIISGCSNDDF-----  545 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  545 (763)
                      |++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999876 58999999987432  12234456677777666   59999999999987776     


Q ss_pred             eEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          546 KALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      .+++|||+++ +|.+++.... ..+++..+..++.|+++||.||   |+.+++|+||+|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 7888776533 3589999999999999999999   778999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH-
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV-  703 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i-  703 (763)
                      +.....   .....++..|+|||++.+..++.++|||||||++|||++|..||......+ ....+...........+. 
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCC
Confidence            643221   123347888999999998899999999999999999999999987643222 111111100000000000 


Q ss_pred             -----HhhcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 -----NKTLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 -----~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                           .......+.... .........+.+++.+||+.||++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 000000000111 111223467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.2e-32  Score=284.37  Aligned_cols=259  Identities=25%  Similarity=0.329  Sum_probs=200.9

Q ss_pred             ccCcCceecccCCceEEEEEe----cCCceEEEEEeehhh----HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCce
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  546 (763)
                      +|.+.+.||+|++|.||++..    .+++.||||++....    ....+.+.+|+++++++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            377789999999999999864    257889999987542    22345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++++|.+++.... .+++.....++.|++++|.||   |+.+++||||+|+||+++.++.++|+|||+++.+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999886543 578888999999999999999   78899999999999999999999999999987754


Q ss_pred             CCCCccccccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERK--VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ..... ......++..|+|||...+..  .+.++||||||+++|||++|..||.......             ...++..
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------------~~~~~~~  222 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-------------SQSEISR  222 (288)
T ss_pred             ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-------------hHHHHHH
Confidence            33221 122345788999999987654  7889999999999999999999986421100             0011111


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ......+..+    ......+.+++.+|++.+|++|||+.++.+.++....+
T Consensus       223 ~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~  270 (288)
T cd05583         223 RILKSKPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ  270 (288)
T ss_pred             HHHccCCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence            1111111111    11245678999999999999999999998877765443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-32  Score=290.86  Aligned_cols=270  Identities=22%  Similarity=0.263  Sum_probs=198.5

Q ss_pred             HHHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC-
Q 046240          468 QDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND-  543 (763)
Q Consensus       468 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  543 (763)
                      .++...+++|.+.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            45566789999999999999999999964 578999999987532  22345677899999999999999999988543 


Q ss_pred             -----CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          544 -----DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       544 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                           ...+++++++ +++|..++...  .+++..+..++.|+++|++||   |+.+++||||||+||++++++.+||+|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEEcCCCCEEEec
Confidence                 3467888876 77898877654  488999999999999999999   788999999999999999999999999


Q ss_pred             ecCceecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhccc-
Q 046240          619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGL-  694 (763)
Q Consensus       619 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~-  694 (763)
                      ||+++....     ......++..|+|||...+ ..++.++|||||||++|||++|+.||........  ......... 
T Consensus       164 fg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         164 FGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             ccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999876432     1223467889999998765 5688899999999999999999999864322111  111111100 


Q ss_pred             ------CChhHHHHHHhhcCCCccccHHH-HHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          695 ------LPVSLMEVVNKTLLSPPEKDFAA-KEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       695 ------~~~~~~~~i~~~l~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                            .+..........+...+...+.. .......+.+++..|++.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                  01110111111111111111110 0012446789999999999999999999885

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.2e-32  Score=293.00  Aligned_cols=268  Identities=20%  Similarity=0.250  Sum_probs=194.5

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecC---------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND---------  543 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  543 (763)
                      ..+|...+.||.|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36789999999999999999965 46899999998765444556788899999999999999999776543         


Q ss_pred             -----CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-CCcEEEe
Q 046240          544 -----DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHLS  617 (763)
Q Consensus       544 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-~~~~kl~  617 (763)
                           ...++|+||++ ++|.+++...  .+++.....++.|+++||.||   |+.+++||||||+||+++. ++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999997 4888777543  478889999999999999999   7889999999999999974 5678999


Q ss_pred             eecCceecCCCCCc-cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcc--
Q 046240          618 DFGIAKLLSGEDQS-MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG--  693 (763)
Q Consensus       618 Dfgla~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~--  693 (763)
                      |||.++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ......  
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~  236 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILESVP  236 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcC
Confidence            99999875422211 11123457889999997654 56788999999999999999999999754322211 111110  


Q ss_pred             c-CChhHHHH---HHhhcC-CCccccH---HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 L-LPVSLMEV---VNKTLL-SPPEKDF---AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 ~-~~~~~~~~---i~~~l~-~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      . .+......   ...... .....+.   ........++.+++.+|+..||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0 00011111   111111 0000000   001123456889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-32  Score=281.85  Aligned_cols=265  Identities=21%  Similarity=0.235  Sum_probs=195.8

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-HHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEEEcc
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-RAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      |.+.+.||+|++|+||+|... +++.|++|++..... .......+|+..+++++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999999775 578899999865432 22234457899999998 999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                       +|++.+++.... ..+++..+..++.|++.+|.||   |+.+++|+||+|+||++++++.++|+|||.++......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             778888876653 4689999999999999999999   77899999999999999999999999999998764322   


Q ss_pred             ccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChhHHHH--HHhhc
Q 046240          633 TQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVSLMEV--VNKTL  707 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~--i~~~l  707 (763)
                      ......++..|+|||+.. ...++.++|+||||++++||++|+.||........  ....+.....+....+.  .....
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            123345788999999774 45678999999999999999999999865322111  11111111111111110  00000


Q ss_pred             C----CCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 L----SPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~----~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .    ....... .........+.+++.+|++.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0    0000000 000111356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.8e-33  Score=269.18  Aligned_cols=201  Identities=25%  Similarity=0.353  Sum_probs=169.2

Q ss_pred             hccCcCceecccCCceEEEEEec---C--CceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeec-CCce
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD---D--GIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSN-DDFK  546 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  546 (763)
                      ..|+....||+|.||.||+|.-.   +  .+.+|+|.++.+..  +.-...-+|+..++.++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            57888999999999999999433   2  34799999875522  234567789999999999999999999877 7789


Q ss_pred             EEEEEccCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC----CcEEEee
Q 046240          547 ALVLEYMPNGSLDIFLYSS----TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED----MIAHLSD  618 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~----~~~kl~D  618 (763)
                      ++++||.+. +|..+++..    .+.++......|+.||+.|+.||   |+.-|+||||||.||+|..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 677777542    23688889999999999999999   89999999999999999877    8999999


Q ss_pred             ecCceecCCCCCcc-ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          619 FGIAKLLSGEDQSM-TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       619 fgla~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      ||+++.+...-... .....+.|++|+|||.+.+ ..|+++.||||.||++.||+|-++-|..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            99999986544332 4456778999999998876 5689999999999999999999888865

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=7.6e-32  Score=290.11  Aligned_cols=263  Identities=24%  Similarity=0.282  Sum_probs=192.5

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  544 (763)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999975 468999999986432  223456788999999999999999999986543      


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..++|+||+.. ++..+..   ..+++.....++.|+++||+||   |+.+++||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 6665542   2478889999999999999999   788999999999999999999999999999876


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh-hcccCChhHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW-VNGLLPVSLMEV  702 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  702 (763)
                      ....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............+ ..+..++...+.
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            4321     123457889999998765 468899999999999999999999997633211111100 111111111111


Q ss_pred             HHh--------hcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 VNK--------TLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 i~~--------~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +..        .....+..+.. ........+.+++..|++.+|++||+++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            110        00000111100 00112456789999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=1.4e-31  Score=281.35  Aligned_cols=251  Identities=25%  Similarity=0.306  Sum_probs=194.3

Q ss_pred             ccCcCceecccCCceEEEEEe----cCCceEEEEEeehhhH----HHHHHHHHHHHHHHhC-CCCccceEEeeeecCCce
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQECA----RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  546 (763)
                      .|++.+.||+|+||.||.+..    .+|+.||+|++.....    ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            377889999999999999965    3688999999875422    2345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++|+||+++++|.+++.... .+++.....++.|+++||.||   |+.+++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987643 578888889999999999999   78999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      .... .......|+..|+|||....  ..++.++||||||+++|||++|..||......             ....++..
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------------~~~~~~~~  222 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-------------NSQAEISR  222 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-------------ccHHHHHH
Confidence            3221 12223458889999998865  34678999999999999999999998642110             01111122


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      ......+..    ...+...+.+++.+|++.+|++||     ++.+++.
T Consensus       223 ~~~~~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         223 RILKSEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HhhccCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            221111111    111345678999999999999997     5566554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=5.5e-32  Score=282.82  Aligned_cols=249  Identities=27%  Similarity=0.383  Sum_probs=200.3

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|...+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999664 78999999987532   233467788999999998 99999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++...+ .+++.....++.|++.||.||   |+.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999997654 589999999999999999999   77899999999999999999999999999988764322


Q ss_pred             Cc------------------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh
Q 046240          630 QS------------------MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV  691 (763)
Q Consensus       630 ~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~  691 (763)
                      ..                  .......++..|+|||...+..++.++||||||++++|+++|..||........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------  230 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT------  230 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH------
Confidence            11                  122334578899999998888899999999999999999999999876431110      


Q ss_pred             cccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCH----HHHHH
Q 046240          692 NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA----KCCNF  748 (763)
Q Consensus       692 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~----~~v~~  748 (763)
                             ...+..... ..+.       .....+.+++.+|++.+|++||++    +++++
T Consensus       231 -------~~~~~~~~~-~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 -------FQKILKLEY-SFPP-------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -------HHHHHhcCC-CCCC-------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                   011111000 0111       114458899999999999999999    66553

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=2.5e-32  Score=293.95  Aligned_cols=264  Identities=25%  Similarity=0.293  Sum_probs=197.8

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc----
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF----  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  545 (763)
                      ..++|...+.||+|++|.||+|... +++.||+|++....  ....+.+.+|+.++++++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999765 68899999986432  2234567789999999999999999998866554    


Q ss_pred             --eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          546 --KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       546 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                        .++|+||+ +++|.+++...  .+++..+..++.|+++|+.||   |+.+|+||||||+||++++++.++|+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999998 56898888753  489999999999999999999   78899999999999999999999999999988


Q ss_pred             ecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhh--------c
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWV--------N  692 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~--------~  692 (763)
                      .....     .....++..|+|||...+ ..++.++|||||||++||+++|+.||........  ......        .
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            65322     223457888999998754 4678999999999999999999999965332111  000111        0


Q ss_pred             ccCChhHHHHHHhhcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          693 GLLPVSLMEVVNKTLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       693 ~~~~~~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .........++... ......+.. ........+.+++.+|+..+|++|||+.+|++
T Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         242 KISSESARNYIQSL-PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hccchhHHHHHHhc-cccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            11111111121111 111111111 11123567899999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=5e-32  Score=287.85  Aligned_cols=271  Identities=23%  Similarity=0.252  Sum_probs=194.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCC------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  544 (763)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999764 688999998864422  12345678999999999999999999875433      


Q ss_pred             --ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          545 --FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       545 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                        ..++|+||+++ ++...+......+++..+..++.|+++||+||   |+.+++||||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              46999999975 66666665555789999999999999999999   7889999999999999999999999999999


Q ss_pred             eecCCCCCcc---------ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhh
Q 046240          623 KLLSGEDQSM---------TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHW  690 (763)
Q Consensus       623 ~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~  690 (763)
                      +.........         ......+++.|+|||+..+ ..++.++|||||||++|||++|+.||........  .....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            7654322111         1123456888999998765 4578999999999999999999999975432211  11111


Q ss_pred             hcccCChhHHHHH--Hh-----hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          691 VNGLLPVSLMEVV--NK-----TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       691 ~~~~~~~~~~~~i--~~-----~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .....+.......  ..     .....+..-..........+.+++.+|+..+|++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111111111000  00     0000000000001112356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=8.1e-32  Score=281.90  Aligned_cols=266  Identities=27%  Similarity=0.300  Sum_probs=199.5

Q ss_pred             cCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      |+..+.||+|++|.||+|... +++.||+|++....  ....+.+..|++++++++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999765 58999999987653  233466778999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++ +|.+++......+++..+..++.++++|++||   |+.+++||||+|+||++++++.+||+|||.++.......  .
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            84 89999987645689999999999999999999   778999999999999999999999999999887643221  2


Q ss_pred             cccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHHHh-----
Q 046240          634 QTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVVNK-----  705 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~-----  705 (763)
                      .....++..|+|||.+.+. .++.++|||||||+++|+++|..||.........  .........+.....+.+.     
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2334467789999988766 8899999999999999999999999764322111  1111111111111111110     


Q ss_pred             hcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .......... .........+.+++..|+..+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000000 000112456899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=9.9e-32  Score=288.65  Aligned_cols=270  Identities=21%  Similarity=0.215  Sum_probs=195.2

Q ss_pred             HhccCc-CceecccCCceEEEEEec-CCceEEEEEeehhhHHH--------------HHHHHHHHHHHHhCCCCccceEE
Q 046240          474 TNRFGR-DNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARA--------------MKSFEVECEVMKNIRHRNLVKII  537 (763)
Q Consensus       474 ~~~~~~-~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~  537 (763)
                      .++|.. .+.||+|+||+||+|... +++.||+|++.......              ...+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 577999999999999654 78999999886432111              12467899999999999999999


Q ss_pred             eeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEe
Q 046240          538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS  617 (763)
Q Consensus       538 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~  617 (763)
                      +++...+..++||||++ |+|.+++.... .++......++.|+++||+||   |+.+++||||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999997 58888886533 578889999999999999999   78899999999999999999999999


Q ss_pred             eecCceecCCCC------------CccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhh
Q 046240          618 DFGIAKLLSGED------------QSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAE  684 (763)
Q Consensus       618 Dfgla~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~  684 (763)
                      |||.++.+....            .........++..|+|||.+.+. .++.++|||||||++|||++|+.||.......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998764111            01111233568889999988754 46899999999999999999999997643322


Q ss_pred             hhh--hhhhcccCChhHHHHHHhh-----cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          685 LSL--KHWVNGLLPVSLMEVVNKT-----LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       685 ~~~--~~~~~~~~~~~~~~~i~~~-----l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...  ........+..+.+.....     ....+.........+...+.+++..|++.+|++||++++++.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            111  1111110000000000000     000000000011122456889999999999999999999986

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-33  Score=294.26  Aligned_cols=306  Identities=22%  Similarity=0.209  Sum_probs=242.8

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccc----------------cCccccccccCCCccEEEcc
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLS----------------GSLPSRIDLALPNVKALSLA  140 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----------------~~lp~~~~~~l~~L~~L~L~  140 (763)
                      ..+..|||++|.|..+-+..|-++++|++++|..|.++....+.                .++..+....++.|+.|||+
T Consensus        78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             cceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            34566777777777666667777777777777777665211111                23444444456777888888


Q ss_pred             cccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCc
Q 046240          141 YNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCS  220 (763)
Q Consensus       141 ~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~  220 (763)
                      .|.|+.+.-..|..-.++++|+|++|+|+.+..+.|.++.+|..|.    |+.|+++...+..|.+++ +|+.|+|..|+
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk----LsrNrittLp~r~Fk~L~-~L~~LdLnrN~  232 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK----LSRNRITTLPQRSFKRLP-KLESLDLNRNR  232 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee----cccCcccccCHHHhhhcc-hhhhhhccccc
Confidence            8888766666777777788888888888877778888888877777    778888876666666677 88888888888


Q ss_pred             cccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEccccccccc
Q 046240          221 ITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGD  300 (763)
Q Consensus       221 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~  300 (763)
                      |.-..--.|.+|++|+.|.|..|.+...-...|..+.+  +++|+|+.|++...-..  .+.+|+.|+.|+||+|.|..+
T Consensus       233 irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~k--me~l~L~~N~l~~vn~g--~lfgLt~L~~L~lS~NaI~ri  308 (873)
T KOG4194|consen  233 IRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEK--MEHLNLETNRLQAVNEG--WLFGLTSLEQLDLSYNAIQRI  308 (873)
T ss_pred             eeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecc--cceeecccchhhhhhcc--cccccchhhhhccchhhhhee
Confidence            87555667888888888888888888777778888866  99999999999844444  788999999999999999999


Q ss_pred             CCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-C--
Q 046240          301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-G--  377 (763)
Q Consensus       301 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~--  377 (763)
                      .++++.-.++|++|+|++|+|+...+++|..|..|++|+|++|.|+.+...+|..+.+|+.|||++|.+++.|.+. .  
T Consensus       309 h~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f  388 (873)
T KOG4194|consen  309 HIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAF  388 (873)
T ss_pred             ecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhh
Confidence            9999999999999999999999888899999999999999999999999999999999999999999999887764 2  


Q ss_pred             -CccccccccccCCC
Q 046240          378 -PFANFTAKSFMGNE  391 (763)
Q Consensus       378 -~~~~l~~~~~~~n~  391 (763)
                       .++.++.+.+.||.
T Consensus       389 ~gl~~LrkL~l~gNq  403 (873)
T KOG4194|consen  389 NGLPSLRKLRLTGNQ  403 (873)
T ss_pred             ccchhhhheeecCce
Confidence             25667788888884

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=2.8e-32  Score=288.41  Aligned_cols=236  Identities=28%  Similarity=0.357  Sum_probs=193.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ...|.+...||+|.|++|..|.+. ++..||||.+++..  ....+.+.+|+++|..++|||||+++.+.......|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456888999999999999999664 79999999998653  233455889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+.+|.+.+++...+...+ .....+..|+.+|++|+   |++.|||||||++||+++.+..+||+|||++.++.... 
T Consensus       135 eya~~ge~~~yl~~~gr~~e-~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~-  209 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKE-KEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL-  209 (596)
T ss_pred             EeccCchhHHHHHhcccchh-hhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeecccc-
Confidence            99999999999988776555 77778899999999999   89999999999999999999999999999999986332 


Q ss_pred             ccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh-----hhhcccCChhHHHHHH
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLK-----HWVNGLLPVSLMEVVN  704 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~  704 (763)
                        .....+|++.|.|||++.+..| ++++|+||+|+++|-++.|..||++..-.+..-+     ..+...++.+..++++
T Consensus       210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr  287 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR  287 (596)
T ss_pred             --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence              3455789999999999998776 5799999999999999999999997433222111     1122223345666777


Q ss_pred             hhcCCCccccHH
Q 046240          705 KTLLSPPEKDFA  716 (763)
Q Consensus       705 ~~l~~~~~~~~~  716 (763)
                      +++..+|..|.+
T Consensus       288 k~lvl~Pskr~~  299 (596)
T KOG0586|consen  288 KFLVLNPSKRGP  299 (596)
T ss_pred             HhhccCccccCC
Confidence            776666666554

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=2e-31  Score=285.73  Aligned_cols=268  Identities=22%  Similarity=0.235  Sum_probs=192.6

Q ss_pred             ccCcCceecccCCceEEEEEec-C--CceEEEEEeehhh--HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC----Cc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-D--GIEVAIKVFHQEC--ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND----DF  545 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  545 (763)
                      +|.+.+.||+|+||.||++... +  ++.||+|++....  ....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999764 4  7789999886432  22345678899999999 599999999875432    45


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++++||+. ++|.+++.... .+++.....++.|++.||+||   |+.+++||||||+||+++.++.+||+|||.++.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788899886 58888876543 588999999999999999999   7889999999999999999999999999999876


Q ss_pred             CCCCCc--cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCChhHH
Q 046240          626 SGEDQS--MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPVSLM  700 (763)
Q Consensus       626 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~  700 (763)
                      ......  .......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||........  ...............
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            432211  11233468999999998765 5689999999999999999999999875322111  011111110000111


Q ss_pred             HHHH-------hhcCCCccccHHH-HHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 EVVN-------KTLLSPPEKDFAA-KEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ~~i~-------~~l~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+..       +.....+...... .......+.+++.+|++.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1100       1111111111110 0112456889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.4e-31  Score=279.55  Aligned_cols=241  Identities=22%  Similarity=0.268  Sum_probs=183.9

Q ss_pred             eecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHH---HHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVEC---EVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      .||+|+||.||+|.. .+++.||+|.+.....   .....+..|.   ..++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            479999999999965 4688999998865321   1112233333   34444579999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|..++.... .+++..+..++.|+++|+.||   |+.+++||||||+||+++.++.+||+|||++..+....    .
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999998886543 689999999999999999999   78899999999999999999999999999987653221    1


Q ss_pred             ccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....|+..|+|||++.++ .++.++||||+||++|||++|+.||.........           ......   ....+..
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~---~~~~~~~  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----------EIDRMT---LTMAVEL  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----------HHHHHh---hccCCCC
Confidence            234689999999998754 6899999999999999999999999763211100           000000   0001110


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                          .......+.+++.+|+..+|++||     ++.++++
T Consensus       219 ----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                011245688999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.2e-31  Score=277.08  Aligned_cols=247  Identities=24%  Similarity=0.299  Sum_probs=192.0

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehh-----hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE-----CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      +|.+.+.||+|+||.||++... .+..+++|+++..     .......+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5788899999999999999664 3455666665432     112334567789999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      +||+++++|..++..   ....+++.....++.|+++|+.||   |+.+++|+||+|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864   234689999999999999999999   7889999999999999986 469999999988764


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ....  ......++..|+|||...+..++.++|+||||+++|+|++|..||........                 ....
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----------------~~~~  217 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV-----------------VLRI  217 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----------------HHHH
Confidence            3221  22234578899999998888889999999999999999999999864221110                 0111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......   .....+..++.+++.+|++.+|++||++.++++
T Consensus       218 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEGPTP---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcCCCC---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            111000   011223557889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=264.88  Aligned_cols=236  Identities=25%  Similarity=0.303  Sum_probs=190.4

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      -++|...+++|+|.||+|..++- .+|+.+|+|+++++.   ......-..|-.+|+..+||.+..+-..|+..+..|.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            36788899999999999999954 579999999998764   23445567799999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||..||.|..++.+.+ .++.....-....|..||.||   |+++||.||+|.+|.++|.+|++||+|||+++.-  -.
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IK  320 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCceEeeecccchhc--cc
Confidence            99999999988887644 466666666788899999999   8899999999999999999999999999999852  22


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh-h----hhhhcccCChhHHHHHH
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS-L----KHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~-~----~~~~~~~~~~~~~~~i~  704 (763)
                      ........+||+.|+|||++....|+.++|.|.+||+||||+.|+.||-....+..- +    ..-.+..+++++..++.
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs  400 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS  400 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence            334556789999999999999999999999999999999999999998653322111 1    11123334456666666


Q ss_pred             hhcCCCccccH
Q 046240          705 KTLLSPPEKDF  715 (763)
Q Consensus       705 ~~l~~~~~~~~  715 (763)
                      ..+.++|..|.
T Consensus       401 GLL~kdP~kRL  411 (516)
T KOG0690|consen  401 GLLKKDPKKRL  411 (516)
T ss_pred             HHhhcChHhhc
Confidence            66666666543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=276.81  Aligned_cols=205  Identities=29%  Similarity=0.449  Sum_probs=170.9

Q ss_pred             HhccCcCceecccCCceEEEE-EecCCceEEEEEeehhh---HH----HHHHHHHHHHHHHhCCCCccceEEeeeec-CC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQEC---AR----AMKSFEVECEVMKNIRHRNLVKIISGCSN-DD  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~---~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  544 (763)
                      .++|-..+.+|+|||+.||+| ++...+.||||+-.-+.   ..    ..+..-+|..|-+.+.||.||++|+|+.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            468888899999999999999 55678899999754221   11    23455689999999999999999999964 46


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecC
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGI  621 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgl  621 (763)
                      ..|-|+|||+|.+|+.++.... .++..+...|.+||+.||.||.+ -+.+|||-||||.|||+-.   -|.+||+|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7889999999999999998765 57888899999999999999975 5789999999999999954   47899999999


Q ss_pred             ceecCCCCCc-----cccccccccccccCccccCC----CCCCcchhHHHHHHHHHHHHcCCCCCchh
Q 046240          622 AKLLSGEDQS-----MTQTQTLATIGYMAPEYGIE----RKVSTRSDIYSYGIMLIETFTRKKPADKM  680 (763)
Q Consensus       622 a~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slGv~l~elltg~~p~~~~  680 (763)
                      +++++++...     ..+....||.||++||.+.-    ..++.|+||||.||++|.++.|+.||+..
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            9999765433     12356689999999996542    45788999999999999999999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=247.92  Aligned_cols=218  Identities=25%  Similarity=0.319  Sum_probs=179.2

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh-hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE-CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ..+.......||+|++|.|-+.++ .+|+..|+|.+... ..+..++..+|+++..+. .+|.+|++||.+......++.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            344555567899999999988855 57999999998755 345567778888887765 799999999999999999999


Q ss_pred             EEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ||.|+. +|+.+...   .+..+++...-+||..+.+||.|||  .+..++|||+||+|||++.+|++|+||||++..+.
T Consensus       124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            999965 77665432   4557888889999999999999997  45689999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccccC----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGI----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      +   +...+...|...|||||.+.    ...|+.|+||||+|+.++||.+++.||+.+.....++.+.+....|
T Consensus       201 d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P  271 (282)
T KOG0984|consen  201 D---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP  271 (282)
T ss_pred             h---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence            2   22334467889999999865    3478999999999999999999999999988887777776654433

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=5.8e-31  Score=305.01  Aligned_cols=145  Identities=27%  Similarity=0.387  Sum_probs=129.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||+||+|... +++.||||++....   ......+.+|+.+++.++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999765 78999999987542   233467888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      ||+++++|..++.... .+++.....++.||+.||.||   |..+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999987543 578888999999999999999   67899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=280.42  Aligned_cols=233  Identities=23%  Similarity=0.387  Sum_probs=186.0

Q ss_pred             CceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCC
Q 046240          480 DNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      .+++|+|.||+||-|.+ ++|+.||||++.+..  .....+++.|+.||+.++||.||.+...|+..+..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999965 479999999997653  334578899999999999999999999999999999999999886


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC---CcEEEeeecCceecCCCCCccc
Q 046240          557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED---MIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       557 ~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      -|+-++....+.++.....-+..||+.||.||   |-++|+|.||||+|||+.+.   ..+||||||.|+++++..   .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            67666665555788877777899999999999   78999999999999999643   479999999999986443   2


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc-------CChhHHHHHHhh
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL-------LPVSLMEVVNKT  706 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~i~~~  706 (763)
                      ....+||+.|+|||++....|+..-|+||.||++|--++|..||....+-..+.....-..       ++..+.+++...
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            3457899999999999999999999999999999999999999976433222222111111       223455666666


Q ss_pred             cCCCccccHHHH
Q 046240          707 LLSPPEKDFAAK  718 (763)
Q Consensus       707 l~~~~~~~~~~~  718 (763)
                      +.....+|++..
T Consensus       803 LqVkm~kRysvd  814 (888)
T KOG4236|consen  803 LQVKMRKRYSVD  814 (888)
T ss_pred             HHHHHHHhcchH
Confidence            665555555433

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.1e-31  Score=270.06  Aligned_cols=236  Identities=30%  Similarity=0.363  Sum_probs=191.4

Q ss_pred             ecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       483 lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      ||+|+||.||++... +++.||+|++.....   .....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 588999999875532   2455788899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccc
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL  638 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  638 (763)
                      .+++.... .+++.....++.|+++|+.|+   |+.+++|+||+|+||+++.++.++|+|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99987654 578999999999999999999   77999999999999999999999999999988764322  1223456


Q ss_pred             ccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHH
Q 046240          639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK  718 (763)
Q Consensus       639 g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  718 (763)
                      ++..|+|||...+...+.++|+||||+++||+++|+.||........             ...+...... .+       
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------------~~~~~~~~~~-~~-------  213 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-------------YEKILKDPLR-FP-------  213 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHhcCCCC-CC-------
Confidence            78899999999888889999999999999999999999976332110             0111110110 01       


Q ss_pred             HHHHHHHHHHHHHccccCcCCCCCHHH
Q 046240          719 EQCVLSIFSLAMECTMELPEKRINAKC  745 (763)
Q Consensus       719 ~~~~~~l~~l~~~cl~~~P~~Rps~~~  745 (763)
                      ......+.+++.+|+..+|++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            111456789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=302.69  Aligned_cols=202  Identities=23%  Similarity=0.323  Sum_probs=173.2

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      -.++|.+.++||+|+||.|..++.. +++.||+|++.+..   .....-|..|-.+|..-+.+-|++++..|++..++|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            4578999999999999999999764 68899999998742   2345668889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||++||+|-.++...+ .++.....-++..|+-||..+   |+.|+|||||||+|||+|..|++|++|||.+-.+..+
T Consensus       153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            999999999999997766 566666555566666677767   8999999999999999999999999999999888644


Q ss_pred             CCccccccccccccccCccccC----C-CCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          629 DQSMTQTQTLATIGYMAPEYGI----E-RKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      +. ......+|||.|++||++.    + +.|++.+|.||+||++|||+.|..||-.
T Consensus       229 G~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  229 GT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             Cc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            43 3456679999999999864    3 6799999999999999999999999854

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=269.25  Aligned_cols=266  Identities=22%  Similarity=0.280  Sum_probs=203.2

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-C-C----ccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-H-R----NLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~~~~~  545 (763)
                      .+.+|.+...+|+|.||.|-.... ..+..||||+++.. ....+..+.|+++++++. + |    -++.+.+||...++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            378999999999999999999844 45789999998643 344556678999999994 2 2    37778889999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC--------------
Q 046240          546 KALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE--------------  610 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~--------------  610 (763)
                      .|+|+|.+ |.++.+++..+. .+++...+..++.|+++++++|   |+.+++|.||||+||++.+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999987 558888987743 4789999999999999999999   8999999999999999821              


Q ss_pred             ------CCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhh-hh
Q 046240          611 ------DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMF-AA  683 (763)
Q Consensus       611 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~-~~  683 (763)
                            +..+|++|||.|++-....     ...+.|..|+|||++.+-.++.++||||+||||+|+.||..-|..-. .+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  3458999999998754322     44678999999999999999999999999999999999999887533 23


Q ss_pred             hhhhhhhhcccCChhHHHH------HHhhcCCCccc--------------c----HHHHHHHHHHHHHHHHHccccCcCC
Q 046240          684 ELSLKHWVNGLLPVSLMEV------VNKTLLSPPEK--------------D----FAAKEQCVLSIFSLAMECTMELPEK  739 (763)
Q Consensus       684 ~~~~~~~~~~~~~~~~~~~------i~~~l~~~~~~--------------~----~~~~~~~~~~l~~l~~~cl~~~P~~  739 (763)
                      ...+.+.+-+..|..+..-      ..+.-...++.              .    ....+.....+++++..++..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            3334444444444322211      11111110110              0    0111234567999999999999999


Q ss_pred             CCCHHHHHH
Q 046240          740 RINAKCCNF  748 (763)
Q Consensus       740 Rps~~~v~~  748 (763)
                      |+|++|++.
T Consensus       397 RiTl~EAL~  405 (415)
T KOG0671|consen  397 RITLREALS  405 (415)
T ss_pred             cccHHHHhc
Confidence            999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.6e-32  Score=258.02  Aligned_cols=269  Identities=24%  Similarity=0.338  Sum_probs=196.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeec--------C
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSN--------D  543 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  543 (763)
                      ..|+...+||+|.||.||+|+.. +|+.||+|+.--++  .+......+|+++|..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666788999999999999654 68889998654322  2334566889999999999999999988843        3


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      ...|+||++|+. +|.-++......++..++.+++.++..||.|+   |...|+|||+||.|||++.++.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            357999999977 67777766555688899999999999999999   88999999999999999999999999999998


Q ss_pred             ecCCCCC--ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhh-hhhhhhhh-ccc----
Q 046240          624 LLSGEDQ--SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAA-ELSLKHWV-NGL----  694 (763)
Q Consensus       624 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-~~~~~~~~-~~~----  694 (763)
                      .+...+.  ....+..+.|.+|++||.+.+ ..|+++.|||+-||++.||+||.+-+++.... ...+.... ...    
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            7753322  233566778999999998765 68999999999999999999999988764322 11222111 111    


Q ss_pred             CCh-hHHHHHHhhcCCC--ccccHHHHHHH------HHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          695 LPV-SLMEVVNKTLLSP--PEKDFAAKEQC------VLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       695 ~~~-~~~~~i~~~l~~~--~~~~~~~~~~~------~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +|. +...+.. .+.-.  ++......++.      ..+-.+++...+..||.+|++++++++
T Consensus       253 WP~~d~lpL~~-sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  253 WPNVDNLPLYQ-SIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CCCcccchHHH-hccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            121 1111111 11000  11100000111      124678899999999999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=281.79  Aligned_cols=240  Identities=23%  Similarity=0.229  Sum_probs=191.9

Q ss_pred             HHhccCcCceecccCCceEEEEE-ecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++.|.....+|.|+|+.|-.+. ..+++..++|++.+..    .+..+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            35677888889999999998884 4578999999997652    2334577676666 7999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe-cCCCcEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL-DEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll-~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |.+.|+-+.+.+.....  ....+..|+.+|+.|+.||   |.+|+|||||||+|||+ ++.++++|+|||.++..... 
T Consensus       396 e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            99999888777765542  2266778999999999999   78999999999999999 58899999999999876433 


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                          ....+-|..|.|||++....|++++|+||||++||+|++|+.||......                 ..+..++..
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------------~ei~~~i~~  528 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------------IEIHTRIQM  528 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------------HHHHHhhcC
Confidence                22345688899999999999999999999999999999999999763222                 112222222


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+..     +.......+++..|++.||.+||+|.++..
T Consensus       529 ~~~s-----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 PKFS-----ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             Cccc-----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            2111     233556789999999999999999999874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-31  Score=234.48  Aligned_cols=198  Identities=24%  Similarity=0.331  Sum_probs=169.0

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +|...++||+|.||+||+|+. ++++.||+|+++-+  .++......+|+.+++.++|+|||++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            456678999999999999965 46889999988644  334566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      |+. +|..+..+-.+.++......++.|+.+|+.+.   |++++.|||+||+|.+++.+|+.|++|||+++.+.-.-  .
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            965 78888776666789999999999999999999   88999999999999999999999999999999875222  2


Q ss_pred             ccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHc-CCCCCch
Q 046240          633 TQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFT-RKKPADK  679 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ellt-g~~p~~~  679 (763)
                      -.+..+.|.+|.+|.++.+. -|+...|+||-||++.|+.. |++-|-+
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg  205 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence            33556789999999998875 57889999999999999998 4444544

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=255.37  Aligned_cols=252  Identities=21%  Similarity=0.234  Sum_probs=192.2

Q ss_pred             HHhccCcC-ceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeec----CCc
Q 046240          473 ATNRFGRD-NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSN----DDF  545 (763)
Q Consensus       473 ~~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~  545 (763)
                      .+++|.+. ++||-|-.|.|-.... ++|+++|+|++...     ...++|++.--.. .|||||+++++|..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556544 5799999999998855 47899999988532     3446677765544 69999999998854    456


Q ss_pred             eEEEEEccCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecC
Q 046240          546 KALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGI  621 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgl  621 (763)
                      +.+|||.++||.|...+..++. .++..+...|..||+.|+.||   |+.+|.||||||+|+|...   +..+|++|||.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            7799999999999999987654 789999999999999999999   8999999999999999964   56799999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      |+.-..   .......+-|++|.|||++....|+..+|+||+||++|-|+.|.+||=......          +++.++.
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------ispgMk~  277 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGMKR  277 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CChhHHh
Confidence            987432   223344678999999999999999999999999999999999999985532211          2222222


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      -+...-..-|+.+.+   +..++..+++...++.+|.+|.|+.++++
T Consensus       278 rI~~gqy~FP~pEWs---~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  278 RIRTGQYEFPEPEWS---CVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HhhccCccCCChhHh---HHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            222222222332222   23556778888889999999999988874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-31  Score=263.45  Aligned_cols=234  Identities=25%  Similarity=0.304  Sum_probs=185.3

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .+|....+||+|+||+|..|..+ +.+.+|||+++++..   .+.+--..|-.+|..- +-|.++++..+|+..+.+|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46889999999999999999554 577899999886531   1222234566666665 578999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+.||+|-..+++-+ .+......-.|..||-||-+|   |+++|+.||||.+||++|.+|++||+|||+++.---+ 
T Consensus       429 MEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-  503 (683)
T ss_pred             EEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeecccccccccC-
Confidence            99999999988887654 355556667899999999999   9999999999999999999999999999999753212 


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh------cccCChhHHHHH
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV------NGLLPVSLMEVV  703 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~i  703 (763)
                       ..++...+||+.|+|||++...+|+..+|.|||||+||||+.|++||++...++. +....      +.-++.++.++.
T Consensus       504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-F~aI~ehnvsyPKslSkEAv~ic  581 (683)
T KOG0696|consen  504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQAIMEHNVSYPKSLSKEAVAIC  581 (683)
T ss_pred             -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHccCcCcccccHHHHHHH
Confidence             2244567899999999999999999999999999999999999999998544332 22222      222344566677


Q ss_pred             HhhcCCCccccH
Q 046240          704 NKTLLSPPEKDF  715 (763)
Q Consensus       704 ~~~l~~~~~~~~  715 (763)
                      ...+.+.|..|.
T Consensus       582 kg~ltK~P~kRL  593 (683)
T KOG0696|consen  582 KGLLTKHPGKRL  593 (683)
T ss_pred             HHHhhcCCcccc
Confidence            777777776654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.7e-30  Score=262.95  Aligned_cols=221  Identities=21%  Similarity=0.151  Sum_probs=174.4

Q ss_pred             cCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCChhhhhcc
Q 046240          486 GSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS  564 (763)
Q Consensus       486 G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  564 (763)
                      |.+|.||++.. .+++.||+|++.....     ..+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999965 4789999999875431     23344555556799999999999999999999999999999998865


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccccccccc
Q 046240          565 STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM  644 (763)
Q Consensus       565 ~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~  644 (763)
                      .. .+++.....++.|+++||.|+   |+++++||||||+||+++.++.++++|||.+..+...     .....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            43 488999999999999999999   7889999999999999999999999999987665321     12234567899


Q ss_pred             CccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHH
Q 046240          645 APEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLS  724 (763)
Q Consensus       645 aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~  724 (763)
                      |||+..+..++.++||||+|+++|||++|..|+.......       ...          ..+ ..+       ......
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~----------~~~-~~~-------~~~~~~  204 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTH----------TTL-NIP-------EWVSEE  204 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccc----------ccc-CCc-------ccCCHH
Confidence            9999988889999999999999999999998865311100       000          000 001       112445


Q ss_pred             HHHHHHHccccCcCCCCCHHH
Q 046240          725 IFSLAMECTMELPEKRINAKC  745 (763)
Q Consensus       725 l~~l~~~cl~~~P~~Rps~~~  745 (763)
                      +.+++.+|++.||++||++.+
T Consensus       205 ~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCCc
Confidence            789999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=5.8e-30  Score=289.13  Aligned_cols=266  Identities=22%  Similarity=0.206  Sum_probs=169.0

Q ss_pred             HHhccCcCceecccCCceEEEEEec-C----CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEee------ee
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-D----GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG------CS  541 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  541 (763)
                      ..++|...+.||+|+||.||+|... +    +..||+|++......  +....|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999765 4    689999987643211  111111  1222222222222221      24


Q ss_pred             cCCceEEEEEccCCCChhhhhccCCCCC-------------------CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 046240          542 NDDFKALVLEYMPNGSLDIFLYSSTCML-------------------DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK  602 (763)
Q Consensus       542 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk  602 (763)
                      .....++|+||+++++|.+++.......                   ....+..++.|+++||+||   |+++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yL---H~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGL---HSTGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHH---HHCCEEeCcCC
Confidence            5568899999999999999886543211                   1223457899999999999   78899999999


Q ss_pred             CCCEEecC-CCcEEEeeecCceecCCCCCccccccccccccccCccccCCC----------------------CCCcchh
Q 046240          603 SSNVLLDE-DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER----------------------KVSTRSD  659 (763)
Q Consensus       603 ~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~D  659 (763)
                      |+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543222 222345789999999964321                      2345679


Q ss_pred             HHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC-hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcC
Q 046240          660 IYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP-VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPE  738 (763)
Q Consensus       660 v~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~  738 (763)
                      ||||||++|||+++..|++........  .......+ ..+...+.......-...+...+.......+++..|++.||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNR--QLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHH--HHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999999988776542111100  00000000 011111111100000000000011122456899999999999


Q ss_pred             CCCCHHHHHH
Q 046240          739 KRINAKCCNF  748 (763)
Q Consensus       739 ~Rps~~~v~~  748 (763)
                      +|||+.++++
T Consensus       440 kR~ta~e~L~  449 (566)
T PLN03225        440 QRISAKAALA  449 (566)
T ss_pred             cCCCHHHHhC
Confidence            9999999986

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=317.12  Aligned_cols=281  Identities=37%  Similarity=0.571  Sum_probs=227.6

Q ss_pred             CCCCEEEcCCCcccC------------------CCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeee
Q 046240          101 PSLTKLALGYNSLVG------------------NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILE  162 (763)
Q Consensus       101 ~~L~~L~L~~n~l~~------------------~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~  162 (763)
                      .+++.|+|++|.+++                  .|.++|.+|..++..+++|++|+|++|.+++.+|.  +.+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            478999999998763                  25556677777776777777777777777766664  4567788888


Q ss_pred             ecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeeccc
Q 046240          163 LGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLEL  242 (763)
Q Consensus       163 L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  242 (763)
                      |++|.+++.+|..|+++++|+.|+    +++|.+.+.+|..+.++. +|++|+|++|++++.+|..++++++|++|+|++
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~----L~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~  221 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLD----LGGNVLVGKIPNSLTNLT-SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY  221 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEE----CccCcccccCChhhhhCc-CCCeeeccCCCCcCcCChHHcCcCCccEEECcC
Confidence            888888777888888888888888    778888888888888887 888888888888888888888888888888888


Q ss_pred             ccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCcccc
Q 046240          243 NKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLE  322 (763)
Q Consensus       243 N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  322 (763)
                      |++++.+|..+.++++  |++|++++|++++.+|.  .+.++++|++|++++|++++.+|..+.++++|+.|+|++|++.
T Consensus       222 n~l~~~~p~~l~~l~~--L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~  297 (968)
T PLN00113        222 NNLSGEIPYEIGGLTS--LNHLDLVYNNLTGPIPS--SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS  297 (968)
T ss_pred             CccCCcCChhHhcCCC--CCEEECcCceeccccCh--hHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeec
Confidence            8888888888888876  88888888888888887  7888888888888888888888888888888888888888888


Q ss_pred             CcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-CCccccccccccCCCc
Q 046240          323 GPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPFANFTAKSFMGNEK  392 (763)
Q Consensus       323 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~  392 (763)
                      +.+|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++.+|.. +.+..+..+++.+|..
T Consensus       298 ~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l  368 (968)
T PLN00113        298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL  368 (968)
T ss_pred             cCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCee
Confidence            888888888888888888888888888888888888888888888888877754 5567777888877753

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-30  Score=281.20  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=204.8

Q ss_pred             HHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeee-----cC
Q 046240          471 SRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCS-----ND  543 (763)
Q Consensus       471 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~~  543 (763)
                      ..-++.|++.+.||.|.+|.||++.. .+|+.+|+|+...... ..++++.|.++++.. .|||++.++|+|.     .+
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            33467789999999999999999954 5788999998875543 345677899999988 6999999999984     45


Q ss_pred             CceEEEEEccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          544 DFKALVLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      +.+++|||||.+|+..+++..- +..+.|..+..|+..++.|+.+|   |...++|||+|-.|||++.++.||++|||.+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEEeeeeee
Confidence            6899999999999999988652 44688889999999999999999   8889999999999999999999999999998


Q ss_pred             eecCCCCCccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV  697 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  697 (763)
                      ..++..  ........||+.|||||++.     ...|+.++|+||+|++..||--|.+|+.++......+..        
T Consensus       171 aQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--------  240 (953)
T KOG0587|consen  171 AQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------  240 (953)
T ss_pred             eeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--------
Confidence            876422  22345568999999999875     345778999999999999999999999886543321111        


Q ss_pred             hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                                -++|....-..+....++.+++..|+..|-++||++.++++
T Consensus       241 ----------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  241 ----------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                      12222222233456778999999999999999999988764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.8e-29  Score=257.40  Aligned_cols=238  Identities=32%  Similarity=0.383  Sum_probs=192.0

Q ss_pred             CCceEEEEEec-CCceEEEEEeehhhHHH-HHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCChhhhhcc
Q 046240          487 SFGYVYKAELD-DGIEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS  564 (763)
Q Consensus       487 ~~g~v~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  564 (763)
                      +||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999776 58999999997654433 67889999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccccccccc
Q 046240          565 STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM  644 (763)
Q Consensus       565 ~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~  644 (763)
                      ... +++.....++.++++++.+|   |+.+++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            543 78899999999999999999   77899999999999999999999999999998765332   223456788999


Q ss_pred             CccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHH
Q 046240          645 APEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLS  724 (763)
Q Consensus       645 aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~  724 (763)
                      |||...+..++.++||||||++++|+++|..||........             ..+.+..   ...... .....+..+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-------------~~~~~~~---~~~~~~-~~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-------------LFKKIGK---PKPPFP-PPEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-------------HHHHHhc---cCCCCc-cccccCCHH
Confidence            99999888899999999999999999999999865311111             1111111   111100 000003457


Q ss_pred             HHHHHHHccccCcCCCCCHHHHHH
Q 046240          725 IFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       725 l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=7.4e-29  Score=272.75  Aligned_cols=264  Identities=18%  Similarity=0.212  Sum_probs=178.5

Q ss_pred             HHhccCcCceecccCCceEEEEEe-----------------cCCceEEEEEeehhhHHHHH--------------HHHHH
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-----------------DDGIEVAIKVFHQECARAMK--------------SFEVE  521 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~e  521 (763)
                      ..++|.+.++||+|+||+||+|..                 ..++.||||++........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999953                 23567999998643322222              23447


Q ss_pred             HHHHHhCCCCcc-----ceEEeeeec--------CCceEEEEEccCCCChhhhhccCC----------------------
Q 046240          522 CEVMKNIRHRNL-----VKIISGCSN--------DDFKALVLEYMPNGSLDIFLYSST----------------------  566 (763)
Q Consensus       522 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  566 (763)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766544     677777753        356899999999999999886421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccC
Q 046240          567 -CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA  645 (763)
Q Consensus       567 -~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~a  645 (763)
                       ...++..+..++.|++++|.|+   |+.+|+||||||+||+++.++.+||+|||+++.+..... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence             1235677888999999999999   778999999999999999999999999999976542211 11122335789999


Q ss_pred             ccccCCCC--------------------C--CcchhHHHHHHHHHHHHcCCC-CCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          646 PEYGIERK--------------------V--STRSDIYSYGIMLIETFTRKK-PADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       646 PE~~~~~~--------------------~--~~~~Dv~slGv~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      ||.+....                    +  ..+.||||+||+++||++|.. |+.....-......+     ......+
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~-----~~~~~~~  453 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY-----DNDLNRW  453 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc-----cchHHHH
Confidence            99865322                    1  124799999999999999875 665421111111100     0000000


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCc---CCCCCHHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELP---EKRINAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~Rps~~~v~~  748 (763)
                      .  +. .....+++..+.......+++.+++..+|   .+|+|++|+++
T Consensus       454 r--~~-~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        454 R--MY-KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             H--hh-cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0  00 00011111122234567888888998765   68999999975

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-30  Score=279.50  Aligned_cols=243  Identities=26%  Similarity=0.373  Sum_probs=188.8

Q ss_pred             cCcCceecccCCc-eEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEccC
Q 046240          477 FGRDNLIGIGSFG-YVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       477 ~~~~~~lg~G~~g-~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      |.-.+++|.|+.| .||+|..+ |+.||||++-.+.   .....+|+..++.- +|||||++++.-.++.+.||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            3334568899887 57999997 7899999886543   34557899999988 69999999999999999999999997


Q ss_pred             CCChhhhhccCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---C--CcEEEeeecCceecC
Q 046240          555 NGSLDIFLYSSTCM---LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---D--MIAHLSDFGIAKLLS  626 (763)
Q Consensus       555 ~g~L~~~l~~~~~~---~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~--~~~kl~Dfgla~~~~  626 (763)
                      + +|.++++.....   ........+..|++.||++|   |+.+||||||||+|||++.   +  ..++|+|||+++.++
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            7 999999874211   11134567899999999999   8899999999999999975   3  478999999999997


Q ss_pred             CCCCcc-ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcC-CCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          627 GEDQSM-TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       627 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      .+..+. ......||-+|+|||++....-+.++||||+||++|+.++| .+||+.....+.....-.             
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~-------------  729 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGN-------------  729 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCc-------------
Confidence            655432 34567799999999999988888899999999999999995 999988544332211100             


Q ss_pred             hhcC-CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLL-SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+. -.+..      ++  +..+++.++++++|..||+|.+|+.
T Consensus       730 ~~L~~L~~~~------d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  730 YTLVHLEPLP------DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cceeeeccCc------hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0000 00111      11  4678999999999999999999973

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=9.5e-30  Score=236.21  Aligned_cols=261  Identities=19%  Similarity=0.288  Sum_probs=199.5

Q ss_pred             HhccCcCceecccCCceEEEEE-ecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecC--CceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSND--DFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  549 (763)
                      .++|++.+++|+|.++.||.|. ..+.++++||+++..   ..+.+.+|+.+|+.++ ||||+++++...+.  ....+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4789999999999999999994 567889999999864   3467789999999997 99999999998765  467899


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCceecCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~  628 (763)
                      +||+++.+....-..    +....+.....+++.||.|+   |+.||.|||+||.||++|.. -..+++|+|+|.++.+.
T Consensus       114 FE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999999877665432    55567777889999999999   99999999999999999865 57999999999998644


Q ss_pred             CCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh---------------c
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV---------------N  692 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~---------------~  692 (763)
                      .   .....+.+..|.-||.+.. ..|+..-|+|||||++.+|+..+.||........++...+               .
T Consensus       187 ~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  187 K---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             c---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            3   3355678889999998764 6688899999999999999999999865333333332221               2


Q ss_pred             ccCChhHHHHHHhhcCCCccccHH---HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          693 GLLPVSLMEVVNKTLLSPPEKDFA---AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       693 ~~~~~~~~~~i~~~l~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+++...+++.+.-.+... ++.   .......+..+++.+.+.+|-.+|||+.|+.+
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~-~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWS-RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cCCChhHhhHhhccccccHH-HhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            22344444444433322111 110   01112356789999999999999999999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.7e-29  Score=263.27  Aligned_cols=204  Identities=22%  Similarity=0.345  Sum_probs=168.1

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .-|..++.||-|+||+|++++. ++...+|+|.+.+..   .......+.|-+||.....+-||++|..|++.+.+|.||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            3477778899999999999954 456679999887653   233456678999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC----
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS----  626 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~----  626 (763)
                      +|++||++-.++-+.+ .+++.-..-.+..+..|+++.   |..|+|||||||+|||+|.+|++||+|||+++-+.    
T Consensus       709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            9999999988876654 455555555677889999999   89999999999999999999999999999985432    


Q ss_pred             -----CCCCcc-------------------------------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHH
Q 046240          627 -----GEDQSM-------------------------------TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIET  670 (763)
Q Consensus       627 -----~~~~~~-------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~el  670 (763)
                           ..+..+                               .....+||..|+|||++....|+.-+|.||.||+||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                 111000                               00133699999999999999999999999999999999


Q ss_pred             HcCCCCCchhhh
Q 046240          671 FTRKKPADKMFA  682 (763)
Q Consensus       671 ltg~~p~~~~~~  682 (763)
                      +.|++||-....
T Consensus       865 ~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  865 LVGQPPFLADTP  876 (1034)
T ss_pred             hhCCCCccCCCC
Confidence            999999976443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-30  Score=263.51  Aligned_cols=200  Identities=25%  Similarity=0.347  Sum_probs=174.3

Q ss_pred             hccCcCceecccCCceEEEEEecCCc-eEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGI-EVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++..+..+|-|+||.|-.+...+.. .+|+|.+++.   .....+....|-.+|...+.|.||++|-.|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555678999999999999776433 3788887654   3445677888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |-|-||.+...+...+ .++.....-++.-+.+|++||   |.++||+|||||+|.++|.+|-+||.|||.|+.+.... 
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-  574 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence            9999999999998765 577777777888899999999   89999999999999999999999999999999986443 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhh
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMF  681 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~  681 (763)
                        .+-.++||+.|.|||++.....+.++|.||+|+++||+++|.+||++..
T Consensus       575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d  623 (732)
T KOG0614|consen  575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD  623 (732)
T ss_pred             --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence              3345789999999999999999999999999999999999999998754

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.96  E-value=1.7e-31  Score=279.18  Aligned_cols=297  Identities=26%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             eEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCC
Q 046240           79 VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKL  158 (763)
Q Consensus        79 v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L  158 (763)
                      +++|.+++|++. .+-.+++.|+.|+.+++.+|++.     ...||..+| .|..|+.||||+|+++ ..|..+.+.+++
T Consensus        57 LEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LK-----nsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~  128 (1255)
T KOG0444|consen   57 LEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLK-----NSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNS  128 (1255)
T ss_pred             hhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccc-----cCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCc
Confidence            333444444443 23333444444444444444432     234566665 5666666666666665 555556666666


Q ss_pred             CeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccc----------------
Q 046240          159 TILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT----------------  222 (763)
Q Consensus       159 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~----------------  222 (763)
                      -.|+||+|+|..+...-|.+|+.|-+||    |++|++. .+|+.+..+. .|++|+|++|.+.                
T Consensus       129 iVLNLS~N~IetIPn~lfinLtDLLfLD----LS~NrLe-~LPPQ~RRL~-~LqtL~Ls~NPL~hfQLrQLPsmtsL~vL  202 (1255)
T KOG0444|consen  129 IVLNLSYNNIETIPNSLFINLTDLLFLD----LSNNRLE-MLPPQIRRLS-MLQTLKLSNNPLNHFQLRQLPSMTSLSVL  202 (1255)
T ss_pred             EEEEcccCccccCCchHHHhhHhHhhhc----cccchhh-hcCHHHHHHh-hhhhhhcCCChhhHHHHhcCccchhhhhh
Confidence            6666666666644444555666666665    5555554 4555555555 5555555555432                


Q ss_pred             ---------cccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcc
Q 046240          223 ---------GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS  293 (763)
Q Consensus       223 ---------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls  293 (763)
                               ..+|.++..|.+|..+|||.|.|. .+|+.+.++.+  |+.|+||+|+|+ .+..  ......+|++|+||
T Consensus       203 hms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~--LrrLNLS~N~it-eL~~--~~~~W~~lEtLNlS  276 (1255)
T KOG0444|consen  203 HMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRN--LRRLNLSGNKIT-ELNM--TEGEWENLETLNLS  276 (1255)
T ss_pred             hcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhh--hheeccCcCcee-eeec--cHHHHhhhhhhccc
Confidence                     246777778888888888888888 78888888876  888888888888 3333  45566778888888


Q ss_pred             cccccccCCcccCCCcCccEEEccCccccC-cccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCC
Q 046240          294 RNNFSGDIPATIGGLKDVQNISLPYNRLEG-PIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGE  372 (763)
Q Consensus       294 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  372 (763)
                      +|+++ .+|+++..+++|+.|++.+|+++- -+|+.++.|.+|+++..++|++.- +|+.++.+.+|+.|.|+.|.+-..
T Consensus       277 rNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LEl-VPEglcRC~kL~kL~L~~NrLiTL  354 (1255)
T KOG0444|consen  277 RNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLEL-VPEGLCRCVKLQKLKLDHNRLITL  354 (1255)
T ss_pred             cchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccccc-CchhhhhhHHHHHhcccccceeec
Confidence            88888 788888888888888888888752 378888888888888888888874 788999999999999999998876


Q ss_pred             CCCCCCccccccccccCCCcccCCC
Q 046240          373 IPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       373 ~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      +....-++.+..+++..||.+.-.|
T Consensus       355 PeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  355 PEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             hhhhhhcCCcceeeccCCcCccCCC
Confidence            6655667888889999998765544

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=246.08  Aligned_cols=267  Identities=23%  Similarity=0.295  Sum_probs=193.2

Q ss_pred             cCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCC-----ceEE
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-----FKAL  548 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  548 (763)
                      .+..+.||.|+||.||.++. ++|+.||.|++.....  ...+.+-+|++++..++|.|++..++..+-..     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34457899999999999955 5899999999875432  23567788999999999999999988775543     5677


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ++|.+.. +|..++-+.. .++...+.-+.+||++||+||   |+.+|.||||||.|.||+++...||||||+++..+.+
T Consensus       135 ~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            8888744 7777776543 567777788899999999999   8999999999999999999999999999999986533


Q ss_pred             CCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh-hh-hhhhhcccCChhHHHH---
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE-LS-LKHWVNGLLPVSLMEV---  702 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-~~-~~~~~~~~~~~~~~~~---  702 (763)
                       .....+..+.|.+|+|||++.+ ..|+.+.||||.||++.|++.++.-|.....-+ .. ..+......-+.++..   
T Consensus       210 -~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  210 -DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             -hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence             3345567788999999999886 578999999999999999999998886532211 11 1111111111111111   


Q ss_pred             -HHhhcCCCccc-------cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          703 -VNKTLLSPPEK-------DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       703 -i~~~l~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                       ....+...+..       ........-.+-..+....+..||+.|.+..+.+.-
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence             11122221111       011111223455677888899999999998887653

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.95  E-value=1.6e-30  Score=271.98  Aligned_cols=277  Identities=25%  Similarity=0.390  Sum_probs=245.8

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      ..++.|||++|++. ..|..+.+-+++-+|+||+|+|       .+||..+|.+|+.|-.||||+|++. .+|+.+..+.
T Consensus       103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I-------etIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~  173 (1255)
T KOG0444|consen  103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI-------ETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLS  173 (1255)
T ss_pred             ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc-------ccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHh
Confidence            56888999999998 7888888889999999999988       4999999999999999999999998 7788899999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCccc-ccCCcccccccccccEEEeecCccccccccccCCcccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN-GILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF  235 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~-~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L  235 (763)
                      .|++|+|++|.+....-..+..+++|+.|.    +++.+-+ ..+|.++.++. +|..+|||.|.+. ..|+.+-++++|
T Consensus       174 ~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLh----ms~TqRTl~N~Ptsld~l~-NL~dvDlS~N~Lp-~vPecly~l~~L  247 (1255)
T KOG0444|consen  174 MLQTLKLSNNPLNHFQLRQLPSMTSLSVLH----MSNTQRTLDNIPTSLDDLH-NLRDVDLSENNLP-IVPECLYKLRNL  247 (1255)
T ss_pred             hhhhhhcCCChhhHHHHhcCccchhhhhhh----cccccchhhcCCCchhhhh-hhhhccccccCCC-cchHHHhhhhhh
Confidence            999999999998766556666777788877    5555433 56899999999 9999999999999 899999999999


Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccc-cCCcccCCCcCccEE
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG-DIPATIGGLKDVQNI  314 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L  314 (763)
                      +.|+||+|+|+ .+.-......+  |++|+||.|+++ .+|.  ++.++++|+.|.+.+|+++- -+|..++.+.+|+.+
T Consensus       248 rrLNLS~N~it-eL~~~~~~W~~--lEtLNlSrNQLt-~LP~--avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf  321 (1255)
T KOG0444|consen  248 RRLNLSGNKIT-ELNMTEGEWEN--LETLNLSRNQLT-VLPD--AVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVF  321 (1255)
T ss_pred             heeccCcCcee-eeeccHHHHhh--hhhhccccchhc-cchH--HHhhhHHHHHHHhccCcccccCCccchhhhhhhHHH
Confidence            99999999999 55556666666  999999999999 8999  89999999999999999873 379999999999999


Q ss_pred             EccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC
Q 046240          315 SLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG  376 (763)
Q Consensus       315 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  376 (763)
                      .+++|+++ ..|+.++.+..|+.|.|+.|++.. +|+++.-++.|++||+..|+---.+|.-
T Consensus       322 ~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiT-LPeaIHlL~~l~vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  322 HAANNKLE-LVPEGLCRCVKLQKLKLDHNRLIT-LPEAIHLLPDLKVLDLRENPNLVMPPKP  381 (1255)
T ss_pred             Hhhccccc-cCchhhhhhHHHHHhcccccceee-chhhhhhcCCcceeeccCCcCccCCCCc
Confidence            99999999 899999999999999999999887 7999999999999999999977666653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=238.07  Aligned_cols=199  Identities=26%  Similarity=0.334  Sum_probs=170.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .+|...++||+|+|++|-.+++. +.+.+|+|+++++.   .++..-.+.|-.+..+. +||.+|.+..+|+.+...+.|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57889999999999999999765 67899999998663   22344456677777766 799999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      .||++||+|-..+++++ .++.....-....|.-||.||   |++||+.||||.+|||+|..|++|++|+|.++.--.  
T Consensus       330 ieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l~--  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--  403 (593)
T ss_pred             EEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCCC--
Confidence            99999999988887766 466666666777888899999   899999999999999999999999999999985322  


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      ....++..+||+.|+|||++.+..|...+|.|++||+|+||+.|+.||+-
T Consensus       404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            22345668999999999999999999999999999999999999999974

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.1e-26  Score=230.94  Aligned_cols=210  Identities=35%  Similarity=0.511  Sum_probs=182.9

Q ss_pred             ecccCCceEEEEEecC-CceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCChhh
Q 046240          483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDI  560 (763)
Q Consensus       483 lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  560 (763)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999997764 899999999765432 35678899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-CCcEEEeeecCceecCCCCCccccccccc
Q 046240          561 FLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHLSDFGIAKLLSGEDQSMTQTQTLA  639 (763)
Q Consensus       561 ~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  639 (763)
                      ++......+++..+..++.++++++.+|   |+.+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            9876534588999999999999999999   7789999999999999999 89999999999987643321  1233557


Q ss_pred             cccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHH
Q 046240          640 TIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK  718 (763)
Q Consensus       640 ~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~  718 (763)
                      ...|++||..... .++.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8889999998777 888999999999999999                                                


Q ss_pred             HHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          719 EQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       719 ~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                          ..+.+++..|++.+|++||++.++++.
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                357899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=8.1e-28  Score=234.80  Aligned_cols=195  Identities=26%  Similarity=0.289  Sum_probs=164.7

Q ss_pred             HhccCcCceecccCCceEEEEE-ecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC------C
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSND------D  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  544 (763)
                      ..+|.-.+.+|.|+- .|..|. .-.++.||+|+....  .....++..+|...+..++|+||++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            357777888999988 666663 346889999987543  223456778999999999999999999998543      3


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..|+|||+|+. +|...+.-   .++......|.+|++.|++||   |+.+|+||||||+||++..++.+||.|||+|+.
T Consensus        95 e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhcc
Confidence            67899999965 88888763   367888999999999999999   899999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      -..   ....+..+.+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+
T Consensus       168 e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  168 EDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             cCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence            432   2455778899999999999988899999999999999999999988764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=4.5e-26  Score=229.57  Aligned_cols=199  Identities=30%  Similarity=0.424  Sum_probs=172.6

Q ss_pred             cCcCceecccCCceEEEEEecC-CceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          477 FGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      |...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5567899999999999997764 889999999866544 56788899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +++|.+++......+++.....++.++++++.+|   |+.+++|+|++|+||+++.++.++|+|||.+..+..... ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            9999999876543378899999999999999999   778999999999999999999999999999987753321 022


Q ss_pred             ccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          635 TQTLATIGYMAPEYG-IERKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      ....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334577889999988 667788899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-27  Score=247.08  Aligned_cols=195  Identities=26%  Similarity=0.368  Sum_probs=166.7

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--------HHHHHHHHHHHHHHhCC---CCccceEEeeeec
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--------RAMKSFEVECEVMKNIR---HRNLVKIISGCSN  542 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  542 (763)
                      .+|...+.+|.|+||.|+.|.++ +...|+||.+.++.-        ...-..-.||+||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46888999999999999999765 567899998876531        11122456999999997   9999999999999


Q ss_pred             CCceEEEEEcc-CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          543 DDFKALVLEYM-PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       543 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                      ++..||+||-- ++.+|.+++..+. .++......|.+||+-|+++|   |+.+|||||||-+||.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeeccc
Confidence            99999999964 5668888888765 588899999999999999999   999999999999999999999999999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCC
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPA  677 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~  677 (763)
                      |....    +......+||..|.|||++.+..| +..-|||++|++||-++...-||
T Consensus       717 aa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  717 AAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             hhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            87653    223456789999999999998887 45689999999999999988886

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=9e-28  Score=254.31  Aligned_cols=253  Identities=24%  Similarity=0.329  Sum_probs=205.1

Q ss_pred             HhccCcCceecccCCceEEEEE-ecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|+...++|+|.||.||+++ .+.++..|+|+++-+.....+.+.+|+-+++..+||||+.++|.|...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            4678889999999999999994 567999999999877666777888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      |.+|+|.+.-+-.+ ++...++..+++...++++||   |+.+-+|||||-.||++++.|.+|++|||.+..+...  -.
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA  167 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence            99999998876544 688888999999999999999   8999999999999999999999999999998765321  12


Q ss_pred             ccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          633 TQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ....+.||++|||||+..   .+.|..++|||+.|+...|+---++|........              .-.+..+..-+
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--------------~l~LmTkS~~q  233 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--------------ALFLMTKSGFQ  233 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--------------HHHHhhccCCC
Confidence            345678999999999753   5778999999999999999988888865533222              22222222222


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .|..  ..+......+.++++.|+...|++||+++.+++
T Consensus       234 pp~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 PPTL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCcc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            2221  111223566889999999999999999987764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-25  Score=229.80  Aligned_cols=130  Identities=25%  Similarity=0.368  Sum_probs=107.9

Q ss_pred             hccCcCceecccCCceEEEE-EecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-----C---CccceEEeeee----
Q 046240          475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-----H---RNLVKIISGCS----  541 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~----  541 (763)
                      .+|.+.++||=|.|++||++ +.++.+.||+|+.+.. ....+....||++|++++     |   ..||++++.|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            68999999999999999999 5567889999998744 234456688999999984     3   47999999995    


Q ss_pred             cCCceEEEEEccCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          542 NDDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       542 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      .+.+.|||+|++ |.+|-.+|.. ..+.++...+.+|++||+.||.|||  ...+|||.||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLH--RECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHH--HhcCccccCCCcceeee
Confidence            455999999998 4466666654 3446899999999999999999998  45689999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.6e-26  Score=237.85  Aligned_cols=201  Identities=26%  Similarity=0.288  Sum_probs=167.9

Q ss_pred             HHHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCC------CCccceEEeeeec
Q 046240          470 LSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIR------HRNLVKIISGCSN  542 (763)
Q Consensus       470 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~  542 (763)
                      .+....+|.+....|+|-|++|.+|..+ .|+.||||++..+.. ..+.=..|+++|++++      --++++++..|..
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            3445678998899999999999999554 588999999976532 2344467999999995      2489999999999


Q ss_pred             CCceEEEEEccCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeee
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDF  619 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Df  619 (763)
                      ..++|||||-+. -+|.+++...+.  .+....+..++.|+.-||..|   -..+|+|.||||+||||++. ..+|||||
T Consensus       506 knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEeccCcceeeeccC
Confidence            999999999774 488888876443  567778889999999999999   78899999999999999876 56899999


Q ss_pred             cCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      |.|.......    .+.+..+..|.|||++.+-+|+...|+||+||+|||+.||+..|.+
T Consensus       582 GSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  582 GSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             cccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            9998765332    2345567789999999999999999999999999999999988865

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.93  E-value=3.2e-28  Score=243.38  Aligned_cols=293  Identities=25%  Similarity=0.386  Sum_probs=219.8

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      ..+..|+..+|+++ ++|+.++++.+|..|++.+|+++       .+|+... +++.|++||...|.++ .+|..++.+.
T Consensus       137 ~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-------~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~  206 (565)
T KOG0472|consen  137 LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-------ALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLE  206 (565)
T ss_pred             hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-------hCCHHHH-HHHHHHhcccchhhhh-cCChhhcchh
Confidence            35777888889998 78899999999999999999986       7777766 4899999999999998 7888899999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccc-cccccccEEEeecCccccccccccCCcccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIV-NLSISLERLYISNCSITGNIPQVMGNLSIF  235 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~-~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L  235 (763)
                      +|.-|+|..|+|. ..| .|.++..|.+|.    +..|+|. .+|++.. ++. +|..|||.+|+++ ..|+.+.-+.+|
T Consensus       207 ~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh----~g~N~i~-~lpae~~~~L~-~l~vLDLRdNklk-e~Pde~clLrsL  277 (565)
T KOG0472|consen  207 SLELLYLRRNKIR-FLP-EFPGCSLLKELH----VGENQIE-MLPAEHLKHLN-SLLVLDLRDNKLK-EVPDEICLLRSL  277 (565)
T ss_pred             hhHHHHhhhcccc-cCC-CCCccHHHHHHH----hcccHHH-hhHHHHhcccc-cceeeeccccccc-cCchHHHHhhhh
Confidence            9999999999998 566 899999999998    6677766 6788776 666 9999999999999 889999999999


Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccccC-----------------------------------------
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGS-----------------------------------------  274 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~-----------------------------------------  274 (763)
                      ..||+|+|.|+ .+|..++++.   |+.|-+.||.+...                                         
T Consensus       278 ~rLDlSNN~is-~Lp~sLgnlh---L~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~  353 (565)
T KOG0472|consen  278 ERLDLSNNDIS-SLPYSLGNLH---LKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSE  353 (565)
T ss_pred             hhhcccCCccc-cCCcccccce---eeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCC
Confidence            99999999999 6777888773   66666666655310                                         


Q ss_pred             -----------------------CCCc-cccccCCcccEEEccccccc-----------------------ccCCcccCC
Q 046240          275 -----------------------IPSC-IDIGNLKVVVEINLSRNNFS-----------------------GDIPATIGG  307 (763)
Q Consensus       275 -----------------------~p~~-~~~~~l~~L~~L~Ls~N~l~-----------------------~~~p~~~~~  307 (763)
                                             +|.. |..+.-.-.+..+++.|++.                       +.+|..++.
T Consensus       354 ~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~  433 (565)
T KOG0472|consen  354 SFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQ  433 (565)
T ss_pred             cccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHh
Confidence                                   0000 00000000122333333322                       134445555


Q ss_pred             CcCccEEEccCccccCcccccccccccccEEeCcCCcc-----------------------CCccchhhhhhccCceEEc
Q 046240          308 LKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKI-----------------------SGFILISLEKLLYLKKLNL  364 (763)
Q Consensus       308 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-----------------------~~~~~~~~~~l~~L~~L~l  364 (763)
                      +++|..|+|++|-+. .+|..++.+..|+.|+++.|++                       ..+.++.+.++.+|..|||
T Consensus       434 l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL  512 (565)
T KOG0472|consen  434 LQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDL  512 (565)
T ss_pred             hhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceecc
Confidence            666666666666665 5566666666666666666555                       4445666888999999999


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCcc
Q 046240          365 SFNKLEGEIPRGGPFANFTAKSFMGNEKL  393 (763)
Q Consensus       365 ~~N~l~~~~p~~~~~~~l~~~~~~~n~~~  393 (763)
                      .+|.+...+|..+.+.++..+.+.|||.-
T Consensus       513 ~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  513 QNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             CCCchhhCChhhccccceeEEEecCCccC
Confidence            99999999999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.5e-26  Score=216.50  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=181.3

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEee-eecCCceEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISG-CSNDDFKALV  549 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv  549 (763)
                      ..+.|.+.+.+|+|.||.+-.+.++ +.+.+++|.++... ...++|.+|...--.+ .|.||+.-|+. |+..+..+.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4577899999999999999999775 67889999987653 2457788887655555 58999988764 5666778899


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec-CC-CcEEEeeecCceecCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-ED-MIAHLSDFGIAKLLSG  627 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~-~~-~~~kl~Dfgla~~~~~  627 (763)
                      +||++.|+|.+-+...+  +......+++.|+++|+.||   |++++||||||.+|||+- .+ ..+|+||||.++..+.
T Consensus       101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999999998887755  67777889999999999999   999999999999999993 33 4799999999886531


Q ss_pred             CCCccccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh---hhhhhhhcccCChhH
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIE-----RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE---LSLKHWVNGLLPVSL  699 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~  699 (763)
                           .......+..|.|||....     -...+.+|||.||+++|.++||+.||+......   ..+..|..+..    
T Consensus       176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~----  246 (378)
T KOG1345|consen  176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN----  246 (378)
T ss_pred             -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC----
Confidence                 1222335667999997543     234678999999999999999999998643322   22333333221    


Q ss_pred             HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                              .+-|..    .....+...++..+-+.++|++|=...++.+
T Consensus       247 --------~~~P~~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  247 --------PALPKK----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             --------ccCchh----hcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence                    111111    1112344566677777777777744444433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1e-25  Score=228.71  Aligned_cols=270  Identities=25%  Similarity=0.315  Sum_probs=197.1

Q ss_pred             HHHHHhccCcCceecccCCceEEEEEec----CCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCC
Q 046240          470 LSRATNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDD  544 (763)
Q Consensus       470 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  544 (763)
                      +....+.|..+++||.|.|++||++...    ..+.||+|.+...  .....+..|+++|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4445677899999999999999999543    4678999988644  3345688899999999 5999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCce
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK  623 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~  623 (763)
                      ...+|+||++.....++...    ++...+......+..||+++   |..||||||+||+|++.+.. +.-.|.|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhHH
Confidence            99999999999888888764    56788888999999999999   89999999999999999854 678999999997


Q ss_pred             ecCCCC------------------------------------------CccccccccccccccCccccCCC-CCCcchhH
Q 046240          624 LLSGED------------------------------------------QSMTQTQTLATIGYMAPEYGIER-KVSTRSDI  660 (763)
Q Consensus       624 ~~~~~~------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv  660 (763)
                      ..+...                                          .........||++|.|||++... ..+++.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            321000                                          00011234699999999998764 56889999


Q ss_pred             HHHHHHHHHHHcCCCCCchhhhhhhhhhhhh--------------ccc--------CChh------HHHHHHhhcCCCcc
Q 046240          661 YSYGIMLIETFTRKKPADKMFAAELSLKHWV--------------NGL--------LPVS------LMEVVNKTLLSPPE  712 (763)
Q Consensus       661 ~slGv~l~elltg~~p~~~~~~~~~~~~~~~--------------~~~--------~~~~------~~~~i~~~l~~~~~  712 (763)
                      ||.||+++-+++++.||.....+...+.+.+              .+.        .+..      ...+....+.....
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            9999999999999999864322222111111              111        1110      01110011111111


Q ss_pred             ---ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          713 ---KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       713 ---~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         .+....+.......++..+|+..+|.+|.|+++++.
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence               111122222347899999999999999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.92  E-value=8.1e-28  Score=240.53  Aligned_cols=263  Identities=28%  Similarity=0.376  Sum_probs=192.7

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      .++.|++++|.+. .+.+.+.+|..|++|++++|+++       ++|+.+. .+..++.|+.++|+++ .+|+.+..+.+
T Consensus        46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-------~lp~aig-~l~~l~~l~vs~n~ls-~lp~~i~s~~~  115 (565)
T KOG0472|consen   46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-------QLPAAIG-ELEALKSLNVSHNKLS-ELPEQIGSLIS  115 (565)
T ss_pred             chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-------hCCHHHH-HHHHHHHhhcccchHh-hccHHHhhhhh
Confidence            4677788888887 56667777777777777777775       6666665 5556666666666665 55555666666


Q ss_pred             CCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccce
Q 046240          158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL  237 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  237 (763)
                      |..|+.++|.+. .                            +|++++.+. .|+.|+..+|+++ ..|+.+..+.+|..
T Consensus       116 l~~l~~s~n~~~-e----------------------------l~~~i~~~~-~l~dl~~~~N~i~-slp~~~~~~~~l~~  164 (565)
T KOG0472|consen  116 LVKLDCSSNELK-E----------------------------LPDSIGRLL-DLEDLDATNNQIS-SLPEDMVNLSKLSK  164 (565)
T ss_pred             hhhhhcccccee-e----------------------------cCchHHHHh-hhhhhhccccccc-cCchHHHHHHHHHH
Confidence            666666666655 3                            344444444 5666666667776 66677777777788


Q ss_pred             eecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEcc
Q 046240          238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLP  317 (763)
Q Consensus       238 L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  317 (763)
                      |++.+|+++...|..+ +++.  |++||...|.+. .+|.  .++.+.+|.-|+|.+|+|. .+| .|.++..|.+|+++
T Consensus       165 l~~~~n~l~~l~~~~i-~m~~--L~~ld~~~N~L~-tlP~--~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g  236 (565)
T KOG0472|consen  165 LDLEGNKLKALPENHI-AMKR--LKHLDCNSNLLE-TLPP--ELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVG  236 (565)
T ss_pred             hhccccchhhCCHHHH-HHHH--HHhcccchhhhh-cCCh--hhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhc
Confidence            8888888874444433 3665  888888888887 6666  6888888888888888888 566 78888888888888


Q ss_pred             CccccCcccccc-cccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCc
Q 046240          318 YNRLEGPIPESF-GYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEK  392 (763)
Q Consensus       318 ~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~  392 (763)
                      .|+|+ .+|.+. ..+++|.+|||.+|+++. .|+.++-+.+|++||+|+|.+++.+++.+.+ ++..+.+.|||.
T Consensus       237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklke-~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLKE-VPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL  309 (565)
T ss_pred             ccHHH-hhHHHHhcccccceeeecccccccc-CchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence            88888 555544 488889999999999887 6788888888999999999999888888777 788888888864

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=8.1e-27  Score=233.30  Aligned_cols=299  Identities=19%  Similarity=0.210  Sum_probs=193.9

Q ss_pred             EEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCe
Q 046240           81 ALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTI  160 (763)
Q Consensus        81 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  160 (763)
                      .++-++-+|+ .+|..+.  +.-+.++|..|+|+       .||+++|..+++|+.|||++|+|+.+-|++|.++++|..
T Consensus        50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~-------~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~  119 (498)
T KOG4237|consen   50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQIS-------SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLS  119 (498)
T ss_pred             eEEccCCCcc-cCcccCC--CcceEEEeccCCcc-------cCChhhccchhhhceecccccchhhcChHhhhhhHhhhH
Confidence            3455556666 4554443  24567777788885       788888888888888888888888888888888888777


Q ss_pred             eeecC-cccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceee
Q 046240          161 LELGG-NSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLD  239 (763)
Q Consensus       161 L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  239 (763)
                      |-+.+ |+|+.+..+.|++|..|+.|.    +.-|.+.-.....|..++ +|..|.+.+|.+..+.-..|..+..+++++
T Consensus       120 Lvlyg~NkI~~l~k~~F~gL~slqrLl----lNan~i~Cir~~al~dL~-~l~lLslyDn~~q~i~~~tf~~l~~i~tlh  194 (498)
T KOG4237|consen  120 LVLYGNNKITDLPKGAFGGLSSLQRLL----LNANHINCIRQDALRDLP-SLSLLSLYDNKIQSICKGTFQGLAAIKTLH  194 (498)
T ss_pred             HHhhcCCchhhhhhhHhhhHHHHHHHh----cChhhhcchhHHHHHHhh-hcchhcccchhhhhhccccccchhccchHh
Confidence            66655 888877778888888888877    667777777777777777 888888888888844445788888888888


Q ss_pred             ccccccc------------CCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCC-cccC
Q 046240          240 LELNKLT------------GPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIP-ATIG  306 (763)
Q Consensus       240 L~~N~l~------------~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~  306 (763)
                      +..|.+-            ...|..+++..-  ..-..+.++++...-+. .....+..+..=-.+.+...++.| ..|.
T Consensus       195 lA~np~icdCnL~wla~~~a~~~ietsgarc--~~p~rl~~~Ri~q~~a~-kf~c~~esl~s~~~~~d~~d~~cP~~cf~  271 (498)
T KOG4237|consen  195 LAQNPFICDCNLPWLADDLAMNPIETSGARC--VSPYRLYYKRINQEDAR-KFLCSLESLPSRLSSEDFPDSICPAKCFK  271 (498)
T ss_pred             hhcCccccccccchhhhHHhhchhhccccee--cchHHHHHHHhcccchh-hhhhhHHhHHHhhccccCcCCcChHHHHh
Confidence            8877732            122333333322  22233344444422221 111111111111112222222333 4567


Q ss_pred             CCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-CCccccccc
Q 046240          307 GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPFANFTAK  385 (763)
Q Consensus       307 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~  385 (763)
                      .+++|+.|+|++|+|+.+-+.+|.++..+++|+|..|+|..+....|.++..|+.|+|.+|+|+...|.. .....+..+
T Consensus       272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l  351 (498)
T KOG4237|consen  272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTL  351 (498)
T ss_pred             hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeee
Confidence            7777777777777777777777777777777777777777776777777777777777777777666643 344556677


Q ss_pred             cccCCCcccCCC
Q 046240          386 SFMGNEKLCGLP  397 (763)
Q Consensus       386 ~~~~n~~~c~~p  397 (763)
                      .+.+|||.|+|-
T Consensus       352 ~l~~Np~~CnC~  363 (498)
T KOG4237|consen  352 NLLSNPFNCNCR  363 (498)
T ss_pred             ehccCcccCccc
Confidence            778888888875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1e-24  Score=259.47  Aligned_cols=196  Identities=17%  Similarity=0.217  Sum_probs=138.7

Q ss_pred             hCCC-CccceEEeee-------ecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046240          527 NIRH-RNLVKIISGC-------SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH  598 (763)
Q Consensus       527 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH  598 (763)
                      .++| +||++++++|       .+.+..+.++||+ +++|.+++......++...+..++.||++||.||   |+++|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAA---HSQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHH---HhCCeee
Confidence            3445 5788888877       2234567778887 5599999976656789999999999999999999   8899999


Q ss_pred             CCCCCCCEEecC-------------------CCcEEEeeecCceecCCCCC--------------ccccccccccccccC
Q 046240          599 CDLKSSNVLLDE-------------------DMIAHLSDFGIAKLLSGEDQ--------------SMTQTQTLATIGYMA  645 (763)
Q Consensus       599 ~dlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~g~~~y~a  645 (763)
                      |||||+|||++.                   ++.+|++|||+++.......              ........||++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999964                   34556666666654211000              000112457899999


Q ss_pred             ccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHH
Q 046240          646 PEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSI  725 (763)
Q Consensus       646 PE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l  725 (763)
                      ||++.+..++.++|||||||+||||++|..|+.......   ........+              +.. .    ......
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~---~~~~~~~~~--------------~~~-~----~~~~~~  241 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM---SSLRHRVLP--------------PQI-L----LNWPKE  241 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH---HHHHHhhcC--------------hhh-h----hcCHHH
Confidence            999999999999999999999999999988865421111   110000000              000 0    012234


Q ss_pred             HHHHHHccccCcCCCCCHHHHHH
Q 046240          726 FSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       726 ~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..++..|++++|.+||++.|+++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhh
Confidence            57788999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=6.5e-24  Score=205.40  Aligned_cols=168  Identities=24%  Similarity=0.230  Sum_probs=128.3

Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      |+|.+++...+..+++..+..++.|+++||.|||   +.+      ||+||+++.++.+|+  ||.++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6888999876667999999999999999999994   444      999999999999999  9998876432       


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                      ...|++.|+|||++.+..++.++|||||||++|||+||+.||.......            .....++.......+..+.
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~~~  130 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS------------AILEILLNGMPADDPRDRS  130 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc------------HHHHHHHHHhccCCccccc
Confidence            1257899999999999999999999999999999999999986532211            1122222222222222111


Q ss_pred             HHHHHHHH--HHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          716 AAKEQCVL--SIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       716 ~~~~~~~~--~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      . ......  .+.+++..|+..+|++||++.++++.+....
T Consensus       131 ~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      131 N-LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             c-HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            1 111222  6899999999999999999999999876554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.90  E-value=3.2e-26  Score=229.01  Aligned_cols=282  Identities=19%  Similarity=0.193  Sum_probs=242.6

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccc-ccccccCCCcccCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY-NRFSGTIQSPITNA  155 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~-N~i~~~~p~~~~~l  155 (763)
                      ...+++.|..|+|+.+.|.+|+.+++|++||||+|.|+       .|.+..|.+|++|.+|-+-+ |+|+.+..+.|.+|
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-------~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL  139 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-------FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGL  139 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchh-------hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhH
Confidence            57899999999999888889999999999999999996       89999999999999887777 99998888999999


Q ss_pred             CCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCc------------ccc
Q 046240          156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCS------------ITG  223 (763)
Q Consensus       156 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~------------l~~  223 (763)
                      ..|+.|.+.-|++.-+..++|..|++|..|.    +.+|.+..+-..+|.++. +++++.+..|.            +..
T Consensus       140 ~slqrLllNan~i~Cir~~al~dL~~l~lLs----lyDn~~q~i~~~tf~~l~-~i~tlhlA~np~icdCnL~wla~~~a  214 (498)
T KOG4237|consen  140 SSLQRLLLNANHINCIRQDALRDLPSLSLLS----LYDNKIQSICKGTFQGLA-AIKTLHLAQNPFICDCNLPWLADDLA  214 (498)
T ss_pred             HHHHHHhcChhhhcchhHHHHHHhhhcchhc----ccchhhhhhccccccchh-ccchHhhhcCccccccccchhhhHHh
Confidence            9999999999999999999999999999998    889988866666888888 99999999998            334


Q ss_pred             ccccccCCccccceeecccccccCCCCccccccCCCCc-cEEEecCCccccCCCCccccccCCcccEEEcccccccccCC
Q 046240          224 NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKL-DTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIP  302 (763)
Q Consensus       224 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L-~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p  302 (763)
                      ..|-.+++..-..-..|.++++..+.+..|..... .+ ..+....+ ..+..|.. .|.++++|+.|+|++|+|+++-+
T Consensus       215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~e-sl~s~~~~~d~-~d~~cP~~-cf~~L~~L~~lnlsnN~i~~i~~  291 (498)
T KOG4237|consen  215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLE-SLPSRLSSEDF-PDSICPAK-CFKKLPNLRKLNLSNNKITRIED  291 (498)
T ss_pred             hchhhcccceecchHHHHHHHhcccchhhhhhhHH-hHHHhhccccC-cCCcChHH-HHhhcccceEeccCCCccchhhh
Confidence            56667788887888888888887666655543311 01 12222222 33355543 69999999999999999999999


Q ss_pred             cccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCC
Q 046240          303 ATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI  373 (763)
Q Consensus       303 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  373 (763)
                      .+|.++.++++|.|..|+|..+-...|.++..|+.|+|.+|+|+.+.|.+|..+.+|..|+|-.|++.+..
T Consensus       292 ~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC  362 (498)
T KOG4237|consen  292 GAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC  362 (498)
T ss_pred             hhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence            99999999999999999999888889999999999999999999999999999999999999999998653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=6e-24  Score=202.40  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=187.4

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCC
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGS  557 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  557 (763)
                      ..+|.....|..|+|+++ |..+++|++.-.  ..+..++|..|.-.++.+.||||..++|.|.......++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            446788899999999998 566777877533  23345678889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccc
Q 046240          558 LDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ  636 (763)
Q Consensus       558 L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  636 (763)
                      |+.+++.... ..+..+..+++.++|+|++|||... +-|----|.+..|++|++.+++|+ .+-++      .+.+...
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~k------fsfqe~g  345 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTK------FSFQEVG  345 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccce------eeeeccc
Confidence            9999998654 6788899999999999999996432 223334689999999999988875 11111      1112233


Q ss_pred             ccccccccCccccCCCCCC---cchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          637 TLATIGYMAPEYGIERKVS---TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       637 ~~g~~~y~aPE~~~~~~~~---~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ..-.+.||+||.++..+-+   .++|+|||.+++||+.|...||......+..+.....+.             ...-  
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl-------------rv~i--  410 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL-------------RVHI--  410 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc-------------cccC--
Confidence            4457889999998866543   479999999999999999999998655554443332221             1110  


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                          +........+++..|+..||.+||.+..|+-.|+++.
T Consensus       411 ----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  411 ----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                0111345778999999999999999999998887653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.3e-22  Score=214.08  Aligned_cols=167  Identities=20%  Similarity=0.202  Sum_probs=130.0

Q ss_pred             HHHHHhccCcCceecccCCceEEEEEec--CCceEEEEEeehh-----hHHHHHHHHHHHHHHHhCCCCccce-EEeeee
Q 046240          470 LSRATNRFGRDNLIGIGSFGYVYKAELD--DGIEVAIKVFHQE-----CARAMKSFEVECEVMKNIRHRNLVK-IISGCS  541 (763)
Q Consensus       470 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~  541 (763)
                      .....++|...+.||+|+||+||+|...  +++.||||++...     .....+.+.+|++++++++|+|+++ ++++  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3345678999999999999999999764  5777899986532     1223566899999999999999985 4432  


Q ss_pred             cCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCCEEecCCCcEEEeeec
Q 046240          542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL-KSSNVLLDEDMIAHLSDFG  620 (763)
Q Consensus       542 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dl-k~~NIll~~~~~~kl~Dfg  620 (763)
                        +..++||||++|++|... ...    .   ...++.+++++|.|+   |+++|+|||| ||+||+++.++.+||+|||
T Consensus        91 --~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             --CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence              457999999999999632 111    1   146788999999999   7899999999 9999999999999999999


Q ss_pred             CceecCCCCCccc------cccccccccccCccccCC
Q 046240          621 IAKLLSGEDQSMT------QTQTLATIGYMAPEYGIE  651 (763)
Q Consensus       621 la~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~  651 (763)
                      +|+.+........      .....+++.|+|||++..
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9998754321111      134567888999998764

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.88  E-value=1.3e-24  Score=238.82  Aligned_cols=298  Identities=27%  Similarity=0.400  Sum_probs=201.2

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      ++..|||++|.+. ..|..+..+.+|+.|+++.|.|.       ++|.... ++.+|++|.|.+|++. ..|..+..+++
T Consensus        46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-------~vp~s~~-~~~~l~~lnL~~n~l~-~lP~~~~~lkn  115 (1081)
T KOG0618|consen   46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-------SVPSSCS-NMRNLQYLNLKNNRLQ-SLPASISELKN  115 (1081)
T ss_pred             eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-------hCchhhh-hhhcchhheeccchhh-cCchhHHhhhc
Confidence            4788888888877 67888888888888888888874       6665554 6777777777777776 66777777777


Q ss_pred             CCeeeecCcccccccccccCCCCchhhhhhh-------------------------------------hhccCCcccccC
Q 046240          158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLV-------------------------------------IGLIGNPLNGIL  200 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-------------------------------------~~l~~n~l~~~~  200 (763)
                      |++|+++.|++. .+|..+..++.++.+..+                                     ++|..|++....
T Consensus       116 l~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~d  194 (1081)
T KOG0618|consen  116 LQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLD  194 (1081)
T ss_pred             ccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhh
Confidence            777777777776 445444444444433321                                     111222211000


Q ss_pred             Cccc--------------------------------------ccccccccEEEeecCccccccccccCCccccceeeccc
Q 046240          201 PSSI--------------------------------------VNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLEL  242 (763)
Q Consensus       201 p~~~--------------------------------------~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  242 (763)
                      -..+                                      ...+.+|+++++++|+++ .+|++++.+.+|+.|+..+
T Consensus       195 ls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~  273 (1081)
T KOG0618|consen  195 LSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANH  273 (1081)
T ss_pred             hhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhcccceEecccc
Confidence            0000                                      001125667777777777 3446666777777777666


Q ss_pred             ccccC----------------------CCCccccccCCCCccEEEecCCccccCCCCcc---------------------
Q 046240          243 NKLTG----------------------PIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI---------------------  279 (763)
Q Consensus       243 N~l~~----------------------~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~---------------------  279 (763)
                      |+|+.                      -+|.....++.  |++|+|..|+|. .+|..+                     
T Consensus       274 N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~s--L~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~l  350 (1081)
T KOG0618|consen  274 NRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKS--LRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTL  350 (1081)
T ss_pred             hhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccce--eeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccccc
Confidence            66652                      13333333333  666666666665 333210                     


Q ss_pred             ---------------------------ccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCccccccccc
Q 046240          280 ---------------------------DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYL  332 (763)
Q Consensus       280 ---------------------------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  332 (763)
                                                 .+.+.++|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..+
T Consensus       351 p~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~  429 (1081)
T KOG0618|consen  351 PSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANL  429 (1081)
T ss_pred             ccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhh
Confidence                                       3556777888888888888555567788888888888888888 778888888


Q ss_pred             ccccEEeCcCCccCCccchhhhhhccCceEEcccccCCC-CCCCCCCccccccccccCCCcc
Q 046240          333 TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG-EIPRGGPFANFTAKSFMGNEKL  393 (763)
Q Consensus       333 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~~~l~~~~~~~n~~~  393 (763)
                      +.|++|...+|+|.. .| .+..++.|+.+|+|.|+|+. .+|...+++++.-+++.||.|+
T Consensus       430 ~~L~tL~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  430 GRLHTLRAHSNQLLS-FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hhhHHHhhcCCceee-ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            888888888888886 45 78899999999999999985 4666677799999999999863

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.87  E-value=5.2e-22  Score=225.93  Aligned_cols=256  Identities=23%  Similarity=0.295  Sum_probs=150.2

Q ss_pred             eEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCC
Q 046240           79 VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKL  158 (763)
Q Consensus        79 v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L  158 (763)
                      -..|+|++++|+ .+|+.+.  ++|+.|++++|+|+       .+|.    .+++|++|+|++|+|+. +|..   .++|
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-------~LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL  264 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-------SLPA----LPPELRTLEVSGNQLTS-LPVL---PPGL  264 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-------CCCC----CCCCCcEEEecCCccCc-ccCc---cccc
Confidence            346778888877 5676665  36778888887775       5554    24677888888888774 3432   3567


Q ss_pred             CeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCcccccee
Q 046240          159 TILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLL  238 (763)
Q Consensus       159 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  238 (763)
                      +.|+|++|+|+. +|..+   ++|+.|+    +++|+++. +|..    .++|++|+|++|+|++ +|...   .+|+.|
T Consensus       265 ~~L~Ls~N~L~~-Lp~lp---~~L~~L~----Ls~N~Lt~-LP~~----p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L  327 (788)
T PRK15387        265 LELSIFSNPLTH-LPALP---SGLCKLW----IFGNQLTS-LPVL----PPGLQELSVSDNQLAS-LPALP---SELCKL  327 (788)
T ss_pred             ceeeccCCchhh-hhhch---hhcCEEE----CcCCcccc-cccc----ccccceeECCCCcccc-CCCCc---cccccc
Confidence            777777777773 44433   3344455    66777663 3432    2267777777777774 33322   346666


Q ss_pred             ecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccC
Q 046240          239 DLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY  318 (763)
Q Consensus       239 ~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  318 (763)
                      ++++|+|++ +|...     .+|+.|+|++|+|+ .+|.  .   ..+|+.|++++|+|+. +|..   ..+|+.|+|++
T Consensus       328 ~Ls~N~L~~-LP~lp-----~~Lq~LdLS~N~Ls-~LP~--l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~  391 (788)
T PRK15387        328 WAYNNQLTS-LPTLP-----SGLQELSVSDNQLA-SLPT--L---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSG  391 (788)
T ss_pred             ccccCcccc-ccccc-----cccceEecCCCccC-CCCC--C---Ccccceehhhcccccc-Cccc---ccccceEEecC
Confidence            677777763 44311     13667777777776 3443  1   2355666666666663 4432   24566666666


Q ss_pred             ccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcc
Q 046240          319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKL  393 (763)
Q Consensus       319 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~  393 (763)
                      |+|++ +|..   .++|+.|++++|+|+++ |..+   .+|+.|++++|+|+..+.....+..+..+++.+|+..
T Consensus       392 N~Lt~-LP~l---~s~L~~LdLS~N~LssI-P~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls  458 (788)
T PRK15387        392 NRLTS-LPVL---PSELKELMVSGNRLTSL-PMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS  458 (788)
T ss_pred             CcccC-CCCc---ccCCCEEEccCCcCCCC-Ccch---hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCC
Confidence            66663 4432   24566666666666653 3322   3455666666666643323344556666666666544

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.87  E-value=4.1e-22  Score=226.76  Aligned_cols=242  Identities=26%  Similarity=0.333  Sum_probs=194.5

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|++.+|+|+. +|.   .+++|++|+|++|+|+       .+|.    ..++|+.|+|++|.|+. +|..   .+
T Consensus       222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-------sLP~----lp~sL~~L~Ls~N~L~~-Lp~l---p~  282 (788)
T PRK15387        222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-------SLPV----LPPGLLELSIFSNPLTH-LPAL---PS  282 (788)
T ss_pred             cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-------cccC----cccccceeeccCCchhh-hhhc---hh
Confidence            478999999999994 664   3689999999999996       6664    24689999999999984 4443   36


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|+.|+|++|+|+. +|..   +++|+.|+    +++|++++ +|..    +.+|+.|++++|+|++ +|..   ..+|+
T Consensus       283 ~L~~L~Ls~N~Lt~-LP~~---p~~L~~Ld----LS~N~L~~-Lp~l----p~~L~~L~Ls~N~L~~-LP~l---p~~Lq  345 (788)
T PRK15387        283 GLCKLWIFGNQLTS-LPVL---PPGLQELS----VSDNQLAS-LPAL----PSELCKLWAYNNQLTS-LPTL---PSGLQ  345 (788)
T ss_pred             hcCEEECcCCcccc-cccc---ccccceeE----CCCCcccc-CCCC----cccccccccccCcccc-cccc---ccccc
Confidence            78899999999995 4543   46788888    88999986 4442    2378899999999995 5532   25899


Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEc
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISL  316 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  316 (763)
                      .|+|++|+|+ .+|...     .+|+.|++++|+|+ .+|.  .   ..+|+.|+|++|+|++ +|..   .++|+.|++
T Consensus       346 ~LdLS~N~Ls-~LP~lp-----~~L~~L~Ls~N~L~-~LP~--l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdL  409 (788)
T PRK15387        346 ELSVSDNQLA-SLPTLP-----SELYKLWAYNNRLT-SLPA--L---PSGLKELIVSGNRLTS-LPVL---PSELKELMV  409 (788)
T ss_pred             eEecCCCccC-CCCCCC-----cccceehhhccccc-cCcc--c---ccccceEEecCCcccC-CCCc---ccCCCEEEc
Confidence            9999999999 456533     23889999999999 5776  2   3579999999999995 5543   368999999


Q ss_pred             cCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCC
Q 046240          317 PYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPR  375 (763)
Q Consensus       317 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  375 (763)
                      ++|+|++ +|..   ..+|+.|++++|+|+. +|..+.++++|+.|+|++|+|++.+|.
T Consensus       410 S~N~Lss-IP~l---~~~L~~L~Ls~NqLt~-LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        410 SGNRLTS-LPML---PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             cCCcCCC-CCcc---hhhhhhhhhccCcccc-cChHHhhccCCCeEECCCCCCCchHHH
Confidence            9999994 6653   3578899999999996 688899999999999999999987664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=6.3e-22  Score=226.85  Aligned_cols=246  Identities=25%  Similarity=0.398  Sum_probs=187.4

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      +.+.|++++++++ .+|..+.  ++|+.|+|++|+|+       .+|..++   ++|+.|+|++|+|+. +|..+.  .+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-------sLP~~l~---~nL~~L~Ls~N~Lts-LP~~l~--~~  242 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-------SLPENLQ---GNIKTLYANSNQLTS-IPATLP--DT  242 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-------cCChhhc---cCCCEEECCCCcccc-CChhhh--cc
Confidence            4788999999998 5776664  57999999999986       7887665   589999999999984 565553  47


Q ss_pred             CCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccce
Q 046240          158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL  237 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  237 (763)
                      |+.|+|++|+++ .+|..+.  ++|+.|+    +++|+++ .+|..+.   .+|+.|+|++|+|+. +|..+.  ++|+.
T Consensus       243 L~~L~Ls~N~L~-~LP~~l~--s~L~~L~----Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~  308 (754)
T PRK15370        243 IQEMELSINRIT-ELPERLP--SALQSLD----LFHNKIS-CLPENLP---EELRYLSVYDNSIRT-LPAHLP--SGITH  308 (754)
T ss_pred             ccEEECcCCccC-cCChhHh--CCCCEEE----CcCCccC-ccccccC---CCCcEEECCCCcccc-Ccccch--hhHHH
Confidence            999999999998 5566554  4788888    7788888 4676654   279999999999984 454443  47889


Q ss_pred             eecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEcc
Q 046240          238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLP  317 (763)
Q Consensus       238 L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  317 (763)
                      |++++|+++ .+|..+.    ++|+.|++++|.++ .+|.  .+  .++|+.|+|++|+|+ .+|..+.  ++|+.|+|+
T Consensus       309 L~Ls~N~Lt-~LP~~l~----~sL~~L~Ls~N~Lt-~LP~--~l--~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs  375 (754)
T PRK15370        309 LNVQSNSLT-ALPETLP----PGLKTLEAGENALT-SLPA--SL--PPELQVLDVSKNQIT-VLPETLP--PTITTLDVS  375 (754)
T ss_pred             HHhcCCccc-cCCcccc----ccceeccccCCccc-cCCh--hh--cCcccEEECCCCCCC-cCChhhc--CCcCEEECC
Confidence            999999998 4565443    24899999999998 4665  33  268999999999998 4666553  689999999


Q ss_pred             CccccCcccccccccccccEEeCcCCccCCccchhhh----hhccCceEEcccccCC
Q 046240          318 YNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE----KLLYLKKLNLSFNKLE  370 (763)
Q Consensus       318 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~l~~N~l~  370 (763)
                      +|+|+ .+|..+.  .+|+.|++++|+|+. +|..+.    .++.+..|++.+|+++
T Consensus       376 ~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        376 RNALT-NLPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CCcCC-CCCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence            99998 4565543  468899999999886 444443    3477889999999987

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=6.7e-21  Score=202.31  Aligned_cols=262  Identities=22%  Similarity=0.242  Sum_probs=194.6

Q ss_pred             ccCcCceecccCCceEEEEEecCC--ceEEEEEeehhhHHHHHHHHHHHHHHHhCCC----CccceEEeee-ecCCceEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELDDG--IEVAIKVFHQECARAMKSFEVECEVMKNIRH----RNLVKIISGC-SNDDFKAL  548 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  548 (763)
                      +|.+.+.||+|+||.||.+.....  ..+|+|+-..........+..|+.++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999976543  4788887765432222267788899888863    5889999998 57778999


Q ss_pred             EEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-----CcEEEeeecCc
Q 046240          549 VLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-----MIAHLSDFGIA  622 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-----~~~kl~Dfgla  622 (763)
                      ||+.+ |.+|.++..... ..++..+...|+.|+..+|+++   |+.|++||||||.|+.++..     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99977 779999875443 5789999999999999999999   89999999999999999865     46999999999


Q ss_pred             e--ecCCCCC----cc-c-cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc
Q 046240          623 K--LLSGEDQ----SM-T-QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL  694 (763)
Q Consensus       623 ~--~~~~~~~----~~-~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~  694 (763)
                      +  .+.....    .. . .....||..|.++....+...+.+.|+||++.++.|+..|..||........ .       
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~-------  246 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-K-------  246 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-H-------
Confidence            8  4322211    11 1 2345699999999999999999999999999999999999999966432111 0       


Q ss_pred             CChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                        ....+...+.....      .....+.++.++...+-..+..++|....+.+.+++...+.
T Consensus       247 --~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  247 --SKFEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             --HHHHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence              00111111111110      00011344566666666678999999999999887776653

>PLN03210 Resistant to P

Probab=99.86  E-value=1.2e-20  Score=231.51  Aligned_cols=282  Identities=24%  Similarity=0.296  Sum_probs=127.1

Q ss_pred             eEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCC
Q 046240           79 VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKL  158 (763)
Q Consensus        79 v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L  158 (763)
                      ++.|++.++.+. .+|..| .+.+|++|+|++|++.       .+|.++. .+++|+.|+|++|...+.+|. ++.+++|
T Consensus       591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-------~L~~~~~-~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~L  659 (1153)
T PLN03210        591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-------KLWDGVH-SLTGLRNIDLRGSKNLKEIPD-LSMATNL  659 (1153)
T ss_pred             cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-------ccccccc-cCCCCCEEECCCCCCcCcCCc-cccCCcc
Confidence            444444444443 344443 2445555555555543       3444432 455555555555433233332 4455555


Q ss_pred             CeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCcccccee
Q 046240          159 TILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLL  238 (763)
Q Consensus       159 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  238 (763)
                      ++|+|++|.....+|..++++++|+.|+    +.+|...+.+|..+ ++. +|++|+|++|...+.+|..   .++|++|
T Consensus       660 e~L~L~~c~~L~~lp~si~~L~~L~~L~----L~~c~~L~~Lp~~i-~l~-sL~~L~Lsgc~~L~~~p~~---~~nL~~L  730 (1153)
T PLN03210        660 ETLKLSDCSSLVELPSSIQYLNKLEDLD----MSRCENLEILPTGI-NLK-SLYRLNLSGCSRLKSFPDI---STNISWL  730 (1153)
T ss_pred             cEEEecCCCCccccchhhhccCCCCEEe----CCCCCCcCccCCcC-CCC-CCCEEeCCCCCCccccccc---cCCcCee
Confidence            5555555544444555555555555555    44444334444443 333 5555555555433333322   2345555


Q ss_pred             ecccccccCCCCccccccCC-----------------------------CCccEEEecCCccccCCCCccccccCCcccE
Q 046240          239 DLELNKLTGPIPVTFGRLQN-----------------------------SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       239 ~L~~N~l~~~~p~~~~~l~~-----------------------------~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +|++|.++ .+|..+ .+++                             ++|+.|+|++|...+.+|.  .++++++|+.
T Consensus       731 ~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~--si~~L~~L~~  806 (1153)
T PLN03210        731 DLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPS--SIQNLHKLEH  806 (1153)
T ss_pred             ecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccCh--hhhCCCCCCE
Confidence            55555554 333322 1111                             1244444444443334444  3444444444


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEccc-cc
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF-NK  368 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~  368 (763)
                      |++++|...+.+|..+ ++++|+.|+|++|..-..+|..   .++|+.|+|++|.|+. +|..+..+++|+.|+|++ |+
T Consensus       807 L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~~  881 (1153)
T PLN03210        807 LEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNN  881 (1153)
T ss_pred             EECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCCC
Confidence            4444443222334333 3444444444444322233321   2345555555555554 344555555555555555 33


Q ss_pred             CCCCCCCCCCccccccccccC
Q 046240          369 LEGEIPRGGPFANFTAKSFMG  389 (763)
Q Consensus       369 l~~~~p~~~~~~~l~~~~~~~  389 (763)
                      +.+.++....++.+..+++.+
T Consensus       882 L~~l~~~~~~L~~L~~L~l~~  902 (1153)
T PLN03210        882 LQRVSLNISKLKHLETVDFSD  902 (1153)
T ss_pred             cCccCcccccccCCCeeecCC
Confidence            444333333344444444443

syringae 6; Provisional

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=4e-21  Score=220.29  Aligned_cols=319  Identities=17%  Similarity=0.233  Sum_probs=228.8

Q ss_pred             hcCCChhhHHHHHHHHHhccCCCCc-ccccCCCCCCCCCcccc----------------eeecCCCCceEEEEecCCCCC
Q 046240           28 ATSNITTDQQALLALEAHISYDPTN-LLAQNWTSNTSVCNWIG----------------ITCDVNSHRVTALNISSLNLQ   90 (763)
Q Consensus        28 ~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~w~~~~~~c~w~g----------------v~c~~~~~~v~~L~L~~~~l~   90 (763)
                      .....+.+...+...++.+.+-+.- .....|..++++|--..                |.|.  ...||++..-+....
T Consensus        57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~  134 (754)
T PRK15370         57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQA  134 (754)
T ss_pred             CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccccc
Confidence            3344567778888888887653321 11123988889995433                5553  456777766553221


Q ss_pred             CcC--Cc--------------------------cc-----CCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEE
Q 046240           91 GEI--PH--------------------------EI-----GYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL  137 (763)
Q Consensus        91 ~~~--~~--------------------------~~-----~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L  137 (763)
                      ...  +.                          .+     +-..+.+.|++++++++       .+|..+.   ++|+.|
T Consensus       135 ~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-------sLP~~Ip---~~L~~L  204 (754)
T PRK15370        135 SSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-------TIPACIP---EQITTL  204 (754)
T ss_pred             ccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-------cCCcccc---cCCcEE
Confidence            110  00                          00     11245789999999886       6776653   579999


Q ss_pred             EcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEee
Q 046240          138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS  217 (763)
Q Consensus       138 ~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~  217 (763)
                      +|++|+|+. +|..+.  ++|++|+|++|+|+. +|..+.  .+|+.|+    +++|++. .+|..+.   .+|++|+|+
T Consensus       205 ~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~----Ls~N~L~-~LP~~l~---s~L~~L~Ls  270 (754)
T PRK15370        205 ILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEME----LSINRIT-ELPERLP---SALQSLDLF  270 (754)
T ss_pred             EecCCCCCc-CChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEE----CcCCccC-cCChhHh---CCCCEEECc
Confidence            999999995 555443  589999999999994 565553  4688888    8899988 5677664   389999999


Q ss_pred             cCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccc
Q 046240          218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF  297 (763)
Q Consensus       218 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l  297 (763)
                      +|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.    +.|+.|++++|+++ .+|.  .+  .++|+.|++++|.+
T Consensus       271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp----~sL~~L~Ls~N~Lt-~LP~--~l--~~sL~~L~Ls~N~L  337 (754)
T PRK15370        271 HNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP----SGITHLNVQSNSLT-ALPE--TL--PPGLKTLEAGENAL  337 (754)
T ss_pred             CCccC-ccccccC--CCCcEEECCCCccc-cCcccch----hhHHHHHhcCCccc-cCCc--cc--cccceeccccCCcc
Confidence            99999 4676554  58999999999999 4665543    23999999999999 4565  22  36899999999999


Q ss_pred             cccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-
Q 046240          298 SGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-  376 (763)
Q Consensus       298 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-  376 (763)
                      ++ +|..+.  ++|+.|+|++|+|+ .+|..+  .++|+.|+|++|+|+.+ |..+.  ..|+.|++++|+|++.+... 
T Consensus       338 t~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~L-P~~l~--~sL~~LdLs~N~L~~LP~sl~  408 (754)
T PRK15370        338 TS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTNL-PENLP--AALQIMQASRNNLVRLPESLP  408 (754)
T ss_pred             cc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCCC-CHhHH--HHHHHHhhccCCcccCchhHH
Confidence            95 676664  79999999999998 567655  36899999999999975 44443  36899999999998543222 


Q ss_pred             ---CCccccccccccCCCccc
Q 046240          377 ---GPFANFTAKSFMGNEKLC  394 (763)
Q Consensus       377 ---~~~~~l~~~~~~~n~~~c  394 (763)
                         ...+.+..+.+.+||...
T Consensus       409 ~~~~~~~~l~~L~L~~Npls~  429 (754)
T PRK15370        409 HFRGEGPQPTRIIVEYNPFSE  429 (754)
T ss_pred             HHhhcCCCccEEEeeCCCccH
Confidence               223556677888887643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.4e-19  Score=193.48  Aligned_cols=258  Identities=29%  Similarity=0.381  Sum_probs=196.1

Q ss_pred             cCcCceecccCCceEEEEEecCCceEEEEEeehhhHH---HHHHHHHHHHHHHhCCCC-ccceEEeeeecCCceEEEEEc
Q 046240          477 FGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR---AMKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  552 (763)
                      |...+.+|.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999777  78999998765432   367789999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeecCceecCCCC
Q 046240          553 MPNGSLDIFLYSST--CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGED  629 (763)
Q Consensus       553 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  629 (763)
                      +.++++.+++....  ..+.......+..+++.++.|+   |..+++|||+||+||+++..+ .++++|||.++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997766543  2578889999999999999999   888899999999999999988 79999999998665433


Q ss_pred             Ccc----ccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          630 QSM----TQTQTLATIGYMAPEYGIE---RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       630 ~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      ...    ......|+..|+|||...+   ..++...|+||+|++++++++|..|+......          .......+.
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----------~~~~~~~~~  226 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----------SATSQTLKI  226 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----------ccHHHHHHH
Confidence            221    2356789999999999887   67889999999999999999999996654321          000011111


Q ss_pred             HHhhcCC--CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          703 VNKTLLS--PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       703 i~~~l~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      +......  ...............+.+++..|+..+|..|.++.+....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111111  0000000001123467888899999999999998877653

>PLN03210 Resistant to P

Probab=99.84  E-value=3.5e-20  Score=227.26  Aligned_cols=294  Identities=22%  Similarity=0.238  Sum_probs=214.2

Q ss_pred             CceEEEEecCCC------CCCcCCcccCCCC-CCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCC
Q 046240           77 HRVTALNISSLN------LQGEIPHEIGYLP-SLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQ  149 (763)
Q Consensus        77 ~~v~~L~L~~~~------l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p  149 (763)
                      .+++.|.+.++.      +...+|+.|..++ +|+.|++.+|.+.       .+|..+  ...+|+.|+|++|++. .++
T Consensus       558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-------~lP~~f--~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-------CMPSNF--RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-------CCCCcC--CccCCcEEECcCcccc-ccc
Confidence            345555554432      2334566666654 4777777777774       777665  4688999999999888 567


Q ss_pred             CcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccccccccc
Q 046240          150 SPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVM  229 (763)
Q Consensus       150 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~  229 (763)
                      ..+..+++|+.|+|++|.....+| .++.+++|+.|+    +.+|.....+|.++..+. +|+.|++++|...+.+|..+
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~----L~~c~~L~~lp~si~~L~-~L~~L~L~~c~~L~~Lp~~i  701 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLK----LSDCSSLVELPSSIQYLN-KLEDLDMSRCENLEILPTGI  701 (1153)
T ss_pred             cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEE----ecCCCCccccchhhhccC-CCCEEeCCCCCCcCccCCcC
Confidence            778889999999998876555666 488889999988    778777778888888888 89999999876555677655


Q ss_pred             CCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccc---------------------------
Q 046240          230 GNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIG---------------------------  282 (763)
Q Consensus       230 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~---------------------------  282 (763)
                       ++++|+.|++++|...+.+|...   .  +|++|+|++|.+. .+|....+.                           
T Consensus       702 -~l~sL~~L~Lsgc~~L~~~p~~~---~--nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~  774 (1153)
T PLN03210        702 -NLKSLYRLNLSGCSRLKSFPDIS---T--NISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMT  774 (1153)
T ss_pred             -CCCCCCEEeCCCCCCcccccccc---C--CcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhh
Confidence             78899999999887665666432   2  3889999999987 556421111                           


Q ss_pred             -cCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCce
Q 046240          283 -NLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKK  361 (763)
Q Consensus       283 -~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  361 (763)
                       ..++|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ .+++|+.|+|++|......|..   ..+|+.
T Consensus       775 ~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~  850 (1153)
T PLN03210        775 MLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISD  850 (1153)
T ss_pred             hccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCE
Confidence             12467788888887777788888889999999998875444677655 6888999999887544434443   357889


Q ss_pred             EEcccccCCCCCCCCCCccccccccccCCCcccCCC
Q 046240          362 LNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       362 L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      |+|++|.++..+.....++++..+++.+++.+...|
T Consensus       851 L~Ls~n~i~~iP~si~~l~~L~~L~L~~C~~L~~l~  886 (1153)
T PLN03210        851 LNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQRVS  886 (1153)
T ss_pred             eECCCCCCccChHHHhcCCCCCEEECCCCCCcCccC
Confidence            999999998655555678888888888866555544

syringae 6; Provisional

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-22  Score=222.48  Aligned_cols=269  Identities=26%  Similarity=0.295  Sum_probs=141.7

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|+.++|-++...+ . ..-.+|+++++++|+++       .+| ++...+.+|+.|+..+|+|+ .+|..+...+
T Consensus       219 ~~l~~L~a~~n~l~~~~~-~-p~p~nl~~~dis~n~l~-------~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~  287 (1081)
T KOG0618|consen  219 PSLTALYADHNPLTTLDV-H-PVPLNLQYLDISHNNLS-------NLP-EWIGACANLEALNANHNRLV-ALPLRISRIT  287 (1081)
T ss_pred             cchheeeeccCcceeecc-c-cccccceeeecchhhhh-------cch-HHHHhcccceEecccchhHH-hhHHHHhhhh
Confidence            345555555565552211 1 12235666666666664       566 33335666666666666664 5555566666


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|+.|++..|.++ -+|....+++.|++|+    |..|+|....+..+.-+..+|..|+.+.|++....--.=..++.|+
T Consensus       288 ~L~~l~~~~nel~-yip~~le~~~sL~tLd----L~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq  362 (1081)
T KOG0618|consen  288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLD----LQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQ  362 (1081)
T ss_pred             hHHHHHhhhhhhh-hCCCcccccceeeeee----ehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHH
Confidence            6666666666666 4455555566666666    4555555322222222222355555555555533322222345555


Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEc
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISL  316 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  316 (763)
                      .|++.+|.|+...-..+.+...  |+.|+|++|+|. .+|.. .+.+++.|++|+||+|+++ .+|..+..++.|+.|..
T Consensus       363 ~LylanN~Ltd~c~p~l~~~~h--LKVLhLsyNrL~-~fpas-~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a  437 (1081)
T KOG0618|consen  363 ELYLANNHLTDSCFPVLVNFKH--LKVLHLSYNRLN-SFPAS-KLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA  437 (1081)
T ss_pred             HHHHhcCcccccchhhhccccc--eeeeeecccccc-cCCHH-HHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence            5666666655444444444443  556666666555 44442 4555555666666666665 45555555666666666


Q ss_pred             cCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEccccc
Q 046240          317 PYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNK  368 (763)
Q Consensus       317 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  368 (763)
                      .+|+|. ..| .+..++.|+.+|+|.|+|+...-..-...++|++||+++|.
T Consensus       438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            666655 444 45555666666666665554322222222556666666655

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-20  Score=176.57  Aligned_cols=201  Identities=23%  Similarity=0.301  Sum_probs=168.0

Q ss_pred             HhccCcCceecccCCceEEEE-EecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCC-CccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRH-RNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ...|..+++||+|+||.+|.| ...+|.+||||+=....  ...++..|..+++.+++ ..|..+..|..+.+.-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            467999999999999999999 56789999999754332  23456778999999974 688888889999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC---CcEEEeeecCceecCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED---MIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~  628 (763)
                      .. |.+|++...-..+.++..+.+-.|.|+..-++|+   |.++++||||||+|+|..-+   ..+.++|||+|+.+-+.
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            87 7899998876666789999999999999999999   78899999999999999644   46899999999987432


Q ss_pred             CC-----ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchh
Q 046240          629 DQ-----SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKM  680 (763)
Q Consensus       629 ~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~  680 (763)
                      ..     .+......||..|.+--...+..-+.+.|+=|+|.+|..+--|..||++.
T Consensus       168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            21     12223456899999888777778888999999999999999999999874

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=5.1e-20  Score=180.89  Aligned_cols=200  Identities=21%  Similarity=0.303  Sum_probs=170.1

Q ss_pred             hccCcCceecccCCceEEEEE-ecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      -.|.++++||+|.||..+.|. +-+++.||||.=...  ....+++.|...++.+ ..++|...|.+..++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            468899999999999999994 457899999963322  3356778899999988 479999999999999999999998


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-----CcEEEeeecCceecCC
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-----MIAHLSDFGIAKLLSG  627 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-----~~~kl~Dfgla~~~~~  627 (763)
                      + |.+|+++..-.++.++..++.-||.|+..-++|+   |++.+|.|||||+|+||..-     ..+.|+|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            7 7799999877777899999999999999999999   78889999999999999753     3589999999998854


Q ss_pred             CCC--c---cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchh
Q 046240          628 EDQ--S---MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKM  680 (763)
Q Consensus       628 ~~~--~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~  680 (763)
                      ...  +   +......||..||+--...+.+-+.+.|+=|+|-+++..+-|..||.+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            332  1   1223456999999999999999999999999999999999999999874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=6.3e-21  Score=186.87  Aligned_cols=177  Identities=15%  Similarity=0.183  Sum_probs=134.6

Q ss_pred             hHHHHH--HHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHH---HHH------HHHHHHHHHhCCCCccce
Q 046240          467 YQDLSR--ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARA---MKS------FEVECEVMKNIRHRNLVK  535 (763)
Q Consensus       467 ~~~~~~--~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~---~~~------~~~e~~~l~~l~h~niv~  535 (763)
                      |.++..  ..++|...+.+|.|+||.||.+.. ++..+|+|+++......   ...      +++|+..+.++.||+|..
T Consensus        21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~   99 (232)
T PRK10359         21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS   99 (232)
T ss_pred             HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence            444432  468999999999999999999866 46789999997543221   122      688999999999999999


Q ss_pred             EEeeeecC--------CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 046240          536 IISGCSND--------DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL  607 (763)
Q Consensus       536 l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIl  607 (763)
                      +.+++...        ...++||||++|.+|.++..     .+.    ....+++.++..+   |..+++|||+||+||+
T Consensus       100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~Nil  167 (232)
T PRK10359        100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESL---HQHGMVSGDPHKGNFI  167 (232)
T ss_pred             ceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHH---HHcCCccCCCChHHEE
Confidence            99886533        35789999999999987732     221    3456888999999   8899999999999999


Q ss_pred             ecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHH
Q 046240          608 LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETF  671 (763)
Q Consensus       608 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell  671 (763)
                      +++++ ++++|||.......... .             ..+.....+..++|+||||+++.-..
T Consensus       168 i~~~g-i~liDfg~~~~~~e~~a-~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        168 VSKNG-LRIIDLSGKRCTAQRKA-K-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EeCCC-EEEEECCCcccccchhh-H-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99988 99999998765421110 0             01334455667999999999977543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=5e-21  Score=213.82  Aligned_cols=251  Identities=20%  Similarity=0.215  Sum_probs=180.4

Q ss_pred             ccCcCceecccCCceEEEEEecCCceEEEEEeehhh-HHHH---HHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC-ARAM---KSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~-~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      +|...+.+|++.|=+|.+|.++.|. |+||++-+.. .-..   .+...|++ ....+|||.+++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777889999999999999999887 9999986543 2122   33333444 555689999999888777788889999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec--CCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL--SGED  629 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~--~~~~  629 (763)
                      |+.. +|++.+..+. -+...+..+|++|++.|+...   |..+|+|||||.+|||++.-.-+.|+||..-+..  +.++
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9866 8888886543 466778889999999999999   8999999999999999999999999999876432  2222


Q ss_pred             Cc---cccccccccccccCccccCC----------CC-CCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhccc
Q 046240          630 QS---MTQTQTLATIGYMAPEYGIE----------RK-VSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGL  694 (763)
Q Consensus       630 ~~---~~~~~~~g~~~y~aPE~~~~----------~~-~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  694 (763)
                      ..   ...........|+|||.+..          .. .+++-||||+||+++|+++ |++||...     ++-.+..+.
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence            11   11122234457999996543          12 5678899999999999999 78887642     122222111


Q ss_pred             CChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                       ......++. .+   +          ...+..++..|++.||++|.++++.++..+..
T Consensus       252 -~~~~e~~Le-~I---e----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  252 -ADDPEQLLE-KI---E----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -ccCHHHHHH-hC---c----------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence             111111111 11   1          12467889999999999999999999875443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=3.4e-20  Score=180.22  Aligned_cols=140  Identities=19%  Similarity=0.184  Sum_probs=109.1

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHH--H------------------------HHHHHHHHHHHHhCCCCcc
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR--A------------------------MKSFEVECEVMKNIRHRNL  533 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  533 (763)
                      ...||+|+||.||+|...+|+.||||+++.....  .                        ......|++.++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998888999999998754211  0                        1122459999999988776


Q ss_pred             ceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc
Q 046240          534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI  613 (763)
Q Consensus       534 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~  613 (763)
                      .....+...  ..++||||++++++....... ..++......++.|++.+|.++|  |+.+|+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEE-CCc
Confidence            444333222  238999999998776543222 35788889999999999999996  678999999999999998 478


Q ss_pred             EEEeeecCceec
Q 046240          614 AHLSDFGIAKLL  625 (763)
Q Consensus       614 ~kl~Dfgla~~~  625 (763)
                      ++|+|||+|...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=6.1e-21  Score=214.90  Aligned_cols=254  Identities=20%  Similarity=0.198  Sum_probs=186.9

Q ss_pred             cCceecccCCceEEEEEec-CCceEEEEEee-----hhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          479 RDNLIGIGSFGYVYKAELD-DGIEVAIKVFH-----QECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       479 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~-----~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ..+.+|.|++|.|+..... .....+.|.+.     ..... ....+..|..+-..++|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4678999999988877443 33334444332     11111 12225667777788899999888888877766666699


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      ||++ +|..++.... .+...++-.+..|+..|+.|+   |+.|+.|||+|++|++++.+|.+||+|||.+..+..+...
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 9998887652 467778888999999999999   8999999999999999999999999999999876533332


Q ss_pred             --cccccccccccccCccccCCCCCCc-chhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          632 --MTQTQTLATIGYMAPEYGIERKVST-RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       632 --~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                        .......|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||..............            ...-.
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~------------~~~~~  544 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN------------YSDQR  544 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc------------ccccc
Confidence              4556788999999999999999987 58999999999999999999987654433220000            00000


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      .........-...+.+-..++.++++.+|.+|-++++|++.
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            01111111223345567788999999999999999999853

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=3.7e-19  Score=190.95  Aligned_cols=216  Identities=26%  Similarity=0.340  Sum_probs=164.5

Q ss_pred             HhCCCCccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 046240          526 KNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSN  605 (763)
Q Consensus       526 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~N  605 (763)
                      +.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....+..+++.||+|+|  ++.--.|+.++++|
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGALKSSN   79 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeeecccc
Confidence            5678999999999999999999999999999999999987778999999999999999999995  34444999999999


Q ss_pred             EEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCC-------CCCcchhHHHHHHHHHHHHcCCCCCc
Q 046240          606 VLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-------KVSTRSDIYSYGIMLIETFTRKKPAD  678 (763)
Q Consensus       606 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slGv~l~elltg~~p~~  678 (763)
                      .++|....+|++|||+....................-|.|||.+.+.       ..+.++||||||++++|+++.+.||.
T Consensus        80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            99999999999999998776421111112222345669999987653       24678999999999999999999998


Q ss_pred             hhhhhhhhhhhhhcccCChhHHHHHHhhcC-CCccccHHH--HHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          679 KMFAAELSLKHWVNGLLPVSLMEVVNKTLL-SPPEKDFAA--KEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       679 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      ........             .+++.+.-. .....++..  ..+...++..++..||..+|++||++++|-..++.+..
T Consensus       160 ~~~~~~~~-------------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  160 LRNLVEDP-------------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccCCh-------------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            74322211             122222111 111122221  12345579999999999999999999999988876665


Q ss_pred             c
Q 046240          756 S  756 (763)
Q Consensus       756 ~  756 (763)
                      .
T Consensus       227 ~  227 (484)
T KOG1023|consen  227 G  227 (484)
T ss_pred             c
Confidence            4

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.2e-18  Score=166.77  Aligned_cols=186  Identities=15%  Similarity=0.116  Sum_probs=138.0

Q ss_pred             CcCceecccCCceEEEEEecCCceEEEEEeehhhHH----HHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEEEc
Q 046240          478 GRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR----AMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       478 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .....+++|+||+||.+.. .+.+++.+.+......    ....+.+|+++|+++. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997766 5788888877644321    1235789999999995 5889999886    346999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC-CCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL-KSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      ++|.+|......        ....+..++++++.++   |+.||+|||| ||+||+++.++.++|+|||++.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998654321        1235778899999999   8899999999 799999999999999999999865432210


Q ss_pred             ---cc--------cccccccccccCccccCC-CCCC-cchhHHHHHHHHHHHHcCCCCCch
Q 046240          632 ---MT--------QTQTLATIGYMAPEYGIE-RKVS-TRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       632 ---~~--------~~~~~g~~~y~aPE~~~~-~~~~-~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                         ..        ..-...++.|++|+...- ...+ .+.+.++-|+-+|.++|+..|+-.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence               00        011225666777774322 1233 567999999999999999988544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.8e-18  Score=168.88  Aligned_cols=139  Identities=21%  Similarity=0.225  Sum_probs=109.6

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHH--------------------------HHHHHHHHHHHHHhCCCCcc
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR--------------------------AMKSFEVECEVMKNIRHRNL  533 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  533 (763)
                      ...||+|++|.||+|...+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999998778999999998754210                          01224578999999999987


Q ss_pred             ceEEeeeecCCceEEEEEccCCCChhhh-hccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCC
Q 046240          534 VKIISGCSNDDFKALVLEYMPNGSLDIF-LYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDED  611 (763)
Q Consensus       534 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~  611 (763)
                      .....+...  ..++||||++++++... +..  ..++......++.++++++.++   |+ .+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~l---H~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRL---YQEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCChhhEEEE-C
Confidence            554444333  24899999998865433 322  2467778899999999999999   55 8999999999999999 7


Q ss_pred             CcEEEeeecCceecC
Q 046240          612 MIAHLSDFGIAKLLS  626 (763)
Q Consensus       612 ~~~kl~Dfgla~~~~  626 (763)
                      +.++|+|||+++..+
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=3.4e-21  Score=171.68  Aligned_cols=161  Identities=29%  Similarity=0.533  Sum_probs=121.3

Q ss_pred             cCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCccccccccccc
Q 046240           97 IGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTI  176 (763)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  176 (763)
                      +.++.+.+.|.||+|+++       .+|+.+. .|.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. +.|..|
T Consensus        29 Lf~~s~ITrLtLSHNKl~-------~vppnia-~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgf   98 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-------VVPPNIA-ELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGF   98 (264)
T ss_pred             ccchhhhhhhhcccCcee-------ecCCcHH-Hhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCcccc
Confidence            445566666667777665       6666665 6777777777777777 67777888888888888888887 778888


Q ss_pred             CCCCchhhhhhhhhccCCccc-ccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccc
Q 046240          177 GNLRNIEWLGLVIGLIGNPLN-GILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGR  255 (763)
Q Consensus       177 ~~l~~L~~L~L~~~l~~n~l~-~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  255 (763)
                      +.++.|+.||    |..|++. ..+|..|+.+. .|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.
T Consensus        99 gs~p~levld----ltynnl~e~~lpgnff~m~-tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~  171 (264)
T KOG0617|consen   99 GSFPALEVLD----LTYNNLNENSLPGNFFYMT-TLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGD  171 (264)
T ss_pred             CCCchhhhhh----ccccccccccCCcchhHHH-HHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHH
Confidence            8888888888    5666665 45677788887 8888888888888 77778888888888888888887 67777777


Q ss_pred             cCCCCccEEEecCCccccCCCC
Q 046240          256 LQNSKLDTLSLCGNSFSGSIPS  277 (763)
Q Consensus       256 l~~~~L~~L~L~~N~l~~~~p~  277 (763)
                      ++.  |++|.+.+|+++ .+|.
T Consensus       172 lt~--lrelhiqgnrl~-vlpp  190 (264)
T KOG0617|consen  172 LTR--LRELHIQGNRLT-VLPP  190 (264)
T ss_pred             HHH--HHHHhcccceee-ecCh
Confidence            776  777777777777 4443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=8e-21  Score=202.55  Aligned_cols=136  Identities=23%  Similarity=0.284  Sum_probs=59.3

Q ss_pred             cccEEEeecCccccc----cccccCCccccceeecccccccCC----CCccccccCCCCccEEEecCCccccCCCCc--c
Q 046240          210 SLERLYISNCSITGN----IPQVMGNLSIFLLLDLELNKLTGP----IPVTFGRLQNSKLDTLSLCGNSFSGSIPSC--I  279 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~--~  279 (763)
                      +|++|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+...++  |++|++++|.+++.....  .
T Consensus       138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~--L~~L~L~~n~i~~~~~~~l~~  215 (319)
T cd00116         138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCN--LEVLDLNNNGLTDEGASALAE  215 (319)
T ss_pred             CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCC--CCEEeccCCccChHHHHHHHH
Confidence            556666666665521    223344445566666666655531    1122222222  555555555544211110  0


Q ss_pred             ccccCCcccEEEcccccccccCCcccC-----CCcCccEEEccCccccC----cccccccccccccEEeCcCCccCC
Q 046240          280 DIGNLKVVVEINLSRNNFSGDIPATIG-----GLKDVQNISLPYNRLEG----PIPESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       280 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      .+..+++|++|++++|++++.....+.     ..++|+.|++++|.++.    .+...+..+++|+++++++|.++.
T Consensus       216 ~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~  292 (319)
T cd00116         216 TLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE  292 (319)
T ss_pred             HhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence            233444555555555555432211111     12455555555555541    122233334455555555555553

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=1.6e-20  Score=167.45  Aligned_cols=179  Identities=23%  Similarity=0.367  Sum_probs=150.8

Q ss_pred             ccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccC
Q 046240          205 VNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNL  284 (763)
Q Consensus       205 ~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l  284 (763)
                      +++. +.+.|.|++|+++ .+|..++.+.+|+.|++.+|+|. .+|..+..++.  |+.|+++-|++. .+|.  .|+.+
T Consensus        30 f~~s-~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~k--lr~lnvgmnrl~-~lpr--gfgs~  101 (264)
T KOG0617|consen   30 FNMS-NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPK--LRILNVGMNRLN-ILPR--GFGSF  101 (264)
T ss_pred             cchh-hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchh--hhheecchhhhh-cCcc--ccCCC
Confidence            3444 7788888999988 67777888999999999999998 78888888876  999999999998 8888  88999


Q ss_pred             CcccEEEcccccccc-cCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEE
Q 046240          285 KVVVEINLSRNNFSG-DIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLN  363 (763)
Q Consensus       285 ~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  363 (763)
                      +.|+.|||.+|++.. .+|..|-.+..|+.|+|++|.++ .+|..++.+++|+.|.+.+|.+.. .|..++.++.|++|.
T Consensus       102 p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~-lpkeig~lt~lrelh  179 (264)
T KOG0617|consen  102 PALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLS-LPKEIGDLTRLRELH  179 (264)
T ss_pred             chhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhh-CcHHHHHHHHHHHHh
Confidence            999999999999874 57888999999999999999999 788889999999999999999886 788899999999999


Q ss_pred             cccccCCCCCCCCCCccc---cccccccCCCcc
Q 046240          364 LSFNKLEGEIPRGGPFAN---FTAKSFMGNEKL  393 (763)
Q Consensus       364 l~~N~l~~~~p~~~~~~~---l~~~~~~~n~~~  393 (763)
                      +.+|+++-.+|+.+.+..   -....+..|||.
T Consensus       180 iqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  180 IQGNRLTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             cccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            999999988887654432   233455666663

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2e-19  Score=192.40  Aligned_cols=222  Identities=25%  Similarity=0.295  Sum_probs=164.3

Q ss_pred             eecccCCceEEEEEe----cCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEEEccC
Q 046240          482 LIGIGSFGYVYKAEL----DDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      ++|+|.||.|+.+..    +.|+.+|+|+..+...  +.......|..++..++ ||.++++...++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            368999999998632    3477789998765421  12225566888899886 9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +|.+...+.... .++..........++-+++++   |+.+++|||+|++||+++.+|++++.|||+++..-...     
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----  151 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence            999887776543 344445555556666677777   99999999999999999999999999999998753222     


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh-hhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL-SLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                       ..+||..|||||+..  ....++|.||||++++||+||..||........ ...-...+......++.++.+..+.+..
T Consensus       152 -~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  152 -IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             -hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHH
Confidence             227899999999987  667889999999999999999999987211110 0011112222234556666666666554


Q ss_pred             cH
Q 046240          714 DF  715 (763)
Q Consensus       714 ~~  715 (763)
                      +.
T Consensus       229 rL  230 (612)
T KOG0603|consen  229 RL  230 (612)
T ss_pred             Hh
Confidence            43

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=8.7e-20  Score=194.58  Aligned_cols=279  Identities=20%  Similarity=0.224  Sum_probs=186.9

Q ss_pred             EEEecCCCCC-CcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccc------cCCCccc
Q 046240           81 ALNISSLNLQ-GEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSG------TIQSPIT  153 (763)
Q Consensus        81 ~L~L~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~------~~p~~~~  153 (763)
                      .|+|.++.++ +.....|..+.+|++|++++|.++..  -...++..+. ..++|++|++++|.+.+      .++..+.
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~--~~~~i~~~l~-~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~   78 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEE--AAKALASALR-PQPSLKELCLSLNETGRIPRGLQSLLQGLT   78 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHH--HHHHHHHHHh-hCCCceEEeccccccCCcchHHHHHHHHHH
Confidence            4677777776 44555667777788888888877420  0012333332 56677788887777662      2233455


Q ss_pred             CCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccc----cccccc
Q 046240          154 NASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITG----NIPQVM  229 (763)
Q Consensus       154 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~----~~~~~~  229 (763)
                      .+++|+.|++++|.+.+..+..|..+.+                        .  ++|++|++++|++++    .+...+
T Consensus        79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~------------------------~--~~L~~L~ls~~~~~~~~~~~l~~~l  132 (319)
T cd00116          79 KGCGLQELDLSDNALGPDGCGVLESLLR------------------------S--SSLQELKLNNNGLGDRGLRLLAKGL  132 (319)
T ss_pred             hcCceeEEEccCCCCChhHHHHHHHHhc------------------------c--CcccEEEeeCCccchHHHHHHHHHH
Confidence            6667777777777766433333322111                        0  159999999999883    334456


Q ss_pred             CCc-cccceeecccccccCC----CCccccccCCCCccEEEecCCccccC----CCCccccccCCcccEEEccccccccc
Q 046240          230 GNL-SIFLLLDLELNKLTGP----IPVTFGRLQNSKLDTLSLCGNSFSGS----IPSCIDIGNLKVVVEINLSRNNFSGD  300 (763)
Q Consensus       230 ~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~~~L~~L~L~~N~l~~~----~p~~~~~~~l~~L~~L~Ls~N~l~~~  300 (763)
                      ..+ ++|+.|++++|.+++.    ++..+..+..  |++|++++|.+++.    ++.  .+..+++|+.|+|++|.+++.
T Consensus       133 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~--L~~L~l~~n~l~~~~~~~l~~--~l~~~~~L~~L~L~~n~i~~~  208 (319)
T cd00116         133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRD--LKELNLANNGIGDAGIRALAE--GLKANCNLEVLDLNNNGLTDE  208 (319)
T ss_pred             HhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCC--cCEEECcCCCCchHHHHHHHH--HHHhCCCCCEEeccCCccChH
Confidence            667 8999999999999843    3334555554  99999999999842    222  345567999999999999744


Q ss_pred             ----CCcccCCCcCccEEEccCccccCcccccccc-----cccccEEeCcCCccCCc----cchhhhhhccCceEEcccc
Q 046240          301 ----IPATIGGLKDVQNISLPYNRLEGPIPESFGY-----LTSLEILDLSNNKISGF----ILISLEKLLYLKKLNLSFN  367 (763)
Q Consensus       301 ----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N  367 (763)
                          ++..+..+++|+.|++++|++++.....+..     .+.|+.|++++|.++..    ....+..+++|+.+++++|
T Consensus       209 ~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N  288 (319)
T cd00116         209 GASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGN  288 (319)
T ss_pred             HHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCC
Confidence                3455677899999999999998643433332     37999999999999732    3455666789999999999


Q ss_pred             cCCCCCCC----C-CCc-cccccccccCCCc
Q 046240          368 KLEGEIPR----G-GPF-ANFTAKSFMGNEK  392 (763)
Q Consensus       368 ~l~~~~p~----~-~~~-~~l~~~~~~~n~~  392 (763)
                      .++.....    . ..+ ..+..+++.+|||
T Consensus       289 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         289 KFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            99865211    1 122 4556666666653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=2.1e-17  Score=161.96  Aligned_cols=136  Identities=16%  Similarity=0.251  Sum_probs=104.7

Q ss_pred             CcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-----CCCccceEEeeeecCC---c-eEE
Q 046240          478 GRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-----RHRNLVKIISGCSNDD---F-KAL  548 (763)
Q Consensus       478 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l  548 (763)
                      ...+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+     .||||++++|++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4467899999999996 3334444 79988755334456789999999999     5799999999998764   3 337


Q ss_pred             EEEc--cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeCCCCCCCEEecC----CCcEEEeeecC
Q 046240          549 VLEY--MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL-EYLNFRHTTPIIHCDLKSSNVLLDE----DMIAHLSDFGI  621 (763)
Q Consensus       549 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L-~~Lh~~h~~~ivH~dlk~~NIll~~----~~~~kl~Dfgl  621 (763)
                      |+||  +++++|.+++....  ++..  ..++.+++.++ +||   |+.+|+||||||+||+++.    ++.++|+||+.
T Consensus        83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  55799999996642  4444  34567777776 899   7899999999999999974    34799999544


Q ss_pred             c
Q 046240          622 A  622 (763)
Q Consensus       622 a  622 (763)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1.1e-17  Score=191.64  Aligned_cols=200  Identities=24%  Similarity=0.252  Sum_probs=158.8

Q ss_pred             HHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC---CCccceEEeeeecCCce
Q 046240          470 LSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR---HRNLVKIISGCSNDDFK  546 (763)
Q Consensus       470 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~  546 (763)
                      .+...+.|.+.+.+|+|+||+||+|...+|+.||+|+=+..+..+   |.--.+++.+++   -+-|+.+...+.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            334456788888999999999999988889999999876554331   111123333333   34566677777777888


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-------CCcEEEeee
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-------DMIAHLSDF  619 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-------~~~~kl~Df  619 (763)
                      ++|+||.+.|+|.+++.. .+.+++.-.+.+..|+++.+++|   |..+||||||||+|.++..       ...++|+||
T Consensus       770 ~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999999984 44689999999999999999999   8889999999999999942       346899999


Q ss_pred             cCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP  676 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p  676 (763)
                      |.+-.+..-.........++|-.+-.+|...++.++..+|-|.+..+++-|+.|+..
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            998665322222344567788899999999999999999999999999999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.72  E-value=2.5e-17  Score=166.47  Aligned_cols=231  Identities=19%  Similarity=0.217  Sum_probs=142.0

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCC----------CccceEEeeee
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRH----------RNLVKIISGCS  541 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~  541 (763)
                      .+..++.||.|+++.||.++.. +|+++|+|++...   .....+.+++|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456788999999999999765 6999999988532   22345566666544444321          12222222221


Q ss_pred             ---------cC---C-----ceEEEEEccCCCChhhhhcc---CCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046240          542 ---------ND---D-----FKALVLEYMPNGSLDIFLYS---STC---MLDIFQRLNIMIDVASALEYLNFRHTTPIIH  598 (763)
Q Consensus       542 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH  598 (763)
                               ..   .     ..+++|+-+ -++|.+++..   ...   ......++.+..|+.+.+++|   |..|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L---h~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL---HSYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH---hhcceEe
Confidence                     11   1     235677776 4477776532   111   233456677889999999999   7899999


Q ss_pred             CCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCC--------CCCCcchhHHHHHHHHHHH
Q 046240          599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE--------RKVSTRSDIYSYGIMLIET  670 (763)
Q Consensus       599 ~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~el  670 (763)
                      +||+|+|++++.+|.++|+||+.....+.   .  ......+..|.|||....        -.++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---R--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE---E--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc---e--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999998776431   1  111344578999996533        3578899999999999999


Q ss_pred             HcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCC
Q 046240          671 FTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR  740 (763)
Q Consensus       671 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  740 (763)
                      ++|..||+..........                 ...        .....++.+.+++...++++|++|
T Consensus       244 WC~~lPf~~~~~~~~~~~-----------------~f~--------~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-----------------DFS--------RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-----------------GGT--------TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc-----------------cch--------hcCCcCHHHHHHHHHHccCCcccC
Confidence            999999986432221100                 000        011235567788888888888877

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.9e-16  Score=159.25  Aligned_cols=141  Identities=19%  Similarity=0.181  Sum_probs=109.9

Q ss_pred             ccCcCceecccCCceEEEEE--ecCCceEEEEEeehhhH------------------------HHHHHHHHHHHHHHhCC
Q 046240          476 RFGRDNLIGIGSFGYVYKAE--LDDGIEVAIKVFHQECA------------------------RAMKSFEVECEVMKNIR  529 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~  529 (763)
                      -|.+.+.||+|+||.||+|.  ..+|+.||+|+++....                        .....+.+|++.++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            37788999999999999997  56899999999874321                        01134578999999997


Q ss_pred             CC--ccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeCCCCCCCE
Q 046240          530 HR--NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP-IIHCDLKSSNV  606 (763)
Q Consensus       530 h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~-ivH~dlk~~NI  606 (763)
                      +.  .+.+++++    ...++||||++++++........ ..+......++.|++.++.+|   |+.+ ++||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKL---YKEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHH---HhcCCEEeCCCChhhE
Confidence            53  34444543    23589999999988876653322 345556678999999999999   8888 99999999999


Q ss_pred             EecCCCcEEEeeecCceec
Q 046240          607 LLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       607 ll~~~~~~kl~Dfgla~~~  625 (763)
                      +++ ++.++++|||.+...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999998754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=1.7e-16  Score=159.67  Aligned_cols=198  Identities=23%  Similarity=0.289  Sum_probs=133.9

Q ss_pred             CCCccceEEeeee---------------------------cCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHH
Q 046240          529 RHRNLVKIISGCS---------------------------NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV  581 (763)
Q Consensus       529 ~h~niv~l~~~~~---------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  581 (763)
                      +|||||++.++|.                           +....|+||...+. +|..++....  .+.....-|..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            5999999987663                           23466889987755 8888887654  4555666789999


Q ss_pred             HHHHHHHHhcCCCCeEeCCCCCCCEEe--cCCC--cEEEeeecCceecCCCC----CccccccccccccccCccccCCCC
Q 046240          582 ASALEYLNFRHTTPIIHCDLKSSNVLL--DEDM--IAHLSDFGIAKLLSGED----QSMTQTQTLATIGYMAPEYGIERK  653 (763)
Q Consensus       582 a~~L~~Lh~~h~~~ivH~dlk~~NIll--~~~~--~~kl~Dfgla~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~  653 (763)
                      ++|+.||   |++||.|||+|++|||+  |+|+  ...|+|||++---+..+    .....-..-|.-.-||||+....+
T Consensus       351 LEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999   88999999999999999  4443  46899999874321100    000112234677789999865432


Q ss_pred             ------CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHH
Q 046240          654 ------VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFS  727 (763)
Q Consensus       654 ------~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~  727 (763)
                            --.|+|.|+.|.+.||+++..-||-.-.+.-...+.+.+..+|                   ..++.++..+.+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-------------------alp~~vpp~~rq  488 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-------------------ALPSRVPPVARQ  488 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-------------------CCcccCChHHHH
Confidence                  1248999999999999999999986522222222222222211                   112233445677


Q ss_pred             HHHHccccCcCCCCCHHHHHHHHh
Q 046240          728 LAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       728 l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      ++...++.+|++|+++.-..+.+.
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            777778888888888766665543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=3.3e-16  Score=154.28  Aligned_cols=144  Identities=22%  Similarity=0.188  Sum_probs=111.4

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhH----------------------HHHHHHHHHHHHHH
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA----------------------RAMKSFEVECEVMK  526 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~  526 (763)
                      ++......|...+.||+|+||.||++...+|+.||||++.....                      ........|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444444778899999999999999888899999998753210                      01123567889999


Q ss_pred             hCCCC--ccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCC
Q 046240          527 NIRHR--NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSS  604 (763)
Q Consensus       527 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~  604 (763)
                      .+.|+  .+...++.    ...++||||+++++|......       .....++.++++++.++   |+.+++||||||+
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKA---YKHGIIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCcc
Confidence            98777  44444442    345899999999998765431       23456889999999999   6789999999999


Q ss_pred             CEEecCCCcEEEeeecCceecC
Q 046240          605 NVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       605 NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ||++++++.++|+|||.+....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=3.7e-16  Score=155.83  Aligned_cols=134  Identities=24%  Similarity=0.322  Sum_probs=112.8

Q ss_pred             ceecccCCceEEEEEecCCceEEEEEeehhh--------HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--------ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +.||+|++|.||+|.. +|..|++|+.....        ......+.+|+.++..+.|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 57789999765321        11234578899999999999988887777777788999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ++|++|.+++....    . ....++.+++.++.++   |+.+++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886532    2 7788999999999999   788999999999999999 78999999998865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=3.6e-17  Score=171.93  Aligned_cols=174  Identities=25%  Similarity=0.385  Sum_probs=131.3

Q ss_pred             CceEEEEEccCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          544 DFKALVLEYMPNGSLDIFLYSS--TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                      ...|+.|++|.-.+|.+|+.+.  ....++.....++.|++.+++|      ++.+|+|+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            3578999999999999999643  3367888899999999999998      7899999999999999999999999999


Q ss_pred             ceecCCCC----CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCC
Q 046240          622 AKLLSGED----QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       622 a~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      ........    .....+.-.||.+||+||++.+..|+.|+||||+|++++|+++ -..++.    ....+...-.+.+|
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIP  478 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCC
Confidence            88765443    1223456689999999999999999999999999999999997 223222    22222332233333


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHH
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCC  746 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v  746 (763)
                      +.       .+...|.            =..+..+.+.+.|++||++.++
T Consensus       479 ~~-------~~~d~p~------------e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  479 PE-------FLQDYPE------------EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hH-------HhhcCcH------------HHHHHHHhcCCCcccCchHHHH
Confidence            21       1111121            2467888899999999955444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=9.3e-16  Score=151.41  Aligned_cols=130  Identities=22%  Similarity=0.345  Sum_probs=106.6

Q ss_pred             eecccCCceEEEEEecCCceEEEEEeehhh--------HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          482 LIGIGSFGYVYKAELDDGIEVAIKVFHQEC--------ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       482 ~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .||+|+||.||+|.+ +|..|++|+.....        ......+.+|+++++.++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999986 46889999864321        112356788999999999887666665666666779999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      +|++|.+++....       . .++.++++++.++   |+.+++|||++|+||+++ ++.+++.|||.+..
T Consensus        80 ~g~~l~~~~~~~~-------~-~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-------D-ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-------H-HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988875432       0 7899999999999   889999999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.9e-15  Score=171.65  Aligned_cols=138  Identities=24%  Similarity=0.279  Sum_probs=112.0

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEe-ehh-------hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVF-HQE-------CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ...|...+.||+|+||+||+|.+.+. .+++|+. ...       .....+.+.+|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34556788999999999999987644 3444432 211       11123567899999999999999988888877778


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++||||+++++|.+++.         ....++.++++++.+|   |+.+++|||+||+||++ .++.++|+|||+++..
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999988774         3567899999999999   78999999999999999 5779999999998763

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=3.5e-15  Score=140.06  Aligned_cols=135  Identities=20%  Similarity=0.247  Sum_probs=115.1

Q ss_pred             cCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCC--CccceEEeeeecCCceEEEEEccCCC
Q 046240          479 RDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRH--RNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       479 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      +.+.+|+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  ..+.+++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999998865 7899999865432  4568889999999976  58999999988888899999999998


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          557 SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       557 ~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      .+..+        +......++.+++++++++|..+..+++|||++|+||++++.+.+++.|||.++.
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77544        4566778899999999999766667899999999999999989999999998865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.58  E-value=2.8e-15  Score=168.41  Aligned_cols=168  Identities=25%  Similarity=0.317  Sum_probs=119.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..+|..++.|-.|+||.||..++. ..+.+|+|+ .++.     .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence            467888999999999999999776 467888854 2221     11110  33333444444                  


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC---
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED---  629 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~---  629 (763)
                         |+=...+...+ .++..        ++.+++|+   |+.+|+|||+||+|.+++.-|++|++|||+++......   
T Consensus       136 ---gDc~tllk~~g-~lPvd--------mvla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG-PLPVD--------MVLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCC-CCcch--------hhHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               22222222211 12211        16689999   89999999999999999999999999999986532110   


Q ss_pred             ------C----ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhh
Q 046240          630 ------Q----SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFA  682 (763)
Q Consensus       630 ------~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~  682 (763)
                            .    .......+||+.|+|||++....|...+|.|++|+++||.+-|+.||.+...
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp  263 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP  263 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence                  0    0111345799999999999999999999999999999999999999988543

>PLN03150 hypothetical protein; Provisional

Probab=99.57  E-value=5.9e-15  Score=169.24  Aligned_cols=138  Identities=30%  Similarity=0.630  Sum_probs=108.6

Q ss_pred             hcCCChhhHHHHHHHHHhccCCCCcccccCCCCCCCCC-----cccceeecCCC----CceEEEEecCCCCCCcCCcccC
Q 046240           28 ATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVC-----NWIGITCDVNS----HRVTALNISSLNLQGEIPHEIG   98 (763)
Q Consensus        28 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~w~~~~~~c-----~w~gv~c~~~~----~~v~~L~L~~~~l~~~~~~~~~   98 (763)
                      .+...+.|..||+.+|+.+. +|..  . +|..  ++|     .|.||.|..+.    ..|+.|+|++|++.|.+|..|+
T Consensus       366 ~~~t~~~~~~aL~~~k~~~~-~~~~--~-~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~  439 (623)
T PLN03150        366 ESKTLLEEVSALQTLKSSLG-LPLR--F-GWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDIS  439 (623)
T ss_pred             ccccCchHHHHHHHHHHhcC-Cccc--C-CCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHh
Confidence            34456789999999999885 4432  2 7963  344     79999995322    2599999999999999999999


Q ss_pred             CCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCC
Q 046240           99 YLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGN  178 (763)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  178 (763)
                      .|++|+.|+|++|.++      |.+|..+. .+++|+.|+|++|+|++.+|..++++++|++|+|++|+++|.+|..++.
T Consensus       440 ~L~~L~~L~Ls~N~l~------g~iP~~~~-~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~  512 (623)
T PLN03150        440 KLRHLQSINLSGNSIR------GNIPPSLG-SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG  512 (623)
T ss_pred             CCCCCCEEECCCCccc------CcCChHHh-CCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence            9999999999988876      57777654 7888888888888888888888888888888888888888777766654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=2e-14  Score=140.35  Aligned_cols=136  Identities=23%  Similarity=0.239  Sum_probs=97.0

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHH--H-HHH---------------------HHHHHHHHHhCCCC--cc
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR--A-MKS---------------------FEVECEVMKNIRHR--NL  533 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~--~-~~~---------------------~~~e~~~l~~l~h~--ni  533 (763)
                      .+.||+|+||+||+|...+|+.||||++......  . ...                     ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998888999999998753211  0 110                     13455566665433  24


Q ss_pred             ceEEeeeecCCceEEEEEccCCCChhhh-hccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCC
Q 046240          534 VKIISGCSNDDFKALVLEYMPNGSLDIF-LYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDED  611 (763)
Q Consensus       534 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~  611 (763)
                      .+.+++    ...++||||++++.+... +....  .. .....++.+++.++.++   |. .+|+||||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChhhEEEE-C
Confidence            444443    235899999999543221 11110  11 45678899999999999   66 8999999999999999 8


Q ss_pred             CcEEEeeecCceecC
Q 046240          612 MIAHLSDFGIAKLLS  626 (763)
Q Consensus       612 ~~~kl~Dfgla~~~~  626 (763)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.52  E-value=1.1e-13  Score=139.60  Aligned_cols=136  Identities=17%  Similarity=0.232  Sum_probs=104.9

Q ss_pred             Cceec-ccCCceEEEEEecCCceEEEEEeehhh-------------HHHHHHHHHHHHHHHhCCCCcc--ceEEeeeecC
Q 046240          480 DNLIG-IGSFGYVYKAELDDGIEVAIKVFHQEC-------------ARAMKSFEVECEVMKNIRHRNL--VKIISGCSND  543 (763)
Q Consensus       480 ~~~lg-~G~~g~v~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  543 (763)
                      ...|| .|+.|+||.+... +..++||.+....             ......+.+|++++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999886 6789999875311             1223567889999999998775  6777765433


Q ss_pred             C----ceEEEEEccCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          544 D----FKALVLEYMPN-GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       544 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                      .    ..++|+||++| .+|.+++...  .++..    .+.++++++.+|   |+.||+||||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    23599999997 6898887543  23332    356889999999   899999999999999999989999999


Q ss_pred             ecCceec
Q 046240          619 FGIAKLL  625 (763)
Q Consensus       619 fgla~~~  625 (763)
                      ||.++..
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988753

>PLN03150 hypothetical protein; Provisional

Probab=99.51  E-value=4.1e-14  Score=162.35  Aligned_cols=118  Identities=37%  Similarity=0.586  Sum_probs=107.2

Q ss_pred             cccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcc
Q 046240          286 VVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLS  365 (763)
Q Consensus       286 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  365 (763)
                      .++.|+|++|.+++.+|..++.+++|+.|+|++|++.|.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCC--CccccccccccCCCcccCCCCCCCCCCC
Q 046240          366 FNKLEGEIPRGG--PFANFTAKSFMGNEKLCGLPHLQVPQCK  405 (763)
Q Consensus       366 ~N~l~~~~p~~~--~~~~l~~~~~~~n~~~c~~p~~~~~~c~  405 (763)
                      +|+++|.+|...  ....+..+++.+|+.+|+.|.  ++.|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            999999999752  234556788999999999874  46785

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=2.3e-15  Score=169.94  Aligned_cols=254  Identities=22%  Similarity=0.254  Sum_probs=187.5

Q ss_pred             hccCcCceecccCCceEEEEEecC--CceEEEEEeehhh--HHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDD--GIEVAIKVFHQEC--ARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  549 (763)
                      ..|...+.||+|+|+.|-......  ...+|+|.+....  .........|..+-+.+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456677889999999998875533  3456666554332  223344455777767775 99999999999999999999


Q ss_pred             EEccCCCChhhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeCCCCCCCEEecCCC-cEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFL-YSSTCMLDIFQRLNIMIDVASALEYLNFRH-TTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h-~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~  626 (763)
                      .+|.+++++...+ +......+.........|+..++.|+   | ..++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999998888 44332455566677889999999999   7 89999999999999999999 99999999998876


Q ss_pred             C-CCCccccccccc-cccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          627 G-EDQSMTQTQTLA-TIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       627 ~-~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      . .+.........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++...........|....         
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---------  247 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---------  247 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---------
Confidence            5 444455566778 9999999998874 456789999999999999999999987655443333332211         


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCN  747 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~  747 (763)
                       ......+..      .......++..+++..+|+.|.+.+++-
T Consensus       248 -~~~~~~~~~------~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 -GRFTQLPWN------SISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -cccccCccc------cCChhhhhcccccccCCchhcccccccc
Confidence             000011111      1123356677777778888888877764

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.46  E-value=5e-15  Score=155.77  Aligned_cols=177  Identities=29%  Similarity=0.492  Sum_probs=132.7

Q ss_pred             CCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCcc
Q 046240          154 NASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS  233 (763)
Q Consensus       154 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~  233 (763)
                      .+.--...||+.|++. .+|..+..+..|+                             .+.|+.|.+. .+|..+.++.
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le-----------------------------~liLy~n~~r-~ip~~i~~L~  121 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLE-----------------------------SLILYHNCIR-TIPEAICNLE  121 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHH-----------------------------HHHHHhccce-ecchhhhhhh
Confidence            3445566778888887 5666666555444                             4445555555 6677777777


Q ss_pred             ccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccE
Q 046240          234 IFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN  313 (763)
Q Consensus       234 ~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  313 (763)
                      .|++|||+.|+++ .+|..++.++   |+.|-+++|+++ .+|.  .++.+..|..||.+.|++. .+|..++++.+|+.
T Consensus       122 ~lt~l~ls~NqlS-~lp~~lC~lp---Lkvli~sNNkl~-~lp~--~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~  193 (722)
T KOG0532|consen  122 ALTFLDLSSNQLS-HLPDGLCDLP---LKVLIVSNNKLT-SLPE--EIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRD  193 (722)
T ss_pred             HHHHhhhccchhh-cCChhhhcCc---ceeEEEecCccc-cCCc--ccccchhHHHhhhhhhhhh-hchHHhhhHHHHHH
Confidence            7777777777777 7777777776   888888888888 6777  6777788888888888887 67778888888888


Q ss_pred             EEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCC
Q 046240          314 ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGE  372 (763)
Q Consensus       314 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  372 (763)
                      |++..|++. .+|..+..| .|..||+|.|+++. +|-.|..+..|++|-|.+|+|+..
T Consensus       194 l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~-iPv~fr~m~~Lq~l~LenNPLqSP  249 (722)
T KOG0532|consen  194 LNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISY-LPVDFRKMRHLQVLQLENNPLQSP  249 (722)
T ss_pred             HHHhhhhhh-hCCHHHhCC-ceeeeecccCceee-cchhhhhhhhheeeeeccCCCCCC
Confidence            888888888 566666654 47788888888886 677888888888888888888753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.46  E-value=3.8e-15  Score=156.65  Aligned_cols=174  Identities=28%  Similarity=0.470  Sum_probs=119.0

Q ss_pred             CCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccccc
Q 046240          131 LPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS  210 (763)
Q Consensus       131 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~  210 (763)
                      +.--...||+.|++. ++|..+..+..|+.|.|+.|.|. .+|..+++|..|.+|+    |+.|+++ .+|..+..++  
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~----ls~NqlS-~lp~~lC~lp--  144 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLD----LSSNQLS-HLPDGLCDLP--  144 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhh----hccchhh-cCChhhhcCc--
Confidence            444556777778777 77777888888888888888887 6777888888888777    6677766 5677777775  


Q ss_pred             ccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEE
Q 046240          211 LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEI  290 (763)
Q Consensus       211 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L  290 (763)
                      |+.|-+++|+++ .+|..++.+..|..||.+.|++. .+|.-++.+.+  |+.|.+..|++. .+|.  .+..| .|..|
T Consensus       145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~s--lr~l~vrRn~l~-~lp~--El~~L-pLi~l  216 (722)
T KOG0532|consen  145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTS--LRDLNVRRNHLE-DLPE--ELCSL-PLIRL  216 (722)
T ss_pred             ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHH--HHHHHHhhhhhh-hCCH--HHhCC-ceeee
Confidence            888888888888 67777777777777777777777 55666666654  666666666666 3444  33433 35555


Q ss_pred             EcccccccccCCcccCCCcCccEEEccCcccc
Q 046240          291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLE  322 (763)
Q Consensus       291 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  322 (763)
                      |+|.|+++ .+|-.|..|+.|++|-|.+|.|+
T Consensus       217 DfScNkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  217 DFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             ecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence            55555555 45555555555555555555555

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=2.6e-12  Score=140.97  Aligned_cols=141  Identities=22%  Similarity=0.254  Sum_probs=98.6

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHHH----------------------------------------HHHHH
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARA----------------------------------------MKSFE  519 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  519 (763)
                      .+.||+|++|.||+|++.+|+.||||+.+......                                        +-++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            46799999999999999999999999986431110                                        01244


Q ss_pred             HHHHHHHhCC----CCccceEEeee-ecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHH-HHHHHhcCC
Q 046240          520 VECEVMKNIR----HRNLVKIISGC-SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA-LEYLNFRHT  593 (763)
Q Consensus       520 ~e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~-L~~Lh~~h~  593 (763)
                      +|+..+.+++    |.+-+.+-..+ ......++||||++|+++.++........   .+..++..++++ +..+   |.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql---~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV---LR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH---Hh
Confidence            4555555542    32223322222 33445799999999999988764322112   234566666653 4555   78


Q ss_pred             CCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       594 ~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      .|++|+|++|.||++++++.++++|||++..++
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            899999999999999999999999999988764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=2.5e-13  Score=149.20  Aligned_cols=182  Identities=31%  Similarity=0.455  Sum_probs=118.7

Q ss_pred             CCCccEEEcccccccccCCCcccCCC-CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccc
Q 046240          131 LPNVKALSLAYNRFSGTIQSPITNAS-KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSI  209 (763)
Q Consensus       131 l~~L~~L~L~~N~i~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~  209 (763)
                      ++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|+    +++|+++. +|....... 
T Consensus       115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~----l~~N~l~~-l~~~~~~~~-  186 (394)
T COG4886         115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD----LSFNDLSD-LPKLLSNLS-  186 (394)
T ss_pred             ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccc----cCCchhhh-hhhhhhhhh-
Confidence            355666666666666 4444444553 6666666666666 3445566666666666    55666653 333333444 


Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +|+.|++++|+++ .+|.....+..|++|.+++|.+. ..+..+.++.+  +..|.+.+|++. .++.  .++.++.++.
T Consensus       187 ~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~--l~~l~l~~n~~~-~~~~--~~~~l~~l~~  259 (394)
T COG4886         187 NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN--LSGLELSNNKLE-DLPE--SIGNLSNLET  259 (394)
T ss_pred             hhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccc--ccccccCCceee-eccc--hhccccccce
Confidence            7777788888877 55655556666888888888544 45666666655  777778888776 3344  5677777888


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccc
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESF  329 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  329 (763)
                      |++++|+++...+  ++.+.+++.|++++|.+...+|...
T Consensus       260 L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         260 LDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             ecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            8888888874333  7788888888888888876655543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.36  E-value=7e-13  Score=145.63  Aligned_cols=203  Identities=33%  Similarity=0.508  Sum_probs=161.0

Q ss_pred             cEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCC-chhhhhhhhhccCCcccccCCcccccccccccE
Q 046240          135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLR-NIEWLGLVIGLIGNPLNGILPSSIVNLSISLER  213 (763)
Q Consensus       135 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~  213 (763)
                      ..|++..|.+.. ....+..++.++.|++.+|+++ .++.....++ +|+.|+    +++|.+. .+|..+..++ +|+.
T Consensus        96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~----l~~N~i~-~l~~~~~~l~-~L~~  167 (394)
T COG4886          96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELD----LSDNKIE-SLPSPLRNLP-NLKN  167 (394)
T ss_pred             ceeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhccccc----ccccchh-hhhhhhhccc-cccc
Confidence            368888888753 3344556688999999999999 5666777774 899998    7888887 4456677777 9999


Q ss_pred             EEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcc
Q 046240          214 LYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS  293 (763)
Q Consensus       214 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls  293 (763)
                      |++++|+++ .+|...+.+++|+.|++++|+++ .+|........  |++|++++|.+. ..+.  .+.++.++..|.++
T Consensus       168 L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~--L~~l~~~~N~~~-~~~~--~~~~~~~l~~l~l~  240 (394)
T COG4886         168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA--LEELDLSNNSII-ELLS--SLSNLKNLSGLELS  240 (394)
T ss_pred             cccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhh--hhhhhhcCCcce-ecch--hhhhcccccccccC
Confidence            999999999 66666668899999999999999 67776544443  899999999655 3444  57888888889999


Q ss_pred             cccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhh
Q 046240          294 RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEK  355 (763)
Q Consensus       294 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  355 (763)
                      +|++. ..+..++.+++++.|++++|+++. ++. ++.+.+|+.|++++|.+....+.....
T Consensus       241 ~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         241 NNKLE-DLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             Cceee-eccchhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhhcc
Confidence            99988 447888899999999999999994 444 888999999999999998876665544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.35  E-value=2.3e-11  Score=132.11  Aligned_cols=168  Identities=17%  Similarity=0.222  Sum_probs=127.5

Q ss_pred             EecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHH
Q 046240          495 ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR  574 (763)
Q Consensus       495 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  574 (763)
                      ...++.+|.|.+.+...........+-++.++.++||||+++++.+...+..|+|+|.+.  .|..++..-    .....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHH
Confidence            455788999998876655445567788899999999999999999999999999999873  455555442    24556


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCC
Q 046240          575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV  654 (763)
Q Consensus       575 ~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  654 (763)
                      ...+.||+.||.|||  ++.+++|++|.-+.|+|++.|..||++|.++....+...  ......--..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            678999999999997  688999999999999999999999999998866432221  111111222355566433222 


Q ss_pred             CcchhHHHHHHHHHHHHcCC
Q 046240          655 STRSDIYSYGIMLIETFTRK  674 (763)
Q Consensus       655 ~~~~Dv~slGv~l~elltg~  674 (763)
                       -..|.|.|||+++|++.|.
T Consensus       182 -~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcc
Confidence             2469999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.30  E-value=6.2e-11  Score=131.42  Aligned_cols=146  Identities=18%  Similarity=0.172  Sum_probs=94.5

Q ss_pred             hccCcCceecccCCceEEEEEecC-CceEEEEEeehhhHH----------------------------------HHH---
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECAR----------------------------------AMK---  516 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~---  516 (763)
                      .+|+. +.||+|++|.||+|+..+ |+.||||+.++....                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45766 789999999999999887 999999999743210                                  011   


Q ss_pred             ---HHHHHHHHHHhCC----CCccceEEeeee-cCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 046240          517 ---SFEVECEVMKNIR----HRNLVKIISGCS-NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL  588 (763)
Q Consensus       517 ---~~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~L  588 (763)
                         ++.+|+..+.+++    +.+.+.+-.++. .....++||||++|+.+.++..-.....+   +..++...++.  |+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---~~~la~~~v~~--~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---MKLLAERGVEV--FF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---HHHHHHHHHHH--HH
Confidence               2334444444442    333333333332 24567899999999999775321111122   22233333332  22


Q ss_pred             HhcCCCCeEeCCCCCCCEEecCCC----cEEEeeecCceecC
Q 046240          589 NFRHTTPIIHCDLKSSNVLLDEDM----IAHLSDFGIAKLLS  626 (763)
Q Consensus       589 h~~h~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~~~  626 (763)
                      +..+..|++|+|+||.||+++.++    .+++.|||++..++
T Consensus       274 ~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            223678999999999999999888    99999999988764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=5.1e-12  Score=124.98  Aligned_cols=202  Identities=20%  Similarity=0.284  Sum_probs=137.7

Q ss_pred             HHHHhCCCCccceEEeeeecC-----CceEEEEEccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 046240          523 EVMKNIRHRNLVKIISGCSND-----DFKALVLEYMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTT  594 (763)
Q Consensus       523 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~  594 (763)
                      .-+-++.|.|||++..|+.+.     .....+.||+..|++..++++.   ...+......+++.||..||.|||. .++
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            334456799999999998544     3567889999999999999763   2356677788999999999999975 678


Q ss_pred             CeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC--CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc
Q 046240          595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED--QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT  672 (763)
Q Consensus       595 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt  672 (763)
                      +|+|+++.-+-|++..+|-+|+.--.-........  .........+-++|.|||+-.....+.++|||+||+...||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999999998886321111100000  0011123346788999999887788889999999999999998


Q ss_pred             CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          673 RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       673 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      |..--.......             ...+-+...+......+          -.+.+.+|+...|..||+|++++.
T Consensus       278 lEiq~tnseS~~-------------~~ee~ia~~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKV-------------EVEENIANVIIGLENGL----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCccee-------------ehhhhhhhheeeccCcc----------ccCcCcccccCCCCCCcchhhhhc
Confidence            865422111000             11111111111111110          125678899999999999988764

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.23  E-value=1.2e-12  Score=134.22  Aligned_cols=216  Identities=23%  Similarity=0.314  Sum_probs=105.0

Q ss_pred             cCCCccEEEcccccccccCC-CcccCCCCCCeeeecCcccccccc--cccCCCCchhhhhhhhhccCCcccccCCccccc
Q 046240          130 ALPNVKALSLAYNRFSGTIQ-SPITNASKLTILELGGNSFSGFIP--NTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVN  206 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~  206 (763)
                      ++.+|+...|.+..+....- .....+++++.|||+.|-|....+  .....|++|+.|+    ++.|++.-...+....
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LN----ls~Nrl~~~~~s~~~~  194 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLN----LSSNRLSNFISSNTTL  194 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcc----cccccccCCccccchh
Confidence            45556666666665552211 244556666666666666553222  3334555555555    4455544333333333


Q ss_pred             ccccccEEEeecCcccc-ccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCC
Q 046240          207 LSISLERLYISNCSITG-NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLK  285 (763)
Q Consensus       207 l~~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~  285 (763)
                      ..+.|+.|.|+.|.|+. .+......+|+|+.|+|+.|.....-......++.  |++|||++|++. ..+..-..+.++
T Consensus       195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~--L~~LdLs~N~li-~~~~~~~~~~l~  271 (505)
T KOG3207|consen  195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQT--LQELDLSNNNLI-DFDQGYKVGTLP  271 (505)
T ss_pred             hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhH--HhhccccCCccc-cccccccccccc
Confidence            33367777777777762 12223445666777777776422222222233332  666666666655 333211344555


Q ss_pred             cccEEEcccccccccC-CcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCc-cchhhhhhccCceEE
Q 046240          286 VVVEINLSRNNFSGDI-PATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF-ILISLEKLLYLKKLN  363 (763)
Q Consensus       286 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~  363 (763)
                      .|..|+++.+.+..+- |+. .                  .-.-....++|++|+++.|+|... .-..+..+++|+.|.
T Consensus       272 ~L~~Lnls~tgi~si~~~d~-~------------------s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~  332 (505)
T KOG3207|consen  272 GLNQLNLSSTGIASIAEPDV-E------------------SLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR  332 (505)
T ss_pred             chhhhhccccCcchhcCCCc-c------------------chhhhcccccceeeecccCccccccccchhhccchhhhhh
Confidence            5555555555554321 111 0                  000012345555555555555432 112233445556666


Q ss_pred             cccccCCC
Q 046240          364 LSFNKLEG  371 (763)
Q Consensus       364 l~~N~l~~  371 (763)
                      +..|.++.
T Consensus       333 ~~~n~ln~  340 (505)
T KOG3207|consen  333 ITLNYLNK  340 (505)
T ss_pred             cccccccc
Confidence            66666654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=4.2e-11  Score=114.79  Aligned_cols=128  Identities=22%  Similarity=0.208  Sum_probs=94.8

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccc-eEEeeeecCCceEEEEEccCCCCh
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV-KIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      .+.++.|.++.||++... ++.|++|+...... ....+.+|+.+++.+.+.+++ +++++..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467889999999999876 77899998764421 123467889999988655544 4554433  345799999999887


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP-----IIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~-----ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ....         .....++.+++++++.|   |+.+     ++|||++|.||+++ ++.++++||+.+..
T Consensus        79 ~~~~---------~~~~~~~~~l~~~l~~L---H~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED---------FSDPENLEKIAKLLKKL---HSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc---------ccCHHHHHHHHHHHHHH---hCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6431         11234567899999999   5555     59999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=2.5e-11  Score=130.93  Aligned_cols=249  Identities=23%  Similarity=0.209  Sum_probs=175.3

Q ss_pred             hccCcCceecc--cCCceEEEEEe---cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCce
Q 046240          475 NRFGRDNLIGI--GSFGYVYKAEL---DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       475 ~~~~~~~~lg~--G~~g~v~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  546 (763)
                      ..|...+.+|.  |.+|.||.+..   .++..+|+|+-+...  ......-.+|+..-..+ .|+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45666788999  99999999955   478899999743221  12223334566666666 499999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS----ALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGI  621 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~----~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgl  621 (763)
                      ++-+|++. .++..+.+.....++......+..+..+    |+.++   |..+++|-|+||.||+...+ ...+++|||+
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCcce
Confidence            99999985 6787777765545666677777777777    88888   99999999999999999999 8899999999


Q ss_pred             ceecCCCCCcccc---ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChh
Q 046240          622 AKLLSGEDQSMTQ---TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       622 a~~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      ...+.........   ....+..-|++||.. .+.++.+.|+|++|.++.|..++..+...-.     ...|..-.    
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~~W~~~r----  339 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK-----NSSWSQLR----  339 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC-----CCCccccc----
Confidence            9888655432221   122577789999975 4566889999999999999999876643310     01111100    


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                            ...  .+.+   ..+.-..++......+++.+|-.|++.+.+.+
T Consensus       340 ------~~~--ip~e---~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 ------QGY--IPLE---FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ------ccc--Cchh---hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                  000  0000   00000223344777888888888888877754

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.16  E-value=2.4e-11  Score=114.58  Aligned_cols=98  Identities=26%  Similarity=0.368  Sum_probs=29.5

Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCccc-CCCcCccEEEccCccccCccc-ccccccccccEE
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLEGPIP-ESFGYLTSLEIL  338 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L  338 (763)
                      |+.|+|++|.|+ .++   .+..++.|+.|++++|+|+.. +..+ ..+++|+.|+|++|+|...-. ..+..+++|+.|
T Consensus        44 L~~L~Ls~N~I~-~l~---~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   44 LEVLDLSNNQIT-KLE---GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             --EEE-TTS--S---T---T----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             CCEEECCCCCCc-ccc---CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            445555555554 232   244455555555555555532 2222 235555555555555543211 234455556666


Q ss_pred             eCcCCccCCcc---chhhhhhccCceEE
Q 046240          339 DLSNNKISGFI---LISLEKLLYLKKLN  363 (763)
Q Consensus       339 ~L~~N~l~~~~---~~~~~~l~~L~~L~  363 (763)
                      +|.+|+++...   ...+..+|+|+.||
T Consensus       119 ~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen  119 SLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             E-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             eccCCcccchhhHHHHHHHHcChhheeC
Confidence            66666555421   12234455555554

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.15  E-value=5.7e-12  Score=122.85  Aligned_cols=130  Identities=25%  Similarity=0.301  Sum_probs=66.2

Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      .|++|||++|.|+ .+..+..-++.++.|++++|.|+                           .+.   .+..+++|+.
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~---------------------------~v~---nLa~L~~L~~  333 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR---------------------------TVQ---NLAELPQLQL  333 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEecccccee---------------------------eeh---hhhhcccceE
Confidence            4555555555555 44444444555555555555554                           222   2344455555


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCcc-chhhhhhccCceEEccccc
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFI-LISLEKLLYLKKLNLSFNK  368 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~  368 (763)
                      ||||+|.++ .+..+-..+-+++.|.|++|.|+.  -+.+..+-+|..||+++|+|.... -..+++++-|+.+.|.+|+
T Consensus       334 LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP  410 (490)
T KOG1259|consen  334 LDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP  410 (490)
T ss_pred             eecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence            555555554 222333334455555555555541  123445556666666666655431 2345566666666666666


Q ss_pred             CCCCC
Q 046240          369 LEGEI  373 (763)
Q Consensus       369 l~~~~  373 (763)
                      +.+.+
T Consensus       411 l~~~v  415 (490)
T KOG1259|consen  411 LAGSV  415 (490)
T ss_pred             ccccc
Confidence            66543

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.15  E-value=2.8e-12  Score=128.25  Aligned_cols=252  Identities=18%  Similarity=0.219  Sum_probs=158.0

Q ss_pred             CCceEEEEecCCCCCC----cCCcccCCCCCCCEEEcCCCcccCCCccccCccccc------cccCCCccEEEccccccc
Q 046240           76 SHRVTALNISSLNLQG----EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRI------DLALPNVKALSLAYNRFS  145 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~------~~~l~~L~~L~L~~N~i~  145 (763)
                      ...++.|+|++|.+..    .+.+.+.+.++|+..++|+= ++|  .+-..+|+.+      ....++|++||||+|.|.
T Consensus        29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftG--R~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G  105 (382)
T KOG1909|consen   29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTG--RLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG  105 (382)
T ss_pred             cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcC--CcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence            3568999999999853    35566788889999998742 221  1112334321      234578999999999887


Q ss_pred             ccCCCc----ccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcc
Q 046240          146 GTIQSP----ITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSI  221 (763)
Q Consensus       146 ~~~p~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l  221 (763)
                      -..+..    +.++..|++|+|.+|.+.-.-...++.  .|..|.      .|+..+.        +++|+++..++|++
T Consensus       106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~------~~kk~~~--------~~~Lrv~i~~rNrl  169 (382)
T KOG1909|consen  106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA------VNKKAAS--------KPKLRVFICGRNRL  169 (382)
T ss_pred             ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH------HHhccCC--------CcceEEEEeecccc
Confidence            555543    345778899999999886222222221  122222      2222211        12788999999988


Q ss_pred             cccc----ccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccc
Q 046240          222 TGNI----PQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF  297 (763)
Q Consensus       222 ~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l  297 (763)
                      ....    ...|...+.|+.+.++.|.|..   ....                   .+-.  .+..+++|+.|||.+|-+
T Consensus       170 en~ga~~~A~~~~~~~~leevr~~qN~I~~---eG~~-------------------al~e--al~~~~~LevLdl~DNtf  225 (382)
T KOG1909|consen  170 ENGGATALAEAFQSHPTLEEVRLSQNGIRP---EGVT-------------------ALAE--ALEHCPHLEVLDLRDNTF  225 (382)
T ss_pred             ccccHHHHHHHHHhccccceEEEecccccC---chhH-------------------HHHH--HHHhCCcceeeecccchh
Confidence            7432    3345566777777777777652   1110                   0001  456667777777777776


Q ss_pred             ccc----CCcccCCCcCccEEEccCccccCcccccc-----cccccccEEeCcCCccCCc----cchhhhhhccCceEEc
Q 046240          298 SGD----IPATIGGLKDVQNISLPYNRLEGPIPESF-----GYLTSLEILDLSNNKISGF----ILISLEKLLYLKKLNL  364 (763)
Q Consensus       298 ~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l  364 (763)
                      +..    +...+..+++|+.|+++++.+...-..+|     ...++|++|.+.+|.|+.-    +.......+.|+.|+|
T Consensus       226 t~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnL  305 (382)
T KOG1909|consen  226 TLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNL  305 (382)
T ss_pred             hhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcC
Confidence            632    34556677788888888888775443333     2367888888888888743    2334445678888888


Q ss_pred             ccccCC
Q 046240          365 SFNKLE  370 (763)
Q Consensus       365 ~~N~l~  370 (763)
                      ++|.+.
T Consensus       306 ngN~l~  311 (382)
T KOG1909|consen  306 NGNRLG  311 (382)
T ss_pred             Cccccc
Confidence            888884

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.11  E-value=1.8e-09  Score=104.00  Aligned_cols=137  Identities=20%  Similarity=0.204  Sum_probs=96.9

Q ss_pred             CceecccCCceEEEEEecC-------CceEEEEEeehhh------H----------------HHHHH----HHHHHHHHH
Q 046240          480 DNLIGIGSFGYVYKAELDD-------GIEVAIKVFHQEC------A----------------RAMKS----FEVECEVMK  526 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~-------~~~vavK~~~~~~------~----------------~~~~~----~~~e~~~l~  526 (763)
                      ...||.|--+.||.|...+       +..+|||+.+...      .                ...+.    .++|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999996543       5799999874110      0                01122    247999999


Q ss_pred             hCCC--CccceEEeeeecCCceEEEEEccCCCChhh-hhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 046240          527 NIRH--RNLVKIISGCSNDDFKALVLEYMPNGSLDI-FLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKS  603 (763)
Q Consensus       527 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~  603 (763)
                      ++..  -++..++++    ...++||||+.++.+.. .+..  ..++..+...+..++..++..++  |..++|||||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCH
Confidence            9853  456666654    45689999998754321 1221  12344455677889999999885  788999999999


Q ss_pred             CCEEecCCCcEEEeeecCceec
Q 046240          604 SNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       604 ~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .||++++ +.++++|||.+...
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeC
Confidence            9999974 68999999988765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.11  E-value=1.1e-11  Score=136.50  Aligned_cols=129  Identities=26%  Similarity=0.308  Sum_probs=60.1

Q ss_pred             CCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCC
Q 046240           99 YLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGN  178 (763)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  178 (763)
                      .+..++.+++..|.+.       .+-..+ ..+++|+.|++.+|+|..+ ...+..+++|++|+|++|+|+.+.+  +..
T Consensus        70 ~l~~l~~l~l~~n~i~-------~~~~~l-~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~  138 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIA-------KILNHL-SKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LST  138 (414)
T ss_pred             HhHhHHhhccchhhhh-------hhhccc-ccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhh
Confidence            4455555556666654       111111 2456666666666666632 2225556666666666666664322  333


Q ss_pred             CCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccc-cccCCccccceeeccccccc
Q 046240          179 LRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP-QVMGNLSIFLLLDLELNKLT  246 (763)
Q Consensus       179 l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  246 (763)
                      ++.|+.|+    +++|.|+..  ..+..+. +|+.+++++|++....+ . ...+.+|+.+++.+|.+.
T Consensus       139 l~~L~~L~----l~~N~i~~~--~~~~~l~-~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  139 LTLLKELN----LSGNLISDI--SGLESLK-SLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             ccchhhhe----eccCcchhc--cCCccch-hhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence            44444444    444444321  1111122 44444455554443322 1 344444444444444444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.10  E-value=1.6e-11  Score=126.09  Aligned_cols=160  Identities=22%  Similarity=0.222  Sum_probs=101.8

Q ss_pred             CceEEEEecCCCCCCcCC--cccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcc-c
Q 046240           77 HRVTALNISSLNLQGEIP--HEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-T  153 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~-~  153 (763)
                      ..++.+.|.++.+. ..+  .....+++++.||||+|-+...+..     ..+...||+|+.|+|+.|++........ .
T Consensus       121 kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v-----~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~  194 (505)
T KOG3207|consen  121 KKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPV-----LKIAEQLPSLENLNLSSNRLSNFISSNTTL  194 (505)
T ss_pred             HhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHH-----HHHHHhcccchhcccccccccCCccccchh
Confidence            45777777777765 333  3567788888888888877632222     1233478888888888888864333322 2


Q ss_pred             CCCCCCeeeecCcccccc-cccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccccc-ccccCC
Q 046240          154 NASKLTILELGGNSFSGF-IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNI-PQVMGN  231 (763)
Q Consensus       154 ~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~-~~~~~~  231 (763)
                      .+++|+.|.|++|.|+.. +.......++|+.|+    |.+|...+.-..+..-+. .|++|||++|++.... -...+.
T Consensus       195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~----L~~N~~~~~~~~~~~i~~-~L~~LdLs~N~li~~~~~~~~~~  269 (505)
T KOG3207|consen  195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLY----LEANEIILIKATSTKILQ-TLQELDLSNNNLIDFDQGYKVGT  269 (505)
T ss_pred             hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhh----hhcccccceecchhhhhh-HHhhccccCCccccccccccccc
Confidence            467788888888888732 223445677788777    666643333223333333 6778888888776322 134667


Q ss_pred             ccccceeecccccccC
Q 046240          232 LSIFLLLDLELNKLTG  247 (763)
Q Consensus       232 l~~L~~L~L~~N~l~~  247 (763)
                      ++.|+.|+++.+.+..
T Consensus       270 l~~L~~Lnls~tgi~s  285 (505)
T KOG3207|consen  270 LPGLNQLNLSSTGIAS  285 (505)
T ss_pred             ccchhhhhccccCcch
Confidence            7777777777777763

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.08  E-value=1.2e-11  Score=135.95  Aligned_cols=219  Identities=30%  Similarity=0.371  Sum_probs=163.9

Q ss_pred             cCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccc
Q 046240          130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSI  209 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~  209 (763)
                      .+..++.+++..|.|.. +-..+..+++|+.|++.+|+|..+ ...+..+++|+.|+    +++|.|+..-+  +..+. 
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~----ls~N~I~~i~~--l~~l~-  140 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLD----LSFNKITKLEG--LSTLT-  140 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchhee----ccccccccccc--hhhcc-
Confidence            56788888999999984 445578889999999999999954 44488899999999    88999986644  34444 


Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      .|+.|++++|.|+..  ..+..+++|+.+++++|+++...+.....+.+  ++.+++.+|.+. .+.   .+..+..+..
T Consensus       141 ~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~--l~~l~l~~n~i~-~i~---~~~~~~~l~~  212 (414)
T KOG0531|consen  141 LLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELIS--LEELDLGGNSIR-EIE---GLDLLKKLVL  212 (414)
T ss_pred             chhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccc--hHHHhccCCchh-ccc---chHHHHHHHH
Confidence            699999999999843  34566899999999999999554410355544  889999999998 333   2445556666


Q ss_pred             EEcccccccccCCcccCCCc--CccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccc
Q 046240          290 INLSRNNFSGDIPATIGGLK--DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFN  367 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  367 (763)
                      +++..|.++..-+  +..+.  .|+.+++++|.+. ..+..+..+..+..|++.+|++...  ..+.....+..+....|
T Consensus       213 ~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~  287 (414)
T KOG0531|consen  213 LSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDN  287 (414)
T ss_pred             hhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcc
Confidence            6889998884433  22233  3889999999998 4546677888999999999998863  33556667777788888


Q ss_pred             cCC
Q 046240          368 KLE  370 (763)
Q Consensus       368 ~l~  370 (763)
                      ++.
T Consensus       288 ~~~  290 (414)
T KOG0531|consen  288 KLA  290 (414)
T ss_pred             hhc
Confidence            776

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.6e-09  Score=100.24  Aligned_cols=131  Identities=22%  Similarity=0.337  Sum_probs=99.5

Q ss_pred             ceecccCCceEEEEEecCCceEEEEEe-ehhh-----HH--HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          481 NLIGIGSFGYVYKAELDDGIEVAIKVF-HQEC-----AR--AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~~~~vavK~~-~~~~-----~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..+++|+-+.+|.+.+- |.++++|.- ++..     ..  ......+|+.++.+++--.|...+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 445677743 2211     11  234567899999998766666666666777778899999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ++|..|.+.+...        ...++..+-..+.-|   |..+|+||||.++||++..+. +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888764        245666667777778   899999999999999998765 99999999874

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.05  E-value=1.3e-10  Score=109.57  Aligned_cols=104  Identities=35%  Similarity=0.454  Sum_probs=42.1

Q ss_pred             ccEEEecCCccccCCCCccccc-cCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccc-cccccccEE
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIG-NLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESF-GYLTSLEIL  338 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L  338 (763)
                      +++|+|.+|.|+ .+..   ++ .+.+|+.|+|++|.|+..  +.+..++.|+.|++++|+|+. +...+ ..+++|++|
T Consensus        21 ~~~L~L~~n~I~-~Ie~---L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   21 LRELNLRGNQIS-TIEN---LGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQEL   93 (175)
T ss_dssp             ----------------S-----TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred             cccccccccccc-cccc---hhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEE
Confidence            778888888887 4443   44 578899999999999854  358888999999999999995 44334 468999999


Q ss_pred             eCcCCccCCcc-chhhhhhccCceEEcccccCCC
Q 046240          339 DLSNNKISGFI-LISLEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       339 ~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~  371 (763)
                      +|++|+|.... -..+..+++|+.|+|.+|+++.
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            99999988753 2567788999999999999874

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.05  E-value=5.4e-11  Score=116.16  Aligned_cols=223  Identities=21%  Similarity=0.271  Sum_probs=127.4

Q ss_pred             ceEEEEecC--------CCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCC
Q 046240           78 RVTALNISS--------LNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQ  149 (763)
Q Consensus        78 ~v~~L~L~~--------~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p  149 (763)
                      ++..|-.++        |-+...+|-.+.-+.+|..+.+|++.-.       .|- ++-..-|.|+.+.+.+..++. .|
T Consensus       183 ~l~~l~vs~~~~p~~~sni~~~~l~f~l~~f~~l~~~~~s~~~~~-------~i~-~~~~~kptl~t~~v~~s~~~~-~~  253 (490)
T KOG1259|consen  183 QLVALVVTPVKDPIDRSNIIPNRLSFNLNAFRNLKTLKFSALSTE-------NIV-DIELLKPTLQTICVHNTTIQD-VP  253 (490)
T ss_pred             heeEEEecCCCCCCccccccccccccchHHhhhhheeeeeccchh-------hee-ceeecCchhheeeeecccccc-cc
Confidence            455665543        2223344555666778888888877542       111 111134567777777665542 11


Q ss_pred             CcccCCCCCCeeeecCc-ccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccc
Q 046240          150 SPITNASKLTILELGGN-SFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQV  228 (763)
Q Consensus       150 ~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~  228 (763)
                      . +--.+.+..+.-+.- -.+|..-..+.....|+.||    |++|.|+. +..+..=+ +.++.|++++|+|..+ .. 
T Consensus       254 ~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~LtelD----LS~N~I~~-iDESvKL~-Pkir~L~lS~N~i~~v-~n-  324 (490)
T KOG1259|consen  254 S-LLPETILADPSGSEPSTSNGSALVSADTWQELTELD----LSGNLITQ-IDESVKLA-PKLRRLILSQNRIRTV-QN-  324 (490)
T ss_pred             c-ccchhhhcCccCCCCCccCCceEEecchHhhhhhcc----ccccchhh-hhhhhhhc-cceeEEeccccceeee-hh-
Confidence            1 111222222222211 12233444555666777888    67777763 33444333 4999999999999943 33 


Q ss_pred             cCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCC
Q 046240          229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGL  308 (763)
Q Consensus       229 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  308 (763)
                      +..+++|+.|||++|.++ .+..+-..+.+  ++.|.|++|.+. .+.   .+.++-                       
T Consensus       325 La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN--IKtL~La~N~iE-~LS---GL~KLY-----------------------  374 (490)
T KOG1259|consen  325 LAELPQLQLLDLSGNLLA-ECVGWHLKLGN--IKTLKLAQNKIE-TLS---GLRKLY-----------------------  374 (490)
T ss_pred             hhhcccceEeecccchhH-hhhhhHhhhcC--EeeeehhhhhHh-hhh---hhHhhh-----------------------
Confidence            888999999999999988 34444344443  666677776665 111   233333                       


Q ss_pred             cCccEEEccCccccCcc-cccccccccccEEeCcCCccCCcc
Q 046240          309 KDVQNISLPYNRLEGPI-PESFGYLTSLEILDLSNNKISGFI  349 (763)
Q Consensus       309 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~  349 (763)
                       +|..||+++|+|+... -..++++|-|++|.|.+|.|.+++
T Consensus       375 -SLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  375 -SLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             -hheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence             4445555555554221 245777888888888888888753

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.04  E-value=2.1e-09  Score=107.96  Aligned_cols=143  Identities=17%  Similarity=0.197  Sum_probs=109.1

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCC--CccceEEeeeecCC---ceEEEEEcc
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRH--RNLVKIISGCSNDD---FKALVLEYM  553 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~  553 (763)
                      .+.++.|..+.||++...+|+.+++|....... .....+.+|+++++.+++  ..+.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            357899999999999887778999998764321 134567889999999975  34677787776643   568999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR------------------------------------------  591 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~------------------------------------------  591 (763)
                      +|.++...+..  ..++..+...++.++++++..||..                                          
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99988776532  2356667777888888888888631                                          


Q ss_pred             -----------CCCCeEeCCCCCCCEEecC--CCcEEEeeecCcee
Q 046240          592 -----------HTTPIIHCDLKSSNVLLDE--DMIAHLSDFGIAKL  624 (763)
Q Consensus       592 -----------h~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~  624 (763)
                                 ....++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       0245799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=1.3e-10  Score=125.47  Aligned_cols=247  Identities=22%  Similarity=0.191  Sum_probs=169.8

Q ss_pred             HHHHhccCcCceecccCCceEEEEEec--CCceEEEEEeehhhHHHHHH--HHHHHHHHHhC-CCCccceEEeeeecCCc
Q 046240          471 SRATNRFGRDNLIGIGSFGYVYKAELD--DGIEVAIKVFHQECARAMKS--FEVECEVMKNI-RHRNLVKIISGCSNDDF  545 (763)
Q Consensus       471 ~~~~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~  545 (763)
                      ..-..+|..+..||.|.|+.|+....+  ++..+++|...+.......+  -..|+.+...+ .|.++++++..+.....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            344568999999999999999998544  67889999776543222222  23466666666 58999999888888888


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCcee
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKL  624 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~  624 (763)
                      .|+--|||+++++...+... ..++...++.+..+++.++.++   |++.++|+|+||+||++..+ +..+++|||.++.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             ccCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchhhhhccccccccc
Confidence            88999999999987766322 2466677888888888888888   89999999999999999886 7889999999874


Q ss_pred             cCCCCCccccccccccccc-cCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGY-MAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      +.-.    .......+..| .+|+......+..++|+||||..+.|.+++..--....       .|..         +.
T Consensus       417 ~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~~---------i~  476 (524)
T KOG0601|consen  417 LAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSLT---------IR  476 (524)
T ss_pred             ccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------ccee---------ee
Confidence            3211    11111223334 35556666778889999999999999999865422210       1100         00


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                      ...+   +...     .....+..+.......++..||.+.+....
T Consensus       477 ~~~~---p~~~-----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  477 SGDT---PNLP-----GLKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             cccc---cCCC-----chHHhhhhhhhhhcCCccccchhhhhhccc
Confidence            0000   1100     012345667777788888888888776543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.95  E-value=5.8e-10  Score=86.45  Aligned_cols=61  Identities=30%  Similarity=0.489  Sum_probs=38.6

Q ss_pred             CCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCccc
Q 046240          101 PSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSF  168 (763)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l  168 (763)
                      |+|++|++++|+++       .+|...|.++++|++|++++|.|+.+.|+.|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~-------~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-------EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-------EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-------ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            35566666666664       56666666666666666666666666666666666666666666654

...

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.94  E-value=9.3e-09  Score=94.57  Aligned_cols=142  Identities=21%  Similarity=0.243  Sum_probs=101.8

Q ss_pred             cCceecccCCceEEEEEecCCceEEEEE-eehhh-------HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          479 RDNLIGIGSFGYVYKAELDDGIEVAIKV-FHQEC-------ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       479 ~~~~lg~G~~g~v~~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ....+-+|+-+.|+++.+. |+.++||. +.+..       .-..+...+|+..+.+++--.|.-..=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4577889999999999987 66666663 32211       113456678999999886555554445565666667999


Q ss_pred             EccCC-CChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC---cEEEeeecCcee
Q 046240          551 EYMPN-GSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM---IAHLSDFGIAKL  624 (763)
Q Consensus       551 e~~~~-g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~  624 (763)
                      ||++| .++.+++...-. ..........+..|-+.+.-|   |..+|+||||..+||++.+++   .+.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99988 467777754321 222223357888888899999   889999999999999997654   358999999764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=1.7e-08  Score=96.99  Aligned_cols=126  Identities=23%  Similarity=0.246  Sum_probs=83.6

Q ss_pred             eEEEEEecCCceEEEEEeehhh--------------------------HHHHHHHHHHHHHHHhCCCC--ccceEEeeee
Q 046240          490 YVYKAELDDGIEVAIKVFHQEC--------------------------ARAMKSFEVECEVMKNIRHR--NLVKIISGCS  541 (763)
Q Consensus       490 ~v~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  541 (763)
                      .||.|...+|..+|+|+.....                          .......++|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999874210                          01123467899999999755  456666553 


Q ss_pred             cCCceEEEEEccC--CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeee
Q 046240          542 NDDFKALVLEYMP--NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       542 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                         ..++||||++  |..+..+....   ++......++.++.+.+..+.  |..|++|||+.+.||+++++ .+.++||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eEEEEec
Confidence               3479999999  65555444322   112234567777777666653  78999999999999999988 9999999


Q ss_pred             cCceec
Q 046240          620 GIAKLL  625 (763)
Q Consensus       620 gla~~~  625 (763)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.88  E-value=1.8e-09  Score=83.61  Aligned_cols=58  Identities=31%  Similarity=0.527  Sum_probs=26.6

Q ss_pred             ccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCc
Q 046240          287 VVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNK  344 (763)
Q Consensus       287 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  344 (763)
                      |++|++++|+|+.+.+..|.++++|+.|++++|+++...|..|..+++|++|++++|+
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            4444444444443333444444444444444444444444444444444444444443

...

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.87  E-value=2.8e-08  Score=102.26  Aligned_cols=259  Identities=13%  Similarity=0.114  Sum_probs=159.2

Q ss_pred             cCceecccCCceEEEE-EecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEee------eecC-CceEEE
Q 046240          479 RDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISG------CSND-DFKALV  549 (763)
Q Consensus       479 ~~~~lg~G~~g~v~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~~-~~~~lv  549 (763)
                      .++.+|+|+-+.+|.. ...   ..+.|+++........+   .+..|... .||-+-.=+.+      ...+ ...-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhh---chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            4577999999999965 333   24567776543222221   23334444 56644331211      1112 224567


Q ss_pred             EEccCCCC-hhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          550 LEYMPNGS-LDIFLYS-----STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       550 ~e~~~~g~-L~~~l~~-----~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      |..+.+.- ...+...     +-...+|...+.++..+|.+.+.|   |..|.+-||+.++|+||++++.|.+.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~l---H~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATL---HEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHH---HhcCCcccccCccceeeecCceEEEEccccee
Confidence            77776642 2222211     112578999999999999999999   78899999999999999999999999855433


Q ss_pred             ecCCCCCccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcC-CCCCchhhhhhh---hhh-hhhcc
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAEL---SLK-HWVNG  693 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~---~~~-~~~~~  693 (763)
                      ...   ........+|...|.+||...     +-.-+...|-|.+||++++++.| ++||++......   -.. ....+
T Consensus       166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            322   223445678999999999643     44557789999999999999996 999987432110   000 11111


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccC--cCCCCCHHHHHHHHhhc
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMEL--PEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~--P~~Rps~~~v~~~L~~~  753 (763)
                      .+    .+.-+...-..+..+...-+..+..+..+..+|+...  |.-||+++..+..|.+.
T Consensus       243 ~f----~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         243 RF----AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             ee----eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            00    0001111111122222223445667888899998764  45899999887776543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.84  E-value=3.3e-09  Score=124.67  Aligned_cols=274  Identities=23%  Similarity=0.295  Sum_probs=156.1

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCc--ccCCCccccCccccccccCCCccEEEcccccccccCCCcccCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNS--LVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNA  155 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~--l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l  155 (763)
                      .+....+-+|.+. .++....+ +.|++|-+..|.  +       ..++...|..++.|+.|||++|.=-+.+|..+++|
T Consensus       524 ~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l-------~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L  594 (889)
T KOG4658|consen  524 SVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWL-------LEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL  594 (889)
T ss_pred             heeEEEEeccchh-hccCCCCC-CccceEEEeecchhh-------hhcCHHHHhhCcceEEEECCCCCccCcCChHHhhh
Confidence            4566666666665 33433333 267778777775  4       26777777778888888888876666788888888


Q ss_pred             CCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccc--cccccccCCcc
Q 046240          156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT--GNIPQVMGNLS  233 (763)
Q Consensus       156 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~--~~~~~~~~~l~  233 (763)
                      -+|++|+|++..++ .+|..+++|..|.+|+    +..+.-...+|.....+. +|++|.+..-...  ...-..+..+.
T Consensus       595 i~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln----l~~~~~l~~~~~i~~~L~-~Lr~L~l~~s~~~~~~~~l~el~~Le  668 (889)
T KOG4658|consen  595 VHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN----LEVTGRLESIPGILLELQ-SLRVLRLPRSALSNDKLLLKELENLE  668 (889)
T ss_pred             hhhhcccccCCCcc-ccchHHHHHHhhheec----cccccccccccchhhhcc-cccEEEeeccccccchhhHHhhhccc
Confidence            88888888888887 6788888888888877    555554444555555566 7888777665422  22222334444


Q ss_pred             ccceeecccccccCCCCccccccCC--CCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCC---
Q 046240          234 IFLLLDLELNKLTGPIPVTFGRLQN--SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGL---  308 (763)
Q Consensus       234 ~L~~L~L~~N~l~~~~p~~~~~l~~--~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---  308 (763)
                      .|+.+........  +-..+..+..  ...+.+.+.++... ..+.  .+..+.+|+.|.+.++.+...........   
T Consensus       669 ~L~~ls~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~--~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~  743 (889)
T KOG4658|consen  669 HLENLSITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLIS--SLGSLGNLEELSILDCGISEIVIEWEESLIVL  743 (889)
T ss_pred             chhhheeecchhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeec--ccccccCcceEEEEcCCCchhhcccccccchh
Confidence            4444444332220  0011111111  01223333333333 2222  46677788888888877763322222211   


Q ss_pred             ---cCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCC
Q 046240          309 ---KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGE  372 (763)
Q Consensus       309 ---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  372 (763)
                         +++..+...++..- ..+....-.++|+.|++..+.....+.+....+..++.+-+..+.+.+.
T Consensus       744 ~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l  809 (889)
T KOG4658|consen  744 LCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL  809 (889)
T ss_pred             hhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence               12222222221111 1223334467888888888776666666666677777666666666655

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.83  E-value=7.6e-10  Score=125.50  Aligned_cols=205  Identities=22%  Similarity=0.276  Sum_probs=146.1

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ..+.+.+.+.+-+|.++.++.+.-. .|...++|+.....   ....+....+-.+.-..++|.+++....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4466777788889999999987443 34334444332111   1112333344444444567777777766777788899


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      +++|..+++|...++..++ .+..........+.++.+||   |...+.|+|++|.|.+...++..+++|||........
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999999887664 23223333445566788999   8888999999999999999999999999843222100


Q ss_pred             ---------------------C--------CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          629 ---------------------D--------QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       629 ---------------------~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                                           .        .........+|+.|.+||...+......+|.|++|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                 0        00112234689999999999999999999999999999999999999987


Q ss_pred             hh
Q 046240          680 MF  681 (763)
Q Consensus       680 ~~  681 (763)
                      ..
T Consensus      1038 ~t 1039 (1205)
T KOG0606|consen 1038 ET 1039 (1205)
T ss_pred             cc
Confidence            44

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.81  E-value=1.4e-09  Score=127.65  Aligned_cols=257  Identities=22%  Similarity=0.198  Sum_probs=161.0

Q ss_pred             cCCCCceEEEEecCCC--CCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCC
Q 046240           73 DVNSHRVTALNISSLN--LQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQS  150 (763)
Q Consensus        73 ~~~~~~v~~L~L~~~~--l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~  150 (763)
                      ......+++|-+.+|.  +.....+.|..++.|++|||++|.--      +.+|..+. +|-+|++|+|++..++ .+|.
T Consensus       541 ~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l------~~LP~~I~-~Li~LryL~L~~t~I~-~LP~  612 (889)
T KOG4658|consen  541 SSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSL------SKLPSSIG-ELVHLRYLDLSDTGIS-HLPS  612 (889)
T ss_pred             CCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCcc------CcCChHHh-hhhhhhcccccCCCcc-ccch
Confidence            3344579999999997  66455566888999999999987543      58999997 8999999999999999 8999


Q ss_pred             cccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccC
Q 046240          151 PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMG  230 (763)
Q Consensus       151 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~  230 (763)
                      .+.++++|.+|++..+.-...+|+....|++|++|.+..  +........-..+..+. +|+.+.......  .+-..+.
T Consensus       613 ~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~--s~~~~~~~~l~el~~Le-~L~~ls~~~~s~--~~~e~l~  687 (889)
T KOG4658|consen  613 GLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR--SALSNDKLLLKELENLE-HLENLSITISSV--LLLEDLL  687 (889)
T ss_pred             HHHHHHhhheeccccccccccccchhhhcccccEEEeec--cccccchhhHHhhhccc-chhhheeecchh--HhHhhhh
Confidence            999999999999999987777788888999999999642  22233333334444444 566555544433  1111223


Q ss_pred             Cccccc----eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCcccccc------CCcccEEEccccccccc
Q 046240          231 NLSIFL----LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGN------LKVVVEINLSRNNFSGD  300 (763)
Q Consensus       231 ~l~~L~----~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~------l~~L~~L~Ls~N~l~~~  300 (763)
                      .+++|.    .+.+.++... ..+..+..+.+  |+.|.+.++.+......  ....      ++++..+...++..- .
T Consensus       688 ~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~--L~~L~i~~~~~~e~~~~--~~~~~~~~~~f~~l~~~~~~~~~~~-r  761 (889)
T KOG4658|consen  688 GMTRLRSLLQSLSIEGCSKR-TLISSLGSLGN--LEELSILDCGISEIVIE--WEESLIVLLCFPNLSKVSILNCHML-R  761 (889)
T ss_pred             hhHHHHHHhHhhhhcccccc-eeecccccccC--cceEEEEcCCCchhhcc--cccccchhhhHHHHHHHHhhccccc-c
Confidence            333333    3333333333 34455566655  77777777776532211  1111      111222222222111 1


Q ss_pred             CCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCc
Q 046240          301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF  348 (763)
Q Consensus       301 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  348 (763)
                      .+...--.++|+.|.+..+.....+......+..++.+-+..+.+.+.
T Consensus       762 ~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l  809 (889)
T KOG4658|consen  762 DLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL  809 (889)
T ss_pred             ccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence            222223457788888887766555555556666666666666666654

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.77  E-value=9.7e-10  Score=110.27  Aligned_cols=222  Identities=16%  Similarity=0.180  Sum_probs=130.2

Q ss_pred             cCCCccEEEccccccccc----CCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccc
Q 046240          130 ALPNVKALSLAYNRFSGT----IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIV  205 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~  205 (763)
                      ....++.|+|++|.|...    +...+.+.++|+.-++++=- +|.+-..+  ...|..|               .+.+.
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~f-tGR~~~Ei--~e~L~~l---------------~~aL~   89 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMF-TGRLKDEI--PEALKML---------------SKALL   89 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhh-cCCcHHHH--HHHHHHH---------------HHHHh
Confidence            355677777777777543    22334445556655554421 11111000  0111111               12333


Q ss_pred             cccccccEEEeecCccccccccc----cCCccccceeecccccccCCCCccccc----------c-CCCCccEEEecCCc
Q 046240          206 NLSISLERLYISNCSITGNIPQV----MGNLSIFLLLDLELNKLTGPIPVTFGR----------L-QNSKLDTLSLCGNS  270 (763)
Q Consensus       206 ~l~~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~----------l-~~~~L~~L~L~~N~  270 (763)
                      +.+ +|++|+||+|-+.-..+..    +++++.|++|+|.+|.+.-.-...+++          . ..++|+.+..++|+
T Consensus        90 ~~~-~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNr  168 (382)
T KOG1909|consen   90 GCP-KLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNR  168 (382)
T ss_pred             cCC-ceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccc
Confidence            344 7889999999887544443    456788999999998886222222111          0 00348888888888


Q ss_pred             cccCCCC---ccccccCCcccEEEccccccccc----CCcccCCCcCccEEEccCccccCc----ccccccccccccEEe
Q 046240          271 FSGSIPS---CIDIGNLKVVVEINLSRNNFSGD----IPATIGGLKDVQNISLPYNRLEGP----IPESFGYLTSLEILD  339 (763)
Q Consensus       271 l~~~~p~---~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~  339 (763)
                      +.. .+.   ...|...+.|+.+.+++|.|...    +...|..+++|+.|||.+|-++..    +...++.+++|+.|+
T Consensus       169 len-~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~  247 (382)
T KOG1909|consen  169 LEN-GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN  247 (382)
T ss_pred             ccc-ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence            762 221   11345567788888888877632    234566778888888888877643    334566677888888


Q ss_pred             CcCCccCCccchhhh-----hhccCceEEcccccCCC
Q 046240          340 LSNNKISGFILISLE-----KLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       340 L~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~  371 (763)
                      ++++.+......+|.     ..++|++|.|.+|.++.
T Consensus       248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~  284 (382)
T KOG1909|consen  248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITR  284 (382)
T ss_pred             ccccccccccHHHHHHHHhccCCCCceeccCcchhHH
Confidence            888887765444433     24677888888887764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.76  E-value=8.8e-08  Score=97.73  Aligned_cols=140  Identities=15%  Similarity=0.078  Sum_probs=98.5

Q ss_pred             ceecccCCceEEEEEecCCceEEEEEeehhhHH-HH----------HHHHHHHHHHHhCCCCc--cceEEeeeec-----
Q 046240          481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR-AM----------KSFEVECEVMKNIRHRN--LVKIISGCSN-----  542 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----  542 (763)
                      +.+-......|++..++ |+.|.||........ ..          ..+.+|...+.++...+  ...++++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            44554455557777664 778999977432211 01          13678888888874333  3344555532     


Q ss_pred             CCceEEEEEccCCC-ChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-------CCc
Q 046240          543 DDFKALVLEYMPNG-SLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-------DMI  613 (763)
Q Consensus       543 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-------~~~  613 (763)
                      ....++|+|++++. +|.+++... ....+......++.+++..+.-|   |..||+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999986 788887531 22345566778999999999999   8999999999999999975       468


Q ss_pred             EEEeeecCcee
Q 046240          614 AHLSDFGIAKL  624 (763)
Q Consensus       614 ~kl~Dfgla~~  624 (763)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998754

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.69  E-value=5.2e-10  Score=121.38  Aligned_cols=101  Identities=31%  Similarity=0.434  Sum_probs=43.9

Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccc-cccccccccEEe
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPE-SFGYLTSLEILD  339 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~  339 (763)
                      |...+.+.|.+. .+..  .+.-++.|+.|+|++|+++...  .+..+++|+.|||++|.|. .+|. ...+++ |+.|.
T Consensus       166 L~~a~fsyN~L~-~mD~--SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDE--SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             HhhhhcchhhHH-hHHH--HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence            444444444444 3333  3444444445555555544221  4444444555555555544 2222 222222 44455


Q ss_pred             CcCCccCCccchhhhhhccCceEEcccccCC
Q 046240          340 LSNNKISGFILISLEKLLYLKKLNLSFNKLE  370 (763)
Q Consensus       340 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  370 (763)
                      |+||.++.  -..+.+|.+|+.||++.|-|+
T Consensus       239 lrnN~l~t--L~gie~LksL~~LDlsyNll~  267 (1096)
T KOG1859|consen  239 LRNNALTT--LRGIENLKSLYGLDLSYNLLS  267 (1096)
T ss_pred             ecccHHHh--hhhHHhhhhhhccchhHhhhh
Confidence            55554443  123344444444455554444

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.66  E-value=2.2e-08  Score=70.93  Aligned_cols=40  Identities=40%  Similarity=0.987  Sum_probs=30.5

Q ss_pred             hhhHHHHHHHHHhccCCCCcccccCCCCC--CCCCcccceeec
Q 046240           33 TTDQQALLALEAHISYDPTNLLAQNWTSN--TSVCNWIGITCD   73 (763)
Q Consensus        33 ~~~~~~l~~~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~   73 (763)
                      ..|.+||++||+.+..+|.+.+. +|..+  .++|+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~-~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLS-SWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCT-T--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccc-cCCCcCCCCCeeeccEEeC
Confidence            57899999999999877877776 99977  799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.64  E-value=5.4e-09  Score=102.45  Aligned_cols=223  Identities=19%  Similarity=0.255  Sum_probs=116.2

Q ss_pred             CCCcccceeecCCCCceEEEEecCCCCCCcCC-ccc-CCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcc
Q 046240           63 SVCNWIGITCDVNSHRVTALNISSLNLQGEIP-HEI-GYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLA  140 (763)
Q Consensus        63 ~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~-~~~-~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~  140 (763)
                      .-|++.||.-   .+-+.-|.+.++.|...-. ..| ...+.++.|||.+|.|++...+.     .+..+||.|+.|+|+
T Consensus        34 ~g~s~~~v~s---~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~-----~ile~lP~l~~LNls  105 (418)
T KOG2982|consen   34 AGLSYLGVSS---LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIG-----AILEQLPALTTLNLS  105 (418)
T ss_pred             cccceeeecc---ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHH-----HHHhcCccceEeecc
Confidence            4566666653   3345566677777653221 223 23577888888888885322111     123467788888888


Q ss_pred             cccccccCCCcccCCCCCCeeeecCccccc-ccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecC
Q 046240          141 YNRFSGTIQSPITNASKLTILELGGNSFSG-FIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC  219 (763)
Q Consensus       141 ~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N  219 (763)
                      .|.+...+-..-..+.+|+.|-|.+..+.- .....+..++.++.|.    ++.|               +++.+.+..|
T Consensus       106 ~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelH----mS~N---------------~~rq~n~Dd~  166 (418)
T KOG2982|consen  106 CNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELH----MSDN---------------SLRQLNLDDN  166 (418)
T ss_pred             CCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhh----hccc---------------hhhhhccccc
Confidence            888774433221345677778787777652 2223445566666665    4444               4555555555


Q ss_pred             cccccccc--ccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccc
Q 046240          220 SITGNIPQ--VMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF  297 (763)
Q Consensus       220 ~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l  297 (763)
                      -++..-|.  .+..++.+..++++-|++....|.         +..+.+..|.+. .......+..++.+.-|+|+.|+|
T Consensus       167 c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpn---------v~sv~v~e~PlK-~~s~ek~se~~p~~~~LnL~~~~i  236 (418)
T KOG2982|consen  167 CIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPN---------VNSVFVCEGPLK-TESSEKGSEPFPSLSCLNLGANNI  236 (418)
T ss_pred             cccccchhhhhhhcCCcHHHHHHHHHhHHhhccc---------chheeeecCccc-chhhcccCCCCCcchhhhhccccc
Confidence            55532221  233344455555555555533331         555556666554 222222334444444555555555


Q ss_pred             cccC-CcccCCCcCccEEEccCcccc
Q 046240          298 SGDI-PATIGGLKDVQNISLPYNRLE  322 (763)
Q Consensus       298 ~~~~-p~~~~~l~~L~~L~Ls~N~l~  322 (763)
                      ..-. -+++.++++|..|.+++|.|.
T Consensus       237 dswasvD~Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  237 DSWASVDALNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             ccHHHHHHHcCCchhheeeccCCccc
Confidence            4211 233444555555555555444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.63  E-value=1.1e-06  Score=93.29  Aligned_cols=167  Identities=20%  Similarity=0.222  Sum_probs=123.8

Q ss_pred             CceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec----CCceEEEEEccCC-CChhhh
Q 046240          488 FGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN----DDFKALVLEYMPN-GSLDIF  561 (763)
Q Consensus       488 ~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~  561 (763)
                      -.+.|++.. .||..|++|+++............-+++.+++.|+|+|++.+++..    +...++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            457899955 4899999999965543333333456788999999999999988863    3467899999876 556555


Q ss_pred             hccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          562 LYSS--------------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       562 l~~~--------------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      -...              +...+....+.++.|+..||.++   |+.|..-+=|.+++|+++.+.+++|+.-|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321              12345677889999999999999   888999999999999999998999988777655432


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCC
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP  676 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p  676 (763)
                      +..                |-+.+   -.+-|.=.||.+++.+.||..-
T Consensus       446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            220                11111   2356889999999999999544

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.63  E-value=1.1e-09  Score=118.79  Aligned_cols=128  Identities=26%  Similarity=0.293  Sum_probs=99.8

Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      .|...+.+.|++. ....++.-++.|+.|+|++|+++.. . .+..++.  |++|||+.|.++ .+|.. ...++. |..
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-~-~Lr~l~~--LkhLDlsyN~L~-~vp~l-~~~gc~-L~~  236 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-D-NLRRLPK--LKHLDLSYNCLR-HVPQL-SMVGCK-LQL  236 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-H-HHHhccc--ccccccccchhc-ccccc-chhhhh-hee
Confidence            6888899999998 7788888899999999999999843 2 7777765  999999999998 66753 233343 888


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCccc-ccccccccccEEeCcCCccCC
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIP-ESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      |.+++|.++..  ..+.++++|+.|||++|-|.+.-. ..++.|..|+.|+|.+|.+--
T Consensus       237 L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  237 LNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             eeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            99999988732  457788888899999998875422 345677888889999998764

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.57  E-value=4.2e-07  Score=89.48  Aligned_cols=134  Identities=25%  Similarity=0.231  Sum_probs=97.0

Q ss_pred             CcCceecccCCceEEEEEecCCceEEEEEeehhh----------------------HHHHHHHHHHHHHHHhCCCC--cc
Q 046240          478 GRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC----------------------ARAMKSFEVECEVMKNIRHR--NL  533 (763)
Q Consensus       478 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--ni  533 (763)
                      .++..||-|--+.||.|..+.|.++|||.=+...                      .-.....++|.++|+++.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            3568899999999999999999999999532110                      01233467899999998644  66


Q ss_pred             ceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc
Q 046240          534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI  613 (763)
Q Consensus       534 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~  613 (763)
                      .+.+++    +...+||||++|--|...-      ++....-.|+..|.+-+...   -..||||||+++-||+++++|.
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheEEEecCCC
Confidence            666654    3457999999996664432      12333445566666666555   3578999999999999999999


Q ss_pred             EEEeeecCcee
Q 046240          614 AHLSDFGIAKL  624 (763)
Q Consensus       614 ~kl~Dfgla~~  624 (763)
                      +.++||--+..
T Consensus       241 ~~vIDwPQ~v~  251 (304)
T COG0478         241 IVVIDWPQAVP  251 (304)
T ss_pred             EEEEeCccccc
Confidence            99999965543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.55  E-value=4.2e-07  Score=100.45  Aligned_cols=141  Identities=22%  Similarity=0.221  Sum_probs=98.1

Q ss_pred             ceecccCCceEEEEEecCCceEEEEEeehhhHH----------------------------------------HHHHHHH
Q 046240          481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR----------------------------------------AMKSFEV  520 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~  520 (763)
                      +.|+.++-|.||+|++.+|+.||||+.++....                                        .+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            679999999999999999999999988532110                                        1112445


Q ss_pred             HHHHHHhCC-----CCccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 046240          521 ECEVMKNIR-----HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA-LEYLNFRHTT  594 (763)
Q Consensus       521 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~-L~~Lh~~h~~  594 (763)
                      |..-+.+++     .+++.-.-=|+.......|+|||++|-.+.+...-+....+   +..++..++++ +..+   -..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~---~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQL---LRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHH---Hhc
Confidence            555555552     34433223333445677899999999998888533323344   44455555554 3333   447


Q ss_pred             CeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       595 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      |++|.|.+|.||+++.+|.+.+.|||+...+++
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999887653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.43  E-value=1.3e-06  Score=86.27  Aligned_cols=107  Identities=23%  Similarity=0.239  Sum_probs=82.0

Q ss_pred             HHHHHHHHHHHHhCCC--CccceEEeeeecCC----ceEEEEEccCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHH
Q 046240          515 MKSFEVECEVMKNIRH--RNLVKIISGCSNDD----FKALVLEYMPNG-SLDIFLYSSTCMLDIFQRLNIMIDVASALEY  587 (763)
Q Consensus       515 ~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~  587 (763)
                      .....+|...+..+..  =.+.+.+++.....    ..++|+|++++. +|.+++..... .+......++.++++.+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            3456778887777743  23455666665432    457999999884 78888876322 4556678899999999999


Q ss_pred             HHhcCCCCeEeCCCCCCCEEecCCC---cEEEeeecCceec
Q 046240          588 LNFRHTTPIIHCDLKSSNVLLDEDM---IAHLSDFGIAKLL  625 (763)
Q Consensus       588 Lh~~h~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~  625 (763)
                      |   |..||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       134 l---H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 L---HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             H---HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9   899999999999999999887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=7.6e-08  Score=105.64  Aligned_cols=98  Identities=17%  Similarity=0.379  Sum_probs=76.0

Q ss_pred             HHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc-------ccccccccccccCcccc
Q 046240          577 IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM-------TQTQTLATIGYMAPEYG  649 (763)
Q Consensus       577 i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-------~~~~~~g~~~y~aPE~~  649 (763)
                      =+.+++.|+.|+|  -+.++||++|.|++|.++.++..||+.|+.+....+.....       ..........|.|||++
T Consensus       104 nl~~v~dgl~flh--~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLH--RSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhc--cCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            3445568999997  56789999999999999999999999999876554321111       11122346679999999


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHcCCCC
Q 046240          650 IERKVSTRSDIYSYGIMLIETFTRKKP  676 (763)
Q Consensus       650 ~~~~~~~~~Dv~slGv~l~elltg~~p  676 (763)
                      .+...+.++|+||+||++|-+..|..+
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcc
Confidence            998889999999999999999954443

>PRK09902 hypothetical protein; Provisional

Probab=98.37  E-value=4.8e-06  Score=80.41  Aligned_cols=138  Identities=16%  Similarity=0.085  Sum_probs=100.5

Q ss_pred             ecccCCceEEEEEecCCceEEEEEeehhh------HHHHHHHHHHHHHHHhCCC--CccceEEeeeec----CCceEEEE
Q 046240          483 IGIGSFGYVYKAELDDGIEVAIKVFHQEC------ARAMKSFEVECEVMKNIRH--RNLVKIISGCSN----DDFKALVL  550 (763)
Q Consensus       483 lg~G~~g~v~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~----~~~~~lv~  550 (763)
                      -|+||-+.|+....++ +.+-+|.-....      +.....|.+|...+.++..  -.+.++..+...    .-..+||+
T Consensus        26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            4678889999988764 468888764211      1245678999999999853  224444422211    12457999


Q ss_pred             EccCC-CChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc--EEEeeecCcee
Q 046240          551 EYMPN-GSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI--AHLSDFGIAKL  624 (763)
Q Consensus       551 e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~  624 (763)
                      |-+++ .+|.+++.... .+.+...+..+..+++.+++-|   |+.++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~L---H~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKM---HSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 57888875532 2456677789999999999999   8999999999999999986666  99999987654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	763
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-34
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-33
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-32
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-24
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-24
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-23
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-22
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-21
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-18
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-16
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-15
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-07
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		6e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-07
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		6e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		5e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		8e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  142 bits (359), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/241 (38%), Positives = 134/241 (55%), Gaps = 12/241 (4%)
Query: 464 RLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECE 523
           R+P  DL  ATN F    LIG G FG VYK  L DG +VA+K    E ++ ++ FE E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS---TCMLDIFQRLNIMID 580
            +   RH +LV +I  C   +   L+ +YM NG+L   LY S   T  +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
            A  L YL   HT  IIH D+KS N+LLDE+ +  ++DFGI+K  +  DQ+        T
Sbjct: 148 AARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKK------PADKMFAAELSLKHWVNGL 694
           +GY+ PEY I+ +++ +SD+YS+G++L E    +       P + +  AE +++   NG 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 695 L 695
           L
Sbjct: 265 L 265

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 92/241 (38%), Positives = 133/241 (55%), Gaps = 12/241 (4%)
Query: 464 RLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECE 523
           R+P  DL  ATN F    LIG G FG VYK  L DG +VA+K    E ++ ++ FE E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS---TCMLDIFQRLNIMID 580
            +   RH +LV +I  C   +   L+ +YM NG+L   LY S   T  +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
            A  L YL   HT  IIH D+KS N+LLDE+ +  ++DFGI+K  +   Q+        T
Sbjct: 148 AARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKK------PADKMFAAELSLKHWVNGL 694
           +GY+ PEY I+ +++ +SD+YS+G++L E    +       P + +  AE +++   NG 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 695 L 695
           L
Sbjct: 265 L 265

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  139 bits (351), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 147/285 (51%), Gaps = 13/285 (4%)
Query: 463 RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMK-SFEVE 521
           +R   ++L  A++ F   N++G G FG VYK  L DG  VA+K   +E  +  +  F+ E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIM 578
            E++    HRNL+++   C     + LV  YM NGS+   L     S   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
           +  A  L YL+      IIH D+K++N+LLDE+  A + DFG+AKL+  +D  +      
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 204
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA---ELSLKHWVNGLL 695
            TIG++APEY    K S ++D++ YG+ML+E  T ++  D    A   ++ L  WV GLL
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               +E +    L    KD     + V  +  +A+ CT   P +R
Sbjct: 265 KEKKLEALVDVDLQGNYKD-----EEVEQLIQVALLCTQSSPMER 304

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 95/285 (33%), Positives = 146/285 (51%), Gaps = 13/285 (4%)
Query: 463 RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMK-SFEVE 521
           +R   ++L  A++ F   N++G G FG VYK  L DG  VA+K   +E  +  +  F+ E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIM 578
            E++    HRNL+++   C     + LV  YM NGS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
           +  A  L YL+      IIH D+K++N+LLDE+  A + DFG+AKL+  +D  +      
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA---ELSLKHWVNGLL 695
             IG++APEY    K S ++D++ YG+ML+E  T ++  D    A   ++ L  WV GLL
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               +E +    L    KD     + V  +  +A+ CT   P +R
Sbjct: 257 KEKKLEALVDVDLQGNYKD-----EEVEQLIQVALLCTQSSPMER 296

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (280), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 115/207 (55%), Gaps = 8/207 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           IG GSFG V++AE   G +VA+K+  ++   A  +  F  E  +MK +RH N+V  +   
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
           +     ++V EY+  GSL   L+ S     LD  +RL++  DVA  + YL+ R+  PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            DLKS N+L+D+     + DFG+++L +     +       T  +MAPE   +   + +S
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAEL 685
           D+YS+G++L E  T ++P   +  A++
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQV 247

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 116/207 (56%), Gaps = 8/207 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           IG GSFG V++AE   G +VA+K+  ++   A  +  F  E  +MK +RH N+V  +   
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
           +     ++V EY+  GSL   L+ S     LD  +RL++  DVA  + YL+ R+  PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVH 162
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            +LKS N+L+D+     + DFG+++L +     ++      T  +MAPE   +   + +S
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAEL 685
           D+YS+G++L E  T ++P   +  A++
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQV 247

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 93/321 (28%), Positives = 150/321 (46%), Gaps = 31/321 (9%)
Query: 452 NGGILLSQATKRRLPYQDLSRATNRFGR------DNLIGIGSFGYVYKAELDDGIEVAIK 505
           N  + +S        + +L   TN F         N +G G FG VYK  +++   VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 506 ----VFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIF 561
               +         + F+ E +VM   +H NLV+++   S+ D   LV  YMPNGSL   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL--- 117
Query: 562 LYSSTCM-----LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
           L   +C+     L    R  I    A+ +   NF H    IH D+KS+N+LLDE   A +
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGI---NFLHENHHIHRDIKSANILLDEAFTAKI 174
Query: 617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           SDFG+A+      Q++  ++ + T  YMAPE  +  +++ +SDIYS+G++L+E  T    
Sbjct: 175 SDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 677 ADKMFAAELSL-KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTME 735
            D+    +L L           ++ + ++K +         A    V +++S+A +C  E
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHE 286
Query: 736 LPEKRINAKCCNFVLCEQFVS 756
              KR + K    +L E   S
Sbjct: 287 KKNKRPDIKKVQQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 93/321 (28%), Positives = 149/321 (46%), Gaps = 31/321 (9%)
Query: 452 NGGILLSQATKRRLPYQDLSRATNRFGR------DNLIGIGSFGYVYKAELDDGIEVAIK 505
           N  + +S        + +L   TN F         N +G G FG VYK  +++   VA+K
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVK 60
Query: 506 ----VFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIF 561
               +         + F+ E +VM   +H NLV+++   S+ D   LV  YMPNGSL   
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL--- 117
Query: 562 LYSSTCM-----LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
           L   +C+     L    R  I    A+ +   NF H    IH D+KS+N+LLDE   A +
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGI---NFLHENHHIHRDIKSANILLDEAFTAKI 174
Query: 617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           SDFG+A+      Q++   + + T  YMAPE  +  +++ +SDIYS+G++L+E  T    
Sbjct: 175 SDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 677 ADKMFAAELSL-KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTME 735
            D+    +L L           ++ + ++K +         A    V +++S+A +C  E
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHE 286
Query: 736 LPEKRINAKCCNFVLCEQFVS 756
              KR + K    +L E   S
Sbjct: 287 KKNKRPDIKKVQQLLQEMTAS 307

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 135/284 (47%), Gaps = 45/284 (15%)
Query: 483 IGIGSFGYVYKAE------LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG V+ AE        D + VA+K        A K F+ E E++ N++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYS---------------STCMLDIFQRLNIMIDV 581
              C + D   +V EYM +G L+ FL +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           AS + YL  +H    +H DL + N L+  +++  + DFG+++ +   D       T+  I
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLM 700
            +M PE  + RK +T SD++S+G++L E FT  K+P  ++   E+        +  ++  
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--------IECITQG 251
Query: 701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
            V+ +  + P E            ++ + + C    P++R+N K
Sbjct: 252 RVLERPRVCPKE------------VYDVMLGCWQREPQQRLNIK 283

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 144/306 (47%), Gaps = 31/306 (10%)
Query: 467 YQDLSRATNRFGR------DNLIGIGSFGYVYKAELDDGIEVAIK----VFHQECARAMK 516
           + +L   TN F         N +G G FG VYK  +++   VA+K    +         +
Sbjct: 11  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQ 69
Query: 517 SFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-----LDI 571
            F+ E +VM   +H NLV+++   S+ D   LV  YMPNGSL   L   +C+     L  
Sbjct: 70  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGTPPLSW 126
Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
             R  I    A+ +   NF H    IH D+KS+N+LLDE   A +SDFG+A+      Q 
Sbjct: 127 HMRCKIAQGAANGI---NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL-KHW 690
           +   + + T  YMAPE  +  +++ +SDIYS+G++L+E  T     D+    +L L    
Sbjct: 184 VMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 242
Query: 691 VNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL 750
                  ++ + ++K +         A    V +++S+A +C  E   KR + K    +L
Sbjct: 243 EIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295
Query: 751 CEQFVS 756
            E   S
Sbjct: 296 QEMTAS 301

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 102/341 (29%), Positives = 152/341 (44%), Gaps = 71/341 (20%)
Query: 89  LQGEIPHEIGYLPSLTKLAXXXXXXXXXXXXXXXXPSRIDLALPNVKALSLAYNRFSGTI 148
           L+GEIP E+ Y+ +L  L                 PS +     N+  +SL+ NR +G I
Sbjct: 451 LEGEIPQELMYVKTLETLILDFNDLTGEI------PSGLS-NCTNLNWISLSNNRLTGEI 503
Query: 149 QSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS 208
              I     L IL+L  NSFSG IP  +G+ R++ WL L   L     NG +P+++   S
Sbjct: 504 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL----FNGTIPAAMFKQS 559
Query: 209 -------ISLER-LYISN------CSITGNIPQVMGNLSIFLLLDLELNKLT--GPIPVT 252
                  I+ +R +YI N      C   GN+ +  G      +   +LN+L+   P  +T
Sbjct: 560 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG------IRSEQLNRLSTRNPCNIT 613
Query: 253 ---FGRLQNSKLDT------LSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA 303
              +G   +   D       L +  N  SG IP   +IG++  +  +NL  N+ SG IP 
Sbjct: 614 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK--EIGSMPYLFILNLGHNDISGSIPD 671
Query: 304 TIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGXXXXXXXXXXXXXXXX 363
            +G L+ +  + L  N+L+G IP++   LT L  +DLSNN +S                 
Sbjct: 672 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS----------------- 714
Query: 364 XXXXXXXGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQC 404
                  G IP  G F  F    F+ N  LCG P   +P+C
Sbjct: 715 -------GPIPEMGQFETFPPAKFLNNPGLCGYP---LPRC 745

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 255 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 313
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL   T   L + Q +++   +
Sbjct: 314 QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 373 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 427
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 468
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 469 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526
Query: 759 SE 760
            +
Sbjct: 527 PQ 528

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 44/299 (14%)
Query: 483 IGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG V+ AE        D I VA+K        A K F  E E++ N++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSS------------TCMLDIFQRLNIMIDVASA 584
              C   D   +V EYM +G L+ FL +                L   Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           + YL  +H    +H DL + N L+ E+++  + DFG+++ +   D       T+  I +M
Sbjct: 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVV 703
            PE  + RK +T SD++S G++L E FT  K+P  ++   E+             +  + 
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------------IECIT 244
Query: 704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELY 762
              +L  P         C   ++ L + C    P  R N K  + +L  Q ++ +S +Y
Sbjct: 245 QGRVLQRPRT-------CPQEVYELMLGCWQREPHMRKNIKGIHTLL--QNLAKASPVY 294

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 102/341 (29%), Positives = 152/341 (44%), Gaps = 71/341 (20%)
Query: 89  LQGEIPHEIGYLPSLTKLAXXXXXXXXXXXXXXXXPSRIDLALPNVKALSLAYNRFSGTI 148
           L+GEIP E+ Y+ +L  L                 PS +     N+  +SL+ NR +G I
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEI------PSGLS-NCTNLNWISLSNNRLTGEI 506
Query: 149 QSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS 208
              I     L IL+L  NSFSG IP  +G+ R++ WL L   L     NG +P+++   S
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL----FNGTIPAAMFKQS 562
Query: 209 -------ISLER-LYISN------CSITGNIPQVMGNLSIFLLLDLELNKLT--GPIPVT 252
                  I+ +R +YI N      C   GN+ +  G      +   +LN+L+   P  +T
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQG------IRSEQLNRLSTRNPCNIT 616
Query: 253 ---FGRLQNSKLDT------LSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA 303
              +G   +   D       L +  N  SG IP   +IG++  +  +NL  N+ SG IP 
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK--EIGSMPYLFILNLGHNDISGSIPD 674
Query: 304 TIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGXXXXXXXXXXXXXXXX 363
            +G L+ +  + L  N+L+G IP++   LT L  +DLSNN +S                 
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS----------------- 717
Query: 364 XXXXXXXGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQC 404
                  G IP  G F  F    F+ N  LCG P   +P+C
Sbjct: 718 -------GPIPEMGQFETFPPAKFLNNPGLCGYP---LPRC 748

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 230
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL   T   L + Q +++   +
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 290 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 344
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 385
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 386 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
Query: 759 SE 760
            +
Sbjct: 444 PQ 445

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 230
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL   T   L + Q +++   +
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 290 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 344
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 385
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 386 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
Query: 759 SE 760
            +
Sbjct: 444 PQ 445

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 3   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 61
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL   T   L + Q +++   +
Sbjct: 62  QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI 120
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 121 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFP 175
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 216
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 217 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 274
Query: 759 SE 760
            +
Sbjct: 275 PQ 276

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 137/282 (48%), Gaps = 32/282 (11%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +    VAIK   +    + ++F  E +VMK +RH  LV++ +  S 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    +V EYM  GSL  FL   T   L + Q +++   +AS + Y+   +    +H DL
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 130
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +++N+L+ E+++  ++DFG+A+L+  ED   T  Q     I + APE  +  + + +SD+
Sbjct: 131 RAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L E  T+                   G +P   M  VN+ +L   E+ +     
Sbjct: 189 WSFGILLTELTTK-------------------GRVPYPGM--VNREVLDQVERGYRMPCP 227
Query: 719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
            +C  S+  L  +C  + PE+R   +     L + F S   +
Sbjct: 228 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 269

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 3   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 61
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL   T   L + Q +++   +
Sbjct: 62  QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI 120
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 121 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 175
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 216
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 217 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 274
Query: 759 SE 760
            +
Sbjct: 275 PQ 276

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 172 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 230
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL   T   L + Q +++   +
Sbjct: 231 QVMKKLRHEKLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 290 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 344
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 385
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 386 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
Query: 759 SE 760
            +
Sbjct: 444 PQ 445

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 137/282 (48%), Gaps = 32/282 (11%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +    VAIK   +    + ++F  E +VMK +RH  LV++ +  S 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    +V EYM  GSL  FL   T   L + Q +++   +AS + Y+   +    +H DL
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 133
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +++N+L+ E+++  ++DFG+A+L+  ED   T  Q     I + APE  +  + + +SD+
Sbjct: 134 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L E  T+                   G +P   M  VN+ +L   E+ +     
Sbjct: 192 WSFGILLTELTTK-------------------GRVPYPGM--VNREVLDQVERGYRMPCP 230
Query: 719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
            +C  S+  L  +C  + PE+R   +     L + F S   +
Sbjct: 231 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 272

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 64
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V+EYM  GSL  FL       L + Q +++   +
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 124 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFP 178
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 219
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 220 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277
Query: 759 SE 760
            +
Sbjct: 278 PQ 279

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 144/302 (47%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 64
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK IRH  LV++ +  S +    +V EYM  GSL  FL       L + Q +++   +
Sbjct: 65  QVMKKIRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 124 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 178
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 219
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 220 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277
Query: 759 SE 760
            +
Sbjct: 278 PQ 279

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 145/302 (48%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 64
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V+EYM  GSL  FL       L + Q +++   +
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 124 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 178
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 219
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 220 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277
Query: 759 SE 760
            +
Sbjct: 278 PQ 279

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 139/308 (45%), Gaps = 31/308 (10%)
Query: 465 LPYQDLSRATNRFGR------DNLIGIGSFGYVYKAELDDGIEVAIKVFHQ----ECARA 514
             + +L   TN F         N  G G FG VYK  +++   VA+K             
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-----L 569
            + F+ E +V    +H NLV+++   S+ D   LV  Y PNGSL   L   +C+     L
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL---LDRLSCLDGTPPL 121
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
               R  I    A+ +   NF H    IH D+KS+N+LLDE   A +SDFG+A+      
Sbjct: 122 SWHXRCKIAQGAANGI---NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL-K 688
           Q +  ++ + T  Y APE  +  +++ +SDIYS+G++L+E  T     D+    +L L  
Sbjct: 179 QXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 237
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF 748
                    ++ + ++K       K   A    V + +S+A +C  E   KR + K    
Sbjct: 238 KEEIEDEEKTIEDYIDK-------KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQ 290
Query: 749 VLCEQFVS 756
           +L E   S
Sbjct: 291 LLQEXTAS 298

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 144/302 (47%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 64
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL       L + Q +++   +
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 124 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 178
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 219
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 220 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277
Query: 759 SE 760
            +
Sbjct: 278 PQ 279

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 23/213 (10%)
Query: 483 IGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG V+ AE        D + VA+K   +    A + F+ E E++  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYS--------------STCMLDIFQRLNIMIDVA 582
              C+      +V EYM +G L+ FL S              +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           + + YL   H    +H DL + N L+ + ++  + DFG+++ +   D      +T+  I 
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKK 675
           +M PE  + RK +T SD++S+G++L E FT  K
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 144/302 (47%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 64
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL       L + Q +++   +
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 124 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 178
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 219
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 220 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277
Query: 759 SE 760
            +
Sbjct: 278 PQ 279

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 136/282 (48%), Gaps = 32/282 (11%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +    VAIK   +    + ++F  E +VMK +RH  LV++ +  S 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    +V EYM  GSL  FL       L + Q +++   +AS + Y+   +    +H DL
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 129
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +++N+L+ E+++  ++DFG+A+L+  ED   T  Q     I + APE  +  + + +SD+
Sbjct: 130 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L E  T+                   G +P   M  VN+ +L   E+ +     
Sbjct: 188 WSFGILLTELTTK-------------------GRVPYPGM--VNREVLDQVERGYRMPCP 226
Query: 719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
            +C  S+  L  +C  + PE+R   +     L + F S   +
Sbjct: 227 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 268

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 23/213 (10%)
Query: 483 IGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG V+ AE        D + VA+K   +    A + F+ E E++  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYS--------------STCMLDIFQRLNIMIDVA 582
              C+      +V EYM +G L+ FL S              +   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           + + YL   H    +H DL + N L+ + ++  + DFG+++ +   D      +T+  I 
Sbjct: 140 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKK 675
           +M PE  + RK +T SD++S+G++L E FT  K
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 136/282 (48%), Gaps = 32/282 (11%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +    VAIK   +    + ++F  E +VMK +RH  LV++ +  S 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    +V EYM  GSL  FL       L + Q +++   +AS + Y+   +    +H DL
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 131
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +++N+L+ E+++  ++DFG+A+L+  ED   T  Q     I + APE  +  + + +SD+
Sbjct: 132 RAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L E  T+                   G +P   M  VN+ +L   E+ +     
Sbjct: 190 WSFGILLTELTTK-------------------GRVPYPGM--VNREVLDQVERGYRMPCP 228
Query: 719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
            +C  S+  L  +C  + PE+R   +     L + F S   +
Sbjct: 229 PECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 270

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 23/213 (10%)
Query: 483 IGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G+FG V+ AE        D + VA+K   +    A + F+ E E++  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYS--------------STCMLDIFQRLNIMIDVA 582
              C+      +V EYM +G L+ FL S              +   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           + + YL   H    +H DL + N L+ + ++  + DFG+++ +   D      +T+  I 
Sbjct: 146 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKK 675
           +M PE  + RK +T SD++S+G++L E FT  K
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 144/302 (47%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 64
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V+EYM  G L  FL       L + Q +++   +
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 124 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 178
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 219
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 220 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277
Query: 759 SE 760
            +
Sbjct: 278 PQ 279

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 143/302 (47%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 64
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL       L + Q +++   +
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL ++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 124 ASGMAYVERMN---YVHRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 178
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 219
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 220 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277
Query: 759 SE 760
            +
Sbjct: 278 PQ 279

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 143/302 (47%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 173 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEA 231
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  GSL  FL       L + Q +++   +
Sbjct: 232 QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 290
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+ +L+  ED   T  Q     
Sbjct: 291 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFP 345
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 346 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 386
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 387 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 444
Query: 759 SE 760
            +
Sbjct: 445 PQ 446

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V I           ++F  E  V++  RH N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
           D+  A+V ++    SL   L+       +FQ ++I    A  ++YL   H   IIH D+K
Sbjct: 104 DNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMK 159
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L E +   + DFG+A + S    S    Q   ++ +MAPE          S +SD
Sbjct: 160 SNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSD 219
Query: 660 IYSYGIMLIETFTRKKP 676
           +YSYGI+L E  T + P
Sbjct: 220 VYSYGIVLYELMTGELP 236

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 143/302 (47%), Gaps = 37/302 (12%)
Query: 468 QDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVEC 522
           Q L++      R++L     +G G FG V+    +    VAIK   +    + ++F  E 
Sbjct: 6   QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEA 64
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDV 581
           +VMK +RH  LV++ +  S +    +V EYM  G L  FL       L + Q +++   +
Sbjct: 65  QVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-T 640
           AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+  ED   T  Q     
Sbjct: 124 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFP 178
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE  +  + + +SD++S+GI+L E  T+                   G +P   M
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTK-------------------GRVPYPGM 219
Query: 701 EVVNKTLLSPPEKDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
             VN+ +L   E+ +      +C  S+  L  +C  + PE+R   +     L + F S  
Sbjct: 220 --VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277
Query: 759 SE 760
            +
Sbjct: 278 PQ 279

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 127/271 (46%), Gaps = 33/271 (12%)
Query: 479 RDNLIGIGSFGYVYKAELDDG-----IEVAIKVFHQECARAMK-SFEVECEVMKNIRHRN 532
           R  +IG G FG VYK  L        + VAIK          +  F  E  +M    H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL-NFR 591
           ++++    S      ++ EYM NG+LD FL        + Q + ++  +A+ ++YL N  
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLATIGYMAPEYGI 650
           +    +H DL + N+L++ +++  +SDFG++++L  + + + T +     I + APE   
Sbjct: 168 Y----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 651 ERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS 709
            RK ++ SD++S+GI++ E  T  ++P  ++   E              +M+ +N     
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------VMKAINDGFRL 269
Query: 710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           P   D      C  +I+ L M+C  +   +R
Sbjct: 270 PTPMD------CPSAIYQLMMQCWQQERARR 294

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 135/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           Y+D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V EYM NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG++++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 631 SMTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 135/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           Y+D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V EYM NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG++++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 631 SMTQTQTLAT-IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 135/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           ++D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V EYM NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG+A++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPE 202
Query: 631 SMTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 135/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           Y+D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 85
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V EYM NGSLD FL        
Sbjct: 86  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 143
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG++++L  + +
Sbjct: 144 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 200
Query: 631 SMTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 201 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 256
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 257 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 284

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 135/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           ++D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V EYM NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG++++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 631 SMTQTQTLAT-IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGIERK 653
            IH DL + N+L++ +    + DFG+ K+L  +D+   + +    + I + APE   E K
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 654 VSTRSDIYSYGIMLIETFT 672
            S  SD++S+G++L E FT
Sbjct: 212 FSVASDVWSFGVVLYELFT 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L +    +D  + L     +   +EYL    T  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 213 SVASDVWSFGVVLYELFT 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 141
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 142 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 201
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 202 SVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 139
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 140 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 199
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 200 SVASDVWSFGVVLYELFT 217

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 135/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           ++D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V EYM NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG++++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 631 SMTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 135/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           ++D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V EYM NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG++++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 631 SMTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 133
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 134 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 193
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 194 SVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 138
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L  + +     +   + I + APE   E K 
Sbjct: 139 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 198
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 199 SVASDVWSFGVVLYELFT 216

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 134/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           ++D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V EYM NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG+ ++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202
Query: 631 SMTQTQTLAT-IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGIERK 653
            IH DL + N+L++ +    + DFG+ K+L  +D+   + +    + I + APE   E K
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 654 VSTRSDIYSYGIMLIETFT 672
            S  SD++S+G++L E FT
Sbjct: 194 FSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 225
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 226 SVASDVWSFGVVLYELFT 243

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 134/282 (47%), Gaps = 32/282 (11%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VAIK   +    + +SF  E ++MK ++H  LV++ +  S 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    +V EYM  GSL  FL       L +   +++   VA+ + Y+   +    IH DL
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 131
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +S+N+L+   +I  ++DFG+A+L+  ED   T  Q     I + APE  +  + + +SD+
Sbjct: 132 RSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L E  T+                   G +P   M   N+ +L   E+ +     
Sbjct: 190 WSFGILLTELVTK-------------------GRVPYPGMN--NREVLEQVERGYRMPCP 228
Query: 719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
           + C +S+  L + C  + PE+R   +     L + F +   +
Sbjct: 229 QDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQ 270

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 132
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 192
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 193 SVASDVWSFGVVLYELFT 210

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 127/262 (48%), Gaps = 34/262 (12%)
Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQECARAMKSFEVECEVMKNIRHRN 532
           D ++G G FG V    L       I VAIK   V + E  R  + F  E  +M    H N
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPN 95
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           ++++    +      +V EYM NGSLD FL        + Q + ++  +AS ++YL+   
Sbjct: 96  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--- 152
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT-IGYMAPEYGIE 651
               +H DL + N+L++ +++  +SDFG++++L  + ++   T+     I + +PE    
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 212
Query: 652 RKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP 710
           RK ++ SD++SYGI+L E  +  ++P  +M   +              +++ V++    P
Sbjct: 213 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------------VIKAVDEGYRLP 258
Query: 711 PEKDFAAKEQCVLSIFSLAMEC 732
           P  D      C  +++ L ++C
Sbjct: 259 PPMD------CPAALYQLMLDC 274

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 140
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 141 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 200
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 201 SVASDVWSFGVVLYELFT 218

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 123/259 (47%), Gaps = 26/259 (10%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VA+K+  +E + +   F  E + M  + H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
           +    +V EY+ NG L  +L S    L+  Q L +  DV   + +L    +   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+D D+   +SDFG+ + +  +DQ ++   T   + + APE     K S++SD+++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 663 YGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQC 721
           +GI++ E F+  K P D    +E+ LK        VS    + +  L+            
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVLK--------VSQGHRLYRPHLASD---------- 232
Query: 722 VLSIFSLAMECTMELPEKR 740
             +I+ +   C  ELPEKR
Sbjct: 233 --TIYQIMYSCWHELPEKR 249

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 467 YQDLSRATNRFGRD---------NLIGIGSFGYVYKAEL----DDGIEVAIKVFHQ-ECA 512
           Y++  RA   F R+          +IG G  G V    L       + VAIK        
Sbjct: 32  YEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF 572
           R  + F  E  +M    H N++++    +      +V EYM NGSLD FL +      I 
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQS 631
           Q + ++  V + + YL+       +H DL + NVL+D +++  +SDFG++++L  + D +
Sbjct: 152 QLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            T T     I + APE    R  S+ SD++S+G+++ E   
Sbjct: 209 XTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 127/262 (48%), Gaps = 34/262 (12%)
Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQECARAMKSFEVECEVMKNIRHRN 532
           D ++G G FG V    L       I VAIK   V + E  R  + F  E  +M    H N
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPN 78
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           ++++    +      +V EYM NGSLD FL        + Q + ++  +AS ++YL+   
Sbjct: 79  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--- 135
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT-IGYMAPEYGIE 651
               +H DL + N+L++ +++  +SDFG++++L  + ++   T+     I + +PE    
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 652 RKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP 710
           RK ++ SD++SYGI+L E  +  ++P  +M   +              +++ V++    P
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------------VIKAVDEGYRLP 241
Query: 711 PEKDFAAKEQCVLSIFSLAMEC 732
           P  D      C  +++ L ++C
Sbjct: 242 PPMD------CPAALYQLMLDC 257

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 18/221 (8%)
Query: 467 YQDLSRATNRFGRD---------NLIGIGSFGYVYKAEL----DDGIEVAIKVFHQ-ECA 512
           Y++  RA   F R+          +IG G  G V    L       + VAIK        
Sbjct: 32  YEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF 572
           R  + F  E  +M    H N++++    +      +V EYM NGSLD FL +      I 
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQS 631
           Q + ++  V + + YL+       +H DL + NVL+D +++  +SDFG++++L  + D +
Sbjct: 152 QLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            T T     I + APE    R  S+ SD++S+G+++ E   
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 480 DNLIGIGSFGYVYKAELDDGIEVAIKVFH----QECARAMKSFEVECEVMKNIRHRNLVK 535
           + +IGIG FG VY+A    G EVA+K       ++ ++ +++   E ++   ++H N++ 
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +   C  +    LV+E+   G L+  L       DI   +N  + +A  + YL+     P
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVP 128
Query: 596 IIHCDLKSSNVLLDEDM--------IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           IIH DLKSSN+L+ + +        I  ++DFG+A+    E    T+        +MAPE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPE 184
Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
                  S  SD++SYG++L E  T + P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 78
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L++S    ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLK 135
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED    + DFG+A + S    S    Q   +I +MAPE          S +SD
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 195
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 196 VYAFGIVLYELMTGQLP 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++E++P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 655 STRSDIYSYGIMLIETFT 672
           S  SD++S+G++L E FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 103/193 (53%), Gaps = 15/193 (7%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V   +   G +VA+K    +     ++F  E  VM  +RH NLV+++ G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL-GVIV 69
Query: 543 DDFKAL--VLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
           ++   L  V EYM  GSL  +L S    +L     L   +DV  A+EYL   +    +H 
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           DL + NVL+ ED +A +SDFG+ K     + S TQ      + + APE   E+K ST+SD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 660 IYSYGIMLIETFT 672
           ++S+GI+L E ++
Sbjct: 182 VWSFGILLWEIYS 194

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 134/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           Y+D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V E M NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG++++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 631 SMTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 103/193 (53%), Gaps = 15/193 (7%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V   +   G +VA+K    +     ++F  E  VM  +RH NLV+++ G   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL-GVIV 84
Query: 543 DDFKAL--VLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
           ++   L  V EYM  GSL  +L S    +L     L   +DV  A+EYL   +    +H 
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           DL + NVL+ ED +A +SDFG+ K     + S TQ      + + APE   E+K ST+SD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 660 IYSYGIMLIETFT 672
           ++S+GI+L E ++
Sbjct: 197 VWSFGILLWEIYS 209

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 74
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 131
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A + S    S    Q   +I +MAPE      +   S +SD
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 192 VYAFGIVLYELMTGQLP 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 76
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 133
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A + S    S    Q   +I +MAPE      +   S +SD
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 193
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 194 VYAFGIVLYELMTGQLP 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 79
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 136
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A + S    S    Q   +I +MAPE      +   S +SD
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 197 VYAFGIVLYELMTGQLP 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 79
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 136
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A + S    S    Q   +I +MAPE      +   S +SD
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 197 VYAFGIVLYELMTGQLP 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 538 SGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL    T  
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 135
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGIERK 653
            IH +L + N+L++ +    + DFG+ K+L  +D+   + +    + I + APE   E K
Sbjct: 136 YIHRNLATRNILVENENRVKIGDFGLTKVLP-QDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 654 VSTRSDIYSYGIMLIETFT 672
            S  SD++S+G++L E FT
Sbjct: 195 FSVASDVWSFGVVLYELFT 213

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 103/193 (53%), Gaps = 15/193 (7%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V   +   G +VA+K    +     ++F  E  VM  +RH NLV+++ G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL-GVIV 256
Query: 543 DDFKAL--VLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
           ++   L  V EYM  GSL  +L S    +L     L   +DV  A+EYL   +    +H 
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           DL + NVL+ ED +A +SDFG+ K     + S TQ      + + APE   E+K ST+SD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 660 IYSYGIMLIETFT 672
           ++S+GI+L E ++
Sbjct: 369 VWSFGILLWEIYS 381

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 102
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 159
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A + S    S    Q   +I +MAPE      +   S +SD
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 220 VYAFGIVLYELMTGQLP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 101
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 158
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A + S    S    Q   +I +MAPE      +   S +SD
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 218
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 219 VYAFGIVLYELMTGQLP 235

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 74
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 131
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A + S    S    Q   +I +MAPE      +   S +SD
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 192 VYAFGIVLYELMTGQLP 208

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V+     +  +VAIK   +E A + + F  E EVM  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                LV E+M +G L  +L +   +      L + +DV   + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ E+ +  +SDFG+ + +  +DQ  + T T   + + +PE     + S++SD++S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 663 YGIMLIETFTRKK 675
           +G+++ E F+  K
Sbjct: 190 FGVLMWEVFSEGK 202

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 90
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L++S    ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLK 147
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED    + DFG+A   S    S    Q   +I +MAPE          S +SD
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 208 VYAFGIVLYELMTGQLP 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 113/223 (50%), Gaps = 22/223 (9%)
Query: 467 YQDLSRATNRFGRD---------NLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           Y+D +RA ++F ++          +IG G FG V    L       + VAIK   V + E
Sbjct: 26  YEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N+V +    +      +V+E+M NG+LD FL        
Sbjct: 86  KQR--RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +A+ + YL        +H DL + N+L++ +++  +SDFG+++++  + +
Sbjct: 144 VIQLVGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 631 SM-TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           ++ T T     + + APE    RK ++ SD++SYGI++ E  +
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V+     +  +VAIK   +E A + + F  E EVM  + H  LV++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                LV E+M +G L  +L +   +      L + +DV   + YL       +IH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ E+ +  +SDFG+ + +  +DQ  + T T   + + +PE     + S++SD++S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 663 YGIMLIETFTRKK 675
           +G+++ E F+  K
Sbjct: 193 FGVLMWEVFSEGK 205

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 134/284 (47%), Gaps = 43/284 (15%)
Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQE 510
           ++D ++  + F +         D ++G G FG V    L       I VAIK   V + E
Sbjct: 28  FEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD 570
             R  + F  E  +M    H N++++    +      +V E M NGSLD FL        
Sbjct: 88  KQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q + ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG++++L  + +
Sbjct: 146 VIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 631 SMTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
           +   T+     I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M   +    
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---- 258
Query: 689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
                     +++ V++    PP  D      C  +++ L ++C
Sbjct: 259 ----------VIKAVDEGYRLPPPMD------CPAALYQLMLDC 286

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V+     +  +VAIK   +E A + + F  E EVM  + H  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                LV E+M +G L  +L +   +      L + +DV   + YL       +IH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ E+ +  +SDFG+ + +  +DQ  + T T   + + +PE     + S++SD++S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 663 YGIMLIETFTRKK 675
           +G+++ E F+  K
Sbjct: 190 FGVLMWEVFSEGK 202

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 74
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 131
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A   S    S    Q   +I +MAPE      +   S +SD
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 192 VYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 94
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 151
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A   S    S    Q   +I +MAPE      +   S +SD
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 211
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 212 VYAFGIVLYELMTGQLP 228

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 5/212 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+  +E + +   F  E +VM N+ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                ++ EYM NG L  +L          Q L +  DV  A+EYL    +   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 663 YGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
           +G+++ E ++  K   + F    + +H   GL
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 90
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L++S    ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLK 147
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED    + DFG+A   S    S    Q   +I +MAPE          S +SD
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 208 VYAFGIVLYELMTGQLP 224

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V+     +  +VAIK   +E A + + F  E EVM  + H  LV++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                LV E+M +G L  +L +   +      L + +DV   + YL       +IH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ E+ +  +SDFG+ + +  +DQ  + T T   + + +PE     + S++SD++S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 663 YGIMLIETFTRKK 675
           +G+++ E F+  K
Sbjct: 188 FGVLMWEVFSEGK 200

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 126/262 (48%), Gaps = 34/262 (12%)
Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIK---VFHQECARAMKSFEVECEVMKNIRHRN 532
           D ++G G FG V    L       I VAIK   V + E  R  + F  E  +M    H N
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPN 78
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           ++++    +      +V E M NGSLD FL        + Q + ++  +AS ++YL+   
Sbjct: 79  IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--- 135
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT-IGYMAPEYGIE 651
               +H DL + N+L++ +++  +SDFG++++L  + ++   T+     I + +PE    
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 652 RKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP 710
           RK ++ SD++SYGI+L E  +  ++P  +M   +              +++ V++    P
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------------VIKAVDEGYRLP 241
Query: 711 PEKDFAAKEQCVLSIFSLAMEC 732
           P  D      C  +++ L ++C
Sbjct: 242 PPMD------CPAALYQLMLDC 257

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG GSFG VYK +    + V +        + +++F+ E  V++  RH N++ +  G S 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGYST 102
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
               A+V ++    SL   L+      ++ + ++I    A  ++YL   H   IIH DLK
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLK 159
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRSD 659
           S+N+ L ED+   + DFG+A   S    S    Q   +I +MAPE      +   S +SD
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 219
Query: 660 IYSYGIMLIETFTRKKP 676
           +Y++GI+L E  T + P
Sbjct: 220 VYAFGIVLYELMTGQLP 236

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 480 DNLIGIGSFGYVYKAELDDGIE----VAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLV 534
           + +IG G FG V +  L    +    VAIK        R  + F  E  +M    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++    +N     ++ E+M NG+LD FL  +     + Q + ++  +AS + YL      
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEM 137
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA---TIGYMAPEYGIE 651
             +H DL + N+L++ +++  +SDFG+++ L       T+T +L     I + APE    
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 652 RKVSTRSDIYSYGIMLIETFT 672
           RK ++ SD +SYGI++ E  +
Sbjct: 198 RKFTSASDAWSYGIVMWEVMS 218

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 5/193 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V+     +  +VAIK   +E A + + F  E EVM  + H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                LV E+M +G L  +L +   +      L + +DV   + YL       +IH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ E+ +  +SDFG+ + +  +DQ  + T T   + + +PE     + S++SD++S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 663 YGIMLIETFTRKK 675
           +G+++ E F+  K
Sbjct: 191 FGVLMWEVFSEGK 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 5/212 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+  +E + +   F  E +VM N+ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                ++ EYM NG L  +L          Q L +  DV  A+EYL    +   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 663 YGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
           +G+++ E ++  K   + F    + +H   GL
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/193 (35%), Positives = 101/193 (52%), Gaps = 15/193 (7%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V   +   G +VA+K    +     ++F  E  VM  +RH NLV+++ G   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL-GVIV 75
Query: 543 DDFKAL--VLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
           ++   L  V EYM  GSL  +L S    +L     L   +DV  A+EYL   +    +H 
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           DL + NVL+ ED +A +SDFG+ K     + S TQ      + + APE   E   ST+SD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKSD 187
Query: 660 IYSYGIMLIETFT 672
           ++S+GI+L E ++
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 114/224 (50%), Gaps = 24/224 (10%)
Query: 467 YQDLSRATNRFGRD---------NLIGIGSFGYVY--------KAELDDGIEVAIKVFHQ 509
           Y+D ++A + F ++          +IG G FG V         K EL   I+  +KV + 
Sbjct: 5   YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKT-LKVGYT 63
Query: 510 ECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCML 569
           E  R  + F  E  +M    H N++ +    +      +V EYM NGSLD FL  +    
Sbjct: 64  EKQR--RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF 121
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
            + Q + ++  +++ ++YL+       +H DL + N+L++ +++  +SDFG++++L  + 
Sbjct: 122 TVIQLVGMLRGISAGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 178
Query: 630 QSMTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           ++   T+     I + APE    RK ++ SD++SYGI++ E  +
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 98/193 (50%), Gaps = 5/193 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V+     +  +VAIK   +E + +   F  E EVM  + H  LV++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                LV E+M +G L  +L +   +      L + +DV   + YL       +IH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 150
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ E+ +  +SDFG+ + +  +DQ  + T T   + + +PE     + S++SD++S
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 663 YGIMLIETFTRKK 675
           +G+++ E F+  K
Sbjct: 210 FGVLMWEVFSEGK 222

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 5/212 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+  +E + +   F  E +VM N+ H  LV++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                ++ EYM NG L  +L          Q L +  DV  A+EYL    +   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 663 YGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
           +G+++ E ++  K   + F    + +H   GL
Sbjct: 198 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 229

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKI---- 536
           +G G FGYV +    D G +VAIK   QE + +  + + +E ++MK + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 537 --ISGCSNDDFKALVLEYMPNGSLDIFL--YSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
             +   + +D   L +EY   G L  +L  + + C L       ++ D++SAL YL   H
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---H 138
Query: 593 TTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
              IIH DLK  N++L    + +I  + D G AK L   DQ    T+ + T+ Y+APE  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELL 195
Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP 676
            ++K +   D +S+G +  E  T  +P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKI---- 536
           +G G FGYV +    D G +VAIK   QE + +  + + +E ++MK + H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 537 --ISGCSNDDFKALVLEYMPNGSLDIFL--YSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
             +   + +D   L +EY   G L  +L  + + C L       ++ D++SAL YL   H
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---H 139
Query: 593 TTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
              IIH DLK  N++L    + +I  + D G AK L   DQ    T+ + T+ Y+APE  
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELL 196
Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP 676
            ++K +   D +S+G +  E  T  +P
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 5/212 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+  +E + +   F  E +VM N+ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                ++ EYM NG L  +L          Q L +  DV  A+EYL    +   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 663 YGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
           +G+++ E ++  K   + F    + +H   GL
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 123/264 (46%), Gaps = 29/264 (10%)
Query: 476 RFGRDNLIGIGSFGYVYKAELDD---GIEVAIKVFH---QECARAMKSFEVECEVMKNIR 529
           R+   + +G G    VY AE  D    I+VAIK      +E    +K FE E      + 
Sbjct: 12  RYKIVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H+N+V +I     DD   LV+EY+   +L  ++  S   L +   +N    +   L+ + 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQI---LDGIK 125
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT-QTLATIGYMAPEY 648
             H   I+H D+K  N+L+D +    + DFGIAK LS  + S+TQT   L T+ Y +PE 
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQ 183
Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL----------LPVS 698
                    +DIYS GI+L E    + P +   A  +++KH  + +          +P S
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 699 LMEVVNKTLLSPPEKDFAAKEQCV 722
           L  V+    L   EKD A + + +
Sbjct: 244 LSNVI----LRATEKDKANRYKTI 263

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 5/212 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+  +E + +   F  E +VM N+ H  LV++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                ++ EYM NG L  +L          Q L +  DV  A+EYL    +   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 663 YGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
           +G+++ E ++  K   + F    + +H   GL
Sbjct: 191 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 222

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 121/243 (49%), Gaps = 18/243 (7%)
Query: 450 LSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAI 504
           L+  G   +QA  R L   +L R         ++G G+FG VYK   + +G    I VAI
Sbjct: 20  LTPSGTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAI 72
Query: 505 KVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY 563
           K+ ++    +A   F  E  +M ++ H +LV+++  C +   + LV + MP+G L  +++
Sbjct: 73  KILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH 131
Query: 564 SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK 623
                +     LN  + +A  + YL  R    ++H DL + NVL+       ++DFG+A+
Sbjct: 132 EHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 188
Query: 624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFA 682
           LL G+++          I +MA E    RK + +SD++SYG+ + E  T   KP D +  
Sbjct: 189 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 248
Query: 683 AEL 685
            E+
Sbjct: 249 REI 251

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 467 YQDLSRATNRFGRD---------NLIGIGSFGYVYKAELD----DGIEVAIKVFHQ-ECA 512
           ++D ++A   F ++          +IG+G FG V    L       I VAIK        
Sbjct: 12  FEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF 572
           +  + F  E  +M    H N++ +    +      ++ EYM NGSLD FL  +     + 
Sbjct: 72  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI 131
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM 632
           Q + ++  + S ++YL+       +H DL + N+L++ +++  +SDFG++++L  + ++ 
Sbjct: 132 QLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA 188
Query: 633 TQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             T+     I + APE    RK ++ SD++SYGI++ E  +
Sbjct: 189 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 480 DNLIGIGSFGYVYKAELDDGIE----VAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLV 534
           + +IG G FG V +  L    +    VAIK        R  + F  E  +M    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++    +N     ++ E+M NG+LD FL  +     + Q + ++  +AS + YL      
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEM 135
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA---TIGYMAPEYGIE 651
             +H DL + N+L++ +++  +SDFG+++ L       T T +L     I + APE    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 652 RKVSTRSDIYSYGIMLIETFT 672
           RK ++ SD +SYGI++ E  +
Sbjct: 196 RKFTSASDAWSYGIVMWEVMS 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 5/212 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+  +E + +   F  E +VM N+ H  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                ++ EYM NG L  +L          Q L +  DV  A+EYL    +   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 663 YGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
           +G+++ E ++  K   + F    + +H   GL
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 223

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 133/284 (46%), Gaps = 36/284 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 143
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRS 658
           +++N+L+ + +   ++DFG+A+L+   + +  +      I + APE   YG     + +S
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGT---FTIKS 199
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                   +G +P   M   N  ++   E+ +   
Sbjct: 200 DVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRMV 238
Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
             + C   ++ L   C  E PE R        VL + F +   +
Sbjct: 239 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 282

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 5/212 (2%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+  +E + +   F  E +VM N+ H  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                ++ EYM NG L  +L          Q L +  DV  A+EYL    +   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 663 YGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
           +G+++ E ++  K   + F    + +H   GL
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 13/214 (6%)
Query: 469 DLSRATNRF-GRDNLIGIGSFGYV----YKAELDD-GIEVAIKVFHQECA-RAMKSFEVE 521
           D +    RF  R   +G G FG V    Y  E D+ G +VA+K    E     +   + E
Sbjct: 14  DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 73
Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E+++N+ H N+VK    C+ D      L++E++P+GSL  +L  +   +++ Q+L   +
Sbjct: 74  IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV 133
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT-QTQTL 638
            +   ++YL  R     +H DL + NVL++ +    + DFG+ K +  + +  T +    
Sbjct: 134 QICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 190
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + + + APE  ++ K    SD++S+G+ L E  T
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 145
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++N+L+ + +   ++DFG+A+L+  ED   T  +     I + APE   YG     + +
Sbjct: 146 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGT---FTIK 200
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF-- 715
           SD++S+GI+L E  T                   +G +P   M   N  ++   E+ +  
Sbjct: 201 SDVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRM 239
Query: 716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
              + C   ++ L   C  E PE R        VL + F +   +
Sbjct: 240 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 284

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 133/284 (46%), Gaps = 36/284 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 141
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRS 658
           +++N+L+ + +   ++DFG+A+L+   + +  +      I + APE   YG     + +S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGT---FTIKS 197
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                   +G +P   M   N  ++   E+ +   
Sbjct: 198 DVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRMV 236
Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
             + C   ++ L   C  E PE R        VL + F +   +
Sbjct: 237 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 280

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 133/285 (46%), Gaps = 36/285 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 144
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRS 658
           +++N+L+ + +   ++DFG+A+L+   + +  +      I + APE   YG     + +S
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGT---FTIKS 200
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                   +G +P   M   N  ++   E+ +   
Sbjct: 201 DVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRMV 239
Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSEL 761
             + C   ++ L   C  E PE R        VL + F +   + 
Sbjct: 240 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQF 284

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 20/223 (8%)
Query: 467 YQDLSRATNRFGRD---------NLIGIGSFGYVYKAELD----DGIEVAIKVFHQ-ECA 512
           ++D + A   F ++          +IG G FG V    L       I VAIK        
Sbjct: 16  FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 75
Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF 572
           +  + F  E  +M    H N++ +    +      ++ E+M NGSLD FL  +     + 
Sbjct: 76  KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 135
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM 632
           Q + ++  +A+ ++YL        +H DL + N+L++ +++  +SDFG+++ L  +    
Sbjct: 136 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 192
Query: 633 TQTQTLA---TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           T T  L     I + APE    RK ++ SD++SYGI++ E  +
Sbjct: 193 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 13/214 (6%)
Query: 469 DLSRATNRF-GRDNLIGIGSFGYV----YKAELDD-GIEVAIKVFHQECA-RAMKSFEVE 521
           D +    RF  R   +G G FG V    Y  E D+ G +VA+K    E     +   + E
Sbjct: 2   DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 61
Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E+++N+ H N+VK    C+ D      L++E++P+GSL  +L  +   +++ Q+L   +
Sbjct: 62  IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV 121
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT-QTQTL 638
            +   ++YL  R     +H DL + NVL++ +    + DFG+ K +  + +  T +    
Sbjct: 122 QICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRD 178
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + + + APE  ++ K    SD++S+G+ L E  T
Sbjct: 179 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 134/303 (44%), Gaps = 56/303 (18%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYVYKAE------LDDGIEVAIKVFHQECARAMKS-FEVE 521
           +  R    + RD  IG G+FG V++A        +    VA+K+  +E +  M++ F+ E
Sbjct: 43  EYPRNNIEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100
Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS----STCMLD------- 570
             +M    + N+VK++  C+      L+ EYM  G L+ FL S    + C L        
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 571 ------------IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD 618
                         ++L I   VA+ + YL+ R     +H DL + N L+ E+M+  ++D
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIAD 217
Query: 619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK-KPA 677
           FG+++ +   D           I +M PE     + +T SD+++YG++L E F+   +P 
Sbjct: 218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 678 DKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELP 737
             M   E+             +  V +  +L+ P       E C L +++L   C  +LP
Sbjct: 278 YGMAHEEV-------------IYYVRDGNILACP-------ENCPLELYNLMRLCWSKLP 317
Query: 738 EKR 740
             R
Sbjct: 318 ADR 320

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 133/284 (46%), Gaps = 36/284 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRS 658
           +++N+L+ + +   ++DFG+A+L+   + +  +      I + APE   YG     + +S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGT---FTIKS 191
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                   +G +P   M   N  ++   E+ +   
Sbjct: 192 DVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRMV 230
Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
             + C   ++ L   C  E PE R        VL + F +   +
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 138/286 (48%), Gaps = 28/286 (9%)
Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           ++G G++G VY   +L + + +AIK   +  +R  +    E  + K+++H+N+V+ +   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           S + F  + +E +P GSL   L S    L   ++  I       LE L + H   I+H D
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 601 LKSSNVLLDE-DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE--RKVSTR 657
           +K  NVL++    +  +SDFG +K L+G +   T+T T  T+ YMAPE   +  R     
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEIIDKGPRGYGKA 205
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA 717
           +DI+S G  +IE  T K P  ++   + +       +  V + +V  +     PE   A 
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAA-------MFKVGMFKVHPEI----PESMSAE 254
Query: 718 KEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELYK 763
            +  +L       +C    P+KR    C N +L ++F+  SS+  K
Sbjct: 255 AKAFIL-------KCFEPDPDKRA---CANDLLVDEFLKVSSKKKK 290

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLV 534
           + +IG+G FG V    L       I VAIK        +  + F  E  +M    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +    +      ++ EYM NGSLD FL  +     + Q + ++  + S ++YL+     
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT-IGYMAPEYGIERK 653
             +H DL + N+L++ +++  +SDFG++++L  + ++   T+     I + APE    RK
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 654 VSTRSDIYSYGIMLIETFT 672
            ++ SD++SYGI++ E  +
Sbjct: 196 FTSASDVWSYGIVMWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLV 534
           + +IG+G FG V    L       I VAIK        +  + F  E  +M    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +    +      ++ EYM NGSLD FL  +     + Q + ++  + S ++YL+     
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT-IGYMAPEYGIERK 653
             +H DL + N+L++ +++  +SDFG++++L  + ++   T+     I + APE    RK
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 654 VSTRSDIYSYGIMLIETFT 672
            ++ SD++SYGI++ E  +
Sbjct: 190 FTSASDVWSYGIVMWEVMS 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 132/280 (47%), Gaps = 36/280 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 137
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRS 658
           +++N+L+ + +   ++DFG+A+L+   + +  +      I + APE   YG     + +S
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGT---FTIKS 193
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                   +G +P   M   N  ++   E+ +   
Sbjct: 194 DVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRMV 232
Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS 756
             + C   ++ L   C  E PE R        VL + F +
Sbjct: 233 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 272

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 133/283 (46%), Gaps = 38/283 (13%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 140
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++N+L+ + +   ++DFG+A+L+  ED   T  +     I + APE   YG     + +
Sbjct: 141 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGT---FTIK 195
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF-- 715
           SD++S+GI+L E  T                   +G +P   M   N  ++   E+ +  
Sbjct: 196 SDVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRM 234
Query: 716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS 758
              + C   ++ L   C  E PE R        VL + F +  
Sbjct: 235 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 277

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 132/280 (47%), Gaps = 36/280 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 136
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRS 658
           +++N+L+ + +   ++DFG+A+L+   + +  +      I + APE   YG     + +S
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGT---FTIKS 192
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                   +G +P   M   N  ++   E+ +   
Sbjct: 193 DVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRMV 231
Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS 756
             + C   ++ L   C  E PE R        VL + F +
Sbjct: 232 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 271

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 141
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++N+L+ + +   ++DFG+A+L+  ED   T  +     I + APE   YG     + +
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGT---FTIK 196
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF-- 715
           SD++S+GI+L E  T                   +G +P   M   N  ++   E+ +  
Sbjct: 197 SDVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRM 235
Query: 716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS 756
              + C   ++ L   C  E PE R        VL + F +
Sbjct: 236 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 276

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 132/280 (47%), Gaps = 36/280 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRS 658
           +++N+L+ + +   ++DFG+A+L+   + +  +      I + APE   YG     + +S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGT---FTIKS 191
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                   +G +P   M   N  ++   E+ +   
Sbjct: 192 DVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRMV 230
Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS 756
             + C   ++ L   C  E PE R        VL + F +
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++N+L+ + +   ++DFG+A+L+  ED   T  +     I + APE   YG     + +
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGT---FTIK 190
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF-- 715
           SD++S+GI+L E  T                   +G +P   M   N  ++   E+ +  
Sbjct: 191 SDVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRM 229
Query: 716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS 756
              + C   ++ L   C  E PE R        VL + F +
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 130
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++N+L+ + +   ++DFG+A+L+  ED   T  +     I + APE   YG     + +
Sbjct: 131 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGT---FTIK 185
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF-- 715
           SD++S+GI+L E  T                   +G +P   M   N  ++   E+ +  
Sbjct: 186 SDVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRM 224
Query: 716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS 756
              + C   ++ L   C  E PE R        VL + F +
Sbjct: 225 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKIISGC 540
           IG G+FG V+   L  D   VA+K   +     +K+ F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +      +V+E +  G    FL +    L +   L ++ D A+ +EYL    +   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTR 657
           L + N L+ E  +  +SDFG+++  +    + +       + + APE   YG   + S+ 
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG---RYSSE 295
Query: 658 SDIYSYGIMLIETFT 672
           SD++S+GI+L ETF+
Sbjct: 296 SDVWSFGILLWETFS 310

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 103/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    +++E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 137
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 197 WAFGVLLWEIAT 208

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           + ++G G+FG V KA+     +VAIK    E  R  K+F VE   +  + H N+VK+   
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCM--LDIFQRLNIMIDVASALEYLNFRHTTPII 597
           C N     LV+EY   GSL   L+ +  +        ++  +  +  + YL+      +I
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 598 HCDLKSSNVLL-DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           H DLK  N+LL     +  + DFG A      D     T    +  +MAPE       S 
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 183
Query: 657 RSDIYSYGIMLIETFTRKKPADKM 680
           + D++S+GI+L E  TR+KP D++
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEI 207

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 28/279 (10%)
Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           ++G G++G VY   +L + + +AIK   +  +R  +    E  + K+++H+N+V+ +   
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           S + F  + +E +P GSL   L S    L   ++  I       LE L + H   I+H D
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQIVHRD 133
Query: 601 LKSSNVLLDE-DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE--RKVSTR 657
           +K  NVL++    +  +SDFG +K L+G +   T+T T  T+ YMAPE   +  R     
Sbjct: 134 IKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEIIDKGPRGYGKA 191
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA 717
           +DI+S G  +IE  T K P  ++   + +       +  V + +V  +     PE   A 
Sbjct: 192 ADIWSLGCTIIEMATGKPPFYELGEPQAA-------MFKVGMFKVHPEI----PESMSAE 240
Query: 718 KEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS 756
            +  +L       +C    P+KR    C N +L ++F+ 
Sbjct: 241 AKAFIL-------KCFEPDPDKR---ACANDLLVDEFLK 269

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 32/282 (11%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+ A  +   +VA+K   +  + ++++F  E  VMK ++H  LVK+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL-EYLNFRHTTPIIHCDL 601
           +    ++ E+M  GSL  FL S        Q L  +ID ++ + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRSDI 660
           +++N+L+   ++  ++DFG+A+++  ED   T  +     I + APE       + +SD+
Sbjct: 311 RAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAK 718
           +S+GI+L+E  T                    G +P   M   N  ++   E+ +     
Sbjct: 369 WSFGILLMEIVT-------------------YGRIPYPGMS--NPEVIRALERGYRMPRP 407
Query: 719 EQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
           E C   ++++ M C    PE+R   +    VL + + +  S+
Sbjct: 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           + ++G G+FG V KA+     +VAIK    E  R  K+F VE   +  + H N+VK+   
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCM--LDIFQRLNIMIDVASALEYLNFRHTTPII 597
           C N     LV+EY   GSL   L+ +  +        ++  +  +  + YL+      +I
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 598 HCDLKSSNVLL-DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           H DLK  N+LL     +  + DFG A      D     T    +  +MAPE       S 
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 657 RSDIYSYGIMLIETFTRKKPADKM 680
           + D++S+GI+L E  TR+KP D++
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEI 206

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 118/243 (48%), Gaps = 29/243 (11%)
Query: 453 GGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVF---- 507
           G +  S+  K RLP    + A N    +  IG G FG V+K  L  D   VAIK      
Sbjct: 1   GAMGGSEFPKSRLP----TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 508 ---HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS 564
                E     + F+ E  +M N+ H N+VK+     N     +V+E++P G L   L  
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114
Query: 565 STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL---LDED--MIAHLSDF 619
               +    +L +M+D+A  +EY+      PI+H DL+S N+    LDE+  + A ++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 620 GIAKLLSGEDQSM-TQTQTLATIGYMAPE-YGIERKVST-RSDIYSYGIMLIETFTRKKP 676
           G+++      QS+ + +  L    +MAPE  G E +  T ++D YS+ ++L    T + P
Sbjct: 174 GLSQ------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 677 ADK 679
            D+
Sbjct: 228 FDE 230

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 119/239 (49%), Gaps = 18/239 (7%)
Query: 454 GILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFH 508
           G   +QA  R L   +L R         ++G G+FG VYK   + +G    I VAIK+ +
Sbjct: 1   GTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN 53
Query: 509 QECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC 567
           +    +A   F  E  +M ++ H +LV+++  C +   + LV + MP+G L  +++    
Sbjct: 54  ETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD 112
Query: 568 MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG 627
            +     LN  + +A  + YL  R    ++H DL + NVL+       ++DFG+A+LL G
Sbjct: 113 NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 169
Query: 628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAEL 685
           +++          I +MA E    RK + +SD++SYG+ + E  T   KP D +   E+
Sbjct: 170 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G FG VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 134
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 103/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    +++E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 141
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 201 WAFGVLLWEIAT 212

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKIISGC 540
           IG G+FG V+   L  D   VA+K   +     +K+ F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +      +V+E +  G    FL +    L +   L ++ D A+ +EYL    +   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTR 657
           L + N L+ E  +  +SDFG+++  +    + +       + + APE   YG   + S+ 
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG---RYSSE 295
Query: 658 SDIYSYGIMLIETFT 672
           SD++S+GI+L ETF+
Sbjct: 296 SDVWSFGILLWETFS 310

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    +++E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 134
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 117/243 (48%), Gaps = 29/243 (11%)
Query: 453 GGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVF---- 507
           G +  S+  K RLP    + A N    +  IG G FG V+K  L  D   VAIK      
Sbjct: 1   GAMGGSEFPKSRLP----TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 508 ---HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS 564
                E     + F+ E  +M N+ H N+VK+     N     +V+E++P G L   L  
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114
Query: 565 STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL---LDED--MIAHLSDF 619
               +    +L +M+D+A  +EY+      PI+H DL+S N+    LDE+  + A ++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 620 GIAKLLSGEDQSM-TQTQTLATIGYMAPE-YGIERKVST-RSDIYSYGIMLIETFTRKKP 676
           G ++      QS+ + +  L    +MAPE  G E +  T ++D YS+ ++L    T + P
Sbjct: 174 GTSQ------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 677 ADK 679
            D+
Sbjct: 228 FDE 230

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 141
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 201 WAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    +++E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRNL 131
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++N+L+ + +   ++DFG+A+L+  ED   T  +     I + APE   YG     + +
Sbjct: 132 RAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGT---FTIK 186
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF-- 715
           SD++S+GI+L E  T                   +G +P   M   N  ++   E+ +  
Sbjct: 187 SDVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRM 225
Query: 716 AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS 756
              + C   ++ L   C  E PE R        VL + F +
Sbjct: 226 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 266

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 140
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 200 WAFGVLLWEIAT 211

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 8   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 67
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 68  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 126
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 127 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 233
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 234 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 261

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   +E    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRN 382
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 442 WAFGVLLWEIAT 453

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 100/192 (52%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY        + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    +V EYMP G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN---FIHRD 155
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE       S +SD+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 215 WAFGVLLWEIAT 226

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    +++E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 150
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 141
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 201 WAFGVLLWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 141
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 201 WAFGVLLWEIAT 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 132/284 (46%), Gaps = 36/284 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G  G V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 543 DDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + S   L I + L++   +A  + ++  R+    IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTRS 658
           +++N+L+ + +   ++DFG+A+L+   + +  +      I + APE   YG     + +S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP-IKWTAPEAINYGT---FTIKS 191
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--A 716
           D++S+GI+L E  T                   +G +P   M   N  ++   E+ +   
Sbjct: 192 DVWSFGILLTEIVT-------------------HGRIPYPGM--TNPEVIQNLERGYRMV 230
Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
             + C   ++ L   C  E PE R        VL + F +   +
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 65
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 125 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 231
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 232 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 259

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 480 DNLIGIGSFGYVYKAELD----DGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLV 534
           + +IG G FG V    L       I VAIK        +  + F  E  +M    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +    +      ++ E+M NGSLD FL  +     + Q + ++  +A+ ++YL      
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DM 128
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA---TIGYMAPEYGIE 651
             +H  L + N+L++ +++  +SDFG+++ L  +    T T  L     I + APE    
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 652 RKVSTRSDIYSYGIMLIETFT 672
           RK ++ SD++SYGI++ E  +
Sbjct: 189 RKFTSASDVWSYGIVMWEVMS 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 7   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 66
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 126 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 232
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 233 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 260

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 5   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 64
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 65  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNW 123
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 124 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 230
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 231 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 258

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 5   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 64
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 65  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 123
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 124 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 230
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 231 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 258

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 229
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 230 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 257

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 35  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 90
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 148
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 149 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+  S  SD+++ G ++ +
Sbjct: 207 TEKSASKSSDLWALGCIIYQ 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 138
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 198 WAFGVLLWEIAT 209

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 483 IGIGSFGYVYKAELDD-----GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVK-- 535
           +G G+FG V     D      G  VA+K          + F+ E +++K +    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 536 -IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +  G    + + LV+EY+P+G L  FL      LD  + L     +   +EYL  R   
Sbjct: 75  GVSYGPGRPELR-LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC- 132
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS-GEDQSMTQTQTLATIGYMAPEYGIERK 653
             +H DL + N+L++ +    ++DFG+AKLL   +D  + +    + I + APE   +  
Sbjct: 133 --VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 654 VSTRSDIYSYGIMLIETFT 672
            S +SD++S+G++L E FT
Sbjct: 191 FSRQSDVWSFGVVLYELFT 209

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 170
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 149
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 209 WAFGVLLWEIAT 220

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 26/209 (12%)
Query: 481 NLIGIGSFGYVYKAELD-DGI--EVAIKVFHQECARA-MKSFEVECEVMKNIRHR-NLVK 535
           ++IG G+FG V KA +  DG+  + AIK   +  ++   + F  E EV+  + H  N++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------LDIFQRLNIMID 580
           ++  C +  +  L +EY P+G+L  FL  S  +               L   Q L+   D
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  ++YL+ +     IH DL + N+L+ E+ +A ++DFG+++   G++  + +T     
Sbjct: 141 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 194
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           + +MA E       +T SD++SYG++L E
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 223

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 138
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 198 WAFGVLLWEIAT 209

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 26/209 (12%)
Query: 481 NLIGIGSFGYVYKAELD-DGI--EVAIKVFHQECARA-MKSFEVECEVMKNIRHR-NLVK 535
           ++IG G+FG V KA +  DG+  + AIK   +  ++   + F  E EV+  + H  N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------LDIFQRLNIMID 580
           ++  C +  +  L +EY P+G+L  FL  S  +               L   Q L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  ++YL+ +     IH DL + N+L+ E+ +A ++DFG+++   G++  + +T     
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           + +MA E       +T SD++SYG++L E
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 86
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------------YSSTCM 568
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L               ++    
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 569 LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L     ++    VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 141
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 201 WAFGVLLWEIAT 212

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 143
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   +E    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRN 343
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 403 WAFGVLLWEIAT 414

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 151
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 169
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 137
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 197 WAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   ++    L +   ++SA+EYL  ++    IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 138
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 198 WAFGVLLWEIAT 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 466 PYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV---- 520
           P Q   +    F    ++G GSF  V  A EL    E AIK+   E    +K  +V    
Sbjct: 1   PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVT 58
Query: 521 -ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E +VM  + H   VK+     +D+     L Y  NG L  ++       +   R     
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTA 117
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
           ++ SALEYL   H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + 
Sbjct: 118 EIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           T  Y++PE   E+     SD+++ G ++ +
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQ 204

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 22/263 (8%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMK---SFEVECEVMK 526
           S  ++R+    ++G G    V+ A +L D  +VA+KV   + AR       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 527 NIRHRNLVKIISGCSNDD----FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            + H  +V +      +        +V+EY+   +L   +++   M     +  I + +A
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IA 123
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATI 641
            A + LNF H   IIH D+K +N+++       + DFGIA+ ++    S+TQT   + T 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS--- 698
            Y++PE      V  RSD+YS G +L E  T + P        ++ +H     +P S   
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 699 ------LMEVVNKTLLSPPEKDF 715
                 L  VV K L   PE  +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRY 266

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 149
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 148
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 146
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 150
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K   ++    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 542 NDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+ LD     +   +     L +   ++SA+EYL  ++    IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 134
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++G D           I + APE     K S +SD+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 661 YSYGIMLIETFT 672
           +++G++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 127/265 (47%), Gaps = 32/265 (12%)
Query: 480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +  +G G FG V+ A  +   +VA+K   +  + ++++F  E  VMK ++H  LVK+ + 
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL-EYLNFRHTTPIIH 598
            + +    ++ E+M  GSL  FL S        Q L  +ID ++ + E + F      IH
Sbjct: 79  VTKEPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIH 134
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTR 657
            DL+++N+L+   ++  ++DFG+A+++  ED   T  +     I + APE       + +
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF-- 715
           SD++S+GI+L+E  T                    G +P   M   N  ++   E+ +  
Sbjct: 193 SDVWSFGILLMEIVT-------------------YGRIPYPGMS--NPEVIRALERGYRM 231
Query: 716 AAKEQCVLSIFSLAMECTMELPEKR 740
              E C   ++++ M C    PE+R
Sbjct: 232 PRPENCPEELYNIMMRCWKNRPEER 256

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 68  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 127
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YSSTCMLDIFQR 574
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L         YS     +  ++
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 575 LN------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L+          VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 188 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 19  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 78
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YSSTCMLDIFQR 574
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L         YS     +  ++
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 575 LN------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L+          VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 139 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 195
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  ++YL    +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---S 151
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 65
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 125 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 231
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 232 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 259

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 115/243 (47%), Gaps = 29/243 (11%)
Query: 453 GGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVF---- 507
           G +  S+  K RLP    + A N    +  IG G FG V+K  L  D   VAIK      
Sbjct: 1   GAMGGSEFPKSRLP----TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 508 ---HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS 564
                E     + F+ E  +M N+ H N+VK+     N     +V+E++P G L   L  
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114
Query: 565 STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL---LDED--MIAHLSDF 619
               +    +L +M+D+A  +EY+      PI+H DL+S N+    LDE+  + A ++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 620 GIAKLLSGEDQSM-TQTQTLATIGYMAPEY--GIERKVSTRSDIYSYGIMLIETFTRKKP 676
            +++      QS+ + +  L    +MAPE     E   + ++D YS+ ++L    T + P
Sbjct: 174 SLSQ------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 677 ADK 679
            D+
Sbjct: 228 FDE 230

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 16  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 75
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YSSTCMLDIFQR 574
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L         YS     +  ++
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 575 LN------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L+          VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 136 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 192
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNW 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 229
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 230 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 257

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 483 IGIGSFG----YVYKAELDD-GIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKI 536
           +G G FG    Y Y    D  G  VA+K   + C   ++S ++ E E+++ + H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 537 ISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
              C +   K+  LV+EY+P GSL  +L    C + + Q L     +   + YL+ +H  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHC-VGLAQLLLFAQQICEGMAYLHAQH-- 132
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERK 653
             IH  L + NVLLD D +  + DFG+AK +  G +    +    + + + APE   E K
Sbjct: 133 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 654 VSTRSDIYSYGIMLIETFT 672
               SD++S+G+ L E  T
Sbjct: 192 FYYASDVWSFGVTLYELLT 210

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 86
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YSSTCMLDIFQR 574
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L         YS     +  ++
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 575 LN------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L+          VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 483 IGIGSFG----YVYKAELDD-GIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKI 536
           +G G FG    Y Y    D  G  VA+K   + C   ++S ++ E E+++ + H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 537 ISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
              C +   K+  LV+EY+P GSL  +L    C+  + Q L     +   + YL+ +H  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLHAQH-- 131
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERK 653
             IH  L + NVLLD D +  + DFG+AK +  G +    +    + + + APE   E K
Sbjct: 132 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 654 VSTRSDIYSYGIMLIETFT 672
               SD++S+G+ L E  T
Sbjct: 191 FYYASDVWSFGVTLYELLT 209

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 20  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 79
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YSSTCMLDIFQR 574
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L         YS     +  ++
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 575 LN------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L+          VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 140 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 196
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 11  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 70
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 130 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 236
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 237 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 264

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 86
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YSSTCMLDIFQR 574
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L         YS     +  ++
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 575 LN------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L+          VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 22/263 (8%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMK---SFEVECEVMK 526
           S  ++R+    ++G G    V+ A +L D  +VA+KV   + AR       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 527 NIRHRNLVKIISGCSNDD----FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            + H  +V +      +        +V+EY+   +L   +++   M     +  I + +A
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IA 123
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATI 641
            A + LNF H   IIH D+K +N+++       + DFGIA+ ++    S+TQT   + T 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS--- 698
            Y++PE      V  RSD+YS G +L E  T + P        ++ +H     +P S   
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARH 243
Query: 699 ------LMEVVNKTLLSPPEKDF 715
                 L  VV K L   PE  +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRY 266

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------------YSSTCM 568
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L               ++    
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 569 LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L     ++    VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 35  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 90
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 148
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 149 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 207 TEKSAXKSSDLWALGCIIYQ 226

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 10  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 69
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 70  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 128
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 129 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 186 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 235
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 236 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 263

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 229
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 230 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 257

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 29  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 88
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 89  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 147
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 148 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 254
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 255 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 282

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 7   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 66
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 126 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 232
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 233 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 260

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 7   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 66
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 126 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 232
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 233 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 65
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG AKLL  E++       
Sbjct: 125 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 231
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 232 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 259

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 36/274 (13%)
Query: 479 RDNLI------GIGSFGYVYKAEL---DDGIEVAIKVFHQECARA-MKSFEVECEVMKNI 528
           RDNL+      G G+FG V +         I+VAIKV  Q   +A  +    E ++M  +
Sbjct: 8   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            +  +V++I  C  +    LV+E    G L  FL      + +     ++  V+  ++YL
Sbjct: 68  DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT-QTQTLATIGYMAPE 647
             ++    +H DL + NVLL     A +SDFG++K L  +D   T ++     + + APE
Sbjct: 127 EEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 648 YGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT 706
               RK S+RSD++SYG+ + E  +  +KP  KM   E+           ++ +E   K 
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----------MAFIE-QGKR 231
Query: 707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           +  PPE        C   +++L  +C +   E R
Sbjct: 232 MECPPE--------CPPELYALMSDCWIYKWEDR 257

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 483 IGIGSFGYVYKAELDD-----GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K          + F+ E +++K + H + +   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 77
Query: 538 SGCSNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            G S    +    LV+EY+P+G L  FL      LD  + L     +   +EYL  R   
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC- 136
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS-GEDQSMTQTQTLATIGYMAPEYGIERK 653
             +H DL + N+L++ +    ++DFG+AKLL   +D  + +    + I + APE   +  
Sbjct: 137 --VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 654 VSTRSDIYSYGIMLIETFT 672
            S +SD++S+G++L E FT
Sbjct: 195 FSRQSDVWSFGVVLYELFT 213

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 33/224 (14%)
Query: 479 RDNLI-----GIGSFGYVYKAE---LDDG-----IEVAIKVFHQECA-RAMKSFEVECEV 524
           RD L+     G G+FG V  AE   LD        +VA+K+   +   + +     E E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 86
Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------------YSSTCM 568
           MK I +H+N++ ++  C+ D    +++EY   G+L  +L               ++    
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 569 LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE 628
           L     ++    VA  +EYL    +   IH DL + NVL+ ED +  ++DFG+A+ +   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           D     T     + +MAPE   +R  + +SD++S+G++L E FT
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 483 IGIGSFGYVYKAELDD-----GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K          + F+ E +++K + H + +   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 76
Query: 538 SGCSNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            G S    +    LV+EY+P+G L  FL      LD  + L     +   +EYL  R   
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC- 135
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS-GEDQSMTQTQTLATIGYMAPEYGIERK 653
             +H DL + N+L++ +    ++DFG+AKLL   +D  + +    + I + APE   +  
Sbjct: 136 --VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 654 VSTRSDIYSYGIMLIETFT 672
            S +SD++S+G++L E FT
Sbjct: 194 FSRQSDVWSFGVVLYELFT 212

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 38  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 93
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 94  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 151
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 152 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 210 TEKSACKSSDLWALGCIIYQ 229

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 36  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 91
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 149
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 150 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 208 TEKSACKSSDLWALGCIIYQ 227

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 479 RDNLI------GIGSFGYVYKAEL---DDGIEVAIKVFHQECARA-MKSFEVECEVMKNI 528
           RDNL+      G G+FG V +         I+VAIKV  Q   +A  +    E ++M  +
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            +  +V++I  C  +    LV+E    G L  FL      + +     ++  V+  ++YL
Sbjct: 394 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT-QTQTLATIGYMAPE 647
             ++    +H +L + NVLL     A +SDFG++K L  +D   T ++     + + APE
Sbjct: 453 EEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 648 YGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT 706
               RK S+RSD++SYG+ + E  +  +KP  KM   E+           ++ +E   K 
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----------MAFIE-QGKR 557
Query: 707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ 753
           +  PPE        C   +++L  +C +   E R      +F+  EQ
Sbjct: 558 MECPPE--------CPPELYALMSDCWIYKWEDRP-----DFLTVEQ 591

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 13/230 (5%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELS 686
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 35  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 90
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 148
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 149 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 207 TEKSACKSSDLWALGCIIYQ 226

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 483 IGIGSFG----YVYKAELDD-GIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKI 536
           +G G FG    Y Y    D  G  VA+K    +C    +S ++ E ++++ + H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 537 ISGCSNDDFKAL--VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
              C +   K+L  V+EY+P GSL  +L   +  + + Q L     +   + YL+ +H  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH-- 137
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERK 653
             IH +L + NVLLD D +  + DFG+AK +  G +    +    + + + APE   E K
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 654 VSTRSDIYSYGIMLIETFTR 673
               SD++S+G+ L E  T 
Sbjct: 197 FYYASDVWSFGVTLYELLTH 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K          + F+ E +++K + H + +   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKY 89
Query: 538 SGCSNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            G S    +    LV+EY+P+G L  FL      LD  + L     +   +EYL  R   
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC- 148
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS-GEDQSMTQTQTLATIGYMAPEYGIERK 653
             +H DL + N+L++ +    ++DFG+AKLL   +D  + +    + I + APE   +  
Sbjct: 149 --VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 654 VSTRSDIYSYGIMLIETFT 672
            S +SD++S+G++L E FT
Sbjct: 207 FSRQSDVWSFGVVLYELFT 225

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/312 (24%), Positives = 141/312 (45%), Gaps = 43/312 (13%)
Query: 457 LSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQE-- 510
           +S   K +L  +D+     +F    ++G G FG V +A+L  +DG  ++VA+K+   +  
Sbjct: 7   ISDELKEKL--EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII 64
Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA------LVLEYMPNGSLDIFLYS 564
            +  ++ F  E   MK   H ++ K++        K       ++L +M +G L  FL +
Sbjct: 65  ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124
Query: 565 STCMLDIFQR-----LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF 619
           S    + F       +  M+D+A  +EYL+ R+    IH DL + N +L EDM   ++DF
Sbjct: 125 SRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADF 181
Query: 620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPAD 678
           G+++ +   D       +   + ++A E   +   +  SD++++G+ + E  TR + P  
Sbjct: 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 679 KMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPE 738
            +  AE+   + + G             L  PPE        C+  ++ L  +C    P+
Sbjct: 242 GIENAEI-YNYLIGG-----------NRLKQPPE--------CMEEVYDLMYQCWSADPK 281
Query: 739 KRINAKCCNFVL 750
           +R +  C    L
Sbjct: 282 QRPSFTCLRMEL 293

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 13/230 (5%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 7   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 66
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 125
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 126 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELS 686
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 483 IGIGSFG----YVYKAELDD-GIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKI 536
           +G G FG    Y Y    D  G  VA+K    +C    +S ++ E ++++ + H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 537 ISGCSNDDFKAL--VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
              C +   K+L  V+EY+P GSL  +L   +  + + Q L     +   + YL+ +H  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHSQH-- 137
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERK 653
             IH +L + NVLLD D +  + DFG+AK +  G +    +    + + + APE   E K
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 654 VSTRSDIYSYGIMLIETFTR 673
               SD++S+G+ L E  T 
Sbjct: 197 FYYASDVWSFGVTLYELLTH 216

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 36  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 91
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 149
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 150 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 208 TEKSACKSSDLWALGCIIYQ 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 35  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 90
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 148
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 149 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 207 TEKSACKSSDLWALGCIIYQ 226

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECARA-MKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +     +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 10  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 65
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 66  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 123
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 124 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 182 TEKSACKSSDLWALGCIIYQ 201

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 35  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 90
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 148
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 149 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 207 TEKSACKSSDLWALGCIIYQ 226

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  +++L    +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 210
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 12  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 67
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 68  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 125
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 126 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 184 TEKSACKSSDLWALGCIIYQ 203

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  +++L    +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 152
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAK-LLSGE-DQSMTQTQTLATIGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +L  E D    +T     + +MA E    
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 8   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 67
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 68  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 126
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG AKLL  E++       
Sbjct: 127 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 233
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 234 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 261

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 35  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 90
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 148
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 149 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 207 TEKSACKSSDLWALGCIIYQ 226

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 11  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 66
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 124
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 125 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 183 TEKSACKSSDLWALGCIIYQ 202

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 33  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 88
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 146
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 147 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 109/209 (52%), Gaps = 26/209 (12%)
Query: 481 NLIGIGSFGYVYKAELD-DGI--EVAIKVFHQECARA-MKSFEVECEVMKNIRHR-NLVK 535
           ++IG G+FG V KA +  DG+  + AIK   +  ++   + F  E EV+  + H  N++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------LDIFQRLNIMID 580
           ++  C +  +  L +EY P+G+L  FL  S  +               L   Q L+   D
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  ++YL+ +     IH +L + N+L+ E+ +A ++DFG+++   G++  + +T     
Sbjct: 148 VARGMDYLSQKQ---FIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 201
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           + +MA E       +T SD++SYG++L E
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  +++L    +
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 156
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 118/250 (47%), Gaps = 37/250 (14%)
Query: 453 GGILLSQATKRRLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAEL--------DDG 499
           G  +L+  ++  LP          F RD L     +G G FG V  AE          + 
Sbjct: 1   GSPMLAGVSEYELP----EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEA 56
Query: 500 IEVAIKVFHQECA-RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGS 557
           + VA+K+   +   + +     E E+MK I +H+N++ ++  C+ D    +++EY   G+
Sbjct: 57  VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 116
Query: 558 LDIFLYSS-----TCMLDI---------FQRL-NIMIDVASALEYLNFRHTTPIIHCDLK 602
           L  +L +          DI         F+ L +    +A  +EYL    +   IH DL 
Sbjct: 117 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLA 173
Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + NVL+ E+ +  ++DFG+A+ ++  D     T     + +MAPE   +R  + +SD++S
Sbjct: 174 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 233
Query: 663 YGIMLIETFT 672
           +G+++ E FT
Sbjct: 234 FGVLMWEIFT 243

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  +++L    +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 152
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 33  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 88
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 146
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 147 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 13/230 (5%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 65
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG AKLL  E++       
Sbjct: 125 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELS 686
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 24  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 83
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 84  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 116/263 (44%), Gaps = 22/263 (8%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMK---SFEVECEVMK 526
           S  ++R+    ++G G    V+ A +L D  +VA+KV   + AR       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 527 NIRHRNLVKIISGCSNDD----FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            + H  +V +      +        +V+EY+   +L   +++   M     +  I + +A
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IA 123
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATI 641
            A + LNF H   IIH D+K +N+L+       + DFGIA+ ++    S+ QT   + T 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS--- 698
            Y++PE      V  RSD+YS G +L E  T + P        ++ +H     +P S   
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 699 ------LMEVVNKTLLSPPEKDF 715
                 L  VV K L   PE  +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRY 266

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  +++L    +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 151
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 126/267 (47%), Gaps = 31/267 (11%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKSFEVECEVMKNI 528
             F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K    E  VM ++
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            + ++ +++  C     + L+ + MP G L  ++      +     LN  + +A  + YL
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
             R    ++H DL + NVL+       ++DFG+AKLL  E++          I +MA E 
Sbjct: 131 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 649 GIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL 707
            + R  + +SD++SYG+ + E  T   KP D + A+E+S           S++E   + L
Sbjct: 188 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SILE-KGERL 235
Query: 708 LSPPEKDFAAKEQCVLSIFSLAMECTM 734
             PP         C + ++ + ++C M
Sbjct: 236 PQPP--------ICTIDVYMIMVKCWM 254

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 33  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 88
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 146
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 147 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 110/226 (48%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 19  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 78
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +          DI     
Sbjct: 79  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  +++L    +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 151
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 13/230 (5%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 14  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 73
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 74  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 132
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 133 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELS 686
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 126/267 (47%), Gaps = 31/267 (11%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKSFEVECEVMKNI 528
             F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K    E  VM ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            + ++ +++  C     + L+ + MP G L  ++      +     LN  + +A  + YL
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
             R    ++H DL + NVL+       ++DFG+AKLL  E++          I +MA E 
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 649 GIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL 707
            + R  + +SD++SYG+ + E  T   KP D + A+E+S           S++E   + L
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SILE-KGERL 232
Query: 708 LSPPEKDFAAKEQCVLSIFSLAMECTM 734
             PP         C + ++ + ++C M
Sbjct: 233 PQPP--------ICTIDVYMIMVKCWM 251

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 32  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 87
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 145
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 146 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 204 TEKSACKSSDLWALGCIIYQ 223

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L  +DG  I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 535 KIISGCSNDDFKALV-LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   LV L YM +G L  F+ + T    +   +   + VA  +++L    +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---S 149
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT--IGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T A   + +MA E    
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
           +K +T+SD++S+G++L E  TR  P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    ++  +VA+K   +    ++++F  E  +MK ++H  LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-NIMIDVASALEYLNFRHTTPIIHCDL 601
           ++   ++ EYM  GSL  FL S      +  +L +    +A  + Y+  ++    IH DL
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 136
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++NVL+ E ++  ++DFG+A+++  ED   T  +     I + APE   +G     + +
Sbjct: 137 RAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGC---FTIK 191
Query: 658 SDIYSYGIMLIETFTRKK 675
           SD++S+GI+L E  T  K
Sbjct: 192 SDVWSFGILLYEIVTYGK 209

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 106/263 (40%), Gaps = 46/263 (17%)
Query: 503 AIKVFHQECARAM-------------KSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV 549
           AIKV H+E    M             ++F  E +VM+ + H N++K I     D     +
Sbjct: 26  AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD 609
            EY+  G+L   + S        QR++   D+AS + YL   H+  IIH DL S N L+ 
Sbjct: 86  TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVR 142
Query: 610 EDMIAHLSDFGIAKLLSGED---------QSMTQTQTLATIG---YMAPEYGIERKVSTR 657
           E+    ++DFG+A+L+  E          +   + +    +G   +MAPE    R    +
Sbjct: 143 ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK 202
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA 717
            D++S+GI+L E   R           +     V G L                  D   
Sbjct: 203 VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL------------------DRYC 244
Query: 718 KEQCVLSIFSLAMECTMELPEKR 740
              C  S F + + C    PEKR
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKR 267

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 32  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 87
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 145
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 146 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 204 TEKSACKSSDLWALGCIIYQ 223

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 17  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 72
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 73  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 130
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 131 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 189 TEKSACKSSDLWALGCIIYQ 208

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 94/395 (23%), Positives = 153/395 (38%), Gaps = 114/395 (28%)
Query: 35  DQQALLALEAHISYDPTNLLAQNWTSNTSVCN--WIGITCDVNS--HRVTALNISSLNLQ 90
           D+QALL ++  +  +PT L   +W   T  CN  W+G+ CD ++  +RV  L++S LNL 
Sbjct: 7   DKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 91  GEIP-----HEIGYL----------------PSLTKLAXXXXXXXXXXXXXXXXPSRIDL 129
              P       + YL                P++ KL                 P  +  
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS- 122
Query: 130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVI 189
            +  +  L  +YN  SGT+   I++   L  +   GN  SG IP++ G+   +       
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL------- 175
Query: 190 GLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPI 249
                           +++IS  RL       TG IP    NL++   +DL  N L G  
Sbjct: 176 --------------FTSMTISRNRL-------TGKIPPTFANLNL-AFVDLSRNMLEGDA 213
Query: 250 PVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK 309
            V FG  +N++                            +I+L++N+ + D+   +G  K
Sbjct: 214 SVLFGSDKNTQ----------------------------KIHLAKNSLAFDL-GKVGLSK 244
Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGXXXXXXXXXXXXXXXXXXXXXX 369
           ++  + L  NR+ G +P+    L  L  L++S N +                        
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC----------------------- 281
Query: 370 XGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQC 404
            GEIP+GG    F   ++  N+ LCG P   +P C
Sbjct: 282 -GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++  G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 11  PNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 70
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+++ MP G L  ++      +     LN 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 130 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 236
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 237 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 264

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF  V  A EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 40  KFGK--ILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 95
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 96  HPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 153
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 154 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 212 TEKSACKSSDLWALGCIIYQ 231

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG VYKA+  + G   A KV   +    ++ + VE E++    H  +VK++    
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVASALEYLNFRHTTPIIH 598
           +D    +++E+ P G++D        ML++ + L    I +     LE LNF H+  IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 132
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGI-----E 651
            DLK+ NVL+  +    L+DFG+    S ++    Q +   + T  +MAPE  +     +
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
                ++DI+S GI LIE    + P  ++    + LK
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 225

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE-----CARAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G +V I V   E       +A K 
Sbjct: 38  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKE 97
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 98  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 156
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 157 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 263
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 264 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 291

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 11  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 70
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG AKLL  E++       
Sbjct: 130 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 236
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 237 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 264

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG AKLL  E++       
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 229
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 230 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 257

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G VY A ++  G EVAI+  + +     +    E  VM+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
             +      D   +V+EY+  GSL   + + TCM D  Q   +  +   ALE+L   H+ 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSN 135
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +IH D+KS N+LL  D    L+DFG    ++ E     +++ + T  +MAPE    +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAY 193
Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + DI+S GIM IE    + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/318 (23%), Positives = 140/318 (44%), Gaps = 62/318 (19%)
Query: 456 LLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQ 509
           L++Q  + +L  +++S +  RF  +  +G   FG VYK  L      +    VAIK    
Sbjct: 11  LINQHKQAKL--KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 510 ECARAMKS-FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM 568
           +    ++  F  E  +   ++H N+V ++   + D   +++  Y  +G L  FL   +  
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 569 LDIFQR---------------LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
            D+                  ++++  +A+ +EYL+  H   ++H DL + NVL+ + + 
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR 673
             +SD G+ + +   D       +L  I +MAPE  +  K S  SDI+SYG++L E F+ 
Sbjct: 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS- 242
Query: 674 KKPADKMFAAELSLKHWVNGLLPV------SLMEVV-NKTLLSPPEKDFAAKEQCVLSIF 726
                              GL P        ++E++ N+ +L  P       + C   ++
Sbjct: 243 ------------------YGLQPYCGYSNQDVVEMIRNRQVLPCP-------DDCPAWVY 277
Query: 727 SLAMECTMELPEKRINAK 744
           +L +EC  E P +R   K
Sbjct: 278 ALMIECWNEFPSRRPRFK 295

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG VYKA+  + G   A KV   +    ++ + VE E++    H  +VK++    
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVASALEYLNFRHTTPIIH 598
           +D    +++E+ P G++D        ML++ + L    I +     LE LNF H+  IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVD------AIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGI-----E 651
            DLK+ NVL+  +    L+DFG+    S ++    Q +   + T  +MAPE  +     +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
                ++DI+S GI LIE    + P  ++    + LK
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 483 IGIGSFG----YVYKAELDD-GIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKI 536
           +G G FG    Y Y    D  G  VA+K    +     +S ++ E ++++ + H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 537 ISGCSNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
             GC  D   A   LV+EY+P GSL  +L   +  + + Q L     +   + YL+ +H 
Sbjct: 99  -KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH- 154
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIER 652
              IH DL + NVLLD D +  + DFG+AK +  G +    +    + + + APE   E 
Sbjct: 155 --YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 653 KVSTRSDIYSYGIMLIETFTR 673
           K    SD++S+G+ L E  T 
Sbjct: 213 KFYYASDVWSFGVTLYELLTH 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 476 RFGRDNLIGIGSFGY-VYKAELDDGIEVAIKVFHQECARAMKSFEV-----ECEVMKNIR 529
           +FG+  ++G GSF   V   EL    E AIK+   E    +K  +V     E +VM  + 
Sbjct: 33  KFGK--ILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLD 88
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H   VK+     +D+     L Y  NG L  ++       +   R     ++ SALEYL 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL- 146
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE  
Sbjct: 147 --HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E+     SD+++ G ++ +
Sbjct: 205 TEKSACKSSDLWALGCIIYQ 224

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 112/230 (48%), Gaps = 13/230 (5%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++G G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 65
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 124
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG AKLL  E++       
Sbjct: 125 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELS 686
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++ Y   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G VY A ++  G EVAI+  + +     +    E  VM+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
             +      D   +V+EY+  GSL   + + TCM D  Q   +  +   ALE+L   H+ 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSN 135
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +IH D+KS N+LL  D    L+DFG    ++ E     ++  + T  +MAPE    +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAY 193
Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + DI+S GIM IE    + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 133/306 (43%), Gaps = 60/306 (19%)
Query: 468 QDLSRATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKS-FEV 520
           +++S +  RF  +  +G   FG VYK  L      +    VAIK    +    ++  F  
Sbjct: 4   KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR------ 574
           E  +   ++H N+V ++   + D   +++  Y  +G L  FL   +   D+         
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 575 ---------LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL 625
                    ++++  +A+ +EYL+  H   ++H DL + NVL+ + +   +SD G+ + +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL 685
              D       +L  I +MAPE  +  K S  SDI+SYG++L E F+             
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS------------- 225
Query: 686 SLKHWVNGLLPV------SLMEVV-NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPE 738
                  GL P        ++E++ N+ +L  P       + C   +++L +EC  E P 
Sbjct: 226 ------YGLQPYCGYSNQDVVEMIRNRQVLPCP-------DDCPAWVYALMIECWNEFPS 272
Query: 739 KRINAK 744
           +R   K
Sbjct: 273 RRPRFK 278

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++  G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 11  PNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 70
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 130 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 236
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 237 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 264

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G VY A ++  G EVAI+  + +     +    E  VM+  ++ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
             +      D   +V+EY+  GSL   + + TCM D  Q   +  +   ALE+L   H+ 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSN 135
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +IH D+KS N+LL  D    L+DFG    ++ E QS   T  + T  +MAPE    +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAY 193
Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + DI+S GIM IE    + P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G VY A ++  G EVAI+  + +     +    E  VM+  ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
             +      D   +V+EY+  GSL   + + TCM D  Q   +  +   ALE+L   H+ 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSN 136
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +IH D+KS N+LL  D    L+DFG    ++ E     ++  + T  +MAPE    +  
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAY 194
Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + DI+S GIM IE    + P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 33/278 (11%)
Query: 466 PYQDLSR--ATNRFGRDNLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKS 517
           P Q L R      F +  ++  G+FG VYK   + +G    I VAIK   +  + +A K 
Sbjct: 4   PNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +     LN 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++       
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP 696
              I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E+S          
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------- 229
Query: 697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
            S++E   + L  PP         C + ++ + ++C M
Sbjct: 230 -SILE-KGERLPQPP--------ICTIDVYMIMVKCWM 257

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 33/226 (14%)
Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA-RAMKSFEVEC 522
           F RD L     +G G+FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91
Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCMLDI----- 571
           E+MK I +H+N++ ++  C+ D    +++ Y   G+L  +L +          DI     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 572 ----FQRL-NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
               F+ L +    +A  +EYL    +   IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 22/263 (8%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMK---SFEVECEVMK 526
           S  ++R+    ++G G    V+ A +L    +VA+KV   + AR       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 527 NIRHRNLVKIISGCSNDD----FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            + H  +V + +    +        +V+EY+   +L   +++   M     +  I + +A
Sbjct: 68  ALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IA 123
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATI 641
            A + LNF H   IIH D+K +N+++       + DFGIA+ ++    S+TQT   + T 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS--- 698
            Y++PE      V  RSD+YS G +L E  T + P        ++ +H     +P S   
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 699 ------LMEVVNKTLLSPPEKDF 715
                 L  VV K L   PE  +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRY 266

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 130/281 (46%), Gaps = 40/281 (14%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+ A  +   +VA+K   +  + ++++F  E  VMK ++H  LVK+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL-EYLNFRHTTPIIHCDL 601
           +    ++ E+M  GSL  FL S        Q L  +ID ++ + E + F      IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIY 661
           +++N+L+   ++  ++DFG+A++ +              I + APE       + +SD++
Sbjct: 305 RAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFGSFTIKSDVW 353
Query: 662 SYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF--AAKE 719
           S+GI+L+E  T                    G +P   M   N  ++   E+ +     E
Sbjct: 354 SFGILLMEIVT-------------------YGRIPYPGMS--NPEVIRALERGYRMPRPE 392
Query: 720 QCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
            C   ++++ M C    PE+R   +    VL + + +  S+
Sbjct: 393 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 433

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 116/263 (44%), Gaps = 22/263 (8%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMK---SFEVECEVMK 526
           S  ++R+    ++G G    V+ A +L    +VA+KV   + AR       F  E +   
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 527 NIRHRNLVKIISGCSNDD----FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            + H  +V +      +        +V+EY+   +L   +++   M     +  I + +A
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IA 123
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATI 641
            A + LNF H   IIH D+K +N+++       + DFGIA+ ++    S+TQT   + T 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS--- 698
            Y++PE      V  RSD+YS G +L E  T + P        ++ +H     +P S   
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 699 ------LMEVVNKTLLSPPEKDF 715
                 L  VV K L   PE  +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRY 266

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 116/263 (44%), Gaps = 22/263 (8%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMK---SFEVECEVMK 526
           S  ++R+    ++G G    V+ A +L    +VA+KV   + AR       F  E +   
Sbjct: 25  SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 84
Query: 527 NIRHRNLVKIISGCSNDD----FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            + H  +V +      +        +V+EY+   +L   +++   M     +  I + +A
Sbjct: 85  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IA 140
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATI 641
            A + LNF H   IIH D+K +N+++       + DFGIA+ ++    S+TQT   + T 
Sbjct: 141 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS--- 698
            Y++PE      V  RSD+YS G +L E  T + P        ++ +H     +P S   
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 260
Query: 699 ------LMEVVNKTLLSPPEKDF 715
                 L  VV K L   PE  +
Sbjct: 261 EGLSADLDAVVLKALAKNPENRY 283

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 107/198 (54%), Gaps = 14/198 (7%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    ++  +VA+K   +    ++++F  E  +MK ++H  LV++ +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-NIMIDVASALEYLNFRHTTPIIHCDL 601
           ++   ++ E+M  GSL  FL S      +  +L +    +A  + Y+  ++    IH DL
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 135
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE---YGIERKVSTR 657
           +++NVL+ E ++  ++DFG+A+++  ED   T  +     I + APE   +G     + +
Sbjct: 136 RAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGC---FTIK 190
Query: 658 SDIYSYGIMLIETFTRKK 675
           S+++S+GI+L E  T  K
Sbjct: 191 SNVWSFGILLYEIVTYGK 208

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++ R   IG G+ G VY A ++  G EVAI+  + +     +    E  VM+  ++ N+V
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
             +      D   +V+EY+  GSL   + + TCM D  Q   +  +   ALE+L   H+ 
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCM-DEGQIAAVCRECLQALEFL---HSN 136
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            +IH ++KS N+LL  D    L+DFG    ++ E QS   T  + T  +MAPE    +  
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAY 194
Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + DI+S GIM IE    + P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG VYKA+  +  +  A KV   +    ++ + VE +++ +  H N+VK++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVASALEYLNFRHTTPIIH 598
            ++   +++E+   G++D        ML++ + L    I +     L+ LN+ H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGI-----E 651
            DLK+ N+L   D    L+DFG+    S ++    Q +   + T  +MAPE  +     +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
           R    ++D++S GI LIE    + P  ++    + LK
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 251

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG VYKA+  +  +  A KV   +    ++ + VE +++ +  H N+VK++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVASALEYLNFRHTTPIIH 598
            ++   +++E+   G++D        ML++ + L    I +     L+ LN+ H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGI-----E 651
            DLK+ N+L   D    L+DFG+    S ++    Q +   + T  +MAPE  +     +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
           R    ++D++S GI LIE    + P  ++    + LK
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 251

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG VYKA+  +  +  A KV   +    ++ + VE +++ +  H N+VK++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVASALEYLNFRHTTPIIH 598
            ++   +++E+   G++D        ML++ + L    I +     L+ LN+ H   IIH
Sbjct: 105 YENNLWILIEFCAGGAVD------AVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT--LATIGYMAPEYGI-----E 651
            DLK+ N+L   D    L+DFG+    S ++    Q +   + T  +MAPE  +     +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
           R    ++D++S GI LIE    + P  ++    + LK
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 251

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRN 532
           F   NL+G GSF  VY+AE +  G+EVAIK+  ++    A  ++  + E ++   ++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           ++++ +   + ++  LVLE   NG ++ +L +        +  + M  + + + YL   H
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL---H 129
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +  I+H DL  SN+LL  +M   ++DFG+A  L    +         T  Y++PE     
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRS 187
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPAD 678
                SD++S G M       + P D
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 112/233 (48%), Gaps = 29/233 (12%)
Query: 464 RLPYQD---LSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQE 510
           +LPY +     R   +FG+   +G G+FG V +A      + D  ++VA+K+     H +
Sbjct: 34  QLPYNEKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 511 CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCML 569
              A+ S   E ++M ++ +H N+V ++  C++     ++ EY   G L  FL   + +L
Sbjct: 92  EKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTP----------IIHCDLKSSNVLLDEDMIAHLSDF 619
           +      I    AS  + L+F                IH D+ + NVLL    +A + DF
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           G+A+ +  +   + +      + +MAPE   +   + +SD++SYGI+L E F+
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 34/284 (11%)
Query: 486 GSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS----GCS 541
           G FG V+KA+L +   VA+K+F  +  ++ ++ E E   +  ++H N+++ I     G S
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-------HTT 594
            D    L+  +   GSL  FL ++    +  +  +I   +A  L YL+         H  
Sbjct: 93  VDVDLWLITAFHEKGSLSDFLKANVVSWN--ELCHIAETMARGLAYLHEDIPGLKDGHKP 150
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTLATIGYMAPEY----- 648
            I H D+KS NVLL  ++ A ++DFG+A K  +G+    T  Q + T  YMAPE      
Sbjct: 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEVLEGAI 209
Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKPADK-----MFAAELSLKHWVNGLLPV--SLME 701
             +R    R D+Y+ G++L E  +R   AD      M   E  +     G  P    + E
Sbjct: 210 NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI-----GQHPSLEDMQE 264
Query: 702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKC 745
           VV      P  +D+  K   +  +     EC     E R++A C
Sbjct: 265 VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 128/285 (44%), Gaps = 35/285 (12%)
Query: 486 GSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG---CSN 542
           G FG V+KA+L +   VA+K+F  +  ++ +S E E      ++H NL++ I+     SN
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 543 DDFK-ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR--------HT 593
            + +  L+  +   GSL  +L  +    +  +  ++   ++  L YL+          H 
Sbjct: 84  LEVELWLITAFHDKGSLTDYLKGNIITWN--ELCHVAETMSRGLSYLHEDVPWCRGEGHK 141
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTLATIGYMAPEY---- 648
             I H D KS NVLL  D+ A L+DFG+A +   G+    T  Q + T  YMAPE     
Sbjct: 142 PSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAPEVLEGA 200
Query: 649 -GIERKVSTRSDIYSYGIMLIETFTRKKPADK-----MFAAELSLKHWVNGLLPV--SLM 700
              +R    R D+Y+ G++L E  +R K AD      M   E  +     G  P    L 
Sbjct: 201 INFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEI-----GQHPSLEELQ 255
Query: 701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKC 745
           EVV    + P  KD   K   +  +     EC     E R++A C
Sbjct: 256 EVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGC 300

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++  + H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 481 NLIGIGSFGYVYKAEL--DDG--IEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLV 534
            ++G G FG V +  L  +DG  ++VA+K    +    R ++ F  E   MK+  H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 535 KIISGCSNDDFKAL-----VLEYMPNGSLDIFLYSSTC-----MLDIFQRLNIMIDVASA 584
           +++  C     + +     +L +M  G L  +L  S        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           +EYL+ R+    +H DL + N +L +DM   ++DFG++K +   D           + ++
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTR 673
           A E   +R  +++SD++++G+ + E  TR
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 480 DNLIGIGSFGYVYKAELDDG----IEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLV 534
           D +IG G FG VY  E  D     I+ AIK   +    + +++F  E  +M+ + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 535 KIIS-GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            +I      +    ++L YM +G L  F+ S      +   ++  + VA  +EYL     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---E 142
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAK-LLSGEDQSMTQ-TQTLATIGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +L  E  S+ Q       + + A E    
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
            + +T+SD++S+G++L E  TR  P
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 147 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++  + H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 587 YLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 483 IGIGSFGYVYKAELD----DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG V + E D      + VA+K    +      AM  F  E   M ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 536 IISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +         K +V E  P GSL   +  +    +L    R    + VA  + YL  +  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR- 141
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIER 652
              IH DL + N+LL    +  + DFG+ + L   +D  + Q        + APE    R
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
             S  SD + +G+ L E FT  +            + W+ GL    ++  ++K     P 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQ------------EPWI-GLNGSQILHKIDKEGERLPR 246
Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKR 740
                 E C   I+++ ++C    PE R
Sbjct: 247 -----PEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 477 FGRDNLI-----GIGSFGYVYKAEL------DDGIEVAIKVFHQECARA-MKSFEVECEV 524
           F R NL+     G G FG V KA             VA+K+  +  + + ++    E  V
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------- 568
           +K + H +++K+   CS D    L++EY   GSL  FL  S  +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 569 -------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI 621
                  L +   ++    ++  ++YL       ++H DL + N+L+ E     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           ++ +  ED  + ++Q    + +MA E   +   +T+SD++S+G++L E  T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 587 YLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 477 FGRDNLI-----GIGSFGYVYKAEL------DDGIEVAIKVFHQECARA-MKSFEVECEV 524
           F R NL+     G G FG V KA             VA+K+  +  + + ++    E  V
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------- 568
           +K + H +++K+   CS D    L++EY   GSL  FL  S  +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 569 -------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI 621
                  L +   ++    ++  ++YL       ++H DL + N+L+ E     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           ++ +  ED  + ++Q    + +MA E   +   +T+SD++S+G++L E  T
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 587 YLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 162 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 483 IGIGSFGYVYKAELD----DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG V + E D      + VA+K    +      AM  F  E   M ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 536 IISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +         K +V E  P GSL   +  +    +L    R    + VA  + YL  +  
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR- 135
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIER 652
              IH DL + N+LL    +  + DFG+ + L   +D  + Q        + APE    R
Sbjct: 136 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
             S  SD + +G+ L E FT  +            + W+ GL    ++  ++K     P 
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQ------------EPWI-GLNGSQILHKIDKEGERLPR 240
Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKR 740
                 E C   I+++ ++C    PE R
Sbjct: 241 -----PEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 587 YLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 172 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 172
Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 173 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 195
Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 11/212 (5%)
Query: 481 NLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLV 534
            ++G G+FG VYK   + DG    I VAIKV  +  + +A K    E  VM  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           +++  C     + LV + MP G L   +  +   L     LN  + +A  + YL      
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYL---EDV 138
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            ++H DL + NVL+       ++DFG+A+LL  ++           I +MA E  + R+ 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 655 STRSDIYSYGIMLIETFT-RKKPADKMFAAEL 685
           + +SD++SYG+ + E  T   KP D + A E+
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 477 FGRDNLI-----GIGSFGYVYKAEL------DDGIEVAIKVFHQECARA-MKSFEVECEV 524
           F R NL+     G G FG V KA             VA+K+  +  + + ++    E  V
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------- 568
           +K + H +++K+   CS D    L++EY   GSL  FL  S  +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 569 -------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI 621
                  L +   ++    ++  ++YL       ++H DL + N+L+ E     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           ++ +  ED  + ++Q    + +MA E   +   +T+SD++S+G++L E  T
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 483 IGIGSFGYVYKAELD----DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG V + E D      + VA+K    +      AM  F  E   M ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 536 IISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +         K +V E  P GSL   +  +    +L    R    + VA  + YL  +  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR- 141
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIER 652
              IH DL + N+LL    +  + DFG+ + L   +D  + Q        + APE    R
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
             S  SD + +G+ L E FT  +            + W+ GL    ++  ++K     P 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQ------------EPWI-GLNGSQILHKIDKEGERLPR 246
Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKR 740
                 E C   I+++ ++C    PE R
Sbjct: 247 -----PEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 483 IGIGSFGYVYKAELD----DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG V + E D      + VA+K    +      AM  F  E   M ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 536 IISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +         K +V E  P GSL   +  +    +L    R    + VA  + YL  +  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR- 131
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIER 652
              IH DL + N+LL    +  + DFG+ + L   +D  + Q        + APE    R
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
             S  SD + +G+ L E FT  +            + W+ GL    ++  ++K     P 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ------------EPWI-GLNGSQILHKIDKEGERLPR 236
Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKR 740
                 E C   I+++ ++C    PE R
Sbjct: 237 -----PEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 587 YLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 156 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 587 YLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 182 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 483 IGIGSFGYVYKAELD----DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG V + E D      + VA+K    +      AM  F  E   M ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 536 IISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +         K +V E  P GSL   +  +    +L    R    + VA  + YL  +  
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR- 135
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIER 652
              IH DL + N+LL    +  + DFG+ + L   +D  + Q        + APE    R
Sbjct: 136 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
             S  SD + +G+ L E FT  +            + W+ GL    ++  ++K     P 
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQ------------EPWI-GLNGSQILHKIDKEGERLPR 240
Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKR 740
                 E C   I+++ ++C    PE R
Sbjct: 241 -----PEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + +++E M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 124/262 (47%), Gaps = 33/262 (12%)
Query: 481 NLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECARAMKSFEVECEVM---KNIRHRN 532
            ++G G FG V+K   + +G    I V IKV   +  R  +SF+   + M    ++ H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAH 94
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +V+++  C     + LV +Y+P GSL   +      L     LN  + +A  + YL   H
Sbjct: 95  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EH 152
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
              ++H +L + NVLL       ++DFG+A LL  +D+ +  ++    I +MA E     
Sbjct: 153 G--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
           K + +SD++SYG+ + E  T        F AE        GL    L EV +  LL   E
Sbjct: 211 KYTHQSDVWSYGVTVWELMT--------FGAEP-----YAGL---RLAEVPD--LLEKGE 252
Query: 713 KDFAAKEQCVLSIFSLAMECTM 734
           +  A  + C + ++ + ++C M
Sbjct: 253 R-LAQPQICTIDVYMVMVKCWM 273

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 33/262 (12%)
Query: 481 NLIGIGSFGYVYKA-ELDDG----IEVAIKVFHQECARAMKSFEVECEVM---KNIRHRN 532
            ++G G FG V+K   + +G    I V IKV   +  R  +SF+   + M    ++ H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAH 76
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +V+++  C     + LV +Y+P GSL   +      L     LN  + +A  + YL   H
Sbjct: 77  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EH 134
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
              ++H +L + NVLL       ++DFG+A LL  +D+ +  ++    I +MA E     
Sbjct: 135 G--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
           K + +SD++SYG+ + E  T        F AE           P + + +     L    
Sbjct: 193 KYTHQSDVWSYGVTVWELMT--------FGAE-----------PYAGLRLAEVPDLLEKG 233
Query: 713 KDFAAKEQCVLSIFSLAMECTM 734
           +  A  + C + ++ + ++C M
Sbjct: 234 ERLAQPQICTIDVYMVMVKCWM 255

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   + C+   +  F +E  ++    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + +++E M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 111/233 (47%), Gaps = 29/233 (12%)
Query: 464 RLPYQD---LSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQE 510
           +LPY +     R   +FG+   +G G+FG V +A      + D  ++VA+K+     H +
Sbjct: 34  QLPYNEKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 511 CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCML 569
              A+ S   E ++M ++ +H N+V ++  C++     ++ EY   G L  FL   + +L
Sbjct: 92  EKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVL 148
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTP----------IIHCDLKSSNVLLDEDMIAHLSDF 619
           +      I     S  + L+F                IH D+ + NVLL    +A + DF
Sbjct: 149 ETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           G+A+ +  +   + +      + +MAPE   +   + +SD++SYGI+L E F+
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 483 IGIGSFGYVYKAELD----DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG V + E D      + VA+K    +      AM  F  E   M ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 536 IISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +         K +V E  P GSL   +  +    +L    R    + VA  + YL  +  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR- 131
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIER 652
              IH DL + N+LL    +  + DFG+ + L   +D  + Q        + APE    R
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
             S  SD + +G+ L E FT  +            + W+ GL    ++  ++K     P 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ------------EPWI-GLNGSQILHKIDKEGERLPR 236
Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKR 740
                 E C   I+++ ++C    PE R
Sbjct: 237 -----PEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 483 IGIGSFGYVYKAELD----DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG V + E D      + VA+K    +      AM  F  E   M ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 536 IISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +         K +V E  P GSL   +  +    +L    R    + VA  + YL  +  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR- 131
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIER 652
              IH DL + N+LL    +  + DFG+ + L   +D  + Q        + APE    R
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
             S  SD + +G+ L E FT  +            + W+ GL    ++  ++K     P 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ------------EPWI-GLNGSQILHKIDKEGERLPR 236
Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKR 740
                 E C   I+++ ++C    PE R
Sbjct: 237 -----PEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 113/232 (48%), Gaps = 31/232 (13%)
Query: 464 RLPYQD---LSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQE 510
           +LPY +     R   +FG+   +G G+FG V +A      + D  ++VA+K+     H +
Sbjct: 26  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 83
Query: 511 CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM- 568
              A+ S   E ++M ++ +H N+V ++  C++     ++ EY   G L  FL       
Sbjct: 84  EKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD 140
Query: 569 --------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG 620
                   L++   L+    VA  + +L  ++    IH D+ + NVLL    +A + DFG
Sbjct: 141 LDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFG 197
Query: 621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           +A+ +  +   + +      + +MAPE   +   + +SD++SYGI+L E F+
Sbjct: 198 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 113/232 (48%), Gaps = 31/232 (13%)
Query: 464 RLPYQD---LSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQE 510
           +LPY +     R   +FG+   +G G+FG V +A      + D  ++VA+K+     H +
Sbjct: 34  QLPYNEKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 511 CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM- 568
              A+ S   E ++M ++ +H N+V ++  C++     ++ EY   G L  FL       
Sbjct: 92  EKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD 148
Query: 569 --------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG 620
                   L++   L+    VA  + +L  ++    IH D+ + NVLL    +A + DFG
Sbjct: 149 LDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFG 205
Query: 621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           +A+ +  +   + +      + +MAPE   +   + +SD++SYGI+L E F+
Sbjct: 206 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 115/237 (48%), Gaps = 35/237 (14%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 16  RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGA 71
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFL------ 562
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L      
Sbjct: 72  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 131
Query: 563 ---YSSTCMLDIFQRLNIMI----DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH 615
              Y    +   F  L  +I     VA  +E+L  R     IH DL + N+LL E  +  
Sbjct: 132 FVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVK 188
Query: 616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 189 ICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 39/303 (12%)
Query: 482 LIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKN--IRHRNLVKIISG 539
           LIG G +G VYK  LD+   VA+KVF        ++F  E  + +   + H N+ + I G
Sbjct: 20  LIGRGRYGAVYKGSLDER-PVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 540 CSNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR--- 591
                        LV+EY PNGSL  +L   T   D      +   V   L YL+     
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 592 --HTTPII-HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE------DQSMTQTQTLATIG 642
             H  P I H DL S NVL+  D    +SDFG++  L+G       ++       + TI 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 643 YMAPEYGIERKVSTRS--------DIYSYGIMLIETFTRKK---PADKMFAAELSLKHWV 691
           YMAPE  +E  V+ R         D+Y+ G++  E F R     P + +   +++ +  V
Sbjct: 194 YMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252
Query: 692 NGLLPVSLMEVVNKTLLSPPEKDFAAKEQ--CVLSIFSLAMECTMELPEKRINAKCCNFV 749
                   M+V+       P+   A KE    V S+     +C  +  E R+ A+     
Sbjct: 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312
Query: 750 LCE 752
           + E
Sbjct: 313 MAE 315

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H DL + N ++  D    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 248

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H DL + N ++  D    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 248

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H DL + N ++  D    + DFG+ + +   D      + L  + +MAP
Sbjct: 142 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 33/235 (14%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 14  RLPY-DASKW--EFPRDRLNLGKPLGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGA 69
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 569 L----DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS 617
                D+++    +         VA  +E+L  R     IH DL + N+LL E  +  + 
Sbjct: 130 FVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKIX 186
Query: 618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 187 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 472 RATNRFGRDNLIGIGSFGY-VYKAELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNI 528
           ++  ++ R   IG GSFG  +     +DG +  IK  +  +  ++  +    E  V+ N+
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR---LNIMIDVASAL 585
           +H N+V+       +    +V++Y   G  D+F   +     +FQ    L+  + +  AL
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGG--DLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG--- 642
           +++   H   I+H D+KS N+ L +D    L DFGIA++L+      T     A IG   
Sbjct: 139 KHV---HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-----TVELARACIGTPY 190
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSL 699
           Y++PE    +  + +SDI++ G +L E  T K   +      L LK       PVSL
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL 247

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 477 FGRDNLIGIGSFGYVYKAE-LDDGIEVAIK---VFHQECARAMKSFEVECEVMKNIRHRN 532
           F  +  IG G F  VY+A  L DG+ VA+K   +F    A+A      E +++K + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI---MIDVASALEYLN 589
           ++K  +    D+   +VLE    G L   +        +     +    + + SALE++ 
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM- 152
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H+  ++H D+K +NV +    +  L D G+ +  S   ++      + T  YM+PE  
Sbjct: 153 --HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 208
Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP--ADKM 680
            E   + +SDI+S G +L E    + P   DKM
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 33/235 (14%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 14  RLPY-DASKW--EFPRDRLNLGKPLGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGA 69
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 569 L----DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS 617
                D+++    +         VA  +E+L  R     IH DL + N+LL E  +  + 
Sbjct: 130 FVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKIC 186
Query: 618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 187 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 480 DNLIGIGSFGYVYKA----ELDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLV 534
           + ++G G FG VY+        + I VA+K   ++C    K  F  E  +MKN+ H ++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           K+I G   ++   +++E  P G L  +L  +   L +   +   + +  A+ YL    + 
Sbjct: 89  KLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESI 144
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE    R+ 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 203
Query: 655 STRSDIYSYGIMLIETFTRKK 675
           +T SD++ + + + E  +  K
Sbjct: 204 TTASDVWMFAVCMWEILSFGK 224

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H DL + N ++  D    + DFG+ + +   D      + L  + +MAP
Sbjct: 144 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 247

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 483 IGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVK 535
           +G G+FG VY+ ++         ++VA+K   +  +   +  F +E  ++    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIMIDVASALE 586
            I        + ++LE M  G L  FL          SS  MLD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           YL   H    IH D+ + N LL       +A + DFG+A+ +            +  + +
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           M PE  +E   ++++D +S+G++L E F+
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 115/238 (48%), Gaps = 36/238 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 15  RLPY-DASKW--EFPRDRLNLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 70
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 71  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 130
Query: 569 L-------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
                   D+++    +         VA  +E+L  R     IH DL + N+LL E  + 
Sbjct: 131 FVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVV 187
Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 188 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 480 DNLIGIGSFGYVYKA----ELDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLV 534
           + ++G G FG VY+        + I VA+K   ++C    K  F  E  +MKN+ H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           K+I G   ++   +++E  P G L  +L  +   L +   +   + +  A+ YL    + 
Sbjct: 77  KLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESI 132
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE    R+ 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 191
Query: 655 STRSDIYSYGIMLIETFTRKK 675
           +T SD++ + + + E  +  K
Sbjct: 192 TTASDVWMFAVCMWEILSFGK 212

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 5   RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 60
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 120
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 177
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 178 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H DL + N ++  D    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 248

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 17/194 (8%)
Query: 483 IGIGSFGYVY-KAELDDGIEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLVKIISGC 540
           +G G+FG V+   E   G+E  IK  +++ ++  M+  E E EV+K++ H N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR---LNIMIDVASALEYLNFRHTTPII 597
            +     +V+E    G L   + S+              +M  + +AL Y + +H   ++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146
Query: 598 HCDLKSSNVLLDEDMIAH----LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
           H DLK  N+L  +D   H    + DFG+A+L   ++ S   T    T  YMAPE   +R 
Sbjct: 147 HKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEV-FKRD 201
Query: 654 VSTRSDIYSYGIML 667
           V+ + DI+S G+++
Sbjct: 202 VTFKCDIWSAGVVM 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 480 DNLIGIGSFGYVYKA----ELDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLV 534
           + ++G G FG VY+        + I VA+K   ++C    K  F  E  +MKN+ H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           K+I G   ++   +++E  P G L  +L  +   L +   +   + +  A+ YL    + 
Sbjct: 73  KLI-GIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESI 128
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE    R+ 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 187
Query: 655 STRSDIYSYGIMLIETFTRKK 675
           +T SD++ + + + E  +  K
Sbjct: 188 TTASDVWMFAVCMWEILSFGK 208

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 5   RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 60
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 177
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 178 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 14  RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 69
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 186
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 187 VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 15/213 (7%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVA----IKVFHQECAR--AMKSFEVEC 522
           D+     R+ + + +G G F  VYKA   +  ++     IK+ H+  A+    ++   E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
           ++++ + H N++ ++    +    +LV ++M    L++ +  ++ +L        M+   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
             LEYL   H   I+H DLK +N+LLDE+ +  L+DFG+AK     +++      + T  
Sbjct: 123 QGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTRW 177
Query: 643 YMAPE--YGIERKVSTRSDIYSYGIMLIETFTR 673
           Y APE  +G  R      D+++ G +L E   R
Sbjct: 178 YRAPELLFG-ARMYGVGVDMWAVGCILAELLLR 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAM--KSFEVECEVMKNIRHRNLVKIIS 538
           L+G GS+G V K    D G  VAIK F +     M  K    E +++K +RH NLV ++ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 539 GCSNDDFKALVLEYMPNGSLD-IFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
            C       LV E++ +  LD + L+ +     + Q+    I     +  + F H+  II
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----INGIGFCHSHNII 146
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVST 656
           H D+K  N+L+ +  +  L DFG A+ L+   +       +AT  Y APE  + + K   
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGK 204
Query: 657 RSDIYSYGIMLIETF 671
             D+++ G ++ E F
Sbjct: 205 AVDVWAIGCLVTEMF 219

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 138 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 113/238 (47%), Gaps = 37/238 (15%)
Query: 464 RLPYQD---LSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQE 510
           +LPY +     R   +FG+   +G G+FG V +A      + D  ++VA+K+     H +
Sbjct: 34  QLPYNEKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 511 CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL------- 562
              A+ S   E ++M ++ +H N+V ++  C++     ++ EY   G L  FL       
Sbjct: 92  EKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPG 148
Query: 563 --------YSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
                   ++    L     L+    VA  + +L  ++    IH D+ + NVLL    +A
Sbjct: 149 LEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVA 205
Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            + DFG+A+ +  +   + +      + +MAPE   +   + +SD++SYGI+L E F+
Sbjct: 206 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 14  RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 69
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 186
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 187 VKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 5   RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 60
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 177
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 178 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 5   RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 60
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 61  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 121 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 177
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 178 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 51  RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 106
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 107 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 166
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 167 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 223
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 477 FGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFH-QECARAMKSFEVECEVMKNIRHRNL 533
           F +   IG GSFG V+K  +D+  +  VAIK+   +E    ++  + E  V+       +
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 534 VKIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            K       D    +++EY+  GS LD+        LD  Q   I+ ++   L+YL   H
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYL---H 136
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +   IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   + 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
              +++DI+S GI  IE   R +P
Sbjct: 195 AYDSKADIWSLGITAIE-LARGEP 217

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 16  RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 71
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 72  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 131
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 132 FVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 188
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 189 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 115/239 (48%), Gaps = 37/239 (15%)
Query: 464 RLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIE-------VAIKVFHQEC 511
           RLPY D S+    F RD L     +G G+FG V +A+   GI+       VA+K+  +  
Sbjct: 14  RLPY-DASKW--EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGA 69
Query: 512 ARA-MKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVL-EYMPNGSLDIFLYSSTCM 568
             +  ++   E +++ +I H  N+V ++  C+      +V+ E+   G+L  +L S    
Sbjct: 70  THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 129
Query: 569 L--------DIFQRLNIM-------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                    D+++    +         VA  +E+L  R     IH DL + N+LL E  +
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 186
Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             + DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A E   G +VA+K       +  +    E  +M++  H N+V + S   
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
             D   +V+E++  G+L DI  ++    ++  Q   + + V  AL YL   H   +IH D
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYL---HNQGVIHRD 166
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           +KS ++LL  D    LSDFG    +S E     +   + T  +MAPE        T  DI
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAPEVISRLPYGTEVDI 224
Query: 661 YSYGIMLIETFTRKKP 676
           +S GIM+IE    + P
Sbjct: 225 WSLGIMVIEMIDGEPP 240

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 477 FGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFH-QECARAMKSFEVECEVMKNIRHRNL 533
           F +   IG GSFG V+K  +D+  +  VAIK+   +E    ++  + E  V+       +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 534 VKIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            K       D    +++EY+  GS LD+        LD  Q   I+ ++   L+YL   H
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYL---H 121
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +   IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   + 
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
              +++DI+S GI  IE   R +P
Sbjct: 180 AYDSKADIWSLGITAIE-LARGEP 202

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 113/245 (46%), Gaps = 44/245 (17%)
Query: 464 RLPYQD---LSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQE 510
           +LPY +     R   +FG+   +G G+FG V +A      + D  ++VA+K+     H +
Sbjct: 19  QLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 76
Query: 511 CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM- 568
              A+ S   E ++M ++ +H N+V ++  C++     ++ EY   G L  FL       
Sbjct: 77  EKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAM 133
Query: 569 ---------------------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL 607
                                L++   L+    VA  + +L  ++    IH D+ + NVL
Sbjct: 134 LGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVL 190
Query: 608 LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
           L    +A + DFG+A+ +  +   + +      + +MAPE   +   + +SD++SYGI+L
Sbjct: 191 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 250
Query: 668 IETFT 672
            E F+
Sbjct: 251 WEIFS 255

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 477 FGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFH-QECARAMKSFEVECEVMKNIRHRNL 533
           F +   IG GSFG V+K  +D+  +  VAIK+   +E    ++  + E  V+       +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 534 VKIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            K       D    +++EY+  GS LD+        LD  Q   I+ ++   L+YL   H
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYL---H 121
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +   IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   + 
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
              +++DI+S GI  IE   R +P
Sbjct: 180 AYDSKADIWSLGITAIE-LARGEP 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 477 FGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFH-QECARAMKSFEVECEVMKNIRHRNL 533
           F +   IG GSFG V+K  +D+  +  VAIK+   +E    ++  + E  V+       +
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 534 VKIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            K       D    +++EY+  GS LD+        LD  Q   I+ ++   L+YL   H
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYL---H 141
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +   IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   + 
Sbjct: 142 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQS 199
Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
              +++DI+S GI  IE   R +P
Sbjct: 200 AYDSKADIWSLGITAIE-LARGEP 222

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H +L + N ++  D    + DFG+ + +   D      + L  + +MAP
Sbjct: 146 YLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 249

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 481 NLIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLV 534
            ++G GSFG V+        D G   A+KV  +     R     ++E +++ ++ H  +V
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           K+      +    L+L+++  G  D+F   S  ++  F   ++   +A     L+  H+ 
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGG--DLFTRLSKEVM--FTEEDVKFYLAELALGLDHLHSL 149
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            II+ DLK  N+LLDE+    L+DFG++K     D          T+ YMAPE    +  
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQGH 207
Query: 655 STRSDIYSYGIMLIETFTRKKP 676
           S  +D +SYG+++ E  T   P
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLP 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA-RAMKSFEV-ECEVMKNIRHRN 532
            ++ +   +G G++G VYKA+   G  VA+K    +     + S  + E  ++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +V +I    ++    LV E+M      +   + T + D      I I +   L  +   H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS----QIKIYLYQLLRGVAHCH 136
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-E 651
              I+H DLK  N+L++ D    L+DFG+A+      +S   T  + T+ Y AP+  +  
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGS 194
Query: 652 RKVSTRSDIYSYGIMLIETFTRK 674
           +K ST  DI+S G +  E  T K
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 35/234 (14%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVFHQEC-ARAMKSFEVE 521
           +  R    FG+  ++G G+FG V  A      +    I+VA+K+  ++  +   ++   E
Sbjct: 41  EFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 522 CEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSL-------------DIFLYSSTC 567
            ++M  +  H N+V ++  C+      L+ EY   G L             D   Y +  
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 568 MLDIFQRLNIM---------IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD 618
            L+  + LN++           VA  +E+L F+     +H DL + NVL+    +  + D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICD 215
Query: 619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           FG+A+ +  +   + +      + +MAPE   E   + +SD++SYGI+L E F+
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH----------------QECA- 512
           S AT+R+     IG+G++G VYKA +   G  VA+K                   +E A 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 513 -RAMKSFEVECEVMKNIRHRNLVKIISGC--SNDDFKALVLEYMPNGSLDIFLYSSTCML 569
            R +++FE          H N+V+++  C  S  D +  V     +   D+  Y      
Sbjct: 65  LRRLEAFE----------HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP 114
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
                  I   +   L  L+F H   I+H DLK  N+L+       L+DFG+A++ S + 
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ- 173
Query: 630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
             M  T  + T+ Y APE  ++   +T  D++S G +  E F RK
Sbjct: 174 --MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 476
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 477 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 19/227 (8%)
Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H +L + N ++  D    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 248

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 477 FGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFH-QECARAMKSFEVECEVMKNIRHRNL 533
           F +   IG GSFG V+K  +D+  +  VAIK+   +E    ++  + E  V+       +
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 534 VKIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            K            +++EY+  GS LD+         D FQ   ++ ++   L+YL   H
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYL---H 137
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +   IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   + 
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKM 680
              +++DI+S GI  IE    + P   M
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 140 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 481 NLIGIGSFGYVYKAELDDGIE-VAIKVFH-QECARAMKSFEVECEVMKNIRHRNLVKIIS 538
            +IG G+   V  A      E VAIK  + ++C  +M     E + M    H N+V   +
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 539 GCSNDDFKALVLEYMPNGS-LDIFLY------SSTCMLDIFQRLNIMIDVASALEYLNFR 591
                D   LV++ +  GS LDI  +        + +LD      I+ +V   LEYL   
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL--- 132
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS-GEDQSMTQTQT--LATIGYMAPEY 648
           H    IH D+K+ N+LL ED    ++DFG++  L+ G D +  + +   + T  +MAPE 
Sbjct: 133 HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 649 GIE-RKVSTRSDIYSYGIMLIETFTRKKPADK 679
             + R    ++DI+S+GI  IE  T   P  K
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATGAAPYHK 224

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 477
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 478 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 583

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA-RAMKSFEV-ECEVMKNIRHRN 532
            ++ +   +G G++G VYKA+   G  VA+K    +     + S  + E  ++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +V +I    ++    LV E+M      +   + T + D      I I +   L  +   H
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS----QIKIYLYQLLRGVAHCH 136
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-E 651
              I+H DLK  N+L++ D    L+DFG+A+      +S   T  + T+ Y AP+  +  
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGS 194
Query: 652 RKVSTRSDIYSYGIMLIETFTRK 674
           +K ST  DI+S G +  E  T K
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 16/212 (7%)
Query: 481 NLIGIGSFGYVYKAELDDGIE-VAIKVFH-QECARAMKSFEVECEVMKNIRHRNLVKIIS 538
            +IG G+   V  A      E VAIK  + ++C  +M     E + M    H N+V   +
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 539 GCSNDDFKALVLEYMPNGS-LDIFLY------SSTCMLDIFQRLNIMIDVASALEYLNFR 591
                D   LV++ +  GS LDI  +        + +LD      I+ +V   LEYL   
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL--- 137
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS-GEDQSMTQTQT--LATIGYMAPEY 648
           H    IH D+K+ N+LL ED    ++DFG++  L+ G D +  + +   + T  +MAPE 
Sbjct: 138 HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 649 GIE-RKVSTRSDIYSYGIMLIETFTRKKPADK 679
             + R    ++DI+S+GI  IE  T   P  K
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAPYHK 229

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 147 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 175 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 144 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 146 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 483 IGIGSFGYVYKAELDDGIEV-AIKVFH-QECAR--AMKSFEVECEVMKNIRHRNLVKIIS 538
           IG GSFG V   + +D  ++ A+K  + Q+C     +++   E ++M+ + H  LV +  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              +++   +V++ +  G L   L  +    +   +L I  ++  AL+YL       IIH
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI-CELVMALDYL---QNQRIIH 138
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTR 657
            D+K  N+LLDE    H++DF IA +L  E    TQ  T+A T  YMAPE    RK +  
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 658 S---DIYSYGIMLIETFTRKKP 676
           S   D +S G+   E    ++P
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRP 216

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 20/248 (8%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 126
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG++  L  E       + + T  YM+PE    
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQG 180
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN--------GLLPVSLMEVV 703
              S +SDI+S G+ L+E    + P   M   EL L + VN         +  +   + V
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFEL-LDYIVNEPPPKLPSAVFSLEFQDFV 239
Query: 704 NKTLLSPP 711
           NK L+  P
Sbjct: 240 NKCLIKNP 247

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCML---------DIFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    +          + + + +  ++A  + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 143 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCML---------DIFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    +          + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N ++ ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 104/227 (45%), Gaps = 19/227 (8%)
Query: 483 IGIGSFGYVYKAELDDGIE------VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY+    D I+      VA+K  ++  + R    F  E  VMK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +V+E M +G L  +L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN +     +H DL + N ++  D    + DFG+ + +          + L  + +MAP
Sbjct: 145 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG 693
           E   +   +T SD++S+G++L E  +  +   +  + E  LK  ++G
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 248

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 106/244 (43%), Gaps = 20/244 (8%)
Query: 452 NGGILLSQATKRRLPYQDLSRATNRFGRDNL-IGIGSFGYVYKAE-LDDGIEVAIKVFHQ 509
           N G+LL++  K   P     R    +    L +G GSFG V++ E    G + A+K    
Sbjct: 53  NEGVLLTEKLK---PVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL 109
Query: 510 ECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCML 569
           E  RA +   + C  + + R   +V +        +  + +E +  GSL   +    C+ 
Sbjct: 110 EVFRAEEL--MACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP 164
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLS-- 626
           +       +  +  ALE L + H+  I+H D+K+ NVLL  D   A L DFG A  L   
Sbjct: 165 ED----RALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPD 220
Query: 627 --GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE 684
             G+D  +T      T  +MAPE  + R    + D++S   M++       P  + F   
Sbjct: 221 GLGKDL-LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGP 279
Query: 685 LSLK 688
           L LK
Sbjct: 280 LCLK 283

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 11/210 (5%)
Query: 473 ATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEV-----MK 526
           AT+R+     IG+G++G VYKA +   G  VA+K                 EV     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 527 NIRHRNLVKIISGC--SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
              H N+V+++  C  S  D +  V     +   D+  Y             I   +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           L  L+F H   I+H DLK  N+L+       L+DFG+A++ S +   M     + T+ Y 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTLWYR 178
Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           APE  ++   +T  D++S G +  E F RK
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 18/243 (7%)
Query: 452 NGGILLSQATKRRLPYQDLSRATNRFGRDNL-IGIGSFGYVYKAE-LDDGIEVAIKVFHQ 509
           N G+LL++  K   P     R    +    L +G GSFG V++ E    G + A+K    
Sbjct: 72  NEGVLLTEKLK---PVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRL 128
Query: 510 ECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCML 569
           E  RA +   + C  + + R   +V +        +  + +E +  GSL   +    C+ 
Sbjct: 129 EVFRAEEL--MACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP 183
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLS-- 626
           +       +  +  ALE L + H+  I+H D+K+ NVLL  D   A L DFG A  L   
Sbjct: 184 ED----RALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPD 239
Query: 627 GEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL 685
           G  +S +T      T  +MAPE  + R    + D++S   M++       P  + F   L
Sbjct: 240 GLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPL 299
Query: 686 SLK 688
            LK
Sbjct: 300 CLK 302

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 119 QVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP 711
              S +SDI+S G+ L+E    + P     A E S         P+++ E+++  +  PP
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRP-------PMAIFELLDYIVNEPP 230
Query: 712 EKDFAAKEQCVLSIFSLAME-----CTMELPEKRINAK 744
            K           +FSL  +     C ++ P +R + K
Sbjct: 231 PK-------LPSGVFSLEFQDFVNKCLIKNPAERADLK 261

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 99
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D++L +     D+++ L        +I   +
Sbjct: 100 HENIIGI-----NDIIRAPTIEQMK----DVYLVTHLMGADLYKLLKTQHLSNDHICYFL 150
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 481 NLIGIGSFGYVYKAELDDGIEV----AIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLV 534
            ++G GSFG V+  +   G +     A+KV  +     R     ++E +++  + H  +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI-DVASALEYLNFRHT 593
           K+      +    L+L+++  G  D+F   S  ++   + +   + ++A AL++L   H+
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDHL---HS 145
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             II+ DLK  N+LLDE+    L+DFG++K     D          T+ YMAPE    R 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 654 VSTRSDIYSYGIMLIETFT 672
            +  +D +S+G+++ E  T
Sbjct: 204 HTQSADWWSFGVLMFEMLT 222

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 119 QVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           IG GSFG VY A ++ +   VAIK       ++ + ++    E   ++ +RH N ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY-R 120
Query: 539 GCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS----ALEYLNFRHT 593
           GC   +  A LV+EY         L S++ +L++ ++    +++A+    AL+ L + H+
Sbjct: 121 GCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI--- 650
             +IH D+K+ N+LL E  +  L DFG A +++           + T  +MAPE  +   
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILAMD 226
Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
           E +   + D++S GI  IE   RK P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 483 IGIGSFGYVY----KAELDDGIE--VAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVK 535
           +G GSFG VY    K  + D  E  VAIK  ++  + R    F  E  VMK     ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD---------IFQRLNIMIDVASALE 586
           ++   S      +++E M  G L  +L S    ++         + + + +  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           YLN       +H DL + N  + ED    + DFG+ + +   D      + L  + +M+P
Sbjct: 140 YLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFT 672
           E   +   +T SD++S+G++L E  T
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 112
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 113 QVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 218

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 481 NLIGIGSFGYVYKAELDDGIEV----AIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLV 534
            ++G GSFG V+  +   G +     A+KV  +     R     ++E +++  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI-DVASALEYLNFRHT 593
           K+      +    L+L+++  G  D+F   S  ++   + +   + ++A AL++L   H+
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALALDHL---HS 144
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             II+ DLK  N+LLDE+    L+DFG++K     D          T+ YMAPE    R 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 654 VSTRSDIYSYGIMLIETFT 672
            +  +D +S+G+++ E  T
Sbjct: 203 HTQSADWWSFGVLMFEMLT 221

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 11/210 (5%)
Query: 473 ATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEV-----MK 526
           AT+R+     IG+G++G VYKA +   G  VA+K                 EV     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 527 NIRHRNLVKIISGC--SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
              H N+V+++  C  S  D +  V     +   D+  Y             I   +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           L  L+F H   I+H DLK  N+L+       L+DFG+A++ S +   M     + T+ Y 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTLWYR 178
Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           APE  ++   +T  D++S G +  E F RK
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 132
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 133 QVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 238

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 114
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 115 QVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 481 NLIGIGSFGYVYKAELDDGIEV----AIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLV 534
            ++G GSFG V+  +   G +     A+KV  +     R     ++E +++  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           K+      +    L+L+++  G L   L S   M         + ++A AL++L   H+ 
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHL---HSL 145
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            II+ DLK  N+LLDE+    L+DFG++K     D          T+ YMAPE    R  
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 655 STRSDIYSYGIMLIETFT 672
           +  +D +S+G+++ E  T
Sbjct: 204 TQSADWWSFGVLMFEMLT 221

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 91/195 (46%), Gaps = 8/195 (4%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G GS+G VYKA   + G  VAIK    E    ++    E  +M+     ++VK      
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
            +    +V+EY   GS+   +      L   +   I+      LEYL+F      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIY 661
           K+ N+LL+ +  A L+DFG+A  L+  D    +   + T  +MAPE   E   +  +DI+
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 662 SYGIMLIETFTRKKP 676
           S GI  IE    K P
Sbjct: 210 SLGITAIEMAEGKPP 224

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 124
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 125 QVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 11/210 (5%)
Query: 473 ATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEV-----MK 526
           AT+R+     IG+G++G VYKA +   G  VA+K                 EV     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 527 NIRHRNLVKIISGC--SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
              H N+V+++  C  S  D +  V     +   D+  Y             I   +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           L  L+F H   I+H DLK  N+L+       L+DFG+A++ S +   M     + T+ Y 
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVVVTLWYR 178
Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           APE  ++   +T  D++S G +  E F RK
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 135 QVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
            E  VM+ + +  +V++I  C  + +  LV+E    G L+ +L  +  + D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTL 638
            V+  ++YL     +  +H DL + NVLL     A +SDFG++K L + E+    QT   
Sbjct: 135 QVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELS 686
             + + APE     K S++SD++S+G+++ E F+  +KP   M  +E++
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKIIS 538
           IG GSFG VY A ++ +   VAIK       ++ + ++    E   ++ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY-R 81
Query: 539 GCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
           GC   +  A LV+EY    + D+       +    Q + I      AL+ L + H+  +I
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPL----QEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI---ERKV 654
           H D+K+ N+LL E  +  L DFG A +++           + T  +MAPE  +   E + 
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILAMDEGQY 191
Query: 655 STRSDIYSYGIMLIETFTRKKP 676
             + D++S GI  IE   RK P
Sbjct: 192 DGKVDVWSLGITCIELAERKPP 213

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 128
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T+   T+ Y+ PE    R   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
            + D++S G++  E    K P +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 84  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 11/216 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 185
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE    
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 239
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL 687
              S +SDI+S G+ L+E    + P     A EL L
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 275

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
            LIG G FG VY       + + +    ++    +K+F+ E    +  RH N+V  +  C
Sbjct: 39  ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    A++       +L   +  +  +LD+ +   I  ++   + YL   H   I+H D
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKD 155
Query: 601 LKSSNVLLDEDMIAHLSDFGI----AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-- 654
           LKS NV  D   +  ++DFG+      L +G  +   + Q    + ++APE  I R++  
Sbjct: 156 LKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPE--IIRQLSP 211
Query: 655 ---------STRSDIYSYGIMLIETFTRKKP 676
                    S  SD+++ G +  E   R+ P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   IG GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EYMP G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   IG GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EYMP G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARA 514
           ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A  
Sbjct: 4   ESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 56
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
                 E E+  ++RH N++++     +     L+LEY P G +    Y     L  F  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDE 112
Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    S
Sbjct: 113 QRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPS 165
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
             +T    T+ Y+ PE    R    + D++S G++  E    K P
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 99
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 100 HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 150
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 84  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKCQHLSNDHICYFL 134
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 80  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 77
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 78  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 81
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 82  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 80  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 84
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 85  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 85
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 86  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 136
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 137 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 76
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 77  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 127
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 128 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 84  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 77
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 78  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 482 LIGIGSFGYV----YKAELDDGIEVAIKVFHQEC---ARAMKSFEVECEVM-KNIRHRNL 533
           +IG GSFG V    +KAE    +  A+KV  ++     +  K    E  V+ KN++H  L
Sbjct: 45  VIGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V +       D    VL+Y+  G L   L    C L+   R     ++ASAL YL   H+
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYL---HS 157
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             I++ DLK  N+LLD      L+DFG+ K     + + T +    T  Y+APE   ++ 
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 654 VSTRSDIYSYGIMLIE 669
                D +  G +L E
Sbjct: 216 YDRTVDWWCLGAVLYE 231

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 80  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 25/226 (11%)
Query: 458 SQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECAR 513
            ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A 
Sbjct: 24  EESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG 76
Query: 514 AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF- 572
                  E E+  ++RH N++++     +     L+LEY P G++    Y     L  F 
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFD 132
Query: 573 -QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
            QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    
Sbjct: 133 EQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAP 185
Query: 631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           S  +T    T+ Y+ PE    R    + D++S G++  E    K P
Sbjct: 186 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 87
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 88  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 138
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 139 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 80  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 80  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYG 649
            H+  +I+ DLK  N+L+D+     ++DFG AK + G      +T TL  T  Y+APE  
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 211
Query: 650 IERKVSTRSDIYSYGIMLIE 669
           + +  +   D ++ G+++ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 12/203 (5%)
Query: 481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMK---SFEVECEVMKNIRHRNLVKI 536
           + +G+G+FG V   E    G +VA+K+ +++  R++      + E + +K  RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
               S      +V+EY+  G L  ++     + ++  R  +   + SA++Y + RH   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH-RHM--V 132
Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVS 655
           +H DLK  NVLLD  M A ++DFG++ ++S  D    +T +  +  Y APE    R    
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRT-SCGSPNYAAPEVISGRLYAG 189
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
              DI+S G++L        P D
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFD 212

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFR 81
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 82  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 81  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 133
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEXIEGRXHD 189
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPP 210

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFR 81
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 82  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYG 649
            H+  +I+ DLK  N+L+D+     ++DFG AK + G      +T TL  T  Y+APE  
Sbjct: 143 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 196
Query: 650 IERKVSTRSDIYSYGIMLIE 669
           + +  +   D ++ G+++ E
Sbjct: 197 LSKGYNKAVDWWALGVLIYE 216

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 172
Query: 590 FRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 173 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 226
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 227 LIFGATDYTSS-IDVWSAGCVLAE 249

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 11/216 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL 687
              S +SDI+S G+ L+E    + P     A EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 11/216 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL 687
              S +SDI+S G+ L+E    + P     A EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 128
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 184
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
            + D++S G++  E    K P +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 128
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
            + D++S G++  E    K P +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 80  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 132
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
            + D++S G++  E    K P +
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 473 ATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRH 530
           ++++F +   +G G++  VYK      G+ VA+K    +      S  + E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC----------MLDIFQRLNIMID 580
            N+V++      ++   LV E+M N  L  ++ S T           ++  FQ       
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ------- 114
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
               L+ L F H   I+H DLK  N+L+++     L DFG+A+       +   +  + T
Sbjct: 115 -WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVT 171
Query: 641 IGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRK 674
           + Y AP+  +  R  ST  DI+S G +L E  T K
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 128
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 129
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 128
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPP 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 75  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 127
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 183
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
            + D++S G++  E    K P +
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+ +   IG G++G V  A +      VAIK      HQ  C R ++    E +++   R
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRFR 99
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I      D  +A  LE M     D+++       D+++ L        +I   +
Sbjct: 100 HENVIGI-----RDILRASTLEAM----RDVYIVQDLMETDLYKLLKSQQLSNDHICYFL 150
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+L++      + DFG+A++   E D +   T+ +AT
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 81  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 133
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHD 189
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPP 210

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 11/215 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F R + +G G+ G V K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-LDIFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  +  +I  +++I   V   L YL  +
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 133
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YMAPE    
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMAPERLQG 187
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS 686
              S +SDI+S G+ L+E    + P     A EL 
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELE 222

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 118
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 176
Query: 590 FRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 177 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPE 230
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 231 LIFGATDYTSS-IDVWSAGCVLAE 253

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAI+      HQ  C R ++    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 84  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARA 514
           ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A  
Sbjct: 4   ESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 56
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
                 E E+  ++RH N++++     +     L+LEY P G++    Y     L  F  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDE 112
Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    S
Sbjct: 113 QRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPS 165
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
             +T    T+ Y+ PE    R    + D++S G++  E    K P
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 25/226 (11%)
Query: 458 SQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECAR 513
            ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A 
Sbjct: 15  EESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG 67
Query: 514 AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF- 572
                  E E+  ++RH N++++     +     L+LEY P G++    Y     L  F 
Sbjct: 68  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFD 123
Query: 573 -QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
            QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    
Sbjct: 124 EQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAP 176
Query: 631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           S  +T    T+ Y+ PE    R    + D++S G++  E    K P
Sbjct: 177 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARA 514
           ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A  
Sbjct: 2   ESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 54
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
                 E E+  ++RH N++++     +     L+LEY P G++    Y     L  F  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDE 110
Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    S
Sbjct: 111 QRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPS 163
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
             +T    T+ Y+ PE    R    + D++S G++  E    K P +
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           IG G FG V++ +   G EVA+K+F    +R  +S+  E E+ + +  RH N++  I+  
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
           + D+       LV +Y  +GSL  F Y +   + +   + + +  AS L +L+      +
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSL--FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQ-SMTQTQTLATIGYMAPEYG 649
               I H DLKS N+L+ ++    ++D G+A +  S  D   +     + T  YMAPE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV- 222
Query: 650 IERKVS-------TRSDIYSYGIMLIETFTR 673
           ++  ++        R+DIY+ G++  E   R
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           IG G FG V++ +   G EVA+K+F    +R  +S+  E E+ + +  RH N++  I+  
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
           + D+       LV +Y  +GSL  F Y +   + +   + + +  AS L +L+      +
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSL--FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQ-SMTQTQTLATIGYMAPEYG 649
               I H DLKS N+L+ ++    ++D G+A +  S  D   +     + T  YMAPE  
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV- 189
Query: 650 IERKVS-------TRSDIYSYGIMLIETFTR 673
           ++  ++        R+DIY+ G++  E   R
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 129
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPPEMIEGRMHD 185
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 116
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 174
Query: 590 FRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 175 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPE 228
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 229 LIFGATDYTSS-IDVWSAGCVLAE 251

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           IG G FG V++ +   G EVA+K+F    +R  +S+  E E+ + +  RH N++  I+  
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
           + D+       LV +Y  +GSL  F Y +   + +   + + +  AS L +L+      +
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSL--FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQ-SMTQTQTLATIGYMAPEYG 649
               I H DLKS N+L+ ++    ++D G+A +  S  D   +     + T  YMAPE  
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV- 186
Query: 650 IERKVS-------TRSDIYSYGIMLIETFTR 673
           ++  ++        R+DIY+ G++  E   R
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           IG G FG V++ +   G EVA+K+F    +R  +S+  E E+ + +  RH N++  I+  
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
           + D+       LV +Y  +GSL  F Y +   + +   + + +  AS L +L+      +
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSL--FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQ-SMTQTQTLATIGYMAPEYG 649
               I H DLKS N+L+ ++    ++D G+A +  S  D   +     + T  YMAPE  
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV- 209
Query: 650 IERKVS-------TRSDIYSYGIMLIETFTR 673
           ++  ++        R+DIY+ G++  E   R
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 99
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 157
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 158 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 211
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 212 LIFGATDYTSS-IDVWSAGCVLAE 234

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 489 GYVYKAELDDGIEVAIKVF--HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND--D 544
           G ++K     G ++ +KV        R  + F  EC  ++   H N++ ++  C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 545 FKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHT-TPII-HCDL 601
              L+  +MP GSL   L+  T  ++D  Q +   +D+A  + +L   HT  P+I    L
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHAL 139
Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR---S 658
            S +V++DEDM A +S       ++    S      +    ++APE   ++   T    +
Sbjct: 140 NSRSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSA 192
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP 696
           D++S+ ++L E  TR+ P   +   E+ +K  + GL P
Sbjct: 193 DMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 27/203 (13%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI--- 536
            +IG GSFG VY+A+L D G  VAIK   Q   +A K+ E+  ++M+ + H N+V++   
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKNREL--QIMRKLDHCNIVRLRYF 81
Query: 537 --ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLNF 590
              SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI-- 138
Query: 591 RHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE- 647
            H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE 
Sbjct: 139 -HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPEL 193
Query: 648 -YGIERKVSTRSDIYSYGIMLIE 669
            +G     S+  D++S G +L E
Sbjct: 194 IFGATDYTSS-IDVWSAGCVLAE 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 159
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 217
Query: 590 FRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 218 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPE 271
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 272 LIFGATDYTSS-IDVWSAGCVLAE 294

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 27/203 (13%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI--- 536
            +IG GSFG VY+A+L D G  VAIK   Q   +A K+ E+  ++M+ + H N+V++   
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKNREL--QIMRKLDHCNIVRLRYF 81
Query: 537 --ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLNF 590
              SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI-- 138
Query: 591 RHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE- 647
            H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE 
Sbjct: 139 -HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPEL 193
Query: 648 -YGIERKVSTRSDIYSYGIMLIE 669
            +G     S+  D++S G +L E
Sbjct: 194 IFGATDYTSS-IDVWSAGCVLAE 215

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 172
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 173 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPE 226
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 227 LIFGATDYTSS-IDVWSAGCVLAE 249

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 88
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 146
Query: 590 FRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 147 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 200
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 201 LIFGATDYTSS-IDVWSAGCVLAE 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 11/216 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL 687
              S +SDI+S G+ L+E    + P     A EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 11/216 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE    
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 177
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL 687
              S +SDI+S G+ L+E    + P     A EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 11/216 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 150
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE    
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 204
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL 687
              S +SDI+S G+ L+E    + P     A EL L
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 150
Query: 590 FRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 151 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 204
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 205 LIFGATDYTSS-IDVWSAGCVLAE 227

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 118/252 (46%), Gaps = 24/252 (9%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRN 532
           + F + + +G G+ G V+K +    G+ +A K+ H E   A+++  + E +V+       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLNIMIDVASALEYLNFR 591
           +V       +D   ++ +E+M  GSLD  L  +  + + I  +++I   V   L YL  +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 142
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H   I+H D+K SN+L++      L DFG+    SG+         + T  YM+PE    
Sbjct: 143 HK--IMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPERLQG 196
Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP----ADKMFAAELSLKHWVN--------GLLPVSL 699
              S +SDI+S G+ L+E    + P    +  M   EL L + VN        G+  +  
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFEL-LDYIVNEPPPKLPSGVFSLEF 255
Query: 700 MEVVNKTLLSPP 711
            + VNK L+  P
Sbjct: 256 QDFVNKCLIKNP 267

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           IG G FG V++ +   G EVA+K+F    +R  +S+  E E+ + +  RH N++  I+  
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
           + D+       LV +Y  +GSL  F Y +   + +   + + +  AS L +L+      +
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSL--FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQ-SMTQTQTLATIGYMAPEYG 649
               I H DLKS N+L+ ++    ++D G+A +  S  D   +     + T  YMAPE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV- 184
Query: 650 IERKVS-------TRSDIYSYGIMLIETFTR 673
           ++  ++        R+DIY+ G++  E   R
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 108
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 166
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 167 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPE 220
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 221 LIFGATDYTSS-IDVWSAGCVLAE 243

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARA 514
           ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A  
Sbjct: 2   ESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 54
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
                 E E+  ++RH N++++     +     L+LEY P G++    Y     L  F  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDE 110
Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    S
Sbjct: 111 QRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPS 163
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
             +T    T+ Y+ PE    R    + D++S G++  E    K P +
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 27/203 (13%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI--- 536
            +IG GSFG VY+A+L D G  VAIK   Q   +A K+ E+  ++M+ + H N+V++   
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--GKAFKNREL--QIMRKLDHCNIVRLRYF 81
Query: 537 --ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLNF 590
              SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI-- 138
Query: 591 RHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE- 647
            H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE 
Sbjct: 139 -HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPEL 193
Query: 648 -YGIERKVSTRSDIYSYGIMLIE 669
            +G     S+  D++S G +L E
Sbjct: 194 IFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 150
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 151 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 204
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 205 LIFGATDYTSS-IDVWSAGCVLAE 227

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E +    +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 76  YFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKK 128
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +     T+ Y+ PE    R   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 73  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 125
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
            + D++S G++  E    K P +
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 85
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 143
Query: 590 FRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 144 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPE 197
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 198 LIFGATDYTSS-IDVWSAGCVLAE 220

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 25/225 (11%)
Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARA 514
           ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A  
Sbjct: 4   ESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 56
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
                 E E+  ++RH N++++     +     L+LEY P G +    Y     L  F  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDE 112
Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    S
Sbjct: 113 QRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPS 165
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
             +     T+ Y+ PE    R    + D++S G++  E    K P
Sbjct: 166 SRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 27/203 (13%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNF 590
               SG   D+ +  LVL+Y+P     +  + S     L +      M  +  +L Y+  
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI-- 138
Query: 591 RHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE- 647
            H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE 
Sbjct: 139 -HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPEL 193
Query: 648 -YGIERKVSTRSDIYSYGIMLIE 669
            +G     S+  D++S G +L E
Sbjct: 194 IFGATDYTSS-IDVWSAGCVLAE 215

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 128
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  K
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGXK 186
Query: 654 -VSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 20/199 (10%)
Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKIIS- 538
            +IG GSFG V++A+L +  EVAIK   Q+     K F+  E ++M+ ++H N+V + + 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 539 ----GCSNDD-FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
               G   D+ F  LVLEY+P        + +  +      L I + +   L  L + H+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 594 TPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE--YGI 650
             I H D+K  N+LLD    +  L DFG AK+L   + +++    + +  Y APE  +G 
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRYYRAPELIFGA 216
Query: 651 ERKVSTRSDIYSYGIMLIE 669
               +T  DI+S G ++ E
Sbjct: 217 T-NYTTNIDIWSTGCVMAE 234

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 81
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 139
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 140 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 193
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 194 LIFGATDYTSS-IDVWSAGCVLAE 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 84
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 142
Query: 590 FRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 143 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 196
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 197 LIFGATDYTSS-IDVWSAGCVLAE 219

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   IG GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 138
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 139 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 192
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 193 LIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           IG G FG V++ +   G EVA+K+F    +R  +S+  E E+ + +  RH N++  I+  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
           + D+       LV +Y  +GSL  F Y +   + +   + + +  AS L +L+      +
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSL--FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQ-SMTQTQTLATIGYMAPEYG 649
               I H DLKS N+L+ ++    ++D G+A +  S  D   +     + T  YMAPE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV- 183
Query: 650 IERKVS-------TRSDIYSYGIMLIETFTR 673
           ++  ++        R+DIY+ G++  E   R
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 93
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 151
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 152 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPE 205
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 206 LIFGATDYTSS-IDVWSAGCVLAE 228

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 84  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +    + +AT
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQE-CARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ  C R ++    E +++   R
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 84
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 85  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +    + +AT
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A E   G +VA+K+      +  +    E  +M++ +H N+V++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
             +   +++E++  G+L DI    S   L+  Q   +   V  AL YL   H   +IH D
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYL---HAQGVIHRD 166
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           +KS ++LL  D    LSDFG    +S +     +   + T  +MAPE       +T  DI
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEVDI 224
Query: 661 YSYGIMLIETFTRKKP 676
           +S GIM+IE    + P
Sbjct: 225 WSLGIMVIEMVDGEPP 240

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  K
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGXK 179
Query: 654 -VSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++   S+D+  +     L       I   +   L+ L F H+
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVA+K+    Q  + +++    E  +MK + H N+VK+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    LV+EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYC---HQKFIVHR 130
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVS-TR 657
           DLK+ N+LLD DM   ++DFG     S E     +  T   +  Y APE    +K     
Sbjct: 131 DLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAEL 685
            D++S G++L    +   P D     EL
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQNLKEL 214

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 80  YFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYC---HSKR 132
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL  +    ++DFG     S    S  +T    T+ Y+ PE    R   
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 656 TRSDIYSYGIMLIE 669
            + D++S G++  E
Sbjct: 189 EKVDLWSLGVLCYE 202

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD 618
           D F      M D+   ++    VA  +E+L+ R     IH DL + N+LL E+ +  + D
Sbjct: 189 DGFYKEPITMEDL---ISYSFQVARGMEFLSSRKC---IHRDLAARNILLSENNVVKICD 242
Query: 619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           FG+A+ +      + +  T   + +MAPE   ++  ST+SD++SYG++L E F+
Sbjct: 243 FGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 537 ---ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D+ +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 138
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 139 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPE 192
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 193 LIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++   S+D+  +     L       I   +   L+ L F H+
Sbjct: 66  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQEC-ARAMKSFEVECEV--MKNIRHRNLVKIIS 538
           +G GSFG V  A     G +VA+K+ +++  A++     +E E+  ++ +RH +++K+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              + D   +V+EY  N   D  +          +R      + SA+EY    H   I+H
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYC---HRHKIVH 135
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST-- 656
            DLK  N+LLDE +   ++DFG++ +++  D +  +T +  +  Y APE  I  K+    
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 191
Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D++S G++L     R+ P D
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFD 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVA+K+    Q  + +++    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    LV+EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQKFIVHR 137
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVS-TR 657
           DLK+ N+LLD DM   ++DFG     S E     +  T   +  Y APE    +K     
Sbjct: 138 DLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAEL 685
            D++S G++L    +   P D     EL
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L+F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLSFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQEC-ARAMKSFEVECEV--MKNIRHRNLVKIIS 538
           +G GSFG V  A     G +VA+K+ +++  A++     +E E+  ++ +RH +++K+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              + D   +V+EY  N   D  +          +R      + SA+EY    H   I+H
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYC---HRHKIVH 126
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST-- 656
            DLK  N+LLDE +   ++DFG++ +++  D +  +T +  +  Y APE  I  K+    
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 182
Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D++S G++L     R+ P D
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFD 204

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 25/226 (11%)
Query: 458 SQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECAR 513
            ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A 
Sbjct: 24  EESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG 76
Query: 514 AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF- 572
                  E E+  ++RH N++++     +     L+LEY P G++    Y     L  F 
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFD 132
Query: 573 -QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
            QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    
Sbjct: 133 EQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAP 185
Query: 631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           S  +     T+ Y+ PE    R    + D++S G++  E    K P
Sbjct: 186 SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           +G G +G V++     G  VA+K+F    +R  KS+  E E+   +  RH N++  I+  
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
                 +    L+  Y   GSL  +L  +T  LD    L I++ +AS L +L+      +
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-----LATIGYMAP 646
               I H DLKS N+L+ ++    ++D G+A + S   QS  Q        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS---QSTNQLDVGNNPRVGTKRYMAP 215
Query: 647 EYGIER------KVSTRSDIYSYGIMLIETFTR 673
           E   E           R DI+++G++L E   R
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQEC-ARAMKSFEVECEV--MKNIRHRNLVKIIS 538
           +G GSFG V  A     G +VA+K+ +++  A++     +E E+  ++ +RH +++K+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              + D   +V+EY  N   D  +          +R      + SA+EY    H   I+H
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYC---HRHKIVH 136
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST-- 656
            DLK  N+LLDE +   ++DFG++ +++  D +  +T +  +  Y APE  I  K+    
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 192
Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D++S G++L     R+ P D
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFD 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 131
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +     T+ Y+ PE    R   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHD 187
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPP 208

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQEC-ARAMKSFEVECEV--MKNIRHRNLVKIIS 538
           +G GSFG V  A     G +VA+K+ +++  A++     +E E+  ++ +RH +++K+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              + D   +V+EY  N   D  +          +R      + SA+EY    H   I+H
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYC---HRHKIVH 130
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST-- 656
            DLK  N+LLDE +   ++DFG++ +++  D +  +T +  +  Y APE  I  K+    
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 186
Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D++S G++L     R+ P D
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFD 208

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++   S+D+  +     L       I   +   L+ L F H+
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVA+K+    Q  + +++    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    LV+EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQKFIVHR 137
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVS-TR 657
           DLK+ N+LLD DM   ++DFG     S E     +  T   +  Y APE    +K     
Sbjct: 138 DLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAEL 685
            D++S G++L    +   P D     EL
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 128
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 186
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 14/193 (7%)
Query: 481 NLIGIGSFGYVY--KAELDDGIEVAIKVFHQECARAMK---SFEVECEVMKNIRHRNLVK 535
           + +G+G+FG V   K EL  G +VA+K+ +++  R++        E + +K  RH +++K
Sbjct: 22  DTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +    S      +V+EY+  G L  ++      LD  +   +   + S ++Y + RH   
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH-RHM-- 136
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KV 654
           ++H DLK  NVLLD  M A ++DFG++ ++S  D    +  +  +  Y APE    R   
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRX-SCGSPNYAAPEVISGRLYA 193
Query: 655 STRSDIYSYGIML 667
               DI+S G++L
Sbjct: 194 GPEVDIWSSGVIL 206

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 481 NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMK---SFEVECEVMKNIRHRNLVKI 536
           + +G+G+FG V   E    G +VA+K+ +++  R++      + E + +K  RH +++K+
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
               S      +V+EY+  G L  ++     + ++  R  +   + SA++Y + RH   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH-RHM--V 132
Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVS 655
           +H DLK  NVLLD  M A ++DFG++ ++S  D    +  +  +  Y APE    R    
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLR-DSCGSPNYAAPEVISGRLYAG 189
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
              DI+S G++L        P D
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFD 212

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 128
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +     T+ Y+ PE    R   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPP 205

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 14/211 (6%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G GSFG V++  +   G + A+K    E  R  +   V C  + + R   +V +     
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 120
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
              +  + +E +  GSL   +    C+ +       +  +  ALE L + HT  I+H D+
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPED----RALYYLGQALEGLEYLHTRRILHGDV 176
Query: 602 KSSNVLLDED-MIAHLSDFGIAKLLS--GEDQS-MTQTQTLATIGYMAPEYGIERKVSTR 657
           K+ NVLL  D   A L DFG A  L   G  +S +T      T  +MAPE  + +    +
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
            DI+S   M++       P  + F   L LK
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 131
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +     T+ Y+ PE    R   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHD 187
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPP 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 76  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 128
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +     T+ Y+ PE    R   
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
            + D++S G++  E    K P +
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 481 NLIGIGSFGYVYKAE----LDDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNIRHRN 532
            ++G G +G V++       + G   A+KV  +      A+     + E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSL-------DIFLYSSTCMLDIFQRLNIMIDVASAL 585
           +V +I          L+LEY+  G L        IF+  + C          + +++ AL
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMAL 134
Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            +L   H   II+ DLK  N++L+      L+DFG+ K  S  D ++T T    TI YMA
Sbjct: 135 GHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHT-FCGTIEYMA 189
Query: 646 PEYGIERKVSTRSDIYSYGIMLIETFT---------RKKPADKMFAAELSL 687
           PE  +    +   D +S G ++ +  T         RKK  DK+   +L+L
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++   S+D+  +     L       I   +   L+ L F H+
Sbjct: 67  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARA 514
           ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A  
Sbjct: 1   ESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 53
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
                 E E+  ++RH N++++     +     L+LEY P G++    Y     L  F  
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDE 109
Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           QR    I ++A+AL Y    H+  +IH D+K  N+LL       +++FG     S    S
Sbjct: 110 QRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPS 162
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
             +T    T+ Y+ PE    R    + D++S G++  E    K P +
Sbjct: 163 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A +   G  VA+K       +  +    E  +M++ +H N+V++ +   
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTTPII 597
             D   +V+E++  G+L DI  ++         R+N   I     + L+ L+  H   +I
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHT---------RMNEEQIAAVCLAVLQALSVLHAQGVI 269
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+KS ++LL  D    LSDFG    +S E     +   + T  +MAPE          
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 658 SDIYSYGIMLIETFTRKKP 676
            DI+S GIM+IE    + P
Sbjct: 328 VDIWSLGIMVIEMVDGEPP 346

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARA 514
           ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A  
Sbjct: 1   ESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 53
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
                 E E+  ++RH N++++     +     L+LEY P G++    Y     L  F  
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDE 109
Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           QR    I ++A+AL Y    H+  +IH D+K  N+LL       ++DFG     S    S
Sbjct: 110 QRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPS 162
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
             +     T+ Y+ PE    R    + D++S G++  E    K P
Sbjct: 163 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 180
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A +   G  VA+K       +  +    E  +M++ +H N+V++ +   
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTTPII 597
             D   +V+E++  G+L DI  ++         R+N   I     + L+ L+  H   +I
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHT---------RMNEEQIAAVCLAVLQALSVLHAQGVI 192
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+KS ++LL  D    LSDFG    +S E     +   + T  +MAPE          
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 658 SDIYSYGIMLIETFTRKKP 676
            DI+S GIM+IE    + P
Sbjct: 251 VDIWSLGIMVIEMVDGEPP 269

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           +G G +G V++     G  VA+K+F    +R  KS+  E E+   +  RH N++  I+  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
                 +    L+  Y   GSL  +L  +T  LD    L I++ +AS L +L+      +
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-----LATIGYMAP 646
               I H DLKS N+L+ ++    ++D G+A + S   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS---QSTNQLDVGNNPRVGTKRYMAP 186
Query: 647 EYGIER------KVSTRSDIYSYGIMLIETFTR 673
           E   E           R DI+++G++L E   R
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARA 514
           ++ KR+   +D        GR   +G G FG VY A E      +A+KV  +   E A  
Sbjct: 2   ESKKRQWALEDFE-----IGRP--LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV 54
Query: 515 MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
                 E E+  ++RH N++++     +     L+LEY P G++    Y     L  F  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDE 110
Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
           QR    I ++A+AL Y    H+  +IH D+K  N+LL       +++FG     S    S
Sbjct: 111 QRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPS 163
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
             +T    T+ Y+ PE    R    + D++S G++  E    K P +
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGC 540
           +G G +G V++     G  VA+K+F    +R  KS+  E E+   +  RH N++  I+  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 541 SNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
                 +    L+  Y   GSL  +L  +T  LD    L I++ +AS L +L+      +
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-----LATIGYMAP 646
               I H DLKS N+L+ ++    ++D G+A + S   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS---QSTNQLDVGNNPRVGTKRYMAP 186
Query: 647 EYGIER------KVSTRSDIYSYGIMLIETFTR 673
           E   E           R DI+++G++L E   R
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 14/211 (6%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G GSFG V++  +   G + A+K    E  R  +   V C  + + R   +V +     
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 136
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
              +  + +E +  GSL   +    C+ +       +  +  ALE L + HT  I+H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPED----RALYYLGQALEGLEYLHTRRILHGDV 192
Query: 602 KSSNVLLDED-MIAHLSDFGIAKLLS--GEDQS-MTQTQTLATIGYMAPEYGIERKVSTR 657
           K+ NVLL  D   A L DFG A  L   G  +S +T      T  +MAPE  + +    +
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
            DI+S   M++       P  + F   L LK
Sbjct: 253 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A +   G  VA+K       +  +    E  +M++ +H N+V++ +   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTTPII 597
             D   +V+E++  G+L DI  ++         R+N   I     + L+ L+  H   +I
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHT---------RMNEEQIAAVCLAVLQALSVLHAQGVI 147
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+KS ++LL  D    LSDFG    +S E     +   + T  +MAPE          
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 658 SDIYSYGIMLIETFTRKKP 676
            DI+S GIM+IE    + P
Sbjct: 206 VDIWSLGIMVIEMVDGEPP 224

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKA--ELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA  +L   +    K+        + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG+AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKA--ELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA  +L   +    K+        + S  + E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A +   G  VA+K       +  +    E  +M++ +H N+V++ +   
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTTPII 597
             D   +V+E++  G+L DI  ++         R+N   I     + L+ L+  H   +I
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHT---------RMNEEQIAAVCLAVLQALSVLHAQGVI 142
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+KS ++LL  D    LSDFG    +S E     +   + T  +MAPE          
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 658 SDIYSYGIMLIETFTRKKP 676
            DI+S GIM+IE    + P
Sbjct: 201 VDIWSLGIMVIEMVDGEPP 219

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 125
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 183
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A +   G  VA+K       +  +    E  +M++ +H N+V++ +   
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTTPII 597
             D   +V+E++  G+L DI  ++         R+N   I     + L+ L+  H   +I
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHT---------RMNEEQIAAVCLAVLQALSVLHAQGVI 138
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+KS ++LL  D    LSDFG    +S E     +   + T  +MAPE          
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 658 SDIYSYGIMLIETFTRKKP 676
            DI+S GIM+IE    + P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           IG GS G V  A +   G  VA+K       +  +    E  +M++ +H N+V++ +   
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 542 NDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTTPII 597
             D   +V+E++  G+L DI  ++         R+N   I     + L+ L+  H   +I
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHT---------RMNEEQIAAVCLAVLQALSVLHAQGVI 149
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+KS ++LL  D    LSDFG    +S E     +   + T  +MAPE          
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 658 SDIYSYGIMLIETFTRKKP 676
            DI+S GIM+IE    + P
Sbjct: 208 VDIWSLGIMVIEMVDGEPP 226

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 14/211 (6%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G GSFG V++  +   G + A+K    E  R  +   V C  + + R   +V +     
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 134
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
              +  + +E +  GSL   +    C+ +       +  +  ALE L + HT  I+H D+
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPED----RALYYLGQALEGLEYLHTRRILHGDV 190
Query: 602 KSSNVLLDED-MIAHLSDFGIAKLLS--GEDQS-MTQTQTLATIGYMAPEYGIERKVSTR 657
           K+ NVLL  D   A L DFG A  L   G  +S +T      T  +MAPE  + +    +
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
            DI+S   M++       P  + F   L LK
Sbjct: 251 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 79  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 131
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +     T+ Y+ PE    R   
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHD 187
Query: 656 TRSDIYSYGIMLIETFTRKKPAD 678
            + D++S G++  E    K P +
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 126/284 (44%), Gaps = 32/284 (11%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLVKIIS--- 538
           IG G +G V+  +   G +VA+KVF   E A   +  E+   V+  +RH N++  I+   
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENILGFIAADI 101
Query: 539 -GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL-----EYLNFRH 592
            G  +     L+ +Y  NGSL  +L S+T  LD    L +     S L     E  + + 
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQ-SMTQTQTLATIGYMAPEYGI 650
              I H DLKS N+L+ ++    ++D G+A K +S  ++  +     + T  YM PE   
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 651 ER------KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV-----SL 699
           E       +    +D+YS+G++L E   R          E  L +  + L+P       +
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARR--CVSGGIVEEYQLPY--HDLVPSDPSYEDM 275
Query: 700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA 743
            E+V    L P   +  + ++C+  +  L  EC    P  R+ A
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 232
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 233 SKGYNKAVDWWALGVLIYE 251

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC---HSKR 129
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL       ++DFG     S    S  +     T+ Y+ PE    R   
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHD 185
Query: 656 TRSDIYSYGIMLIETFTRKKP 676
            + D++S G++  E    K P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 10/206 (4%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L  +       D    V+EY   G L   L       +   R     ++ SALEYL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL-- 121
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +++ D+K  N++LD+D    ++DFG+ K   G     T      T  Y+APE   
Sbjct: 122 -HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T T  + T+ Y APE  +  +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCK 178
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVA+++    Q  + +++    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    LV+EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQKFIVHR 137
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS-TRS 658
           DLK+ N+LLD DM   ++DFG +   +  ++  T      +  Y APE    +K      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEV 194
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAEL 685
           D++S G++L    +   P D     EL
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 29/204 (14%)
Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE-VECEVMKNIRHRNLVKI-- 536
            +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H N+V++  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 537 ---ISGCSND-DFKALVLEYMPNGSLDIFLYSSTC---MLDIFQRLNIMIDVASALEYLN 589
               SG   D  +  LVL+Y+P     +  + S     +  I+ +L  M  +  +L Y+ 
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI- 138
Query: 590 FRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAK-LLSGEDQSMTQTQTLATIGYMAPE 647
             H+  I H D+K  N+LLD D  +  L DFG AK L+ GE         + +  Y APE
Sbjct: 139 --HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSXICSRYYRAPE 192
Query: 648 --YGIERKVSTRSDIYSYGIMLIE 669
             +G     S+  D++S G +L E
Sbjct: 193 LIFGATDYTSS-IDVWSAGCVLAE 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 470 LSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIE-VAIKVFHQECARAMKSFEVECEV--- 524
           L RA  ++     IG G++G V+KA +L +G   VA+K    +            EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 525 --MKNIRHRNLVKIISGC--SNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
             ++   H N+V++   C  S  D +    LV E++     D+  Y             I
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETI 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
              +   L  L+F H+  ++H DLK  N+L+       L+DFG+A++ S +   M  T  
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           + T+ Y APE  ++   +T  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 149
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 205 SKGYNKAVDWWALGVLIYE 223

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+P G +    +S    +  F   +     A  +    +
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 149
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 150 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 205 SKGYNKAVDWWALGVLIYE 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 10/206 (4%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L  +       D    V+EY   G L   L       +   R     ++ SALEYL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL-- 121
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +++ D+K  N++LD+D    ++DFG+ K   G     T      T  Y+APE   
Sbjct: 122 -HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 178
Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 10/206 (4%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L  +       D    V+EY   G L   L       +   R     ++ SALEYL  
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL-- 124
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +++ D+K  N++LD+D    ++DFG+ K   G     T      T  Y+APE   
Sbjct: 125 -HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 181
Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
           +       D +  G+++ E    + P
Sbjct: 182 DNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 10/206 (4%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L  +       D    V+EY   G L   L       +   R     ++ SALEYL  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYL-- 121
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +++ D+K  N++LD+D    ++DFG+ K   G     T      T  Y+APE   
Sbjct: 122 -HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLE 178
Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
           +       D +  G+++ E    + P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 12/207 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM-IDVASALEYLN 589
             L  +       D    V+EY   G L  F + S   +   +R      ++ SALEYL 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL- 121
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H+  +++ D+K  N++LD+D    ++DFG+ K   G     T      T  Y+APE  
Sbjct: 122 --HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVL 177
Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP 676
            +       D +  G+++ E    + P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG+AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 6   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 64  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 123 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIK 177
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVA+++    Q  + +++    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    LV+EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQKFIVHR 137
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS-TRS 658
           DLK+ N+LLD DM   ++DFG +   +  ++     +   +  Y APE    +K      
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPEV 194
Query: 659 DIYSYGIMLIETFTRKKPADKMFAAEL 685
           D++S G++L    +   P D     EL
Sbjct: 195 DVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      VA+KV  +   E          E E+  ++ H N++++ +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              +     L+LEY P G L   L  S C  D  +   IM ++A AL Y    H   +IH
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYC---HGKKVIH 146
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LL       ++DFG     S    S+ +     T+ Y+ PE    R  + + 
Sbjct: 147 RDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKV 202
Query: 659 DIYSYGIMLIETFTRKKP 676
           D++  G++  E      P
Sbjct: 203 DLWCIGVLCYELLVGNPP 220

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 12/207 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM-IDVASALEYLN 589
             L  +       D    V+EY   G L  F + S   +   +R      ++ SALEYL 
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL- 126
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H+  +++ D+K  N++LD+D    ++DFG+ K   G     T      T  Y+APE  
Sbjct: 127 --HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVL 182
Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP 676
            +       D +  G+++ E    + P
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 34  EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 92  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 150
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 151 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 205
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWE 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVF----HQEC-ARAMKSFEVECEVMKNIR 529
           R+   + IG G++G V  A  + + + VAIK      HQ    R ++    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFR 83
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDV 581
           H N++ I     ND  +A  +E M     D+++       D+++ L        +I   +
Sbjct: 84  HENIIGI-----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE-DQSMTQTQTLAT 640
              L  L + H+  ++H DLK SN+LL+      + DFG+A++   + D +   T+ +AT
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 12/207 (5%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM-IDVASALEYLN 589
             L  +       D    V+EY   G L  F + S   +   +R      ++ SALEYL 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL- 121
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             H+  +++ D+K  N++LD+D    ++DFG+ K   G     T      T  Y+APE  
Sbjct: 122 --HSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVL 177
Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP 676
            +       D +  G+++ E    + P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVA+K+    Q  + +++    E  +MK + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    LV+EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQKFIVHR 137
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEYGIERKVS- 655
           DLK+ N+LLD DM   ++DFG +      ++     +  A  G   Y APE    +K   
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 656 TRSDIYSYGIMLIETFTRKKPADKMFAAEL 685
              D++S G++L    +   P D     EL
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 11  EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 69  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 128 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 182
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWE 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 470 LSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIE-VAIKVFHQECARAMKSFEVECEV--- 524
           L RA  ++     IG G++G V+KA +L +G   VA+K    +            EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 525 --MKNIRHRNLVKIISGC--SNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
             ++   H N+V++   C  S  D +    LV E++     D+  Y             I
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETI 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
              +   L  L+F H+  ++H DLK  N+L+       L+DFG+A++ S +   M  T  
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           + T+ Y APE  ++   +T  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 9   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 67  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 125
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 126 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 180
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 181 WMAPESINFRRFTSASDVWMFGVCMWE 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 477 FGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFH-QECARAMKSFEVECEVMKNIRHRNL 533
           F + + IG GSFG VYK  +D+  +  VAIK+   +E    ++  + E  V+       +
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 534 VKIISGCSNDDFKALVLEYMPNGS-LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            +            +++EY+  GS LD+        L+      I+ ++   L+YL   H
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYL---H 133
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +   IH D+K++NVLL E     L+DFG+A  L+  D  + +   + T  +MAPE   + 
Sbjct: 134 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQS 191
Query: 653 KVSTRSDIYSYGIMLIE 669
               ++DI+S GI  IE
Sbjct: 192 AYDFKADIWSLGITAIE 208

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 6   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 64  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 123 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 177
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 6   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 64  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 123 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 177
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVAIK+    Q    +++    E  +MK + H N+VK+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    L++EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYC---HQKRIVHR 135
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVS-TR 657
           DLK+ N+LLD DM   ++DFG     S E     +  T   +  Y APE    +K     
Sbjct: 136 DLKAENLLLDADMNIKIADFG----FSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAEL 685
            D++S G++L    +   P D     EL
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQNLKEL 219

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 470 LSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIE-VAIKVFHQECARAMKSFEVECEV--- 524
           L RA  ++     IG G++G V+KA +L +G   VA+K    +            EV   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 525 --MKNIRHRNLVKIISGC--SNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
             ++   H N+V++   C  S  D +    LV E++     D+  Y             I
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETI 122
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
              +   L  L+F H+  ++H DLK  N+L+       L+DFG+A++ S +   M  T  
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSV 179
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           + T+ Y APE  ++   +T  D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E      +A+KV  +   E A        E E+  ++RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTP 595
              +     L+LEY P G++    Y     L  F  QR    I ++A+AL Y    H+  
Sbjct: 80  YFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYC---HSKR 132
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           +IH D+K  N+LL  +    ++DFG     S    S  +     T+ Y+ PE    R   
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHD 188
Query: 656 TRSDIYSYGIMLIE 669
            + D++S G++  E
Sbjct: 189 EKVDLWSLGVLCYE 202

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 8   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 66  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 124
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 125 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 179
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWE 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVF-HQECARAMKSFEV-ECEVMKNIRHRNLVKIISG 539
           IG GS+G V+K    D G  VAIK F   E    +K   + E  ++K ++H NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR---LNIMIDVA-SALEYLNFRHTTP 595
                   LV EY  +  L          LD +QR    +++  +    L+ +NF H   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLH--------ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKV 654
            IH D+K  N+L+ +  +  L DFG A+LL+G   S      +AT  Y +PE  + + + 
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 655 STRSDIYSYGIMLIETFT 672
               D+++ G +  E  +
Sbjct: 181 GPPVDVWAIGCVFAELLS 198

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 13/208 (6%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVA+K+    Q    +++    E  +MK + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    LV+EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYC---HQKYIVHR 138
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVS-TR 657
           DLK+ N+LLD DM   ++DFG     S E     +  T   +  Y APE    +K     
Sbjct: 139 DLKAENLLLDGDMNIKIADFG----FSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAEL 685
            D++S G++L    +   P D     EL
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 3   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 61  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 120 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 174
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWE 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G+F  V +  ++  G E A K+ + +   AR  +  E E  + + ++H N+V++   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
            S + F  LV + +  G     L+      + +   +    +   LE +N  H   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 600 DLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           DLK  N+LL    +     L+DFG+A  + G+ Q+        T GY++PE   +     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGK 185
Query: 657 RSDIYSYGIML 667
             D+++ G++L
Sbjct: 186 PVDMWACGVIL 196

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 125
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 183
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 25/231 (10%)
Query: 473 ATNRFGRDN-----LIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMK 526
           ++NR G DN     ++G GSFG V  A + + G   A+KV  ++    ++  +VEC + +
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTE 73
Query: 527 NI------RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID 580
                    H  L ++       D    V+E++  G L +F    +   D  +      +
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAE 132
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           + SAL +L   H   II+ DLK  NVLLD +    L+DFG+ K   G    +T      T
Sbjct: 133 IISALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGT 187
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP-----ADKMFAAELS 686
             Y+APE   E       D ++ G++L E      P      D +F A L+
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 35/238 (14%)
Query: 464 RLPY-QDLSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQECA 512
           +LPY        NR      +G G+FG V +A      + D  + VA+K+     H    
Sbjct: 34  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 93
Query: 513 RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSL--------DIFLY 563
            A+ S   E +V+  +  H N+V ++  C+      ++ EY   G L        D F+ 
Sbjct: 94  EALMS---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 564 SSTC---------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
           S T           LD+   L+    VA  + +L  ++    IH DL + N+LL    I 
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRIT 207
Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            + DFG+A+ +  +   + +      + +MAPE       +  SD++SYGI L E F+
Sbjct: 208 KICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  + + +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +VLEY P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 481 NLIGIGSFGYVYKAE----LDDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNIRHRN 532
            ++G G +G V++       + G   A+KV  +      A+     + E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 533 LVKIISGCSNDDFKALVLEYMPNGSL-------DIFLYSSTCMLDIFQRLNIMIDVASAL 585
           +V +I          L+LEY+  G L        IF+  + C          + +++ AL
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMAL 134
Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            +L   H   II+ DLK  N++L+      L+DFG+ K  S  D ++T      TI YMA
Sbjct: 135 GHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHX-FCGTIEYMA 189
Query: 646 PEYGIERKVSTRSDIYSYGIMLIETFT---------RKKPADKMFAAELSL 687
           PE  +    +   D +S G ++ +  T         RKK  DK+   +L+L
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 12/191 (6%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G+F  V +  ++  G E A K+ + +   AR  +  E E  + + ++H N+V++   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
            S + F  LV + +  G     L+      + +   +    +   LE +N  H   I+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 600 DLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           DLK  N+LL    +     L+DFG+A  + G+ Q+        T GY++PE   +     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKDPYGK 185
Query: 657 RSDIYSYGIML 667
             D+++ G++L
Sbjct: 186 PVDMWACGVIL 196

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 181
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVAIK+    Q    +++    E  +MK + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    L++EY   G +  +L +   M +   R      + SA++Y    H   I+H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYC---HQKRIVHR 138
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEYGIERKVS- 655
           DLK+ N+LLD DM   ++DFG +      ++     +  A  G   Y APE    +K   
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 656 TRSDIYSYGIMLIETFTRKKPADKMFAAEL 685
              D++S G++L    +   P D     EL
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++     D    S+   + +    + +  +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQL---LQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 178
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 35/238 (14%)
Query: 464 RLPY-QDLSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQECA 512
           +LPY        NR      +G G+FG V +A      + D  + VA+K+     H    
Sbjct: 27  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 86
Query: 513 RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSL--------DIFLY 563
            A+ S   E +V+  +  H N+V ++  C+      ++ EY   G L        D F+ 
Sbjct: 87  EALMS---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 143
Query: 564 SSTC---------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
           S T           LD+   L+    VA  + +L  ++    IH DL + N+LL    I 
Sbjct: 144 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRIT 200
Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            + DFG+A+ +  +   + +      + +MAPE       +  SD++SYGI L E F+
Sbjct: 201 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 178
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+  G +    +S    +  F   +     A  +    +
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 143
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+DE     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 198
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 199 SKGYNKAVDWWALGVLIYE 217

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 180
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 35/238 (14%)
Query: 464 RLPY-QDLSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQECA 512
           +LPY        NR      +G G+FG V +A      + D  + VA+K+     H    
Sbjct: 11  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 513 RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSL--------DIFLY 563
            A+ S   E +V+  +  H N+V ++  C+      ++ EY   G L        D F+ 
Sbjct: 71  EALMS---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 564 SSTC---------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
           S T           LD+   L+    VA  + +L  ++    IH DL + N+LL    I 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRIT 184
Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            + DFG+A+ +  +   + +      + +MAPE       +  SD++SYGI L E F+
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 50  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 108
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 164
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G       T T
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWT 218
Query: 638 L-ATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           L  T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 219 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G      +T  
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWX 197
Query: 638 LA-TIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           LA T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 198 LAGTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 35/238 (14%)
Query: 464 RLPY-QDLSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQECA 512
           +LPY        NR      +G G+FG V +A      + D  + VA+K+     H    
Sbjct: 34  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 93
Query: 513 RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSL--------DIFLY 563
            A+ S   E +V+  +  H N+V ++  C+      ++ EY   G L        D F+ 
Sbjct: 94  EALMS---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 564 SSTC---------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
           S T           LD+   L+    VA  + +L  ++    IH DL + N+LL    I 
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRIT 207
Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            + DFG+A+ +  +   + +      + +MAPE       +  SD++SYGI L E F+
Sbjct: 208 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 35/238 (14%)
Query: 464 RLPY-QDLSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVF----HQECA 512
           +LPY        NR      +G G+FG V +A      + D  + VA+K+     H    
Sbjct: 29  QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 88
Query: 513 RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSL--------DIFLY 563
            A+ S   E +V+  +  H N+V ++  C+      ++ EY   G L        D F+ 
Sbjct: 89  EALMS---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 145
Query: 564 SSTC---------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
           S T           LD+   L+    VA  + +L  ++    IH DL + N+LL    I 
Sbjct: 146 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRIT 202
Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            + DFG+A+ +  +   + +      + +MAPE       +  SD++SYGI L E F+
Sbjct: 203 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 6   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 64  TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+       L DFG+++ +  ED +  + ++    I 
Sbjct: 123 ALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 177
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 179
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 27/189 (14%)
Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECA--------RAMKSFEVECEV 524
           + ++   + +G G+FG+V+ A + +   EV +K   +E            +    +E  +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN------IM 578
           +  + H N++K++    N  F  LV+E   +G LD+F +     +D   RL+      I 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAF-----IDRHPRLDEPLASYIF 136
Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
             + SA+ YL  +    IIH D+K  N+++ ED    L DFG A  L   ++        
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFC 190
Query: 639 ATIGYMAPE 647
            TI Y APE
Sbjct: 191 GTIEYCAPE 199

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKN 527
           +R T+ +     +G G+F  V +  +     E A K+ + +   AR  +  E E  + + 
Sbjct: 27  TRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRL 86
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           ++H N+V++    S + F  LV + +  G     L+      + +   +    +   LE 
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIHQILES 142
Query: 588 LNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           +N  H   I+H DLK  N+LL    +     L+DFG+A  + GE Q+        T GY+
Sbjct: 143 VNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--GTPGYL 200
Query: 645 APEYGIERKVSTRSDIYSYGIML 667
           +PE   +       DI++ G++L
Sbjct: 201 SPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L K+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 9/202 (4%)
Query: 477 FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEV-ECEVMKNIRHRNL 533
           F +   IG G++G VYKA     G  VA+K    +     + S  + E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           VK++     ++   LV E++ +  L  F+  ++ +  I   L I   +   L+ L F H+
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-R 652
             ++H DLK  N+L++ +    L+DFG+A+      +  T    + T+ Y APE  +  +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLGCK 182
Query: 653 KVSTRSDIYSYGIMLIETFTRK 674
             ST  DI+S G +  E  TR+
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L K+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 386 EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 444 TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+  +    L DFG+++ +  ED +  + ++    I 
Sbjct: 503 ALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 557
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWE 584

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L K+     ++    +V+EY P G +    +S    +  F   +     A  +    +
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+++D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   + ++ G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+  G +    +S    +  F   +     A  +    +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 519 EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL------DIFLYSSTCMLDIF 572
           E E E++K + H  ++KI +    +D+  +VLE M  G L      +  L  +TC L  +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGED 629
           Q L        A++YL   H   IIH DLK  NVLL   +ED +  ++DFG +K+L GE 
Sbjct: 261 QML-------LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 309
Query: 630 QSMTQTQTL-ATIGYMAPEY-------GIERKVSTRSDIYSYGIMLI----------ETF 671
             M   +TL  T  Y+APE        G  R V    D +S G++L           E  
Sbjct: 310 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHR 362
Query: 672 TRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
           T+    D++ + + +    V   +    +++V K L+  P+  F  +E
Sbjct: 363 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 410

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 519 EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL------DIFLYSSTCMLDIF 572
           E E E++K + H  ++KI +    +D+  +VLE M  G L      +  L  +TC L  +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGED 629
           Q L        A++YL   H   IIH DLK  NVLL   +ED +  ++DFG +K+L GE 
Sbjct: 121 QML-------LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 169
Query: 630 QSMTQTQTL-ATIGYMAPEY-------GIERKVSTRSDIYSYGIMLI----------ETF 671
             M   +TL  T  Y+APE        G  R V    D +S G++L           E  
Sbjct: 170 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHR 222
Query: 672 TRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
           T+    D++ + + +    V   +    +++V K L+  P+  F  +E
Sbjct: 223 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 270

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 477 FGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVMKN------IR 529
           F    ++G GSFG V+ AE     +  AIK   ++    +   +VEC +++         
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWE 77
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H  L  +       +    V+EY+  G L ++   S    D+ +      ++   L++L 
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLSRATFYAAEIILGLQFL- 135
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTLATIGYMAPEY 648
             H+  I++ DLK  N+LLD+D    ++DFG+ K  + G+ ++    +   T  Y+APE 
Sbjct: 136 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCGTPDYIAPEI 190
Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKP 676
            + +K +   D +S+G++L E    + P
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 519 EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL------DIFLYSSTCMLDIF 572
           E E E++K + H  ++KI +    +D+  +VLE M  G L      +  L  +TC L  +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGED 629
           Q L        A++YL   H   IIH DLK  NVLL   +ED +  ++DFG +K+L GE 
Sbjct: 247 QML-------LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 295
Query: 630 QSMTQTQTL-ATIGYMAPEY-------GIERKVSTRSDIYSYGIMLI----------ETF 671
             M   +TL  T  Y+APE        G  R V    D +S G++L           E  
Sbjct: 296 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHR 348
Query: 672 TRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
           T+    D++ + + +    V   +    +++V K L+  P+  F  +E
Sbjct: 349 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 519 EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL------DIFLYSSTCMLDIF 572
           E E E++K + H  ++KI +    +D+  +VLE M  G L      +  L  +TC L  +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGED 629
           Q L        A++YL   H   IIH DLK  NVLL   +ED +  ++DFG +K+L GE 
Sbjct: 128 QML-------LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 176
Query: 630 QSMTQTQTL-ATIGYMAPEY-------GIERKVSTRSDIYSYGIMLI----------ETF 671
             M   +TL  T  Y+APE        G  R V    D +S G++L           E  
Sbjct: 177 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHR 229
Query: 672 TRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
           T+    D++ + + +    V   +    +++V K L+  P+  F  +E
Sbjct: 230 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 277

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV----ECEVMKNIRHRNLVKII 537
           IG G+FG V+KA     G +VA+K    E  +  + F +    E ++++ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 83
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-NIMIDVASA---------LEY 587
             C     KA        GS  I+L    C  D+   L N+++    +         L  
Sbjct: 84  EICRT---KASPYNRC-KGS--IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL--LSGEDQSMTQTQTLATIGYMA 645
           L + H   I+H D+K++NVL+  D +  L+DFG+A+   L+   Q       + T+ Y  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 646 PEYGI-ERKVSTRSDIYSYGIMLIETFTR 673
           PE  + ER      D++  G ++ E +TR
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 519 EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL------DIFLYSSTCMLDIF 572
           E E E++K + H  ++KI +    +D+  +VLE M  G L      +  L  +TC L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGED 629
           Q L        A++YL   H   IIH DLK  NVLL   +ED +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 630 QSMTQTQTL-ATIGYMAPEY-------GIERKVSTRSDIYSYGIMLI----------ETF 671
             M   +TL  T  Y+APE        G  R V    D +S G++L           E  
Sbjct: 171 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHR 223
Query: 672 TRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
           T+    D++ + + +    V   +    +++V K L+  P+  F  +E
Sbjct: 224 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 50  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 108
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 109 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHA 164
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 220
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 221 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 251

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 519 EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL------DIFLYSSTCMLDIF 572
           E E E++K + H  ++KI +    +D+  +VLE M  G L      +  L  +TC L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGED 629
           Q L        A++YL   H   IIH DLK  NVLL   +ED +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 630 QSMTQTQTL-ATIGYMAPEY-------GIERKVSTRSDIYSYGIMLI----------ETF 671
             M   +TL  T  Y+APE        G  R V    D +S G++L           E  
Sbjct: 171 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHR 223
Query: 672 TRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
           T+    D++ + + +    V   +    +++V K L+  P+  F  +E
Sbjct: 224 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V +  +L  G E A K+ + +   AR  +  E E  + + ++H N+V++   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
            S + F  LV + +  G     L+      + +   +    +   LE +   H   ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 600 DLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           DLK  N+LL    +     L+DFG+A  + G+ Q+        T GY++PE   +     
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLRKEAYGK 185
Query: 657 RSDIYSYGIML 667
             DI++ G++L
Sbjct: 186 PVDIWACGVIL 196

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+++D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  I +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIIISKGYNKAVDWWALGVLIYE 230

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 519 EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL------DIFLYSSTCMLDIF 572
           E E E++K + H  ++KI +    +D+  +VLE M  G L      +  L  +TC L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGED 629
           Q L        A++YL   H   IIH DLK  NVLL   +ED +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 630 QSMTQTQTL-ATIGYMAPEY-------GIERKVSTRSDIYSYGIMLI----------ETF 671
             M   +TL  T  Y+APE        G  R V    D +S G++L           E  
Sbjct: 171 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPPFSEHR 223
Query: 672 TRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
           T+    D++ + + +    V   +    +++V K L+  P+  F  +E
Sbjct: 224 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 30  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 88
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 89  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 144
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 200
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 231

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV----ECEVMKNIRHRNLVKII 537
           IG G+FG V+KA     G +VA+K    E  +  + F +    E ++++ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 83
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-NIMIDVASA---------LEY 587
             C     KA        GS  I+L    C  D+   L N+++    +         L  
Sbjct: 84  EICRT---KASPYNRC-KGS--IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL--LSGEDQSMTQTQTLATIGYMA 645
           L + H   I+H D+K++NVL+  D +  L+DFG+A+   L+   Q       + T+ Y  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 646 PEYGI-ERKVSTRSDIYSYGIMLIETFTR 673
           PE  + ER      D++  G ++ E +TR
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV---ECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E    E  +++ +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+  G +    +S    +  F   +     A  +    +
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQIVLTFEY 151
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G    +       T  Y+APE  +
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 206
Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +  +   D ++ G+++ E
Sbjct: 207 SKGYNKAVDWWALGVLIYE 225

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 18/224 (8%)
Query: 465 LPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVE 521
           +P + +   ++ F   +L+G G++G V  A     G  VAIK      +   A+++   E
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-E 59
Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMI 579
            +++K+ +H N++ I +    D F+     Y+    +  D+    ST ML      +I  
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML---SDDHIQY 116
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL--SGED------QS 631
            +   L  +   H + +IH DLK SN+L++ +    + DFG+A+++  S  D      Q 
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 632 MTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRK 674
              T+ +AT  Y APE  +   K S   D++S G +L E F R+
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV----ECEVMKNIRHRNLVKII 537
           IG G+FG V+KA     G +VA+K    E  +  + F +    E ++++ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 83
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-NIMIDVASA---------LEY 587
             C     KA            I+L    C  D+   L N+++    +         L  
Sbjct: 84  EICRT---KASPYN---RCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 137
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL--LSGEDQSMTQTQTLATIGYMA 645
           L + H   I+H D+K++NVL+  D +  L+DFG+A+   L+   Q       + T+ Y  
Sbjct: 138 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 646 PEYGI-ERKVSTRSDIYSYGIMLIETFTR 673
           PE  + ER      D++  G ++ E +TR
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 469 DLSRATNRFGRDNLIGIGSFGYV----YKAELDDGIEVAIKVFHQECARAMKS-FEVECE 523
           ++ R     GR   IG G FG V    Y +  +  + VAIK      + +++  F  E  
Sbjct: 386 EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            M+   H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++
Sbjct: 444 TMRQFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIG 642
           AL YL  +     +H D+ + NVL+       L DFG+++ +  ED +  + ++    I 
Sbjct: 503 ALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIK 557
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIE 669
           +MAPE    R+ ++ SD++ +G+ + E
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWE 584

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 14/192 (7%)
Query: 481 NLIGIGSFGYVYKAELDDGIE--VAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVKII 537
           +++G G+F  V  AE D   +  VAIK   +E     + S E E  V+  I+H N+V + 
Sbjct: 24  DVLGTGAFSEVILAE-DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               +     L+++ +  G L    +        +   +    +   L+ + + H   I+
Sbjct: 83  DIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 598 HCDLKSSNVL---LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
           H DLK  N+L   LDED    +SDFG++K+   ED     +    T GY+APE   ++  
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 655 STRSDIYSYGIM 666
           S   D +S G++
Sbjct: 196 SKAVDCWSIGVI 207

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV----ECEVMKNIRHRNLVKII 537
           IG G+FG V+KA     G +VA+K    E  +  + F +    E ++++ ++H N+V +I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 82
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-NIMIDVASA---------LEY 587
             C     KA        GS  I+L    C  D+   L N+++    +         L  
Sbjct: 83  EICRT---KASPYNRC-KGS--IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL--LSGEDQSMTQTQTLATIGYMA 645
           L + H   I+H D+K++NVL+  D +  L+DFG+A+   L+   Q       + T+ Y  
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 646 PEYGI-ERKVSTRSDIYSYGIMLIETFTR 673
           PE  + ER      D++  G ++ E +TR
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 14/192 (7%)
Query: 481 NLIGIGSFGYVYKAELDDGIE--VAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVKII 537
           +++G G+F  V  AE D   +  VAIK   +E     + S E E  V+  I+H N+V + 
Sbjct: 24  DVLGTGAFSEVILAE-DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               +     L+++ +  G L    +        +   +    +   L+ + + H   I+
Sbjct: 83  DIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 598 HCDLKSSNVL---LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
           H DLK  N+L   LDED    +SDFG++K+   ED     +    T GY+APE   ++  
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 655 STRSDIYSYGIM 666
           S   D +S G++
Sbjct: 196 SKAVDCWSIGVI 207

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 472 RATNRFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKN 527
           R   R+ R   +G G F   Y+    D  EV A KV  +         +    E  + K+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           + + ++V       +DDF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAP 646
           L   H   +IH DLK  N+ L++DM   + DFG+A  +  + +   + +TL  T  Y+AP
Sbjct: 158 L---HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RKKTLCGTPNYIAP 211
Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           E   ++  S   DI+S G +L      K P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 14/192 (7%)
Query: 481 NLIGIGSFGYVYKAELDDGIE--VAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVKII 537
           +++G G+F  V  AE D   +  VAIK   +E     + S E E  V+  I+H N+V + 
Sbjct: 24  DVLGTGAFSEVILAE-DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               +     L+++ +  G L    +        +   +    +   L+ + + H   I+
Sbjct: 83  DIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 598 HCDLKSSNVL---LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
           H DLK  N+L   LDED    +SDFG++K+   ED     +    T GY+APE   ++  
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 655 STRSDIYSYGIM 666
           S   D +S G++
Sbjct: 196 SKAVDCWSIGVI 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 91/190 (47%), Gaps = 9/190 (4%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECA-RAMKSFEV-ECEVMKNIRHRNLVKIISGC 540
           IG G++G VYKA+ + G   A+K    E     + S  + E  ++K ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
                  LV E++ +  L   L      L+     + ++ + + + Y    H   ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRD 125
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTRSD 659
           LK  N+L++ +    ++DFG+A+      +    T  + T+ Y AP+  +  +K ST  D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 660 IYSYGIMLIE 669
           I+S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISG- 539
           +G G +G V++  L  G  VA+K+F    +R  +S+  E E+   +  RH N++  I+  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF---SSRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 540 --CSNDDFK-ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF-----R 591
               N   +  L+  Y  +GSL  FL   T  L+    L + +  A  L +L+      +
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS-GEDQ-SMTQTQTLATIGYMAPEYG 649
               I H D KS NVL+  ++   ++D G+A + S G D   +     + T  YMAPE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV- 188
Query: 650 IERKVST-------RSDIYSYGIMLIETFTR 673
           ++ ++ T        +DI+++G++L E   R
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 18/224 (8%)
Query: 465 LPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVE 521
           +P + +   ++ F   +L+G G++G V  A     G  VAIK      +   A+++   E
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-E 59
Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMI 579
            +++K+ +H N++ I +    D F+     Y+    +  D+    ST ML      +I  
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML---SDDHIQY 116
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL--SGED------QS 631
            +   L  +   H + +IH DLK SN+L++ +    + DFG+A+++  S  D      Q 
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 632 MTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRK 674
              T+ +AT  Y APE  +   K S   D++S G +L E F R+
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 481 NLIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVMKN------IRHRNL 533
            ++G GSFG V+ AE     +  AIK   ++    +   +VEC +++         H  L
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
             +       +    V+EY+  G  D+  +  +C      R       A  +  L F H+
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFY--AAEIILGLQFLHS 136
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL-LSGEDQSMTQTQTLATIGYMAPEYGIER 652
             I++ DLK  N+LLD+D    ++DFG+ K  + G+ ++        T  Y+APE  + +
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NXFCGTPDYIAPEILLGQ 193
Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
           K +   D +S+G++L E    + P
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 19/226 (8%)
Query: 457 LSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECA 512
           L++  KR+    D        GR   +G G FG VY A E  +   +A+KV  +   E  
Sbjct: 4   LAEMPKRKFTIDDFD-----IGRP--LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE 56
Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF 572
                   E E+  ++RH N++++ +   +     L+LE+ P G L   L       D  
Sbjct: 57  GVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQ 115
Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM 632
           +    M ++A AL Y    H   +IH D+K  N+L+       ++DFG     S    S+
Sbjct: 116 RSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSL 168
Query: 633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
            +     T+ Y+ PE    +    + D++  G++  E      P D
Sbjct: 169 RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 91/190 (47%), Gaps = 9/190 (4%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECA-RAMKSFEV-ECEVMKNIRHRNLVKIISGC 540
           IG G++G VYKA+ + G   A+K    E     + S  + E  ++K ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
                  LV E++ +  L   L      L+     + ++ + + + Y    H   ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRD 125
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTRSD 659
           LK  N+L++ +    ++DFG+A+      +    T  + T+ Y AP+  +  +K ST  D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 660 IYSYGIMLIE 669
           I+S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 10/209 (4%)
Query: 472 RATNRFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKN 527
           R   R+ R   +G G F   Y+    D  EV A KV  +         +    E  + K+
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           + + ++V       +DDF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           L   H   +IH DLK  N+ L++DM   + DFG+A  +  + +   +     T  Y+APE
Sbjct: 142 L---HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPE 196
Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
              ++  S   DI+S G +L      K P
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 87/191 (45%), Gaps = 13/191 (6%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G+F  V +      G+E A K+ + +   AR  +  E E  + + ++H N+V++   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              + F  LV + +  G     L+      + +   +    +   LE + + H+  I+H 
Sbjct: 97  IQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHR 152
Query: 600 DLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           +LK  N+LL    +     L+DFG+A  +   + S        T GY++PE   +   S 
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYLSPEVLKKDPYSK 209
Query: 657 RSDIYSYGIML 667
             DI++ G++L
Sbjct: 210 PVDIWACGVIL 220

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 91/190 (47%), Gaps = 9/190 (4%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECA-RAMKSFEV-ECEVMKNIRHRNLVKIISGC 540
           IG G++G VYKA+ + G   A+K    E     + S  + E  ++K ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
                  LV E++ +  L   L      L+     + ++ + + + Y    H   ++H D
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRD 125
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTRSD 659
           LK  N+L++ +    ++DFG+A+      +    T  + T+ Y AP+  +  +K ST  D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 660 IYSYGIMLIE 669
           I+S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 10/209 (4%)
Query: 472 RATNRFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKN 527
           R   R+ R   +G G F   Y+    D  EV A KV  +         +    E  + K+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           + + ++V       +DDF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           L   H   +IH DLK  N+ L++DM   + DFG+A  +  + +   +     T  Y+APE
Sbjct: 158 L---HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPE 212
Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
              ++  S   DI+S G +L      K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  +E+L  R     IH DL + N+LL E  +  + DFG+A+ +  +   + +      
Sbjct: 202 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 10/209 (4%)
Query: 472 RATNRFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKN 527
           R   R+ R   +G G F   Y+    D  EV A KV  +         +    E  + K+
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           + + ++V       +DDF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           L   H   +IH DLK  N+ L++DM   + DFG+A  +  + +   +     T  Y+APE
Sbjct: 158 L---HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPE 212
Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
              ++  S   DI+S G +L      K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  +E+L  R     IH DL + N+LL E  +  + DFG+A+ +  +   + +      
Sbjct: 200 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYK--AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNLVKIISG 539
           IG GS+G   K   + D  I V  ++ +     A K   V E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 540 CSNDDFKAL--VLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFR--- 591
             +     L  V+EY   G L   +   T     LD    L +M  +  AL+  + R   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 592 -HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            HT  ++H DLK +NV LD      L DFG+A++L+  D S  +T  + T  YM+PE   
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKT-FVGTPYYMSPEQMN 189
Query: 651 ERKVSTRSDIYSYGIMLIE 669
               + +SDI+S G +L E
Sbjct: 190 RMSYNEKSDIWSLGCLLYE 208

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  +E+L  R     IH DL + N+LL E  +  + DFG+A+ +  +   + +      
Sbjct: 209 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+APE  + +  +   D ++ G+++ +
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYQ 230

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           VA  +E+L  R     IH DL + N+LL E  +  + DFG+A+ +  +   + +      
Sbjct: 207 VAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 89/192 (46%), Gaps = 14/192 (7%)
Query: 481 NLIGIGSFGYVYKAELDDGIE--VAIKVFHQECARAMK-SFEVECEVMKNIRHRNLVKII 537
           +++G G+F  V  AE D   +  VAIK   ++     + S E E  V+  I+H N+V + 
Sbjct: 24  DVLGTGAFSEVILAE-DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               +     L+++ +  G L    +        +   +    +   L+ + + H   I+
Sbjct: 83  DIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 138
Query: 598 HCDLKSSNVL---LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
           H DLK  N+L   LDED    +SDFG++K+   ED     +    T GY+APE   ++  
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 655 STRSDIYSYGIM 666
           S   D +S G++
Sbjct: 196 SKAVDCWSIGVI 207

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRHRNLVKIIS 538
           +G GSFG V+      +G   A+KV  +E    +K  E    E  ++  + H  ++++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              +     ++++Y+  G L   L  S    +   +     +V  ALEYL   H+  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYL---HSKDIIY 129
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            DLK  N+LLD++    ++DFG AK +      +       T  Y+APE    +  +   
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYNKSI 184
Query: 659 DIYSYGIMLIETFTRKKP---------ADKMFAAELSLKHWVN 692
           D +S+GI++ E      P          +K+  AEL    + N
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFN 227

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 12/200 (6%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G FG VY A E  +   +A+KV  +   E          E E+  ++RH N++++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              +     L+LE+ P G L   L       D  +    M ++A AL Y    H   +IH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYC---HERKVIH 137
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+L+       ++DFG     S    S+ +     T+ Y+ PE    +    + 
Sbjct: 138 RDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKV 193
Query: 659 DIYSYGIMLIETFTRKKPAD 678
           D++  G++  E      P D
Sbjct: 194 DLWCAGVLCYEFLVGMPPFD 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 475 NRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFH--------QECARAMKSFEVECEVM 525
            ++   ++IG G    V +      G E A+K+          ++     ++   E  ++
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 526 KNIR-HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
           + +  H +++ +I    +  F  LV + M  G L  +L     + +   R +IM    S 
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-SIM---RSL 209
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTLATIGY 643
           LE ++F H   I+H DLK  N+LLD++M   LSDFG +  L  GE       +   T GY
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGY 265
Query: 644 MAPE 647
           +APE
Sbjct: 266 LAPE 269

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKN 527
           ++ ++ +     +G G+F  V +      G+E A K+ + +   AR  +  E E  + + 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           ++H N+V++      + F  LV + +  G     L+      + +   +    +   LE 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILES 117
Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           + + H+  I+H +LK  N+LL    +     L+DFG+A  +   + S        T GY+
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYL 174
Query: 645 APEYGIERKVSTRSDIYSYGIML 667
           +PE   +   S   DI++ G++L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 10/211 (4%)
Query: 471 SRAT-NRFGRDNLIGIGSFGYV-YKAELDDGIEVAIKVFHQECARAMKSFE---VECEVM 525
           SR T N F    L+G G+FG V    E   G   A+K+  +E   A         E  V+
Sbjct: 3   SRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 62
Query: 526 KNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL 585
           +N RH  L  +       D    V+EY   G L   L       +   R     ++ SAL
Sbjct: 63  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSAL 121
Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
           +YL+      +++ DLK  N++LD+D    ++DFG+ K   G     T      T  Y+A
Sbjct: 122 DYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 177
Query: 646 PEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           PE   +       D +  G+++ E    + P
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 483 IGIGSFGYVYKAELD-DGIEVAIKVFHQ--ECARAMKSFEVECEVMKNIRHRNLVKIIS- 538
           IG G++G V  A     G +VAIK      +     K    E +++K+ +H N++ I   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 539 ---GCSNDDFKAL--VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
                   +FK++  VL+ M +    I   S    L+     ++   +   L  L + H+
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE-----HVRYFLYQLLRGLKYMHS 177
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL--SGEDQSMTQTQTLATIGYMAPEYGIE 651
             +IH DLK SN+L++E+    + DFG+A+ L  S  +     T+ +AT  Y APE  + 
Sbjct: 178 AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS 237
Query: 652 RKVSTRS-DIYSYGIMLIETFTRKK 675
               T++ D++S G +  E   R++
Sbjct: 238 LHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 114/262 (43%), Gaps = 27/262 (10%)
Query: 447 STGLSNGGILLSQATKRRLPYQDLSRATNRFGRDN-----LIGIGSFGYVYKAEL----D 497
           + G   G  LL+   K  L   +L+    + G +N     ++G G++G V+        D
Sbjct: 23  ADGGDGGEQLLT--VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHD 80
Query: 498 DGIEVAIKVFHQ----ECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK-ALVLEY 552
            G   A+KV  +    + A+  +    E +V+++IR    +  +      + K  L+L+Y
Sbjct: 81  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 140
Query: 553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM 612
           +  G L    ++     + F    + I V   +  L   H   II+ D+K  N+LLD + 
Sbjct: 141 INGGEL----FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 196
Query: 613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE--YGIERKVSTRSDIYSYGIMLIET 670
              L+DFG++K     D++        TI YMAP+   G +       D +S G+++ E 
Sbjct: 197 HVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
Query: 671 FTRKKP----ADKMFAAELSLK 688
            T   P     +K   AE+S +
Sbjct: 256 LTGASPFTVDGEKNSQAEISRR 277

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 47/231 (20%)
Query: 475 NRFGRD----NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIR 529
            RFG D     LIG G FG V+KA+   DG    I+       +A    E E + +  + 
Sbjct: 8   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLD 63
Query: 530 HRNLVKIISGC----------SNDDFKA--------------------LVLEYMPNGSLD 559
           H N+V   +GC          S+D  ++                    + +E+   G+L+
Sbjct: 64  HVNIVHY-NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 560 IFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD 618
            ++       LD    L +   +   ++Y+   H+  +IH DLK SN+ L +     + D
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYI---HSKKLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           FG+   L  + +   +T++  T+ YM+PE    +      D+Y+ G++L E
Sbjct: 180 FGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 18/224 (8%)
Query: 465 LPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVE 521
           +P + +   ++ F   +L+G G++G V  A     G  VAIK      +   A+++   E
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-E 59
Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMI 579
            +++K+ +H N++ I +    D F+     Y+    +  D+    ST ML      +I  
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML---SDDHIQY 116
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL--SGEDQSMTQTQT 637
            +   L  +   H + +IH DLK SN+L++ +    + DFG+A+++  S  D S    Q 
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 638 ------LATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRK 674
                 +AT  Y APE  +   K S   D++S G +L E F R+
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKN 527
           ++ ++ +     +G G+F  V +      G+E A K+ + +   AR  +  E E  + + 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           ++H N+V++      + F  LV + +  G     L+      + +   +    +   LE 
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILES 117
Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           + + H+  I+H +LK  N+LL    +     L+DFG+A  +   + S        T GY+
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYL 174
Query: 645 APEYGIERKVSTRSDIYSYGIML 667
           +PE   +   S   DI++ G++L
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVIL 197

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 10/212 (4%)
Query: 470 LSRAT-NRFGRDNLIGIGSFGYV-YKAELDDGIEVAIKVFHQECARAMKSFE---VECEV 524
           ++R T N F    L+G G+FG V    E   G   A+K+  +E   A         E  V
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
           ++N RH  L  +       D    V+EY   G L   L       +   R     ++ SA
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSA 121
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           L+YL+      +++ DLK  N++LD+D    ++DFG+ K   G     T      T  Y+
Sbjct: 122 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYL 177
Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           APE   +       D +  G+++ E    + P
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 128
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKN 527
           ++ ++ +     +G G+F  V +      G+E A K+ + +   AR  +  E E  + + 
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           ++H N+V++      + F  LV + +  G     L+      + +   +    +   LE 
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILES 116
Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           + + H+  I+H +LK  N+LL    +     L+DFG+A  +   + S        T GY+
Sbjct: 117 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGYL 173
Query: 645 APEYGIERKVSTRSDIYSYGIML 667
           +PE   +   S   DI++ G++L
Sbjct: 174 SPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +     
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---- 199
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             T  Y+AP   + +  +   D ++ G+++ E
Sbjct: 200 -GTPEYLAPAIILSKGYNKAVDWWALGVLIYE 230

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 43/220 (19%)
Query: 483 IGIGSFGYVYKAE--LDD---GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G FG V++A+  +DD    I+  I++ ++E AR     EV+   +  + H  +V+  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIK-RIRLPNRELAREKVMREVKA--LAKLEHPGIVRYF 69
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLY---------------SSTCMLDIFQR---LNIMI 579
           +     +      E +   S  ++LY               +  C ++  +R   L+I +
Sbjct: 70  NAWLEKN----TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT------ 633
            +A A+E+L   H+  ++H DLK SN+    D +  + DFG+   +  +++  T      
Sbjct: 126 QIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 634 ----QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
                T  + T  YM+PE       S + DI+S G++L E
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 9/206 (4%)
Query: 475 NRFGRDNLIGIGSFGYV-YKAELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L  +       D    V+EY   G L   L       +   R     ++ SAL+YL+ 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 266
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
                +++ DLK  N++LD+D    ++DFG+ K   G     T      T  Y+APE   
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
           +       D +  G+++ E    + P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 6/159 (3%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
           VE +++  +  R +V +           LV+  M  G +   +Y+       FQ    + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTL 638
             A  +  L   H   II+ DLK  NVLLD+D    +SD G+A +L +G+    T+T+  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGY 349
Query: 639 A-TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           A T G+MAPE  +  +     D ++ G+ L E    + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVY--KAELDDGIEVAIKVFHQECARAMK--- 516
           +  L +Q LS   +R+ R   +G G++G V   K +L  G E AIK+  +          
Sbjct: 11  RENLYFQGLS---DRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSG 66
Query: 517 SFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN 576
           +   E  V+K + H N++K+     +     LV+E    G L    +    +   F  ++
Sbjct: 67  ALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVD 122
Query: 577 IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMT 633
             + +   L    + H   I+H DLK  N+LL+    D +  + DFG++      +    
Sbjct: 123 AAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGK 179
Query: 634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
             + L T  Y+APE  + +K   + D++S G++L
Sbjct: 180 MKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 212

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 6/159 (3%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
           VE +++  +  R +V +           LV+  M  G +   +Y+       FQ    + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTL 638
             A  +  L   H   II+ DLK  NVLLD+D    +SD G+A +L +G+    T+T+  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGY 349
Query: 639 A-TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           A T G+MAPE  +  +     D ++ G+ L E    + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 6/159 (3%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
           VE +++  +  R +V +           LV+  M  G +   +Y+       FQ    + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTL 638
             A  +  L   H   II+ DLK  NVLLD+D    +SD G+A +L +G+    T+T+  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGY 349
Query: 639 A-TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           A T G+MAPE  +  +     D ++ G+ L E    + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYK--AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNLVKIISG 539
           IG GS+G   K   + D  I V  ++ +     A K   V E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 540 CSNDDFKAL--VLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFR--- 591
             +     L  V+EY   G L   +   T     LD    L +M  +  AL+  + R   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 592 -HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            HT  ++H DLK +NV LD      L DFG+A++L+  D+   + + + T  YM+PE   
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDEDFAK-EFVGTPYYMSPEQMN 189
Query: 651 ERKVSTRSDIYSYGIMLIE 669
               + +SDI+S G +L E
Sbjct: 190 RMSYNEKSDIWSLGCLLYE 208

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 6/159 (3%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
           VE +++  +  R +V +           LV+  M  G +   +Y+       FQ    + 
Sbjct: 234 VEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA-KLLSGEDQSMTQTQTL 638
             A  +  L   H   II+ DLK  NVLLD+D    +SD G+A +L +G+    T+T+  
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGY 349
Query: 639 A-TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           A T G+MAPE  +  +     D ++ G+ L E    + P
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 483 IGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEV---------ECEVMKNIRHRN 532
           IG G++G V  A     G +VAIK       +   +F+V         E +++K+ +H N
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 533 LVKIIS----GCSNDDFKAL--VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALE 586
           ++ I           +FK++  VL+ M +    I   S    L+     ++   +   L 
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE-----HVRYFLYQLLR 169
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL--SGEDQSMTQTQTLATIGYM 644
            L + H+  +IH DLK SN+L++E+    + DFG+A+ L  S  +     T+ +AT  Y 
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 645 APEYGIERKVSTRS-DIYSYGIMLIETFTRKK 675
           APE  +     T++ D++S G +  E   R++
Sbjct: 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 9/199 (4%)
Query: 475 NRFGRDNLIGIGSFGYV-YKAELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L  +       D    V+EY   G L   L       +   R     ++ SAL+YL+ 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 269
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
                +++ DLK  N++LD+D    ++DFG+ K   G     T      T  Y+APE   
Sbjct: 270 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE 325
Query: 651 ERKVSTRSDIYSYGIMLIE 669
           +       D +  G+++ E
Sbjct: 326 DNDYGRAVDWWGLGVVMYE 344

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 128
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 14/191 (7%)
Query: 481 NLIGIGSFGYVY--KAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
            ++G G+F  V+  K  L  G   A+K   +  A    S E E  V+K I+H N+V +  
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
              +     LV++ +  G     L+       ++   +  + +   L  + + H   I+H
Sbjct: 74  IYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129
Query: 599 CDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
            DLK  N+L    +E+    ++DFG++K+    +Q+   +    T GY+APE   ++  S
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 656 TRSDIYSYGIM 666
              D +S G++
Sbjct: 186 KAVDCWSIGVI 196

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 483 IGIGSFGYVYK--AELDDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHRNLVKIISG 539
           IG GS+G   K   + D  I V  ++ +     A K   V E  +++ ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 540 CSNDDFKAL--VLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFR--- 591
             +     L  V+EY   G L   +   T     LD    L +M  +  AL+  + R   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 592 -HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            HT  ++H DLK +NV LD      L DFG+A++L+  D S  +   + T  YM+PE   
Sbjct: 134 GHT--VLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKA-FVGTPYYMSPEQMN 189
Query: 651 ERKVSTRSDIYSYGIMLIE 669
               + +SDI+S G +L E
Sbjct: 190 RMSYNEKSDIWSLGCLLYE 208

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 475 NRFGRD----NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIR 529
            RFG D     LIG G FG V+KA+   DG    IK       +A    E E + +  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLD 62
Query: 530 HRNLVKIISGC---------------SNDDFKALV--LEYMPNGSLDIFLYSSTC-MLDI 571
           H N+V   +GC               S    K L   +E+   G+L+ ++       LD 
Sbjct: 63  HVNIVHY-NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
              L +   +   ++Y+   H+  +I+ DLK SN+ L +     + DFG+   L  + + 
Sbjct: 122 VLALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK- 177
Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             + ++  T+ YM+PE    +      D+Y+ G++L E
Sbjct: 178 --RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 9/206 (4%)
Query: 475 NRFGRDNLIGIGSFGYV-YKAELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
           N F    L+G G+FG V    E   G   A+K+  +E   A         E  V++N RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L  +       D    V+EY   G L   L       +   R     ++ SAL+YL+ 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLHS 128
Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
                +++ DLK  N++LD+D    ++DFG+ K   G     T      T  Y+APE   
Sbjct: 129 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLE 184
Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
           +       D +  G+++ E    + P
Sbjct: 185 DNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 473 ATNRF---GRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI 528
           A N F    +  ++G G FG V+K  E   G+++A K+      +  +  + E  VM  +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            H NL+++     + +   LV+EY+  G L   +   +  L     +  M  +   + ++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 589 NFRHTTPIIHCDLKSSNVL---LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
              H   I+H DLK  N+L    D   I  + DFG+A+     ++         T  ++A
Sbjct: 204 ---HQMYILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKV---NFGTPEFLA 256
Query: 646 PEYGIERKVSTRSDIYSYGIM 666
           PE      VS  +D++S G++
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVI 277

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 128
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 128
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 128
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEV 520
           K   P Q+ ++  ++F R   +G GSFG V   +  + G   A+K+  ++    +K  E 
Sbjct: 29  KWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 521 ---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
              E  +++ +    LVK+     ++    +V+EY+  G +    +S    +  F   + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHA 143
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
               A  +    + H+  +I+ DLK  N+L+D+     ++DFG AK + G    +  T  
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 203
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
                 +APE  + +  +   D ++ G+++ E
Sbjct: 204 A-----LAPEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 521 ECEVMKNIRHRNLVKIISGCS--NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM 578
           E  ++K + H N+VK++      N+D   +V E +  G   +    +   L   Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP--VMEVPTLKPLSEDQARFYF 143
Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
            D+   +EYL   H   IIH D+K SN+L+ ED    ++DFG++    G D  +  + T+
Sbjct: 144 QDLIKGIEYL---HYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTV 198
Query: 639 ATIGYMAPEYGIE-RKVSTRS--DIYSYGIML 667
            T  +MAPE   E RK+ +    D+++ G+ L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 11/213 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADKMFAAELSLKHW 690
            D++S GI+L      + P D+   +      W
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDW 220

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 13  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 126
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQ 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 128
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 29/239 (12%)
Query: 480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKS----FEVECEVMKNIRHRNLVK 535
           D  IG GSF  VYK  LD    V +     +  +  KS    F+ E E +K ++H N+V+
Sbjct: 31  DIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 536 II----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI------DVASAL 585
                 S         LV E   +G+L  +L         F+   I +       +   L
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKR-------FKVXKIKVLRSWCRQILKGL 142
Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           ++L+ R T PIIH DLK  N+ +        + D G+A L     ++      + T  + 
Sbjct: 143 QFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFX 197
Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV 703
           APE   E K     D+Y++G   +E  T + P  +   A    +   +G+ P S  +V 
Sbjct: 198 APE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 37/228 (16%)
Query: 472 RATNRFGRDNLIGIGSFGYVYKAE--LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR 529
           R  + F    ++G G+FG V KA   LD       K+ H E    + +   E  ++ ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLN 60
Query: 530 H-------------RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC--MLDIFQR 574
           H             RN VK ++         + +EY  NG+L   ++S       D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK-------LLSG 627
           L   I     LE L++ H+  IIH DLK  N+ +DE     + DFG+AK       +L  
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 628 EDQSM-----TQTQTLATIGYMAPEY-GIERKVSTRSDIYSYGIMLIE 669
           + Q++       T  + T  Y+A E        + + D+YS GI+  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 20/199 (10%)
Query: 477 FGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMK----SFEVECEVMKNIRH 530
           F     +G G+F  V  AE     +   K+F  +C   +A+K    S E E  V++ I+H
Sbjct: 24  FEFKETLGTGAFSEVVLAEE----KATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
            N+V +     + +   LV++ +  G     L+        +   +    +   L+ + +
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGE----LFDRIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 591 RHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
            H   I+H DLK  N+L    DE+    +SDFG++K+   E +    +    T GY+APE
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPE 192
Query: 648 YGIERKVSTRSDIYSYGIM 666
              ++  S   D +S G++
Sbjct: 193 VLAQKPYSKAVDCWSIGVI 211

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 128
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 17/217 (7%)
Query: 489 GYVYKAELDDGIEVAIKVF--HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND--D 544
           G ++K     G ++ +KV        R  + F  EC  ++   H N++ ++  C +    
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 545 FKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHT-TPII--HCD 600
              L+  + P GSL   L+  T  ++D  Q +   +D A    +L   HT  P+I  H  
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFL---HTLEPLIPRHA- 138
Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L S +V +DED  A +S   +        QS  +    A +   A +   E      +D 
Sbjct: 139 LNSRSVXIDEDXTARISXADVKFSF----QSPGRXYAPAWVAPEALQKKPEDTNRRSADX 194
Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV 697
           +S+ ++L E  TR+ P   +   E+  K  + GL P 
Sbjct: 195 WSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPT 231

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 24/223 (10%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRH 530
           +R+ R   +G G++G VYKA +      VAIK     H+E      +   E  ++K ++H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQH 92
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
           RN++++ S   ++    L+ EY  N   D+  Y      D+  R+ I   +   +  +NF
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN---DLKKYMDKNP-DVSMRV-IKSFLYQLINGVNF 147
Query: 591 RHTTPIIHCDLKSSNVLL-----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            H+   +H DLK  N+LL      E  +  + DFG+A+      +    T  + T+ Y  
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRP 205
Query: 646 PEYGI-ERKVSTRSDIYS----YGIMLIET--FTRKKPADKMF 681
           PE  +  R  ST  DI+S    +  ML++T  F      D++F
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF 248

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 27/231 (11%)
Query: 465 LPYQDLSRATNRFGRDNL--------IGIGSFGYVYKAELDDGIEV-AIKVFHQECARAM 515
           +P +D  + +N   R  L        +G GSFG V  A+     E+ AIK+  ++    +
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVV--I 58
Query: 516 KSFEVECEVMKNI------RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCML 569
           +  +VEC +++        +   L ++ S     D    V+EY+  G L   +Y     +
Sbjct: 59  QDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQ-QV 114
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK--LLSG 627
             F+    +   A     L F H   II+ DLK  NV+LD +    ++DFG+ K  ++ G
Sbjct: 115 GKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG 174
Query: 628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPAD 678
               +T  +   T  Y+APE    +      D ++YG++L E    + P D
Sbjct: 175 ----VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 474 TNRFGRDNLIGIGSFGYVY--KAELDDGIEVAIKVFHQECARAMK---SFEVECEVMKNI 528
           ++R+ R   +G G++G V   K +L  G E AIK+  +          +   E  V+K +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            H N++K+     +     LV+E    G L    +    +   F  ++  + +   L   
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGT 117
Query: 589 NFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            + H   I+H DLK  N+LL+    D +  + DFG++      +      + L T  Y+A
Sbjct: 118 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIA 174
Query: 646 PEYGIERKVSTRSDIYSYGIML 667
           PE  + +K   + D++S G++L
Sbjct: 175 PEV-LRKKYDEKCDVWSCGVIL 195

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 483 IGIGSFGYVYK--AELDDGIEV--AIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++  VYK  ++L D +     I++ H+E A      EV   ++K+++H N+V +  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS--LLKDLKHANIVTLHD 67
Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
               +    LV EY+     D+  Y   C  +I    N+ + +   L  L + H   ++H
Sbjct: 68  IIHTEKSLTLVFEYLDK---DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLH 123
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-ERKVSTR 657
            DLK  N+L++E     L+DFG+A+  S    + T    + T+ Y  P+  +     ST+
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 658 SDIYSYGIMLIETFT 672
            D++  G +  E  T
Sbjct: 182 IDMWGVGCIFYEMAT 196

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 17/237 (7%)
Query: 443 RRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE- 501
           R+G + G +NGG    Q +  ++P+  ++    R+    +IG GSFG V KA  D  +  
Sbjct: 68  RQGMTGGPNNGGYDDDQGSYVQVPHDHVA---YRYEVLKVIGKGSFGQVVKA-YDHKVHQ 123
Query: 502 -VAIKVFHQECARAMKSFEVECEVMKNIRHR---NLVKIISGCSNDDFKALVLEYMPNGS 557
            VA+K+   E  R  +    E  +++++R +   N + +I    N  F+  +       S
Sbjct: 124 HVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS 182
Query: 558 LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS 617
           ++++          F    +     S L+ L+  H   IIHCDLK  N+LL +   + + 
Sbjct: 183 MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242
Query: 618 --DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             DFG +        +  Q++      Y APE  +  +     D++S G +L E  T
Sbjct: 243 VIDFGSSCYEHQRVYTXIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 17/237 (7%)
Query: 443 RRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE- 501
           R+G + G +NGG    Q +  ++P+  ++    R+    +IG GSFG V KA  D  +  
Sbjct: 68  RQGMTGGPNNGGYDDDQGSYVQVPHDHVA---YRYEVLKVIGKGSFGQVVKA-YDHKVHQ 123
Query: 502 -VAIKVFHQECARAMKSFEVECEVMKNIRHR---NLVKIISGCSNDDFKALVLEYMPNGS 557
            VA+K+   E  R  +    E  +++++R +   N + +I    N  F+  +       S
Sbjct: 124 HVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS 182
Query: 558 LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS 617
           ++++          F    +     S L+ L+  H   IIHCDLK  N+LL +   + + 
Sbjct: 183 MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242
Query: 618 --DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             DFG +        +  Q++      Y APE  +  +     D++S G +L E  T
Sbjct: 243 VIDFGSSCYEHQRVYTXIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 112/247 (45%), Gaps = 25/247 (10%)
Query: 440 KSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRAT----NRFGRDNLIGIGSFGYVYKA- 494
           +ST   K  G +     +S   +     Q+L++       R+   + +G G++G V  + 
Sbjct: 12  ESTSLYKKAGSAAAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSY 71
Query: 495 ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS----GCSNDDFKA 547
           ++  G+++A+K      Q    A +++  E  ++K+++H N++ ++       S ++F  
Sbjct: 72  DVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPATSLEEFND 130
Query: 548 LVL-EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNV 606
           + L  ++    L+  +       D  Q L     +   L  L + H+  IIH DLK SN+
Sbjct: 131 VYLVTHLMGADLNNIVKCQKLTDDHVQFL-----IYQILRGLKYIHSADIIHRDLKPSNL 185
Query: 607 LLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGI 665
            ++ED    + DFG+A+    E      T  +AT  Y APE  +     +   DI+S G 
Sbjct: 186 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGC 240
Query: 666 MLIETFT 672
           ++ E  T
Sbjct: 241 IMAELLT 247

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 17/232 (7%)
Query: 444 RGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVY--KAELDDGIE 501
           RG + G S G      AT         +  ++R+    ++G GSFG V   K ++  G E
Sbjct: 19  RGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQE 77
Query: 502 VAIKVFHQECARAMKSFEV---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL 558
            A+KV  +   +     E    E +++K + H N++K+     +  +  LV E    G L
Sbjct: 78  CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL 137
Query: 559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAH 615
               +        F  ++    +   L  + + H   I+H DLK  N+LL+   +D    
Sbjct: 138 ----FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIR 193
Query: 616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
           + DFG++        S      + T  Y+APE  +      + D++S G++L
Sbjct: 194 IIDFGLSTHFEA---SKKMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 241

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 17/232 (7%)
Query: 444 RGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVY--KAELDDGIE 501
           RG + G S G      AT         +  ++R+    ++G GSFG V   K ++  G E
Sbjct: 18  RGHAAGTSGGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQE 76
Query: 502 VAIKVFHQECARAMKSFEV---ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL 558
            A+KV  +   +     E    E +++K + H N++K+     +  +  LV E    G L
Sbjct: 77  CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL 136
Query: 559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAH 615
               +        F  ++    +   L  + + H   I+H DLK  N+LL+   +D    
Sbjct: 137 ----FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIR 192
Query: 616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
           + DFG++        S      + T  Y+APE  +      + D++S G++L
Sbjct: 193 IIDFGLSTHFEA---SKKMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 240

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFE-VECEVMKN--IRHRNLVKIISG 539
           +G G++G V  A ++   E A+ V   +  RA+   E ++ E+  N  + H N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 128
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 87/191 (45%), Gaps = 12/191 (6%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G+F  V +  ++  G E A K+ + +   AR  +  E E  + + ++H N+V++   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
            S +    L+ + +  G     L+      + +   +    +   LE +   H   ++H 
Sbjct: 90  ISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 600 DLKSSNVLLDEDM---IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           DLK  N+LL   +      L+DFG+A  + GE Q+        T GY++PE   +     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 203
Query: 657 RSDIYSYGIML 667
             D+++ G++L
Sbjct: 204 PVDLWACGVIL 214

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           IG G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 94  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 196
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 483 IGIGSFGYV-----YKAELDDGIEVAIK-VFHQECARAMKSFEVECEV--MKNIRHRNLV 534
           +G GSFG V     YK +     +VA+K +  Q   ++     VE E+  +K +RH +++
Sbjct: 17  LGEGSFGKVKLATHYKTQQ----KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           K+    +      +V+EY      D  +       D  +R      +  A+EY    H  
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--FQQIICAIEYC---HRH 127
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            I+H DLK  N+LLD+++   ++DFG++ +++  D +  +T +  +  Y APE  I  K+
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-INGKL 183
Query: 655 ST--RSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
                 D++S GI+L      + P D  F   L  K
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVA+K+    Q  + +++    E  + K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    LV EY   G +  +L +     +   R      + SA++Y    H   I+H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYC---HQKFIVHR 137
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEYGIERKVS- 655
           DLK+ N+LLD D    ++DFG +      ++     +  A  G   Y APE    +K   
Sbjct: 138 DLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 656 TRSDIYSYGIMLIETFTRKKPADKMFAAEL 685
              D++S G++L    +   P D     EL
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKEL 221

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAM---KSFEVECEVMKNIRHRNLVKIISG 539
           +G G+ G V  A ++   E A+ V   +  RA+   ++ + E  + K + H N+VK    
Sbjct: 14  LGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI-FQRLNIMIDVASALEYLNFRHTTPIIH 598
               + + L LEY   G L   +     M +   QR      + + + YL   H   I H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYL---HGIGITH 127
Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 659 -DIYSYGIMLIETFTRKKPADK 679
            D++S GI+L      + P D+
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 483 IGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G++G V   Y A L    +VA+K      Q    A +++  E  ++K+++H N++ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 537 IS----GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +       S +DF  + L     G+    +  S  + D     ++   V   L  L + H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD----EHVQFLVYQLLRGLKYIH 148
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +  IIH DLK SNV ++ED    + DFG+A+     D+ M  T  +AT  Y APE  +  
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYVATRWYRAPEIMLNW 203
Query: 653 KVSTRS-DIYSYGIMLIETFTRK 674
               ++ DI+S G ++ E    K
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRH 530
            R+   + +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 87
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIM 578
            N++ ++              + P  SL    D++L +     D+      Q+L   ++ 
Sbjct: 88  ENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
             +   L  L + H+  IIH DLK SN+ ++ED    + DFG+A+  + E      T  +
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYV 190
Query: 639 ATIGYMAPEYGIERKVSTRS-DIYSYGIMLIETFT 672
           AT  Y APE  +      ++ DI+S G ++ E  T
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRH 530
            R+   + +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKH 87
Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIM 578
            N++ ++              + P  SL    D++L +     D+      Q+L   ++ 
Sbjct: 88  ENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 135
Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
             +   L  L + H+  IIH DLK SN+ ++ED    + DFG+A+  + E      T  +
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYV 190
Query: 639 ATIGYMAPEYGIERKVSTRS-DIYSYGIMLIETFT 672
           AT  Y APE  +      ++ DI+S G ++ E  T
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 94  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 196
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 7/157 (4%)
Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMI 579
           E ++++ +  R +V +       D   LVL  M  G L   +Y          + +    
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
           ++   LE L   H   I++ DLK  N+LLD+     +SD G+A  +    +  T    + 
Sbjct: 294 EICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVG 347
Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           T+GYMAPE     + +   D ++ G +L E    + P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 96  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+  + E      T  +AT  Y AP
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 100 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAP 202
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 7/157 (4%)
Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMI 579
           E ++++ +  R +V +       D   LVL  M  G L   +Y          + +    
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
           ++   LE L   H   I++ DLK  N+LLD+     +SD G+A  +    +  T    + 
Sbjct: 294 EICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVG 347
Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           T+GYMAPE     + +   D ++ G +L E    + P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 40/242 (16%)
Query: 453 GGILLSQATKRRLPY-QDLSRAT----NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKV 506
           G  +L  + +R   Y Q+L++       R+   + +G G++G V  A +   G+ VA+K 
Sbjct: 18  GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 77
Query: 507 F---HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL----D 559
                Q    A +++  E  ++K+++H N++ ++              + P  SL    D
Sbjct: 78  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDV------------FTPARSLEEFND 124
Query: 560 IFLYSSTCMLDI-----FQRL---NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED 611
           ++L +     D+      Q+L   ++   +   L  L + H+  IIH DLK SN+ ++ED
Sbjct: 125 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 184
Query: 612 MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS-DIYSYGIMLIET 670
               + DFG+A+    E      T  +AT  Y APE  +      ++ DI+S G ++ E 
Sbjct: 185 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239
Query: 671 FT 672
            T
Sbjct: 240 LT 241

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G+E A K   +  +RA +        E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +          +   L+ +N+ HT  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHTKK 135
Query: 596 IIHCDLKSSNV-LLDEDM-IAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD+++ I H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 87  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 134
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 189
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G+E A K   +  +RA +        E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +          +   L+ +N+ HT  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHTKK 135
Query: 596 IIHCDLKSSNV-LLDEDM-IAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD+++ I H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 85  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 187
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 86  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 188
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 108 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 210
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 20/203 (9%)
Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
            L+G G++G VYK   +  G   AIKV         +  + E  ++K   H   +    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 540 C-------SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
                     DD   LV+E+   GS+   + ++    +  +   I       L  L+  H
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLH 146
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEY--- 648
              +IH D+K  NVLL E+    L DFG++  L   D+++ +  T + T  +MAPE    
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 649 --GIERKVSTRSDIYSYGIMLIE 669
               +     +SD++S GI  IE
Sbjct: 204 DENPDATYDFKSDLWSLGITAIE 226

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G+E A K   +  +RA +        E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     +            +   L+ +N+ HT  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESL----SEEEATSFIKQILDGVNYLHTKK 135
Query: 596 IIHCDLKSSNV-LLDEDM-IAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD+++ I H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 91  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 40/242 (16%)
Query: 453 GGILLSQATKRRLPY-QDLSRAT----NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKV 506
           G  +L  + +R   Y Q+L++       R+   + +G G++G V  A +   G+ VA+K 
Sbjct: 1   GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 60
Query: 507 F---HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL----D 559
                Q    A +++  E  ++K+++H N++ ++              + P  SL    D
Sbjct: 61  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDV------------FTPARSLEEFND 107
Query: 560 IFLYSSTCMLDI-----FQRL---NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED 611
           ++L +     D+      Q+L   ++   +   L  L + H+  IIH DLK SN+ ++ED
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167
Query: 612 MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS-DIYSYGIMLIET 670
               + DFG+A+    E      T  +AT  Y APE  +      ++ DI+S G ++ E 
Sbjct: 168 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 671 FT 672
            T
Sbjct: 223 LT 224

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G+E A K   +  +RA +        E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     +            +   L+ +N+ HT  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESL----SEEEATSFIKQILDGVNYLHTKK 135
Query: 596 IIHCDLKSSNV-LLDEDM-IAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD+++ I H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 109 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 211
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 101 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 101 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 474 TNRFGRDNLIGIGSFGYVY--KAELDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNI 528
           ++R+    ++G GSFG V   K ++  G E A+KV  +   +     E    E +++K +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            H N++K+     +  +  LV E    G L    +        F  ++    +   L  +
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGI 145
Query: 589 NFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            + H   I+H DLK  N+LL+   +D    + DFG++        S      + T  Y+A
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIA 202
Query: 646 PEYGIERKVSTRSDIYSYGIML 667
           PE  +      + D++S G++L
Sbjct: 203 PEV-LHGTYDEKCDVWSTGVIL 223

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 474 TNRFGRDNLIGIGSFGYVY--KAELDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNI 528
           ++R+    ++G GSFG V   K ++  G E A+KV  +   +     E    E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            H N+ K+     +  +  LV E    G L    +        F  ++    +   L  +
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 589 NFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            + H   I+H DLK  N+LL+   +D    + DFG++        S      + T  Y+A
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKXKDKIGTAYYIA 196
Query: 646 PEYGIERKVSTRSDIYSYGIML 667
           PE  +      + D++S G++L
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVIL 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 91  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAP 193
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 96  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 198
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 101 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 203
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 56/106 (52%), Gaps = 10/106 (9%)
Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
            + + +  AL YL  +H   +IH D+K SN+LLDE     L DFGI+  L  +D++  ++
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRS 184
Query: 636 QTLATIGYMAPEY-----GIERKVSTRSDIYSYGIMLIETFTRKKP 676
              A   YMAPE        +     R+D++S GI L+E  T + P
Sbjct: 185 AGCAA--YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 94  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 196
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 86  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 188
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G+E A K   +  +RA +        E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +          +   L+ +N+ HT  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHTKK 135
Query: 596 IIHCDLKSSNV-LLDEDM-IAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD+++ I H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 100 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 202
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 40/242 (16%)
Query: 453 GGILLSQATKRRLPY-QDLSRAT----NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKV 506
           G  +L  + +R   Y Q+L++       R+   + +G G++G V  A +   G+ VA+K 
Sbjct: 1   GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 60
Query: 507 F---HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL----D 559
                Q    A +++  E  ++K+++H N++ ++              + P  SL    D
Sbjct: 61  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDV------------FTPARSLEEFND 107
Query: 560 IFLYSSTCMLDI-----FQRL---NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED 611
           ++L +     D+      Q+L   ++   +   L  L + H+  IIH DLK SN+ ++ED
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167
Query: 612 MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS-DIYSYGIMLIET 670
               + DFG+A+    E      T  +AT  Y APE  +      ++ DI+S G ++ E 
Sbjct: 168 SELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 671 FT 672
            T
Sbjct: 223 LT 224

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 91  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 91  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 193
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 ----GCSNDDFKALVL-EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
                 S ++F  + L  ++    L+  + S     D  Q L     +   L  L + H+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL-----IYQILRGLKYIHS 143
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             IIH DLK SN+ ++ED    + DFG+ +    E      T  +AT  Y APE  +   
Sbjct: 144 ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIMLNWM 198
Query: 654 VSTRS-DIYSYGIMLIETFT 672
              ++ DI+S G ++ E  T
Sbjct: 199 HYNQTVDIWSVGCIMAELLT 218

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 483 IGIGSFGYVYKAELDDGIE-VAIKV--FHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G++G V+KA+  +  E VA+K      +      S   E  ++K ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
             +D    LV E+      D+  Y  +C  D+   + +   +   L+ L F H+  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEI-VKSFLFQLLKGLGFCHSRNVLHR 125
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRS 658
           DLK  N+L++ +    L+DFG+A+      +    +  + T+ Y  P+     K+ ST  
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 659 DIYSYGIMLIETFTRKKP 676
           D++S G +  E     +P
Sbjct: 184 DMWSAGCIFAELANAARP 201

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 94  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 196
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 88  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 135
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 190
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 472 RATNRFGRDNLIGIGSFGYVY-KAELDDGIEVAIKVFHQECARAMK-SFEVECEVMKNIR 529
           R  NR+     IG GSFG +Y   ++  G EVAIK+   EC +       +E ++ K ++
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQ 62
Query: 530 HRNLVKIISGCSND-DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
               +  I  C  + D+  +V+E +     D+F + S      F    +++     +  +
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRI 118
Query: 589 NFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSG----------EDQSMTQT 635
            + H+   IH D+K  N L+    +  + ++ DFG+AK              E++++T T
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLI 668
              A+I       GIE+  S R D+ S G +L+
Sbjct: 179 ARYASIN---THLGIEQ--SRRDDLESLGYVLM 206

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAM--KSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V  A +   G +VAIK  ++     +  K    E  ++K++RH N++ ++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 540 CSND----DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVASALEYLNFRH 592
            + D    DF    L  MP      F+ +    L   ++L    I   V   L+ L + H
Sbjct: 93  FTPDETLDDFTDFYL-VMP------FMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
              IIH DLK  N+ ++ED    + DFG+A+    E         + T  Y APE  +  
Sbjct: 146 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MXGXVVTRWYRAPEVILNW 200
Query: 653 KVSTRS-DIYSYGIMLIETFTRK 674
              T++ DI+S G ++ E  T K
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 472 RATNRFGRDNLIGIGSFGYVY-KAELDDGIEVAIKVFHQECARAMK-SFEVECEVMKNIR 529
           R  NR+     IG GSFG +Y   ++  G EVAIK+   EC +       +E ++ K ++
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQ 60
Query: 530 HRNLVKIISGCSND-DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
               +  I  C  + D+  +V+E +     D+F + S      F    +++     +  +
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRI 116
Query: 589 NFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSG----------EDQSMTQT 635
            + H+   IH D+K  N L+    +  + ++ DFG+AK              E++++T T
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLI 668
              A+I       GIE+  S R D+ S G +L+
Sbjct: 177 ARYASIN---THLGIEQ--SRRDDLESLGYVLM 204

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 95  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 197
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 17/237 (7%)
Query: 443 RRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE- 501
           R+G + G +NGG    Q +  ++P+  ++    R+    +IG G FG V KA  D  +  
Sbjct: 68  RQGMTGGPNNGGYDDDQGSYVQVPHDHVA---YRYEVLKVIGKGXFGQVVKA-YDHKVHQ 123
Query: 502 -VAIKVFHQECARAMKSFEVECEVMKNIRHR---NLVKIISGCSNDDFKALVLEYMPNGS 557
            VA+K+   E  R  +    E  +++++R +   N + +I    N  F+  +       S
Sbjct: 124 HVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS 182
Query: 558 LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS 617
           ++++          F    +     S L+ L+  H   IIHCDLK  N+LL +   + + 
Sbjct: 183 MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242
Query: 618 --DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             DFG +     E Q +     + +  Y APE  +  +     D++S G +L E  T
Sbjct: 243 VIDFGSS---CYEHQRV--YXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 20/196 (10%)
Query: 480 DNLIGIGSFGYVYKAELDDG--IEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +N IG GS+G V K  +  G  I  A K   +     +  F+ E E+MK++ H N++++ 
Sbjct: 31  ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 89
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTT 594
               ++    LV+E    G     L+       +F+  +   IM DV SA+ Y    H  
Sbjct: 90  ETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYC---HKL 142
Query: 595 PIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
            + H DLK  N L      D    L DFG+A     +   M +T+ + T  Y++P+  +E
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQV-LE 198
Query: 652 RKVSTRSDIYSYGIML 667
                  D +S G+M+
Sbjct: 199 GLYGPECDEWSAGVMM 214

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 20/196 (10%)
Query: 480 DNLIGIGSFGYVYKAELDDG--IEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +N IG GS+G V K  +  G  I  A K   +     +  F+ E E+MK++ H N++++ 
Sbjct: 14  ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN---IMIDVASALEYLNFRHTT 594
               ++    LV+E    G     L+       +F+  +   IM DV SA+ Y    H  
Sbjct: 73  ETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYC---HKL 125
Query: 595 PIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
            + H DLK  N L      D    L DFG+A     +   M +T+ + T  Y++P+  +E
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQV-LE 181
Query: 652 RKVSTRSDIYSYGIML 667
                  D +S G+M+
Sbjct: 182 GLYGPECDEWSAGVMM 197

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G+E A K   +  +RA +        E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +          +   L+ +N+ HT  
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE----EEATSFIKQILDGVNYLHTKK 135
Query: 596 IIHCDLKSSNV-LLDEDM-IAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD+++ I H+   DFG+A  +   +  +       T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 9/187 (4%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG V++  E   G   A K          ++   E + M  +RH  LV +     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +D+   ++ E+M  G L   +      +   + +  M  V   L ++   H    +H DL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDL 281
Query: 602 KSSNVLLDEDMIAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           K  N++        L   DFG+   L   D   +   T  T  + APE    + V   +D
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 660 IYSYGIM 666
           ++S G++
Sbjct: 339 MWSVGVL 345

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 474 TNRFGRDNLIGIGSFGYVY--KAELDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNI 528
           ++R+    ++G GSFG V   K ++  G E A+KV  +   +     E    E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            H N++K+     +  +  LV E    G L    +        F  ++    +   L  +
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 589 NFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            + H   I+H DLK  N+LL+   +D    + DFG++        S      + T  Y+A
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIA 196
Query: 646 PEYGIERKVSTRSDIYSYGIML 667
           PE  +      + D++S G++L
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVIL 217

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/80 (38%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIGYMAPEYGIERKVST 656
           H D+K  N+L+  D  A+L DFGIA   +  D+ +TQ   T+ T+ Y APE   E   + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 657 RSDIYSYGIMLIETFTRKKP 676
           R+DIY+   +L E  T   P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 12/130 (9%)
Query: 521 ECEVMKNIR-HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR--LNI 577
           E ++++ +  H N++++      + F  LV + M  G L  +L     + +   R  +  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
           +++V  AL  LN      I+H DLK  N+LLD+DM   L+DFG +  L   D      + 
Sbjct: 133 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREV 183
Query: 638 LATIGYMAPE 647
             T  Y+APE
Sbjct: 184 CGTPSYLAPE 193

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 472 RATNRFGRDNLIGIGSFGYVYKAE--LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR 529
           R  + F    ++G G+FG V KA   LD       K+ H E    + +   E  ++ ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLN 60
Query: 530 H-------------RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC--MLDIFQR 574
           H             RN VK ++         + +EY  N +L   ++S       D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK-------LLSG 627
           L   I     LE L++ H+  IIH DLK  N+ +DE     + DFG+AK       +L  
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 628 EDQSM-----TQTQTLATIGYMAPEY-GIERKVSTRSDIYSYGIMLIE 669
           + Q++       T  + T  Y+A E        + + D+YS GI+  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 12/130 (9%)
Query: 521 ECEVMKNIR-HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR--LNI 577
           E ++++ +  H N++++      + F  LV + M  G L  +L     + +   R  +  
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
           +++V  AL  LN      I+H DLK  N+LLD+DM   L+DFG +  L   D      + 
Sbjct: 120 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREV 170
Query: 638 LATIGYMAPE 647
             T  Y+APE
Sbjct: 171 CGTPSYLAPE 180

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 76/187 (40%), Gaps = 9/187 (4%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG V++  E   G   A K          ++   E + M  +RH  LV +     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +D+   ++ E+M  G L   +      +   + +  M  V   L ++   H    +H DL
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDL 175
Query: 602 KSSNVLLDEDMIAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           K  N++        L   DFG+   L   D   +   T  T  + APE    + V   +D
Sbjct: 176 KPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 232
Query: 660 IYSYGIM 666
           ++S G++
Sbjct: 233 MWSVGVL 239

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 483 IGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G++G V   Y A L    +VA+K      Q    A +++  E  ++K+++H N++ +
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 537 IS----GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +       S +DF  + L     G+ D+   ++          ++   V   L  L + H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGA-DL---NNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +  IIH DLK SNV ++ED    + DFG+A+     D+ M  T  +AT  Y APE  +  
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEM--TGYVATRWYRAPEIMLNW 203
Query: 653 KVSTRS-DIYSYGIMLIETFTRK 674
               ++ DI+S G ++ E    K
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 504 IKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY 563
           I+ FH+E          E  ++K++ H N++K+     +  +  LV E+   G L     
Sbjct: 86  IEKFHEEIYN-------EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-FEQI 137
Query: 564 SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED---MIAHLSDFG 620
            +    D     NIM  + S + YL   H   I+H D+K  N+LL+     +   + DFG
Sbjct: 138 INRHKFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
           ++   S   +       L T  Y+APE  +++K + + D++S G+++
Sbjct: 195 LSSFFS---KDYKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIM 237

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + D+G+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM-- 632
           L+I I +A A+E+L   H+  ++H DLK SN+    D +  + DFG+   +  +++    
Sbjct: 167 LHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 633 --------TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
                   T    + T  YM+PE       S + DI+S G++L E
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 500 IEVAIKVFHQECARAMKSFEV--ECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGS 557
           +E AIK+  +       + ++  E  V+K + H N++K+     +     LV+E    G 
Sbjct: 63  VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 558 LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIA 614
           L    +        F  ++  + +   L  + + H   I+H DLK  N+LL   ++D + 
Sbjct: 123 L----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178
Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLI 668
            + DFG++ +   + +     + L T  Y+APE  + +K   + D++S G++L 
Sbjct: 179 KIVDFGLSAVFENQKK---MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 483 IGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKI 536
           +G G++G V   Y A L    +VA+K      Q    A +++  E  ++K+++H N++ +
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 537 IS----GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +       S +DF  + L     G+ D+   ++          ++   V   L  L + H
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGA-DL---NNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +  IIH DLK SNV ++ED    + DFG+A+     D+ M  T  +AT  Y APE  +  
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEM--TGYVATRWYRAPEIMLNW 195
Query: 653 KVSTRS-DIYSYGIMLIETFTRK 674
               ++ DI+S G ++ E    K
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 108 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 210
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 85  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 187
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 109 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 211
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 539 ----GCSNDDFKALVL-EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
                 S ++F  + L  ++    L+  +  +    D  Q L     +   L  L + H+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL-----IYQILRGLKYIHS 139
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y APE  +   
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM 194
Query: 654 VSTRS-DIYSYGIMLIETFT 672
              ++ DI+S G ++ E  T
Sbjct: 195 HYNQTVDIWSVGCIMAELLT 214

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 472 RATNRFGRDNLIGIGSFGYVY-KAELDDGIEVAIKVFHQECARAMK-SFEVECEVMKNIR 529
           R  N++     IG GSFG +Y  A +  G EVAIK+   EC +       +E +  K ++
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKL---ECVKTKHPQLHIESKFYKMMQ 62
Query: 530 HRNLVKIISGCSND-DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
               +  I  C  + D+  +V+E +     D+F + S      F    +++     +  +
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRI 118
Query: 589 NFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSG----------EDQSMTQT 635
            + H+   IH D+K  N L+    +  + ++ DFG+AK              E++++T T
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLI 668
              A+I       GIE+  S R D+ S G +L+
Sbjct: 179 ARYASIN---THLGIEQ--SRRDDLESLGYVLM 206

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 12/130 (9%)
Query: 521 ECEVMKNIR-HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR--LNI 577
           E ++++ +  H N++++      + F  LV + M  G L  +L     + +   R  +  
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
           +++V  AL  LN      I+H DLK  N+LLD+DM   L+DFG +  L   D        
Sbjct: 133 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRSV 183
Query: 638 LATIGYMAPE 647
             T  Y+APE
Sbjct: 184 CGTPSYLAPE 193

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 17/194 (8%)
Query: 481 NLIGIGSFGYVYKAELDD-GIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLVKI-- 536
           +++G G+   V++      G   AIKVF+     R +     E EV+K + H+N+VK+  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLY--SSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           I   +    K L++E+ P GSL   L   S+   L   + L ++ DV   + +L      
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 595 PIIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            I+H ++K  N++     D   +  L+DFG A+ L  ++Q ++      T  Y+ P+   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDM-Y 187
Query: 651 ERKVSTRSDIYSYG 664
           ER V  +     YG
Sbjct: 188 ERAVLRKDHQKKYG 201

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 99  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 146
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 201
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 28/231 (12%)
Query: 481 NLIGIGSFGYVYKAELDD-GIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHRNLVKI-- 536
           +++G G+   V++      G   AIKVF+     R +     E EV+K + H+N+VK+  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLY--SSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           I   +    K L++E+ P GSL   L   S+   L   + L ++ DV   + +L      
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 595 PIIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            I+H ++K  N++     D   +  L+DFG A+ L  ++Q +       T  Y+ P+   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX---LYGTEEYLHPDM-Y 187
Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME 701
           ER V  +     YG  +            +++  ++  H   G LP    E
Sbjct: 188 ERAVLRKDHQKKYGATV-----------DLWSIGVTFYHAATGSLPFRPFE 227

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 112 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E         +AT  Y AP
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRAP 214
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 12/212 (5%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKII 537
            +G G F   ++    D  EV A K+  +         +   +E  + +++ H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               ++DF  +VLE     SL + L+     L   +    +  +    +YL   H   +I
Sbjct: 88  GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGCQYL---HRNRVI 143
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVST 656
           H DLK  N+ L+ED+   + DFG+A  +  + +   + +TL  T  Y+APE   ++  S 
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
             D++S G ++      K P +     E  L+
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 232

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 95  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E      T  +AT  Y AP
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 197
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 12/212 (5%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKII 537
            +G G F   ++    D  EV A K+  +         +   +E  + +++ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               ++DF  +VLE     SL + L+     L   +    +  +    +YL   H   +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGCQYL---HRNRVI 139
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVST 656
           H DLK  N+ L+ED+   + DFG+A  +  + +   + +TL  T  Y+APE   ++  S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
             D++S G ++      K P +     E  L+
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 228

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 12/212 (5%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKII 537
            +G G F   ++    D  EV A K+  +         +   +E  + +++ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               ++DF  +VLE     SL + L+     L   +    +  +    +YL   H   +I
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGCQYL---HRNRVI 139
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVST 656
           H DLK  N+ L+ED+   + DFG+A  +  + +   + +TL  T  Y+APE   ++  S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
             D++S G ++      K P +     E  L+
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 228

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 483 IGIGSFGYVYKAELDDGIE-VAIKV--FHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           IG G++G V+KA+  +  E VA+K      +      S   E  ++K ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
             +D    LV E+      D+  Y  +C  D+   + +   +   L+ L F H+  ++H 
Sbjct: 70  LHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEI-VKSFLFQLLKGLGFCHSRNVLHR 125
Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRS 658
           DLK  N+L++ +    L++FG+A+      +    +  + T+ Y  P+     K+ ST  
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 659 DIYSYGIMLIETFTRKKP 676
           D++S G +  E     +P
Sbjct: 184 DMWSAGCIFAELANAGRP 201

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 18/194 (9%)
Query: 482 LIGIGSFGYVYKAELDDGI---EVAIKVFHQECARAMKSFEV--ECEVMKNIRHRNLVKI 536
           ++G GSFG V K +  D I   E A+KV ++  A+   +  +  E E++K + H N++K+
Sbjct: 29  MLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                +     +V E    G L    +        F   +    +      + + H   I
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 597 IHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
           +H DLK  N+LL   ++D    + DFG++       Q+      + T  Y+APE  +   
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEV-LRGT 198
Query: 654 VSTRSDIYSYGIML 667
              + D++S G++L
Sbjct: 199 YDEKCDVWSAGVIL 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 18/194 (9%)
Query: 482 LIGIGSFGYVYKAELDDGI---EVAIKVFHQECARAMKSFEV--ECEVMKNIRHRNLVKI 536
           ++G GSFG V K +  D I   E A+KV ++  A+   +  +  E E++K + H N++K+
Sbjct: 29  MLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                +     +V E    G L    +        F   +    +      + + H   I
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 597 IHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
           +H DLK  N+LL   ++D    + DFG++       Q+      + T  Y+APE  +   
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEV-LRGT 198
Query: 654 VSTRSDIYSYGIML 667
              + D++S G++L
Sbjct: 199 YDEKCDVWSAGVIL 212

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/203 (22%), Positives = 90/203 (44%), Gaps = 12/203 (5%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKN 527
           +R T  +     +G G+F  V +  ++  G E A  + + +   AR  +  E E  + + 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           ++H N+V++    S +    L+ + +  G     L+      + +   +    +   LE 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEA 122
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDM---IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           +   H   ++H +LK  N+LL   +      L+DFG+A  + GE Q+        T GY+
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYL 180
Query: 645 APEYGIERKVSTRSDIYSYGIML 667
           +PE   +       D+++ G++L
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVIL 203

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 14/217 (6%)
Query: 468 QDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQ-ECARAMKS--FEVECE 523
           +DL      +    +IG G+FG V         +V A+K+  + E  +   S  F  E +
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
           +M       +V++     +D +  +V+EYMP G L + L S+  + + + R     +V  
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVL 179
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           AL+ +   H+   IH D+K  N+LLD+     L+DFG    ++ E      T  + T  Y
Sbjct: 180 ALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDY 235
Query: 644 MAPEY----GIERKVSTRSDIYSYGIMLIETFTRKKP 676
           ++PE     G +       D +S G+ L E      P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 56/125 (44%), Gaps = 9/125 (7%)
Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
            I +    AL +L  +    IIH D+K SN+LLD      L DFGI+  L     S+ +T
Sbjct: 129 KITLATVKALNHL--KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKT 183
Query: 636 QTLATIGYMAPEY----GIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV 691
           +      YMAPE        +    RSD++S GI L E  T + P  K  +    L   V
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 692 NGLLP 696
            G  P
Sbjct: 244 KGDPP 248

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 14/217 (6%)
Query: 468 QDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQ-ECARAMKS--FEVECE 523
           +DL      +    +IG G+FG V         +V A+K+  + E  +   S  F  E +
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
           +M       +V++     +D +  +V+EYMP G L + L S+  + + + R     +V  
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVL 184
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           AL+ +   H+   IH D+K  N+LLD+     L+DFG    ++ E      T  + T  Y
Sbjct: 185 ALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDY 240
Query: 644 MAPEY----GIERKVSTRSDIYSYGIMLIETFTRKKP 676
           ++PE     G +       D +S G+ L E      P
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 18/194 (9%)
Query: 482 LIGIGSFGYVYKAELDDGI---EVAIKVFHQECARAMKSFEV--ECEVMKNIRHRNLVKI 536
           ++G GSFG V K +  D I   E A+KV ++  A+   +  +  E E++K + H N++K+
Sbjct: 29  MLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                +     +V E    G L    +        F   +    +      + + H   I
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 597 IHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
           +H DLK  N+LL   ++D    + DFG++       Q+      + T  Y+APE  +   
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEV-LRGT 198
Query: 654 VSTRSDIYSYGIML 667
              + D++S G++L
Sbjct: 199 YDEKCDVWSAGVIL 212

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 14/217 (6%)
Query: 468 QDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEV-AIKVFHQ-ECARAMKS--FEVECE 523
           +DL      +    +IG G+FG V         +V A+K+  + E  +   S  F  E +
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
           +M       +V++     +D +  +V+EYMP G L + L S+  + + + R     +V  
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVL 184
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           AL+ +   H+   IH D+K  N+LLD+     L+DFG    ++ E      T  + T  Y
Sbjct: 185 ALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDY 240
Query: 644 MAPEY----GIERKVSTRSDIYSYGIMLIETFTRKKP 676
           ++PE     G +       D +S G+ L E      P
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 483 IGIGSFGYVYKA---ELDD-----GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           +G G+F  ++K    E+ D       EV +KV  +      +SF     +M  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
                C   D   LV E++  GSLD +L  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EEN 132
Query: 595 PIIHCDLKSSNVLL--DEDM------IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            +IH ++ + N+LL  +ED          LSD GI+  +  +D  + Q +    I ++ P
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPWVPP 186
Query: 647 EYGIE--RKVSTRSDIYSYGIMLIE 669
           E  IE  + ++  +D +S+G  L E
Sbjct: 187 E-CIENPKNLNLATDKWSFGTTLWE 210

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQ-ECARAMKS--FEVECEVMKNIRHRNLVKII 537
           +IG G+FG V         +V A+K+  + E  +   S  F  E ++M       +V++ 
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               +D +  +V+EYMP G L + L S+  + + + +     +V  AL+ +   H+  +I
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKF-YTAEVVLALDAI---HSMGLI 196
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEY----GIER 652
           H D+K  N+LLD+     L+DFG    +  ++  M    T + T  Y++PE     G + 
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
                 D +S G+ L E      P
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 10/211 (4%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKII 537
            +G G F   ++    D  EV A K+  +         +   +E  + +++ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               ++DF  +VLE     SL + L+     L   +    +  +    +YL   H   +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGCQYL---HRNRVI 163
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H DLK  N+ L+ED+   + DFG+A  +  + +   +     T  Y+APE   ++  S  
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
            D++S G ++      K P +     E  L+
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLR 252

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    +  FG+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 109 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E         +AT  Y AP
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAP 211
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 29/206 (14%)
Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIKV-----FHQECARAMKSFEVECEVMKNIRHRNLV 534
            +IG G+F  V +    + G + A+K+     F      + +  + E  +   ++H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDI---------FLYSSTCMLDIFQRLNIMIDVASAL 585
           +++   S+D    +V E+M    L           F+YS        +++         L
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI---------L 140
Query: 586 EYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           E L + H   IIH D+K  NVLL   +      L DFG+A  L   +  +     + T  
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPH 198
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLI 668
           +MAPE           D++  G++L 
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 10/211 (4%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKII 537
            +G G F   ++    D  EV A K+  +         +   +E  + +++ H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               ++DF  +VLE     SL + L+     L   +    +  +    +YL   H   +I
Sbjct: 106 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGCQYL---HRNRVI 161
Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H DLK  N+ L+ED+   + DFG+A  +  + +   +     T  Y+APE   ++  S  
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
            D++S G ++      K P +     E  L+
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKETYLR 250

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + D G+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + D G+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 37/228 (16%)
Query: 472 RATNRFGRDNLIGIGSFGYVYKAE--LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR 529
           R  + F    ++G G+FG V KA   LD       K+ H E    + +   E  ++ ++ 
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVXLLASLN 60
Query: 530 H-------------RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC--MLDIFQR 574
           H             RN VK  +         +  EY  N +L   ++S       D + R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK-------LLSG 627
           L   I     LE L++ H+  IIH +LK  N+ +DE     + DFG+AK       +L  
Sbjct: 121 LFRQI-----LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 628 EDQSM-----TQTQTLATIGYMAPEY-GIERKVSTRSDIYSYGIMLIE 669
           + Q++       T  + T  Y+A E        + + D YS GI+  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 81  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 85  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E         +AT  Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAP 187
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 483 IGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKI 536
           IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK + H+N++ +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 537 ISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR- 591
           ++             + P  +L    D++L       ++ Q + + +D    + YL ++ 
Sbjct: 89  LNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYLLYQM 135
Query: 592 -------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
                  H+  IIH DLK SN+++  D    + DFG+A+       S   T  + T  Y 
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTPYVVTRYYR 192
Query: 645 APEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           APE  +        DI+S G ++ E    K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E         +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 483 IGIGSFGYVYKA---ELDD-----GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           +G G+F  ++K    E+ D       EV +KV  +      +SF     +M  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
                C   D   LV E++  GSLD +L  +   ++I  +L +   +A A+ +L      
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFL---EEN 132
Query: 595 PIIHCDLKSSNVLL--DEDM------IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            +IH ++ + N+LL  +ED          LSD GI+  +  +D  + Q +    I ++ P
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPWVPP 186
Query: 647 EYGIE--RKVSTRSDIYSYGIMLIE 669
           E  IE  + ++  +D +S+G  L E
Sbjct: 187 E-CIENPKNLNLATDKWSFGTTLWE 210

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DFG+A+    E         +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/151 (23%), Positives = 70/151 (46%), Gaps = 7/151 (4%)
Query: 521 ECEVMKNIRHRNLVKIISGCSNDDFKAL--VLEYMPNGSLDIFLYSSTCMLDIFQRLNIM 578
           E ++++ +RH+N+++++    N++ + +  V+EY   G  ++          + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
             +   LEYL   H+  I+H D+K  N+LL       +S  G+A+ L       T   + 
Sbjct: 116 CQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 639 ATIGYMAPEY--GIERKVSTRSDIYSYGIML 667
            +  +  PE   G++     + DI+S G+ L
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G+ VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + D G+A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 6/169 (3%)
Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMI 579
           +E  + +++ H+++V       ++DF  +VLE     SL + L+     L   +    + 
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLR 122
Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            +    +YL   H   +IH DLK  N+ L+ED+   + DFG+A  +  + +   +     
Sbjct: 123 QIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCG 177
Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
           T  Y+APE   ++  S   D++S G ++      K P +     E  L+
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 226

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVM--KNIRHR 531
           ++R+     IG G+FG V +   D   +  + V + E   A+    V+ E++  +++RH 
Sbjct: 19  SDRYDFVKDIGSGNFG-VARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHP 76
Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           N+V+           A+++EY   G L    Y   C    F            L  +++ 
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLS--DFGIAKLLSGEDQSMTQTQTLATIG---YMAP 646
           H+  I H DLK  N LLD      L   DFG +K       S+  +Q  +T+G   Y+AP
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAP 186
Query: 647 EYGIERKVSTR-SDIYSYGIML 667
           E  + ++   + +D++S G+ L
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTL 208

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 60/125 (48%), Gaps = 9/125 (7%)
Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
            I + +  ALE+L+ + +  +IH D+K SNVL++      + DFGI+  L     S+ +T
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKT 211
Query: 636 QTLATIGYMAPEYG----IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV 691
                  YMAPE       ++  S +SDI+S GI +IE    + P D        LK  V
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 692 NGLLP 696
               P
Sbjct: 272 EEPSP 276

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 73
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 74  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HER 120
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 121 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTP 177
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 81  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 81  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGT---SFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 40/221 (18%)
Query: 481 NLIGIGSFGYVYKAELDDGIE--VAIKVFHQ------ECARAMKSFEVECEVMKNIRHRN 532
           +LIG GS+GYVY A  D   E  VAIK  ++      +C R ++    E  ++  ++   
Sbjct: 32  HLIGRGSYGYVYLA-YDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDY 86
Query: 533 LVKIISGCSNDD---FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           ++++      DD   F  L +      S    L+ +   L      +I   + + L   N
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFL---TEEHIKTILYNLLLGEN 143
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS------------------ 631
           F H + IIH DLK +N LL++D    + DFG+A+ ++ E  +                  
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 632 --MTQTQTLATIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
                T  + T  Y APE  + ++  T+S DI+S G +  E
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 483 IGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII---- 537
           +G G  G V+ A  +D    VAIK       +++K    E ++++ + H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 538 -SGCS-NDDFKAL--------VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
            SG    DD  +L        V EYM     ++       +L+   RL  M  +   L+Y
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL--EQGPLLEEHARL-FMYQLLRGLKY 135
Query: 588 LNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATIGYMA 645
           +   H+  ++H DLK +N+ ++ ED++  + DFG+A+++          ++ L T  Y +
Sbjct: 136 I---HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 646 PEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
           P   +     T++ D+++ G +  E  T K
Sbjct: 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 115/269 (42%), Gaps = 31/269 (11%)
Query: 467 YQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVM 525
           ++D+ + T+      L+G G++  V  A  L +G E A+K+  ++   +      E E +
Sbjct: 10  FEDMYKLTS-----ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETL 64
Query: 526 KNIR-HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
              + ++N++++I    +D    LV E +  GS+   +       +  +   ++ DVA+A
Sbjct: 65  YQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQK-HFNEREASRVVRDVAAA 123
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHLS----DFGIAKLLSGEDQSMTQTQTLA 639
           L++L   HT  I H DLK  N+L +  + ++ +     D G    L+     +T  +   
Sbjct: 124 LDFL---HTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTT 180
Query: 640 TIG---YMAPEY-----GIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV 691
             G   YMAPE              R D++S G++L    +   P      A+     W 
Sbjct: 181 PCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCG---WD 237
Query: 692 NG----LLPVSLMEVVNKTLLSPPEKDFA 716
            G    +    L E + +     P+KD+A
Sbjct: 238 RGEVCRVCQNKLFESIQEGKYEFPDKDWA 266

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           N F    +IG G FG VY   + D G   A+K   ++  + MK  E        +  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIM 241
Query: 534 VKIISG-------CSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
           + ++S        C +  F      + +L+ M  G L   L        +F   ++    
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYA 297
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           A  +  L   H   +++ DLK +N+LLDE     +SD G+A   S +        ++ T 
Sbjct: 298 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 353
Query: 642 GYMAPEYGIERKVS--TRSDIYSYGIMLIE------TFTRKKPADK 679
           GYMAPE  +++ V+  + +D +S G ML +       F + K  DK
Sbjct: 354 GYMAPEV-LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           N F    +IG G FG VY   + D G   A+K   ++  + MK  E        +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIM 242
Query: 534 VKIISG-------CSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
           + ++S        C +  F      + +L+ M  G L   L        +F   ++    
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYA 298
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           A  +  L   H   +++ DLK +N+LLDE     +SD G+A   S +        ++ T 
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 642 GYMAPEYGIERKVS--TRSDIYSYGIMLIE------TFTRKKPADK 679
           GYMAPE  +++ V+  + +D +S G ML +       F + K  DK
Sbjct: 355 GYMAPEV-LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 73
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 74  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 120
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 177
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 118
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 119 NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 165
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 222
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 35/207 (16%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G G++G V  A +   G  VA+K      Q    A +++  E  ++K+++H N++ ++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 539 GCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDI-----FQRL---NIMIDVASALE 586
                        + P  SL    D++L +     D+      Q+L   ++   +   L 
Sbjct: 89  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            L + H+  IIH DLK SN+ ++ED    + DF +A+    E      T  +AT  Y AP
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAP 191
Query: 647 EYGIERKVSTRS-DIYSYGIMLIETFT 672
           E  +      ++ DI+S G ++ E  T
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 483 IGIGSFGYVYKAE-LDDGIEVAIK--VFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G F YV   E L DG   A+K  + H++  R  +  + E ++ +   H N++++++ 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--EEAQREADMHRLFNHPNILRLVAY 94
Query: 540 CSND----DFKALVLEYMPNGSL--DI-FLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           C  +        L+L +   G+L  +I  L      L   Q L +++ +   LE +   H
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---H 151
Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL----LSGEDQSMTQTQTLA---TIGYMA 645
                H DLK +N+LL ++    L D G        + G  Q++T     A   TI Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 646 PE-YGIERK--VSTRSDIYSYGIMLIETFTRKKPADKMF 681
           PE + ++    +  R+D++S G +L      + P D +F
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 74
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 75  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 121
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 122 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 178
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 79
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 80  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 126
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 127 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 183
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 184 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 81  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           N F    +IG G FG VY   + D G   A+K   ++  + MK  E        +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIM 242
Query: 534 VKIISG-------CSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
           + ++S        C +  F      + +L+ M  G L   L        +F   ++    
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYA 298
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           A  +  L   H   +++ DLK +N+LLDE     +SD G+A   S +        ++ T 
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 642 GYMAPEYGIERKVS--TRSDIYSYGIMLIE------TFTRKKPADK 679
           GYMAPE  +++ V+  + +D +S G ML +       F + K  DK
Sbjct: 355 GYMAPEV-LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           N F    +IG G FG VY   + D G   A+K   ++  + MK  E        +  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIM 242
Query: 534 VKIISG-------CSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
           + ++S        C +  F      + +L+ M  G L   L        +F   ++    
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYA 298
Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           A  +  L   H   +++ DLK +N+LLDE     +SD G+A   S +        ++ T 
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTH 354
Query: 642 GYMAPEYGIERKVS--TRSDIYSYGIMLIE------TFTRKKPADK 679
           GYMAPE  +++ V+  + +D +S G ML +       F + K  DK
Sbjct: 355 GYMAPEV-LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 81
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 82  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 128
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 185
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 118
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 119 NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 165
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 222
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 74
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 75  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 121
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 122 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 178
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 81  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQE----CARAMKSFEVECEV--MKNIRHRNLVK 535
           +G G F  V K  +   G E A K   +       R +   E+E EV  ++ IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  +   + YL   H+  
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYL---HSKR 128
Query: 596 IIHCDLKSSNVLLDEDMIAH----LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N++L +  + +    L DFGIA  +   ++         T  ++APE    
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNY 185
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 186 EPLGLEADMWSIGVI 200

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A LD    VAIK      Q    A +++  E  +MK +
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 81
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  +L    D++L       ++ Q + + +D    
Sbjct: 82  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HER 128
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 185
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQE----CARAMKSFEVECEV--MKNIRHRNLVK 535
           +G G F  V K  +   G E A K   +       R +   E+E EV  ++ IRH N++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  +   + YL   H+  
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYL---HSKR 135
Query: 596 IIHCDLKSSNVLLDEDMIAH----LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N++L +  + +    L DFGIA  +   ++         T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNY 192
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQE----CARAMKSFEVECEV--MKNIRHRNLVK 535
           +G G F  V K  +   G E A K   +       R +   E+E EV  ++ IRH N++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  +   + YL   H+  
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYL---HSKR 149
Query: 596 IIHCDLKSSNVLLDEDMIAH----LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N++L +  + +    L DFGIA  +   ++         T  ++APE    
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNY 206
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 207 EPLGLEADMWSIGVI 221

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI- 528
           SR T  F     IG G FG V+K  +  DG   AIK   +  A ++       EV  +  
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 529 --RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVAS 583
             +H ++V+  S  + DD   +  EY   GSL   +  +  ++  F+     ++++ V  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL 608
            L Y+   H+  ++H D+K SN+ +
Sbjct: 127 GLRYI---HSMSLVHMDIKPSNIFI 148

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI- 528
           SR T  F     IG G FG V+K  +  DG   AIK   +  A ++       EV  +  
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 62
Query: 529 --RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVAS 583
             +H ++V+  S  + DD   +  EY   GSL   +  +  ++  F+     ++++ V  
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL 608
            L Y+   H+  ++H D+K SN+ +
Sbjct: 123 GLRYI---HSMSLVHMDIKPSNIFI 144

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKV----FHQE--CARAMKSFEVECEVMKNIRHRNLVK 535
           +G G++G V  A +   G +VAIK     F  E    RA +    E  ++K+++H N++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 105
Query: 536 IIS----GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           ++       S  +F    L  MP    D+       M   F    I   V   L+ L + 
Sbjct: 106 LLDVFTPASSLRNFYDFYL-VMPFMQTDL----QKIMGMEFSEEKIQYLVYQMLKGLKYI 160
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H+  ++H DLK  N+ ++ED    + DFG+A+    E      T  + T  Y APE  + 
Sbjct: 161 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILS 215
Query: 652 RKVSTRS-DIYSYGIMLIETFTRK 674
                ++ DI+S G ++ E  T K
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI- 528
           SR T  F     IG G FG V+K  +  DG   AIK   +  A ++       EV  +  
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 529 --RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVAS 583
             +H ++V+  S  + DD   +  EY   GSL   +  +  ++  F+     ++++ V  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL 608
            L Y+   H+  ++H D+K SN+ +
Sbjct: 125 GLRYI---HSMSLVHMDIKPSNIFI 146

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 483 IGIGSFGY----VYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           IG+GS+      ++KA     +E A+K+  +      +  E+   +++  +H N++ +  
Sbjct: 30  IGVGSYSVCKRCIHKAT---NMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKD 83
Query: 539 GCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
              +  +  +V E M  G L D  L          +   ++  +   +EYL   H   ++
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYL---HAQGVV 138
Query: 598 HCDLKSSNVL-LDED---MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
           H DLK SN+L +DE        + DFG AK L  E+  +       T  ++APE    + 
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLERQG 196
Query: 654 VSTRSDIYSYGIMLIETFTRKKP 676
                DI+S G++L    T   P
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 11/202 (5%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKI 536
           +IG GS+  V    L     + A+KV  +E       +   + E  V +    H  LV +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
            S    +     V+EY+  G L   +     + +   R     +++ AL YL   H   I
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYL---HERGI 131
Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           I+ DLK  NVLLD +    L+D+G+ K   G     T +    T  Y+APE         
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D ++ G+++ E    + P D
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 471 SRATNRFGRDNLIGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI- 528
           SR T  F     IG G FG V+K  +  DG   AIK   +  A ++       EV  +  
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 529 --RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL---NIMIDVAS 583
             +H ++V+  S  + DD   +  EY   GSL   +  +  ++  F+     ++++ V  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL 608
            L Y+   H+  ++H D+K SN+ +
Sbjct: 125 GLRYI---HSMSLVHMDIKPSNIFI 146

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 11/202 (5%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKI 536
           +IG GS+  V    L     + A+KV  +E       +   + E  V +    H  LV +
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
            S    +     V+EY+  G L   +     + +   R     +++ AL YL   H   I
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYL---HERGI 127
Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           I+ DLK  NVLLD +    L+D+G+ K   G     T +    T  Y+APE         
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D ++ G+++ E    + P D
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFD 207

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVMKNI------RHRNLV 534
           ++G GSFG V  +E     E+ A+K+  ++    ++  +VEC +++        +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++ S     D    V+EY+  G L   +Y     +  F+  + +   A     L F  + 
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAK--LLSGEDQSMTQTQTLATIGYMAPEYGIER 652
            II+ DLK  NV+LD +    ++DFG+ K  +  G    +T      T  Y+APE    +
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDYIAPEIIAYQ 517
Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
                 D +++G++L E    + P
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKV----FHQE--CARAMKSFEVECEVMKNIRHRNLVK 535
           +G G++G V  A +   G +VAIK     F  E    RA +    E  ++K+++H N++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIG 87
Query: 536 IIS----GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           ++       S  +F    L  MP    D+       M   F    I   V   L+ L + 
Sbjct: 88  LLDVFTPASSLRNFYDFYL-VMPFMQTDL----QKIMGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H+  ++H DLK  N+ ++ED    + DFG+A+    E      T  + T  Y APE  + 
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILS 197
Query: 652 RKVSTRS-DIYSYGIMLIETFTRK 674
                ++ DI+S G ++ E  T K
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 11/202 (5%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKI 536
           +IG GS+  V    L     + A+KV  +E       +   + E  V +    H  LV +
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
            S    +     V+EY+  G L   +     + +   R     +++ AL YL   H   I
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYL---HERGI 142
Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           I+ DLK  NVLLD +    L+D+G+ K   G     T +    T  Y+APE         
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 200
Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D ++ G+++ E    + P D
Sbjct: 201 SVDWWALGVLMFEMMAGRSPFD 222

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 483 IGIGSFGYVYKA-ELDDGIEVAIK-VFH--QECARAMKSFEVECEVMKNIR-HRNLVKII 537
           +G G++G V+K+ +   G  VA+K +F   Q    A ++F  E  ++  +  H N+V ++
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 538 S--GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     ND    LV +YM     D+       +L+   +  ++  +   ++YL   H+  
Sbjct: 76  NVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVYQLIKVIKYL---HSGG 129
Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG-------------------EDQSMTQTQ 636
           ++H D+K SN+LL+ +    ++DFG+++                       +D     T 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 637 TLATIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
            +AT  Y APE  +     T+  D++S G +L E
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 509 QECARAMKSF-EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC 567
           + C+  M +F + E  V K   H N+V   +    D+   +V  +M  GS    +   T 
Sbjct: 47  EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTH 104
Query: 568 MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF--GIAKLL 625
            +D    L I   +   L+ L++ H    +H  +K+S++L+  D   +LS     ++ + 
Sbjct: 105 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 164
Query: 626 SGEDQSMTQ---TQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKM 680
            G+ Q +       ++  + +++PE   +  +    +SDIYS GI   E      P   M
Sbjct: 165 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 224
Query: 681 FAAELSLKHWVNGLLP 696
            A ++ L+  +NG +P
Sbjct: 225 PATQMLLEK-LNGTVP 239

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G+++ E
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 509 QECARAMKSF-EVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTC 567
           + C+  M +F + E  V K   H N+V   +    D+   +V  +M  GS    +   T 
Sbjct: 63  EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTH 120
Query: 568 MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF--GIAKLL 625
            +D    L I   +   L+ L++ H    +H  +K+S++L+  D   +LS     ++ + 
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 626 SGEDQSMTQ---TQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKM 680
            G+ Q +       ++  + +++PE   +  +    +SDIYS GI   E      P   M
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
Query: 681 FAAELSLKHWVNGLLP 696
            A ++ L+  +NG +P
Sbjct: 241 PATQMLLEK-LNGTVP 255

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G+++ E
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVMKNI------RHRNLV 534
           ++G GSFG V  +E     E+ A+K+  ++    ++  +VEC +++        +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++ S     D    V+EY+  G L   +Y     +  F+  + +   A     L F  + 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAK--LLSGEDQSMTQTQTLATIGYMAPEYGIER 652
            II+ DLK  NV+LD +    ++DFG+ K  +  G    +T      T  Y+APE    +
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDYIAPEIIAYQ 196
Query: 653 KVSTRSDIYSYGIMLIETFTRKKP 676
                 D +++G++L E    + P
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 85/200 (42%), Gaps = 16/200 (8%)
Query: 474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           ++R+     IG G+FG           E+    + +   +  ++ + E    +++RH N+
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V+           A+V+EY   G L    +   C    F            +  +++ H 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 594 TPIIHCDLKSSNVLLDEDMIAHL--SDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEY 648
             + H DLK  N LLD      L  +DFG +K       S+  +Q  + +G   Y+APE 
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK------ASVLHSQPKSAVGTPAYIAPEV 187
Query: 649 GIERKVSTR-SDIYSYGIML 667
            ++++   + +D++S G+ L
Sbjct: 188 LLKKEYDGKVADVWSCGVTL 207

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 20/215 (9%)
Query: 474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           ++R+     IG G+FG           E+    + +   +   + + E    +++RH N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNI 77
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V+           A+V+EY   G     L+   C    F            +  +++ H 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLS--DFGIAKLLSGEDQSMTQTQTLATIG---YMAPEY 648
             + H DLK  N LLD      L   DFG +K       S+  +Q  +T+G   Y+APE 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEV 187
Query: 649 GIERKVSTR-SDIYSYG----IMLIETFTRKKPAD 678
            ++++   + +D++S G    +ML+  +  + P +
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 58/238 (24%)
Query: 483 IGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVE-----CEVMKNIRHRNLVKI 536
           IG GS+G V  A  +    + AIK+ ++   R +   +VE       +MK + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 537 ISGCSNDDFKALVLEYMPNG----SLDIFLYSST--CMLDI------------------- 571
                ++ +  LV+E    G     L++F+  ST  C +D+                   
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 572 ----------FQRL----NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL--DEDMIAH 615
                      QR     NIM  + SAL YL   H   I H D+K  N L   ++     
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYL---HNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 616 LSDFGIA----KLLSGEDQSMTQTQTLATIGYMAPEY--GIERKVSTRSDIYSYGIML 667
           L DFG++    KL +GE   MT      T  ++APE           + D +S G++L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA--GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 479 RDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKI 536
           +++++G G+   V     L    E A+K+  ++          E E++   + HRN++++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
           I     +D   LV E M  GS+   ++      +  +   ++ DVASAL++L   H   I
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFL---HNKGI 132
Query: 597 IHCDLKSSNVLLD---EDMIAHLSDFGIAK--LLSGEDQSMTQTQTLATIG---YMAPE- 647
            H DLK  N+L +   +     + DFG+     L+G+   ++  + L   G   YMAPE 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 648 ---YGIERKV-STRSDIYSYGIML 667
              +  E  +   R D++S G++L
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 84/202 (41%), Gaps = 11/202 (5%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKI 536
           +IG GS+  V    L     + A++V  +E       +   + E  V +    H  LV +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
            S    +     V+EY+  G L   +     + +   R     +++ AL YL   H   I
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYL---HERGI 174
Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           I+ DLK  NVLLD +    L+D+G+ K   G     T +    T  Y+APE         
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 657 RSDIYSYGIMLIETFTRKKPAD 678
             D ++ G+++ E    + P D
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFD 254

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 481 NLIGIGSFGYVYKAE-LDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKI 536
            ++  G F +VY+A+ +  G E A+K      +E  RA+   +  C + K   H N+V+ 
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHPNIVQF 91
Query: 537 ISGCS-----NDDFKA--LVLEYMPNGSLDIFL--YSSTCMLDIFQRLNIMIDVASALEY 587
            S  S     +D  +A  L+L  +  G L  FL    S   L     L I      A+++
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
           ++ R   PIIH DLK  N+LL       L DFG A  +S
Sbjct: 152 MH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD--GIEVAIKVF---HQECARAMKSFEVECEVMKNIR 529
            R+ +   IG G+ G V  A  D   GI VA+K      Q    A +++  E  ++K + 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVN 79
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASAL 585
           H+N++ +++             + P  +L    D++L       ++ Q +++ +D    +
Sbjct: 80  HKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD-HERM 126
Query: 586 EYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            YL ++        H+  IIH DLK SN+++  D    + DFG+A+  S    +   T  
Sbjct: 127 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAST---NFMMTPY 183
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           + T  Y APE  +        DI+S G ++ E
Sbjct: 184 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 22/194 (11%)
Query: 483 IGIGSFGY----VYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           IG+GS+      V+KA     +E A+KV  +      +  E+   +++  +H N++ +  
Sbjct: 35  IGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKD 88
Query: 539 GCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
              +     LV E M  G L D  L          +   ++  +   +EYL   H+  ++
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYL---HSQGVV 143
Query: 598 HCDLKSSNVL-LDED---MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
           H DLK SN+L +DE        + DFG AK L  E+  +       T  ++APE    + 
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLKRQG 201
Query: 654 VSTRSDIYSYGIML 667
                DI+S GI+L
Sbjct: 202 YDEGCDIWSLGILL 215

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 474 TNRFGRDNLIGIGSFGYVYKAELDDGIE--VAIKVFHQECARAMKSFEVECEVMKNIRHR 531
           ++ F  ++ +G G+   VY+ +   G +   A+KV  +   +  K    E  V+  + H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHP 108
Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           N++K+          +LVLE +  G L    +        +   +    V   LE + + 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 592 HTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE- 647
           H   I+H DLK  N+L      D    ++DFG++K++  E Q + +T    T GY APE 
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYCAPEI 221
Query: 648 -----YGIERKVSTRSDIYSYGIM 666
                YG E       D++S GI+
Sbjct: 222 LRGCAYGPE------VDMWSVGII 239

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/187 (21%), Positives = 81/187 (43%), Gaps = 9/187 (4%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG V++  E   G     K  +        + + E  +M  + H  L+ +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +     L+LE++  G L   + +    +   + +N M      L+++   H   I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDI 175
Query: 602 KSSNVLLDEDMIAHLS--DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           K  N++ +    + +   DFG+A  L+ ++       T AT  + APE      V   +D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTD 232
Query: 660 IYSYGIM 666
           +++ G++
Sbjct: 233 MWAIGVL 239

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/215 (22%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           ++R+     IG G+FG           E+    + +   +  ++ + E    +++RH N+
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 76
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V+           A+V+EY   G     L+   C    F            +  +++ H 
Sbjct: 77  VRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLS--DFGIAKLLSGEDQSMTQTQTLATIG---YMAPEY 648
             + H DLK  N LLD      L   DFG +K       S+  +Q  +T+G   Y+APE 
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEV 186
Query: 649 GIERKVSTR-SDIYSYG----IMLIETFTRKKPAD 678
            ++++   + +D++S G    +ML+  +  + P +
Sbjct: 187 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 221

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 88/183 (48%), Gaps = 26/183 (14%)
Query: 466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIE---VAIK----VFHQ--ECARAMK 516
           P+ D  +  +R+   +LIG GS+G+V   E  D +E   VAIK    VF    +C R ++
Sbjct: 45  PHSDW-QIPDRYEIRHLIGTGSYGHV--CEAYDKLEKRVVAIKKILRVFEDLIDCKRILR 101
Query: 517 SFEVECEVMKNIRHRNLVKIISGCSNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDI 571
               E  ++  + H ++VK++      D +      +VLE   +    +F   +   L  
Sbjct: 102 ----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF--RTPVYLTE 155
Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
                ++ ++   ++Y+   H+  I+H DLK +N L+++D    + DFG+A+ +   +  
Sbjct: 156 LHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212
Query: 632 MTQ 634
            +Q
Sbjct: 213 NSQ 215

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 22/194 (11%)
Query: 483 IGIGSFGY----VYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           IG+GS+      V+KA     +E A+KV  +      +  E+   +++  +H N++ +  
Sbjct: 35  IGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKD 88
Query: 539 GCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
              +     LV E M  G L D  L          +   ++  +   +EYL   H+  ++
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQK--FFSEREASFVLHTIGKTVEYL---HSQGVV 143
Query: 598 HCDLKSSNVL-LDED---MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
           H DLK SN+L +DE        + DFG AK L  E+  +       T  ++APE    + 
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLKRQG 201
Query: 654 VSTRSDIYSYGIML 667
                DI+S GI+L
Sbjct: 202 YDEGCDIWSLGILL 215

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 475 NRFGRDNLIGIGSFGYVYKAELDD--GIEVAIKVF---HQECARAMKSFEVECEVMKNIR 529
            R+ +   IG G+ G V  A  D   GI VA+K      Q    A +++  E  ++K + 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVN 81
Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASAL 585
           H+N++ +++             + P  +L    D++L       ++ Q +++ +D    +
Sbjct: 82  HKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD-HERM 128
Query: 586 EYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
            YL ++        H+  IIH DLK SN+++  D    + DFG+A+       +   T  
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPY 185
Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
           + T  Y APE  +    +   DI+S G ++ E
Sbjct: 186 VVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPAFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 22/203 (10%)
Query: 483 IGIGSFGY----VYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           IG+GS+      ++KA      E A+K+  +      +  E+   +++  +H N++ +  
Sbjct: 30  IGVGSYSVCKRCIHKAT---NXEFAVKIIDKSKRDPTEEIEI---LLRYGQHPNIITLKD 83
Query: 539 GCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
              +  +  +V E    G L D  L          +   ++  +   +EYL   H   ++
Sbjct: 84  VYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTVEYL---HAQGVV 138
Query: 598 HCDLKSSNVL-LDED---MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
           H DLK SN+L +DE        + DFG AK L  E+  +       T  ++APE    + 
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--XTPCYTANFVAPEVLERQG 196
Query: 654 VSTRSDIYSYGIMLIETFTRKKP 676
                DI+S G++L    T   P
Sbjct: 197 YDAACDIWSLGVLLYTXLTGYTP 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 9/107 (8%)
Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
            I + +  ALE+L+ + +  +IH D+K SNVL++      + DFGI+  L  +   + + 
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKD 167
Query: 636 QTLATIGYMAPEYG----IERKVSTRSDIYSYGIMLIETFTRKKPAD 678
                  YMAPE       ++  S +SDI+S GI +IE    + P D
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 479 RDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKI 536
           +++++G G+   V     L    E A+K+  ++          E E++   + HRN++++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
           I     +D   LV E M  GS+   ++      +  +   ++ DVASAL++L   H   I
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFL---HNKGI 132
Query: 597 IHCDLKSSNVLLDE-DMIAHLS----DFGIAKLLSGEDQSMTQTQTLATIG---YMAPE- 647
            H DLK  N+L +  + ++ +     D G    L+G+   ++  + L   G   YMAPE 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 648 ---YGIERKV-STRSDIYSYGIML 667
              +  E  +   R D++S G++L
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 133
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 190
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 191 EPLGLEADMWSIGVI 205

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 133
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 190
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 191 EPLGLEADMWSIGVI 205

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 14/109 (12%)
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           LE ++  H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +   + T+ YM
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 645 APEYGIERKVSTRS------------DIYSYGIMLIETFTRKKPADKMF 681
            PE  I+   S+R             D++S G +L      K P  ++ 
Sbjct: 180 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 227

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 14/199 (7%)
Query: 477 FGRDNLIGIGSFGYVYKAE-LDDGIEVAIK----VFHQECARAMKSFEVECEVMKNIRHR 531
           F R + +G GS+G V+K    +DG   A+K     F     RA K  EV     K  +H 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH-EKVGQHP 117
Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
             V++           L  E +   SL     +    L   Q    + D   AL +L   
Sbjct: 118 CCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL--- 173
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H+  ++H D+K +N+ L       L DFG+   L        Q        YMAPE  ++
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPEL-LQ 229
Query: 652 RKVSTRSDIYSYGIMLIET 670
               T +D++S G+ ++E 
Sbjct: 230 GSYGTAADVFSLGLTILEV 248

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 14/109 (12%)
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           LE ++  H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +   + T+ YM
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 645 APEYGIERKVSTRS------------DIYSYGIMLIETFTRKKPADKMF 681
            PE  I+   S+R             D++S G +L      K P  ++ 
Sbjct: 176 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 81
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 82  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HER 128
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTP 185
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 89/187 (47%), Gaps = 19/187 (10%)
Query: 517 SFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL---DIFLY----SSTCML 569
            F+ E +++ +I++   +      +N D   ++ EYM N S+   D + +    + TC +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
            I     I+  V ++  Y++  +   I H D+K SN+L+D++    LSDFG ++ +   D
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--D 204
Query: 630 QSMTQTQTLATIGYMAPEYGIERKV--STRSDIYSYGIMLIETFTRKKPADKMFAAELSL 687
           + +  ++   T  +M PE+          + DI+S GI L   F    P    F+ ++SL
Sbjct: 205 KKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISL 258
Query: 688 KHWVNGL 694
               N +
Sbjct: 259 VELFNNI 265

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           LE ++  H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +   + T+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 645 APEYGIERKVSTRS------------DIYSYGIMLIETFTRKKP 676
            PE  I+   S+R             D++S G +L      K P
Sbjct: 177 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 85
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 86  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HER 132
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 133 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTP 189
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        D++S G ++ E    K
Sbjct: 190 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 74
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 75  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HER 121
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 122 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTP 178
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        D++S G ++ E    K
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S   T 
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSM 632
            IM D+ +A+++L   H+  I H D+K  N+L    ++D +  L+DFG AK  +   Q+ 
Sbjct: 132 EIMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNA 185
Query: 633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
            QT    T  Y+APE     K     D++S G+++
Sbjct: 186 LQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           LE ++  H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 645 APEYGIERKVSTRS------------DIYSYGIMLIETFTRKKP 676
            PE  I+   S+R             D++S G +L      K P
Sbjct: 196 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSM 632
            IM D+ +A+++L   H+  I H D+K  N+L    ++D +  L+DFG AK  +   Q+ 
Sbjct: 113 EIMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNA 166
Query: 633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
            QT    T  Y+APE     K     D++S G+++
Sbjct: 167 LQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           LE ++  H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 645 APEYGIERKVSTRS------------DIYSYGIMLIETFTRKKP 676
            PE  I+   S+R             D++S G +L      K P
Sbjct: 224 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 14/104 (13%)
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           LE ++  H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 645 APEYGIERKVSTRS------------DIYSYGIMLIETFTRKKP 676
            PE  I+   S+R             D++S G +L      K P
Sbjct: 224 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 29/206 (14%)
Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIKV-----FHQECARAMKSFEVECEVMKNIRHRNLV 534
            +IG G F  V +    + G + A+K+     F      + +  + E  +   ++H ++V
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDI---------FLYSSTCMLDIFQRLNIMIDVASAL 585
           +++   S+D    +V E+M    L           F+YS        +++         L
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI---------L 142
Query: 586 EYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           E L + H   IIH D+K   VLL   +      L  FG+A  L   +  +     + T  
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPH 200
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLI 668
           +MAPE           D++  G++L 
Sbjct: 201 FMAPEVVKREPYGKPVDVWGCGVILF 226

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 18/195 (9%)
Query: 483 IGIGSFGYVYK-AELDDGIEVAIKVFHQECARAMK------SFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K   +   ++ +        E E  ++K I+H N++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     N     L+LE +  G L  FL     + +  +    +  + + + YL   H+  
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYL---HSLQ 134
Query: 596 IIHCDLKSSNV-LLDEDMIA---HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           I H DLK  N+ LLD ++      + DFG+A  +   D          T  ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNY 191
Query: 652 RKVSTRSDIYSYGIM 666
             +   +D++S G++
Sbjct: 192 EPLGLEADMWSIGVI 206

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFH--QECARAMKS-FEVECEVMKNIRHRNLVKII 537
           +IG G+FG V   +L +  +V A+K+ +  +   RA  + F  E +V+ N   + +  + 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD------IFQRLNIMIDVASALEYLNFR 591
               +D+   LV++Y   G L   L      L           + I ID    L Y    
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY---- 196
Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFG-IAKLLSGEDQSMTQTQTLATIGYMAPEY-- 648
                +H D+K  N+L+D +    L+DFG   KL+  ED ++  +  + T  Y++PE   
Sbjct: 197 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQ 249
Query: 649 ---GIERKVSTRSDIYSYGIMLIETFTRKKP 676
              G + +     D +S G+ + E    + P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 109/258 (42%), Gaps = 62/258 (24%)
Query: 501 EVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDI 560
           E+A+    + C R +   EV         + N  +II          L+LEY   G  +I
Sbjct: 78  EIAVLELAKSCPRVINLHEV---------YENTSEII----------LILEYAAGG--EI 116
Query: 561 FLYSSTCMLDIFQRL---NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-----DM 612
           F   S C+ ++ + +   +++  +   LE + + H   I+H DLK  N+LL       D+
Sbjct: 117 F---SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
              + DFG+++ +     +    + + T  Y+APE      ++T +D+++ GI+     T
Sbjct: 174 --KIVDFGMSRKIG---HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
Query: 673 RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMEC 732
              P    F  E + + ++N               +S    D++  E+   S+  LA + 
Sbjct: 229 HTSP----FVGEDNQETYLN---------------ISQVNVDYS--EETFSSVSQLATDF 267
Query: 733 TMEL----PEKRINAKCC 746
              L    PEKR  A+ C
Sbjct: 268 IQSLLVKNPEKRPTAEIC 285

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 37/218 (16%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 80
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 81  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HER 127
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S     
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMEP 184
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +        DI+S G ++ E    K
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 29/206 (14%)
Query: 481 NLIGIGSFGYVYKA-ELDDGIEVAIKV-----FHQECARAMKSFEVECEVMKNIRHRNLV 534
            +IG G F  V +    + G + A+K+     F      + +  + E  +   ++H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 535 KIISGCSNDDFKALVLEYMPNGSLDI---------FLYSSTCMLDIFQRLNIMIDVASAL 585
           +++   S+D    +V E+M    L           F+YS        +++         L
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI---------L 140
Query: 586 EYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           E L + H   IIH D+K   VLL   +      L  FG+A  L   +  +     + T  
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAGGRVGTPH 198
Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLI 668
           +MAPE           D++  G++L 
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/215 (21%), Positives = 90/215 (41%), Gaps = 20/215 (9%)
Query: 474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           ++R+     IG G+FG           E+    + +   +  ++ + E    +++RH N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V+           A+V+EY   G     L+   C    F            +  +++ H 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 594 TPIIHCDLKSSNVLLDEDMIAHLS--DFGIAKLLSGEDQSMTQTQTLATIG---YMAPEY 648
             + H DLK  N LLD      L    FG +K       S+  +Q  +T+G   Y+APE 
Sbjct: 134 MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK------SSVLHSQPKSTVGTPAYIAPEV 187
Query: 649 GIERKVSTR-SDIYSYG----IMLIETFTRKKPAD 678
            ++++   + +D++S G    +ML+  +  + P +
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE 222

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 14/149 (9%)
Query: 532 NLVKIISGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           N++K+I    +   K  ALV EY+ N            +  I    +I   +   L+ L+
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDF-------KQLYQILTDFDIRFYMYELLKALD 146
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIA-HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
           + H+  I+H D+K  NV++D       L D+G+A+      +   +   +A+  +  PE 
Sbjct: 147 YCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR---VASRYFKGPEL 203
Query: 649 GIERKVSTRS-DIYSYGIMLIETFTRKKP 676
            ++ ++   S D++S G ML     R++P
Sbjct: 204 LVDYQMYDYSLDMWSLGCMLASMIFRREP 232

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 14/149 (9%)
Query: 532 NLVKIISGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           N++K+I    +   K  ALV EY+ N            +  I    +I   +   L+ L+
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDF-------KQLYQILTDFDIRFYMYELLKALD 151
Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIA-HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
           + H+  I+H D+K  NV++D       L D+G+A+      +   +   +A+  +  PE 
Sbjct: 152 YCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR---VASRYFKGPEL 208
Query: 649 GIERKVSTRS-DIYSYGIMLIETFTRKKP 676
            ++ ++   S D++S G ML     R++P
Sbjct: 209 LVDYQMYDYSLDMWSLGCMLASMIFRREP 237

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 14/133 (10%)
Query: 547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNV 606
           ALV E++ N      LY +    DI  R   M ++  AL+Y    H+  I+H D+K  NV
Sbjct: 110 ALVFEHVNNTDFKQ-LYQTLTDYDI--RF-YMYEILKALDYC---HSMGIMHRDVKPHNV 162
Query: 607 LLD-EDMIAHLSDFGIAKLLS-GEDQSMTQTQTLATIGYMAPEYGIERKVSTRS-DIYSY 663
           L+D E     L D+G+A+    G++ ++     +A+  +  PE  ++ ++   S D++S 
Sbjct: 163 LIDHEHRKLRLIDWGLAEFYHPGQEYNV----RVASRYFKGPELLVDYQMYDYSLDMWSL 218
Query: 664 GIMLIETFTRKKP 676
           G ML     RK+P
Sbjct: 219 GCMLASMIFRKEP 231

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 475 NRFGRDNLIGIGSFGYV---YKAELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNI 528
            R+     IG G+ G V   Y A L+    VAIK      Q    A +++  E  +MK +
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 82
Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRLNIMIDVASA 584
            H+N++ +++             + P  SL    D+++       ++ Q + + +D    
Sbjct: 83  NHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HER 129
Query: 585 LEYLNFR--------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           + YL ++        H+  IIH DLK SN+++  D    + DFG+A+       S     
Sbjct: 130 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVP 186
Query: 637 TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
            + T  Y APE  +        DI+S G ++ E
Sbjct: 187 FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 219

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 14/104 (13%)
Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           LE ++  H   I+H DLK +N L+ + M+  L DFGIA  +  +   + +   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 645 APEYGIERKVSTRS------------DIYSYGIMLIETFTRKKP 676
            PE  I+   S+R             D++S G +L      K P
Sbjct: 196 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 29/233 (12%)
Query: 473 ATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMK--SFEVEC------- 522
           A  R G   L+G G FG V+    L D ++VAIKV  +         S  V C       
Sbjct: 31  AEYRLG--PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 523 -EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY-SSTCMLDIFQRLNIMID 580
            +V     H  +++++      +   LVLE  P  + D+F Y +    L           
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
           V +A+++    H+  ++H D+K  N+L+D     A L DFG   LL  E      T    
Sbjct: 148 VVAAIQHC---HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDG 200
Query: 640 TIGYMAPEYGIERKV--STRSDIYSYGIMLIETFTRKKPADK---MFAAELSL 687
           T  Y  PE+ I R    +  + ++S GI+L +      P ++   +  AEL  
Sbjct: 201 TRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF 252

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	763
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-86
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-83
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-80
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-79
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-71
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-78
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-75
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-67
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-65
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-56
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-46
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-46
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-41
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-30
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-12
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-54
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-49
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-49
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-40
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-04
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-48
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-46
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-42
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-42
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-37
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-07
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-41
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-41
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-41
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-36
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-35
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-29
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-41
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-39
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-35
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-34
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-34
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-33
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-37
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-35
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-35
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-35
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-27
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-31
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-31
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-29
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-11
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-31
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-31
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-23
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-07
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-29
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-29
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-28
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-28
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-27
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-23
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-15
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-28
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-28
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-25
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-22
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-22
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-17
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-21
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-11
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-22
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-22
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-21
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-04
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-19
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-07
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-08
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-07
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-05
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-18
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-05
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-11
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-04
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-04

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  274 bits (704), Expect = 2e-86
 Identities = 94/367 (25%), Positives = 149/367 (40%), Gaps = 67/367 (18%)

Query: 34  TDQQALLALEAHISYDPTNLLAQNWTSNTSVCN--WIGITCDVNSHRVTALNISSLNLQG 91
            D+QALL ++  +  +PT L   +W   T  CN  W+G+ CD                  
Sbjct: 6   QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCD------------------ 44

Query: 92  EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLA-YNRFSGTIQS 150
                      +  L L   +L     +  SL +     LP +  L +   N   G I  
Sbjct: 45  ----TDTQTYRVNNLDLSGLNLPKPYPIPSSLAN-----LPYLNFLYIGGINNLVGPIPP 95

Query: 151 PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS 210
            I   ++L  L +   + SG IP+ +  ++                              
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKT----------------------------- 126

Query: 211 LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNS 270
           L  L  S  +++G +P  + +L   + +  + N+++G IP ++G         +++  N 
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS-MTISRNR 185

Query: 271 FSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFG 330
            +G IP      NL  +  ++LSRN   GD     G  K+ Q I L  N L   +    G
Sbjct: 186 LTGKIPP--TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVG 241

Query: 331 YLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGN 390
              +L  LDL NN+I G +   L +L +L  LN+SFN L GEIP+GG    F   ++  N
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301

Query: 391 EKLCGLP 397
           + LCG P
Sbjct: 302 KCLCGSP 308

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  279 bits (717), Expect = 3e-83
 Identities = 102/361 (28%), Positives = 154/361 (42%), Gaps = 34/361 (9%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG------------------N 116
           N   + +L++S   L G IP  +G L  L  L L  N L G                   
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475

Query: 117 NSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTI 176
           N L+G +PS +     N+  +SL+ NR +G I   I     L IL+L  NSFSG IP  +
Sbjct: 476 NDLTGEIPSGL-SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534

Query: 177 GNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL 236
           G+ R++ WL L      N  NG +P+++   S  +     +   I G     + N  +  
Sbjct: 535 GDCRSLIWLDLN----TNLFNGTIPAAMFKQSGKI-----AANFIAGKRYVYIKNDGMKK 585

Query: 237 LLDLELN--KLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSR 294
                 N  +  G       RL  S  +  ++    + G         N   ++ +++S 
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRL--STRNPCNITSRVYGGHTSPTF--DNNGSMMFLDMSY 641

Query: 295 NNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE 354
           N  SG IP  IG +  +  ++L +N + G IP+  G L  L ILDLS+NK+ G I  ++ 
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701

Query: 355 KLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSK 414
            L  L +++LS N L G IP  G F  F    F+ N  LCG P  +             +
Sbjct: 702 ALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQR 761

Query: 415 K 415
            
Sbjct: 762 S 762

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  271 bits (696), Expect = 3e-80
 Identities = 97/320 (30%), Positives = 146/320 (45%), Gaps = 27/320 (8%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG----------------NNS 118
           +   +  L+IS   L G+    I     L  L +  N  VG                 N 
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENK 280

Query: 119 LSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIP-NTIG 177
            +G +P  +  A   +  L L+ N F G +     + S L  L L  N+FSG +P +T+ 
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340

Query: 178 NLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL 237
            +R ++ L L      N  +G LP S+ NLS SL  L +S+ + +G I   +       L
Sbjct: 341 KMRGLKVLDLS----FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396

Query: 238 --LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN 295
             L L+ N  TG IP T      S+L +L L  N  SG+IPS +  G+L  + ++ L  N
Sbjct: 397 QELYLQNNGFTGKIPPTLSNC--SELVSLHLSFNYLSGTIPSSL--GSLSKLRDLKLWLN 452

Query: 296 NFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEK 355
              G+IP  +  +K ++ + L +N L G IP      T+L  + LSNN+++G I   + +
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512

Query: 356 LLYLKKLNLSFNKLEGEIPR 375
           L  L  L LS N   G IP 
Sbjct: 513 LENLAILKLSNNSFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  268 bits (687), Expect = 6e-79
 Identities = 96/378 (25%), Positives = 170/378 (44%), Gaps = 46/378 (12%)

Query: 24  VAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALN 83
             A+ + ++  +   L++ +  +  D   L   +W+SN + C + G+TC     +VT+++
Sbjct: 2   FQASPSQSLYREIHQLISFKDVLP-DKNLL--PDWSSNKNPCTFDGVTCR--DDKVTSID 56

Query: 84  ISSLNLQ---GEIPHEIGYLPSLTKLALGYNSLVG-----------------NNSLSGSL 123
           +SS  L      +   +  L  L  L L  + + G                  NSLSG +
Sbjct: 57  LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPV 116

Query: 124 PSRIDLA-LPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIPNTI---GN 178
            +   L     +K L+++ N      +       + L +L+L  NS SG           
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176

Query: 179 LRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLL 238
              ++ L +     GN ++G +   +     +LE L +S+ + +  IP + G+ S    L
Sbjct: 177 CGELKHLAIS----GNKISGDVD--VSRCV-NLEFLDVSSNNFSTGIPFL-GDCSALQHL 228

Query: 239 DLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFS 298
           D+  NKL+G           ++L  L++  N F G IP    + +L+    ++L+ N F+
Sbjct: 229 DISGNKLSGDFSRAISTC--TELKLLNISSNQFVGPIPPLP-LKSLQY---LSLAENKFT 282

Query: 299 GDIPATIGG-LKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFI-LISLEKL 356
           G+IP  + G    +  + L  N   G +P  FG  + LE L LS+N  SG + + +L K+
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342

Query: 357 LYLKKLNLSFNKLEGEIP 374
             LK L+LSFN+  GE+P
Sbjct: 343 RGLKVLDLSFNEFSGELP 360

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  246 bits (630), Expect = 6e-71
 Identities = 91/325 (28%), Positives = 139/325 (42%), Gaps = 30/325 (9%)

Query: 70  ITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG-------------- 115
                    +  L IS   + G++   +    +L  L +  N+                 
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHL 228

Query: 116 ---NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFI 172
               N LSG     I      +K L+++ N+F G I  P      L  L L  N F+G I
Sbjct: 229 DISGNKLSGDFSRAI-STCTELKLLNISSNQFVGPI--PPLPLKSLQYLSLAENKFTGEI 285

Query: 173 PNTI-GNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP-QVMG 230
           P+ + G    +  L L     GN   G +P    + S  LE L +S+ + +G +P   + 
Sbjct: 286 PDFLSGACDTLTGLDLS----GNHFYGAVPPFFGSCS-LLESLALSSNNFSGELPMDTLL 340

Query: 231 NLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEI 290
            +    +LDL  N+ +G +P +   L ++ L TL L  N+FSG I   +       + E+
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNL-SASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399

Query: 291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL 350
            L  N F+G IP T+    ++ ++ L +N L G IP S G L+ L  L L  N + G I 
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459

Query: 351 ISLEKLLYLKKLNLSFNKLEGEIPR 375
             L  +  L+ L L FN L GEIP 
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPS 484

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  254 bits (651), Expect = 1e-78
 Identities = 100/306 (32%), Positives = 148/306 (48%), Gaps = 14/306 (4%)

Query: 440 KSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDG 499
           K ++   S   +     L      R+P  DL  ATN F    LIG G FG VYK  L DG
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63

Query: 500 IEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLD 559
            +VA+K    E ++ ++ FE E E +   RH +LV +I  C   +   L+ +YM NG+L 
Sbjct: 64  AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123

Query: 560 IFLY---SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
             LY     T  +   QRL I I  A  L YL   HT  IIH D+KS N+LLDE+ +  +
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKI 180

Query: 617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           +DFGI+K  +  DQ+   T    T+GY+ PEY I+ +++ +SD+YS+G++L E    +  
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

Query: 677 ADKMFAA-ELSLKHWVNGLLPVS-LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
             +      ++L  W         L ++V+  L      +   K          A++C  
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK------FGDTAVKCLA 294

Query: 735 ELPEKR 740
              E R
Sbjct: 295 LSSEDR 300

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  245 bits (628), Expect = 4e-75
 Identities = 98/286 (34%), Positives = 151/286 (52%), Gaps = 15/286 (5%)

Query: 463 RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKS-FEVE 521
           +R   ++L  A++ F   N++G G FG VYK  L DG  VA+K   +E  +  +  F+ E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY---SSTCMLDIFQRLNIM 578
            E++    HRNL+++   C     + LV  YM NGS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
           +  A  L YL+      IIH D+K++N+LLDE+  A + DFG+AKL+  +D  +T T   
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVR 196

Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE---LSLKHWVNGLL 695
            TIG++APEY    K S ++D++ YG+ML+E  T ++  D    A    + L  WV GLL
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 696 PV-SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               L  +V+  L    + ++  +E  V  +  +A+ CT   P +R
Sbjct: 257 KEKKLEALVDVDL----QGNYKDEE--VEQLIQVALLCTQSSPMER 296

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  224 bits (573), Expect = 2e-67
 Identities = 85/292 (29%), Positives = 137/292 (46%), Gaps = 27/292 (9%)

Query: 463 RRLPYQDLSRATNRF------GRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARA-- 514
               + +L   TN F         N +G G FG VYK  ++    VA+K           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTE 71

Query: 515 --MKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY--SSTCMLD 570
              + F+ E +VM   +H NLV+++   S+ D   LV  YMPNGSL   L     T  L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
              R  I    A+ + +L   H    IH D+KS+N+LLDE   A +SDFG+A+      Q
Sbjct: 132 WHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW 690
           ++  ++ + T  YMAPE  +  +++ +SDIYS+G++L+E  T     D+    +  L   
Sbjct: 189 TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLDI 246

Query: 691 VNGLL--PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
              +     ++ + ++K +      D  +    V +++S+A +C  E   KR
Sbjct: 247 KEEIEDEEKTIEDYIDKKM-----NDADSTS--VEAMYSVASQCLHEKKNKR 291

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  219 bits (561), Expect = 1e-65
 Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 22/306 (7%)

Query: 458 SQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKS 517
             ++   L  ++L   +       +   G FG V+KA+L     VA+K+F  +  +    
Sbjct: 7   HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQ 64

Query: 518 FEVECEVMKNIRHRNLVKIISGCSNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQ 573
            E E   +  ++H N+++ I              L+  +   GSL  FL ++   +   +
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNE 122

Query: 574 RLNIMIDVASALEYL-------NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
             +I   +A  L YL          H   I H D+KS NVLL  ++ A ++DFG+A    
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 627 GEDQSMTQTQTLATIGYMAPEY-----GIERKVSTRSDIYSYGIMLIETFTRKKPADKMF 681
               +      + T  YMAPE        +R    R D+Y+ G++L E  +R   AD   
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 682 AA-ELSLKHWVNGLLPVSLM-EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEK 739
               L  +  +     +  M EVV      P  +D+  K   +  +     EC     E 
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 740 RINAKC 745
           R++A C
Sbjct: 303 RLSAGC 308

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  202 bits (515), Expect = 4e-56
 Identities = 62/341 (18%), Positives = 120/341 (35%), Gaps = 35/341 (10%)

Query: 48  YDPTNLLAQNWTSNTSVCNW---IGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLT 104
                    NW  N  +  W    G++ + ++ RVT L++      G +P  IG L  L 
Sbjct: 50  QGFGTQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELE 108

Query: 105 KLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTI--QSPITNASKLTILE 162
            LALG +    N  L    P  I  A  + +        +  T     P  + S L    
Sbjct: 109 VLALGSHGEKVNERL--FGPKGI-SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDC 165

Query: 163 LGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT 222
           +  +     I  +         +    G + N +  +   +++ L+  L + Y+ N    
Sbjct: 166 INSDPQQKSIKKSSRITLKDTQI----GQLSNNITFV-SKAVMRLT-KLRQFYMGNSPFV 219

Query: 223 GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIG 282
                       +   + E  +      + +  L++  L  + +        +P+   + 
Sbjct: 220 AENI-----CEAWENENSEYAQQYKTEDLKWDNLKD--LTDVEVYNCPNLTKLPT--FLK 270

Query: 283 NLKVVVEINLSRNNF--------SGDIPATIGGLKDVQNISLPYNRL-EGPIPESFGYLT 333
            L  +  IN++ N               A     + +Q I + YN L   P+  S   + 
Sbjct: 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK 330

Query: 334 SLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
            L +L+   N++ G +  +    + L  LNL++N++   IP
Sbjct: 331 KLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITE-IP 369

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  173 bits (441), Expect = 4e-46
 Identities = 50/345 (14%), Positives = 110/345 (31%), Gaps = 48/345 (13%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG-------------NNSLSG 121
            + + T +   S N+   +   +  L  L +  +G +  V                    
Sbjct: 181 ITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239

Query: 122 SLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSF--------SGFIP 173
           +   + D  L ++  + +        + + +    ++ ++ +  N               
Sbjct: 240 TEDLKWD-NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298

Query: 174 NTIGNLRNIEWLGLVIGLIGNPL-NGILPSSIVNLSISLERLYISNCSITGNIPQVMGNL 232
                   I+ + +      N L    + +S+  +   L  L      + G +P   G+ 
Sbjct: 299 ADAPVGEKIQIIYI----GYNNLKTFPVETSLQKMK-KLGMLECLYNQLEGKLPA-FGSE 352

Query: 233 SIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINL 292
                L+L  N++T       G  +   ++ LS   N     IP+  D  ++ V+  I+ 
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQ--VENLSFAHNKLK-YIPNIFDAKSVSVMSAIDF 409

Query: 293 SRNNFSG-------DIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKI 345
           S N            +  T     +V +I+L  N++     E F   + L  ++L  N +
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469

Query: 346 SGF-------ILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFT 383
           +            + +    L  ++L FNKL   +          
Sbjct: 470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  172 bits (439), Expect = 9e-46
 Identities = 54/334 (16%), Positives = 103/334 (30%), Gaps = 56/334 (16%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
           ++   L    +   +      +  + +GYN+L      +  + + +   +  +  L   Y
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNL-----KTFPVETSL-QKMKKLGMLECLY 339

Query: 142 NRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL-------------- 187
           N+  G + +   +  KL  L L  N  +    N  G    +E L                
Sbjct: 340 NQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDA 398

Query: 188 -------VIGLIGNPLNGI-------LPSSIVNLSISLERLYISNCSITGNIPQVMGNLS 233
                   I    N +  +       L  +     I++  + +SN  I+    ++    S
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG-INVSSINLSNNQISKFPKELFSTGS 457

Query: 234 IFLLLDLELNKLTG-------PIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKV 286
               ++L  N LT             F       L ++ L  N  +  +        L  
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYL--LTSIDLRFNKLT-KLSDDFRATTLPY 514

Query: 287 VVEINLSRNNFSGDIPATIGGLKDVQ------NISLPYNRLEGPIPESFGYLTSLEILDL 340
           +V I+LS N+FS   P        ++            NR     PE      SL  L +
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI 573

Query: 341 SNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
            +N I     ++ +    +  L++  N       
Sbjct: 574 GSNDIRK---VNEKITPNISVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  160 bits (407), Expect = 1e-41
 Identities = 52/342 (15%), Positives = 108/342 (31%), Gaps = 48/342 (14%)

Query: 66  NWIGITCDVNSHRVTALNISSLNLQ-GEIPHEIGYLPSLTKLALGYNSLVG--------- 115
           +W  +       ++  + I   NL+   +   +  +  L  L   YN L G         
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEI 353

Query: 116 --------NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSP-ITNASKLTILELGGN 166
                    N ++  +P+        V+ LS A+N+           + S ++ ++   N
Sbjct: 354 KLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYN 412

Query: 167 SFSGF-------IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC 219
                       +  T     N+  + L      N ++          S  L  + +   
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINL----SNNQISKFPKELFSTGS-PLSSINLMGN 467

Query: 220 SITG-------NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS 272
            +T        +  +   N  +   +DL  NKLT  +   F       L  + L  NSFS
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFS 526

Query: 273 GSIPSCI----DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPES 328
              P+       +    +  + +   N    + P  I     +  + +  N +   + E 
Sbjct: 527 K-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK 584

Query: 329 FGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
                ++ +LD+ +N      L  +   +      L ++K +
Sbjct: 585 I--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  127 bits (320), Expect = 1e-30
 Identities = 31/237 (13%), Positives = 68/237 (28%), Gaps = 9/237 (3%)

Query: 154 NASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLER 213
           +  ++T L L G   SG +P+ IG L  +E L L             P  I    +S E+
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISAN-MSDEQ 137

Query: 214 LYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSG 273
                                  L+   +N       +        K   +    N+ + 
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT- 196

Query: 274 SIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLT 333
            +     +  L  + +  +  + F  +        +     +  Y +        +  L 
Sbjct: 197 FVSK--AVMRLTKLRQFYMGNSPFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLK 249

Query: 334 SLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGN 390
            L  +++ N      +   L+ L  ++ +N++ N+          +           
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 68.1 bits (167), Expect = 6e-12
 Identities = 16/117 (13%), Positives = 37/117 (31%), Gaps = 7/117 (5%)

Query: 291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISG--- 347
           N   + +      ++     V  +SL      G +P++ G LT LE+L L ++       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 348 -FILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKS---FMGNEKLCGLPHLQ 400
            F    +   +  ++        +       P  +F+         + +   +    
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  191 bits (487), Expect = 2e-55
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 26/263 (9%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           IG GSFG VYK +     +VA+K+ +      + +++F+ E  V++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +     A+V ++    SL   L++S    ++ + ++I    A  ++YL   H   IIH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRD 145

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIERKVSTR 657
           LKS+N+ L ED    + DFG+A   S    S    Q   +I +MAPE          S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA 717
           SD+Y++GI+L E  T + P   +   +              ++E+V +  LSP       
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRD-------------QIIEMVGRGSLSPDLSKVR- 251

Query: 718 KEQCVLSIFSLAMECTMELPEKR 740
              C   +  L  EC  +  ++R
Sbjct: 252 -SNCPKRMKRLMAECLKKKRDER 273

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  192 bits (489), Expect = 2e-55
 Identities = 67/198 (33%), Positives = 109/198 (55%), Gaps = 8/198 (4%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           IG GSFG V++AE   G +VA+K+  ++   A  +  F  E  +MK +RH N+V  +   
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
           +     ++V EY+  GSL   L+ S     LD  +RL++  DVA  + YL+     PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            +LKS N+L+D+     + DFG+++L +    S        T  +MAPE   +   + +S
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKS 220

Query: 659 DIYSYGIMLIETFTRKKP 676
           D+YS+G++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  187 bits (476), Expect = 6e-54
 Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 32/261 (12%)

Query: 453 GGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQEC 511
           GG    ++    L   ++      + +   IG G FG V+K   + D   VAIK      
Sbjct: 4   GGSEFPKSRLPTLADNEIE-----YEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56

Query: 512 -------ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS 564
                      + F+ E  +M N+ H N+VK+     N     +V+E++P G L   L  
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD 114

Query: 565 STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-----DMIAHLSDF 619
               +    +L +M+D+A  +EY+      PI+H DL+S N+ L        + A ++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 620 GIAKLLSGEDQSMTQTQTLATIGYMAPE--YGIERKVSTRSDIYSYGIMLIETFTRKKPA 677
           G+++         + +  L    +MAPE     E   + ++D YS+ ++L    T + P 
Sbjct: 174 GLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

Query: 678 DKMFAAELSLKHWV--NGLLP 696
           D+    ++   + +   GL P
Sbjct: 229 DEYSYGKIKFINMIREEGLRP 249

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  187 bits (478), Expect = 6e-54
 Identities = 70/262 (26%), Positives = 108/262 (41%), Gaps = 33/262 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G+FG V KA+     +VAIK    E     K+F VE   +  + H N+VK+  G   
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLY-GACL 71

Query: 543 DDFKALVLEYMPNGSLDIFLYSS--TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +    LV+EY   GSL   L+ +           ++  +  +  + YL+      +IH D
Sbjct: 72  NPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 601 LKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           LK  N+LL     +  + DFG A      D     T    +  +MAPE       S + D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185

Query: 660 IYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL-LSPPEKDFAAK 718
           ++S+GI+L E  TR+KP D++            G     +M  V+        +      
Sbjct: 186 VFSWGIILWEVITRRKPFDEI------------GGPAFRIMWAVHNGTRPPLIKN----- 228

Query: 719 EQCVLSIFSLAMECTMELPEKR 740
                 I SL   C  + P +R
Sbjct: 229 --LPKPIESLMTRCWSKDPSQR 248

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  188 bits (479), Expect = 6e-54
 Identities = 77/310 (24%), Positives = 117/310 (37%), Gaps = 37/310 (11%)

Query: 465 LPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEV 524
               + S   +      LIG G +G VYK  LD    VA+KVF        ++F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFS---FANRQNFINEKNI 58

Query: 525 MK--NIRHRNLVKIISGCSNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
            +   + H N+ + I G             LV+EY PNGSL  +L   T   D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRL 116

Query: 578 MIDVASALEYL------NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
              V   L YL         +   I H DL S NVL+  D    +SDFG++  L+G    
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 632 MTQTQTLA------TIGYMAPEY-------GIERKVSTRSDIYSYGIMLIETFTRKK--- 675
               +  A      TI YMAPE                + D+Y+ G++  E F R     
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 676 PADKMFAAELSLKHWVNGLLPVSLME--VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECT 733
           P + +   +++ +  V        M+  V  +       + +      V S+     +C 
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296

Query: 734 MELPEKRINA 743
            +  E R+ A
Sbjct: 297 DQDAEARLTA 306

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (465), Expect = 1e-52
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFH----QECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           IGIG FG VY+A    G EVA+K       ++ ++ +++   E ++   ++H N++ +  
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
            C  +    LV+E+   G L+  L      +     +N  + +A  + YL+     PIIH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 599 CDLKSSNVLLDEDMIAH--------LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            DLKSSN+L+ + +           ++DFG+A+        M+         +MAPE   
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMSAA---GAYAWMAPEVIR 187

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
               S  SD++SYG++L E  T + P
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP 213

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  182 bits (464), Expect = 5e-52
 Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 36/272 (13%)

Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G FG   K    + G  + +K   +      ++F  E +VM+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
            D     + EY+  G+L   + S        QR++   D+AS + YL   H+  IIH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDL 134

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA------------TIGYMAPEYG 649
            S N L+ E+    ++DFG+A+L+  E       ++L                +MAPE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSL-MEVVNKTLL 708
             R    + D++S+GI+L E   R                     LP ++   +  +  L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------DYLPRTMDFGLNVRGFL 240

Query: 709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
                       C  S F + + C    PEKR
Sbjct: 241 DRY-----CPPNCPPSFFPITVRCCDLDPEKR 267

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  178 bits (455), Expect = 3e-51
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 23/225 (10%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           +     G ++K     G ++ +KV        R  + F  EC  ++   H N++ ++ G 
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL-GA 75

Query: 541 SND---DFKALVLEYMPNGSLDIFLYSSTCM-LDIFQRLNIMIDVASALEYLNFRHT--T 594
                     L+  +MP GSL   L+  T   +D  Q +   +D+A  + +L   HT   
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEP 132

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE---YGIE 651
            I    L S +V++DEDM A +S   +         S      +    ++APE      E
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPE 185

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP 696
                 +D++S+ ++L E  TR+ P   +   E+ +K  + GL P
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  180 bits (458), Expect = 4e-51
 Identities = 56/274 (20%), Positives = 103/274 (37%), Gaps = 39/274 (14%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIIS 538
            LIG G FG VY        EVAI++   E      +K+F+ E    +  RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
            C +    A++       +L   +  +  +LD+ +   I  ++   + YL   H   I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILH 153

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA---TIGYMAPE-------- 647
            DLKS NV  D   +  ++DFG+  +         + +       + ++APE        
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 648 -YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT 706
               +   S  SD+++ G +  E   R+ P    F                +++  +   
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP----FK----------TQPAEAIIWQMGTG 258

Query: 707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           +         ++      I  + + C     E+R
Sbjct: 259 MKPNL-----SQIGMGKEISDILLFCWAFEQEER 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  178 bits (453), Expect = 1e-50
 Identities = 69/286 (24%), Positives = 112/286 (39%), Gaps = 28/286 (9%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEV--MKNIRHRNLVKIIS 538
             +G G +G V++     G  VA+K+F     R  KS+  E E+     +RH N++  I+
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 539 GCSNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL-----N 589
                   +    L+  Y   GSL  +L  +T  LD    L I++ +AS L +L      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA--TIGYMAPE 647
            +    I H DLKS N+L+ ++    ++D G+A + S     +         T  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 648 ------YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME 701
                          R DI+++G++L E   R      +   +      V        M 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 702 --VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKC 745
             V       P   +    +  + S+  L  EC  + P  R+ A  
Sbjct: 248 KVVCVDQ-QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  179 bits (456), Expect = 1e-50
 Identities = 70/285 (24%), Positives = 111/285 (38%), Gaps = 24/285 (8%)

Query: 480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
              IG G +G V+  +   G +VA+KVF      A    E E      +RH N++  I+ 
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAA 99

Query: 540 CSNDDFK----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL-----NF 590
                       L+ +Y  NGSL  +L S+T  LD    L +     S L +L     + 
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA--TIGYMAPE- 647
           +    I H DLKS N+L+ ++    ++D G+A     +   +         T  YM PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

Query: 648 -----YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME- 701
                     +    +D+YS+G++L E   R      +   +L     V        M  
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277

Query: 702 -VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKC 745
            V  K  L P   +  + ++C+  +  L  EC    P  R+ A  
Sbjct: 278 IVCIKK-LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  184 bits (468), Expect = 8e-49
 Identities = 71/375 (18%), Positives = 136/375 (36%), Gaps = 42/375 (11%)

Query: 24  VAAAATSNITTDQQALLALEAHISYDP---------TNLLAQNWTSNTSVCNW---IGIT 71
           +    T+    D +AL A+   +               + + NW  N  +  W    G+ 
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318

Query: 72  CDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLAL 131
            D N+ RVT L+++    +G +P  IG L  L  L+ G +S   +  L G      D++ 
Sbjct: 319 LD-NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377

Query: 132 PNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGL 191
                + + Y +        +  +  L               ++  +L++       IG 
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKD-----TQIGN 432

Query: 192 IGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPV 251
           + N +  I   +I  L+  L+ +Y +N   T +   V          + +  K      +
Sbjct: 433 LTNRITFI-SKAIQRLT-KLQIIYFANSPFTYDNIAVDW-----EDANSDYAKQYENEEL 485

Query: 252 TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG---------DIP 302
           ++  L++  L  + L        +P    + +L  +  +N++ N              + 
Sbjct: 486 SWSNLKD--LTDVELYNCPNMTQLPDF--LYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 303 ATIGGLKDVQNISLPYNRLEG-PIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKK 361
                   +Q   + YN LE  P   S   +  L +LD  +NK+    L +    + L  
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTD 599

Query: 362 LNLSFNKLEGEIPRG 376
           L L +N++E EIP  
Sbjct: 600 LKLDYNQIE-EIPED 613

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  159 bits (403), Expect = 2e-40
 Identities = 52/362 (14%), Positives = 105/362 (29%), Gaps = 58/362 (16%)

Query: 84  ISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLA-LPNVKALSLAYN 142
                    +  +    P +    +GYN+L          P+   L  +  +  L   +N
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLE-------EFPASASLQKMVKLGLLDCVHN 583

Query: 143 RFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL--------------- 187
           +    +        KLT L+L  N       +       +E LG                
Sbjct: 584 KVR-HL-EAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAK 641

Query: 188 ------VIGLIGNPLNGILPSSIVNLS----ISLERLYISNCSITGNIPQVMGNLSIFLL 237
                  +    N +     +   ++     I+   + +S   I     ++    S    
Sbjct: 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIST 701

Query: 238 LDLELNKLT-------GPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEI 290
           + L  N +T        P    +       L T+ L  N  + S+        L  +  +
Sbjct: 702 IILSNNLMTSIPENSLKPKDGNYKNTYL--LTTIDLRFNKLT-SLSDDFRATTLPYLSNM 758

Query: 291 NLSRNNFSGDIPATIGGLKDVQ------NISLPYNRLEGPIPESFGYLTSLEILDLSNNK 344
           ++S N FS   P        ++            NR+    P       SL  L + +N 
Sbjct: 759 DVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817

Query: 345 ISGFILISLEKLLYLKKLNLSFNKL-EGEIPRGGPFANFTAKSFMGN--EKLCGLPHLQV 401
           I     +  +    L  L+++ N     ++    P+        + +  + + G   L +
Sbjct: 818 IRK---VDEKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGI 874

Query: 402 PQ 403
            +
Sbjct: 875 ER 876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 91.5 bits (227), Expect = 4e-19
 Identities = 29/192 (15%), Positives = 59/192 (30%), Gaps = 9/192 (4%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
                + + +S   +Q            ++ + L  N +      S             +
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730

Query: 135 KALSLAYNRFSGTIQS-PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLI- 192
             + L +N+ +        T    L+ +++  N FS   P    N   ++  G+      
Sbjct: 731 TTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789

Query: 193 -GNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLT-GPIP 250
            GN +    P+ I     SL +L I +  I     ++   L I   LD+  N      + 
Sbjct: 790 EGNRILRQWPTGITTCP-SLIQLQIGSNDIRKVDEKLTPQLYI---LDIADNPNISIDVT 845

Query: 251 VTFGRLQNSKLD 262
                ++     
Sbjct: 846 SVCPYIEAGMYV 857

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 13/86 (15%), Positives = 29/86 (33%), Gaps = 10/86 (11%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
            +     +  + P  I   PSL +L +G N +         +  ++    P +  L +A 
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-------RKVDEKL---TPQLYILDIAD 836

Query: 142 NRFSGTIQSPITNASKLTILELGGNS 167
           N       + +    +  +  L  + 
Sbjct: 837 NPNISIDVTSVCPYIEAGMYVLLYDK 862

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  171 bits (436), Expect = 7e-48
 Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 28/287 (9%)

Query: 480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEV--MKNIRHRNLVKII 537
              IG G FG V++ +   G EVA+K+F     R  +S+  E E+     +RH N++  I
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102

Query: 538 SGCSNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL----- 588
           +  + D+       LV +Y  +GSL  +L   T  + +   + + +  AS L +L     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIV 160

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA--TIGYMAP 646
             +    I H DLKS N+L+ ++    ++D G+A        ++         T  YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 647 E------YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           E           +   R+DIY+ G++  E   R          +L     V     V  M
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280

Query: 701 E--VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKC 745
              V  +  L P   +     + +  +  +  EC       R+ A  
Sbjct: 281 RKVVCEQK-LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  177 bits (450), Expect = 5e-47
 Identities = 72/301 (23%), Positives = 113/301 (37%), Gaps = 19/301 (6%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALS 138
           +T LN++   L+            LT L +G+N++         L   +   LP +K L+
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK-------LEPELCQKLPMLKVLN 79

Query: 139 LAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG 198
           L +N  S          + LT L L  NS      N     +N+  L L      N L+ 
Sbjct: 80  LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS----HNGLSS 135

Query: 199 ILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL--LDLELNKLTGPIPVTFGRL 256
               + V L  +L+ L +SN  I     + +   +   L  L+L  N++    P  F  +
Sbjct: 136 TKLGTQVQLE-NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194

Query: 257 QNSKLDTLSLCGNSFSGSIPSCIDIG-NLKVVVEINLSRNNFSGDIPATIGGLKDV--QN 313
               L  L L       S+   + +      +  ++LS +  S     T  GLK      
Sbjct: 195 GR--LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252

Query: 314 ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI 373
           + L YN L     +SF +L  LE   L  N I      SL  L  ++ LNL  +  +  I
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312

Query: 374 P 374
            
Sbjct: 313 S 313

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  175 bits (447), Expect = 1e-46
 Identities = 69/364 (18%), Positives = 118/364 (32%), Gaps = 48/364 (13%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG------------------NNSLSG 121
           T+L++    +    P     LP L  L L +N L                    +NS+  
Sbjct: 52  TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111

Query: 122 SLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRN 181
              +       N+  L L++N  S T          L  L L  N         +    N
Sbjct: 112 IKNNPFV-KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFAN 170

Query: 182 IEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMG---NLSIFLLL 238
              L   + L  N +    P     +   L  L+++N  +  ++ + +      +    L
Sbjct: 171 SS-L-KKLELSSNQIKEFSPGCFHAIG-RLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227

Query: 239 DLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFS 298
            L  ++L+     TF  L+ + L  L L  N+ +           L  +    L  NN  
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF--AWLPQLEYFFLEYNNIQ 285

Query: 299 GDIPATIGGLKDVQ---------NISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFI 349
                ++ GL +V+           S+    L      SF +L  LE L++ +N I G  
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345

Query: 350 LISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKS------------FMGNEKLCGLP 397
                 L+ LK L+LS +           F +                  + ++    L 
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405

Query: 398 HLQV 401
           HL+V
Sbjct: 406 HLEV 409

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  166 bits (422), Expect = 2e-43
 Identities = 68/314 (21%), Positives = 108/314 (34%), Gaps = 31/314 (9%)

Query: 76  SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVK 135
               T  +IS  +L         +L  L  L +  N + G       + S +   L N+K
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-------IKSNMFTGLINLK 356

Query: 136 ALSLAYNRFSGTIQSPIT----NASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGL 191
            LSL+ +  S    +  T      S L IL L  N  S    +    L ++E L L    
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDL---- 412

Query: 192 IGNPLNGILP-SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG--P 248
             N +   L       L  ++  +Y+S              +     L L    L     
Sbjct: 413 GLNEIGQELTGQEWRGLE-NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471

Query: 249 IPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFS--------GD 300
            P  F  L+N  L  L L  N+ +      +    L+ +  ++L  NN +        G 
Sbjct: 472 SPSPFQPLRN--LTILDLSNNNIANINDDML--EGLEKLEILDLQHNNLARLWKHANPGG 527

Query: 301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLK 360
               + GL  +  ++L  N  +    E F  L  L+I+DL  N ++          + LK
Sbjct: 528 PIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK 587

Query: 361 KLNLSFNKLEGEIP 374
            LNL  N +     
Sbjct: 588 SLNLQKNLITSVEK 601

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  162 bits (412), Expect = 4e-42
 Identities = 61/273 (22%), Positives = 105/273 (38%), Gaps = 18/273 (6%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
           +  L+  +P  +     N+  L+L +N+      +  T  S+LT L++G N+ S   P  
Sbjct: 13  HLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF 235
              L  ++ L     L  N L+ +   +    + +L  L++ + SI              
Sbjct: 69  CQKLPMLKVL----NLQHNELSQLSDKTFAFCT-NLTELHLMSNSIQKIKNNPFVKQKNL 123

Query: 236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN 295
           + LDL  N L+     T  +L+N  L  L L  N         +DI     + ++ LS N
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLEN--LQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 296 NFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGY---LTSLEILDLSNNKISGFILIS 352
                 P     +  +  + L   +L   + E        TS+  L LSN+++S     +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 353 LEKLLY--LKKLNLSFNKLEGEIPRGGPFANFT 383
              L +  L  L+LS+N L         FA   
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGN--DSFAWLP 272

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  161 bits (410), Expect = 7e-42
 Identities = 66/331 (19%), Positives = 115/331 (34%), Gaps = 25/331 (7%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
           LN+   ++ G   +    L +L  L+L  +        + +  S   LA   +  L+L  
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS---LAHSPLHILNLTK 390

Query: 142 NRFSGTIQSPITNASKLTILELGGNSFSGFIP-NTIGNLRNIEWLGLVIGLIGNPLNGIL 200
           N+ S       +    L +L+LG N     +       L NI  + L      N    + 
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS----YNKYLQLT 446

Query: 201 PSSIVNLSISLERLYISNCSITG--NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN 258
            +S   +  SL+RL +   ++    + P     L    +LDL  N +          L+ 
Sbjct: 447 RNSFALVP-SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505

Query: 259 SKLDTLSLCGNSFSGSIPSCID------IGNLKVVVEINLSRNNFSGDIPATIGGLKDVQ 312
             L+ L L  N+ +              +  L  +  +NL  N F          L +++
Sbjct: 506 --LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563

Query: 313 NISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLY-LKKLNLSFNKLEG 371
            I L  N L       F    SL+ L+L  N I+             L +L++ FN  + 
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623

Query: 372 EIPRGGPFANFTAKS-----FMGNEKLCGLP 397
                  F N+  ++      + +  LC  P
Sbjct: 624 TCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  148 bits (376), Expect = 2e-37
 Identities = 53/314 (16%), Positives = 103/314 (32%), Gaps = 44/314 (14%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
              ++    +   N+Q    H +  L ++  L L  +                       
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK-------------------- 309

Query: 135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGN 194
              S++                 L  L +  N   G   N    L N+++L L      +
Sbjct: 310 --QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS----NS 363

Query: 195 PLN--GILPSSIVNLSI-SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPV 251
             +   +   + V+L+   L  L ++   I+         L    +LDL LN++   +  
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423

Query: 252 -TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG--DIPATIGGL 308
             +  L+N  +  + L  N +     +      +  +  + L R         P+    L
Sbjct: 424 QEWRGLEN--IFEIYLSYNKYLQLTRN--SFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479

Query: 309 KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKIS--------GFILISLEKLLYLK 360
           +++  + L  N +     +    L  LEILDL +N ++        G  +  L+ L +L 
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539

Query: 361 KLNLSFNKLEGEIP 374
            LNL  N  +    
Sbjct: 540 ILNLESNGFDEIPV 553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  107 bits (269), Expect = 3e-24
 Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 11/180 (6%)

Query: 208 SISLERLYISNCSITGNIPQ-VMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSL 266
           ++S E    S+  +T  +P  +  N+++   L+L  N+L       F R     L +L +
Sbjct: 3   TVSHEVADCSHLKLT-QVPDDLPTNITV---LNLTHNQLRRLPAANFTRYSQ--LTSLDV 56

Query: 267 CGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIP 326
             N+ S   P       L ++  +NL  N  S     T     ++  + L  N ++    
Sbjct: 57  GFNTISKLEPELC--QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114

Query: 327 ESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKS 386
             F    +L  LDLS+N +S   L +  +L  L++L LS NK++           F   S
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS--EELDIFANSS 172

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (251), Expect = 5e-22
 Identities = 39/229 (17%), Positives = 72/229 (31%), Gaps = 29/229 (12%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
               +  + +S         +    +PSL +L L   +L   +S            L N+
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP-----LRNL 482

Query: 135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGN 194
             L L+ N  +      +    KL IL+L  N+ +    +                    
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA------------------- 523

Query: 195 PLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFG 254
              G     +  LS  L  L + +        +V  +L    ++DL LN L       F 
Sbjct: 524 -NPGGPIYFLKGLS-HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581

Query: 255 RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA 303
              +  L +L+L  N  +            + + E+++  N F     +
Sbjct: 582 NQVS--LKSLNLQKNLITSVEKKVFG-PAFRNLTELDMRFNPFDCTCES 627

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 52.3 bits (126), Expect = 5e-07
 Identities = 31/173 (17%), Positives = 56/173 (32%), Gaps = 15/173 (8%)

Query: 52  NLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYN 111
           N LA+ W           +        +  LN+ S             L  L  + LG N
Sbjct: 514 NNLARLWKHANPGGPIYFLK---GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570

Query: 112 SLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSG 170
           +L         LP+ +     ++K+L+L  N  +   +         LT L++  N F  
Sbjct: 571 NLNT-------LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623

Query: 171 FIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS-ISLERLYISNCSIT 222
              + I    N  W+      I    +  L ++  +     +     S+C  +
Sbjct: 624 TCES-IAWFVN--WINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDS 673

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  154 bits (391), Expect = 4e-42
 Identities = 66/293 (22%), Positives = 125/293 (42%), Gaps = 26/293 (8%)

Query: 462 KRRLPYQD---LSRATNRFGRDNLIGIGSFGYVYKAELD-----DGIEVAIKVFHQEC-A 512
           K+     D     +   +  RD  +G G FG V     D      G +VA+K    E   
Sbjct: 7   KKPATEVDPTHFEKRFLKRIRD--LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG 64

Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLD 570
             +   + E E+++N+ H N+VK    C+ D      L++E++P+GSL  +L  +   ++
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124

Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGED 629
           + Q+L   + +   ++YL  R     +H DL + NVL++ +    + DFG+ K + + ++
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

Query: 630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLK 688
               +    + + + APE  ++ K    SD++S+G+ L E  T     +  M      + 
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

Query: 689 HWVNGLLPVSLMEVVNK-TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
                +    L+  + +   L  P         C   ++ L  +C    P  R
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPN-------CPDEVYQLMRKCWEFQPSNR 287

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  154 bits (390), Expect = 1e-41
 Identities = 72/320 (22%), Positives = 129/320 (40%), Gaps = 34/320 (10%)

Query: 439 YKSTRRGKSTGLSNGGILLSQATKRRLPYQD---LSRATNRFGRDNLIGIGSFGYVYKAE 495
           Y           +   +    A       +D         +F +   +G G+FG V    
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQ--LGKGNFGSVEMCR 61

Query: 496 LD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA--L 548
            D      G  VA+K         ++ FE E E++K+++H N+VK    C +   +   L
Sbjct: 62  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121

Query: 549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL 608
           ++EY+P GSL  +L      +D  + L     +   +EYL  +     IH DL + N+L+
Sbjct: 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILV 178

Query: 609 DEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
           + +    + DFG+ K+L   ++    +    + I + APE   E K S  SD++S+G++L
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238

Query: 668 IETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNKT----LLSPPEKDFAAKEQ 720
            E FT  + +    A  + +     G      + +  ++        L  P+        
Sbjct: 239 YELFTYIEKSKSPPAEFMRMI----GNDKQGQMIVFHLIELLKNNGRLPRPDG------- 287

Query: 721 CVLSIFSLAMECTMELPEKR 740
           C   I+ +  EC      +R
Sbjct: 288 CPDEIYMIMTECWNNNVNQR 307

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  160 bits (406), Expect = 1e-41
 Identities = 60/310 (19%), Positives = 109/310 (35%), Gaps = 28/310 (9%)

Query: 82  LNISSLNL-QGEIPHEIGYLPSLTKLALGYNSLVGNNSLSG------------SLPSRID 128
             ++ L+    +I      L +++  +L   ++      S                    
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321

Query: 129 LALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGN--SFSGFIPNTIGNLRNIEWLG 186
           L L ++K L+   N+          +   L  L+L  N  SF G    +     ++++L 
Sbjct: 322 LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 187 LVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQ-VMGNLSIFLLLDLELNKL 245
           L      N +  +  S+ + L   LE L   + ++       V  +L   + LD+     
Sbjct: 380 L----SFNGVITM-SSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 246 TGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI 305
                  F  L  S L+ L + GNSF  +    I    L+ +  ++LS+       P   
Sbjct: 434 RVAFNGIFNGL--SSLEVLKMAGNSFQENFLPDI-FTELRNLTFLDLSQCQLEQLSPTAF 490

Query: 306 GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLY-LKKLNL 364
             L  +Q +++ +N         +  L SL++LD S N I       L+     L  LNL
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550

Query: 365 SFNKLEGEIP 374
           + N       
Sbjct: 551 TQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  159 bits (404), Expect = 2e-41
 Identities = 57/313 (18%), Positives = 106/313 (33%), Gaps = 29/313 (9%)

Query: 82  LNISSLNLQGEIPH-EIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLA 140
           L +     +G +   +   L  L  L +    L   +     +    +  L NV + SL 
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC-LTNVSSFSLV 290

Query: 141 YNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIG---------- 190
                       +       LEL    F  F    + +L+ + +     G          
Sbjct: 291 SVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348

Query: 191 -----LIGNPLN--GILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELN 243
                L  N L+  G    S    + SL+ L +S   +       +G   +   LD + +
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTT-SLKYLDLSFNGVITMSSNFLGLEQL-EHLDFQHS 406

Query: 244 KLTGPIPV-TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDI- 301
            L        F  L+N  L  L +       +         L  +  + ++ N+F  +  
Sbjct: 407 NLKQMSEFSVFLSLRN--LIYLDISHTHTRVAFNGIF--NGLSSLEVLKMAGNSFQENFL 462

Query: 302 PATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKK 361
           P     L+++  + L   +LE   P +F  L+SL++L++S+N          + L  L+ 
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522

Query: 362 LNLSFNKLEGEIP 374
           L+ S N +     
Sbjct: 523 LDYSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  154 bits (391), Expect = 1e-39
 Identities = 64/340 (18%), Positives = 112/340 (32%), Gaps = 35/340 (10%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG--NNSLSGSLPSRIDLALPNVKA 136
              L++S   L+    +     P L  L L    +    + +            L ++  
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS---------LSHLST 80

Query: 137 LSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL 196
           L L  N          +  S L  L     + +      IG+L+ ++ L     +  N +
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL----NVAHNLI 136

Query: 197 NGI-LPSSIVNLSISLERLYISNCSITGNIPQVMGNLS----IFLLLDLELNKLTGPIPV 251
               LP    NL+ +LE L +S+  I       +  L     + L LDL LN +    P 
Sbjct: 137 QSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195

Query: 252 TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGD------IPATI 305
            F   +  +L  L+L  N  S ++     I  L  +    L    F  +        + +
Sbjct: 196 AF---KEIRLHKLTLRNNFDSLNVMKTC-IQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 306 GGLKDVQNISLPYNRLE---GPIPESFGYLTSLEILDLSNNKISGFILIS-LEKLLYLKK 361
            GL ++         L+     I + F  LT++    L +  I      S      +L+ 
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311

Query: 362 LNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQV 401
           +N  F +      +      FT+           LP L+ 
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  144 bits (364), Expect = 3e-36
 Identities = 60/307 (19%), Positives = 100/307 (32%), Gaps = 35/307 (11%)

Query: 83  NISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG--NNSLSGSLPSRIDLALPNVKALSLA 140
               LN   +IP  +    S   L L +N L    + S             P ++ L L+
Sbjct: 13  QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFS---------FPELQVLDLS 60

Query: 141 YNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGIL 200
                        + S L+ L L GN            L +++ L  V       L  + 
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV----ETNLASLE 116

Query: 201 PSSIVNLSISLERLYISNCSITG-NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
              I +L  +L+ L +++  I    +P+   NL+    LDL  NK+          L   
Sbjct: 117 NFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175

Query: 260 KLD--TLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPAT-IGGLKDVQNISL 316
            L   +L L  N  +   P       L    ++ L  N  S ++  T I GL  ++   L
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIRLH---KLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232

Query: 317 PYNR------LEGPIPESFGYLTSLEILDLSNNKISGF---ILISLEKLLYLKKLNLSFN 367
                     LE     +   L +L I +     +  +   I+     L  +   +L   
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292

Query: 368 KLEGEIP 374
            +E    
Sbjct: 293 TIERVKD 299

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  141 bits (357), Expect = 3e-35
 Identities = 59/354 (16%), Positives = 107/354 (30%), Gaps = 65/354 (18%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLT----KLALGYNSLVG--------------- 115
           N   +  L++SS  +Q     ++  L  +      L L  N +                 
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206

Query: 116 --NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQ------SPITNASKLTILELGGNS 167
             NN  S ++       L  ++   L    F           S +     LTI E     
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 168 FSGF---IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGN 224
              +   I +    L N+    LV       +  +   S    +   + L + NC     
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLV----SVTIERVKDFS---YNFGWQHLELVNCKFGQF 319

Query: 225 IPQVMGNLSIFLL-------------------LDLELNKLT--GPIPVTFGRLQNSKLDT 263
               + +L                        LDL  N L+  G    +     +  L  
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS--LKY 377

Query: 264 LSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLE 322
           L L  N       + + +  L+    ++   +N       ++   L+++  + + +    
Sbjct: 378 LDLSFNGVITMSSNFLGLEQLE---HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 323 GPIPESFGYLTSLEILDLSNNKISGFIL-ISLEKLLYLKKLNLSFNKLEGEIPR 375
                 F  L+SLE+L ++ N      L     +L  L  L+LS  +LE   P 
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  127 bits (321), Expect = 8e-31
 Identities = 53/285 (18%), Positives = 101/285 (35%), Gaps = 26/285 (9%)

Query: 45  HISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNIS--SLNLQGEIPHEIGYLPS 102
                PT  L        +         +V+   +  L++S   L+ +G          S
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374

Query: 103 LTKLALGYNSLVG-----------------NNSLSGSLPSRIDLALPNVKALSLAYNRFS 145
           L  L L +N ++                  +++L       + L+L N+  L +++    
Sbjct: 375 LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 146 GTIQSPITNASKLTILELGGNSFSGFI-PNTIGNLRNIEWLGLVIGLIGNPLNGILPSSI 204
                     S L +L++ GNSF     P+    LRN+ +L L        L  + P++ 
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS----QCQLEQLSPTAF 490

Query: 205 VNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTL 264
            +LS SL+ L +S+ +           L+   +LD  LN +            +S L  L
Sbjct: 491 NSLS-SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS-LAFL 548

Query: 265 SLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK 309
           +L  N F+ +      +  +K   ++ +         P+   G+ 
Sbjct: 549 NLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  123 bits (310), Expect = 2e-29
 Identities = 57/325 (17%), Positives = 94/325 (28%), Gaps = 63/325 (19%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
               +  L     NL       IG+L +L +L + +N +                     
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-------------------- 137

Query: 135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGN 194
                     S  +    +N + L  L+L  N         +  L  +  L L + L  N
Sbjct: 138 ----------SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 195 PLNGILPSSIVNLSISLERLYISNCSITGNIPQ-VMGNLSIFLLLDLELNKLTG------ 247
           P+N I P +   +   L +L + N   + N+ +  +  L+   +  L L +         
Sbjct: 188 PMNFIQPGAFKEI--RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 248 PIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGG 307
                   L N  ++   L    +       +    L  V   +L               
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL-FNCLTNVSSFSLVSVTIERVKD--FSY 302

Query: 308 LKDVQNISLPYNRLEGPIPESFGYLTSL-------------------EILDLSNNKIS-- 346
               Q++ L   +           L  L                   E LDLS N +S  
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362

Query: 347 GFILISLEKLLYLKKLNLSFNKLEG 371
           G    S      LK L+LSFN +  
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 92.0 bits (229), Expect = 2e-19
 Identities = 23/125 (18%), Positives = 43/125 (34%), Gaps = 3/125 (2%)

Query: 259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY 318
                L L  N             +   +  ++LSR             L  +  + L  
Sbjct: 28  FSTKNLDLSFNPLRHLGSY--SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGP 378
           N ++     +F  L+SL+ L      ++      +  L  LK+LN++ N ++        
Sbjct: 86  NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEY 144

Query: 379 FANFT 383
           F+N T
Sbjct: 145 FSNLT 149

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  152 bits (386), Expect = 2e-41
 Identities = 68/273 (24%), Positives = 120/273 (43%), Gaps = 29/273 (10%)

Query: 483 IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V     D      G  VA+K         ++ FE E E++K+++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 538 SGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
             C +   +   L++EY+P GSL  +L      +D  + L     +   +EYL  +    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKV 654
            IH DL + N+L++ +    + DFG+ K+L   ++    +    + I + APE   E K 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194

Query: 655 STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNKT----L 707
           S  SD++S+G++L E FT  + +    A  + +     G      + +  ++        
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI----GNDKQGQMIVFHLIELLKNNGR 250

Query: 708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           L  P+        C   I+ +  EC      +R
Sbjct: 251 LPRPDG-------CPDEIYMIMTECWNNNVNQR 276

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  150 bits (380), Expect = 6e-41
 Identities = 70/263 (26%), Positives = 114/263 (43%), Gaps = 34/263 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V+     +  +VAIK    E A + + F  E EVM  + H  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                LV E+M +G L  +L +   +      L + +DV   + YL       +IH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 131

Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+ E+ +  +SDFG+ + +  +DQ  + T T   + + +PE     + S++SD++S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190

Query: 663 YGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEKDFAA 717
           +G+++ E F+  K P +                   S  EVV        L  P      
Sbjct: 191 FGVLMWEVFSEGKIPYENR-----------------SNSEVVEDISTGFRLYKP------ 227

Query: 718 KEQCVLSIFSLAMECTMELPEKR 740
                  ++ +   C  E PE R
Sbjct: 228 -RLASTHVYQIMNHCWRERPEDR 249

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  157 bits (398), Expect = 1e-40
 Identities = 57/317 (17%), Positives = 91/317 (28%), Gaps = 26/317 (8%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVG------------------NNSLS 120
              L  S   L          L +LT L L    +                     N L 
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 121 GSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLR 180
             +          +K L       S     P+ N   L  L LG N  S           
Sbjct: 95  -FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153

Query: 181 NIEWLGLVIGLIGNPLNGILPSSIVNL-SISLERLYISNCSITGNIPQVMGNLSIFLLLD 239
            ++ L        N ++ +    + +L   +   L ++   I G I     + ++F  L+
Sbjct: 154 KLKVLDF----QNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLN 208

Query: 240 LELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG 299
               +    I           L   +          P+  +      V  INL ++ F  
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268

Query: 300 DIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYL 359
               T      +Q + L    L   +P     L++L+ L LS NK      IS      L
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327

Query: 360 KKLNLSFNKLEGEIPRG 376
             L++  N    E+  G
Sbjct: 328 THLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  153 bits (388), Expect = 3e-39
 Identities = 59/312 (18%), Positives = 111/312 (35%), Gaps = 17/312 (5%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
           + HR+  L +++  L       +    +L  L      +        S+          +
Sbjct: 79  SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-------SIDFIPLHNQKTL 131

Query: 135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGN 194
           ++L L  N  S           KL +L+   N+        + +L+    L L   L GN
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL--NLNGN 189

Query: 195 PLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL--LDLELNKLTGPIPVT 252
            + GI P +    S   + L          I + + N +I  L     E        P  
Sbjct: 190 DIAGIEPGAF--DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247

Query: 253 FGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQ 312
           F  L    +++++L  + F     +         + E++L+  + S ++P+ + GL  ++
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFH--CFSGLQELDLTATHLS-ELPSGLVGLSTLK 304

Query: 313 NISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL-ISLEKLLYLKKLNLSFNKLEG 371
            + L  N+ E     S     SL  L +  N     +    LE L  L++L+LS + +E 
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364

Query: 372 EIPRGGPFANFT 383
                    N +
Sbjct: 365 SDCCNLQLRNLS 376

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  140 bits (356), Expect = 3e-35
 Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 21/302 (6%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
               +  L++++ +L  E+P  +  L +L KL L  N          +L        P++
Sbjct: 276 CFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF-------ENLCQISASNFPSL 327

Query: 135 KALSLAYNRFSGTIQSP-ITNASKLTILELGGN--SFSGFIPNTIGNLRNIEWLGLVIGL 191
             LS+  N     + +  + N   L  L+L  +    S      + NL +++ L L    
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNL---- 383

Query: 192 IGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQ-VMGNLSIFLLLDLELNKLTGPIP 250
             N    +   +       LE L ++   +     Q    NL +  +L+L  + L     
Sbjct: 384 SYNEPLSLKTEAFKECP-QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442

Query: 251 VTFGRLQNSKLDTLSLCGNSFSGSIPSCID-IGNLKVVVEINLSRNNFSGDIPATIGGLK 309
             F  L    L  L+L GN F        + +  L  +  + LS  + S         LK
Sbjct: 443 QLFDGLPA--LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500

Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
            + ++ L +NRL     E+  +L  +  L+L++N IS  +   L  L   + +NL  N L
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559

Query: 370 EG 371
           + 
Sbjct: 560 DC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  138 bits (351), Expect = 1e-34
 Identities = 59/331 (17%), Positives = 105/331 (31%), Gaps = 22/331 (6%)

Query: 51  TNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLP--SLTKLAL 108
               + N+    ++        +     +       ++ +   P     L   S+  + L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261

Query: 109 GYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSF 168
             +          ++ S        ++ L L     S  + S +   S L  L L  N F
Sbjct: 262 QKHYFF-------NISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313

Query: 169 SGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT--GNIP 226
                 +  N  ++  L +     GN     L +  +    +L  L +S+  I       
Sbjct: 314 ENLCQISASNFPSLTHLSI----KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369

Query: 227 QVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKV 286
             + NLS    L+L  N+        F       L+ L L          +     NL +
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ--LELLDLAFTRLKV-KDAQSPFQNLHL 426

Query: 287 VVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPI---PESFGYLTSLEILDLSNN 343
           +  +NLS +           GL  +Q+++L  N           S   L  LEIL LS  
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486

Query: 344 KISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
            +S     +   L  +  ++LS N+L     
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  138 bits (349), Expect = 3e-34
 Identities = 59/309 (19%), Positives = 108/309 (34%), Gaps = 22/309 (7%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGY--LPSLTKLALGYNSLVGNNSLSGSLPSRIDLALP 132
           +S    +LN         I   +    + SL               +S ++     L   
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD---EDISPAVFE--GLCEM 254

Query: 133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLI 192
           +V++++L  + F     +     S L  L+L     S  +P+ +  L  ++ L L     
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVL----S 309

Query: 193 GNPLNGILPSSIVNLSISLERLYISNCSITGNI-PQVMGNLSIFLLLDLELNKLTGPIPV 251
            N    +   S  N   SL  L I   +    +    + NL     LDL  + +      
Sbjct: 310 ANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SDC 367

Query: 252 TFGRLQN-SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG-DIPATIGGLK 309
              +L+N S L +L+L  N                 +  ++L+       D  +    L 
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTE--AFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425

Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILI---SLEKLLYLKKLNLSF 366
            ++ ++L ++ L+    + F  L +L+ L+L  N      +    SL+ L  L+ L LSF
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485

Query: 367 NKLEGEIPR 375
             L      
Sbjct: 486 CDLSSIDQH 494

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  136 bits (344), Expect = 1e-33
 Identities = 65/304 (21%), Positives = 112/304 (36%), Gaps = 25/304 (8%)

Query: 78  RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL 137
            V ++N+          +       L +L L    L         LPS + + L  +K L
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-------SELPSGL-VGLSTLKKL 306

Query: 138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFI-PNTIGNLRNIEWLGLVIGLIGNPL 196
            L+ N+F    Q   +N   LT L + GN+    +    + NL N+  L L      + +
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS----HDDI 362

Query: 197 NGI--LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG-PIPVTF 253
                    + NLS  L+ L +S         +         LLDL   +L        F
Sbjct: 363 ETSDCCNLQLRNLS-HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421

Query: 254 GRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDI---PATIGGLKD 310
             L    L  L+L  +    S         L  +  +NL  N+F         ++  L  
Sbjct: 422 QNLHL--LKVLNLSHSLLDISSEQLF--DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477

Query: 311 VQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
           ++ + L +  L      +F  L  +  +DLS+N+++   + +L  L  +  LNL+ N + 
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHIS 536

Query: 371 GEIP 374
             +P
Sbjct: 537 IILP 540

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  125 bits (316), Expect = 3e-30
 Identities = 48/285 (16%), Positives = 94/285 (32%), Gaps = 33/285 (11%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
           N  L+  +P  +     + + L  ++N       +  +    LT L+L          +T
Sbjct: 21  NLGLN-EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 176 IGNLRNIEWLGL--------------------VIGLIGNPLNGILPSSIVNLSISLERLY 215
             +   ++ L L                     +  I   ++ I    + N   +LE LY
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK-TLESLY 135

Query: 216 ISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSI 275
           + +  I+              +LD + N +          LQ +   +L+L GN  +G  
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195

Query: 276 PSCIDIGNLKVVVEINLSRNNFSGDIPATIGG--LKDVQNISLPYNRLEGPIPESFGYL- 332
           P   D    +    +N         I   +    ++ +   +      E   P  F  L 
Sbjct: 196 PGAFDSAVFQ---SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 333 -TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG 376
             S+E ++L  +        +      L++L+L+   L  E+P G
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  101 bits (254), Expect = 2e-22
 Identities = 40/194 (20%), Positives = 63/194 (32%), Gaps = 6/194 (3%)

Query: 206 NLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLS 265
            L  S E L  S   +          L     LDL   ++      TF       LDTL 
Sbjct: 30  TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR--LDTLV 87

Query: 266 LCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPI 325
           L  N       + +     K +  +   +   S      +   K ++++ L  N +    
Sbjct: 88  LTANPLIFMAETAL--SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145

Query: 326 PESFGYLTSLEILDLSNNKISGFILISLEKL--LYLKKLNLSFNKLEGEIPRGGPFANFT 383
                    L++LD  NN I       +  L       LNL+ N + G  P     A F 
Sbjct: 146 LPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQ 205

Query: 384 AKSFMGNEKLCGLP 397
           + +F G + L  + 
Sbjct: 206 SLNFGGTQNLLVIF 219

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 89.3 bits (222), Expect = 1e-18
 Identities = 31/162 (19%), Positives = 47/162 (29%), Gaps = 9/162 (5%)

Query: 214 LYISNCSITGNIPQVMGNLSIFL-LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS 272
               N  +   IP     L      L+   N L      TF RL N  L  L L      
Sbjct: 17  YNCENLGLN-EIPG---TLPNSTECLEFSFNVLPTIQNTTFSRLIN--LTFLDLTRCQIY 70

Query: 273 GSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYL 332
                     +   +  + L+ N         + G K ++++      +           
Sbjct: 71  WIHEDTF--QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQ 128

Query: 333 TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
            +LE L L +N IS   L        LK L+   N +     
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  150 bits (381), Expect = 2e-40
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 40/291 (13%)

Query: 458 SQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDG-----IEVAIKVFHQEC- 511
           +QA  R L   +  +         ++G G+FG VYK           I VAIK   +   
Sbjct: 5   NQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57

Query: 512 ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI 571
            +A K    E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +  
Sbjct: 58  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGS 116

Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
              LN  + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++ 
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHW 690
                    I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E      
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ 227

Query: 691 VNGLLPVSLMEVVNKTL-LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
                   +  ++ K   L  P         C + ++ +  +C M   + R
Sbjct: 228 --------ISSILEKGERLPQPPI-------CTIDVYMIMRKCWMIDADSR 263

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  152 bits (385), Expect = 2e-40
 Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 38/267 (14%)

Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKIISGC 540
           IG G+FG V+   L  D   VA+K   +     +K+ F  E  ++K   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +      +V+E +  G    FL +    L +   L ++ D A+ +EYL  +     IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E  +  +SDFG+++  +    + +       + + APE     + S+ SD+
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNKTL----LSPPEK 713
           +S+GI+L ETF+                    G  P   +S  +          L  PE 
Sbjct: 299 WSFGILLWETFS-------------------LGASPYPNLSNQQTREFVEKGGRLPCPEL 339

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKR 740
                  C  ++F L  +C    P +R
Sbjct: 340 -------CPDAVFRLMEQCWAYEPGQR 359

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  150 bits (380), Expect = 3e-40
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 25/279 (8%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELD-----DGIEVAIKVFHQECARAMKSFEVECEVMK 526
           F   +L     +G G+FG V     D      G  VA+K          + F+ E +++K
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79

Query: 527 NIRHRNLVKIISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
            +    +VK          ++  LV+EY+P+G L  FL      LD  + L     +   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGY 643
           +EYL  R     +H DL + N+L++ +    ++DFG+AKLL   +D  + +    + I +
Sbjct: 140 MEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196

Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEV 702
            APE   +   S +SD++S+G++L E FT   K           +    +      L+E+
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256

Query: 703 VNK-TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           + +   L  P         C   +  L   C    P+ R
Sbjct: 257 LEEGQRLPAPPA-------CPAEVHELMKLCWAPSPQDR 288

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  148 bits (376), Expect = 3e-40
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 42/284 (14%)

Query: 474 TNRFGR-DNLIGIGSFGYVYKA-ELDDGIEVAIKVF--HQECARAMKSFEVECEVMKNIR 529
             RF + D  IG GSF  VYK  + +  +EVA       +      + F+ E E++K ++
Sbjct: 24  DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83

Query: 530 HRNLVKIISGCSNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
           H N+V+          K      LV E M +G+L  +L     ++ I    +    +   
Sbjct: 84  HPNIVRFY-DSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKG 141

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG- 642
           L++L+   T PIIH DLK  N+ +        + D G+A L          +   A IG 
Sbjct: 142 LQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGT 193

Query: 643 --YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
             +MAPE   E K     D+Y++G+ ++E  T + P  +   A    +   +G+ P S  
Sbjct: 194 PEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252

Query: 701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           +V       P  K+                 C  +  ++R + K
Sbjct: 253 KV-----AIPEVKEIIEG-------------CIRQNKDERYSIK 278

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  148 bits (375), Expect = 9e-40
 Identities = 64/292 (21%), Positives = 122/292 (41%), Gaps = 57/292 (19%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELDDG----IEVAIKVFHQECA--RAMKSFEVECEVM 525
             R+ L     +G G FG V +  L       ++VA+K    + +  R ++ F  E   M
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90

Query: 526 KNIRHRNLVKIISGCSNDDFKA-----LVLEYMPNGSLDIFL-----YSSTCMLDIFQRL 575
           K+  H N+++++  C     +      ++L +M  G L  +L      +    + +   L
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
             M+D+A  +EYL+ R+    +H DL + N +L +DM   ++DFG++K +   D      
Sbjct: 151 KFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207

Query: 636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL 695
                + ++A E   +R  +++SD++++G+ + E  TR                   G+ 
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-------------------GMT 248

Query: 696 P---VSLMEVVNK----TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           P   V   E+ +       L  P       E C+  ++ +   C    P  R
Sbjct: 249 PYPGVQNHEMYDYLLHGHRLKQP-------EDCLDELYEIMYSCWRTDPLDR 293

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (379), Expect = 1e-39
 Identities = 77/359 (21%), Positives = 137/359 (38%), Gaps = 54/359 (15%)

Query: 405 KHQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQATKRR 464
            H  R  S    IL+    P    + ++  L+         ++        +    +   
Sbjct: 13  HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72

Query: 465 LPYQ--------DLSRATNRFGRDNLIGIGSFGYVYKAELDDG----IEVAIKVFHQEC- 511
                         S     F    +IG G FG VY   L D     I  A+K  ++   
Sbjct: 73  PELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130

Query: 512 ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL-VLEYMPNGSLDIFLYSSTCMLD 570
              +  F  E  +MK+  H N++ ++  C   +   L VL YM +G L  F+ + T    
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 190

Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           +   +   + VA  +++L  +     +H DL + N +LDE     ++DFG+A+ +  ++ 
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247

Query: 631 SMTQTQTLAT--IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
                +T A   + +MA E    +K +T+SD++S+G++L E  TR               
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR--------------- 292

Query: 689 HWVNGLLP---VSLMEVVNKTL----LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               G  P   V+  ++    L    L  P       E C   ++ + ++C     E R
Sbjct: 293 ----GAPPYPDVNTFDITVYLLQGRRLLQP-------EYCPDPLYEVMLKCWHPKAEMR 340

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (371), Expect = 1e-39
 Identities = 75/263 (28%), Positives = 117/263 (44%), Gaps = 34/263 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VA+K+   E + +   F  E + M  + H  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
           +    +V EY+ NG L  +L S    L+  Q L +  DV   + +L        IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLA 131

Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+D D+   +SDFG+ + +  +DQ ++   T   + + APE     K S++SD+++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190

Query: 663 YGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEKDFAA 717
           +GI++ E F+  K P D                   +  EVV K      L  P      
Sbjct: 191 FGILMWEVFSLGKMPYDLY-----------------TNSEVVLKVSQGHRLYRP------ 227

Query: 718 KEQCVLSIFSLAMECTMELPEKR 740
                 +I+ +   C  ELPEKR
Sbjct: 228 -HLASDTIYQIMYSCWHELPEKR 249

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  147 bits (372), Expect = 2e-39
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 44/276 (15%)

Query: 480 DNLIGIGSFGYVYKAELDDG----IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L D     I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 535 KIISGCSNDDFKAL-VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +   L VL YM +G L  F+ + T    +   +   + VA  ++YL  +  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK- 148

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED--QSMTQTQTLATIGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T     + +MA E    
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNK--- 705
           +K +T+SD++S+G++L E  TR                   G  P   V+  ++      
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTR-------------------GAPPYPDVNTFDITVYLLQ 247

Query: 706 -TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
              L  P       E C   ++ + ++C     E R
Sbjct: 248 GRRLLQP-------EYCPDPLYEVMLKCWHPKAEMR 276

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  147 bits (373), Expect = 2e-39
 Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 43/291 (14%)

Query: 466 PYQDLSRATNRFGRDNL-----IGIGSFGYVYKAEL----DDGIEVAIKVFHQEC-ARAM 515
           P +     T       +     IG G  G V    L       + VAIK        R  
Sbjct: 35  PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR 94

Query: 516 KSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL 575
           + F  E  +M    H N++++    +      +V EYM NGSLD FL +      I Q +
Sbjct: 95  RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQ 634
            ++  V + + YL+       +H DL + NVL+D +++  +SDFG++++L    D + T 
Sbjct: 155 GMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211

Query: 635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNG 693
           T     I + APE    R  S+ SD++S+G+++ E     ++P   M             
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM------------- 258

Query: 694 LLPVSLMEVVNKT----LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               +  +V++       L  P         C  ++  L ++C  +   +R
Sbjct: 259 ----TNRDVISSVEEGYRLPAPMG-------CPHALHQLMLDCWHKDRAQR 298

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  146 bits (370), Expect = 3e-39
 Identities = 67/265 (25%), Positives = 118/265 (44%), Gaps = 32/265 (12%)

Query: 483 IGIGSFGYVYKAEL---DDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKIIS 538
           +G G+FG V +         I+VAIKV  Q   +A       E ++M  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
            C  +    LV+E    G L  FL      + +     ++  V+  ++YL  ++    +H
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVH 133

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
            DL + NVLL     A +SDFG++K L + +     ++     + + APE    RK S+R
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193

Query: 658 SDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNK-TLLSPPEKDF 715
           SD++SYG+ + E  +  +KP  KM   E              +M  + +   +  P    
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGKRMECP---- 235

Query: 716 AAKEQCVLSIFSLAMECTMELPEKR 740
               +C   +++L  +C +   E R
Sbjct: 236 ---PECPPELYALMSDCWIYKWEDR 257

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  145 bits (369), Expect = 3e-39
 Identities = 61/263 (23%), Positives = 115/263 (43%), Gaps = 34/263 (12%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V   +     +VAIK+   E + +   F  E +VM N+ H  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK 602
                ++ EYM NG L  +L          Q L +  DV  A+EYL  +     +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 147

Query: 603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYS 662
           + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206

Query: 663 YGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEKDFAA 717
           +G+++ E ++  K P ++                  +  E          L  P      
Sbjct: 207 FGVLMWEIYSLGKMPYERF-----------------TNSETAEHIAQGLRLYRPHL---- 245

Query: 718 KEQCVLSIFSLAMECTMELPEKR 740
                  ++++   C  E  ++R
Sbjct: 246 ---ASEKVYTIMYSCWHEKADER 265

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  147 bits (374), Expect = 4e-39
 Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 43/291 (14%)

Query: 466 PYQDLSRATNRFGRDNL-----IGIGSFGYVYKAEL----DDGIEVAIKVFHQEC-ARAM 515
           P Q +          N+     +G G FG V    L       I VAIK        +  
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90

Query: 516 KSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL 575
           + F  E  +M    H N++++    +      +V EYM NGSLD FL        + Q +
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQ 634
            ++  +AS ++YL+       +H DL + N+L++ +++  +SDFG+ ++L    + + T 
Sbjct: 151 GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207

Query: 635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNG 693
                 I + +PE    RK ++ SD++SYGI+L E  +  ++P  +M             
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM------------- 254

Query: 694 LLPVSLMEVVNKT----LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               S  +V+        L PP         C  +++ L ++C  +    R
Sbjct: 255 ----SNQDVIKAVDEGYRLPPPMD-------CPAALYQLMLDCWQKDRNNR 294

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (377), Expect = 7e-39
 Identities = 70/266 (26%), Positives = 127/266 (47%), Gaps = 36/266 (13%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
             +G G FG V+    +    VAIK        + ++F  E +VMK +RH  LV++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
           S +    +V EYM  GSL  FL   T   L + Q +++   +AS + Y+   +    +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304

Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           DL+++N+L+ E+++  ++DFG+A+L+   + +  Q      I + APE  +  + + +SD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 363

Query: 660 IYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEKD 714
           ++S+GI+L E  T+ + P   M                    EV+++      +  P + 
Sbjct: 364 VWSFGILLTELTTKGRVPYPGM-----------------VNREVLDQVERGYRMPCPPE- 405

Query: 715 FAAKEQCVLSIFSLAMECTMELPEKR 740
                 C  S+  L  +C  + PE+R
Sbjct: 406 ------CPESLHDLMCQCWRKEPEER 425

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  150 bits (381), Expect = 7e-39
 Identities = 63/223 (28%), Positives = 115/223 (51%), Gaps = 12/223 (5%)

Query: 456 LLSQATKRRLPYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDGIEVAIKVFHQE 510
           L +     +   Q L++      R++L     +G G FG V+    +    VAIK     
Sbjct: 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-P 301

Query: 511 CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSST-CML 569
              + ++F  E +VMK +RH  LV++ +  S +    +V EYM  GSL  FL   T   L
Sbjct: 302 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYL 360

Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
            + Q +++   +AS + Y+   +    +H DL+++N+L+ E+++  ++DFG+A+L+   +
Sbjct: 361 RLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417

Query: 630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
            +  Q      I + APE  +  + + +SD++S+GI+L E  T
Sbjct: 418 YTARQGAKFP-IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  145 bits (367), Expect = 8e-39
 Identities = 66/299 (22%), Positives = 119/299 (39%), Gaps = 44/299 (14%)

Query: 457 LSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDG----IEVAIKVFHQEC- 511
           L  A    +    +         D +IG G FG VY  E  D     I+ AIK   +   
Sbjct: 3   LDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE 62

Query: 512 ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-FKALVLEYMPNGSLDIFLYSSTCMLD 570
            + +++F  E  +M+ + H N++ +I      +    ++L YM +G L  F+ S      
Sbjct: 63  MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122

Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED- 629
           +   ++  + VA  +EYL  +     +H DL + N +LDE     ++DFG+A+ +   + 
Sbjct: 123 VKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179

Query: 630 -QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
                       + + A E     + +T+SD++S+G++L E  TR               
Sbjct: 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR--------------- 224

Query: 689 HWVNGLLP---VSLMEVVNKTL----LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               G  P   +   ++ +       L  P       E C  S++ +  +C    P  R
Sbjct: 225 ----GAPPYRHIDPFDLTHFLAQGRRLPQP-------EYCPDSLYQVMQQCWEADPAVR 272

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  145 bits (369), Expect = 8e-39
 Identities = 62/269 (23%), Positives = 118/269 (43%), Gaps = 33/269 (12%)

Query: 480 DNLIGIGSFGYVYKAELDDG-----IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNL 533
             ++G G FG V+K           I V IKV   +   ++ ++       + ++ H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V+++  C     + LV +Y+P GSL   +      L     LN  + +A  + YL     
Sbjct: 78  VRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG- 135

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
             ++H +L + NVLL       ++DFG+A LL  +D+ +  ++    I +MA E     K
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 654 VSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL-LSPP 711
            + +SD++SYG+ + E  T   +P   +  AE              + +++ K   L+ P
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------------VPDLLEKGERLAQP 239

Query: 712 EKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           +        C + ++ + ++C M     R
Sbjct: 240 QI-------CTIDVYMVMVKCWMIDENIR 261

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  145 bits (367), Expect = 1e-38
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 28/280 (10%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELDD-----GIEVAIKVFHQEC-ARAMKSFEVECEVM 525
           F +  L     +G G FG V     D      G  VA+K    +   +    ++ E +++
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87

Query: 526 KNIRHRNLVKIISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
           + + H +++K    C +    +  LV+EY+P GSL  +L   +  + + Q L     +  
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICE 145

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIG 642
            + YL+ +H    IH DL + NVLLD D +  + DFG+AK +  G +    +    + + 
Sbjct: 146 GMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202

Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS-LME 701
           + APE   E K    SD++S+G+ L E  T    +       L L     G + V  L E
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 702 VVNK-TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           ++ +   L  P+K       C   ++ L   C       R
Sbjct: 263 LLERGERLPRPDK-------CPAEVYHLMKNCWETEASFR 295

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  144 bits (366), Expect = 2e-38
 Identities = 64/293 (21%), Positives = 119/293 (40%), Gaps = 58/293 (19%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELDDG----IEVAIKVFHQECA--RAMKSFEVECEVM 525
                      +G G FG V +A+L       ++VA+K+   +      ++ F  E   M
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79

Query: 526 KNIRHRNLVKIISGCSNDDFKA------LVLEYMPNGSLDIFLYSSTCM-----LDIFQR 574
           K   H ++ K++        K       ++L +M +G L  FL +S        L +   
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ 634
           +  M+D+A  +EYL+ R+    IH DL + N +L EDM   ++DFG+++ +   D     
Sbjct: 140 VRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196

Query: 635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
             +   + ++A E   +   +  SD++++G+ + E  TR                   G 
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR-------------------GQ 237

Query: 695 LP---VSLMEVVNK----TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
            P   +   E+ N       L  P        +C+  ++ L  +C    P++R
Sbjct: 238 TPYAGIENAEIYNYLIGGNRLKQP-------PECMEEVYDLMYQCWSADPKQR 283

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  147 bits (374), Expect = 2e-38
 Identities = 63/266 (23%), Positives = 124/266 (46%), Gaps = 36/266 (13%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
             +G G FG V+ A  +   +VA+K      + ++++F  E  VMK ++H  LVK+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
           + +    ++ E+M  GSL  FL S       + + ++    +A  + ++  R+    IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHR 308

Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSD 659
           DL+++N+L+   ++  ++DFG+A+++  +++   +      I + APE       + +SD
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 660 IYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEKD 714
           ++S+GI+L+E  T  + P   M                 S  EV+        +  PE  
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGM-----------------SNPEVIRALERGYRMPRPEN- 409

Query: 715 FAAKEQCVLSIFSLAMECTMELPEKR 740
                 C   ++++ M C    PE+R
Sbjct: 410 ------CPEELYNIMMRCWKNRPEER 429

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (363), Expect = 2e-38
 Identities = 69/296 (23%), Positives = 111/296 (37%), Gaps = 49/296 (16%)

Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC--- 511
           Q+    +  +DL            +G GSFG V + E        + VA+K    +    
Sbjct: 9   QSLTCLIGEKDLRL-------LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ 61

Query: 512 ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI 571
             AM  F  E   M ++ HRNL+++         K +V E  P GSL   L        +
Sbjct: 62  PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL 120

Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
                  + VA  + YL  +     IH DL + N+LL    +  + DFG+ + L   D  
Sbjct: 121 GTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

Query: 632 MTQTQ-TLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKH 689
               +       + APE    R  S  SD + +G+ L E FT  ++P   +         
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------- 228

Query: 690 WVNGLLPVSLMEVVNKTL-----LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
                   +  ++++K       L  PE        C   I+++ ++C    PE R
Sbjct: 229 --------NGSQILHKIDKEGERLPRPED-------CPQDIYNVMVQCWAHKPEDR 269

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  144 bits (364), Expect = 3e-38
 Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 40/291 (13%)

Query: 458 SQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDG-----IEVAIKVFHQEC- 511
           +QA  R L   +  +         ++G G+FG VYK           I VAIK   +   
Sbjct: 5   NQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57

Query: 512 ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDI 571
            +A K    E  VM ++ + ++ +++  C     + L+ + MP G L  ++      +  
Sbjct: 58  PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGS 116

Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
              LN  + +A  + YL  R    ++H DL + NVL+       ++DFG+AKLL  E++ 
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHW 690
                    I +MA E  + R  + +SD++SYG+ + E  T   KP D + A+E      
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ 227

Query: 691 VNGLLPVSLMEVVNKTL-LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
                   +  ++ K   L  P         C + ++ + ++C M   + R
Sbjct: 228 --------ISSILEKGERLPQPPI-------CTIDVYMIMVKCWMIDADSR 263

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  142 bits (360), Expect = 5e-38
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 40/267 (14%)

Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G +G VY+       + VA+K    E    ++ F  E  VMK I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 542 NDDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +    ++ E+M  G+L  +L       +     L +   ++SA+EYL  ++    IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  ++DFG+++L++  D           I + APE     K S +SD+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNKTL----LSPPEK 713
           +++G++L E  T                    G+ P   + L +V         +  PE 
Sbjct: 196 WAFGVLLWEIATY-------------------GMSPYPGIDLSQVYELLEKDYRMERPEG 236

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKR 740
                  C   ++ L   C    P  R
Sbjct: 237 -------CPEKVYELMRACWQWNPSDR 256

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  143 bits (363), Expect = 5e-38
 Identities = 68/270 (25%), Positives = 121/270 (44%), Gaps = 39/270 (14%)

Query: 483 IGIGSFGYVYKAEL-----DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKI 536
           IG G FG VYK  L        + VAIK        +    F  E  +M    H N++++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
               S      ++ EYM NG+LD FL        + Q + ++  +A+ ++YL   +    
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ-TLATIGYMAPEYGIERKVS 655
           +H DL + N+L++ +++  +SDFG++++L  + ++   T      I + APE    RK +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228

Query: 656 TRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT----LLSP 710
           + SD++S+GI++ E  T  ++P  ++                 S  EV+        L  
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWEL-----------------SNHEVMKAINDGFRLPT 271

Query: 711 PEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           P         C  +I+ L M+C  +   +R
Sbjct: 272 PMD-------CPSAIYQLMMQCWQQERARR 294

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  141 bits (359), Expect = 6e-38
 Identities = 64/264 (24%), Positives = 124/264 (46%), Gaps = 36/264 (13%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           +G G FG V+    +   +VA+K    + + +  +F  E  +MK ++H+ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 543 DDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL 601
           +    ++ EYM NGSL  FL + +   L I + L++   +A  + ++  R+    IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135

Query: 602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIY 661
           +++N+L+ + +   ++DFG+A+L+  +++   +      I + APE       + +SD++
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194

Query: 662 SYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEKDFA 716
           S+GI+L E  T  + P   M                 +  EV+        +  P+    
Sbjct: 195 SFGILLTEIVTHGRIPYPGM-----------------TNPEVIQNLERGYRMVRPDN--- 234

Query: 717 AKEQCVLSIFSLAMECTMELPEKR 740
               C   ++ L   C  E PE R
Sbjct: 235 ----CPEELYQLMRLCWKERPEDR 254

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  148 bits (376), Expect = 9e-38
 Identities = 89/389 (22%), Positives = 150/389 (38%), Gaps = 49/389 (12%)

Query: 373 IPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMILLVIVLP--LSAALI 430
           IP G  F            K  GL +     C + +   +S      +   P  L+    
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282

Query: 431 AVVVLALKYKSTRRGKSTGLSNGGILLSQATKRRLPYQD---LSRATNRFGRDNL----- 482
            +  L     +    + T       +    +    P+ D   L        RDNL     
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342

Query: 483 -IGIGSFGYVYKAEL---DDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLVKII 537
            +G G+FG V +         I+VAIKV  Q   +A       E ++M  + +  +V++I
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL---NFRHTT 594
             C  +    LV+E    G L  FL      + +     ++  V+  ++YL   NF    
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF---- 457

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS-MTQTQTLATIGYMAPEYGIERK 653
             +H +L + NVLL     A +SDFG++K L  +D     ++     + + APE    RK
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 654 VSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNK-TLLSPP 711
            S+RSD++SYG+ + E  +  +KP  KM   E              +M  + +   +  P
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGKRMECP 561

Query: 712 EKDFAAKEQCVLSIFSLAMECTMELPEKR 740
                   +C   +++L  +C +   E R
Sbjct: 562 -------PECPPELYALMSDCWIYKWEDR 583

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  141 bits (358), Expect = 1e-37
 Identities = 64/266 (24%), Positives = 114/266 (42%), Gaps = 34/266 (12%)

Query: 483 IGIGSFGYVYKAEL---DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G+FG V K           VA+K+   E            E  VM+ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
             C  + +  LV+E    G L+ +L  +   +     + ++  V+  ++YL   +    +
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESN---FV 139

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           H DL + NVLL     A +SDFG++K L + E+    QT     + + APE     K S+
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199

Query: 657 RSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNK-TLLSPPEKD 714
           +SD++S+G+++ E F+  +KP   M  +E              +  ++ K   +  P   
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERMGCP--- 242

Query: 715 FAAKEQCVLSIFSLAMECTMELPEKR 740
                 C   ++ L   C     E R
Sbjct: 243 ----AGCPREMYDLMNLCWTYDVENR 264

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (370), Expect = 1e-37
 Identities = 64/267 (23%), Positives = 116/267 (43%), Gaps = 36/267 (13%)

Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           + +G G +G VY+       + VA+K   +E    ++ F  E  VMK I+H NLV+++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
           C+ +    ++ E+M  G+L  +L       +     L +   ++SA+EYL  ++    IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            +L + N L+ E+ +  ++DFG+++L++  D           I + APE     K S +S
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 659 DIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEK 713
           D++++G++L E  T    P   +                  L +V         +  PE 
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGI-----------------DLSQVYELLEKDYRMERPEG 443

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKR 740
                  C   ++ L   C    P  R
Sbjct: 444 -------CPEKVYELMRACWQWNPSDR 463

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  139 bits (353), Expect = 4e-37
 Identities = 57/265 (21%), Positives = 107/265 (40%), Gaps = 33/265 (12%)

Query: 483 IGIGSFGYVYKAELDDG----IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKII 537
           IG G FG V++          + VAIK           + F  E   M+   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
              + +    +++E    G L  FL      LD+   +     +++AL YL  +     +
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 138

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+ + NVL+  +    L DFG+++ +  +      ++    I +MAPE    R+ ++ 
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTSA 197

Query: 658 SDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNK-TLLSPPEKDF 715
           SD++ +G+ + E      KP   +   +              ++  +     L  P    
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNND--------------VIGRIENGERLPMPPN-- 241

Query: 716 AAKEQCVLSIFSLAMECTMELPEKR 740
                C  +++SL  +C    P +R
Sbjct: 242 -----CPPTLYSLMTKCWAYDPSRR 261

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  139 bits (353), Expect = 5e-37
 Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 62/297 (20%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL------DDGIEVAIKVFHQECARAMKSFEVECEVM 525
             R ++     +G G+FG V+ AE        D + VA+K        A K F+ E E++
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71

Query: 526 KNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------------YSSTCMLD 570
            N++H ++VK    C + D   +V EYM +G L+ FL                 +   L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
           + Q L+I   +AS + YL  +H    +H DL + N L+  +++  + DFG+++ +   D 
Sbjct: 132 LSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW 690
                 T+  I +M PE  + RK +T SD++S+G++L E FT                  
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY----------------- 231

Query: 691 VNGLLP---VSLMEVVNKT----LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
             G  P   +S  EV+       +L  P         C   ++ + + C    P++R
Sbjct: 232 --GKQPWFQLSNTEVIECITQGRVLERP-------RVCPKEVYDVMLGCWQREPQQR 279

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  140 bits (355), Expect = 5e-37
 Identities = 63/292 (21%), Positives = 112/292 (38%), Gaps = 57/292 (19%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELDDGIE------VAIKVFHQEC-ARAMKSFEVECEV 524
             R+ +     +G GSFG VY+      ++      VAIK  ++    R    F  E  V
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------YSSTCMLDIFQRL 575
           MK     ++V+++   S      +++E M  G L  +L                 + + +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
            +  ++A  + YLN       +H DL + N ++ ED    + DFG+ + +   D      
Sbjct: 142 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198

Query: 636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL 695
           + L  + +M+PE   +   +T SD++S+G++L E  T                       
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL-------------------AEQ 239

Query: 696 P---VSLMEVVNK----TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           P   +S  +V+       LL  P       + C   +F L   C    P+ R
Sbjct: 240 PYQGLSNEQVLRFVMEGGLLDKP-------DNCPDMLFELMRMCWQYNPKMR 284

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  139 bits (353), Expect = 1e-36
 Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 61/296 (20%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELDDGIE------VAIKVFHQECARAMKSFEVECEVM 525
             R ++     +G G+FG V+ AE  + +       VA+K   +    A + F+ E E++
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97

Query: 526 KNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS--------------TCMLDI 571
             ++H+++V+    C+      +V EYM +G L+ FL S                  L +
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
            Q L +   VA+ + YL   H    +H DL + N L+ + ++  + DFG+++ +   D  
Sbjct: 158 GQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214

Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV 691
               +T+  I +M PE  + RK +T SD++S+G++L E FT                   
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY------------------ 256

Query: 692 NGLLP---VSLMEVVNKT----LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
            G  P   +S  E ++       L  P         C   ++++   C    P++R
Sbjct: 257 -GKQPWYQLSNTEAIDCITQGRELERP-------RACPPEVYAIMRGCWQREPQQR 304

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  145 bits (368), Expect = 1e-36
 Identities = 61/286 (21%), Positives = 112/286 (39%), Gaps = 36/286 (12%)

Query: 466 PYQDLSRATNRFGRDNL-----IGIGSFGYVYKAELDDG----IEVAIKVFHQEC-ARAM 515
            Y   S       R+ +     IG G FG V++          + VAIK           
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435

Query: 516 KSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL 575
           + F  E   M+   H ++VK+I   + +    +++E    G L  FL      LD+   +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLI 494

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
                +++AL YL  +     +H D+ + NVL+  +    L DFG+++ +         +
Sbjct: 495 LYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-S 550

Query: 636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGL 694
           +    I +MAPE    R+ ++ SD++ +G+ + E      KP   +   ++         
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------- 601

Query: 695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               +  + N   L  P         C  +++SL  +C    P +R
Sbjct: 602 ----IGRIENGERLPMPPN-------CPPTLYSLMTKCWAYDPSRR 636

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  138 bits (350), Expect = 3e-36
 Identities = 64/292 (21%), Positives = 119/292 (40%), Gaps = 57/292 (19%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEV 524
             R N+     +G G+FG VY+ ++         ++VA+K   + C  +    F +E  +
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS------TCMLDIFQRLNIM 578
           +    H+N+V+ I        + +++E M  G L  FL  +         L +   L++ 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQT 635
            D+A   +YL   H    IH D+ + N LL       +A + DFG+A+ +          
Sbjct: 147 RDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203

Query: 636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL 695
             +  + +M PE  +E   ++++D +S+G++L E F+                    G +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYM 244

Query: 696 P---VSLMEVVNK----TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           P    S  EV+        + PP+        C   ++ +  +C    PE R
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPKN-------CPGPVYRIMTQCWQHQPEDR 289

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  136 bits (346), Expect = 3e-36
 Identities = 60/265 (22%), Positives = 112/265 (42%), Gaps = 33/265 (12%)

Query: 483 IGIGSFGYVYKAEL----DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKII 537
           +G G FG VY+        + I VA+K   ++C     + F  E  +MKN+ H ++VK+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
                +    +++E  P G L  +L  +   L +   +   + +  A+ YL   +    +
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CV 135

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR 657
           H D+   N+L+       L DFG+++ +  ED       T   I +M+PE    R+ +T 
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-VTRLPIKWMSPESINFRRFTTA 194

Query: 658 SDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNK-TLLSPPEKDF 715
           SD++ + + + E  +  K+P   +   +              ++ V+ K   L  P+   
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWLENKD--------------VIGVLEKGDRLPKPDL-- 238

Query: 716 AAKEQCVLSIFSLAMECTMELPEKR 740
                C   +++L   C    P  R
Sbjct: 239 -----CPPVLYTLMTRCWDYDPSDR 258

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  135 bits (343), Expect = 7e-36
 Identities = 75/267 (28%), Positives = 120/267 (44%), Gaps = 42/267 (15%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
             IG G FG V   +   G +VA+K    +     ++F  E  VM  +RH NLV+++   
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 541 SNDDFKA-LVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
             +     +V EYM  GSL  +L S    +L     L   +DV  A+EYL   +    +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            DL + NVL+ ED +A +SDFG+ K     + S TQ      + + APE   E+K ST+S
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 659 DIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL----LSPPEK 713
           D++S+GI+L E ++  + P  ++                  L +VV +      +  P+ 
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRI-----------------PLKDVVPRVEKGYKMDAPDG 238

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKR 740
                  C  +++ +   C       R
Sbjct: 239 -------CPPAVYEVMKNCWHLDAAMR 258

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  136 bits (344), Expect = 9e-36
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 63/298 (21%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELDDG------IEVAIKVFHQEC-ARAMKSFEVECEV 524
                +     +G   FG VYK  L           VAIK    +      + F  E  +
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------------YSSTCML 569
              ++H N+V ++   + D   +++  Y  +G L  FL                +    L
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 570 DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
           +    ++++  +A+ +EYL+  H   ++H DL + NVL+ + +   +SD G+ + +   D
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH 689
                  +L  I +MAPE  +  K S  SDI+SYG++L E F+                 
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY---------------- 226

Query: 690 WVNGLLP---VSLMEVVNKT----LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
              GL P    S  +VV       +L  P       + C   +++L +EC  E P +R
Sbjct: 227 ---GLQPYCGYSNQDVVEMIRNRQVLPCP-------DDCPAWVYALMIECWNEFPSRR 274

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  137 bits (346), Expect = 9e-36
 Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 17/242 (7%)

Query: 440 KSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDD 498
           K  R G  T  + G +L  +       Y++     +       +G GSFG V++  +   
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMKDKQT 82

Query: 499 GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL 558
           G + A+K    E  R       E      +    +V +        +  + +E +  GSL
Sbjct: 83  GFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137

Query: 559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLS 617
              +    C+    + L  +      LEYL   HT  I+H D+K+ NVLL  D   A L 
Sbjct: 138 GQLIKQMGCL-PEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALC 193

Query: 618 DFGIAKLLSGEDQSMTQTQTLATIG---YMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           DFG A  L  +    +        G   +MAPE  + +    + DI+S   M++      
Sbjct: 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

Query: 675 KP 676
            P
Sbjct: 254 HP 255

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  137 bits (348), Expect = 1e-35
 Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 57/292 (19%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEV 524
             R N+     +G G+FG VY+ ++         ++VA+K   + C  +    F +E  +
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS------TCMLDIFQRLNIM 578
           +    H+N+V+ I        + ++LE M  G L  FL  +         L +   L++ 
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQT 635
            D+A   +YL   H    IH D+ + N LL       +A + DFG+A+ +          
Sbjct: 188 RDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244

Query: 636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL 695
             +  + +M PE  +E   ++++D +S+G++L E F+                    G +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYM 285

Query: 696 P---VSLMEVVNK----TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
           P    S  EV+        + PP       + C   ++ +  +C    PE R
Sbjct: 286 PYPSKSNQEVLEFVTSGGRMDPP-------KNCPGPVYRIMTQCWQHQPEDR 330

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  139 bits (352), Expect = 2e-35
 Identities = 67/192 (34%), Positives = 101/192 (52%), Gaps = 13/192 (6%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V   +   G +VA+K    +     ++F  E  VM  +RH NLV+++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 543 DDFKA-LVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +     +V EYM  GSL  +L S    +L     L   +DV  A+EYL   +    +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + NVL+ ED +A +SDFG+ K     + S TQ      + + APE   E+K ST+SD+
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369

Query: 661 YSYGIMLIETFT 672
           +S+GI+L E ++
Sbjct: 370 WSFGILLWEIYS 381

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  134 bits (339), Expect = 3e-35
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 31/214 (14%)

Query: 483 IGIGSFGYVYKAEL--------DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           +G G+F  ++K               EV +KV  +      +SF     +M  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
                C   D   LV E++  GSLD +L  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133

Query: 595 PIIHCDLKSSNVLLD--------EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
            +IH ++ + N+LL               LSD GI+  +    + + Q      I ++ P
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQ----ERIPWVPP 186

Query: 647 E---YGIERKVSTRSDIYSYGIMLIETFTR-KKP 676
           E       + ++  +D +S+G  L E  +   KP
Sbjct: 187 ECIENP--KNLNLATDKWSFGTTLWEICSGGDKP 218

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  134 bits (340), Expect = 8e-35
 Identities = 71/342 (20%), Positives = 138/342 (40%), Gaps = 66/342 (19%)

Query: 456 LLSQATKRRLPYQD---LSRATNRFGRDNLIGIGSFGYVYKAEL--------DDGIEVAI 504
           +L+  ++  LP        R     G+   +G G+FG V  AE          + + VA+
Sbjct: 15  MLAGVSEYELPEDPKWEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAV 72

Query: 505 KVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL 562
           K+   +   + +     E E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L
Sbjct: 73  KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132

Query: 563 YSS---------------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL 607
            +                   +     ++    +A  +EYL  +     IH DL + NVL
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189

Query: 608 LDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
           + E+ +  ++DFG+A+ ++  D     T     + +MAPE   +R  + +SD++S+G+++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

Query: 668 IETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNK----TLLSPPEKDFAAKEQ 720
            E FT                    G  P   + + E+         +  P         
Sbjct: 250 WEIFTL-------------------GGSPYPGIPVEELFKLLKEGHRMDKP-------AN 283

Query: 721 CVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELY 762
           C   ++ +  +C   +P +R   K     L       ++E Y
Sbjct: 284 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEY 325

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  139 bits (353), Expect = 8e-35
 Identities = 60/305 (19%), Positives = 111/305 (36%), Gaps = 22/305 (7%)

Query: 78  RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSG------------SLPS 125
            +    ++  N   +   +   L +++ ++L   S+     +               L  
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQ 321

Query: 126 RIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWL 185
              L LP +K+L+L  N+  G+I         L+ L+L  N+ S     +  +L      
Sbjct: 322 FPTLDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379

Query: 186 GLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP-QVMGNLSIFLLLDLELNK 244
              + L  N    I+ ++ + L   L+ L   + ++          +L   L LD+    
Sbjct: 380 --HLDLSFNGAI-IMSANFMGLE-ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435

Query: 245 LTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPAT 304
                   F  L  + L+TL + GNSF  +  S +   N   +  ++LS+          
Sbjct: 436 TKIDFDGIFLGL--TSLNTLKMAGNSFKDNTLSNV-FANTTNLTFLDLSKCQLEQISWGV 492

Query: 305 IGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNL 364
              L  +Q +++ +N L       +  L SL  LD S N+I     I       L   NL
Sbjct: 493 FDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552

Query: 365 SFNKL 369
           + N +
Sbjct: 553 TNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  128 bits (325), Expect = 3e-31
 Identities = 58/308 (18%), Positives = 104/308 (33%), Gaps = 35/308 (11%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL--VGNNSLSGSLPSRIDLALPNVKA 136
              +++S   L+    +       L  L L    +  + + +  G         L ++  
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHG---------LHHLSN 84

Query: 137 LSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL 196
           L L  N          +  + L  L       +      IG L  ++ L     +  N +
Sbjct: 85  LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL----NVAHNFI 140

Query: 197 NGI-LPSSIVNLSISLERLYISNCSITGNIPQVMGNLS----IFLLLDLELNKLTGPIPV 251
           +   LP+   NL+ +L  + +S   I       +  L     + L LD+ LN +      
Sbjct: 141 HSCKLPAYFSNLT-NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQ 199

Query: 252 TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDI------PATI 305
            F   Q  KL  L+L GN  S +I     + NL  +    L    F  +       P+ +
Sbjct: 200 AF---QGIKLHELTLRGNFNSSNIMKTC-LQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255

Query: 306 GGLKD--VQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLN 363
            GL D  +    L Y          F  L ++  + L+   I    L  + K    + L+
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLS 313

Query: 364 LSFNKLEG 371
           +   +L+ 
Sbjct: 314 IIRCQLKQ 321

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  118 bits (298), Expect = 6e-28
 Identities = 50/280 (17%), Positives = 88/280 (31%), Gaps = 24/280 (8%)

Query: 70  ITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDL 129
           +       +  +L+I    L+ + P     LP L  L L  N    +             
Sbjct: 300 LEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGSISFKKVA-------- 348

Query: 130 ALPNVKALSLAYNRFSGTIQSPITN--ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL 187
            LP++  L L+ N  S +     ++   + L  L+L  N     +      L  ++ L  
Sbjct: 349 -LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDF 406

Query: 188 VIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG 247
                 + L  +   S       L  L IS  +   +   +   L+    L +  N    
Sbjct: 407 Q----HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462

Query: 248 PIPV-TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIG 306
                 F    N  L  L L                 L  +  +N+S NN      +   
Sbjct: 463 NTLSNVFANTTN--LTFLDLSKCQLEQISWGVF--DTLHRLQLLNMSHNNLLFLDSSHYN 518

Query: 307 GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKIS 346
            L  +  +   +NR+E        +  SL   +L+NN ++
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  117 bits (296), Expect = 1e-27
 Identities = 53/303 (17%), Positives = 92/303 (30%), Gaps = 29/303 (9%)

Query: 91  GEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQS 150
           G +   I  +P++T        L         +P  I     + K + L++N        
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-------KVPDDI---PSSTKNIDLSFNPLKILKSY 50

Query: 151 PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS 210
             +N S+L  L+L               L ++  L     L GNP+    P S   L+ S
Sbjct: 51  SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNL----ILTGNPIQSFSPGSFSGLT-S 105

Query: 211 LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG-PIPVTFGRLQNSKLDTLSLCGN 269
           LE L      +       +G L     L++  N +    +P  F  L N  L  + L  N
Sbjct: 106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN--LVHVDLSYN 163

Query: 270 SFSGSIPSCID--IGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPE 327
                  + +     N +V + +++S N     I         +  ++L  N     I +
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMK 222

Query: 328 -SFGYLTSLEILDLSNNKISGFILIS------LEKLLYLKKLNLSFNKLEGEIPRGGPFA 380
                L  L +  L   +      +       +E L  +                   F 
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH 282

Query: 381 NFT 383
              
Sbjct: 283 CLA 285

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  113 bits (286), Expect = 2e-26
 Identities = 53/304 (17%), Positives = 89/304 (29%), Gaps = 34/304 (11%)

Query: 86  SLNLQG----EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
           SL++       I  +      L +L L        N  S ++       L  +    L  
Sbjct: 185 SLDMSLNPIDFIQDQAFQGIKLHELTLR------GNFNSSNIMKTCLQNLAGLHVHRLIL 238

Query: 142 NRFSGTIQSPITNAS--------KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIG 193
             F       I   S         +    L   +           L N+  + L     G
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA----G 294

Query: 194 NPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTF 253
             +  +            + L I  C +       +  L     L L +NK +  I    
Sbjct: 295 VSIKYLEDVP---KHFKWQSLSIIRCQLKQFPTLDLPFLKS---LTLTMNKGS--ISFKK 346

Query: 254 GRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN 313
             L +  L  L L  N+ S S            +  ++LS N     + A   GL+++Q+
Sbjct: 347 VALPS--LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH 403

Query: 314 ISLPYNRLEGPIPES-FGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGE 372
           +   ++ L+     S F  L  L  LD+S              L  L  L ++ N  +  
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463

Query: 373 IPRG 376
               
Sbjct: 464 TLSN 467

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  135 bits (341), Expect = 1e-34
 Identities = 69/321 (21%), Positives = 130/321 (40%), Gaps = 66/321 (20%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL--------DDGIEVAIKVFHQEC-ARAMKSFEVEC 522
           F RD L     +G G FG V  AE          + + VA+K+   +   + +     E 
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137

Query: 523 EVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS---------------T 566
           E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +                 
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 567 CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
             +     ++    +A  +EYL  +     IH DL + NVL+ E+ +  ++DFG+A+ ++
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDIN 254

Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS 686
             D     T     + +MAPE   +R  + +SD++S+G+++ E FT              
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL------------- 301

Query: 687 LKHWVNGLLP---VSLMEVVNKTL----LSPPEKDFAAKEQCVLSIFSLAMECTMELPEK 739
                 G  P   + + E+         +  P         C   ++ +  +C   +P +
Sbjct: 302 ------GGSPYPGIPVEELFKLLKEGHRMDKP-------ANCTNELYMMMRDCWHAVPSQ 348

Query: 740 RINAKCCNFVLCEQFVSNSSE 760
           R   K     L       ++E
Sbjct: 349 RPTFKQLVEDLDRILTLTTNE 369

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (335), Expect = 1e-34
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN 532
            +  G   ++G G++G VY   +L + + +AIK   +  +R  +    E  + K+++H+N
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------NIMIDVASA 584
           +V+ +   S + F  + +E +P GSL      S  +   +  L             +   
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSL------SALLRSKWGPLKDNEQTIGFYTKQILEG 134

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQSMTQTQTLA-TIG 642
           L+YL   H   I+H D+K  NVL++    +  +SDFG +K L+G       T+T   T+ 
Sbjct: 135 LKYL---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQ 188

Query: 643 YMAPE--YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           YMAPE      R     +DI+S G  +IE  T K P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  133 bits (338), Expect = 1e-34
 Identities = 76/306 (24%), Positives = 129/306 (42%), Gaps = 71/306 (23%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELDDGIE------VAIKVFHQEC-ARAMKSFEVECEV 524
           + R+N+     IG G+FG V++A     +       VA+K+  +E  A     F+ E  +
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS------------------- 565
           M    + N+VK++  C+      L+ EYM  G L+ FL S                    
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 566 ----TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI 621
                  L   ++L I   VA+ + YL+ R     +H DL + N L+ E+M+  ++DFG+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGL 220

Query: 622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMF 681
           ++ +   D           I +M PE     + +T SD+++YG++L E F+         
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY-------- 272

Query: 682 AAELSLKHWVNGLLP---VSLMEVVNK----TLLSPPEKDFAAKEQCVLSIFSLAMECTM 734
                      GL P   ++  EV+       +L+ P       E C L +++L   C  
Sbjct: 273 -----------GLQPYYGMAHEEVIYYVRDGNILACP-------ENCPLELYNLMRLCWS 314

Query: 735 ELPEKR 740
           +LP  R
Sbjct: 315 KLPADR 320

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  132 bits (334), Expect = 2e-34
 Identities = 77/261 (29%), Positives = 116/261 (44%), Gaps = 37/261 (14%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGI---EVAIKVFHQECAR---AMKSFEVECEVMKNI 528
            R+   + +G G    VY AE  D I   +VAIK            +K FE E      +
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            H+N+V +I     DD   LV+EY+   +L  ++  S   L +   +N    +   +++ 
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKH- 126

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPE 647
              H   I+H D+K  N+L+D +    + DFGIAK LS  + S+TQT   L T+ Y +PE
Sbjct: 127 --AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPE 182

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE----LSLKH----------WVNG 693
                     +DIYS GI+L E    + P    F  E    +++KH           V  
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKHIQDSVPNVTTDVRK 238

Query: 694 LLPVSLMEVVNKTLLSPPEKD 714
            +P SL  V+ +      EKD
Sbjct: 239 DIPQSLSNVILRAT----EKD 255

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  134 bits (339), Expect = 2e-34
 Identities = 74/337 (21%), Positives = 135/337 (40%), Gaps = 66/337 (19%)

Query: 439 YKSTRRGKSTGLSNGGILLSQATKRRLPYQD---LSRATNRFGRDNLIGIGSFGYVYKAE 495
           +       +T       +L+  ++  LP      L R     G+   +G G+FG V  AE
Sbjct: 32  HHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKP--LGEGAFGQVVLAE 89

Query: 496 L--------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDF 545
                    +   +VA+K+   +   + +     E E+MK I +H+N++ ++  C+ D  
Sbjct: 90  AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149

Query: 546 KALVLEYMPNGSLDIFLYSSTCM---------------LDIFQRLNIMIDVASALEYLNF 590
             +++EY   G+L  +L +                   L     ++    VA  +EYL  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
           +     IH DL + NVL+ ED +  ++DFG+A+ +   D     T     + +MAPE   
Sbjct: 210 KK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 266

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNK-- 705
           +R  + +SD++S+G++L E FT                    G  P   V + E+     
Sbjct: 267 DRIYTHQSDVWSFGVLLWEIFTL-------------------GGSPYPGVPVEELFKLLK 307

Query: 706 --TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
               +  P         C   ++ +  +C   +P +R
Sbjct: 308 EGHRMDKPSN-------CTNELYMMMRDCWHAVPSQR 337

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  131 bits (333), Expect = 5e-34
 Identities = 68/327 (20%), Positives = 125/327 (38%), Gaps = 71/327 (21%)

Query: 454 GILLSQATKRRLPYQD---LSRATNRFGRDNLIGIGSFGYVYKAELDDG------IEVAI 504
           G L       ++         R     G+   +G G FG V KA             VA+
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGKT--LGEGEFGKVVKATAFHLKGRAGYTTVAV 58

Query: 505 KVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY 563
           K+  +      ++    E  V+K + H +++K+   CS D    L++EY   GSL  FL 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR 118

Query: 564 SS-----------------------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            S                          L +   ++    ++  ++YL       ++H D
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N+L+ E     +SDFG+++ +  ED  + ++Q    + +MA E   +   +T+SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP---VSLMEVVNK----TLLSPPEK 713
           +S+G++L E  T                    G  P   +    + N       +  P+ 
Sbjct: 236 WSFGVLLWEIVTL-------------------GGNPYPGIPPERLFNLLKTGHRMERPDN 276

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKR 740
                  C   ++ L ++C  + P+KR
Sbjct: 277 -------CSEEMYRLMLQCWKQEPDKR 296

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  131 bits (332), Expect = 5e-34
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 14/223 (6%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIK---VFHQECARAMKSFEVECEVMKNIRH 530
             F  +  IG G F  VY+A  L DG+ VA+K   +F    A+A      E +++K + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF---QRLNIMIDVASALEY 587
            N++K  +    D+   +VLE    G L   +        +          + + SALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           +   H+  ++H D+K +NV +    +  L D G+ +  S +  +   +    T  YM+PE
Sbjct: 152 M---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLV-GTPYYMSPE 206

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKP--ADKMFAAELSLK 688
              E   + +SDI+S G +L E    + P   DKM    L  K
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (332), Expect = 5e-34
 Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 34/259 (13%)

Query: 471 SRATNRFGR---DNLIGIGSFGYVYKAELDDGI---EVAIKVFHQECAR---AMKSFEVE 521
           SR   +FG      L+G G  G VY+AE  D +    VA+K+  +  +         + E
Sbjct: 27  SREGTQFGPYRLRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQRE 84

Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
                 ++  ++V I      D    + +  +    L   L      L   + + I+  +
Sbjct: 85  ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQI 143

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LAT 640
            SAL+     H     H D+K  N+L+  D  A+L DFGIA   +  D+ +TQ    + T
Sbjct: 144 GSALDAA---HAAGATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGT 198

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE---LSLKH-------- 689
           + YMAPE   E   + R+DIY+   +L E  T   P    +  +   +   H        
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAHINQAIPRP 254

Query: 690 -WVNGLLPVSLMEVVNKTL 707
             V   +PV+   V+ + +
Sbjct: 255 STVRPGIPVAFDAVIARGM 273

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  131 bits (331), Expect = 1e-33
 Identities = 61/259 (23%), Positives = 115/259 (44%), Gaps = 32/259 (12%)

Query: 438 KYKSTRRGKSTGLSNGGILLSQATKRRLPYQD---LSRATNRFGRDNLIGIGSFGYVYKA 494
           KY+   +   +   N    +      +LPY +     R   +FG+   +G G+FG V +A
Sbjct: 11  KYQVRWKIIESYEGNSYTFIDP---TQLPYNEKWEFPRNNLQFGKT--LGAGAFGKVVEA 65

Query: 495 EL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFK 546
                   D  ++VA+K+      A   ++   E ++M ++ +H N+V ++  C++    
Sbjct: 66  TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125

Query: 547 ALVLEYMPNGSLDIFL-------------YSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++ EY   G L  FL               +         L+    VA  + +L  ++ 
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN- 184

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
              IH D+ + NVLL    +A + DFG+A+ +  +   + +      + +MAPE   +  
Sbjct: 185 --CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV 242

Query: 654 VSTRSDIYSYGIMLIETFT 672
            + +SD++SYGI+L E F+
Sbjct: 243 YTVQSDVWSYGILLWEIFS 261

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  128 bits (325), Expect = 2e-33
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 28/228 (12%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR 529
            R    F    LIG G FG V+KA+   DG    IK       +A +    E + +  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62

Query: 530 HRNLVK----------------IISGCSNDDFKALVLEYMPNGSLDIFL-YSSTCMLDIF 572
           H N+V                   S  S      + +E+   G+L+ ++       LD  
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM 632
             L +   +   ++Y+   H+  +I+ DLK SN+ L +     + DFG+   L  + +  
Sbjct: 123 LALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKM 680
               TL    YM+PE    +      D+Y+ G++L E       A + 
Sbjct: 180 RSKGTLR---YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  129 bits (326), Expect = 3e-33
 Identities = 71/326 (21%), Positives = 121/326 (37%), Gaps = 53/326 (16%)

Query: 465 LPYQD---LSRATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARA 514
           LPY       R    FG+   +G G+FG V +A        D  + VA+K+         
Sbjct: 12  LPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69

Query: 515 MKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL----------- 562
            ++   E +V+  +  H N+V ++  C+      ++ EY   G L  FL           
Sbjct: 70  REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129

Query: 563 ------YSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
                       LD+   L+    VA  + +L  ++    IH DL + N+LL    I  +
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKI 186

Query: 617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KK 675
            DFG+A+ +  +   + +      + +MAPE       +  SD++SYGI L E F+    
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246

Query: 676 PADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTME 735
           P   M       K    G              +  PE            ++ +   C   
Sbjct: 247 PYPGMPVDSKFYKMIKEG------------FRMLSPEH-------APAEMYDIMKTCWDA 287

Query: 736 LPEKRINAKCCNFVLCEQFVSNSSEL 761
            P KR   K    ++ +Q   +++ +
Sbjct: 288 DPLKRPTFKQIVQLIEKQISESTNHI 313

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (324), Expect = 6e-33
 Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 32/225 (14%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEV 524
           F RD L     +G G+FG V +A+            VA+K+  +       ++   E ++
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83

Query: 525 MKNI-RHRNLVKIISGCSNDDFKALV-LEYMPNGSLDIFLYSS---------------TC 567
           + +I  H N+V ++  C+      +V +E+   G+L  +L S                  
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 568 MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG 627
            L +   +     VA  +E+L  R     IH DL + N+LL E  +  + DFG+A+ +  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           +   + +      + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  128 bits (325), Expect = 6e-33
 Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 64/296 (21%)

Query: 477 FGRDNL-----IGIGSFGYVYKAELDDG---IEVAIKVFHQEC-ARAMKSFEVECEVMKN 527
              +++     IG G+FG V KA +      ++ AIK   +       + F  E EV+  
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 81

Query: 528 I-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL---------------YSSTCMLDI 571
           +  H N++ ++  C +  +  L +EY P+G+L  FL                S+   L  
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
            Q L+   DVA  ++YL+ +     IH DL + N+L+ E+ +A ++DFG+++   G++  
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVY 195

Query: 632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV 691
           + +T     + +MA E       +T SD++SYG++L E  +                   
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL------------------ 237

Query: 692 NGLLP---VSLMEVVNK----TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR 740
            G  P   ++  E+  K      L  P         C   ++ L  +C  E P +R
Sbjct: 238 -GGTPYCGMTCAELYEKLPQGYRLEKPLN-------CDDEVYDLMRQCWREKPYER 285

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  127 bits (322), Expect = 1e-32
 Identities = 64/264 (24%), Positives = 113/264 (42%), Gaps = 38/264 (14%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGI---EVAIKVFHQECAR---AMKSFEVECEVMKNI 528
           +R+    ++G G    V+ A   D     +VA+KV   + AR       F  E +    +
Sbjct: 12  DRYELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69

Query: 529 RHRNLVKII-SGCSNDDFKA---LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
            H  +V +  +G +         +V+EY+   +L   +++    +   + + ++ D   A
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQA 128

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGY 643
           L +    H   IIH D+K +N+++       + DFGIA+ ++    S+TQT   + T  Y
Sbjct: 129 LNF---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE----LSLKH---------W 690
           ++PE      V  RSD+YS G +L E  T + P    F  +    ++ +H          
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSA 241

Query: 691 VNGLLPVSLMEVVNKTLLSPPEKD 714
            +  L   L  VV K L     K+
Sbjct: 242 RHEGLSADLDAVVLKAL----AKN 261

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  128 bits (324), Expect = 1e-32
 Identities = 68/329 (20%), Positives = 120/329 (36%), Gaps = 72/329 (21%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEV 524
           F R+NL     +G G+FG V  A           I+VA+K+  ++  +   ++   E ++
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101

Query: 525 MKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL--------------------- 562
           M  +  H N+V ++  C+      L+ EY   G L  +L                     
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 563 -YSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI 621
                 +L     L     VA  +E+L F+     +H DL + NVL+    +  + DFG+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGL 218

Query: 622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMF 681
           A+ +  +   + +      + +MAPE   E   + +SD++SYGI+L E F+         
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL-------- 270

Query: 682 AAELSLKHWVNGLLP---VSLMEVVNKTL-----LSPPEKDFAAKEQCVLSIFSLAMECT 733
                      G+ P   + +     K +     +  P             I+ +   C 
Sbjct: 271 -----------GVNPYPGIPVDANFYKLIQNGFKMDQPFY-------ATEEIYIIMQSCW 312

Query: 734 MELPEKRINAKCCNFVLCEQFVSNSSELY 762
                KR +       L  Q       +Y
Sbjct: 313 AFDSRKRPSFPNLTSFLGCQLADAEEAMY 341

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  126 bits (319), Expect = 3e-32
 Identities = 56/259 (21%), Positives = 94/259 (36%), Gaps = 31/259 (11%)

Query: 466 PYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH------QECARAMKSF 518
           P +  S     F R + +G GS+G V+K    +DG   A+K         ++ AR +   
Sbjct: 48  PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA-- 105

Query: 519 EVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
             E    + + +H   V++           L  E     SL     +    L   Q    
Sbjct: 106 --EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGY 162

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
           + D   AL +L   H+  ++H D+K +N+ L       L DFG+   L     +    + 
Sbjct: 163 LRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG----TAGAGEV 215

Query: 638 LA-TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP 696
                 YMAPE  ++    T +D++S G+ ++E     +        E   +    G LP
Sbjct: 216 QEGDPRYMAPEL-LQGSYGTAADVFSLGLTILEVACNMELP---HGGE-GWQQLRQGYLP 270

Query: 697 VSLMEVVNKTLLSPPEKDF 715
                      LS   +  
Sbjct: 271 PEF-----TAGLSSELRSV 284

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  127 bits (321), Expect = 3e-32
 Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 36/291 (12%)

Query: 83  NISSLNLQG---EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
            +++L +          +  L +L +L L  +++   + L+          L  + +L+L
Sbjct: 89  KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISPLAN---------LTKMYSLNL 139

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             N     + SP++N + L  L +  +      P  I NL ++  L L      N +  I
Sbjct: 140 GANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLN----YNQIEDI 192

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
             S + +L+ SL         IT   P  + N++    L +  NK+T   P     L   
Sbjct: 193 --SPLASLT-SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQ- 244

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYN 319
            L  L +  N  S  I +   + +L  +  +N+  N  S DI   +  L  + ++ L  N
Sbjct: 245 -LTWLEIGTNQIS-DINA---VKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNN 297

Query: 320 RLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
           +L     E  G LT+L  L LS N I+   +  L  L  +   + +   ++
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  125 bits (317), Expect = 1e-31
 Identities = 62/295 (21%), Positives = 119/295 (40%), Gaps = 35/295 (11%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
             LN++   +    P  +  L  LT L +G N +   ++L           L N++ L L
Sbjct: 69  EYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQN---------LTNLRELYL 117

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             +  S    SP+ N +K+  L LG N     +   + N+  + +L +      + +  +
Sbjct: 118 NEDNISDI--SPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVT----ESKVKDV 170

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
             + I NL+  L  L ++   I    P  + +L+        +N++T   P     +   
Sbjct: 171 --TPIANLT-DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR- 222

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYN 319
            L++L +  N  +   P    + NL  +  + +  N  S DI A +  L  ++ +++  N
Sbjct: 223 -LNSLKIGNNKITDLSP----LANLSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSN 275

Query: 320 RLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
           ++          L+ L  L L+NN++    +  +  L  L  L LS N +    P
Sbjct: 276 QISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  123 bits (310), Expect = 9e-31
 Identities = 64/305 (20%), Positives = 115/305 (37%), Gaps = 39/305 (12%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALS 138
           +T L ++   +   I   I YL +L  L L  N +   + LS          L  +  L 
Sbjct: 46  ITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISPLSN---------LVKLTNLY 94

Query: 139 LAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG 198
           +  N+   T  S + N + L  L L  ++ S   P  + NL  +  L L      N    
Sbjct: 95  IGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL----GANHNLS 146

Query: 199 ILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN 258
              S + N++  L  L ++   +    P  + NL+    L L  N++    P     L +
Sbjct: 147 D-LSPLSNMT-GLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTS 200

Query: 259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY 318
             L   +   N  +   P    + N+  +  + +  N  +   P  +  L  +  + +  
Sbjct: 201 --LHYFTAYVNQITDITP----VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT 252

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGP 378
           N++      +   LT L++L++ +N+IS   +  L  L  L  L L+ N+L  E      
Sbjct: 253 NQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME--V 306

Query: 379 FANFT 383
               T
Sbjct: 307 IGGLT 311

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  118 bits (298), Expect = 4e-29
 Identities = 59/302 (19%), Positives = 119/302 (39%), Gaps = 37/302 (12%)

Query: 70  ITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDL 129
           I  D +        +   ++   +      L S+TKL +    +     +          
Sbjct: 15  IFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQGIEY-------- 64

Query: 130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVI 189
            L N++ L+L  N+ +    SP++N  KLT L +G N  +      + NL N+  L    
Sbjct: 65  -LTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKITDISA--LQNLTNLREL---- 115

Query: 190 GLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPI 249
            L  + ++ I  S + NL+  +  L +       ++  +  N++    L +  +K+    
Sbjct: 116 YLNEDNISDI--SPLANLT-KMYSLNLGANHNLSDLSPL-SNMTGLNYLTVTESKVKDVT 171

Query: 250 PVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK 309
           P     L +  L +LSL  N      P    + +L  +       N  +   P  +  + 
Sbjct: 172 P--IANLTD--LYSLSLNYNQIEDISP----LASLTSLHYFTAYVNQITDITP--VANMT 221

Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
            + ++ +  N++    P     L+ L  L++  N+IS   + +++ L  LK LN+  N++
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277

Query: 370 EG 371
             
Sbjct: 278 SD 279

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 39/184 (21%), Positives = 72/184 (39%), Gaps = 18/184 (9%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIP 250
            +  P+N I P    +L+    R  +   S+T  + Q    L     L +   K+     
Sbjct: 7   TLPAPINQIFP--DADLA-EGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKVASIQG 61

Query: 251 VTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKD 310
                L N  L+ L+L GN  +   P    + NL  +  + +  N  + DI A +  L +
Sbjct: 62  --IEYLTN--LEYLNLNGNQITDISP----LSNLVKLTNLYIGTNKIT-DISA-LQNLTN 111

Query: 311 VQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
           ++ + L  + +    P     LT +  L+L  N     +   L  +  L  L ++ +K++
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVK 168

Query: 371 GEIP 374
              P
Sbjct: 169 DVTP 172

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 65.6 bits (161), Expect = 1e-11
 Identities = 21/110 (19%), Positives = 44/110 (40%), Gaps = 10/110 (9%)

Query: 261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNR 320
             TL+         I       +L   +   L + + +  +      L+ +  + +   +
Sbjct: 2   AATLATLPAP----INQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK 55

Query: 321 LEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
           +     +   YLT+LE L+L+ N+I+   +  L  L+ L  L +  NK+ 
Sbjct: 56  VASI--QGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT 101

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (325), Expect = 4e-32
 Identities = 44/211 (20%), Positives = 90/211 (42%), Gaps = 17/211 (8%)

Query: 476 RFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLV 534
            F   +++G G+ G +    + D  +VA+K    EC       + E ++++    H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           +      +  F+ + +E     +L  ++          + + ++    S L +L   H+ 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSL 137

Query: 595 PIIHCDLKSSNVLLDE-----DMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEY 648
            I+H DLK  N+L+        + A +SDFG+ K L+    S ++   +  T G++APE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 649 ---GIERKVSTRSDIYSYGIMLIETFTRKKP 676
                +   +   DI+S G +     +    
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  126 bits (318), Expect = 8e-32
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 9/206 (4%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKV--FHQECARAMKSFEVECEVMKNIRHR 531
            ++ R   IG GSFG     +  +DG +  IK     +  ++  +    E  V+ N++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNF 590
           N+V+       +    +V++Y   G L   + +    +    Q L+  + +  AL+++  
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV-- 141

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H   I+H D+KS N+ L +D    L DFGIA++L+     + +     T  Y++PE   
Sbjct: 142 -HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACI-GTPYYLSPEICE 198

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKP 676
            +  + +SDI++ G +L E  T K  
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  124 bits (314), Expect = 1e-31
 Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 21/233 (9%)

Query: 459 QATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKV--FHQECARAMK 516
                 L +Q +S     +     IG G    V++   +     AIK     +   + + 
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71

Query: 517 SFEVECEVMKNIRHRNL--VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQR 574
           S+  E   +  ++  +   +++      D +  +V+E   N  L+ +L      +D ++R
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPWER 129

Query: 575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ 634
            +   ++  A+  +   H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +
Sbjct: 130 KSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVK 185

Query: 635 TQTLATIGYMAPE-----------YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
              + T+ YM PE              + K+S +SD++S G +L      K P
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (312), Expect = 2e-31
 Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 31/241 (12%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFH----QECARAMKSFEVECEVMKNIRH 530
            +     +G G F YV   E L DG   A+K       Q+   A +    E ++ +   H
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR----EADMHRLFNH 85

Query: 531 RNLVKIISGCSNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIF---QRLNIMIDVAS 583
            N++++++ C  +        L+L +   G+L   +       +     Q L +++ +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA---- 639
            LE +   H     H DLK +N+LL ++    L D G         +   Q  TL     
Sbjct: 146 GLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 640 ---TIGYMAPEYGIERK----VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN 692
              TI Y APE     +    +  R+D++S G +L      + P D +F    S+   V 
Sbjct: 203 QRCTISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261

Query: 693 G 693
            
Sbjct: 262 N 262

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  124 bits (312), Expect = 4e-31
 Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 21/217 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKV--FHQECARAMKSFEVECEVMKNIRHRN 532
             +     IG G    V++   +     AIK     +   + + S+  E   +  ++  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 533 L--VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
              +++      D +  +V+E   N  L+ +L      +D ++R +   ++  A+  +  
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTI-- 124

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE--- 647
            H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +   + T+ YM PE   
Sbjct: 125 -HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 648 --------YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
                      + K+S +SD++S G +L      K P
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  124 bits (313), Expect = 6e-31
 Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 21/217 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKV--FHQECARAMKSFEVECEVMKNIRHRN 532
             +     IG G    V++   +     AIK     +   + + S+  E   +  ++  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 533 L--VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
              +++      D +  +V+E   N  L+ +L      +D ++R +   ++  A+  +  
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTI-- 171

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE--- 647
            H   I+H DLK +N L+ + M+  L DFGIA  +  +  S+ +   +  + YM PE   
Sbjct: 172 -HQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 648 --------YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
                      + K+S +SD++S G +L      K P
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (322), Expect = 8e-31
 Identities = 53/249 (21%), Positives = 96/249 (38%), Gaps = 28/249 (11%)

Query: 482 LIGIGSFGYVYKAELD---DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKII 537
            I  G  G++Y A  D   +G  V +K       A A      E + +  + H ++V+I 
Sbjct: 87  CIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 538 -----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
                +    D    +V+EY+   SL          L + + +  ++++  AL YL   H
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYL---H 199

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT-LATIGYMAPEYGIE 651
           +  +++ DLK  N++L E+ +  L D G           +        T G+ APE  + 
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEI-VR 250

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP 711
              +  +DIY+ G  L          +  +   L     V      S   ++ + +   P
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK-TYDSYGRLLRRAIDPDP 309

Query: 712 EKDFA-AKE 719
            + F  A+E
Sbjct: 310 RQRFTTAEE 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  122 bits (309), Expect = 9e-31
 Identities = 42/303 (13%), Positives = 98/303 (32%), Gaps = 33/303 (10%)

Query: 54  LAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYL--PSLTKLALGYN 111
             +++ ++ +  +      + N+ ++      +L         +     P    L L   
Sbjct: 35  WQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK---ATADLLEDATQPGRVALELRSV 91

Query: 112 SLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGF 171
            L          P +    L +++ +++        +   +   + L  L L  N     
Sbjct: 92  PLP-------QFPDQAF-RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA- 141

Query: 172 IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSI--------SLERLYISNCSITG 223
           +P +I +L  +  L +       P    LP  + +           +L+ L +    I  
Sbjct: 142 LPASIASLNRLRELSIR----ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR- 196

Query: 224 NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGN 283
           ++P  + NL     L +  + L+  +      L    L+ L L G +   + P     G 
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK--LEELDLRGCTALRNYPP--IFGG 251

Query: 284 LKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNN 343
              +  + L   +    +P  I  L  ++ + L        +P     L +  I+ +  +
Sbjct: 252 RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

Query: 344 KIS 346
             +
Sbjct: 312 LQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  115 bits (290), Expect = 3e-28
 Identities = 55/289 (19%), Positives = 95/289 (32%), Gaps = 36/289 (12%)

Query: 88  NLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRI-DLALPNVKALSLAYNRFSG 146
           N      H      +     +   +     +L  +    + D   P   AL L       
Sbjct: 40  NADRNRWHSAWRQANSNNPQIETRT---GRALK-ATADLLEDATQPGRVALELRSVPLP- 94

Query: 147 TIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVN 206
                    S L  + +        +P+T+     +E L L      NPL   LP+SI +
Sbjct: 95  QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTL----ARNPLR-ALPASIAS 148

Query: 207 LSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSL 266
           L+  L  L I  C     +P+ + +                        L N  L +L L
Sbjct: 149 LN-RLRELSIRACPELTELPEPLASTDA---------------SGEHQGLVN--LQSLRL 190

Query: 267 CGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY-NRLEGPI 325
                  S+P+   I NL+ +  + +  +  S  +   I  L  ++ + L     L    
Sbjct: 191 EWTGIR-SLPA--SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN-Y 245

Query: 326 PESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
           P  FG    L+ L L +      + + + +L  L+KL+L        +P
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  101 bits (254), Expect = 1e-23
 Identities = 47/282 (16%), Positives = 88/282 (31%), Gaps = 41/282 (14%)

Query: 94  PHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPIT 153
            H   +      L        G+ +L           L   +    A      +      
Sbjct: 5   HHHHHHSSGRENL-----YFQGSTALR-PYHD----VLSQWQRHYNADRNRWHSAWR-QA 53

Query: 154 NASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLER 213
           N++   I    G +      + + +      + L   L   PL    P     LS  L+ 
Sbjct: 54  NSNNPQIETRTGRALKA-TADLLEDATQPGRVALE--LRSVPLP-QFPDQAFRLS-HLQH 108

Query: 214 LYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSG 273
           + I    +   +P  M   +    L L  N L   +P +   L    L  LS+       
Sbjct: 109 MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNR--LRELSIRACPELT 164

Query: 274 SIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLT 333
            +P    + +                       GL ++Q++ L +  +   +P S   L 
Sbjct: 165 ELPE--PLASTD---------------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQ 206

Query: 334 SLEILDLSNNKISGFILISLEKLLYLKKLNLS-FNKLEGEIP 374
           +L+ L + N+ +S  +  ++  L  L++L+L     L    P
Sbjct: 207 NLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR-NYP 246

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 50.7 bits (122), Expect = 8e-07
 Identities = 23/159 (14%), Positives = 47/159 (29%), Gaps = 23/159 (14%)

Query: 63  SVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLV-------- 114
            + +            + +L +    ++  +P  I  L +L  L +  + L         
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHH 227

Query: 115 ----------GNNSLSGSLPSRIDLALPNVKALSLA-YNRFSGTIQSPITNASKLTILEL 163
                     G  +L  + P         +K L L   +    T+   I   ++L  L+L
Sbjct: 228 LPKLEELDLRGCTALR-NYPPIF-GGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDL 284

Query: 164 GGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPS 202
            G      +P+ I  L     + +   L          +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVA 323

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (303), Expect = 2e-30
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 12/205 (5%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKV--FHQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
            IG GS+G   K     DG  +  K   +        +    E  +++ ++H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 539 GCSNDDFKAL--VLEYMPNGSLDIFLYSSTCMLDIF---QRLNIMIDVASALEYLNFRHT 593
              +     L  V+EY   G L   +   T           L +M  +  AL+  + R  
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 594 TP--IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
               ++H DLK +NV LD      L DFG+A++L+  D S  +T  + T  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTF-VGTPYYMSPEQMNR 190

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKP 676
              + +SDI+S G +L E      P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (296), Expect = 4e-29
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 16/201 (7%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN 532
                    IG GS G V  A E   G +VA+K+      +  +    E  +M++ +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           +V++       +   +++E++  G+L DI    S   L+  Q   +   V  AL YL   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYL--- 157

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEY 648
           H   +IH D+KS ++LL  D    LSDFG    +S   + + + ++L  +G   +MAPE 
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSL--VGTPYWMAPEV 212

Query: 649 GIERKVSTRSDIYSYGIMLIE 669
                 +T  DI+S GIM+IE
Sbjct: 213 ISRSLYATEVDIWSLGIMVIE 233

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  117 bits (294), Expect = 4e-29
 Identities = 59/289 (20%), Positives = 103/289 (35%), Gaps = 50/289 (17%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR 529
            R  + F    ++G G+FG V KA    D    AIK         + +   E  ++ ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLN 60

Query: 530 HRNLVKII-SGCSNDDFKA------------LVLEYMPNGSLDIFLYSSTCMLDIFQRLN 576
           H+ +V+   +     +F              + +EY  NG+L   ++S        +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 577 IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
           +   +  AL Y+   H+  IIH DLK  N+ +DE     + DFG+AK +      +    
Sbjct: 121 LFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 637 TLAT---------IG---YMAPE-------YGIERKVSTRSDIYSYGIMLIE-------T 670
                        IG   Y+A E       Y    K+    D+YS GI+  E        
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN--EKI----DMYSLGIIFFEMIYPFSTG 231

Query: 671 FTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKE 719
             R     K+ +  +      +        +++   +   P K   A+ 
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART 280

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  117 bits (295), Expect = 5e-29
 Identities = 56/296 (18%), Positives = 102/296 (34%), Gaps = 32/296 (10%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
           N +R     ++  +L+  +        ++ +L L  N L         + +        +
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-------QISAADLAPFTKL 60

Query: 135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGN 194
           + L+L+ N    T    + + S L  L+L  N         +    +IE L        N
Sbjct: 61  ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA----NN 109

Query: 195 PLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG-PIPVTF 253
            ++ +  S         + +Y++N  IT       G  S    LDL+LN++         
Sbjct: 110 NISRVSCSRGQG----KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 254 GRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN 313
                  L+ L+L  N     +   +    LK    ++LS N  +  +         V  
Sbjct: 166 ASSDT--LEHLNLQYNFIY-DVKGQVVFAKLK---TLDLSSNKLA-FMGPEFQSAAGVTW 218

Query: 314 ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL-ISLEKLLYLKKLNLSFNK 368
           ISL  N+L   I ++  +  +LE  DL  N      L     K   ++ +     K
Sbjct: 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  116 bits (293), Expect = 7e-29
 Identities = 53/313 (16%), Positives = 102/313 (32%), Gaps = 30/313 (9%)

Query: 93  IPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI 152
           I              +  +SL           + +  +  NVK L L+ N  S    + +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLK-------QALASLRQSAWNVKELDLSGNPLSQISAADL 54

Query: 153 TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLE 212
              +KL +L L  N     +   + +L  +  L L      N +       ++    S+E
Sbjct: 55  APFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN----NNYV-----QELLVGP-SIE 102

Query: 213 RLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS 272
            L+ +N +I+               + L  NK+T    +  G      +  L L  N   
Sbjct: 103 TLHAANNNISRVSCSRGQGKKN---IYLANNKITMLRDLDEGCRSR--VQYLDLKLNEID 157

Query: 273 GSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYL 332
            ++       +   +  +NL  N    D+   +     ++ + L  N+L   +   F   
Sbjct: 158 -TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSA 213

Query: 333 TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEK 392
             +  + L NNK+   I  +L     L+  +L  N       R   F+       +  + 
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQT 271

Query: 393 LCGLPHLQVPQCK 405
           +  L      +C 
Sbjct: 272 VKKLTGQNEEECT 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  116 bits (292), Expect = 7e-29
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN 532
             ++ R   IG G+ G VY A ++  G EVAI+  + +     +    E  VM+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           +V  +      D   +V+EY+  GSL D+    +   +D  Q   +  +   ALE+L   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFL--- 132

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGI 650
           H+  +IH D+KS N+LL  D    L+DFG    ++      ++  T+  T  +MAPE   
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTMVGTPYWMAPEVVT 189

Query: 651 ERKVSTRSDIYSYGIMLIE 669
            +    + DI+S GIM IE
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  119 bits (301), Expect = 9e-29
 Identities = 71/295 (24%), Positives = 125/295 (42%), Gaps = 39/295 (13%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
           T +N S+  L    P  +  L  L  + +  N +     L+          L N+  L+L
Sbjct: 71  TQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN---------LTNLTGLTL 119

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             N+ +     P+ N + L  LEL  N+ S      +  L +++ L       GN +  +
Sbjct: 120 FNNQITDI--DPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-----GNQVTDL 170

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
            P  + NL+ +LERL IS+  ++     V+  L+    L    N+++   P+       +
Sbjct: 171 KP--LANLT-TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG----ILT 221

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYN 319
            LD LSL GN     I +   + +L  + +++L+ N  S   P  + GL  +  + L  N
Sbjct: 222 NLDELSLNGNQLK-DIGT---LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275

Query: 320 RLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
           ++    P     LT+L  L+L+ N++    +  +  L  L  L L FN +    P
Sbjct: 276 QISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  117 bits (296), Expect = 3e-28
 Identities = 59/297 (19%), Positives = 114/297 (38%), Gaps = 38/297 (12%)

Query: 78  RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL 137
            + +  I+      +I      L    K  LG  ++    S +          L  V  L
Sbjct: 2   PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQTD---------LDQVTTL 51

Query: 138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN 197
                         +   + LT +    N  +   P  + NL  +  + +      N + 
Sbjct: 52  QADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM----NNNQIA 103

Query: 198 GILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQ 257
            I  + + NL+ +L  L + N  IT   P  + NL+    L+L  N ++    ++     
Sbjct: 104 DI--TPLANLT-NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS----G 154

Query: 258 NSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLP 317
            + L  LS  GN  +   P    + NL  +  +++S N  S    + +  L +++++   
Sbjct: 155 LTSLQQLSF-GNQVTDLKP----LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIAT 207

Query: 318 YNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
            N++    P   G LT+L+ L L+ N++    + +L  L  L  L+L+ N++    P
Sbjct: 208 NNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  117 bits (295), Expect = 4e-28
 Identities = 68/305 (22%), Positives = 120/305 (39%), Gaps = 39/305 (12%)

Query: 70  ITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDL 129
           I  D          +   N+   +      L  +T L      +   + +          
Sbjct: 17  IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEY-------- 66

Query: 130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVI 189
            L N+  ++ + N+ +    +P+ N +KL  + +  N  +   P  + NL N+  L L  
Sbjct: 67  -LNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF- 120

Query: 190 GLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPI 249
               N +  I    + NL+ +L RL +S+ +I+      +  L+    L    N++T   
Sbjct: 121 ---NNQITDI--DPLKNLT-NLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLK 171

Query: 250 PVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK 309
           P     L    L+ L +  N  S  I     +  L  +  +  + N  S   P  +G L 
Sbjct: 172 P--LANLTT--LERLDISSNKVS-DISV---LAKLTNLESLIATNNQISDITP--LGILT 221

Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
           ++  +SL  N+L+     +   LT+L  LDL+NN+IS   L  L  L  L +L L  N++
Sbjct: 222 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQI 277

Query: 370 EGEIP 374
               P
Sbjct: 278 SNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  115 bits (289), Expect = 3e-27
 Identities = 54/289 (18%), Positives = 111/289 (38%), Gaps = 36/289 (12%)

Query: 83  NISSLNLQGEI--PHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLA 140
           ++  L+   ++     +  L +L +L +  N +   + L+          L N+++L   
Sbjct: 157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK---------LTNLESLIAT 207

Query: 141 YNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGIL 200
            N+ S    +P+   + L  L L GN        T+ +L N+  L L      N ++ + 
Sbjct: 208 NNQISDI--TPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL----ANNQISNLA 259

Query: 201 PSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSK 260
           P  +  L+  L  L +    I+   P  +  L+    L+L  N+L    P++        
Sbjct: 260 P--LSGLT-KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS----NLKN 310

Query: 261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNR 320
           L  L+L  N+ S   P    + +L  +  +    N  S D+ + +  L ++  +S  +N+
Sbjct: 311 LTYLTLYFNNISDISP----VSSLTKLQRLFFYNNKVS-DVSS-LANLTNINWLSAGHNQ 364

Query: 321 LEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
           +    P     LT +  L L++   +   +     +     +      L
Sbjct: 365 ISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  101 bits (254), Expect = 7e-23
 Identities = 62/300 (20%), Positives = 111/300 (37%), Gaps = 45/300 (15%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
            +L  ++  +    P  +G L +L +L+L  N L    +L+          L N+  L L
Sbjct: 202 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLAS---------LTNLTDLDL 250

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
           A N+ S     P++  +KLT L+LG N  S   P  +  L  +  L L      N L  I
Sbjct: 251 ANNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELN----ENQLEDI 302

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
             S I NL  +L  L +   +I+   P  + +L+    L    NK++    +       +
Sbjct: 303 --SPISNLK-NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLA----NLT 353

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYN 319
            ++ LS   N  S   P    + NL  + ++ L+   ++         +     +     
Sbjct: 354 NINWLSAGHNQISDLTP----LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409

Query: 320 RLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPF 379
            L    P +     S    D++ N  S           Y  +++ +F++          F
Sbjct: 410 ALI--APATISDGGSYTEPDITWNLPS-----------YTNEVSYTFSQPVTIGKGTTTF 456

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 77.7 bits (192), Expect = 4e-15
 Identities = 47/223 (21%), Positives = 80/223 (35%), Gaps = 29/223 (13%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
           T L + +  +    P  +  L +LT L L  N L   + +S          L N+  L+L
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISN---------LKNLTYLTL 316

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
            +N  S    SP+++ +KL  L    N  S      + NL NI WL        N ++ +
Sbjct: 317 YFNNISDI--SPVSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSA----GHNQISDL 368

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
             + + NL+  + +L +++ + T        N+SI   +      L  P  ++       
Sbjct: 369 --TPLANLT-RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS----DGG 421

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIP 302
                 +  N  S               V I      FSG + 
Sbjct: 422 SYTEPDITWNLPS-YTNEV--SYTFSQPVTIGKGTTTFSGTVT 461

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  115 bits (291), Expect = 1e-28
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 20/222 (9%)

Query: 460 ATKRRLPYQDLSRATN---RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAM 515
           + ++   Y+ + R  +    +     +G G+FG VYKA   + G   A KV   +    +
Sbjct: 1   SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60

Query: 516 KSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL 575
           + + VE E++    H  +VK++    +D    +++E+ P G++D  +      L   Q  
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
            +   +  AL +L   H+  IIH DLK+ NVL+  +    L+DFG++       +++ + 
Sbjct: 121 VVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKR 174

Query: 636 QTLATIG---YMAPE-----YGIERKVSTRSDIYSYGIMLIE 669
            +   IG   +MAPE        +     ++DI+S GI LIE
Sbjct: 175 DSF--IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  115 bits (289), Expect = 2e-28
 Identities = 46/224 (20%), Positives = 88/224 (39%), Gaps = 29/224 (12%)

Query: 472 RATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIK-VFHQECARAMKSFEVECEVMKNIR 529
           R    F     +G G FG V++A+   D    AIK +       A +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 530 HRNLVKIISGCSNDDFKA------------LVLEYMPNGSLD--IFLYSSTCMLDIFQRL 575
           H  +V+  +     +               + ++     +L   +    +    +    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT 635
           +I + +A A+E+L   H+  ++H DLK SN+    D +  + DFG+   +  +++  T  
Sbjct: 122 HIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 636 QTLATIG----------YMAPEYGIERKVSTRSDIYSYGIMLIE 669
             +              YM+PE       S + DI+S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  114 bits (288), Expect = 4e-28
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 14/200 (7%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN 532
              F     +G GS+G VYKA   + G  VAIK    E    ++    E  +M+     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +VK       +    +V+EY   GS+   +      L   +   I+      LEYL   H
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---H 142

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEYG 649
               IH D+K+ N+LL+ +  A L+DFG+A  L+    +M +  T+  IG   +MAPE  
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT---DTMAKRNTV--IGTPFWMAPEVI 197

Query: 650 IERKVSTRSDIYSYGIMLIE 669
            E   +  +DI+S GI  IE
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  119 bits (300), Expect = 6e-28
 Identities = 62/329 (18%), Positives = 102/329 (31%), Gaps = 42/329 (12%)

Query: 80  TALNISSLNLQGEIPHEI-GYLPSLTKLALGYNS-------------------LVGNNSL 119
             L + S      I  E    LP+L  L LG +                    L      
Sbjct: 51  QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110

Query: 120 SGSLPSRIDLALPNVKALSLAYNRFSG-TIQSPITNASKLTILELGGNSFSGFIPNTIGN 178
              L       L  +  L L+ N+     +       + L  ++   N       + +  
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170

Query: 179 LRNIEWLGLVIGLIGNPLNGILPSSIVNL-----SISLERLYISNCSITGNIPQVMGN-- 231
           L+          L  N L   +            ++ LE L +S    T +I     N  
Sbjct: 171 LQGKT--LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228

Query: 232 ----------LSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDI 281
                         +      + +  P   TF  L  S +  L L       S+ S +  
Sbjct: 229 SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRV-F 286

Query: 282 GNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLS 341
             LK +  +NL+ N  +        GL ++Q ++L YN L      +F  L  +  +DL 
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346

Query: 342 NNKISGFILISLEKLLYLKKLNLSFNKLE 370
            N I+     + + L  L+ L+L  N L 
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  109 bits (275), Expect = 8e-25
 Identities = 64/339 (18%), Positives = 115/339 (33%), Gaps = 51/339 (15%)

Query: 71  TCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL----------------- 113
           +C  +            NL  ++P     L +  +L L +N +                 
Sbjct: 1   SCSFDGRIA---FYRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53

Query: 114 -VGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFI 172
            +G+     ++       LPN++ L L  ++              L  L L     S  +
Sbjct: 54  ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV 113

Query: 173 --PNTIGNLRNIEWLGLVIGLIGNPLNGI-LPSSIVNLSISLERLYISNCSITGNIPQVM 229
                  NL+ +  L     L  N +  + L  S   L+ SL+ +  S+  I       +
Sbjct: 114 LKDGYFRNLKALTRL----DLSKNQIRSLYLHPSFGKLN-SLKSIDFSSNQIFLVCEHEL 168

Query: 230 GNLSI--FLLLDLELNKLTGPIPVTFGR----LQNSKLDTLSLCGNSFSGSIPSC----- 278
             L         L  N L   + V +G+     +N  L+ L + GN ++  I        
Sbjct: 169 EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228

Query: 279 -----IDIGNLKVVVEINLSRNNFSGDIPATIGGLKD--VQNISLPYNRLEGPIPESFGY 331
                  +     ++      +N       T  GL    V+++ L +  +       F  
Sbjct: 229 SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET 288

Query: 332 LTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
           L  L++L+L+ NKI+     +   L  L+ LNLS+N L 
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  106 bits (265), Expect = 1e-23
 Identities = 55/315 (17%), Positives = 105/315 (33%), Gaps = 32/315 (10%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL--VGNNSLSGSLPSRIDLALP 132
           N   V      S  +       +     +     G++++     N+ +G       LA  
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG-------LARS 266

Query: 133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLI 192
           +V+ L L++                L +L L  N  +         L N++ L L     
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS---- 322

Query: 193 GNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVT 252
            N L  +  S+   L   +  + +    I     Q    L     LDL  N LT    + 
Sbjct: 323 YNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIP 381

Query: 253 ------FGRLQNSKLDTLSLCGNSFS------GSIPSCIDIGNLKVVVEINLSRNNFSG- 299
                     +   L  ++L  N          ++     +  +  +  + L++N FS  
Sbjct: 382 SIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441

Query: 300 DIPATIGGLKDVQNISLPYNRLEGPI-----PESFGYLTSLEILDLSNNKISGFILISLE 354
               T      ++ + L  N L+         + F  L+ L++L L++N ++        
Sbjct: 442 SGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501

Query: 355 KLLYLKKLNLSFNKL 369
            L  L+ L+L+ N+L
Sbjct: 502 HLTALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  101 bits (253), Expect = 3e-22
 Identities = 67/323 (20%), Positives = 118/323 (36%), Gaps = 36/323 (11%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALS 138
           V  L++S   +          L  L  L L YN +         +       L N++ L+
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-------KIADEAFYGLDNLQVLN 320

Query: 139 LAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG 198
           L+YN       S      K+  ++L  N  +     T   L  ++ L L      N L  
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR----DNALTT 376

Query: 199 ILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL-LLDLELNKLTG-PIPVTFGRL 256
           I      +   S+  +++S   +       +  +++   L+ L  N+L    I     R+
Sbjct: 377 I------HFIPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDILYFLLRV 425

Query: 257 QNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-----GGLKDV 311
            +  L  L L  N FS S            + ++ L  N         +      GL  +
Sbjct: 426 PH--LQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482

Query: 312 QNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG 371
           Q + L +N L    P  F +LT+L  L L++N+++      L     L+ L++S N+L  
Sbjct: 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN--LEILDISRNQL-- 538

Query: 372 EIPRGGPFANFTAKSFMGNEKLC 394
             P    F + +      N+ +C
Sbjct: 539 LAPNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 64.8 bits (158), Expect = 8e-11
 Identities = 29/122 (23%), Positives = 47/122 (38%), Gaps = 8/122 (6%)

Query: 265 SLCGNSFSG--SIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLE 322
            +    F     +P       L     + LS N       ++   L+ +Q + L      
Sbjct: 7   RIAFYRFCNLTQVPQ-----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61

Query: 323 GPI-PESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFAN 381
             I  E+F  L +L ILDL ++KI      + + L +L +L L F  L   + + G F N
Sbjct: 62  LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121

Query: 382 FT 383
             
Sbjct: 122 LK 123

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  116 bits (293), Expect = 8e-28
 Identities = 56/296 (18%), Positives = 102/296 (34%), Gaps = 32/296 (10%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
           N +R     ++  +L+  +        ++ +L L  N L         + +        +
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-------QISAADLAPFTKL 60

Query: 135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGN 194
           + L+L+ N    T    + + S L  L+L  N         +    +IE L        N
Sbjct: 61  ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA----NN 109

Query: 195 PLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG-PIPVTF 253
            ++ +  S         + +Y++N  IT       G  S    LDL+LN++         
Sbjct: 110 NISRVSCSRGQG----KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165

Query: 254 GRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN 313
                  L+ L+L  N     +   +    LK    ++LS N  +  +         V  
Sbjct: 166 ASSDT--LEHLNLQYNFIY-DVKGQVVFAKLK---TLDLSSNKLA-FMGPEFQSAAGVTW 218

Query: 314 ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL-ISLEKLLYLKKLNLSFNK 368
           ISL  N+L   I ++  +  +LE  DL  N      L     K   ++ +     K
Sbjct: 219 ISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  113 bits (284), Expect = 1e-26
 Identities = 53/313 (16%), Positives = 102/313 (32%), Gaps = 30/313 (9%)

Query: 93  IPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI 152
           I              +  +SL           + +  +  NVK L L+ N  S    + +
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLK-------QALASLRQSAWNVKELDLSGNPLSQISAADL 54

Query: 153 TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLE 212
              +KL +L L  N     +   + +L  +  L     L  N +       ++    S+E
Sbjct: 55  APFTKLELLNLSSNVLYETLD--LESLSTLRTL----DLNNNYV-----QELLVGP-SIE 102

Query: 213 RLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS 272
            L+ +N +I+               + L  NK+T    +  G      +  L L  N   
Sbjct: 103 TLHAANNNISRVSCSRGQGKKN---IYLANNKITMLRDLDEGCRSR--VQYLDLKLNEID 157

Query: 273 GSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYL 332
            ++       +   +  +NL  N    D+   +     ++ + L  N+L   +   F   
Sbjct: 158 -TVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSA 213

Query: 333 TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEK 392
             +  + L NNK+   I  +L     L+  +L  N       R   F+       +  + 
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQT 271

Query: 393 LCGLPHLQVPQCK 405
           +  L      +C 
Sbjct: 272 VKKLTGQNEEECT 284

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 88.4 bits (219), Expect = 2e-18
 Identities = 44/318 (13%), Positives = 83/318 (26%), Gaps = 47/318 (14%)

Query: 83  NISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYN 142
            + +L+L      E+   PS+  L    N++         +           K + LA N
Sbjct: 81  TLRTLDLNNNYVQELLVGPSIETLHAANNNI-------SRVSCSR---GQGKKNIYLANN 130

Query: 143 RFSGTIQSPITNASKLTILELGGNSFSGF-IPNTIGNLRNIEWLGLVIGLIGNPLNGILP 201
           + +          S++  L+L  N            +   +E L L      N +  +  
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ----YNFIYDV-- 184

Query: 202 SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKL 261
              V  +  L+ L +S+  +   +     + +    + L  NKL   I       QN  L
Sbjct: 185 KGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQN--L 239

Query: 262 DTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRL 321
           +   L GN F           N +V      +    +G               +     L
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299

Query: 322 EGP-------------------------IPESFGYLTSLEILDLSNNKISGFILISLEKL 356
             P                         +            +D    +    I     + 
Sbjct: 300 PAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRK 359

Query: 357 LYLKKLNLSFNKLEGEIP 374
                L      L+ ++ 
Sbjct: 360 QAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 87.6 bits (217), Expect = 3e-18
 Identities = 33/294 (11%), Positives = 74/294 (25%), Gaps = 49/294 (16%)

Query: 83  NISSLNLQG------EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKA 136
            +  L+L+                 +L  L L YN +         +     +    +K 
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-------DVKG--QVVFAKLKT 195

Query: 137 LSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL 196
           L L+ N+ +  +     +A+ +T + L  N     I   +   +N+E   L     GN  
Sbjct: 196 LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL----RGNGF 249

Query: 197 NGILPSSIVNLSISLERLYI-SNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGR 255
           +        + +  ++ +   +   +TG   +     ++          L  P       
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309

Query: 256 LQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS 315
           L+  +   LS  G+                               +          + I 
Sbjct: 310 LKRKEHALLSGQGSETER---------------------------LECERENQARQREID 342

Query: 316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
               +    I +      +   L+     +   +         L          
Sbjct: 343 ALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  114 bits (287), Expect = 2e-27
 Identities = 72/339 (21%), Positives = 123/339 (36%), Gaps = 45/339 (13%)

Query: 77  HRVTALNISSLNLQGEIPHEI-GYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVK 135
            +V  LN++ L ++ EI      Y  ++ KL +G+N++         LP  +   +P + 
Sbjct: 69  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-------YLPPHVFQNVPLLT 120

Query: 136 ALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGN 194
            L L  N  S ++   I  N  KLT L +  N+      +T     +++ L L      N
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS----SN 175

Query: 195 PLNGILPSSIVNL---------------SISLERLYISNCSITGNIPQVMGNLSIFLLLD 239
            L  +  S I +L                I++E L  S+ SI      V   L+I   L 
Sbjct: 176 RLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTI---LK 232

Query: 240 LELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG 299
           L+ N LT              L  + L  N     I        ++ +  + +S N    
Sbjct: 233 LQHNNLT-DTA-WLLNYPG--LVEVDLSYNELE-KIMYHP-FVKMQRLERLYISNNRLV- 285

Query: 300 DIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYL 359
            +      +  ++ + L +N L   +  +      LE L L +N I     + L     L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVT---LKLSTHHTL 341

Query: 360 KKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPH 398
           K L LS N  +        F N    +    ++ C + +
Sbjct: 342 KNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDY 379

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 99.7 bits (249), Expect = 1e-22
 Identities = 50/289 (17%), Positives = 102/289 (35%), Gaps = 29/289 (10%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
           ++I           E   L +   +    +++         LP+ +  +   V+ L+L  
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-------KLPAALLDSFRQVELLNLND 78

Query: 142 NRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILP 201
            +           A  +  L +G N+     P+   N+  +  L L      N L+ +  
Sbjct: 79  LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE----RNDLSSLPR 134

Query: 202 SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKL 261
               N    L  L +SN ++           +    L L  N+LT    V    + +  L
Sbjct: 135 GIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPS--L 188

Query: 262 DTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRL 321
              ++  N  S ++   I    ++   E++ S N+ +  +        ++  + L +N L
Sbjct: 189 FHANVSYNLLS-TLAIPI---AVE---ELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238

Query: 322 EGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
                        L  +DLS N++   +     K+  L++L +S N+L 
Sbjct: 239 T-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 22/121 (18%), Positives = 45/121 (37%), Gaps = 8/121 (6%)

Query: 256 LQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS 315
             +  +D  +   + + G     I + N K    +    +       A +   + V+ ++
Sbjct: 23  FYDVHIDMQTQ--DVYFG--FEDITLNNQK---IVTFKNSTMRKLPAALLDSFRQVELLN 75

Query: 316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPR 375
           L   ++E     +F Y  +++ L +  N I        + +  L  L L  N L   +PR
Sbjct: 76  LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR 134

Query: 376 G 376
           G
Sbjct: 135 G 135

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 12/83 (14%), Positives = 29/83 (34%), Gaps = 1/83 (1%)

Query: 294 RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISL 353
           R      I + +       ++ +     +         L + +I+   N+ +       L
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65

Query: 354 EKLLYLKKLNLSFNKLEGEIPRG 376
           +    ++ LNL+  ++E EI   
Sbjct: 66  DSFRQVELLNLNDLQIE-EIDTY 87

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  114 bits (288), Expect = 4e-27
 Identities = 63/326 (19%), Positives = 121/326 (37%), Gaps = 32/326 (9%)

Query: 64  VCNWIGITCDVNSHRVTAL------NISSLNLQG----EIPHEI-GYLPSLTKLALGYNS 112
            C+        +  R  A+          L+L       +  +     P L +L L  N 
Sbjct: 8   ECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67

Query: 113 LVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGF 171
           +        ++       L N++ L L  NR    I   + T  S LT L++  N     
Sbjct: 68  V-------SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVIL 119

Query: 172 IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGN 231
           +     +L N++ L +      N L  I   +   L+ SLE+L +  C++T    + + +
Sbjct: 120 LDYMFQDLYNLKSLEVG----DNDLVYISHRAFSGLN-SLEQLTLEKCNLTSIPTEALSH 174

Query: 232 LSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIG-NLKVVVEI 290
           L   ++L L    +      +F RL    L  L +    +  ++      G NL     +
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYR--LKVLEISHWPYLDTMTPNCLYGLNLT---SL 229

Query: 291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL 350
           +++  N +      +  L  ++ ++L YN +          L  L+ + L   +++    
Sbjct: 230 SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP 289

Query: 351 ISLEKLLYLKKLNLSFNKLEGEIPRG 376
            +   L YL+ LN+S N+L   +   
Sbjct: 290 YAFRGLNYLRVLNVSGNQLT-TLEES 314

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 86.7 bits (215), Expect = 5e-18
 Identities = 57/269 (21%), Positives = 98/269 (36%), Gaps = 21/269 (7%)

Query: 83  NISSLNLQG----EIPHEI-GYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL 137
           N+ +L L+      IP  +   L +LTKL +  N +V        L   +   L N+K+L
Sbjct: 81  NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-------ILLDYMFQDLYNLKSL 133

Query: 138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN 197
            +  N          +  + L  L L   + +      + +L  +  L L        +N
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL----RHLNIN 189

Query: 198 GILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQ 257
            I   S   L   L+ L IS+      +            L +    LT    +    L 
Sbjct: 190 AIRDYSFKRLY-RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLV 248

Query: 258 NSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLP 317
              L  L+L  N  S +I   + +  L  + EI L     +   P    GL  ++ +++ 
Sbjct: 249 Y--LRFLNLSYNPIS-TIEGSM-LHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304

Query: 318 YNRLEGPIPESFGYLTSLEILDLSNNKIS 346
            N+L       F  + +LE L L +N ++
Sbjct: 305 GNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (278), Expect = 5e-27
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARA-MKSFEVECEVMKNIRHRN 532
           + +    +IG G+   V  A       +VAIK  + E  +  M     E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLN------IMIDVASAL 585
           +V   +     D   LV++ +  GS+ DI  +           L+      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG--- 642
           EYL   H    IH D+K+ N+LL ED    ++DFG++  L+              +G   
Sbjct: 135 EYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 643 YMAPEYGIERKVS--TRSDIYSYGIMLIE 669
           +MAPE  +E+      ++DI+S+GI  IE
Sbjct: 192 WMAPEV-MEQVRGYDFKADIWSFGITAIE 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  111 bits (278), Expect = 6e-27
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 17/195 (8%)

Query: 480 DNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKI- 536
            +++G G+   V++      G   AIKVF+     R +     E EV+K + H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 537 -ISGCSNDDFKALVLEYMPNGSLDIFLYS--STCMLDIFQRLNIMIDVASALEYLNFRHT 593
            I   +    K L++E+ P GSL   L    +   L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RE 130

Query: 594 TPIIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             I+H ++K  N++     D   +  L+DFG A+ L  ++Q ++      T  Y+ P+  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDM- 186

Query: 650 IERKVSTRSDIYSYG 664
            ER V  +     YG
Sbjct: 187 YERAVLRKDHQKKYG 201

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  115 bits (289), Expect = 9e-27
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE-CARAMKSFEVECEVMKNI 528
           ++    +     +G G FGYV +    D G +VAIK   QE   +  + + +E ++MK +
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 529 RHRNLVKII------SGCSNDDFKALVLEYMPNGSLDIFL--YSSTCMLDIFQRLNIMID 580
            H N+V            + +D   L +EY   G L  +L  + + C L       ++ D
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
           ++SAL YL   H   IIH DLK  N++L    + +I  + D G AK L  +   +     
Sbjct: 130 ISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF- 183

Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIML 667
           + T+ Y+APE   ++K +   D +S+G + 
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (278), Expect = 1e-26
 Identities = 42/270 (15%), Positives = 84/270 (31%), Gaps = 24/270 (8%)

Query: 466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAELDD------GIEVAIKVFHQECARAMKSFE 519
           P  +    +      +L+G G+F  VY+A   D        +  +KV             
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115

Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL----DIFLYSSTCMLDIFQRL 575
              E +K       +K  S     +   LV E    G+L    +++  +   ++     +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH-----------LSDFGIAKL 624
           +  + +   +E +   H   IIH D+K  N +L    +             L D G +  
Sbjct: 176 SFAMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE 684
           +    +    T    T G+   E    +  + + D +     +           K    E
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292

Query: 685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKD 714
              +     L  + +       +L+ P+  
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (282), Expect = 1e-26
 Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 40/242 (16%)

Query: 468 QDLSRATNRFGR----DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECE 523
            ++             + ++G GS G V       G  VA+K    +         +E +
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIK 60

Query: 524 VM-KNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL-DI-----FLYSSTCMLDIFQRLN 576
           ++ ++  H N+++     + D F  + LE   N +L D+         +  +   +  ++
Sbjct: 61  LLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 577 IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-------------EDMIAHLSDFGIAK 623
           ++  +AS + +L   H+  IIH DLK  N+L+              E++   +SDFG+ K
Sbjct: 120 LLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

Query: 624 LLSGEDQSMTQTQTLA--TIGYMAPE-------YGIERKVSTRSDIYSYGIMLIETFTRK 674
            L     S          T G+ APE          +R+++   DI+S G +     ++ 
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 675 KP 676
           K 
Sbjct: 237 KH 238

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  110 bits (277), Expect = 1e-26
 Identities = 60/232 (25%), Positives = 89/232 (38%), Gaps = 31/232 (13%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISG 539
           ++  G F +VY+A+ +  G E A+K          ++   E   MK +  H N+V+  S 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 540 CS-------NDDFKALVLEYMPNGSLDIFL--YSSTCMLDIFQRLNIMIDVASALEYLNF 590
            S           + L+L  +  G L  FL    S   L     L I      A+++++ 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA----------T 640
           R   PIIH DLK  N+LL       L DFG A  +S         Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 641 IGYMAPE----YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK 688
             Y  PE    Y     +  + DI++ G +L     R+ P    F     L+
Sbjct: 214 PMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  111 bits (279), Expect = 2e-26
 Identities = 36/288 (12%), Positives = 83/288 (28%), Gaps = 50/288 (17%)

Query: 470 LSRATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQEC---ARAMKSFEVECEVM 525
           L        R  ++G        +A   + G    + V +      + A+K  + E   +
Sbjct: 73  LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132

Query: 526 KNIR----------HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY------SSTCML 569
           + +R          H   +       +   K ++   +    + +           + + 
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192

Query: 570 DIFQ----------------RLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
              +                RL + + V   L  L   H   ++H  L+  +++LD+   
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGLVHTYLRPVDIVLDQRGG 249

Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE-----YGIERKVSTRSDIYSYGIMLI 668
             L+ F       G        +  A     A             ++   D ++ G+ + 
Sbjct: 250 VFLTGFEHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308

Query: 669 ETFTRKKP---ADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK 713
             +    P      +  +E   +   N  +P  +  ++   L  P E 
Sbjct: 309 WIWCADLPNTDDAALGGSEWIFRSCKN--IPQPVRALLEGFLRYPKED 354

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  110 bits (276), Expect = 2e-26
 Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 23/206 (11%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKV---FHQECARAMKSFEVECEVMKNIR 529
              F     IG GSFG VY A ++ +   VAIK      ++     +    E   ++ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H N ++       +    LV+EY    + D+        L   +   +       L YL 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYL- 170

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAP 646
             H+  +IH D+K+ N+LL E  +  L DFG A         M    +   +G   +MAP
Sbjct: 171 --HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSF--VGTPYWMAP 219

Query: 647 EYGIERKVST---RSDIYSYGIMLIE 669
           E  +         + D++S GI  IE
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIE 245

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  113 bits (283), Expect = 4e-26
 Identities = 65/324 (20%), Positives = 112/324 (34%), Gaps = 70/324 (21%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL--------------VGNNSLSGSLPS 125
             LN+    L   +P  +     +T L +  N+L              V  N L+ SLP 
Sbjct: 43  AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT-SLPV 98

Query: 126 RIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWL 185
                L  +   S                   L  L + GN  +  +P     L+ +   
Sbjct: 99  LPP-GLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLPPGLQELS-- 147

Query: 186 GLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKL 245
                +  N L   LP+    L     +L+  N  +T ++P +   L     L +  N+L
Sbjct: 148 -----VSDNQLAS-LPALPSEL----CKLWAYNNQLT-SLPMLPSGLQE---LSVSDNQL 193

Query: 246 TGPIPVTFGRLQN---------------SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEI 290
              +P     L                 S L  L + GN  + S+P       LK   E+
Sbjct: 194 AS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPV--LPSELK---EL 246

Query: 291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL 350
            +S N  +  +P    GL    ++S+  N+L   +PES  +L+S   ++L  N +S   L
Sbjct: 247 MVSGNRLT-SLPMLPSGL---LSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTL 301

Query: 351 ISLEKLLYLKKLNLSFNKLEGEIP 374
            +L ++      +    + +    
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 84.6 bits (209), Expect = 4e-17
 Identities = 57/324 (17%), Positives = 103/324 (31%), Gaps = 64/324 (19%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL-----------VGNNSLSGSLPSRID 128
             L +S   L   +P     L  L+  +     L           +  N L+ SLP    
Sbjct: 84  RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPVLP- 140

Query: 129 LALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLV 188
              P ++ LS++ N+ + ++ +  +    L  L    N  +  +P     L+ +      
Sbjct: 141 ---PGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQELS----- 187

Query: 189 IGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGP 248
             +  N L   LP+    L     +L+  N  +T ++P +   L     L +  N+LT  
Sbjct: 188 --VSDNQLA-SLPTLPSEL----YKLWAYNNRLT-SLPALPSGLKE---LIVSGNRLTS- 235

Query: 249 IPVTFGRLQN---------------SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS 293
           +PV    L+                S L +LS+  N  +  +P    + +L     +NL 
Sbjct: 236 LPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPE--SLIHLSSETTVNLE 292

Query: 294 RNNFSGDIPATIGGLKDVQNISLPYNR---LEGPIPESFGYLTSLEILDLSNNKISGFIL 350
            N  S      +  +      S P  R        P     L       L   +      
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352

Query: 351 I----SLEKLLYLKKLNLSFNKLE 370
                   +       +L  ++L 
Sbjct: 353 ADRWHMFGQEDNADAFSLFLDRLS 376

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 6e-26
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 16/198 (8%)

Query: 484 GIGSFGYVYKA-ELDDGIEVAIKVFHQE-CARAMKSF-EVECEVMKNIRHRNLVKIISGC 540
           G      V  A     G  V ++  + E C+  M +F + E  V K   H N+V   +  
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 541 SNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
             D+   +V  +M  GS  D+        ++      I+  V  AL+Y+   H    +H 
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI---HHMGYVHR 152

Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLS--GEDQSMTQTQTLATIG---YMAPEYGIERKV 654
            +K+S++L+  D   +LS       +   G+ Q +       ++    +++PE  +++ +
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-LQQNL 211

Query: 655 S---TRSDIYSYGIMLIE 669
                +SDIYS GI   E
Sbjct: 212 QGYDAKSDIYSVGITACE 229

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  109 bits (275), Expect = 6e-26
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 17/195 (8%)

Query: 480 DNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKI- 536
            +++G G+   V++      G   AIKVF+     R +     E EV+K + H+N+VK+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 537 -ISGCSNDDFKALVLEYMPNGSLDIFLYS--STCMLDIFQRLNIMIDVASALEYLNFRHT 593
            I   +    K L++E+ P GSL   L    +   L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RE 130

Query: 594 TPIIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
             I+H ++K  N++     D   +  L+DFG A+ L  ++Q ++      T  Y+ P+  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDM- 186

Query: 650 IERKVSTRSDIYSYG 664
            ER V  +     YG
Sbjct: 187 YERAVLRKDHQKKYG 201

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (269), Expect = 8e-26
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNL 533
            F +   IG GSFG V+K  +      VAIK+   E A       + E  V+       +
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82

Query: 534 VKIISGCSNDDFKALVLEYMPNGSL-DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
            K       D    +++EY+  GS  D+        LD  Q   I+ ++   L+YL   H
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYL---H 136

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG---YMAPEYG 649
           +   IH D+K++NVLL E     L+DFG+A  L+    +  +  T   +G   +MAPE  
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTF--VGTPFWMAPEVI 191

Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKP 676
            +    +++DI+S GI  IE    + P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 1e-25
 Identities = 65/232 (28%), Positives = 99/232 (42%), Gaps = 29/232 (12%)

Query: 458 SQATKRRLPYQDLSRATN---RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR 513
           S +  R L   DLS   +    F    L+G G++G VYK   +  G   AIKV       
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GD 62

Query: 514 AMKSFEVECEVMKNI-RHRNLVKII------SGCSNDDFKALVLEYMPNGSL-DIFLYSS 565
             +  + E  ++K    HRN+          +    DD   LV+E+   GS+ D+   + 
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122

Query: 566 TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL 625
              L       I  ++   L +L   H   +IH D+K  NVLL E+    L DFG++  L
Sbjct: 123 GNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179

Query: 626 SGEDQSMTQTQTLATIG---YMAPE-----YGIERKVSTRSDIYSYGIMLIE 669
               +++ +  T   IG   +MAPE        +     +SD++S GI  IE
Sbjct: 180 D---RTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (264), Expect = 3e-25
 Identities = 48/237 (20%), Positives = 90/237 (37%), Gaps = 44/237 (18%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECA--RAMKSFEVECEVMKN 527
           SR T  F     IG G FG V+K  +  DG   AIK   +  A     ++   E      
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 528 I-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF---QRLNIMIDVAS 583
           + +H ++V+  S  + DD   +  EY   GSL   +  +  ++  F   +  ++++ V  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDED-------------------MIAHLSDFGIAKL 624
            L Y+   H+  ++H D+K SN+ +                      ++  + D G    
Sbjct: 127 GLRYI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 625 LSGEDQSMTQTQTLATIGYMAPE-----YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           +     S  Q +      ++A E     Y    K    +DI++  + ++     +  
Sbjct: 184 I-----SSPQVEE-GDSRFLANEVLQENYTHLPK----ADIFALALTVVCAAGAEPL 230

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (264), Expect = 9e-25
 Identities = 26/244 (10%), Positives = 62/244 (25%), Gaps = 45/244 (18%)

Query: 470 LSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ---ECARAMKSFEVECEVM 525
           LS+   +      + +G    V+   +++   + A+KVF          ++         
Sbjct: 57  LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116

Query: 526 KNIRHRNLVKIISGC----------------------SNDDFKA----LVLEYM-----P 554
             +   +  +                             DD+      L++         
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176

Query: 555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA 614
             S   F+Y       I     +   +      L    +  ++H      N+ +  D   
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANL---QSKGLVHGHFTPDNLFIMPDGRL 233

Query: 615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY--GIERKVSTRSDIYSYGIMLIETFT 672
            L D      + G     +       + Y   E+        +   + +  G+ +   + 
Sbjct: 234 MLGDVSALWKV-GTRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288

Query: 673 RKKP 676
              P
Sbjct: 289 LFLP 292

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  103 bits (259), Expect = 1e-24
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 16/201 (7%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRH 530
             F     +G G FG VY A E      +A+KV  +              E E+  ++RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
            N++++     +     L+LEY P G++   L   +   +       + ++A+AL Y   
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYC-- 125

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYG 649
            H+  +IH D+K  N+LL       ++DFG +           +   L  T+ Y+ PE  
Sbjct: 126 -HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEM- 178

Query: 650 IERKV-STRSDIYSYGIMLIE 669
           IE ++   + D++S G++  E
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYE 199

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  107 bits (270), Expect = 1e-24
 Identities = 56/321 (17%), Positives = 104/321 (32%), Gaps = 31/321 (9%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLA-LPNVKALSLA 140
           L++S  +L        G L SL  L L  N          +L        L N++ L + 
Sbjct: 79  LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-------TLGVTSLFPNLTNLQTLRIG 131

Query: 141 -YNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
               FS   +      + L  LE+   S   +   ++ ++R+I  L L      +    +
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL----HLSESAFL 187

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
           L      LS S+  L + + ++       +    +   +     + +     +F  L   
Sbjct: 188 LEIFADILS-SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246

Query: 260 KLDTLSLCGNSFSG--------------SIPSCIDIGNLKVVVEINLSRNNFSGDIPATI 305
               L L    F                 + S +       +  +++ +     D+    
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306

Query: 306 GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILIS---LEKLLYLKKL 362
             L+ V+ I++  +++         +L SLE LDLS N +    L +         L+ L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 363 NLSFNKLEGEIPRGGPFANFT 383
            LS N L      G       
Sbjct: 367 VLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  105 bits (264), Expect = 6e-24
 Identities = 57/340 (16%), Positives = 115/340 (33%), Gaps = 44/340 (12%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
               +  L I +L+L+      +  +  +  L L  +           L       L +V
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES-------AFLLEIFADILSSV 198

Query: 135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL---VIGL 191
           + L L     +    SP+      + ++      S     +   L  +    L    +  
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258

Query: 192 IGNPLNGILPSSIVNLS----------ISLERLYISNCSITGNIPQVMGNLSIFLLLDLE 241
               LNG+   +               +++ RL+I    +  ++  V   L     + +E
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318

Query: 242 LNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSG-SIPSCIDIGNLKVVVEINLSRNNFS-- 298
            +K+          L++  L+ L L  N      + +    G    +  + LS+N+    
Sbjct: 319 NSKVFLVPCSFSQHLKS--LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376

Query: 299 GDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF---ILISLEK 355
                 +  LK++ ++ +  N    P+P+S  +   +  L+LS+  I      I  +LE 
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEV 435

Query: 356 LL--------------YLKKLNLSFNKLEGEIPRGGPFAN 381
           L                L++L +S NKL+  +P    F  
Sbjct: 436 LDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 96.3 bits (240), Expect = 7e-21
 Identities = 43/315 (13%), Positives = 100/315 (31%), Gaps = 31/315 (9%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALS 138
           + +L++S   +      ++    +L  L L  + +        ++      +L +++ L 
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-------NTIEGDAFYSLGSLEHLD 80

Query: 139 LAYNRFSGTIQSPITNASKLTILELGGNSFSGF-IPNTIGNLRNIEWLGLVIGLIGNPLN 197
           L+ N  S    S     S L  L L GN +    + +   NL N++ L +         +
Sbjct: 81  LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI---GNVETFS 137

Query: 198 GILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQ 257
            I       L+ SL  L I   S+     Q + ++     L L L++    + +    L 
Sbjct: 138 EIRRIDFAGLT-SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196

Query: 258 NSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIP--------------- 302
           +  +  L L   + +    S + +  +   ++    R +   D                 
Sbjct: 197 S--VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254

Query: 303 -ATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKK 361
                            +  +           ++  L +    +   +      L  +K+
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314

Query: 362 LNLSFNKLEGEIPRG 376
           + +  +K+   +P  
Sbjct: 315 ITVENSKVF-LVPCS 328

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 91.7 bits (228), Expect = 2e-19
 Identities = 43/254 (16%), Positives = 90/254 (35%), Gaps = 35/254 (13%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
           + S + S+PS +      +K+L L++N+ +      +   + L +L L  +  +    + 
Sbjct: 14  SRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF 235
             +L ++E L L      N L+ +  S    LS SL+ L +                   
Sbjct: 70  FYSLGSLEHLDLS----DNHLSSLSSSWFGPLS-SLKYLNLMGNPYQ------------- 111

Query: 236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN 295
                     T  +   F  L N  L TL +        I   ID   L  + E+ +   
Sbjct: 112 ----------TLGVTSLFPNLTN--LQTLRIGNVETFSEIRR-IDFAGLTSLNELEIKAL 158

Query: 296 NFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEK 355
           +       ++  ++D+ +++L  +     +      L+S+  L+L +  ++ F    L  
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218

Query: 356 LLYLKKLNLSFNKL 369
                 +     + 
Sbjct: 219 DEVSSPMKKLAFRG 232

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 89.0 bits (221), Expect = 1e-18
 Identities = 44/286 (15%), Positives = 105/286 (36%), Gaps = 26/286 (9%)

Query: 92  EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRID----LALPNVKALSLAYNRFSGT 147
           E+   + Y+  L+++     +L G    + S    +     +    ++ L +        
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301

Query: 148 IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGIL--PSSIV 205
           + +  +   K+  + +  +       +   +L+++E+L L      N +       S+  
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDL----SENLMVEEYLKNSACK 357

Query: 206 NLSISLERLYISNCSIT--GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDT 263
               SL+ L +S   +       +++  L     LD+  N    P+P +    +   +  
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK--MRF 414

Query: 264 LSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEG 323
           L+L        + +CI     + +  +++S NN           L  +Q + +  N+L+ 
Sbjct: 415 LNLSSTGIR-VVKTCI----PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKT 465

Query: 324 PIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
               S      L ++ +S N++        ++L  L+K+ L  N  
Sbjct: 466 LPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 52/319 (16%), Positives = 102/319 (31%), Gaps = 39/319 (12%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRI----DLALPNVKAL 137
           L +        +      L S+  L L   +L         +         LA       
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236

Query: 138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLV----IGLIG 193
             ++N     +   I   S++   +   N    F P+    +  +  +  V    + +  
Sbjct: 237 DESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295

Query: 194 NPLNGILPSSIVNLSISLERLYISNC---SITGNIPQVMGNLSIFLLLDLELNKLTGPIP 250
             L   L +    L   ++R+ + N     +  +  Q + +L     LDL  N +     
Sbjct: 296 FYLFYDLSTVYSLLE-KVKRITVENSKVFLVPCSFSQHLKSLEF---LDLSENLMVEEYL 351

Query: 251 VTFGRLQN-SKLDTLSLCGNSFSGSIPSCIDI-GNLKVVVEINLSRNNFSGDIPATIGGL 308
                      L TL L  N    S+    +I   LK +  +++SRN F   +P +    
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP 409

Query: 309 KDVQNISLPYNRLEG-----------------PIPESFGYLTSLEILDLSNNKISGFILI 351
           + ++ ++L    +                    +     +L  L+ L +S NK+    L 
Sbjct: 410 EKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK--TLP 467

Query: 352 SLEKLLYLKKLNLSFNKLE 370
                  L  + +S N+L+
Sbjct: 468 DASLFPVLLVMKISRNQLK 486

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 68.2 bits (167), Expect = 5e-12
 Identities = 41/228 (17%), Positives = 81/228 (35%), Gaps = 25/228 (10%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
              +V  + + +  +         +L SL  L L  N +V     + +       A P++
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG----AWPSL 363

Query: 135 KALSLAYNRFS--GTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLI 192
           + L L+ N           +     LT L++  N+F   +P++      + +L L     
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS---- 418

Query: 193 GNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVT 252
              +  ++ + I     +LE L +SN ++  +    +  L     L +  NKL      +
Sbjct: 419 STGIR-VVKTCIPQ---TLEVLDVSNNNLD-SFSLFLPRLQE---LYISRNKLKTLPDAS 470

Query: 253 FGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGD 300
                   L  + +  N    S+P  I    L  + +I L  N +   
Sbjct: 471 L----FPVLLVMKISRNQLK-SVPDGI-FDRLTSLQKIWLHTNPWDCS 512

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 64.7 bits (158), Expect = 6e-11
 Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 6/125 (4%)

Query: 259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY 318
                      SF+ SIPS +       +  ++LS N  +      +    ++Q + L  
Sbjct: 5   DASGVCDGRSRSFT-SIPSGL----TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGP 378
           +R+     ++F  L SLE LDLS+N +S         L  LK LNL  N  +  +     
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSL 118

Query: 379 FANFT 383
           F N T
Sbjct: 119 FPNLT 123

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  105 bits (263), Expect = 1e-24
 Identities = 70/278 (25%), Positives = 111/278 (39%), Gaps = 24/278 (8%)

Query: 483 IGIGSFGYVYKAEL-DDGIEVAIKVFHQECARA-MKSFEVECEVMKNIRHRNLVK----- 535
           +G G+ G V+K      G+ +A K+ H E   A       E +V+       +V      
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
              G  +     + +E+M  GSLD  +      +       + I V   L YL  +H   
Sbjct: 101 YSDGEIS-----ICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-- 152

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           I+H D+K SN+L++      L DFG++  L     SM  +  + T  YM+PE       S
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYS 208

Query: 656 TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF 715
            +SDI+S G+ L+E    + P     A EL L          +      +T   P  K  
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF- 267

Query: 716 AAKEQCVLSIFSLAM----ECTMELPEKRINAKCCNFV 749
               +  ++IF L      E   +LP    + +  +FV
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  103 bits (259), Expect = 3e-24
 Identities = 56/227 (24%), Positives = 86/227 (37%), Gaps = 21/227 (9%)

Query: 456 LLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARA 514
           + S    +  P Q              IG G++G V K      G  +A+K         
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62

Query: 515 -MKSFEVECEV-MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF 572
             K   ++ +V M++     +V+       +    + +E M + S D F         + 
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLD 119

Query: 573 QRLN------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
             +       I +    AL +L       IIH D+K SN+LLD      L DFGI+  L 
Sbjct: 120 DVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177

Query: 627 GEDQSMTQTQTLATIGYMAPE----YGIERKVSTRSDIYSYGIMLIE 669
               S+ +T+      YMAPE        +    RSD++S GI L E
Sbjct: 178 ---DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  101 bits (255), Expect = 6e-24
 Identities = 45/201 (22%), Positives = 85/201 (42%), Gaps = 20/201 (9%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHR 531
           R+ R   +G G F   ++  + D     A K+  +         +   +E  + +++ H+
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           ++V       ++DF  +VLE     SL         + +   R   +  +    +YL   
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYL--- 131

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI-G---YMAPE 647
           H   +IH DLK  N+ L+ED+   + DFG+A  +          +    + G   Y+APE
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPE 185

Query: 648 YGIERKV-STRSDIYSYGIML 667
             + +K  S   D++S G ++
Sbjct: 186 V-LSKKGHSFEVDVWSIGCIM 205

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  104 bits (260), Expect = 7e-24
 Identities = 70/262 (26%), Positives = 107/262 (40%), Gaps = 59/262 (22%)

Query: 444 RGKSTGLSNGG-ILLSQATKRRLPYQDLSRATNRFGRDNL---------IGIGSFGYVYK 493
           +GK   L+N   I LS +  +   + DL+          L         +G G+ G V  
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153

Query: 494 A-ELDDGIEVAIKVFH--------QECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD 544
           A E     +VAI++             A    + E E E++K + H  ++KI +    +D
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213

Query: 545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEYLNFRH 592
           +  +VLE M  G L             F ++                 +  A++YL   H
Sbjct: 214 Y-YIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQMLLAVQYL---H 256

Query: 593 TTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE- 647
              IIH DLK  NVLL   +ED +  ++DFG +K+L GE   M    TL  T  Y+APE 
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR---TLCGTPTYLAPEV 312

Query: 648 --YGIERKVSTRSDIYSYGIML 667
                    +   D +S G++L
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVIL 334

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (258), Expect = 7e-24
 Identities = 40/294 (13%), Positives = 93/294 (31%), Gaps = 61/294 (20%)

Query: 470 LSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVF--------------------- 507
           L        R  ++G        +A + + G    + V                      
Sbjct: 68  LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 127

Query: 508 -------HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM-PNGSL- 558
                  +Q+ A+    F    +++K+ + + ++++     +    +    Y     +L 
Sbjct: 128 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 187

Query: 559 ----DIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI 613
                +  +SST   L    RL + + V   L  L   H   ++H  L+  +++LD+   
Sbjct: 188 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGLVHTYLRPVDIVLDQRGG 244

Query: 614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY-----------GIERKVSTRSDIYS 662
             L+ F              +  +  + G+  PE                 ++   D ++
Sbjct: 245 VFLTGFEHLVRDG------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 663 YGIMLIETFTRKKP---ADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK 713
            G+++   +    P      +  +E   +   N  +P  +  ++   L  P E 
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--IPQPVRALLEGFLRYPKED 350

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (253), Expect = 8e-24
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 469 DLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE---CARAMKSFEVECEV 524
            +      F   NL+G GSF  VY+A  +  G+EVAIK+  ++    A  ++  + E ++
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64

Query: 525 MKNIRHRNLVKIISGCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
              ++H +++++      D     LVLE   NG ++ +L +        +  + M  + +
Sbjct: 65  HCQLKHPSILELY-NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIG 642
            + YL   H+  I+H DL  SN+LL  +M   ++DFG+A  L    +      TL  T  
Sbjct: 124 GMLYL---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPN 177

Query: 643 YMAPEYGIERKV-STRSDIYSYGIML 667
           Y++PE    R      SD++S G M 
Sbjct: 178 YISPEI-ATRSAHGLESDVWSLGCMF 202

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  101 bits (255), Expect = 1e-23
 Identities = 45/201 (22%), Positives = 85/201 (42%), Gaps = 20/201 (9%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHR 531
           R+ R   +G G F   ++  + D     A K+  +         +   +E  + +++ H+
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           ++V       ++DF  +VLE     SL         + +   R   +  +    +YL   
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYL--- 157

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI-G---YMAPE 647
           H   +IH DLK  N+ L+ED+   + DFG+A  +          +    + G   Y+APE
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPE 211

Query: 648 YGIERKV-STRSDIYSYGIML 667
             + +K  S   D++S G ++
Sbjct: 212 V-LSKKGHSFEVDVWSIGCIM 231

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  100 bits (252), Expect = 2e-23
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 40/209 (19%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
            F    ++G G+F  V+   +   G   A+K   +  A    S E E  V+K I+H N+V
Sbjct: 12  IFME--VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVA 582
            +     +     LV++ +  G L             F R+             ++  V 
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVL 116

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
           SA++YL   H   I+H DLK  N+L    +E+    ++DFG++K+   ++  M+   T  
Sbjct: 117 SAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMS---TAC 168

Query: 640 -TIGYMAPEYGIERKVSTRSDIYSYGIML 667
            T GY+APE   ++  S   D +S G++ 
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  104 bits (260), Expect = 2e-23
 Identities = 65/426 (15%), Positives = 126/426 (29%), Gaps = 65/426 (15%)

Query: 39  LLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQG----EIP 94
           +   +       +NL       +  + +            +T  N   +  +     ++P
Sbjct: 9   VKPRQPEYKCIDSNLQYDCVFYDVHI-DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 67

Query: 95  HEI-GYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPIT 153
             +      +  L L    +         + +        ++ L + +N           
Sbjct: 68  AALLDSFRQVELLNLNDLQIE-------EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ 120

Query: 154 NASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLER 213
           N   LT+L L  N  S        N   +  L +      N L  I   +    + SL+ 
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM----SNNNLERIEDDTFQATT-SLQN 175

Query: 214 LYISNCSIT----------------GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQ 257
           L +S+  +T                 N+   +        LD   N +            
Sbjct: 176 LQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-----VVRGPV 230

Query: 258 NSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLP 317
           N +L  L L  N+ +      ++   L    E++LS N     +      ++ ++ + + 
Sbjct: 231 NVELTILKLQHNNLT-DTAWLLNYPGLV---EVDLSYNELEKIMYHPFVKMQRLERLYIS 286

Query: 318 YNRLEGPIPESFGYLTSLEILDLSNNKISG-----FILISLEKL---------------L 357
            NRL   +      + +L++LDLS+N +            LE L                
Sbjct: 287 NNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTHH 345

Query: 358 YLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMI 417
            LK L LS N  +        F N    +    ++ C + +        +   K     +
Sbjct: 346 TLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL 404

Query: 418 LLVIVL 423
           L  I L
Sbjct: 405 LQYIAL 410

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  103 bits (258), Expect = 3e-23
 Identities = 56/313 (17%), Positives = 106/313 (33%), Gaps = 46/313 (14%)

Query: 68  IGITCDVNSHRVTALNISSLNLQGEIPHEI-GYLPSLTKLALGYNSLVGNNSLSGSLPSR 126
           + I   +N++   + N S  N       +         K AL   +    N     L   
Sbjct: 1   MSIMLPINNNFSLSQN-SFYNTISGTYADYFSAWDKWEKQALPGEN---RNEAVSLLK-- 54

Query: 127 IDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLG 186
            +  +     L L     S     P     ++T+LE+  N+    +P    +L  ++   
Sbjct: 55  -ECLINQFSELQLNRLNLS---SLPDNLPPQITVLEITQNALI-SLPELPASLEYLD--- 106

Query: 187 LVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLT 246
                  N L+  LP    +L    + L + N  +T  +P++   L     ++ + N+LT
Sbjct: 107 ----ACDNRLS-TLPELPASL----KHLDVDNNQLT-MLPELPALLEY---INADNNQLT 153

Query: 247 GPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIG 306
             +P     L+      LS+  N  +  +P      +L+    +++S N     +PA   
Sbjct: 154 M-LPELPTSLE-----VLSVRNNQLT-FLPELP--ESLE---ALDVSTNLLE-SLPAVPV 200

Query: 307 GL----KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKL 362
                 +         NR+   IPE+   L     + L +N +S  I  SL +       
Sbjct: 201 RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259

Query: 363 NLSFNKLEGEIPR 375
           +           +
Sbjct: 260 HGPRIYFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 83.1 bits (205), Expect = 1e-16
 Identities = 53/251 (21%), Positives = 88/251 (35%), Gaps = 41/251 (16%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
           + L ++ LNL   +P  +   P +T L +  N+L+       SLP        +++ L  
Sbjct: 62  SELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-------SLPELP----ASLEYLDA 107

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             NR S T+     +   L  L++  N  +  +P     L  I           N L   
Sbjct: 108 CDNRLS-TLPELPAS---LKHLDVDNNQLT-MLPELPALLEYIN-------ADNNQLTM- 154

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
           LP    +L    E L + N  +T  +P++  +L     LD+  N L   +P    R  +S
Sbjct: 155 LPELPTSL----EVLSVRNNQLTF-LPELPESLEA---LDVSTNLLES-LPAVPVRNHHS 205

Query: 260 K--LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLP 317
           +          N  +  IP  I   +L     I L  N  S  I  ++       +   P
Sbjct: 206 EETEIFFRCRENRIT-HIPENI--LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262

Query: 318 YNRLEGPIPES 328
                    + 
Sbjct: 263 RIYFSMSDGQQ 273

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (251), Expect = 4e-23
 Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 49/213 (23%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKV-----FHQECARAMKSFEVECEVMKNIRHRNLVKI 536
           IG G F  V +    + G + A+K+     F      + +  + E  +   ++H ++V++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 537 ISGCSNDDFKALVLEYMPNGSL---------DIFLYS----STCMLDIFQRLNIMIDVAS 583
           +   S+D    +V E+M    L           F+YS    S  M  I            
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           AL Y    H   IIH D+K   VLL   +      L  FG+A  L            + T
Sbjct: 142 ALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 641 IGYMAPE------YGIERKVSTRSDIYSYGIML 667
             +MAPE      YG         D++  G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 48/214 (22%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---------HQECARAMKSFEVECEVMKNI-RHR 531
           +G G    V +        E A+K+           +E     ++   E ++++ +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMI 579
           N++++      + F  LV + M  G L             F  L             IM 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLSEKETRKIMR 131

Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            +   +  L   H   I+H DLK  N+LLD+DM   L+DFG +  L    + +   +   
Sbjct: 132 ALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKL--REVCG 185

Query: 640 TIGYMAPE------YGIERKVSTRSDIYSYGIML 667
           T  Y+APE                 D++S G+++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (253), Expect = 7e-23
 Identities = 46/210 (21%), Positives = 88/210 (41%), Gaps = 50/210 (23%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF--HQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G+F  V +  ++  G E A  +    +  AR  +  E E  + + ++H N+V++   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEY 587
            S +    L+ + +  G L             F+ +            + +  +  A+ +
Sbjct: 79  ISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGY 643
               H   ++H +LK  N+LL    +     L+DFG+A  + GE Q+       A T GY
Sbjct: 126 C---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGY 179

Query: 644 MAPE------YGIERKVSTRSDIYSYGIML 667
           ++PE      YG         D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKP------VDLWACGVIL 203

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 38/203 (18%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G GSFG V K  +     E A+KV +      +   +   E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEY 587
             +     +V E    G L             F  +             I+  V S + Y
Sbjct: 90  LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           +   H   I+H DLK  N+LL   ++D    + DFG++     ++  M     + T  Y+
Sbjct: 137 M---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYI 190

Query: 645 APEYGIERKVSTRSDIYSYGIML 667
           APE  +      + D++S G++L
Sbjct: 191 APEV-LRGTYDEKCDVWSAGVIL 212

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 38/208 (18%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
                  IG GS+G V  A +    I  A K   +     +  F+ E E+MK++ H N++
Sbjct: 12  TLEN--TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVA 582
           ++     ++    LV+E    G L             F+R+             IM DV 
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGEL-------------FERVVHKRVFRESDAARIMKDVL 116

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
           SA+ Y    H   + H DLK  N L      D    L DFG+A       + M     + 
Sbjct: 117 SAVAYC---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMM--RTKVG 170

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIML 667
           T  Y++P+  +E       D +S G+M+
Sbjct: 171 TPYYVSPQV-LEGLYGPECDEWSAGVMM 197

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (255), Expect = 1e-22
 Identities = 65/344 (18%), Positives = 108/344 (31%), Gaps = 53/344 (15%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
             L++S   +Q         L  L+ L L  N +        SL       L +++ L  
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-------SLALGAFSGLSSLQKLVA 107

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGF-IPNTIGNLRNIEWLGLVIGLIGNPLNG 198
                +     PI +   L  L +  N    F +P    NL N+E L L      N +  
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS----SNKIQS 163

Query: 199 ILPSSIV---NLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIP-VTFG 254
           I  + +     + +    L +S   +    P     +     L L  N  +  +      
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQ 222

Query: 255 RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNN------FSGDIPATIGGL 308
            L   ++  L L      G++    D   L+ +  + +          +  DI      L
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEK-FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281

Query: 309 KDVQNISLPYNRLEGPIPESF-------------------GYLTSLEILDLSNNKISGFI 349
            +V + SL    +E     S+                     L SL+ L  ++NK     
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-- 339

Query: 350 LISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKL 393
             S   L  L+ L+LS N L         F    ++S  G   L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLS--------FKGCCSQSDFGTTSL 375

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 99.8 bits (249), Expect = 6e-22
 Identities = 47/265 (17%), Positives = 94/265 (35%), Gaps = 22/265 (8%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
             +    +P  +     + K L L++N           +  +L +L+L            
Sbjct: 16  ELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF 235
             +L ++  L     L GNP+  +   +   LS SL++L     ++       +G+L   
Sbjct: 72  YQSLSHLSTL----ILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTL 126

Query: 236 LLLDLELNKLT-GPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCID-IGNLKVV-VEINL 292
             L++  N +    +P  F  L N  L+ L L  N       + +  +  + ++ + ++L
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTN--LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 293 SRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPE-SFGYLTSLEILDL------SNNKI 345
           S N  +  I         +  ++L  N     + +     L  LE+  L      +   +
Sbjct: 185 SLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 346 SGFILISLEKLLYLKKLNLSFNKLE 370
             F   +LE L  L         L+
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLD 268

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 99.4 bits (248), Expect = 7e-22
 Identities = 60/337 (17%), Positives = 109/337 (32%), Gaps = 29/337 (8%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALS 138
              L++S   L+    +     P L  L L    +        ++      +L ++  L 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-------QTIEDGAYQSLSHLSTLI 82

Query: 139 LAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG 198
           L  N          +  S L  L     + +      IG+L+ ++ L     +  N +  
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL----NVAHNLIQS 138

Query: 199 ILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS----IFLLLDLELNKLTGPIPVTFG 254
                  +   +LE L +S+  I       +  L     + L LDL LN +    P  F 
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF- 197

Query: 255 RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPAT---IGGLKDV 311
             +  +L  L+L  N  S ++     I  L  +    L    F  +          L+ +
Sbjct: 198 --KEIRLHKLTLRNNFDSLNVMKTC-IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254

Query: 312 QNISLPYNRLEG------PIPESFGYLTSLEILDLSNNKISGF-ILISLEKLLYLKKLNL 364
            N+++   RL         I + F  LT++    L +  I             +L+ +N 
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314

Query: 365 SFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQV 401
            F +      +      FT+           LP L+ 
Sbjct: 315 KFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 98.6 bits (246), Expect = 1e-21
 Identities = 56/317 (17%), Positives = 115/317 (36%), Gaps = 51/317 (16%)

Query: 82  LNISSLNLQG-EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRI------------D 128
             ++ L+    +I      L +++  +L   ++      S +   +              
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321

Query: 129 LALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGN--SFSGFIPNTIGNLRNIEWLG 186
           L L ++K L+   N+          +   L  L+L  N  SF G    +     ++++L 
Sbjct: 322 LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 187 LVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQ-VMGNLSIFLLLDLELNKL 245
           L      N +  +  S+ + L   LE L   + ++       V  +L   + LD+     
Sbjct: 380 LS----FNGVITM-SSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 246 TGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI 305
                  F  L +  L+ L + GNSF  +    I    L+ +  ++LS+           
Sbjct: 434 RVAFNGIFNGLSS--LEVLKMAGNSFQENFLPDI-FTELRNLTFLDLSQCQLE------- 483

Query: 306 GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLS 365
                     L         P +F  L+SL++L++++N++        ++L  L+K+ L 
Sbjct: 484 ---------QLS--------PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526

Query: 366 FNKLEGEIPRGGPFANF 382
            N  +   PR    + +
Sbjct: 527 TNPWDCSCPRIDYLSRW 543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 24/125 (19%), Positives = 45/125 (36%), Gaps = 3/125 (2%)

Query: 259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY 318
                L L  N     + S     +   +  ++LSR             L  +  + L  
Sbjct: 28  FSTKNLDLSFNPLR-HLGSY-SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGP 378
           N ++     +F  L+SL+ L      ++      +  L  LK+LN++ N ++        
Sbjct: 86  NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY 144

Query: 379 FANFT 383
           F+N T
Sbjct: 145 FSNLT 149

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 22/200 (11%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARA-MKSFEVECEV-MKNIRHRNLVKIISG 539
           +G G++G V K   +  G  +A+K           K   ++ ++ M+ +     V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN------IMIDVASALEYLNFRHT 593
              +    + +E M + SLD F      ++D  Q +       I + +  ALE+L+ + +
Sbjct: 75  LFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE----YG 649
             +IH D+K SNVL++      + DFGI+  L      + +        YMAPE      
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPEL 185

Query: 650 IERKVSTRSDIYSYGIMLIE 669
            ++  S +SDI+S GI +IE
Sbjct: 186 NQKGYSVKSDIWSLGITMIE 205

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 14/195 (7%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARA-MKSFEVECEV-MKNIRHRNLVKIISG 539
           +G G+ G V+K      G  +A+K   +   +   K   ++ +V +K+     +V+    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHC 599
              +    + +E M     +         +       + + +  AL YL  +H   +IH 
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149

Query: 600 DLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE-----YGIERKV 654
           D+K SN+LLDE     L DFGI+  L        + ++     YMAPE        +   
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206

Query: 655 STRSDIYSYGIMLIE 669
             R+D++S GI L+E
Sbjct: 207 DIRADVWSLGISLVE 221

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 46/213 (21%), Positives = 85/213 (39%), Gaps = 37/213 (17%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEV-----------------ECEVM 525
           +  G F  +   E  D    A+K + +      + F                   E +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 526 KNIRHRNLVKIISGCSNDDFKALVLEYMPNGSL-------DIFLYSSTCMLDIFQRLNIM 578
            +I++   +      +N D   ++ EYM N S+        +   + TC + I     I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 579 IDVASALEYL-NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
             V ++  Y+ N ++   I H D+K SN+L+D++    LSDFG ++ +  +       + 
Sbjct: 158 KSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKG 209

Query: 638 LA-TIGYMAPE--YGIERKVSTRSDIYSYGIML 667
              T  +M PE           + DI+S GI L
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 50/208 (24%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGC 540
           +G GSF    K          A+K+  +   R   + + E   +K    H N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEYL 588
            +     LV+E +  G L             F+R+             IM  + SA+ ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 589 NFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
              H   ++H DLK  N+L    ++++   + DFG A+L   ++Q +       T+ Y A
Sbjct: 123 ---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 646 PE------YGIERKVSTRSDIYSYGIML 667
           PE      Y          D++S G++L
Sbjct: 178 PELLNQNGYD------ESCDLWSLGVIL 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (251), Expect = 2e-22
 Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 39/204 (19%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF---HQECARAMKSFEVECEVMKNIRHRNLVKIIS 538
           +G GSFG V    +   G E A+KV      +     +S   E +++K + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALE 586
              +  +  LV E    G L             F  +             I+  V S + 
Sbjct: 94  FFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARIIRQVLSGIT 140

Query: 587 YLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           Y+   H   I+H DLK  N+LL    +D    + DFG++       + M     + T  Y
Sbjct: 141 YM---HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKM--KDKIGTAYY 194

Query: 644 MAPEYGIERKVSTRSDIYSYGIML 667
           +APE  +      + D++S G++L
Sbjct: 195 IAPEV-LHGTYDEKCDVWSTGVIL 217

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 45/209 (21%), Positives = 87/209 (41%), Gaps = 49/209 (23%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G+F  V +      G+E A K+ +  +  AR  +  E E  + + ++H N+V++   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEY 587
              + F  LV + +  G L             F+ +            + +  +  ++ Y
Sbjct: 74  IQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIAY 120

Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
               H+  I+H +LK  N+LL    +     L+DFG+A  +  + ++        T GY+
Sbjct: 121 C---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYL 174

Query: 645 APE------YGIERKVSTRSDIYSYGIML 667
           +PE      Y          DI++ G++L
Sbjct: 175 SPEVLKKDPYSKP------VDIWACGVIL 197

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 28/200 (14%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKII 537
            +G G FG VY A E  +   +A+KV  +              E E+  ++RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN------IMIDVASALEYLNFR 591
           +   +     L+LE+ P G L  +       L    R +       M ++A AL Y    
Sbjct: 81  NYFHDRKRIYLMLEFAPRGEL--YKE-----LQKHGRFDEQRSATFMEELADALHYC--- 130

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGI 650
           H   +IH D+K  N+L+       ++DFG +           + +T+  T+ Y+ PE  I
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEM-I 184

Query: 651 ERKV-STRSDIYSYGIMLIE 669
           E K    + D++  G++  E
Sbjct: 185 EGKTHDEKVDLWCAGVLCYE 204

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (250), Expect = 3e-22
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 38/203 (18%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF--HQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G++G V    +    +E AIK+         +      E  V+K + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEY 587
             +     LV+E    G L             F  +             I+  V S + Y
Sbjct: 105 FEDKRNYYLVMECYKGGEL-------------FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           L   H   I+H DLK  N+LL   ++D +  + DFG++ +     + M   + L T  Y+
Sbjct: 152 L---HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKM--KERLGTAYYI 205

Query: 645 APEYGIERKVSTRSDIYSYGIML 667
           APE  + +K   + D++S G++L
Sbjct: 206 APEV-LRKKYDEKCDVWSIGVIL 227

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.8 bits (249), Expect = 3e-22
 Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 38/203 (18%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF--HQECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G GSFG V K  +     E A+KV        +   +   E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEY 587
             +     +V E    G L             F  +             I+  V S + Y
Sbjct: 90  LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           +   H   I+H DLK  N+LL   ++D    + DFG++     ++  M     + T  Y+
Sbjct: 137 M---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKM--KDRIGTAYYI 190

Query: 645 APEYGIERKVSTRSDIYSYGIML 667
           APE  +      + D++S G++L
Sbjct: 191 APEV-LRGTYDEKCDVWSAGVIL 212

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.0 bits (247), Expect = 7e-22
 Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 51/221 (23%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKV-------------FHQECARAMKSFEVE 521
              R   +G G++G V    E +   E AIKV              ++   +  +    E
Sbjct: 39  FKVR--KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------ 575
             ++K++ H N++K+     +  +  LV E+   G L             F+++      
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRHKF 143

Query: 576 ------NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLS 626
                 NIM  + S + YL   H   I+H D+K  N+LL   +  +   + DFG++   S
Sbjct: 144 DECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
            +D  +     L T  Y+APE  +++K + + D++S G+++
Sbjct: 201 -KDYKL--RDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIM 237

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.1 bits (242), Expect = 7e-22
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 49/214 (22%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF--------HQECARAMKSFEVECEVMKNIR-HRN 532
           IG G    V +      G E A+K+          ++     ++   E  +++ +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMID 580
           ++ +I    +  F  LV + M  G L             F  L            +IM  
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRS 208

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA- 639
           +  A+ +L   H   I+H DLK  N+LLD++M   LSDFG +  L    + +     L  
Sbjct: 209 LLEAVSFL---HANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLR---ELCG 261

Query: 640 TIGYMAPE------YGIERKVSTRSDIYSYGIML 667
           T GY+APE                 D+++ G++L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 98.1 bits (245), Expect = 9e-22
 Identities = 65/320 (20%), Positives = 112/320 (35%), Gaps = 73/320 (22%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
             L +S+  L+ ++P E+     L  + +  NSL         LP       P+++ ++ 
Sbjct: 134 EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-------KLPD----LPPSLEFIAA 180

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             N+        + N   LT +    NS    +P+   +L +I           N L   
Sbjct: 181 GNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV-------AGNNILE-- 228

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
               + NL   L  +Y  N  +   +P +  +L    + D  L  L    P     L   
Sbjct: 229 ELPELQNLP-FLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL----PELPQSLT-- 280

Query: 260 KLDTLSLCGNSFSGSIPS--------------CIDIGNLKVVVEINLSRNNFSGDIPATI 305
            LD      +  S   P+              C    +L+   E+N+S N    ++PA  
Sbjct: 281 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE---ELNVSNNKLI-ELPALP 336

Query: 306 GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF--ILISLEKLLY----- 358
             L   + +   +N L   +PE      +L+ L +  N +  F  I  S+E L       
Sbjct: 337 PRL---ERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLA 389

Query: 359 --------LKKLNLSFNKLE 370
                   LK+L++  N L 
Sbjct: 390 EVPELPQNLKQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 95.8 bits (239), Expect = 4e-21
 Identities = 55/295 (18%), Positives = 100/295 (33%), Gaps = 46/295 (15%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGN------NSLSGSLPSRIDLALPNVK 135
               S NL  E+P E   + S T+    ++    N           ++    D       
Sbjct: 16  PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAH 74

Query: 136 ALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNP 195
            L L     S ++     +   L  L    NS +  +P    +L+++      +      
Sbjct: 75  ELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNL----KA 125

Query: 196 LNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGR 255
           L+ + P         LE L +SN  +   +P++  N S   ++D++ N L   +P     
Sbjct: 126 LSDLPP--------LLEYLGVSNNQLE-KLPEL-QNSSFLKIIDVDNNSLKK-LPDLPPS 174

Query: 256 LQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS 315
           L+      ++   N     +P   ++ NL  +  I    N+    +P     L   ++I 
Sbjct: 175 LE-----FIAAGNNQLE-ELP---ELQNLPFLTAIYADNNSLK-KLPDLPLSL---ESIV 221

Query: 316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
              N LE         L  L  +   NN +        +    L+ LN+  N L 
Sbjct: 222 AGNNILE--ELPELQNLPFLTTIYADNNLLKTL----PDLPPSLEALNVRDNYLT 270

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 88.9 bits (221), Expect = 1e-18
 Identities = 56/321 (17%), Positives = 109/321 (33%), Gaps = 75/321 (23%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
             +   +  L+ E+P E+  LP LT +    NSL         LP        +++++  
Sbjct: 176 EFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-------KLPDL----PLSLESIVA 222

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             N         + N   LT +    N     +P+   +L  +        +  N L  +
Sbjct: 223 GNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALN-------VRDNYLTDL 272

Query: 200 --LPSSIVNLSIS-------------LERLYISNCSITGNIPQVMGNLSIFLLLDLELNK 244
             LP S+  L +S             L  L  S+  I  ++  +  +L     L++  NK
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDLPPSLEE---LNVSNNK 328

Query: 245 LTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPAT 304
           L   +P    RL+      L    N  +  +P      NLK   ++++  N    + P  
Sbjct: 329 LIE-LPALPPRLER-----LIASFNHLA-EVPELP--QNLK---QLHVEYNPLR-EFPDI 375

Query: 305 IGGLKDV----------------QNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF 348
              ++D+                + + +  N L    P+      S+E L +++ ++   
Sbjct: 376 PESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FPDI---PESVEDLRMNSERVVDP 431

Query: 349 ILISLEKLLYLKKLNLSFNKL 369
              + E    L+      +  
Sbjct: 432 YEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 73.1 bits (180), Expect = 1e-13
 Identities = 32/190 (16%), Positives = 57/190 (30%), Gaps = 41/190 (21%)

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
           +P    N+  S    Y +      N P   G      +  L                   
Sbjct: 26  MPVEAENVK-SKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR------------- 71

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYN 319
           +   L L     S S+P      +L+    +  S N+ + ++P     LK +   +    
Sbjct: 72  QAHELELNNLGLS-SLPE--LPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124

Query: 320 RLEGPIPE---------------SFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNL 364
            L    P                     + L+I+D+ NN +        +    L+ +  
Sbjct: 125 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLP----DLPPSLEFIAA 180

Query: 365 SFNKLEGEIP 374
             N+LE E+P
Sbjct: 181 GNNQLE-ELP 189

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 64.2 bits (157), Expect = 6e-11
 Identities = 31/191 (16%), Positives = 63/191 (32%), Gaps = 39/191 (20%)

Query: 199 ILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN 258
           I P ++ N    L+     + ++T  +P    N+          ++     P   G  + 
Sbjct: 3   INPRNVSNTF--LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59

Query: 259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY 318
             +  L  C +                   E+ L+    S  +P     L   +++    
Sbjct: 60  MAVSRLRDCLDR------------QAH---ELELNNLGLS-SLPELPPHL---ESLVASC 100

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFI---------------LISLEKLLYLKKLN 363
           N L   +PE    L SL + + +   +S                  L  L+   +LK ++
Sbjct: 101 NSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIID 159

Query: 364 LSFNKLEGEIP 374
           +  N L+ ++P
Sbjct: 160 VDNNSLK-KLP 169

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 28/177 (15%), Positives = 54/177 (30%), Gaps = 34/177 (19%)

Query: 83  NISSLNLQG-EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
           N+  LN    EI       PSL +L +  N L+        LP+      P ++ L  ++
Sbjct: 298 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-------ELPA----LPPRLERLIASF 346

Query: 142 NRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLI--------- 192
           N  +  +     N   L  L +  N      P+   ++ ++     +  +          
Sbjct: 347 NHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQL 401

Query: 193 ---GNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLT 246
               NPL    P    ++    E L +++  +                   E +   
Sbjct: 402 HVETNPLR-EFPDIPESV----EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 96.6 bits (241), Expect = 1e-21
 Identities = 45/209 (21%), Positives = 87/209 (41%), Gaps = 49/209 (23%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHRNLVKIISG 539
           +G G+F  V +      G+E A K+ +  +  AR  +  E E  + + ++H N+V++   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEY 587
              + F  LV + +  G L             F+ +            + +  +  ++ Y
Sbjct: 97  IQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIAY 143

Query: 588 LNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
               H+  I+H +LK  N+LL    +     L+DFG+A  +  + ++        T GY+
Sbjct: 144 C---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYL 197

Query: 645 APE------YGIERKVSTRSDIYSYGIML 667
           +PE      Y          DI++ G++L
Sbjct: 198 SPEVLKKDPYSKP------VDIWACGVIL 220

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 54/218 (24%), Positives = 83/218 (38%), Gaps = 44/218 (20%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLV 534
              D L G G+   V     L    E A+K+  ++          E E++   + HRN++
Sbjct: 16  LQEDVL-GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVA 582
           ++I     +D   LV E M  GS+                +             ++ DVA
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVA 121

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLS-GEDQSMTQTQTL 638
           SAL++L   H   I H DLK  N+L    ++     + DF +   +    D S   T  L
Sbjct: 122 SALDFL---HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 639 ATI----GYMAPE-----YGIERKVSTRSDIYSYGIML 667
            T      YMAPE              R D++S G++L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 95.7 bits (238), Expect = 2e-21
 Identities = 51/236 (21%), Positives = 82/236 (34%), Gaps = 54/236 (22%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVF-----HQECARAMKSFEVECEVMKNIRHRNLVKI 536
           IG GS+G V  A E       AIK+       Q   + ++  + E  +MK + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 537 ISGCSNDDFKALVLEYMPNGSL------------------DIFLYSSTCMLDIFQRL--- 575
                ++ +  LV+E    G L                   +      C     + +   
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 576 ------------------NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL- 616
                             NIM  + SAL YL   H   I H D+K  N L   +    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYL---HNQGICHRDIKPENFLFSTNKSFEIK 210

Query: 617 -SDFGIAKLLSGEDQSMTQ--TQTLATIGYMAPE--YGIERKVSTRSDIYSYGIML 667
             DFG++K     +       T    T  ++APE           + D +S G++L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 16/196 (8%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVEC-----EVMKNIRHRNLVK 535
           ++G GSF  V  A EL    E AIK+  +         +V       +VM  + H   VK
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDHPFFVK 94

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +     +D+     L Y  NG L  ++       +   R     ++ SALEYL   H   
Sbjct: 95  LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYL---HGKG 150

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKV 654
           IIH DLK  N+LL+EDM   ++DFG AK+LS E +      +   T  Y++PE  +  K 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSPEL-LTEKS 208

Query: 655 STRS-DIYSYGIMLIE 669
           + +S D+++ G ++ +
Sbjct: 209 ACKSSDLWALGCIIYQ 224

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 44/206 (21%), Positives = 84/206 (40%), Gaps = 24/206 (11%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV----ECEVMKNIRH 530
             G   L+G GS+G V +    +     A+K+  ++  R + + E     E ++++ +RH
Sbjct: 8   LMGD--LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 531 RNLVK---IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           +N+++   ++          +V+EY   G  ++          + Q       +   LEY
Sbjct: 66  KNVIQLVDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEY 124

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI----GY 643
           L   H+  I+H D+K  N+LL       +S  G    ++          T  T      +
Sbjct: 125 L---HSQGIVHKDIKPGNLLLTTGGTLKISALG----VAEALHPFAADDTCRTSQGSPAF 177

Query: 644 MAPE--YGIERKVSTRSDIYSYGIML 667
             PE   G++     + DI+S G+ L
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTL 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 41/206 (19%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH-QECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
           +G G+FG V+   E   G+E  IK  +       M+  E E EV+K++ H N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL----------------NIMIDVASA 584
            +     +V+E    G L              +R+                 +M  + +A
Sbjct: 90  EDYHNMYIVMETCEGGEL-------------LERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
           L Y    H+  ++H DLK  N+L           + DFG+A+L    D+    T    T 
Sbjct: 137 LAYF---HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHS--TNAAGTA 190

Query: 642 GYMAPEYGIERKVSTRSDIYSYGIML 667
            YMAPE   +R V+ + DI+S G+++
Sbjct: 191 LYMAPEV-FKRDVTFKCDIWSAGVVM 215

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 49/213 (23%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH--------QECARAMKSFEVECEVMKNIRHRNL 533
           +G G+ G V  A E     +VAIK+             A    + E E E++K + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDV 581
           +KI +    +D+  +VLE M  G L             F ++                 +
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQM 123

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
             A++YL   H   IIH DLK  NVLL   +ED +  ++DFG +K+L GE   M    TL
Sbjct: 124 LLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMR---TL 176

Query: 639 A-TIGYMAPE---YGIERKVSTRSDIYSYGIML 667
             T  Y+APE          +   D +S G++L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.2 bits (237), Expect = 4e-21
 Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 39/209 (18%)

Query: 477 FGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVK 535
             +  ++G G FG V+K  E   G+++A K+      +  +  + E  VM  + H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-------------NIMIDVA 582
           +     + +   LV+EY+  G L             F R+               M  + 
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL-------------FDRIIDESYNLTELDTILFMKQIC 197

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
             + ++   H   I+H DLK  N+L    D   I  + DFG+A+      + +       
Sbjct: 198 EGIRHM---HQMYILHLDLKPENILCVNRDAKQIK-IIDFGLARRY-KPREKL--KVNFG 250

Query: 640 TIGYMAPEYGIERK-VSTRSDIYSYGIML 667
           T  ++APE  +    VS  +D++S G++ 
Sbjct: 251 TPEFLAPEV-VNYDFVSFPTDMWSVGVIA 278

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 58/286 (20%), Positives = 93/286 (32%), Gaps = 31/286 (10%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
           +  L  ++P  I    P+   L L  N  S   +        L  L L  N  S      
Sbjct: 42  DLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKA 97

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF 235
              LR ++ L +      N L  I P    NL  SL  L I +  I      V   L   
Sbjct: 98  FSPLRKLQKLYIS----KNHLVEIPP----NLPSSLVELRIHDNRIRKVPKGVFSGLRNM 149

Query: 236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN 295
             +++  N L        G     KL+ L +     +  IP        + + E++L  N
Sbjct: 150 NCIEMGGNPLE-NSGFEPGAFDGLKLNYLRISEAKLT-GIPK----DLPETLNELHLDHN 203

Query: 296 NFSGDIPA-TIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE 354
                I    +     +  + L +N++      S  +L +L  L L NNK+S  +   L 
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261

Query: 355 KLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQ 400
            L  L+ + L  N +  ++             F          +  
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVN---------DFCPVGFGVKRAYYN 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 59/310 (19%), Positives = 103/310 (33%), Gaps = 44/310 (14%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL--VGNNSLSGSLPSRIDLALPNVKAL 137
             +  S L L+  +P EI   P  T L L  N +  +  +   G         L ++ AL
Sbjct: 36  RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKG---------LQHLYAL 83

Query: 138 SLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL 196
            L  N+ S  I     +   KL  L +  N      PN   +L  +        +  N +
Sbjct: 84  VLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELR-------IHDNRI 135

Query: 197 NGILPSSIVNLSISLERLYISNCSITGNI--PQVMGNLSIFLLLDLELNKLTGPIPVTFG 254
             +       L  ++  + +    +  +   P     L +   L +   KLTG       
Sbjct: 136 RKVPKGVFSGLR-NMNCIEMGGNPLENSGFEPGAFDGLKL-NYLRISEAKLTGIPKDLPE 193

Query: 255 RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA-TIGGLKDVQN 313
            L       L L  N    +I    D+     +  + L  N     I   ++  L  ++ 
Sbjct: 194 TLN-----ELHLDHNKIQ-AIELE-DLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRE 245

Query: 314 ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF------ILISLEKLLYLKKLNLSFN 367
           + L  N+L   +P     L  L+++ L  N I+         +    K  Y   ++L  N
Sbjct: 246 LHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN 304

Query: 368 KLE-GEIPRG 376
            +   E+   
Sbjct: 305 PVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 61/304 (20%), Positives = 97/304 (31%), Gaps = 69/304 (22%)

Query: 83  NISSLNLQG----EIP-HEIGYLPSLTKLALGYNSL--VGNNSLSGSLPSRIDLALPNVK 135
           + + L+LQ     E+   +   L  L  L L  N +  +   + S          L  ++
Sbjct: 55  DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSP---------LRKLQ 105

Query: 136 ALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNP 195
            L ++ N     I   +   S L  L +  N            LRN+  + +     GNP
Sbjct: 106 KLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG----GNP 158

Query: 196 LNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGR 255
           L            + L  L IS   +TG    +   L+    L L+ NK+         R
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE---LHLDHNKIQAIELEDLLR 215

Query: 256 LQNSKLDTLSLCGNSFSGSIPSCIDIG---NLKVVVEINLSRNNFSGDIPATIGGLKDVQ 312
                L  L L  N         I+ G    L  + E++L  N  S  +PA +  LK +Q
Sbjct: 216 YSK--LYRLGLGHNQ-----IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ 267

Query: 313 NISLPYNRLEG--------------------------PI------PESFGYLTSLEILDL 340
            + L  N +                            P+      P +F  +T    +  
Sbjct: 268 VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQF 327

Query: 341 SNNK 344
            N K
Sbjct: 328 GNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 27/90 (30%), Positives = 35/90 (38%), Gaps = 4/90 (4%)

Query: 289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF 348
            +  S       +P  I    D   + L  N +     + F  L  L  L L NNKIS  
Sbjct: 37  VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKI 93

Query: 349 ILISLEKLLYLKKLNLSFNKLEGEIPRGGP 378
              +   L  L+KL +S N L  EIP   P
Sbjct: 94  HEKAFSPLRKLQKLYISKNHLV-EIPPNLP 122

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 56/211 (26%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVM-KNIRHRNLVKIISGC 540
           IG+GS+    +       +E A+K+      ++ +    E E++ +  +H N++ +    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVY 85

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVASALEYL 588
            +  +  +V E M  G L               ++             ++  +   +EYL
Sbjct: 86  DDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 589 NFRHTTPIIHCDLKSSNVLL-----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIG 642
              H   ++H DLK SN+L      + + I  + DFG AK L  E+  +    T   T  
Sbjct: 133 ---HAQGVVHRDLKPSNILYVDESGNPESIR-ICDFGFAKQLRAENGLLM---TPCYTAN 185

Query: 643 YMAPE------YGIERKVSTRSDIYSYGIML 667
           ++APE      Y          DI+S G++L
Sbjct: 186 FVAPEVLERQGYDAA------CDIWSLGVLL 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 52/215 (24%), Positives = 82/215 (38%), Gaps = 53/215 (24%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
                  +G G+   VY+  +       A+KV  +      K    E  V+  + H N++
Sbjct: 56  EVES--ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNII 111

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVA 582
           K+          +LVLE +  G L             F R+            + +  + 
Sbjct: 112 KLKEIFETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQIL 158

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            A+ YL   H   I+H DLK  N+L      D    ++DFG++K++      M    T+ 
Sbjct: 159 EAVAYL---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMK---TVC 211

Query: 640 -TIGYMAPE------YGIERKVSTRSDIYSYGIML 667
            T GY APE      YG E       D++S GI+ 
Sbjct: 212 GTPGYCAPEILRGCAYGPE------VDMWSVGIIT 240

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 63/339 (18%), Positives = 108/339 (31%), Gaps = 48/339 (14%)

Query: 80  TALNISSLNLQGEIPHEI-GYLPSLTKLALGYNSLV------------------GNNSL- 119
             L +        I +     L SL  L L YN  +                     +L 
Sbjct: 57  QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLD 116

Query: 120 SGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIPNTIGN 178
              L       L +++ L L  N       +    N  +  +L+L  N         + N
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLN 176

Query: 179 LRNIEWLGLVIGLIGNPLNGILPSSIVNLSI-------SLERLYISNCSITGNIPQVM-G 230
            +   +  L   L    L  +    +            S+  L +S      ++ +    
Sbjct: 177 FQGKHFTLL--RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234

Query: 231 NLSIFLLLDLEL------------NKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSC 278
            ++   +  L L                 P   TF  L+ S + T  L  +    ++   
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKS 293

Query: 279 IDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLEGPIPESFGYLTSLEI 337
           +   +   + ++ L++N  +  I      GL  +  ++L  N L       F  L  LE+
Sbjct: 294 V-FSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEV 351

Query: 338 LDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG 376
           LDLS N I      S   L  LK+L L  N+L+  +P G
Sbjct: 352 LDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 59/301 (19%), Positives = 100/301 (33%), Gaps = 38/301 (12%)

Query: 101 PSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-TNASKLT 159
             +  + L  NS+         L       L +++ L +        I++      S L 
Sbjct: 30  AHVNYVDLSLNSI-------AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 160 ILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG-ILPSSI-VNLSISLERLYIS 217
           IL+L  N F          L N+E L L        L+G +L  +    L+ SLE L + 
Sbjct: 83  ILKLDYNQFLQLETGAFNGLANLEVLTLT----QCNLDGAVLSGNFFKPLT-SLEMLVLR 137

Query: 218 NCSITGNIPQ-VMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGN------S 270
           + +I    P     N+  F +LDL  NK+           Q      L L          
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197

Query: 271 FSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNI-------------SLP 317
           +      C +      +  ++LS N F   +            I             S  
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257

Query: 318 YNRLEGPIPESFGYL--TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPR 375
           +   + P   +F  L  + ++  DLS +KI   +         L++L L+ N++  +I  
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDD 316

Query: 376 G 376
            
Sbjct: 317 N 317

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 67.1 bits (164), Expect = 9e-12
 Identities = 46/257 (17%), Positives = 90/257 (35%), Gaps = 17/257 (6%)

Query: 100 LPSLTKLALGYNSL--VGNNSLSG-SLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS 156
           +     L L +N +  +    L          L L ++    +                +
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212

Query: 157 KLTILELGGNSFSGFIPNTIGNLRNIEWL-GLVIGLIGNPLNGILPSSIVNLS------- 208
            +T L+L GN F   +     +      +  L++    N  +    ++  +         
Sbjct: 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGL 272

Query: 209 --ISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSL 266
               ++   +S   I   +  V  + +    L L  N++       F  L +  L  L+L
Sbjct: 273 EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH--LLKLNL 330

Query: 267 CGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIP 326
             N    SI S +   NL  +  ++LS N+       +  GL +++ ++L  N+L+    
Sbjct: 331 SQNFLG-SIDSRM-FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPD 388

Query: 327 ESFGYLTSLEILDLSNN 343
             F  LTSL+ + L  N
Sbjct: 389 GIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 37/177 (20%), Positives = 63/177 (35%), Gaps = 16/177 (9%)

Query: 202 SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPV-TFGRLQNSK 260
             +  L   +  + +S  SI          L     L +E       I   TF  L  S 
Sbjct: 23  HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL--SS 80

Query: 261 LDTLSLCGNSFSGSIPSCI--DIGNLKVVVEINLSRNNF-SGDIPATI-GGLKDVQNISL 316
           L  L L  N F   + +     + NL+    + L++ N     +       L  ++ + L
Sbjct: 81  LIILKLDYNQFL-QLETGAFNGLANLE---VLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136

Query: 317 PYNRLEGPIPES-FGYLTSLEILDLSNNKISGF---ILISLEKLLYLKKLNLSFNKL 369
             N ++   P S F  +    +LDL+ NK+       L++ +   +   L LS   L
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG-KHFTLLRLSSITL 192

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.4 bits (139), Expect = 1e-08
 Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 1/98 (1%)

Query: 287 VVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPE-SFGYLTSLEILDLSNNKI 345
           V  ++LS N+ +     +   L+D+Q + +        I   +F  L+SL IL L  N+ 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 346 SGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFT 383
                 +   L  L+ L L+   L+G +  G  F   T
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT 129

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 51/224 (22%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV-------------------- 520
            IG GS+G V  A   +D    A+KV  ++       F                      
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 521 ------ECEVMKNIRHRNLVKIIS--GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-- 570
                 E  ++K + H N+VK++      N+D   +V E +  G +      +   L   
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLKPLSED 137

Query: 571 ----IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
                FQ      D+   +EYL   H   IIH D+K SN+L+ ED    ++DFG++    
Sbjct: 138 QARFYFQ------DLIKGIEYL---HYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 627 GEDQSMTQTQTLATIGYMAPE--YGIERKVS-TRSDIYSYGIML 667
           G D ++    T+ T  +MAPE      +  S    D+++ G+ L
Sbjct: 189 GSD-ALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 90.7 bits (225), Expect = 5e-20
 Identities = 47/291 (16%), Positives = 88/291 (30%), Gaps = 35/291 (12%)

Query: 87  LNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRI--DLALPNVKALSLAYNRF 144
           L           +   +  L+L   ++     +   +       L +  ++ L+L     
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTV-RAARIPSRILFGALRVLGISGLQELTLENLEV 107

Query: 145 SGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSI 204
           +GT   P+  A+   +  L              NLRN+ W            +  L    
Sbjct: 108 TGTAPPPLLEATGPDLNIL--------------NLRNVSWATR---------DAWLAELQ 144

Query: 205 VNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPV--TFGRLQNSKLD 262
             L   L+ L I+         + +        LDL  N   G   +      L+   L 
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 263 TLSLCGNSF-SGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNR 320
            L+L      + S            +  ++LS N+      A        + +++L +  
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 321 LEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG 371
           L+            L +LDLS N++         +L  +  L+L  N    
Sbjct: 265 LKQVPKGLP---AKLSVLDLSYNRLDRNPSPD--ELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.2 bits (195), Expect = 4e-16
 Identities = 48/237 (20%), Positives = 82/237 (34%), Gaps = 42/237 (17%)

Query: 177 GNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGN-IPQVMGNLSIF 235
           G  R++E+L   +    +             S+SL+RL +    I    +   +  L I 
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIK----SLSLKRLTVRAARIPSRILFGALRVLGIS 95

Query: 236 LLLDLEL--NKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIP----------------- 276
            L +L L   ++TG  P          L+ L+L   S++                     
Sbjct: 96  GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155

Query: 277 ---------SCIDIGNLKVVVEINLSRNNFSGDIPATI----GGLKDVQNISLPYNRLE- 322
                    SC  +     +  ++LS N   G+              +Q ++L    +E 
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215

Query: 323 --GPIPESFGYLTSLEILDLSNNKISGFI-LISLEKLLYLKKLNLSFNKLEGEIPRG 376
             G           L+ LDLS+N +       S +    L  LNLSF  L+ ++P+G
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 34/194 (17%), Positives = 59/194 (30%), Gaps = 19/194 (9%)

Query: 60  SNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSL 119
           S  +   W+          +  L+I+  +       ++   P+L+ L L  N  +G   L
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191

Query: 120 SGSLPSRIDLALPNVKALSLAYNRF---SGTIQSPITNASKLTILELGGNSFSGFIPNTI 176
             +L        P ++ L+L        SG   +      +L  L+L  NS         
Sbjct: 192 ISALCPL---KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

Query: 177 -GNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGN-IPQVMGNLSI 234
                 +  L L        L  +       L   L  L +S   +  N  P  +  +  
Sbjct: 249 CDWPSQLNSLNLS----FTGLKQVPK----GLPAKLSVLDLSYNRLDRNPSPDELPQVGN 300

Query: 235 FLLLDLELNKLTGP 248
              L L+ N     
Sbjct: 301 ---LSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 26/164 (15%), Positives = 54/164 (32%), Gaps = 9/164 (5%)

Query: 218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSG-SIP 276
           NC    ++    G  S+  LL     +           +++  L  L++         + 
Sbjct: 29  NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDI--IKSLSLKRLTVRAARIPSRILF 86

Query: 277 SCIDIGNLKVVVEINLSRNNFSGDIPATIGGL--KDVQNISLPYNRLEGP---IPESFGY 331
             + +  +  + E+ L     +G  P  +      D+  ++L           + E   +
Sbjct: 87  GALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQW 146

Query: 332 L-TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP 374
           L   L++L ++      F    +     L  L+LS N   GE  
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 90.7 bits (225), Expect = 7e-20
 Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 15/177 (8%)

Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFL--YSSTCMLD 570
             M +  V+   M     +N V  +   S   +  + ++     +L  ++    S    +
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162

Query: 571 IFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ 630
               L+I I +A A+E+L   H+  ++H DLK SN+    D +  + DFG+   +  +++
Sbjct: 163 HGVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219

Query: 631 SMTQTQTLA----------TIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPA 677
             T    +           T  YM+PE       S + DI+S G++L E        
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 91.3 bits (227), Expect = 8e-20
 Identities = 42/201 (20%), Positives = 80/201 (39%), Gaps = 35/201 (17%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG V++  E   G     K  +        + + E  +M  + H  L+ +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-------------NIMIDVASALEYL 588
           +     L+LE++  G             ++F R+             N M      L+++
Sbjct: 119 DKYEMVLILEFLSGG-------------ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHL--SDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
              H   I+H D+K  N++ +    + +   DFG+A  L   D+ +    T AT  + AP
Sbjct: 166 ---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIV--KVTTATAEFAAP 219

Query: 647 EYGIERKVSTRSDIYSYGIML 667
           E      V   +D+++ G++ 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 49/309 (15%), Positives = 98/309 (31%), Gaps = 41/309 (13%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL--VGNNSLSGSLPSRIDLALPNVKAL 137
             +  S L L+ ++P ++   P    L L  N +  + +              L N+  L
Sbjct: 34  RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKN---------LKNLHTL 81

Query: 138 SLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL 196
            L  N+ S  I         KL  L L  N            L+ +        +  N +
Sbjct: 82  ILINNKIS-KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELR-------VHENEI 133

Query: 197 NGILPSSIVNLSISLERLYISNCSITGNI--PQVMGNLSIFLLLDLELNKLTGPIPVTFG 254
             +  S    L+  +  + +    +  +         +     + +    +T        
Sbjct: 134 TKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP 192

Query: 255 RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNI 314
            L       L L GN  +  + +   +  L  + ++ LS N+ S     ++     ++ +
Sbjct: 193 SLT-----ELHLDGNKIT-KVDAA-SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245

Query: 315 SLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF------ILISLEKLLYLKKLNLSFNK 368
            L  N+L   +P        ++++ L NN IS              K      ++L  N 
Sbjct: 246 HLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP 304

Query: 369 LE-GEIPRG 376
           ++  EI   
Sbjct: 305 VQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 54/290 (18%), Positives = 100/290 (34%), Gaps = 36/290 (12%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
           +  L   +P  +    P+   L L  N+ +        N   L  L L  N  S   P  
Sbjct: 40  DLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQ-VMGNLSI 234
              L  +E L     L  N L  +       +  +L+ L +    IT  + + V   L+ 
Sbjct: 96  FAPLVKLERL----YLSKNQLKELPE----KMPKTLQELRVHENEIT-KVRKSVFNGLNQ 146

Query: 235 FLLLDLELNKLT-GPIPV-TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINL 292
            ++++L  N L    I    F  ++   L  + +   + + +IP     G    + E++L
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKK--LSYIRIADTNIT-TIPQ----GLPPSLTELHL 199

Query: 293 SRNNFSGDIPA-TIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILI 351
             N  +  + A ++ GL ++  + L +N +      S      L  L L+NNK+   +  
Sbjct: 200 DGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257

Query: 352 SLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQV 401
            L    Y++ + L  N +              +  F              
Sbjct: 258 GLADHKYIQVVYLHNNNIS----------AIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 60/302 (19%), Positives = 111/302 (36%), Gaps = 40/302 (13%)

Query: 83  NISSLNLQG----EIP-HEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL 137
           + + L+LQ     EI   +   L +L  L L  N +         +       L  ++ L
Sbjct: 53  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-------KISPGAFAPLVKLERL 105

Query: 138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN 197
            L+ N+    +   +     L  L +  N  +    +    L  +  + L      NPL 
Sbjct: 106 YLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELG----TNPLK 158

Query: 198 --GILPSSIVNLSISLERLYISNCSITGNIPQ-VMGNLSIFLLLDLELNKLTGPIPVTFG 254
             GI   +   +   L  + I++ +IT  IPQ +  +L+    L L+ NK+T     +  
Sbjct: 159 SSGIENGAFQGMK-KLSYIRIADTNIT-TIPQGLPPSLTE---LHLDGNKITKVDAASLK 213

Query: 255 RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNI 314
            L N  L  L L  NS S ++ +   + N   + E++L+ N     +P  +   K +Q +
Sbjct: 214 GLNN--LAKLGLSFNSIS-AVDNGS-LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 268

Query: 315 SLPYNRLEG------PIPESFGYLTSLEILDLSNNKISGFIL--ISLEKLLYLKKLNLSF 366
            L  N +          P       S   + L +N +  + +   +   +     + L  
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328

Query: 367 NK 368
            K
Sbjct: 329 YK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 4/89 (4%)

Query: 290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFI 349
           +  S       +P  +    D   + L  N++       F  L +L  L L NNKIS   
Sbjct: 36  VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 92

Query: 350 LISLEKLLYLKKLNLSFNKLEGEIPRGGP 378
             +   L+ L++L LS N+L+ E+P   P
Sbjct: 93  PGAFAPLVKLERLYLSKNQLK-ELPEKMP 120

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 30/202 (14%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQE--------CARAMKSFEVECEVMKNIRHRNL 533
           +G G+FG+V+ A   +   EV +K   +E            +    +E  ++  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN------IMIDVASALEY 587
           +K++    N  F  LV+E   +G LD+F +     +D   RL+      I   + SA+ Y
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAF-----IDRHPRLDEPLASYIFRQLVSAVGY 145

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           L       IIH D+K  N+++ ED    L DFG A  L  E   +  T    TI Y APE
Sbjct: 146 L---RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAPE 199

Query: 648 YGIERK--VSTRSDIYSYGIML 667
             +          +++S G+ L
Sbjct: 200 V-LMGNPYRGPELEMWSLGVTL 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 46/208 (22%), Positives = 74/208 (35%), Gaps = 42/208 (20%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH------QECARAMKSFEVECEVMKNIRHRNLVK 535
           +G G F  V K  +   G E A K              + +  E E  +++ IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVAS 583
           +     N     L+LE +  G L             F  L              +  +  
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEATQFLKQILD 119

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            + YL   H+  I H DLK  N++L      +    L DFGIA  +              
Sbjct: 120 GVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFG 173

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIML 667
           T  ++APE      +   +D++S G++ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 35/261 (13%), Positives = 68/261 (26%), Gaps = 58/261 (22%)

Query: 478 GR---DNLIGIGSFGYVYKAE---LDDGIEVAIKVFHQECARAMKS---FEVECEVMKNI 528
           GR       G       ++A    LD   +VA+     +                 +  I
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
               + +++          +V E++  GSL     +S         +  M  +A+A +  
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA 145

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H   +       S V +  D        G                 LA    M    
Sbjct: 146 ---HRAGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD-- 178

Query: 649 GIERKVSTRSDIYSYGIMLIETFTRKKP---ADKMFAAELSLKH---------WVNGLLP 696
                 + + DI   G  L      + P   A        + +           ++  +P
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233

Query: 697 VSLMEVVNKTLLSPPEKDFAA 717
             +  V  +++        A+
Sbjct: 234 FQISAVAARSVQGDGGIRSAS 254

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 91.1 bits (226), Expect = 3e-19
 Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 37/202 (18%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G+FG V++  E   G   A K          ++   E + M  +RH  LV +     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-------------NIMIDVASALEYL 588
           +D+   ++ E+M  G L             F+++               M  V   L ++
Sbjct: 225 DDNEMVMIYEFMSGGEL-------------FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 589 NFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
              H    +H DLK  N++      + +  L DFG+   L    QS+    T  T  + A
Sbjct: 272 ---HENNYVHLDLKPENIMFTTKRSNELK-LIDFGLTAHLD-PKQSV--KVTTGTAEFAA 324

Query: 646 PEYGIERKVSTRSDIYSYGIML 667
           PE    + V   +D++S G++ 
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLS 346

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 89.3 bits (222), Expect = 4e-19
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)

Query: 482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE---VECEVMKNIRHRNLVKII 537
            IG GSFG V   +  D     A+K  +++             E ++M+ + H  LV + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII 597
               +++   +V++ +  G L   L  +    +   +L I  ++  AL+YL       II
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYL---QNQRII 137

Query: 598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVS- 655
           H D+K  N+LLDE    H++DF IA +L  E    TQ  T+A T  YMAPE     +   
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMAPEM-FSSRKGA 192

Query: 656 --TRS-DIYSYGIMLIETFTRKKP 676
             + + D +S G+   E    ++P
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRP 216

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 45/208 (21%), Positives = 75/208 (36%), Gaps = 42/208 (20%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH------QECARAMKSFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G+E A K              + +  E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVAS 583
           +     N     L+LE +  G L             F  L            + +  +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            + YL   HT  I H DLK  N++L           L DFG+A  +  +           
Sbjct: 127 GVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFG 180

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIML 667
           T  ++APE      +   +D++S G++ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 45/208 (21%), Positives = 74/208 (35%), Gaps = 42/208 (20%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH------QECARAMKSFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G+E A K                +  E E  +++ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVAS 583
           +     N     L+LE +  G L             F  L            + +  +  
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEEEATSFIKQILD 126

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            + YL   HT  I H DLK  N++L           L DFG+A  +  +           
Sbjct: 127 GVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFG 180

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIML 667
           T  ++APE      +   +D++S G++ 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.8 bits (216), Expect = 7e-19
 Identities = 47/211 (22%), Positives = 95/211 (45%), Gaps = 20/211 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR------AMKSFEVECEVMKN 527
            ++ +   IG G++G V+KA   +    VA+K    +         A++    E  ++K 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           ++H+N+V++     +D    LV E+     L  +  S    LD     + +  +   L +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
               H+  ++H DLK  N+L++ +    L++FG+A+      +    +  + T+ Y  P+
Sbjct: 117 C---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPD 171

Query: 648 --YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
             +G  +  ST  D++S G +  E     +P
Sbjct: 172 VLFG-AKLYSTSIDMWSAGCIFAELANAGRP 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 40/201 (19%), Positives = 76/201 (37%), Gaps = 36/201 (17%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS 541
           +G G FG V++  E         K    +        + E  ++   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL-------------NIMIDVASALEYL 588
           + +   ++ E++                DIF+R+             + +  V  AL++L
Sbjct: 72  SMEELVMIFEFISGL-------------DIFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 589 NFRHTTPIIHCDLKSSNVLL--DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
              H+  I H D++  N++          + +FG A+ L     +           Y AP
Sbjct: 119 ---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF--RLLFTAPEYYAP 172

Query: 647 EYGIERKVSTRSDIYSYGIML 667
           E      VST +D++S G ++
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 44/208 (21%), Positives = 75/208 (36%), Gaps = 42/208 (20%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFH------QECARAMKSFEVECEVMKNIRHRNLVK 535
           +G G F  V K  E   G++ A K              + +  E E  ++K I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL------------NIMIDVAS 583
           +     N     L+LE +  G L             F  L              +  + +
Sbjct: 79  LHEVYENKTDVILILELVAGGEL-------------FDFLAEKESLTEEEATEFLKQILN 125

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            + YL   H+  I H DLK  N++L           + DFG+A  +              
Sbjct: 126 GVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEF--KNIFG 179

Query: 640 TIGYMAPEYGIERKVSTRSDIYSYGIML 667
           T  ++APE      +   +D++S G++ 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 27/220 (12%)

Query: 469 DLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECE---- 523
           D+     R+ + + +G G F  VYKA + +    VAIK         +       +    
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK------LGHRSEAKDGINR 57

Query: 524 -------VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLN 576
                  +++ + H N++ ++    +    +LV ++M    L++ +  ++ +L       
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKA 116

Query: 577 IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQ 636
            M+     LEYL   H   I+H DLK +N+LLDE+ +  L+DFG+AK     +++   T 
Sbjct: 117 YMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--TH 171

Query: 637 TLATIGYMAPE--YGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T  Y APE  +G  R      D+++ G +L E   R 
Sbjct: 172 QVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRV 210

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 87.9 bits (218), Expect = 3e-18
 Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 27/231 (11%)

Query: 455 ILLSQATKRRLPYQDLSRATNRFGRDN-----LIGIGSFGYVYKAELDDGIEV-AIKVFH 508
            L S    R L ++ L       G D      ++G G FG V+  ++    ++ A K  +
Sbjct: 162 FLDSLYFLRFLQWKWLEA--QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN 219

Query: 509 QECARAMKSFEVEC-----EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY 563
           ++  R  K    +      +++  +  R +V +           LV+  M  G +   +Y
Sbjct: 220 KK--RLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277

Query: 564 SSTCMLDIF--QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFG 620
           +       F   R       + S LE+L   H   II+ DLK  NVLLD+D    +SD G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNVRISDLG 334

Query: 621 IAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
           +A  L       T+T+  A T G+MAPE  +  +    S D ++ G+ L E
Sbjct: 335 LAVELKAGQ---TKTKGYAGTPGFMAPEL-LLGEEYDFSVDYFALGVTLYE 381

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.9 bits (211), Expect = 4e-18
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 19/212 (8%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR------AMKSFEVECEV 524
                ++ +   +G G++G VYKA+   G  VA+K    +         A++    E  +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
           +K + H N+V +I    ++    LV E+M    L   L  +   L   Q    +  +   
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRG 131

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           + +    H   I+H DLK  N+L++ D    L+DFG+A+      +S   T  + T+ Y 
Sbjct: 132 VAHC---HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYR 186

Query: 645 APE--YGIERKVSTRSDIYSYGIMLIETFTRK 674
           AP+   G  +K ST  DI+S G +  E  T K
Sbjct: 187 APDVLMG-SKKYSTSVDIWSIGCIFAEMITGK 217

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 47/214 (21%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEV---MKNIRHR 531
           +  +  L G+G  G V +      G + A+K+ +        S +   EV    +     
Sbjct: 31  QLSKQVL-GLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGP 82

Query: 532 NLVKII----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLN---------- 576
           ++V I+    +         +++E M  G L             I +R +          
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAE 132

Query: 577 IMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMT 633
           IM D+ +A+++L   H+  I H D+K  N+L    ++D +  L+DFG AK       ++ 
Sbjct: 133 IMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQ 187

Query: 634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIML 667
                 T  Y+APE     K     D++S G+++
Sbjct: 188 TP--CYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 85.3 bits (211), Expect = 5e-18
 Identities = 54/256 (21%), Positives = 93/256 (36%), Gaps = 21/256 (8%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIP-N 174
            + ++  +PS +     N   L     +     +   +    L  +E+  N     I  +
Sbjct: 18  ESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73

Query: 175 TIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVM--GNL 232
              NL  +  + +      N L  I P +  NL  +L+ L ISN  I  ++P V    +L
Sbjct: 74  VFSNLPKLHEIRI---EKANNLLYINPEAFQNLP-NLQYLLISNTGIK-HLPDVHKIHSL 128

Query: 233 SIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINL 292
              LL   +   +      +F  L   +   L L  N     I +     N   + E+NL
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSF-ESVILWLNKNGIQ-EIHN--SAFNGTQLDELNL 184

Query: 293 SRNNFSGDIPATI-GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILI 351
           S NN   ++P  +  G      + +   R+          L  L      N K     L 
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK----KLP 240

Query: 352 SLEKLLYLKKLNLSFN 367
           +LEKL+ L + +L++ 
Sbjct: 241 TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 45/235 (19%), Positives = 75/235 (31%), Gaps = 21/235 (8%)

Query: 172 IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP----Q 227
           IP+ +   RN   L  V       L  I   +       LE++ IS   +   I      
Sbjct: 24  IPSDL--PRNAIELRFV----LTKLRVIQKGAFSGFG-DLEKIEISQNDVLEVIEADVFS 76

Query: 228 VMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVV 287
            +  L    +     N L    P  F  L N  L  L +        +P    I +L+ V
Sbjct: 77  NLPKLHEIRIEKA--NNLLYINPEAFQNLPN--LQYLLISNTGIK-HLPDVHKIHSLQKV 131

Query: 288 VEINLSRNNFSGDIPA-TIGGL-KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKI 345
           + +++  N     I   +  GL  +   + L  N ++     +F      E+    NN +
Sbjct: 132 L-LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNL 190

Query: 346 SGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQ 400
                           L++S  ++   +P  G   N           L  LP L+
Sbjct: 191 EELPNDVFHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARSTYNLKKLPTLE 243

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 40/197 (20%), Positives = 57/197 (28%), Gaps = 18/197 (9%)

Query: 75  NSHRVTALNISSLNLQGEIPHEI-GYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPN 133
           N  ++  + I   N    I  E    LP+L  L +    +         LP    +    
Sbjct: 77  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-------HLPDVHKIHSLQ 129

Query: 134 VKALSLAYNRFSGTIQS-PITN-ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGL 191
              L +  N    TI+       + +  IL L  N     I N+  N   ++ L L    
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNL---S 185

Query: 192 IGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG-PIP 250
             N L  +        S     L IS   I       + NL    L       L   P  
Sbjct: 186 DNNNLEELPNDVFHGAS-GPVILDISRTRIHSLPSYGLENLK--KLRARSTYNLKKLPTL 242

Query: 251 VTFGRLQNSKLDTLSLC 267
                L  + L   S C
Sbjct: 243 EKLVALMEASLTYPSHC 259

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 44/251 (17%), Positives = 81/251 (32%), Gaps = 51/251 (20%)

Query: 439 YKSTRRGKSTGLSNGGILLSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELD 497
           +          L    +           Y   S+          +G G F  V +     
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSK---------ELGRGKFAVVRQCISKS 52

Query: 498 DGIEVAIKVFH--QECARAMKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVLEYMP 554
            G E A K     +           E  V++  +    ++ +     N     L+LEY  
Sbjct: 53  TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112

Query: 555 NGSLDIFLYSSTCMLDIFQRL--------------NIMIDVASALEYLNFRHTTPIIHCD 600
            G +             F                  ++  +   + YL   H   I+H D
Sbjct: 113 GGEI-------------FSLCLPELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLD 156

Query: 601 LKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK-VST 656
           LK  N+LL          + DFG+++ + G    +   + + T  Y+APE  +    ++T
Sbjct: 157 LKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACEL--REIMGTPEYLAPEI-LNYDPITT 212

Query: 657 RSDIYSYGIML 667
            +D+++ GI+ 
Sbjct: 213 ATDMWNIGIIA 223

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 86.0 bits (213), Expect = 7e-18
 Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 11/219 (5%)

Query: 158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
              L L  N+      +T  +L ++E L L      N +  I   +   L+ SL  L + 
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLG----RNSIRQIEVGAFNGLA-SLNTLELF 131

Query: 218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPS 277
           +  +T         LS    L L  N +       F R+ +  L  L L        I  
Sbjct: 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPS--LMRLDLGELKKLEYISE 189

Query: 278 CIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEI 337
                 L  +  +NL   N   D+P  +  L  ++ + +  N      P SF  L+SL+ 
Sbjct: 190 GA-FEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK 246

Query: 338 LDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG 376
           L + N+++S     + + L  L +LNL+ N L   +P  
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHD 284

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 55/278 (19%), Positives = 95/278 (34%), Gaps = 33/278 (11%)

Query: 71  TCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLA 130
           +C     +V     +   L  E+P  I    +   L L  N++         + +     
Sbjct: 51  SCSNQFSKV---VCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-------MIQADTFRH 97

Query: 131 LPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVI 189
           L +++ L L  N     I+       + L  LEL  N  +         L  +  L L  
Sbjct: 98  LHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR- 155

Query: 190 GLIGNPLNGILPSSIVNLSISLERLYISNC----SITGNIPQVMGNLSIFLLLDLELNKL 245
               NP+  I   +   +  SL RL +        I+    + + NL     L+L +  +
Sbjct: 156 ---NNPIESIPSYAFNRVP-SLMRLDLGELKKLEYISEGAFEGLFNLKY---LNLGMCNI 208

Query: 246 TGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI 305
              +P     L    L+ L + GN F   I        L  + ++ +  +  S       
Sbjct: 209 KD-MP-NLTPLVG--LEELEMSGNHFP-EIRPG-SFHGLSSLKKLWVMNSQVSLIERNAF 262

Query: 306 GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNN 343
            GL  +  ++L +N L     + F  L  L  L L +N
Sbjct: 263 DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 4/87 (4%)

Query: 290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFI 349
           +  +R   S ++P  I    + + ++L  N ++    ++F +L  LE+L L  N I    
Sbjct: 59  VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115

Query: 350 LISLEKLLYLKKLNLSFNKLEGEIPRG 376
           + +   L  L  L L  N L   IP G
Sbjct: 116 VGAFNGLASLNTLELFDNWLT-VIPSG 141

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 84.3 bits (209), Expect = 7e-18
 Identities = 67/295 (22%), Positives = 103/295 (34%), Gaps = 49/295 (16%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
           T +  +S  L   +P  I    S T+L L  N L        SLP  +   L  +  LSL
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-------SLPHGVFDKLTQLTKLSL 59

Query: 140 AYNRFSGTIQSPITNA--SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN 197
           + N  S       ++   + L  L+L  N     + +    L  +E L        + L 
Sbjct: 60  SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQ----HSNLK 114

Query: 198 GILPSSI-VNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNK-LTGPIPVTFGR 255
            +   S+ ++L  +L  L IS+         +   LS   +L +  N      +P  F  
Sbjct: 115 QMSEFSVFLSLR-NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173

Query: 256 LQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS 315
           L+N  L  L L        +       +L  +  +N+S NNF                 S
Sbjct: 174 LRN--LTFLDLSQCQLE-QLSPTA-FNSLSSLQVLNMSHNNFF----------------S 213

Query: 316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLY-LKKLNLSFNKL 369
           L            +  L SL++LD S N I       L+     L  LNL+ N  
Sbjct: 214 LD--------TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 53/265 (20%), Positives = 99/265 (37%), Gaps = 43/265 (16%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGN--SFSGFIP 173
           +  L+ S+P+ I     +   L L  N+            ++LT L L  N  SF G   
Sbjct: 16  SKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71

Query: 174 NTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQ--VMGN 231
            +     ++++L L      N +   + S+ + L   LE L   + ++   + +  V  +
Sbjct: 72  QSDFGTTSLKYLDLS----FNGVI-TMSSNFLGLE-QLEHLDFQHSNLK-QMSEFSVFLS 124

Query: 232 LSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEIN 291
           L   + LD+            F  L +  L+ L + GNSF  +                 
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSS--LEVLKMAGNSFQENFL--------------- 167

Query: 292 LSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILI 351
                     P     L+++  + L   +LE   P +F  L+SL++L++S+N        
Sbjct: 168 ----------PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217

Query: 352 SLEKLLYLKKLNLSFNKLEGEIPRG 376
             + L  L+ L+ S N +     + 
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQ 241

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 41/205 (20%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKII--- 537
           +G+G  G V +        + A+K+  Q+C +A +    E E+     +  ++V+I+   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML-QDCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 538 -SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-IFQRLN----------IMIDVASAL 585
            +  +      +V+E +  G L             I  R +          IM  +  A+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 586 EYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
           +YL   H+  I H D+K  N+L      + I  L+DFG AK  +  +   T      T  
Sbjct: 175 QYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPY 228

Query: 643 YMAPEYGIERKVSTRSDIYSYGIML 667
           Y+APE     K     D++S G+++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 21/201 (10%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNL 533
              +   +G G++G V  A        VA+K+   + A       + E  + K + H N+
Sbjct: 10  DLVQ--TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-----LDIFQRLNIMIDVASALEYL 588
           VK        + + L LEY   G L   +     M        F +L       + + YL
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY 648
              H   I H D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE 
Sbjct: 122 ---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 649 GIERK--VSTRSDIYSYGIML 667
            ++R+   +   D++S GI+L
Sbjct: 179 -LKRREFHAEPVDVWSCGIVL 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR------AMKSFEVECE 523
            ++  ++    L+G GS+G V K    D G  VAIK F +          AM+    E +
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIK 76

Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
           ++K +RH NLV ++  C       LV E++ + ++   L      LD       +  + +
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
            + +    H+  IIH D+K  N+L+ +  +  L DFG A+ L+   +       +AT  Y
Sbjct: 136 GIGFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWY 190

Query: 644 MAPE--YGIERKVSTRSDIYSYGIMLIETFTRK 674
            APE   G + K     D+++ G ++ E F  +
Sbjct: 191 RAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGE 222

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.3 bits (209), Expect = 2e-17
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEV-ECEV 524
             +   +    +    +IG GSFG V++A+L +  EVAIK   Q+     K F+  E ++
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQI 85

Query: 525 MKNIRHRNLVK----IISGCSNDDFKA--LVLEYMP---NGSLDIFLYSSTCMLDIFQRL 575
           M+ ++H N+V       S     D     LVLEY+P     +   +      M  +  +L
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 576 NIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQSMTQ 634
             M  +  +L Y+   H+  I H D+K  N+LLD    +  L DFG AK+L    +    
Sbjct: 146 -YMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPN-- 198

Query: 635 TQTLATIGYMAPE-------YGIERKVSTRSDIYSYGIMLIETFTRK 674
              + +  Y APE       Y      +T  DI+S G ++ E    +
Sbjct: 199 VSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 38/204 (18%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRHRNLVKII 537
            +G+G+FG V   E    G +VA+K+ +++  R++        E + +K  RH +++K+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SALEYLN 589
              S      +V+EY+  G L  F Y       I +   +    A        SA++Y  
Sbjct: 78  QVISTPTDFFMVMEYVSGGEL--FDY-------ICKHGRVEEMEARRLFQQILSAVDYC- 127

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI----GYMA 645
             H   ++H DLK  NVLLD  M A ++DFG++ +       M+  + L T      Y A
Sbjct: 128 --HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAA 178

Query: 646 PEYGIERK--VSTRSDIYSYGIML 667
           PE  I  +       DI+S G++L
Sbjct: 179 PEV-ISGRLYAGPEVDIWSCGVIL 201

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 19/208 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECAR------AMKSFEVECEVMKNI 528
            ++     IG G++G VYKA+ + G   A+K    E          ++    E  ++K +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
           +H N+VK+           LV E++    L   L      L+     + ++ + + + Y 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE- 647
              H   ++H DLK  N+L++ +    ++DFG+A+      +    T  + T+ Y AP+ 
Sbjct: 117 ---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDV 171

Query: 648 -YGIERKVSTRSDIYSYGIMLIETFTRK 674
             G  +K ST  DI+S G +  E     
Sbjct: 172 LMG-SKKYSTTIDIWSVGCIFAEMVNGT 198

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 11/219 (5%)

Query: 158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
             +L L  N       N+  +LR++E L L      N +  I   +   L+ +L  L + 
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLS----RNHIRTIEIGAFNGLA-NLNTLELF 120

Query: 218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPS 277
           +  +T         LS    L L  N +       F R+ +  L  L L        I  
Sbjct: 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPS--LRRLDLGELKRLSYISE 178

Query: 278 CIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEI 337
                 L  +  +NL+  N   +IP  +  L  +  + L  N L    P SF  L  L+ 
Sbjct: 179 GA-FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK 235

Query: 338 LDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG 376
           L +  ++I      + + L  L ++NL+ N L   +P  
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD 273

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 60/278 (21%), Positives = 99/278 (35%), Gaps = 33/278 (11%)

Query: 71  TCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLA 130
           +C     +V        NL+ E+P  I    +   L L  N +         +       
Sbjct: 40  SCSNQFSKV---ICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-------IIKVNSFKH 86

Query: 131 LPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVI 189
           L +++ L L+ N    TI+       + L  LEL  N  +         L  ++ L L  
Sbjct: 87  LRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR- 144

Query: 190 GLIGNPLNGILPSSIVNLSISLERLYISNC----SITGNIPQVMGNLSIFLLLDLELNKL 245
               NP+  I   +   +  SL RL +        I+    + + NL     L+L +  L
Sbjct: 145 ---NNPIESIPSYAFNRIP-SLRRLDLGELKRLSYISEGAFEGLSNLRY---LNLAMCNL 197

Query: 246 TGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI 305
              IP     L    LD L L GN  S +I        L  + ++ + ++          
Sbjct: 198 RE-IP-NLTPLIK--LDELDLSGNHLS-AIRPGS-FQGLMHLQKLWMIQSQIQVIERNAF 251

Query: 306 GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNN 343
             L+ +  I+L +N L     + F  L  LE + L +N
Sbjct: 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 52/322 (16%), Positives = 107/322 (33%), Gaps = 64/322 (19%)

Query: 78  RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL----VGNNS------LSGSLPSRI 127
            +T+L+  + ++  ++   I  L  LTKL    N++    +  N+         +  + +
Sbjct: 43  TLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTNL 100

Query: 128 DLA-LPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLG 186
           D+  L  +  L+   N+ +   +  ++    LT L    N+ +      + +   +  L 
Sbjct: 101 DVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELD 154

Query: 187 LVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLT 246
                    LN  +    V     L  L  S   IT  +   +    +   L+ + N +T
Sbjct: 155 CH-------LNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT 204

Query: 247 GPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIG 306
             + +     QN +L  L    N  +      ID+  L  +   + S N  + ++   + 
Sbjct: 205 K-LDLN----QNIQLTFLDCSSNKLT-----EIDVTPLTQLTYFDCSVNPLT-ELD--VS 251

Query: 307 GLKDVQNISLPYNRLE-------------------GPIPESFGYLTSLEILDLSNNKISG 347
            L  +  +      L                            + T L +LD     I+ 
Sbjct: 252 TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITE 311

Query: 348 FILISLEKLLYLKKLNLSFNKL 369
              + L +   L  L L+  +L
Sbjct: 312 ---LDLSQNPKLVYLYLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 80.5 bits (199), Expect = 5e-16
 Identities = 51/289 (17%), Positives = 94/289 (32%), Gaps = 44/289 (15%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
              ++  +Q         L +LT L    +S+     +           L  +  L    
Sbjct: 23  EVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEK---------LTGLTKLICTS 73

Query: 142 NRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILP 201
           N  +      ++  + LT L    N  +      +  L  + +L        N L  +  
Sbjct: 74  NNITTL---DLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNC----DTNKLTKLDV 123

Query: 202 SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKL 261
           S    L      L  +  ++T  I   + + +    LD  LNK    + VT      ++L
Sbjct: 124 SQNPLL----TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT----PQTQL 172

Query: 262 DTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRL 321
            TL    N  +      +D+   K++  +N   NN +  +   +     +  +    N+L
Sbjct: 173 TTLDCSFNKITE-----LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL 224

Query: 322 EGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
              I      LT L   D S N ++    + +  L  L  L+     L 
Sbjct: 225 TE-ID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 79.7 bits (197), Expect = 9e-16
 Identities = 36/274 (13%), Positives = 83/274 (30%), Gaps = 43/274 (15%)

Query: 96  EIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNA 155
           ++ +   LT+L    N  +    ++             +  L  ++N+ +   +  ++  
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLDVTP---------QTQLTTLDCSFNKIT---ELDVSQN 190

Query: 156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLY 215
             L  L    N+ +      +     + +L        N L  I    +  L+  L    
Sbjct: 191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCS----SNKLTEI---DVTPLT-QLTYFD 239

Query: 216 ISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSI 275
            S   +T      +  L+    L      L   I +T     N++L      G       
Sbjct: 240 CSVNPLTELDVSTLSKLTT---LHCIQTDLLE-IDLT----HNTQLIYFQAEGCRKI--- 288

Query: 276 PSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL 335
              +D+ +   +  ++      + ++   +     +  + L    L   +     + T L
Sbjct: 289 -KELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKL 341

Query: 336 EILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
           + L   N  I      S+ K+  L     +  + 
Sbjct: 342 KSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 37/297 (12%), Positives = 94/297 (31%), Gaps = 50/297 (16%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLA-LPNVKALS 138
           T L+        ++   +     LT L   +N +           + +D++    +  L+
Sbjct: 151 TELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI-----------TELDVSQNKLLNRLN 197

Query: 139 LAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG 198
              N  +  +   +    +LT L+   N  +      +  L  + +         NPL  
Sbjct: 198 CDTNNIT-KL--DLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDC----SVNPLTE 247

Query: 199 ILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN 258
           +  S++  L      L+     +   I   + + +  +    E  +    + VT     N
Sbjct: 248 LDVSTLSKL----TTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVT----HN 296

Query: 259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY 318
           ++L  L       +      +D+     +V + L+    + ++   +     ++++S   
Sbjct: 297 TQLYLLDCQAAGIT-----ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFI-----LISLEKLLYLKKLNLSFNKLE 370
             ++       G + +L     +  +            SL   +    L+   N + 
Sbjct: 349 AHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 15/88 (17%), Positives = 27/88 (30%), Gaps = 8/88 (9%)

Query: 283 NLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN 342
           N    V               +   L  + ++    + +   +      LT L  L  ++
Sbjct: 19  NFASEVAAAFEMQA---TDTISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTS 73

Query: 343 NKISGFILISLEKLLYLKKLNLSFNKLE 370
           N I+    + L +   L  L    NKL 
Sbjct: 74  NNITT---LDLSQNTNLTYLACDSNKLT 98

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.5 bits (209), Expect = 4e-17
 Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 30/228 (13%)

Query: 458 SQATKRRLPYQDLSRATNRFGRDN-----LIGIGSFGYVYKAELDDGIEV-AIKVFHQEC 511
           S    R L ++ L R      ++      ++G G FG V   ++    ++ A K   ++ 
Sbjct: 164 SIYFNRFLQWKWLER--QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK- 220

Query: 512 ARAMKSFEVEC-----EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSST 566
            R  K           ++++ +  R +V +       D   LVL  M  G  D+  +   
Sbjct: 221 -RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG--DLKFHIYH 277

Query: 567 CMLDIFQRLNIMI---DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK 623
                F     +    ++   LE L   H   I++ DLK  N+LLD+     +SD G+A 
Sbjct: 278 MGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAV 334

Query: 624 LLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
            +          +    T+GYMAPE  ++ +  T S D ++ G +L E
Sbjct: 335 HVPEGQ----TIKGRVGTVGYMAPEV-VKNERYTFSPDWWALGCLLYE 377

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 32/205 (15%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
            F +D  IG G+FG             VA+K   +  A   ++ + E    +++RH N+V
Sbjct: 23  DFVKD--IGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIV 79

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SALE 586
           +           A+++EY   G L  +         I        D A        S + 
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGEL--YER-------ICNAGRFSEDEARFFFQQLLSGVS 130

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHL--SDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           Y    H+  I H DLK  N LLD      L   DFG +K      Q  +   T A   Y+
Sbjct: 131 YC---HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YI 184

Query: 645 APEYGIERK--VSTRSDIYSYGIML 667
           APE  + R+      +D++S G+ L
Sbjct: 185 APEV-LLRQEYDGKIADVWSCGVTL 208

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 83.8 bits (207), Expect = 5e-17
 Identities = 53/356 (14%), Positives = 97/356 (27%), Gaps = 55/356 (15%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL------------------VGNNSLS 120
            T LNIS   +      +I  L  L  L + +N +                  + +N L 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 121 GSLPSRIDLALPNVKALSLAYNRF-SGTIQSPITNASKLTILELGGNSFSGFIPNTI--- 176
             +         N+K L L++N F +  I     N S+L  L L            I   
Sbjct: 83  -KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

Query: 177 -------------------GNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
                                L++     L I    N     +    V    +LE   I 
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198

Query: 218 NCSITGNIPQVMGNLS------IFLLLDLELNKLTGPIPVT-FGRLQNSKLDTLSLCGNS 270
                      +  L+          L L   + T    +     + ++ +   S+    
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258

Query: 271 FSGSIPSCIDIG---NLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPE 327
             G +          +LK +    +  + F            ++   +   +        
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318

Query: 328 SFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFT 383
               ++    LD SNN ++  +  +   L  L+ L L  N+L+             
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 78.4 bits (193), Expect = 3e-15
 Identities = 57/329 (17%), Positives = 117/329 (35%), Gaps = 14/329 (4%)

Query: 60  SNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSL 119
                        D N+  +  +  ++      +   +  + +L    +         S 
Sbjct: 149 ETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSY 208

Query: 120 SGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITN---ASKLTILELGGNSFSGFIPNTI 176
             S+ +++    P +  L+L     +      I      + +    +      G +    
Sbjct: 209 FLSILAKL-QTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD 267

Query: 177 GNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL 236
            +        L I  + + + G   S I  +  ++     +              +S FL
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327

Query: 237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDI-GNLKVVVEINLSRN 295
            LD   N LT  +    G L    L+TL L  N     +    ++   +K + ++++S+N
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTE--LETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQN 384

Query: 296 NFSGDIPATI-GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE 354
           + S D         K + ++++  N L   I         +++LDL +NKI   I   + 
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVV 441

Query: 355 KLLYLKKLNLSFNKLEGEIPRGGPFANFT 383
           KL  L++LN++ N+L+  +P  G F   T
Sbjct: 442 KLEALQELNVASNQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 74.9 bits (184), Expect = 3e-14
 Identities = 45/330 (13%), Positives = 106/330 (32%), Gaps = 21/330 (6%)

Query: 18  LLLYLVVAAAATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSH 77
             L++V       +   D          +S     L     +   S+   +     +++ 
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225

Query: 78  RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL 137
            +  +  +  +    I   + +  ++   ++    L G              +L  +   
Sbjct: 226 TLNNIETTWNSFI-RILQLV-WHTTVWYFSISNVKLQGQLDFR--DFDYSGTSLKALSIH 281

Query: 138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN 197
            +  + F           S + I     +            +     L        N L 
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS----NNLLT 337

Query: 198 GILPSSIVNLSISLERLYISNCSITGNIPQVMG---NLSIFLLLDLELNKLT-GPIPVTF 253
             +  +  +L+  LE L +    +   + ++      +     LD+  N ++        
Sbjct: 338 DTVFENCGHLT-ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395

Query: 254 GRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN 313
              ++  L +L++  N  + +I  C+    +KV   ++L  N     IP  +  L+ +Q 
Sbjct: 396 SWTKS--LLSLNMSSNILTDTIFRCLP-PRIKV---LDLHSNKIK-SIPKQVVKLEALQE 448

Query: 314 ISLPYNRLEGPIPESFGYLTSLEILDLSNN 343
           +++  N+L+      F  LTSL+ + L  N
Sbjct: 449 LNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 73.7 bits (181), Expect = 9e-14
 Identities = 54/355 (15%), Positives = 101/355 (28%), Gaps = 66/355 (18%)

Query: 80  TALNISSLNLQGEIPH--EIGYLPSLTKLALGYNSL---------------VGNNSLSGS 122
             L++S       +P   E G +  L  L L    L               V        
Sbjct: 93  KHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 123 LPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILEL---------GGNSFSGFIP 173
                   L +    SL     +      I + S  T+  L           N  S F+ 
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211

Query: 174 NTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNI-----PQV 228
                  N +   L +  I    N  +    +    ++    ISN  + G +        
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271

Query: 229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV 288
             +L    +  +  +    P    +    N  +   ++ G      +     I       
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV-HMLCPSKISPFL--- 327

Query: 289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLE-------------------------- 322
            ++ S N  +  +    G L +++ + L  N+L+                          
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387

Query: 323 -GPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG 376
                    +  SL  L++S+N ++  I   L     +K L+L  NK++  IP+ 
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQ 439

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 73.0 bits (179), Expect = 1e-13
 Identities = 50/301 (16%), Positives = 108/301 (35%), Gaps = 18/301 (5%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRID--LALP 132
               +   NI  +    +  + +  L  L       N  + N   + +   RI   +   
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247

Query: 133 NVKALSLAYNRFSGTIQSPITNAS-----KLTILELGGNSFSGFIPNTIGNLRNIEWLGL 187
            V   S++  +  G +     + S      L+I ++  + F            N+     
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307

Query: 188 VIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG 247
            +    +    +       +S     L  SN  +T  + +  G+L+    L L++N+L  
Sbjct: 308 TV----SGTRMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362

Query: 248 PIPVTFGRLQN-SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIG 306
            +            L  L +  NS S            K ++ +N+S N  +  I   + 
Sbjct: 363 -LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD-CSWTKSLLSLNMSSNILTDTIFRCL- 419

Query: 307 GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF 366
               ++ + L  N+++  IP+    L +L+ L++++N++        ++L  L+K+ L  
Sbjct: 420 -PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477

Query: 367 N 367
           N
Sbjct: 478 N 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 64.5 bits (157), Expect = 7e-11
 Identities = 53/301 (17%), Positives = 99/301 (32%), Gaps = 42/301 (13%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
            N L   +P  +         L+++ N  S    S I + SKL IL +  N       + 
Sbjct: 9   KNGLI-HVPKDL---SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64

Query: 176 IGNLRNIEWLGL-----------------VIGLIGNPLNGI-LPSSIVNLSISLERLYIS 217
               + +E+L L                  + L  N  + + +     N+S  L+ L +S
Sbjct: 65  FKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMS-QLKFLGLS 123

Query: 218 NCSITGNIPQVMGNLSIF-LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSF----- 271
              +  +    + +L+I  +LL L         P          L  +      F     
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD 183

Query: 272 -SGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPES-- 328
            S    + +++ N+K V+E N      S  I A +     + N++L              
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLS--ILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241

Query: 329 -FGYLTSLEILDLSNNKISGFIL-----ISLEKLLYLKKLNLSFNKLEGEIPRGGPFANF 382
              + T++    +SN K+ G +       S   L  L    +  +      P+   +  F
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIF 299

Query: 383 T 383
           +
Sbjct: 300 S 300

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 64.1 bits (156), Expect = 7e-11
 Identities = 32/123 (26%), Positives = 53/123 (43%), Gaps = 13/123 (10%)

Query: 263 TLSLCGNSFSGSIPSCI--DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNR 320
            +    N     +P  +      L      N+S+N  S    + I  L  ++ + + +NR
Sbjct: 4   LVDRSKNGLI-HVPKDLSQKTTIL------NISQNYISELWTSDILSLSKLRILIISHNR 56

Query: 321 LEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFA 380
           ++      F +   LE LDLS+NK+     IS    + LK L+LSFN  +  +P    F 
Sbjct: 57  IQYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFG 112

Query: 381 NFT 383
           N +
Sbjct: 113 NMS 115

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 27/204 (13%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNL 533
              +   +G G++G V  A        VA+K+   + A       + E  + K + H N+
Sbjct: 10  DLVQ--TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SAL 585
           VK        + + L LEY   G L  F         I   + +    A        + +
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGEL--FDR-------IEPDIGMPEPDAQRFFHQLMAGV 118

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            YL   H   I H D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+A
Sbjct: 119 VYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 646 PEYGIERK--VSTRSDIYSYGIML 667
           PE  ++R+   +   D++S GI+L
Sbjct: 176 PEL-LKRREFHAEPVDVWSCGIVL 198

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 50/312 (16%), Positives = 104/312 (33%), Gaps = 46/312 (14%)

Query: 71  TCDVNSHRVTAL------NISSLNLQG----EIPHEI-GYLPSLTKLALGYNSLVGNNSL 119
            C  +S  + ++       + SL+L       I +       +L  L L  N +      
Sbjct: 35  ICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN----- 89

Query: 120 SGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIPNTI-G 177
             ++      +L +++ L L+YN  S  + S      S LT L L GN +      ++  
Sbjct: 90  --TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS 146

Query: 178 NLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL 237
           +L  ++ L +      +    I       L+  LE L I    +    P+ + ++     
Sbjct: 147 HLTKLQILRV---GNMDTFTKIQRKDFAGLT-FLEELEIDASDLQSYEPKSLKSIQNVSH 202

Query: 238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF 297
           L L + +    + +       S ++ L L                            +  
Sbjct: 203 LILHMKQHILLLEIFVDVT--SSVECLELRDTDLD------------------TFHFSEL 242

Query: 298 SGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLL 357
           S     ++      +N+ +    L   + +    ++ L  L+ S N++        ++L 
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT 301

Query: 358 YLKKLNLSFNKL 369
            L+K+ L  N  
Sbjct: 302 SLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 36/212 (16%), Positives = 77/212 (36%), Gaps = 10/212 (4%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIP 250
           L  N +  I  S +     +L+ L +++  I         +L     LDL  N L+    
Sbjct: 59  LSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSS 117

Query: 251 VTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA-TIGGLK 309
             F  L  S L  L+L GN +  ++       +L  +  + +   +    I      GL 
Sbjct: 118 SWFKPL--SSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174

Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
            ++ + +  + L+   P+S   + ++  L L   +    + I ++    ++ L L    L
Sbjct: 175 FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDL 234

Query: 370 EGEIPRGGPFANFTAKSFMGNEKLCGLPHLQV 401
           +        F+  +        K     ++++
Sbjct: 235 DTF-----HFSELSTGETNSLIKKFTFRNVKI 261

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 20/86 (23%), Positives = 38/86 (44%), Gaps = 4/86 (4%)

Query: 291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL 350
             S  + +  IP+ +   + V+++ L  NR+            +L+ L L++N I+    
Sbjct: 37  KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93

Query: 351 ISLEKLLYLKKLNLSFNKLEGEIPRG 376
            S   L  L+ L+LS+N L   +   
Sbjct: 94  DSFSSLGSLEHLDLSYNYLS-NLSSS 118

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.3 bits (206), Expect = 5e-17
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 38/204 (18%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRHRNLVKII 537
            +G+G+FG V   +    G +VA+K+ +++  R++        E + +K  RH +++K+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SALEYLN 589
              S      +V+EY+  G L  F Y       I +   +    +        S ++Y  
Sbjct: 83  QVISTPSDIFMVMEYVSGGEL--FDY-------ICKNGRLDEKESRRLFQQILSGVDYC- 132

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI----GYMA 645
             H   ++H DLK  NVLLD  M A ++DFG++ +       M+  + L T      Y A
Sbjct: 133 --HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAA 183

Query: 646 PEYGIERK--VSTRSDIYSYGIML 667
           PE  I  +       DI+S G++L
Sbjct: 184 PEV-ISGRLYAGPEVDIWSSGVIL 206

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.4 bits (204), Expect = 6e-17
 Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 33/217 (15%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK----VF--HQECARAMKSFEVECEVMK 526
             R+     IG G+ G V  A +      VAIK     F       RA +    E  +MK
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79

Query: 527 NIRHRNLVKI----ISGCSNDDFKA--LVLEYMP---NGSLDIFLYSSTCMLDIFQRLNI 577
            + H+N++ +        S ++F+   +V+E M       + + L        ++Q L  
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC- 138

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
                  +++L   H+  IIH DLK SN+++  D    + DFG+A+       S   T  
Sbjct: 139 ------GIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 186

Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           + T  Y APE  +        DI+S G ++ E     
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQEC------ARAMKSFEVECEVMKN 527
            ++ +   IG GS+G V+K    D G  VAIK F +          A++    E  ++K 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           ++H NLV ++          LV EY  + ++   L      +      +I      A+ +
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
               H    IH D+K  N+L+ +  +  L DFG A+LL+G          +AT  Y +PE
Sbjct: 118 C---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPE 172

Query: 648 --YGIERKVSTRSDIYSYGIMLIETFTRK 674
              G + +     D+++ G +  E  +  
Sbjct: 173 LLVG-DTQYGPPVDVWAIGCVFAELLSGV 200

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 31/199 (15%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEV--MKNIRHRNLVKIISG 539
           IG G+F  V  A  +  G EVAIK+  +         ++  EV  MK + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLD-----IFQRLNIMIDVASALEYLNFRHTT 594
              +    L++EY   G +  +L +   M +      F+++       SA++Y    H  
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYC---HQK 133

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI----GYMAPEYGI 650
            I+H DLK+ N+LLD DM   ++DFG     S      T    L        Y APE   
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFG----FS---NEFTVGGKLDAFCGAPPYAAPEL-F 185

Query: 651 ERKVST--RSDIYSYGIML 667
           + K       D++S G++L
Sbjct: 186 QGKKYDGPEVDVWSLGVIL 204

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 58/270 (21%), Positives = 104/270 (38%), Gaps = 34/270 (12%)

Query: 100 LPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLT 159
           L +  K+A G +++    + +          L  +  LS      + TI   +   + L 
Sbjct: 18  LANAIKIAAGKSNVTDTVTQAD---------LDGITTLSAFGTGVT-TI-EGVQYLNNLI 66

Query: 160 ILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC 219
            LEL  N  +   P  + NL  I  L L     GNPL  +  S+I  L  S++ L +++ 
Sbjct: 67  GLELKDNQITDLAP--LKNLTKITELELS----GNPLKNV--SAIAGLQ-SIKTLDLTST 117

Query: 220 SITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI 279
            IT   P  +  LS   +L L+LN++T   P+       + L  LS+        +    
Sbjct: 118 QITDVTP--LAGLSNLQVLYLDLNQITNISPLA----GLTNLQYLSIGNAQ----VSDLT 167

Query: 280 DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILD 339
            + NL  +  +    N  S DI   +  L ++  + L  N++           ++L I+ 
Sbjct: 168 PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVT 223

Query: 340 LSNNKISGFILISLEKLLYLKKLNLSFNKL 369
           L+N  I+   +     L+    +       
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 42/221 (19%), Positives = 83/221 (37%), Gaps = 25/221 (11%)

Query: 150 SPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSI 209
            P    +    +  G ++ +  +     +L  I  L       G  +  I    +  L+ 
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSA----FGTGVTTI--EGVQYLN- 63

Query: 210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGN 269
           +L  L + +  IT ++  +  NL+    L+L  N L     +         + TL L   
Sbjct: 64  NLIGLELKDNQIT-DLAPL-KNLTKITELELSGNPLKNVSAIA----GLQSIKTLDLTST 117

Query: 270 SFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESF 329
             +   P    +  L  +  + L  N  + +I   + GL ++Q +S+   ++        
Sbjct: 118 QITDVTP----LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPL 169

Query: 330 GYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
             L+ L  L   +NKIS   +  L  L  L +++L  N++ 
Sbjct: 170 ANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 49/275 (17%), Positives = 90/275 (32%), Gaps = 56/275 (20%)

Query: 96  EIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNA 155
            + YL +L  L L  N +     L           L  +  L L+ N     + S I   
Sbjct: 58  GVQYLNNLIGLELKDNQITDLAPLKN---------LTKITELELSGNPLK-NV-SAIAGL 106

Query: 156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLY 215
             +  L+L     +   P  +  L N++ L L      N +  I  S +  L+ +L+ L 
Sbjct: 107 QSIKTLDLTSTQITDVTP--LAGLSNLQVLYLD----LNQITNI--SPLAGLT-NLQYLS 157

Query: 216 ISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSI 275
           I N  ++        +L+        L  L+             KL TL    N  S  I
Sbjct: 158 IGNAQVS--------DLT-------PLANLS-------------KLTTLKADDNKIS-DI 188

Query: 276 PSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL 335
                + +L  ++E++L  N  S D+   +    ++  ++L    +          L   
Sbjct: 189 SP---LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243

Query: 336 EILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
               +     +     ++         NL++N   
Sbjct: 244 --NVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 46/217 (21%), Positives = 80/217 (36%), Gaps = 31/217 (14%)

Query: 83  NISSLNLQG---EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
            I+ L L G   +    I  L S+  L L    +     L+G         L N++ L L
Sbjct: 86  KITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG---------LSNLQVLYL 136

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             N+ +    SP+   + L  L +G    S   P  + NL  +  L        N ++ I
Sbjct: 137 DLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD----DNKISDI 188

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
             S + +L  +L  +++ N  I+   P  + N S   ++ L    +T           N+
Sbjct: 189 --SPLASLP-NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV-----FYNN 238

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNN 296
            L   ++     SG+  +   I +       NL+ N 
Sbjct: 239 NLVVPNVVKGP-SGAPIAPATISDNGTYASPNLTWNL 274

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 6/97 (6%)

Query: 274 SIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLT 333
           +I        L   ++I   ++N +  +      L  +  +S     +     E   YL 
Sbjct: 8   AINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLN 63

Query: 334 SLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
           +L  L+L +N+I+   L  L+ L  + +L LS N L+
Sbjct: 64  NLIGLELKDNQITD--LAPLKNLTKITELELSGNPLK 98

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 81.9 bits (202), Expect = 9e-17
 Identities = 49/272 (18%), Positives = 100/272 (36%), Gaps = 76/272 (27%)

Query: 477 FGRDNL-----IGIGSFGYVYKAEL------DDGIEVAIKVFHQE-CARAMKSFEVECEV 524
           F RD L     +G G+FG V +A+            VA+K+  +       ++   E ++
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78

Query: 525 MKNI-RHRNLVKIISGCSNDDFKALV-LEYMPNGSLDIFL-------------------- 562
           + +I  H N+V ++  C+      +V +E+   G+L  +L                    
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138

Query: 563 --YSSTCMLDIFQRLNIMI-----DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI-- 613
             Y     +D+ +RL+ +        +  +E  +          +    + L  E +I  
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198

Query: 614 --------AHLS-------------------------DFGIAKLLSGEDQSMTQTQTLAT 640
                     L+                         DFG+A+ +  +   + +      
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           + +MAPE   +R  + +SD++S+G++L E F+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 19/208 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQEC-----ARAMKSFEVECEVMKNI 528
             + + + +G G++  VYK         VA+K    E        A++    E  ++K++
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
           +H N+V +      +    LV EY+    L  +L     ++++      +  +   L Y 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE- 647
              H   ++H DLK  N+L++E     L+DFG+A+  S   ++      + T+ Y  P+ 
Sbjct: 117 ---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPDI 171

Query: 648 -YGIERKVSTRSDIYSYGIMLIETFTRK 674
             G     ST+ D++  G +  E  T +
Sbjct: 172 LLG-STDYSTQIDMWGVGCIFYEMATGR 198

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 82.6 bits (204), Expect = 2e-16
 Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 24/200 (12%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVEC--------EVMKNIRHRN 532
           +IG G FG VY     D  ++ A+K   +   R                  ++       
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDK--KRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +V +       D  + +L+ M  G L   L       +   R     ++   LE++   H
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEHM---H 309

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIE 651
              +++ DLK +N+LLDE     +SD G+A   S +     +      T GYMAPE  ++
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEV-LQ 363

Query: 652 RKVS-TRS-DIYSYGIMLIE 669
           + V+   S D +S G ML +
Sbjct: 364 KGVAYDSSADWFSLGCMLFK 383

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 49/218 (22%), Positives = 82/218 (37%), Gaps = 24/218 (11%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIK--VFHQECARAMKSFEV---------EC 522
            + +     I  GS+G V      +GI VAIK         R +              E 
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 523 EVMKNIRHRNLVK---IISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
            ++ +  H N++    I             LV E M    L   ++    ++        
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
           M  +   L  L   H   ++H DL   N+LL ++    + DF +A+  +  D +   T  
Sbjct: 140 MYHILLGLHVL---HEAGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANK--THY 193

Query: 638 LATIGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
           +    Y APE  ++ K  T+  D++S G ++ E F RK
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 51/230 (22%), Positives = 95/230 (41%), Gaps = 28/230 (12%)

Query: 460 ATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR----- 513
                +     + + +R+ R   +G G++G VYKA +      VAIK    E        
Sbjct: 19  PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG 78

Query: 514 -AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-LDI 571
            A++    E  ++K ++HRN++++ S   ++    L+ EY      D+  Y      + +
Sbjct: 79  TAIR----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSM 131

Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH-----LSDFGIAKLLS 626
               + +  + + + +    H+   +H DLK  N+LL     +      + DFG+A+   
Sbjct: 132 RVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

Query: 627 GEDQSMTQTQTLATIGYMAPE--YGIERKVSTRSDIYSYGIMLIETFTRK 674
              +    T  + T+ Y  PE   G  R  ST  DI+S   +  E   + 
Sbjct: 189 IPIRQF--THEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKT 235

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.1 bits (198), Expect = 5e-16
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 37/220 (16%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEV-ECEVMKNIRHR 531
              +    +IG GSFG VY+A+L D G  VAIK   Q+     K F+  E ++M+ + H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 532 NLVKII------SGCSNDDFKALVLEYMP---NGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
           N+V++           ++ +  LVL+Y+P         +  +   +  I+ +L  M  + 
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLF 166

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
            +L Y+   H+  I H D+K  N+LLD D  +  L DFG AK L    +       + + 
Sbjct: 167 RSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPN--VSYICSR 220

Query: 642 GYMAPE-------YGIERKVSTRSDIYSYGIMLIETFTRK 674
            Y APE       Y      ++  D++S G +L E    +
Sbjct: 221 YYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 47/201 (23%), Positives = 79/201 (39%), Gaps = 26/201 (12%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIK------VFHQECARAMKSFEVECEVMKNIRHR--N 532
           L+G G FG VY    + D + VAIK      +             +E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLY--SSTCMLDIFQRLNIMIDVASALEYLNF 590
           +++++      D   L+LE  P    D+F +      + +   R +    V  A+ +   
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHC-- 165

Query: 591 RHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEY 648
            H   ++H D+K  N+L+D +     L DFG   LL       T       T  Y  PE+
Sbjct: 166 -HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYSPPEW 219

Query: 649 GIERK--VSTRSDIYSYGIML 667
            I         + ++S GI+L
Sbjct: 220 -IRYHRYHGRSAAVWSLGILL 239

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 78.9 bits (195), Expect = 6e-16
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 21/201 (10%)

Query: 477 FGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVEC-----EVMKNIRH 530
           F R   +G GSFG V   +  + G   A+K+  ++    +K  ++E       +++ +  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK--QIEHTLNEKRILQAVNF 100

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+  G +   L       +   R      +    EYL  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYL-- 157

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYG 649
            H+  +I+ DLK  N+L+D+     ++DFG AK + G      +T TL  T   +APE  
Sbjct: 158 -HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEI- 209

Query: 650 IERKVSTRS-DIYSYGIMLIE 669
           I  K   ++ D ++ G+++ E
Sbjct: 210 ILSKGYNKAVDWWALGVLIYE 230

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 79.5 bits (196), Expect = 9e-16
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 27/214 (12%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK----VF--HQECARAMKSFEVECEVMK 526
             R+     IG G+ G V  A +      VAIK     F       RA +    E  +MK
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116

Query: 527 NIRHRNLVKII----SGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID 580
            + H+N++ ++       + ++F+   LV+E M     ++       +        ++  
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSY-LLYQ 172

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           +   +++L   H+  IIH DLK SN+++  D    + DFG+A+   G    M  T  + T
Sbjct: 173 MLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMM--TPYVVT 226

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
             Y APE  +        DI+S G ++ E    K
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 24/220 (10%)

Query: 472 RATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEV----ECEVMK 526
              +++ +   IG G+FG V+KA     G +VA+K    E  +  + F +    E ++++
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQ 71

Query: 527 NIRHRNLVK---IISGCSNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM 578
            ++H N+V    I    ++   +      LV ++  +  L   L +      + +   +M
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVM 130

Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ--TQ 636
             + + L Y+   H   I+H D+K++NVL+  D +  L+DFG+A+  S    S     T 
Sbjct: 131 QMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 637 TLATIGYMAPE--YGIERKVSTRSDIYSYGIMLIETFTRK 674
            + T+ Y  PE   G ER      D++  G ++ E +TR 
Sbjct: 188 RVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 44/233 (18%), Positives = 90/233 (38%), Gaps = 38/233 (16%)

Query: 468 QDLSRATNRFGRDNL-IGIGSFGYVYKA---ELDDGIEVAIKVFHQECARAMKSFEVECE 523
            +  R  + F  +   +G G++G+VYKA   +  D  + A+K           S     E
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACRE 68

Query: 524 V--MKNIRHRNLVK---IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM 578
           +  ++ ++H N++    +    ++     L+ +Y      D++            +  + 
Sbjct: 69  IALLRELKHPNVISLQKVFLSHADRKV-WLLFDYA---EHDLWHIIKFHRASKANKKPVQ 124

Query: 579 IDVA----------SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH----LSDFGIAKL 624
           +               + YL   H   ++H DLK +N+L+  +        ++D G A+L
Sbjct: 125 LPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

Query: 625 LSGEDQSMTQ-TQTLATIGYMAPE--YGIERKVSTRSDIYSYGIMLIETFTRK 674
            +   + +      + T  Y APE   G  R  +   DI++ G +  E  T +
Sbjct: 182 FNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 233

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 39/204 (19%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEV---ECEVMKNIRHRNLVKII 537
            +G GSFG V  A       +VA+K   ++  +          E   +K +RH +++K+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 538 SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SALEYLN 589
              +      +V+EY   G L  F Y       I ++  +  D           A+EY  
Sbjct: 76  DVITTPTDIVMVIEYA-GGEL--FDY-------IVEKKRMTEDEGRRFFQQIICAIEYC- 124

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI----GYMA 645
             H   I+H DLK  N+LLD+++   ++DFG++ +       MT    L T      Y A
Sbjct: 125 --HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSPNYAA 175

Query: 646 PEYGIERK--VSTRSDIYSYGIML 667
           PE  I  K       D++S GI+L
Sbjct: 176 PEV-INGKLYAGPEVDVWSCGIVL 198

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 34/182 (18%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVEC-----EVMKNIRHRNLVK 535
           +IG G+FG V         +V A+K+  +         +        ++M       +V+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWVVQ 133

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SALEY 587
           +     +D +  +V+EYMP G L          +++    ++    A         AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
           +   H+   IH D+K  N+LLD+    H  L+DFG    ++ E      T  + T  Y++
Sbjct: 184 I---HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYIS 237

Query: 646 PE 647
           PE
Sbjct: 238 PE 239

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 28/203 (13%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFH----QECARAMKSFEVECEV--MKNIR----H 530
           L+G G FG V+    L D ++VAIKV         +    S     EV  +  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY--SSTCMLDIFQRLNIMIDVASALEYL 588
             +++++      +   LVLE       D+F Y      + +   R      V +A+++ 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQ-DLFDYITEKGPLGEGPSR-CFFGQVVAAIQHC 155

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAP 646
              H+  ++H D+K  N+L+D     A L DFG   LL               T  Y  P
Sbjct: 156 ---HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-----EPYTDFDGTRVYSPP 207

Query: 647 EYGIERK--VSTRSDIYSYGIML 667
           E+ I R    +  + ++S GI+L
Sbjct: 208 EW-ISRHQYHALPATVWSLGILL 229

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 26/221 (11%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECAR-AMKSFEV----ECEV 524
           S AT+R+     IG+G++G VYKA +   G  VA+K               +    E  +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 525 MKNIR---HRNLVK---IISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLN 576
           ++ +    H N+V+   + +    D      LV E++     D+  Y             
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAET 121

Query: 577 I---MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT 633
           I   M      L++L   H   I+H DLK  N+L+       L+DFG+A++ S +   M 
Sbjct: 122 IKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MA 175

Query: 634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
            T  + T+ Y APE  ++   +T  D++S G +  E F RK
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 41/206 (19%)

Query: 482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVEC-----EVMKNIRHRNLVK 535
            +G GSFG V+      +G   A+KV  +E    +K  +VE       ++  + H  +++
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTNDERLMLSIVTHPFIIR 70

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SALEY 587
           +     +     ++++Y+  G L  F       L   QR      VA         ALEY
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGEL--FSL-----LRKSQRFP--NPVAKFYAAEVCLALEY 121

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTL-ATIGYM 644
           L   H+  II+ DLK  N+LLD++   H  ++DFG AK +         T TL  T  Y+
Sbjct: 122 L---HSKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP------DVTYTLCGTPDYI 170

Query: 645 APEYGIERKVSTRS-DIYSYGIMLIE 669
           APE  +  K   +S D +S+GI++ E
Sbjct: 171 APEV-VSTKPYNKSIDWWSFGILIYE 195

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 473 ATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQE--------CARAMKSFEVECE 523
           ++++F +   +G G++  VYK      G+ VA+K    +          R       E  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EIS 55

Query: 524 VMKNIRHRNLVKIISGCSNDDFKALVLEYMPN---GSLD-IFLYSSTCMLDIFQRLNIMI 579
           +MK ++H N+V++      ++   LV E+M N     +D   + ++   L++        
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA 639
            +   L +    H   I+H DLK  N+L+++     L DFG+A+       +   +  + 
Sbjct: 116 QLLQGLAFC---HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVV 170

Query: 640 TIGYMAPE--YGIERKVSTRSDIYSYGIMLIETFTRK 674
           T+ Y AP+   G  R  ST  DI+S G +L E  T K
Sbjct: 171 TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGK 206

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 36/218 (16%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK----VFHQE--CARAMKSFEVECEVMK 526
              +     +G G++G V  A +   G +VAIK     F  E    RA +    E  ++K
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78

Query: 527 NIRHRNLVKI----ISGCSNDDFKA--LVLEYMP---NGSLDIFLYSSTCMLDIFQRLNI 577
           +++H N++ +        S  +F    LV+ +M       + +          ++Q L  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK- 137

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
                  L+Y+   H+  ++H DLK  N+ ++ED    + DFG+A+     D  M  T  
Sbjct: 138 ------GLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGY 183

Query: 638 LATIGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
           + T  Y APE  +      ++ DI+S G ++ E  T K
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.6 bits (189), Expect = 5e-15
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 29/215 (13%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK----VFHQE--CARAMKSFEVECEVMK 526
             R+   + +G G++G V  A +   G+ VA+K     F       R  +    E  ++K
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLK 83

Query: 527 NIRHRNLVKI----ISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID 580
           +++H N++ +        S ++F    LV   M    L+  +       D  Q   ++  
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQ 140

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           +   L+Y+   H+  IIH DLK SN+ ++ED    + DFG+A+  + E      T  +AT
Sbjct: 141 ILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVAT 192

Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +      ++ DI+S G ++ E  T +
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 60/255 (23%), Positives = 88/255 (34%), Gaps = 42/255 (16%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
              L  ++P  I       + + L  NR S    +       LTIL L  N  +      
Sbjct: 20  QQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 176 IGNLRNIEWLGLVIGLIGNP-LNGILPSSIVNLSISLERLYISNCSITGNIPQVM-GNLS 233
              L  +E L L      N  L  + P++   L   L  L++  C +   +   +   L+
Sbjct: 76  FTGLALLEQLDLS----DNAQLRSVDPATFHGLG-RLHTLHLDRCGLQ-ELGPGLFRGLA 129

Query: 234 IFLLLDLELNKLTGPIPV-TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINL 292
               L L+ N L   +P  TF  L N  L  L L GN  S                  ++
Sbjct: 130 ALQYLYLQDNALQA-LPDDTFRDLGN--LTHLFLHGNRIS------------------SV 168

Query: 293 SRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILIS 352
               F G        L  +  + L  NR+    P +F  L  L  L L  N +S     +
Sbjct: 169 PERAFRG--------LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220

Query: 353 LEKLLYLKKLNLSFN 367
           L  L  L+ L L+ N
Sbjct: 221 LAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 42/190 (22%), Positives = 72/190 (37%), Gaps = 13/190 (6%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELN-KLTGPI 249
           L GN ++ +  +S      +L  L++ +  +          L++   LDL  N +L    
Sbjct: 39  LHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97

Query: 250 PVTFGRLQNSKLDTLSLCGNSFSGSIPSCI--DIGNLKVVVEINLSRNNFSGDIPATI-G 306
           P TF  L    L TL L        +   +   +  L+    + L  N     +P     
Sbjct: 98  PATFHGLGR--LHTLHLDRCGLQ-ELGPGLFRGLAALQ---YLYLQDNALQ-ALPDDTFR 150

Query: 307 GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF 366
            L ++ ++ L  NR+      +F  L SL+ L L  N+++     +   L  L  L L  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 367 NKLEGEIPRG 376
           N L   +P  
Sbjct: 211 NNLS-ALPTE 219

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 36/173 (20%), Positives = 59/173 (34%), Gaps = 15/173 (8%)

Query: 100 LPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-TNASKL 158
           L  L +L L       +N+   S+       L  +  L L        +   +    + L
Sbjct: 79  LALLEQLDLS------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL 131

Query: 159 TILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISN 218
             L L  N+      +T  +L N+  L L     GN ++ +   +   L  SL+RL +  
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLH----GNRISSVPERAFRGLH-SLDRLLLHQ 186

Query: 219 CSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSF 271
             +    P    +L   + L L  N L+         L    L  L L  N +
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL--RALQYLRLNDNPW 237

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 77.6 bits (191), Expect = 6e-15
 Identities = 53/308 (17%), Positives = 105/308 (34%), Gaps = 15/308 (4%)

Query: 82  LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY 141
           L++               + +L  L L    L   N              P +  ++L +
Sbjct: 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQH 258

Query: 142 NRFSGTIQSPI---TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG 198
              +      +        +  L +   + +  I              L+I  + N +  
Sbjct: 259 IETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL 318

Query: 199 ILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN 258
               ++ ++   +    +S             + S F  L+   N  T  +      L+ 
Sbjct: 319 FSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378

Query: 259 SKLDTLSLCGNSFSGSIPSCIDI-GNLKVVVEINLSRNNF-SGDIPATIGGLKDVQNISL 316
             L TL L  N    +      +  N+  +  +++S N+  S     T    + +  ++L
Sbjct: 379 --LQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435

Query: 317 PYNRLEGPIPESFGYLT-SLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPR 375
             N L G +   F  L   +++LDL NN+I   I   +  L  L++LN++ N+L+  +P 
Sbjct: 436 SSNMLTGSV---FRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPD 490

Query: 376 GGPFANFT 383
            G F   T
Sbjct: 491 -GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 71.8 bits (176), Expect = 4e-13
 Identities = 47/327 (14%), Positives = 97/327 (29%), Gaps = 51/327 (15%)

Query: 79  VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALS 138
             AL++S  ++      +I +L  L  L L +N +        SL   + L   +++ L 
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-------RSLDFHVFLFNQDLEYLD 106

Query: 139 LAYNRFSGTIQS-PITNASKLTILELGGNSFSGF-IPNTIGNLRNIEWLGLVIGLIGNPL 196
           +++NR    +Q+      + L  L+L  N F    +    GNL  + +LGL         
Sbjct: 107 VSHNR----LQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS----AAKF 158

Query: 197 NGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL------------------- 237
             +    + +L +S   L + +  I G   + +   +  +L                   
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218

Query: 238 ---------LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS-GSIPSCIDIGNLKVV 287
                    + L        +       +   L  ++L     +             + V
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278

Query: 288 VEINLSRNNFSGDIPATIGG-----LKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN 342
             +N+     +  I           LK +    +            +     + I  LS 
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338

Query: 343 NKISGFILISLEKLLYLKKLNLSFNKL 369
           +      ++          LN + N  
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVF 365

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 12/112 (10%)

Query: 274 SIPSCI--DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGY 331
            +P  +      L      +LS+N+ S      I  L +++ + L +NR+       F +
Sbjct: 45  HVPKDLPPRTKAL------SLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF 98

Query: 332 LTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFT 383
              LE LD+S+N++     IS   +  L+ L+LSFN  +  +P    F N T
Sbjct: 99  NQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLT 146

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.3 bits (188), Expect = 8e-15
 Identities = 74/340 (21%), Positives = 129/340 (37%), Gaps = 43/340 (12%)

Query: 348 FILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAK--SFMGNEKLCGLPHLQVPQCK 405
           F+L +    +  K       + +    R  P  NF+      M  E+    P+  + +C 
Sbjct: 27  FLLKNDGTFIGYK------ERPQDVDQREAPLNNFSVAQCQLMKTER--PRPNTFIIRCL 78

Query: 406 HQTRPKSSKKMILLVIVLPLSAALIAVVVLALKYKSTRRGKSTGLSNGGILLSQATKRRL 465
             T        +            I  V   LK ++         S      S  +    
Sbjct: 79  QWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSP-----SDNSGAEE 133

Query: 466 PYQDLSRATNRFGRDN-----LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFE 519
               L++  +R   +      L+G G+FG V   +    G   A+K+  +E   A    E
Sbjct: 134 MEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--E 191

Query: 520 VEC-----EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-- 572
           V        V++N RH  L  +       D    V+EY   G  ++F + S     +F  
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRE--RVFSE 247

Query: 573 QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS 631
            R      ++ SAL+YL+      +++ DLK  N++LD+D    ++DFG+ K    +  +
Sbjct: 248 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305

Query: 632 MTQTQTL-ATIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
               +T   T  Y+APE  +E     R+ D +  G+++ E
Sbjct: 306 ---MKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYE 341

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 42/211 (19%), Positives = 82/211 (38%), Gaps = 41/211 (19%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVEC-----EVMKNIRHRNLVK 535
           +IG G+FG V   +L +  +V A+K+ ++         E  C     +V+ N   + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA--ETACFREERDVLVNGDSKWITT 138

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID----------VASAL 585
           +     +D+   LV++Y   G  D+             +    +           +  A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGG--DLLTL--------LSKFEDRLPEEMARFYLAEMVIAI 188

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           + +   H    +H D+K  N+L+D +   H  L+DFG    L  +    +    + T  Y
Sbjct: 189 DSV---HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242

Query: 644 MAPE----YGIERKVSTRS-DIYSYGIMLIE 669
           ++PE        +       D +S G+ + E
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK---VFHQE--CARAMKSFEVECEVMKN 527
             R+   + IG G++G V  A +  + + VAIK    F  +  C R ++    E +++  
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLR 81

Query: 528 IRHRNLVK---IISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            RH N++    II   + +  K   +V + M    L   L +     D       +  + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC--YFLYQIL 138

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-TQTLATI 641
             L+Y+   H+  ++H DLK SN+LL+      + DFG+A++   +       T+ +AT 
Sbjct: 139 RGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 642 GYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
            Y APE  +  K  T+S DI+S G +L E  + +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 38/201 (18%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVEC-----EVMKNIRHRNLVK 535
           +IG G+F  V   ++    +V A+K+ ++     +K  EV C     +V+ N   R + +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--DMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID----------VASAL 585
           +     ++++  LV+EY   G  D+             +    I           +  A+
Sbjct: 126 LHFAFQDENYLYLVMEYYVGG--DLLTL--------LSKFGERIPAEMARFYLAEIVMAI 175

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTLATIGY 643
           + +   H    +H D+K  N+LLD     H  L+DFG    L  +    +    + T  Y
Sbjct: 176 DSV---HRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDY 229

Query: 644 MAPEYGIERKVSTRSDIYSYG 664
           ++PE  I + V       SYG
Sbjct: 230 LSPE--ILQAVGGGPGTGSYG 248

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 48/211 (22%)

Query: 482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVEC-----EVMKNIRHRNLVK 535
           L+G G+FG V        G   A+K+  +E   A    EV        V++N RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLTA 69

Query: 536 IISGCSNDDFKALVLEYMPNGSL-------DIF------LYSSTCMLDIFQRLNIMIDVA 582
           +       D    V+EY   G L        +F       Y +              ++ 
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTL-A 639
           SALEYL   H+  +++ D+K  N++LD+D   H  ++DFG+ K    +  +    +T   
Sbjct: 116 SALEYL---HSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGAT---MKTFCG 167

Query: 640 TIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
           T  Y+APE  +E     R+ D +  G+++ E
Sbjct: 168 TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYE 197

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.0 bits (180), Expect = 5e-14
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 36/225 (16%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKA--ELDDGIEVAIKVFHQECAR------AMKSFEVEC 522
            RA  ++     IG G++G V+KA    + G  VA+K    +          ++      
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------ 60

Query: 523 EV-----MKNIRHRNLVK---IISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIF 572
           EV     ++   H N+V+   + +    D      LV E++     D+  Y         
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGV 117

Query: 573 QRLNI---MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED 629
               I   M  +   L++L   H+  ++H DLK  N+L+       L+DFG+A++ S + 
Sbjct: 118 PTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ- 173

Query: 630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
             M  T  + T+ Y APE  ++   +T  D++S G +  E F RK
Sbjct: 174 --MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 31/223 (13%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR 529
            +  +RF  + + G G+FG V    E   G+ VAIK   Q+     +  +   + +  + 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77

Query: 530 HRNLVKII-------SGCSNDDFKALVLEYMP---NGSLDIFLYSSTCMLDIFQRLNIMI 579
           H N+V++             D +  +V+EY+P   +     +         I  ++  + 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLF 136

Query: 580 DVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
            +  ++  L+   +  + H D+K  NVL++  D    L DFG AK LS   +       +
Sbjct: 137 QLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPN--VAYI 192

Query: 639 ATIGYMAPE-------YGIERKVSTRSDIYSYGIMLIETFTRK 674
            +  Y APE       Y      +T  DI+S G +  E    +
Sbjct: 193 CSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 72.8 bits (179), Expect = 8e-14
 Identities = 49/242 (20%), Positives = 91/242 (37%), Gaps = 67/242 (27%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII---- 537
           +G GSFG V +  +++ G   A+K   Q+     +    E ++MK + H N++K++    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 538 --------------------------------SGCSNDDFKA--LVLEYMP---NGSLDI 560
                                              +    K   +++EY+P   +  L  
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130

Query: 561 FLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDF 619
           F+ S   +      +  +  +  A+ ++   H+  I H D+K  N+L++ +D    L DF
Sbjct: 131 FIRSGRSIPMNLISI-YIYQLFRAVGFI---HSLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 620 GIAKLLSGEDQSMTQTQTLATIGYMAPE-------YGIERKVSTRSDIYSYGIMLIETFT 672
           G AK L    +       + +  Y APE       Y      +   D++S G +  E   
Sbjct: 187 GSAKKLI-PSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELIL 237

Query: 673 RK 674
            K
Sbjct: 238 GK 239

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 29/215 (13%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK----VFHQE--CARAMKSFEVECEVMK 526
              +     +G G++G V  A +   G +VAIK     F  E    RA +    E  ++K
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLK 79

Query: 527 NIRHRNLVKII----SGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMID 580
           ++RH N++ ++       + DDF    LV+ +M    L   +       D  Q   ++  
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF--LVYQ 136

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           +   L Y+   H   IIH DLK  N+ ++ED    + DFG+A+     D  M  T  + T
Sbjct: 137 MLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGYVVT 188

Query: 641 IGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             Y APE  +     T++ DI+S G ++ E  T K
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 40/223 (17%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK----VFHQE--CARAMKSFEVECEVMK 526
            +R+   +LIG GS+G+V +A +  +   VAIK    VF     C R ++    E  ++ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILN 107

Query: 527 NIRHRNLVK---IISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
            + H ++VK   I+     + F    +VLE   +        +   + ++  +  ++ ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNL 165

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
              ++Y+   H+  I+H DLK +N L+++D    + DFG+A+ +   +   +Q       
Sbjct: 166 LVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 642 GYMAPEYGIERK---------VSTR----------SDIYSYGI 665
             M        K         V TR           + Y+  I
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.5 bits (180), Expect = 1e-13
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 30/228 (13%)

Query: 459 QATKRRLPYQDLSRATNRFGRDN-----LIGIGSFGYVYKAELDDGIEV-AIKVFHQECA 512
           + T   +   D +   +R    +     ++G GSFG V  +E     E+ A+K+  ++  
Sbjct: 320 EKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV 379

Query: 513 RAMKSFEVECEVM-KNI-----RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSST 566
                 +VEC ++ K +     +   L ++ S     D    V+EY+  G  D+  +   
Sbjct: 380 IQDD--DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG--DLMYHIQQ 435

Query: 567 CMLDIF--QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK 623
                F          ++A  L +L    +  II+ DLK  NV+LD +    ++DFG+ K
Sbjct: 436 V--GRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490

Query: 624 LLSGEDQSMTQTQTLA-TIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
               +      T+T   T  Y+APE  I  +   +S D +++G++L E
Sbjct: 491 ENIWDGV---TTKTFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYE 534

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 73.2 bits (179), Expect = 1e-13
 Identities = 52/270 (19%), Positives = 102/270 (37%), Gaps = 56/270 (20%)

Query: 100 LPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLT 159
                K  L   S+    + +          L ++  +    +    ++   I     +T
Sbjct: 20  FAETIKDNLKKKSVTDAVTQNE---------LNSIDQIIANNSDIK-SV-QGIQYLPNVT 68

Query: 160 ILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC 219
            L L GN  +   P  + NL+N+ WL L      N +  +  SS+ +L   L+ L + + 
Sbjct: 69  KLFLNGNKLTDIKP--LTNLKNLGWLFLD----ENKIKDL--SSLKDLK-KLKSLSLEHN 119

Query: 220 SITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI 279
            I+ +I   + +L     L L  NK+T    ++    + +KLDTLSL  N  S  I    
Sbjct: 120 GIS-DI-NGLVHLPQLESLYLGNNKITDITVLS----RLTKLDTLSLEDNQIS-DIVPLA 172

Query: 280 DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILD 339
            +  L+    + LS+N+           + D++ ++                L +L++L+
Sbjct: 173 GLTKLQ---NLYLSKNH-----------ISDLRALA---------------GLKNLDVLE 203

Query: 340 LSNNKISGFILISLEKLLYLKKLNLSFNKL 369
           L + +     +     L+    +  +   L
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 67.1 bits (163), Expect = 1e-11
 Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 21/181 (11%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIP 250
            +  P+  I P      +    +  +   S+T  + Q    L+    +    + +     
Sbjct: 6   TVSTPIKQIFPDD--AFA-ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK---- 56

Query: 251 VTFGRLQN-SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK 309
            +   +Q    +  L L GN     +     + NLK +  + L  N    D+ + +  LK
Sbjct: 57  -SVQGIQYLPNVTKLFLNGNK----LTDIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLK 109

Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
            ++++SL +N +         +L  LE L L NNKI+   +  L +L  L  L+L  N++
Sbjct: 110 KLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 165

Query: 370 E 370
            
Sbjct: 166 S 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 64.7 bits (157), Expect = 6e-11
 Identities = 47/203 (23%), Positives = 82/203 (40%), Gaps = 25/203 (12%)

Query: 172 IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS--ISLERLYISNCSITGNIP--Q 227
           +   I  +   +     I      L     +  V  +   S++++  +N  I  ++   Q
Sbjct: 7   VSTPIKQIFPDDAFAETIKDN---LKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQGIQ 62

Query: 228 VMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVV 287
            + N++    L L  NKLT   P+T        L  L L  N     I     + +LK +
Sbjct: 63  YLPNVTK---LFLNGNKLTDIKPLT----NLKNLGWLFLDENK----IKDLSSLKDLKKL 111

Query: 288 VEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISG 347
             ++L  N  S DI   +  L  ++++ L  N++          LT L+ L L +N+IS 
Sbjct: 112 KSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD 167

Query: 348 FILISLEKLLYLKKLNLSFNKLE 370
             ++ L  L  L+ L LS N + 
Sbjct: 168 --IVPLAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 63/295 (21%), Positives = 101/295 (34%), Gaps = 81/295 (27%)

Query: 83  NISSLNLQG-EIPH--EIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
           +I  +     +I     I YLP++TKL L  N L     L+          L N+  L L
Sbjct: 44  SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLTN---------LKNLGWLFL 94

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             N+    + S + +  KL  L L  N            + +I                 
Sbjct: 95  DENKIK-DL-SSLKDLKKLKSLSLEHN-----------GISDIN---------------- 125

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLE-LNKLTGPIPVTFGRLQN 258
               +V+L   LE LY+ N  IT                D+  L++LT            
Sbjct: 126 ---GLVHLP-QLESLYLGNNKIT----------------DITVLSRLT------------ 153

Query: 259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY 318
            KLDTLSL  N  S  I     +  L+    + LS+N+ S D+ A + GLK++  + L  
Sbjct: 154 -KLDTLSLEDNQIS-DIVPLAGLTKLQ---NLYLSKNHIS-DLRA-LAGLKNLDVLELFS 206

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI 373
                        L     +  ++  +    +IS +       +     +   E+
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 57/221 (25%), Positives = 103/221 (46%), Gaps = 30/221 (13%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK---VFHQE--CARAMKSFEVECEVMKN 527
           ++ F   +L+G G++G V  A     G  VAIK    F +     R ++    E +++K+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKH 65

Query: 528 IRHRNLVK---IISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            +H N++    I    S ++F    ++ E M     D+    ST ML        +    
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT---DLHRVISTQMLSDDHIQYFIYQTL 122

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ-------- 634
            A++ L   H + +IH DLK SN+L++ +    + DFG+A+++       ++        
Sbjct: 123 RAVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 635 TQTLATIGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
            + +AT  Y APE  +     +R+ D++S G +L E F R+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 32/223 (14%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK--VF--HQECARAMKSFEVECEVMKNI 528
            +R+     +G G  G V+ A + D    VAIK  V    Q    A++    E ++++ +
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRL 65

Query: 529 RHRNLVKII------------SGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQR 574
            H N+VK+                S  +  +  +V EYM    L   L     + +  + 
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHAR- 123

Query: 575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMT 633
              M  +   L+Y+   H+  ++H DLK +N+ ++ ED++  + DFG+A+++        
Sbjct: 124 -LFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 634 Q-TQTLATIGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
             ++ L T  Y +P   +     T++ D+++ G +  E  T K
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 44/172 (25%), Positives = 69/172 (40%), Gaps = 10/172 (5%)

Query: 206 NLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLS 265
           +L      L++S   +       +   +    L+L+  +LT  + V  G L    L TL 
Sbjct: 28  DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQV-DGTLPV--LGTLD 83

Query: 266 LCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLEGP 324
           L  N    S+P       L  +  +++S N  +  +P     GL ++Q + L  N L+  
Sbjct: 84  LSHNQLQ-SLPLLGQ--TLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTL 139

Query: 325 IPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG 376
            P        LE L L+NN ++      L  L  L  L L  N L   IP+G
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKG 190

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 40/217 (18%), Positives = 74/217 (34%), Gaps = 32/217 (14%)

Query: 151 PITNASKLTILELGGNSFSGF---IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNL 207
            ++  +    +     + +     +P     L           L  N L     ++++  
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPPDLPKDTTILH----------LSENLLYTFSLATLMPY 54

Query: 208 SISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLC 267
           +  L +L +    +T  +  V G L +   LDL  N+L   +P+    L    L  L + 
Sbjct: 55  T-RLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTL--PALTVLDVS 108

Query: 268 GNSFSGSIPSCI--DIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLEGP 324
            N  + S+P      +G L+   E+ L  N     +P  +      ++ +SL  N L   
Sbjct: 109 FNRLT-SLPLGALRGLGELQ---ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTEL 163

Query: 325 IPESFGYLTSLEILDLSNNKISG-----FILISLEKL 356
                  L +L+ L L  N +       F    L   
Sbjct: 164 PAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFA 200

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 19/189 (10%)

Query: 158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
            TIL L  N    F   T+     +  L L        L  +    +      L  L +S
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLD----RAELTKL---QVDGTLPVLGTLDLS 85

Query: 218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPS 277
           +  +  ++P +   L    +LD+  N+LT         L   +L  L L GN    ++P 
Sbjct: 86  HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL--GELQELYLKGNELK-TLPP 141

Query: 278 CI--DIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLEGPIPESFGYLTS 334
            +      L+   +++L+ NN + ++PA +  GL+++  + L  N L   IP+ F     
Sbjct: 142 GLLTPTPKLE---KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHL 196

Query: 335 LEILDLSNN 343
           L    L  N
Sbjct: 197 LPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 53.6 bits (129), Expect = 9e-08
 Identities = 46/222 (20%), Positives = 77/222 (34%), Gaps = 27/222 (12%)

Query: 100 LPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLT 159
           + S  ++     +L        +LP  +     +   L L+ N       + +   ++LT
Sbjct: 9   VASHLEVNCDKRNL-------TALPPDL---PKDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 160 ILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC 219
            L L     +  +    G L  +  L L      N L   LP     L  +L  L +S  
Sbjct: 59  QLNLDRAELTK-LQ-VDGTLPVLGTLDLS----HNQLQS-LPLLGQTLP-ALTVLDVSFN 110

Query: 220 SITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI 279
            +T      +  L     L L+ N+L    P         KL+ LSL  N+ +  +P+ +
Sbjct: 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT--PKLEKLSLANNNLT-ELPAGL 167

Query: 280 --DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYN 319
              + NL     + L  N+    IP    G   +    L  N
Sbjct: 168 LNGLENLD---TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 43/190 (22%), Positives = 71/190 (37%), Gaps = 18/190 (9%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
           T L++S   L       +     LT+L L    L         L   +D  LP +  L L
Sbjct: 34  TILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-------TKLQ--VDGTLPVLGTLDL 84

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
           ++N+   ++         LT+L++  N  +      +  L  ++ L L     GN L  +
Sbjct: 85  SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK----GNELKTL 139

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
            P  +      LE+L ++N ++T     ++  L     L L+ N L       FG     
Sbjct: 140 PPGLLTPTP-KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSH--- 195

Query: 260 KLDTLSLCGN 269
            L    L GN
Sbjct: 196 LLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 21/81 (25%), Positives = 34/81 (41%), Gaps = 5/81 (6%)

Query: 289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF 348
           E+N  + N +  +P  +   KD   + L  N L      +    T L  L+L   +++  
Sbjct: 14  EVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-- 68

Query: 349 ILISLEKLLYLKKLNLSFNKL 369
            L     L  L  L+LS N+L
Sbjct: 69  KLQVDGTLPVLGTLDLSHNQL 89

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 35/164 (21%), Positives = 61/164 (37%), Gaps = 44/164 (26%)

Query: 483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKII--- 537
           +G+G  G V +        + A+K+              E E+     +  ++V+I+   
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 80

Query: 538 -SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRL--------------NIMIDVA 582
            +  +      +V+E +  G L             F R+               IM  + 
Sbjct: 81  ENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKSIG 127

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAK 623
            A++YL   H+  I H D+K  N+L      + I  L+DFG AK
Sbjct: 128 EAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 30/178 (16%), Positives = 66/178 (37%), Gaps = 16/178 (8%)

Query: 197 NGILPSSIVNLSISLERLYISNCSITGNIP--QVMGNLSIFLLLDLELNKLTGPIPVTFG 254
           +     +   ++ SL  + ++N ++T ++   +   N+     L +     T   P++  
Sbjct: 33  SSTANITEAQMN-SLTYITLANINVT-DLTGIEYAHNIKD---LTINNIHATNYNPIS-- 85

Query: 255 RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNI 314
               S L+ L + G   +       ++  L  +  +++S +     I   I  L  V +I
Sbjct: 86  --GLSNLERLRIMGKDVTSDKIP--NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 315 SLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGE 372
            L YN     I      L  L+ L++  + +       +E    L +L      + G+
Sbjct: 142 DLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 37/220 (16%), Positives = 70/220 (31%), Gaps = 43/220 (19%)

Query: 128 DLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL 187
           D          L  +  +   ++     + LT + L   + +      I    NI+ L +
Sbjct: 19  DSTFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLTG--IEYAHNIKDLTI 73

Query: 188 VIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG 247
                         + I  LS +LERL I    +T +    +  L               
Sbjct: 74  N----NIHATNY--NPISGLS-NLERLRIMGKDVTSDKIPNLSGL--------------- 111

Query: 248 PIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGG 307
                      + L  L +  ++   SI +   I  L  V  I+LS N    DI   +  
Sbjct: 112 -----------TSLTLLDISHSAHDDSILT--KINTLPKVNSIDLSYNGAITDIMP-LKT 157

Query: 308 LKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISG 347
           L +++++++ ++ +             L  L   +  I G
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 22/139 (15%), Positives = 56/139 (40%), Gaps = 11/139 (7%)

Query: 231 NLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEI 290
               +L   L  +       +T  ++ +  L  ++L   +    +     I     + ++
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNS--LTYITLANIN----VTDLTGIEYAHNIKDL 71

Query: 291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL 350
            ++  + + +    I GL +++ + +    +      +   LTSL +LD+S++     IL
Sbjct: 72  TINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 351 ISLEKLLYLKKLNLSFNKL 369
             +  L  +  ++LS+N  
Sbjct: 130 TKINTLPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 22/143 (15%), Positives = 49/143 (34%), Gaps = 18/143 (12%)

Query: 83  NISSLNLQG-EIPH--EIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
           +++ + L    +     I Y  ++  L +        N +SG         L N++ L +
Sbjct: 45  SLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNPISG---------LSNLERLRI 95

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
                +      ++  + LT+L++  ++    I   I  L  +  + L      N     
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS----YNGAITD 151

Query: 200 LPSSIVNLSISLERLYISNCSIT 222
           +   +  L   L+ L I    + 
Sbjct: 152 I-MPLKTLP-ELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 22/120 (18%), Positives = 45/120 (37%), Gaps = 14/120 (11%)

Query: 80  TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
             L I   ++  +    +  L SLT L +       +++   S+ ++I+  LP V ++ L
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDI------SHSAHDDSILTKIN-TLPKVNSIDL 143

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
           +YN     I  P+    +L  L +  +    +    I +   +  L          + G 
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL----YAFSQTIGGK 196

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 14/178 (7%)

Query: 206 NLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPV-TFGRLQNSKLDTL 264
           NL  S + L +S   +         +     +LDL   ++   I    +  L +  L TL
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSH--LSTL 81

Query: 265 SLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA-TIGGLKDVQNISLPYNRL-E 322
            L GN    S+        L  + ++     N +  +    IG LK ++ +++ +N +  
Sbjct: 82  ILTGNPIQ-SLALGA-FSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS 138

Query: 323 GPIPESFGYLTSLEILDLSNNKI---SGFILISLEKLLYLK-KLNLSFNKLEGEIPRG 376
             +PE F  LT+LE LDLS+NKI       L  L ++  L   L+LS N +   I  G
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 47/233 (20%), Positives = 91/233 (39%), Gaps = 19/233 (8%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
             +    +P  +     + K L L++N           +  +L +L+L            
Sbjct: 16  ELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVM-GNLSI 234
             +L ++  L L     GNP+  +   +   LS SL++L     ++  ++     G+L  
Sbjct: 72  YQSLSHLSTLIL----TGNPIQSLALGAFSGLS-SLQKLVAVETNLA-SLENFPIGHLKT 125

Query: 235 FLLLDLELNKLTG-PIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI--DIGNLKVV-VEI 290
              L++  N +    +P  F  L N  L+ L L  N    SI       +  + ++ + +
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTN--LEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSL 182

Query: 291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNN 343
           +LS N  +  I         ++ ++L  N+L+      F  LTSL+ + L  N
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 14/192 (7%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP-QVMGNLSIFLLLDLELNKLTGPI 249
           L  NPL  +   S  +    L+ L +S C I   I      +LS    L L  N +    
Sbjct: 35  LSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 250 PVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF-SGDIPATIGGL 308
              F  L  S L  L     + + S+ +   IG+LK + E+N++ N   S  +P     L
Sbjct: 93  LGAFSGL--SSLQKLVAVETNLA-SLENFP-IGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 309 KDVQNISLPYNRLEGPIPESFGYLTSLEI----LDLSNNKISGFILISLEKLLYLKKLNL 364
            +++++ L  N+++         L  + +    LDLS N ++ FI     K + LK+L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELAL 207

Query: 365 SFNKLEGEIPRG 376
             N+L+  +P G
Sbjct: 208 DTNQLK-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 51/251 (20%), Positives = 89/251 (35%), Gaps = 37/251 (14%)

Query: 63  SVCNWIGITCDVNSHRVTAL------NISSLNLQG----EIPHEI-GYLPSLTKLALGYN 111
            V     IT          +      +  +L+L       +        P L  L L   
Sbjct: 3   CVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62

Query: 112 SLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSG 170
            +        ++      +L ++  L L  N    ++     +  S L  L     + + 
Sbjct: 63  EI-------QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS 114

Query: 171 FIPNTIGNLRNIEWLGLVIGLIGNPLNGI-LPSSIVNLSISLERLYISNCSITGNIP--- 226
                IG+L+ ++ L +      N +    LP    NL+ +LE L +S+  I  +I    
Sbjct: 115 LENFPIGHLKTLKELNVA----HNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQ-SIYCTD 168

Query: 227 -QVMGNLSIFLL-LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNL 284
            +V+  + +  L LDL LN +    P  F  ++   L  L+L  N    S+P  I    L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR---LKELALDTNQLK-SVPDGI-FDRL 223

Query: 285 KVVVEINLSRN 295
             + +I L  N
Sbjct: 224 TSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 21/81 (25%), Positives = 35/81 (43%), Gaps = 13/81 (16%)

Query: 301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE-----K 355
           IP  +      +N+ L +N L      SF     L++LDLS  +I      ++E      
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-----TIEDGAYQS 74

Query: 356 LLYLKKLNLSFNKLEGEIPRG 376
           L +L  L L+ N ++  +  G
Sbjct: 75  LSHLSTLILTGNPIQ-SLALG 94

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 44/200 (22%), Positives = 86/200 (43%), Gaps = 25/200 (12%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK----VFHQE--CARAMKSFEVECEVMK 526
            + +   +LIG GS+GYVY A + +    VAIK    +F     C R ++    E  ++ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILN 80

Query: 527 NIRHRNLVK---IISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
            ++   +++   +I       F    +VLE   +  L     +   + +   +  I+ ++
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNL 138

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATI 641
                ++   H + IIH DLK +N LL++D    + DFG+A+ ++ E  +          
Sbjct: 139 LLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 642 GYMAPEYGIERK----VSTR 657
                   ++++    V TR
Sbjct: 196 EPGPHNKNLKKQLTSHVVTR 215

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.5 bits (171), Expect = 7e-13
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 40/209 (19%)

Query: 482 LIGIGSFGYVYKAEL----DDGIEVAIKVFHQECARAMKSFEVEC-----EVMKNIRHRN 532
           ++G G +G V++       + G   A+KV  +       + +         +++ ++H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKA-MIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SA 584
           +V +I          L+LEY+  G L          + + +    M D A         A
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL---------FMQLEREGIFMEDTACFYLAEISMA 133

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTLA-TI 641
           L +L   H   II+ DLK  N++L+     H  L+DFG+ K    +      T T   TI
Sbjct: 134 LGHL---HQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTFCGTI 185

Query: 642 GYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
            YMAPE  + R    R+ D +S G ++ +
Sbjct: 186 EYMAPEI-LMRSGHNRAVDWWSLGALMYD 213

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 69.1 bits (170), Expect = 9e-13
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 36/206 (17%)

Query: 482 LIGIGSFGYVYKAEL----DDGIEVAIKVFHQECARAMKSFEVECE--VMKNIRHRNLVK 535
           ++G GSFG V+  +     D     A+KV  +   +       + E  ++  + H  +VK
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------SALEY 587
           +      +    L+L+++  G L            + + +    +           AL++
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDL---------FTRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTL-ATIGYM 644
           L   H+  II+ DLK  N+LLDE+   H  L+DFG++K     ++      +   T+ YM
Sbjct: 142 L---HSLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGTVEYM 193

Query: 645 APEYGIERKVSTRS-DIYSYGIMLIE 669
           APE  + R+  T+S D +S+G+++ E
Sbjct: 194 APEV-VNRRGHTQSADWWSFGVLMFE 218

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 44/233 (18%)

Query: 461 TKRRLPYQDLSRATNRFGRDN-----LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARA 514
           T   +   D +   +R    +     ++G GSFG V  +E        A+K+  ++    
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60

Query: 515 MKSFEVECEVM-KNI-----RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM 568
               +VEC ++ K +     +   L ++ S     D    V+EY+  G L         M
Sbjct: 61  DD--DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---------M 109

Query: 569 LDIFQRLNIMIDVA--------SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSD 618
             I Q        A          L +L    +  II+ DLK  NV+LD +   H  ++D
Sbjct: 110 YHIQQVGRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSE--GHIKIAD 164

Query: 619 FGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
           FG+ K    +      T+T   T  Y+APE  I  +   +S D +++G++L E
Sbjct: 165 FGMCKENIWDGV---TTKTFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYE 213

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 19/197 (9%)

Query: 482 LIGIGSFGYVYKAELDDGIEV-AIKVFHQECARAMKSFEVECEVM-KNI-----RHRNLV 534
           ++G GSFG V  A + +  ++ A+KV  ++        +VEC +  K I      H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMTEKRILSLARNHPFLT 87

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++       D    V+E++  G L   +  S    +   R     ++ SAL +L   H  
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFL---HDK 143

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIERK 653
            II+ DLK  NVLLD +    L+DFG+ K       +   T T   T  Y+APE  ++  
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEI-LQEM 199

Query: 654 VSTRS-DIYSYGIMLIE 669
           +   + D ++ G++L E
Sbjct: 200 LYGPAVDWWAMGVLLYE 216

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 69.9 bits (170), Expect = 2e-12
 Identities = 83/611 (13%), Positives = 169/611 (27%), Gaps = 188/611 (30%)

Query: 150 SPITNASKL--TILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNL 207
             ++   +L  T+L         F+   +    N ++L   +  I        PS +   
Sbjct: 59  DAVSGTLRLFWTLLSKQEEMVQKFVEEVLR--INYKFL---MSPIKTEQRQ--PSMM--- 108

Query: 208 SISLERLYISNCSITGNIPQVMGNLSI-----FLLLDLELNKLTGPIP-VT------FGR 255
                R+YI       N  QV    ++     +L L   L +L  P   V        G+
Sbjct: 109 ----TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR-PAKNVLIDGVLGSGK 163

Query: 256 LQNSKLDTLSLCGNS-----FSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKD 310
              + +  L +C +          I   +++ N      +          I        D
Sbjct: 164 ---TWV-ALDVCLSYKVQCKMDFKI-FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 311 -VQNISLPYNRLEGPIPESF---GYLTSLEILD-LSNNK-ISGF-----ILI-------- 351
              NI L  + ++  +        Y   L +L  + N K  + F     IL+        
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278

Query: 352 -----SLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKH 406
                +    + L   +++    E +         +       + +   LP  +V     
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVK----SLLLKYL------DCRPQDLPR-EV--LT- 324

Query: 407 QTRPKSSKKMILLVIVLPLSAALIAVVV----------LALKYKSTRRGKSTGLSNGGIL 456
                            P   ++IA  +            +          + L+     
Sbjct: 325 ---------------TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV---- 365

Query: 457 LSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARA 514
           L  A  R++ +  LS     F     I       ++   +   + V +   H+     + 
Sbjct: 366 LEPAEYRKM-FDRLSV----FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420

Query: 515 MKS---------FEVECEVMKNIR-HRNLV---KIISGCSNDDFKALVLE-YMPNGSLDI 560
            K           E++ ++      HR++V    I     +DD     L+ Y        
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-------F 473

Query: 561 FLY--------SSTCMLDIFQRLNIMIDVASALEYLNF-------RHTTPIIHCDLKSSN 605
           + +             + +F+ +           +L+F       RH +   +      N
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMV-----------FLDFRFLEQKIRHDSTAWNASGSILN 522

Query: 606 VLLD---------------EDMIAHLSDFGI---AKLLSGEDQSMTQTQTLATIGYMAPE 647
            L                 E ++  + DF       L+  +   + +      I  MA +
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR------IALMAED 576

Query: 648 YGI----ERKV 654
             I     ++V
Sbjct: 577 EAIFEEAHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 9e-06
 Identities = 56/347 (16%), Positives = 103/347 (29%), Gaps = 96/347 (27%)

Query: 450 LSNGGIL--LSQATKRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVF 507
                IL     A       +D+         D    I S     K E+D  I       
Sbjct: 16  YQYKDILSVFEDAFVDNFDCKDVQ--------DMPKSILS-----KEEIDHIIMSK---- 58

Query: 508 HQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV--LEYMPNG-SLDIFLYS 564
               +  ++ F       + +  + + +++      ++K L+  ++      S+   +Y 
Sbjct: 59  -DAVSGTLRLFWTLLSKQEEMVQKFVEEVL----RINYKFLMSPIKTEQRQPSMMTRMYI 113

Query: 565 STCMLD-------IFQRLNI-----MIDVASALEYLNFRHTTPIIHCDL---KSS---NV 606
                D       +F + N+      + +  AL  L       +I   L   K+    +V
Sbjct: 114 EQ--RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR-PAKNVLIDGVLGSGKTWVALDV 170

Query: 607 LLDEDMIAHLSDFGIAKLLSGEDQS----MTQTQTLATIGYMAPEY--GIERKVSTRSDI 660
            L   +   + DF I  L      S    +   Q L     + P +    +   + +  I
Sbjct: 171 CLSYKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKLLYQ--IDPNWTSRSDHSSNIKLRI 227

Query: 661 YS-------------YGIML-----------IETF---------TRKKP-ADKMFAA--- 683
           +S             Y   L              F         TR K   D + AA   
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287

Query: 684 ELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAM 730
            +SL H    L P  +  ++ K L   P+     +E    +   L++
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDL--PREVLTTNPRRLSI 332

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 52/229 (22%), Positives = 94/229 (41%), Gaps = 30/229 (13%)

Query: 458 SQATKRRLPYQDLSRATNRFGRDN-----LIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC 511
            +  K  +  ++  +A++  G  +     +IG GS+  V    L       A++V  +E 
Sbjct: 30  IEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL 89

Query: 512 ARAMKSFEVECEVM-KNI-----RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS 565
               +  +++     K++      H  LV + S    +     V+EY+  G  D+  +  
Sbjct: 90  VNDDE--DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG--DLMFHMQ 145

Query: 566 TCMLDIF--QRLNIMI-DVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA 622
                    +       +++ AL YL   H   II+ DLK  NVLLD +    L+D+G+ 
Sbjct: 146 RQ--RKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

Query: 623 KLLSGEDQSMTQTQTL-ATIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
           K           T T   T  Y+APE  +  +    S D ++ G+++ E
Sbjct: 201 KEGLRPGD---TTSTFCGTPNYIAPEI-LRGEDYGFSVDWWALGVLMFE 245

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 31/203 (15%)

Query: 482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVM--KNI-----RHRNL 533
           ++G GSFG V+ AE        AIK   ++        +VEC  M  K +      H  L
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVEC-TMVEKRVLSLAWEHPFL 80

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF--QRLNIMI-DVASALEYLNF 590
             +       +    V+EY+  G  D+  +  +C    F   R      ++   L++L  
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGG--DLMYHIQSC--HKFDLSRATFYAAEIILGLQFL-- 134

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPE 647
            H+  I++ DLK  N+LLD+D   H  ++DFG+ K     D     T T   T  Y+APE
Sbjct: 135 -HSKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE 188

Query: 648 YGIERKVSTRS-DIYSYGIMLIE 669
             +  +    S D +S+G++L E
Sbjct: 189 I-LLGQKYNHSVDWWSFGVLLYE 210

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 21/198 (10%)

Query: 482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVM--KNI-----RHRNL 533
           +IG GS+  V    L       A+KV  +E     +  +++  V   K++      H  L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--DIDW-VQTEKHVFEQASNHPFL 72

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V + S    +     V+EY+  G L   +     + +   R     +++ AL YL   H 
Sbjct: 73  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYL---HE 128

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL-ATIGYMAPEYGIER 652
             II+ DLK  NVLLD +    L+D+G+ K           T T   T  Y+APE  +  
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEI-LRG 184

Query: 653 KVSTRS-DIYSYGIMLIE 669
           +    S D ++ G+++ E
Sbjct: 185 EDYGFSVDWWALGVLMFE 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 49/212 (23%)

Query: 482 LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVM------KNIRHRNLV 534
           +IG GSFG V  A    + +  A+KV  ++     K  E +  +       KN++H  LV
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMSERNVLLKNVKHPFLV 102

Query: 535 KIISGCSNDDFKALVLEYMPNGSL-------DIFL------YSSTCMLDIFQRLNIMIDV 581
            +       D    VL+Y+  G L         FL      Y++              ++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EI 148

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTL- 638
           ASAL YL   H+  I++ DLK  N+LLD     H  L+DFG+ K     + +   T T  
Sbjct: 149 ASALGYL---HSLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFC 200

Query: 639 ATIGYMAPEYGIERKVSTRS-DIYSYGIMLIE 669
            T  Y+APE  + ++   R+ D +  G +L E
Sbjct: 201 GTPEYLAPEV-LHKQPYDRTVDWWCLGAVLYE 231

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.9 bits (164), Expect = 6e-12
 Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 46/214 (21%)

Query: 482 LIGIGSFGYVYKAELDDGIEV----AIKVFHQECARAMKSFEVEC-----EVMKNIRHRN 532
           ++G G++G V+      G +     A+KV  +      K+   E      +V+++IR   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA-TIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 533 -LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA--------S 583
            LV +      +    L+L+Y+  G L            + QR                 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL---------FTHLSQRERFTEHEVQIYVGEIVL 170

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTLATI 641
           ALE+L   H   II+ D+K  N+LLD +   H  L+DFG++K    ++          TI
Sbjct: 171 ALEHL---HKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD-FCGTI 224

Query: 642 GYMAPE------YGIERKVSTRSDIYSYGIMLIE 669
            YMAP+       G ++ V    D +S G+++ E
Sbjct: 225 EYMAPDIVRGGDSGHDKAV----DWWSLGVLMYE 254

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 49/240 (20%), Positives = 87/240 (36%), Gaps = 39/240 (16%)

Query: 131 LPNVKALSLAYNRFSGTIQSPI-TNASKLTILELGGNSFSGFIP-NTIGNLRNIEWLGLV 188
            P+ + L L       TI S   +N   ++ + +  +     +  ++  NL  +  + + 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI- 87

Query: 189 IGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQV--MGNLSIFLLLDLELNKLT 246
                  L  I P ++  L   L+ L I N  +    P +  + +  IF +L++  N   
Sbjct: 88  --RNTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143

Query: 247 GPIPV-TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI 305
             IPV  F  L N    TL L  N F+ S+       N   +  + L++N +   I    
Sbjct: 144 TSIPVNAFQGLCNE-TLTLKLYNNGFT-SVQG--YAFNGTKLDAVYLNKNKYLTVID--- 196

Query: 306 GGLKDVQNISLPYNRLEGPIPESFGYLTS-LEILDLSNNKISGFILISLEKLLYLKKLNL 364
                                ++FG + S   +LD+S   ++      LE L  L   N 
Sbjct: 197 --------------------KDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 34/195 (17%), Positives = 65/195 (33%), Gaps = 16/195 (8%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYIS-NCSITGNIPQVMGNLSIFLLLDLELNKLTGPI 249
           LI   L  I   +  NL  ++ R+Y+S + ++         NLS    +++   +    I
Sbjct: 38  LIETHLRTIPSHAFSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96

Query: 250 PV-TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA-TIGG 307
                  L    L  L +         P    + +  +   + ++ N +   IP     G
Sbjct: 97  DPDALKEL--PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153

Query: 308 L-KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNK----ISGFILISLEKLLYLKKL 362
           L  +   + L  N     +       T L+ + L+ NK    I       +        L
Sbjct: 154 LCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP--SLL 210

Query: 363 NLSFNKLEGEIPRGG 377
           ++S   +   +P  G
Sbjct: 211 DVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 25/119 (21%), Positives = 41/119 (34%), Gaps = 5/119 (4%)

Query: 261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYN 319
             TL L       +IPS     NL  +  I +S +     + +     L  V +I +   
Sbjct: 33  TQTLKLIETHLR-TIPSH-AFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 320 RLEGPIP-ESFGYLTSLEILDLSNNKISGF-ILISLEKLLYLKKLNLSFNKLEGEIPRG 376
           R    I  ++   L  L+ L + N  +  F  L  +        L ++ N     IP  
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 44/242 (18%), Positives = 85/242 (35%), Gaps = 25/242 (10%)

Query: 128 DLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGL 187
           D A       +L     +          + +  +    +         I  L N+  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75

Query: 188 VIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG 247
                GN L  I    + NL  +L  L++    +  ++   + +L     L LE N ++ 
Sbjct: 76  N----GNKLTDI--KPLANLK-NLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISD 126

Query: 248 PIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGG 307
              +        +L++L L  N     I     +  L  +  ++L  N  S DI   + G
Sbjct: 127 INGLV----HLPQLESLYLGNNK----ITDITVLSRLTKLDTLSLEDNQIS-DIVP-LAG 176

Query: 308 LKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFN 367
           L  +QN+ L  N +      +   L +L++L+L + +     +     L+    +  +  
Sbjct: 177 LTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234

Query: 368 KL 369
            L
Sbjct: 235 SL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 25/202 (12%)

Query: 173 PNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS--ISLERLYISNCSITGNIP--QV 228
           P  I  + + +        I + L     +  V  +   S++++  +N  I  ++   Q 
Sbjct: 11  PTPIKQIFSDDAF---AETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQGIQY 66

Query: 229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV 288
           + N++    L L  NKLT   P+         L  L L  N     +     + +LK + 
Sbjct: 67  LPNVTK---LFLNGNKLTDIKPLA----NLKNLGWLFLDENK----VKDLSSLKDLKKLK 115

Query: 289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF 348
            ++L  N  S DI   +  L  ++++ L  N++          LT L+ L L +N+IS  
Sbjct: 116 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD- 170

Query: 349 ILISLEKLLYLKKLNLSFNKLE 370
            ++ L  L  L+ L LS N + 
Sbjct: 171 -IVPLAGLTKLQNLYLSKNHIS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 37/181 (20%), Positives = 71/181 (39%), Gaps = 21/181 (11%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIP 250
            +  P+  I        +    +  +   S+T  + Q    L+    +    + +     
Sbjct: 9   TVPTPIKQIFSDD--AFA-ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK---- 59

Query: 251 VTFGRLQN-SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK 309
            +   +Q    +  L L GN     +     + NLK +  + L  N    D+ + +  LK
Sbjct: 60  -SVQGIQYLPNVTKLFLNGNK----LTDIKPLANLKNLGWLFLDENKVK-DLSS-LKDLK 112

Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
            ++++SL +N +         +L  LE L L NNKI+   +  L +L  L  L+L  N++
Sbjct: 113 KLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 168

Query: 370 E 370
            
Sbjct: 169 S 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 53/299 (17%), Positives = 100/299 (33%), Gaps = 45/299 (15%)

Query: 70  ITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDL 129
           I  D         N+   ++   +      L S+ ++    + +     +          
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQY-------- 66

Query: 130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVI 189
            LPNV  L L  N+ +     P+ N   L  L L  N         + +L+ ++ L L  
Sbjct: 67  -LPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSL-- 119

Query: 190 GLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPI 249
               N ++ I  + +V+L   LE LY+ N  IT +I  V+  L+    L LE N+++  +
Sbjct: 120 --EHNGISDI--NGLVHLP-QLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIV 172

Query: 250 PVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK 309
           P+       +KL  L L  N     I     +  LK +  + L               L 
Sbjct: 173 PLA----GLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 224

Query: 310 DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNK 368
               +      L             +    +S++       +      +  +++  F +
Sbjct: 225 VPNTVKNTDGSL-------------VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQ 270

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 63/295 (21%), Positives = 100/295 (33%), Gaps = 81/295 (27%)

Query: 83  NISSLNLQG-EIPH--EIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSL 139
           +I  +     +I     I YLP++TKL L  N L     L+          L N+  L L
Sbjct: 47  SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLAN---------LKNLGWLFL 97

Query: 140 AYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI 199
             N+    + S + +  KL  L L  N            + +I  L              
Sbjct: 98  DENKVK-DL-SSLKDLKKLKSLSLEHN-----------GISDINGLV------------- 131

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLE-LNKLTGPIPVTFGRLQN 258
                 +L   LE LY+ N  IT                D+  L++LT            
Sbjct: 132 ------HLP-QLESLYLGNNKIT----------------DITVLSRLT------------ 156

Query: 259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY 318
            KLDTLSL  N  S  I     +  L+    + LS+N+ S D+ A + GLK++  + L  
Sbjct: 157 -KLDTLSLEDNQIS-DIVPLAGLTKLQ---NLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI 373
                        L     +  ++  +    +IS +       +     +   E+
Sbjct: 210 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 31/174 (17%), Positives = 63/174 (36%), Gaps = 31/174 (17%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE---------LDDGIEVAIKV------FHQECA---RAMK 516
            ++   +     + G +Y+A               + ++K+         E     RA K
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 517 SFEVECEV-MKNIRHRNLVKII-SGCSNDDFKALVLEYMPNG-SL-DIFLYSSTCMLDIF 572
             +V     + +     +   +  G   D ++ LVL  +  G SL      S   +L   
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER 159

Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAK 623
             L +   +  ALE+L   H    +H ++ + N+ +   D+  +  L+ +G A 
Sbjct: 160 SVLQVACRLLDALEFL---HENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 31/165 (18%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRH-RN 532
             F     IG G+FG +   + L     VAIK+   +         +E    K +     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66

Query: 533 LVKIISGCSNDDFKALVLEYMPNG-SL-DIFLY-------SSTCMLDIFQRLNIMIDVAS 583
           + ++        + A+VLE +  G SL D+F          +  M+ I Q    +I   S
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAI-Q----LI---S 116

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLL-----DEDMIAHLSDFGIAK 623
            +EY+   H+  +I+ D+K  N L+         + H+ DF +AK
Sbjct: 117 RMEYV---HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 8/114 (7%)

Query: 257 QNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISL 316
           + + +  L L     +  +     +  L +V  ++LS N     +P  +  L+ ++ +  
Sbjct: 439 EYADVRVLHLAHKDLT-VLCH---LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQA 493

Query: 317 PYNRLEGPIPESFGYLTSLEILDLSNNKISGF-ILISLEKLLYLKKLNLSFNKL 369
             N LE    +    L  L+ L L NN++     +  L     L  LNL  N L
Sbjct: 494 SDNALE--NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.3 bits (148), Expect = 7e-10
 Identities = 35/216 (16%), Positives = 66/216 (30%), Gaps = 23/216 (10%)

Query: 189 IGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGP 248
                           V  S  L+    S   +    P+    L   +LL   L+ L   
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE 401

Query: 249 IPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV---EINLSRNNFSGDIPATI 305
                       +D +         S     +            ++L+  + +  +   +
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-L 459

Query: 306 GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLS 365
             L  V ++ L +NRL   +P +   L  LE+L  S+N +    +  +  L  L++L L 
Sbjct: 460 EQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE--NVDGVANLPRLQELLLC 516

Query: 366 FNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQV 401
            N+L+                    + L   P L +
Sbjct: 517 NNRLQ---------------QSAAIQPLVSCPRLVL 537

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 54.0 bits (129), Expect = 1e-07
 Identities = 41/297 (13%), Positives = 87/297 (29%), Gaps = 22/297 (7%)

Query: 51  TNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGY 110
              L            W           V   ++ + +L  ++P     +      +   
Sbjct: 271 MGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKE 330

Query: 111 NSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSG 170
             L+ +        S  D  L       L+  + S  +QS + +  +L  LE        
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFR---CELSVEK-STVLQSELESCKELQELEP---ENKW 383

Query: 171 FIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMG 230
            +   I  +R ++ L      +    + +     +  +   +         +    +   
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQY-FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD 442

Query: 231 NLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEI 290
                  L L    LT        +L    +  L L  N    ++P  +    L+ +  +
Sbjct: 443 VRV----LHLAHKDLTVLCH--LEQLLL--VTHLDLSHNRLR-ALPPAL--AALRCLEVL 491

Query: 291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEG-PIPESFGYLTSLEILDLSNNKIS 346
             S N    ++   +  L  +Q + L  NRL+     +       L +L+L  N + 
Sbjct: 492 QASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 32/222 (14%), Positives = 75/222 (33%), Gaps = 28/222 (12%)

Query: 150 SPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS- 208
            P    +      LG  S +  +      L  ++             + I   S+  +  
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDN-------SNI--QSLAGMQF 61

Query: 209 -ISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLC 267
             +L+ L++S+  I+ ++  +  +L+    L +  N+L          + ++ L  L L 
Sbjct: 62  FTNLKELHLSHNQIS-DLSPL-KDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLD 114

Query: 268 GNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPE 327
            N     +     + +LK +  +++  N     I   +G L  ++ + L  N +      
Sbjct: 115 NNE----LRDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--G 166

Query: 328 SFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
               L  +  +DL+  K     +    +L     +     + 
Sbjct: 167 GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 53/284 (18%), Positives = 91/284 (32%), Gaps = 46/284 (16%)

Query: 97  IGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS 156
              L +  K  LG  S+    S            L  V+  +   +    ++ + +   +
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVSQKE---------LSGVQNFNGDNSNIQ-SL-AGMQFFT 63

Query: 157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYI 216
            L  L L  N  S   P  + +L  +E L +      N L  +        S  L RL++
Sbjct: 64  NLKELHLSHNQISDLSP--LKDLTKLEELSVN----RNRLKNLNGIP----SACLSRLFL 113

Query: 217 SNCSITGNIP-QVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSI 275
            N  +        + NL I   L +  NKL   + +       SKL+ L L GN     I
Sbjct: 114 DNNELRDTDSLIHLKNLEI---LSIRNNKLKSIVMLG----FLSKLEVLDLHGNE----I 162

Query: 276 PSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL 335
            +   +  LK V  I+L+      +       L     +  P  R              +
Sbjct: 163 TNTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW-------------I 209

Query: 336 EILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPF 379
               +SN        +  E  +Y  +++  F++          F
Sbjct: 210 SPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAIF 253

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 37/180 (20%), Positives = 72/180 (40%), Gaps = 24/180 (13%)

Query: 193 GNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVT 252
             P+N + P     L+ +  +  +   S+T  + Q    LS     + + + +     + 
Sbjct: 6   PTPINQVFP--DPGLA-NAVKQNLGKQSVTDLVSQ--KELSGVQNFNGDNSNIQSLAGMQ 60

Query: 253 FGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDV- 311
                 + L  L L  N     I     + +L  + E++++RN         + G+    
Sbjct: 61  ----FFTNLKELHLSHNQ----ISDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSAC 107

Query: 312 -QNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
              + L  N L     +S  +L +LEIL + NNK+    ++ L  L  L+ L+L  N++ 
Sbjct: 108 LSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT 163

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 47/226 (20%), Positives = 85/226 (37%), Gaps = 52/226 (23%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSF----EVECEVMKNIRHRNLVKI 536
            +G G F  V+ A+ + +   VA+K+      R  K +    E E ++++ +   +  K 
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 537 ISGCSN------DDFKA---------LVLEYMPNGSLDIFLYSSTCMLDIFQRLN----- 576
            S  +N      D F           +V E +   +L   +          + +      
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-----HRGIPLIYVK 134

Query: 577 -IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH------LSDFGIAKLLSGED 629
            I   +   L+Y++ R    IIH D+K  NVL++            ++D G A      D
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYD 189

Query: 630 QSMTQT-QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK 674
           +  T + QT     Y +PE  +       +DI+S   ++ E  T  
Sbjct: 190 EHYTNSIQTRE---YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 42/193 (21%), Positives = 71/193 (36%), Gaps = 23/193 (11%)

Query: 85  SSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLA-LPNVKALSLAYNR 143
           S   L   +P  +        L L +N+L         L +      L N+ +L L++N 
Sbjct: 26  SKQQLP-NVPQSL--PSYTALLDLSHNNL-------SRLRAEWTPTRLTNLHSLLLSHNH 75

Query: 144 FSGTIQSPI-TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPS 202
            +  I S        L  L+L  N           +L+ +E L L      N +  +  +
Sbjct: 76  LN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY----NNHIVVVDRN 130

Query: 203 SIVNLSISLERLYISNCSITGNIP----QVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN 258
           +  +++  L++LY+S   I+   P    +    L   +LLDL  NKL         +L  
Sbjct: 131 AFEDMA-QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188

Query: 259 SKLDTLSLCGNSF 271
              + L L  N  
Sbjct: 189 WVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 17/147 (11%)

Query: 238 LDLELNKLTG-PIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIG---NLKVVVEINLS 293
           LDL  N L+      T  RL N  L +L L  N  +  I S         +  +  ++LS
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTN--LHSLLLSHNHLN-FISS----EAFVPVPNLRYLDLS 96

Query: 294 RNNFSGDIPA-TIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF---I 349
            N+    +       L+ ++ + L  N +      +F  +  L+ L LS N+IS F   +
Sbjct: 97  SNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVEL 155

Query: 350 LISLEKLLYLKKLNLSFNKLEGEIPRG 376
           +    KL  L  L+LS NKL+ ++P  
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLK-KLPLT 181

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 39/181 (21%), Positives = 59/181 (32%), Gaps = 33/181 (18%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP-QVMGNLSIFLLLDLELNKLTGPI 249
           L  N L+ +          +L  L +S+  +   I  +    +     LDL  N L    
Sbjct: 46  LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLD 104

Query: 250 PVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK 309
              F  L    L+ L L  N     +                  RN F          + 
Sbjct: 105 EFLFSDL--QALEVLLLYNNHIV-VVD-----------------RNAFED--------MA 136

Query: 310 DVQNISLPYNRLEGPIPESFG---YLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF 366
            +Q + L  N++     E       L  L +LDLS+NK+    L  L+KL    K  L  
Sbjct: 137 QLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196

Query: 367 N 367
           +
Sbjct: 197 H 197

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 54/243 (22%), Positives = 94/243 (38%), Gaps = 55/243 (22%)

Query: 461 TKRRLPYQDLSRATNRFGRD------NLIGIGSFGYVYKA-ELDDGIEVAIK----VFHQ 509
           T R   Y D       +G          +G G +  V++A  + +  +V +K    V  +
Sbjct: 16  THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK 75

Query: 510 ECARAMKSFEVECEVMKNIR-HRNLVKII----SGCSNDDFKALVLEYMPNGSLDIFLYS 564
           +  R       E ++++N+R   N++ +        S     ALV E++ N        +
Sbjct: 76  KIKR-------EIKILENLRGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQLYQT 126

Query: 565 ST---CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFG 620
            T       +++ L        AL+Y    H+  I+H D+K  NV++D E     L D+G
Sbjct: 127 LTDYDIRFYMYEILK-------ALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 176

Query: 621 IAKLLSGEDQSMTQTQTLATIGYMAPE-------YGIERKVSTRSDIYSYGIMLIETFTR 673
           +A+      Q       +A+  +  PE       Y          D++S G ML     R
Sbjct: 177 LAEFYH-PGQEY--NVRVASRYFKGPELLVDYQMY------DYSLDMWSLGCMLASMIFR 227

Query: 674 KKP 676
           K+P
Sbjct: 228 KEP 230

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 15/148 (10%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRH-RNLVKIISG 539
           IG GSFG +Y    +  G EVAIK    EC +       +E ++ K ++    +  I   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 540 CSNDDFKALVLEYMPNG-SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
            +  D+  +V+E +  G SL+      +    +   L +   + S +EY+   H+   IH
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIH 128

Query: 599 CDLKSSNVLL---DEDMIAHLSDFGIAK 623
            D+K  N L+    +  + ++ DFG+AK
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 12/182 (6%)

Query: 206 NLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPV-TFGRLQNSKLDTL 264
           N+    ++L + +  ++    +    L+   LL L  NKL   +P   F  L    L+TL
Sbjct: 34  NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKEL--KNLETL 90

Query: 265 SLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLEG 323
            +  N    ++P  +    L  + E+ L RN     +P  +   L  +  +SL YN L+ 
Sbjct: 91  WVTDNKLQ-ALPIGV-FDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS 147

Query: 324 PIPE-SFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANF 382
            +P+  F  LTSL+ L L NN++      + +KL  LK L L  N+L+  +P G  F + 
Sbjct: 148 -LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA-FDSL 204

Query: 383 TA 384
             
Sbjct: 205 EK 206

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 51/210 (24%), Positives = 75/210 (35%), Gaps = 33/210 (15%)

Query: 158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
              L+L  N  S         L  +  L L      N L   LP+ I     +LE L+++
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYL----NDNKLQT-LPAGIFKELKNLETLWVT 93

Query: 218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPS 277
           +  +      V   L     L L+ N+L    P  F  L  +KL  LSL  N    S+P 
Sbjct: 94  DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL--TKLTYLSLGYNELQ-SLPK 150

Query: 278 CIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEI 337
                              F          L  ++ + L  N+L+     +F  LT L+ 
Sbjct: 151 -----------------GVFDK--------LTSLKELRLYNNQLKRVPEGAFDKLTELKT 185

Query: 338 LDLSNNKISGFILISLEKLLYLKKLNLSFN 367
           L L NN++      + + L  LK L L  N
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.9 bits (112), Expect = 9e-06
 Identities = 40/171 (23%), Positives = 59/171 (34%), Gaps = 16/171 (9%)

Query: 100 LPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-TNASKL 158
           L  L  L L  N L        +LP+ I   L N++ L +  N+    +   +      L
Sbjct: 60  LTKLRLLYLNDNKLQ-------TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNL 111

Query: 159 TILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISN 218
             L L  N      P    +L  + +L L      N L  +       L+ SL+ L + N
Sbjct: 112 AELRLDRNQLKSLPPRVFDSLTKLTYLSLG----YNELQSLPKGVFDKLT-SLKELRLYN 166

Query: 219 CSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGN 269
             +          L+    L L+ N+L       F  L   KL  L L  N
Sbjct: 167 NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL--EKLKMLQLQEN 215

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 41/212 (19%), Positives = 78/212 (36%), Gaps = 44/212 (20%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRH-RNLVKIISG 539
           IG GSFG +++   L +  +VAIK    E  R+       E    K +     +  +   
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 540 CSNDDFKALV-------LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
                   LV       LE + +     F   +  M    Q    M+   + ++ +   H
Sbjct: 75  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAK-Q----ML---ARVQSI---H 123

Query: 593 TTPIIHCDLKSSNVLLDEDM-----IAHLSDFGIAK----------LLSGEDQSMTQTQT 637
              +++ D+K  N L+         + ++ DFG+ K          +   E ++++ T  
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIE 669
             +I       G E+  S R D+ + G + + 
Sbjct: 184 YMSI---NTHLGREQ--SRRDDLEALGHVFMY 210

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.5 bits (147), Expect = 8e-10
 Identities = 49/231 (21%), Positives = 96/231 (41%), Gaps = 40/231 (17%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIK----VFHQE--CARAMKSFEVECEVMK 526
             ++     +G G++G V+K+ +   G  VA+K     F       R  +    E  ++ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILT 63

Query: 527 NIR-HRNLVKIISGCSNDDFKA--LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVAS 583
            +  H N+V +++    D+ +   LV +YM    L   + ++       Q   ++  +  
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQ--YVVYQLIK 120

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ--------- 634
            ++YL   H+  ++H D+K SN+LL+ +    ++DFG+++      +             
Sbjct: 121 VIKYL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 635 ----------TQTLATIGYMAPEYGIERKVSTRS-DIYSYGIMLIETFTRK 674
                     T  +AT  Y APE  +     T+  D++S G +L E    K
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.0 bits (139), Expect = 4e-09
 Identities = 35/198 (17%), Positives = 57/198 (28%), Gaps = 52/198 (26%)

Query: 473 ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKV--------FHQECARAMKSFEVECEV 524
            T +  R   IG G FG V++    D   VAIK+         +    +  +    E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 525 MKNI---------RHRNLVKIISGC------------------------------SNDDF 545
            K +         R    + + S                                  DD 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSN 605
             +VLE+   G         T +  +    +I+  + ++L            H DL   N
Sbjct: 137 LFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGN 192

Query: 606 VLLDEDMIAHLSDFGIAK 623
           VLL +  +  L      K
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 35/175 (20%), Positives = 69/175 (39%), Gaps = 47/175 (26%)

Query: 482 LIGIGSFGYVYKA------ELDDGIEVAIKVFHQEC------ARAMKSFEVECEVMKNIR 529
            IG G FG +Y A       +       +KV   +        +  +      ++ K IR
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 530 HRNLVKI---------ISGCSNDDFKALVLEYMPNG-SL-DIFLY-------SSTCMLDI 571
            R L  +         +   +   ++ ++++    G  L  I+          +   L +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAK 623
            +    ++D+   LEY+   H    +H D+K+SN+LL   + D + +L D+G+A 
Sbjct: 160 -R----ILDI---LEYI---HEHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 31/156 (19%)

Query: 483 IGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRHRNLV-KIISG 539
           IG GSFG +Y    +    EVAIK    E  +        E ++ + ++    +  +   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 540 CSNDDFKALVLEYMPNG-SL-DIFLY-------SSTCMLDIFQRLNIMIDVASALEYLNF 590
               D+  LV++ +  G SL D+F +        +  ML   Q    MI   + +E++  
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLAD-Q----MI---NRVEFV-- 119

Query: 591 RHTTPIIHCDLKSSNVLLDEDM---IAHLSDFGIAK 623
            H+   +H D+K  N L+         ++ DFG+AK
Sbjct: 120 -HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 54/307 (17%), Positives = 109/307 (35%), Gaps = 43/307 (14%)

Query: 102 SLTKLALGYNSL--VGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGT-----IQSPITN 154
            + KL+L    L   G   LS +L +     LP ++ L L+ N           +  +  
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRT-----LPTLQELHLSDNLLGDAGLQLLCEGLLDP 140

Query: 155 ASKLTILELGGNSFS----GFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS 210
             +L  L+L   S S      + + +    + + L +    I      +L   + +    
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200

Query: 211 LERLYISNCSIT----GNIPQVMGNLSIFLLLDLELNKLT--GPIPVTFGRLQ-NSKLDT 263
           LE L + +C +T     ++  ++ + +    L L  NKL   G   +  G L  +S+L T
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260

Query: 264 LSLCGNSFSGSIPSCIDIG----NLKVVVEINLSRNNFSGD-IPATIGGLKDV----QNI 314
           L +     +     C D+       + + E++L+ N    +        L +     +++
Sbjct: 261 LWIWECGITAK--GCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318

Query: 315 SLPYNRL--EG--PIPESFGYLTSLEILDLSNNKI--SGFILIS--LEKLLY-LKKLNLS 365
            +                      L  L +SNN++  +G   +   L +    L+ L L+
Sbjct: 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 378

Query: 366 FNKLEGE 372
              +   
Sbjct: 379 DCDVSDS 385

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.5 bits (124), Expect = 6e-07
 Identities = 57/307 (18%), Positives = 112/307 (36%), Gaps = 43/307 (14%)

Query: 102 SLTKLALGYNSL--VGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPI-----TN 154
            L KL L Y SL       L+  L +      P+ K L+++ N  +      +      +
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRA-----KPDFKELTVSNNDINEAGVRVLCQGLKDS 197

Query: 155 ASKLTILELGGNSFS----GFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS 210
             +L  L+L     +      +   + +  ++  L L    +G+     L   +++ S  
Sbjct: 198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257

Query: 211 LERLYISNCSIT----GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFG---RLQNSKLDT 263
           L  L+I  C IT    G++ +V+        L L  N+L                 +L++
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317

Query: 264 LSLCGNSFSGSIPSCIDIGNL----KVVVEINLSRNNFSGDIPATIG-GLKDV----QNI 314
           L +   SF+ +   C    ++    + ++E+ +S N         +  GL       + +
Sbjct: 318 LWVKSCSFTAA--CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375

Query: 315 SLPYNRL--EG--PIPESFGYLTSLEILDLSNNKI--SGFILIS--LEKLLY-LKKLNLS 365
            L    +       +  +     SL  LDLSNN +  +G + +   + +    L++L L 
Sbjct: 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 435

Query: 366 FNKLEGE 372
                 E
Sbjct: 436 DIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 49/300 (16%), Positives = 90/300 (30%), Gaps = 61/300 (20%)

Query: 102 SLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGT----IQSPITNASK 157
            +  L +    L  +   +  LP      L   + + L     +      I S +     
Sbjct: 4   DIQSLDIQCEEL-SDARWAELLP-----LLQQCQVVRLDDCGLTEARCKDISSALRVNPA 57

Query: 158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
           L  L L  N                         +G+     +   +   S  +++L + 
Sbjct: 58  LAELNLRSNE------------------------LGDVGVHCVLQGLQTPSCKIQKLSLQ 93

Query: 218 NCSIT----GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRL---QNSKLDTLSLCGNS 270
           NC +T    G +   +  L     L L  N L                 +L+ L L   S
Sbjct: 94  NCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCS 153

Query: 271 FSGSIPSCIDIG----NLKVVVEINLSRNNFSGDIPATIG-GLKD----VQNISLPYNRL 321
            S +  SC  +           E+ +S N+ +      +  GLKD    ++ + L    +
Sbjct: 154 LSAA--SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211

Query: 322 --EG--PIPESFGYLTSLEILDLSNNKI--SGFILIS---LEKLLYLKKLNLSFNKLEGE 372
             +    +        SL  L L +NK+   G   +    L     L+ L +    +  +
Sbjct: 212 TSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 50/288 (17%), Positives = 94/288 (32%), Gaps = 52/288 (18%)

Query: 102 SLTKLALGYNSL--VGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGT-----IQSPITN 154
            L  L L    +       L G + S       +++ L+L  N+             +  
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVAS-----KASLRELALGSNKLGDVGMAELCPGLLHP 254

Query: 155 ASKLTILELGGNSFS----GFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS 210
           +S+L  L +     +    G +   +    +++ L L    +G+    +L  +++     
Sbjct: 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ 314

Query: 211 LERLYISNCSITG----NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRL---QNSKLDT 263
           LE L++ +CS T     +   V+      L L +  N+L         +      S L  
Sbjct: 315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 374

Query: 264 LSLCGNSFSGSIPSCIDIG----NLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYN 319
           L L     S S  SC  +         + E++LS N           G   +  +     
Sbjct: 375 LWLADCDVSDS--SCSSLAATLLANHSLRELDLSNNCL---------GDAGILQLV---E 420

Query: 320 RLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLL----YLKKLN 363
            +  P          LE L L +   S  +   L+ L      L+ ++
Sbjct: 421 SVRQPG-------CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 36/173 (20%), Positives = 69/173 (39%), Gaps = 46/173 (26%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKI---- 536
            IG G FG +Y A   +   + A  V   E          E +  + +  ++ +K     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDCIKKWIER 102

Query: 537 ---------------ISGCSNDDFKALVLEYMPNG-SL-DIFLYS------STCMLDIFQ 573
                          ++      ++ +V+E +  G  L  I   +      +   L I +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGI-R 159

Query: 574 RLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAK 623
               M+DV   LEY+   H    +H D+K++N+LL   + D + +L+D+G++ 
Sbjct: 160 ----MLDV---LEYI---HENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 50/224 (22%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSF----EVECEVMKNI 528
             R+    +IG GSFG V KA        VA+K+      R  K F      E  +++++
Sbjct: 96  AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKM-----VRNEKRFHRQAAEEIRILEHL 150

Query: 529 RHR------NLVKIISGCSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLN- 576
           R +      N++ ++     ++F       +  E      L + LY        FQ  + 
Sbjct: 151 RKQDKDNTMNVIHML-----ENFTFRNHICMTFE-----LLSMNLYELIKKNK-FQGFSL 199

Query: 577 -----IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGED 629
                    +   L+ L   H   IIHCDLK  N+LL +   +   + DFG +     E 
Sbjct: 200 PLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EH 253

Query: 630 QSMTQT-QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
           Q +    Q+     Y APE  +  +     D++S G +L E  T
Sbjct: 254 QRVYTYIQSRF---YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 4/116 (3%)

Query: 262 DTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNR 320
             L L  N F+  + +      L  + +IN S N  + DI      G   V  I L  NR
Sbjct: 35  AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNR 92

Query: 321 LEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG 376
           LE    + F  L SL+ L L +N+I+     S   L  ++ L+L  N++   +  G
Sbjct: 93  LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 28/142 (19%), Positives = 54/142 (38%), Gaps = 11/142 (7%)

Query: 206 NLSISLERLYISNCSITGNIPQ-VMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTL 264
           ++      L ++N   T      +   L     ++   NK+T      F       ++ +
Sbjct: 29  HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG--VNEI 86

Query: 265 SLCGNSFSGSIPSCI--DIGNLKVVVEINLSRNNFSGDIPA-TIGGLKDVQNISLPYNRL 321
            L  N    ++   +   + +LK    + L  N  +  +   +  GL  V+ +SL  N++
Sbjct: 87  LLTSNRLE-NVQHKMFKGLESLK---TLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141

Query: 322 EGPIPESFGYLTSLEILDLSNN 343
               P +F  L SL  L+L  N
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLAN 163

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 30/151 (19%), Positives = 58/151 (38%), Gaps = 19/151 (12%)

Query: 236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN 295
           + L   +  +   +  T   L+      L+L  N+    I     +  ++ +  ++L RN
Sbjct: 28  VELHGMIPPIEK-MDATLSTLKA--CKHLALSTNN----IEKISSLSGMENLRILSLGRN 80

Query: 296 NFSGDIPATIGGLKDV----QNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF-IL 350
                    I  L  V    + + + YN++          L +L +L +SNNKI+ +  +
Sbjct: 81  LIK-----KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEI 133

Query: 351 ISLEKLLYLKKLNLSFNKLEGEIPRGGPFAN 381
             L  L  L+ L L+ N L  +       + 
Sbjct: 134 DKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 20/104 (19%), Positives = 44/104 (42%), Gaps = 4/104 (3%)

Query: 267 CGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA-TIGGLKDVQNISLPYNRLEGPI 325
           C    +        +   + + E+ +        +    + GL +++N+++  + L    
Sbjct: 15  CTRDGALDSLH--HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72

Query: 326 PESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
           P++F +   L  L+LS N +   +     + L L++L LS N L
Sbjct: 73  PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 29/133 (21%), Positives = 57/133 (42%), Gaps = 10/133 (7%)

Query: 238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI--DIGNLKVVVEINLSRN 295
           + LE N +    P  F      KL  + L  N  S  +       + +L     + L  N
Sbjct: 37  IRLEQNTIKVIPPGAFSPY--KKLRRIDLSNNQIS-ELAPDAFQGLRSLN---SLVLYGN 90

Query: 296 NFSGDIPATI-GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE 354
             + ++P ++  GL  +Q + L  N++     ++F  L +L +L L +NK+      +  
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149

Query: 355 KLLYLKKLNLSFN 367
            L  ++ ++L+ N
Sbjct: 150 PLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 3/91 (3%)

Query: 287 VVEINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKI 345
           + EI L +N     IP       K ++ I L  N++    P++F  L SL  L L  NKI
Sbjct: 34  ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92

Query: 346 SGFILISLEKLLYLKKLNLSFNKLEGEIPRG 376
           +       E L  L+ L L+ NK+   +   
Sbjct: 93  TELPKSLFEGLFSLQLLLLNANKIN-CLRVD 122

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 23/82 (28%), Positives = 34/82 (41%), Gaps = 17/82 (20%)

Query: 300 DIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE----- 354
           ++P        +  I L  N ++   P +F     L  +DLSNN+IS      L      
Sbjct: 29  NLPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-----ELAPDAFQ 77

Query: 355 KLLYLKKLNLSFNKLEGEIPRG 376
            L  L  L L  NK+  E+P+ 
Sbjct: 78  GLRSLNSLVLYGNKIT-ELPKS 98

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 58/229 (25%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSF----EVECEVMKNI 528
            +R+  D+LIG GSFG V KA    +   VAIK+      +  K+F    ++E  +++ +
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELM 107

Query: 529 RHR------NLVKIISGCSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLN- 576
                     +V +        F       LV E      L   LY          R   
Sbjct: 108 NKHDTEMKYYIVHLK-----RHFMFRNHLCLVFE-----MLSYNLYD-------LLRNTN 150

Query: 577 -----------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--LSDFGIAK 623
                          + +AL +L     + IIHCDLK  N+LL     +   + DFG   
Sbjct: 151 FRGVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG--- 206

Query: 624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT 672
             S         Q + +  Y +PE  +        D++S G +L+E  T
Sbjct: 207 --SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 52.6 bits (125), Expect = 3e-07
 Identities = 28/162 (17%), Positives = 63/162 (38%), Gaps = 18/162 (11%)

Query: 229 MGNLSIFL--LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLK- 285
             +LS  L  +  L   K+ G   ++ G+     L +L +       S+   I   +L  
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220

Query: 286 -VVVEINLSRNNFSGDIPATI-------GGLKDVQNISLPYNRLEGPIPESFG---YLTS 334
              + + +   ++  D    +           +++ + +     +  + E F     L  
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280

Query: 335 LEILDLSNNKISGF----ILISLEKLLYLKKLNLSFNKLEGE 372
           LE +D+S   ++      +L  ++K+ +LK +N+ +N L  E
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 4e-04
 Identities = 21/170 (12%), Positives = 49/170 (28%), Gaps = 17/170 (10%)

Query: 202 SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKL 261
           S +++    L  L I   +      +   NL     L++    L   +           L
Sbjct: 165 SPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKS---LEIISGGLPDSVVEDILGSDLPNL 221

Query: 262 DTLSLC-------GNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGG---LKDV 311
           + L L         +                 +  + +        +         L  +
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281

Query: 312 QNISLPYNRL--EG--PIPESFGYLTSLEILDLSNNKISGFILISLEKLL 357
           + + +    L  EG   + +    +  L+ +++  N +S  +   L+K L
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 45/145 (31%), Positives = 66/145 (45%), Gaps = 19/145 (13%)

Query: 238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF 297
           L L  NKL   I      L  + L  L L GN    S+P+ +    L  + E+ L  N  
Sbjct: 68  LALGGNKLH-DISA-LKEL--TNLTYLILTGNQLQ-SLPNGVFDK-LTNLKELVLVENQL 121

Query: 298 SGDIPATI-GGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISL--- 353
              +P  +   L ++  ++L +N+L+      F  LT+L  LDLS N+     L SL   
Sbjct: 122 Q-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ-----LQSLPEG 175

Query: 354 --EKLLYLKKLNLSFNKLEGEIPRG 376
             +KL  LK L L  N+L+  +P G
Sbjct: 176 VFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 40/183 (21%), Positives = 74/183 (40%), Gaps = 26/183 (14%)

Query: 200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS 259
            P           +  +   S+T  + Q   N    ++ +    K    I          
Sbjct: 13  FPDDA---FAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYL------P 63

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATI-GGLKDVQNISLPY 318
            +  L+L GN     I +  ++ NL  +    L+ N     +P  +   L +++ + L  
Sbjct: 64  NVRYLALGGNKLH-DISALKELTNLTYL---ILTGNQLQS-LPNGVFDKLTNLKELVLVE 118

Query: 319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE-----KLLYLKKLNLSFNKLEGEI 373
           N+L+      F  LT+L  L+L++N++      SL      KL  L +L+LS+N+L+  +
Sbjct: 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQ-----SLPKGVFDKLTNLTELDLSYNQLQ-SL 172

Query: 374 PRG 376
           P G
Sbjct: 173 PEG 175

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 19/146 (13%)

Query: 238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF 297
           LDL+   L      TF  L  +KL  L+L  N    ++ + +    L  +  + L+ N  
Sbjct: 40  LDLQSTGLATLSDATFRGL--TKLTWLNLDYNQLQ-TLSAGVFDD-LTELGTLGLANNQL 95

Query: 298 SGDIPATI-GGLKDVQNISLPYNRLEGPIPES-FGYLTSLEILDLSNNKISGFILISLE- 354
           +  +P  +   L  +  + L  N+L+  +P   F  LT L+ L L+ N++      S+  
Sbjct: 96  A-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-----SIPA 148

Query: 355 ----KLLYLKKLNLSFNKLEGEIPRG 376
               KL  L+ L+LS N+L+  +P G
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQS-VPHG 173

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 74/388 (19%), Positives = 118/388 (30%), Gaps = 153/388 (39%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVF-----HQECARAMKSFEVECEVMKN 527
             R+     +G G F  V+ +  +     VA+KV      + E A        E  ++K+
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL------DEIRLLKS 89

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-----TCM--------LDIFQR 574
           +R+ +         ND  + +V++      LD F  S       CM        L  +  
Sbjct: 90  VRNSD--------PNDPNREMVVQL-----LDDFKISGVNGTHICMVFEVLGHHLLKWII 136

Query: 575 LN------------IMIDVASALEYLNFRHTTP-IIHCDLKSSNVLL------------- 608
            +            I+  V   L+YL   HT   IIH D+K  N+LL             
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193

Query: 609 ------------------------------------DEDMIAHLSDFGIAKLLSGEDQSM 632
                                                E +   ++D G A  +       
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED 253

Query: 633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-------------------- 672
            QT+      Y + E  I    +T +DI+S   M  E  T                    
Sbjct: 254 IQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308

Query: 673 ----------------RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFA 716
                             K + + F  +  LKH +  L P  L EV+ +        +++
Sbjct: 309 ALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH-ITKLKPWGLFEVLVEKY------EWS 361

Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAK 744
            +E    + F L M   +  PEKR  A 
Sbjct: 362 QEEAAGFTDFLLPM-LELI-PEKRATAA 387

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 52/246 (21%), Positives = 85/246 (34%), Gaps = 72/246 (29%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSF----EVECEVMKNI 528
            N F     +G G+FG V   + +D+    A+KV      R +K +    ++E +++K I
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKI 88

Query: 529 RHR-----NLVKIISGCSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLN-- 576
           ++      N+VK         F       L+ E      L   LY            N  
Sbjct: 89  QNDDINNNNIVKYH-----GKFMYYDHMCLIFE-----PLGPSLYE-------IITRNNY 131

Query: 577 ----------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
                       I++  AL YL       + H DLK  N+LLD+                
Sbjct: 132 NGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188

Query: 627 GEDQ----------------SMTQTQTLATI----GYMAPEYGIERKVSTRSDIYSYGIM 666
            + Q                +  ++    +I     Y APE  +       SD++S+G +
Sbjct: 189 KKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248

Query: 667 LIETFT 672
           L E +T
Sbjct: 249 LAELYT 254

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 38/274 (13%), Positives = 87/274 (31%), Gaps = 55/274 (20%)

Query: 134 VKALSLAYNRFSG----TIQSPITNASKLTILELGGNSFSG----FIPNTIGNLRNIEWL 185
           ++  SL  +  +     ++ + +     +  + L GN+       ++   I + +++E  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 186 GLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKL 245
                  G   + I P ++  L  +L    +    +                + L  N  
Sbjct: 66  EFSDIFTGRVKDEI-PEALRLLLQAL----LKCPKLHT--------------VRLSDNAF 106

Query: 246 T--GPIPVTFGRLQNSKLDTLSLCGNSFS--------GSIPSCIDIGNLKV---VVEINL 292
                 P+     +++ L+ L L  N            ++         K    +  I  
Sbjct: 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166

Query: 293 SRNNFSGDIPAT-----IGGLKDVQNISLPYNRL-----EGPIPESFGYLTSLEILDLSN 342
            RN    +             + +  + +  N +     E  + E   Y   L++LDL +
Sbjct: 167 GRNRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225

Query: 343 NKIS--GFILIS--LEKLLYLKKLNLSFNKLEGE 372
           N  +  G   ++  L+    L++L L+   L   
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 44/308 (14%), Positives = 92/308 (29%), Gaps = 63/308 (20%)

Query: 101 PSLTKLALGYNSL--VGNNSLSGSLPSRIDLALPNVKALSLAYNRFS----------GTI 148
            S+ ++ L  N++       LS ++ S       +++    +                 +
Sbjct: 32  DSVKEIVLSGNTIGTEAARWLSENIAS-----KKDLEIAEFSDIFTGRVKDEIPEALRLL 86

Query: 149 QSPITNASKLTILELGGNSFSG----FIPNTIGNLRNIEWLGLV---IG-----LIGNPL 196
              +    KL  + L  N+F       + + +     +E L L    +G      I   L
Sbjct: 87  LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146

Query: 197 NGILPSSIVNLSISLERLYISNCSITGN----IPQVMGNLSIFLLLDLELNKLTGP-IPV 251
             +  +     +  L  +      +         +   +  +   + +  N +    I  
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206

Query: 252 TFGRL--QNSKLDTLSLCGNSFS--GSIPSCIDIGNLKVVVEINLSRNNFSGD-IPATIG 306
                     +L  L L  N+F+  GS    I + +   + E+ L+    S     A + 
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266

Query: 307 GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKIS--GFILIS---LEKLLYLKK 361
               ++N                     L+ L L  N+I       +     EK+  L  
Sbjct: 267 AFSKLEN-------------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 307

Query: 362 LNLSFNKL 369
           L L+ N+ 
Sbjct: 308 LELNGNRF 315

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 47/247 (19%), Positives = 78/247 (31%), Gaps = 78/247 (31%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA--ELDDGIEVAIKVFHQECARAMKSF----EVECEVMKN 527
             R+     +G G+FG V +         +VA+K+      R +  +     +E  V+K 
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKK 72

Query: 528 IRHR------NLVKIISGCSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRLN 576
           I+ +        V +      D F       +  E      L    +        F + N
Sbjct: 73  IKEKDKENKFLCVLMS-----DWFNFHGHMCIAFE-----LLGKNTFE-------FLKEN 115

Query: 577 ------------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH--------- 615
                       +   +  AL +L   H   + H DLK  N+L                 
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172

Query: 616 ----------LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGI 665
                     ++DFG     S        T  +AT  Y  PE  +E   +   D++S G 
Sbjct: 173 EKSVKNTSIRVADFG-----SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGC 227

Query: 666 MLIETFT 672
           +L E + 
Sbjct: 228 ILFEYYR 234

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 19/117 (16%)

Query: 267 CGNSFSGSIPSCI--DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGP 324
           C +    S+P+ I  +   L       L  N  +   P     L +++ + L  N+L   
Sbjct: 26  CRSKRHASVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL 79

Query: 325 IPESFGYLTSLEILDLSNNKISGFILISLE-----KLLYLKKLNLSFNKLEGEIPRG 376
               F  LT L +LDL  N+++      L      +L++LK+L +  NKL  E+PRG
Sbjct: 80  PVGVFDSLTQLTVLDLGTNQLT-----VLPSAVFDRLVHLKELFMCCNKLT-ELPRG 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 4e-05
 Identities = 31/150 (20%), Positives = 51/150 (34%), Gaps = 30/150 (20%)

Query: 220 SITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN-SKLDTLSLCGNSFSGSIPSC 278
            +   I   + N +   + +L L+          G       L+ LSL        + S 
Sbjct: 9   DMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG----LISV 64

Query: 279 IDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEIL 338
            ++  L  + ++ LS                         NR+ G +      L +L  L
Sbjct: 65  SNLPKLPKLKKLELSE------------------------NRIFGGLDMLAEKLPNLTHL 100

Query: 339 DLSNNKISGF-ILISLEKLLYLKKLNLSFN 367
           +LS NK+     L  L+KL  LK L+L   
Sbjct: 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 27/89 (30%), Positives = 40/89 (44%), Gaps = 3/89 (3%)

Query: 283 NLKVVVEINLS-RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLS 341
               V E+ L    +  G I        +++ +SL    L      +   L  L+ L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79

Query: 342 NNKISGFILISLEKLLYLKKLNLSFNKLE 370
            N+I G + +  EKL  L  LNLS NKL+
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 13/119 (10%)

Query: 79  VTALNISSLNLQ-GEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL 137
           V  L + +     G+I        +L  L+L    L+   S+S  LP      LP +K L
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI---SVSN-LPK-----LPKLKKL 76

Query: 138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL 196
            L+ NR  G +         LT L L GN       +T+  L+ +E L   + L    +
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECL-KSLDLFNCEV 132

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 24/110 (21%), Positives = 40/110 (36%), Gaps = 5/110 (4%)

Query: 283 NLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN 342
           N     E++L R      I      L     I    N +   + + F  L  L+ L ++N
Sbjct: 17  NAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73

Query: 343 NKISGFILISLEKLLYLKKLNLSFNKLE--GEIPRGGPFANFTAKSFMGN 390
           N+I        + L  L +L L+ N L   G++       + T    + N
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 18/109 (16%), Positives = 32/109 (29%), Gaps = 29/109 (26%)

Query: 260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYN 319
           + D +    N     I        L+ +  + ++ N                        
Sbjct: 43  QFDAIDFSDNE----IRKLDGFPLLRRLKTLLVNNNRIC--------------------- 77

Query: 320 RLEGPIPESFGYLTSLEILDLSNNKISGF-ILISLEKLLYLKKLNLSFN 367
           R+   + ++   L  L  L L+NN +     L  L  L  L  L +  N
Sbjct: 78  RIGEGLDQA---LPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 16/108 (14%)

Query: 274 SIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLT 333
            +P  I       V E+ L  N F+  +P  +   K +  I L  NR+     +SF  +T
Sbjct: 24  VLPKGIPRD----VTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT 78

Query: 334 SLEILDLSNNKISGFILISL-----EKLLYLKKLNLSFNKLEGEIPRG 376
            L  L LS N+     L  +     + L  L+ L+L  N +   +P G
Sbjct: 79  QLLTLILSYNR-----LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 6e-05
 Identities = 28/143 (19%), Positives = 57/143 (39%), Gaps = 12/143 (8%)

Query: 225 IPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN-SKLDTLSLCGNSFSGSIPSCIDIGN 283
           I   + N +   + +L L+          G      +L+ LS         + S  ++  
Sbjct: 7   IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG----LTSIANLPK 62

Query: 284 LKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGP-IPESFGYLTSLEILDLSN 342
           L  + ++ LS N  SG +        ++ +++L  N+++     E    L +L+ LDL N
Sbjct: 63  LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122

Query: 343 NKISG------FILISLEKLLYL 359
            +++        +   L +L YL
Sbjct: 123 CEVTNLNDYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 23/82 (28%), Positives = 42/82 (51%), Gaps = 3/82 (3%)

Query: 289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF 348
            ++ SR+N  G +       ++++ +S     L      +   L  L+ L+LS+N++SG 
Sbjct: 23  VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGG 79

Query: 349 ILISLEKLLYLKKLNLSFNKLE 370
           + +  EK   L  LNLS NK++
Sbjct: 80  LEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.7 bits (93), Expect = 7e-04
 Identities = 27/109 (24%), Positives = 43/109 (39%), Gaps = 12/109 (11%)

Query: 88  NLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGT 147
           + +G++         L  L+     L    S++  LP      L  +K L L+ NR SG 
Sbjct: 29  SNEGKLEGLTDEFEELEFLSTINVGLT---SIAN-LPK-----LNKLKKLELSDNRVSGG 79

Query: 148 IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL 196
           ++        LT L L GN       +TI  L+ +E L   + L    +
Sbjct: 80  LEVLAEKCPNLTHLNLSGNKIKDL--STIEPLKKLENL-KSLDLFNCEV 125

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 42/243 (17%), Positives = 86/243 (35%), Gaps = 70/243 (28%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAELD---DGIEVAIKVFHQECARAMKSF----EVECEVMK 526
           + R+   + +G G+FG V +  +D    G  VA+K+      + +  +      E +V++
Sbjct: 13  SARYEIVDTLGEGAFGKVVEC-IDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLE 66

Query: 527 NIRHR------NLVKIISGCSNDDFK-----ALVLEYMPNGSLDIFLYSSTCMLDIFQRL 575
           ++           V+++     + F+      +V E      L +  Y        F + 
Sbjct: 67  HLNTTDPNSTFRCVQML-----EWFEHHGHICIVFE-----LLGLSTYD-------FIKE 109

Query: 576 N------------IMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK 623
           N            +   +  ++ +L   H+  + H DLK  N+L  +       +  I +
Sbjct: 110 NGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166

Query: 624 LLSGEDQS----------MTQTQTLATI----GYMAPEYGIERKVSTRSDIYSYGIMLIE 669
                                 +  +T+     Y APE  +    S   D++S G +LIE
Sbjct: 167 DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226

Query: 670 TFT 672
            + 
Sbjct: 227 YYL 229

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 28/81 (34%), Positives = 39/81 (48%), Gaps = 13/81 (16%)

Query: 301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISL-----EK 355
           +P  I      Q + L  N++    P  F  LT L  LDL NN+     L  L     +K
Sbjct: 24  VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQ-----LTVLPAGVFDK 76

Query: 356 LLYLKKLNLSFNKLEGEIPRG 376
           L  L +L+L+ N+L+  IPRG
Sbjct: 77  LTQLTQLSLNDNQLKS-IPRG 96

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 13/81 (16%)

Query: 301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISL-----EK 355
           +PA I    D Q + L  N++    P  F +L +L+ L  ++NK     L ++     +K
Sbjct: 27  VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNK-----LTAIPTGVFDK 79

Query: 356 LLYLKKLNLSFNKLEGEIPRG 376
           L  L +L+L+ N L+  IPRG
Sbjct: 80  LTQLTQLDLNDNHLKS-IPRG 99

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 25/81 (30%), Positives = 33/81 (40%), Gaps = 17/81 (20%)

Query: 301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE-----K 355
           IP+          + L  N+L+      F  LT L  L LS N+     + SL      K
Sbjct: 26  IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ-----IQSLPDGVFDK 74

Query: 356 LLYLKKLNLSFNKLEGEIPRG 376
           L  L  L L  NKL+  +P G
Sbjct: 75  LTKLTILYLHENKLQ-SLPNG 94

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 8e-04
 Identities = 60/331 (18%), Positives = 106/331 (32%), Gaps = 65/331 (19%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYL-----PSLTKLALGYNSL--VGNNSLSGSLPSRI 127
             H VT+L++S  NL      E+         S+T L L  NSL    ++ L   L +  
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA-- 77

Query: 128 DLALPNVKALSLAYNRFSGTIQSPITNA-----SKLTILELGGNSFS-----GFIPNTIG 177
                NV +L+L+ N  S      +          +T+L+LG N FS      F      
Sbjct: 78  --IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSN 135

Query: 178 NLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL 237
              +I  L L    +G   +  L   +  +  ++  L +   ++            +   
Sbjct: 136 LPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA-----SKNCAELAKF 190

Query: 238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIG-----NLKVVVEINL 292
           L                    + + +L L  N       S  ++          VV +NL
Sbjct: 191 L----------------ASIPASVTSLDLSANLLGLK--SYAELAYIFSSIPNHVVSLNL 232

Query: 293 SRNNFSGD----IPATIGGLKDVQNISLPYNRLEGPIPESFGYL-------TSLEILDLS 341
             N   G     +      LK +Q + L Y+ ++    E    L         + ++D +
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292

Query: 342 NNKISGFILISLEKLL-----YLKKLNLSFN 367
             +I     I +  L+          +L   
Sbjct: 293 GKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	763
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.98
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.98
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.98
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.97
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.97
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.97
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.96
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.95
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.85
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.8
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.75
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.72
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.72
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.69
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.68
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.65
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.5
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.48
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.46
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.43
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.33
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.31
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.3
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.3
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.26
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.24
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.14
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.95
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.93
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.85
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.82
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.81
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.81
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.81
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.4
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.37
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.37
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.33
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.33
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.24
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.1
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.88
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.77
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.77
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.73
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.65
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.6
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.37
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.34
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.09
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.05
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.02
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.01
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.0
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.98
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.88
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.88
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.68
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.62
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.59
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.3
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.0
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.17
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.11
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.61

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-52  Score=436.61  Aligned_cols=260  Identities=30%  Similarity=0.479  Sum_probs=215.2

Q ss_pred             hccCcCceecccCCceEEEEEec------CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|.+.+.||+|+||+||+|.+.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888899999999999999763      478899999987666667889999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEE
Q 046240          549 VLEYMPNGSLDIFLYSST------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL  616 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl  616 (763)
                      |||||++|+|.++++..+            ..+++.++..|+.|||+||+||   |+++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997532            3689999999999999999999   6789999999999999999999999


Q ss_pred             eeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccC
Q 046240          617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLL  695 (763)
Q Consensus       617 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  695 (763)
                      +|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||......+.          
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~----------  239 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV----------  239 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----------
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence            99999987654433333445679999999999999999999999999999999999 8999976432211          


Q ss_pred             ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       696 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                         ...+........|       +.++.++.+++.+||+.||++|||+++|.+.|+++.+..
T Consensus       240 ---~~~i~~~~~~~~p-------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          240 ---IECITQGRVLQRP-------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             ---HHHHHHTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ---HHHHHcCCCCCCC-------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence               0111111111111       134667899999999999999999999999998876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1e-51  Score=436.10  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=209.3

Q ss_pred             hccCcCceecccCCceEEEEEec------CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|...+.||+|+||+||+|.+.      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56778889999999999999764      478899999987666667889999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          549 VLEYMPNGSLDIFLYSST--------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      |||||++|+|.++++...              .+++|.++..|+.|||+||+||   |+++||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHhhEEECCCCcE
Confidence            999999999999987532              3589999999999999999999   67899999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcc
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  693 (763)
                      ||+|||+|+.+...+.........||+.|||||++.+..++.++|||||||++|||+| |+.||......+         
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---------  268 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---------  268 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---------
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---------
Confidence            9999999997754444444455679999999999999999999999999999999999 899997643221         


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                           ..+.+.+..  .+.    .++.++.++.+++.+||+.||++||||+||++.|+.+.+.++
T Consensus       269 -----~~~~i~~g~--~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          269 -----AIDCITQGR--ELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             -----HHHHHHHTC--CCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             -----HHHHHHcCC--CCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence                 111111111  011    112346678999999999999999999999999998877654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-51  Score=429.15  Aligned_cols=260  Identities=27%  Similarity=0.408  Sum_probs=204.5

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||+||+|.+.+  .||||+++..  .....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3578889999999999999998764  5999998643  34456789999999999999999999998865 56899999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      ||++|+|.++++.....+++.++..|+.|||+||+||   |+++||||||||+|||+++++.+||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999987766799999999999999999999   6789999999999999999999999999999876543333


Q ss_pred             cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          632 MTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .......||+.|||||++.   .+.|+.++|||||||++|||+||+.||........             +...+.+...
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-------------~~~~~~~~~~  255 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-------------IIFMVGRGYA  255 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-------------HHHHHHTTCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-------------HHHHHhcCCC
Confidence            3445568999999999875   34689999999999999999999999976432211             1111211111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      . |.. ......++..+.+++.+||+.+|++||||.||++.|+.+-
T Consensus       256 ~-p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          256 S-PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             C-CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             C-CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            1 110 0111234667899999999999999999999999886543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.4e-52  Score=434.03  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=210.0

Q ss_pred             ccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      +++..+.||+|+||+||+|.+.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999763      46889999997543 2345789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc
Q 046240          549 VLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI  613 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~  613 (763)
                      |||||++|+|.+++....               ..+++..+..|+.|||+||+||   |+++||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCccccceEECCCCC
Confidence            999999999999996431               3589999999999999999999   6789999999999999999999


Q ss_pred             EEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhc
Q 046240          614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVN  692 (763)
Q Consensus       614 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~  692 (763)
                      +||+|||+|+.+...+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||......+        
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--------  255 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--------  255 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--------
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence            99999999987754443334455679999999999999999999999999999999999 899997643221        


Q ss_pred             ccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          693 GLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       693 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                            +.+.+.....      .+.++.++..+.+++.+||+.||++||||+||++.|+..
T Consensus       256 ------~~~~i~~~~~------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 ------VVEMIRNRQV------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ------HHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ------HHHHHHcCCC------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  1111211110      011123567789999999999999999999999999753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-50  Score=423.90  Aligned_cols=280  Identities=24%  Similarity=0.284  Sum_probs=206.2

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC----ceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD----FKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  550 (763)
                      ++|.+.+.||+|+||+||+|.+. |+.||||+++..... ....+.|+..+.+++|||||+++++|.+++    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            46788899999999999999884 899999999765322 223345667777889999999999997654    579999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      |||++|+|.++++..  .+++..+.+++.|+++||+|||..     |.++||||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999765  489999999999999999999743     4569999999999999999999999999999887


Q ss_pred             CCCCCc--cccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC-
Q 046240          626 SGEDQS--MTQTQTLATIGYMAPEYGIER------KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP-  696 (763)
Q Consensus       626 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-  696 (763)
                      ......  .......||+.|||||++.+.      .++.++|||||||++|||+||..|+............+...... 
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            543322  122346799999999998654      46789999999999999999998876532211111111111111 


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                      +.....+.....+.+-........+...+.+++.+||+.||++||||.||++.|+++.+++.
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            11222221111111111111122346778999999999999999999999999998877654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-50  Score=424.42  Aligned_cols=249  Identities=25%  Similarity=0.283  Sum_probs=207.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +.|+..+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999764 79999999998665455567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      +||+|.+++...  .+++.....++.||+.||+||   |+++||||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            999999999764  489999999999999999999   788999999999999999999999999999998753322  2


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||........              ...+..........
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--------------~~~i~~~~~~~~~~  292 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------------MKMIRDNLPPRLKN  292 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------------HHHHHHSSCCCCSC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--------------HHHHHcCCCCCCCc
Confidence            3456899999999999999999999999999999999999999976332211              11111111100000


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          ...+..++.+++.+||..||++|||++|+++
T Consensus       293 ----~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 ----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                1123456889999999999999999999976

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-49  Score=420.53  Aligned_cols=249  Identities=23%  Similarity=0.347  Sum_probs=201.3

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++...  .....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999965 57999999999754  23456788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+||+|.+++...+ ..+++.....++.||+.||+||   |+++||||||||+|||+++++.+||+|||+|+.+...  
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            999999999997543 3578889999999999999999   7889999999999999999999999999999876421  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .......+||+.|||||++.+..|+.++|||||||++|||+||+.||........ +            ..++.......
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~------------~~i~~~~~~~~  245 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL-V------------LKIISGSFPPV  245 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H------------HHHHHTCCCCC
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-H------------HHHHcCCCCCC
Confidence            1123446799999999999999999999999999999999999999976432221 1            11111111101


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +       ..+..++.+++.+||+.||++|||++|+++
T Consensus       246 ~-------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 S-------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1       112456889999999999999999999985

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.3e-50  Score=427.06  Aligned_cols=268  Identities=22%  Similarity=0.367  Sum_probs=217.4

Q ss_pred             HHHHhccCcCceecccCCceEEEEEecC------CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCC-CccceEEeeeec
Q 046240          471 SRATNRFGRDNLIGIGSFGYVYKAELDD------GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRH-RNLVKIISGCSN  542 (763)
Q Consensus       471 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~  542 (763)
                      +...++|++.+.||+|+||+||+|.+..      ++.||||+++... ....+.+.+|++++++++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            3446789999999999999999997642      3679999997653 3446779999999999965 999999999976


Q ss_pred             C-CceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCE
Q 046240          543 D-DFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNV  606 (763)
Q Consensus       543 ~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NI  606 (763)
                      . +..++|||||++|+|.++++...               ..+++..+..++.|||+||+||   |+++||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL---H~~~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH---hhCCeecCccCccce
Confidence            5 56899999999999999996532               2478999999999999999999   788999999999999


Q ss_pred             EecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhh
Q 046240          607 LLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAEL  685 (763)
Q Consensus       607 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~  685 (763)
                      |+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||....... 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-  295 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  295 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999998755444444456679999999999999999999999999999999998 999997643211 


Q ss_pred             hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCccc
Q 046240          686 SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE  760 (763)
Q Consensus       686 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~~  760 (763)
                                  .+...+.......      .++.+..++.+++..||+.||++|||+.||++.|+++++.+..+
T Consensus       296 ------------~~~~~i~~g~~~~------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~q  352 (353)
T 4ase_A          296 ------------EFCRRLKEGTRMR------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ  352 (353)
T ss_dssp             ------------HHHHHHHHTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC--
T ss_pred             ------------HHHHHHHcCCCCC------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhCC
Confidence                        1222222211100      11123567899999999999999999999999999998876654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-49  Score=412.52  Aligned_cols=248  Identities=26%  Similarity=0.349  Sum_probs=208.6

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999965 579999999998653   223567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||++||+|.+++...+ .++......++.||+.||+||   |+++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999997654 589999999999999999999   788999999999999999999999999999998865444


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .......+||+.|||||++.+..|+.++||||+||++|||+||+.||........             ...++..... -
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------------~~~i~~~~~~-~  253 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-------------FAKIIKLEYD-F  253 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHTCCC-C
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHcCCCC-C
Confidence            4444567899999999999999999999999999999999999999976432211             1111111111 1


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCN  747 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~  747 (763)
                      |.       ....++.+++.+|+..||++|||++|+.
T Consensus       254 p~-------~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 PE-------KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CT-------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             Cc-------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            11       1244578999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9e-50  Score=419.12  Aligned_cols=256  Identities=23%  Similarity=0.297  Sum_probs=206.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .+.|...++||+|+||+||+|.. .+|+.||||+++....     ..+|+.++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            35688889999999999999976 4799999999975422     24699999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+||+|.+++...+ .+++.....++.||++||+||   |+++||||||||+|||++.++ .+||+|||+|+.+......
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999997654 589999999999999999999   789999999999999999987 6999999999987543321


Q ss_pred             ---cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          632 ---MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       632 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                         ......+||+.|||||++.+..|+.++|||||||++|||+||+.||........             ...+...   
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~~i~~~---  271 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------------CLKIASE---  271 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-------------HHHHHHS---
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------------HHHHHcC---
Confidence               122345799999999999999999999999999999999999999976432211             1111111   


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                       .+.. ......+...+.+++.+||+.||++|||+.|+++.|.+.++.
T Consensus       272 -~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          272 -PPPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             -CCGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence             0000 001112356688999999999999999999999988766543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4e-49  Score=425.54  Aligned_cols=249  Identities=25%  Similarity=0.283  Sum_probs=207.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +.|+..+.||+|+||+||+|... +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999764 79999999997655445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      +||+|.+++...  .+++..+..++.||++||+||   |+++||||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence            999999999764  489999999999999999999   788999999999999999999999999999998753322  2


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||........              ...+..........
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--------------~~~i~~~~~~~~~~  369 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------------MKMIRDNLPPRLKN  369 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------------HHHHHHSCCCCCSC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--------------HHHHHcCCCCCCcc
Confidence            3456899999999999999999999999999999999999999976332211              11111111100000


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          ...+..++.+++.+||..||++|||+.|+++
T Consensus       370 ----~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 ----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ----TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                0112456889999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-48  Score=401.86  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=194.5

Q ss_pred             CcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeec----CCceEEEE
Q 046240          478 GRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSN----DDFKALVL  550 (763)
Q Consensus       478 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  550 (763)
                      ...+.||+|+||+||+|... +++.||+|++....  ....+.+.+|++++++++|||||+++++|..    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999664 68999999997542  3456778999999999999999999999864    34689999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEecC-CCcEEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP--IIHCDLKSSNVLLDE-DMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~  627 (763)
                      |||++|+|.+++.... .+++..+..++.||++||+||   |+++  ||||||||+|||++. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~yl---H~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997644 689999999999999999999   5555  999999999999984 78999999999986432


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...............+..+           
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~-----------  248 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-----------  248 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-----------
Confidence            1    2344689999999998865 69999999999999999999999997532221111111111100           


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          .   .....+..++.+++.+||+.||++|||++|+++
T Consensus       249 ----~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ----A---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----G---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----C---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0   011112346789999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.6e-48  Score=395.81  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=189.7

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999976 479999999997542   223567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+ +|+|.+++...+ .++......++.|++.||+||   |+++|+||||||+|||+++++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 678988887654 689999999999999999999   78899999999999999999999999999998764322 


Q ss_pred             ccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||........ .            ..+..... .
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-~------------~~i~~~~~-~  230 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-F------------KNISNGVY-T  230 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHTCC-C
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-H------------HHHHcCCC-C
Confidence              2234679999999999988876 5799999999999999999999976322111 1            11111111 1


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .|.       ....++.+++.+|++.||++|||++|+++
T Consensus       231 ~p~-------~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 LPK-------FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCT-------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCC-------CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111       12456789999999999999999999986

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.7e-47  Score=395.04  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=188.8

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC--------
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD--------  544 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------  544 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            5699999999999999999976 478999999987443 344567899999999999999999999986544        


Q ss_pred             ----ceEEEEEccCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          545 ----FKALVLEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       545 ----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                          ..|+|||||++|+|.+++.....  ..++.....++.|+++||+||   |+++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~yl---H~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH---HHCcCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976542  456677889999999999999   788999999999999999999999999


Q ss_pred             ecCceecCCCCCc----------cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh
Q 046240          619 FGIAKLLSGEDQS----------MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK  688 (763)
Q Consensus       619 fgla~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~  688 (763)
                      ||+|+.+......          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||.........+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            9999887533221          11234579999999999999999999999999999999996   7765322211111


Q ss_pred             hhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       689 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .......|                   ...........+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~p-------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          239 DVRNLKFP-------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHTTCCC-------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCC-------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111111                   111122344678999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.9e-48  Score=401.85  Aligned_cols=242  Identities=26%  Similarity=0.340  Sum_probs=193.1

Q ss_pred             hccCcCceecccCCceEEEEEec----CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|++.+.||+|+||+||+|...    +++.||||+++...  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999652    47889999997542  1223467889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |||||+||+|.+++...+ .++......++.|++.||+||   |+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997654 689999999999999999999   7889999999999999999999999999999875432


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      ..  .....+||+.|||||++.+..|+.++||||+||++|||+||+.||......+. .            ..+..... 
T Consensus       180 ~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~------------~~i~~~~~-  243 (304)
T 3ubd_A          180 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-M------------TMILKAKL-  243 (304)
T ss_dssp             -C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHCCC-
T ss_pred             Cc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-H------------HHHHcCCC-
Confidence            22  23456899999999999999999999999999999999999999976432221 1            11111111 


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      ..|.       .+..++.+++.+||+.||++|||+
T Consensus       244 ~~p~-------~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          244 GMPQ-------FLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CCCC-------cCCHHHHHHHHHHcccCHHHCCCC
Confidence            1111       124567899999999999999996

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.8e-44  Score=380.21  Aligned_cols=303  Identities=35%  Similarity=0.645  Sum_probs=214.8

Q ss_pred             CCChhhHHHHHHHHHhccCCCCcccccCCCCCCCCCc--ccceeecCCC--CceEEEEecCCCCCC--cCCcccCCCCCC
Q 046240           30 SNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCN--WIGITCDVNS--HRVTALNISSLNLQG--EIPHEIGYLPSL  103 (763)
Q Consensus        30 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~L~L~~~~l~~--~~~~~~~~l~~L  103 (763)
                      .+.+.|.+||++||+.+. ||. .++ +|..+.+||.  |.||+|+...  ++|+.|+|++|++++  .+|+.|+++++|
T Consensus         2 ~c~~~~~~aL~~~k~~~~-~~~-~l~-~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L   78 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLG-NPT-TLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHhcC-Ccc-ccc-CCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence            467889999999999985 665 565 8988889998  9999998654  799999999999998  888888888887


Q ss_pred             CEEEcCC-CcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCch
Q 046240          104 TKLALGY-NSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNI  182 (763)
Q Consensus       104 ~~L~L~~-n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  182 (763)
                      ++|+|++ |.++      +.+|..+. ++++|++|+|++|+|++.+|..|.++++|++|+|++|+|++.+|..|.++   
T Consensus        79 ~~L~L~~~n~l~------~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---  148 (313)
T 1ogq_A           79 NFLYIGGINNLV------GPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL---  148 (313)
T ss_dssp             SEEEEEEETTEE------SCCCGGGG-GCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC---
T ss_pred             CeeeCCCCCccc------ccCChhHh-cCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcC---
Confidence            7777773 5554      34443332 44444444444444444444444444444444444444443333333222   


Q ss_pred             hhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCcc-ccceeecccccccCCCCccccccCCCCc
Q 046240          183 EWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS-IFLLLDLELNKLTGPIPVTFGRLQNSKL  261 (763)
Q Consensus       183 ~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~~~L  261 (763)
                                               + +|++|+|++|++++.+|..+..++ +                          |
T Consensus       149 -------------------------~-~L~~L~L~~N~l~~~~p~~l~~l~~~--------------------------L  176 (313)
T 1ogq_A          149 -------------------------P-NLVGITFDGNRISGAIPDSYGSFSKL--------------------------F  176 (313)
T ss_dssp             -------------------------T-TCCEEECCSSCCEEECCGGGGCCCTT--------------------------C
T ss_pred             -------------------------C-CCCeEECcCCcccCcCCHHHhhhhhc--------------------------C
Confidence                                     2 444555555555544444444443 4                          5


Q ss_pred             cEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCc
Q 046240          262 DTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLS  341 (763)
Q Consensus       262 ~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  341 (763)
                      ++|++++|++++.+|.  .+..++ |++|+|++|++++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus       177 ~~L~L~~N~l~~~~~~--~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls  252 (313)
T 1ogq_A          177 TSMTISRNRLTGKIPP--TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR  252 (313)
T ss_dssp             CEEECCSSEEEEECCG--GGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred             cEEECcCCeeeccCCh--HHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence            5555555555555555  455555 77777777777777777788888888888888888866665 7788899999999


Q ss_pred             CCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcccCCCCCCCCCC
Q 046240          342 NNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQC  404 (763)
Q Consensus       342 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p~~~~~~c  404 (763)
                      +|++++.+|..+..+++|+.|+|++|++++.+|....++.+..+++.+|+++|+.|   .++|
T Consensus       253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p---~~~C  312 (313)
T 1ogq_A          253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC  312 (313)
T ss_dssp             SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred             CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCC---CCCC
Confidence            99998888889999999999999999999999988888999999999999999987   4456

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=390.28  Aligned_cols=268  Identities=24%  Similarity=0.251  Sum_probs=201.9

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeec------CCc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSN------DDF  545 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  545 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999966 579999999996542  3445678899999999999999999998753      357


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .|+|||||+ |+|.+++...+ .+++..+..++.||+.||.||   |+++||||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 67888887654 689999999999999999999   7889999999999999999999999999999876


Q ss_pred             CCCCC--ccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh--hcccCCh---
Q 046240          626 SGEDQ--SMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW--VNGLLPV---  697 (763)
Q Consensus       626 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~--~~~~~~~---  697 (763)
                      .....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+...... +...  ..+..+.   
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGGT
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHHh
Confidence            43221  2233457899999999998765 569999999999999999999999976432221 1111  1111111   


Q ss_pred             ------hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 ------SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ------~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                            .....+...-...+..-.........++.+++.+|+..||++|||+.|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  111122111111111000000112456789999999999999999999885

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.9e-44  Score=382.54  Aligned_cols=268  Identities=20%  Similarity=0.255  Sum_probs=199.7

Q ss_pred             HHHhccCcCceecccCCceEEEEEec----CCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCce
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  546 (763)
                      ...++|++.+.||+|+||+||+|..+    +++.||+|++....  ....+.+|+++++.+ +||||+++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34678999999999999999999653    46889999986543  235678899999998 699999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCceec
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLL  625 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~  625 (763)
                      |+||||+++|+|.+++.    .++..+...++.|++.||+||   |+++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999984    378899999999999999999   78999999999999999877 79999999999876


Q ss_pred             CCCCCc--------------------------cccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCc
Q 046240          626 SGEDQS--------------------------MTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPAD  678 (763)
Q Consensus       626 ~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~  678 (763)
                      ......                          ......+||++|+|||++.+. .|+.++||||+||++|||+||+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            432210                          112345799999999998775 58999999999999999999999996


Q ss_pred             hhhhhhhhhhhhhc---------------------ccCC-hhHHHHHHhhcCCC---cccc---------HHHHHHHHHH
Q 046240          679 KMFAAELSLKHWVN---------------------GLLP-VSLMEVVNKTLLSP---PEKD---------FAAKEQCVLS  724 (763)
Q Consensus       679 ~~~~~~~~~~~~~~---------------------~~~~-~~~~~~i~~~l~~~---~~~~---------~~~~~~~~~~  724 (763)
                      ........+.....                     ...+ ........+.....   +...         .........+
T Consensus       249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~  328 (361)
T 4f9c_A          249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE  328 (361)
T ss_dssp             CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred             CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence            43322222111110                     0011 11222221111100   0000         0000112346


Q ss_pred             HHHHHHHccccCcCCCCCHHHHHH
Q 046240          725 IFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       725 l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+++.+|+..||++|||++|+++
T Consensus       329 a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          329 AYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhc
Confidence            789999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-43  Score=401.69  Aligned_cols=251  Identities=20%  Similarity=0.257  Sum_probs=209.1

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+..|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            6899999999999999999966 479999999998665556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC--CcEEEeeecCceecCCCCCc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED--MIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +||+|.+++......+++.....++.||++||+||   |+++|+||||||+|||++.+  +.+||+|||+|+.+....  
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--  311 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  311 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence            99999999976666789999999999999999999   78899999999999999854  899999999999875432  


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       .....+||+.|||||++.+..|+.++||||+||++|||++|+.||........ +..            +..... ..+
T Consensus       312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~------------i~~~~~-~~~  376 (573)
T 3uto_A          312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRN------------VKSCDW-NMD  376 (573)
T ss_dssp             -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH------------HHTTCC-CCC
T ss_pred             -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHH------------HHhCCC-CCC
Confidence             23346799999999999999999999999999999999999999976433221 111            111001 001


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   .......++.+++.+||..||++||++.|+++
T Consensus       377 ~~---~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 DS---AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SG---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc---cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11   11123456789999999999999999999986

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=2.6e-43  Score=418.37  Aligned_cols=322  Identities=30%  Similarity=0.470  Sum_probs=200.0

Q ss_pred             hhcCCChhhHHHHHHHHHhccCCCCcccccCCCCCCCCCcccceeecCCCCceEEEEecCCCCCCc---CC---------
Q 046240           27 AATSNITTDQQALLALEAHISYDPTNLLAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGE---IP---------   94 (763)
Q Consensus        27 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~---~~---------   94 (763)
                      +++...+.|++||++||+.+. ||. .++ +|..++|||+|.||+|+  .++|+.|+|+++.+.|.   +|         
T Consensus         5 ~~~~~~~~~~~all~~k~~~~-~~~-~l~-~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L   79 (768)
T 3rgz_A            5 SPSQSLYREIHQLISFKDVLP-DKN-LLP-DWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL   79 (768)
T ss_dssp             ---CCHHHHHHHHHHHHTTCS-CTT-SST-TCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred             ccccCCHHHHHHHHHHHhhCC-Ccc-ccc-CCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence            334446789999999999997 887 776 89888899999999998  68999999999999886   44         


Q ss_pred             --------------cccCCCCCCCEEEcCCCcccCCCccccCccc--cccccCCCccEEEcccccccccCCCcc-cCCCC
Q 046240           95 --------------HEIGYLPSLTKLALGYNSLVGNNSLSGSLPS--RIDLALPNVKALSLAYNRFSGTIQSPI-TNASK  157 (763)
Q Consensus        95 --------------~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~--~~~~~l~~L~~L~L~~N~i~~~~p~~~-~~l~~  157 (763)
                                    +.|+.+++|++|+|++|.++      |.+|.  .+ .++++|++|+|++|.+++.+|..+ .++++
T Consensus        80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~------~~~~~~~~l-~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~  152 (768)
T 3rgz_A           80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLS------GPVTTLTSL-GSCSGLKFLNVSSNTLDFPGKVSGGLKLNS  152 (768)
T ss_dssp             CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEE------EEGGGGGGG-GGCTTCCEEECCSSEEECCSSCCSCCCCTT
T ss_pred             cccCCcCCCcCCCchhhccCCCCCEEECCCCcCC------CcCCChHHH-hCCCCCCEEECcCCccCCcCCHHHhccCCC
Confidence                          46677777788888777775      45665  43 377777777777777777776655 67777


Q ss_pred             CCeeeecCcccccccccc---cCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccc
Q 046240          158 LTILELGGNSFSGFIPNT---IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSI  234 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~  234 (763)
                      |++|+|++|++++..|..   +.++++|++|+    +++|.+++..|.  ..+. +|++|+|++|++++.+|. ++.+++
T Consensus       153 L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~----Ls~n~l~~~~~~--~~l~-~L~~L~Ls~n~l~~~~~~-l~~l~~  224 (768)
T 3rgz_A          153 LEVLDLSANSISGANVVGWVLSDGCGELKHLA----ISGNKISGDVDV--SRCV-NLEFLDVSSNNFSTGIPF-LGDCSA  224 (768)
T ss_dssp             CSEEECCSSCCEEETHHHHHHTTCCTTCCEEE----CCSSEEESCCBC--TTCT-TCCEEECCSSCCCSCCCB-CTTCCS
T ss_pred             CCEEECCCCccCCcCChhhhhhccCCCCCEEE----CCCCcccccCCc--ccCC-cCCEEECcCCcCCCCCcc-cccCCC
Confidence            777777777777666655   56666666666    445555544332  3343 555555555555554444 555555


Q ss_pred             cceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCC-cCccE
Q 046240          235 FLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGL-KDVQN  313 (763)
Q Consensus       235 L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~  313 (763)
                      |++|+|++|++++.+|..+.++++  |++|+|++|++++.+|.  .  .+++|++|+|++|++++.+|..+... ++|++
T Consensus       225 L~~L~Ls~n~l~~~~~~~l~~l~~--L~~L~Ls~n~l~~~~~~--~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~  298 (768)
T 3rgz_A          225 LQHLDISGNKLSGDFSRAISTCTE--LKLLNISSNQFVGPIPP--L--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTG  298 (768)
T ss_dssp             CCEEECCSSCCCSCHHHHTTTCSS--CCEEECCSSCCEESCCC--C--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSE
T ss_pred             CCEEECcCCcCCCcccHHHhcCCC--CCEEECCCCcccCccCc--c--ccCCCCEEECcCCccCCccCHHHHhhcCcCCE
Confidence            555555555555555555555544  55555555555544443  1  44445555555555554444444443 45555


Q ss_pred             EEccCccccCcccccccccccccEEeCcCCccCCccchh-hhhhccCceEEcccccCCCCCC
Q 046240          314 ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILIS-LEKLLYLKKLNLSFNKLEGEIP  374 (763)
Q Consensus       314 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~p  374 (763)
                      |+|++|++++.+|..|+.+++|++|+|++|++++.+|.. +..+++|++|++++|++++.+|
T Consensus       299 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p  360 (768)
T 3rgz_A          299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP  360 (768)
T ss_dssp             EECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCC
T ss_pred             EECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCcccc
Confidence            555555555444555555555555555555554333332 4444555555555555544444

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=3.4e-43  Score=407.99  Aligned_cols=349  Identities=23%  Similarity=0.333  Sum_probs=307.0

Q ss_pred             CChhhHHHHHHHHHhccCCCCccc------ccCCCCCCCCCcc---cceeecCCCCceEEEEecCCCCCCcCCcccCCCC
Q 046240           31 NITTDQQALLALEAHISYDPTNLL------AQNWTSNTSVCNW---IGITCDVNSHRVTALNISSLNLQGEIPHEIGYLP  101 (763)
Q Consensus        31 ~~~~~~~~l~~~~~~~~~~~~~~~------~~~w~~~~~~c~w---~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~  101 (763)
                      ....|+.||.+++.++..+.+..-      ..+|..+.++|.|   .||+|+.. ++|+.|+|+++++.|.+|++|++|+
T Consensus        27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~  105 (636)
T 4eco_A           27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT  105 (636)
T ss_dssp             HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred             hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence            345799999999998764433211      1279988999999   99999865 8999999999999999999999999


Q ss_pred             CCCEEEcCCCcc------cC------------------------------------------------------------
Q 046240          102 SLTKLALGYNSL------VG------------------------------------------------------------  115 (763)
Q Consensus       102 ~L~~L~L~~n~l------~~------------------------------------------------------------  115 (763)
                      +|++|+|++|.+      .+                                                            
T Consensus       106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~  185 (636)
T 4eco_A          106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD  185 (636)
T ss_dssp             TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred             cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence            999999999975      11                                                            


Q ss_pred             ------CCccccCccccccccCCCccEEEccccccccc-----------------CCCccc--CCCCCCeeeecCccccc
Q 046240          116 ------NNSLSGSLPSRIDLALPNVKALSLAYNRFSGT-----------------IQSPIT--NASKLTILELGGNSFSG  170 (763)
Q Consensus       116 ------~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~-----------------~p~~~~--~l~~L~~L~L~~N~l~~  170 (763)
                            .|.++| ||..+. ++++|++|+|++|.|++.                 +|..++  ++++|++|+|++|++.+
T Consensus       186 l~l~~~~n~l~~-ip~~l~-~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~  263 (636)
T 4eco_A          186 TQIGQLSNNITF-VSKAVM-RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT  263 (636)
T ss_dssp             TTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred             hhhccccCCCcc-CCHHHh-cccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence                  246666 888755 899999999999999986                 999999  99999999999999999


Q ss_pred             ccccccCCCCchhhhhhhhhccCCc-ccc-cCCcccccc------cccccEEEeecCcccccccc--ccCCccccceeec
Q 046240          171 FIPNTIGNLRNIEWLGLVIGLIGNP-LNG-ILPSSIVNL------SISLERLYISNCSITGNIPQ--VMGNLSIFLLLDL  240 (763)
Q Consensus       171 ~~p~~~~~l~~L~~L~L~~~l~~n~-l~~-~~p~~~~~l------~~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L  240 (763)
                      .+|..|+++++|++|+    +++|+ +++ .+|..+..+      + +|++|+|++|+++ .+|.  .|+++++|++|+|
T Consensus       264 ~~p~~l~~l~~L~~L~----Ls~n~~l~~~~lp~~~~~L~~~~~l~-~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L  337 (636)
T 4eco_A          264 KLPTFLKALPEMQLIN----VACNRGISGEQLKDDWQALADAPVGE-KIQIIYIGYNNLK-TFPVETSLQKMKKLGMLEC  337 (636)
T ss_dssp             SCCTTTTTCSSCCEEE----CTTCTTSCHHHHHHHHHHHHHSGGGG-TCCEEECCSSCCS-SCCCHHHHTTCTTCCEEEC
T ss_pred             cChHHHhcCCCCCEEE----CcCCCCCccccchHHHHhhhccccCC-CCCEEECCCCcCC-ccCchhhhccCCCCCEEeC
Confidence            9999999999999999    88998 998 899999887      6 9999999999999 8888  9999999999999


Q ss_pred             ccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCc-ccEEEcccccccccCCcccCCCc--CccEEEcc
Q 046240          241 ELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKV-VVEINLSRNNFSGDIPATIGGLK--DVQNISLP  317 (763)
Q Consensus       241 ~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls  317 (763)
                      ++|+++|.+| .+..+++  |++|+|++|+++ .+|.  .+.++++ |++|++++|+++ .+|..+..++  +|+.|+++
T Consensus       338 ~~N~l~g~ip-~~~~l~~--L~~L~L~~N~l~-~lp~--~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls  410 (636)
T 4eco_A          338 LYNQLEGKLP-AFGSEIK--LASLNLAYNQIT-EIPA--NFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFS  410 (636)
T ss_dssp             CSCCCEEECC-CCEEEEE--ESEEECCSSEEE-ECCT--TSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECC
T ss_pred             cCCcCccchh-hhCCCCC--CCEEECCCCccc-cccH--hhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECc
Confidence            9999999999 8999977  999999999999 8888  7999999 999999999999 7888888765  99999999


Q ss_pred             CccccCccccccc-------ccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-CCc--------cc
Q 046240          318 YNRLEGPIPESFG-------YLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPF--------AN  381 (763)
Q Consensus       318 ~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~--------~~  381 (763)
                      +|++++.+|..+.       .+++|++|+|++|+++.+++..+..+++|+.|+|++|+++ .+|.. ...        +.
T Consensus       411 ~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~  489 (636)
T 4eco_A          411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYL  489 (636)
T ss_dssp             SSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGG
T ss_pred             CCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCC
Confidence            9999999999888       8889999999999999877777888999999999999999 45543 221        17


Q ss_pred             cccccccCCCcccCCC
Q 046240          382 FTAKSFMGNEKLCGLP  397 (763)
Q Consensus       382 l~~~~~~~n~~~c~~p  397 (763)
                      +..+++.+|... ..|
T Consensus       490 L~~L~Ls~N~l~-~lp  504 (636)
T 4eco_A          490 LTSIDLRFNKLT-KLS  504 (636)
T ss_dssp             CCEEECCSSCCC-BCC
T ss_pred             ccEEECcCCcCC-ccC
Confidence            888888888654 444

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.3e-42  Score=388.91  Aligned_cols=247  Identities=23%  Similarity=0.274  Sum_probs=196.5

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHH---HHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFE---VECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      ++|++.++||+|+||+||+|... +|+.||||++.+...   .......   .++.+++.++|||||+++++|.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999664 799999999975431   1122233   3456666779999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||++||+|..++...+ .++......++.||+.||+||   |+++||||||||+|||++.+|.+||+|||+|+.+..
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999999997654 589999999999999999999   889999999999999999999999999999998753


Q ss_pred             CCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ..    ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||........              .++....
T Consensus       345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--------------~~i~~~i  406 (689)
T 3v5w_A          345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEIDRMT  406 (689)
T ss_dssp             CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--------------HHHHHHH
T ss_pred             CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--------------HHHHHhh
Confidence            32    234689999999999864 5799999999999999999999999976322110              1111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCN  747 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~  747 (763)
                      +...+...    .....++.+++..|+..||++|++     ++||.
T Consensus       407 ~~~~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          407 LTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             HHCCCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             cCCCCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            11111110    112456789999999999999998     56654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-42  Score=368.97  Aligned_cols=290  Identities=33%  Similarity=0.497  Sum_probs=230.3

Q ss_pred             cCCCChHHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeee
Q 046240          462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGC  540 (763)
Q Consensus       462 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~  540 (763)
                      ...+++.++....++|...+.||+|+||.||+|...+|+.||||++..... .....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            456788999999999999999999999999999888899999999875532 2234688999999999999999999999


Q ss_pred             ecCCceEEEEEccCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEe
Q 046240          541 SNDDFKALVLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS  617 (763)
Q Consensus       541 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~  617 (763)
                      ...+..++||||+++|+|.+++....   ..+++..+..++.|+++||+|||..+..+|+||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997643   258999999999999999999976555699999999999999999999999


Q ss_pred             eecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhh---hhhhhhhhhccc
Q 046240          618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFA---AELSLKHWVNGL  694 (763)
Q Consensus       618 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~---~~~~~~~~~~~~  694 (763)
                      |||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   .......|....
T Consensus       177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            9999987653322 233445699999999999888899999999999999999999999975321   111222333222


Q ss_pred             CCh-hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          695 LPV-SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       695 ~~~-~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                      ... ....+.+..+      ...........+.+++..|++.+|++|||+.+|++.|+.....+.
T Consensus       256 ~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~  314 (326)
T 3uim_A          256 LKEKKLEALVDVDL------QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAER  314 (326)
T ss_dssp             TSSCCSTTSSCTTC------TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSS
T ss_pred             hhchhhhhhcChhh------ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhh
Confidence            221 1111111111      111123446789999999999999999999999999987655543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2e-42  Score=367.99  Aligned_cols=286  Identities=34%  Similarity=0.526  Sum_probs=226.1

Q ss_pred             CCCChHHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec
Q 046240          463 RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN  542 (763)
Q Consensus       463 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  542 (763)
                      .+++..++..++++|...+.||+|+||.||+|...+|+.||||++........+.+.+|+++++.++||||+++++++..
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            45566667778899999999999999999999988899999999876655556788999999999999999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeee
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                      .+..++||||+++|+|.+++....   ..+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999997643   2589999999999999999999   6789999999999999999999999999


Q ss_pred             cCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh-hhhhhhhcccC-Ch
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE-LSLKHWVNGLL-PV  697 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~-~~  697 (763)
                      |+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....|..... ..
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            99987643333333345568999999999988899999999999999999999999987532211 11111110000 00


Q ss_pred             hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          698 SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       698 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ...+++      .+.........+...+.+++.+||+.||++||++.++++.|+.+++..
T Consensus       264 ~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          264 QLEQIV------DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CCCSSS------SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cHHHhc------ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            000000      011111112345778999999999999999999999999999877643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.6e-42  Score=365.96  Aligned_cols=276  Identities=25%  Similarity=0.315  Sum_probs=213.4

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC----ceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD----FKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  549 (763)
                      .++|++.+.||+|+||+||+|... ++.||||++..... ......+|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999876 78999999976533 2345567899999999999999999997754    46999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEeCCCCCCCEEecCCCcEEEeee
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT----------PIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~----------~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                      |||+++|+|.+++....  +++..+..++.|+++||+||   |+.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~L---H~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYL---HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH---TCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHH---HhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999997654  89999999999999999999   666          9999999999999999999999999


Q ss_pred             cCceecCCCCCccccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh-hhhhhhcc
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-----RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL-SLKHWVNG  693 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~-~~~~~~~~  693 (763)
                      |+++.+.............||+.|+|||++.+     ..++.++|||||||++|||+||+.||........ ........
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99988765444333445679999999999876     3566789999999999999999999976432211 11111111


Q ss_pred             cCC-hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          694 LLP-VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       694 ~~~-~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ... ....+.+.................+..++.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            111 122222222222111111122234467799999999999999999999999999987543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1e-41  Score=404.58  Aligned_cols=321  Identities=35%  Similarity=0.574  Sum_probs=270.8

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCC-CCCEEEcCCCcccC--------------------CCccccCccccccccCCCcc
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLP-SLTKLALGYNSLVG--------------------NNSLSGSLPSRIDLALPNVK  135 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~-~L~~L~L~~n~l~~--------------------~~~~~~~lp~~~~~~l~~L~  135 (763)
                      .++++|+|++|.+++.+|..+.+++ +|++|+|++|.+++                    .|.+.+.+|..+. ++++|+
T Consensus       343 ~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~-~l~~L~  421 (768)
T 3rgz_A          343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS-NCSELV  421 (768)
T ss_dssp             TTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGG-GCTTCC
T ss_pred             CCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHh-cCCCCC
Confidence            4566666666666666666665554 55555555555431                    1223345665554 788888


Q ss_pred             EEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEE
Q 046240          136 ALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLY  215 (763)
Q Consensus       136 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~  215 (763)
                      +|+|++|++++.+|..|.++++|++|+|++|++++.+|..|..+++|++|+    +++|++++.+|..+.+++ +|++|+
T Consensus       422 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~----L~~N~l~~~~p~~l~~l~-~L~~L~  496 (768)
T 3rgz_A          422 SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI----LDFNDLTGEIPSGLSNCT-NLNWIS  496 (768)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE----CCSSCCCSCCCGGGGGCT-TCCEEE
T ss_pred             EEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEE----ecCCcccCcCCHHHhcCC-CCCEEE
Confidence            888888888888888888888888888888888888888888888888888    788899888888888888 899999


Q ss_pred             eecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCcc----------------
Q 046240          216 ISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI----------------  279 (763)
Q Consensus       216 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~----------------  279 (763)
                      |++|++++.+|..|+.+++|++|+|++|++++.+|..+.++++  |+.|++++|.++|.+|...                
T Consensus       497 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~  574 (768)
T 3rgz_A          497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS--LIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKR  574 (768)
T ss_dssp             CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTT--CCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCE
T ss_pred             ccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCC--CCEEECCCCccCCcCChHHhcccchhhhhcccccc
Confidence            9999999888988999999999999999998888988888876  9999999998888777521                


Q ss_pred             ----------------------------------------------------ccccCCcccEEEcccccccccCCcccCC
Q 046240          280 ----------------------------------------------------DIGNLKVVVEINLSRNNFSGDIPATIGG  307 (763)
Q Consensus       280 ----------------------------------------------------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  307 (763)
                                                                          .+..+++|+.|||++|+++|.+|..|++
T Consensus       575 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~  654 (768)
T 3rgz_A          575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS  654 (768)
T ss_dssp             EEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGG
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhc
Confidence                                                                2344678999999999999999999999


Q ss_pred             CcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccc
Q 046240          308 LKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSF  387 (763)
Q Consensus       308 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~  387 (763)
                      +++|+.|+|++|+++|.+|..|+.+++|+.|||++|++++.+|..+..+++|++||+++|+++|.+|..+.+..+....+
T Consensus       655 l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~  734 (768)
T 3rgz_A          655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF  734 (768)
T ss_dssp             CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGG
T ss_pred             cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCcccCCCCCCCCCCCCCC
Q 046240          388 MGNEKLCGLPHLQVPQCKHQT  408 (763)
Q Consensus       388 ~~n~~~c~~p~~~~~~c~~~~  408 (763)
                      .||+.+||.|   +++|....
T Consensus       735 ~gN~~Lcg~~---l~~C~~~~  752 (768)
T 3rgz_A          735 LNNPGLCGYP---LPRCDPSN  752 (768)
T ss_dssp             CSCTEEESTT---SCCCCSCC
T ss_pred             cCCchhcCCC---CcCCCCCc
Confidence            9999999987   45887543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.7e-41  Score=364.87  Aligned_cols=262  Identities=24%  Similarity=0.438  Sum_probs=214.7

Q ss_pred             HhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      .++|.+.+.||+|+||.||+|...        ++..||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468999999999999999999652        35679999997553 34567789999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          544 DFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      +..++||||+++|+|.+++....               ..+++..+..++.|+++||+||   |+++|+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchhhEEE
Confidence            99999999999999999997643               2478899999999999999999   77899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||+| |+.||.......   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999997754443333445567889999999999999999999999999999999 999987632211   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                                 ....+........      ...+...+.+++..||+.+|++||++.|+++.|++++...+
T Consensus       314 -----------~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          314 -----------LFKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             -----------HHHHHHTTCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -----------HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence                       1111211111110      01235568999999999999999999999999998876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-41  Score=355.65  Aligned_cols=250  Identities=27%  Similarity=0.320  Sum_probs=207.6

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|+..+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999975 57899999999766545567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++|+|.+++...  .++...+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            9999999999765  488999999999999999999   778999999999999999999999999999987653322  


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........             +..... ....
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------------~~~~~~-~~~~  237 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------------IATNGT-PELQ  237 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHHCS-CCCS
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhCCC-CCCC
Confidence            23446799999999999999999999999999999999999999976432211111             111100 0000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .    .+.+...+.+++.+||+.||++|||++|+++
T Consensus       238 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 N----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             C----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C----ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0    1123456889999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=354.56  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=213.8

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|...+.||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367889999999999999999764 6899999998766566678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.......
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999988666799999999999999999999   77899999999999999999999999999998764332211


Q ss_pred             ------------ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHH
Q 046240          633 ------------TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM  700 (763)
Q Consensus       633 ------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  700 (763)
                                  ......||+.|+|||++.+..++.++|||||||++|||++|..|+.........        ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~--------~~~~~~  237 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--------FGLNVR  237 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT--------SSBCHH
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH--------Hhhhhh
Confidence                        111457899999999999999999999999999999999999998653221110        011122


Q ss_pred             HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       701 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      .........          .+...+.+++..||+.||++||++.++++.|+++..
T Consensus       238 ~~~~~~~~~----------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          238 GFLDRYCPP----------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHHTCCT----------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccccCCC----------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            222222111          123457899999999999999999999999887654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.5e-41  Score=396.55  Aligned_cols=341  Identities=21%  Similarity=0.277  Sum_probs=291.7

Q ss_pred             CCChhhHHHHHHHHHhccCCCCcccccCCCCCC-----CC--Ccc------------cceeecCCCCceEEEEecCCCCC
Q 046240           30 SNITTDQQALLALEAHISYDPTNLLAQNWTSNT-----SV--CNW------------IGITCDVNSHRVTALNISSLNLQ   90 (763)
Q Consensus        30 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~L~L~~~~l~   90 (763)
                      +....|+.||++||+++. +|      +|..+.     ++  |.|            .||+|+. .++|+.|+|++|++.
T Consensus       265 ~~~~~d~~ALl~~k~~l~-~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~  336 (876)
T 4ecn_A          265 AEYIKDYKALKAIWEALD-GK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK  336 (876)
T ss_dssp             CHHHHHHHHHHHHHHHTT-GG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred             ccchHHHHHHHHHHHHcC-CC------CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence            345689999999999985 44      575443     55  999            9999986 589999999999999


Q ss_pred             CcCCcccCCCCCCCEEEc-CCCcccCC-----------------------------------------------------
Q 046240           91 GEIPHEIGYLPSLTKLAL-GYNSLVGN-----------------------------------------------------  116 (763)
Q Consensus        91 ~~~~~~~~~l~~L~~L~L-~~n~l~~~-----------------------------------------------------  116 (763)
                      |.+|++|++|++|++|+| ++|.+++.                                                     
T Consensus       337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~  416 (876)
T 4ecn_A          337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP  416 (876)
T ss_dssp             EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred             CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence            999999999999999999 88876433                                                     


Q ss_pred             ------------------CccccCccccccccCCCccEEEcccccccc-----------------cCCCccc--CCCCCC
Q 046240          117 ------------------NSLSGSLPSRIDLALPNVKALSLAYNRFSG-----------------TIQSPIT--NASKLT  159 (763)
Q Consensus       117 ------------------~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~-----------------~~p~~~~--~l~~L~  159 (763)
                                        |.+.+ ||..+. ++++|++|+|++|+|++                 .+|..++  ++++|+
T Consensus       417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~-~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~  494 (876)
T 4ecn_A          417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLT  494 (876)
T ss_dssp             CCCCCCCCCCTTTTTCCSCEEEE-ECGGGG-GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCC
T ss_pred             cccccccchhhceeccccCcccc-hhHHHh-cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCC
Confidence                              33444 887754 89999999999999998                 3899887  999999


Q ss_pred             eeeecCcccccccccccCCCCchhhhhhhhhccCCc-ccc-cCCccccccc------ccccEEEeecCcccccccc--cc
Q 046240          160 ILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNP-LNG-ILPSSIVNLS------ISLERLYISNCSITGNIPQ--VM  229 (763)
Q Consensus       160 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~-l~~-~~p~~~~~l~------~~L~~L~L~~N~l~~~~~~--~~  229 (763)
                      +|+|++|++.+.+|..|+++++|+.|+    +++|+ +++ .+|..+.++.      ++|++|+|++|+++ .+|.  .|
T Consensus       495 ~L~Ls~N~l~~~iP~~l~~L~~L~~L~----Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l  569 (876)
T 4ecn_A          495 DVELYNCPNMTQLPDFLYDLPELQSLN----IACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL  569 (876)
T ss_dssp             EEEEESCTTCCSCCGGGGGCSSCCEEE----CTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred             EEECcCCCCCccChHHHhCCCCCCEEE----CcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence            999999999999999999999999999    88998 998 8898777653      48999999999999 8888  99


Q ss_pred             CCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCc-ccEEEcccccccccCCcccCCC
Q 046240          230 GNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKV-VVEINLSRNNFSGDIPATIGGL  308 (763)
Q Consensus       230 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l  308 (763)
                      +++++|+.|+|++|+++ .+| .|..+++  |+.|+|++|+++ .+|.  .+.++++ |+.|+|++|+++ .+|..+..+
T Consensus       570 ~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~--L~~L~Ls~N~l~-~lp~--~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~  641 (876)
T 4ecn_A          570 QKMVKLGLLDCVHNKVR-HLE-AFGTNVK--LTDLKLDYNQIE-EIPE--DFCAFTDQVEGLGFSHNKLK-YIPNIFNAK  641 (876)
T ss_dssp             TTCTTCCEEECTTSCCC-BCC-CCCTTSE--ESEEECCSSCCS-CCCT--TSCEECTTCCEEECCSSCCC-SCCSCCCTT
T ss_pred             hcCCCCCEEECCCCCcc-cch-hhcCCCc--ceEEECcCCccc-cchH--HHhhccccCCEEECcCCCCC-cCchhhhcc
Confidence            99999999999999999 888 8999977  999999999999 8888  7899999 999999999999 788888877


Q ss_pred             cC--ccEEEccCccccCcccccc---c--ccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCc--
Q 046240          309 KD--VQNISLPYNRLEGPIPESF---G--YLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPF--  379 (763)
Q Consensus       309 ~~--L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--  379 (763)
                      +.  |+.|+|++|++++.+|...   .  .+++|+.|+|++|+++.+++..+..+++|+.|+|++|+++..++.....  
T Consensus       642 ~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~  721 (876)
T 4ecn_A          642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKD  721 (876)
T ss_dssp             CSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTT
T ss_pred             ccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcccc
Confidence            65  9999999999998766422   2  3458999999999999876666778999999999999999444433222  


Q ss_pred             ------cccccccccCCCcc
Q 046240          380 ------ANFTAKSFMGNEKL  393 (763)
Q Consensus       380 ------~~l~~~~~~~n~~~  393 (763)
                            +.+..+++.+|...
T Consensus       722 ~~l~nl~~L~~L~Ls~N~L~  741 (876)
T 4ecn_A          722 GNYKNTYLLTTIDLRFNKLT  741 (876)
T ss_dssp             SCCTTGGGCCEEECCSSCCC
T ss_pred             ccccccCCccEEECCCCCCc
Confidence                  27888888888544

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.1e-41  Score=356.84  Aligned_cols=261  Identities=26%  Similarity=0.435  Sum_probs=212.1

Q ss_pred             HhccCcCceecccCCceEEEEEec----CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|.+.+.||+|+||.||+|...    .+..||||+++.. .....+.+.+|++++++++||||+++++++...+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467889999999999999999774    3456999999765 33456778999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            9999999999999987666799999999999999999999   7789999999999999999999999999999887533


Q ss_pred             CCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          629 DQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       629 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........              .+.+...
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------------~~~~~~~  270 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--------------ISSVEEG  270 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--------------HHHHHTT
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--------------HHHHHcC
Confidence            221 22233456788999999988899999999999999999999 9999976432211              1111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ......      ..+...+.+++..||+.||++||++.+|++.|+.++...
T Consensus       271 ~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          271 YRLPAP------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             CCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             CCCCCC------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            111101      123556899999999999999999999999999887764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-40  Score=351.20  Aligned_cols=282  Identities=31%  Similarity=0.446  Sum_probs=224.2

Q ss_pred             ccCCCChHHHHHHHhccCcC------ceecccCCceEEEEEecCCceEEEEEeehhh----HHHHHHHHHHHHHHHhCCC
Q 046240          461 TKRRLPYQDLSRATNRFGRD------NLIGIGSFGYVYKAELDDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNIRH  530 (763)
Q Consensus       461 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h  530 (763)
                      ....+++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            44668899999999988877      8999999999999987 47899999986431    2345778999999999999


Q ss_pred             CccceEEeeeecCCceEEEEEccCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS--TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       531 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      |||+++++++...+..++||||+++++|.+++...  ...+++..+..++.|+++||.||   |+.+|+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998643  33689999999999999999999   67899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK  688 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~  688 (763)
                      +.++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|..||........ ..
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LL  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HH
Confidence            9999999999999987654333333345678999999998765 589999999999999999999999976432211 11


Q ss_pred             hhhc--ccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          689 HWVN--GLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       689 ~~~~--~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      .+..  ......+.+.+++.+...       ...+...+.+++..||+.+|++||++.+|++.|+++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMNDA-------DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCSCC-------CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhhhhhhhhhhcccccccc-------chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1100  001112223333222111       12346678999999999999999999999999988653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.2e-41  Score=354.17  Aligned_cols=274  Identities=24%  Similarity=0.356  Sum_probs=212.9

Q ss_pred             HhccCcCceecccCCceEEEEEe-----cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecC--Cce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-----DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  546 (763)
                      .++|++.+.||+|+||+||+|.+     .+++.||||++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46899999999999999999974     36889999999876666677899999999999999999999998543  468


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999987666789999999999999999999   77899999999999999999999999999998775


Q ss_pred             CCCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc-CChh-HHHHH
Q 046240          627 GEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL-LPVS-LMEVV  703 (763)
Q Consensus       627 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~i  703 (763)
                      ..... .......++..|+|||++.+..++.++||||||+++|||+||..|+........   ...... .... ...+.
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH---HHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH---hhhcCccccchhHHHHH
Confidence            33221 223344577889999999989999999999999999999999999876433221   111111 1111 11222


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ..........   ....+...+.+++..||+.+|++|||+.++++.|+++..+
T Consensus       243 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          243 ELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            2221111111   1123456789999999999999999999999999987654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-40  Score=350.89  Aligned_cols=260  Identities=29%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             HHhccCcCceecccCCceEEEEEecCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ..++|.+.+.||+|+||+||+|.. +|+.||||++....  ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            357899999999999999999977 48899999986442  344567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          551 EYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTP--IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ||+++|+|.+++.....  .+++..+..++.|+++||+||   |+.+  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999976542  488999999999999999999   6777  9999999999999999999999999998653


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........              ..+...
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--------------~~~~~~  254 (309)
T 3p86_A          191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--------------AAVGFK  254 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--------------HHHHHS
T ss_pred             ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------------HHHHhc
Confidence            221  2234467899999999999999999999999999999999999999764322211              011100


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ... ...    ...+...+.+++..||+.+|++|||+.++++.|++.+...
T Consensus       255 ~~~-~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          255 CKR-LEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCC-CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCC-CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            000 000    0123456889999999999999999999999999887763

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.3e-42  Score=371.25  Aligned_cols=259  Identities=26%  Similarity=0.371  Sum_probs=212.4

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            468899999999999999999875 78999999987542 3344568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++|+|.+++...+..+++.....++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            9999999999987665689999999999999999999   7789999999999999999999999999999875432221


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .......++..|+|||.+.+..++.++|||||||++|||+| |..||.......              ..+.+.+.... 
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--------------~~~~~~~~~~~-  334 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--------------TREFVEKGGRL-  334 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--------------HHHHHHTTCCC-
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcCCCC-
Confidence            12222345778999999988899999999999999999999 999997643221              11222211111 


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      +.     ++.++..+.+++..||+.+|++|||+.++++.|+++..
T Consensus       335 ~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          335 PC-----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            10     11235578899999999999999999999999987754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-40  Score=354.53  Aligned_cols=262  Identities=23%  Similarity=0.271  Sum_probs=212.4

Q ss_pred             cCCCChHHHHHHHhc----------cCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCC
Q 046240          462 KRRLPYQDLSRATNR----------FGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRH  530 (763)
Q Consensus       462 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h  530 (763)
                      ...++++++..+++.          |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            345777888777653          677789999999999999775 799999999986654556778899999999999


Q ss_pred             CccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC
Q 046240          531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE  610 (763)
Q Consensus       531 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~  610 (763)
                      |||+++++++...+..++||||+++++|.+++...  .+++..+..++.|+++||.||   |+.+|+||||||+||+++.
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTL  176 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECT
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECC
Confidence            99999999999999999999999999999998754  489999999999999999999   6789999999999999999


Q ss_pred             CCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh
Q 046240          611 DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW  690 (763)
Q Consensus       611 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~  690 (763)
                      ++.+||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .   
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-~---  250 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-M---  250 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H---
T ss_pred             CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H---
Confidence            99999999999987653322  23445799999999999999999999999999999999999999976322111 0   


Q ss_pred             hcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          691 VNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       691 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                               ..+ .....  +..  .........+.+++.+|++.||++||++.++++
T Consensus       251 ---------~~~-~~~~~--~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          251 ---------KRL-RDSPP--PKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ---------HHH-HHSSC--CCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---------HHH-hcCCC--CCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     011 11100  000  001112456889999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-40  Score=344.44  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=213.6

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            468999999999999999999998888999999975432 2356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence            99999999987665689999999999999999999   778999999999999999999999999999987653322 22


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..........             .+........+.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------------~~~~~~~~~~~~  228 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-------------KVSQGHRLYRPH  228 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------------HHHTTCCCCCCT
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-------------HHHcCCCCCCCC
Confidence            334556788999999988889999999999999999999 999997643322111             011100011111


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                             .....+.+++..|++.+|++|||+.++++.|+++.+++
T Consensus       229 -------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          229 -------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             -------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             -------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence                   12346889999999999999999999999999987765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.3e-41  Score=345.67  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=213.1

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|+..+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            367899999999999999999988889999999975532 2356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            99999999987766789999999999999999999   78899999999999999999999999999998764221 122


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||........              .+.+.........
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~~  229 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------------VEDISTGFRLYKP  229 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------HHHHHTTCCCCCC
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH--------------HHHHhcCccCCCC
Confidence            334556788999999988899999999999999999999 9999976332211              1111111111111


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      .      .....+.+++..|++.+|++||++.++++.|+++.++
T Consensus       230 ~------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          230 R------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             T------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            0      1245688999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.2e-40  Score=361.17  Aligned_cols=260  Identities=26%  Similarity=0.472  Sum_probs=202.2

Q ss_pred             HhccCcCceecccCCceEEEEEec----CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|.+.+.||+|+||.||+|...    ++..||||+++.. .....+.+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            368999999999999999999764    5778999999754 23456788999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            9999999999999987766799999999999999999999   6789999999999999999999999999999876533


Q ss_pred             CCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          629 DQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       629 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......              ..+.+...
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------------~~~~i~~~  266 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------------VIKAVDEG  266 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------------HHHHHHTT
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcC
Confidence            221 12223345778999999998999999999999999999998 999986533221              11222222


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ......      ..+...+.+++..||+.+|++||++.+|+++|+++...
T Consensus       267 ~~~~~~------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          267 YRLPPP------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             EECCCC------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCC------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            111111      12355689999999999999999999999999887665

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.8e-40  Score=352.90  Aligned_cols=247  Identities=25%  Similarity=0.301  Sum_probs=204.8

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35799999999999999999976 57999999999754  2345667889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++...+ .++......++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999987654 588999999999999999999   77899999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCccccCCCCCC-cchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVS-TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        ......||+.|+|||++.+..+. .++||||+||++|||++|+.||........              .+.+......
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------------~~~i~~~~~~  232 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL--------------RERVLRGKYR  232 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------HHHHHHCCCC
T ss_pred             --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH--------------HHHHHhCCCC
Confidence              23456799999999999887765 799999999999999999999976432211              1111111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .|.       .....+.+++.+|+..||++|||++|+++
T Consensus       233 ~p~-------~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          233 IPF-------YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCT-------TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCC-------CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111       12445789999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.5e-40  Score=369.62  Aligned_cols=323  Identities=21%  Similarity=0.227  Sum_probs=284.8

Q ss_pred             CCCcccc--eeecCCC--------CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCC
Q 046240           63 SVCNWIG--ITCDVNS--------HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALP  132 (763)
Q Consensus        63 ~~c~w~g--v~c~~~~--------~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~  132 (763)
                      ..|.|.+  |.|+...        .++++|+|++|.+++..|..|+++++|++|+|++|.+.      +.++...|.+++
T Consensus         6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~------~~i~~~~~~~l~   79 (455)
T 3v47_A            6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG------LVIRNNTFRGLS   79 (455)
T ss_dssp             -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTT------CEECTTTTTTCT
T ss_pred             ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCccc------ceECcccccccc
Confidence            4566555  7776532        67999999999999988999999999999999999885      578888888999


Q ss_pred             CccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccc--cCCCCchhhhhhhhhccCCcccccCCcc-cccccc
Q 046240          133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT--IGNLRNIEWLGLVIGLIGNPLNGILPSS-IVNLSI  209 (763)
Q Consensus       133 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~~l~~n~l~~~~p~~-~~~l~~  209 (763)
                      +|++|+|++|++++..|..|.++++|++|+|++|++++..+..  |.++++|++|+    +++|++++..|.. +.+++ 
T Consensus        80 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~----L~~n~l~~~~~~~~~~~l~-  154 (455)
T 3v47_A           80 SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV----LRDNNIKKIQPASFFLNMR-  154 (455)
T ss_dssp             TCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEE----CCSSBCCSCCCCGGGGGCT-
T ss_pred             cCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEE----CCCCccCccCcccccCCCC-
Confidence            9999999999999999999999999999999999999855544  99999999999    8899999998887 66777 


Q ss_pred             cccEEEeecCccccccccccCCc----------------------------------cccceeecccccccCCCCccccc
Q 046240          210 SLERLYISNCSITGNIPQVMGNL----------------------------------SIFLLLDLELNKLTGPIPVTFGR  255 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l----------------------------------~~L~~L~L~~N~l~~~~p~~~~~  255 (763)
                      +|++|+|++|++++..+..+..+                                  ++|++|+|++|++++..|..+..
T Consensus       155 ~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~  234 (455)
T 3v47_A          155 RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD  234 (455)
T ss_dssp             TCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHH
T ss_pred             cccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhc
Confidence            99999999999999888877655                                  67888888888887655544422


Q ss_pred             c-------------------------------------CCCCccEEEecCCccccCCCCccccccCCcccEEEccccccc
Q 046240          256 L-------------------------------------QNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFS  298 (763)
Q Consensus       256 l-------------------------------------~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~  298 (763)
                      .                                     ..++|++|++++|++++.+|.  .+..+++|++|+|++|+++
T Consensus       235 ~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~Ls~n~l~  312 (455)
T 3v47_A          235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKS--VFSHFTDLEQLTLAQNEIN  312 (455)
T ss_dssp             HTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTT--TTTTCTTCCEEECTTSCCC
T ss_pred             cccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchh--hcccCCCCCEEECCCCccc
Confidence            1                                     113489999999999988888  7899999999999999999


Q ss_pred             ccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-C
Q 046240          299 GDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-G  377 (763)
Q Consensus       299 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~  377 (763)
                      +..|..|.++++|+.|+|++|++++..|..|..+++|++|+|++|+++++.|..|..+++|++|+|++|++++.++.. .
T Consensus       313 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  392 (455)
T 3v47_A          313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFD  392 (455)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             ccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhc
Confidence            999999999999999999999999888999999999999999999999999999999999999999999999877755 5


Q ss_pred             CccccccccccCCCcccCCCC
Q 046240          378 PFANFTAKSFMGNEKLCGLPH  398 (763)
Q Consensus       378 ~~~~l~~~~~~~n~~~c~~p~  398 (763)
                      .++.+..+++.+|++.|+||.
T Consensus       393 ~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          393 RLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             TCTTCCEEECCSSCBCCCTTT
T ss_pred             cCCcccEEEccCCCcccCCCc
Confidence            678999999999999999983

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=351.58  Aligned_cols=251  Identities=18%  Similarity=0.243  Sum_probs=207.4

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999765 68899999987543 3346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC--CCcEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE--DMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~  630 (763)
                      +++|+|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.  ++.+||+|||+++.+.... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            999999999987666789999999999999999999   7789999999999999987  7899999999998875332 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ..            .+....    
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~------------~i~~~~----  219 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IE------------NIMNAE----  219 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HH------------HHHHTC----
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-HH------------HHHcCC----
Confidence              22345689999999999988899999999999999999999999976432211 11            111111    


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .............++.+++.+|+..||++|||+.|+++
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111111223556889999999999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-40  Score=348.27  Aligned_cols=263  Identities=26%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            36799999999999999999975 47899999998532   234467789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++...+ .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999997654 589999999999999999999   77899999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ..              
T Consensus       166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~--------------  229 (294)
T 4eqm_A          166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD-SV--------------  229 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS-CC--------------
T ss_pred             c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-cC--------------
Confidence            1 2233456899999999999999999999999999999999999999874432221111111 11              


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCC-CHHHHHHHHhhccccC
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-NAKCCNFVLCEQFVSN  757 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~v~~~L~~~~~~~  757 (763)
                       +.........++..+.+++.+|++.||++|| +++++.+.|++.+..+
T Consensus       230 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          230 -PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             -CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             -CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence             1110111112355688999999999999999 8999999999888764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=355.60  Aligned_cols=269  Identities=23%  Similarity=0.375  Sum_probs=211.6

Q ss_pred             HHhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCC
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDD  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  544 (763)
                      ..++|.+.+.||+|+||.||+|..      .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999975      246689999997542 33467789999999999 8999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTC----------------------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK  602 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk  602 (763)
                      ..++||||+++|+|.+++.....                      .+++..+..++.|+++||+||   |+.+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCC
Confidence            99999999999999999976532                      378899999999999999999   77899999999


Q ss_pred             CCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhh
Q 046240          603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMF  681 (763)
Q Consensus       603 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~  681 (763)
                      |+||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654433333445567889999999988899999999999999999998 999997632


Q ss_pred             hhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCcccc
Q 046240          682 AAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSEL  761 (763)
Q Consensus       682 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~~~  761 (763)
                      ...             .....+.........      ..+...+.+++..||+.||++||++.++++.|+.++.....+.
T Consensus       280 ~~~-------------~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~  340 (344)
T 1rjb_A          280 VDA-------------NFYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM  340 (344)
T ss_dssp             CSH-------------HHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred             cHH-------------HHHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence            211             112222222111111      1124568999999999999999999999999999999887776


Q ss_pred             cC
Q 046240          762 YK  763 (763)
Q Consensus       762 ~~  763 (763)
                      |+
T Consensus       341 ~~  342 (344)
T 1rjb_A          341 YQ  342 (344)
T ss_dssp             --
T ss_pred             hc
Confidence            63

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-40  Score=359.60  Aligned_cols=270  Identities=21%  Similarity=0.359  Sum_probs=215.4

Q ss_pred             CChHHHHHHHhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceE
Q 046240          465 LPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKI  536 (763)
Q Consensus       465 ~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l  536 (763)
                      ....+.....++|.+.+.||+|+||.||+|.+      .+++.||||++.... ....+.+.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            33444455678999999999999999999963      246889999997643 34456789999999999 79999999


Q ss_pred             EeeeecCC-ceEEEEEccCCCChhhhhccCCC------------------------------------------------
Q 046240          537 ISGCSNDD-FKALVLEYMPNGSLDIFLYSSTC------------------------------------------------  567 (763)
Q Consensus       537 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  567 (763)
                      ++++.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998765 48999999999999999976432                                                


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          568 -----------------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       568 -----------------~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                                       .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             188899999999999999999   778999999999999999999999999999987654443


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ........+|+.|+|||++.+..++.++|||||||++|||+| |..||.......             .....+......
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------------~~~~~~~~~~~~  315 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------------EFCRRLKEGTRM  315 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------------HHHHHHHHTCCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------------HHHHHHHcCCCC
Confidence            334455678999999999998999999999999999999999 999997633221             111111111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ...      ..+...+.+++..||+.+|++||++.++++.|+++++.
T Consensus       316 ~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          316 RAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            110      11245688999999999999999999999999987754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.8e-40  Score=346.14  Aligned_cols=259  Identities=23%  Similarity=0.389  Sum_probs=211.5

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|.+.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            568999999999999999999999888999999975532 2356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++......+++..+..++.|+++||.||   |+++|+||||||+||+++.++.+||+|||+++...... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  177 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  177 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence            99999999987555799999999999999999999   77899999999999999999999999999998764221 112


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      .....+++.|+|||++.+..++.++||||||+++|||+| |+.||........              .+.+.........
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--------------~~~~~~~~~~~~~  243 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------------AEHIAQGLRLYRP  243 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------------HHHHHTTCCCCCC
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--------------HHHHhcccCCCCC
Confidence            233456788999999988899999999999999999999 9999976432211              1111111111111


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .      .....+.+++..||+.+|++||++.++++.|.+++.++
T Consensus       244 ~------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          244 H------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             T------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             C------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            1      12346889999999999999999999999999887665

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-40  Score=357.99  Aligned_cols=261  Identities=26%  Similarity=0.421  Sum_probs=214.8

Q ss_pred             HhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      .++|.+.+.||+|+||.||+|...        .+..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468999999999999999999752        34579999997653 34557789999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          544 DFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      +..++||||+++|+|.+++....               ..+++..+..++.|+++||+||   |+.+|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCcceEEE
Confidence            99999999999999999997643               3589999999999999999999   77899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987754443334445567889999999999999999999999999999999 999987633221   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                                 ..+.+.........      ..+...+.+++..||+.+|++||++.+|++.|++++...
T Consensus       302 -----------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          302 -----------LFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             -----------HHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             -----------HHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                       11112211111111      123456899999999999999999999999999887654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-40  Score=357.32  Aligned_cols=270  Identities=15%  Similarity=0.169  Sum_probs=212.1

Q ss_pred             HhccCcCceecccCCceEEEEEecC------CceEEEEEeehhhHHH-----------HHHHHHHHHHHHhCCCCccceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD------GIEVAIKVFHQECARA-----------MKSFEVECEVMKNIRHRNLVKI  536 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l  536 (763)
                      .++|.+.+.||+|+||.||+|...+      ++.||||++.......           ......|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999997754      4789999987543211           1223456667778899999999


Q ss_pred             EeeeecC----CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec--C
Q 046240          537 ISGCSND----DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD--E  610 (763)
Q Consensus       537 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~--~  610 (763)
                      ++++...    ...++||||+ +++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYI---HEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEecCCHHHEEEecCC
Confidence            9998764    4589999999 9999999987766799999999999999999999   678999999999999999  8


Q ss_pred             CCcEEEeeecCceecCCCCCcc-----ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh
Q 046240          611 DMIAHLSDFGIAKLLSGEDQSM-----TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL  685 (763)
Q Consensus       611 ~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~  685 (763)
                      ++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            8999999999998775332211     11334599999999999999999999999999999999999999986432221


Q ss_pred             hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          686 SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       686 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                       ..............+++++++...         .++.++.+++..||+.+|++||++.++++.|++++.+.
T Consensus       270 -~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          270 -YVRDSKIRYRENIASLMDKCFPAA---------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             -HHHHHHHHHHHCHHHHHHHHSCTT---------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -HHHHHHHHhhhhHHHHHHHhcccc---------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence             111111112234455555555321         12456889999999999999999999999999888763

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.2e-40  Score=346.62  Aligned_cols=265  Identities=27%  Similarity=0.370  Sum_probs=201.4

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHh--CCCCccceEEeeeec----CCceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKN--IRHRNLVKIISGCSN----DDFKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~  547 (763)
                      .++|.+.+.||+|+||+||+|.. +++.||||++....   ...+.+|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999987 58999999997543   3445566777766  789999999998654    34688


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      +||||+++|+|.+++...  .+++..+..++.|+++||+|||..     ++++|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  589999999999999999999521     1889999999999999999999999999999


Q ss_pred             eecCCCCCc--cccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcC----------CCCCchhhhhh
Q 046240          623 KLLSGEDQS--MTQTQTLATIGYMAPEYGIER------KVSTRSDIYSYGIMLIETFTR----------KKPADKMFAAE  684 (763)
Q Consensus       623 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg----------~~p~~~~~~~~  684 (763)
                      +........  .......||+.|+|||++.+.      .++.++|||||||++|||+||          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            876533221  112345799999999998776      456799999999999999999          66665422111


Q ss_pred             hhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       685 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      ...         ......+.................+...+.+++..||+.||++|||+.+|++.|+++
T Consensus       241 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSF---------EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCH---------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cch---------hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            100         011111111111111111112234567899999999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=354.27  Aligned_cols=262  Identities=28%  Similarity=0.455  Sum_probs=212.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ..++|...+.||+|+||.||+|...      +++.||||+++... ....+.+.+|++++++++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            4578999999999999999999774      34789999997653 3446778999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 046240          546 KALVLEYMPNGSLDIFLYSST-----------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK  602 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk  602 (763)
                      .++||||+++|+|.+++....                       ..+++..+..++.|+++||.||   |+++|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCC
Confidence            999999999999999987632                       4688999999999999999999   77899999999


Q ss_pred             CCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhh
Q 046240          603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMF  681 (763)
Q Consensus       603 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~  681 (763)
                      |+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999987643332223345568899999999988899999999999999999999 999997643


Q ss_pred             hhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          682 AAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       682 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ....             ...+........+.       .+...+.+++..||+.+|++||++.++++.|+++.++.
T Consensus       282 ~~~~-------------~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          282 HEEV-------------IYYVRDGNILACPE-------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             HHHH-------------HHHHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             hHHH-------------HHHHhCCCcCCCCC-------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            2211             01111111111111       23456899999999999999999999999999988774

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.3e-40  Score=347.90  Aligned_cols=264  Identities=24%  Similarity=0.389  Sum_probs=216.9

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  545 (763)
                      .++|...+.||+|+||.||+|..      .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999974      356889999997553 23457789999999999 99999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          546 KALVLEYMPNGSLDIFLYSSTC-----------------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      .++||||+++|+|.+++.....                 .+++..+..++.|+++||.||   |+.+|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEE
Confidence            9999999999999999976432                 488999999999999999999   77899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||+| |..||.......   
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  255 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---  255 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence            9999999999999987754433333344567889999999988899999999999999999999 999987632211   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCcc
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSS  759 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~  759 (763)
                                .....+..........      .+...+.+++..|++.||++||++.++++.|++++.+.++
T Consensus       256 ----------~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          256 ----------KFYKMIKEGFRMLSPE------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             ----------HHHHHHHHTCCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             ----------HHHHHhccCCCCCCcc------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence                      1222222222111111      1245689999999999999999999999999998876544

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.6e-40  Score=352.82  Aligned_cols=251  Identities=21%  Similarity=0.264  Sum_probs=205.6

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHH------HHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR------AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999765 6899999999754321      246788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC----cEEEeeecCc
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM----IAHLSDFGIA  622 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla  622 (763)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||.||   |+.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997643 689999999999999999999   778999999999999998876    7999999999


Q ss_pred             eecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      +.+....   ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ...             
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~-------------  229 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN-------------  229 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH-------------
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-------------
Confidence            8865322   22345799999999999999999999999999999999999999976432211 111             


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         ...................+.+++..|+..||++|||+.|+++
T Consensus       230 ---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          230 ---ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ---HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               1111111111111223456889999999999999999999885

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.9e-40  Score=352.55  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=204.2

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999765 78999999986443 2334668899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++|+|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999997653 589999999999999999999   7889999999999999999999999999999876433333


Q ss_pred             cccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+..            ......
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------~~~~~~  229 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------KKTYLN  229 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT------------TCTTST
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc------------ccccCC
Confidence            33345679999999999887765 77999999999999999999999764332222222211            111111


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.      ......+.+++.+|++.||++|||+.|+++
T Consensus       230 ~~------~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          230 PW------KKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             TG------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc------ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11      112455789999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=358.41  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=210.1

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|.+.+.||+|+||+||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999743      4678999998644 234456788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC---cEEEe
Q 046240          547 ALVLEYMPNGSLDIFLYSST------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM---IAHLS  617 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~---~~kl~  617 (763)
                      ++||||+++|+|.+++....      ..+++..+..++.|+++||+||   |+++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997532      3588999999999999999999   778999999999999999554   59999


Q ss_pred             eecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCC
Q 046240          618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       618 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      |||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||.......            
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------------  294 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------------  294 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------------
Confidence            9999986543332233344567999999999988999999999999999999998 999997643221            


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                        ..+.+.......+.      ..+...+.+++..||+.+|++||++.+|++.|+.+.+.
T Consensus       295 --~~~~i~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          295 --VLEFVTSGGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             --HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence              11111111111111      12345688999999999999999999999999876654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.6e-40  Score=352.18  Aligned_cols=253  Identities=20%  Similarity=0.253  Sum_probs=204.4

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHH-----HHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECAR-----AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      ..++|++.+.||+|+||+||+|.. .+|+.||||++......     ..+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356899999999999999999966 47899999999754321     356789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc---EEEeeec
Q 046240          547 ALVLEYMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI---AHLSDFG  620 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~---~kl~Dfg  620 (763)
                      ++||||+++++|.+.+...   ...+++..+..++.|+++||+||   |+++|+||||||+||+++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999998877542   23578999999999999999999   7789999999999999986654   9999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHH
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM  700 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  700 (763)
                      +++.+.....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ...            
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~------------  242 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--LFE------------  242 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--HHH------------
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--HHH------------
Confidence            9988753321  234457999999999999999999999999999999999999999763211  111            


Q ss_pred             HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.....    .............+.+++.+|++.||++||++.++++
T Consensus       243 ~i~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          243 GIIKGKY----KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHTCC----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCC----CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111111    1111111223556889999999999999999999985

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-39  Score=344.54  Aligned_cols=269  Identities=24%  Similarity=0.276  Sum_probs=204.0

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|++.+.||+|+||+||+|...+|+.||+|++.....  .....+.+|++++++++||||+++++++..++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            478999999999999999999988899999999875432  234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++ +|.+++......++...+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+..... 
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            9985 78777776666789999999999999999999   778999999999999999999999999999987643222 


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChh------HHHH
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVS------LMEV  702 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~------~~~~  702 (763)
                       ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  .........+..      ...+
T Consensus       175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence             2344578999999998876 56899999999999999999999999764332211  111111111110      0111


Q ss_pred             HHhhcCCCcccc-HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 VNKTLLSPPEKD-FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ............ ......+..++.+++.+|++.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111111000000 0111123456889999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.3e-40  Score=347.01  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=214.0

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|.+.+.||+|+||.||+|..      .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            57899999999999999999965      245789999997543 34567789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 046240          547 ALVLEYMPNGSLDIFLYSST-----------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKS  603 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~  603 (763)
                      ++||||+++++|.+++....                       ..+++..+..++.|+++||.||   |+.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH---HHTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH---HHCCCcccccch
Confidence            99999999999999997643                       2378899999999999999999   678999999999


Q ss_pred             CCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhh
Q 046240          604 SNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFA  682 (763)
Q Consensus       604 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~  682 (763)
                      +||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987754443333344567889999999988889999999999999999999 9999976332


Q ss_pred             hhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          683 AELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       683 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ..              ..+.+.........      ..+...+.+++..|++.||++||++.++++.|++++.+
T Consensus       259 ~~--------------~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ER--------------LFNLLKTGHRMERP------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GG--------------HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HH--------------HHHHhhcCCcCCCC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            11              11222211111110      12345689999999999999999999999999988765

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.6e-40  Score=351.32  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=204.5

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCc----eEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGI----EVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      .++|+..+.||+|+||+||+|.+. +++    +||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            367999999999999999999754 444    46888876443 234577899999999999999999999998765 78


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +|+||+++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999988767799999999999999999999   678999999999999999999999999999988754


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...........+|..|+|||++.+..++.++|||||||++|||+| |+.||.......              ..+.+...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------------~~~~~~~~  235 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------ISSILEKG  235 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------------HHHHHHTT
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------------HHHHHHcC
Confidence            444333445567889999999999999999999999999999999 999997643221              22222222


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ......      ..+...+.+++..||+.+|++||++.++++.|+++.++
T Consensus       236 ~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          236 ERLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCCCC------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCCC------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            111111      11345688999999999999999999999999877654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=346.81  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=205.7

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHH------HHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR------AMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ..++|...+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++...+.
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467999999999999999999765 6899999998754211      35678899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC----cEEEeeecC
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM----IAHLSDFGI  621 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~----~~kl~Dfgl  621 (763)
                      .++||||+++++|.+++.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++.++    .+||+|||+
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999997643 689999999999999999999   778999999999999999887    899999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      ++.+....   ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ...            
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~------------  228 (326)
T 2y0a_A          165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN------------  228 (326)
T ss_dssp             CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH------------
T ss_pred             CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHH------------
Confidence            98875332   22345799999999999999999999999999999999999999976332211 010            


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +..    ................+.+++..|+..||++|||+.++++
T Consensus       229 ~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 VSA----VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHH----TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHh----cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            100    0111111111223456889999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2e-39  Score=345.91  Aligned_cols=247  Identities=24%  Similarity=0.309  Sum_probs=203.5

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|+..+.||+|+||+||+|... +|+.||+|+++...   ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            67999999999999999999765 68999999998653   223566789999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|..++...+ .++......++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence            9999999999887643 588999999999999999999   77899999999999999999999999999998643222 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||........             ...+...... .
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------------~~~i~~~~~~-~  224 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------------FELILMEEIR-F  224 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCCC-C
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-------------HHHHHcCCCC-C
Confidence             123456799999999999999999999999999999999999999976332211             1111111111 1


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      +.       ....++.+++.+|++.+|++||     +++|+++
T Consensus       225 p~-------~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 PR-------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CT-------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC-------CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            11       1245678999999999999999     8888864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6e-40  Score=345.63  Aligned_cols=272  Identities=22%  Similarity=0.367  Sum_probs=212.4

Q ss_pred             HhccCcCceecccCCceEEEEEe-----cCCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecC--Cc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-----DDGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSND--DF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  545 (763)
                      .++|+..+.||+|+||.||+|.+     .+++.||+|++..... ...+.+.+|++++++++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35688999999999999999983     3688999999975432 3356788999999999999999999999876  66


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++||||+++++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            8999999999999999976666789999999999999999999   7789999999999999999999999999999887


Q ss_pred             CCCCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh-hHHHHH
Q 046240          626 SGEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV-SLMEVV  703 (763)
Q Consensus       626 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~i  703 (763)
                      ...... .......+|..|+|||++.+..++.++||||||+++|||++|..|+........   ......... ....+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL---KMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH---HHHCSCCGGGHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh---hccCCcccccCHHHHH
Confidence            543321 223445688889999999888999999999999999999999999765432221   111111111 222222


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcc
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQF  754 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~  754 (763)
                      ...........   ...+...+.+++..||+.||++|||+.++++.|++++
T Consensus       254 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKEGKRLPC---PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCCCCC---CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            22221111100   1123567899999999999999999999999998865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.5e-40  Score=349.53  Aligned_cols=275  Identities=23%  Similarity=0.309  Sum_probs=216.1

Q ss_pred             HhccCcCceecccCCceEEEEEe-----cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeee--cCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-----DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS--NDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  546 (763)
                      .++|++.+.||+|+||.||+|.+     .+++.||||++........+.+.+|++++++++||||+++++++.  .....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36899999999999999999984     468899999998766666778999999999999999999999886  45568


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999999987555689999999999999999999   77899999999999999999999999999999875


Q ss_pred             CCCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          627 GEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       627 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...............  .......+...
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~  256 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER--DVPALSRLLEL  256 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc--ccccHHHHHHH
Confidence            43322 2234456888899999998888999999999999999999999998765433222111111  11122222222


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      .........   ...+...+.+++..|++.+|++||++.++++.|+++...
T Consensus       257 ~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          257 LEEGQRLPA---PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             hhcccCCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            211111110   112356789999999999999999999999999987664

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=359.18  Aligned_cols=254  Identities=21%  Similarity=0.267  Sum_probs=205.1

Q ss_pred             HHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ...++|.+.+.||+|+||+||+|.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3568899999999999999999965 578999999987542  3445678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec---CCCcEEEeeecCceec
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLL  625 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~  625 (763)
                      ||||+++|+|.+.+.... .++......++.|+++||.||   |+++|+||||||+||+++   .++.+||+|||+++..
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999999887654 589999999999999999999   778999999999999998   4678999999999876


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .....  ......||+.|+|||++.+..++.++||||+||++|||++|..||........ .            ..+...
T Consensus       164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~------------~~i~~~  228 (444)
T 3soa_A          164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-Y------------QQIKAG  228 (444)
T ss_dssp             CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H------------HHHHHT
T ss_pred             cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-H------------HHHHhC
Confidence            53322  22346799999999999999999999999999999999999999976332211 1            111111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .. ..+...   .......+.+++..|++.||++|||+.|+++
T Consensus       229 ~~-~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          229 AY-DFPSPE---WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CC-CCCTTT---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC-CCCccc---cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11 111110   0112456889999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-40  Score=355.27  Aligned_cols=252  Identities=18%  Similarity=0.236  Sum_probs=207.4

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999664 7899999999866555566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC--CCcEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE--DMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~  630 (763)
                      +++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.  ++.+||+|||+++.+.... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            999999999987666789999999999999999999   7789999999999999974  4789999999998875332 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ..            .+........
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~------------~i~~~~~~~~  270 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQ------------NVKRCDWEFD  270 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HH------------HHHHCCCCCC
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-HH------------HHHhCCCCCC
Confidence              22345689999999999999999999999999999999999999976432211 11            1111111111


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +..    .......+.+++..|++.||++||++.++++
T Consensus       271 ~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          271 EDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            110    0112456889999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-39  Score=347.95  Aligned_cols=264  Identities=24%  Similarity=0.441  Sum_probs=213.3

Q ss_pred             HhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      .++|.+.+.||+|+||.||+|...        +++.||+|++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999763        46789999997553 34567788999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          544 DFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      +..++||||+++|+|.+++....               ..+++..+..++.|+++||+||   |+.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCccceEEE
Confidence            99999999999999999997643               2378899999999999999999   77899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence            9999999999999988754433333344567889999999988889999999999999999999 999987632221   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCccc
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE  760 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~~  760 (763)
                                 ....+.........      ..+...+.+++..||+.+|++||++.++++.|++++.....+
T Consensus       268 -----------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~  323 (334)
T 2pvf_A          268 -----------LFKLLKEGHRMDKP------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE  323 (334)
T ss_dssp             -----------HHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -----------HHHHHhcCCCCCCC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence                       11111111111111      113456889999999999999999999999999887764433

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.3e-40  Score=345.31  Aligned_cols=262  Identities=28%  Similarity=0.405  Sum_probs=197.9

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||+||+|....  .||+|++...  .....+.+.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            4689999999999999999998753  5999998643  234567789999999999999999999965 4556899999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++++|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            9999999999977766799999999999999999999   7789999999999999999999999999999876433333


Q ss_pred             cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          632 MTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .......||+.|+|||.+.   +..++.++||||||+++|||++|+.||........             ..+.+.....
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------~~~~~~~~~~  243 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------------IIEMVGRGSL  243 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-------------HHHHHHHTSC
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-------------HHHHhccccc
Confidence            3334567899999999876   66788899999999999999999999976432221             1111211111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ......  ....++..+.+++..|++.+|++||++.+++++|+++.++
T Consensus       244 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          244 SPDLSK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             CCCTTS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             Ccchhh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence            110000  0112356789999999999999999999999999988753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=345.06  Aligned_cols=287  Identities=25%  Similarity=0.334  Sum_probs=207.6

Q ss_pred             ChHHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC--CCCccceEEeeeecC
Q 046240          466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI--RHRNLVKIISGCSND  543 (763)
Q Consensus       466 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~  543 (763)
                      +........++|.+.+.||+|+||.||+|... ++.||||++.....   ....+|.+++...  +||||+++++++...
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            33333445689999999999999999999876 89999999875432   3334455555554  899999999999877


Q ss_pred             ----CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEecCCCcE
Q 046240          544 ----DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----HTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       544 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                          ...++||||+++|+|.+++...  .+++..+..++.|++.||+|||..     |..+|+||||||+||+++.++.+
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence                6789999999999999999765  489999999999999999999432     13399999999999999999999


Q ss_pred             EEeeecCceecCCCCCc--cccccccccccccCccccCCCCCCcc------hhHHHHHHHHHHHHcCCCCCchhhhhhhh
Q 046240          615 HLSDFGIAKLLSGEDQS--MTQTQTLATIGYMAPEYGIERKVSTR------SDIYSYGIMLIETFTRKKPADKMFAAELS  686 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~slGv~l~elltg~~p~~~~~~~~~~  686 (763)
                      ||+|||+++.+......  .......||+.|+|||++.+...+.+      +|||||||++|||+||..|+.........
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            99999999876433221  11234579999999999887766665      99999999999999995444321111100


Q ss_pred             hhhhhcccCC-hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          687 LKHWVNGLLP-VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       687 ~~~~~~~~~~-~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                      .......... ....+.+...............+.+...+.+++..||+.||++||++.+|++.|+++.+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            0000000001 11222222111111111112223567889999999999999999999999999998887654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-39  Score=342.94  Aligned_cols=265  Identities=15%  Similarity=0.142  Sum_probs=212.7

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++....  ..+.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999975 578999999986442  234578899999999 79999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc-----EEEeeecCceecC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI-----AHLSDFGIAKLLS  626 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~  626 (763)
                      |+ +++|.+++...+..+++..+..++.|+++||+||   |+++|+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 9999999987666799999999999999999999   7889999999999999987766     9999999998875


Q ss_pred             CCCCc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          627 GEDQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       627 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      .....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........          .....
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----------~~~~~  232 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK----------QKYER  232 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----------HHHHH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH----------HHHHH
Confidence            43221     1234567999999999999999999999999999999999999999763211100          00011


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      +.........   ......++..+.+++..||+.+|++||++++|++.|++++.+.
T Consensus       233 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          233 IGEKKQSTPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHHHHHHSCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhhccCccH---HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            1111110000   0011123567899999999999999999999999999888763

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=353.24  Aligned_cols=249  Identities=21%  Similarity=0.283  Sum_probs=199.6

Q ss_pred             cCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      |...+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            33467899999999999966 47899999999876555667889999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe--cCCCcEEEeeecCceecCCCCCccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL--DEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||++  +.++.+||+|||+++.+....   .
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            999998877666789999999999999999999   77899999999999999  567899999999999875332   2


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........             ...++......... 
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------------~~~i~~~~~~~~~~-  310 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-------------LNNILACRWDLEDE-  310 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHTCCCSCSG-
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhccCCCChh-
Confidence            2345699999999999999999999999999999999999999976432211             11122111111111 


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .   ......++.+++.+|++.+|++||++.|+++
T Consensus       311 ~---~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 E---FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             G---GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h---hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0   1123456899999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-39  Score=350.37  Aligned_cols=253  Identities=21%  Similarity=0.340  Sum_probs=205.3

Q ss_pred             HHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ...++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34678999999999999999999764 68999999997542  3445678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC---CcEEEeeecCceec
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED---MIAHLSDFGIAKLL  625 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~  625 (763)
                      ||||+++|+|.+++.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++.+   +.+||+|||+++..
T Consensus       106 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            999999999998887643 588999999999999999999   77899999999999999865   45999999999876


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||++|..||........             ...+...
T Consensus       182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~  245 (362)
T 2bdw_A          182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------------YAQIKAG  245 (362)
T ss_dssp             TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHT
T ss_pred             cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHhC
Confidence            5322   22346799999999999999999999999999999999999999976332211             0111111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .. ..+....   ......+.+++.+|++.||++||++.++++
T Consensus       246 ~~-~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          246 AY-DYPSPEW---DTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CC-CCCTTGG---GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CC-CCCcccc---cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11 1111110   123456889999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.4e-40  Score=349.53  Aligned_cols=264  Identities=19%  Similarity=0.220  Sum_probs=210.7

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||+||+|.. .+|+.||||++....  ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            36799999999999999999975 578999999987542  234578899999999 99999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc-----EEEeeecCceecC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI-----AHLSDFGIAKLLS  626 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~  626 (763)
                      |+ +++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.     +||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 9999999987656799999999999999999999   6789999999999999998887     9999999999764


Q ss_pred             CCCCcc-----ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          627 GEDQSM-----TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       627 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..        ....
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~--------~~~~  231 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KE--------RYQK  231 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HH--------HHHH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HH--------HHHH
Confidence            332211     12456799999999999999999999999999999999999999976321110  00        0111


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      +..........   ...+.++ ++.+++..|++.+|++||++++|.+.|+++..+.
T Consensus       232 i~~~~~~~~~~---~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          232 IGDTKRATPIE---VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHSCHH---HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhhhccCCHH---HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            11111110000   0001123 7899999999999999999999999998777653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=343.23  Aligned_cols=255  Identities=27%  Similarity=0.380  Sum_probs=199.9

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|++.+.||+|+||+||+|... ++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            357889999999999999999876 788999998754  235678899999999999999999999874  478999999


Q ss_pred             CCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc-EEEeeecCceecCCCCC
Q 046240          554 PNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI-AHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       554 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~  630 (763)
                      ++|+|.+++.....  .+++..+..++.|+++||+|||..|.++|+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999986543  4788899999999999999997666689999999999999998876 799999999765321  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........            ..+....  .
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------~~~~~~~--~  222 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM------------WAVHNGT--R  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH------------HHHHTTC--C
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH------------HHHhcCC--C
Confidence               2234689999999999999999999999999999999999999975322111100            0011100  0


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      +...    ..+...+.+++.+||+.+|++|||++++++.|+++.+.
T Consensus       223 ~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          223 PPLI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             CCCB----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             CCcc----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            1100    11245688999999999999999999999999877654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.9e-40  Score=340.25  Aligned_cols=259  Identities=23%  Similarity=0.361  Sum_probs=199.3

Q ss_pred             HhccCcCceecccCCceEEEEEec----CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|++.+.||+|+||.||+|...    .+..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            468999999999999999999764    2457999998754 2344677899999999999999999999985 457899


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++++|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            9999999999999987666789999999999999999999   6789999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .. .......+++.|+|||.+.+..++.++|||||||++|||++ |..||........             ...+.....
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-------------~~~i~~~~~  235 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------------IGRIENGER  235 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------------HHHHHTTCC
T ss_pred             cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-------------HHHHHcCCC
Confidence            21 12233456788999999988899999999999999999997 9999976432211             011111100


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ...+       ..+...+.+++..|++.+|++||++.++++.|++++++.
T Consensus       236 ~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          236 LPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            0011       123456889999999999999999999999999887654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-39  Score=344.89  Aligned_cols=271  Identities=25%  Similarity=0.386  Sum_probs=212.9

Q ss_pred             hcc-CcCceecccCCceEEEEEec-----CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--Cc
Q 046240          475 NRF-GRDNLIGIGSFGYVYKAELD-----DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DF  545 (763)
Q Consensus       475 ~~~-~~~~~lg~G~~g~v~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  545 (763)
                      ++| ++.+.||+|+||+||++.+.     +++.||||++.... ....+.+.+|++++++++||||+++++++...  ..
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            344 88999999999999988653     68899999998653 34567789999999999999999999999874  57


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++||||+++|+|.+++....  +++..+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            899999999999999997654  89999999999999999999   7789999999999999999999999999999987


Q ss_pred             CCCCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh-hHHHHH
Q 046240          626 SGEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV-SLMEVV  703 (763)
Q Consensus       626 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~i  703 (763)
                      ...... .......++..|+|||++.+..++.++|||||||++|||++|..||............+....... ...+.+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            543321 223345678889999999988999999999999999999999999986543322222211111111 222222


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      .........      ..+...+.+++..||+.+|++||++.++++.|+++.++
T Consensus       265 ~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          265 ERGERLPRP------DKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcccCCCCC------ccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            222211111      12356789999999999999999999999999887654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9e-40  Score=347.84  Aligned_cols=262  Identities=24%  Similarity=0.455  Sum_probs=195.0

Q ss_pred             HHhccCcCceecccCCceEEEEEecC-C---ceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDD-G---IEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      ..++|.+.+.||+|+||.||+|.... +   ..||||++...  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999997653 3   27999998754  234567889999999999999999999999877655


Q ss_pred             ------EEEEEccCCCChhhhhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEE
Q 046240          547 ------ALVLEYMPNGSLDIFLYSST-----CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAH  615 (763)
Q Consensus       547 ------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~k  615 (763)
                            ++||||+++|+|.+++....     ..+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986422     2588999999999999999999   778999999999999999999999


Q ss_pred             EeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhccc
Q 046240          616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGL  694 (763)
Q Consensus       616 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  694 (763)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||........         
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---------  248 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---------  248 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---------
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---------
Confidence            999999987654443333344567889999999998999999999999999999999 9999876432211         


Q ss_pred             CChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                          ...+........+.       .+...+.+++..|++.||++|||+.++++.|++++...
T Consensus       249 ----~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          249 ----YNYLIGGNRLKQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ----HHHHHTTCCCCCCT-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ----HHHHhcCCCCCCCC-------ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                11111111111111       12456899999999999999999999999999887653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-39  Score=336.38  Aligned_cols=258  Identities=25%  Similarity=0.377  Sum_probs=212.4

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|...+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            367889999999999999999988889999999976532 2367889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++++|.+++......+++..+..++.|+++||.||   |+.+++||||||+||+++.++.+||+|||+++...... ...
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence            99999999987766789999999999999999999   77899999999999999999999999999998764221 112


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........              .+.+.........
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------------~~~i~~~~~~~~~  227 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------------VEDISTGFRLYKP  227 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------HHHHHTTCCCCCC
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--------------HHHHhcCCcCCCC
Confidence            234457788999999988889999999999999999999 8999876332211              1111111110000


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      .      .....+.+++..|++.+|++||++.++++.|+++.++
T Consensus       228 ~------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          228 R------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             T------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             c------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            0      1245688999999999999999999999999987654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=343.48  Aligned_cols=276  Identities=20%  Similarity=0.258  Sum_probs=209.1

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC--ceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD--FKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  549 (763)
                      .++|.+.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367999999999999999999765 58999999997543 233566789999999999999999999997765  77999


Q ss_pred             EEccCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe----cCCCcEEEeeecCce
Q 046240          550 LEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIAK  623 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~  623 (763)
                      |||+++++|.+++.....  .+++..+..++.|+++||+||   |+.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976433  389999999999999999999   77899999999999999    788889999999998


Q ss_pred             ecCCCCCccccccccccccccCccccC--------CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh---hhhhhhc
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGI--------ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL---SLKHWVN  692 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~---~~~~~~~  692 (763)
                      .+....   ......||+.|+|||++.        +..++.++|||||||++|||++|+.||........   .+.....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            875432   223456899999999875        57889999999999999999999999975322111   1111111


Q ss_pred             ccCChh---HHHHHHhhcCC--CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          693 GLLPVS---LMEVVNKTLLS--PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       693 ~~~~~~---~~~~i~~~l~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      +..+..   ...........  ...............+.+++..|++.||++|||++|+++...+...
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            100000   00000000000  0000011123456778999999999999999999999998775544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.4e-39  Score=342.99  Aligned_cols=251  Identities=21%  Similarity=0.268  Sum_probs=198.6

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC------
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------  544 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  544 (763)
                      ..++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999775 79999999987432 334577899999999999999999999985543      


Q ss_pred             ---------------------------------------------------ceEEEEEccCCCChhhhhccCCC--CCCH
Q 046240          545 ---------------------------------------------------FKALVLEYMPNGSLDIFLYSSTC--MLDI  571 (763)
Q Consensus       545 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~  571 (763)
                                                                         ..++||||+++++|.+++.....  ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999976432  4566


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc----------cccccccccc
Q 046240          572 FQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS----------MTQTQTLATI  641 (763)
Q Consensus       572 ~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~g~~  641 (763)
                      ..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            67889999999999999   7789999999999999999999999999999987543211          1223457999


Q ss_pred             cccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHH
Q 046240          642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQC  721 (763)
Q Consensus       642 ~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~  721 (763)
                      .|+|||++.+..++.++|||||||++|||++|..|+......                   .........   +......
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~-------------------~~~~~~~~~---~~~~~~~  298 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-------------------ITDVRNLKF---PLLFTQK  298 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH-------------------HHHHHTTCC---CHHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH-------------------HHHhhccCC---CcccccC
Confidence            999999999999999999999999999999998775432111                   000001010   1112223


Q ss_pred             HHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          722 VLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       722 ~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...+.+++..|++.||++||++.|+++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            456789999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.4e-39  Score=362.40  Aligned_cols=259  Identities=24%  Similarity=0.449  Sum_probs=211.8

Q ss_pred             HHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..++|...+.||+|+||.||+|...++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            356889999999999999999999888999999997643 23567899999999999999999999986 5678999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++|+|.+++.... ..+++..+..++.|+++||+||   |+++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence            99999999997542 2578889999999999999999   67899999999999999999999999999998764221 1


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .......++..|+|||++....++.++|||||||++|||+| |+.||.......              ..+.+...... 
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--------------~~~~i~~~~~~-  404 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------------VIRALERGYRM-  404 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------------HHHHHHHTCCC-
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcCCCC-
Confidence            12233456788999999988899999999999999999999 999997643221              11111111111 


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      +.     +..++..+.+++..||+.+|++|||+++|++.|++.....
T Consensus       405 ~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          405 PR-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CC-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            11     1124567899999999999999999999999999887653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=348.23  Aligned_cols=243  Identities=24%  Similarity=0.322  Sum_probs=196.2

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|++.+.||+|+||+||+|... +|+.||||++....   ....+.+.+|..+++.+ +||||+++++++...+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999765 68999999998653   22346678899999988 69999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|..++...+ .+++..+..++.|++.||+||   |+++|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            999999999999987654 589999999999999999999   7789999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........             ...+......
T Consensus       178 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------------~~~i~~~~~~  242 (353)
T 3txo_A          178 G--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-------------FEAILNDEVV  242 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCCC
T ss_pred             C--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-------------HHHHHcCCCC
Confidence            2  233456799999999999988999999999999999999999999976432211             1112221111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      . +.       .....+.+++..|++.+|++||++
T Consensus       243 ~-p~-------~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          243 Y-PT-------WLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             C-CT-------TSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             C-CC-------CCCHHHHHHHHHHhhhCHHHccCC
Confidence            1 11       124457899999999999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-39  Score=338.34  Aligned_cols=244  Identities=23%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|... +|+.||+|+++....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57999999999999999999765 789999999986532   23466788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++.... .++......++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++.....  
T Consensus        86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            9999999999997654 588999999999999999999   7889999999999999999999999999999876422  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||........             ...++...... 
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------------~~~i~~~~~~~-  222 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------------YEKILNAELRF-  222 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHCCCCC-
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhCCCCC-
Confidence               2345799999999999999999999999999999999999999976332211             11222221111 


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      +.       ....++.+++.+|+..||++||     +++++++
T Consensus       223 p~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          223 PP-------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CT-------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC-------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            11       1244678999999999999999     7888873

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-39  Score=348.49  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=212.4

Q ss_pred             HHHhccCcCceecccCCceEEEEEec-CC-----ceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD-DG-----IEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      ...++|...+.||+|+||.||+|... ++     +.||+|++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            34578999999999999999999764 22     479999997553 34567789999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC
Q 046240          544 DFKALVLEYMPNGSLDIFLYSS-------------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE  610 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~  610 (763)
                      +..++||||+++|+|.+++...             ...+++..+..++.|+++||+||   |+.+|+||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCcccceEEECC
Confidence            9999999999999999998653             23578899999999999999999   6789999999999999999


Q ss_pred             CCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhh
Q 046240          611 DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKH  689 (763)
Q Consensus       611 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~  689 (763)
                      ++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||+| |..||.......     
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----  274 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-----  274 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-----
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-----
Confidence            99999999999987654333333344567889999999988899999999999999999999 999987632211     


Q ss_pred             hhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          690 WVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       690 ~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                              .....+..........      .+...+.+++..||+.+|++||++.++++.|++...+
T Consensus       275 --------~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          275 --------KFYKLVKDGYQMAQPA------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             --------HHHHHHHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------HHHHHHhcCCCCCCCC------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                    1122222221111111      1245688999999999999999999999999887654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.7e-40  Score=347.78  Aligned_cols=267  Identities=24%  Similarity=0.382  Sum_probs=215.1

Q ss_pred             HHHHHHHhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeee
Q 046240          468 QDLSRATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGC  540 (763)
Q Consensus       468 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~  540 (763)
                      ++.....++|.+.+.||+|+||.||+|...      +++.||+|++.... ......+.+|+.++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344455688999999999999999999654      36789999997543 33456788999999999999999999999


Q ss_pred             ecCCceEEEEEccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC
Q 046240          541 SNDDFKALVLEYMPNGSLDIFLYSST---------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED  611 (763)
Q Consensus       541 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~  611 (763)
                      ...+..++||||+++|+|.+++....         ..+++..+..++.|+++||.||   |+++|+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCCccCCCccceEEEcCC
Confidence            99999999999999999999986522         3468899999999999999999   77899999999999999999


Q ss_pred             CcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhh
Q 046240          612 MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHW  690 (763)
Q Consensus       612 ~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~  690 (763)
                      +.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........ .   
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~---  250 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-L---  250 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-H---
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-H---
Confidence            9999999999987643332223344567889999999988899999999999999999999 8999876432211 0   


Q ss_pred             hcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          691 VNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       691 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                               ..+........+.       .+...+.+++..|++.+|++||++.++++.|++.+.+.
T Consensus       251 ---------~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          251 ---------RFVMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             ---------HHHHTTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             ---------HHHHcCCcCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence                     1111111111111       23456889999999999999999999999999887754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-39  Score=339.95  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=204.6

Q ss_pred             HhccCcCceecccCCceEEEEEec-CC-------ceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DG-------IEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      .++|.+.+.||+|+||+||+|... ++       ..||+|++........+.+.+|++++++++||||+++++++..++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            367899999999999999999654 33       4799999987666667789999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc--------EEEe
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI--------AHLS  617 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~--------~kl~  617 (763)
                      .++||||+++|+|.+++......+++..+..++.|+++||.||   |+++|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999987766689999999999999999999   7889999999999999998877        9999


Q ss_pred             eecCceecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCC-CCCchhhhhhhhhhhhhcccC
Q 046240          618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRK-KPADKMFAAELSLKHWVNGLL  695 (763)
Q Consensus       618 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~  695 (763)
                      |||.+.....      .....+++.|+|||++.+ ..++.++|||||||++|||++|. .|+....... ..        
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~--------  228 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KL--------  228 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HH--------
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HH--------
Confidence            9999875431      223457889999999887 77899999999999999999965 4444322111 00        


Q ss_pred             ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       696 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                           ........ .+..       ....+.+++..||+.||++|||+.++++.|++++...
T Consensus       229 -----~~~~~~~~-~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          229 -----QFYEDRHQ-LPAP-------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             -----HHHHTTCC-CCCC-------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             -----HHhhccCC-CCCC-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                 11111111 1111       1234789999999999999999999999999887653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-39  Score=337.68  Aligned_cols=248  Identities=25%  Similarity=0.328  Sum_probs=195.2

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--------------------------HHHHHHHHHHHHHHh
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--------------------------RAMKSFEVECEVMKN  527 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~  527 (763)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            6799999999999999999966 4689999999864321                          123567899999999


Q ss_pred             CCCCccceEEeeeec--CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCC
Q 046240          528 IRHRNLVKIISGCSN--DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSN  605 (763)
Q Consensus       528 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~N  605 (763)
                      ++||||+++++++..  .+..++||||+++++|.+++..  ..+++..+..++.|+++||+||   |+.+|+||||||+|
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYL---HYQKIIHRDIKPSN  167 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHH
Confidence            999999999999986  5688999999999999887654  3589999999999999999999   77899999999999


Q ss_pred             EEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHcCCCCCchhhh
Q 046240          606 VLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK---VSTRSDIYSYGIMLIETFTRKKPADKMFA  682 (763)
Q Consensus       606 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~  682 (763)
                      |+++.++.+||+|||+++.+.....  ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||.....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            9999999999999999987653322  233457999999999987655   47889999999999999999999976322


Q ss_pred             hhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          683 AELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       683 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...              ...+.......+..     ......+.+++.+||+.||++||++.|+++
T Consensus       246 ~~~--------------~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 MCL--------------HSKIKSQALEFPDQ-----PDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHH--------------HHHHHHCCCCCCSS-----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHH--------------HHHHhcccCCCCCc-----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            111              11111111111111     012456889999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-39  Score=363.91  Aligned_cols=259  Identities=24%  Similarity=0.409  Sum_probs=214.0

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|.+.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            457888999999999999999776 48899999997543 2356789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++|+|.+++... ...+++..+..++.|+++||+||   |+++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            9999999999763 34689999999999999999999   77899999999999999999999999999998764332 1


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .......++..|+|||++.+..++.++|||||||++|||+| |..||......              ...+.+.+.....
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------------~~~~~~~~~~~~~  439 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QVYELLEKDYRME  439 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------------GHHHHHHTTCCCC
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHHHcCCCCC
Confidence            22234456788999999988899999999999999999999 99998764321              1222222221111


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .      ...+...+.+++..||+.+|++||++.+|+++|+.++...
T Consensus       440 ~------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          440 R------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             C------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence            1      1123567899999999999999999999999999987664

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.2e-39  Score=338.71  Aligned_cols=253  Identities=27%  Similarity=0.409  Sum_probs=202.4

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHH-------HHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECAR-------AMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      .++|+..+.||+|+||+||+|.. .+++.||+|++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999976 47899999998643211       1267889999999999999999999997665 


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEecCCCc-----EEEee
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP--IIHCDLKSSNVLLDEDMI-----AHLSD  618 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~dlk~~NIll~~~~~-----~kl~D  618 (763)
                       ++||||+++|+|.+++......+++..+..++.|+++||+||   |+.+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999999877777899999999999999999999   6677  999999999999988776     99999


Q ss_pred             ecCceecCCCCCccccccccccccccCcccc--CCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC
Q 046240          619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYG--IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       619 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      ||+++....     ......||+.|+|||++  ....++.++|||||||++|||++|+.||............       
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------  240 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN-------  240 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH-------
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH-------
Confidence            999975432     23345789999999998  4556789999999999999999999999763322111111       


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                          .+......  +..    ...+...+.+++..||+.||++||++.++++.|+++
T Consensus       241 ----~~~~~~~~--~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 ----MIREEGLR--PTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----HHHHSCCC--CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----HHhccCCC--CCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                11111111  100    112355689999999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.8e-40  Score=348.51  Aligned_cols=258  Identities=24%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             hccCcCceecccCCceEEEEEec-CCce----EEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIE----VAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|.+.+.||+|+||+||+|... +++.    ||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57889999999999999999754 4554    7888775432 223345678999999999999999999986 456889


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            9999999999999987656788899999999999999999   7789999999999999999999999999999987655


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..........++..|+|||++.+..++.++|||||||++|||+| |+.||.......              ..+.+....
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~  234 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------------VPDLLEKGE  234 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------------HHHHHHTTC
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------------HHHHHHcCC
Confidence            44444455678889999999998899999999999999999999 999997633211              112222111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ......      .+...+.+++..||+.+|++||++.++++.|+++...
T Consensus       235 ~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          235 RLAQPQ------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             BCCCCT------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCCCC------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            111000      1234578999999999999999999999999887654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.3e-39  Score=334.15  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=205.7

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC--CceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND--DFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  549 (763)
                      .++|.+.+.||+|+||.||+|... ++.||||++....  ....+.+.+|+.++++++||||+++++++...  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            367899999999999999999886 8899999997542  34456789999999999999999999999877  788999


Q ss_pred             EEccCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTP--IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      |||+++|+|.+++..... .+++..+..++.|+++||+||   |+.+  |+||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987544 589999999999999999999   7777  9999999999999999999999998865432


Q ss_pred             CCCCccccccccccccccCccccCCCCCCc---chhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVST---RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                             .....+|+.|+|||.+.+..++.   ++|||||||++|||++|+.||...........             +.
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------------~~  224 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-------------VA  224 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH-------------HH
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH-------------HH
Confidence                   22346899999999988765544   79999999999999999999976433221111             11


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      .....  +..    ...+...+.+++..||+.||++|||++++++.|+++.+
T Consensus       225 ~~~~~--~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          225 LEGLR--PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HSCCC--CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             hcCCC--CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11111  000    01134568999999999999999999999999998765

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.9e-39  Score=342.81  Aligned_cols=250  Identities=22%  Similarity=0.261  Sum_probs=182.7

Q ss_pred             CceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEEEccCCCC
Q 046240          480 DNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVLEYMPNGS  557 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  557 (763)
                      .+.||+|+||+||+|... +++.||||++....   ...+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999765 68999999997542   355678999999997 9999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC---cEEEeeecCceecCCCCCcccc
Q 046240          558 LDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM---IAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       558 L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      |.+++.... .+++..+..++.|+++||+||   |+++|+||||||+||+++.++   .+||+|||+++.......  ..
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence            999997654 689999999999999999999   778999999999999997665   899999999987643322  22


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKD  714 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~  714 (763)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||........          .....+++.+.........
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCHHHHHHHHTTTCCCCC
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccHHHHHHHHHcCCCCCC
Confidence            345689999999999999999999999999999999999999976432110          0112223333322222222


Q ss_pred             HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          715 FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       715 ~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .........++.+++..|++.||++||+++++++
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            2222334667899999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.8e-39  Score=342.77  Aligned_cols=269  Identities=22%  Similarity=0.378  Sum_probs=215.4

Q ss_pred             ChHHHHHHHhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEE
Q 046240          466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKII  537 (763)
Q Consensus       466 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~  537 (763)
                      .........++|.+.+.||+|+||+||+|..      .+++.||||++.... ....+.+.+|+.+++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3334444568999999999999999999964      356889999997643 33456788999999999 799999999


Q ss_pred             eeeecCC-ceEEEEEccCCCChhhhhccCCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCC
Q 046240          538 SGCSNDD-FKALVLEYMPNGSLDIFLYSSTC---------------MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDL  601 (763)
Q Consensus       538 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dl  601 (763)
                      +++...+ ..++||||+++++|.+++.....               .+++..+..++.|+++||.||   |+.+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH---HhCCcccccC
Confidence            9987755 58999999999999999976543               278899999999999999999   7789999999


Q ss_pred             CCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchh
Q 046240          602 KSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKM  680 (763)
Q Consensus       602 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~  680 (763)
                      ||+||+++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654433333445667899999999988899999999999999999998 99998763


Q ss_pred             hhhhhhhhhhhcccCChhHHHHHHhhcC-CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          681 FAAELSLKHWVNGLLPVSLMEVVNKTLL-SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       681 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ....             .....+..... ..+.       .+...+.+++..||+.+|++||++.++++.|+++++.+
T Consensus       255 ~~~~-------------~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDE-------------EFCRRLKEGTRMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSH-------------HHHHHHHHTCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhH-------------HHHHHhccCccCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            2211             11111111111 1111       12446889999999999999999999999999887654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.3e-39  Score=338.79  Aligned_cols=268  Identities=22%  Similarity=0.267  Sum_probs=200.3

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|.+.+.||+|+||+||+|...+|+.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            47889999999999999999888899999999864422  2346778999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++ +|.+++......++......++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence            986 89888877656789999999999999999999   778999999999999999999999999999987642221  


Q ss_pred             ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhh--hhcccCChhHHHHH-----H
Q 046240          633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH--WVNGLLPVSLMEVV-----N  704 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~i-----~  704 (763)
                      ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||............  ......+.....+.     +
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            2234568999999999875 46899999999999999999999999764332211111  00000000000000     0


Q ss_pred             hhcCC-CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLS-PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..... .+.............+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000 000000000112456789999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-39  Score=345.57  Aligned_cols=261  Identities=23%  Similarity=0.258  Sum_probs=203.7

Q ss_pred             HHHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-----HHHHHHHHHHHHHHHhCCCCccceEEeeee
Q 046240          468 QDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-----ARAMKSFEVECEVMKNIRHRNLVKIISGCS  541 (763)
Q Consensus       468 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  541 (763)
                      .++....++|.+.+.||+|+||.||+|.. .+++.||+|++....     ....+.+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            45667789999999999999999999966 468899999997652     234577899999999999999999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhccC---------------------------------------CCCCCHHHHHHHHHHHH
Q 046240          542 NDDFKALVLEYMPNGSLDIFLYSS---------------------------------------TCMLDIFQRLNIMIDVA  582 (763)
Q Consensus       542 ~~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~ia  582 (763)
                      +.+..++||||+++|+|.+++...                                       ...+++..+..++.|++
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            999999999999999999988521                                       11234566778999999


Q ss_pred             HHHHHHHhcCCCCeEeCCCCCCCEEecCCC--cEEEeeecCceecCCCCC--ccccccccccccccCccccCC--CCCCc
Q 046240          583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDM--IAHLSDFGIAKLLSGEDQ--SMTQTQTLATIGYMAPEYGIE--RKVST  656 (763)
Q Consensus       583 ~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~--~~~~~  656 (763)
                      +||+||   |+.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||++.+  ..++.
T Consensus       179 ~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYL---HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHH---HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHH---HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            999999   778999999999999998776  899999999987643221  112345679999999998865  67899


Q ss_pred             chhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccC
Q 046240          657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMEL  736 (763)
Q Consensus       657 ~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~  736 (763)
                      ++|||||||++|||++|+.||........             ...++.........    ........+.+++..|++.+
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~  318 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDADT-------------ISQVLNKKLCFENP----NYNVLSPLARDLLSNLLNRN  318 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCCCTTSG----GGGGSCHHHHHHHHHHSCSC
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHHH-------------HHHHHhcccccCCc----ccccCCHHHHHHHHHHcCCC
Confidence            99999999999999999999976433221             11122211111111    11123456889999999999


Q ss_pred             cCCCCCHHHHHH
Q 046240          737 PEKRINAKCCNF  748 (763)
Q Consensus       737 P~~Rps~~~v~~  748 (763)
                      |++||++.++++
T Consensus       319 p~~Rps~~~~l~  330 (345)
T 3hko_A          319 VDERFDAMRALQ  330 (345)
T ss_dssp             TTTSCCHHHHHH
T ss_pred             hhHCCCHHHHhc
Confidence            999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.8e-39  Score=333.12  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=193.6

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhH----HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA----RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|+..+.||+|+||.||+|... ++.||||++.....    ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57889999999999999999875 88999999875432    23467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC--------CCcEEEeeecCc
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE--------DMIAHLSDFGIA  622 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~--------~~~~kl~Dfgla  622 (763)
                      ||+++++|.+++...  .+++..+..++.|+++||+|||.....+|+||||||+||+++.        ++.+||+|||.+
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            999999999998643  5899999999999999999995322223999999999999986        678999999999


Q ss_pred             eecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      +.+....    .....|++.|+|||.+.+..++.++||||||+++|||++|+.||............             
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------  226 (271)
T 3dtc_A          164 REWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-------------  226 (271)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-------------
T ss_pred             ccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh-------------
Confidence            8764322    22456899999999998889999999999999999999999999764332211111             


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      ..........      ..+...+.+++..|++.+|++||++.|+++.|+++
T Consensus       227 ~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 AMNKLALPIP------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HTSCCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hcCCCCCCCC------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1111110000      12345689999999999999999999999999763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-39  Score=360.36  Aligned_cols=252  Identities=29%  Similarity=0.410  Sum_probs=206.6

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC-ceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD-FKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  552 (763)
                      .++|...+.||+|+||.||+|... |+.||||+++...  ..+.+.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467889999999999999999886 7899999997553  4567899999999999999999999987665 78999999


Q ss_pred             cCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++|+|.+++...+. .+++..+..++.|+++||+||   |+++|+||||||+|||++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999986543 468999999999999999999   7789999999999999999999999999999864321   


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        .....++..|+|||.+.+..++.++|||||||++|||+| |+.||.......              ....+.+.....
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------------~~~~i~~~~~~~  406 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------VVPRVEKGYKMD  406 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------------HHHHHHTTCCCC
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcCCCCC
Confidence              122356889999999999999999999999999999999 999997632211              111111111100


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                            .+..++..+.+++..||+.+|++|||+.++++.|+++...
T Consensus       407 ------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          407 ------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                  0112456789999999999999999999999999887644

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.8e-39  Score=332.30  Aligned_cols=259  Identities=23%  Similarity=0.261  Sum_probs=209.0

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ..++|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4578999999999999999999765 577899999987655556788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe---cCCCcEEEeeecCceecCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |+++++|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||++   +.++.+||+|||++..+...
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            999999999887643 588999999999999999999   77899999999999999   78899999999999876533


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .   ......||+.|+|||++.+. ++.++||||||+++|||++|+.||........ ...            + .....
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~------------~-~~~~~  224 (277)
T 3f3z_A          163 K---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLK------------I-REGTF  224 (277)
T ss_dssp             S---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------H-HHCCC
T ss_pred             c---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHH------------H-HhCCC
Confidence            2   22345689999999987654 89999999999999999999999976432221 111            1 11111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH--HHhhcccc
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF--VLCEQFVS  756 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~--~L~~~~~~  756 (763)
                      ..+   ......+...+.+++..|++.||++||++.++++  .+++.+..
T Consensus       225 ~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          225 TFP---EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             CCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             CCC---chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence            111   1111123556889999999999999999999985  45544444

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.2e-39  Score=336.29  Aligned_cols=266  Identities=25%  Similarity=0.404  Sum_probs=208.9

Q ss_pred             HhccCcCceecccCCceEEEEEecC----CceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeee-ecCCceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD----GIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGC-SNDDFKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~  547 (763)
                      ..+|...+.||+|+||.||+|...+    +..||+|.+... .....+.+.+|+.++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3578889999999999999997542    236899988753 234567789999999999999999999986 4556889


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||+++|+|.+++......+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.+..
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999987666789999999999999999999   778999999999999999999999999999987643


Q ss_pred             CCC--ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          628 EDQ--SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       628 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ...  ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||........ .            ..+..
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~------------~~~~~  247 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-T------------VYLLQ  247 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-H------------HHHHT
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-H------------HHHhc
Confidence            321  112334567889999999988899999999999999999999 5556554322111 0            11111


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCccccc
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELY  762 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~~~~  762 (763)
                      ......+.       .+...+.+++..|++.+|++||++.++++.|++++.....+.|
T Consensus       248 ~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~y  298 (298)
T 3f66_A          248 GRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  298 (298)
T ss_dssp             TCCCCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCSCC
T ss_pred             CCCCCCCc-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccCCC
Confidence            11111111       1245688999999999999999999999999999887665544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-39  Score=358.50  Aligned_cols=259  Identities=19%  Similarity=0.224  Sum_probs=206.8

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHH---HHHHHHHHHHHHHhCCCCccceEEeeeecCC
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR---AMKSFEVECEVMKNIRHRNLVKIISGCSNDD  544 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  544 (763)
                      ++....++|++.++||+|+||+||+|... +++.||+|++......   ....+.+|+.++..++||||++++++|.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            34445689999999999999999999775 5789999999864322   2334788999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..|+||||+++|+|.+++......+++..+..++.|++.||.||   |+.+|+||||||+|||++.++.+||+|||+++.
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            99999999999999999987556799999999999999999999   778999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSL  699 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  699 (763)
                      ...... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||........             .
T Consensus       225 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-------------~  290 (437)
T 4aw2_A          225 LMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------------Y  290 (437)
T ss_dssp             CCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------H
T ss_pred             cccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-------------H
Confidence            643322 2234467999999999986     56789999999999999999999999976432211             1


Q ss_pred             HHHHHhh-cCCCccccHHHHHHHHHHHHHHHHHccccCcCC--CCCHHHHHH
Q 046240          700 MEVVNKT-LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEK--RINAKCCNF  748 (763)
Q Consensus       700 ~~~i~~~-l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~v~~  748 (763)
                      ..++... -...|...    ......+.+++.+|+..+|++  ||+++|+++
T Consensus       291 ~~i~~~~~~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          291 GKIMNHKERFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHTHHHHCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HhhhhccccccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1111111 01111110    012345788999999888888  999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.7e-39  Score=336.47  Aligned_cols=267  Identities=21%  Similarity=0.228  Sum_probs=199.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47899999999999999999764 68999999997442  2334677899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++ ++.+.+......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9986 55555555445789999999999999999999   77899999999999999999999999999998764322  


Q ss_pred             cccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc---ccCChhHHHHHHhhc
Q 046240          632 MTQTQTLATIGYMAPEYGIERK-VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN---GLLPVSLMEVVNKTL  707 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l  707 (763)
                      .......+|+.|+|||++.+.. ++.++|||||||++|||++|..|+...............   .......... .+..
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~  234 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM-TKLP  234 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG-GGST
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh-cccc
Confidence            2234457899999999987765 799999999999999999988886432222211111111   0000000000 0000


Q ss_pred             CCC--cc-----ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSP--PE-----KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~--~~-----~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...  +.     ............+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000  00     000000112456789999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.9e-39  Score=347.48  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=199.0

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|++.+.||+|+||+||+|... +++.||+|++++..   ....+.+.+|..++.++ +||||+++++++...+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            368999999999999999999765 68899999998653   22345678899999887 89999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|..++...+ .+++..+..++.|++.||+||   |+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999987643 589999999999999999999   7789999999999999999999999999999863222


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........     .........+.+...-.
T Consensus       207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~-----~~~~~~~~~~~i~~~~~  279 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQNTEDYLFQVILEKQI  279 (396)
T ss_dssp             T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------CCHHHHHHHHHHCCC
T ss_pred             C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc-----chhhHHHHHHHHhcccc
Confidence            2  2334567999999999999999999999999999999999999999643211100     00000111222221111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      ..|.       .+...+.+++..|++.||++||++
T Consensus       280 ~~p~-------~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 RIPR-------SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCCC-------cCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1111       124567899999999999999996

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=346.28  Aligned_cols=269  Identities=19%  Similarity=0.196  Sum_probs=203.7

Q ss_pred             HhccCcCceecccCCceEEEEEec----CCceEEEEEeehhhHH-----------HHHHHHHHHHHHHhCCCCccceEEe
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQECAR-----------AMKSFEVECEVMKNIRHRNLVKIIS  538 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  538 (763)
                      .++|.+.+.||+|+||.||+|...    ++..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            368999999999999999999775    5788999998643211           1234667889999999999999999


Q ss_pred             eeec----CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC--
Q 046240          539 GCSN----DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM--  612 (763)
Q Consensus       539 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~--  612 (763)
                      ++..    ....++||||+ +++|.+++...+ .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcCHHHEEEccCCCC
Confidence            9977    67899999999 999999998655 689999999999999999999   678999999999999999887  


Q ss_pred             cEEEeeecCceecCCCCCc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhh
Q 046240          613 IAHLSDFGIAKLLSGEDQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL  687 (763)
Q Consensus       613 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~  687 (763)
                      .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999877432211     11244579999999999999999999999999999999999999996532221111


Q ss_pred             hhh---hcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCccc
Q 046240          688 KHW---VNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE  760 (763)
Q Consensus       688 ~~~---~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~~  760 (763)
                      ...   .....+....    .....         ..+...+.+++..||+.+|++||++.+|++.|++...+....
T Consensus       271 ~~~~~~~~~~~~~~~~----~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  333 (345)
T 2v62_A          271 QTAKTNLLDELPQSVL----KWAPS---------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPL  333 (345)
T ss_dssp             HHHHHHHHHTTTHHHH----HHSCT---------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCC
T ss_pred             HHHHHhhcccccHHHH----hhccc---------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCC
Confidence            111   1111111111    11100         023457899999999999999999999999999876654443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.6e-40  Score=345.97  Aligned_cols=259  Identities=22%  Similarity=0.342  Sum_probs=197.3

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc----
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF----  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  545 (763)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....   ......+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999975 578999999997542   3345678899999999999999999999876553    


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++||||+++++|.+++...+ .+++.....++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            399999999999999997644 589999999999999999999   7789999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          626 SGEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       626 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............             
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~-------------  233 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------------  233 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------------
Confidence            533222 223345689999999999999999999999999999999999999976433221111111             


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHH-HHHhhc
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCN-FVLCEQ  753 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~-~~L~~~  753 (763)
                          ..+.........+...+.+++.+||+.||++||++.+++ +.+.+.
T Consensus       234 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          234 ----EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ----CCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----CCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                111111111112355688999999999999999766655 445443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-39  Score=362.55  Aligned_cols=258  Identities=28%  Similarity=0.462  Sum_probs=205.9

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|...+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            46788999999999999999999888889999997543 234678999999999999999999999876 6789999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++|+|.+++... ...+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  336 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence            999999999753 23588999999999999999999   77899999999999999999999999999998764322 11


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||.+.+..++.++|||||||++|||+| |+.||......+.              .+.+.+.... +
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--------------~~~i~~~~~~-~  401 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGYRM-P  401 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------HHHHHTTCCC-C
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--------------HHHHHcCCCC-C
Confidence            2233456789999999988899999999999999999999 9999976432211              1111111110 0


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .     ...++..+.+++..||+.+|++|||++++++.|++.+...
T Consensus       402 ~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          402 C-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             C-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            0     1124567899999999999999999999999999887654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=343.71  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=201.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67999999999999999999765 688999999976532   23467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|..++.... .+++..+..++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence            9999999999997643 589999999999999999999   78899999999999999999999999999998765322 


Q ss_pred             ccccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          631 SMTQTQTLATIGYMAPEYGIE---RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                        ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||........           ......+....
T Consensus       170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----------~~~~~~~~~~~  236 (384)
T 4fr4_A          170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----------KEIVHTFETTV  236 (384)
T ss_dssp             --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----------HHHHHHHHHCC
T ss_pred             --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----------HHHHHHHhhcc
Confidence              2345679999999999863   4589999999999999999999999974221110           01111111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC-HHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-AKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-~~~v~~  748 (763)
                      ...+.       .+...+.+++..|++.+|++||+ ++++.+
T Consensus       237 ~~~p~-------~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 VTYPS-------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCCT-------TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             cCCCC-------cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11111       12456889999999999999998 666653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-39  Score=346.68  Aligned_cols=245  Identities=23%  Similarity=0.348  Sum_probs=199.3

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHH---HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECAR---AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|++......   ....+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999976 57899999999765322   2457889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+ +|+|.+++.... .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-  162 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred             ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence            999 678888776543 589999999999999999999   67899999999999999999999999999998764332 


Q ss_pred             ccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        ......||+.|+|||++.+..+ ++++|||||||++|||++|+.||........     ....         ......
T Consensus       163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----~~~i---------~~~~~~  226 (336)
T 3h4j_B          163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----FKKV---------NSCVYV  226 (336)
T ss_dssp             --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----BCCC---------CSSCCC
T ss_pred             --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----HHHH---------HcCCCC
Confidence              2234579999999999988776 7899999999999999999999976322110     0000         000000


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.       .....+.+++.+|+..||++|||++|+++
T Consensus       227 ~p~-------~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          227 MPD-------FLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCT-------TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             Ccc-------cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            111       12445789999999999999999999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-38  Score=340.81  Aligned_cols=280  Identities=24%  Similarity=0.345  Sum_probs=214.3

Q ss_pred             CCChHHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHh--CCCCccceEEeeee
Q 046240          464 RLPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKN--IRHRNLVKIISGCS  541 (763)
Q Consensus       464 ~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~  541 (763)
                      ..+..-.....++|.+.+.||+|+||.||+|... |+.||||++....   ...+.+|++++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            3444444556789999999999999999999874 8999999997543   3556778888887  68999999999998


Q ss_pred             cCC----ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEecCCC
Q 046240          542 NDD----FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----HTTPIIHCDLKSSNVLLDEDM  612 (763)
Q Consensus       542 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~dlk~~NIll~~~~  612 (763)
                      ...    ..++||||+++|+|.+++...  .+++..+..++.|+++||+|||..     |+.+|+||||||+||+++.++
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence            776    789999999999999999764  489999999999999999999521     178999999999999999999


Q ss_pred             cEEEeeecCceecCCCCCcc--ccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcC----------C
Q 046240          613 IAHLSDFGIAKLLSGEDQSM--TQTQTLATIGYMAPEYGIER------KVSTRSDIYSYGIMLIETFTR----------K  674 (763)
Q Consensus       613 ~~kl~Dfgla~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg----------~  674 (763)
                      .+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999998775433211  22445789999999998765      334789999999999999999          5


Q ss_pred             CCCchhhhhhhhhhhhhcccCChhHHHHHH-hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          675 KPADKMFAAELSLKHWVNGLLPVSLMEVVN-KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       675 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~-~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .||..........         ....+.+. .........+. ....+...+.+++..||+.+|++||++.+|++.|+++
T Consensus       265 ~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          265 LPYYDLVPSDPSV---------EEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CTTTTTSCSSCCH---------HHHHHHHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCccccCcCcccH---------HHHHHHHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            6665422111000         01111111 11111111111 1224567899999999999999999999999999998


Q ss_pred             cccCcc
Q 046240          754 FVSNSS  759 (763)
Q Consensus       754 ~~~~~~  759 (763)
                      .++...
T Consensus       335 ~~~~~~  340 (342)
T 1b6c_B          335 SQQEGI  340 (342)
T ss_dssp             HHTTC-
T ss_pred             HHHhcC
Confidence            877543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-39  Score=333.91  Aligned_cols=259  Identities=26%  Similarity=0.406  Sum_probs=210.2

Q ss_pred             hccCcCc-eecccCCceEEEEEec---CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDN-LIGIGSFGYVYKAELD---DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|.+.+ .||+|+||.||+|...   +++.||+|+++.. .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 8999999999999753   5788999999764 234567789999999999999999999999 45678999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            999999999999987666799999999999999999999   77899999999999999999999999999998875333


Q ss_pred             Cc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          630 QS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       630 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .. .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......              ..+.+....
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------------~~~~i~~~~  230 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGK  230 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------------HHHHHHTTC
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--------------HHHHHhcCC
Confidence            21 12233456889999999988889999999999999999999 999997643221              111111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .  +..    ...+...+.+++..||+.+|++||++.++++.|++++...
T Consensus       231 ~--~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          231 R--MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             C--CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             c--CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            0  000    0123557899999999999999999999999999887664

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4e-39  Score=344.44  Aligned_cols=248  Identities=25%  Similarity=0.339  Sum_probs=201.6

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  547 (763)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|+++....   ...+.+..|..+++.+ +||||+++++++...+..|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999775 689999999986532   2345677899999887 8999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||+++|+|.+++.... .+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++....
T Consensus        95 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            9999999999999987643 588999999999999999999   778999999999999999999999999999986432


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .            ..+.....
T Consensus       171 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~------------~~i~~~~~  235 (345)
T 1xjd_A          171 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-F------------HSIRMDNP  235 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHCCC
T ss_pred             CC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-H------------HHHHhCCC
Confidence            22  123456799999999999999999999999999999999999999976432211 0            11111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHH-HHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK-CCN  747 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~v~  747 (763)
                       ..+.       .....+.+++.+|+..+|++||++. ++.
T Consensus       236 -~~p~-------~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 -FYPR-------WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -CCCT-------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -CCCc-------ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence             0111       1245678999999999999999987 554

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9e-39  Score=338.01  Aligned_cols=246  Identities=22%  Similarity=0.222  Sum_probs=194.6

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  548 (763)
                      ..++|+..+.||+|+||+||+|... +|+.||||++....  .........|+..+.++ +||||+++++++.+++..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3468999999999999999999775 79999999986432  22334445566666555 89999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+ +++|.+++......+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999 6688888877666799999999999999999999   6789999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....    .........+.           
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~~~~~-----------  271 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGYLPP-----------  271 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTTCCCH-----------
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhccCCCc-----------
Confidence            2   2334568999999998875 789999999999999999999766544211    11111111111           


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                             .....+...+.+++..|++.||++|||++|+++
T Consensus       272 -------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 -------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                   111223567899999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-39  Score=355.94  Aligned_cols=255  Identities=21%  Similarity=0.252  Sum_probs=204.5

Q ss_pred             HHHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          470 LSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       470 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      +....++|.+.+.||+|+||+||+|... +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3344678999999999999999999765 688999999976432   123457889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .|+||||+++|+|.+++...  .++......++.|++.||+||   |+.+|+||||||+|||++.++.+||+|||+++.+
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            99999999999999998764  488899999999999999999   7789999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccCCCC----CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERK----VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      ..... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||........             ...
T Consensus       219 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------------~~~  284 (410)
T 3v8s_A          219 NKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------------YSK  284 (410)
T ss_dssp             CTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHH
T ss_pred             ccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-------------HHH
Confidence            53322 1233567999999999987654    78999999999999999999999976332211             111


Q ss_pred             HHHhh-cCCCccccHHHHHHHHHHHHHHHHHccccCcCC--CCCHHHHHH
Q 046240          702 VVNKT-LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEK--RINAKCCNF  748 (763)
Q Consensus       702 ~i~~~-l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--Rps~~~v~~  748 (763)
                      ++... -...+..     ......+.+++..|+..+|++  ||+++||++
T Consensus       285 i~~~~~~~~~p~~-----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          285 IMNHKNSLTFPDD-----NDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHTHHHHCCCCTT-----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHhccccccCCCc-----ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            21111 0111110     012445789999999988988  999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=340.07  Aligned_cols=260  Identities=27%  Similarity=0.461  Sum_probs=204.1

Q ss_pred             hccCcCceecccCCceEEEEEecC-----CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDD-----GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|...+.||+|+||.||+|....     +..||+|++.... ......+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567778999999999999997642     2459999997542 3445678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999999999987666799999999999999999999   7789999999999999999999999999999876433


Q ss_pred             CC-ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          629 DQ-SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       629 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      .. ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......              ..+.+...
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------------~~~~~~~~  266 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------VMKAINDG  266 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------------HHHHHHTT
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--------------HHHHHHCC
Confidence            22 112233446788999999998999999999999999999999 999996533221              11111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ... +.     ...+...+.+++..||+.+|++||++.++++.|++++...
T Consensus       267 ~~~-~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          267 FRL-PT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             CCC-CC-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CcC-CC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            110 10     0123456899999999999999999999999998877653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.7e-39  Score=348.98  Aligned_cols=271  Identities=21%  Similarity=0.261  Sum_probs=204.3

Q ss_pred             HhccCcCceeccc--CCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIG--SFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G--~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|++.+.||+|  +||+||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999765 78999999997553  3445778899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          549 VLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      ||||+++|+|.+++... ...+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999998764 23689999999999999999999   778999999999999999999999999999876532


Q ss_pred             CCC-----ccccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh---
Q 046240          628 EDQ-----SMTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV---  697 (763)
Q Consensus       628 ~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  697 (763)
                      ...     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||............ .....+.   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~  259 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLD  259 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-hcCCCCcccc
Confidence            211     111233478999999999887  67999999999999999999999999764322211111 1111000   


Q ss_pred             -------hH-------------HHHHHhhcCCCc---cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 -------SL-------------MEVVNKTLLSPP---EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 -------~~-------------~~~i~~~l~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                             ..             .+.+........   .............+.+++.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                   00             000000000000   0000112234567899999999999999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-38  Score=339.58  Aligned_cols=248  Identities=22%  Similarity=0.297  Sum_probs=193.0

Q ss_pred             HhccCcCceecccCCceEEEEEe----cCCceEEEEEeehhh----HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      .++|++.+.||+|+||.||+|..    .+|+.||+|+++...    ......+.+|+++++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999976    478999999997542    2234567889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++||||+++++|.+++.... .++......++.|++.||.||   |+++|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999987643 578889999999999999999   7789999999999999999999999999999764


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........             ...+...
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------~~~i~~~  236 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-------------IDKILKC  236 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------------HHHHHHT
T ss_pred             ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHhC
Confidence            32221  22345789999999999999999999999999999999999999976432211             1112211


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      .... +.       .....+.+++.+|++.+|++||     ++.++++
T Consensus       237 ~~~~-p~-------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 KLNL-PP-------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CCCC-CT-------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCCC-CC-------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            1111 11       1245678999999999999999     5666654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-38  Score=338.42  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=206.0

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHH------HHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR------AMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++...+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3578999999999999999999765 6899999998754211      25678899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC----cEEEeeecC
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM----IAHLSDFGI  621 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~----~~kl~Dfgl  621 (763)
                      .++||||+++++|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999997643 588999999999999999999   778999999999999999887    799999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ...            
T Consensus       166 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~------------  229 (321)
T 2a2a_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN------------  229 (321)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH------------
T ss_pred             ceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHH------------
Confidence            98765322   22345689999999999999999999999999999999999999976332211 111            


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          ...................+.+++..|++.||++|||+.|+++
T Consensus       230 ----i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          230 ----ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ----HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ----HHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                1111111111111223456889999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=344.07  Aligned_cols=259  Identities=25%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCce----EEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIE----VAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      .++|++.+.||+|+||.||+|... +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999754 4554    577776533 2234567889999999999999999999998765 78


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +|+||+++|+|.+++......+++..+..++.|+++||.||   |+++|+||||||+||+++.++.+||+|||+++.+..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999999987766799999999999999999999   778999999999999999999999999999988754


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |..||.......              ..+.+...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------------~~~~~~~~  235 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------ISSILEKG  235 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------------HHHHHHTT
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHcC
Confidence            443333444567889999999999999999999999999999999 999997643221              22222222


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ......      ..+...+.+++..||+.+|++||++.|+++.|+++...
T Consensus       236 ~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          236 ERLPQP------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            111111      11245688999999999999999999999999987754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-38  Score=337.51  Aligned_cols=267  Identities=22%  Similarity=0.392  Sum_probs=201.1

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEec----CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeec
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSN  542 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  542 (763)
                      ++....++|.+.+.||+|+||.||+|...    +++.||+|+++..  .....+.+.+|+.++++++||||+++++++..
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            33345678999999999999999999654    3458999998754  23445778999999999999999999999977


Q ss_pred             CC-----ceEEEEEccCCCChhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC
Q 046240          543 DD-----FKALVLEYMPNGSLDIFLYS-----STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM  612 (763)
Q Consensus       543 ~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~  612 (763)
                      .+     ..++||||+++++|.+++..     ....+++..+..++.|+++||.||   |+.+|+||||||+||+++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCC
Confidence            65     35999999999999999843     234689999999999999999999   788999999999999999999


Q ss_pred             cEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhh
Q 046240          613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWV  691 (763)
Q Consensus       613 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~  691 (763)
                      .+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||.......       
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------  257 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------  257 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-------
Confidence            999999999987654333333344567889999999999999999999999999999999 889987633221       


Q ss_pred             cccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          692 NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       692 ~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                             ..+.+.........      ..+...+.+++..||+.+|++||++.++++.|++++.+-+
T Consensus       258 -------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          258 -------MYDYLLHGHRLKQP------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             -------HHHHHHTTCCCCCB------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -------HHHHHHcCCCCCCC------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                   11111111110000      1234568999999999999999999999999998876543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=334.48  Aligned_cols=264  Identities=23%  Similarity=0.345  Sum_probs=208.0

Q ss_pred             hccCcCceecccCCceEEEEEec-C---CceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce-EE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-D---GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK-AL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l  548 (763)
                      ..|...+.||+|+||+||+|... +   +..||+|++.... ....+.+.+|+.++++++||||+++++++...+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            35667789999999999999753 2   2379999987543 34567788999999999999999999999876654 99


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+.+|+|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999988666789999999999999999999   7789999999999999999999999999999866432


Q ss_pred             CC--ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          629 DQ--SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       629 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ..  ........++..|+|||.+.+..++.++|||||||++|||++|..|+.......             .....+...
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-------------~~~~~~~~~  244 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------------DLTHFLAQG  244 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-------------GHHHHHHTT
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-------------HHHHHhhcC
Confidence            21  122234567889999999999999999999999999999999655543311111             112222211


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCccc
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE  760 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~~  760 (763)
                      ......      ..+...+.+++..|++.+|++|||+.+++++|++++..-...
T Consensus       245 ~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          245 RRLPQP------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             CCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCCC------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            111111      112456889999999999999999999999999887765443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=345.54  Aligned_cols=251  Identities=21%  Similarity=0.259  Sum_probs=189.6

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....  ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3578999999999999999999775 57899999997543  34567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecCceecCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~  628 (763)
                      |+++|+|.+++...+ .+++..+..++.|+++||.||   |+.+|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999987654 589999999999999999999   6789999999999999975   889999999999876432


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............            ....
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~------------~~~~  269 (349)
T 2w4o_A          205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN------------CEYY  269 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT------------TCCC
T ss_pred             c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh------------CCCc
Confidence            1   223456899999999999999999999999999999999999999764332211111111            1110


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      . +..   ........+.+++.+|++.||++||++.++++
T Consensus       270 ~-~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 F-ISP---WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             C-CTT---TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             c-CCc---hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 000   00112456889999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=347.32  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=195.8

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCC--CccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRH--RNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|.+.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++++++|  |||+++++++..++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999998888999999998744  23445778999999999976  9999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      || +.+++|.+++.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++ ++.+||+|||+++.+....
T Consensus        88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            99 56789999997654 688999999999999999999   678999999999999997 5789999999998775443


Q ss_pred             CccccccccccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChh
Q 046240          630 QSMTQTQTLATIGYMAPEYGIE-----------RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||..........           
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----------  230 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-----------  230 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-----------
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH-----------
Confidence            3333445679999999998754           678999999999999999999999997532221111           


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ..+++.........      .....+.+++..||+.||++|||+.++++
T Consensus       231 -~~~~~~~~~~~~~~------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          231 -HAIIDPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             -HHHHCTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHhcCCcccCCcc------cCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence             11121111111111      11345789999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-38  Score=342.54  Aligned_cols=246  Identities=26%  Similarity=0.335  Sum_probs=199.9

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|...+.||+|+||+||+|.. .+|+.||||++...   .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            46689999999999999999975 57899999998643   233456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||++ |++.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++....  
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            99997 577777765555789999999999999999999   778999999999999999999999999999987542  


Q ss_pred             CccccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          630 QSMTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                          .....||+.|+|||++.   +..++.++|||||||++|||++|+.||.........             ..+....
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------------~~~~~~~  269 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------------YHIAQNE  269 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------------HHHHHSC
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-------------HHHHhcC
Confidence                23356899999999874   577899999999999999999999998764322110             1111110


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         .+....   ..+...+.+++..||+.+|++|||++++++
T Consensus       270 ---~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          270 ---SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             ---CCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence               111000   112456789999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.1e-39  Score=338.55  Aligned_cols=261  Identities=22%  Similarity=0.258  Sum_probs=201.2

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      -++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999765 78899999997543   23357788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999997643 589999999999999999999   77899999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      . .......+++.|+|||++.+..++.++||||||+++|||++|+.||.......  ...            .+......
T Consensus       189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~------------~~~~~~~~  253 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV--MGA------------HINQAIPR  253 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--HHH------------HHHSCCCC
T ss_pred             c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH--HHH------------HhccCCCC
Confidence            1 12234568999999999999999999999999999999999999997643221  111            11111100


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCC-CHHHHHHHHhhccccC
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-NAKCCNFVLCEQFVSN  757 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~v~~~L~~~~~~~  757 (763)
                       +   ......+...+.+++.+||+.+|++|| +++++++.|++.+...
T Consensus       254 -~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 -P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             -G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             -c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence             0   000112345688999999999999999 9999999999888775

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.9e-39  Score=333.87  Aligned_cols=259  Identities=23%  Similarity=0.382  Sum_probs=206.5

Q ss_pred             HhccCcCceecccCCceEEEEEecC----CceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD----GIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|...+.||+|+||.||+|...+    +..||+|++... .....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4689999999999999999997542    346999998765 234567789999999999999999999998754 5689


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++++|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            9999999999999987666789999999999999999999   7789999999999999999999999999999876432


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .. .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......              ..+.+....
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------------~~~~~~~~~  231 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------------VIGVLEKGD  231 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------------HHHHHHHTC
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------------HHHHHhcCC
Confidence            21 12234457889999999988899999999999999999998 999986532221              111111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .....      ..+...+.+++..|++.+|++||++.++++.|+++.+.+
T Consensus       232 ~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          232 RLPKP------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCC------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            11100      112456889999999999999999999999999876643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-38  Score=339.46  Aligned_cols=251  Identities=24%  Similarity=0.280  Sum_probs=199.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|...+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57999999999999999999765 68999999997652   33456678899999988 899999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++|+|..++...+ .+++..+..++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++......
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999987643 588999999999999999999   77899999999999999999999999999998643222


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........     ........+.+...-..
T Consensus       165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~~~~~i~~~~~~  237 (345)
T 3a8x_A          165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNTEDYLFQVILEKQIR  237 (345)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------CHHHHHHHHHHCCCC
T ss_pred             --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-----cccHHHHHHHHHcCCCC
Confidence              12345679999999999999999999999999999999999999996532111000     00001111112111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      .|.       .....+.+++.+|++.||++||++
T Consensus       238 ~p~-------~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 IPR-------SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCT-------TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCC-------CCCHHHHHHHHHHhcCCHhHCCCC
Confidence            111       124567899999999999999996

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-38  Score=331.24  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=206.7

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3478999999999999999999765 78999999997543 234577889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|.+++.... .++...+..++.|+++||.||   |+.+++||||||+||+++.++.+||+|||.+..+.....
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999987543 588999999999999999999   778999999999999999999999999999987643332


Q ss_pred             ccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||............+...            ....
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~~~  228 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------KTYL  228 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT------------CTTS
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc------------cccc
Confidence            223345678999999999887665 779999999999999999999997643322222222111            1000


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.      ......+.+++..|++.+|++|||++++++
T Consensus       229 ~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 NPW------KKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TTG------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Cch------hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            110      112456789999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-39  Score=341.45  Aligned_cols=270  Identities=25%  Similarity=0.388  Sum_probs=213.5

Q ss_pred             HhccCcCceecccCCceEEEEEe-----cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC--ce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-----DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD--FK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  546 (763)
                      .++|.+.+.||+|+||.||+|..     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46789999999999999999974     368899999997665556678899999999999999999999987654  78


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++++|.+++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999987766789999999999999999999   67899999999999999999999999999998875


Q ss_pred             CCCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC-h----hHH
Q 046240          627 GEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP-V----SLM  700 (763)
Q Consensus       627 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~----~~~  700 (763)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||+||..|+........   ........ .    ...
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM---RMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH---HHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH---HhhccccchhhhHHHHH
Confidence            43321 112334577889999999888899999999999999999999999875432211   11111111 1    111


Q ss_pred             HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       701 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      +.+....... .     ...+...+.+++..||+.+|++||++.++++.|+++..
T Consensus       274 ~~~~~~~~~~-~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          274 ELLKNNGRLP-R-----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHTTCCCC-C-----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhhcCCCCC-C-----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            2222111110 0     11235678999999999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-39  Score=348.21  Aligned_cols=264  Identities=25%  Similarity=0.406  Sum_probs=199.8

Q ss_pred             hccCcCceecccCCceEEEEEec--CC--ceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeec-CCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD--DG--IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSN-DDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l  548 (763)
                      .+|...+.||+|+||+||+|...  ++  ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            35677889999999999999753  22  468999886432 3456788999999999999999999998754 457899


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++......+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.+...
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999987766789999999999999999999   7789999999999999999999999999999876432


Q ss_pred             CCc--cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          629 DQS--MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       629 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ...  .......+++.|+|||++.+..++.++|||||||++|||+| |.+||.......              ....+..
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------------~~~~~~~  311 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------------ITVYLLQ  311 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------------HHHHHHT
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------------HHHHHHc
Confidence            211  12234557889999999999999999999999999999999 677776532211              1111111


Q ss_pred             hc-CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCccccc
Q 046240          706 TL-LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSELY  762 (763)
Q Consensus       706 ~l-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~~~~  762 (763)
                      .. ...+       ..+...+.+++..||+.+|++||++.++++.|++++.....+.|
T Consensus       312 ~~~~~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~  362 (373)
T 3c1x_A          312 GRRLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  362 (373)
T ss_dssp             TCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred             CCCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence            10 0111       12355689999999999999999999999999988876544433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-38  Score=338.28  Aligned_cols=259  Identities=24%  Similarity=0.313  Sum_probs=188.2

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999764 68999999987543 2234677899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          552 YMPNGSLDIFLYSST-----CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      |++ |+|.+++....     ..+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 58888875421     3588999999999999999999   77899999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccC--------
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLL--------  695 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~--------  695 (763)
                      ....  ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  .........        
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            3221  2234578999999999876 46899999999999999999999999764332211  001000000        


Q ss_pred             -------------ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          696 -------------PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       696 -------------~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                                   +....+.+.....          +.....+.+++..|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTK----------EPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCS----------SCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhccccc----------ccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                         0011111111000          112456899999999999999999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-38  Score=340.03  Aligned_cols=244  Identities=20%  Similarity=0.274  Sum_probs=203.3

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|...+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999765 789999999976532   23467788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++...+ .++...+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999997643 588999999999999999999   7889999999999999999999999999999876432  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||........             ...+...... .
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------------~~~i~~~~~~-~  257 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------------YEKIVSGKVR-F  257 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCCC-C
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-------------HHHHHcCCCC-C
Confidence               2345799999999999999999999999999999999999999976322111             1111111111 1


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                      +.       .+...+.+++.+|++.||++||+     ++++++
T Consensus       258 p~-------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 PS-------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CT-------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC-------CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            11       12456889999999999999998     777764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-38  Score=331.33  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=204.2

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999764 68999999997543  344577889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc---EEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI---AHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~  627 (763)
                      ||+++++|.+.+.... .+++..+..++.|++.||.||   |+.+|+||||||+||+++.++.   +||+|||.+.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999988886643 588999999999999999999   7789999999999999986655   99999999987643


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..   ......|++.|+|||++.+..++.++||||||+++|||++|+.||........              ...+....
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------------~~~~~~~~  223 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--------------YAQIKAGA  223 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------HHHHHHTC
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--------------HHHHHhcc
Confidence            22   22345789999999999999999999999999999999999999976332211              11111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...+...   ...+...+.+++..|++.+|++|||+.|+++
T Consensus       224 ~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          224 YDYPSPE---WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CCCCTTT---TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCchh---hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1111110   0112456889999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=346.60  Aligned_cols=254  Identities=16%  Similarity=0.104  Sum_probs=204.1

Q ss_pred             HHhccCcCceecccCCceEEEEE------ecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC---CCccceEEeeeecC
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAE------LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR---HRNLVKIISGCSND  543 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  543 (763)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||||++....   ...+.+|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45789999999999999999993      4568899999997553   345677888888886   99999999999999


Q ss_pred             CceEEEEEccCCCChhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---------
Q 046240          544 DFKALVLEYMPNGSLDIFLYS----STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---------  610 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---------  610 (763)
                      +..++||||+++|+|.+++..    ....+++..+..++.|+++||+||   |+.+|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999974    344699999999999999999999   7889999999999999998         


Q ss_pred             --CCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh
Q 046240          611 --DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK  688 (763)
Q Consensus       611 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~  688 (763)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  296 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE  296 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec
Confidence              899999999999876433333344566799999999999999999999999999999999999999865332211000


Q ss_pred             hhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCC-CCHHHHHHHHhhccccC
Q 046240          689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR-INAKCCNFVLCEQFVSN  757 (763)
Q Consensus       689 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-ps~~~v~~~L~~~~~~~  757 (763)
                      .                .....+         ..+.+.+++..|++.+|.+| |+++++.+.|++.+.+.
T Consensus       297 ~----------------~~~~~~---------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          297 G----------------LFRRLP---------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             S----------------CCTTCS---------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             h----------------hccccC---------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            0                000001         13456788888888898888 46777777777766653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4e-39  Score=336.89  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=214.3

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4678999999999999999999775 58899999997543 345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+++++|.+++... ...+++..+..++.+++.||.||   |+.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            99999999999763 34689999999999999999999   67899999999999999999999999999998765332 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      ........+++.|+|||++.+..++.++||||||+++|||++ |..||......              ...+.+......
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--------------~~~~~~~~~~~~  231 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QVYELLEKDYRM  231 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------------GHHHHHHTTCCC
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------------HHHHHHhccCCC
Confidence            223344557889999999988899999999999999999999 99998763221              112222222111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ...      ..+...+.+++..|++.+|++||++.++++.|++.+.+.
T Consensus       232 ~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          232 ERP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCC------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            111      123456899999999999999999999999998877653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=352.49  Aligned_cols=258  Identities=21%  Similarity=0.260  Sum_probs=204.4

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD  544 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  544 (763)
                      +.....++|++.+.||+|+||+||+|... +|+.||+|++++..   ....+.+.+|..++..++||||+++++++.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            33344688999999999999999999774 78999999997642   223445788999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..|+||||+++|+|.+++...+..+++..+..++.|++.||+||   |+.+|+||||||+|||++.++.+||+|||+++.
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence            99999999999999999987555689999999999999999999   778999999999999999999999999999988


Q ss_pred             cCCCCCccccccccccccccCccccC-------CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGI-------ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV  697 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  697 (763)
                      +..... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||........            
T Consensus       212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------------  278 (412)
T 2vd5_A          212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------------  278 (412)
T ss_dssp             CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------------
T ss_pred             ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------------
Confidence            653322 1223467999999999886       46789999999999999999999999976432211            


Q ss_pred             hHHHHHHhh-cCCCccccHHHHHHHHHHHHHHHHHccccCcCCC---CCHHHHHH
Q 046240          698 SLMEVVNKT-LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKR---INAKCCNF  748 (763)
Q Consensus       698 ~~~~~i~~~-l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---ps~~~v~~  748 (763)
                       ...++... ....+.    ....+..++.+++.+|+. +|++|   |+++|+++
T Consensus       279 -~~~i~~~~~~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          279 -YGKIVHYKEHLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             -HHHHHTHHHHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             -HHHHHhcccCcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence             11111100 001111    011234567899999998 89988   57887764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=331.23  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=184.4

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHH---HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECAR---AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|.. .+|+.||+|++......   ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            6799999999999999999976 57899999999765322   2467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||.+........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            99999999999987666789999999999999999999   778999999999999999999999999999987642221


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........                 +.+.....
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~~~~~  228 (278)
T 3cok_A          168 --KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------------LNKVVLAD  228 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCSSC
T ss_pred             --cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------------HHHHhhcc
Confidence              22335689999999999988999999999999999999999999975321110                 00000011


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....    ......+.+++.+|++.||++||+++++++
T Consensus       229 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 YEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1000    112446789999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=344.97  Aligned_cols=276  Identities=28%  Similarity=0.351  Sum_probs=198.2

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeee-----cCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS-----NDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----~~~~~~l  548 (763)
                      .++|.+.+.||+|+||.||+|.. +++.||||++....... ...+.|+..+..++||||+++++++.     .....++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            36899999999999999999976 58999999997553221 12233444455689999999997543     2336789


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEeCCCCCCCEEecCCCcEEEeee
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT---------PIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~---------~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                      ||||+++|+|.+++....  .++..+..++.|+++||+||   |+.         +|+||||||+||+++.++.+||+||
T Consensus        90 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~L---H~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYL---HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHH---HCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHH---HhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            999999999999997654  58889999999999999999   555         9999999999999999999999999


Q ss_pred             cCceecCCCCC------ccccccccccccccCccccCC-------CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh
Q 046240          620 GIAKLLSGEDQ------SMTQTQTLATIGYMAPEYGIE-------RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS  686 (763)
Q Consensus       620 gla~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~  686 (763)
                      |+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..|+.........
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99987753221      112234569999999999876       45677999999999999999998776432211100


Q ss_pred             ---hhhhhcccCCh-hHHHHHHhhcCCCc-cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          687 ---LKHWVNGLLPV-SLMEVVNKTLLSPP-EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       687 ---~~~~~~~~~~~-~~~~~i~~~l~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                         ........... .....+.....+.. .........+...+.+++..||+.||++|||+.|+++.|++++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence               00001111111 12222221111111 000111122456799999999999999999999999999887654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.7e-39  Score=349.52  Aligned_cols=250  Identities=21%  Similarity=0.302  Sum_probs=196.6

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCC--CCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIR--HRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|...+++.||||++...  .....+.+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            569999999999999999998888999999998644  2345677899999999996  599999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      | +.+++|.+++.... .+++..+..++.||++||.||   |+.+|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56889999997654 688889999999999999999   788999999999999996 57999999999987754333


Q ss_pred             ccccccccccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhH
Q 046240          631 SMTQTQTLATIGYMAPEYGIE-----------RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSL  699 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  699 (763)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+            
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------------  277 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------------  277 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------------
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH------------
Confidence            323345679999999998764           468899999999999999999999997532211111            


Q ss_pred             HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+++..........      ....+.+++..||+.||++||++.|+++
T Consensus       278 ~~~~~~~~~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          278 HAIIDPNHEIEFPDI------PEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHCTTSCCCCCCC------SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCccccCCCCcc------chHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            112221111110110      1345789999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.3e-39  Score=339.42  Aligned_cols=265  Identities=21%  Similarity=0.246  Sum_probs=208.3

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeee----cCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS----NDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~l  548 (763)
                      .++|.+.+.||+|+||.||++.. .+|+.||||++........+.+.+|+++++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999976 578999999987665566778899999999999999999999986    3447889


Q ss_pred             EEEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          549 VLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      ||||+++|+|.+++..   ....+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||.++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999875   345689999999999999999999   6789999999999999999999999999998765


Q ss_pred             CCCCCcc-------ccccccccccccCccccCCCC---CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccC
Q 046240          626 SGEDQSM-------TQTQTLATIGYMAPEYGIERK---VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL  695 (763)
Q Consensus       626 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  695 (763)
                      .......       ......|++.|+|||++.+..   ++.++|||||||++|||++|+.||...........       
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------  257 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-------  257 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-------
Confidence            3111100       012345799999999987544   68999999999999999999999976432221111       


Q ss_pred             ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCcc
Q 046240          696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSS  759 (763)
Q Consensus       696 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~  759 (763)
                           ..+...... +..     ..+...+.+++..||+.||++||++.++++.|+.+....+.
T Consensus       258 -----~~~~~~~~~-~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          258 -----LAVQNQLSI-PQS-----PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             -----HHHHCC--C-CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             -----HHhhccCCC-Ccc-----ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence                 111111111 110     11245689999999999999999999999999987666443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-38  Score=349.47  Aligned_cols=246  Identities=25%  Similarity=0.389  Sum_probs=204.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHH---HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR---AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|... +|+.||||++......   ....+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57899999999999999999765 7999999999765322   3467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++...+ .+++.....++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-  170 (476)
T 2y94_A           96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  170 (476)
T ss_dssp             ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence            9999999999997643 589999999999999999999   78899999999999999999999999999998865322 


Q ss_pred             ccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||........             ...+.+. ...
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------------~~~i~~~-~~~  234 (476)
T 2y94_A          171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-------------FKKICDG-IFY  234 (476)
T ss_dssp             --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-------------HHHHHTT-CCC
T ss_pred             --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-------------HHHHhcC-CcC
Confidence              2234579999999999988765 6899999999999999999999976322110             1111111 111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.       .....+.+++..|++.||++|||+.++++
T Consensus       235 ~p~-------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          235 TPQ-------YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CCT-------TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCc-------cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            111       12345789999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-38  Score=330.55  Aligned_cols=257  Identities=25%  Similarity=0.432  Sum_probs=209.1

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|.+.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            46899999999999999999998888899999997543 234678899999999999999999999874 4689999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++|.+++.... ..+++..+..++.|+++||+||   |+.+|+||||||+||++++++.+||+|||.++....... .
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            9999999997542 2588999999999999999999   778999999999999999999999999999988653321 2


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........              .+.+.+......
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~  231 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------------IQNLERGYRMVR  231 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--------------HHHHHTTCCCCC
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH--------------HHHHhcccCCCC
Confidence            2234456888999999988889999999999999999999 9999876332211              111111111000


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      .      ..+...+.+++..|++.+|++||++.++++.|++.+..
T Consensus       232 ~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          232 P------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            0      12245689999999999999999999999999887654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=351.78  Aligned_cols=278  Identities=20%  Similarity=0.257  Sum_probs=210.8

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC--ceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD--FKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  549 (763)
                      .++|.+.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367999999999999999999765 58999999997543 233566789999999999999999999998765  77999


Q ss_pred             EEccCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe----cCCCcEEEeeecCce
Q 046240          550 LEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAHLSDFGIAK  623 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~  623 (763)
                      |||+++|+|.+++.....  .+++..+..++.|++.||+||   |+.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976432  389999999999999999999   77899999999999999    778889999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCC--------CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh---hhhhhhc
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIE--------RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL---SLKHWVN  692 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~---~~~~~~~  692 (763)
                      ......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||........   .+.....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            764322   2234568999999998764        5678899999999999999999999975322111   1111111


Q ss_pred             ccCChhHH---HHHHhhcC--CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          693 GLLPVSLM---EVVNKTLL--SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       693 ~~~~~~~~---~~i~~~l~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      +..+....   ........  ..........+.....+.+++..|++.||++||++.++++.+.+++.+.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            11100000   00000000  0000001112345677899999999999999999999999998887763

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-38  Score=340.51  Aligned_cols=243  Identities=22%  Similarity=0.296  Sum_probs=199.3

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|...+.||+|+||+||+|... +|+.||+|+++....   ...+.+..|..+++.+ +||+|+++++++...+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999775 578999999986532   2345678899999988 79999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++...+ .+++..+..++.|++.||+||   |+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            999999999999987643 588999999999999999999   7789999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........             ...+......
T Consensus       175 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------------~~~i~~~~~~  239 (353)
T 2i0e_A          175 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------------FQSIMEHNVA  239 (353)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCCC
T ss_pred             C--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-------------HHHHHhCCCC
Confidence            2  123456799999999999999999999999999999999999999976432211             1112221111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      . |.       ....++.+++..|+..+|++||++
T Consensus       240 ~-p~-------~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          240 Y-PK-------SMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             C-CT-------TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             C-CC-------CCCHHHHHHHHHHhhcCHHHcCCC
Confidence            1 11       124568899999999999999964

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-38  Score=334.10  Aligned_cols=266  Identities=21%  Similarity=0.273  Sum_probs=206.7

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeee-ecCCceEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC-SNDDFKALVL  550 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  550 (763)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++....  ....+.+|+++++.++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999975 578999999876442  234578899999999988777666655 6677889999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe---cCCCcEEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~  627 (763)
                      ||+ +++|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||++   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 9999999986666799999999999999999999   77899999999999999   7889999999999988754


Q ss_pred             CCCc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          628 EDQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       628 ~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      ....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........          ......+
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----------~~~~~~~  230 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK----------RQKYERI  230 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS----------SSHHHHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh----------hhhhhhh
Confidence            3321     122356789999999999999999999999999999999999999976322110          0111122


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ..........   .....++..+.+++..|++.+|++||+++++++.|++++++.
T Consensus       231 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          231 SEKKMSTPIE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHSCHH---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hcccccchhh---hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            2221111100   000122457899999999999999999999999999988764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.7e-38  Score=338.58  Aligned_cols=260  Identities=23%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|.+.+.||+|+||.||+|..      .+++.||||++... .......+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999974      35778999999644 234556788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEe
Q 046240          547 ALVLEYMPNGSLDIFLYSST------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLS  617 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~  617 (763)
                      ++||||+++++|.+++....      ..+++..+..++.|+++||.||   |+.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999997643      3588999999999999999999   7789999999999999984   4569999


Q ss_pred             eecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCC
Q 046240          618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       618 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      |||+++...............+++.|+|||++.+..++.++|||||||++|||+| |..||.......            
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------------  253 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------------  253 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------------
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------------
Confidence            9999986643333333344567899999999988899999999999999999999 999987633221            


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                        ..+.+.........      ..+...+.+++..||+.+|++||++.++++.|..+..+
T Consensus       254 --~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          254 --VLEFVTSGGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             --HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHHHHhcCCCCCCC------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence              11111111111111      11345688999999999999999999999999876654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-38  Score=344.16  Aligned_cols=250  Identities=28%  Similarity=0.308  Sum_probs=194.4

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHH-HHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEV-MKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|..+ ++.++||||+++++++...+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367999999999999999999765 68899999997653   2233455667666 466899999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|.+++...+ .++......++.|++.||+||   |+++|+||||||+||+++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999987643 578888999999999999999   7789999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|..||........             ...++.....
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------------~~~i~~~~~~  257 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------------YDNILNKPLQ  257 (373)
T ss_dssp             C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-------------HHHHHHSCCC
T ss_pred             C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-------------HHHHHhcccC
Confidence            2  123456799999999999999999999999999999999999999976332211             1122222222


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVL  750 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L  750 (763)
                      ..+.        ....+.+++..|++.||++||++.+.++.+
T Consensus       258 ~~~~--------~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          258 LKPN--------ITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             CCSS--------SCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             CCCC--------CCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence            1111        234578999999999999999986544443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-38  Score=328.45  Aligned_cols=258  Identities=21%  Similarity=0.249  Sum_probs=205.5

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH------HHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA------RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.....      ...+.+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999775 689999999875421      1356788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC----cEEEeeecCc
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM----IAHLSDFGIA  622 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla  622 (763)
                      ++||||+++++|.+++.... .+++..+..++.|+++||.||   |+.+++||||||+||+++.++    .+||+|||.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999997543 589999999999999999999   778999999999999998877    8999999999


Q ss_pred             eecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      .......   ......+++.|+|||++.+..++.++||||||+++|||++|+.||........ ....            
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~------------  223 (283)
T 3bhy_A          160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNI------------  223 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHH------------
T ss_pred             eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHh------------
Confidence            8764322   22345689999999999989999999999999999999999999976432211 1111            


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH--HHhhccc
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF--VLCEQFV  755 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~--~L~~~~~  755 (763)
                          ..................+.+++.+|++.+|++||++.++++  .++....
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          224 ----SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             ----HTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             ----HhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence                111111111111223556889999999999999999999996  3444433

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.4e-38  Score=348.95  Aligned_cols=270  Identities=21%  Similarity=0.248  Sum_probs=198.5

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC-----Cc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSND-----DF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  545 (763)
                      .++|.+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999664 6889999999753  234567789999999999999999999999766     57


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .|+||||++ ++|.+++... ..+++..+..++.|+++||+||   |+.+|+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~L---H~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFI---HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999987 5999988764 3589999999999999999999   7789999999999999999999999999999887


Q ss_pred             CCCCCc--------------------cccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhh
Q 046240          626 SGEDQS--------------------MTQTQTLATIGYMAPEYG-IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE  684 (763)
Q Consensus       626 ~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~  684 (763)
                      ......                    .......||++|+|||++ ....++.++||||+||++|||++|..||.......
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            533211                    123556799999999985 56779999999999999999998766554311100


Q ss_pred             ---------------------------hhhhhh---hc--------ccCChhHHHHHHhhcCCCccccHHHHHHHHHHHH
Q 046240          685 ---------------------------LSLKHW---VN--------GLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIF  726 (763)
Q Consensus       685 ---------------------------~~~~~~---~~--------~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~  726 (763)
                                                 ..+...   ..        ..........+...-...+.............+.
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  339 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI  339 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence                                       000000   00        0011112222222111111110011112356788


Q ss_pred             HHHHHccccCcCCCCCHHHHHH
Q 046240          727 SLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       727 ~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +++.+|+..||++|||++|+++
T Consensus       340 dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          340 NLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhcCCcccCCCHHHHhc
Confidence            9999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.1e-39  Score=338.96  Aligned_cols=268  Identities=20%  Similarity=0.240  Sum_probs=198.4

Q ss_pred             HhccCcC-ceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRD-NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++|.+. +.||+|+||+||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++...+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 7899999999999975 47899999999765444456788999999985 7999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc---EEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI---AHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~  627 (763)
                      ||+++++|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.   +||+|||+++....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFL---HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999997643 588999999999999999999   6789999999999999988765   99999999876542


Q ss_pred             CCC-----ccccccccccccccCccccCC-----CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccC-C
Q 046240          628 EDQ-----SMTQTQTLATIGYMAPEYGIE-----RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL-P  696 (763)
Q Consensus       628 ~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~  696 (763)
                      ...     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||.........   |..... +
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~  243 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG---WDRGEACP  243 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC---C----CCH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc---ccccccch
Confidence            211     111223468999999998764     56889999999999999999999999764321110   100000 0


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .....+......................+.+++.+|++.||++|||+.|+++
T Consensus       244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0111111111111111111111223557899999999999999999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=334.85  Aligned_cols=267  Identities=22%  Similarity=0.302  Sum_probs=200.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999775 58999999886442  2345677899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++++|..++.... .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||.++....... 
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            999999998876543 589999999999999999999   778999999999999999999999999999987653222 


Q ss_pred             cccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHHH-hhc
Q 046240          632 MTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVVN-KTL  707 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i~-~~l  707 (763)
                       ......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.........  .........+. ...... ...
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  235 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR-HQQVFSTNQY  235 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH-HHHHHHTCGG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc-cccccccccc
Confidence             2234578999999998875 67899999999999999999999999764332211  11222221111 111111 110


Q ss_pred             C-----CCccc--c-HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 L-----SPPEK--D-FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~-----~~~~~--~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .     ..+..  . ..........+.+++..|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0     00000  0 0000123456889999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-38  Score=341.65  Aligned_cols=252  Identities=21%  Similarity=0.244  Sum_probs=192.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|.+.+.||+|+||+||++... +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999765 789999999975432 235678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc--EEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI--AHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~~~~~~~  630 (763)
                      +++|+|.+++...+ .++...+..++.|+++||+||   |+++|+||||||+||+++.++.  +||+|||+++...... 
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            99999999986644 589999999999999999999   7789999999999999987765  9999999997542211 


Q ss_pred             ccccccccccccccCccccCCCCCCcc-hhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTR-SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......             .....+......
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------------~~~~~~~~~~~~  237 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-------------DYRKTIQRILSV  237 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-------------CHHHHHHHHHTT
T ss_pred             --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-------------HHHHHHHHHhcC
Confidence              2234579999999999988877665 899999999999999999997643211             111122221111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......  .......+.+++.+|++.+|++|||+.|+++
T Consensus       238 ~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          238 KYSIPD--DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            111000  0012346789999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.7e-39  Score=348.77  Aligned_cols=270  Identities=21%  Similarity=0.310  Sum_probs=192.8

Q ss_pred             HHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCC--c
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDD--F  545 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  545 (763)
                      ...++|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999965 57899999998543  2344567789999999997 999999999997544  7


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .|+||||++ ++|..++...  .++...+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999998 5898888764  488899999999999999999   7889999999999999999999999999999876


Q ss_pred             CCCCC-------------------ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh
Q 046240          626 SGEDQ-------------------SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL  685 (763)
Q Consensus       626 ~~~~~-------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~  685 (763)
                      .....                   ........||++|+|||++.+ ..++.++||||+||++|||++|+.||........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            42111                   112234579999999999876 6789999999999999999999999976432211


Q ss_pred             hhhhhh---cc--------cCChhHHHHHHhh---c---CCCccccHHH----------HHHHHHHHHHHHHHccccCcC
Q 046240          686 SLKHWV---NG--------LLPVSLMEVVNKT---L---LSPPEKDFAA----------KEQCVLSIFSLAMECTMELPE  738 (763)
Q Consensus       686 ~~~~~~---~~--------~~~~~~~~~i~~~---l---~~~~~~~~~~----------~~~~~~~l~~l~~~cl~~~P~  738 (763)
                       +....   ..        .........+...   .   .......+..          ...+...+.+++.+|+..||+
T Consensus       240 -~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          240 -LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             -HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             -HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence             11111   00        0001111111110   0   0000000000          002245688999999999999


Q ss_pred             CCCCHHHHHH
Q 046240          739 KRINAKCCNF  748 (763)
Q Consensus       739 ~Rps~~~v~~  748 (763)
                      +|||++|+++
T Consensus       319 ~R~t~~e~l~  328 (388)
T 3oz6_A          319 KRISANDALK  328 (388)
T ss_dssp             GSCCHHHHTT
T ss_pred             cCCCHHHHhC
Confidence            9999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.1e-38  Score=325.42  Aligned_cols=246  Identities=23%  Similarity=0.321  Sum_probs=200.3

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....   .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            468999999999999999999665 678999999975432   2346788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++.... .++...+..++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            99999999999987643 588999999999999999999   7889999999999999999999999999998654322 


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                         ......|++.|+|||.+.+..++.++||||||+++|||++|..||........              ...+......
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~  225 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--------------YKRISRVEFT  225 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------------HHHHHHTCCC
T ss_pred             ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--------------HHHHHhCCCC
Confidence               22345789999999999999999999999999999999999999976332211              1111111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.       .....+.+++..|++.+|++||++.|+++
T Consensus       226 ~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          226 FPD-------FVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CCT-------TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCC-------cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111       12445789999999999999999999995

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-38  Score=335.78  Aligned_cols=262  Identities=24%  Similarity=0.329  Sum_probs=199.1

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh---hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE---CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++...   .......+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999975 57899999998742   234567788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      |||+++++|.+++..   ....++...+..++.++++||.||   |+.+++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864   334688999999999999999999   77899999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ....  ......+++.|+|||++.+..++.++||||||+++|||++|+.||..........            ...+...
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~~~~~  253 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL------------CKKIEQC  253 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH------------HHHHHTT
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH------------HHHhhcc
Confidence            3221  2234568999999999999999999999999999999999999986532111111            1111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      -.  +...   ...+...+.+++..||+.||++||++.+|++.|+++....
T Consensus       254 ~~--~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          254 DY--PPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CS--CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cC--CCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            00  0000   0112456889999999999999999999999998876553

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.8e-38  Score=350.82  Aligned_cols=265  Identities=22%  Similarity=0.188  Sum_probs=195.7

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC------C
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSND------D  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  544 (763)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999965 46899999999754  234567788999999999999999999999654      3


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..|+||||++++ +.+.+..   .+++..+..++.|+++||+||   |+.+|+||||||+|||++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~---~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCCC-HHHHHhh---cCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            569999999875 5555533   378899999999999999999   778999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccC-------
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLL-------  695 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~-------  695 (763)
                      ....   .......||++|+|||++.+..++.++||||+||++|||++|+.||.+.......  .........       
T Consensus       214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          214 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ---C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             cCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            6432   2234567999999999999999999999999999999999999999764322111  111111111       


Q ss_pred             ChhHHHHHHhhcCCCcc------------ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          696 PVSLMEVVNKTLLSPPE------------KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       696 ~~~~~~~i~~~l~~~~~------------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .......+...-.....            ............+.+++.+|+..||++|||++|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111221111000000            001111223567899999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-38  Score=341.31  Aligned_cols=277  Identities=23%  Similarity=0.241  Sum_probs=210.1

Q ss_pred             cCCCChHHHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-----CCccce
Q 046240          462 KRRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-----HRNLVK  535 (763)
Q Consensus       462 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~  535 (763)
                      ...+++.+.....++|.+.+.||+|+||+||+|.. .+++.||||++.... .....+..|+.+++.+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            44455555556678999999999999999999976 478899999997432 33456778999999986     999999


Q ss_pred             EEeeeecCCceEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC----
Q 046240          536 IISGCSNDDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE----  610 (763)
Q Consensus       536 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~----  610 (763)
                      +++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+||   |+++|+||||||+||+++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 889999987654 3588999999999999999999   7889999999999999975    


Q ss_pred             ---------------------CCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHH
Q 046240          611 ---------------------DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIE  669 (763)
Q Consensus       611 ---------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~e  669 (763)
                                           ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 789999999999875422     234568999999999999999999999999999999


Q ss_pred             HHcCCCCCchhhhhhh-hhhhhhcccCChhHH-HHHHhh----cC------CCcccc--H-----------HHHHHHHHH
Q 046240          670 TFTRKKPADKMFAAEL-SLKHWVNGLLPVSLM-EVVNKT----LL------SPPEKD--F-----------AAKEQCVLS  724 (763)
Q Consensus       670 lltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~-~~i~~~----l~------~~~~~~--~-----------~~~~~~~~~  724 (763)
                      |++|+.||........ ..........+.... +.....    ..      ..+...  .           .........
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999999976432221 111111122222111 110000    00      000000  0           000111256


Q ss_pred             HHHHHHHccccCcCCCCCHHHHHH
Q 046240          725 IFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       725 l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.+++..|++.||++|||++|+++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc
Confidence            789999999999999999999875

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-38  Score=352.61  Aligned_cols=316  Identities=19%  Similarity=0.214  Sum_probs=289.0

Q ss_pred             cccceeecCC---------CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccE
Q 046240           66 NWIGITCDVN---------SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKA  136 (763)
Q Consensus        66 ~w~gv~c~~~---------~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~  136 (763)
                      .|..|.|...         ..+++.|+|++|+|++..+..|.++++|++|+|++|.++       .+++..|.++++|++
T Consensus        12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-------~~~~~~~~~l~~L~~   84 (477)
T 2id5_A           12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-------AVEPGAFNNLFNLRT   84 (477)
T ss_dssp             TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC-------EECTTTTTTCTTCCE
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccC-------EeChhhhhCCccCCE
Confidence            3567788542         257999999999999888999999999999999999996       676667779999999


Q ss_pred             EEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEe
Q 046240          137 LSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYI  216 (763)
Q Consensus       137 L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L  216 (763)
                      |+|++|+|+++.+..|.++++|++|+|++|++++..|..|.++++|+.|+    +++|.+++..|..|.++. +|++|+|
T Consensus        85 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~----l~~n~l~~~~~~~~~~l~-~L~~L~l  159 (477)
T 2id5_A           85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE----VGDNDLVYISHRAFSGLN-SLEQLTL  159 (477)
T ss_dssp             EECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE----ECCTTCCEECTTSSTTCT-TCCEEEE
T ss_pred             EECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE----CCCCccceeChhhccCCC-CCCEEEC
Confidence            99999999988888899999999999999999999999999999999999    889999999999999998 9999999


Q ss_pred             ecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEccccc
Q 046240          217 SNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNN  296 (763)
Q Consensus       217 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~  296 (763)
                      ++|++++..+..|..+++|+.|+|++|.+++..+..|..+++  |+.|++++|.+.+.+|.  ......+|++|+|++|+
T Consensus       160 ~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~--L~~L~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~  235 (477)
T 2id5_A          160 EKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYR--LKVLEISHWPYLDTMTP--NCLYGLNLTSLSITHCN  235 (477)
T ss_dssp             ESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTT--CCEEEEECCTTCCEECT--TTTTTCCCSEEEEESSC
T ss_pred             CCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcc--cceeeCCCCccccccCc--ccccCccccEEECcCCc
Confidence            999999888888999999999999999999888889999977  99999999998888887  55566699999999999


Q ss_pred             ccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC
Q 046240          297 FSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG  376 (763)
Q Consensus       297 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  376 (763)
                      +++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++++.|..|..+++|+.|+|++|++++.++..
T Consensus       236 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  315 (477)
T 2id5_A          236 LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV  315 (477)
T ss_dssp             CCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGG
T ss_pred             ccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhH
Confidence            99666678999999999999999999888889999999999999999999999999999999999999999999877754


Q ss_pred             -CCccccccccccCCCcccCCC
Q 046240          377 -GPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       377 -~~~~~l~~~~~~~n~~~c~~p  397 (763)
                       ..++.+..+++.+|++.|+|+
T Consensus       316 ~~~l~~L~~L~l~~N~l~c~c~  337 (477)
T 2id5_A          316 FHSVGNLETLILDSNPLACDCR  337 (477)
T ss_dssp             BSCGGGCCEEECCSSCEECSGG
T ss_pred             cCCCcccCEEEccCCCccCccc
Confidence             567889999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.6e-38  Score=331.27  Aligned_cols=260  Identities=24%  Similarity=0.368  Sum_probs=207.0

Q ss_pred             HhccCcCc-eecccCCceEEEEEec---CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          474 TNRFGRDN-LIGIGSFGYVYKAELD---DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       474 ~~~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      .++|.+.+ .||+|+||.||+|...   +++.||||++....  ....+.+.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            46788887 9999999999999542   46889999997543  23356789999999999999999999999 566789


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||+++++|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++....
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999997654 588999999999999999999   778999999999999999999999999999987754


Q ss_pred             CCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          628 EDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       628 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......              ..+.+..
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------------~~~~~~~  235 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEK  235 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------HHHHHHT
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------------HHHHHHc
Confidence            3322 12233446788999999988889999999999999999999 999997643221              1111111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                      ...  +..    ...+...+.+++..||+.||++||++.++++.|++.+.+.+
T Consensus       236 ~~~--~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          236 GER--MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             TCC--CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCC--CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            110  000    01235568999999999999999999999999998877643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1e-37  Score=337.35  Aligned_cols=256  Identities=22%  Similarity=0.335  Sum_probs=205.5

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--------HHHHHHHHHHHHHHHhC-CCCccceEEe
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--------ARAMKSFEVECEVMKNI-RHRNLVKIIS  538 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~  538 (763)
                      ......++|.+.+.||+|+||.||+|... +|+.||||++....        ....+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34456688999999999999999999775 79999999986432        12346678999999999 7999999999


Q ss_pred             eeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       539 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                      ++...+..++||||+++++|.+++.... .+++..+..++.|++.||.||   |+.+|+||||||+||+++.++.+||+|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999999987543 589999999999999999999   678999999999999999999999999


Q ss_pred             ecCceecCCCCCccccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc
Q 046240          619 FGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI------ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN  692 (763)
Q Consensus       619 fgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~  692 (763)
                      ||++..+....   ......||+.|+|||++.      ...++.++|||||||++|||++|..||........ ...   
T Consensus       244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~---  316 (365)
T 2y7j_A          244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-LRM---  316 (365)
T ss_dssp             CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH---
T ss_pred             cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-HHH---
Confidence            99998775332   223467899999999875      34688999999999999999999999976322110 111   


Q ss_pred             ccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          693 GLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       693 ~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                               +.....    .............+.+++.+|++.||++||++.++++
T Consensus       317 ---------i~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          317 ---------IMEGQY----QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---------HHHTCC----CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---------HHhCCC----CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                     111100    0001111123456889999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.4e-38  Score=331.18  Aligned_cols=265  Identities=21%  Similarity=0.274  Sum_probs=209.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeee-ecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC-SNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++....  ..+.+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999976 679999999986542  234578899999999988866666555 66678899999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe---cCCCcEEEeeecCceecCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |+ +++|.+++......+++..+..++.|+++||+||   |+++|+||||||+||++   +.++.+||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 8999999986666799999999999999999999   77899999999999999   47889999999999887543


Q ss_pred             CCc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          629 DQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       629 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......          .......+.
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------~~~~~~~~~  231 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----------KRQKYERIS  231 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----------SSSHHHHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh----------hhhhhhhhc
Confidence            321     11245579999999999999999999999999999999999999997632111          001111122


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .........   .....++..+.+++..||+.+|++||++.++++.|+++..+.
T Consensus       232 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          232 EKKMSTPIE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHSCHH---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccccCCchH---HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            211111100   001123456899999999999999999999999999888764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-37  Score=323.98  Aligned_cols=251  Identities=23%  Similarity=0.292  Sum_probs=205.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|++++++++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            67999999999999999999765 678999999976532   22467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|.+++...+ .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++......  
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence            9999999999987654 588999999999999999999   7889999999999999999999999999999765422  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.||........             ...+...... .
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------------~~~~~~~~~~-~  231 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------------HRRIVNVDLK-F  231 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHTTCCC-C
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------------HHHHhccccC-C
Confidence              12345689999999999999999999999999999999999999976432211             0111111111 1


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH--HHhhcc
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF--VLCEQF  754 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~--~L~~~~  754 (763)
                      +.       .....+.+++..|++.+|++||+++++++  .+....
T Consensus       232 ~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          232 PP-------FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             CT-------TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             CC-------cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            11       12446789999999999999999999985  444433

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.3e-38  Score=350.67  Aligned_cols=195  Identities=24%  Similarity=0.363  Sum_probs=153.8

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeec-----CCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSN-----DDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~  545 (763)
                      .++|.+.+.||+|+||+||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999654 7899999998653  23456778899999999999999999999943     357


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .|+||||++ ++|..++.... .+++..+..++.||++||+||   |+.+|+||||||+|||++.++.+||+|||+++.+
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEeccc-cchhhhcccCC-CCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            899999985 68888886543 689999999999999999999   7789999999999999999999999999999876


Q ss_pred             CCCCCc-------------------------cccccccccccccCcccc-CCCCCCcchhHHHHHHHHHHHHcC
Q 046240          626 SGEDQS-------------------------MTQTQTLATIGYMAPEYG-IERKVSTRSDIYSYGIMLIETFTR  673 (763)
Q Consensus       626 ~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~elltg  673 (763)
                      ......                         ......+||++|+|||++ .+..++.++|||||||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            422111                         123455789999999975 567799999999999999999994

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.1e-39  Score=364.65  Aligned_cols=259  Identities=27%  Similarity=0.461  Sum_probs=210.9

Q ss_pred             HHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            356788999999999999999999888899999997543 234678999999999999999999999876 678999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++|+|.+++... ...+++..+..++.||++||+||   |+++|+||||||+|||++.++.+||+|||+++.+.... .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            9999999999753 23588999999999999999999   77899999999999999999999999999998764211 1


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+              ..+.+.......
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--------------~~~~i~~~~~~~  484 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------------VLDQVERGYRMP  484 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--------------HHHHHHTTCCCC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcCCCCC
Confidence            12233456788999999988899999999999999999999 999997643221              111111111100


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .      ...+...+.+++..||+.+|++||++++|+++|++++...
T Consensus       485 ~------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          485 C------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             C------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             C------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            0      1123567899999999999999999999999999887653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-38  Score=339.06  Aligned_cols=262  Identities=24%  Similarity=0.283  Sum_probs=197.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  544 (763)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999976 57899999998543  2334567889999999999999999999997653      


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..|+||||+ +++|.+++...  .++...+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            459999999 78999998764  488999999999999999999   778999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh--cccC------
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV--NGLL------  695 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~--~~~~------  695 (763)
                      ....     .....+|++|+|||++.+ ..++.++||||+||++|||++|+.||........ +....  .+..      
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHH
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence            5422     234578999999998876 7899999999999999999999999976432211 11111  1111      


Q ss_pred             ---ChhHHHHHHhhcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          696 ---PVSLMEVVNKTLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       696 ---~~~~~~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         +......+.. +...+.... .........+.+++.+|+..||++|||+.++++
T Consensus       252 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          252 RLQSDEAKNYMKG-LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             TCSCHHHHHHHHH-SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhhhHHHHHHHHh-CCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence               1122222222 111111111 001122456889999999999999999999987

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-39  Score=368.40  Aligned_cols=257  Identities=26%  Similarity=0.410  Sum_probs=203.0

Q ss_pred             ccCcCc-eecccCCceEEEEEec---CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          476 RFGRDN-LIGIGSFGYVYKAELD---DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       476 ~~~~~~-~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            333344 7999999999999764   46679999997542 2346778999999999999999999999976 5689999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++......+++..+..++.|+++||+||   |+++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999999999987666799999999999999999999   778999999999999999999999999999987643322


Q ss_pred             c-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          631 S-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       631 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      . .......+++.|+|||++.+..++.++|||||||++|||+| |+.||......+              ..+.+.....
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------------~~~~i~~~~~  557 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGKR  557 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------------HHHHHHTTCC
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHcCCC
Confidence            1 11223345689999999998999999999999999999998 999997643221              1111211110


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ..      ....+...+.+++..||+.+|++||++.+|++.|+..+.+
T Consensus       558 ~~------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          558 ME------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CC------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CC------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            00      0112456789999999999999999999999999887655

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=334.60  Aligned_cols=269  Identities=26%  Similarity=0.291  Sum_probs=197.5

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-----HHHHHHHHHHHHHHHhC---CCCccceEEeeeecC
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-----ARAMKSFEVECEVMKNI---RHRNLVKIISGCSND  543 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~  543 (763)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|++....     ......+.+|+++++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467999999999999999999976 578999999986432     11234556777777766   499999999999765


Q ss_pred             C-----ceEEEEEccCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEe
Q 046240          544 D-----FKALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS  617 (763)
Q Consensus       544 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~  617 (763)
                      .     ..++||||++ ++|.+++..... .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5789999997 499998876543 489999999999999999999   77899999999999999999999999


Q ss_pred             eecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh--hhhcccC
Q 046240          618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK--HWVNGLL  695 (763)
Q Consensus       618 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~--~~~~~~~  695 (763)
                      |||+++.+....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........  .......
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999998764222   23456789999999999999999999999999999999999999976433221111  1000000


Q ss_pred             ChhHHH---HHHhhcC-CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          696 PVSLME---VVNKTLL-SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       696 ~~~~~~---~i~~~l~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...+..   +...... ..+.............+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            000000   0000000 0000000111123456889999999999999999999876

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.5e-38  Score=332.49  Aligned_cols=251  Identities=22%  Similarity=0.267  Sum_probs=201.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4578999999999999999999765 789999999986544445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe---cCCCcEEEeeecCceecCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |+++++|.+++.... .+++.....++.|++.||.||   |+.+|+||||||+||++   +.++.+||+|||+++.....
T Consensus        87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999999886543 588999999999999999999   77899999999999999   78899999999998764321


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                          ......|++.|+|||++.+..++.++|||||||++|||++|+.||........ ...            +......
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~------------i~~~~~~  225 (304)
T 2jam_A          163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-FEK------------IKEGYYE  225 (304)
T ss_dssp             ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH------------HHHCCCC
T ss_pred             ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHH------------HHcCCCC
Confidence                22334689999999999999999999999999999999999999976332211 111            1111110


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       .+..   ........+.+++..|++.||++||++.++++
T Consensus       226 -~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 -FESP---FWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             -CCTT---TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             -CCcc---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0000   00122456889999999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-38  Score=331.41  Aligned_cols=250  Identities=27%  Similarity=0.323  Sum_probs=196.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            468999999999999999999764 689999999976542 235778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe---cCCCcEEEeeecCceec
Q 046240          552 YMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       552 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~  625 (763)
                      |+++|+|.+++...   ...+++..+..++.|+++||+||   |+.+|+||||||+||++   +.++.+||+|||+++.+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988542   34689999999999999999999   77899999999999999   45678999999999876


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ....   ......|++.|+|||++. +.++.++|||||||++|||++|+.||.............             ..
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~-------------~~  240 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-------------YK  240 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------HC
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc-------------cC
Confidence            4322   223456899999999875 568999999999999999999999997643222111100             00


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .........     .....+.+++..|++.||++||++.|+++
T Consensus       241 ~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 EPNYAVECR-----PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCCCC--C-----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CcccccccC-----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000000     02345789999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-39  Score=344.42  Aligned_cols=265  Identities=14%  Similarity=0.106  Sum_probs=205.0

Q ss_pred             HhccCcCceecccCCceEEEEEec---------CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccce---------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD---------DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVK---------  535 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  535 (763)
                      .++|.+.+.||+|+||.||+|...         +++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            368999999999999999999765         3789999998754     45778999999999999988         


Q ss_pred             ------EEeeeec-CCceEEEEEccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEE
Q 046240          536 ------IISGCSN-DDFKALVLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVL  607 (763)
Q Consensus       536 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIl  607 (763)
                            +++++.. .+..++||||+ +++|.+++... ...+++..+..++.|+++||+||   |+++|+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFL---HENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEE
Confidence                  5666665 67889999999 99999999865 34689999999999999999999   7789999999999999


Q ss_pred             ecCCC--cEEEeeecCceecCCCCCc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchh
Q 046240          608 LDEDM--IAHLSDFGIAKLLSGEDQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKM  680 (763)
Q Consensus       608 l~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~  680 (763)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876432211     1123457999999999999999999999999999999999999999874


Q ss_pred             hhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          681 FAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       681 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ...........        ..+ .......... ..........+.+++..|++.||++||+++++++.|++++.+.
T Consensus       272 ~~~~~~~~~~~--------~~~-~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          272 LPNTEDIMKQK--------QKF-VDKPGPFVGP-CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             TTCHHHHHHHH--------HHH-HHSCCCEECT-TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CcCHHHHHHHH--------Hhc-cCChhhhhhh-ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            32211111110        000 0000000000 0000011456899999999999999999999999999888764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.3e-38  Score=330.42  Aligned_cols=262  Identities=26%  Similarity=0.390  Sum_probs=199.1

Q ss_pred             HhccCcCceecccCCceEEEEEec--CCc--eEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--DGI--EVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|++.+.||+|+||+||+|.+.  +++  .||+|+++...   ....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            468999999999999999999753  333  68999887542   234577889999999999999999999998765 8


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++|+||+++++|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            899999999999999987655689999999999999999999   67899999999999999999999999999998875


Q ss_pred             CCCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          627 GEDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       627 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ..... .......++..|+|||++.+..++.++||||||+++|||++ |+.||........              ...+.
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------------~~~~~  238 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKID  238 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------------HHHHH
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH--------------HHHHH
Confidence            43322 12234557888999999988889999999999999999999 9999976432211              00111


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                      ......+.     ...+...+.+++..|++.+|++||++.++++.|++....+.
T Consensus       239 ~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  287 (291)
T 1u46_A          239 KEGERLPR-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM  287 (291)
T ss_dssp             TSCCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             ccCCCCCC-----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence            11001111     01235568999999999999999999999999998876654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=338.98  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=201.4

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--------HHHHHHHHHHHHHHhCCCCccceEEeeeecC
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--------RAMKSFEVECEVMKNIRHRNLVKIISGCSND  543 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  543 (763)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++.....        .....+.+|+.++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999965 5789999999975421        1233567799999999999999999999999


Q ss_pred             CceEEEEEccCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          544 DFKALVLEYMPNG-SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       544 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      +..++||||+.+| +|.+++.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999887654 589999999999999999999   7789999999999999999999999999999


Q ss_pred             eecCCCCCccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      +......   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......       ..        
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~--------  239 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------EA--------  239 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------TT--------
T ss_pred             eECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------hh--------
Confidence            8865332   2234568999999999888776 789999999999999999999997632210       00        


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                          .. ..+..       +...+.+++..|++.+|++||++.++++-
T Consensus       240 ----~~-~~~~~-------~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 ----AI-HPPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----CC-CCSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----cc-CCCcc-------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00 01111       23458899999999999999999999873

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-38  Score=352.28  Aligned_cols=248  Identities=24%  Similarity=0.300  Sum_probs=194.6

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999965 478999999998652   23345677899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |||+++|+|..++.... .+++..+..++.|+++||+||   |+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---hhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999987644 689999999999999999999   65 89999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........             ...+..... 
T Consensus       303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------------~~~i~~~~~-  366 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------------FELILMEEI-  366 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCC-
T ss_pred             C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------------HHHHHhCCC-
Confidence            2  223456799999999999999999999999999999999999999976332211             011111111 


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      ..+.       .....+.+++..|++.||++||     +++|+++
T Consensus       367 ~~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 RFPR-------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCCT-------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCc-------cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            1111       1245688999999999999999     9999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-38  Score=338.55  Aligned_cols=258  Identities=29%  Similarity=0.436  Sum_probs=205.0

Q ss_pred             hccCcCceecccCCceEEEEEec-CCce--EEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIE--VAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|...+.||+|+||.||+|... ++..  ||+|++.... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999664 5664  4999887532 33456788999999999 899999999999999999999


Q ss_pred             EEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          550 LEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      |||+++++|.+++....               ..+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCccceEEEcCCCeE
Confidence            99999999999997643               3689999999999999999999   77899999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcc
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  693 (763)
                      ||+|||+++....   ........+++.|+|||++.+..++.++|||||||++|||+| |+.||........        
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--------  250 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------  250 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--------
Confidence            9999999875321   112233456889999999988889999999999999999998 9999976432211        


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                            .+.+.........      ..+...+.+++.+|++.+|++||++.++++.|.+++.+..
T Consensus       251 ------~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          251 ------YEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             ------HHHGGGTCCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             ------HHHhhcCCCCCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence                  0111111000000      1124568899999999999999999999999998877653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.8e-38  Score=333.91  Aligned_cols=262  Identities=19%  Similarity=0.261  Sum_probs=202.2

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeec--CCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSN--DDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  549 (763)
                      .++|++.+.||+|+||+||+|.. .+++.||||++....   .+.+.+|++++++++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36899999999999999999965 578999999987442   356789999999997 9999999999987  5678999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeecCceecCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGE  628 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~  628 (763)
                      |||+++++|.+++..    ++...+..++.|+++||+||   |+.+|+||||||+||+++.++ .+||+|||+++.+...
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999998853    78889999999999999999   778999999999999999776 8999999999876533


Q ss_pred             CCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .   ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.........+........+....+.+++.-
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            2   2234578999999999876 67899999999999999999999999543222222222221111222222222111


Q ss_pred             CC-----------Ccccc------HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LS-----------PPEKD------FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~-----------~~~~~------~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..           ....+      ..........+.+++.+|++.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            10           00000      0001113567899999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.3e-38  Score=345.81  Aligned_cols=253  Identities=22%  Similarity=0.239  Sum_probs=192.8

Q ss_pred             HHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--------HHHHHHHHHHHHHHhCCCCccceEEeeeec
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--------RAMKSFEVECEVMKNIRHRNLVKIISGCSN  542 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  542 (763)
                      ...++|.+.+.||+|+||+||+|.. .+++.||||++.....        .....+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4568999999999999999999965 4689999999975421        122357889999999999999999999865


Q ss_pred             CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC---CcEEEeee
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED---MIAHLSDF  619 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~---~~~kl~Df  619 (763)
                       +..++||||+++|+|.+++.... .+++.....++.|+++||+||   |+.+|+||||||+||+++.+   +.+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCCCcceEEEeec
Confidence             45789999999999999887654 689999999999999999999   67899999999999999754   45999999


Q ss_pred             cCceecCCCCCccccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      |+++......   ......||+.|+|||++.   ...++.++|||||||++|||++|+.||........           
T Consensus       287 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-----------  352 (419)
T 3i6u_A          287 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----------  352 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-----------
T ss_pred             ccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-----------
Confidence            9998764322   223457899999999975   36788899999999999999999999975322111           


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ..+.+....   ....+.........+.+++.+|++.||++||++.|+++
T Consensus       353 --~~~~i~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 --LKDQITSGK---YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --HHHHHHTTC---CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHHhcCC---CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              111111111   11111111223567899999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=338.39  Aligned_cols=268  Identities=20%  Similarity=0.231  Sum_probs=196.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHH-HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR-AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|.+.+.||+|+||+||+|... +++.||+|++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999765 7899999998754322 222455799999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++ |+|.+++...+..+++..+..++.|++.||.||   |+.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            98 488888877666789999999999999999999   77899999999999999999999999999998654222  1


Q ss_pred             ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhH------HHHH
Q 046240          633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSL------MEVV  703 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~------~~~i  703 (763)
                      ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  .........+..+      .+..
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            2334568999999998876 67899999999999999999999999764332211  1111111111000      0000


Q ss_pred             HhhcCCC-ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLSP-PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....... ..............+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000000 00001111123456789999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7e-38  Score=352.55  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=204.5

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|...+.||+|+||.||+|... +|+.||+|++.....   .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999765 799999999976532   2345678899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          550 LEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |||++||+|.+++...+ ..+++..+..++.||+.||+||   |+.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999987643 3589999999999999999999   6789999999999999999999999999999887533


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......          ....+...+...-.
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----------~~~~i~~~i~~~~~  406 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----------KREEVERLVKEVPE  406 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----------CHHHHHHHHHHCCC
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----------hHHHHHHHhhcccc
Confidence            2   2234579999999999999999999999999999999999999997632110          00111122211111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      ..+       ......+.+++..|++.||++||     +++||++
T Consensus       407 ~~p-------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 EYS-------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCC-------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cCC-------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            111       11245688999999999999999     6777763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.6e-38  Score=326.84  Aligned_cols=250  Identities=23%  Similarity=0.316  Sum_probs=204.2

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec---------
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN---------  542 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  542 (763)
                      ...+|+..+.||+|+||.||+|... +++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4578999999999999999999775 78999999997543    345689999999999999999998854         


Q ss_pred             -------CCceEEEEEccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          543 -------DDFKALVLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       543 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                             ....++||||+++++|.+++... ...+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHEEEcCCCCE
Confidence                   34579999999999999999754 34689999999999999999999   67899999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL  694 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~  694 (763)
                      ||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|||++|..|+.......          
T Consensus       162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----------  228 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF----------  228 (284)
T ss_dssp             EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH----------
T ss_pred             EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHH----------
Confidence            999999998775332   2234568999999999999999999999999999999999999875421110          


Q ss_pred             CChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                           ..+....+   +.       .....+.+++..|++.||++||++.++++.+.....+.
T Consensus       229 -----~~~~~~~~---~~-------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          229 -----TDLRDGII---SD-------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             -----HHHHTTCC---CT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             -----HHhhcccc---cc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                 01111111   00       12345789999999999999999999999998766553

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.4e-37  Score=326.19  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=204.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999765 58899999987542   33456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||.++......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999886543 588999999999999999999   77899999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........             ..+..... .
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~-~  233 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------------LRIKKNEY-S  233 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------------HHHHTTCC-C
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHhhccC-C
Confidence            2  223456899999999999989999999999999999999999999764322110             01111101 1


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.       .....+.+++.+|++.+|++||+++++++
T Consensus       234 ~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          234 IPK-------HINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CCT-------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             Ccc-------ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            111       12345789999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.1e-38  Score=334.73  Aligned_cols=263  Identities=20%  Similarity=0.260  Sum_probs=207.3

Q ss_pred             CCCChHHHHHHHhccCcC-ceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhC-CCCccceEE
Q 046240          463 RRLPYQDLSRATNRFGRD-NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNI-RHRNLVKII  537 (763)
Q Consensus       463 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~  537 (763)
                      ..+.++......++|.+. +.||+|+||.||+|... +++.||+|++.....  .....+.+|+.+++.+ .||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            344556666777888887 88999999999999665 689999999875432  2356788999999999 469999999


Q ss_pred             eeeecCCceEEEEEccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCc
Q 046240          538 SGCSNDDFKALVLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMI  613 (763)
Q Consensus       538 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~  613 (763)
                      +++...+..++||||+++|+|.+++... ...+++..+..++.|++.||+||   |+.+|+||||||+||+++.   ++.
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESCBTTBCC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHEEEecCCCCCc
Confidence            9999999999999999999999998653 34689999999999999999999   7789999999999999988   789


Q ss_pred             EEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcc
Q 046240          614 AHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       614 ~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~  693 (763)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........       
T Consensus       173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------  242 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-------  242 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------
T ss_pred             EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-------
Confidence            9999999998764322   223457899999999999999999999999999999999999999764332211       


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                            ..+.. .....+...   ...+...+.+++..|++.+|++|||++++++
T Consensus       243 ------~~i~~-~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          243 ------LNISQ-VNVDYSEET---FSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ------HHHHH-TCCCCCTTT---TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------HHHHh-cccccCchh---hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                  01111 111111110   1123456889999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-38  Score=341.25  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=198.0

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++.....    ...+|++++.++ +||||+++++++.+++..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4678999999999999999999765 689999999975532    234688888887 7999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC----CcEEEeeecCceecC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED----MIAHLSDFGIAKLLS  626 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~~  626 (763)
                      ||+++|+|.+++.... .+++.....++.|+++||+||   |+.+|+||||||+||++.++    +.+||+|||+++.+.
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999987654 589999999999999999999   77899999999999998433    359999999998765


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......           ...+...+...
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----------~~~~~~~i~~~  238 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----------PEEILARIGSG  238 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----------HHHHHHHHHHC
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----------HHHHHHHHccC
Confidence            3322  2234578999999999988889999999999999999999999997521110           00111111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      -...+..   ........+.+++.+|++.||++||++.++++
T Consensus       239 ~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          239 KFSLSGG---YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCCCST---TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCcc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1100100   00112456889999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.1e-38  Score=334.33  Aligned_cols=269  Identities=25%  Similarity=0.318  Sum_probs=201.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++|+..+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            468999999999999999999765 58999999986442  234566789999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|..+..... .+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999999988865543 589999999999999999999   778999999999999999999999999999987643222


Q ss_pred             ccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhh-hhcccCChhHHHHHHhhcC
Q 046240          631 SMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH-WVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~  708 (763)
                        ......|++.|+|||++.+. .++.++|||||||++|||++|+.||............ ...+...+.......+.-.
T Consensus       180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence              22345689999999998765 7899999999999999999999999764332221111 1111122222222221110


Q ss_pred             -C---Cc-----cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 -S---PP-----EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 -~---~~-----~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       .   .+     .........+...+.+++.+|++.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             0   00     0000111123567899999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-37  Score=341.04  Aligned_cols=250  Identities=20%  Similarity=0.257  Sum_probs=189.6

Q ss_pred             hccCcC-ceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHh-CCCCccceEEeeeec----CCceE
Q 046240          475 NRFGRD-NLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKN-IRHRNLVKIISGCSN----DDFKA  547 (763)
Q Consensus       475 ~~~~~~-~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~  547 (763)
                      ++|.+. +.||+|+||+||+|... +|+.||||++...     ..+.+|++++.+ .+||||+++++++..    ....|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999664 6899999998643     345678888754 589999999998865    56789


Q ss_pred             EEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecCce
Q 046240          548 LVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAK  623 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~  623 (763)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.||   |+.+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999997653 3689999999999999999999   6789999999999999997   7899999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........          .......+
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------~~~~~~~i  279 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGMKTRI  279 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS----------CCSHHHHH
T ss_pred             ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc----------cHHHHHHH
Confidence            764222   22346789999999999999999999999999999999999999976322110          01111111


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...-...+....   ..+..++.+++..||+.||++|||+.++++
T Consensus       280 ~~~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          280 RMGQYEFPNPEW---SEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             HHTCCCCCTTTT---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HcCcccCCCccc---ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111111111100   123456889999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.3e-38  Score=337.79  Aligned_cols=263  Identities=23%  Similarity=0.283  Sum_probs=186.7

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC------C
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSND------D  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  544 (763)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999965 57899999998643  234456788999999999999999999998654      5


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..++|+||+ +++|.+++...  .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 68999888753  589999999999999999999   778999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhh--------hcc
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHW--------VNG  693 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~--------~~~  693 (763)
                      ....     .....||++|+|||++.+ ..++.++|||||||++|||++|+.||.........  ....        ...
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5321     234578999999999876 68899999999999999999999999764322111  1111        111


Q ss_pred             cCChhHHHHHHhhcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .........+.. +...+..... ........+.+++.+|+..||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          257 ISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CCCHHHHHHHHT-SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhHHHHHHHhc-cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            111222333332 2222222211 11122456889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.6e-37  Score=332.10  Aligned_cols=248  Identities=21%  Similarity=0.281  Sum_probs=204.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|.+.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999765 57899999987542   34456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999886543 589999999999999999999   67899999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                      .  ......|+..|+|||++.+..++.++|||||||++|||++|+.||........             ...+..... .
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------------~~~~~~~~~-~  259 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------------YLRIKKNEY-S  259 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHTCC-C
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-------------HHHHhcCCC-C
Confidence            2  22345689999999999998999999999999999999999999976332211             011111111 1


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.       .+...+.+++.+||+.||++||++.++++
T Consensus       260 ~~~-------~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 IPK-------HINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CCT-------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCc-------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111       12345789999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.7e-38  Score=340.22  Aligned_cols=275  Identities=20%  Similarity=0.242  Sum_probs=203.7

Q ss_pred             hHHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhh-----------HHHHHHHHHHHHHHHhCCCCccce
Q 046240          467 YQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC-----------ARAMKSFEVECEVMKNIRHRNLVK  535 (763)
Q Consensus       467 ~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv~  535 (763)
                      ..++....++|.+.+.||+|+||.||+|...+|+.||||++....           ....+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            456777889999999999999999999988889999999885321           123477899999999999999999


Q ss_pred             EEeeeec-----CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC
Q 046240          536 IISGCSN-----DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE  610 (763)
Q Consensus       536 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~  610 (763)
                      +++++..     ....++||||++ |+|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~  169 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDLHPGNILLAD  169 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECT
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCCChHHEEEcC
Confidence            9999843     346799999998 588888877666799999999999999999999   6789999999999999999


Q ss_pred             CCcEEEeeecCceecCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hh
Q 046240          611 DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SL  687 (763)
Q Consensus       611 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~  687 (763)
                      ++.+||+|||+++......   ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||........  ..
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i  246 (362)
T 3pg1_A          170 NNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI  246 (362)
T ss_dssp             TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999997643222   2334578999999998876 7789999999999999999999999976432211  11


Q ss_pred             hhhhccc--------CChhHHHHHHhhcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          688 KHWVNGL--------LPVSLMEVVNKTLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       688 ~~~~~~~--------~~~~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .......        ......+.+.......+..... ........+.+++..|++.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1111110        0111222222222222222111 11223456899999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-38  Score=337.23  Aligned_cols=272  Identities=22%  Similarity=0.296  Sum_probs=198.3

Q ss_pred             HHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHH-----HHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR-----AMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ...++|...+.||+|+||.||+|... +|+.||||++......     ..+.+.+|++++++++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999775 6899999998743221     23467889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++||||+++ +|..++......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999986 88888877666788889999999999999999   7789999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh--hcccCChhHHH-
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW--VNGLLPVSLME-  701 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~-  701 (763)
                      .....  ......+|+.|+|||++.+ ..++.++|||||||++|||++|..||............+  ........+.+ 
T Consensus       163 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          163 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             cCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            43222  2344578999999999865 458999999999999999999999987643322111100  00000000000 


Q ss_pred             --HHHhh-cCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHH
Q 046240          702 --VVNKT-LLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV  749 (763)
Q Consensus       702 --~i~~~-l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~  749 (763)
                        ..+.. ....+.... .........+.+++..|++.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              00000 000000000 0001234578999999999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-37  Score=350.55  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=201.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ..++|.+.+.||+|+||+||+|... +++.||||++.....  .....+.+|++++++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999765 789999999975432  2356788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec---CCCcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~  626 (763)
                      |||+++|+|.+.+.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++   .++.+||+|||+++.+.
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999988886543 589999999999999999999   778999999999999995   45679999999998764


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...   ......||+.|+|||++.+ .++.++||||+||++|||++|..||........ ..            .+....
T Consensus       176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~------------~i~~~~  238 (486)
T 3mwu_A          176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LK------------RVETGK  238 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH------------HHHHTC
T ss_pred             CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH------------HHHhCC
Confidence            322   2334579999999999865 589999999999999999999999976432211 11            111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....    ..........+.+++.+|++.+|++|||+.++++
T Consensus       239 ~~~~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          239 YAFD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CCSC----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCC----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1100    0011123456889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.5e-37  Score=347.37  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=200.8

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|...+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|++++++++||||+++++++...+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67899999999999999999775 699999999976532   23467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      ||++||+|..++...   ...+++.....++.||+.||.||   |+.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            999999999998654   23689999999999999999999   778999999999999999999999999999988653


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHH-HHHHhh
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM-EVVNKT  706 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~  706 (763)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........          ...+. .+....
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----------~~~~~~~i~~~~  409 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----------NKELKQRVLEQA  409 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----------HHHHHHHHHHCC
T ss_pred             CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----------HHHHHHHHhhcc
Confidence            322  22345799999999999999999999999999999999999999976321100          00111 111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      .. .+.       .....+.+++..|++.+|++||++
T Consensus       410 ~~-~p~-------~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 VT-YPD-------KFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CC-CCT-------TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             cC-CCc-------ccCHHHHHHHHHhccCCHhHCCCC
Confidence            11 111       124567899999999999999975

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.4e-38  Score=332.11  Aligned_cols=251  Identities=27%  Similarity=0.333  Sum_probs=200.6

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4578999999999999999999765 68999999997542  34678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++++|.+++......+++..+..++.+++.||.||   |+.+++||||||+||+++.++.+||+|||.+..+..... 
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            9999999999975555789999999999999999999   778999999999999999999999999999987643221 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..........              .+....  .+
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~--~~  243 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF--------------MIPTNP--PP  243 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--------------HHHHSC--CC
T ss_pred             -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH--------------HHhcCC--Cc
Confidence             2334568999999999999999999999999999999999999997643221100              000000  00


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..  .....+...+.+++..|++.||++||++.++++
T Consensus       244 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          244 TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00  001123456889999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.7e-38  Score=340.72  Aligned_cols=265  Identities=26%  Similarity=0.341  Sum_probs=205.3

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            368999999999999999999765 7899999998754 23445778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+++++|.+++.... .+++.....++.++++||.||   |+. +|+||||||+||+++.++.+||+|||+++.+...  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~l---h~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYL---REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999997654 588999999999999999999   443 8999999999999999999999999998765311  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh--h-----------------
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW--V-----------------  691 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~--~-----------------  691 (763)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............  .                 
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              2234578999999999999999999999999999999999999997643322211100  0                 


Q ss_pred             ------cccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          692 ------NGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       692 ------~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                            ....+....+.++......+....  ...+...+.+++..|++.||++|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                  000011122222222211111100  0112456899999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-38  Score=334.55  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=199.0

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            468999999999999999999775 6899999999766555567888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++++|.+++......+++..+..++.|+++||.||   |+.+++||||||+||+++.++.+||+|||++......  ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ  172 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            999999999876555789999999999999999999   6789999999999999999999999999987543211  11


Q ss_pred             ccccccccccccCcccc-----CCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          633 TQTQTLATIGYMAPEYG-----IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ......|+..|+|||++     .+..++.++||||||+++|||++|+.||........ ...            +...  
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~------------~~~~--  237 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLK------------IAKS--  237 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH------------HHHS--
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHH------------Hhcc--
Confidence            12335689999999987     467789999999999999999999999976432211 111            1110  


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ..+..  .....+...+.+++..|++.+|++|||+.++++
T Consensus       238 -~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 -DPPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -CCCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -CCccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             00000  001123456889999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-38  Score=330.61  Aligned_cols=252  Identities=29%  Similarity=0.405  Sum_probs=198.4

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecC-CceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND-DFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  552 (763)
                      .++|+..+.||+|+||.||+|... |+.||+|+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            468999999999999999999875 8899999987543  356788999999999999999999997554 478999999


Q ss_pred             cCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          553 MPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++++|.+++..... .+++..+..++.|+++||+||   |+.+++||||||+||+++.++.+||+|||++......   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999976432 378889999999999999999   7789999999999999999999999999998865322   


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        .....++..|+|||.+.+..++.++||||||+++|||+| |+.||.......              ....+.......
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------------~~~~~~~~~~~~  234 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------VVPRVEKGYKMD  234 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------------HHHHHTTTCCCC
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHhcCCCCC
Confidence              122357889999999988899999999999999999998 999987632211              111111111000


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ..      ..+...+.+++..||+.+|++||++.++++.|+++...
T Consensus       235 ~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          235 AP------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Cc------ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            00      12345688999999999999999999999999887544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-37  Score=325.85  Aligned_cols=248  Identities=27%  Similarity=0.333  Sum_probs=204.8

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            46789999999999999999965 478999999997543 2345778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++++|.+++...  .+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||++..+..... 
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            99999999998753  589999999999999999999   778999999999999999999999999999987653321 


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......|++.|+|||++.+..++.++||||||+++|||++|+.||........              ...+.+......
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~  239 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--------------LFLIPKNNPPTL  239 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------------HHHHHHSCCCCC
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--------------HHHhhcCCCCCC
Confidence             23445789999999999999999999999999999999999999876432211              011111110000


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..      .+...+.+++..||+.+|++||++.++++
T Consensus       240 ~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          240 EG------NYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             CS------SCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cc------ccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            01      12456889999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-37  Score=335.07  Aligned_cols=271  Identities=22%  Similarity=0.304  Sum_probs=201.3

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeec--------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSN--------  542 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  542 (763)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36899999999999999999976 578999999986442  2234567889999999999999999999876        


Q ss_pred             CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      .+..++||||+++ ++...+......+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999986 67777766555789999999999999999999   7789999999999999999999999999999


Q ss_pred             eecCCCCC--ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCCh
Q 046240          623 KLLSGEDQ--SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPV  697 (763)
Q Consensus       623 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~  697 (763)
                      +.+.....  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  .........+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            87753222  122345678999999998875 56899999999999999999999999864332211  11111111111


Q ss_pred             hHHH-----HHHhhcCCCccc-cHHH---HHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 SLME-----VVNKTLLSPPEK-DFAA---KEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ~~~~-----~i~~~l~~~~~~-~~~~---~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....     .....-...... ....   .......+.+++.+|++.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0000     000000000000 0000   0011345889999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2e-37  Score=323.79  Aligned_cols=244  Identities=20%  Similarity=0.259  Sum_probs=197.7

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  548 (763)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++...  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4678999999999999999999775 7899999998753  223456778899999999 99999999999999999999


Q ss_pred             EEEccCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC--------------
Q 046240          549 VLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED--------------  611 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~--------------  611 (763)
                      ||||+++++|.+++....   ..+++..+..++.|+++||+||   |+++|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997532   3589999999999999999999   77899999999999999844              


Q ss_pred             -----CcEEEeeecCceecCCCCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh
Q 046240          612 -----MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL  685 (763)
Q Consensus       612 -----~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~  685 (763)
                           ..+||+|||.+......      ....||+.|+|||.+.+. .++.++|||||||++|||++|.+|+.....   
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                 47999999999876432      223589999999998765 667899999999999999999987654211   


Q ss_pred             hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          686 SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       686 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       .            ..+........+.       .+...+.+++..|++.||++||++.++++
T Consensus       237 -~------------~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -W------------HEIRQGRLPRIPQ-------VLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -H------------HHHHTTCCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -H------------HHHHcCCCCCCCc-------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             1            1111111111111       12456889999999999999999999976

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-37  Score=347.31  Aligned_cols=265  Identities=18%  Similarity=0.237  Sum_probs=210.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCC-CccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRH-RNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++.....  ...+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999975 5789999998865432  2457789999999976 566666677778888999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe---cCCCcEEEeeecCceecCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~  628 (763)
                      |+ +++|.+++......+++..+..|+.||+.||+||   |+++|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 9999999986666799999999999999999999   77899999999999999   68899999999999987543


Q ss_pred             CCc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          629 DQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       629 ~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      ...     .......||..|+|||++.+..++.++|||||||++|||++|+.||.........          .....+.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~----------~~~~~i~  229 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----------QKYEKIS  229 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH----------HHHHHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH----------HHHHHHh
Confidence            321     1223567999999999999999999999999999999999999999763221100          0111111


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ........   ......+..++.+++..||+.+|++||++.+|++.|++++.+.
T Consensus       230 ~~~~~~~~---~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          230 EKKVATSI---EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHSCH---HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hccccccH---HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            11111110   0111223567899999999999999999999999999887764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=336.88  Aligned_cols=257  Identities=26%  Similarity=0.296  Sum_probs=189.2

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeee--------c
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCS--------N  542 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~  542 (763)
                      ...+|.+.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            356899999999999999999976 478999999987665566678899999999996 999999999983        3


Q ss_pred             CCceEEEEEccCCCChhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEecCCCcEEEee
Q 046240          543 DDFKALVLEYMPNGSLDIFLYS--STCMLDIFQRLNIMIDVASALEYLNFRHTTP--IIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                      ....++||||++ |+|.+++..  ....+++..+..++.|+++||.||   |+.+  |+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM---HRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCEEEccCCcccEEECCCCCEEEec
Confidence            345789999996 688888754  334689999999999999999999   6677  99999999999999999999999


Q ss_pred             ecCceecCCCCCcc----------ccccccccccccCcccc---CCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh
Q 046240          619 FGIAKLLSGEDQSM----------TQTQTLATIGYMAPEYG---IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL  685 (763)
Q Consensus       619 fgla~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~  685 (763)
                      ||+++.........          ......+|+.|+|||++   .+..++.++|||||||++|||++|+.||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99998765322211          11234589999999988   56778999999999999999999999997532211 


Q ss_pred             hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          686 SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       686 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                                      ++.......+...      ....+.+++..||+.+|++||++.|+++.|+++...
T Consensus       261 ----------------~~~~~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          261 ----------------IVNGKYSIPPHDT------QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ---------------------CCCCTTCC------SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------hhcCcccCCcccc------cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                            1111111111111      123478999999999999999999999999877654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.2e-37  Score=349.66  Aligned_cols=251  Identities=22%  Similarity=0.287  Sum_probs=200.6

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH-------------HHHHHHHHHHHHHHhCCCCccceEEe
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-------------RAMKSFEVECEVMKNIRHRNLVKIIS  538 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~  538 (763)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999765 688999999875421             22467889999999999999999999


Q ss_pred             eeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC---cEE
Q 046240          539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM---IAH  615 (763)
Q Consensus       539 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~---~~k  615 (763)
                      ++......++||||+++|+|.+++.... .+++..+..++.|++.||.||   |+.+|+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999998886643 589999999999999999999   778999999999999998775   699


Q ss_pred             EeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccC
Q 046240          616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLL  695 (763)
Q Consensus       616 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  695 (763)
                      |+|||+++.+....   ......||+.|+|||++. +.++.++||||+||++|||++|..||........          
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------  255 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI----------  255 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----------
Confidence            99999998875332   233457999999999876 4689999999999999999999999976432211          


Q ss_pred             ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       696 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                             +.....................+.+++..|++.||++|||++|+++
T Consensus       256 -------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          256 -------IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             -------HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                   1111111111111111223556899999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.7e-37  Score=319.79  Aligned_cols=246  Identities=25%  Similarity=0.382  Sum_probs=195.1

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            67999999999999999999775 789999999976532   23457889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++++|.+++.... .+++.....++.|+++||.||   |+.+++||||||+||+++.++.+||+|||++....... 
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             eccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-
Confidence            9999999999987643 588999999999999999999   67899999999999999999999999999998764322 


Q ss_pred             ccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.......              ..+.+......
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~  229 (276)
T 2h6d_A          166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--------------LFKKIRGGVFY  229 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------HHHHHHHCCCC
T ss_pred             --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------------HHHHhhcCccc
Confidence              2234568999999999887765 689999999999999999999997632211              11111111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+.       .+...+.+++.+|++.||++||++.++++
T Consensus       230 ~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          230 IPE-------YLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cch-------hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            111       12345889999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-37  Score=350.17  Aligned_cols=251  Identities=23%  Similarity=0.312  Sum_probs=198.0

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ..++|.+.+.||+|+||+||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++......++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3568999999999999999999765 78899999997543  22356788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~  626 (763)
                      |||+++|+|.+.+.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++.   ++.+||+|||+++.+.
T Consensus       115 ~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            99999999988886543 588999999999999999999   7789999999999999976   4559999999998875


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...   ......||+.|+|||++. ..++.++||||+||++|||++|..||........ .            ..+....
T Consensus       191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~------------~~i~~~~  253 (494)
T 3lij_A          191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-L------------RKVEKGK  253 (494)
T ss_dssp             TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHTC
T ss_pred             CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-H------------HHHHhCC
Confidence            332   234467999999999876 5699999999999999999999999976432211 1            1111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ... +...   .......+.+++..|++.+|++|||+.++++
T Consensus       254 ~~~-~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          254 YTF-DSPE---WKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCC-CSGG---GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC-Cchh---cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            111 1100   0112456889999999999999999999984

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.1e-37  Score=323.11  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=197.6

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH----HHHHHHHHHHHHHHhCCCCccceEEeeee--cCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA----RAMKSFEVECEVMKNIRHRNLVKIISGCS--NDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~  545 (763)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.....    ...+.+.+|++++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3478999999999999999999764 688999999976532    24567899999999999999999999984  4568


Q ss_pred             eEEEEEccCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          546 KALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      .++||||++++ +.+++.. ....+++..+..++.|+++||.||   |+++|+||||||+||+++.++.+||+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999987 5555543 344689999999999999999999   778999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERK--VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      ..............|+..|+|||++.+..  ++.++||||||+++|||++|+.||.......              ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~  224 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--------------LFEN  224 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------------HHHH
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--------------HHHH
Confidence            65433333334567899999999987643  4789999999999999999999997632211              1111


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.+.....+.       .+...+.+++.+|++.||++||+++++++
T Consensus       225 i~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          225 IGKGSYAIPG-------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHCCCCCCS-------SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HhcCCCCCCC-------ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111111111       12456889999999999999999999996

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.8e-37  Score=323.20  Aligned_cols=247  Identities=24%  Similarity=0.357  Sum_probs=196.7

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeec----CCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSN----DDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  547 (763)
                      +.|.+.+.||+|+||.||+|.. .++..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4577888999999999999966 468899999987542  3456778999999999999999999998864    45689


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEec-CCCcEEEeeecCcee
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP--IIHCDLKSSNVLLD-EDMIAHLSDFGIAKL  624 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~  624 (763)
                      +||||+++++|.+++.... .+++..+..++.|+++||.||   |+.+  |+||||||+||+++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHH---HcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999997643 588999999999999999999   6666  99999999999997 789999999999976


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ....    ......|++.|+|||++. +.++.++|||||||++|||++|+.||..................+        
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  248 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------  248 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--------
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--------
Confidence            4322    223456899999999876 458999999999999999999999997633222111111111000        


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                             .   .........+.+++..||+.+|++|||+.++++
T Consensus       249 -------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 -------A---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------G---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------c---ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   0   001112346889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=327.15  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=196.8

Q ss_pred             ccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      +|.....||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            344556899999999999975 5788999999976655556778999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-CCcEEEeeecCceecCCCCCc
Q 046240          555 NGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       555 ~g~L~~~l~~~~~--~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      +++|.+++.....  ..++..+..++.|+++||.||   |+.+|+||||||+||+++. ++.+||+|||.++....... 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999976532  456888899999999999999   6789999999999999987 89999999999987643221 


Q ss_pred             cccccccccccccCccccCCCC--CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          632 MTQTQTLATIGYMAPEYGIERK--VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                       ......|++.|+|||++.+..  ++.++||||||+++|||++|+.||............            .  .....
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------~--~~~~~  243 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK------------V--GMFKV  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH------------H--HHHCC
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh------------h--ccccc
Confidence             223456899999999987543  789999999999999999999999753222111000            0  00111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .+...    ..+...+.+++..||+.||++||++.++++
T Consensus       244 ~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 HPEIP----ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11110    112456889999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7e-38  Score=352.25  Aligned_cols=251  Identities=24%  Similarity=0.323  Sum_probs=203.5

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ..++|.+.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4578999999999999999999765 78999999986542   2345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe---cCCCcEEEeeecCceec
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL---DEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~  625 (763)
                      ||||+.+|+|.+++.... .+++..+..++.|+++||.||   |+++|+||||||+||++   +.++.+||+|||+++.+
T Consensus       104 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999999887654 588999999999999999999   77899999999999999   56789999999999876


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ....   ......||+.|+|||++.+ .++.++||||+||++|||++|..||........ ..            .+...
T Consensus       180 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~------------~i~~~  242 (484)
T 3nyv_A          180 EASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-LK------------KVEKG  242 (484)
T ss_dssp             CCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HH------------HHHHC
T ss_pred             cccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-HH------------HHHcC
Confidence            5332   2234569999999998865 689999999999999999999999976432211 11            11111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .... +.   .........+.+++.+|++.+|++|||+.++++
T Consensus       243 ~~~~-~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          243 KYTF-EL---PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCC-CS---GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCC-CC---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            1110 00   011123456889999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-37  Score=359.31  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=199.6

Q ss_pred             ceecccCCceEEEEEec---CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD---DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||+||+|.+.   .++.||||+++....  ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   467899999976532  345789999999999999999999999965 458899999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC-cccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ-SMTQ  634 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~  634 (763)
                      |+|.+++.... .+++..+..++.||++||+||   |+++|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997643 589999999999999999999   678999999999999999999999999999987653332 1222


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......              ..+.+.+......  
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------------~~~~i~~~~~~~~--  593 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERMGC--  593 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------HHHHHHTTCCCCC--
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcCCCCCC--
Confidence            33456789999999999999999999999999999999 999997643322              1112221111100  


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                          ...+..++.+++..||+.||++||++.+|++.|++.+.+
T Consensus       594 ----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          594 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                112456789999999999999999999999999987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-37  Score=332.34  Aligned_cols=269  Identities=23%  Similarity=0.261  Sum_probs=192.9

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ..++|.+.+.||+|+||+||+|.. .+++.||||++....  ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            357899999999999999999965 478999999996443  22345677899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe-----cCCCcEEEeeecCcee
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL-----DEDMIAHLSDFGIAKL  624 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll-----~~~~~~kl~Dfgla~~  624 (763)
                      |||+++ +|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||++     +.++.+||+|||+++.
T Consensus       112 ~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            999985 8988887654 588999999999999999999   77899999999999999     4555699999999987


Q ss_pred             cCCCCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc-ccCCh-hHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN-GLLPV-SLME  701 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~-~~~~  701 (763)
                      +.....  ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||............... +..+. ....
T Consensus       187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          187 FGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            642221  23345689999999998764 5899999999999999999999999764332211111000 00000 0000


Q ss_pred             HHH-----hhcCCCccc--cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VVN-----KTLLSPPEK--DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i~-----~~l~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...     .........  ..........++.+++.+|++.||++|||++|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000     000000000  00011113456889999999999999999999976

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3e-37  Score=324.32  Aligned_cols=251  Identities=21%  Similarity=0.286  Sum_probs=202.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---------HHHHHHHHHHHHHHHhCC-CCccceEEeeeec
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---------ARAMKSFEVECEVMKNIR-HRNLVKIISGCSN  542 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  542 (763)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....         ....+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            478999999999999999999765 68999999986432         233567789999999995 9999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      .+..++||||+++++|.+++.... .+++..+..++.|+++||.||   |+.+++||||||+||+++.++.+||+|||.+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence            999999999999999999997643 588999999999999999999   7789999999999999999999999999999


Q ss_pred             eecCCCCCccccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGI------ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      ..+....   ......+++.|+|||++.      ...++.++||||||+++|||++|..||........           
T Consensus       172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----------  237 (298)
T 1phk_A          172 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-----------  237 (298)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------
T ss_pred             hhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-----------
Confidence            8765332   223456899999999874      45788999999999999999999999976332111           


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ...+....... +...   ...+...+.+++..|++.||++||++.++++
T Consensus       238 --~~~~~~~~~~~-~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          238 --LRMIMSGNYQF-GSPE---WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHHHTCCCC-CTTT---GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHhcCCccc-Cccc---ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              01111111111 1110   1123556899999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.8e-38  Score=325.07  Aligned_cols=253  Identities=22%  Similarity=0.267  Sum_probs=200.6

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeee--cCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCS--NDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  548 (763)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999765 7899999999754  2345677899999999999999999999874  4568899


Q ss_pred             EEEccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeCCCCCCCEEecCCCcEEEeeec
Q 046240          549 VLEYMPNGSLDIFLYSS---TCMLDIFQRLNIMIDVASALEYLNFRHTTP-----IIHCDLKSSNVLLDEDMIAHLSDFG  620 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~-----ivH~dlk~~NIll~~~~~~kl~Dfg  620 (763)
                      ||||+++++|.+++...   ...+++..+..++.|+++||+||   |+.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC---HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH---hcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998753   23589999999999999999999   4555     9999999999999999999999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHH
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM  700 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  700 (763)
                      .++.......  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .            .
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~------------~  226 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-A------------G  226 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------H
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-H------------H
Confidence            9987643221  12335689999999999988999999999999999999999999976432211 0            1


Q ss_pred             HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHh
Q 046240          701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLC  751 (763)
Q Consensus       701 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~  751 (763)
                      .+........+.       .+...+.+++.+||+.+|++||++.++++.+.
T Consensus       227 ~i~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          227 KIREGKFRRIPY-------RYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHHHTCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             HHhhcccccCCc-------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            111111111111       12456889999999999999999999998543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-37  Score=324.22  Aligned_cols=250  Identities=23%  Similarity=0.252  Sum_probs=185.9

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|++....  ....+.+..+...++.++||||+++++++..++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46899999999999999999976 578999999997542  222333445555677789999999999999999999999


Q ss_pred             EccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          551 EYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       551 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ||+++ +|.+++..   ....+++..+..++.|+++||+||   |++ +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99985 77776643   345789999999999999999999   666 99999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCcccc----CCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYG----IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      ...   ......||+.|+|||++    .+..++.++|||||||++|||++|+.||...........            ..
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------~~  226 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK------------QV  226 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH------------HH
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH------------HH
Confidence            322   22334689999999995    567789999999999999999999999975322221111            11


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.......+..      .+...+.+++..|++.+|++|||+.|+++
T Consensus       227 ~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          227 VEEPSPQLPAD------KFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHSCCCCCCTT------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hccCCCCcccc------cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            22111111111      12456889999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.3e-37  Score=332.70  Aligned_cols=269  Identities=20%  Similarity=0.203  Sum_probs=201.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecC-----Cce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSND-----DFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  546 (763)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999654 78899999997432 34457788999999999999999999998654     368


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++ +|.+++...  .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            999999975 898888764  488999999999999999999   77899999999999999999999999999998764


Q ss_pred             CCCCc-cccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCC------
Q 046240          627 GEDQS-MTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLP------  696 (763)
Q Consensus       627 ~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~------  696 (763)
                      ..... .......||+.|+|||++. +..++.++|||||||++|||++|+.||.........  ..........      
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            32221 1224457999999999865 455899999999999999999999999764322211  1111111110      


Q ss_pred             --hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 --VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 --~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        ............................+.+++.+|++.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0111111111111110000011123456889999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.6e-37  Score=332.45  Aligned_cols=264  Identities=22%  Similarity=0.284  Sum_probs=204.8

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHH-----------------HHHHHHHHHHHHhCCCCccceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARA-----------------MKSFEVECEVMKNIRHRNLVKI  536 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l  536 (763)
                      .++|.+.+.||+|+||.||+|.. +|+.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999988 89999999998654321                 1788999999999999999999


Q ss_pred             EeeeecCCceEEEEEccCCCChhhh------hccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEeCCCCCCCEEe
Q 046240          537 ISGCSNDDFKALVLEYMPNGSLDIF------LYSS-TCMLDIFQRLNIMIDVASALEYLNFRHT-TPIIHCDLKSSNVLL  608 (763)
Q Consensus       537 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~dlk~~NIll  608 (763)
                      ++++...+..++||||+++++|.++      +... ...+++..+..++.|+++||.||   |+ .+|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 44789999999999999999999   65 899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCC-CCCc-chhHHHHHHHHHHHHcCCCCCchhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVST-RSDIYSYGIMLIETFTRKKPADKMFAAELS  686 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~slGv~l~elltg~~p~~~~~~~~~~  686 (763)
                      +.++.+||+|||.+......    ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||.........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999876432    23446789999999998877 6666 999999999999999999999764331111


Q ss_pred             hhhhhcccC--ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          687 LKHWVNGLL--PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       687 ~~~~~~~~~--~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .........  +......... ..  ..........+...+.+++..|++.||++||++.|+++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYP-LT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTT-TC--C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhccCcCCccchhhhhcc-cc--ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111111111  1000000000 00  00000011223567899999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-38  Score=346.84  Aligned_cols=240  Identities=16%  Similarity=0.155  Sum_probs=186.7

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh---hHHHHHHHHHHHH---HHHhCCCCccceEE-------ee
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE---CARAMKSFEVECE---VMKNIRHRNLVKII-------SG  539 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~niv~l~-------~~  539 (763)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|++   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788999999999999999976 56899999998733   2334577889994   55555899999998       55


Q ss_pred             eecCC-----------------ceEEEEEccCCCChhhhhccCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046240          540 CSNDD-----------------FKALVLEYMPNGSLDIFLYSSTC------MLDIFQRLNIMIDVASALEYLNFRHTTPI  596 (763)
Q Consensus       540 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~ia~~L~~Lh~~h~~~i  596 (763)
                      +...+                 ..++||||+ +|+|.+++...+.      .+++..+..++.|+++||+||   |+.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH---HhCCe
Confidence            55443                 378999999 6799999875322      233578888999999999999   77899


Q ss_pred             EeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCC-----------CCCcchhHHHHHH
Q 046240          597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-----------KVSTRSDIYSYGI  665 (763)
Q Consensus       597 vH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slGv  665 (763)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986431     2234567 999999998877           8999999999999


Q ss_pred             HHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHH
Q 046240          666 MLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKC  745 (763)
Q Consensus       666 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  745 (763)
                      ++|||++|+.||........ ...                .....+        .+...+.+++.+||+.||++||++.+
T Consensus       302 il~elltg~~Pf~~~~~~~~-~~~----------------~~~~~~--------~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG-SEW----------------IFRSCK--------NIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHSSCCC------CC-SGG----------------GGSSCC--------CCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHCCCCCcccccccc-hhh----------------hhhhcc--------CCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            99999999999976332111 000                000001        12346889999999999999999999


Q ss_pred             HHH
Q 046240          746 CNF  748 (763)
Q Consensus       746 v~~  748 (763)
                      +++
T Consensus       357 ~l~  359 (377)
T 3byv_A          357 AME  359 (377)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-38  Score=337.26  Aligned_cols=253  Identities=25%  Similarity=0.321  Sum_probs=199.2

Q ss_pred             HhccCcCceecccCCceEEEEEe----cCCceEEEEEeehhh----HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDD  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  544 (763)
                      .++|.+.+.||+|+||.||+|..    .+++.||||+++...    ....+.+.+|+++++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999976    368999999986432    12334567799999999 6999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..++||||+++|+|.+++.... .+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999997644 588999999999999999999   678999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      +..... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......             ...++
T Consensus       209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------------~~~~~  274 (355)
T 1vzo_A          209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-------------SQAEI  274 (355)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-------------CHHHH
T ss_pred             cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-------------hHHHH
Confidence            642221 22334579999999999875  457899999999999999999999997532111             11111


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      ........+...    ..+...+.+++.+||..||++||     +++++++
T Consensus       275 ~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          275 SRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             HHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            111111111111    11245678999999999999999     8888875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.6e-37  Score=326.21  Aligned_cols=268  Identities=20%  Similarity=0.261  Sum_probs=195.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeee-----------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS-----------  541 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  541 (763)
                      .++|...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            368999999999999999999775 58999999997665566778899999999999999999999873           


Q ss_pred             ---cCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec-CCCcEEEe
Q 046240          542 ---NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLS  617 (763)
Q Consensus       542 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~-~~~~~kl~  617 (763)
                         +....++||||++ |+|.+++...  .++......++.|+++||+||   |+.+|+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYI---HSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               4467899999998 5999988653  488999999999999999999   778999999999999997 56799999


Q ss_pred             eecCceecCCCCC-ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcc--
Q 046240          618 DFGIAKLLSGEDQ-SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG--  693 (763)
Q Consensus       618 Dfgla~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~--  693 (763)
                      |||+++....... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .......  
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~  242 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIP  242 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence            9999987643211 112234567999999998765 7789999999999999999999999976433221 1111111  


Q ss_pred             cCCh-hHHHHH-------HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 LLPV-SLMEVV-------NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 ~~~~-~~~~~i-------~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .... ...++.       .................+...+.+++.+|++.||++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0111 111111       111111111000111123567899999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.7e-38  Score=331.24  Aligned_cols=261  Identities=27%  Similarity=0.325  Sum_probs=185.0

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            578999999999999999999754 68899999986543 2345678889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          552 YMPNGSLDIFLYS-------STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       552 ~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      |+++++|.+++..       ....+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||.+..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            9999999999864       234689999999999999999999   678999999999999999999999999999877


Q ss_pred             cCCCCC---ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHH
Q 046240          625 LSGEDQ---SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM  700 (763)
Q Consensus       625 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  700 (763)
                      ......   ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||............ .....+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~  249 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-LQNDPPSLET  249 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-HTSSCCCTTC
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-hccCCCcccc
Confidence            643221   112234568999999998865 56899999999999999999999999764322211111 1111110000


Q ss_pred             HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...+....          ..+...+.+++..||+.||++||++.++++
T Consensus       250 ~~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          250 GVQDKEML----------KKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -----CCC----------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccchhh----------hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000000          012346889999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.3e-37  Score=332.73  Aligned_cols=264  Identities=22%  Similarity=0.193  Sum_probs=193.4

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  544 (763)
                      .++|...+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999654 6899999999753  2344567889999999999999999999997654      


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..++||||+++ +|.+++..   .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            68999999975 67777753   478899999999999999999   778999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc----------
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL----------  694 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~----------  694 (763)
                      .....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.......          
T Consensus       177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTT
T ss_pred             ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHH
Confidence            54221   22345789999999999999999999999999999999999999976433221 11111110          


Q ss_pred             CChhHHHHHHhhcCCCc------------cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          695 LPVSLMEVVNKTLLSPP------------EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ........+...-....            .............+.+++.+|+..||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            01111111111000000            0001112234667899999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.6e-37  Score=328.65  Aligned_cols=252  Identities=23%  Similarity=0.254  Sum_probs=196.7

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--------HHHHHHHHHHHHHHHhCCCCccceEEeeeecC
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--------ARAMKSFEVECEVMKNIRHRNLVKIISGCSND  543 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  543 (763)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999764 68899999986432        11234578999999999999999999999766


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc---EEEeeec
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI---AHLSDFG  620 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~---~kl~Dfg  620 (763)
                      + .++||||+++++|.+++.... .+++.....++.|+++||.||   |+.+|+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 899999999999999887543 688999999999999999999   6789999999999999987654   9999999


Q ss_pred             CceecCCCCCccccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV  697 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  697 (763)
                      +++......   ......||+.|+|||++.   ...++.++|||||||++|||++|..||........            
T Consensus       163 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------  227 (322)
T 2ycf_A          163 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------------  227 (322)
T ss_dssp             TCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------------
T ss_pred             cceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------------
Confidence            998764221   223456899999999863   56789999999999999999999999976322111            


Q ss_pred             hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ..+.+......   ............+.+++.+|++.||++||++.++++
T Consensus       228 -~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 -LKDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -HHHHHHHTCCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHhCccc---cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             11111111100   011111223567899999999999999999999984

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.9e-37  Score=330.99  Aligned_cols=268  Identities=24%  Similarity=0.256  Sum_probs=201.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecC-----Cce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSND-----DFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  546 (763)
                      .++|.+.+.||+|+||.||+|... +|+.||||++... .......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999765 6899999998643 233456778999999999999999999988654     678


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||++ ++|.+++...  .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5898888764  489999999999999999999   67899999999999999999999999999998764


Q ss_pred             CCCCcc--------ccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhh--hhhhcc--
Q 046240          627 GEDQSM--------TQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL--KHWVNG--  693 (763)
Q Consensus       627 ~~~~~~--------~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~--~~~~~~--  693 (763)
                      ......        ......||+.|+|||++. +..++.++|||||||++|||++|+.||..........  ......  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            322111        122346899999999865 4778999999999999999999999997643222111  010000  


Q ss_pred             -------cCChhHHHHHHhhcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 -------LLPVSLMEVVNKTLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 -------~~~~~~~~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                             .......+.+..... .+.... .....+...+.+++.+|++.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPM-YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccccchhhHHhhcccC-CCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   001122222222111 111111 111233567889999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.5e-37  Score=323.56  Aligned_cols=253  Identities=23%  Similarity=0.282  Sum_probs=193.0

Q ss_pred             HHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec---------
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN---------  542 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  542 (763)
                      ..++|+..+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            467899999999999999999976 47899999999654 2345778899999999999999999998854         


Q ss_pred             ----CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEee
Q 046240          543 ----DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSD  618 (763)
Q Consensus       543 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~D  618 (763)
                          .+..++||||+++++|.+++......++......++.|+++||+||   |+.+|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI---HSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHH---HhCCeecccCCHHhEEEcCCCCEEEee
Confidence                3567899999999999999987666678889999999999999999   678999999999999999999999999


Q ss_pred             ecCceecCCCCC------------ccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh
Q 046240          619 FGIAKLLSGEDQ------------SMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL  685 (763)
Q Consensus       619 fgla~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~  685 (763)
                      ||+++.......            ........|++.|+|||++.+. .++.++|||||||++|||++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            999987642210            1122345689999999998754 78999999999999999998   5543221111


Q ss_pred             hhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          686 SLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       686 ~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .....             .......+..   ........+.+++..|++.||++|||+.++++
T Consensus       237 ~~~~~-------------~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 ILKKL-------------RSVSIEFPPD---FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHH-------------HSTTCCCCTT---CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhc-------------cccccccCcc---ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            11111             1000000110   01122455789999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.1e-38  Score=332.11  Aligned_cols=259  Identities=21%  Similarity=0.302  Sum_probs=198.6

Q ss_pred             ChHHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCC--CCccceEEeeee
Q 046240          466 PYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIR--HRNLVKIISGCS  541 (763)
Q Consensus       466 ~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~  541 (763)
                      .++.+....++|.+.+.||+|+||.||++...+++.||||++...  .....+.+.+|++++++++  ||||+++++++.
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            333444456789999999999999999998888999999998643  2345677899999999997  599999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          542 NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       542 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                      ..+..++||| +.+++|.+++.... .+++..+..++.|+++||.||   |+.+|+||||||+||++++ +.+||+|||+
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEEEC-CeEEEeeccc
Confidence            9999999999 56889999997654 688999999999999999999   7789999999999999975 7999999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCC-----------CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIE-----------RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW  690 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~  690 (763)
                      ++.+.............|++.|+|||.+.+           ..++.++|||||||++|||++|+.||..........   
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---  249 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---  249 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH---
Confidence            987654333323345578999999998765           478889999999999999999999997632221111   


Q ss_pred             hcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          691 VNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       691 ~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                               ..+++.........      .....+.+++..||+.||++||++.|+++
T Consensus       250 ---------~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          250 ---------HAIIDPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ---------HHHHCTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HHHHhcccccCCcc------cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                     11111111111011      11346889999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.9e-37  Score=356.30  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=207.5

Q ss_pred             HHHhccCcCceecccCCceEEEEEec----CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD----DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      ...++|.+.+.||+|+||.||+|...    .+..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence            34578999999999999999999764    2467999998754 23445778999999999999999999999854 568


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecC
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS  626 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~  626 (763)
                      ++||||+++|+|.+++......+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++...
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            999999999999999987666789999999999999999999   67899999999999999999999999999998764


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .... .......+++.|+|||++.+..++.++|||||||++|||++ |..||........             ...+...
T Consensus       543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-------------~~~i~~~  608 (656)
T 2j0j_A          543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------------IGRIENG  608 (656)
T ss_dssp             C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------------HHHHHHT
T ss_pred             CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-------------HHHHHcC
Confidence            3322 22233456789999999988899999999999999999997 9999976432211             0111111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .....+       ..+...+.+++..||+.||++||++.++++.|+++++.+
T Consensus       609 ~~~~~~-------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          609 ERLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCC-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            100111       123456889999999999999999999999999887653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.3e-37  Score=355.14  Aligned_cols=243  Identities=22%  Similarity=0.291  Sum_probs=200.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|.+.+.||+|+||.||+|... +++.||||+++...   ....+.+..|..++..+ +||+|+++++++...+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            468999999999999999999765 68899999998653   22356678899999987 79999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|+|..++...+ .+++..+..++.||+.||+||   |+++|+||||||+|||++.++.+||+|||+++.....
T Consensus       420 V~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            999999999999997654 589999999999999999999   7789999999999999999999999999999864322


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.             ...++.....
T Consensus       496 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-------------~~~i~~~~~~  560 (674)
T 3pfq_A          496 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------------FQSIMEHNVA  560 (674)
T ss_dssp             TC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHSSCCC
T ss_pred             Cc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-------------HHHHHhCCCC
Confidence            22  33456799999999999999999999999999999999999999976432211             1111111111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINA  743 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~  743 (763)
                      . |.       ....++.+++..|++.||++||++
T Consensus       561 ~-p~-------~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          561 Y-PK-------SMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             C-CT-------TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             C-Cc-------cCCHHHHHHHHHHccCCHHHCCCC
Confidence            1 11       124568899999999999999997

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-37  Score=335.79  Aligned_cols=266  Identities=22%  Similarity=0.285  Sum_probs=194.8

Q ss_pred             HHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec-------
Q 046240          471 SRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN-------  542 (763)
Q Consensus       471 ~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  542 (763)
                      ....++|.+.+.||+|+||+||+|.. .+|+.||||++....    ....+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999965 579999999986542    223469999999999999999999843       


Q ss_pred             -------------------------------CCceEEEEEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHH
Q 046240          543 -------------------------------DDFKALVLEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYL  588 (763)
Q Consensus       543 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~L  588 (763)
                                                     ....++||||+++ +|.+.+..   ....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           2347899999985 77666653   344689999999999999999999


Q ss_pred             HhcCCCCeEeCCCCCCCEEec-CCCcEEEeeecCceecCCCCCccccccccccccccCccccCCC-CCCcchhHHHHHHH
Q 046240          589 NFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIM  666 (763)
Q Consensus       589 h~~h~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~  666 (763)
                         |+.+|+||||||+||+++ .++.+||+|||+++.+....   ......+|+.|+|||++.+. .++.++||||+||+
T Consensus       158 ---H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 ---HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             ---HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             ---HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence               789999999999999998 68899999999998764332   22345689999999988764 58999999999999


Q ss_pred             HHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH--hhcCC--Cc---ccc--HHHHHHHHHHHHHHHHHccccCc
Q 046240          667 LIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN--KTLLS--PP---EKD--FAAKEQCVLSIFSLAMECTMELP  737 (763)
Q Consensus       667 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~--~~l~~--~~---~~~--~~~~~~~~~~l~~l~~~cl~~~P  737 (763)
                      +|||++|+.||........ +...+.....+...++..  .....  .+   ...  ..........+.+++.+|++.+|
T Consensus       232 l~ell~g~~pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            9999999999986433221 111111101111111111  00000  00   000  00111234568999999999999


Q ss_pred             CCCCCHHHHHH
Q 046240          738 EKRINAKCCNF  748 (763)
Q Consensus       738 ~~Rps~~~v~~  748 (763)
                      ++|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999984

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.3e-37  Score=330.78  Aligned_cols=262  Identities=22%  Similarity=0.262  Sum_probs=198.4

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce----
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK----  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  546 (763)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46899999999999999999965 47899999999754  233457788999999999999999999999877655    


Q ss_pred             --EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          547 --ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       547 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                        ++||||++ ++|.+++..   .+++..+..++.|+++||+||   |+.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 578777743   488999999999999999999   778999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhh--hh--------hcc
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLK--HW--------VNG  693 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~--~~--------~~~  693 (763)
                      ....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...........  ..        ...
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            5322     234568999999998876 7889999999999999999999999976432221111  10        011


Q ss_pred             cCChhHHHHHHhhcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .........+. .+...+..... ....+...+.+++..|++.||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          269 LNDKAAKSYIQ-SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CSCHHHHHHHH-HSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhh-ccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            01111122222 22222222111 11123567899999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.2e-38  Score=340.24  Aligned_cols=254  Identities=9%  Similarity=0.058  Sum_probs=180.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhC--CCCccceEE-------eee
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNI--RHRNLVKII-------SGC  540 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~  540 (763)
                      ..+|...+.||+|+||+||+|... +|+.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346889999999999999999764 78999999998642   23456677785555444  699988865       333


Q ss_pred             ecC-----------------CceEEEEEccCCCChhhhhccCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeE
Q 046240          541 SND-----------------DFKALVLEYMPNGSLDIFLYSSTCMLDIFQR------LNIMIDVASALEYLNFRHTTPII  597 (763)
Q Consensus       541 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~ia~~L~~Lh~~h~~~iv  597 (763)
                      ...                 ...++||||++ |+|.+++...+..+++..+      ..++.|+++||+||   |+++|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L---H~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL---QSKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH---HHTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH---HHCCCc
Confidence            322                 33799999999 8999999864434455556      78889999999999   778999


Q ss_pred             eCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCC
Q 046240          598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKK  675 (763)
Q Consensus       598 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~  675 (763)
                      ||||||+|||++.++.+||+|||+++.....     .....+++.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999876321     113456799999999987  789999999999999999999999


Q ss_pred             CCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          676 PADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       676 p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ||.........  .+......          ..............+...+.+++.+||+.||++||++.++++
T Consensus       292 Pf~~~~~~~~~--~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKG--SWKRPSLR----------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTT--CCCBCCTT----------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCccccc--chhhhhhh----------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99764322110  00000000          000000000000123456889999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.4e-37  Score=336.15  Aligned_cols=258  Identities=24%  Similarity=0.265  Sum_probs=197.7

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC--------CCccceEEeeee---
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIR--------HRNLVKIISGCS---  541 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~---  541 (763)
                      .++|.+.+.||+|+||+||+|.. .+++.||||++.... ...+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46899999999999999999965 568899999997542 34567788999999985        788999999987   


Q ss_pred             -cCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEecCCC-------
Q 046240          542 -NDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLDEDM-------  612 (763)
Q Consensus       542 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~dlk~~NIll~~~~-------  612 (763)
                       .....++||||+.++.+..+.......+++..+..++.|+++||+||   |++ +|+||||||+|||++.++       
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence             56689999999955555555444445689999999999999999999   666 999999999999999775       


Q ss_pred             ------------------------------------------cEEEeeecCceecCCCCCccccccccccccccCccccC
Q 046240          613 ------------------------------------------IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI  650 (763)
Q Consensus       613 ------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~  650 (763)
                                                                .+||+|||.++.....     .....||+.|+|||++.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc
Confidence                                                      7999999999876422     23457899999999999


Q ss_pred             CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhh-----hhhhhhh--hcccCChhH------------------------
Q 046240          651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA-----ELSLKHW--VNGLLPVSL------------------------  699 (763)
Q Consensus       651 ~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-----~~~~~~~--~~~~~~~~~------------------------  699 (763)
                      +..++.++|||||||++|||++|+.||......     .......  ..+..+...                        
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            999999999999999999999999999753211     0011100  011111110                        


Q ss_pred             ----HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 ----MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 ----~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                          .+.+....        .........+.+++.+||+.||++|||++|+++
T Consensus       347 ~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          347 PWGLFEVLVEKY--------EWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCHHHHHHHTS--------CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CcchhHhhhhhc--------ccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                01110000        011234667899999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.8e-37  Score=318.95  Aligned_cols=251  Identities=23%  Similarity=0.300  Sum_probs=201.2

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4578999999999999999999765 789999999975432  2456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC---CcEEEeeecCceecC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED---MIAHLSDFGIAKLLS  626 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~  626 (763)
                      +||+++++|.+++.... .+++..+..++.|+++||.||   |+.+++||||||+||+++.+   +.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999988886543 588999999999999999999   77899999999999999754   479999999998764


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          627 GEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       627 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ...   ......+++.|+|||.+.+ .++.++||||||+++|||++|..||........ ...            +....
T Consensus       176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~------------~~~~~  238 (287)
T 2wei_A          176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKR------------VETGK  238 (287)
T ss_dssp             CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------HHHCC
T ss_pred             CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHH------------HHcCC
Confidence            322   1233458999999998765 489999999999999999999999976432211 111            11111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....    ......+...+.+++..|++.+|++|||+.++++
T Consensus       239 ~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          239 YAFD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCC----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCC----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            1000    0011123456889999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8e-37  Score=337.30  Aligned_cols=198  Identities=23%  Similarity=0.288  Sum_probs=170.6

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhC------CCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNI------RHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~  546 (763)
                      ..+|++.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            467999999999999999999654 68999999997543 3345667788888877      577999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc--EEEeeecCce
Q 046240          547 ALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI--AHLSDFGIAK  623 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~  623 (763)
                      ++||||+. ++|.+++.... ..+++..+..++.|+++||+||   |+.+|+||||||+|||++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 58888876643 3589999999999999999999   6779999999999999999887  9999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhh
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMF  681 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~  681 (763)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            65322     233578999999999999999999999999999999999999997643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=327.92  Aligned_cols=255  Identities=25%  Similarity=0.304  Sum_probs=196.1

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeec----
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSN----  542 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----  542 (763)
                      ++....++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..    
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3334568899999999999999999976 478999999987542 2346788999999999 79999999999976    


Q ss_pred             --CCceEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeee
Q 046240          543 --DDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       543 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                        .+..++||||+++++|.+++.... ..++......++.|++.||.||   |+.+|+||||||+||+++.++.+||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence              467899999999999999997643 3688999999999999999999   6789999999999999999999999999


Q ss_pred             cCceecCCCCCccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL  694 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~  694 (763)
                      |++.......  .......|++.|+|||++.     +..++.++|||||||++|||++|..||..........       
T Consensus       174 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------  244 (326)
T 2x7f_A          174 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------  244 (326)
T ss_dssp             TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------
T ss_pred             cCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-------
Confidence            9998764221  1223456899999999986     5678999999999999999999999997643221110       


Q ss_pred             CChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                            .+...........      .+...+.+++..||..||++||++.++++
T Consensus       245 ------~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          245 ------LIPRNPAPRLKSK------KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ------HHHHSCCCCCSCS------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ------HhhcCccccCCcc------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  0111000000000      12456889999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=330.09  Aligned_cols=260  Identities=22%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             HHhccCcCceecccCCceEEEEEecCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ..++|.+.+.||+|+||.||+|...+  .||+|+++...  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35789999999999999999998764  59999986432  223355678999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC-
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED-  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-  629 (763)
                      ||+++++|.+++...+..+++..+..++.|+++||+||   |+.+|+||||||+||+++ ++.+||+|||+++...... 
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            99999999999987766789999999999999999999   678999999999999998 6799999999987653211 


Q ss_pred             --CccccccccccccccCccccCC---------CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChh
Q 046240          630 --QSMTQTQTLATIGYMAPEYGIE---------RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS  698 (763)
Q Consensus       630 --~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  698 (763)
                        .........|++.|+|||++.+         ..++.++|||||||++|||++|+.||.......... .         
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~---------  254 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-Q---------  254 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-H---------
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H---------
Confidence              1122234568999999998764         457889999999999999999999997643222110 0         


Q ss_pred             HHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       699 ~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                          +..........     ..+...+.+++..||+.+|++||++.+++++|+++..+.
T Consensus       255 ----~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          255 ----MGTGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             ----HHTTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ----hccCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                11111000000     012345889999999999999999999999999887664

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=7.3e-36  Score=345.97  Aligned_cols=162  Identities=19%  Similarity=0.205  Sum_probs=110.1

Q ss_pred             cccceeecccccccCCCC-ccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccc-cCCcccCCCcC
Q 046240          233 SIFLLLDLELNKLTGPIP-VTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG-DIPATIGGLKD  310 (763)
Q Consensus       233 ~~L~~L~L~~N~l~~~~p-~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~  310 (763)
                      ++|+.|++++|++++..| ..+..+++  |++|++++|.+++..|.  .+.++++|++|++++|++++ .+|..|+.+++
T Consensus       399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  474 (606)
T 3vq2_A          399 EELQHLDFQHSTLKRVTEFSAFLSLEK--LLYLDISYTNTKIDFDG--IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN  474 (606)
T ss_dssp             TTCCEEECTTSEEESTTTTTTTTTCTT--CCEEECTTSCCEECCTT--TTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred             CCCCeeECCCCccCCccChhhhhcccc--CCEEECcCCCCCccchh--hhcCCCCCCEEECCCCcCCCcchHHhhccCCC
Confidence            333333333333333333 33444433  55555555555555555  56667777777777777776 36777777888


Q ss_pred             ccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCcc-ccccccccC
Q 046240          311 VQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFA-NFTAKSFMG  389 (763)
Q Consensus       311 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~l~~~~~~~  389 (763)
                      |+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+++..++....++ .+..+++.+
T Consensus       475 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~  554 (606)
T 3vq2_A          475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN  554 (606)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCS
T ss_pred             CCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccC
Confidence            8888888888887777778888888888888888888778888888888888888888885444434444 478888888


Q ss_pred             CCcccCCCC
Q 046240          390 NEKLCGLPH  398 (763)
Q Consensus       390 n~~~c~~p~  398 (763)
                      ||+.|+|+.
T Consensus       555 N~~~c~c~~  563 (606)
T 3vq2_A          555 NSVACICEH  563 (606)
T ss_dssp             CCCCCSSTT
T ss_pred             CCcccCCcc
Confidence            988888873

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4e-36  Score=321.68  Aligned_cols=264  Identities=20%  Similarity=0.271  Sum_probs=202.3

Q ss_pred             HhccCcCceecccCCceEEEEEe--cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCc------cceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL--DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN------LVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  545 (763)
                      .++|++.+.||+|+||+||+|..  .+++.||||++.... ...+.+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999976  368899999997542 34567788999999887654      9999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC--------------
Q 046240          546 KALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE--------------  610 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~--------------  610 (763)
                      .++||||+ +++|.+++.... ..+++..+..++.|+++||+||   |+++|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889988887654 3688999999999999999999   6789999999999999987              


Q ss_pred             -----CCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh
Q 046240          611 -----DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL  685 (763)
Q Consensus       611 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~  685 (763)
                           ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 668999999999875422     2345689999999999999999999999999999999999999976433221


Q ss_pred             -hhhhhhcccCChhHH-----------------------HHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC
Q 046240          686 -SLKHWVNGLLPVSLM-----------------------EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI  741 (763)
Q Consensus       686 -~~~~~~~~~~~~~~~-----------------------~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp  741 (763)
                       .......+..+....                       ..+......... .......+...+.+++.+|++.||++||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG-GCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhh-hcccchhhHHHHHHHHHHHhCcCccccc
Confidence             111111111221111                       111111110000 0001122356789999999999999999


Q ss_pred             CHHHHHH
Q 046240          742 NAKCCNF  748 (763)
Q Consensus       742 s~~~v~~  748 (763)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-36  Score=332.28  Aligned_cols=263  Identities=25%  Similarity=0.318  Sum_probs=194.2

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC------ceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------FKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  547 (763)
                      ..+|...+.||+|+||+||+|....+..||+|++.....    ...+|+++++.++||||+++++++...+      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357999999999999999999887777799998864321    2236999999999999999999985433      378


Q ss_pred             EEEEccCCCChhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec-CCCcEEEeeecCcee
Q 046240          548 LVLEYMPNGSLDIFLY--SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKL  624 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~  624 (763)
                      +||||++++.+.....  .....+++..+..++.|+++||+||   |+.+|+||||||+||+++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998865544432  1234688999999999999999999   778999999999999999 789999999999988


Q ss_pred             cCCCCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc--ccCCh-hHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN--GLLPV-SLM  700 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~--~~~~~-~~~  700 (763)
                      +....   ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.....  +..+. .+.
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence            64332   22345789999999988664 589999999999999999999999976433221 111111  11111 111


Q ss_pred             HHHHhhcCC--Cccc---cHH--HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          701 EVVNKTLLS--PPEK---DFA--AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       701 ~~i~~~l~~--~~~~---~~~--~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      . .......  .+..   ...  .......++.+++.+|++.||++|||+.|+++
T Consensus       268 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          268 T-MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             H-HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             h-hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            1 1111100  0000   000  00113457899999999999999999999985

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=339.83  Aligned_cols=307  Identities=20%  Similarity=0.176  Sum_probs=277.2

Q ss_pred             CCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccC
Q 046240           75 NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITN  154 (763)
Q Consensus        75 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~  154 (763)
                      ...++++|+|++|.+++..|..|.++++|++|+|++|.++       .+|...|.++++|++|+|++|++++..|..|.+
T Consensus        54 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~  126 (477)
T 2id5_A           54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-------LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD  126 (477)
T ss_dssp             TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-------SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred             CCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-------ccCcccccCCCCCCEEECCCCccccCChhHccc
Confidence            3568999999999999988999999999999999999996       889888889999999999999999999999999


Q ss_pred             CCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccc
Q 046240          155 ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSI  234 (763)
Q Consensus       155 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~  234 (763)
                      +++|++|+|++|+++++.+..|.++++|+.|+    +++|++++..+..+.++. +|++|+|++|++.+..+..|..+++
T Consensus       127 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~----l~~n~l~~~~~~~l~~l~-~L~~L~l~~n~i~~~~~~~~~~l~~  201 (477)
T 2id5_A          127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLT----LEKCNLTSIPTEALSHLH-GLIVLRLRHLNINAIRDYSFKRLYR  201 (477)
T ss_dssp             CTTCCEEEECCTTCCEECTTSSTTCTTCCEEE----EESCCCSSCCHHHHTTCT-TCCEEEEESCCCCEECTTCSCSCTT
T ss_pred             cccCCEEECCCCccceeChhhccCCCCCCEEE----CCCCcCcccChhHhcccC-CCcEEeCCCCcCcEeChhhcccCcc
Confidence            99999999999999999999999999999999    889999987777788888 9999999999999999999999999


Q ss_pred             cceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEE
Q 046240          235 FLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNI  314 (763)
Q Consensus       235 L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  314 (763)
                      |+.|++++|.+.+.+|.......+  |+.|+|++|++++..+.  .+..+++|+.|+|++|++++..+..|.++++|+.|
T Consensus       202 L~~L~l~~~~~~~~~~~~~~~~~~--L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  277 (477)
T 2id5_A          202 LKVLEISHWPYLDTMTPNCLYGLN--LTSLSITHCNLTAVPYL--AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEI  277 (477)
T ss_dssp             CCEEEEECCTTCCEECTTTTTTCC--CSEEEEESSCCCSCCHH--HHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEE
T ss_pred             cceeeCCCCccccccCcccccCcc--ccEEECcCCcccccCHH--HhcCccccCeeECCCCcCCccChhhccccccCCEE
Confidence            999999999988888877666654  99999999999944334  68899999999999999999889999999999999


Q ss_pred             EccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCccc
Q 046240          315 SLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLC  394 (763)
Q Consensus       315 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c  394 (763)
                      +|++|++++..|..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|++++..+....+.......+.++...|
T Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C  357 (477)
T 2id5_A          278 QLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTC  357 (477)
T ss_dssp             ECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBE
T ss_pred             ECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCcee
Confidence            99999999988999999999999999999999999999999999999999999999876533222233345667777888


Q ss_pred             CCC
Q 046240          395 GLP  397 (763)
Q Consensus       395 ~~p  397 (763)
                      ..|
T Consensus       358 ~~p  360 (477)
T 2id5_A          358 ATP  360 (477)
T ss_dssp             EES
T ss_pred             CCc
Confidence            766

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=324.97  Aligned_cols=262  Identities=22%  Similarity=0.266  Sum_probs=196.5

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc-----
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF-----  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  545 (763)
                      .++|...+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36789999999999999999976 478999999986532  3345678899999999999999999999987654     


Q ss_pred             -eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          546 -KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       546 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                       .++||||++ ++|.+++..   .+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588877743   488999999999999999999   678999999999999999999999999999986


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhh--------hhcc
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKH--------WVNG  693 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~--------~~~~  693 (763)
                      ....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.........  ...        +...
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5321     234568999999998876 67899999999999999999999999864322110  000        0011


Q ss_pred             cCChhHHHHHHhhcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .........+. .+...+.... .........+.+++.+|++.||++||++.++++
T Consensus       251 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          251 LNDKAAKSYIQ-SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CSCHHHHHHHH-TSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhHHHHHHHH-hCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            01111111221 1111111110 001123557899999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.1e-36  Score=327.19  Aligned_cols=201  Identities=25%  Similarity=0.319  Sum_probs=171.4

Q ss_pred             HHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CC-----ccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HR-----NLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~  545 (763)
                      ..++|.+.+.||+|+||+||+|... +++.||||++.... .....+.+|+.+++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999665 68899999997542 33456778888888874 44     49999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec--CCCcEEEeeecCc
Q 046240          546 KALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD--EDMIAHLSDFGIA  622 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla  622 (763)
                      .++||||+++ +|.+++.... ..+++..+..++.|++.||.|||. |+.+|+||||||+||+++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999999965 8988887653 468999999999999999999953 468999999999999995  4788999999999


Q ss_pred             eecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhh
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMF  681 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~  681 (763)
                      +.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            876422     234578999999999999999999999999999999999999998643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-36  Score=325.06  Aligned_cols=275  Identities=21%  Similarity=0.245  Sum_probs=189.2

Q ss_pred             HHHHHHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc-
Q 046240          468 QDLSRATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF-  545 (763)
Q Consensus       468 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-  545 (763)
                      .......++|.+.+.||+|+||.||+|... +|+.||||++.... .......++++.++.++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455667789999999999999999999764 68999999886542 223345677888888999999999999865332 


Q ss_pred             ------eEEEEEccCCCChhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-CCcEEE
Q 046240          546 ------KALVLEYMPNGSLDIFLY--SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-DMIAHL  616 (763)
Q Consensus       546 ------~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-~~~~kl  616 (763)
                            .++||||++++.+..+..  .....++...+..++.|++.|+.|||. |+.+|+||||||+||+++. ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                  789999998753332221  233468889999999999999999942 3999999999999999997 899999


Q ss_pred             eeecCceecCCCCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc--c
Q 046240          617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN--G  693 (763)
Q Consensus       617 ~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~--~  693 (763)
                      +|||+++.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......  +
T Consensus       174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~  249 (360)
T 3e3p_A          174 CDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVLG  249 (360)
T ss_dssp             CCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHC
T ss_pred             eeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHcC
Confidence            9999998765332   22345689999999988654 489999999999999999999999976433221 111111  1


Q ss_pred             cCChhHHHHHHhhcCC-----CccccHHH-----HHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 LLPVSLMEVVNKTLLS-----PPEKDFAA-----KEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~-----~~~~~~~~-----~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+......+......     ........     .......+.+++.+|++.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111111111110000     00000000     0012567899999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=334.19  Aligned_cols=200  Identities=23%  Similarity=0.324  Sum_probs=153.4

Q ss_pred             HhccCc-CceecccCCceEEEEEec---CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeee--cCCceE
Q 046240          474 TNRFGR-DNLIGIGSFGYVYKAELD---DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCS--NDDFKA  547 (763)
Q Consensus       474 ~~~~~~-~~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~  547 (763)
                      .+.|.+ +++||+|+||+||+|...   +++.||||++....  ....+.+|+.++++++||||+++++++.  .....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            455665 568999999999999865   57899999987542  2346788999999999999999999994  467899


Q ss_pred             EEEEccCCCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe----cCCCcEE
Q 046240          548 LVLEYMPNGSLDIFLYSS--------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL----DEDMIAH  615 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll----~~~~~~k  615 (763)
                      +||||+++ +|.+++...        ...+++..+..++.|++.||+||   |+.+|+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999975 676666421        12488999999999999999999   77899999999999999    6778999


Q ss_pred             EeeecCceecCCCCC-ccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          616 LSDFGIAKLLSGEDQ-SMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       616 l~Dfgla~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                      |+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            999999987643221 122345678999999999877 4589999999999999999999999965

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-36  Score=334.08  Aligned_cols=262  Identities=24%  Similarity=0.301  Sum_probs=192.1

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecC------Cce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND------DFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  546 (763)
                      ..+|...+.||+|+||.||+|... +|+.||||++....    ....+|++++++++||||+++++++...      ...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            347899999999999999999775 68999999986542    2234699999999999999999988432      236


Q ss_pred             EEEEEccCCCChhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCc
Q 046240          547 ALVLEYMPNGSLDIFLY---SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIA  622 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla  622 (763)
                      ++||||+++ ++...+.   .....+++..+..++.|+++||+||   |+.+|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999986 5554443   2344689999999999999999999   78999999999999999965 67899999999


Q ss_pred             eecCCCCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcc---cCChh
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG---LLPVS  698 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~  698 (763)
                      +.+....   ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+...+..   ...+.
T Consensus       205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHH
T ss_pred             hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence            8764332   22345789999999998764 78999999999999999999999997643222 12221111   11111


Q ss_pred             HHHHHHhhcCC--Ccc--ccHHH---HHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          699 LMEVVNKTLLS--PPE--KDFAA---KEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       699 ~~~~i~~~l~~--~~~--~~~~~---~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.+. ......  .+.  .....   ......++.+++.+|+..||++||++.|+++
T Consensus       281 ~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            1111 100000  000  00000   0112456899999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-36  Score=324.49  Aligned_cols=268  Identities=24%  Similarity=0.300  Sum_probs=198.4

Q ss_pred             HHhccCcCceecccCCceEEEEEe--cCCceEEEEEeehhhH--HHHHHHHHHHHHHHhC---CCCccceEEeeee----
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAEL--DDGIEVAIKVFHQECA--RAMKSFEVECEVMKNI---RHRNLVKIISGCS----  541 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  541 (763)
                      +.++|.+.+.||+|+||.||+|..  .+|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999977  4688999999864321  1223456677777666   8999999999987    


Q ss_pred             -cCCceEEEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeee
Q 046240          542 -NDDFKALVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       542 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                       .....++||||++ |+|.+++.... ..+++..+..++.|+++||.||   |+.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999998 59999887643 3589999999999999999999   7789999999999999999999999999


Q ss_pred             cCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhh---cccCC
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWV---NGLLP  696 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~---~~~~~  696 (763)
                      |+++.....   .......++..|+|||++.+..++.++|||||||++|||++|+.||........ .....   .....
T Consensus       165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~  240 (326)
T 1blx_A          165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCG
T ss_pred             cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCc
Confidence            999875421   123446789999999999999999999999999999999999999976432211 11110   00000


Q ss_pred             hhHHH---HHHhhcCCCcccc-HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 VSLME---VVNKTLLSPPEKD-FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~~~~~---~i~~~l~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..+..   ............. ..........+.+++.+|++.+|++||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000   0000000000000 0000123456889999999999999999999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.3e-36  Score=332.15  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=186.3

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +.|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.+++++ +||||+++++++...+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4455678899999999987766789999999987543   24567899999876 8999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCC------CHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-------------CcE
Q 046240          554 PNGSLDIFLYSSTCML------DIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-------------MIA  614 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~------~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-------------~~~  614 (763)
                      + |+|.+++.......      .+..+..++.|++.||+||   |+.+|+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 59999997653211      2223467999999999999   67899999999999999754             489


Q ss_pred             EEeeecCceecCCCCCcc--ccccccccccccCccccCC-------CCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhh
Q 046240          615 HLSDFGIAKLLSGEDQSM--TQTQTLATIGYMAPEYGIE-------RKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAE  684 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~  684 (763)
                      ||+|||+++.+.......  ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999999875433211  2234579999999998865       678999999999999999999 999997643222


Q ss_pred             hhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       685 ~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..               ++...... +.........+..++.+++.+|++.||++||++.+|++
T Consensus       248 ~~---------------i~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 SN---------------IIRGIFSL-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HH---------------HHHTCCCC-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH---------------HhcCCCCc-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11               11111111 00000011234567899999999999999999999985

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.2e-35  Score=344.22  Aligned_cols=302  Identities=22%  Similarity=0.250  Sum_probs=278.8

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      +++.|++++|.+++..+..|+.+++|++|+|++|.++       .+|..+. ++++|++|++++|.+++..|..+.++++
T Consensus       255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------~lp~~l~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~  326 (606)
T 3t6q_A          255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-------ELPSGLV-GLSTLKKLVLSANKFENLCQISASNFPS  326 (606)
T ss_dssp             EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-------CCCSSCC-SCTTCCEEECTTCCCSBGGGGCGGGCTT
T ss_pred             ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-------CCChhhc-ccccCCEEECccCCcCcCchhhhhccCc
Confidence            7999999999999888888999999999999999995       7888764 8999999999999999999999999999


Q ss_pred             CCeeeecCcccccccc-cccCCCCchhhhhhhhhccCCcccccC--CcccccccccccEEEeecCccccccccccCCccc
Q 046240          158 LTILELGGNSFSGFIP-NTIGNLRNIEWLGLVIGLIGNPLNGIL--PSSIVNLSISLERLYISNCSITGNIPQVMGNLSI  234 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~~l~~n~l~~~~--p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~  234 (763)
                      |++|++++|++.+.+| ..|.++++|+.|+    +++|.+++..  |..+.+++ +|++|++++|++++..|..|..+++
T Consensus       327 L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~----l~~n~l~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~  401 (606)
T 3t6q_A          327 LTHLSIKGNTKRLELGTGCLENLENLRELD----LSHDDIETSDCCNLQLRNLS-HLQSLNLSYNEPLSLKTEAFKECPQ  401 (606)
T ss_dssp             CSEEECCSCSSCCBCCSSTTTTCTTCCEEE----CCSSCCCEEEESTTTTTTCT-TCCEEECCSCSCEEECTTTTTTCTT
T ss_pred             CCEEECCCCCcccccchhhhhccCcCCEEE----CCCCccccccCcchhcccCC-CCCEEECCCCcCCcCCHHHhcCCcc
Confidence            9999999999986665 4599999999999    8899999876  88899998 9999999999999999999999999


Q ss_pred             cceeecccccccCCCCcc-ccccCCCCccEEEecCCccccCCCCccccccCCcccEEEccccccccc---CCcccCCCcC
Q 046240          235 FLLLDLELNKLTGPIPVT-FGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGD---IPATIGGLKD  310 (763)
Q Consensus       235 L~~L~L~~N~l~~~~p~~-~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~  310 (763)
                      |++|++++|++++..|.. +.++++  |++|++++|.+++..|.  .+..+++|++|++++|++++.   .+..+..+++
T Consensus       402 L~~L~l~~n~l~~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~  477 (606)
T 3t6q_A          402 LELLDLAFTRLKVKDAQSPFQNLHL--LKVLNLSHSLLDISSEQ--LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR  477 (606)
T ss_dssp             CSEEECTTCCEECCTTCCTTTTCTT--CCEEECTTCCCBTTCTT--TTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTT
T ss_pred             CCeEECCCCcCCCcccchhhhCccc--CCEEECCCCccCCcCHH--HHhCCCCCCEEECCCCCCCccccccchhhccCCC
Confidence            999999999999876654 888876  99999999999988888  789999999999999999873   3467999999


Q ss_pred             ccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-CCccccccccccC
Q 046240          311 VQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPFANFTAKSFMG  389 (763)
Q Consensus       311 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~  389 (763)
                      |+.|++++|++++..|..|..+++|++|+|++|++++..|..+..++.| .|++++|++++.+|.. ..++.+..+++.+
T Consensus       478 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  556 (606)
T 3t6q_A          478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQ  556 (606)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTT
T ss_pred             ccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCC
Confidence            9999999999998889999999999999999999999999999999999 9999999999988865 5577889999999


Q ss_pred             CCcccCCC
Q 046240          390 NEKLCGLP  397 (763)
Q Consensus       390 n~~~c~~p  397 (763)
                      ||+.|+|+
T Consensus       557 N~~~c~c~  564 (606)
T 3t6q_A          557 NPLDCTCS  564 (606)
T ss_dssp             CCEECSGG
T ss_pred             CCccccCC
Confidence            99999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=333.67  Aligned_cols=250  Identities=21%  Similarity=0.283  Sum_probs=187.1

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..+|...+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            457888999999999997766666789999999865432   2346799999999 799999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-----CCcEEEeeecCceecCC
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-----DMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~  627 (763)
                      ++ |+|.+++..............++.|+++||+||   |+.+|+||||||+||+++.     ...+||+|||+++....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 599999987655455556678999999999999   7789999999999999953     33688999999987653


Q ss_pred             CCCc-cccccccccccccCccccC---CCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          628 EDQS-MTQTQTLATIGYMAPEYGI---ERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       628 ~~~~-~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      .... .......||+.|+|||++.   ...++.++|||||||++|||++ |..||..........               
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~---------------  240 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---------------  240 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH---------------
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH---------------
Confidence            3221 2234567999999999987   4667889999999999999999 999986532221110               


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.......... .  .......+.+++.+|++.||++||++.+|++
T Consensus       241 ~~~~~~~~~~~-~--~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          241 LLGACSLDCLH-P--EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HTTCCCCTTSC-T--TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhccCCccccC-c--cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00000000000 0  0112345789999999999999999999983

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-36  Score=324.38  Aligned_cols=253  Identities=26%  Similarity=0.276  Sum_probs=175.9

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHH-HHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECE-VMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++|...+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367889999999999999999774 78999999997542 233445556665 666779999999999999999999999


Q ss_pred             EccCCCChhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          551 EYMPNGSLDIFLYS----STCMLDIFQRLNIMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       551 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      ||+++ +|.+++..    ....+++..+..++.|+++||.||   |+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL---KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH---HHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH---hccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 77766652    234688999999999999999999   566 9999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCcccc----CCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYG----IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      ....   ......|++.|+|||++    .+..++.++|||||||++|||++|+.||..................+.    
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  249 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ----  249 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC----
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC----
Confidence            4322   22334689999999998    466789999999999999999999999976332211111111110000    


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                           +.....      ..+...+.+++..||+.||++||++.++++
T Consensus       250 -----~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 -----LSNSEE------REFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -----CCCCSS------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCccc------ccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                 000000      112456889999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-36  Score=319.66  Aligned_cols=251  Identities=22%  Similarity=0.237  Sum_probs=179.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .++|+..+.||+|+||.||+|... +|+.||||++....  ....+.+..+..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467889999999999999999775 78999999997542  222334445556788889999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      ||+ ++.+..+.......+++..+..++.|+++||.||   |++ +|+||||||+||+++.++.+||+|||++..+....
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL---KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 5566666554445689999999999999999999   553 89999999999999999999999999997764322


Q ss_pred             CccccccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          630 QSMTQTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                         ......+++.|+|||++.     ...++.++|||||||++|||++|+.||............            ++.
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------~~~  244 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK------------VLQ  244 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH------------HHH
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH------------Hhc
Confidence               223456899999999984     567889999999999999999999999763222111111            111


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......+..     ..+...+.+++..||+.||++||+++++++
T Consensus       245 ~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          245 EEPPLLPGH-----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             SCCCCCCSS-----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCCCCCcc-----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111011110     012456889999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-35  Score=319.83  Aligned_cols=264  Identities=20%  Similarity=0.262  Sum_probs=198.1

Q ss_pred             HhccCcCceecccCCceEEEEEec-CC-ceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCc------cceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DG-IEVAIKVFHQECARAMKSFEVECEVMKNIRHRN------LVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  545 (763)
                      .++|.+.+.||+|+||+||+|... ++ +.||+|+++... ...+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999764 44 689999997542 34567788999999997765      8999999999999


Q ss_pred             eEEEEEccCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe----------------
Q 046240          546 KALVLEYMPNGSLDIFLYS-STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL----------------  608 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll----------------  608 (763)
                      .++||||+.+ ++.+++.. ....+++..+..++.|+++||+||   |+.+|+||||||+||++                
T Consensus        97 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            9999999955 55555544 334689999999999999999999   78899999999999999                


Q ss_pred             ---cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh
Q 046240          609 ---DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL  685 (763)
Q Consensus       609 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~  685 (763)
                         +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               56789999999999875322     2345789999999999999999999999999999999999999976433221


Q ss_pred             -hhhhhhcccCChhHHH-----------------------HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC
Q 046240          686 -SLKHWVNGLLPVSLME-----------------------VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI  741 (763)
Q Consensus       686 -~~~~~~~~~~~~~~~~-----------------------~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp  741 (763)
                       .......+..|.....                       .+......... ...........+.+++.+||+.||++||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS-YMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG-GCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccc-cccccchhHHHHHHHHHHHhcCChhhCc
Confidence             1111111112211110                       01111000000 0000112245789999999999999999


Q ss_pred             CHHHHHH
Q 046240          742 NAKCCNF  748 (763)
Q Consensus       742 s~~~v~~  748 (763)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.7e-36  Score=322.53  Aligned_cols=256  Identities=19%  Similarity=0.220  Sum_probs=174.0

Q ss_pred             HhccCcCc-eecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec----CCceE
Q 046240          474 TNRFGRDN-LIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN----DDFKA  547 (763)
Q Consensus       474 ~~~~~~~~-~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  547 (763)
                      .++|.+.+ .||+|+||+||+|... +|+.||||++......    .......++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            57888854 6999999999999765 7899999999754211    1222334566799999999999875    44589


Q ss_pred             EEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecCce
Q 046240          548 LVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAK  623 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~  623 (763)
                      +||||+++|+|.+++.... ..+++..+..++.|+++||.||   |+.+|+||||||+||+++.   ++.+||+|||+++
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999997654 3689999999999999999999   7789999999999999976   4569999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      .....    ......+|+.|+|||++.+..++.++|||||||++|||++|+.||..........          .....+
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~  245 (336)
T 3fhr_A          180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------GMKRRI  245 (336)
T ss_dssp             EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------hHHHhh
Confidence            76422    2234568999999999988899999999999999999999999997643221100          000000


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH--HHhhc
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF--VLCEQ  753 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~--~L~~~  753 (763)
                      .......+...   ...+...+.+++..|++.||++|||+.|+++  .+.+.
T Consensus       246 ~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          246 RLGQYGFPNPE---WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -----CCCTTT---STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hccccccCchh---hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            00000001100   0123456889999999999999999999997  44443

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-35  Score=323.89  Aligned_cols=316  Identities=16%  Similarity=0.143  Sum_probs=257.3

Q ss_pred             CCCCCCCCCc----ccceeecC----------------CCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCC
Q 046240           57 NWTSNTSVCN----WIGITCDV----------------NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGN  116 (763)
Q Consensus        57 ~w~~~~~~c~----w~gv~c~~----------------~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  116 (763)
                      +|..+.+||.    |.++.|+.                ...+++.|++++|.++...+..|..+++|++|+|++|.++  
T Consensus         5 ~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~--   82 (390)
T 3o6n_A            5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE--   82 (390)
T ss_dssp             --CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC--
T ss_pred             CCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc--
Confidence            7887778875    54444431                1157889999999999655556899999999999999995  


Q ss_pred             CccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcc
Q 046240          117 NSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL  196 (763)
Q Consensus       117 ~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l  196 (763)
                           .++...+..+++|++|+|++|.+++..|..|.++++|++|+|++|+++.+.+..|+++++|++|+    +++|.+
T Consensus        83 -----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~----L~~n~l  153 (390)
T 3o6n_A           83 -----EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS----MSNNNL  153 (390)
T ss_dssp             -----EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE----CCSSCC
T ss_pred             -----ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE----CCCCcc
Confidence                 77777778999999999999999999899999999999999999999977777789999999999    889999


Q ss_pred             cccCCcccccccccccEEEeecCccccccccccCCc----------------cccceeecccccccCCCCccccccCCCC
Q 046240          197 NGILPSSIVNLSISLERLYISNCSITGNIPQVMGNL----------------SIFLLLDLELNKLTGPIPVTFGRLQNSK  260 (763)
Q Consensus       197 ~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l----------------~~L~~L~L~~N~l~~~~p~~~~~l~~~~  260 (763)
                      ++..|..+.+++ +|++|++++|++++.....+..+                ++|+.|++++|.++.. |...  .  ++
T Consensus       154 ~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~-~~~~--~--~~  227 (390)
T 3o6n_A          154 ERIEDDTFQATT-SLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVV-RGPV--N--VE  227 (390)
T ss_dssp             CBCCTTTTSSCT-TCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEE-ECCC--C--SS
T ss_pred             CccChhhccCCC-CCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeec-cccc--c--cc
Confidence            988888898888 99999999999996543333222                2345555555555522 2222  1  24


Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeC
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDL  340 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  340 (763)
                      |+.|++++|++++. +   .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|
T Consensus       228 L~~L~l~~n~l~~~-~---~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L  302 (390)
T 3o6n_A          228 LTILKLQHNNLTDT-A---WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL  302 (390)
T ss_dssp             CCEEECCSSCCCCC-G---GGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEEC
T ss_pred             ccEEECCCCCCccc-H---HHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEEC
Confidence            88999999999853 3   58899999999999999999999999999999999999999994 6777788999999999


Q ss_pred             cCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcccCCC
Q 046240          341 SNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       341 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      ++|++++ +|..+..+++|+.|++++|+++...  ...++.+..+++.+|++.|++.
T Consensus       303 ~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~~  356 (390)
T 3o6n_A          303 SHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL  356 (390)
T ss_dssp             CSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH
T ss_pred             CCCccee-cCccccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccchhH
Confidence            9999997 5667889999999999999998764  3457889999999999998753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.5e-36  Score=320.58  Aligned_cols=242  Identities=21%  Similarity=0.259  Sum_probs=198.2

Q ss_pred             HHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHH------HHHHHHHHHHHHHhCC--CCccceEEeeeec
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECAR------AMKSFEVECEVMKNIR--HRNLVKIISGCSN  542 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~  542 (763)
                      ...++|.+.+.||+|+||.||+|.. .+++.||||++......      ..+.+.+|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457899999999999999999965 57899999999755321      2245667999999996  5999999999999


Q ss_pred             CCceEEEEEccCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec-CCCcEEEeeec
Q 046240          543 DDFKALVLEYMPN-GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFG  620 (763)
Q Consensus       543 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~-~~~~~kl~Dfg  620 (763)
                      .+..++|+||+.+ ++|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||+++ +++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999986 89999987643 588999999999999999999   788999999999999999 78999999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhH
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSL  699 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  699 (763)
                      +++.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......                
T Consensus       196 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----------------  255 (320)
T 3a99_A          196 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------------  255 (320)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------------
T ss_pred             cccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh----------------
Confidence            99876432    2234568999999998876665 67899999999999999999999763211                


Q ss_pred             HHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 MEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 ~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         ..........        +...+.+++.+||+.+|++||+++++++
T Consensus       256 ---~~~~~~~~~~--------~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 ---IRGQVFFRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---HHCCCCCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---hccccccccc--------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1111111111        2345789999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=319.21  Aligned_cols=245  Identities=22%  Similarity=0.321  Sum_probs=190.1

Q ss_pred             HHHHHHhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH------HHHHHHHHHHHHHHhC----CCCccceEE
Q 046240          469 DLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA------RAMKSFEVECEVMKNI----RHRNLVKII  537 (763)
Q Consensus       469 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~  537 (763)
                      +.....++|.+.+.||+|+||.||+|.. .+++.||||++.....      .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3445678899999999999999999966 4788999999965421      1223456789999998    899999999


Q ss_pred             eeeecCCceEEEEEc-cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec-CCCcEE
Q 046240          538 SGCSNDDFKALVLEY-MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAH  615 (763)
Q Consensus       538 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~-~~~~~k  615 (763)
                      +++...+..++|+|| +.+++|.+++.... .+++..+..++.|+++||+||   |+.+|+||||||+||+++ .++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 78999999997644 589999999999999999999   677999999999999999 889999


Q ss_pred             EeeecCceecCCCCCccccccccccccccCccccCCCCCC-cchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhccc
Q 046240          616 LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS-TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL  694 (763)
Q Consensus       616 l~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~  694 (763)
                      |+|||+++......    .....|+..|+|||++.+..+. .++|||||||++|||++|+.||.....            
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------  244 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------  244 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------
Confidence            99999998765322    2345689999999988766664 589999999999999999999976321            


Q ss_pred             CChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                             +.........        .+...+.+++.+|++.+|++||++.|+++
T Consensus       245 -------~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 -------ILEAELHFPA--------HVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -------HHHTCCCCCT--------TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------HhhhccCCcc--------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   1111111111        12345789999999999999999999987

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=1.6e-35  Score=315.00  Aligned_cols=279  Identities=18%  Similarity=0.238  Sum_probs=179.5

Q ss_pred             CChhhHHHHHHHHHhccCCCCcccccCC----CCCCCCCcccceeecC--------CCCceEEEEecCCCCCCcCCcccC
Q 046240           31 NITTDQQALLALEAHISYDPTNLLAQNW----TSNTSVCNWIGITCDV--------NSHRVTALNISSLNLQGEIPHEIG   98 (763)
Q Consensus        31 ~~~~~~~~l~~~~~~~~~~~~~~~~~~w----~~~~~~c~w~gv~c~~--------~~~~v~~L~L~~~~l~~~~~~~~~   98 (763)
                      ...+|..||++||+.+..||.+.+. +|    ....++|.|.|+.|..        ...+|+.|+|++|+++ .+|+.++
T Consensus        24 ~~~~~~~aLl~~k~~~~~~~~~~~~-~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~  101 (328)
T 4fcg_A           24 ALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF  101 (328)
T ss_dssp             CCCCHHHHHHHHHHHHHHCCTTHHH-HHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred             cCchHHHHHHHHHHhccCCchhhhh-hhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence            3568899999999998878887775 89    4567899999999952        3468899999999988 6788888


Q ss_pred             CCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCC
Q 046240           99 YLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGN  178 (763)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  178 (763)
                      .+++|++|+|++|.++       .+|..+. .+++|++|+|++|.|+ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus       102 ~l~~L~~L~L~~n~l~-------~lp~~~~-~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~  172 (328)
T 4fcg_A          102 RLSHLQHMTIDAAGLM-------ELPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS  172 (328)
T ss_dssp             GGTTCSEEEEESSCCC-------CCCSCGG-GGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE
T ss_pred             hCCCCCEEECCCCCcc-------chhHHHh-ccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh
Confidence            8888888888888774       6666553 6777777777777777 56777777777777777777777666665443


Q ss_pred             CCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCC
Q 046240          179 LRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN  258 (763)
Q Consensus       179 l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  258 (763)
                      ..                   ++..+.++. +|++|+|++|+|+ .+|..++.+++|++|+|++|++++ +|..      
T Consensus       173 ~~-------------------~~~~~~~l~-~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~------  224 (328)
T 4fcg_A          173 TD-------------------ASGEHQGLV-NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPA------  224 (328)
T ss_dssp             EC--------------------CCCEEEST-TCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGG------
T ss_pred             cc-------------------chhhhccCC-CCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchh------
Confidence            11                   112233343 5555666655555 445555555555555555555552 3333      


Q ss_pred             CCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEE
Q 046240          259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEIL  338 (763)
Q Consensus       259 ~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  338 (763)
                                            +..+++|++|+|++|++.+.+|..|+++++|+.|+|++|++.+.+|..+..+++|++|
T Consensus       225 ----------------------l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L  282 (328)
T 4fcg_A          225 ----------------------IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL  282 (328)
T ss_dssp             ----------------------GGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEE
T ss_pred             ----------------------hccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEE
Confidence                                  4444455555555555555555555555555555555555555555555555555555


Q ss_pred             eCcCCccCCccchhhhhhccCceEEcccccCC
Q 046240          339 DLSNNKISGFILISLEKLLYLKKLNLSFNKLE  370 (763)
Q Consensus       339 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  370 (763)
                      +|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus       283 ~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             ECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             eCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            55555555555555555555555555555443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.7e-35  Score=321.45  Aligned_cols=265  Identities=19%  Similarity=0.241  Sum_probs=196.4

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-----------CCccceEEeeee
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-----------HRNLVKIISGCS  541 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  541 (763)
                      .++|.+.+.||+|+||+||+|.. .+++.||||++.... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35799999999999999999976 578999999997543 23466788999998886           899999999987


Q ss_pred             cCC----ceEEEEEccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeCCCCCCCEEec------
Q 046240          542 NDD----FKALVLEYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTT-PIIHCDLKSSNVLLD------  609 (763)
Q Consensus       542 ~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~dlk~~NIll~------  609 (763)
                      ..+    ..++||||+ +++|.+++... ...+++..+..++.|++.||+||   |++ +|+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM---HRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH---HhcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 88999998763 33589999999999999999999   666 999999999999994      


Q ss_pred             CCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhh-----h
Q 046240          610 EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA-----E  684 (763)
Q Consensus       610 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-----~  684 (763)
                      ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     .
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4458999999999876422     23356899999999999999999999999999999999999999753211     1


Q ss_pred             hhhhhhh--cccCChhHHH---HHHhhcCC-----C-cc-----------ccHHHHHHHHHHHHHHHHHccccCcCCCCC
Q 046240          685 LSLKHWV--NGLLPVSLME---VVNKTLLS-----P-PE-----------KDFAAKEQCVLSIFSLAMECTMELPEKRIN  742 (763)
Q Consensus       685 ~~~~~~~--~~~~~~~~~~---~i~~~l~~-----~-~~-----------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps  742 (763)
                      .......  .+..|.....   ........     . ..           ............+.+++..|++.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            1111110  1111111000   00000000     0 00           000011234678899999999999999999


Q ss_pred             HHHHHH
Q 046240          743 AKCCNF  748 (763)
Q Consensus       743 ~~~v~~  748 (763)
                      ++|+++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.5e-35  Score=331.01  Aligned_cols=285  Identities=22%  Similarity=0.270  Sum_probs=245.2

Q ss_pred             CCceEEEEecCCCCCCcC-CcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCc--c
Q 046240           76 SHRVTALNISSLNLQGEI-PHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSP--I  152 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~--~  152 (763)
                      ..+++.|+|++|.+.+.+ +..|.++++|++|+|++|.++       .+++..+.++++|++|+|++|.+++..|..  |
T Consensus        53 l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~-------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  125 (455)
T 3v47_A           53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-------QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF  125 (455)
T ss_dssp             CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTC-------EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTT
T ss_pred             CccccEEECcCCcccceECcccccccccCCEEeCCCCccC-------ccChhhccCcccCCEEeCCCCCCCccccCcccc
Confidence            467888999988887555 557888899999999888885       455555568888888888888888755444  8


Q ss_pred             cCCCCCCeeeecCcccccccccc-cCCCCchhhhhhhhhccCCcccccCCcccccc------------------------
Q 046240          153 TNASKLTILELGGNSFSGFIPNT-IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNL------------------------  207 (763)
Q Consensus       153 ~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l------------------------  207 (763)
                      .++++|++|+|++|++++..|.. |.++++|++|+    +++|.+++..|..+..+                        
T Consensus       126 ~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~----L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~  201 (455)
T 3v47_A          126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD----LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG  201 (455)
T ss_dssp             TTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEE----CTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTT
T ss_pred             cCcccCCEEECCCCccCccCcccccCCCCcccEEe----CCCCcccccChhhhhccccccccccccccCcccccchhhcc
Confidence            88888888888888888877766 78888888888    77888888777766554                        


Q ss_pred             ----------cccccEEEeecCccccccccccCC---------------------------------------cccccee
Q 046240          208 ----------SISLERLYISNCSITGNIPQVMGN---------------------------------------LSIFLLL  238 (763)
Q Consensus       208 ----------~~~L~~L~L~~N~l~~~~~~~~~~---------------------------------------l~~L~~L  238 (763)
                                + +|++|+|++|++++..|..+..                                       .++|++|
T Consensus       202 ~~~~~~~~~~~-~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L  280 (455)
T 3v47_A          202 WEKCGNPFKNT-SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTC  280 (455)
T ss_dssp             HHHHCCTTTTC-EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEE
T ss_pred             ccccccccccc-eeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEE
Confidence                      4 7999999999888766654432                                       2689999


Q ss_pred             ecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccC
Q 046240          239 DLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY  318 (763)
Q Consensus       239 ~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  318 (763)
                      ++++|++++..|..+..+++  |++|+|++|++++..|.  .+.++++|++|+|++|++++..|..|.++++|+.|+|++
T Consensus       281 ~l~~n~l~~~~~~~~~~l~~--L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  356 (455)
T 3v47_A          281 DLSKSKIFALLKSVFSHFTD--LEQLTLAQNEINKIDDN--AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY  356 (455)
T ss_dssp             ECCSSCCCEECTTTTTTCTT--CCEEECTTSCCCEECTT--TTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCS
T ss_pred             EecCccccccchhhcccCCC--CCEEECCCCcccccChh--HhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCC
Confidence            99999999999999999977  99999999999988887  799999999999999999998899999999999999999


Q ss_pred             ccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC
Q 046240          319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG  376 (763)
Q Consensus       319 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  376 (763)
                      |++++..|..|..+++|++|+|++|+|+++++..|..+++|+.|++++|++++.+|..
T Consensus       357 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          357 NHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            9999888999999999999999999999988888999999999999999999999854

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=6.2e-35  Score=339.92  Aligned_cols=307  Identities=19%  Similarity=0.224  Sum_probs=245.2

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      ..+++|||++|+|+++.+.+|.++++|++|+|++|+|+       .+|+++|.++++|++|+|++|+|++..+..|.+++
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-------~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~  124 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-------TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS  124 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-------EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCT
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-------CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCC
Confidence            57999999999999888889999999999999999996       89999999999999999999999988888999999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCccccc-CCcccccccccccEEEeecCccccccccccCCccc-
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI-LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSI-  234 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~-~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~-  234 (763)
                      +|++|+|++|+|+++.+..|+++++|++|+    +++|.+++. +|..+..+. +|++|+|++|+|++..+..|..+.+ 
T Consensus       125 ~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~----Ls~N~l~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~L~~l  199 (635)
T 4g8a_A          125 SLQKLVAVETNLASLENFPIGHLKTLKELN----VAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQM  199 (635)
T ss_dssp             TCCEEECTTSCCCCSTTCCCTTCTTCCEEE----CCSSCCCCCCCCGGGGGCT-TCCEEECCSSCCCEECGGGGHHHHTC
T ss_pred             CCCEEECCCCcCCCCChhhhhcCcccCeec----cccCccccCCCchhhccch-hhhhhcccCccccccccccccchhhh
Confidence            999999999999998888999999999999    889998764 577778887 9999999999887665544332221 


Q ss_pred             --------------------------------------------------------------------------------
Q 046240          235 --------------------------------------------------------------------------------  234 (763)
Q Consensus       235 --------------------------------------------------------------------------------  234 (763)
                                                                                                      
T Consensus       200 ~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~  279 (635)
T 4g8a_A          200 PLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC  279 (635)
T ss_dssp             TTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGG
T ss_pred             hhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------cceeecccccccCCCCccc-----------
Q 046240          235 --------------------------------------------------FLLLDLELNKLTGPIPVTF-----------  253 (763)
Q Consensus       235 --------------------------------------------------L~~L~L~~N~l~~~~p~~~-----------  253 (763)
                                                                        |+.|++.+|.+.+..+..+           
T Consensus       280 ~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n  359 (635)
T 4g8a_A          280 NLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN  359 (635)
T ss_dssp             GSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESC
T ss_pred             chhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccc
Confidence                                                              1222222222211100000           


Q ss_pred             --------cccCC-------------------------------------------------------------------
Q 046240          254 --------GRLQN-------------------------------------------------------------------  258 (763)
Q Consensus       254 --------~~l~~-------------------------------------------------------------------  258 (763)
                              ..+++                                                                   
T Consensus       360 ~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~  439 (635)
T 4g8a_A          360 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFS  439 (635)
T ss_dssp             CSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSC
T ss_pred             cCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccc
Confidence                    00111                                                                   


Q ss_pred             -----CCccEEEecCCccccCCCCccccccCCcccEEEcccccc-cccCCcccCCCcCccEEEccCccccCccccccccc
Q 046240          259 -----SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF-SGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYL  332 (763)
Q Consensus       259 -----~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  332 (763)
                           .+++.++++.|.+.+..|.  .+..++.|+.|+|++|++ .+..|..|..+++|+.|+|++|+|++..|..|.++
T Consensus       440 ~~~~l~~l~~l~ls~n~l~~~~~~--~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l  517 (635)
T 4g8a_A          440 VFLSLRNLIYLDISHTHTRVAFNG--IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL  517 (635)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTT--TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             cccccccccccccccccccccccc--ccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCC
Confidence                 1133333344444433343  456677888888888874 44678899999999999999999999999999999


Q ss_pred             ccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-CCc-cccccccccCCCcccCCC
Q 046240          333 TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPF-ANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       333 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~-~~l~~~~~~~n~~~c~~p  397 (763)
                      ++|++|+|++|+|+++.+..|..+++|++|+|++|+|++.+|.. ..+ ..++.+++.+|||.|+|.
T Consensus       518 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          518 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             TTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99999999999999999999999999999999999999998875 344 578999999999999986

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=3.3e-35  Score=338.89  Aligned_cols=316  Identities=16%  Similarity=0.150  Sum_probs=260.1

Q ss_pred             CCCCCCCCCc----ccceeecC----------------CCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCC
Q 046240           57 NWTSNTSVCN----WIGITCDV----------------NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGN  116 (763)
Q Consensus        57 ~w~~~~~~c~----w~gv~c~~----------------~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  116 (763)
                      +|..+.+||.    |.++.|+.                ...+++.|++++|.+....+..|..+++|++|+|++|.++  
T Consensus        11 ~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~--   88 (597)
T 3oja_B           11 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE--   88 (597)
T ss_dssp             CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCC--
T ss_pred             CCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCC--
Confidence            7887777773    66655542                1146788999999998766667889999999999999985  


Q ss_pred             CccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcc
Q 046240          117 NSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPL  196 (763)
Q Consensus       117 ~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l  196 (763)
                           .+|+..|..+++|++|+|++|.|++..|..|+++++|++|+|++|+|+++.+..|+++++|++|+    +++|.+
T Consensus        89 -----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~----Ls~N~l  159 (597)
T 3oja_B           89 -----EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS----MSNNNL  159 (597)
T ss_dssp             -----EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE----CCSSCC
T ss_pred             -----CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE----eeCCcC
Confidence                 67776777999999999999999998888999999999999999999988778889999999999    889999


Q ss_pred             cccCCcccccccccccEEEeecCccccccccccCCc----------------cccceeecccccccCCCCccccccCCCC
Q 046240          197 NGILPSSIVNLSISLERLYISNCSITGNIPQVMGNL----------------SIFLLLDLELNKLTGPIPVTFGRLQNSK  260 (763)
Q Consensus       197 ~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l----------------~~L~~L~L~~N~l~~~~p~~~~~l~~~~  260 (763)
                      ++..|..+.+++ +|++|+|++|++++.....+.++                ++|+.|++++|.++.. |..+.    ++
T Consensus       160 ~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~-~~~~~----~~  233 (597)
T 3oja_B          160 ERIEDDTFQATT-SLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVV-RGPVN----VE  233 (597)
T ss_dssp             CBCCTTTTTTCT-TCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEE-ECSCC----SC
T ss_pred             CCCChhhhhcCC-cCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCccccc-ccccC----CC
Confidence            998888899888 99999999999987643333221                2344455555555422 22221    24


Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeC
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDL  340 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  340 (763)
                      |+.|+|++|.+++.  .  .+..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus       234 L~~L~L~~n~l~~~--~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L  308 (597)
T 3oja_B          234 LTILKLQHNNLTDT--A--WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL  308 (597)
T ss_dssp             CCEEECCSSCCCCC--G--GGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEEC
T ss_pred             CCEEECCCCCCCCC--h--hhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEEC
Confidence            88999999999852  3  68899999999999999999999999999999999999999995 6777888999999999


Q ss_pred             cCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcccCCC
Q 046240          341 SNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       341 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      ++|+++. +|..+..+++|+.|+|++|++++..+  ..++.+..+++.+|++.|.+.
T Consensus       309 s~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~L~~L~l~~N~~~~~~~  362 (597)
T 3oja_B          309 SHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKL--STHHTLKNLTLSHNDWDCNSL  362 (597)
T ss_dssp             CSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCCC--CTTCCCSEEECCSSCEEHHHH
T ss_pred             CCCCCCc-cCcccccCCCCCEEECCCCCCCCcCh--hhcCCCCEEEeeCCCCCChhH
Confidence            9999997 67778999999999999999997753  457889999999999998754

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=3.9e-35  Score=335.74  Aligned_cols=154  Identities=21%  Similarity=0.241  Sum_probs=110.1

Q ss_pred             CCcccceeecCC-----------CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCC
Q 046240           64 VCNWIGITCDVN-----------SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALP  132 (763)
Q Consensus        64 ~c~w~gv~c~~~-----------~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~  132 (763)
                      .|.|.|+ |+..           ..++++|+|++|++++..|..|.++++|++|+|++|+++       .+++..|.+++
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-------~~~~~~~~~l~   74 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-------TIEGDAFYSLG   74 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCC-------EECTTTTTTCT
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcC-------ccChhhccccc
Confidence            4888887 7642           247899999999999888888999999999999999885       55655566777


Q ss_pred             CccEEEcccccccccCCCcccCCCCCCeeeecCcccccc-cccccCCCCchhhhhhhhhccCCcccccCC-ccccccccc
Q 046240          133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGF-IPNTIGNLRNIEWLGLVIGLIGNPLNGILP-SSIVNLSIS  210 (763)
Q Consensus       133 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p-~~~~~l~~~  210 (763)
                      +|++|+|++|+|++..|..|+++++|++|+|++|++++. .|..|+++++|++|+    +++|.+.+.+| ..+.+++ +
T Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~----L~~n~~~~~~~~~~~~~l~-~  149 (549)
T 2z81_A           75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR----IGNVETFSEIRRIDFAGLT-S  149 (549)
T ss_dssp             TCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE----EEESSSCCEECTTTTTTCC-E
T ss_pred             cCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE----CCCCccccccCHhhhhccc-c
Confidence            788888888877776666677777777777777777753 456677777777777    55666433333 4555555 6


Q ss_pred             ccEEEeecCccccccccccC
Q 046240          211 LERLYISNCSITGNIPQVMG  230 (763)
Q Consensus       211 L~~L~L~~N~l~~~~~~~~~  230 (763)
                      |++|++++|++++..|..++
T Consensus       150 L~~L~L~~n~l~~~~~~~l~  169 (549)
T 2z81_A          150 LNELEIKALSLRNYQSQSLK  169 (549)
T ss_dssp             EEEEEEEETTCCEECTTTTT
T ss_pred             cCeeeccCCcccccChhhhh
Confidence            66666666666655555443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.5e-35  Score=336.53  Aligned_cols=273  Identities=25%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeec------CCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSN------DDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  545 (763)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            37899999999999999999966 46899999998754 33456778999999999999999999998765      677


Q ss_pred             eEEEEEccCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCc---EEEeeec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTC--MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMI---AHLSDFG  620 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~---~kl~Dfg  620 (763)
                      .++||||+++|+|.+++.....  .+++..+..++.+++.||+||   |+.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976432  578889999999999999999   6789999999999999997664   9999999


Q ss_pred             CceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHH
Q 046240          621 IAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM  700 (763)
Q Consensus       621 la~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  700 (763)
                      .++......   ......|++.|+|||++.+..++.++|||||||++|||++|..||.......    .|..........
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~----~~~~~i~~~~~~  242 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----QWHGKVREKSNE  242 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----HSSTTCC-----
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----hhhhhhhcccch
Confidence            998764332   2234678999999999999999999999999999999999999997532211    111111000000


Q ss_pred             HH-HHh----hcCCCc--cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHH-----HHHHHhhcccc
Q 046240          701 EV-VNK----TLLSPP--EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKC-----CNFVLCEQFVS  756 (763)
Q Consensus       701 ~~-i~~----~l~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~-----v~~~L~~~~~~  756 (763)
                      .. ...    ......  .............+.+++..|+..||++|||+.+     ..+.+..++..
T Consensus       243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            00 000    000000  0000011124667899999999999999999987     34555544443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-34  Score=330.26  Aligned_cols=143  Identities=18%  Similarity=0.257  Sum_probs=124.5

Q ss_pred             ccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCcccc-Ccccccccc
Q 046240          253 FGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLE-GPIPESFGY  331 (763)
Q Consensus       253 ~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~  331 (763)
                      +..+++  |++|++++|.+.+..|.. .+..+++|++|++++|++++..|..|.++++|+.|++++|+++ +.+|..+..
T Consensus       392 ~~~l~~--L~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~  468 (570)
T 2z63_A          392 FLGLEQ--LEHLDFQHSNLKQMSEFS-VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE  468 (570)
T ss_dssp             EETCTT--CCEEECTTSEEESCTTSC-TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred             ccccCC--CCEEEccCCccccccchh-hhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhc
Confidence            555544  777777777777655521 5788999999999999999889999999999999999999998 578999999


Q ss_pred             cccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-CCccccccccccCCCcccCCCC
Q 046240          332 LTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKLCGLPH  398 (763)
Q Consensus       332 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~p~  398 (763)
                      +++|++|+|++|+++++.|..|..+++|+.|++++|++++.+|.. ..++.+..+++.+|++.|+||.
T Consensus       469 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            999999999999999988999999999999999999999988764 5678899999999999999884

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-34  Score=346.50  Aligned_cols=95  Identities=15%  Similarity=0.126  Sum_probs=59.9

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccc-cccccCCCccEEEcccccccccCC-Cccc
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPS-RIDLALPNVKALSLAYNRFSGTIQ-SPIT  153 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~-~~~~~l~~L~~L~L~~N~i~~~~p-~~~~  153 (763)
                      ..+++.|+|++|.|++..|..|+++++|++|+|++|.++      +.+|. ..+.++++|++|+|++|.+++..+ ..|+
T Consensus        72 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~------~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~  145 (844)
T 3j0a_A           72 LPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS------DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG  145 (844)
T ss_dssp             CTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCS------SCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGG
T ss_pred             CCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCC------cccccCccccccCCCCEEECCCCcccccccchhHh
Confidence            356777777777777777777777777777777777765      23332 234466666666666666665544 3566


Q ss_pred             CCCCCCeeeecCccccccccccc
Q 046240          154 NASKLTILELGGNSFSGFIPNTI  176 (763)
Q Consensus       154 ~l~~L~~L~L~~N~l~~~~p~~~  176 (763)
                      ++++|++|+|++|++++..+..|
T Consensus       146 ~L~~L~~L~Ls~N~i~~~~~~~l  168 (844)
T 3j0a_A          146 KLNSLKSIDFSSNQIFLVCEHEL  168 (844)
T ss_dssp             TCSSCCEEEEESSCCCCCCSGGG
T ss_pred             hCCCCCEEECCCCcCCeeCHHHc
Confidence            66666666666666655444433

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.2e-34  Score=328.78  Aligned_cols=161  Identities=21%  Similarity=0.247  Sum_probs=118.7

Q ss_pred             CCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCC--CCccccccCCcccEEEcccccccccCC-cccC
Q 046240          230 GNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSI--PSCIDIGNLKVVVEINLSRNNFSGDIP-ATIG  306 (763)
Q Consensus       230 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~--p~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~  306 (763)
                      ..+++|++|++++|++++..|..+.++++  |++|+|++|++++..  |.  .+.++++|++|++++|++++.+| ..+.
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~  425 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKR--LQTLILQRNGLKNFFKVAL--MTKNMSSLETLDVSLNSLNSHAYDRTCA  425 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSS--CCEEECCSSCCCBTTHHHH--TTTTCTTCCEEECTTSCCBSCCSSCCCC
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCC--CCEEECCCCCcCCcccchh--hhcCCCCCCEEECCCCcCCCccChhhhc
Confidence            56677777777777777777777777765  777777777777422  23  46777777778888887776344 4477


Q ss_pred             CCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCC-CCCccccccc
Q 046240          307 GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPR-GGPFANFTAK  385 (763)
Q Consensus       307 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~l~~~  385 (763)
                      .+++|+.|+|++|++++..|..+.  ++|+.|+|++|+|+.+ |..+..+++|++|+|++|++++.++. ...++.+..+
T Consensus       426 ~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L  502 (562)
T 3a79_B          426 WAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYI  502 (562)
T ss_dssp             CCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCC-CTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCE
T ss_pred             CcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCccc-ChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEE
Confidence            777788888888877766665544  6888888888888864 44444888999999999999865555 4567788888


Q ss_pred             cccCCCcccCCC
Q 046240          386 SFMGNEKLCGLP  397 (763)
Q Consensus       386 ~~~~n~~~c~~p  397 (763)
                      ++.+|++.|+|+
T Consensus       503 ~l~~N~~~c~c~  514 (562)
T 3a79_B          503 WLHDNPWDCTCP  514 (562)
T ss_dssp             ECCSCCBCCCHH
T ss_pred             EecCCCcCCCcc
Confidence            899999988876

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=6.2e-34  Score=329.79  Aligned_cols=300  Identities=19%  Similarity=0.164  Sum_probs=245.9

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|+|++|.|++..|..|+++++|++|+|++|.++       .+++..|.++++|++|+|++|++++..|..|.+++
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  105 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-------WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPK  105 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCC-------EECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCT
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccc-------eeChhhccCccccCeeeCCCCcccccChhhhcccc
Confidence            57999999999999888999999999999999999996       67667777999999999999999999999999999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|++|+|++|++++..|..|+++++|++|+    +++|.+++..+..+.++. +|++|+|++|++++..|..|+.+++|+
T Consensus       106 ~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~----L~~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~  180 (606)
T 3t6q_A          106 ALKHLFFIQTGISSIDFIPLHNQKTLESLY----LGSNHISSIKLPKGFPTE-KLKVLDFQNNAIHYLSKEDMSSLQQAT  180 (606)
T ss_dssp             TCCEEECTTSCCSCGGGSCCTTCTTCCEEE----CCSSCCCCCCCCTTCCCT-TCCEEECCSSCCCEECHHHHHTTTTCC
T ss_pred             cccEeeccccCcccCCcchhccCCcccEEE----CCCCcccccCcccccCCc-ccCEEEcccCcccccChhhhhhhcccc
Confidence            999999999999998899999999999999    889999986656666677 999999999999988899999999999


Q ss_pred             --eeecccccccCCCCcccccc-------------------------------------------------CCCCccEEE
Q 046240          237 --LLDLELNKLTGPIPVTFGRL-------------------------------------------------QNSKLDTLS  265 (763)
Q Consensus       237 --~L~L~~N~l~~~~p~~~~~l-------------------------------------------------~~~~L~~L~  265 (763)
                        .|++++|++++..|..+...                                                 ...+|+.|+
T Consensus       181 ~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~  260 (606)
T 3t6q_A          181 NLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN  260 (606)
T ss_dssp             SEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEE
T ss_pred             eeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEE
Confidence              88999999987776655321                                                 001367777


Q ss_pred             ecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCcc
Q 046240          266 LCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKI  345 (763)
Q Consensus       266 L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  345 (763)
                      +++|.+++..+.  .+.++++|++|++++|+++ .+|..+.++++|++|++++|++++..|..+..+++|++|++++|.+
T Consensus       261 l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~  337 (606)
T 3t6q_A          261 LQKHYFFNISSN--TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTK  337 (606)
T ss_dssp             CTTCCCSSCCTT--TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSS
T ss_pred             eecCccCccCHH--HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCc
Confidence            888888765555  5777888888888888887 6777788888888888888888877777777888888888888877


Q ss_pred             CCcc-chhhhhhccCceEEcccccCCCCC--CC-CCCccccccccccCCC
Q 046240          346 SGFI-LISLEKLLYLKKLNLSFNKLEGEI--PR-GGPFANFTAKSFMGNE  391 (763)
Q Consensus       346 ~~~~-~~~~~~l~~L~~L~l~~N~l~~~~--p~-~~~~~~l~~~~~~~n~  391 (763)
                      .+.. +..+..+++|++|++++|.+++..  |. ...++.++.+++.+|.
T Consensus       338 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~  387 (606)
T 3t6q_A          338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE  387 (606)
T ss_dssp             CCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCS
T ss_pred             ccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCc
Confidence            7444 344777778888888888777654  32 3456667777777764

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=3.9e-34  Score=336.03  Aligned_cols=312  Identities=23%  Similarity=0.230  Sum_probs=238.9

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCC--cc----------------cc-----Ccc---ccccccC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNN--SL----------------SG-----SLP---SRIDLAL  131 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~----------------~~-----~lp---~~~~~~l  131 (763)
                      +++.|+|++|.+++..|..|+.+++|++|+|++|.+++..  .+                .+     .+|   ...+..+
T Consensus       249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l  328 (680)
T 1ziw_A          249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL  328 (680)
T ss_dssp             CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTC
T ss_pred             CCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccC
Confidence            4777777777777777777777777777777777765310  00                00     122   2245567


Q ss_pred             CCccEEEcccccccccCCCcccCCCCCCeeeecC----------------------------cccccccccccCCCCchh
Q 046240          132 PNVKALSLAYNRFSGTIQSPITNASKLTILELGG----------------------------NSFSGFIPNTIGNLRNIE  183 (763)
Q Consensus       132 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~----------------------------N~l~~~~p~~~~~l~~L~  183 (763)
                      ++|++|++++|.+++..+..|.++++|++|+|++                            |+++++.|.+|.++++|+
T Consensus       329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~  408 (680)
T 1ziw_A          329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE  408 (680)
T ss_dssp             TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCC
Confidence            7788888888888877777777766666665544                            455556667777777777


Q ss_pred             hhhhhhhccCCcccccCC-cccccccccccEEEeecCccccccccccCCccccceeeccccccc--CCCCccccccCCCC
Q 046240          184 WLGLVIGLIGNPLNGILP-SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLT--GPIPVTFGRLQNSK  260 (763)
Q Consensus       184 ~L~L~~~l~~n~l~~~~p-~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~~~  260 (763)
                      .|+    +++|.+++.+| ..+.++. +|++|++++|++++..+..|..+++|+.|++++|.++  +..|..|.++++  
T Consensus       409 ~L~----L~~N~l~~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~--  481 (680)
T 1ziw_A          409 VLD----LGLNEIGQELTGQEWRGLE-NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN--  481 (680)
T ss_dssp             EEE----CCSSCCEEECCSGGGTTCT-TCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT--
T ss_pred             EEe----CCCCcCccccCcccccCcc-cccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC--
Confidence            777    67777776665 4555665 7777777777777777777777888888888888776  467888888876  


Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEcccccccccCC--------cccCCCcCccEEEccCccccCccccccccc
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIP--------ATIGGLKDVQNISLPYNRLEGPIPESFGYL  332 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  332 (763)
                      |+.|+|++|++++..|.  .+.++++|++|+|++|++++..+        ..|.++++|+.|+|++|+++...+..|..+
T Consensus       482 L~~L~Ls~N~l~~i~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l  559 (680)
T 1ziw_A          482 LTILDLSNNNIANINDD--MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL  559 (680)
T ss_dssp             CCEEECCSSCCCCCCTT--TTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             CCEEECCCCCCCcCChh--hhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccc
Confidence            99999999999976666  68899999999999999986522        237889999999999999996656679999


Q ss_pred             ccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCC--CccccccccccCCCcccCCCC
Q 046240          333 TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGG--PFANFTAKSFMGNEKLCGLPH  398 (763)
Q Consensus       333 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~--~~~~l~~~~~~~n~~~c~~p~  398 (763)
                      ++|+.|+|++|+|+++++..|..+++|+.|+|++|++++.+|...  .++.+..+++.+|||.|+|+.
T Consensus       560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            999999999999999888889999999999999999998777542  467889999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.9e-35  Score=302.68  Aligned_cols=234  Identities=13%  Similarity=0.044  Sum_probs=183.8

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999765 58999999997542   33457789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++++|.+++...   ....+...++.|+++||+||   |+++|+||||||+||+++.++.+||+++|         
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            9999999999999543   35557888999999999999   77899999999999999999999998443         


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                                   |++       .++.++|||||||++|||+||+.||............ ..             ....
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-~~-------------~~~~  220 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-ER-------------DTAG  220 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-CB-------------CTTS
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-HH-------------Hhcc
Confidence                         333       3688999999999999999999999864321100000 00             0000


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .+.........+...+.+++.+||+.||++| |+.|+++.|+++....
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0000000111234568999999999999999 9999999999876553

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-34  Score=341.06  Aligned_cols=293  Identities=22%  Similarity=0.227  Sum_probs=207.8

Q ss_pred             CCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccc
Q 046240           64 VCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNR  143 (763)
Q Consensus        64 ~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~  143 (763)
                      .|.|..|.+  -+.++++|||++|.|++..|..|.++++|++|+|++|.+.      +.+++..|.++++|++|+|++|.
T Consensus        13 ~~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~------~~i~~~~f~~L~~L~~L~Ls~N~   84 (844)
T 3j0a_A           13 FCNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP------LTIDKEAFRNLPNLRILDLGSSK   84 (844)
T ss_dssp             CCCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCC------CEECTTTTSSCTTCCEEECTTCC
T ss_pred             CCCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCc------cccCHHHhcCCCCCCEEECCCCc
Confidence            356777776  4578999999999999999999999999999999999654      58888888899999999999999


Q ss_pred             ccccCCCcccCCCCCCeeeecCcccccccccc--cCCCCchhhhhhhhhccCCcccccCC-cccccccccccEEEeecCc
Q 046240          144 FSGTIQSPITNASKLTILELGGNSFSGFIPNT--IGNLRNIEWLGLVIGLIGNPLNGILP-SSIVNLSISLERLYISNCS  220 (763)
Q Consensus       144 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~~l~~n~l~~~~p-~~~~~l~~~L~~L~L~~N~  220 (763)
                      |++..|..|.++++|++|+|++|++++.+|..  |+++++|+.|+    +++|.+++..+ ..|.+++ +|++|+|++|.
T Consensus        85 l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~----Ls~N~l~~~~~~~~~~~L~-~L~~L~Ls~N~  159 (844)
T 3j0a_A           85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD----LSKNQIRSLYLHPSFGKLN-SLKSIDFSSNQ  159 (844)
T ss_dssp             CCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEE----EESCCCCCCCCCGGGGTCS-SCCEEEEESSC
T ss_pred             CcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEE----CCCCcccccccchhHhhCC-CCCEEECCCCc
Confidence            99999999999999999999999999866655  99999999999    88999988765 5678888 99999999999


Q ss_pred             cccccccccCCc--cccceeecccccccCCCCccccccCC----CCccEEEecCCc------------------------
Q 046240          221 ITGNIPQVMGNL--SIFLLLDLELNKLTGPIPVTFGRLQN----SKLDTLSLCGNS------------------------  270 (763)
Q Consensus       221 l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~----~~L~~L~L~~N~------------------------  270 (763)
                      +++..+..|..+  ++|+.|+|++|.+++..|..+..+.+    ..|+.|++++|.                        
T Consensus       160 i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~  239 (844)
T 3j0a_A          160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA  239 (844)
T ss_dssp             CCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECC
T ss_pred             CCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecc
Confidence            998888888776  66777777777766655554433211    124555555554                        


Q ss_pred             --------------------------------------cccCCCCccccccCCcccEEEcccccccccCCcccCCCcCcc
Q 046240          271 --------------------------------------FSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQ  312 (763)
Q Consensus       271 --------------------------------------l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  312 (763)
                                                            +.+..|.  .+..+++|+.|+|++|++++..|..|.++++|+
T Consensus       240 ~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~  317 (844)
T 3j0a_A          240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR--VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ  317 (844)
T ss_dssp             SSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC--CSSSCCCCCEEEEESCCCCEECTTTTTTCSSCC
T ss_pred             cccccccccccccCCCChhhhhccccCCccEEECCCCcccccChh--hhhcCCCCCEEECCCCcCCCCChHHhcCCCCCC
Confidence                                                  4433333  344455555555555555544444555555555


Q ss_pred             EEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCC
Q 046240          313 NISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       313 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  371 (763)
                      .|+|++|++++..|..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|.+++
T Consensus       318 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~  376 (844)
T 3j0a_A          318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT  376 (844)
T ss_dssp             EEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred             EEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence            55555555554444455555555555555555555444445555555555555555543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-34  Score=339.33  Aligned_cols=239  Identities=23%  Similarity=0.289  Sum_probs=191.7

Q ss_pred             HhccCcCceecccCCceEEEEEec--CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc-----
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF-----  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  545 (763)
                      .++|.+.+.||+|+||.||+|...  +|+.||||++... .......+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999765  6899999998643 23445678899999999999999999999987665     


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .|+||||+++++|.+++..   .+++..+..++.|+++||.||   |+++|+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHH---HHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999987754   589999999999999999999   67899999999999999986 8999999999876


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ...      ....||+.|+|||++.+.. +.++|||||||++|||++|..|+.......          .+         
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~---------  285 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP---------  285 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CC---------
T ss_pred             ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------cc---------
Confidence            432      3456899999999886554 889999999999999999998876522110          00         


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC-HHHHHHHHhhc
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-AKCCNFVLCEQ  753 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-~~~v~~~L~~~  753 (763)
                            ....  .......+.+++.+|++.||++||+ ++++.+.+...
T Consensus       286 ------~~~~--~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 ------EDDP--VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ------TTCH--HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ------cccc--ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                  0000  0112356889999999999999995 56666665544

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-34  Score=325.05  Aligned_cols=298  Identities=23%  Similarity=0.271  Sum_probs=184.6

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccc-cCCCcccC
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSG-TIQSPITN  154 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~-~~p~~~~~  154 (763)
                      ..++++|+|++|++++..|..|+++++|++|+|++|+++       .+|..   .+++|++|+|++|.|++ .+|..|++
T Consensus        44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~  113 (520)
T 2z7x_B           44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-------KISCH---PTVNLKHLDLSFNAFDALPICKEFGN  113 (520)
T ss_dssp             CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-------EEECC---CCCCCSEEECCSSCCSSCCCCGGGGG
T ss_pred             cccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-------ecCcc---ccCCccEEeccCCccccccchhhhcc
Confidence            356677777777777666667777777777777777664       55554   56677777777777765 35666777


Q ss_pred             CCCCCeeeecCcccccccccccCCCCch--hhhhhhhhccCCcc--cccCCccccccc----------------------
Q 046240          155 ASKLTILELGGNSFSGFIPNTIGNLRNI--EWLGLVIGLIGNPL--NGILPSSIVNLS----------------------  208 (763)
Q Consensus       155 l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~~l~~n~l--~~~~p~~~~~l~----------------------  208 (763)
                      +++|++|+|++|+|++   ..|.++++|  +.|+    +++|.+  .+..|..+..+.                      
T Consensus       114 l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~----l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~  186 (520)
T 2z7x_B          114 MSQLKFLGLSTTHLEK---SSVLPIAHLNISKVL----LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV  186 (520)
T ss_dssp             CTTCCEEEEEESSCCG---GGGGGGTTSCEEEEE----EEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCC
T ss_pred             CCcceEEEecCcccch---hhccccccceeeEEE----eecccccccccccccccccccceEEEEeccCcchhhhhhhhh
Confidence            7777777777776653   233444444  4444    444444  334444333311                      


Q ss_pred             ------------------------------------------------------------ccccEEEeecCccccccccc
Q 046240          209 ------------------------------------------------------------ISLERLYISNCSITGNIPQV  228 (763)
Q Consensus       209 ------------------------------------------------------------~~L~~L~L~~N~l~~~~~~~  228 (763)
                                                                                  ++|++|++++|++++.+|..
T Consensus       187 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~  266 (520)
T 2z7x_B          187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR  266 (520)
T ss_dssp             TTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCC
T ss_pred             hcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccc
Confidence                                                                        14555566666665555554


Q ss_pred             c-----------------------------------------------------CCccccceeecccccccCCCCccccc
Q 046240          229 M-----------------------------------------------------GNLSIFLLLDLELNKLTGPIPVTFGR  255 (763)
Q Consensus       229 ~-----------------------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~  255 (763)
                      +                                                     ..+++|++|++++|++++.+|..+..
T Consensus       267 ~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  346 (520)
T 2z7x_B          267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH  346 (520)
T ss_dssp             CCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCC
T ss_pred             hhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhcc
Confidence            4                                                     45556666666666666556666666


Q ss_pred             cCCCCccEEEecCCcccc--CCCCccccccCCcccEEEcccccccccCCc-ccCCCcCccEEEccCccccCccccccccc
Q 046240          256 LQNSKLDTLSLCGNSFSG--SIPSCIDIGNLKVVVEINLSRNNFSGDIPA-TIGGLKDVQNISLPYNRLEGPIPESFGYL  332 (763)
Q Consensus       256 l~~~~L~~L~L~~N~l~~--~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  332 (763)
                      +++  |++|+|++|++++  .+|.  .+..+++|++|++++|++++.+|. .+..+++|+.|++++|++++..|..+.  
T Consensus       347 l~~--L~~L~L~~N~l~~l~~~~~--~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--  420 (520)
T 2z7x_B          347 LTE--LETLILQMNQLKELSKIAE--MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--  420 (520)
T ss_dssp             CSS--CCEEECCSSCCCBHHHHHH--HHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--
T ss_pred             CCC--CCEEEccCCccCccccchH--HHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--
Confidence            654  6666666666664  2333  455666666666666666653443 356666666666666666655555443  


Q ss_pred             ccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCC-CCCccccccccccCCCcccCCC
Q 046240          333 TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPR-GGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       333 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      ++|+.|+|++|+|+. +|..+..+++|++|++++|+++..++. ...++.+..+++.+|++.|+|+
T Consensus       421 ~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          421 PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             TTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCEEECCCCcccc-cchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence            677777777777774 455555788888888888888865444 3456777788888888887765

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=3.6e-34  Score=332.17  Aligned_cols=296  Identities=17%  Similarity=0.273  Sum_probs=185.8

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCc-ccCCCcccc-Cccccccc-----cCCCccEEEcccccccccC
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNS-LVGNNSLSG-SLPSRIDL-----ALPNVKALSLAYNRFSGTI  148 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~-~lp~~~~~-----~l~~L~~L~L~~N~i~~~~  148 (763)
                      ..++++|+|++|++.+.+|+.|+++++|++|+|++|+ ++      | .+|..++.     .+++|++|+|++|+++ .+
T Consensus       248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~------~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~i  320 (636)
T 4eco_A          248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS------GEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TF  320 (636)
T ss_dssp             CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSC------HHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SC
T ss_pred             cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCc------cccchHHHHhhhccccCCCCCEEECCCCcCC-cc
Confidence            4689999999999999999999999999999999998 75      5 56766541     2377777777777777 66


Q ss_pred             CC--cccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccccc-ccEEEeecCcccccc
Q 046240          149 QS--PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS-LERLYISNCSITGNI  225 (763)
Q Consensus       149 p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~-L~~L~L~~N~l~~~~  225 (763)
                      |.  .|+++++|++|+|++|+++|.+| .|+++++|+.|+    +++|+++ .+|..+.++. + |++|+|++|+++ .+
T Consensus       321 p~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~----L~~N~l~-~lp~~l~~l~-~~L~~L~Ls~N~l~-~l  392 (636)
T 4eco_A          321 PVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN----LAYNQIT-EIPANFCGFT-EQVENLSFAHNKLK-YI  392 (636)
T ss_dssp             CCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE----CCSSEEE-ECCTTSEEEC-TTCCEEECCSSCCS-SC
T ss_pred             CchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE----CCCCccc-cccHhhhhhc-ccCcEEEccCCcCc-cc
Confidence            66  77777777777777777777777 777777777777    6677776 6666677766 5 777777777776 55


Q ss_pred             ccccCCcc--ccceeecccccccCCCCcccc-------ccCCCCccEEEecCCccccCCCCccccccCC-----------
Q 046240          226 PQVMGNLS--IFLLLDLELNKLTGPIPVTFG-------RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLK-----------  285 (763)
Q Consensus       226 ~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~-----------  285 (763)
                      |..+..++  +|++|++++|++++.+|..+.       .+.+  |++|+|++|+++ .+|.. .+..++           
T Consensus       393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~--L~~L~Ls~N~l~-~lp~~-~~~~l~~L~~L~Ls~N~  468 (636)
T 4eco_A          393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN--VSSINLSNNQIS-KFPKE-LFSTGSPLSSINLMGNM  468 (636)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCC--EEEEECCSSCCC-SCCTH-HHHTTCCCSEEECCSSC
T ss_pred             chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCC--CCEEECcCCccC-cCCHH-HHccCCCCCEEECCCCC
Confidence            66655543  666666666666666665555       3333  555555555555 33331 123344           


Q ss_pred             --------------------cccEEEcccccccccCCcccC--CCcCccEEEccCccccCcccccccccccccEEeC---
Q 046240          286 --------------------VVVEINLSRNNFSGDIPATIG--GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDL---  340 (763)
Q Consensus       286 --------------------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L---  340 (763)
                                          +|++|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|   
T Consensus       469 l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N  546 (636)
T 4eco_A          469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ  546 (636)
T ss_dssp             CSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred             CCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence                                4555555555555 3444443  55555555555555553 4445555555555555   


Q ss_pred             ---cCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCccc
Q 046240          341 ---SNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLC  394 (763)
Q Consensus       341 ---~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c  394 (763)
                         ++|++.+.+|..+..+++|+.|+|++|++ +.+|... .+.+..+++.+|++.|
T Consensus       547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNIS  601 (636)
T ss_dssp             BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCE
T ss_pred             cccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCcc
Confidence               33444555555555555555555555555 3333321 1445555555555444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.9e-34  Score=299.95  Aligned_cols=229  Identities=19%  Similarity=0.244  Sum_probs=177.3

Q ss_pred             hccCcC-ceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHH-HhCCCCccceEEeeeec----CCceE
Q 046240          475 NRFGRD-NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVM-KNIRHRNLVKIISGCSN----DDFKA  547 (763)
Q Consensus       475 ~~~~~~-~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~  547 (763)
                      ++|.+. +.||+|+||.||+|.. .+++.||+|++...     ..+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            556666 7899999999999966 57899999998643     3456788887 55689999999999876    66789


Q ss_pred             EEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecCce
Q 046240          548 LVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAK  623 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~  623 (763)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.||   |+.+|+||||||+||+++.   ++.+||+|||++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999997653 3689999999999999999999   7789999999999999998   7899999999987


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      ...                        +..++.++|||||||++|||++|+.||............ ..           
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~-----------  212 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KT-----------  212 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-CC-----------
T ss_pred             ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-HH-----------
Confidence            642                        234677999999999999999999999764322110000 00           


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ................+...+.+++..|++.||++||++.|+++
T Consensus       213 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          213 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             00000011111111223567899999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-34  Score=307.84  Aligned_cols=242  Identities=19%  Similarity=0.156  Sum_probs=183.7

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhh--------HHHHHHHHHHHHHHHhCC---------CCccceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--------ARAMKSFEVECEVMKNIR---------HRNLVKI  536 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l  536 (763)
                      .++|.+.+.||+|+||+||+|.. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999987 68999999997542        112367888999998886         6565555


Q ss_pred             Eee-----------------eec-------------CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHH
Q 046240          537 ISG-----------------CSN-------------DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALE  586 (763)
Q Consensus       537 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~  586 (763)
                      .+.                 +..             .+..++||||+++|++.+.+..  ..+++..+..++.|++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 433             6789999999999976666543  35789999999999999999


Q ss_pred             HHHhcC-CCCeEeCCCCCCCEEecCCC--------------------cEEEeeecCceecCCCCCccccccccccccccC
Q 046240          587 YLNFRH-TTPIIHCDLKSSNVLLDEDM--------------------IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA  645 (763)
Q Consensus       587 ~Lh~~h-~~~ivH~dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~a  645 (763)
                      ||   | +.+|+||||||+|||++.++                    .+||+|||+|+....       ....||+.|+|
T Consensus       176 ~l---H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~a  245 (336)
T 2vuw_A          176 VA---EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMD  245 (336)
T ss_dssp             HH---HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTC
T ss_pred             HH---HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccC
Confidence            99   6 78999999999999999887                    899999999987642       13478999999


Q ss_pred             ccccCCCCCCcchhHHHHHHH-HHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHH
Q 046240          646 PEYGIERKVSTRSDIYSYGIM-LIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLS  724 (763)
Q Consensus       646 PE~~~~~~~~~~~Dv~slGv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~  724 (763)
                      ||++.+.. +.++||||+|++ .+++++|..||.......             ...+.+....................+
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH-------------YLTDKMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH-------------HHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh-------------HHHHhhhhhhccCcccchhhhhhcCHH
Confidence            99988766 889999998777 788899999986521100             001111111111222222334456778


Q ss_pred             HHHHHHHccccCcCCCCCHHHHH
Q 046240          725 IFSLAMECTMELPEKRINAKCCN  747 (763)
Q Consensus       725 l~~l~~~cl~~~P~~Rps~~~v~  747 (763)
                      +.+++.+|++.|     |++|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     888887

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-34  Score=314.96  Aligned_cols=238  Identities=16%  Similarity=0.121  Sum_probs=177.5

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCC-CccceEE------------
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRH-RNLVKII------------  537 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~------------  537 (763)
                      .+|...+.||+|+||+||+|.. .+|+.||||++....   ....+.+.+|+.+++.++| +|.....            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4577889999999999999974 579999999987332   2336778899999999977 3221111            


Q ss_pred             ---------eeeec-----CCceEEEEEccCCCChhhhhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 046240          538 ---------SGCSN-----DDFKALVLEYMPNGSLDIFLY------SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPII  597 (763)
Q Consensus       538 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~iv  597 (763)
                               .++..     ....+++|+++ +++|.+++.      .....+++..+..++.|+++||+||   |+++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL---HHYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH---HHTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcc
Confidence                     11111     12356677765 678988884      2233577888999999999999999   788999


Q ss_pred             eCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCcccc----------CCCCCCcchhHHHHHHHH
Q 046240          598 HCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG----------IERKVSTRSDIYSYGIML  667 (763)
Q Consensus       598 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~slGv~l  667 (763)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999875321     334567 999999998          666788999999999999


Q ss_pred             HHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHH
Q 046240          668 IETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCN  747 (763)
Q Consensus       668 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~  747 (763)
                      |||++|+.||.........                 ...+...+.        ++..+.+++..||+.||++||++.+++
T Consensus       308 ~elltg~~Pf~~~~~~~~~-----------------~~~~~~~~~--------~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGS-----------------EWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCS-----------------GGGGSSCCC--------CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhhH-----------------HHHHhhccc--------CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999999764322110                 001111111        134588999999999999999987774

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.1e-32  Score=323.61  Aligned_cols=301  Identities=23%  Similarity=0.246  Sum_probs=254.7

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .++++|+|++|++++..+..|+++++|++|+|++|.++       .+++..+.++++|++|+|++|.|+++.+..|.+++
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-------~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~   97 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS-------KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCT   97 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCC-------CCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccC-------ccCHHHHhcccCcCEEECCCCccCccChhhhccCC
Confidence            58999999999999888888999999999999999996       66667777999999999999999987777899999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccC--Cccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMG--NLSI  234 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~--~l~~  234 (763)
                      +|++|+|++|+++++.|..|+++++|++|+    +++|.+++..|..+.++. +|++|+|++|++++..+..+.  .+++
T Consensus        98 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~----Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~~~~  172 (680)
T 1ziw_A           98 NLTELHLMSNSIQKIKNNPFVKQKNLITLD----LSHNGLSSTKLGTQVQLE-NLQELLLSNNKIQALKSEELDIFANSS  172 (680)
T ss_dssp             TCSEEECCSSCCCCCCSCTTTTCTTCCEEE----CCSSCCSCCCCCSSSCCT-TCCEEECCSSCCCCBCHHHHGGGTTCE
T ss_pred             CCCEEECCCCccCccChhHccccCCCCEEE----CCCCcccccCchhhcccc-cCCEEEccCCcccccCHHHhhcccccc
Confidence            999999999999988889999999999999    889999999999998888 999999999999988877665  4589


Q ss_pred             cceeecccccccCCCCccccccCC-------------------------CCccEEEecCCccccCCCCccccccCCc--c
Q 046240          235 FLLLDLELNKLTGPIPVTFGRLQN-------------------------SKLDTLSLCGNSFSGSIPSCIDIGNLKV--V  287 (763)
Q Consensus       235 L~~L~L~~N~l~~~~p~~~~~l~~-------------------------~~L~~L~L~~N~l~~~~p~~~~~~~l~~--L  287 (763)
                      |++|++++|++++..|..+..+.+                         .+|+.|++++|.+++..|.  .+.+++.  |
T Consensus       173 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~--~~~~l~~~~L  250 (680)
T 1ziw_A          173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT--TFLGLKWTNL  250 (680)
T ss_dssp             ESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT--TTGGGGGSCC
T ss_pred             ccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh--HhhccCcCCC
Confidence            999999999999888877765432                         3478888888888877777  6777755  9


Q ss_pred             cEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCC---------ccchhhhhhcc
Q 046240          288 VEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISG---------FILISLEKLLY  358 (763)
Q Consensus       288 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~---------~~~~~~~~l~~  358 (763)
                      ++|+|++|++++..|..|+.+++|+.|+|++|++++..|..|..+++|+.|++++|...+         +....|..+++
T Consensus       251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~  330 (680)
T 1ziw_A          251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC  330 (680)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTT
T ss_pred             CEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCC
Confidence            999999999988888889999999999999999988888888888888888888875442         12236778888


Q ss_pred             CceEEcccccCCCCCCCC-CCccccccccccCCC
Q 046240          359 LKKLNLSFNKLEGEIPRG-GPFANFTAKSFMGNE  391 (763)
Q Consensus       359 L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~  391 (763)
                      |+.|++++|++++.+|.. ..++.+..+++.+|.
T Consensus       331 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  364 (680)
T 1ziw_A          331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF  364 (680)
T ss_dssp             CCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCB
T ss_pred             CCEEECCCCccCCCChhHhccccCCcEEECCCCc
Confidence            888888888888876653 456677777777764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.9e-33  Score=313.90  Aligned_cols=138  Identities=22%  Similarity=0.287  Sum_probs=119.8

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .++++|+|++|.+++..|..|.++++|++|+|++|+++       .+++..|.++++|++|+|++|+|++ +|..  .++
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~-------~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~   90 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-------YLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTV   90 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCC-------EEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccC-------CcChHHhhcccCCCEEecCCCceee-cCcc--ccC
Confidence            68999999999999888889999999999999999996       6666667799999999999999995 5554  899


Q ss_pred             CCCeeeecCccccc-ccccccCCCCchhhhhhhhhccCCcccccCCcccccccccc--cEEEeecCcc--ccccccccCC
Q 046240          157 KLTILELGGNSFSG-FIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISL--ERLYISNCSI--TGNIPQVMGN  231 (763)
Q Consensus       157 ~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L--~~L~L~~N~l--~~~~~~~~~~  231 (763)
                      +|++|+|++|+|++ .+|..|+++++|++|+    +++|.+++   ..+..+. +|  ++|+|++|++  .+..|..|..
T Consensus        91 ~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~----L~~n~l~~---~~~~~l~-~L~L~~L~l~~n~l~~~~~~~~~l~~  162 (520)
T 2z7x_B           91 NLKHLDLSFNAFDALPICKEFGNMSQLKFLG----LSTTHLEK---SSVLPIA-HLNISKVLLVLGETYGEKEDPEGLQD  162 (520)
T ss_dssp             CCSEEECCSSCCSSCCCCGGGGGCTTCCEEE----EEESSCCG---GGGGGGT-TSCEEEEEEEECTTTTSSCCTTTTTT
T ss_pred             CccEEeccCCccccccchhhhccCCcceEEE----ecCcccch---hhccccc-cceeeEEEeecccccccccccccccc
Confidence            99999999999997 4789999999999999    88999886   4566666 77  9999999999  6777776666


Q ss_pred             c
Q 046240          232 L  232 (763)
Q Consensus       232 l  232 (763)
                      +
T Consensus       163 l  163 (520)
T 2z7x_B          163 F  163 (520)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.1e-32  Score=291.76  Aligned_cols=268  Identities=18%  Similarity=0.240  Sum_probs=193.6

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      +++.+++++++++ .+|..+.  ++|++|+|++|.++       .++...+.++++|++|+|++|.|++..|..|.++++
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~-------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  101 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-------EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK  101 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-------CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTT
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCC-------EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCC
Confidence            3566777777777 4665554  67888888888885       666666678888888888888888777888888888


Q ss_pred             CCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccc--ccccccCCcccc
Q 046240          158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITG--NIPQVMGNLSIF  235 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~--~~~~~~~~l~~L  235 (763)
                      |++|+|++|+++. +|..+.  ++|++|+    +++|.+++..+..+.++. +|++|++++|+++.  ..+..|.++++|
T Consensus       102 L~~L~Ls~n~l~~-l~~~~~--~~L~~L~----l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L  173 (330)
T 1xku_A          102 LERLYLSKNQLKE-LPEKMP--KTLQELR----VHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKL  173 (330)
T ss_dssp             CCEEECCSSCCSB-CCSSCC--TTCCEEE----CCSSCCCBBCHHHHTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTC
T ss_pred             CCEEECCCCcCCc-cChhhc--ccccEEE----CCCCcccccCHhHhcCCc-cccEEECCCCcCCccCcChhhccCCCCc
Confidence            8888888888874 444333  5666666    677777766666666666 77777777777753  566677777777


Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEE
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS  315 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  315 (763)
                      ++|++++|+++ .+|..+.  +  +|++|++++|++++..|.  .+.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus       174 ~~L~l~~n~l~-~l~~~~~--~--~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  246 (330)
T 1xku_A          174 SYIRIADTNIT-TIPQGLP--P--SLTELHLDGNKITKVDAA--SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH  246 (330)
T ss_dssp             CEEECCSSCCC-SCCSSCC--T--TCSEEECTTSCCCEECTG--GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred             CEEECCCCccc-cCCcccc--c--cCCEEECCCCcCCccCHH--HhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEE
Confidence            77777777777 3454443  2  377777777777766565  677777777777777777776666777777777777


Q ss_pred             ccCccccCcccccccccccccEEeCcCCccCCccchhhhhh------ccCceEEcccccCCC
Q 046240          316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKL------LYLKKLNLSFNKLEG  371 (763)
Q Consensus       316 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~~  371 (763)
                      |++|+++ .+|..+..+++|++|+|++|+|+++.+..|...      ..|+.|++++|++..
T Consensus       247 L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~  307 (330)
T 1xku_A          247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  307 (330)
T ss_dssp             CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             CCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence            7777777 566677777777777777777777766666432      567777777777753

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=2.1e-32  Score=313.71  Aligned_cols=296  Identities=20%  Similarity=0.261  Sum_probs=226.2

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .++++|+|++|.|++..|..|+++++|++|+|++|.++       .+++..|.++++|++|+|++|+|+ .+|..  .++
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-------~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~  121 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-------SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMA  121 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCC-------EECTTTTTTCTTCCEEECTTSCCC-EECSC--CCT
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCC-------cCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccc
Confidence            57899999999999877788999999999999999885       676667778999999999999998 45554  788


Q ss_pred             CCCeeeecCcccccc-cccccCCCCchhhhhhhhhccCCcccccCCcccccccccc--cEEEeecCcc--ccccccccCC
Q 046240          157 KLTILELGGNSFSGF-IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISL--ERLYISNCSI--TGNIPQVMGN  231 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L--~~L~L~~N~l--~~~~~~~~~~  231 (763)
                      +|++|+|++|+|++. +|..|+++++|++|+    +++|++++.   .+.++. +|  ++|+|++|++  ++..|..|..
T Consensus       122 ~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~----L~~n~l~~~---~~~~l~-~L~L~~L~L~~n~l~~~~~~~~~l~~  193 (562)
T 3a79_B          122 SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG----LSAAKFRQL---DLLPVA-HLHLSCILLDLVSYHIKGGETESLQI  193 (562)
T ss_dssp             TCSEEECCSSCCSBCCCCGGGGGCTTCCEEE----EECSBCCTT---TTGGGT-TSCEEEEEEEESSCCCCSSSCCEEEE
T ss_pred             cCCEEECCCCCccccCchHhhcccCcccEEe----cCCCccccC---chhhhh-hceeeEEEeecccccccccCcccccc
Confidence            999999999999874 468899999999988    778888753   344444 55  8888888887  6666655554


Q ss_pred             cc------------------------------------------------------------------------------
Q 046240          232 LS------------------------------------------------------------------------------  233 (763)
Q Consensus       232 l~------------------------------------------------------------------------------  233 (763)
                      +.                                                                              
T Consensus       194 l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~  273 (562)
T 3a79_B          194 PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF  273 (562)
T ss_dssp             CCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH
T ss_pred             cCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh
Confidence            33                                                                              


Q ss_pred             ---ccceeecccccccCCCCccc-----------------------------------------------------cccC
Q 046240          234 ---IFLLLDLELNKLTGPIPVTF-----------------------------------------------------GRLQ  257 (763)
Q Consensus       234 ---~L~~L~L~~N~l~~~~p~~~-----------------------------------------------------~~l~  257 (763)
                         +|++|++++|+++|.+|..+                                                     ..++
T Consensus       274 ~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~  353 (562)
T 3a79_B          274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPS  353 (562)
T ss_dssp             TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCC
T ss_pred             hcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCC
Confidence               67777777777777777654                                                     3443


Q ss_pred             CCCccEEEecCCccccCCCCccccccCCcccEEEccccccccc--CCcccCCCcCccEEEccCccccCccc-cccccccc
Q 046240          258 NSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGD--IPATIGGLKDVQNISLPYNRLEGPIP-ESFGYLTS  334 (763)
Q Consensus       258 ~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~  334 (763)
                      +  |++|++++|++++.+|.  .+.++++|++|+|++|++++.  +|..|.++++|+.|+|++|++++.+| ..+..+++
T Consensus       354 ~--L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          354 S--FTFLNFTQNVFTDSVFQ--GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             C--CCEEECCSSCCCTTTTT--TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             C--ceEEECCCCccccchhh--hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            3  88888888888877777  678888888888888888863  34667888888888888888887344 45778888


Q ss_pred             ccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcccCCC
Q 046240          335 LEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       335 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      |++|+|++|++++..|..+.  ++|+.|+|++|+++..++....++.+..+++.+|... ..|
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~-~l~  489 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVP  489 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC-CCC
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC-CCC
Confidence            88888888888776555443  6888888888888865555567778888888888644 444

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.3e-32  Score=324.49  Aligned_cols=296  Identities=19%  Similarity=0.254  Sum_probs=203.6

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCc-ccCCCcccc-Ccccccc------ccCCCccEEEccccccccc
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNS-LVGNNSLSG-SLPSRID------LALPNVKALSLAYNRFSGT  147 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~-~lp~~~~------~~l~~L~~L~L~~N~i~~~  147 (763)
                      ..+++.|+|++|++.+.+|..|+++++|++|+|++|+ ++      | .+|..+.      ..+++|++|+|++|+|+ .
T Consensus       490 L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ls------g~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~  562 (876)
T 4ecn_A          490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS------AAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-E  562 (876)
T ss_dssp             CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSC------HHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-B
T ss_pred             CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcc------cccchHHHHhhhhcccccCCccEEEeeCCcCC-c
Confidence            4689999999999999999999999999999999998 75      5 5776543      34558999999999999 7


Q ss_pred             CCC--cccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccccc-ccEEEeecCccccc
Q 046240          148 IQS--PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS-LERLYISNCSITGN  224 (763)
Q Consensus       148 ~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~-L~~L~L~~N~l~~~  224 (763)
                      +|.  .|.++++|++|+|++|+|+ .+| .|+++++|+.|+    +++|+++ .+|..+.++. + |++|+|++|+|+ .
T Consensus       563 ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~----Ls~N~l~-~lp~~l~~l~-~~L~~L~Ls~N~L~-~  633 (876)
T 4ecn_A          563 FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLK----LDYNQIE-EIPEDFCAFT-DQVEGLGFSHNKLK-Y  633 (876)
T ss_dssp             CCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEE----CCSSCCS-CCCTTSCEEC-TTCCEEECCSSCCC-S
T ss_pred             cCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEE----CcCCccc-cchHHHhhcc-ccCCEEECcCCCCC-c
Confidence            787  8999999999999999998 677 899999999998    7888888 7888888888 6 999999999988 6


Q ss_pred             cccccCCccc--cceeecccccccCCCCccc---cccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccc
Q 046240          225 IPQVMGNLSI--FLLLDLELNKLTGPIPVTF---GRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG  299 (763)
Q Consensus       225 ~~~~~~~l~~--L~~L~L~~N~l~~~~p~~~---~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~  299 (763)
                      +|..+..++.  |+.|+|++|++++.+|...   ..+...+|+.|+|++|+++ .+|.. .+..+++|+.|+|++|+|+ 
T Consensus       634 lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~-~~~~l~~L~~L~Ls~N~L~-  710 (876)
T 4ecn_A          634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTE-LFATGSPISTIILSNNLMT-  710 (876)
T ss_dssp             CCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHH-HHHTTCCCSEEECCSCCCS-
T ss_pred             CchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHH-HHccCCCCCEEECCCCcCC-
Confidence            7777776654  8888888888876655322   2222123666666666666 44431 2235555666666666655 


Q ss_pred             cCCcccCC--------CcCccEEEccCccccCccccccc--ccccccEEeCcCCccCCccchhhhhhccCceEEccc---
Q 046240          300 DIPATIGG--------LKDVQNISLPYNRLEGPIPESFG--YLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF---  366 (763)
Q Consensus       300 ~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~---  366 (763)
                      .+|..+..        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|++   
T Consensus       711 ~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~  788 (876)
T 4ecn_A          711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD  788 (876)
T ss_dssp             CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBC
T ss_pred             ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCC
Confidence            33332221        125556666666555 4455454  55566666666666555 354555555566665544   


Q ss_pred             ---ccCCCCCCCC-CCccccccccccCCCc
Q 046240          367 ---NKLEGEIPRG-GPFANFTAKSFMGNEK  392 (763)
Q Consensus       367 ---N~l~~~~p~~-~~~~~l~~~~~~~n~~  392 (763)
                         |++.+.+|.. ..++.+..+++.+|..
T Consensus       789 ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L  818 (876)
T 4ecn_A          789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI  818 (876)
T ss_dssp             TTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred             cccccccccChHHHhcCCCCCEEECCCCCC
Confidence               4455555533 3345555555555543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=3.2e-32  Score=290.37  Aligned_cols=282  Identities=20%  Similarity=0.228  Sum_probs=246.1

Q ss_pred             CCcccceeecCC---------CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCc
Q 046240           64 VCNWIGITCDVN---------SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV  134 (763)
Q Consensus        64 ~c~w~gv~c~~~---------~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L  134 (763)
                      .|.|..+.|...         ..+++.|+|++|++++..+..|+++++|++|+|++|.++       .+++..+.++++|
T Consensus        30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~l~~L  102 (330)
T 1xku_A           30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-------KISPGAFAPLVKL  102 (330)
T ss_dssp             EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-------CBCTTTTTTCTTC
T ss_pred             cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCC-------eeCHHHhcCCCCC
Confidence            578999999642         257899999999999887889999999999999999996       5655566799999


Q ss_pred             cEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccc--cCCccccccccccc
Q 046240          135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG--ILPSSIVNLSISLE  212 (763)
Q Consensus       135 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~--~~p~~~~~l~~~L~  212 (763)
                      ++|+|++|.|+ .+|..+.  ++|++|++++|++++..+..|.++++|+.|+    +++|.+..  ..+..+.+++ +|+
T Consensus       103 ~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~----l~~n~l~~~~~~~~~~~~l~-~L~  174 (330)
T 1xku_A          103 ERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVE----LGTNPLKSSGIENGAFQGMK-KLS  174 (330)
T ss_dssp             CEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEE----CCSSCCCGGGBCTTGGGGCT-TCC
T ss_pred             CEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEE----CCCCcCCccCcChhhccCCC-CcC
Confidence            99999999999 4555554  7999999999999998889999999999999    88999964  7788888888 999


Q ss_pred             EEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEc
Q 046240          213 RLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINL  292 (763)
Q Consensus       213 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~L  292 (763)
                      +|++++|+++. +|..+.  ++|++|++++|++++..|..+..+++  |++|+|++|++++..+.  .+..+++|++|+|
T Consensus       175 ~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~--L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~L  247 (330)
T 1xku_A          175 YIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNN--LAKLGLSFNSISAVDNG--SLANTPHLRELHL  247 (330)
T ss_dssp             EEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTT--CCEEECCSSCCCEECTT--TGGGSTTCCEEEC
T ss_pred             EEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCC--CCEEECCCCcCceeChh--hccCCCCCCEEEC
Confidence            99999999995 555443  89999999999999888999999977  99999999999987776  7899999999999


Q ss_pred             ccccccccCCcccCCCcCccEEEccCccccCcccccccc------cccccEEeCcCCccCC--ccchhhhhhccCceEEc
Q 046240          293 SRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGY------LTSLEILDLSNNKISG--FILISLEKLLYLKKLNL  364 (763)
Q Consensus       293 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l  364 (763)
                      ++|+++ .+|..+..+++|+.|++++|++++..+..|..      .+.|+.|++++|.+..  +.|..|..+..++.++|
T Consensus       248 ~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L  326 (330)
T 1xku_A          248 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL  326 (330)
T ss_dssp             CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC
T ss_pred             CCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEe
Confidence            999999 78889999999999999999999877777754      3789999999999874  67889999999999999


Q ss_pred             cccc
Q 046240          365 SFNK  368 (763)
Q Consensus       365 ~~N~  368 (763)
                      ++|+
T Consensus       327 ~~N~  330 (330)
T 1xku_A          327 GNYK  330 (330)
T ss_dssp             ----
T ss_pred             cccC
Confidence            9985

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.3e-32  Score=293.66  Aligned_cols=286  Identities=21%  Similarity=0.265  Sum_probs=196.5

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      +++.+++++++++ .+|..+.  ++|++|+|++|.++       .+++..+.++++|++|+|++|+|++..|..|.++++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~-------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  103 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-------ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRK  103 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCC-------EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTT
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCC-------ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCC
Confidence            3566777778777 5666553  67888888888875       566666667888888888888888777888888888


Q ss_pred             CCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccc--cccccccCCcccc
Q 046240          158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT--GNIPQVMGNLSIF  235 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~--~~~~~~~~~l~~L  235 (763)
                      |++|+|++|+++. +|..+.  ++|++|+    +++|.+++..+..+.+++ +|++|++++|+++  +..+..|..+ +|
T Consensus       104 L~~L~L~~n~l~~-l~~~~~--~~L~~L~----l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l-~L  174 (332)
T 2ft3_A          104 LQKLYISKNHLVE-IPPNLP--SSLVELR----IHDNRIRKVPKGVFSGLR-NMNCIEMGGNPLENSGFEPGAFDGL-KL  174 (332)
T ss_dssp             CCEEECCSSCCCS-CCSSCC--TTCCEEE----CCSSCCCCCCSGGGSSCS-SCCEEECCSCCCBGGGSCTTSSCSC-CC
T ss_pred             CCEEECCCCcCCc-cCcccc--ccCCEEE----CCCCccCccCHhHhCCCc-cCCEEECCCCccccCCCCcccccCC-cc
Confidence            8888888888874 443333  6677766    667777766555666666 7777777777775  3566677777 77


Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEE
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS  315 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  315 (763)
                      ++|++++|++++ +|..+.  +  +|++|++++|++++..|.  .+..+++|++|+|++|++++..+..|..+++|+.|+
T Consensus       175 ~~L~l~~n~l~~-l~~~~~--~--~L~~L~l~~n~i~~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  247 (332)
T 2ft3_A          175 NYLRISEAKLTG-IPKDLP--E--TLNELHLDHNKIQAIELE--DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH  247 (332)
T ss_dssp             SCCBCCSSBCSS-CCSSSC--S--SCSCCBCCSSCCCCCCTT--SSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEE
T ss_pred             CEEECcCCCCCc-cCcccc--C--CCCEEECCCCcCCccCHH--HhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEE
Confidence            777777777774 454443  2  377777777777765555  577777777777777777776666777777777777


Q ss_pred             ccCccccCcccccccccccccEEeCcCCccCCccchhhhhh------ccCceEEcccccCC--CCCCCC-CCcccccccc
Q 046240          316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKL------LYLKKLNLSFNKLE--GEIPRG-GPFANFTAKS  386 (763)
Q Consensus       316 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~--~~~p~~-~~~~~l~~~~  386 (763)
                      |++|+++ .+|..+..+++|+.|++++|+|+++.+..|...      ..|+.|++++|+++  +..|.. ..++.+..++
T Consensus       248 L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~  326 (332)
T 2ft3_A          248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQ  326 (332)
T ss_dssp             CCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEE
T ss_pred             CCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhh
Confidence            7777777 566667777777777777777777666666543      55777777777776  233321 2344455555


Q ss_pred             ccCC
Q 046240          387 FMGN  390 (763)
Q Consensus       387 ~~~n  390 (763)
                      +.+|
T Consensus       327 l~~n  330 (332)
T 2ft3_A          327 FGNY  330 (332)
T ss_dssp             C---
T ss_pred             cccc
Confidence            5444

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-33  Score=301.71  Aligned_cols=288  Identities=19%  Similarity=0.244  Sum_probs=237.7

Q ss_pred             CCCCCCCCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEE
Q 046240           58 WTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL  137 (763)
Q Consensus        58 w~~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L  137 (763)
                      |......|.|.|+ |+          +++++++ .+|..+.  ++|++|+|++|.++       .+|...+.++++|++|
T Consensus        23 ~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~-------~~~~~~~~~l~~L~~L   81 (353)
T 2z80_A           23 SNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRIT-------YISNSDLQRCVNLQAL   81 (353)
T ss_dssp             ----CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCC-------EECTTTTTTCTTCCEE
T ss_pred             CCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCc-------ccCHHHhccCCCCCEE
Confidence            4445678999887 74          5678888 5676655  58999999999995       7788777899999999


Q ss_pred             EcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCC-cccccccccccEEEe
Q 046240          138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILP-SSIVNLSISLERLYI  216 (763)
Q Consensus       138 ~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p-~~~~~l~~~L~~L~L  216 (763)
                      +|++|+|++..|..|.++++|++|+|++|+|+++.+..|+++++|++|+    +++|++++..+ ..+.+++ +|++|++
T Consensus        82 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~----L~~n~l~~l~~~~~~~~l~-~L~~L~l  156 (353)
T 2z80_A           82 VLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN----LLGNPYKTLGETSLFSHLT-KLQILRV  156 (353)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEE----CTTCCCSSSCSSCSCTTCT-TCCEEEE
T ss_pred             ECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEE----CCCCCCcccCchhhhccCC-CCcEEEC
Confidence            9999999998889999999999999999999987777799999999999    88999886544 4677777 9999999


Q ss_pred             ecC-ccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccc
Q 046240          217 SNC-SITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN  295 (763)
Q Consensus       217 ~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N  295 (763)
                      ++| .++...+..|.++++|++|++++|++++..|..+..+++  |++|++++|+++ .+|.. .+..+++|+.|++++|
T Consensus       157 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~--L~~L~l~~n~l~-~~~~~-~~~~~~~L~~L~L~~n  232 (353)
T 2z80_A          157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN--VSHLILHMKQHI-LLLEI-FVDVTSSVECLELRDT  232 (353)
T ss_dssp             EESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSE--EEEEEEECSCST-THHHH-HHHHTTTEEEEEEESC
T ss_pred             CCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhcccc--CCeecCCCCccc-cchhh-hhhhcccccEEECCCC
Confidence            999 578777889999999999999999999888999999977  999999999987 44441 3556889999999999


Q ss_pred             cccccCCcccC---CCcCccEEEccCccccC----cccccccccccccEEeCcCCccCCccchhhhhhccCceEEccccc
Q 046240          296 NFSGDIPATIG---GLKDVQNISLPYNRLEG----PIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNK  368 (763)
Q Consensus       296 ~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  368 (763)
                      ++++..+..+.   ....++.++|++|.+++    .+|..+..+++|+.|+|++|+++.+++..|..+++|++|++++|+
T Consensus       233 ~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~  312 (353)
T 2z80_A          233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNP  312 (353)
T ss_dssp             BCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCC
Confidence            99976655544   35677888888888775    367788899999999999999998666667899999999999999


Q ss_pred             CCCCCCC
Q 046240          369 LEGEIPR  375 (763)
Q Consensus       369 l~~~~p~  375 (763)
                      +++.+|.
T Consensus       313 ~~~~~~~  319 (353)
T 2z80_A          313 WDCSCPR  319 (353)
T ss_dssp             BCCCHHH
T ss_pred             ccCcCCC
Confidence            9987763

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.8e-32  Score=291.04  Aligned_cols=281  Identities=22%  Similarity=0.263  Sum_probs=245.5

Q ss_pred             CCcccceeecCC---------CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCc
Q 046240           64 VCNWIGITCDVN---------SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV  134 (763)
Q Consensus        64 ~c~w~gv~c~~~---------~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L  134 (763)
                      .|.|..+.|...         ..+++.|+|++|++++..|..|.++++|++|+|++|.++       .+++..+.++++|
T Consensus        32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~l~~L  104 (332)
T 2ft3_A           32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-------KIHEKAFSPLRKL  104 (332)
T ss_dssp             EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-------EECGGGSTTCTTC
T ss_pred             cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccC-------ccCHhHhhCcCCC
Confidence            478999999653         247999999999999888889999999999999999996       6666667799999


Q ss_pred             cEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCccc--ccCCccccccccccc
Q 046240          135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLN--GILPSSIVNLSISLE  212 (763)
Q Consensus       135 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~--~~~p~~~~~l~~~L~  212 (763)
                      ++|+|++|.++ .+|..+.  ++|++|++++|+++++.+..|.++++|+.|+    +++|.++  +..|..+..+  +|+
T Consensus       105 ~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~----l~~n~l~~~~~~~~~~~~l--~L~  175 (332)
T 2ft3_A          105 QKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIE----MGGNPLENSGFEPGAFDGL--KLN  175 (332)
T ss_dssp             CEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEE----CCSCCCBGGGSCTTSSCSC--CCS
T ss_pred             CEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEE----CCCCccccCCCCcccccCC--ccC
Confidence            99999999999 4555554  8999999999999988888899999999999    8899996  4677777776  899


Q ss_pred             EEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEc
Q 046240          213 RLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINL  292 (763)
Q Consensus       213 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~L  292 (763)
                      +|++++|++++ +|..+.  ++|++|+|++|++++..|..+..+++  |+.|+|++|++++..+.  .+..+++|++|+|
T Consensus       176 ~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~--L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L  248 (332)
T 2ft3_A          176 YLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSK--LYRLGLGHNQIRMIENG--SLSFLPTLRELHL  248 (332)
T ss_dssp             CCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTT--CSCCBCCSSCCCCCCTT--GGGGCTTCCEEEC
T ss_pred             EEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCC--CCEEECCCCcCCcCChh--HhhCCCCCCEEEC
Confidence            99999999996 555544  79999999999999888899999977  99999999999987776  7899999999999


Q ss_pred             ccccccccCCcccCCCcCccEEEccCccccCccccccccc------ccccEEeCcCCccC--CccchhhhhhccCceEEc
Q 046240          293 SRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYL------TSLEILDLSNNKIS--GFILISLEKLLYLKKLNL  364 (763)
Q Consensus       293 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~l  364 (763)
                      ++|+++ .+|..+..+++|+.|++++|++++..+..|..+      ++|+.|++++|++.  .+.|..|..+++|+.+++
T Consensus       249 ~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l  327 (332)
T 2ft3_A          249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQF  327 (332)
T ss_dssp             CSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC
T ss_pred             CCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhc
Confidence            999999 788889999999999999999998777777653      67999999999998  778899999999999999


Q ss_pred             cccc
Q 046240          365 SFNK  368 (763)
Q Consensus       365 ~~N~  368 (763)
                      ++|+
T Consensus       328 ~~n~  331 (332)
T 2ft3_A          328 GNYK  331 (332)
T ss_dssp             ----
T ss_pred             cccc
Confidence            9985

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.98  E-value=2.7e-32  Score=298.09  Aligned_cols=295  Identities=22%  Similarity=0.259  Sum_probs=242.8

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .++++|+|++|.+++..+..|..+++|++|+|++|.++       .+|+..+.++++|++|+|++|.|+...+..|.+++
T Consensus        69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~  141 (390)
T 3o6n_A           69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-------YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP  141 (390)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-------cCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCC
Confidence            57999999999999877889999999999999999985       67777777899999999999999976666789999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccc---------------cccccEEEeecCcc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNL---------------SISLERLYISNCSI  221 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l---------------~~~L~~L~L~~N~l  221 (763)
                      +|++|+|++|++++..|..|.++++|+.|+    +++|.+++.....+.++               ..+|++|++++|++
T Consensus       142 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~----l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l  217 (390)
T 3o6n_A          142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQ----LSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI  217 (390)
T ss_dssp             TCCEEECCSSCCCBCCTTTTSSCTTCCEEE----CCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCC
T ss_pred             CCcEEECCCCccCccChhhccCCCCCCEEE----CCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCee
Confidence            999999999999988888999999999999    78888886533322221               12566677777777


Q ss_pred             ccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccC
Q 046240          222 TGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDI  301 (763)
Q Consensus       222 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~  301 (763)
                      +.. |..  ..++|+.|++++|++++.  ..+..+++  |++|+|++|.+++..|.  .+..+++|++|+|++|++++ +
T Consensus       218 ~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~--L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~L~~n~l~~-~  287 (390)
T 3o6n_A          218 NVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPG--LVEVDLSYNELEKIMYH--PFVKMQRLERLYISNNRLVA-L  287 (390)
T ss_dssp             CEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTT--CSEEECCSSCCCEEESG--GGTTCSSCCEEECCSSCCCE-E
T ss_pred             eec-ccc--ccccccEEECCCCCCccc--HHHcCCCC--ccEEECCCCcCCCcChh--HccccccCCEEECCCCcCcc-c
Confidence            644 322  247899999999999964  57888876  99999999999988788  89999999999999999995 5


Q ss_pred             CcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccc
Q 046240          302 PATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFAN  381 (763)
Q Consensus       302 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~  381 (763)
                      |..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+.+.   +..+++|+.|++++|++++.... ..+..
T Consensus       288 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~  362 (390)
T 3o6n_A          288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRN  362 (390)
T ss_dssp             ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTT
T ss_pred             CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccchhHH-HHHHH
Confidence            667788999999999999999 56777899999999999999999863   67789999999999999874322 12344


Q ss_pred             cccccccCCCcccCCC
Q 046240          382 FTAKSFMGNEKLCGLP  397 (763)
Q Consensus       382 l~~~~~~~n~~~c~~p  397 (763)
                      +....+.+++..|..+
T Consensus       363 ~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          363 VARPAVDDADQHCKID  378 (390)
T ss_dssp             CCTTTBCCCCSCCCTT
T ss_pred             HHhhcccccCceeccc
Confidence            4555667777777765

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.98  E-value=1.3e-31  Score=310.15  Aligned_cols=161  Identities=22%  Similarity=0.216  Sum_probs=144.4

Q ss_pred             cccEEEeecCccccccc-cccCCccccceeecccccccCCCCccccccCCCCccEEEecCCcccc-CCCCccccccCCcc
Q 046240          210 SLERLYISNCSITGNIP-QVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSG-SIPSCIDIGNLKVV  287 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~-~~p~~~~~~~l~~L  287 (763)
                      +|++|++++|++.+..| ..|..+++|++|++++|.+++..|..+.++++  |++|++++|++++ .+|.  .+..+++|
T Consensus       400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~~--~~~~l~~L  475 (606)
T 3vq2_A          400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS--LNTLKMAGNSFKDNTLSN--VFANTTNL  475 (606)
T ss_dssp             TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTT--CCEEECTTCEEGGGEECS--CCTTCTTC
T ss_pred             CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCC--CCEEECCCCcCCCcchHH--hhccCCCC
Confidence            56666666666666666 67889999999999999999999999999977  9999999999997 4777  78999999


Q ss_pred             cEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhc-cCceEEccc
Q 046240          288 VEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLL-YLKKLNLSF  366 (763)
Q Consensus       288 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~  366 (763)
                      ++|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|++|+|++|+|+. +|..+..++ +|+.|++++
T Consensus       476 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~  554 (606)
T 3vq2_A          476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTN  554 (606)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCS
T ss_pred             CEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccC
Confidence            999999999999999999999999999999999999899999999999999999999997 555588887 599999999


Q ss_pred             ccCCCCCCC
Q 046240          367 NKLEGEIPR  375 (763)
Q Consensus       367 N~l~~~~p~  375 (763)
                      |++.+..+.
T Consensus       555 N~~~c~c~~  563 (606)
T 3vq2_A          555 NSVACICEH  563 (606)
T ss_dssp             CCCCCSSTT
T ss_pred             CCcccCCcc
Confidence            999987764

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.98  E-value=3.2e-32  Score=313.91  Aligned_cols=295  Identities=23%  Similarity=0.264  Sum_probs=248.6

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|+|++|.|++..|..|+.+++|++|+|++|.++       .+|+..|.++++|++|+|++|.|++..+..|.+++
T Consensus        75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~  147 (597)
T 3oja_B           75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-------YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTP  147 (597)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC-------CCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCC
Confidence            57999999999999888889999999999999999996       68888888999999999999999987777889999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccc---------------cccccEEEeecCcc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNL---------------SISLERLYISNCSI  221 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l---------------~~~L~~L~L~~N~l  221 (763)
                      +|++|+|++|+|++..|..|+++++|+.|+    +++|.+++..+..+.++               ..+|++|++++|.+
T Consensus       148 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~----L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l  223 (597)
T 3oja_B          148 KLTTLSMSNNNLERIEDDTFQATTSLQNLQ----LSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI  223 (597)
T ss_dssp             TCCEEECCSSCCCBCCTTTTTTCTTCCEEE----CTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCC
T ss_pred             CCCEEEeeCCcCCCCChhhhhcCCcCcEEE----CcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcc
Confidence            999999999999999999999999999999    88999887543332221               12456666666666


Q ss_pred             ccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccC
Q 046240          222 TGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDI  301 (763)
Q Consensus       222 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~  301 (763)
                      +...+..   .++|+.|+|++|.+++  +..+..+++  |+.|+|++|.+++.+|.  .+..+++|+.|+|++|++++ +
T Consensus       224 ~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~--L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~-l  293 (597)
T 3oja_B          224 NVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPG--LVEVDLSYNELEKIMYH--PFVKMQRLERLYISNNRLVA-L  293 (597)
T ss_dssp             CEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTT--CSEEECCSSCCCEEESG--GGTTCSSCCEEECTTSCCCE-E
T ss_pred             ccccccc---CCCCCEEECCCCCCCC--ChhhccCCC--CCEEECCCCccCCCCHH--HhcCccCCCEEECCCCCCCC-C
Confidence            6433332   2689999999999996  467888876  99999999999988888  89999999999999999996 5


Q ss_pred             CcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccc
Q 046240          302 PATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFAN  381 (763)
Q Consensus       302 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~  381 (763)
                      |..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|+++.   +..+++|+.|++++|++++..... .+..
T Consensus       294 ~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~~-~~~~  368 (597)
T 3oja_B          294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRA-LFRN  368 (597)
T ss_dssp             ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHH-HTTT
T ss_pred             CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHHH-HHHH
Confidence            777888999999999999999 67778899999999999999999864   667889999999999998754321 2344


Q ss_pred             cccccccCCCcccCCC
Q 046240          382 FTAKSFMGNEKLCGLP  397 (763)
Q Consensus       382 l~~~~~~~n~~~c~~p  397 (763)
                      +....+.+++..|+.+
T Consensus       369 ~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          369 VARPAVDDADQHCKID  384 (597)
T ss_dssp             CCTTTBCCCCCCCCTT
T ss_pred             HhhhccccccccCCcc
Confidence            4555677888888864

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.97  E-value=8.5e-32  Score=309.47  Aligned_cols=162  Identities=22%  Similarity=0.265  Sum_probs=138.5

Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCC-ccccccCCCCccEEEecCCccccCCCCccccccCCccc
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIP-VTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV  288 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~  288 (763)
                      +|++|++++|++++..+. +..+++|++|++++|.+++..| ..+.++++  |++|++++|.+.+..|.  .+.++++|+
T Consensus       374 ~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~--~~~~l~~L~  448 (570)
T 2z63_A          374 SLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN--LIYLDISHTHTRVAFNG--IFNGLSSLE  448 (570)
T ss_dssp             CCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTT--CCEEECTTSCCEECCTT--TTTTCTTCC
T ss_pred             ccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCC--CCEEeCcCCcccccchh--hhhcCCcCc
Confidence            344444444444433333 6677788888888888886665 46788876  99999999999988888  789999999


Q ss_pred             EEEccccccc-ccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccc
Q 046240          289 EINLSRNNFS-GDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFN  367 (763)
Q Consensus       289 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  367 (763)
                      +|++++|+++ +.+|..+..+++|+.|+|++|++++..|..|..+++|++|+|++|+++++++..|..+++|+.|++++|
T Consensus       449 ~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N  528 (570)
T 2z63_A          449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN  528 (570)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCC
Confidence            9999999998 578999999999999999999999888999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCC
Q 046240          368 KLEGEIPRG  376 (763)
Q Consensus       368 ~l~~~~p~~  376 (763)
                      ++++.+|..
T Consensus       529 ~~~~~~~~~  537 (570)
T 2z63_A          529 PWDCSCPRI  537 (570)
T ss_dssp             CBCCCTTTT
T ss_pred             cccCCCcch
Confidence            999998865

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.97  E-value=8e-31  Score=281.64  Aligned_cols=281  Identities=20%  Similarity=0.310  Sum_probs=226.1

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCC
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNA  155 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l  155 (763)
                      ..++++|+|++|.+++. +. +..+++|++|+|++|.++       .+|  .+..+++|++|+|++|.+++..+  +.++
T Consensus        65 ~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~-------~~~--~~~~l~~L~~L~l~~n~i~~~~~--~~~l  131 (347)
T 4fmz_A           65 LTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKIT-------DIS--ALQNLTNLRELYLNEDNISDISP--LANL  131 (347)
T ss_dssp             CTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-------CCG--GGTTCTTCSEEECTTSCCCCCGG--GTTC
T ss_pred             cCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCccc-------Cch--HHcCCCcCCEEECcCCcccCchh--hccC
Confidence            45788888888888854 33 888888888888888885       444  25578888888888888886543  7888


Q ss_pred             CCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCcccc
Q 046240          156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF  235 (763)
Q Consensus       156 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L  235 (763)
                      ++|++|++++|.....++ .+..+++|++|+    +++|.+.+..+  +..++ +|++|++++|++.+..+  +..+++|
T Consensus       132 ~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~----l~~~~~~~~~~--~~~l~-~L~~L~l~~n~l~~~~~--~~~l~~L  201 (347)
T 4fmz_A          132 TKMYSLNLGANHNLSDLS-PLSNMTGLNYLT----VTESKVKDVTP--IANLT-DLYSLSLNYNQIEDISP--LASLTSL  201 (347)
T ss_dssp             TTCCEEECTTCTTCCCCG-GGTTCTTCCEEE----CCSSCCCCCGG--GGGCT-TCSEEECTTSCCCCCGG--GGGCTTC
T ss_pred             CceeEEECCCCCCccccc-chhhCCCCcEEE----ecCCCcCCchh--hccCC-CCCEEEccCCccccccc--ccCCCcc
Confidence            888888888886654444 488888888888    77888876544  66676 89999999999886544  8888999


Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEE
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS  315 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  315 (763)
                      +.|++++|.+++..+  +..+++  |++|++++|++++ ++.   +..+++|++|++++|++++.  ..+..+++|+.|+
T Consensus       202 ~~L~l~~n~l~~~~~--~~~~~~--L~~L~l~~n~l~~-~~~---~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~  271 (347)
T 4fmz_A          202 HYFTAYVNQITDITP--VANMTR--LNSLKIGNNKITD-LSP---LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLN  271 (347)
T ss_dssp             CEEECCSSCCCCCGG--GGGCTT--CCEEECCSSCCCC-CGG---GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred             ceeecccCCCCCCch--hhcCCc--CCEEEccCCccCC-Ccc---hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEE
Confidence            999999999886544  777765  9999999999984 332   77889999999999999854  5688999999999


Q ss_pred             ccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCc
Q 046240          316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEK  392 (763)
Q Consensus       316 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~  392 (763)
                      +++|++++.  ..+..+++|+.|++++|++++..+..+..+++|+.|++++|++++.+| ...++.+..+++.+|+.
T Consensus       272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVI  345 (347)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC--
T ss_pred             ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhcc
Confidence            999999864  358889999999999999999889999999999999999999998877 55677888888888863

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1.5e-31  Score=282.08  Aligned_cols=251  Identities=25%  Similarity=0.303  Sum_probs=157.5

Q ss_pred             CcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccc
Q 046240           65 CNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRF  144 (763)
Q Consensus        65 c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i  144 (763)
                      |.|.++.|+            +++++ .+|..+.  ++|++|+|++|.++       .+|..+|.++++|++|+|++|.|
T Consensus         7 C~~~~l~c~------------~~~l~-~ip~~~~--~~l~~L~L~~n~l~-------~i~~~~~~~l~~L~~L~L~~n~l   64 (306)
T 2z66_A            7 CSGTEIRCN------------SKGLT-SVPTGIP--SSATRLELESNKLQ-------SLPHGVFDKLTQLTKLSLSSNGL   64 (306)
T ss_dssp             EETTEEECC------------SSCCS-SCCSCCC--TTCCEEECCSSCCC-------CCCTTTTTTCTTCSEEECCSSCC
T ss_pred             eCCCEEEcC------------CCCcc-cCCCCCC--CCCCEEECCCCccC-------ccCHhHhhccccCCEEECCCCcc
Confidence            566666664            45566 4555443  67888888888885       78888777888888888888888


Q ss_pred             ccc--CCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCC-cccccccccccEEEeecCcc
Q 046240          145 SGT--IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILP-SSIVNLSISLERLYISNCSI  221 (763)
Q Consensus       145 ~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p-~~~~~l~~~L~~L~L~~N~l  221 (763)
                      +..  .|..+.++++|++|+|++|++++ +|..|.++++|++|+    +++|++++..+ ..+.++. +|++|++++|++
T Consensus        65 ~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~----l~~n~l~~~~~~~~~~~l~-~L~~L~l~~n~l  138 (306)
T 2z66_A           65 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD----FQHSNLKQMSEFSVFLSLR-NLIYLDISHTHT  138 (306)
T ss_dssp             CEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEE----CTTSEEESSTTTTTTTTCT-TCCEEECTTSCC
T ss_pred             CcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEE----CCCCcccccccchhhhhcc-CCCEEECCCCcC
Confidence            743  35666778888888888888874 555576666666665    55555554443 3444444 666666666666


Q ss_pred             ccccccccCCccccceeecccccccC-CCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEccccccccc
Q 046240          222 TGNIPQVMGNLSIFLLLDLELNKLTG-PIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGD  300 (763)
Q Consensus       222 ~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~  300 (763)
                      ++..+..|..+++|++|+|++|.+++ ..|..+..+++  |++|+|++|++++..|.  .+..+++|++|+|++|++++.
T Consensus       139 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~--L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~  214 (306)
T 2z66_A          139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN--LTFLDLSQCQLEQLSPT--AFNSLSSLQVLNMSHNNFFSL  214 (306)
T ss_dssp             EECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT--CCEEECTTSCCCEECTT--TTTTCTTCCEEECTTSCCSBC
T ss_pred             CccchhhcccCcCCCEEECCCCccccccchhHHhhCcC--CCEEECCCCCcCCcCHH--HhcCCCCCCEEECCCCccCcc
Confidence            65556666666666666666666654 34555555544  55666666655544444  455555555566665555555


Q ss_pred             CCcccCCCcCccEEEccCccccCcccccccccc-cccEEeCcCCccCC
Q 046240          301 IPATIGGLKDVQNISLPYNRLEGPIPESFGYLT-SLEILDLSNNKISG  347 (763)
Q Consensus       301 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~  347 (763)
                      .+..+..+++|+.|+|++|++++..|..+..++ +|++|+|++|+++.
T Consensus       215 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          215 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             CSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             ChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            454555555555555555555555555555553 55555555555554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=9.2e-31  Score=290.49  Aligned_cols=249  Identities=22%  Similarity=0.251  Sum_probs=166.6

Q ss_pred             EEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCC
Q 046240           80 TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLT  159 (763)
Q Consensus        80 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~  159 (763)
                      ..++.++++++ .+|..+.  ++++.|+|++|+++       .++...|.++++|++|+|++|.|+++.+..|.++++|+
T Consensus        46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~-------~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~  115 (440)
T 3zyj_A           46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-------IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN  115 (440)
T ss_dssp             CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCC-------EECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCC
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCC-------eeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCC
Confidence            45667777777 5666554  56777777777774       56656666777777777777777766667777777777


Q ss_pred             eeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceee
Q 046240          160 ILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLD  239 (763)
Q Consensus       160 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  239 (763)
                      +|+|++|+|+++.+..|.+++                             +|++|+|++|+|+...+..|..+++|++|+
T Consensus       116 ~L~L~~n~l~~~~~~~~~~l~-----------------------------~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  166 (440)
T 3zyj_A          116 TLELFDNRLTTIPNGAFVYLS-----------------------------KLKELWLRNNPIESIPSYAFNRIPSLRRLD  166 (440)
T ss_dssp             EEECCSSCCSSCCTTTSCSCS-----------------------------SCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred             EEECCCCcCCeeCHhHhhccc-----------------------------cCceeeCCCCcccccCHHHhhhCcccCEeC
Confidence            777777777765555666655                             455555555555555555566666666666


Q ss_pred             ccc-ccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccC
Q 046240          240 LEL-NKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY  318 (763)
Q Consensus       240 L~~-N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  318 (763)
                      |++ |.++...+..|.++++  |++|+|++|+++ .+|.   +..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus       167 l~~~~~l~~i~~~~~~~l~~--L~~L~L~~n~l~-~~~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  240 (440)
T 3zyj_A          167 LGELKRLSYISEGAFEGLSN--LRYLNLAMCNLR-EIPN---LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ  240 (440)
T ss_dssp             CCCCTTCCEECTTTTTTCSS--CCEEECTTSCCS-SCCC---CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CCCCCCcceeCcchhhcccc--cCeecCCCCcCc-cccc---cCCCcccCEEECCCCccCccChhhhccCccCCEEECCC
Confidence            665 3333333335555654  666666666666 4443   56667777777777777776677777777777777777


Q ss_pred             ccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCC
Q 046240          319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI  373 (763)
Q Consensus       319 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  373 (763)
                      |++++..+..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|++.+..
T Consensus       241 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC  295 (440)
T 3zyj_A          241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNC  295 (440)
T ss_dssp             CCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred             CceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCC
Confidence            7777666777777777777777777777776667777777777777777766543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.97  E-value=4.4e-31  Score=302.08  Aligned_cols=293  Identities=20%  Similarity=0.209  Sum_probs=230.2

Q ss_pred             EEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCee
Q 046240           82 LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTIL  161 (763)
Q Consensus        82 L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L  161 (763)
                      .|+++++++ .+|..+.  ++|++|+|++|.++       .+++..+.++++|++|+|++|+|++..|..|.++++|++|
T Consensus        10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~-------~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   79 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKIT-------YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHL   79 (549)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-------EECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             EECCCCccc-cccccCC--CCccEEECcCCccC-------ccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEE
Confidence            789999999 6777665  79999999999996       6666667799999999999999999999999999999999


Q ss_pred             eecCcccccccccccCCCCchhhhhhhhhccCCcccc-cCCcccccccccccEEEeecCc-cccccccccCCccccceee
Q 046240          162 ELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG-ILPSSIVNLSISLERLYISNCS-ITGNIPQVMGNLSIFLLLD  239 (763)
Q Consensus       162 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~-~~p~~~~~l~~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~  239 (763)
                      +|++|++++..|..|+++++|++|+    +++|.+++ ..|..+.++. +|++|++++|+ +....+..|+++++|++|+
T Consensus        80 ~Ls~n~l~~~~~~~~~~l~~L~~L~----Ls~n~l~~~~~~~~~~~l~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~  154 (549)
T 2z81_A           80 DLSDNHLSSLSSSWFGPLSSLKYLN----LMGNPYQTLGVTSLFPNLT-NLQTLRIGNVETFSEIRRIDFAGLTSLNELE  154 (549)
T ss_dssp             ECTTSCCCSCCHHHHTTCTTCCEEE----CTTCCCSSSCSSCSCTTCT-TCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred             ECCCCccCccCHHHhccCCCCcEEE----CCCCcccccchhhhhhccC-CccEEECCCCccccccCHhhhhcccccCeee
Confidence            9999999999888899999999999    88999987 4678888998 99999999999 4544457899999999999


Q ss_pred             cccccccCCCCccccccCC----------------------CCccEEEecCCccccCC--CCcccc--------------
Q 046240          240 LELNKLTGPIPVTFGRLQN----------------------SKLDTLSLCGNSFSGSI--PSCIDI--------------  281 (763)
Q Consensus       240 L~~N~l~~~~p~~~~~l~~----------------------~~L~~L~L~~N~l~~~~--p~~~~~--------------  281 (763)
                      +++|++++..|..+..+++                      ++|++|++++|++++..  |.. ..              
T Consensus       155 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~L~~L~l~~n  233 (549)
T 2z81_A          155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLP-VDEVSSPMKKLAFRGS  233 (549)
T ss_dssp             EEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCS-SCCCCCCCCEEEEESC
T ss_pred             ccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccc-hhhhhhcccceecccc
Confidence            9999999888888766532                      23667777777766421  000 00              


Q ss_pred             -------------------------------------------------------------------------ccCCccc
Q 046240          282 -------------------------------------------------------------------------GNLKVVV  288 (763)
Q Consensus       282 -------------------------------------------------------------------------~~l~~L~  288 (763)
                                                                                               ...++|+
T Consensus       234 ~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~  313 (549)
T 2z81_A          234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK  313 (549)
T ss_dssp             EEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCC
T ss_pred             ccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccce
Confidence                                                                                     0012345


Q ss_pred             EEEcccccccccCCccc-CCCcCccEEEccCccccCccc---ccccccccccEEeCcCCccCCccc--hhhhhhccCceE
Q 046240          289 EINLSRNNFSGDIPATI-GGLKDVQNISLPYNRLEGPIP---ESFGYLTSLEILDLSNNKISGFIL--ISLEKLLYLKKL  362 (763)
Q Consensus       289 ~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L  362 (763)
                      .|++++|+++ .+|..+ ..+++|+.|+|++|++++.+|   ..++.+++|++|+|++|+++++.+  ..+..+++|++|
T Consensus       314 ~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L  392 (549)
T 2z81_A          314 RITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL  392 (549)
T ss_dssp             EEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEE
T ss_pred             EEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEE
Confidence            5555555554 345444 468888888888888887654   346778888888888888887643  567888888888


Q ss_pred             EcccccCCCCCCCCCCccccccccccCCC
Q 046240          363 NLSFNKLEGEIPRGGPFANFTAKSFMGNE  391 (763)
Q Consensus       363 ~l~~N~l~~~~p~~~~~~~l~~~~~~~n~  391 (763)
                      ++++|++++.++.....+.+..+++.+|.
T Consensus       393 ~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~  421 (549)
T 2z81_A          393 DISRNTFHPMPDSCQWPEKMRFLNLSSTG  421 (549)
T ss_dssp             ECTTCCCCCCCSCCCCCTTCCEEECTTSC
T ss_pred             ECCCCCCccCChhhcccccccEEECCCCC
Confidence            88888888654444556778888888775

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=2.1e-30  Score=288.73  Aligned_cols=249  Identities=22%  Similarity=0.252  Sum_probs=154.9

Q ss_pred             EEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCC
Q 046240           80 TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLT  159 (763)
Q Consensus        80 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~  159 (763)
                      ..++.++++++ .+|..+.  ++|++|+|++|.|+       .++...|.++++|++|+|++|+|+++.|..|.++++|+
T Consensus        57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~-------~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~  126 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-------MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLN  126 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCC-------EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCc-------eECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCC
Confidence            34556666666 3454433  45566666665553       34444444555555555555555555555555555555


Q ss_pred             eeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceee
Q 046240          160 ILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLD  239 (763)
Q Consensus       160 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  239 (763)
                      +|+|++|+|+++.+..|.+++                             +|++|+|++|+|+...+..|..+++|+.|+
T Consensus       127 ~L~L~~n~l~~~~~~~~~~l~-----------------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  177 (452)
T 3zyi_A          127 TLELFDNWLTVIPSGAFEYLS-----------------------------KLRELWLRNNPIESIPSYAFNRVPSLMRLD  177 (452)
T ss_dssp             EEECCSSCCSBCCTTTSSSCT-----------------------------TCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred             EEECCCCcCCccChhhhcccC-----------------------------CCCEEECCCCCcceeCHhHHhcCCcccEEe
Confidence            555555555544444454444                             566666666666655555666666666666


Q ss_pred             ccc-ccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccC
Q 046240          240 LEL-NKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPY  318 (763)
Q Consensus       240 L~~-N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  318 (763)
                      |++ |.+....+..|.++++  |++|+|++|+++ .+|.   +..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus       178 l~~~~~l~~i~~~~~~~l~~--L~~L~L~~n~l~-~~~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  251 (452)
T 3zyi_A          178 LGELKKLEYISEGAFEGLFN--LKYLNLGMCNIK-DMPN---LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN  251 (452)
T ss_dssp             CCCCTTCCEECTTTTTTCTT--CCEEECTTSCCS-SCCC---CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTT
T ss_pred             CCCCCCccccChhhccCCCC--CCEEECCCCccc-cccc---ccccccccEEECcCCcCcccCcccccCccCCCEEEeCC
Confidence            666 3444333334666654  666666666666 3443   56667777777777777776677777777777777777


Q ss_pred             ccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCC
Q 046240          319 NRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI  373 (763)
Q Consensus       319 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  373 (763)
                      |++++..+..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|++.+..
T Consensus       252 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC  306 (452)
T 3zyi_A          252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC  306 (452)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred             CcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence            7777666777777777777777777777766666777777777777777776544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.97  E-value=2.4e-30  Score=301.15  Aligned_cols=282  Identities=24%  Similarity=0.277  Sum_probs=229.4

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|+|++|+|+++.|.+|.+|++|++|+|++|+|+       .+|..+|.++++|++|+|++|+|+++.+..|++++
T Consensus        76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-------~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~  148 (635)
T 4g8a_A           76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-------SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK  148 (635)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-------EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCT
T ss_pred             CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC-------CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCc
Confidence            57999999999999888889999999999999999996       88999998999999999999999988888899999


Q ss_pred             CCCeeeecCcccccc-cccccCCCCchhhhhhhhhccCCcccccCCccccc-----------------------------
Q 046240          157 KLTILELGGNSFSGF-IPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVN-----------------------------  206 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~-----------------------------  206 (763)
                      +|++|+|++|+|++. .|..++++++|++|+    +++|++++..|..+..                             
T Consensus       149 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~----L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~  224 (635)
T 4g8a_A          149 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLD----LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI  224 (635)
T ss_dssp             TCCEEECCSSCCCCCCCCGGGGGCTTCCEEE----CCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC
T ss_pred             ccCeeccccCccccCCCchhhccchhhhhhc----ccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccch
Confidence            999999999999864 578888999999888    4455444332221110                             


Q ss_pred             --------------------------------------------------------------------------------
Q 046240          207 --------------------------------------------------------------------------------  206 (763)
Q Consensus       207 --------------------------------------------------------------------------------  206 (763)
                                                                                                      
T Consensus       225 ~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~  304 (635)
T 4g8a_A          225 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNC  304 (635)
T ss_dssp             EEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGG
T ss_pred             hhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhh
Confidence                                                                                            


Q ss_pred             -----------------------------------------------------------------ccccccEEEeecCcc
Q 046240          207 -----------------------------------------------------------------LSISLERLYISNCSI  221 (763)
Q Consensus       207 -----------------------------------------------------------------l~~~L~~L~L~~N~l  221 (763)
                                                                                       ++ +|+.|++++|.+
T Consensus       305 ~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~-~L~~L~ls~n~l  383 (635)
T 4g8a_A          305 LTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP-SLEFLDLSRNGL  383 (635)
T ss_dssp             GTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT-TCCEEECCSSCC
T ss_pred             hcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc-ccccchhhcccc
Confidence                                                                             11 233344444433


Q ss_pred             ccc--------------------------------------------------cccccCCccccceeecccccccCCCCc
Q 046240          222 TGN--------------------------------------------------IPQVMGNLSIFLLLDLELNKLTGPIPV  251 (763)
Q Consensus       222 ~~~--------------------------------------------------~~~~~~~l~~L~~L~L~~N~l~~~~p~  251 (763)
                      ...                                                  .+..|..+++++.++++.|.+++..|.
T Consensus       384 ~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~  463 (635)
T 4g8a_A          384 SFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG  463 (635)
T ss_dssp             BEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTT
T ss_pred             ccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccccccccccccccc
Confidence            210                                                  012234455556666666666666677


Q ss_pred             cccccCCCCccEEEecCCccc-cCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCccccccc
Q 046240          252 TFGRLQNSKLDTLSLCGNSFS-GSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFG  330 (763)
Q Consensus       252 ~~~~l~~~~L~~L~L~~N~l~-~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  330 (763)
                      .+..++.  ++.|+|++|++. +.+|.  .+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.
T Consensus       464 ~~~~~~~--L~~L~Ls~N~~~~~~~~~--~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  539 (635)
T 4g8a_A          464 IFNGLSS--LEVLKMAGNSFQENFLPD--IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK  539 (635)
T ss_dssp             TTTTCTT--CCEEECTTCEEGGGEECS--CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGT
T ss_pred             ccccchh--hhhhhhhhcccccccCch--hhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHh
Confidence            7777766  999999999854 45677  789999999999999999999999999999999999999999998899999


Q ss_pred             ccccccEEeCcCCccCCccchhhhhh-ccCceEEcccccCCCCCC
Q 046240          331 YLTSLEILDLSNNKISGFILISLEKL-LYLKKLNLSFNKLEGEIP  374 (763)
Q Consensus       331 ~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p  374 (763)
                      .+++|++|+|++|+|+++.|..+..+ ++|+.|+|++|+|++...
T Consensus       540 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          540 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             TCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99999999999999999999999988 689999999999998764

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=6.1e-31  Score=277.34  Aligned_cols=274  Identities=21%  Similarity=0.252  Sum_probs=230.3

Q ss_pred             CEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccc--cccccCCCCc
Q 046240          104 TKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGF--IPNTIGNLRN  181 (763)
Q Consensus       104 ~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~  181 (763)
                      +.++.+++.++       .+|..++   ++|++|+|++|+|+.+.+..|.++++|++|+|++|+++..  .+..+.++++
T Consensus        10 ~~l~c~~~~l~-------~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~   79 (306)
T 2z66_A           10 TEIRCNSKGLT-------SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS   79 (306)
T ss_dssp             TEEECCSSCCS-------SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSC
T ss_pred             CEEEcCCCCcc-------cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccc
Confidence            57888888886       7887664   6899999999999977777789999999999999999843  3677888999


Q ss_pred             hhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccc-cccCCccccceeecccccccCCCCccccccCCCC
Q 046240          182 IEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP-QVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSK  260 (763)
Q Consensus       182 L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~  260 (763)
                      |++|+    +++|.+++ +|..+.+++ +|++|++++|++++..+ ..+..+++|++|++++|.+++..|..+..+++  
T Consensus        80 L~~L~----Ls~n~i~~-l~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~--  151 (306)
T 2z66_A           80 LKYLD----LSFNGVIT-MSSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS--  151 (306)
T ss_dssp             CCEEE----CCSCSEEE-EEEEEETCT-TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTT--
T ss_pred             cCEEE----CCCCcccc-ChhhcCCCC-CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcC--
Confidence            99999    88998884 677788888 99999999999997665 68999999999999999999888888988876  


Q ss_pred             ccEEEecCCcccc-CCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEe
Q 046240          261 LDTLSLCGNSFSG-SIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILD  339 (763)
Q Consensus       261 L~~L~L~~N~l~~-~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  339 (763)
                      |++|++++|.+++ .+|.  .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+
T Consensus       152 L~~L~l~~n~l~~~~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  229 (306)
T 2z66_A          152 LEVLKMAGNSFQENFLPD--IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD  229 (306)
T ss_dssp             CCEEECTTCEEGGGEECS--CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred             CCEEECCCCccccccchh--HHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence            9999999999986 5677  788999999999999999988899999999999999999999987777889999999999


Q ss_pred             CcCCccCCccchhhhhhc-cCceEEcccccCCCCCCCCC---CccccccccccCCCcccCCC
Q 046240          340 LSNNKISGFILISLEKLL-YLKKLNLSFNKLEGEIPRGG---PFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       340 L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~---~~~~l~~~~~~~n~~~c~~p  397 (763)
                      |++|++++..+..+..++ +|+.|+|++|++++..+...   -+.....+....+...|..|
T Consensus       230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p  291 (306)
T 2z66_A          230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP  291 (306)
T ss_dssp             CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred             CCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence            999999998888888884 89999999999988654221   11222333444555666554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.97  E-value=4.5e-30  Score=275.76  Aligned_cols=283  Identities=22%  Similarity=0.312  Sum_probs=243.5

Q ss_pred             CCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccC
Q 046240           75 NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITN  154 (763)
Q Consensus        75 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~  154 (763)
                      ...++++|+++++.+.. ++ .+..+++|++|+|++|.++       .+|.  +..+++|++|+|++|.+++.  +.|.+
T Consensus        42 ~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~-------~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~  108 (347)
T 4fmz_A           42 ELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT-------DISP--LSNLVKLTNLYIGTNKITDI--SALQN  108 (347)
T ss_dssp             HHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-------CCGG--GTTCTTCCEEECCSSCCCCC--GGGTT
T ss_pred             hcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc-------cchh--hhcCCcCCEEEccCCcccCc--hHHcC
Confidence            34689999999999984 44 4999999999999999996       5665  66999999999999999964  46999


Q ss_pred             CCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccc
Q 046240          155 ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSI  234 (763)
Q Consensus       155 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~  234 (763)
                      +++|++|+|++|++++..+  +.++++|+.|+    +++|.....++. +..++ +|++|++++|.+.+..+  +..+++
T Consensus       109 l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~----l~~n~~~~~~~~-~~~l~-~L~~L~l~~~~~~~~~~--~~~l~~  178 (347)
T 4fmz_A          109 LTNLRELYLNEDNISDISP--LANLTKMYSLN----LGANHNLSDLSP-LSNMT-GLNYLTVTESKVKDVTP--IANLTD  178 (347)
T ss_dssp             CTTCSEEECTTSCCCCCGG--GTTCTTCCEEE----CTTCTTCCCCGG-GTTCT-TCCEEECCSSCCCCCGG--GGGCTT
T ss_pred             CCcCCEEECcCCcccCchh--hccCCceeEEE----CCCCCCcccccc-hhhCC-CCcEEEecCCCcCCchh--hccCCC
Confidence            9999999999999997654  99999999999    788866655444 77887 99999999999996655  899999


Q ss_pred             cceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEE
Q 046240          235 FLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNI  314 (763)
Q Consensus       235 L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  314 (763)
                      |++|++++|.+++..+  +..+++  |+.|++++|.+++. +   .+..+++|++|++++|++++..+  +..+++|+.|
T Consensus       179 L~~L~l~~n~l~~~~~--~~~l~~--L~~L~l~~n~l~~~-~---~~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  248 (347)
T 4fmz_A          179 LYSLSLNYNQIEDISP--LASLTS--LHYFTAYVNQITDI-T---PVANMTRLNSLKIGNNKITDLSP--LANLSQLTWL  248 (347)
T ss_dssp             CSEEECTTSCCCCCGG--GGGCTT--CCEEECCSSCCCCC-G---GGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             CCEEEccCCccccccc--ccCCCc--cceeecccCCCCCC-c---hhhcCCcCCEEEccCCccCCCcc--hhcCCCCCEE
Confidence            9999999999995443  777866  99999999999854 3   27889999999999999996544  9999999999


Q ss_pred             EccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC-CCccccccccccCCCcc
Q 046240          315 SLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKL  393 (763)
Q Consensus       315 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~  393 (763)
                      ++++|++++.  ..+..+++|++|++++|+++++  ..+..+++|+.|++++|++++..|.. ..++.+..+++.+|+..
T Consensus       249 ~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  324 (347)
T 4fmz_A          249 EIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT  324 (347)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred             ECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccc
Confidence            9999999964  4689999999999999999985  46889999999999999999877653 45788999999999754


Q ss_pred             c
Q 046240          394 C  394 (763)
Q Consensus       394 c  394 (763)
                      .
T Consensus       325 ~  325 (347)
T 4fmz_A          325 D  325 (347)
T ss_dssp             C
T ss_pred             c
Confidence            4

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.97  E-value=6.7e-30  Score=285.74  Aligned_cols=279  Identities=28%  Similarity=0.368  Sum_probs=182.4

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCC
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNA  155 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l  155 (763)
                      ..++++|+|++|.+++..+  +.++++|++|+|++|.++       .++.  +.++++|++|+|++|.+++..+  +.++
T Consensus        67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~-------~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l  133 (466)
T 1o6v_A           67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-------DITP--LANLTNLTGLTLFNNQITDIDP--LKNL  133 (466)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-------CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTC
T ss_pred             hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc-------cChh--hcCCCCCCEEECCCCCCCCChH--HcCC
Confidence            4678899999998886543  888888999998888885       4444  4577888888888888876543  7777


Q ss_pred             CCCCeeeecCcccccccc-------------------cccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEe
Q 046240          156 SKLTILELGGNSFSGFIP-------------------NTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYI  216 (763)
Q Consensus       156 ~~L~~L~L~~N~l~~~~p-------------------~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L  216 (763)
                      ++|++|++++|++++...                   ..+.++++|+.|+    +++|.+++.  ..+..+. +|++|++
T Consensus       134 ~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~----l~~n~l~~~--~~l~~l~-~L~~L~l  206 (466)
T 1o6v_A          134 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD----ISSNKVSDI--SVLAKLT-NLESLIA  206 (466)
T ss_dssp             TTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEE----CCSSCCCCC--GGGGGCT-TCSEEEC
T ss_pred             CCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEE----CcCCcCCCC--hhhccCC-CCCEEEe
Confidence            888888888877765321                   1255566666666    677777654  2356666 7778888


Q ss_pred             ecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEccccc
Q 046240          217 SNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNN  296 (763)
Q Consensus       217 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~  296 (763)
                      ++|++++..|  ++.+++|++|++++|++++.  ..+..+++  |+.|++++|.+++..|    +..+++|++|++++|+
T Consensus       207 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~--L~~L~l~~n~l~~~~~----~~~l~~L~~L~l~~n~  276 (466)
T 1o6v_A          207 TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTN--LTDLDLANNQISNLAP----LSGLTKLTELKLGANQ  276 (466)
T ss_dssp             CSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTT--CSEEECCSSCCCCCGG----GTTCTTCSEEECCSSC
T ss_pred             cCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCC--CCEEECCCCccccchh----hhcCCCCCEEECCCCc
Confidence            8777776555  66677777777777777642  24555554  7777777777664322    5566666666666666


Q ss_pred             ccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC
Q 046240          297 FSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG  376 (763)
Q Consensus       297 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  376 (763)
                      +++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++. +..
T Consensus       277 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l  349 (466)
T 1o6v_A          277 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSL  349 (466)
T ss_dssp             CCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGG
T ss_pred             cCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhh
Confidence            664333  6666666666666666664433  5566666666666666666544  55666666666666666654 333


Q ss_pred             CCccccccccccCCC
Q 046240          377 GPFANFTAKSFMGNE  391 (763)
Q Consensus       377 ~~~~~l~~~~~~~n~  391 (763)
                      ..++.+..+++.+|.
T Consensus       350 ~~l~~L~~L~l~~n~  364 (466)
T 1o6v_A          350 ANLTNINWLSAGHNQ  364 (466)
T ss_dssp             TTCTTCCEEECCSSC
T ss_pred             ccCCCCCEEeCCCCc
Confidence            445555555555554

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.97  E-value=1.9e-32  Score=306.95  Aligned_cols=235  Identities=21%  Similarity=0.190  Sum_probs=135.5

Q ss_pred             CCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCC
Q 046240          101 PSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLR  180 (763)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  180 (763)
                      ++|++|+|++|.++       .+++..+..+++|++|+|++|.|++..|  |.++++|++|+|++|+|+++.+.     +
T Consensus        34 ~~L~~L~Ls~n~l~-------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~   99 (487)
T 3oja_A           34 WNVKELDLSGNPLS-------QISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----P   99 (487)
T ss_dssp             GGCCEEECCSSCCC-------CCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----T
T ss_pred             CCccEEEeeCCcCC-------CCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----C
Confidence            36777777777664       4555555566777777777777665554  66667777777777776644322     5


Q ss_pred             chhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCcccc-ccCCC
Q 046240          181 NIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFG-RLQNS  259 (763)
Q Consensus       181 ~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~~  259 (763)
                      +|+.|+    +++|.+++..+..+   + +|++|+|++|+|++..|..|+.+++|++|+|++|.+++..|..+. .+++ 
T Consensus       100 ~L~~L~----L~~N~l~~~~~~~l---~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~-  170 (487)
T 3oja_A          100 SIETLH----AANNNISRVSCSRG---Q-GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT-  170 (487)
T ss_dssp             TCCEEE----CCSSCCCCEEECCC---S-SCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTT-
T ss_pred             CcCEEE----CcCCcCCCCCcccc---C-CCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCc-
Confidence            555555    55666655544322   2 566666666666665566666666666666666666655555554 4443 


Q ss_pred             CccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEe
Q 046240          260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILD  339 (763)
Q Consensus       260 ~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  339 (763)
                       |+.|+|++|.+++. |.   ...+++|+.|+|++|+|++. |..|..+++|+.|+|++|+|++ +|..+..+++|+.|+
T Consensus       171 -L~~L~Ls~N~l~~~-~~---~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~  243 (487)
T 3oja_A          171 -LEHLNLQYNFIYDV-KG---QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFD  243 (487)
T ss_dssp             -CCEEECTTSCCCEE-EC---CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEE
T ss_pred             -ccEEecCCCccccc-cc---cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEE
Confidence             66666666666533 22   22355666666666666543 3335555666666666666653 454555556666666


Q ss_pred             CcCCccC-CccchhhhhhccCceEEcc
Q 046240          340 LSNNKIS-GFILISLEKLLYLKKLNLS  365 (763)
Q Consensus       340 L~~N~l~-~~~~~~~~~l~~L~~L~l~  365 (763)
                      +++|++. +.+|..+..++.|+.++++
T Consensus       244 l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          244 LRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             cCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            6666655 3345555555555555544

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=281.34  Aligned_cols=278  Identities=19%  Similarity=0.167  Sum_probs=240.3

Q ss_pred             CCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCC
Q 046240          101 PSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLR  180 (763)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  180 (763)
                      +.....++++|.++       .+|..++   ++|++|+|++|+|++..+..|.++++|++|+|++|+|+++.|..|++++
T Consensus        31 ~~~~~c~~~~~~l~-------~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  100 (353)
T 2z80_A           31 DRNGICKGSSGSLN-------SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG  100 (353)
T ss_dssp             CTTSEEECCSTTCS-------SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             CCCeEeeCCCCCcc-------ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCC
Confidence            34445788899886       8888775   5899999999999988888999999999999999999999899999999


Q ss_pred             chhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccc-cccCCccccceeecccc-cccCCCCccccccCC
Q 046240          181 NIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP-QVMGNLSIFLLLDLELN-KLTGPIPVTFGRLQN  258 (763)
Q Consensus       181 ~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~  258 (763)
                      +|++|+    +++|++++..+..+.++. +|++|+|++|++++..+ ..|..+++|++|++++| .+++..|..|.++++
T Consensus       101 ~L~~L~----Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  175 (353)
T 2z80_A          101 SLEHLD----LSYNYLSNLSSSWFKPLS-SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF  175 (353)
T ss_dssp             TCCEEE----CCSSCCSSCCHHHHTTCT-TCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred             CCCEEE----CCCCcCCcCCHhHhCCCc-cCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCC
Confidence            999999    889999976555588888 99999999999996555 58999999999999999 577777888999977


Q ss_pred             CCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCccccccc---ccccc
Q 046240          259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFG---YLTSL  335 (763)
Q Consensus       259 ~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L  335 (763)
                        |++|++++|++++..|.  .+..+++|++|++++|+++...+..+..+++|+.|++++|++++..+..+.   ..+.+
T Consensus       176 --L~~L~l~~n~l~~~~~~--~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l  251 (353)
T 2z80_A          176 --LEELEIDASDLQSYEPK--SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI  251 (353)
T ss_dssp             --EEEEEEEETTCCEECTT--TTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCC
T ss_pred             --CCEEECCCCCcCccCHH--HHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchh
Confidence              99999999999988888  899999999999999999855545566789999999999999976665443   46778


Q ss_pred             cEEeCcCCccCCc----cchhhhhhccCceEEcccccCCCCCCCC-CCccccccccccCCCcccCCC
Q 046240          336 EILDLSNNKISGF----ILISLEKLLYLKKLNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       336 ~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      +.++|++|.+++.    +|..+..+++|+.|++++|+++..++.. ..++.+..+++.+|++.|++|
T Consensus       252 ~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          252 KKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            8899999988873    6778899999999999999999655543 578899999999999999886

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=3.2e-30  Score=268.85  Aligned_cols=262  Identities=22%  Similarity=0.233  Sum_probs=189.7

Q ss_pred             ceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccC
Q 046240           69 GITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTI  148 (763)
Q Consensus        69 gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~  148 (763)
                      ++.|...  ..+.++.++++++ .+|..+  .++|++|+|++|.++       .+|...+..+++|++|+|++|.|++..
T Consensus         5 ~C~C~~~--~~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~-------~~~~~~~~~~~~L~~L~l~~n~l~~~~   72 (285)
T 1ozn_A            5 ACVCYNE--PKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRIS-------HVPAASFRACRNLTILWLHSNVLARID   72 (285)
T ss_dssp             TCEEECS--SSCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCC-------EECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CceECCC--CCeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCC-------ccCHHHcccCCCCCEEECCCCccceeC
Confidence            5667543  2367888888888 456544  467888888888875       566666667778888888888877777


Q ss_pred             CCcccCCCCCCeeeecCcc-cccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccccccc
Q 046240          149 QSPITNASKLTILELGGNS-FSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQ  227 (763)
Q Consensus       149 p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~  227 (763)
                      |..|.++++|++|+|++|+ ++...|..|.+++                             +|++|+|++|++++..|.
T Consensus        73 ~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~-----------------------------~L~~L~l~~n~l~~~~~~  123 (285)
T 1ozn_A           73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG-----------------------------RLHTLHLDRCGLQELGPG  123 (285)
T ss_dssp             TTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCT-----------------------------TCCEEECTTSCCCCCCTT
T ss_pred             HhhcCCccCCCEEeCCCCCCccccCHHHhcCCc-----------------------------CCCEEECCCCcCCEECHh
Confidence            7777777778888887776 6655566666555                             566666666666666666


Q ss_pred             ccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCC
Q 046240          228 VMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGG  307 (763)
Q Consensus       228 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  307 (763)
                      .|..+++|++|+|++|++++..+..|..+++  |++|+|++|++++..+.  .+..+++|++|+|++|++++..|..|..
T Consensus       124 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~--L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~  199 (285)
T 1ozn_A          124 LFRGLAALQYLYLQDNALQALPDDTFRDLGN--LTHLFLHGNRISSVPER--AFRGLHSLDRLLLHQNRVAHVHPHAFRD  199 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTT--CCEEECCSSCCCEECTT--TTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred             HhhCCcCCCEEECCCCcccccCHhHhccCCC--ccEEECCCCcccccCHH--HhcCccccCEEECCCCcccccCHhHccC
Confidence            6777777777777777777655556666655  77777777777754444  5777888888888888888877888888


Q ss_pred             CcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCC
Q 046240          308 LKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG  376 (763)
Q Consensus       308 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~  376 (763)
                      +++|+.|++++|++++..+..+..+++|+.|+|++|++....+. ..-...++.+..+.|.+.+..|..
T Consensus       200 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             CTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGG
T ss_pred             cccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchH
Confidence            88888888888888877667788888888888888888764332 123345666677888888877754

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.97  E-value=1.5e-29  Score=282.94  Aligned_cols=214  Identities=24%  Similarity=0.357  Sum_probs=94.8

Q ss_pred             cCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCc
Q 046240          153 TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNL  232 (763)
Q Consensus       153 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l  232 (763)
                      .++++|++|++++|++++.  ..+..+++|+.|+    +++|.+++..|  +..+. +|++|++++|++++.  ..+..+
T Consensus       174 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~----l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~--~~l~~l  242 (466)
T 1o6v_A          174 ANLTTLERLDISSNKVSDI--SVLAKLTNLESLI----ATNNQISDITP--LGILT-NLDELSLNGNQLKDI--GTLASL  242 (466)
T ss_dssp             TTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE----CCSSCCCCCGG--GGGCT-TCCEEECCSSCCCCC--GGGGGC
T ss_pred             ccCCCCCEEECcCCcCCCC--hhhccCCCCCEEE----ecCCccccccc--ccccC-CCCEEECCCCCcccc--hhhhcC
Confidence            3344444444444444432  1244444444444    44444444333  33333 444555555444432  234444


Q ss_pred             cccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCcc
Q 046240          233 SIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQ  312 (763)
Q Consensus       233 ~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  312 (763)
                      ++|++|++++|.+++..|  +..+++  |++|++++|.+++. +.   +..+++|+.|++++|++++..+  +..+++|+
T Consensus       243 ~~L~~L~l~~n~l~~~~~--~~~l~~--L~~L~l~~n~l~~~-~~---~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~  312 (466)
T 1o6v_A          243 TNLTDLDLANNQISNLAP--LSGLTK--LTELKLGANQISNI-SP---LAGLTALTNLELNENQLEDISP--ISNLKNLT  312 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG--GTTCTT--CSEEECCSSCCCCC-GG---GTTCTTCSEEECCSSCCSCCGG--GGGCTTCS
T ss_pred             CCCCEEECCCCccccchh--hhcCCC--CCEEECCCCccCcc-cc---ccCCCccCeEEcCCCcccCchh--hcCCCCCC
Confidence            445555555554443322  344433  44455555444422 11   3344444445555554443222  44444445


Q ss_pred             EEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCc
Q 046240          313 NISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEK  392 (763)
Q Consensus       313 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~  392 (763)
                      .|+|++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++.+| ...++.+..+++.+|++
T Consensus       313 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~  387 (466)
T 1o6v_A          313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAW  387 (466)
T ss_dssp             EEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEE
T ss_pred             EEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcc
Confidence            55555554444333  34444455555555544442  234444445555555554444444 33344444444444433

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=9.2e-30  Score=283.47  Aligned_cols=230  Identities=20%  Similarity=0.192  Sum_probs=180.9

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|+|++|+|++..|..|.++++|++|+|++|.|+       .++...|.++++|++|+|++|+|++..+..|.+++
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  147 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-------QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLS  147 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-------EECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCT
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-------CcChhhccCcccCCEEECCCCcCCccChhhhcccC
Confidence            57999999999999999999999999999999999996       77778888999999999999999988888999999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|++|+|++|+|+.+.+..|.++++|+.|+    +++|                        |.+....+..|.++++|+
T Consensus       148 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~----l~~~------------------------~~l~~i~~~~~~~l~~L~  199 (452)
T 3zyi_A          148 KLRELWLRNNPIESIPSYAFNRVPSLMRLD----LGEL------------------------KKLEYISEGAFEGLFNLK  199 (452)
T ss_dssp             TCCEEECCSCCCCEECTTTTTTCTTCCEEE----CCCC------------------------TTCCEECTTTTTTCTTCC
T ss_pred             CCCEEECCCCCcceeCHhHHhcCCcccEEe----CCCC------------------------CCccccChhhccCCCCCC
Confidence            999999999999987777888777655555    3332                        333333344566666666


Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEc
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISL  316 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  316 (763)
                      +|+|++|++++ +| .+..+++  |++|+|++|++++..|.  .|.++++|+.|+|++|++++..|..|.++++|+.|+|
T Consensus       200 ~L~L~~n~l~~-~~-~~~~l~~--L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  273 (452)
T 3zyi_A          200 YLNLGMCNIKD-MP-NLTPLVG--LEELEMSGNHFPEIRPG--SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL  273 (452)
T ss_dssp             EEECTTSCCSS-CC-CCTTCTT--CCEEECTTSCCSEECGG--GGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             EEECCCCcccc-cc-ccccccc--ccEEECcCCcCcccCcc--cccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEEC
Confidence            66666666663 33 3555544  77777777777766666  6777777888888888887777777888888888888


Q ss_pred             cCccccCcccccccccccccEEeCcCCccCC
Q 046240          317 PYNRLEGPIPESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       317 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      ++|+|++..+..|..+++|+.|+|++|++.-
T Consensus       274 ~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          274 AHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             CSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             CCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            8888887666777778888888888887654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=1.9e-29  Score=279.89  Aligned_cols=251  Identities=22%  Similarity=0.212  Sum_probs=220.5

Q ss_pred             CCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCch
Q 046240          103 LTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNI  182 (763)
Q Consensus       103 L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  182 (763)
                      ...++.+++.++       .+|..++   ++++.|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|.+++  
T Consensus        45 ~~~v~c~~~~l~-------~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~--  112 (440)
T 3zyj_A           45 FSKVICVRKNLR-------EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLA--  112 (440)
T ss_dssp             SCEEECCSCCCS-------SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCS--
T ss_pred             CCEEEeCCCCcC-------cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCc--
Confidence            456888888885       7888765   6789999999999988888999999999999999999877777776655  


Q ss_pred             hhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCcc
Q 046240          183 EWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLD  262 (763)
Q Consensus       183 ~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~  262 (763)
                                                 +|++|+|++|+|+...+..|..+++|++|+|++|+|+...+..|.++++  |+
T Consensus       113 ---------------------------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~--L~  163 (440)
T 3zyj_A          113 ---------------------------NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPS--LR  163 (440)
T ss_dssp             ---------------------------SCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTT--CC
T ss_pred             ---------------------------cCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcc--cC
Confidence                                       6778888899999788889999999999999999999887888999977  99


Q ss_pred             EEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcC
Q 046240          263 TLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN  342 (763)
Q Consensus       263 ~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  342 (763)
                      +|+|++|+..+.++.. .|.++++|++|+|++|+++ .+| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++
T Consensus       164 ~L~l~~~~~l~~i~~~-~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  240 (440)
T 3zyj_A          164 RLDLGELKRLSYISEG-AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ  240 (440)
T ss_dssp             EEECCCCTTCCEECTT-TTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred             EeCCCCCCCcceeCcc-hhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCC
Confidence            9999995544355442 6899999999999999999 455 489999999999999999988899999999999999999


Q ss_pred             CccCCccchhhhhhccCceEEcccccCCCCCCCC-CCccccccccccCCCcccCCC
Q 046240          343 NKISGFILISLEKLLYLKKLNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       343 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      |+|+++.+..|..+++|+.|+|++|++++.++.. ..++.+..+++.+|||.|+|.
T Consensus       241 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             CceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence            9999999999999999999999999999887765 567889999999999999986

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.96  E-value=1.7e-30  Score=274.51  Aligned_cols=229  Identities=29%  Similarity=0.498  Sum_probs=170.8

Q ss_pred             CCceEEEEecC-CCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccC
Q 046240           76 SHRVTALNISS-LNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITN  154 (763)
Q Consensus        76 ~~~v~~L~L~~-~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~  154 (763)
                      ..+++.|+|++ |++.+.+|..|+++++|++|+|++|.++      +.+|..+ .++++|++|+|++|.|++.+|..|.+
T Consensus        75 l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~------~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~  147 (313)
T 1ogq_A           75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS------GAIPDFL-SQIKTLVTLDFSYNALSGTLPPSISS  147 (313)
T ss_dssp             CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE------EECCGGG-GGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred             CCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeC------CcCCHHH-hCCCCCCEEeCCCCccCCcCChHHhc
Confidence            46899999995 9999999999999999999999999986      4677655 48999999999999999999999999


Q ss_pred             CCCCCeeeecCcccccccccccCCCC-chhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCcc
Q 046240          155 ASKLTILELGGNSFSGFIPNTIGNLR-NIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS  233 (763)
Q Consensus       155 l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~  233 (763)
                      +++|++|+|++|++++.+|..|..++ +|+                             +|+|++|++++.+|..|..++
T Consensus       148 l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~-----------------------------~L~L~~N~l~~~~~~~~~~l~  198 (313)
T 1ogq_A          148 LPNLVGITFDGNRISGAIPDSYGSFSKLFT-----------------------------SMTISRNRLTGKIPPTFANLN  198 (313)
T ss_dssp             CTTCCEEECCSSCCEEECCGGGGCCCTTCC-----------------------------EEECCSSEEEEECCGGGGGCC
T ss_pred             CCCCCeEECcCCcccCcCCHHHhhhhhcCc-----------------------------EEECcCCeeeccCChHHhCCc
Confidence            99999999999999988888887776 444                             455555555555555555554


Q ss_pred             ccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccE
Q 046240          234 IFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN  313 (763)
Q Consensus       234 ~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  313 (763)
                       |++|+|++|++++..|..|..+++  |+.|+|++|++++.+|.   +..+++|++|+|++|++++.+|..|..+++|+.
T Consensus       199 -L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  272 (313)
T 1ogq_A          199 -LAFVDLSRNMLEGDASVLFGSDKN--TQKIHLAKNSLAFDLGK---VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS  272 (313)
T ss_dssp             -CSEEECCSSEEEECCGGGCCTTSC--CSEEECCSSEECCBGGG---CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCE
T ss_pred             -ccEEECcCCcccCcCCHHHhcCCC--CCEEECCCCceeeecCc---ccccCCCCEEECcCCcccCcCChHHhcCcCCCE
Confidence             555555555555555555555544  55566666655544443   455666777777777777667777777777777


Q ss_pred             EEccCccccCcccccccccccccEEeCcCCc-cCC
Q 046240          314 ISLPYNRLEGPIPESFGYLTSLEILDLSNNK-ISG  347 (763)
Q Consensus       314 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~  347 (763)
                      |+|++|++++.+|.. ..+++|+.|++++|+ +.+
T Consensus       273 L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          273 LNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             EECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred             EECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence            777777777666664 667777777777776 554

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=8.8e-30  Score=265.52  Aligned_cols=251  Identities=23%  Similarity=0.216  Sum_probs=203.7

Q ss_pred             CEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchh
Q 046240          104 TKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIE  183 (763)
Q Consensus       104 ~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  183 (763)
                      ++++.+++.++       .+|..+   .++|++|+|++|.|++..+..|.++++|++|+|++|+++++.|..|.+++   
T Consensus        14 ~~~~c~~~~l~-------~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~---   80 (285)
T 1ozn_A           14 VTTSCPQQGLQ-------AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA---   80 (285)
T ss_dssp             CEEECCSSCCS-------SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT---
T ss_pred             eEEEcCcCCcc-------cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCcc---
Confidence            56666666664       555543   24666667777766666666666666666666666666655555554443   


Q ss_pred             hhhhhhhccCCcccccCCcccccccccccEEEeecCc-cccccccccCCccccceeecccccccCCCCccccccCCCCcc
Q 046240          184 WLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCS-ITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLD  262 (763)
Q Consensus       184 ~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~  262 (763)
                                                +|++|+|++|+ ++...|..|..+++|++|+|++|++++..|..+.++++  |+
T Consensus        81 --------------------------~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~--L~  132 (285)
T 1ozn_A           81 --------------------------LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA--LQ  132 (285)
T ss_dssp             --------------------------TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT--CC
T ss_pred             --------------------------CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcC--CC
Confidence                                      78888888897 88777899999999999999999999888999999977  99


Q ss_pred             EEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcC
Q 046240          263 TLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN  342 (763)
Q Consensus       263 ~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  342 (763)
                      +|++++|++++..+.  .+..+++|++|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++
T Consensus       133 ~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  210 (285)
T 1ozn_A          133 YLYLQDNALQALPDD--TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA  210 (285)
T ss_dssp             EEECCSSCCCCCCTT--TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             EEECCCCcccccCHh--HhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCC
Confidence            999999999966665  689999999999999999988778899999999999999999988899999999999999999


Q ss_pred             CccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcccCCC
Q 046240          343 NKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       343 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      |+++++.+..+..+++|+.|++++|++++..+....+..+.......+...|..|
T Consensus       211 n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (285)
T ss_dssp             SCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             CcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCc
Confidence            9999988889999999999999999999876654333444555566677777665

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.7e-31  Score=282.18  Aligned_cols=273  Identities=18%  Similarity=0.215  Sum_probs=178.9

Q ss_pred             CCCCCCCCCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCcccccc------cc
Q 046240           57 NWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRID------LA  130 (763)
Q Consensus        57 ~w~~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~------~~  130 (763)
                      +|.....|+.+..+.......+++.|++++|.+  .+|..+...  |++|+|++|.+..     +.+|..++      .+
T Consensus        23 ~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~-----~~~~~~~~~~~~~~~~   93 (312)
T 1wwl_A           23 DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRA-----ARIPSRILFGALRVLG   93 (312)
T ss_dssp             CGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEE-----EECBHHHHHHHHHHHT
T ss_pred             chHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccC-----CCcCHHHHHHHHHhcC
Confidence            454333444454444333344566666666666  455544443  6666666666631     23333332      13


Q ss_pred             CCCccEEEcccccccccCCCcc--cCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccc
Q 046240          131 LPNVKALSLAYNRFSGTIQSPI--TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS  208 (763)
Q Consensus       131 l~~L~~L~L~~N~i~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~  208 (763)
                      +++|++|+|++|+|++.+|..+  .++++|++|+|++|++++. |..|+++...                       ..+
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~-----------------------~~~  149 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQW-----------------------LKP  149 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTT-----------------------CCT
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHh-----------------------hcC
Confidence            5666666666666666666554  5666666666666666654 4444333100                       003


Q ss_pred             ccccEEEeecCccccccccccCCccccceeecccccccCC--CCccc--cccCCCCccEEEecCCccccC--CCCccccc
Q 046240          209 ISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGP--IPVTF--GRLQNSKLDTLSLCGNSFSGS--IPSCIDIG  282 (763)
Q Consensus       209 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~~l~~~~L~~L~L~~N~l~~~--~p~~~~~~  282 (763)
                       +|++|+|++|++++..|..|+.+++|++|+|++|++.+.  .|..+  ..+++  |++|+|++|++++.  ++. ..+.
T Consensus       150 -~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~-~~~~  225 (312)
T 1wwl_A          150 -GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT--LQVLALRNAGMETPSGVCS-ALAA  225 (312)
T ss_dssp             -TCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTT--CCEEECTTSCCCCHHHHHH-HHHH
T ss_pred             -CCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCC--CCEEECCCCcCcchHHHHH-HHHh
Confidence             788888888888877778888888888888888887654  23333  66655  88888888888721  111 0245


Q ss_pred             cCCcccEEEcccccccccCC-cccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCce
Q 046240          283 NLKVVVEINLSRNNFSGDIP-ATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKK  361 (763)
Q Consensus       283 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  361 (763)
                      ++++|++|+|++|++++..| ..+..+++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|+.
T Consensus       226 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~  300 (312)
T 1wwl_A          226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGN  300 (312)
T ss_dssp             TTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEE
T ss_pred             cCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCE
Confidence            67888888888888887665 55667888899999999888 6676665  8899999999999886 54 888889999


Q ss_pred             EEcccccCCC
Q 046240          362 LNLSFNKLEG  371 (763)
Q Consensus       362 L~l~~N~l~~  371 (763)
                      |++++|++++
T Consensus       301 L~L~~N~l~~  310 (312)
T 1wwl_A          301 LSLKGNPFLD  310 (312)
T ss_dssp             EECTTCTTTC
T ss_pred             EeccCCCCCC
Confidence            9999998875

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=3.3e-29  Score=266.18  Aligned_cols=277  Identities=18%  Similarity=0.246  Sum_probs=179.6

Q ss_pred             CCCCcccccCCCC--CCCCCcccceeecCCCCceEEEEecCCCCCCc----CCccc--CCCCCCCEEEcCCCcccCCCcc
Q 046240           48 YDPTNLLAQNWTS--NTSVCNWIGITCDVNSHRVTALNISSLNLQGE----IPHEI--GYLPSLTKLALGYNSLVGNNSL  119 (763)
Q Consensus        48 ~~~~~~~~~~w~~--~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~----~~~~~--~~l~~L~~L~L~~n~l~~~~~~  119 (763)
                      .|+...+. .|..  ..++|.|.+..|.......     .-+...|.    ++..+  ...+++++|+|++|.++     
T Consensus        26 ~~~~~aLl-~~k~~~~~~~~~~~~~w~~~~~~~~-----~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-----   94 (328)
T 4fcg_A           26 RPYHDVLS-QWQRHYNADRNRWHSAWRQANSNNP-----QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-----   94 (328)
T ss_dssp             CCHHHHHH-HHHHHHHHCCTTHHHHHHHHTTTCT-----TSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-----
T ss_pred             chHHHHHH-HHHHhccCCchhhhhhhcccccccc-----cccccCCcchhhhHHHHhcccccceeEEEccCCCch-----
Confidence            35555565 6864  3578999999884322100     01111111    11111  12345555555555553     


Q ss_pred             ccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCccccc
Q 046240          120 SGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGI  199 (763)
Q Consensus       120 ~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~  199 (763)
                        .+|..++ .+++|++|+|++|.|+ .+|..|.++++|++|+|++|+++ .+|..|++++                   
T Consensus        95 --~lp~~l~-~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~-------------------  150 (328)
T 4fcg_A           95 --QFPDQAF-RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLN-------------------  150 (328)
T ss_dssp             --SCCSCGG-GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCT-------------------
T ss_pred             --hcChhhh-hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCc-------------------
Confidence              4554444 3555555555555555 44455555555555555555554 3343333333                   


Q ss_pred             CCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCcc
Q 046240          200 LPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCI  279 (763)
Q Consensus       200 ~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~  279 (763)
                                +|++|+|++|++.+.+|..+...               ..+..+.++++  |++|+|++|+++ .+|.  
T Consensus       151 ----------~L~~L~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~--L~~L~L~~n~l~-~lp~--  200 (328)
T 4fcg_A          151 ----------RLRELSIRACPELTELPEPLAST---------------DASGEHQGLVN--LQSLRLEWTGIR-SLPA--  200 (328)
T ss_dssp             ----------TCCEEEEEEETTCCCCCSCSEEE---------------C-CCCEEESTT--CCEEEEEEECCC-CCCG--
T ss_pred             ----------CCCEEECCCCCCccccChhHhhc---------------cchhhhccCCC--CCEEECcCCCcC-cchH--
Confidence                      44455555544444444433320               11122444654  778888888777 6776  


Q ss_pred             ccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccC
Q 046240          280 DIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYL  359 (763)
Q Consensus       280 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  359 (763)
                      .+.++++|++|+|++|++++ +|..++.+++|+.|+|++|++.+.+|..++.+++|++|+|++|++.+.+|..+..+++|
T Consensus       201 ~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L  279 (328)
T 4fcg_A          201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL  279 (328)
T ss_dssp             GGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTC
T ss_pred             hhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCC
Confidence            68888999999999999995 67789999999999999999999999999999999999999999999999999999999


Q ss_pred             ceEEcccccCCCCCCCC-CCccccccccccCC
Q 046240          360 KKLNLSFNKLEGEIPRG-GPFANFTAKSFMGN  390 (763)
Q Consensus       360 ~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n  390 (763)
                      +.|+|++|++.+.+|.. +.++.+..+.+..|
T Consensus       280 ~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~  311 (328)
T 4fcg_A          280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPH  311 (328)
T ss_dssp             CEEECTTCTTCCCCCGGGGGSCTTCEEECCGG
T ss_pred             CEEeCCCCCchhhccHHHhhccCceEEeCCHH
Confidence            99999999999999965 44555555554433

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=2.5e-31  Score=280.85  Aligned_cols=226  Identities=18%  Similarity=0.260  Sum_probs=166.2

Q ss_pred             ceEEEEecCCCC-CCcCCcccC-------CCCCCCEEEcCCCcccCCCccccCcccccc-ccCCCccEEEcccccccccC
Q 046240           78 RVTALNISSLNL-QGEIPHEIG-------YLPSLTKLALGYNSLVGNNSLSGSLPSRID-LALPNVKALSLAYNRFSGTI  148 (763)
Q Consensus        78 ~v~~L~L~~~~l-~~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~-~~l~~L~~L~L~~N~i~~~~  148 (763)
                      .++.|+|++|.+ .+.+|..+.       ++++|++|+|++|.++      +.+|..+| ..+++|++|+|++|+|++. 
T Consensus        64 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~------~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-  136 (312)
T 1wwl_A           64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT------GTAPPPLLEATGPDLNILNLRNVSWATR-  136 (312)
T ss_dssp             HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCB------SCCCCCSSSCCSCCCSEEEEESCBCSSS-
T ss_pred             HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCccc------chhHHHHHHhcCCCccEEEccCCCCcch-
Confidence            388999999999 456777766       8999999999999986      58888875 7899999999999999987 


Q ss_pred             CCcccCC-----CCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccc
Q 046240          149 QSPITNA-----SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITG  223 (763)
Q Consensus       149 p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~  223 (763)
                      |..+.++     ++|++|+|++|+|++..|..|+++++|+.|+                             |++|++.+
T Consensus       137 ~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~-----------------------------Ls~N~l~~  187 (312)
T 1wwl_A          137 DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD-----------------------------LSDNPELG  187 (312)
T ss_dssp             SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEE-----------------------------CCSCTTCH
T ss_pred             hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEE-----------------------------CCCCCcCc
Confidence            8888887     9999999999999988888888877555554                             44444443


Q ss_pred             c--ccccc--CCccccceeecccccccCC--CC-ccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEccccc
Q 046240          224 N--IPQVM--GNLSIFLLLDLELNKLTGP--IP-VTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNN  296 (763)
Q Consensus       224 ~--~~~~~--~~l~~L~~L~L~~N~l~~~--~p-~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~  296 (763)
                      .  .+..+  ..+++|++|+|++|+|++.  ++ ..+.++++  |++|+|++|++++.+|.. .+..+++|++|+|++|+
T Consensus       188 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~~-~~~~l~~L~~L~Ls~N~  264 (312)
T 1wwl_A          188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ--LQGLDLSHNSLRDAAGAP-SCDWPSQLNSLNLSFTG  264 (312)
T ss_dssp             HHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCC--CSEEECTTSCCCSSCCCS-CCCCCTTCCEEECTTSC
T ss_pred             chHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCC--CCEEECCCCcCCcccchh-hhhhcCCCCEEECCCCc
Confidence            2  12222  5566666666666666521  11 22334444  777777777776555321 35566778888888888


Q ss_pred             ccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCC
Q 046240          297 FSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       297 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      |+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus       265 l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          265 LK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            87 5666665  7788888888888855 55 7788888888888888875

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.96  E-value=8.2e-29  Score=275.00  Aligned_cols=255  Identities=20%  Similarity=0.203  Sum_probs=163.5

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .++++|+|++|.+++. | .|+.+++|++|+|++|.++       .+|   +..+++|++|+|++|+|++. +  +++++
T Consensus        42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~-------~~~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l~  106 (457)
T 3bz5_A           42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNIT-------TLD---LSQNTNLTYLACDSNKLTNL-D--VTPLT  106 (457)
T ss_dssp             TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCS-------CCC---CTTCTTCSEEECCSSCCSCC-C--CTTCT
T ss_pred             CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCC-------eEc---cccCCCCCEEECcCCCCcee-e--cCCCC
Confidence            5677777777777753 4 5777777777777777775       343   34677777777777777764 2  67777


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|++|+|++|+++++ |  ++++++|++|+    +++|++++. +  +.++. +|++|++++|+..+.+  .++.+++|+
T Consensus       107 ~L~~L~L~~N~l~~l-~--~~~l~~L~~L~----l~~N~l~~l-~--l~~l~-~L~~L~l~~n~~~~~~--~~~~l~~L~  173 (457)
T 3bz5_A          107 KLTYLNCDTNKLTKL-D--VSQNPLLTYLN----CARNTLTEI-D--VSHNT-QLTELDCHLNKKITKL--DVTPQTQLT  173 (457)
T ss_dssp             TCCEEECCSSCCSCC-C--CTTCTTCCEEE----CTTSCCSCC-C--CTTCT-TCCEEECTTCSCCCCC--CCTTCTTCC
T ss_pred             cCCEEECCCCcCCee-c--CCCCCcCCEEE----CCCCcccee-c--cccCC-cCCEEECCCCCccccc--ccccCCcCC
Confidence            777777777777763 3  67777777777    667777763 2  55555 6777777777544444  366677777


Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEc
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISL  316 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  316 (763)
                      +|++++|++++ +|  +..+++  |+.|++++|++++.     .+..+++|++|++++|++++ +|  ++.+++|+.|++
T Consensus       174 ~L~ls~n~l~~-l~--l~~l~~--L~~L~l~~N~l~~~-----~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l  240 (457)
T 3bz5_A          174 TLDCSFNKITE-LD--VSQNKL--LNRLNCDTNNITKL-----DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDC  240 (457)
T ss_dssp             EEECCSSCCCC-CC--CTTCTT--CCEEECCSSCCSCC-----CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEEC
T ss_pred             EEECCCCccce-ec--cccCCC--CCEEECcCCcCCee-----ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEe
Confidence            77777777775 33  555544  77777777777643     25666777777777777775 34  666677777777


Q ss_pred             cCccccCcccccccccc-------cccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCC
Q 046240          317 PYNRLEGPIPESFGYLT-------SLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP  374 (763)
Q Consensus       317 s~N~l~~~~p~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  374 (763)
                      ++|++++..+..+..++       +|+.|++++|++.+.+|  +..+++|+.|++++|++.+.+|
T Consensus       241 ~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~  303 (457)
T 3bz5_A          241 SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLD  303 (457)
T ss_dssp             CSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEE
T ss_pred             eCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceec
Confidence            77777765544444443       34455555555444443  3445566666666666555554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.96  E-value=1.4e-28  Score=273.03  Aligned_cols=275  Identities=19%  Similarity=0.131  Sum_probs=219.5

Q ss_pred             CCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccC
Q 046240           75 NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITN  154 (763)
Q Consensus        75 ~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~  154 (763)
                      ...++++|+|++|++++. |  ++.+++|++|+|++|.++       .+|   +.++++|++|+|++|++++. |  +++
T Consensus        62 ~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~-------~~~---~~~l~~L~~L~L~~N~l~~l-~--~~~  125 (457)
T 3bz5_A           62 KLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLT-------NLD---VTPLTKLTYLNCDTNKLTKL-D--VSQ  125 (457)
T ss_dssp             GCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS-------CCC---CTTCTTCCEEECCSSCCSCC-C--CTT
T ss_pred             ccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCc-------eee---cCCCCcCCEEECCCCcCCee-c--CCC
Confidence            356899999999999974 4  999999999999999996       344   45899999999999999974 4  899


Q ss_pred             CCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccc
Q 046240          155 ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSI  234 (763)
Q Consensus       155 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~  234 (763)
                      +++|++|++++|+|+++ +  ++++++|+.|+    +++|+..+.+  .+..++ +|++|++++|++++ +|  ++.+++
T Consensus       126 l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~----l~~n~~~~~~--~~~~l~-~L~~L~ls~n~l~~-l~--l~~l~~  192 (457)
T 3bz5_A          126 NPLLTYLNCARNTLTEI-D--VSHNTQLTELD----CHLNKKITKL--DVTPQT-QLTTLDCSFNKITE-LD--VSQNKL  192 (457)
T ss_dssp             CTTCCEEECTTSCCSCC-C--CTTCTTCCEEE----CTTCSCCCCC--CCTTCT-TCCEEECCSSCCCC-CC--CTTCTT
T ss_pred             CCcCCEEECCCCcccee-c--cccCCcCCEEE----CCCCCccccc--ccccCC-cCCEEECCCCccce-ec--cccCCC
Confidence            99999999999999975 3  88999999999    7788666666  466777 99999999999996 44  888999


Q ss_pred             cceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCc-----
Q 046240          235 FLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK-----  309 (763)
Q Consensus       235 L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-----  309 (763)
                      |+.|++++|++++.   .+..+++  |++|++++|++++ +|    +..+++|+.|++++|++++..+..+..++     
T Consensus       193 L~~L~l~~N~l~~~---~l~~l~~--L~~L~Ls~N~l~~-ip----~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~  262 (457)
T 3bz5_A          193 LNRLNCDTNNITKL---DLNQNIQ--LTFLDCSSNKLTE-ID----VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCI  262 (457)
T ss_dssp             CCEEECCSSCCSCC---CCTTCTT--CSEEECCSSCCSC-CC----CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECT
T ss_pred             CCEEECcCCcCCee---ccccCCC--CCEEECcCCcccc-cC----ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEecc
Confidence            99999999999965   3777766  9999999999996 44    66788999999999999987665555554     


Q ss_pred             --CccEEEccCccccCcccccccccccccEEeCcCCccCCccch--------hhhhhccCceEEcccccCCCCCCCCCCc
Q 046240          310 --DVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILI--------SLEKLLYLKKLNLSFNKLEGEIPRGGPF  379 (763)
Q Consensus       310 --~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~l~~N~l~~~~p~~~~~  379 (763)
                        +|+.|++++|.+.+.+|  ++.+++|+.|+|++|++.+.+|.        .+..+++|+.|++++|++++. + ...+
T Consensus       263 ~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~-l~~l  338 (457)
T 3bz5_A          263 QTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D-VSHN  338 (457)
T ss_dssp             TCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C-CTTC
T ss_pred             CCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c-cccC
Confidence              55666777776666665  46778888888888876665543        245557788888888888884 3 4556


Q ss_pred             cccccccccCCCc
Q 046240          380 ANFTAKSFMGNEK  392 (763)
Q Consensus       380 ~~l~~~~~~~n~~  392 (763)
                      +.+..+++.+|..
T Consensus       339 ~~L~~L~l~~N~l  351 (457)
T 3bz5_A          339 TKLKSLSCVNAHI  351 (457)
T ss_dssp             TTCSEEECCSSCC
T ss_pred             CcCcEEECCCCCC
Confidence            7777787777753

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=1.9e-30  Score=274.86  Aligned_cols=270  Identities=20%  Similarity=0.190  Sum_probs=226.9

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.++++.+.+...++..+..+++|++|+|++|.++       .+++..+..+++|++|+|++|.+++..+  |.+++
T Consensus        10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~-------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~   80 (317)
T 3o53_A           10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-------QISAADLAPFTKLELLNLSSNVLYETLD--LESLS   80 (317)
T ss_dssp             TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCC-------CCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCT
T ss_pred             CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccC-------cCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcC
Confidence            45777788888887666667778889999999999885       6666667789999999999999987665  88999


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|++|+|++|+|+++.+     .++|+.|+    +++|++++..+..   +. +|++|++++|++++..+..|+.+++|+
T Consensus        81 ~L~~L~Ls~n~l~~l~~-----~~~L~~L~----l~~n~l~~~~~~~---~~-~L~~L~l~~N~l~~~~~~~~~~l~~L~  147 (317)
T 3o53_A           81 TLRTLDLNNNYVQELLV-----GPSIETLH----AANNNISRVSCSR---GQ-GKKNIYLANNKITMLRDLDEGCRSRVQ  147 (317)
T ss_dssp             TCCEEECCSSEEEEEEE-----CTTCCEEE----CCSSCCSEEEECC---CS-SCEEEECCSSCCCSGGGBCTGGGSSEE
T ss_pred             CCCEEECcCCccccccC-----CCCcCEEE----CCCCccCCcCccc---cC-CCCEEECCCCCCCCccchhhhccCCCC
Confidence            99999999999986543     37888888    8899988776554   33 899999999999998888999999999


Q ss_pred             eeecccccccCCCCcccc-ccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEE
Q 046240          237 LLDLELNKLTGPIPVTFG-RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS  315 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~-~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  315 (763)
                      +|+|++|++++..|..+. .+++  |++|+|++|.+++. |.   ...+++|++|+|++|++++ +|..+..+++|+.|+
T Consensus       148 ~L~Ls~N~l~~~~~~~~~~~l~~--L~~L~L~~N~l~~~-~~---~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~  220 (317)
T 3o53_A          148 YLDLKLNEIDTVNFAELAASSDT--LEHLNLQYNFIYDV-KG---QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS  220 (317)
T ss_dssp             EEECTTSCCCEEEGGGGGGGTTT--CCEEECTTSCCCEE-EC---CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred             EEECCCCCCCcccHHHHhhccCc--CCEEECCCCcCccc-cc---ccccccCCEEECCCCcCCc-chhhhcccCcccEEE
Confidence            999999999987777764 6665  99999999999854 43   3458999999999999995 455699999999999


Q ss_pred             ccCccccCcccccccccccccEEeCcCCccC-CccchhhhhhccCceEEcc-cccCCCCCCCC
Q 046240          316 LPYNRLEGPIPESFGYLTSLEILDLSNNKIS-GFILISLEKLLYLKKLNLS-FNKLEGEIPRG  376 (763)
Q Consensus       316 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~-~N~l~~~~p~~  376 (763)
                      |++|+++ .+|..+..+++|+.|+|++|+++ +..+..+..+++|+.|+++ .+.+++..|..
T Consensus       221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             CcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            9999999 57888999999999999999999 7788899999999999999 44577766543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2e-28  Score=279.91  Aligned_cols=283  Identities=21%  Similarity=0.262  Sum_probs=183.3

Q ss_pred             CCcccccCCCCCCCCCcccceeec------CCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCc
Q 046240           50 PTNLLAQNWTSNTSVCNWIGITCD------VNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSL  123 (763)
Q Consensus        50 ~~~~~~~~w~~~~~~c~w~gv~c~------~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l  123 (763)
                      ....++ .|..+.++|.|.|..|.      ....+++.|++++|+|+ .+|..+.  ++|++|+|++|.|+       .+
T Consensus         8 ~~~~w~-~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-------~l   76 (622)
T 3g06_A            8 YDAVWS-AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-------SL   76 (622)
T ss_dssp             --CHHH-HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-------CC
T ss_pred             HHHHHH-HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-------CC
Confidence            344455 68877889999664321      11245899999999999 7787776  89999999999986       67


Q ss_pred             cccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcc
Q 046240          124 PSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSS  203 (763)
Q Consensus       124 p~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~  203 (763)
                      |.    .+++|++|+|++|+|++ +|.   .+++|++|+|++|+|+++ |.   .+++|+.|+    +++|++++ +|..
T Consensus        77 p~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~----L~~N~l~~-lp~~  139 (622)
T 3g06_A           77 PA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLW----IFGNQLTS-LPVL  139 (622)
T ss_dssp             CC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEE----CCSSCCSC-CCCC
T ss_pred             CC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEE----CCCCCCCc-CCCC
Confidence            76    47899999999999985 444   678899999999999864 43   567777777    78888876 4543


Q ss_pred             cccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCcccccc
Q 046240          204 IVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGN  283 (763)
Q Consensus       204 ~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~  283 (763)
                      +   + +|++|+|++|+|++ +|.   .+++|+.|++++|+|++ +|   ..+++  |+.|++++|++++ +|.  .   
T Consensus       140 l---~-~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~--L~~L~Ls~N~l~~-l~~--~---  199 (622)
T 3g06_A          140 P---P-GLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSG--LQELSVSDNQLAS-LPT--L---  199 (622)
T ss_dssp             C---T-TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTT--CCEEECCSSCCSC-CCC--C---
T ss_pred             C---C-CCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCC--CcEEECCCCCCCC-CCC--c---
Confidence            3   3 88899999998885 343   23566777777777773 44   22332  6777777777763 443  1   


Q ss_pred             CCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEE
Q 046240          284 LKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLN  363 (763)
Q Consensus       284 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  363 (763)
                      +++|+.|++++|.++. +|..   +++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+.+++    .+++|+.|+
T Consensus       200 ~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~  267 (622)
T 3g06_A          200 PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM----LPSGLLSLS  267 (622)
T ss_dssp             CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEE
T ss_pred             cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc----ccccCcEEe
Confidence            2455666666666652 3322   3556666666666653 33   234556666666666655332    345566666


Q ss_pred             cccccCCCCCCCCCCccccccccccCCCc
Q 046240          364 LSFNKLEGEIPRGGPFANFTAKSFMGNEK  392 (763)
Q Consensus       364 l~~N~l~~~~p~~~~~~~l~~~~~~~n~~  392 (763)
                      |++|+|+..++....++++..+++.+|+.
T Consensus       268 Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l  296 (622)
T 3g06_A          268 VYRNQLTRLPESLIHLSSETTVNLEGNPL  296 (622)
T ss_dssp             CCSSCCCSCCGGGGGSCTTCEEECCSCCC
T ss_pred             CCCCCCCcCCHHHhhccccCEEEecCCCC
Confidence            66666663322223445555555555544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=1.5e-27  Score=246.43  Aligned_cols=218  Identities=22%  Similarity=0.298  Sum_probs=165.5

Q ss_pred             CCCCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccc
Q 046240           62 TSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY  141 (763)
Q Consensus        62 ~~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~  141 (763)
                      .++|.|.|+.|... .+++.+++++++++ .+|..+.  ++|++|+|++|.++       .+|...|.++++|++|+|++
T Consensus         2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~-------~~~~~~~~~l~~L~~L~l~~   70 (270)
T 2o6q_A            2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLS-------SLPSKAFHRLTKLRLLYLND   70 (270)
T ss_dssp             CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCS-------CCCTTSSSSCTTCCEEECCS
T ss_pred             CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCC-------eeCHHHhcCCCCCCEEECCC
Confidence            47999999999643 45778999999999 4676554  67888888888885       67776777888888888888


Q ss_pred             ccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcc
Q 046240          142 NRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSI  221 (763)
Q Consensus       142 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l  221 (763)
                      |.|+.+.+..|.++++|++|+|++|+++++.+..|.+++                             +|++|+|++|++
T Consensus        71 n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-----------------------------~L~~L~l~~n~l  121 (270)
T 2o6q_A           71 NKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLV-----------------------------NLAELRLDRNQL  121 (270)
T ss_dssp             SCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCS-----------------------------SCCEEECCSSCC
T ss_pred             CccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHccccc-----------------------------CCCEEECCCCcc
Confidence            888877667778888888888888888866666666555                             566666666777


Q ss_pred             ccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccC
Q 046240          222 TGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDI  301 (763)
Q Consensus       222 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~  301 (763)
                      ++..+..|..+++|++|+|++|++++..+..|..+++  |++|+|++|++++..+.  .+.++++|++|+|++|++++..
T Consensus       122 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~  197 (270)
T 2o6q_A          122 KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTS--LKELRLYNNQLKRVPEG--AFDKLTELKTLKLDNNQLKRVP  197 (270)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT--CCEEECCSSCCSCCCTT--TTTTCTTCCEEECCSSCCSCCC
T ss_pred             CeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcc--cceeEecCCcCcEeChh--HhccCCCcCEEECCCCcCCcCC
Confidence            6666666777777777777777777655555666655  77777777777755554  5777888888888888888766


Q ss_pred             CcccCCCcCccEEEccCccccC
Q 046240          302 PATIGGLKDVQNISLPYNRLEG  323 (763)
Q Consensus       302 p~~~~~l~~L~~L~Ls~N~l~~  323 (763)
                      +..|..+++|+.|+|++|.+..
T Consensus       198 ~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          198 EGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCC
T ss_pred             HHHhccccCCCEEEecCCCeeC
Confidence            6778888888888888888764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=9.5e-29  Score=276.97  Aligned_cols=244  Identities=21%  Similarity=0.167  Sum_probs=200.0

Q ss_pred             CCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccccc
Q 046240          131 LPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS  210 (763)
Q Consensus       131 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~  210 (763)
                      .++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|  |+++++|++|+    +++|.+++..+.     + +
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~----Ls~N~l~~l~~~-----~-~  100 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLD----LNNNYVQELLVG-----P-S  100 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEE----CCSSEEEEEEEC-----T-T
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEE----ecCCcCCCCCCC-----C-C
Confidence            4489999999999998888899999999999999999987766  99999999999    889988865432     3 8


Q ss_pred             ccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccc-cCCcccE
Q 046240          211 LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIG-NLKVVVE  289 (763)
Q Consensus       211 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~-~l~~L~~  289 (763)
                      |++|+|++|.|++..+..   +++|+.|+|++|.+++..|..+.++++  |++|+|++|.+++.+|.  .+. .+++|+.
T Consensus       101 L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~--~l~~~l~~L~~  173 (487)
T 3oja_A          101 IETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSR--VQYLDLKLNEIDTVNFA--ELAASSDTLEH  173 (487)
T ss_dssp             CCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSS--EEEEECTTSCCCEEEGG--GGGGGTTTCCE
T ss_pred             cCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCC--CCEEECCCCCCCCcChH--HHhhhCCcccE
Confidence            999999999999877654   578999999999999888888888876  99999999999987776  554 7899999


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccC
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL  369 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  369 (763)
                      |+|++|.|++..+  +..+++|+.|+|++|++++.+| .+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++
T Consensus       174 L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l  249 (487)
T 3oja_A          174 LNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF  249 (487)
T ss_dssp             EECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred             EecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence            9999999987633  4468999999999999996444 58899999999999999997 566788889999999999999


Q ss_pred             C-CCCCC-CCCcccccccccc-------CCCcccCCC
Q 046240          370 E-GEIPR-GGPFANFTAKSFM-------GNEKLCGLP  397 (763)
Q Consensus       370 ~-~~~p~-~~~~~~l~~~~~~-------~n~~~c~~p  397 (763)
                      + +.+|. ...++.+..+.+.       .|+..|.++
T Consensus       250 ~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~  286 (487)
T 3oja_A          250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP  286 (487)
T ss_dssp             CHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred             cCcchHHHHHhCCCCcEEeccccccccCCCcccccCC
Confidence            8 33332 2445555555554       677777776

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=3.3e-29  Score=284.60  Aligned_cols=185  Identities=17%  Similarity=0.072  Sum_probs=131.1

Q ss_pred             ecccCCceEEEE-EecCCceEEEEEeehh----------hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEEE
Q 046240          483 IGIGSFGYVYKA-ELDDGIEVAIKVFHQE----------CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       483 lg~G~~g~v~~~-~~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .+.|++|.+..+ +.--|+.+|+|++...          .....+++.+|+++|+++ .|+||+++++++.+++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            455666655554 2335789999999642          233456799999999999 7999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||++|++|.+++...+ +++..   +|+.||++||+|+   |++|||||||||+|||+++++.+||+|||+|+.......
T Consensus       322 Eyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             ECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             ecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            9999999999998754 45543   5899999999999   889999999999999999999999999999987653322


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPA  677 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~  677 (763)
                        .....+||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus       395 --~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          395 --WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             --cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence              2344679999999999865 4677899999999998887765543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=4.3e-29  Score=264.36  Aligned_cols=261  Identities=20%  Similarity=0.125  Sum_probs=218.0

Q ss_pred             CCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCch
Q 046240          103 LTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNI  182 (763)
Q Consensus       103 L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  182 (763)
                      ++.++++.+.+.       .++..++..+++|++|+|++|.|++..|..|.++++|++|+|++|++++..+  |.++++|
T Consensus        12 l~i~~ls~~~l~-------~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L   82 (317)
T 3o53_A           12 YKIEKVTDSSLK-------QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTL   82 (317)
T ss_dssp             EEEESCCTTTHH-------HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTC
T ss_pred             eeEeeccccchh-------hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCC
Confidence            445667777663       6677777788999999999999999888999999999999999999997765  9999999


Q ss_pred             hhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCcc
Q 046240          183 EWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLD  262 (763)
Q Consensus       183 ~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~  262 (763)
                      ++|+    +++|++++..+     .+ +|++|++++|++++..+..   +++|++|++++|++++..|..+..+++  |+
T Consensus        83 ~~L~----Ls~n~l~~l~~-----~~-~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~--L~  147 (317)
T 3o53_A           83 RTLD----LNNNYVQELLV-----GP-SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSR--VQ  147 (317)
T ss_dssp             CEEE----CCSSEEEEEEE-----CT-TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSS--EE
T ss_pred             CEEE----CcCCccccccC-----CC-CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCC--CC
Confidence            9999    88999886432     24 9999999999999877655   578999999999999888888998876  99


Q ss_pred             EEEecCCccccCCCCcccc-ccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCc
Q 046240          263 TLSLCGNSFSGSIPSCIDI-GNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLS  341 (763)
Q Consensus       263 ~L~L~~N~l~~~~p~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  341 (763)
                      +|+|++|.+++..|.  .+ ..+++|++|+|++|++++. | ....+++|+.|+|++|++++ +|..+..+++|+.|+|+
T Consensus       148 ~L~Ls~N~l~~~~~~--~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~  222 (317)
T 3o53_A          148 YLDLKLNEIDTVNFA--ELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLR  222 (317)
T ss_dssp             EEECTTSCCCEEEGG--GGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECT
T ss_pred             EEECCCCCCCcccHH--HHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECc
Confidence            999999999976666  44 4789999999999999966 3 34458999999999999995 55559999999999999


Q ss_pred             CCccCCccchhhhhhccCceEEcccccCC-CCCCCC-CCccccccccccCCCcc
Q 046240          342 NNKISGFILISLEKLLYLKKLNLSFNKLE-GEIPRG-GPFANFTAKSFMGNEKL  393 (763)
Q Consensus       342 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~-~~~~~l~~~~~~~n~~~  393 (763)
                      +|+|+. +|..+..+++|+.|++++|+++ +.+|.. ..++.+..+++.+++.+
T Consensus       223 ~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l  275 (317)
T 3o53_A          223 NNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL  275 (317)
T ss_dssp             TSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHH
T ss_pred             CCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhc
Confidence            999997 5777899999999999999998 433332 44556666666644333

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.95  E-value=7e-27  Score=259.24  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=161.5

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|++++|++++ +|..   .++|++|+|++|+++       .+|.  +.++++|++|++++|++++ +|..+   .
T Consensus       111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~-------~lp~--~~~l~~L~~L~l~~N~l~~-lp~~~---~  173 (454)
T 1jl5_A          111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE-------KLPE--LQNSSFLKIIDVDNNSLKK-LPDLP---P  173 (454)
T ss_dssp             TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS-------SCCC--CTTCTTCCEEECCSSCCSC-CCCCC---T
T ss_pred             CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC-------CCcc--cCCCCCCCEEECCCCcCcc-cCCCc---c
Confidence            355566666665553 2211   157777888777775       4662  4577777777777777775 44433   4


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|++|++++|++++ +| .|+++++|+.|+    +++|++++ +|...    .+|++|++++|+++ .+| .++.+++|+
T Consensus       174 ~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~----l~~N~l~~-l~~~~----~~L~~L~l~~n~l~-~lp-~~~~l~~L~  240 (454)
T 1jl5_A          174 SLEFIAAGNNQLEE-LP-ELQNLPFLTAIY----ADNNSLKK-LPDLP----LSLESIVAGNNILE-ELP-ELQNLPFLT  240 (454)
T ss_dssp             TCCEEECCSSCCSS-CC-CCTTCTTCCEEE----CCSSCCSS-CCCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCC
T ss_pred             cccEEECcCCcCCc-Cc-cccCCCCCCEEE----CCCCcCCc-CCCCc----CcccEEECcCCcCC-ccc-ccCCCCCCC
Confidence            77777777777776 44 577777777777    66777765 33322    26777777777777 455 377777777


Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccc--cCCcc----------
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG--DIPAT----------  304 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~----------  304 (763)
                      +|++++|++++ +|..+   .  +|+.|++++|++++ +|.  .   .++|++|++++|++++  ..|..          
T Consensus       241 ~L~l~~N~l~~-l~~~~---~--~L~~L~l~~N~l~~-l~~--~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~  308 (454)
T 1jl5_A          241 TIYADNNLLKT-LPDLP---P--SLEALNVRDNYLTD-LPE--L---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNE  308 (454)
T ss_dssp             EEECCSSCCSS-CCSCC---T--TCCEEECCSSCCSC-CCC--C---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSC
T ss_pred             EEECCCCcCCc-ccccc---c--ccCEEECCCCcccc-cCc--c---cCcCCEEECcCCccCcccCcCCcCCEEECcCCc
Confidence            77777777774 44322   2  26666666666663 443  1   2445555555555544  12211          


Q ss_pred             ---cCCC-cCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCC--CCCCC-C
Q 046240          305 ---IGGL-KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG--EIPRG-G  377 (763)
Q Consensus       305 ---~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~-~  377 (763)
                         +..+ ++|+.|++++|++++ +|..   +++|+.|++++|+++++ |.   .+++|+.|++++|++++  .+|.. +
T Consensus       309 l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~l-p~---~l~~L~~L~L~~N~l~~l~~ip~~l~  380 (454)
T 1jl5_A          309 IRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEV-PE---LPQNLKQLHVEYNPLREFPDIPESVE  380 (454)
T ss_dssp             CSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred             CCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccc-cc---hhhhccEEECCCCCCCcCCCChHHHH
Confidence               1123 578888888888885 5543   58899999999999874 43   46889999999999988  55543 2


Q ss_pred             Cc-------------cccccccccCCCccc
Q 046240          378 PF-------------ANFTAKSFMGNEKLC  394 (763)
Q Consensus       378 ~~-------------~~l~~~~~~~n~~~c  394 (763)
                      .+             +.++.+++.+|+...
T Consensus       381 ~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          381 DLRMNSHLAEVPELPQNLKQLHVETNPLRE  410 (454)
T ss_dssp             EEECCC------------------------
T ss_pred             hhhhcccccccccccCcCCEEECCCCcCCc
Confidence            23             567778888886543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.94  E-value=5.4e-26  Score=252.12  Aligned_cols=263  Identities=24%  Similarity=0.324  Sum_probs=165.4

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|++++|.+++ +|..   +++|++|++++|+++       .+|..    .++|++|++++|++++ +| .|.+++
T Consensus        91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-------~l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~  153 (454)
T 1jl5_A           91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-------ALSDL----PPLLEYLGVSNNQLEK-LP-ELQNSS  153 (454)
T ss_dssp             TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-------CCCSC----CTTCCEEECCSSCCSS-CC-CCTTCT
T ss_pred             CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-------cccCC----CCCCCEEECcCCCCCC-Cc-ccCCCC
Confidence            467777777777775 5543   367777777777775       33321    1577888888888875 55 477788


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|++|++++|++++ +|..+   ++|++|+    +++|++++ +| ++.+++ +|++|++++|++++ +|...   ++|+
T Consensus       154 ~L~~L~l~~N~l~~-lp~~~---~~L~~L~----L~~n~l~~-l~-~~~~l~-~L~~L~l~~N~l~~-l~~~~---~~L~  218 (454)
T 1jl5_A          154 FLKIIDVDNNSLKK-LPDLP---PSLEFIA----AGNNQLEE-LP-ELQNLP-FLTAIYADNNSLKK-LPDLP---LSLE  218 (454)
T ss_dssp             TCCEEECCSSCCSC-CCCCC---TTCCEEE----CCSSCCSS-CC-CCTTCT-TCCEEECCSSCCSS-CCCCC---TTCC
T ss_pred             CCCEEECCCCcCcc-cCCCc---ccccEEE----CcCCcCCc-Cc-cccCCC-CCCEEECCCCcCCc-CCCCc---Cccc
Confidence            88888888888775 45443   3666666    77777776 45 577776 78888888888775 33322   4778


Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEc
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISL  316 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  316 (763)
                      +|++++|+++ .+|. +..+++  |++|++++|++++ +|.  .   +++|+.|++++|++++ +|..   +++|+.|++
T Consensus       219 ~L~l~~n~l~-~lp~-~~~l~~--L~~L~l~~N~l~~-l~~--~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l  284 (454)
T 1jl5_A          219 SIVAGNNILE-ELPE-LQNLPF--LTTIYADNNLLKT-LPD--L---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDV  284 (454)
T ss_dssp             EEECCSSCCS-SCCC-CTTCTT--CCEEECCSSCCSS-CCS--C---CTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred             EEECcCCcCC-cccc-cCCCCC--CCEEECCCCcCCc-ccc--c---ccccCEEECCCCcccc-cCcc---cCcCCEEEC
Confidence            8888888887 5663 777765  8888888888874 554  1   3678888888888875 4443   367777888


Q ss_pred             cCccccCc--cccccc-------------cc-ccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCcc
Q 046240          317 PYNRLEGP--IPESFG-------------YL-TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFA  380 (763)
Q Consensus       317 s~N~l~~~--~p~~~~-------------~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  380 (763)
                      ++|++++.  .|..+.             .+ ++|+.|++++|+++++ |..   +++|+.|++++|++++ +|.  .+.
T Consensus       285 s~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~l-p~~---~~~L~~L~L~~N~l~~-lp~--~l~  357 (454)
T 1jl5_A          285 SENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL-PAL---PPRLERLIASFNHLAE-VPE--LPQ  357 (454)
T ss_dssp             CSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSC-CCC--CCT
T ss_pred             cCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCccccc-ccc---CCcCCEEECCCCcccc-ccc--hhh
Confidence            88777752  221111             11 3455555555555542 221   3455555555555553 222  244


Q ss_pred             ccccccccCCCc
Q 046240          381 NFTAKSFMGNEK  392 (763)
Q Consensus       381 ~l~~~~~~~n~~  392 (763)
                      .++.+++.+|+.
T Consensus       358 ~L~~L~L~~N~l  369 (454)
T 1jl5_A          358 NLKQLHVEYNPL  369 (454)
T ss_dssp             TCCEEECCSSCC
T ss_pred             hccEEECCCCCC
Confidence            555555555543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.3e-26  Score=240.22  Aligned_cols=210  Identities=21%  Similarity=0.269  Sum_probs=112.8

Q ss_pred             ccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccE
Q 046240          134 VKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLER  213 (763)
Q Consensus       134 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~  213 (763)
                      |++|+|++|+|++..+..|.++++|++|+|++|+++++.+..|.++++|++|+    +++|.+++..+..+.++. +|++
T Consensus        30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~----L~~n~l~~~~~~~~~~l~-~L~~  104 (276)
T 2z62_A           30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI----LTGNPIQSLALGAFSGLS-SLQK  104 (276)
T ss_dssp             CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEE----CTTCCCCEECTTTTTTCT-TCCE
T ss_pred             ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEE----CCCCccCccChhhhcCCc-cccE
Confidence            44444444444444444455555555555555555544444444433222222    222222222222222222 4445


Q ss_pred             EEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcc
Q 046240          214 LYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS  293 (763)
Q Consensus       214 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls  293 (763)
                      |++++|++++..+..++.+++|++|+|++|++++.                         .+|.  .+.++++|++|+|+
T Consensus       105 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------------------~l~~--~~~~l~~L~~L~Ls  157 (276)
T 2z62_A          105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF-------------------------KLPE--YFSNLTNLEHLDLS  157 (276)
T ss_dssp             EECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-------------------------CCCG--GGGGCTTCCEEECC
T ss_pred             EECCCCCccccCchhcccCCCCCEEECcCCcccee-------------------------cCch--hhccCCCCCEEECC
Confidence            55555555544444455555555555555555432                         1344  45555566666666


Q ss_pred             cccccccCCcccCCCcCcc----EEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccC
Q 046240          294 RNNFSGDIPATIGGLKDVQ----NISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL  369 (763)
Q Consensus       294 ~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  369 (763)
                      +|++++..+..|..+++|+    .|++++|++++..+..+. ..+|+.|+|++|+++++++..|..+++|+.|++++|++
T Consensus       158 ~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~  236 (276)
T 2z62_A          158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW  236 (276)
T ss_dssp             SSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCB
T ss_pred             CCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcc
Confidence            6666655555555555555    677777777754444443 34788888888888877777777888888888888888


Q ss_pred             CCCCCCC
Q 046240          370 EGEIPRG  376 (763)
Q Consensus       370 ~~~~p~~  376 (763)
                      ++..|..
T Consensus       237 ~c~c~~l  243 (276)
T 2z62_A          237 DCSCPRI  243 (276)
T ss_dssp             CCCTTTT
T ss_pred             cccCCch
Confidence            8766543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=8.3e-26  Score=234.19  Aligned_cols=225  Identities=23%  Similarity=0.283  Sum_probs=163.4

Q ss_pred             EEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCee
Q 046240           82 LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTIL  161 (763)
Q Consensus        82 L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L  161 (763)
                      ++..+.+++ .+|..+.  ++|++|+|++|.++       .++...+.++++|++|+|++|+|++..+..|.++++|++|
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~-------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L   81 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLR-------HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL   81 (276)
T ss_dssp             EECTTSCCS-SCCSSSC--TTCCEEECTTCCCC-------EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred             EEecCCCcc-ccCCCCC--CCccEEECCCCccc-------ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEE
Confidence            344455565 4666554  57888999888885       6676666788889999999999888888888889999999


Q ss_pred             eecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccc-cccccCCccccceeec
Q 046240          162 ELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGN-IPQVMGNLSIFLLLDL  240 (763)
Q Consensus       162 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L  240 (763)
                      +|++|++++..+..|.++++|++|+    +++|++.+..+..+.++. +|++|+|++|++++. +|..|..+++|++|+|
T Consensus        82 ~L~~n~l~~~~~~~~~~l~~L~~L~----l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~L  156 (276)
T 2z62_A           82 ILTGNPIQSLALGAFSGLSSLQKLV----AVETNLASLENFPIGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL  156 (276)
T ss_dssp             ECTTCCCCEECTTTTTTCTTCCEEE----CTTSCCCCSTTCCCTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEEC
T ss_pred             ECCCCccCccChhhhcCCccccEEE----CCCCCccccCchhcccCC-CCCEEECcCCccceecCchhhccCCCCCEEEC
Confidence            9999999888888889999999888    778888887777788887 999999999999874 5889999999999999


Q ss_pred             ccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCccc-EEEcccccccccCCcccCCCcCccEEEccCc
Q 046240          241 ELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV-EINLSRNNFSGDIPATIGGLKDVQNISLPYN  319 (763)
Q Consensus       241 ~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  319 (763)
                      ++|++++..+..+..+.+  |+                       .|. .|++++|++++..+..+.. .+|+.|+|++|
T Consensus       157 s~N~l~~~~~~~~~~l~~--L~-----------------------~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n  210 (276)
T 2z62_A          157 SSNKIQSIYCTDLRVLHQ--MP-----------------------LLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTN  210 (276)
T ss_dssp             CSSCCCEECGGGGHHHHT--CT-----------------------TCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSS
T ss_pred             CCCCCCcCCHHHhhhhhh--cc-----------------------ccceeeecCCCcccccCccccCC-CcccEEECCCC
Confidence            999998766666665543  43                       111 3444444444333333322 25556666666


Q ss_pred             cccCcccccccccccccEEeCcCCccCC
Q 046240          320 RLEGPIPESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       320 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      ++++..+..|..+++|+.|+|++|+++.
T Consensus       211 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          211 QLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             CCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             ceeecCHhHhcccccccEEEccCCcccc
Confidence            6654444455666666666666666664

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.93  E-value=2.3e-25  Score=254.54  Aligned_cols=242  Identities=26%  Similarity=0.307  Sum_probs=203.9

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|+|++|+|+ .+|.   .+++|++|+|++|+|+       .+|.    .+++|++|+|++|.|+++ |.   .++
T Consensus        61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-------~lp~----~l~~L~~L~Ls~N~l~~l-~~---~l~  121 (622)
T 3g06_A           61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-------SLPV----LPPGLLELSIFSNPLTHL-PA---LPS  121 (622)
T ss_dssp             TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-------CCCC----CCTTCCEEEECSCCCCCC-CC---CCT
T ss_pred             CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-------cCCC----CCCCCCEEECcCCcCCCC-CC---CCC
Confidence            58999999999999 5665   6799999999999996       6776    679999999999999964 44   678


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|++|+|++|+|++ +|..   +++|++|+    +++|++++ +|..+   . +|+.|++++|+|++ +|   ..+++|+
T Consensus       122 ~L~~L~L~~N~l~~-lp~~---l~~L~~L~----Ls~N~l~~-l~~~~---~-~L~~L~L~~N~l~~-l~---~~~~~L~  184 (622)
T 3g06_A          122 GLCKLWIFGNQLTS-LPVL---PPGLQELS----VSDNQLAS-LPALP---S-ELCKLWAYNNQLTS-LP---MLPSGLQ  184 (622)
T ss_dssp             TCCEEECCSSCCSC-CCCC---CTTCCEEE----CCSSCCSC-CCCCC---T-TCCEEECCSSCCSC-CC---CCCTTCC
T ss_pred             CcCEEECCCCCCCc-CCCC---CCCCCEEE----CcCCcCCC-cCCcc---C-CCCEEECCCCCCCC-Cc---ccCCCCc
Confidence            99999999999996 5544   48888888    88999986 34422   3 89999999999995 55   5578999


Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEc
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISL  316 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  316 (763)
                      .|+|++|+|++ +|..+   .  +|+.|++++|.++ .+|.  .   +++|+.|+|++|+|++ +|   ..+++|+.|+|
T Consensus       185 ~L~Ls~N~l~~-l~~~~---~--~L~~L~L~~N~l~-~l~~--~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~L  248 (622)
T 3g06_A          185 ELSVSDNQLAS-LPTLP---S--ELYKLWAYNNRLT-SLPA--L---PSGLKELIVSGNRLTS-LP---VLPSELKELMV  248 (622)
T ss_dssp             EEECCSSCCSC-CCCCC---T--TCCEEECCSSCCS-SCCC--C---CTTCCEEECCSSCCSC-CC---CCCTTCCEEEC
T ss_pred             EEECCCCCCCC-CCCcc---c--hhhEEECcCCccc-ccCC--C---CCCCCEEEccCCccCc-CC---CCCCcCcEEEC
Confidence            99999999995 55433   3  4999999999999 5665  2   4789999999999996 55   56689999999


Q ss_pred             cCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCC
Q 046240          317 PYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPR  375 (763)
Q Consensus       317 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  375 (763)
                      ++|+|+ .+|.   .+++|+.|+|++|+|+. +|..+..+++|+.|+|++|++++.+|.
T Consensus       249 s~N~L~-~lp~---~~~~L~~L~Ls~N~L~~-lp~~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          249 SGNRLT-SLPM---LPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             CSSCCS-CCCC---CCTTCCEEECCSSCCCS-CCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             CCCCCC-cCCc---ccccCcEEeCCCCCCCc-CCHHHhhccccCEEEecCCCCCCcCHH
Confidence            999999 4565   57899999999999996 578899999999999999999987764

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=3.8e-25  Score=228.39  Aligned_cols=136  Identities=23%  Similarity=0.268  Sum_probs=76.9

Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +|++|+|++|++++..+..|..+++|++|+|++|++++..+..                            +..+++|++
T Consensus        86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~----------------------------~~~l~~L~~  137 (270)
T 2o6q_A           86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRV----------------------------FDSLTKLTY  137 (270)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTT----------------------------TTTCTTCCE
T ss_pred             CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHH----------------------------hCcCcCCCE
Confidence            4555555555555444445555555555555555555433333                            445555555


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccC
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL  369 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  369 (763)
                      |+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+++++.+..|..+++|+.|+|++|++
T Consensus       138 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  217 (270)
T 2o6q_A          138 LSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW  217 (270)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             EECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence            55555555544444455566666666666666655555566666666666666666665555566666666666666666


Q ss_pred             CCCC
Q 046240          370 EGEI  373 (763)
Q Consensus       370 ~~~~  373 (763)
                      .+..
T Consensus       218 ~c~c  221 (270)
T 2o6q_A          218 DCTC  221 (270)
T ss_dssp             CCSS
T ss_pred             eCCC
Confidence            5543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=4.5e-25  Score=229.91  Aligned_cols=201  Identities=20%  Similarity=0.191  Sum_probs=100.1

Q ss_pred             cCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccc
Q 046240          130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSI  209 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~  209 (763)
                      ++++|+++++++|.++. +|..+.  ++|++|+|++|+|++..+..|.+++                             
T Consensus         8 ~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~-----------------------------   55 (290)
T 1p9a_G            8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYT-----------------------------   55 (290)
T ss_dssp             CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCT-----------------------------
T ss_pred             ccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCC-----------------------------
Confidence            55566666666666663 333332  4556666666666555444444433                             


Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +|++|+|++|+|++..+.  +.+++|++|+|++|+|+ .+|..+..+++  |++|+|++|++++..|.  .|.++++|++
T Consensus        56 ~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~--L~~L~l~~N~l~~l~~~--~~~~l~~L~~  128 (290)
T 1p9a_G           56 RLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPA--LTVLDVSFNRLTSLPLG--ALRGLGELQE  128 (290)
T ss_dssp             TCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTT--CCEEECCSSCCCCCCSS--TTTTCTTCCE
T ss_pred             CCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCC--CCEEECCCCcCcccCHH--HHcCCCCCCE
Confidence            455555555555533322  45556666666666665 44444444443  55555555555533333  3445555555


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccC
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL  369 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  369 (763)
                      |+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+. +|..+..+.+|+.|+|++|++
T Consensus       129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-ip~~~~~~~~L~~l~L~~Np~  207 (290)
T 1p9a_G          129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW  207 (290)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCB
T ss_pred             EECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCc-cChhhcccccCCeEEeCCCCc
Confidence            5555555554444444445555555555555554333344445555555555555543 233333334444444444444


Q ss_pred             C
Q 046240          370 E  370 (763)
Q Consensus       370 ~  370 (763)
                      .
T Consensus       208 ~  208 (290)
T 1p9a_G          208 L  208 (290)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.92  E-value=3.1e-28  Score=272.15  Aligned_cols=279  Identities=18%  Similarity=0.161  Sum_probs=141.2

Q ss_pred             ceEEEEecCCCCCC----cCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCC----CccEEEcccccccc---
Q 046240           78 RVTALNISSLNLQG----EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALP----NVKALSLAYNRFSG---  146 (763)
Q Consensus        78 ~v~~L~L~~~~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~----~L~~L~L~~N~i~~---  146 (763)
                      +++.|+|++|+++.    .++..+..+++|++|+|++|.+.      +..+..++..++    +|++|+|++|+|+.   
T Consensus        29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~------~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~  102 (461)
T 1z7x_W           29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG------DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC  102 (461)
T ss_dssp             TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH------HHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGH
T ss_pred             CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCC------hHHHHHHHHHHhhCCCceeEEEccCCCCCHHHH
Confidence            45566666666553    23445555566666666665553      112222333333    46666666666553   


Q ss_pred             -cCCCcccCCCCCCeeeecCcccccccccccC-----CCCchhhhhhhhhccCCcccccC----CcccccccccccEEEe
Q 046240          147 -TIQSPITNASKLTILELGGNSFSGFIPNTIG-----NLRNIEWLGLVIGLIGNPLNGIL----PSSIVNLSISLERLYI  216 (763)
Q Consensus       147 -~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~~l~~n~l~~~~----p~~~~~l~~~L~~L~L  216 (763)
                       .++..|.++++|++|+|++|++++..+..+.     .+++|++|+    +++|.+++..    +..+..++ +|++|+|
T Consensus       103 ~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~----L~~n~l~~~~~~~l~~~l~~~~-~L~~L~L  177 (461)
T 1z7x_W          103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ----LEYCSLSAASCEPLASVLRAKP-DFKELTV  177 (461)
T ss_dssp             HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE----CTTSCCBGGGHHHHHHHHHHCT-TCCEEEC
T ss_pred             HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEE----CCCCCCCHHHHHHHHHHHhhCC-CCCEEEC
Confidence             3355555666666666666665543332222     234455555    5555555432    33333334 5666666


Q ss_pred             ecCccccccccccCC-----ccccceeecccccccCC----CCccccccCCCCccEEEecCCccccCC-----CCccccc
Q 046240          217 SNCSITGNIPQVMGN-----LSIFLLLDLELNKLTGP----IPVTFGRLQNSKLDTLSLCGNSFSGSI-----PSCIDIG  282 (763)
Q Consensus       217 ~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~p~~~~~l~~~~L~~L~L~~N~l~~~~-----p~~~~~~  282 (763)
                      ++|.++...+..+..     +++|++|+|++|.+++.    ++..+..+++  |++|++++|.+++..     +.  .+.
T Consensus       178 ~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~--L~~L~Ls~n~l~~~~~~~l~~~--~~~  253 (461)
T 1z7x_W          178 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS--LRELALGSNKLGDVGMAELCPG--LLH  253 (461)
T ss_dssp             CSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTT--CCEEECCSSBCHHHHHHHHHHH--HTS
T ss_pred             cCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCC--ccEEeccCCcCChHHHHHHHHH--Hhc
Confidence            666655443333322     34566666666665542    3444444443  666666666554321     11  112


Q ss_pred             cCCcccEEEccccccccc----CCcccCCCcCccEEEccCccccCccccccccc-----ccccEEeCcCCccCCc----c
Q 046240          283 NLKVVVEINLSRNNFSGD----IPATIGGLKDVQNISLPYNRLEGPIPESFGYL-----TSLEILDLSNNKISGF----I  349 (763)
Q Consensus       283 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~----~  349 (763)
                      .+++|++|++++|+++..    ++..+..+++|+.|+|++|.+++..+..+...     ++|++|+|++|.+++.    .
T Consensus       254 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  333 (461)
T 1z7x_W          254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF  333 (461)
T ss_dssp             TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHH
Confidence            355566666666665543    34445555666666666666554333333322     4566666666665544    2


Q ss_pred             chhhhhhccCceEEcccccCCC
Q 046240          350 LISLEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       350 ~~~~~~l~~L~~L~l~~N~l~~  371 (763)
                      +..+..+++|+.|++++|+++.
T Consensus       334 ~~~l~~~~~L~~L~Ls~n~i~~  355 (461)
T 1z7x_W          334 SSVLAQNRFLLELQISNNRLED  355 (461)
T ss_dssp             HHHHHHCSSCCEEECCSSBCHH
T ss_pred             HHHHhhCCCccEEEccCCcccc
Confidence            3444445666666666665554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=1.3e-24  Score=226.50  Aligned_cols=205  Identities=22%  Similarity=0.271  Sum_probs=166.3

Q ss_pred             ccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccc
Q 046240           96 EIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT  175 (763)
Q Consensus        96 ~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  175 (763)
                      .++++++|+++++++|.++       .+|..++   ++|+.|+|++|.|++..+..|.++++|++|+|++|+|+++.+. 
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-------~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-   73 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-------ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-   73 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-------SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-
T ss_pred             cccccCCccEEECCCCCCC-------cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-
Confidence            4677888899999888885       7777765   6788899999999888888888889999999999988854331 


Q ss_pred             cCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccc
Q 046240          176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGR  255 (763)
Q Consensus       176 ~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  255 (763)
                       +.++                             +|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.+
T Consensus        74 -~~l~-----------------------------~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~  122 (290)
T 1p9a_G           74 -GTLP-----------------------------VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRG  122 (290)
T ss_dssp             -SCCT-----------------------------TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTT
T ss_pred             -CCCC-----------------------------cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcC
Confidence             2222                             6778888888887 66778888889999999999998777788888


Q ss_pred             cCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccc
Q 046240          256 LQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL  335 (763)
Q Consensus       256 l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  335 (763)
                      +++  |++|+|++|++++..+.  .|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++ .+|..+..+++|
T Consensus       123 l~~--L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L  197 (290)
T 1p9a_G          123 LGE--LQELYLKGNELKTLPPG--LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL  197 (290)
T ss_dssp             CTT--CCEEECTTSCCCCCCTT--TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCC
T ss_pred             CCC--CCEEECCCCCCCccChh--hcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccC
Confidence            876  89999999998866555  6788888999999999998776777788889999999999988 677777778889


Q ss_pred             cEEeCcCCccCC
Q 046240          336 EILDLSNNKISG  347 (763)
Q Consensus       336 ~~L~L~~N~l~~  347 (763)
                      +.|+|++|++..
T Consensus       198 ~~l~L~~Np~~C  209 (290)
T 1p9a_G          198 PFAFLHGNPWLC  209 (290)
T ss_dssp             SEEECCSCCBCC
T ss_pred             CeEEeCCCCccC
Confidence            999999988764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.92  E-value=9.6e-28  Score=268.09  Aligned_cols=283  Identities=18%  Similarity=0.154  Sum_probs=172.6

Q ss_pred             ceEEEEecCCCCCC----cCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccC----C
Q 046240           78 RVTALNISSLNLQG----EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTI----Q  149 (763)
Q Consensus        78 ~v~~L~L~~~~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~----p  149 (763)
                      ++++|+|++|+++.    .++..|..+++|++|+|++|.+++.  ....+...++...++|++|+|++|++++..    +
T Consensus        86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~--~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  163 (461)
T 1z7x_W           86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA--GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  163 (461)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH--HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchH--HHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence            57777777777763    4466677777777777777766410  000111222223456777777777776533    4


Q ss_pred             CcccCCCCCCeeeecCcccccccccccC-----CCCchhhhhhhhhccCCccccc----CCcccccccccccEEEeecCc
Q 046240          150 SPITNASKLTILELGGNSFSGFIPNTIG-----NLRNIEWLGLVIGLIGNPLNGI----LPSSIVNLSISLERLYISNCS  220 (763)
Q Consensus       150 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~~l~~n~l~~~----~p~~~~~l~~~L~~L~L~~N~  220 (763)
                      ..+..+++|++|+|++|+++...+..+.     .+++|+.|+    +++|.+++.    ++..+..++ +|++|+|++|+
T Consensus       164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~----L~~n~l~~~~~~~l~~~l~~~~-~L~~L~Ls~n~  238 (461)
T 1z7x_W          164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK----LESCGVTSDNCRDLCGIVASKA-SLRELALGSNK  238 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEE----CTTSCCBTTHHHHHHHHHHHCT-TCCEEECCSSB
T ss_pred             HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEE----ccCCCCcHHHHHHHHHHHHhCC-CccEEeccCCc
Confidence            4555567777777777777654444443     245666666    667766653    355555555 77777777777


Q ss_pred             ccccc-----ccccCCccccceeecccccccCC----CCccccccCCCCccEEEecCCccccCCCCccccc-----cCCc
Q 046240          221 ITGNI-----PQVMGNLSIFLLLDLELNKLTGP----IPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIG-----NLKV  286 (763)
Q Consensus       221 l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~-----~l~~  286 (763)
                      +++..     +..+..+++|++|+|++|+++..    ++..+..+++  |++|+|++|.+++..+.  .+.     ..++
T Consensus       239 l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~--L~~L~Ls~n~i~~~~~~--~l~~~l~~~~~~  314 (461)
T 1z7x_W          239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES--LKELSLAGNELGDEGAR--LLCETLLEPGCQ  314 (461)
T ss_dssp             CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTT--CCEEECTTCCCHHHHHH--HHHHHHTSTTCC
T ss_pred             CChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCC--cceEECCCCCCchHHHH--HHHHHhccCCcc
Confidence            66432     22333567777777777777643    4555555554  77777777776543222  122     2256


Q ss_pred             ccEEEccccccccc----CCcccCCCcCccEEEccCccccCcccccccc-----cccccEEeCcCCccCC----ccchhh
Q 046240          287 VVEINLSRNNFSGD----IPATIGGLKDVQNISLPYNRLEGPIPESFGY-----LTSLEILDLSNNKISG----FILISL  353 (763)
Q Consensus       287 L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~  353 (763)
                      |++|+|++|.+++.    ++..+..+++|+.|+|++|++++..+..+..     .++|++|+|++|++++    .++..+
T Consensus       315 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l  394 (461)
T 1z7x_W          315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL  394 (461)
T ss_dssp             CCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHH
T ss_pred             ceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHH
Confidence            77777777777654    3455566677777777777776554444432     5577777777777775    466666


Q ss_pred             hhhccCceEEcccccCCC
Q 046240          354 EKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       354 ~~l~~L~~L~l~~N~l~~  371 (763)
                      ..+++|++|++++|++++
T Consensus       395 ~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          395 LANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HHCCCCCEEECCSSSCCH
T ss_pred             HhCCCccEEECCCCCCCH
Confidence            777777777777777764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=3.9e-25  Score=228.51  Aligned_cols=209  Identities=23%  Similarity=0.261  Sum_probs=98.7

Q ss_pred             cCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCccccccccccc
Q 046240           97 IGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTI  176 (763)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  176 (763)
                      +..+++|+.|++++|.++       .++.  +..+++|++|+|++|.+++.  ..+.++++|++|+|++|++++..+..|
T Consensus        37 ~~~l~~L~~L~l~~~~i~-------~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~  105 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIK-------SVQG--IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVF  105 (272)
T ss_dssp             HHHHTTCCEEECTTSCCC-------CCTT--GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             cccccceeeeeeCCCCcc-------cccc--cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHh
Confidence            334455555555555543       2221  22455555555555555532  245555555555555555555444444


Q ss_pred             CCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCcccccc
Q 046240          177 GNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRL  256 (763)
Q Consensus       177 ~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  256 (763)
                      +++++                             |++|+|++|++++..+..|+.+++|++|+|++|++++..+..+..+
T Consensus       106 ~~l~~-----------------------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  156 (272)
T 3rfs_A          106 DKLTN-----------------------------LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKL  156 (272)
T ss_dssp             TTCTT-----------------------------CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             cCCcC-----------------------------CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccC
Confidence            44443                             3444444444443333344444444444444444443333334444


Q ss_pred             CCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCccccccccccccc
Q 046240          257 QNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLE  336 (763)
Q Consensus       257 ~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  336 (763)
                      ++  |++|++++|++++..+.  .+..+++|++|+|++|++++..|..|..+++|+.|+|++|.+.+.       +++|+
T Consensus       157 ~~--L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~  225 (272)
T 3rfs_A          157 TN--LTELDLSYNQLQSLPEG--VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIR  225 (272)
T ss_dssp             TT--CCEEECCSSCCCCCCTT--TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTH
T ss_pred             cc--CCEEECCCCCcCccCHH--HhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHH
Confidence            33  44444444444433333  344445555555555555544444455555555555555544422       33455


Q ss_pred             EEeCcCCccCCccchhhhhh
Q 046240          337 ILDLSNNKISGFILISLEKL  356 (763)
Q Consensus       337 ~L~L~~N~l~~~~~~~~~~l  356 (763)
                      .|++..|+++|.+|..++.+
T Consensus       226 ~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          226 YLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             HHHHHHHHTGGGBBCTTSCB
T ss_pred             HHHHHHHhCCCcccCccccc
Confidence            55555555555555544433

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.92  E-value=1.4e-24  Score=221.43  Aligned_cols=191  Identities=23%  Similarity=0.317  Sum_probs=133.0

Q ss_pred             CCCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccc
Q 046240           63 SVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYN  142 (763)
Q Consensus        63 ~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N  142 (763)
                      +||.|.|++|..   ..+++++++++++ .+|..+.  ++|++|+|++|.++       .++...+.++++|++|+|++|
T Consensus         3 ~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~-------~~~~~~~~~l~~L~~L~L~~n   69 (251)
T 3m19_A            3 TCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLA-------TLSDATFRGLTKLTWLNLDYN   69 (251)
T ss_dssp             -CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCC-------CCCTTTTTTCTTCCEEECTTS
T ss_pred             cCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcC-------ccCHhHhcCcccCCEEECCCC
Confidence            588999999963   4567899999998 5676655  57888888888885       566666667888888888888


Q ss_pred             cccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccc
Q 046240          143 RFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT  222 (763)
Q Consensus       143 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~  222 (763)
                      .|++..+..|.++++|++|+|++|+|++..+..|.+++                             +|++|+|++|+|+
T Consensus        70 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-----------------------------~L~~L~L~~N~l~  120 (251)
T 3m19_A           70 QLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLT-----------------------------QLDKLYLGGNQLK  120 (251)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT-----------------------------TCCEEECCSSCCC
T ss_pred             cCCccCHhHhccCCcCCEEECCCCcccccChhHhcccC-----------------------------CCCEEEcCCCcCC
Confidence            88877777788888888888888888876666666665                             4555555555555


Q ss_pred             cccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccc
Q 046240          223 GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG  299 (763)
Q Consensus       223 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~  299 (763)
                      +..+..|..+++|++|+|++|+|++..+..|..+++  |++|+|++|++++..+.  .+..+++|+.|+|++|+++.
T Consensus       121 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          121 SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN--LQTLSLSTNQLQSVPHG--AFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT--CCEEECCSSCCSCCCTT--TTTTCTTCCEEECCSCCBCT
T ss_pred             CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC--CCEEECCCCcCCccCHH--HHhCCCCCCEEEeeCCceeC
Confidence            555555566666666666666666555545655554  66666666666654444  46666667777777777664

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=1.9e-24  Score=218.82  Aligned_cols=196  Identities=21%  Similarity=0.247  Sum_probs=116.4

Q ss_pred             CCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccc-ccccCCCcccCCCCCCeeeecC-cccccccccccCCC
Q 046240          102 SLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNR-FSGTIQSPITNASKLTILELGG-NSFSGFIPNTIGNL  179 (763)
Q Consensus       102 ~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~-i~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l  179 (763)
                      +|++|+|++|+++       .+|...|.++++|++|+|++|+ ++++.+..|.++++|++|+|++ |+|+++.+..|.++
T Consensus        32 ~l~~L~l~~n~l~-------~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l  104 (239)
T 2xwt_C           32 STQTLKLIETHLR-------TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL  104 (239)
T ss_dssp             TCCEEEEESCCCS-------EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECC
T ss_pred             cccEEEEeCCcce-------EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCC
Confidence            6777777777774       5666666667777777777775 6666666677777777777776 77766555566555


Q ss_pred             CchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc---eeecccc-cccCCCCccccc
Q 046240          180 RNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL---LLDLELN-KLTGPIPVTFGR  255 (763)
Q Consensus       180 ~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~  255 (763)
                      ++|                             ++|++++|++++ +|. |..+++|+   +|++++| ++++..+..|.+
T Consensus       105 ~~L-----------------------------~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~  153 (239)
T 2xwt_C          105 PLL-----------------------------KFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQG  153 (239)
T ss_dssp             TTC-----------------------------CEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTT
T ss_pred             CCC-----------------------------CEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccc
Confidence            544                             444444444443 232 44444444   5555555 554444444555


Q ss_pred             cCCCCcc-EEEecCCccccCCCCccccccCCcccEEEccccc-ccccCCcccCCC-cCccEEEccCccccCccccccccc
Q 046240          256 LQNSKLD-TLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNN-FSGDIPATIGGL-KDVQNISLPYNRLEGPIPESFGYL  332 (763)
Q Consensus       256 l~~~~L~-~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l  332 (763)
                      +++  |+ +|++++|+++ .+|.. .+.. ++|++|+|++|+ +++..+..|.++ ++|+.|++++|++++. |..  .+
T Consensus       154 l~~--L~~~L~l~~n~l~-~i~~~-~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~  225 (239)
T 2xwt_C          154 LCN--ETLTLKLYNNGFT-SVQGY-AFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GL  225 (239)
T ss_dssp             TBS--SEEEEECCSCCCC-EECTT-TTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TC
T ss_pred             hhc--ceeEEEcCCCCCc-ccCHh-hcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--Hh
Confidence            544  55 5555555555 33331 2333 567777777773 665556667777 7777777777777743 332  46


Q ss_pred             ccccEEeCcCC
Q 046240          333 TSLEILDLSNN  343 (763)
Q Consensus       333 ~~L~~L~L~~N  343 (763)
                      ++|+.|+++++
T Consensus       226 ~~L~~L~l~~~  236 (239)
T 2xwt_C          226 EHLKELIARNT  236 (239)
T ss_dssp             TTCSEEECTTC
T ss_pred             ccCceeeccCc
Confidence            67777777665

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2.4e-25  Score=251.44  Aligned_cols=187  Identities=17%  Similarity=0.165  Sum_probs=145.0

Q ss_pred             cCcCceecccCCceEEEEEecCCceEEEEEeehh--------hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          477 FGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--------CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      +...+.||+|+||.||+|... ++.+++|+....        .....+.+.+|++++++++||||+++..++...+..++
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ----------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345678999999999999554 678999976321        11224568999999999999999976666667778899


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++++|.+++..         +..++.|+++||+||   |+++|+||||||+|||++.  .+||+|||+++.....
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999999875         457999999999999   7789999999999999998  9999999999987532


Q ss_pred             CCcc-----ccccccccccccCccccCC--CCCCcchhHHHHHHHHHHHHcCCCCCc
Q 046240          629 DQSM-----TQTQTLATIGYMAPEYGIE--RKVSTRSDIYSYGIMLIETFTRKKPAD  678 (763)
Q Consensus       629 ~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~elltg~~p~~  678 (763)
                      ....     ......||+.|||||++..  ..|+..+|+|+..+-..+-+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2111     1235679999999999876  668888999999999888887776653

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.9e-24  Score=223.30  Aligned_cols=208  Identities=21%  Similarity=0.261  Sum_probs=147.5

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCC
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNA  155 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l  155 (763)
                      ..+++.|++++|.++. + +.++.+++|++|+|++|.++       .++  .+..+++|++|+|++|.|++..+..|.++
T Consensus        40 l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~-------~~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l  108 (272)
T 3rfs_A           40 LNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLH-------DIS--ALKELTNLTYLILTGNQLQSLPNGVFDKL  108 (272)
T ss_dssp             HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCC-------CCG--GGTTCTTCCEEECTTSCCCCCCTTTTTTC
T ss_pred             ccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCC-------Cch--hhcCCCCCCEEECCCCccCccChhHhcCC
Confidence            3679999999999984 3 46899999999999999996       343  34589999999999999999888899999


Q ss_pred             CCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCcccc
Q 046240          156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF  235 (763)
Q Consensus       156 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L  235 (763)
                      ++|++|+|++|++++..+..|+++++|+                             +|+|++|++++..+..|+.+++|
T Consensus       109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~-----------------------------~L~L~~n~l~~~~~~~~~~l~~L  159 (272)
T 3rfs_A          109 TNLKELVLVENQLQSLPDGVFDKLTNLT-----------------------------YLNLAHNQLQSLPKGVFDKLTNL  159 (272)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCC-----------------------------EEECCSSCCCCCCTTTTTTCTTC
T ss_pred             cCCCEEECCCCcCCccCHHHhccCCCCC-----------------------------EEECCCCccCccCHHHhccCccC
Confidence            9999999999999988887787777555                             45555555554444455555555


Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEE
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS  315 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  315 (763)
                      ++|+|++|++++..+..+..+++  |++|++++|++++..|.  .+..+++|++|+|++|++.+.       +++|+.|+
T Consensus       160 ~~L~l~~n~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~  228 (272)
T 3rfs_A          160 TELDLSYNQLQSLPEGVFDKLTQ--LKDLRLYQNQLKSVPDG--VFDRLTSLQYIWLHDNPWDCT-------CPGIRYLS  228 (272)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTT--CCEEECCSSCCSCCCTT--TTTTCTTCCEEECCSSCBCCC-------TTTTHHHH
T ss_pred             CEEECCCCCcCccCHHHhcCCcc--CCEEECCCCcCCccCHH--HHhCCcCCCEEEccCCCcccc-------CcHHHHHH
Confidence            55555555555444444555544  56666666666544444  455666666666666666532       34566666


Q ss_pred             ccCccccCccccccccccc
Q 046240          316 LPYNRLEGPIPESFGYLTS  334 (763)
Q Consensus       316 Ls~N~l~~~~p~~~~~l~~  334 (763)
                      ++.|+++|.+|..++.++.
T Consensus       229 ~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          229 EWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             HHHHHTGGGBBCTTSCBCG
T ss_pred             HHHHhCCCcccCcccccCC
Confidence            7777777777766665544

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=4.5e-26  Score=243.37  Aligned_cols=263  Identities=18%  Similarity=0.230  Sum_probs=182.8

Q ss_pred             CCcccceeecCCCCceEEEEecCCCCCCcCCcccCCC--CCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccc
Q 046240           64 VCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYL--PSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAY  141 (763)
Q Consensus        64 ~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~  141 (763)
                      |..|.++.|+  ...++.|+++++.+.   +..+..+  ++++.|++++|.+.       ..+..++ .+++|++|+|++
T Consensus        36 c~~W~~~~~~--~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~-------~~~~~~~-~~~~L~~L~L~~  102 (336)
T 2ast_B           36 CKRWYRLASD--ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMD-------QPLAEHF-SPFRVQHMDLSN  102 (336)
T ss_dssp             CHHHHHHHTC--STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEEC-------SCCCSCC-CCBCCCEEECTT
T ss_pred             HHHHHHHhcC--chhheeeccccccCC---HHHHHhhhhccceEEEcCCcccc-------ccchhhc-cCCCCCEEEccC
Confidence            4479999886  346888999998877   4566666  78888888888775       3333344 678888888888


Q ss_pred             cccccc-CCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecC-
Q 046240          142 NRFSGT-IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC-  219 (763)
Q Consensus       142 N~i~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N-  219 (763)
                      |.+++. +|..+.++++|++|+|++|++++..+..|++++                             +|++|+|++| 
T Consensus       103 ~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~-----------------------------~L~~L~L~~~~  153 (336)
T 2ast_B          103 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS-----------------------------NLVRLNLSGCS  153 (336)
T ss_dssp             CEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCT-----------------------------TCSEEECTTCB
T ss_pred             CCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCC-----------------------------CCCEEECCCCC
Confidence            887765 666777778888888888877766666665555                             4555555555 


Q ss_pred             ccccc-cccccCCccccceeecccc-cccCC-CCccccccC-CCCccEEEecCCc--cc-cCCCCccccccCCcccEEEc
Q 046240          220 SITGN-IPQVMGNLSIFLLLDLELN-KLTGP-IPVTFGRLQ-NSKLDTLSLCGNS--FS-GSIPSCIDIGNLKVVVEINL  292 (763)
Q Consensus       220 ~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~-~~~L~~L~L~~N~--l~-~~~p~~~~~~~l~~L~~L~L  292 (763)
                      .+++. ++..+..+++|++|+|++| .+++. ++..+..++ +  |++|++++|.  ++ +.+|.  .+..+++|++|++
T Consensus       154 ~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~--L~~L~l~~~~~~~~~~~l~~--~~~~~~~L~~L~l  229 (336)
T 2ast_B          154 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET--ITQLNLSGYRKNLQKSDLST--LVRRCPNLVHLDL  229 (336)
T ss_dssp             SCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT--CCEEECCSCGGGSCHHHHHH--HHHHCTTCSEEEC
T ss_pred             CCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccC--CCEEEeCCCcccCCHHHHHH--HHhhCCCCCEEeC
Confidence            44432 4445556666666666666 66543 455555555 4  7777777773  33 23444  4667788888888


Q ss_pred             cccc-ccccCCcccCCCcCccEEEccCcc-ccCcccccccccccccEEeCcCCccCCccchhhhhhc-cCceEEcccccC
Q 046240          293 SRNN-FSGDIPATIGGLKDVQNISLPYNR-LEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLL-YLKKLNLSFNKL  369 (763)
Q Consensus       293 s~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l  369 (763)
                      ++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++| ++   ...+..+. .++.|++++|++
T Consensus       230 ~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l  305 (336)
T 2ast_B          230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHF  305 (336)
T ss_dssp             TTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCS
T ss_pred             CCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccC
Confidence            8888 676777788888999999999885 33222236788999999999999 43   34455553 478888999999


Q ss_pred             CCCCCCC
Q 046240          370 EGEIPRG  376 (763)
Q Consensus       370 ~~~~p~~  376 (763)
                      ++..|..
T Consensus       306 ~~~~~~~  312 (336)
T 2ast_B          306 TTIARPT  312 (336)
T ss_dssp             CCTTCSS
T ss_pred             ccccCCc
Confidence            9888754

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=7e-26  Score=244.38  Aligned_cols=253  Identities=18%  Similarity=0.197  Sum_probs=157.8

Q ss_pred             EEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccc----cccccCC-CccEEEcccccccccCCCcccCC
Q 046240           81 ALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPS----RIDLALP-NVKALSLAYNRFSGTIQSPITNA  155 (763)
Q Consensus        81 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~----~~~~~l~-~L~~L~L~~N~i~~~~p~~~~~l  155 (763)
                      .++|++|++++.+|..+...++|++|+|++|.++       .++.    ..+..++ +|++|+|++|.|++..+..|..+
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~-------~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~   74 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLY-------SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI   74 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGG-------GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCC-------hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHH
Confidence            3678999999988888888888999999999985       5554    5556788 89999999999998888877775


Q ss_pred             -----CCCCeeeecCcccccccccccCCC-----CchhhhhhhhhccCCcccccCCcccccc----cccccEEEeecCcc
Q 046240          156 -----SKLTILELGGNSFSGFIPNTIGNL-----RNIEWLGLVIGLIGNPLNGILPSSIVNL----SISLERLYISNCSI  221 (763)
Q Consensus       156 -----~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~~l~~n~l~~~~p~~~~~l----~~~L~~L~L~~N~l  221 (763)
                           ++|++|+|++|+|++..+..+...     ++|+.|+    +++|.+++..+..+...    ..+|++|+|++|++
T Consensus        75 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~----Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l  150 (362)
T 3goz_A           75 LAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLD----LGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL  150 (362)
T ss_dssp             HHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEE----CCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCG
T ss_pred             HhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEE----CcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcC
Confidence                 899999999999987766644433     6666666    66666665554444332    22666666666666


Q ss_pred             ccccc----cccCCcc-ccceeecccccccCCCCcccccc-----CCCCccEEEecCCccccC----CCCcccccc-CCc
Q 046240          222 TGNIP----QVMGNLS-IFLLLDLELNKLTGPIPVTFGRL-----QNSKLDTLSLCGNSFSGS----IPSCIDIGN-LKV  286 (763)
Q Consensus       222 ~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~~~L~~L~L~~N~l~~~----~p~~~~~~~-l~~  286 (763)
                      ++..+    ..+..++ +|++|+|++|++++..+..+...     .+  |++|+|++|.+++.    ++.  .+.. .++
T Consensus       151 ~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~--L~~L~Ls~N~i~~~~~~~l~~--~l~~~~~~  226 (362)
T 3goz_A          151 GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS--VTSLDLSANLLGLKSYAELAY--IFSSIPNH  226 (362)
T ss_dssp             GGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTT--CCEEECTTSCGGGSCHHHHHH--HHHHSCTT
T ss_pred             CHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCC--CCEEECCCCCCChhHHHHHHH--HHhcCCCC
Confidence            64322    2233343 66666666666665554433322     22  66666666666531    222  2222 235


Q ss_pred             ccEEEcccccccccCC----cccCCCcCccEEEccCccccCc-------ccccccccccccEEeCcCCccCCc
Q 046240          287 VVEINLSRNNFSGDIP----ATIGGLKDVQNISLPYNRLEGP-------IPESFGYLTSLEILDLSNNKISGF  348 (763)
Q Consensus       287 L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~L~~N~l~~~  348 (763)
                      |++|+|++|++++..+    ..+..+++|+.|+|++|.+.+.       ++..+..+++|+.||+++|++...
T Consensus       227 L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             CCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             ceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            6666666666654332    2234455566666666653322       222444555555555555555544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=9.6e-24  Score=213.66  Aligned_cols=201  Identities=15%  Similarity=0.194  Sum_probs=163.6

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCc-ccCCCccccCccccccccCCCccEEEccc-ccccccCCCccc
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNS-LVGNNSLSGSLPSRIDLALPNVKALSLAY-NRFSGTIQSPIT  153 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~lp~~~~~~l~~L~~L~L~~-N~i~~~~p~~~~  153 (763)
                      ..+++.|+|++|++++..+..|.++++|++|+|++|. ++       .+|...|.++++|++|+|++ |+|+++.+..|.
T Consensus        30 ~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-------~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~  102 (239)
T 2xwt_C           30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-------QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALK  102 (239)
T ss_dssp             CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-------EECTTTEESCTTCCEEEEEEETTCCEECTTSEE
T ss_pred             CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-------eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhC
Confidence            3579999999999998777899999999999999997 74       88988888999999999999 999988889999


Q ss_pred             CCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecC-ccccccccccCCc
Q 046240          154 NASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC-SITGNIPQVMGNL  232 (763)
Q Consensus       154 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N-~l~~~~~~~~~~l  232 (763)
                      ++++|++|+|++|++++ +|. |.++++|+                          .|++|++++| ++++..+..|.++
T Consensus       103 ~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~--------------------------~L~~L~l~~N~~l~~i~~~~~~~l  154 (239)
T 2xwt_C          103 ELPLLKFLGIFNTGLKM-FPD-LTKVYSTD--------------------------IFFILEITDNPYMTSIPVNAFQGL  154 (239)
T ss_dssp             CCTTCCEEEEEEECCCS-CCC-CTTCCBCC--------------------------SEEEEEEESCTTCCEECTTTTTTT
T ss_pred             CCCCCCEEeCCCCCCcc-ccc-cccccccc--------------------------cccEEECCCCcchhhcCcccccch
Confidence            99999999999999996 554 66666544                          3558888888 8887777778888


Q ss_pred             cccc-eeecccccccCCCCccccccCCCCccEEEecCCc-cccCCCCccccccC-CcccEEEcccccccccCCcccCCCc
Q 046240          233 SIFL-LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNS-FSGSIPSCIDIGNL-KVVVEINLSRNNFSGDIPATIGGLK  309 (763)
Q Consensus       233 ~~L~-~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~-l~~~~p~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~  309 (763)
                      ++|+ +|++++|+++...+..|.. .+  |+.|+|++|+ +++..+.  .|.++ ++|+.|++++|++++. |..  .++
T Consensus       155 ~~L~~~L~l~~n~l~~i~~~~~~~-~~--L~~L~L~~n~~l~~i~~~--~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~  226 (239)
T 2xwt_C          155 CNETLTLKLYNNGFTSVQGYAFNG-TK--LDAVYLNKNKYLTVIDKD--AFGGVYSGPSLLDVSQTSVTAL-PSK--GLE  226 (239)
T ss_dssp             BSSEEEEECCSCCCCEECTTTTTT-CE--EEEEECTTCTTCCEECTT--TTTTCSBCCSEEECTTCCCCCC-CCT--TCT
T ss_pred             hcceeEEEcCCCCCcccCHhhcCC-CC--CCEEEcCCCCCcccCCHH--HhhccccCCcEEECCCCccccC-Chh--Hhc
Confidence            8888 8888888888333333443 44  8888888884 8755555  67788 8899999999988854 433  567


Q ss_pred             CccEEEccCc
Q 046240          310 DVQNISLPYN  319 (763)
Q Consensus       310 ~L~~L~Ls~N  319 (763)
                      +|+.|+++++
T Consensus       227 ~L~~L~l~~~  236 (239)
T 2xwt_C          227 HLKELIARNT  236 (239)
T ss_dssp             TCSEEECTTC
T ss_pred             cCceeeccCc
Confidence            8888888775

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=2.2e-24  Score=227.48  Aligned_cols=208  Identities=17%  Similarity=0.186  Sum_probs=138.5

Q ss_pred             CCCccEEEcccccccccCCCcc--cCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccc
Q 046240          131 LPNVKALSLAYNRFSGTIQSPI--TNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS  208 (763)
Q Consensus       131 l~~L~~L~L~~N~i~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~  208 (763)
                      +++|++|+|++|.+++..|..+  .++++|++|+|++|++++..+.       +..                 ..+..++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~-------~~~-----------------~~~~~~~  145 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSW-------LAE-----------------LQQWLKP  145 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSS-------HHH-----------------HHTTBCS
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhh-------hHH-----------------HHhhhcc
Confidence            3456666666666666666655  5666666666666666543220       000                 1222333


Q ss_pred             ccccEEEeecCccccccccccCCccccceeecccccccCC--C--CccccccCCCCccEEEecCCccccCCCCc-c-ccc
Q 046240          209 ISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGP--I--PVTFGRLQNSKLDTLSLCGNSFSGSIPSC-I-DIG  282 (763)
Q Consensus       209 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~~~L~~L~L~~N~l~~~~p~~-~-~~~  282 (763)
                       +|++|+|++|++++..+..|+.+++|++|+|++|++.+.  +  +..+..+++  |++|+|++|+++ .++.. . .+.
T Consensus       146 -~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~--L~~L~Ls~N~l~-~l~~~~~~l~~  221 (310)
T 4glp_A          146 -GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPA--IQNLALRNTGME-TPTGVCAALAA  221 (310)
T ss_dssp             -CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCC--CCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred             -CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCC--CCEEECCCCCCC-chHHHHHHHHh
Confidence             777788888888777777777788888888888876542  1  122345554  778888888776 22220 0 135


Q ss_pred             cCCcccEEEcccccccccCCcccCCC---cCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccC
Q 046240          283 NLKVVVEINLSRNNFSGDIPATIGGL---KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYL  359 (763)
Q Consensus       283 ~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  359 (763)
                      .+++|++|+|++|+|++..|..+..+   ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+++ |. +..+++|
T Consensus       222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L  296 (310)
T 4glp_A          222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEV  296 (310)
T ss_dssp             HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCC
T ss_pred             cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCc
Confidence            67788888888888887777777766   58888888888888 5666554  7888888888888875 32 6777888


Q ss_pred             ceEEcccccCCC
Q 046240          360 KKLNLSFNKLEG  371 (763)
Q Consensus       360 ~~L~l~~N~l~~  371 (763)
                      +.|+|++|+++.
T Consensus       297 ~~L~L~~N~l~~  308 (310)
T 4glp_A          297 DNLTLDGNPFLV  308 (310)
T ss_dssp             SCEECSSTTTSC
T ss_pred             cEEECcCCCCCC
Confidence            888888888873

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=3.6e-24  Score=225.74  Aligned_cols=228  Identities=16%  Similarity=0.164  Sum_probs=150.7

Q ss_pred             ceEEEEecCCCCCCcCCc---ccCCCCCCCEEEcCCCcccCCCccccCcccccc-ccCCCccEEEcccccccccCC----
Q 046240           78 RVTALNISSLNLQGEIPH---EIGYLPSLTKLALGYNSLVGNNSLSGSLPSRID-LALPNVKALSLAYNRFSGTIQ----  149 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~---~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~-~~l~~L~~L~L~~N~i~~~~p----  149 (763)
                      +++.|.+.++.++...-.   .+..+++|++|+|++|.++      +.+|..++ ..+++|++|+|++|.|++..+    
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~------~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~  138 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKIT------GTMPPLPLEATGLALSSLRLRNVSWATGRSWLAE  138 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCB------SCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHH
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEec------cchhhhhhhccCCCCCEEEeecccccchhhhhHH
Confidence            467788888776532111   1223567999999999986      56776664 689999999999999998665    


Q ss_pred             CcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccccc-ccc
Q 046240          150 SPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNI-PQV  228 (763)
Q Consensus       150 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~-~~~  228 (763)
                      ..+..+++|++|+|++|+|++..+..|+++++|++|+    +++|++.+...                      .. +..
T Consensus       139 ~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~----Ls~N~l~~~~~----------------------~~~~~~  192 (310)
T 4glp_A          139 LQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLD----LSDNPGLGERG----------------------LMAALC  192 (310)
T ss_dssp             HHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEE----CCSCTTCHHHH----------------------HHTTSC
T ss_pred             HHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEE----CCCCCCccchh----------------------hhHHHh
Confidence            3456789999999999999988888888877655555    44454432100                      11 122


Q ss_pred             cCCccccceeecccccccCCCCc----cccccCCCCccEEEecCCccccCCCCccccccC---CcccEEEcccccccccC
Q 046240          229 MGNLSIFLLLDLELNKLTGPIPV----TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNL---KVVVEINLSRNNFSGDI  301 (763)
Q Consensus       229 ~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l---~~L~~L~Ls~N~l~~~~  301 (763)
                      ++.+++|++|+|++|+++ .+|.    .+.++++  |++|+|++|++++..|.  .+..+   ++|++|+|++|+|+ .+
T Consensus       193 ~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~--L~~L~Ls~N~l~~~~p~--~~~~~~~~~~L~~L~Ls~N~l~-~l  266 (310)
T 4glp_A          193 PHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQ--PHSLDLSHNSLRATVNP--SAPRCMWSSALNSLNLSFAGLE-QV  266 (310)
T ss_dssp             TTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCC--CSSEECTTSCCCCCCCS--CCSSCCCCTTCCCEECCSSCCC-SC
T ss_pred             hhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCC--CCEEECCCCCCCccchh--hHHhccCcCcCCEEECCCCCCC-ch
Confidence            345555666666666654 2222    1334443  66666666666655454  33333   57777777777777 45


Q ss_pred             CcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCC
Q 046240          302 PATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       302 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      |..+.  ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus       267 p~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          267 PKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             hhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            65554  6788888888888753 33 5677888888888888764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.90  E-value=2.9e-23  Score=222.68  Aligned_cols=150  Identities=16%  Similarity=0.149  Sum_probs=91.8

Q ss_pred             EEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCC-CcccCCCCCCe
Q 046240           82 LNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQ-SPITNASKLTI  160 (763)
Q Consensus        82 L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p-~~~~~l~~L~~  160 (763)
                      ++.++++|+ .+|..+  .+++++|+|++|+|+       .||++.|.++++|++|+|++|++.+.+| ..|.++++|++
T Consensus        14 v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-------~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~   83 (350)
T 4ay9_X           14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-------VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE   83 (350)
T ss_dssp             EEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-------EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCE
T ss_pred             EEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-------CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhh
Confidence            445567777 566655  357888888888885       7777777778888888888887755444 46777777654


Q ss_pred             -eeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeec-CccccccccccCCcc-ccce
Q 046240          161 -LELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISN-CSITGNIPQVMGNLS-IFLL  237 (763)
Q Consensus       161 -L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~  237 (763)
                       +++++|+|+.+.|+.|.++++|++|+    +++|.+.+..+..+.... ++..|++.+ |++....+..|..+. .++.
T Consensus        84 ~l~~~~N~l~~l~~~~f~~l~~L~~L~----l~~n~l~~~~~~~~~~~~-~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~  158 (350)
T 4ay9_X           84 IRIEKANNLLYINPEAFQNLPNLQYLL----ISNTGIKHLPDVHKIHSL-QKVLLDIQDNINIHTIERNSFVGLSFESVI  158 (350)
T ss_dssp             EEEEEETTCCEECTTSBCCCTTCCEEE----EEEECCSSCCCCTTCCBS-SCEEEEEESCTTCCEECTTSSTTSBSSCEE
T ss_pred             hhcccCCcccccCchhhhhcccccccc----ccccccccCCchhhcccc-hhhhhhhccccccccccccchhhcchhhhh
Confidence             55666777777777777777665555    455555544444444444 455555543 344444444444443 3444


Q ss_pred             eeccccccc
Q 046240          238 LDLELNKLT  246 (763)
Q Consensus       238 L~L~~N~l~  246 (763)
                      |+|++|+|+
T Consensus       159 L~L~~N~i~  167 (350)
T 4ay9_X          159 LWLNKNGIQ  167 (350)
T ss_dssp             EECCSSCCC
T ss_pred             hcccccccc
Confidence            455555544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=1.5e-25  Score=244.06  Aligned_cols=244  Identities=18%  Similarity=0.210  Sum_probs=154.1

Q ss_pred             cCCcccCCCCCCCEEEcCCCcccCCCccccCcccc---ccccCCCccEEEcccc---cccccCCCcc-------cCCCCC
Q 046240           92 EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSR---IDLALPNVKALSLAYN---RFSGTIQSPI-------TNASKL  158 (763)
Q Consensus        92 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~---~~~~l~~L~~L~L~~N---~i~~~~p~~~-------~~l~~L  158 (763)
                      .++..+..+++|++|+|++|.++      +..+..   .+..+++|++|+|++|   ++++.+|..+       .++++|
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~------~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L   96 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIG------TEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL   96 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEEC------HHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTC
T ss_pred             HHHHHHhcCCCccEEECCCCCCC------HHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcc
Confidence            45566777777777777777764      111111   1335677777777774   3444445443       566667


Q ss_pred             CeeeecCccccc----ccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccC----
Q 046240          159 TILELGGNSFSG----FIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMG----  230 (763)
Q Consensus       159 ~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~----  230 (763)
                      ++|+|++|+|++    .+|..+.+++                             +|++|+|++|.++...+..+.    
T Consensus        97 ~~L~Ls~n~l~~~~~~~l~~~l~~~~-----------------------------~L~~L~L~~n~l~~~~~~~l~~~l~  147 (386)
T 2ca6_A           97 HTVRLSDNAFGPTAQEPLIDFLSKHT-----------------------------PLEHLYLHNNGLGPQAGAKIARALQ  147 (386)
T ss_dssp             CEEECCSCCCCTTTHHHHHHHHHHCT-----------------------------TCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             cEEECCCCcCCHHHHHHHHHHHHhCC-----------------------------CCCEEECcCCCCCHHHHHHHHHHHH
Confidence            777777777664    2344444444                             555666666665533333222    


Q ss_pred             Cc---------cccceeeccccccc-CCCC---ccccccCCCCccEEEecCCccc--c---CCCCccccccCCcccEEEc
Q 046240          231 NL---------SIFLLLDLELNKLT-GPIP---VTFGRLQNSKLDTLSLCGNSFS--G---SIPSCIDIGNLKVVVEINL  292 (763)
Q Consensus       231 ~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~~~L~~L~L~~N~l~--~---~~p~~~~~~~l~~L~~L~L  292 (763)
                      .+         ++|++|+|++|+++ +.+|   ..+..+++  |++|+|++|+++  |   .+|.  .+..+++|++|+|
T Consensus       148 ~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~--L~~L~L~~n~l~~~g~~~l~~~--~l~~~~~L~~L~L  223 (386)
T 2ca6_A          148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL--LHTVKMVQNGIRPEGIEHLLLE--GLAYCQELKVLDL  223 (386)
T ss_dssp             HHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT--CCEEECCSSCCCHHHHHHHHHT--TGGGCTTCCEEEC
T ss_pred             HHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCC--cCEEECcCCCCCHhHHHHHHHH--HhhcCCCccEEEC
Confidence            22         66777777777665 2333   34445544  777777777766  2   3343  4667778888888


Q ss_pred             cccccc----ccCCcccCCCcCccEEEccCccccCc----ccccc--cccccccEEeCcCCccCC----ccchhh-hhhc
Q 046240          293 SRNNFS----GDIPATIGGLKDVQNISLPYNRLEGP----IPESF--GYLTSLEILDLSNNKISG----FILISL-EKLL  357 (763)
Q Consensus       293 s~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~  357 (763)
                      ++|.++    +.+|..+..+++|+.|+|++|++++.    ++..+  +.+++|+.|+|++|++++    .+|..+ .+++
T Consensus       224 s~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~  303 (386)
T 2ca6_A          224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP  303 (386)
T ss_dssp             CSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCT
T ss_pred             cCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCC
Confidence            888875    45677777888888888888888755    45555  337888888888888887    355555 5678


Q ss_pred             cCceEEcccccCCCCCC
Q 046240          358 YLKKLNLSFNKLEGEIP  374 (763)
Q Consensus       358 ~L~~L~l~~N~l~~~~p  374 (763)
                      +|+.|++++|++++..+
T Consensus       304 ~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          304 DLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             TCCEEECTTSBSCTTSH
T ss_pred             CceEEEccCCcCCcchh
Confidence            88888888888876543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=8.3e-26  Score=246.18  Aligned_cols=267  Identities=16%  Similarity=0.175  Sum_probs=205.2

Q ss_pred             CceEEEEecCCCCCCcCC----cccCCCCCCCEEEcCCCcccCCCccccCccccc------cccCCCccEEEcccccccc
Q 046240           77 HRVTALNISSLNLQGEIP----HEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRI------DLALPNVKALSLAYNRFSG  146 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~----~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~------~~~l~~L~~L~L~~N~i~~  146 (763)
                      .+++.|+|++|.+++..+    ..|..+++|++|+|++|.+   +.+.+.+|..+      +..+++|++|+|++|.|++
T Consensus        32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~---~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~  108 (386)
T 2ca6_A           32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT---GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP  108 (386)
T ss_dssp             SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT---TSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred             CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCccccc---CccccchhHHHHHHHHHHhhCCcccEEECCCCcCCH
Confidence            579999999999987644    4588999999999999876   34556777766      3588999999999999997


Q ss_pred             ----cCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccc
Q 046240          147 ----TIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT  222 (763)
Q Consensus       147 ----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~  222 (763)
                          .+|..+.++++|++|+|++|+|+...+..+...  |..+      ..|++.+..       + +|++|+|++|+++
T Consensus       109 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~l------~~~~~~~~~-------~-~L~~L~L~~n~l~  172 (386)
T 2ca6_A          109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQEL------AVNKKAKNA-------P-PLRSIICGRNRLE  172 (386)
T ss_dssp             TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHHH------HHHHHHHTC-------C-CCCEEECCSSCCT
T ss_pred             HHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHHH------hhhhhcccC-------C-CCcEEECCCCCCC
Confidence                477788999999999999999986555444431  1111      112222111       2 8999999999987


Q ss_pred             -cccc---cccCCccccceeecccccccC-----CCCccccccCCCCccEEEecCCccc----cCCCCccccccCCcccE
Q 046240          223 -GNIP---QVMGNLSIFLLLDLELNKLTG-----PIPVTFGRLQNSKLDTLSLCGNSFS----GSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       223 -~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~~~L~~L~L~~N~l~----~~~p~~~~~~~l~~L~~  289 (763)
                       +.++   ..+..+++|++|+|++|+++.     ..|..+..+++  |+.|+|++|.++    +.+|.  .+..+++|++
T Consensus       173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~--L~~L~Ls~n~l~~~g~~~l~~--~l~~~~~L~~  248 (386)
T 2ca6_A          173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE--LKVLDLQDNTFTHLGSSALAI--ALKSWPNLRE  248 (386)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTT--CCEEECCSSCCHHHHHHHHHH--HGGGCTTCCE
T ss_pred             cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCC--ccEEECcCCCCCcHHHHHHHH--HHccCCCcCE
Confidence             3444   467788899999999999872     34547777766  999999999995    46666  6888999999


Q ss_pred             EEccccccccc----CCccc--CCCcCccEEEccCccccC----cccccc-cccccccEEeCcCCccCCccc--hhh-hh
Q 046240          290 INLSRNNFSGD----IPATI--GGLKDVQNISLPYNRLEG----PIPESF-GYLTSLEILDLSNNKISGFIL--ISL-EK  355 (763)
Q Consensus       290 L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~~--~~~-~~  355 (763)
                      |+|++|+|++.    +|..+  +.+++|+.|+|++|.+++    .+|..+ ..+++|+.|+|++|++++..+  ..+ ..
T Consensus       249 L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~  328 (386)
T 2ca6_A          249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV  328 (386)
T ss_dssp             EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHH
T ss_pred             EECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHH
Confidence            99999999875    56666  448999999999999997    477777 668999999999999998763  333 34


Q ss_pred             hccCceEEccc
Q 046240          356 LLYLKKLNLSF  366 (763)
Q Consensus       356 l~~L~~L~l~~  366 (763)
                      ++.++.+++..
T Consensus       329 l~~~~~~~l~~  339 (386)
T 2ca6_A          329 FSTRGRGELDE  339 (386)
T ss_dssp             HHHHTCCEECC
T ss_pred             hhhcCcchhhh
Confidence            56666555543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=1.3e-22  Score=206.94  Aligned_cols=133  Identities=23%  Similarity=0.259  Sum_probs=67.2

Q ss_pred             cEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEE
Q 046240          212 ERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEIN  291 (763)
Q Consensus       212 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~  291 (763)
                      ++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++  |++|+|++|++++..+.  .+..+++|++|+
T Consensus        62 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~  137 (251)
T 3m19_A           62 TWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQ--LDKLYLGGNQLKSLPSG--VFDRLTKLKELR  137 (251)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT--CCEEECCSSCCCCCCTT--TTTTCTTCCEEE
T ss_pred             CEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCC--CCEEEcCCCcCCCcChh--HhccCCcccEEE
Confidence            33333333333333333444444444444444444333333444433  44444444444433332  344555556666


Q ss_pred             cccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCc
Q 046240          292 LSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF  348 (763)
Q Consensus       292 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  348 (763)
                      |++|+|++..+..|+.+++|+.|+|++|++++..+..|..+++|+.|+|++|++...
T Consensus       138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            666666555455566666666666666666655555566666666666666666553

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=7.6e-23  Score=219.45  Aligned_cols=238  Identities=16%  Similarity=0.135  Sum_probs=186.9

Q ss_pred             CcccceeecCC---------CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCcc
Q 046240           65 CNWIGITCDVN---------SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVK  135 (763)
Q Consensus        65 c~w~gv~c~~~---------~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~  135 (763)
                      |+|..|.|+..         ..++++|+|++|+|+.+.+.+|.++++|++|+|++|++.      +.+|..+|.++++|+
T Consensus         9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~------~~i~~~~f~~L~~l~   82 (350)
T 4ay9_X            9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL------EVIEADVFSNLPKLH   82 (350)
T ss_dssp             EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTC------CEECTTSBCSCTTCC
T ss_pred             eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCC------CccChhHhhcchhhh
Confidence            78889999753         257999999999999666678999999999999999986      478999999999987


Q ss_pred             E-EEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEE
Q 046240          136 A-LSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERL  214 (763)
Q Consensus       136 ~-L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L  214 (763)
                      + +.++.|+|+++.|+.|.++++|++|++++|+|++..+..+.+..++..|++   ...|++....+..|..+...|++|
T Consensus        83 ~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l---~~~~~i~~l~~~~f~~~~~~l~~L  159 (350)
T 4ay9_X           83 EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI---QDNINIHTIERNSFVGLSFESVIL  159 (350)
T ss_dssp             EEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEE---ESCTTCCEECTTSSTTSBSSCEEE
T ss_pred             hhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhh---ccccccccccccchhhcchhhhhh
Confidence            6 677789999999999999999999999999999888888888888888883   244677776677788877679999


Q ss_pred             EeecCccccccccccCCccccceeeccc-ccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcc
Q 046240          215 YISNCSITGNIPQVMGNLSIFLLLDLEL-NKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS  293 (763)
Q Consensus       215 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls  293 (763)
                      +|++|+|+.+.+..| ..++|+.|++++ |.++...+..|.++++  |++|+|++|+|+ .+|.. .   +.+|+.|.+.
T Consensus       160 ~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~--L~~LdLs~N~l~-~lp~~-~---~~~L~~L~~l  231 (350)
T 4ay9_X          160 WLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASG--PVILDISRTRIH-SLPSY-G---LENLKKLRAR  231 (350)
T ss_dssp             ECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEEC--CSEEECTTSCCC-CCCSS-S---CTTCCEEECT
T ss_pred             ccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcc--cchhhcCCCCcC-ccChh-h---hccchHhhhc
Confidence            999999996555555 557899999975 6777554556788876  889999999888 45541 3   3445555554


Q ss_pred             cccccccCCcccCCCcCccEEEccCcc
Q 046240          294 RNNFSGDIPATIGGLKDVQNISLPYNR  320 (763)
Q Consensus       294 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~  320 (763)
                      ++.--..+| .+..+++|+.++++++.
T Consensus       232 ~~~~l~~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          232 STYNLKKLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             TCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred             cCCCcCcCC-CchhCcChhhCcCCCCc
Confidence            443333555 37777888888877654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=4.6e-25  Score=237.93  Aligned_cols=255  Identities=16%  Similarity=0.166  Sum_probs=187.9

Q ss_pred             EEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCC----CcccCCC-CCCeeeecCcccccccccccCCC
Q 046240          105 KLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQ----SPITNAS-KLTILELGGNSFSGFIPNTIGNL  179 (763)
Q Consensus       105 ~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l  179 (763)
                      .++|++|.++      |.+|... ...++|++|+|++|.|++..+    ..|.+++ +|++|+|++|+|++..+..|..+
T Consensus         2 ~~~ls~n~~~------~~~~~~~-~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~   74 (362)
T 3goz_A            2 NYKLTLHPGS------NPVEEFT-SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQI   74 (362)
T ss_dssp             EEECCCCTTC------CHHHHHH-TSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred             ccccccccch------HHHHHHH-hCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHH
Confidence            4567777775      4555543 355669999999999998777    7788888 89999999999998888778776


Q ss_pred             -----CchhhhhhhhhccCCcccccCCcccccc-----cccccEEEeecCccccccccccCC-----ccccceeeccccc
Q 046240          180 -----RNIEWLGLVIGLIGNPLNGILPSSIVNL-----SISLERLYISNCSITGNIPQVMGN-----LSIFLLLDLELNK  244 (763)
Q Consensus       180 -----~~L~~L~L~~~l~~n~l~~~~p~~~~~l-----~~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~  244 (763)
                           ++|++|+    +++|.+++..+..+...     . +|++|+|++|+|++..+..+..     .++|++|+|++|+
T Consensus        75 l~~~~~~L~~L~----Ls~n~l~~~~~~~l~~~l~~~~~-~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~  149 (362)
T 3goz_A           75 LAAIPANVTSLN----LSGNFLSYKSSDELVKTLAAIPF-TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGND  149 (362)
T ss_dssp             HHTSCTTCCEEE----CCSSCGGGSCHHHHHHHHHTSCT-TCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSC
T ss_pred             HhccCCCccEEE----CcCCcCChHHHHHHHHHHHhCCC-CccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCc
Confidence                 8888888    88898888777765554     4 8999999999998776655443     2689999999999


Q ss_pred             ccCCCCccc----cccCCCCccEEEecCCccccCCCCcc--ccccC-CcccEEEccccccccc----CCcccCC-CcCcc
Q 046240          245 LTGPIPVTF----GRLQNSKLDTLSLCGNSFSGSIPSCI--DIGNL-KVVVEINLSRNNFSGD----IPATIGG-LKDVQ  312 (763)
Q Consensus       245 l~~~~p~~~----~~l~~~~L~~L~L~~N~l~~~~p~~~--~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~  312 (763)
                      ++...+..+    ...+ .+|++|+|++|++++..+...  .+... ++|++|+|++|+|+..    ++..+.. .++|+
T Consensus       150 l~~~~~~~l~~~l~~~~-~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~  228 (362)
T 3goz_A          150 LGIKSSDELIQILAAIP-ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV  228 (362)
T ss_dssp             GGGSCHHHHHHHHHTSC-TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCC
T ss_pred             CCHHHHHHHHHHHhcCC-ccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCce
Confidence            885444333    3333 148999999999886555310  12334 5889999999988863    3445555 35899


Q ss_pred             EEEccCccccCccc----ccccccccccEEeCcCCccCCccch-------hhhhhccCceEEcccccCCCC
Q 046240          313 NISLPYNRLEGPIP----ESFGYLTSLEILDLSNNKISGFILI-------SLEKLLYLKKLNLSFNKLEGE  372 (763)
Q Consensus       313 ~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~l~~N~l~~~  372 (763)
                      .|+|++|++++..+    ..+..+++|+.|+|++|.+..+.+.       .+..+++|+.||+++|++...
T Consensus       229 ~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             EEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             EEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            99999998886544    3446678899999999986655433       455677888889999888755

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.89  E-value=8.6e-24  Score=238.59  Aligned_cols=209  Identities=24%  Similarity=0.373  Sum_probs=137.2

Q ss_pred             CCCCCCCCC-----cccce-eecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCcccccccc
Q 046240           57 NWTSNTSVC-----NWIGI-TCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLA  130 (763)
Q Consensus        57 ~w~~~~~~c-----~w~gv-~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~  130 (763)
                      +|..+.++|     .|.|+ .|..  .+++.|+|++|+|++ +|..+.  ++|++|+|++|.|+       .+|    ..
T Consensus        35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-------~ip----~~   98 (571)
T 3cvr_A           35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-------SLP----EL   98 (571)
T ss_dssp             HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-------CCC----CC
T ss_pred             HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-------ccc----cc
Confidence            676667788     79999 7863  489999999999996 777663  88999999999995       677    24


Q ss_pred             CCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccccc
Q 046240          131 LPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS  210 (763)
Q Consensus       131 l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~  210 (763)
                      +++|++|+|++|+|++ +|. |.+  +|++|+|++|+|++ +|.   .+++|+.|+    +++|.+++ +|.        
T Consensus        99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~----Ls~N~l~~-lp~--------  157 (571)
T 3cvr_A           99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN----ADNNQLTM-LPE--------  157 (571)
T ss_dssp             CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE----CCSSCCSC-CCC--------
T ss_pred             cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe----CCCCccCc-CCC--------
Confidence            7899999999999997 666 665  89999999999986 444   445444444    44444443 332        


Q ss_pred             ccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCcccccc-----CC
Q 046240          211 LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGN-----LK  285 (763)
Q Consensus       211 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~-----l~  285 (763)
                                          .+++|++|+|++|+|++ +|. |.  +  +|+.|+|++|+|+ .+|.   +..     .+
T Consensus       158 --------------------~l~~L~~L~Ls~N~L~~-lp~-l~--~--~L~~L~Ls~N~L~-~lp~---~~~~L~~~~~  207 (571)
T 3cvr_A          158 --------------------LPTSLEVLSVRNNQLTF-LPE-LP--E--SLEALDVSTNLLE-SLPA---VPVRNHHSEE  207 (571)
T ss_dssp             --------------------CCTTCCEEECCSSCCSC-CCC-CC--T--TCCEEECCSSCCS-SCCC---CC--------
T ss_pred             --------------------cCCCcCEEECCCCCCCC-cch-hh--C--CCCEEECcCCCCC-chhh---HHHhhhcccc
Confidence                                33445555555555543 333 32  2  2555555555555 3333   111     11


Q ss_pred             cccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccc
Q 046240          286 VVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLT  333 (763)
Q Consensus       286 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  333 (763)
                      .|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..++
T Consensus       208 ~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             cceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            2266666666666 4566666667777777777777666666665543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.6e-22  Score=212.70  Aligned_cols=130  Identities=22%  Similarity=0.283  Sum_probs=75.7

Q ss_pred             cCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCC
Q 046240          229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGL  308 (763)
Q Consensus       229 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  308 (763)
                      +..+++|++|+|++|++++. +. +..+++  |++|++++|++++ ++   .+..+++|++|+|++|++++..+  +..+
T Consensus       103 ~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~--L~~L~l~~n~l~~-~~---~l~~l~~L~~L~l~~n~l~~~~~--l~~l  172 (308)
T 1h6u_A          103 IAGLQSIKTLDLTSTQITDV-TP-LAGLSN--LQVLYLDLNQITN-IS---PLAGLTNLQYLSIGNAQVSDLTP--LANL  172 (308)
T ss_dssp             GTTCTTCCEEECTTSCCCCC-GG-GTTCTT--CCEEECCSSCCCC-CG---GGGGCTTCCEEECCSSCCCCCGG--GTTC
T ss_pred             hcCCCCCCEEECCCCCCCCc-hh-hcCCCC--CCEEECCCCccCc-Cc---cccCCCCccEEEccCCcCCCChh--hcCC
Confidence            44444444444444444432 21 444433  5555555555542 22   14555666666666666664322  6666


Q ss_pred             cCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCC
Q 046240          309 KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGE  372 (763)
Q Consensus       309 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  372 (763)
                      ++|+.|++++|++++..+  +..+++|++|+|++|++++..+  +..+++|+.|++++|++++.
T Consensus       173 ~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~  232 (308)
T 1h6u_A          173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ  232 (308)
T ss_dssp             TTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred             CCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence            777777777777764433  6667777777777777776543  66777777777777777653

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=2.5e-22  Score=198.59  Aligned_cols=183  Identities=22%  Similarity=0.263  Sum_probs=103.2

Q ss_pred             CCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccc
Q 046240           64 VCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNR  143 (763)
Q Consensus        64 ~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~  143 (763)
                      .|+|.+|.|+.            ++++ .+|..+  .++|++|+|++|.++       .+|...+..+++|++|+|++|+
T Consensus         6 ~C~~~~v~c~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~-------~~~~~~~~~l~~L~~L~l~~n~   63 (208)
T 2o6s_A            6 SCSGTTVECYS------------QGRT-SVPTGI--PAQTTYLDLETNSLK-------SLPNGVFDELTSLTQLYLGGNK   63 (208)
T ss_dssp             EEETTEEECCS------------SCCS-SCCSCC--CTTCSEEECCSSCCC-------CCCTTTTTTCTTCSEEECCSSC
T ss_pred             EECCCEEEecC------------CCcc-CCCCCC--CCCCcEEEcCCCccC-------cCChhhhcccccCcEEECCCCc
Confidence            47888888853            4444 344333  347777777777774       5666666667777777777777


Q ss_pred             ccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccc
Q 046240          144 FSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITG  223 (763)
Q Consensus       144 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~  223 (763)
                      |++..+..|.++++|++|+|++|+|+++.+..|.+++                             +|++|+|++|+|++
T Consensus        64 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-----------------------------~L~~L~L~~N~l~~  114 (208)
T 2o6s_A           64 LQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLT-----------------------------QLKELALNTNQLQS  114 (208)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-----------------------------TCCEEECCSSCCCC
T ss_pred             cCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCcc-----------------------------CCCEEEcCCCcCcc
Confidence            7766556666677777777777776655554454444                             45555555555554


Q ss_pred             ccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCc
Q 046240          224 NIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA  303 (763)
Q Consensus       224 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~  303 (763)
                      ..+..|..+++|++|+|++|++++..+..+..+++  |++|++++|.+.+.         ++.|+.|+++.|+++|.+|.
T Consensus       115 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~--L~~L~l~~N~~~~~---------~~~l~~L~~~~n~~~g~ip~  183 (208)
T 2o6s_A          115 LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS--LQYIWLHDNPWDCT---------CPGIRYLSEWINKHSGVVRN  183 (208)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT--CCEEECCSCCBCCC---------TTTTHHHHHHHHHCTTTBBC
T ss_pred             cCHhHhccCCcCCEEECCCCccceeCHHHhccCCC--ccEEEecCCCeecC---------CCCHHHHHHHHHhCCceeec
Confidence            44445555555555555555555444433444433  44555554444321         22344444444444444444


Q ss_pred             ccCCC
Q 046240          304 TIGGL  308 (763)
Q Consensus       304 ~~~~l  308 (763)
                      .++.+
T Consensus       184 ~~~~l  188 (208)
T 2o6s_A          184 SAGSV  188 (208)
T ss_dssp             TTSSB
T ss_pred             cCccc
Confidence            44433

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=3e-22  Score=210.63  Aligned_cols=63  Identities=22%  Similarity=0.399  Sum_probs=30.6

Q ss_pred             cccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCC
Q 046240          281 IGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       281 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..+  +..+++|+.|+|++|++++
T Consensus       169 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            3444445555555555443222  4445555555555555553322  4555555555555555544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=4.7e-22  Score=205.72  Aligned_cols=147  Identities=15%  Similarity=0.096  Sum_probs=117.6

Q ss_pred             HHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhH------------------HHHHHHHHHHHHHHhCCCCccc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA------------------RAMKSFEVECEVMKNIRHRNLV  534 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv  534 (763)
                      ....|.+.+.||+|+||.||+|...+|+.||+|+++....                  .....+.+|++++++++  | +
T Consensus        88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~  164 (282)
T 1zar_A           88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L  164 (282)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred             CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence            3455667799999999999999888899999999864321                  13466889999999999  4 5


Q ss_pred             eEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       535 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      ++.+++.. +..++||||++|++|.+ +...       ....++.|+++||.||   |+.+|+||||||+||+++ ++.+
T Consensus       165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~-------~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NILl~-~~~v  231 (282)
T 1zar_A          165 AVPKVYAW-EGNAVLMELIDAKELYR-VRVE-------NPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVS-EEGI  231 (282)
T ss_dssp             SSCCEEEE-ETTEEEEECCCCEEGGG-CCCS-------CHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEE-TTEE
T ss_pred             CcCeEEec-cceEEEEEecCCCcHHH-cchh-------hHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHEEEE-CCcE
Confidence            56665443 56699999999999988 4221       2446999999999999   788999999999999999 9999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccC
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI  650 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~  650 (763)
                      ||+|||+++..               ..|+|||++.
T Consensus       232 kl~DFG~a~~~---------------~~~~a~e~l~  252 (282)
T 1zar_A          232 WIIDFPQSVEV---------------GEEGWREILE  252 (282)
T ss_dssp             EECCCTTCEET---------------TSTTHHHHHH
T ss_pred             EEEECCCCeEC---------------CCCCHHHHHH
Confidence            99999998743               2467888763

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=1.6e-21  Score=220.18  Aligned_cols=189  Identities=24%  Similarity=0.330  Sum_probs=133.6

Q ss_pred             CccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccccccc
Q 046240          133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLE  212 (763)
Q Consensus       133 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~  212 (763)
                      +|+.|+|++|.|++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|+.|+    +++|++++ +|. +.+   +|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~----Ls~N~l~~-ip~-l~~---~L~  123 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLD----ACDNRLST-LPE-LPA---SLK  123 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEE----CCSSCCSC-CCC-CCT---TCC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEE----ccCCCCCC-cch-hhc---CCC
Confidence            45555555555554 333231  44555555555555 233   2344455444    44555554 444 332   688


Q ss_pred             EEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEc
Q 046240          213 RLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINL  292 (763)
Q Consensus       213 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~L  292 (763)
                      +|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++  |++|+|++|+|++ +|.   +.  ++|+.|+|
T Consensus       124 ~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~--L~~L~Ls~N~L~~-lp~---l~--~~L~~L~L  187 (571)
T 3cvr_A          124 HLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTS--LEVLSVRNNQLTF-LPE---LP--ESLEALDV  187 (571)
T ss_dssp             EEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTT--CCEEECCSSCCSC-CCC---CC--TTCCEEEC
T ss_pred             EEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCC--cCEEECCCCCCCC-cch---hh--CCCCEEEC
Confidence            99999999987 555   67899999999999996 665   3444  9999999999995 776   33  89999999


Q ss_pred             ccccccccCCcccCCCcCc-------cEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhcc
Q 046240          293 SRNNFSGDIPATIGGLKDV-------QNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLY  358 (763)
Q Consensus       293 s~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  358 (763)
                      ++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..|..+..+..
T Consensus       188 s~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          188 STNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             cCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            999999 5666 665  77       99999999999 57887888999999999999999999999888765

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=4.5e-21  Score=189.48  Aligned_cols=181  Identities=22%  Similarity=0.239  Sum_probs=128.5

Q ss_pred             CEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchh
Q 046240          104 TKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIE  183 (763)
Q Consensus       104 ~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  183 (763)
                      +.++.+++.++       .+|..+.   ++|++|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|.+++   
T Consensus        10 ~~v~c~~~~l~-------~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~---   76 (208)
T 2o6s_A           10 TTVECYSQGRT-------SVPTGIP---AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT---   76 (208)
T ss_dssp             TEEECCSSCCS-------SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT---
T ss_pred             CEEEecCCCcc-------CCCCCCC---CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCC---
Confidence            45666666664       5565443   4677777777777766666667777777777777777655444444433   


Q ss_pred             hhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccE
Q 046240          184 WLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDT  263 (763)
Q Consensus       184 ~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~  263 (763)
                                                +|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++  |++
T Consensus        77 --------------------------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~  128 (208)
T 2o6s_A           77 --------------------------SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQ--LKD  128 (208)
T ss_dssp             --------------------------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT--CCE
T ss_pred             --------------------------CcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCc--CCE
Confidence                                      6778888888888777777888888888888888888766666777765  888


Q ss_pred             EEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCccccccccccc
Q 046240          264 LSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTS  334 (763)
Q Consensus       264 L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  334 (763)
                      |+|++|++++..+.  .+..+++|++|++++|.+.+       .+++|+.|+++.|+++|.+|..++.++.
T Consensus       129 L~l~~N~l~~~~~~--~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          129 LRLYQNQLKSVPDG--VFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             EECCSSCCSCCCTT--TTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             EECCCCccceeCHH--HhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            88888888755554  56777888888888887663       3456777777778887777777766654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.85  E-value=1.4e-22  Score=216.27  Aligned_cols=243  Identities=16%  Similarity=0.188  Sum_probs=180.4

Q ss_pred             CCCEEEcCCCcccCCCccccCccccccccC--CCccEEEcccccccccCCCcccCCCCCCeeeecCcccccc-cccccCC
Q 046240          102 SLTKLALGYNSLVGNNSLSGSLPSRIDLAL--PNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGF-IPNTIGN  178 (763)
Q Consensus       102 ~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l--~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~  178 (763)
                      .+++|++++|.+.          +..+..+  ++++.|++++|.+++..+. +.++++|++|+|++|++++. ++..+  
T Consensus        48 ~~~~l~l~~~~~~----------~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~--  114 (336)
T 2ast_B           48 LWQTLDLTGKNLH----------PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGIL--  114 (336)
T ss_dssp             TSSEEECTTCBCC----------HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHH--
T ss_pred             hheeeccccccCC----------HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHH--
Confidence            3667777776552          1222244  6677777777777665554 44567777777777766543 33333  


Q ss_pred             CCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccc-cccCC-CCcccccc
Q 046240          179 LRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELN-KLTGP-IPVTFGRL  256 (763)
Q Consensus       179 l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l  256 (763)
                                                ..++ +|++|+|++|++++..+..++.+++|++|+|++| .+++. ++..+.++
T Consensus       115 --------------------------~~~~-~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~  167 (336)
T 2ast_B          115 --------------------------SQCS-KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC  167 (336)
T ss_dssp             --------------------------TTBC-CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHC
T ss_pred             --------------------------hhCC-CCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcC
Confidence                                      3333 7888999999998888999999999999999999 68753 67778888


Q ss_pred             CCCCccEEEecCC-ccccC-CCCccccccCC-cccEEEcccc--ccc-ccCCcccCCCcCccEEEccCcc-ccCcccccc
Q 046240          257 QNSKLDTLSLCGN-SFSGS-IPSCIDIGNLK-VVVEINLSRN--NFS-GDIPATIGGLKDVQNISLPYNR-LEGPIPESF  329 (763)
Q Consensus       257 ~~~~L~~L~L~~N-~l~~~-~p~~~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~  329 (763)
                      ++  |++|++++| .+++. ++.  .+..++ +|++|++++|  .++ +.+|..+..+++|+.|++++|. +++..+..+
T Consensus       168 ~~--L~~L~l~~~~~l~~~~~~~--~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l  243 (336)
T 2ast_B          168 SR--LDELNLSWCFDFTEKHVQV--AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF  243 (336)
T ss_dssp             TT--CCEEECCCCTTCCHHHHHH--HHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred             CC--CCEEcCCCCCCcChHHHHH--HHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHH
Confidence            76  999999999 88853 455  578899 9999999999  555 4567788899999999999999 777788899


Q ss_pred             cccccccEEeCcCCc-cCCccchhhhhhccCceEEcccccCCCCCCCCC--Cc-cccccccccCCCcc
Q 046240          330 GYLTSLEILDLSNNK-ISGFILISLEKLLYLKKLNLSFNKLEGEIPRGG--PF-ANFTAKSFMGNEKL  393 (763)
Q Consensus       330 ~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~--~~-~~l~~~~~~~n~~~  393 (763)
                      ..+++|++|+|++|. +.......+..+++|+.|++++|     ++..+  .+ ..+..+.+.+|...
T Consensus       244 ~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-----i~~~~~~~l~~~l~~L~l~~n~l~  306 (336)
T 2ast_B          244 FQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-----VPDGTLQLLKEALPHLQINCSHFT  306 (336)
T ss_dssp             GGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-----SCTTCHHHHHHHSTTSEESCCCSC
T ss_pred             hCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-----cCHHHHHHHHhhCcceEEecccCc
Confidence            999999999999995 43333336888999999999999     33321  12 23666777666543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.83  E-value=5.1e-22  Score=232.48  Aligned_cols=227  Identities=22%  Similarity=0.211  Sum_probs=99.6

Q ss_pred             CCChhhHHHHHHHHHhccCCCCcccccCCCC-CCCCCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEc
Q 046240           30 SNITTDQQALLALEAHISYDPTNLLAQNWTS-NTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLAL  108 (763)
Q Consensus        30 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L  108 (763)
                      +....++++++++......+....-. .|.. .+..++|.++.++  ..+++.|+|.+|++.. .+..+     |+.++|
T Consensus       128 s~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s--~~~~~~l~L~~n~~~~-~~~~~-----l~~l~L  198 (727)
T 4b8c_D          128 SLVDCTKQALMEMADTLTDSKTAKKQ-QPTGDSTPSGTATNSAVS--TPLTPKIELFANGKDE-ANQAL-----LQHKKL  198 (727)
T ss_dssp             ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred             hccccchhhhhhhhhhcccccCcccC-CCcCCCCccccCCCceec--CCccceEEeeCCCCCc-chhhH-----hhcCcc
Confidence            34567888999998765432222222 4643 3456789998886  3689999999999985 34333     445555


Q ss_pred             CCCcccCC----CccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhh
Q 046240          109 GYNSLVGN----NSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEW  184 (763)
Q Consensus       109 ~~n~l~~~----~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  184 (763)
                      +.|.|.+.    +.+  .+|...+..+++|+.|+|++|.|+ .+|..+.++++|++|+|++|+|+ .+|..|++|++|+.
T Consensus       199 s~~~i~~~~~~~n~~--~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~  274 (727)
T 4b8c_D          199 SQYSIDEDDDIENRM--VMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRV  274 (727)
T ss_dssp             -------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCE
T ss_pred             CcccccCccccccce--ecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCE
Confidence            55555321    111  245555556777777777777776 45555556777777777777776 56666677776666


Q ss_pred             hhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEE
Q 046240          185 LGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTL  264 (763)
Q Consensus       185 L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L  264 (763)
                      |+    |++|+|+ .+|..|.++. +|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. .+..|
T Consensus       275 L~----Ls~N~l~-~lp~~~~~l~-~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-~~~~l  346 (727)
T 4b8c_D          275 LD----LSHNRLT-SLPAELGSCF-QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV-TGLIF  346 (727)
T ss_dssp             EE----CTTSCCS-SCCSSGGGGT-TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH-HHHHH
T ss_pred             Ee----CcCCcCC-ccChhhcCCC-CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcch-hhhHH
Confidence            66    5666666 5566666666 6666666666665 45555666666666666666666666665544321 12235


Q ss_pred             EecCCccccCCCC
Q 046240          265 SLCGNSFSGSIPS  277 (763)
Q Consensus       265 ~L~~N~l~~~~p~  277 (763)
                      +|++|.+++.+|.
T Consensus       347 ~l~~N~l~~~~p~  359 (727)
T 4b8c_D          347 YLRDNRPEIPLPH  359 (727)
T ss_dssp             HHHHCCCCCCCCC
T ss_pred             hhccCcccCcCcc
Confidence            5666666655554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=3.2e-20  Score=186.13  Aligned_cols=162  Identities=21%  Similarity=0.223  Sum_probs=110.6

Q ss_pred             CCCCCCCCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEE
Q 046240           58 WTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKAL  137 (763)
Q Consensus        58 w~~~~~~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L  137 (763)
                      |..+...|+|.+|.|..            ++++ .+|..+.  ++|++|+|++|.|+       .+++..+.++++|++|
T Consensus        12 ~~~~~~~Cs~~~v~c~~------------~~l~-~ip~~~~--~~L~~L~Ls~n~i~-------~~~~~~~~~l~~L~~L   69 (229)
T 3e6j_A           12 ACPSQCSCSGTTVDCRS------------KRHA-SVPAGIP--TNAQILYLHDNQIT-------KLEPGVFDSLINLKEL   69 (229)
T ss_dssp             CCCTTCEEETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSSCCC-------CCCTTTTTTCTTCCEE
T ss_pred             cCCCCCEEeCCEeEccC------------CCcC-ccCCCCC--CCCCEEEcCCCccC-------ccCHHHhhCccCCcEE
Confidence            55577899999999863            3344 4554443  77788888888775       4555556677778888


Q ss_pred             EcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEee
Q 046240          138 SLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS  217 (763)
Q Consensus       138 ~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~  217 (763)
                      +|++|+|+.+.+..|.++++|++|+|++|+|+++.+..|..+++|+.|+    +++|+++ .+|..+..+. +|++|+|+
T Consensus        70 ~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~----Ls~N~l~-~lp~~~~~l~-~L~~L~L~  143 (229)
T 3e6j_A           70 YLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF----MCCNKLT-ELPRGIERLT-HLTHLALD  143 (229)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE----CCSSCCC-SCCTTGGGCT-TCSEEECC
T ss_pred             ECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe----ccCCccc-ccCcccccCC-CCCEEECC
Confidence            8888887766666777778888888888888776666677777666666    5566655 4455555555 66666666


Q ss_pred             cCccccccccccCCccccceeecccccccC
Q 046240          218 NCSITGNIPQVMGNLSIFLLLDLELNKLTG  247 (763)
Q Consensus       218 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  247 (763)
                      +|+|++..+..|..+++|+.|+|++|.+..
T Consensus       144 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A          144 QNQLKSIPHGAFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred             CCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence            666665555566666666666666666653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=1.2e-20  Score=188.03  Aligned_cols=157  Identities=23%  Similarity=0.226  Sum_probs=122.4

Q ss_pred             ccEEEeecCccccccccccCCccccceeecccccccCCCC-ccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          211 LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIP-VTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       211 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      -+++++++|.++. +|..+.  ..+++|+|++|+|++..| ..|..+++  |++|+|++|++++..+.  .|.++++|++
T Consensus        13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~--L~~L~L~~N~i~~i~~~--~~~~l~~L~~   85 (220)
T 2v70_A           13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQ--LRKINFSNNKITDIEEG--AFEGASGVNE   85 (220)
T ss_dssp             TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTT--CCEEECCSSCCCEECTT--TTTTCTTCCE
T ss_pred             CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCC--CCEEECCCCcCCEECHH--HhCCCCCCCE
Confidence            3577788887774 455443  345778888888876644 34677765  88888888888866665  6788888888


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccC
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL  369 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  369 (763)
                      |+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.|..|..+++|+.|+|++|++
T Consensus        86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  165 (220)
T 2v70_A           86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF  165 (220)
T ss_dssp             EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred             EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence            88888888877777788888888888888888877788888888888888888888888788888888888888888888


Q ss_pred             CCCCC
Q 046240          370 EGEIP  374 (763)
Q Consensus       370 ~~~~p  374 (763)
                      ++..+
T Consensus       166 ~c~c~  170 (220)
T 2v70_A          166 NCNCY  170 (220)
T ss_dssp             ECSGG
T ss_pred             cCCCc
Confidence            87655

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=5e-20  Score=183.46  Aligned_cols=152  Identities=21%  Similarity=0.269  Sum_probs=107.1

Q ss_pred             EEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCe
Q 046240           81 ALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTI  160 (763)
Q Consensus        81 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  160 (763)
                      .+++++|+++ .+|..+.  +.+++|+|++|.|+      +..|..+|..+++|++|+|++|+|+++.+..|.++++|++
T Consensus        15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~------~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~   85 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFT------VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE   85 (220)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCC------EECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCC------ccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCE
Confidence            7888999998 4676654  35689999999886      2335667778899999999999999888888899999999


Q ss_pred             eeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeec
Q 046240          161 LELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDL  240 (763)
Q Consensus       161 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  240 (763)
                      |+|++|+|+++.+..|.++++|++|+    |++|++++..|..|.++. +|++|+|++|+|++..|..|..+++|+.|+|
T Consensus        86 L~Ls~N~l~~~~~~~~~~l~~L~~L~----Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  160 (220)
T 2v70_A           86 ILLTSNRLENVQHKMFKGLESLKTLM----LRSNRITCVGNDSFIGLS-SVRLLSLYDNQITTVAPGAFDTLHSLSTLNL  160 (220)
T ss_dssp             EECCSSCCCCCCGGGGTTCSSCCEEE----CTTSCCCCBCTTSSTTCT-TCSEEECTTSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             EECCCCccCccCHhHhcCCcCCCEEE----CCCCcCCeECHhHcCCCc-cCCEEECCCCcCCEECHHHhcCCCCCCEEEe
Confidence            99999999888787787777666555    555555555555555554 5555555555555554555555555555555


Q ss_pred             cccccc
Q 046240          241 ELNKLT  246 (763)
Q Consensus       241 ~~N~l~  246 (763)
                      ++|.+.
T Consensus       161 ~~N~l~  166 (220)
T 2v70_A          161 LANPFN  166 (220)
T ss_dssp             CSCCEE
T ss_pred             cCcCCc
Confidence            555554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=1.9e-22  Score=228.87  Aligned_cols=188  Identities=17%  Similarity=0.192  Sum_probs=93.6

Q ss_pred             cCCCccEEEcccccccccCCCcccCCCCCCeeeecCcc-------------cccccccccCCCCchhhhhhhhhccCCcc
Q 046240          130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNS-------------FSGFIPNTIGNLRNIEWLGLVIGLIGNPL  196 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~L~~~l~~n~l  196 (763)
                      .+++|+.|+|++|+|+ .+|..++++++|+.|++++|.             +.+.+|..++++++|+.|+.   +..|.+
T Consensus       347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~---l~~n~~  422 (567)
T 1dce_A          347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP---MRAAYL  422 (567)
T ss_dssp             TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCG---GGHHHH
T ss_pred             cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcc---hhhccc
Confidence            4556666666666665 456666666666666665554             33444445555555554441   111111


Q ss_pred             cccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCC
Q 046240          197 NGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIP  276 (763)
Q Consensus       197 ~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p  276 (763)
                                 . +|..+.+++|.|+...+.      .|+.|+|++|+|++ +|. +..+++  |+.|+|++|+|+ .+|
T Consensus       423 -----------~-~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~--L~~L~Ls~N~l~-~lp  479 (567)
T 1dce_A          423 -----------D-DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLL--VTHLDLSHNRLR-ALP  479 (567)
T ss_dssp             -----------H-HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTT--CCEEECCSSCCC-CCC
T ss_pred             -----------c-hhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-cccccc--CcEeecCccccc-ccc
Confidence                       1 344444444444432221      24555555555553 333 444443  555555555555 444


Q ss_pred             CccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcc-cccccccccccEEeCcCCccCCc
Q 046240          277 SCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPI-PESFGYLTSLEILDLSNNKISGF  348 (763)
Q Consensus       277 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~  348 (763)
                      .  .++++++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.. |..++.+++|+.|+|++|+|++.
T Consensus       480 ~--~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          480 P--ALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             G--GGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             h--hhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence            4  44555555555555555553 33 4555555555555555555443 44555555555555555555543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=5.2e-20  Score=183.38  Aligned_cols=151  Identities=22%  Similarity=0.283  Sum_probs=103.4

Q ss_pred             EEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCe
Q 046240           81 ALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTI  160 (763)
Q Consensus        81 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  160 (763)
                      .+++++++++ .+|..+.  ++|++|+|++|.|+       .+|...|..+++|++|+|++|+|+++.|..|.++++|++
T Consensus        15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~-------~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~   84 (220)
T 2v9t_B           15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIK-------VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS   84 (220)
T ss_dssp             EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCC-------EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCE
T ss_pred             EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCC-------CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCE
Confidence            5667778888 5666554  67888888888885       677777778888888888888888888888888888888


Q ss_pred             eeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeec
Q 046240          161 LELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDL  240 (763)
Q Consensus       161 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  240 (763)
                      |+|++|+|+.+.+..|.++++|                             ++|+|++|+|++..|..|..+++|++|+|
T Consensus        85 L~Ls~N~l~~l~~~~f~~l~~L-----------------------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  135 (220)
T 2v9t_B           85 LVLYGNKITELPKSLFEGLFSL-----------------------------QLLLLNANKINCLRVDAFQDLHNLNLLSL  135 (220)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTC-----------------------------CEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             EECCCCcCCccCHhHccCCCCC-----------------------------CEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence            8888888886666666666654                             45555555555555555555555555555


Q ss_pred             ccccccCCCCccccccCCCCccEEEecCCccc
Q 046240          241 ELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS  272 (763)
Q Consensus       241 ~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~  272 (763)
                      ++|+|++..+..|..+++  |++|+|++|.+.
T Consensus       136 ~~N~l~~~~~~~~~~l~~--L~~L~L~~N~~~  165 (220)
T 2v9t_B          136 YDNKLQTIAKGTFSPLRA--IQTMHLAQNPFI  165 (220)
T ss_dssp             CSSCCSCCCTTTTTTCTT--CCEEECCSSCEE
T ss_pred             CCCcCCEECHHHHhCCCC--CCEEEeCCCCcC
Confidence            555555544445555544  555555555554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=4.2e-20  Score=198.87  Aligned_cols=159  Identities=23%  Similarity=0.174  Sum_probs=122.6

Q ss_pred             cccEEEeecCccccccccccC-CccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCccc
Q 046240          210 SLERLYISNCSITGNIPQVMG-NLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV  288 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~  288 (763)
                      .+++|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++  |++|+|++|+|++..+.  .|.++++|+
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~--L~~L~Ls~N~l~~~~~~--~~~~l~~L~  115 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN--LRYLDLSSNHLHTLDEF--LFSDLQALE  115 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTT--CCEEECCSSCCCEECTT--TTTTCTTCC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCC--CCEEECCCCcCCcCCHH--HhCCCcCCC
Confidence            567778888888777777776 7888888888888888766677777765  88888888888765555  577888888


Q ss_pred             EEEcccccccccCCcccCCCcCccEEEccCccccCcccccc---cccccccEEeCcCCccCCccchhhhhhcc--CceEE
Q 046240          289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESF---GYLTSLEILDLSNNKISGFILISLEKLLY--LKKLN  363 (763)
Q Consensus       289 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~  363 (763)
                      +|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|+.+.+..+..++.  |+.|+
T Consensus       116 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~  195 (361)
T 2xot_A          116 VLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY  195 (361)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEE
T ss_pred             EEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEE
Confidence            88888888887778888888888888888888886555555   56888888888888888877777887776  37788


Q ss_pred             cccccCCCC
Q 046240          364 LSFNKLEGE  372 (763)
Q Consensus       364 l~~N~l~~~  372 (763)
                      |++|++.+.
T Consensus       196 l~~N~~~C~  204 (361)
T 2xot_A          196 LHNNPLECD  204 (361)
T ss_dssp             CCSSCEECC
T ss_pred             ecCCCccCC
Confidence            888877754

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=2.5e-22  Score=227.89  Aligned_cols=205  Identities=16%  Similarity=0.153  Sum_probs=174.6

Q ss_pred             cCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccc-------------ccccCCCcccCCCCCCeee-
Q 046240           97 IGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNR-------------FSGTIQSPITNASKLTILE-  162 (763)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~-------------i~~~~p~~~~~l~~L~~L~-  162 (763)
                      +..+++|+.|+|++|+++       .+|.++. ++++|+.|++++|.             +.+.+|..++++++|+.|+ 
T Consensus       345 ~~~~~~L~~L~Ls~n~L~-------~Lp~~i~-~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~  416 (567)
T 1dce_A          345 SATDEQLFRCELSVEKST-------VLQSELE-SCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP  416 (567)
T ss_dssp             CSTTTTSSSCCCCHHHHH-------HHHHHHH-HHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCG
T ss_pred             cccCccceeccCChhhHH-------hhHHHHH-HHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcc
Confidence            367899999999999995       8999987 89999999998886             6778888999999999999 


Q ss_pred             ecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeeccc
Q 046240          163 LGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLEL  242 (763)
Q Consensus       163 L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  242 (763)
                      ++.|.+           ++|+.+.    +.+|.++...+.       .|++|+|++|+|++ +|. |+.+++|+.|+|++
T Consensus       417 l~~n~~-----------~~L~~l~----l~~n~i~~l~~~-------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~  472 (567)
T 1dce_A          417 MRAAYL-----------DDLRSKF----LLENSVLKMEYA-------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSH  472 (567)
T ss_dssp             GGHHHH-----------HHHHHHH----HHHHHHHHHHHT-------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCS
T ss_pred             hhhccc-----------chhhhhh----hhcccccccCcc-------CceEEEecCCCCCC-CcC-ccccccCcEeecCc
Confidence            788765           3566666    567776653322       68999999999996 565 99999999999999


Q ss_pred             ccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccC-CcccCCCcCccEEEccCccc
Q 046240          243 NKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDI-PATIGGLKDVQNISLPYNRL  321 (763)
Q Consensus       243 N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l  321 (763)
                      |+|+ .+|..+.++++  |+.|+|++|+|++ +|   .++++++|+.|+|++|+|++.. |..|+.+++|+.|+|++|++
T Consensus       473 N~l~-~lp~~~~~l~~--L~~L~Ls~N~l~~-lp---~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l  545 (567)
T 1dce_A          473 NRLR-ALPPALAALRC--LEVLQASDNALEN-VD---GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL  545 (567)
T ss_dssp             SCCC-CCCGGGGGCTT--CCEEECCSSCCCC-CG---GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred             cccc-ccchhhhcCCC--CCEEECCCCCCCC-Cc---ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence            9999 88999999987  9999999999995 66   4899999999999999999887 99999999999999999999


Q ss_pred             cCccccc---ccccccccEEeC
Q 046240          322 EGPIPES---FGYLTSLEILDL  340 (763)
Q Consensus       322 ~~~~p~~---~~~l~~L~~L~L  340 (763)
                      ++.+|..   +..+++|+.|++
T Consensus       546 ~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          546 CQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             GGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCccHHHHHHHHCcccCccCC
Confidence            9765532   233677777764

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=2e-20  Score=186.35  Aligned_cols=154  Identities=20%  Similarity=0.256  Sum_probs=92.3

Q ss_pred             cEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEE
Q 046240          212 ERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEIN  291 (763)
Q Consensus       212 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~  291 (763)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|++..+..|..+++  |++|+|++|++++..|.  .|.++++|++|+
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~--L~~L~Ls~N~i~~~~~~--~~~~l~~L~~L~   86 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKK--LRRIDLSNNQISELAPD--AFQGLRSLNSLV   86 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTT--CCEEECCSSCCCEECTT--TTTTCSSCCEEE
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCC--CCEEECCCCcCCCcCHH--HhhCCcCCCEEE
Confidence            34555555555 3333332  45556666666665544445555544  66666666666555455  556666666666


Q ss_pred             cccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCC
Q 046240          292 LSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       292 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  371 (763)
                      |++|+|+...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|++.+
T Consensus        87 Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           87 LYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            66666665545556666666666666666666666666666666666666666666666666666666666666666655


Q ss_pred             C
Q 046240          372 E  372 (763)
Q Consensus       372 ~  372 (763)
                      .
T Consensus       167 ~  167 (220)
T 2v9t_B          167 D  167 (220)
T ss_dssp             S
T ss_pred             C
Confidence            3

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=4.6e-20  Score=198.53  Aligned_cols=182  Identities=20%  Similarity=0.217  Sum_probs=117.4

Q ss_pred             ceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccc-cCCCccEEEccccccccc
Q 046240           69 GITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDL-ALPNVKALSLAYNRFSGT  147 (763)
Q Consensus        69 gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~-~l~~L~~L~L~~N~i~~~  147 (763)
                      ++.|..     +.+++++++|+ .+|..+.  +.++.|+|++|+|+       .++...|. ++++|++|+|++|+|+++
T Consensus        15 ~C~C~~-----~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~-------~l~~~~~~~~l~~L~~L~L~~N~i~~i   79 (361)
T 2xot_A           15 NCLCAS-----NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLS-------RLRAEWTPTRLTNLHSLLLSHNHLNFI   79 (361)
T ss_dssp             TCEEET-----TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCC-------EECTTSSSSCCTTCCEEECCSSCCCEE
T ss_pred             CCEECC-----CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCC-------ccChhhhhhcccccCEEECCCCcCCcc
Confidence            456753     36888899998 4676554  45888999988885       67777776 788888888888888888


Q ss_pred             CCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccccccc
Q 046240          148 IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQ  227 (763)
Q Consensus       148 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~  227 (763)
                      .+..|.++++|++|+|++|+|+++.+..|.++++|+.|+                             |++|+|++..|.
T Consensus        80 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~-----------------------------L~~N~i~~~~~~  130 (361)
T 2xot_A           80 SSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL-----------------------------LYNNHIVVVDRN  130 (361)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE-----------------------------CCSSCCCEECTT
T ss_pred             ChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE-----------------------------CCCCcccEECHH
Confidence            888888888888888888888877777777776555554                             444444444444


Q ss_pred             ccCCccccceeecccccccCCCCccc---cccCCCCccEEEecCCccccCCCCccccccCCc--ccEEEccccccc
Q 046240          228 VMGNLSIFLLLDLELNKLTGPIPVTF---GRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKV--VVEINLSRNNFS  298 (763)
Q Consensus       228 ~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~--L~~L~Ls~N~l~  298 (763)
                      .|.++++|+.|+|++|+|++..+..|   ..+++  |+.|+|++|+|++..+.  .+..++.  |+.|+|++|++.
T Consensus       131 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~--L~~L~L~~N~l~~l~~~--~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          131 AFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPK--LMLLDLSSNKLKKLPLT--DLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             TTTTCTTCCEEECCSSCCCSCCGGGTC----CTT--CCEEECCSSCCCCCCHH--HHHHSCHHHHTTEECCSSCEE
T ss_pred             HhCCcccCCEEECCCCcCCeeCHHHhcCcccCCc--CCEEECCCCCCCccCHH--HhhhccHhhcceEEecCCCcc
Confidence            55555555555555555553322223   23433  55555555555532222  3444444  356666666665

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=3.6e-20  Score=192.99  Aligned_cols=192  Identities=22%  Similarity=0.293  Sum_probs=140.3

Q ss_pred             CCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccc
Q 046240          132 PNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISL  211 (763)
Q Consensus       132 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L  211 (763)
                      .++..+.+..+.+++..  .+..+++|++|++++|.++.. + .+..++                             +|
T Consensus        24 ~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~-----------------------------~L   70 (291)
T 1h6t_A           24 AETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLP-----------------------------NV   70 (291)
T ss_dssp             HHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCT-----------------------------TC
T ss_pred             HHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCC-----------------------------CC
Confidence            44555667777766433  345677888888888887743 2 233333                             67


Q ss_pred             cEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEE
Q 046240          212 ERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEIN  291 (763)
Q Consensus       212 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~  291 (763)
                      ++|+|++|++++..+  +..+++|++|+|++|++++ +| .+..+++  |++|+|++|++++ ++   .+..+++|+.|+
T Consensus        71 ~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~--L~~L~L~~n~i~~-~~---~l~~l~~L~~L~  140 (291)
T 1h6t_A           71 TKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKK--LKSLSLEHNGISD-IN---GLVHLPQLESLY  140 (291)
T ss_dssp             CEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTT--CCEEECTTSCCCC-CG---GGGGCTTCCEEE
T ss_pred             CEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCC--CCEEECCCCcCCC-Ch---hhcCCCCCCEEE
Confidence            777777777775544  7777778888888887774 33 3667765  8888888888874 33   477788888888


Q ss_pred             cccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCC
Q 046240          292 LSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       292 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  371 (763)
                      +++|++++.  ..+..+++|+.|+|++|++++..+  +..+++|+.|+|++|+|+++ + .+..+++|+.|++++|+++.
T Consensus       141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             ccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            888888864  578888888888888888886555  88888889999999888874 3 47888889999999998876


Q ss_pred             C
Q 046240          372 E  372 (763)
Q Consensus       372 ~  372 (763)
                      .
T Consensus       215 ~  215 (291)
T 1h6t_A          215 K  215 (291)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.80  E-value=3.2e-19  Score=178.89  Aligned_cols=157  Identities=21%  Similarity=0.208  Sum_probs=128.2

Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +.+.+++++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++  |++|+|++|++++..+.  .|..+++|++
T Consensus        20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~--L~~L~L~~N~l~~i~~~--~~~~l~~L~~   92 (229)
T 3e6j_A           20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLIN--LKELYLGSNQLGALPVG--VFDSLTQLTV   92 (229)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTT--CCEEECCSSCCCCCCTT--TTTTCTTCCE
T ss_pred             eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccC--CcEEECCCCCCCCcChh--hcccCCCcCE
Confidence            4567888888887 4554443  78888888888888877888888866  88888888888754444  5788888889


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccC
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL  369 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  369 (763)
                      |+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+++.+..|..+++|+.|+|++|++
T Consensus        93 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  171 (229)
T 3e6j_A           93 LDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPW  171 (229)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCB
T ss_pred             EECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCc
Confidence            999999888777777888889999999999988 6788888889999999999999888778888888999999999988


Q ss_pred             CCCCC
Q 046240          370 EGEIP  374 (763)
Q Consensus       370 ~~~~p  374 (763)
                      ++..+
T Consensus       172 ~c~c~  176 (229)
T 3e6j_A          172 DCECR  176 (229)
T ss_dssp             CTTBG
T ss_pred             cCCcc
Confidence            87665

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.80  E-value=1.1e-19  Score=189.40  Aligned_cols=108  Identities=23%  Similarity=0.356  Sum_probs=60.1

Q ss_pred             cCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCC
Q 046240          229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGL  308 (763)
Q Consensus       229 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  308 (763)
                      +..+++|++|+|++|++++.  ..+..+++  |++|++++|++++. +   .+..+++|++|++++|++++..|  +..+
T Consensus       108 l~~l~~L~~L~L~~n~i~~~--~~l~~l~~--L~~L~l~~n~l~~~-~---~l~~l~~L~~L~L~~N~l~~~~~--l~~l  177 (291)
T 1h6t_A          108 LKDLKKLKSLSLEHNGISDI--NGLVHLPQ--LESLYLGNNKITDI-T---VLSRLTKLDTLSLEDNQISDIVP--LAGL  177 (291)
T ss_dssp             GTTCTTCCEEECTTSCCCCC--GGGGGCTT--CCEEECCSSCCCCC-G---GGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred             hccCCCCCEEECCCCcCCCC--hhhcCCCC--CCEEEccCCcCCcc-h---hhccCCCCCEEEccCCccccchh--hcCC
Confidence            44444444444444444422  23444433  55555555555532 2   35566666666666666664433  6666


Q ss_pred             cCccEEEccCccccCcccccccccccccEEeCcCCccCCc
Q 046240          309 KDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF  348 (763)
Q Consensus       309 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  348 (763)
                      ++|+.|+|++|++++ ++ .+..+++|+.|++++|+++..
T Consensus       178 ~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          178 TKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             TTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred             CccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence            666777777776664 33 266677777777777766653

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=7.3e-20  Score=208.91  Aligned_cols=169  Identities=28%  Similarity=0.381  Sum_probs=82.8

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|+|++|.|.. ++ .|..+++|+.|+|++|.|+       .+|+  +..+++|+.|+|++|.|++.  ..+..++
T Consensus        43 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~-------~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~  109 (605)
T 1m9s_A           43 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLT-------DIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLK  109 (605)
T ss_dssp             TTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCC-------CCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCT
T ss_pred             CCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCC-------CChh--hccCCCCCEEECcCCCCCCC--hhhccCC
Confidence            345555555555552 22 3555555555555555553       2332  33555555555555555532  2455555


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFL  236 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  236 (763)
                      +|++|+|++|+|+++  ..|..++                             +|+.|+|++|+|++.  ..|..+++|+
T Consensus       110 ~L~~L~Ls~N~l~~l--~~l~~l~-----------------------------~L~~L~Ls~N~l~~l--~~l~~l~~L~  156 (605)
T 1m9s_A          110 KLKSLSLEHNGISDI--NGLVHLP-----------------------------QLESLYLGNNKITDI--TVLSRLTKLD  156 (605)
T ss_dssp             TCCEEECTTSCCCCC--GGGGGCT-----------------------------TCSEEECCSSCCCCC--GGGGSCTTCS
T ss_pred             CCCEEEecCCCCCCC--ccccCCC-----------------------------ccCEEECCCCccCCc--hhhcccCCCC
Confidence            555555555555532  2244444                             455555555555533  3445555555


Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccc
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG  299 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~  299 (763)
                      .|+|++|+|++..|  +..+++  |+.|+|++|+|++ +|   .+..+++|+.|+|++|++++
T Consensus       157 ~L~Ls~N~l~~~~~--l~~l~~--L~~L~Ls~N~i~~-l~---~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          157 TLSLEDNQISDIVP--LAGLTK--LQNLYLSKNHISD-LR---ALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             EEECCSSCCCCCGG--GTTCTT--CCEEECCSSCCCB-CG---GGTTCTTCSEEECCSEEEEC
T ss_pred             EEECcCCcCCCchh--hccCCC--CCEEECcCCCCCC-Ch---HHccCCCCCEEEccCCcCcC
Confidence            55555555554333  444433  5555555555542 22   24445555555555555543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.80  E-value=1.4e-21  Score=225.42  Aligned_cols=66  Identities=9%  Similarity=0.063  Sum_probs=33.8

Q ss_pred             CceEEEEecCCCCCCc----CCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccccc
Q 046240           77 HRVTALNISSLNLQGE----IPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFS  145 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~  145 (763)
                      .++++|+|++|.+++.    ++..+..+++|++|+|++|.+++..  .+.++ .++.++++|++|+|++|.+.
T Consensus       164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~--~~~l~-~~~~~~~~L~~L~L~~~~~~  233 (592)
T 3ogk_B          164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKIS--PKDLE-TIARNCRSLVSVKVGDFEIL  233 (592)
T ss_dssp             TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCC--HHHHH-HHHHHCTTCCEEECSSCBGG
T ss_pred             CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccC--HHHHH-HHHhhCCCCcEEeccCccHH
Confidence            4567777777766544    2334455666666666666653100  00111 12234556666666665554

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=3.8e-20  Score=211.19  Aligned_cols=190  Identities=22%  Similarity=0.311  Sum_probs=91.3

Q ss_pred             ccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccE
Q 046240          134 VKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLER  213 (763)
Q Consensus       134 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~  213 (763)
                      +..+.++.+.++...+  +..+++|+.|+|++|.|+.+ + .|..+++|+.|+    |++|.+++..|  +..+. +|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~----Ls~N~l~~~~~--l~~l~-~L~~   91 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLF----LNGNKLTDIKP--LTNLK-NLGW   91 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEE----CTTSCCCCCGG--GGGCT-TCCE
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEE----eeCCCCCCChh--hccCC-CCCE
Confidence            4444444444443322  34455555555555555432 1 234444333333    33333333222  33333 5555


Q ss_pred             EEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcc
Q 046240          214 LYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS  293 (763)
Q Consensus       214 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls  293 (763)
                      |+|++|+|++ +| .+..+++|+.|+|++|+|++.  ..+..+++  |+.|+|++|++++. +   .+..+++|+.|+|+
T Consensus        92 L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~--L~~L~Ls~N~l~~l-~---~l~~l~~L~~L~Ls  161 (605)
T 1m9s_A           92 LFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQ--LESLYLGNNKITDI-T---VLSRLTKLDTLSLE  161 (605)
T ss_dssp             EECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTT--CSEEECCSSCCCCC-G---GGGSCTTCSEEECC
T ss_pred             EECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCc--cCEEECCCCccCCc-h---hhcccCCCCEEECc
Confidence            5555555553 22 455555555555555555532  23444443  55555555555532 1   34555555555555


Q ss_pred             cccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCc
Q 046240          294 RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGF  348 (763)
Q Consensus       294 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  348 (763)
                      +|+|++..|  +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.
T Consensus       162 ~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          162 DNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             SSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred             CCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence            555554433  55555555555555555532 2 355555555555555555543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.79  E-value=4.7e-22  Score=229.34  Aligned_cols=182  Identities=10%  Similarity=0.073  Sum_probs=112.7

Q ss_pred             ceEEEEecCCC-CCC-cCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccc----cCCCc
Q 046240           78 RVTALNISSLN-LQG-EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSG----TIQSP  151 (763)
Q Consensus        78 ~v~~L~L~~~~-l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~----~~p~~  151 (763)
                      ++++|+|++|. ++. .++..+..+++|++|+|++|.+++...  ..++ .+...+++|++|+|++|.+++    .++..
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~--~~l~-~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~  215 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDG--KWLH-ELAQHNTSLEVLNFYMTEFAKISPKDLETI  215 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCS--HHHH-HHHHHCCCCCEEECTTCCCSSCCHHHHHHH
T ss_pred             cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcch--hHHH-HHHhcCCCccEEEeeccCCCccCHHHHHHH
Confidence            49999999886 221 122334578999999999998752100  0022 233478899999999999873    34455


Q ss_pred             ccCCCCCCeeeecCcccccccccccCCCCchhhhhhhh-----------------------hccCCcccccCCccccccc
Q 046240          152 ITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVI-----------------------GLIGNPLNGILPSSIVNLS  208 (763)
Q Consensus       152 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-----------------------~l~~n~l~~~~p~~~~~l~  208 (763)
                      +.++++|++|+|++|.+.+ +|..+.++++|+.|+++.                       ++.++ ..+.+|..+..++
T Consensus       216 ~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~-~~~~l~~~~~~~~  293 (592)
T 3ogk_B          216 ARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM-GPNEMPILFPFAA  293 (592)
T ss_dssp             HHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC-CTTTGGGGGGGGG
T ss_pred             HhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc-chhHHHHHHhhcC
Confidence            6678999999999998875 556666666776666320                       01111 1233455555565


Q ss_pred             ccccEEEeecCccccccc-cccCCccccceeecccccccCCCCccccccCCCCccEEEec
Q 046240          209 ISLERLYISNCSITGNIP-QVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLC  267 (763)
Q Consensus       209 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~  267 (763)
                       +|++|+|++|.+++... ..+..+++|++|+|++|...+.++..+..+++  |++|+++
T Consensus       294 -~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~--L~~L~L~  350 (592)
T 3ogk_B          294 -QIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQ--LKRLRIE  350 (592)
T ss_dssp             -GCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTT--CCEEEEE
T ss_pred             -CCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCC--CCEEEee
Confidence             88888888888765443 33567777777777733222222333334443  6666666

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.77  E-value=1.9e-19  Score=191.14  Aligned_cols=278  Identities=13%  Similarity=0.110  Sum_probs=178.3

Q ss_pred             CceEEEEecCCCCCCcCCcccCC-CCCCCEEEcCCCccc--CC--Ccccc---------Ccccccccc--------CCCc
Q 046240           77 HRVTALNISSLNLQGEIPHEIGY-LPSLTKLALGYNSLV--GN--NSLSG---------SLPSRIDLA--------LPNV  134 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~-l~~L~~L~L~~n~l~--~~--~~~~~---------~lp~~~~~~--------l~~L  134 (763)
                      .+++.|.++++ +.+.--..+.. +++|++|||++|+|.  ..  ..+.+         .||+..|.+        +++|
T Consensus        25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L  103 (329)
T 3sb4_A           25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTL  103 (329)
T ss_dssp             HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTC
T ss_pred             CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCC
Confidence            35677777654 21111122333 677888888888875  10  11111         567777877        8888


Q ss_pred             cEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccccccc-E
Q 046240          135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLE-R  213 (763)
Q Consensus       135 ~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~-~  213 (763)
                      +.|+|.+ .++.+.+.+|.++++|+.|++++|.++.+.+.+|.++.++..+.+............-+..|.+.. +|+ .
T Consensus       104 ~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~-~L~~~  181 (329)
T 3sb4_A          104 EKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE-PLETT  181 (329)
T ss_dssp             CC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC-CCEEE
T ss_pred             cEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc-cccee
Confidence            8888888 788777788888888888888888888788888888777776653211111122222333444444 454 4


Q ss_pred             EEeecCc-cccccccccCCccccceeecccccccCCCCcccc-ccCCCCccEEEecCCccccCCCCccccccCCcccEEE
Q 046240          214 LYISNCS-ITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFG-RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEIN  291 (763)
Q Consensus       214 L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~  291 (763)
                      +.+.... +.......-....+++.+.+.++-.. .....+. .+.+  |+.|+|++|+++ .+|.. .|.++++|+.|+
T Consensus       182 i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~--L~~l~L~~n~i~-~I~~~-aF~~~~~L~~l~  256 (329)
T 3sb4_A          182 IQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPN--LVSLDISKTNAT-TIPDF-TFAQKKYLLKIK  256 (329)
T ss_dssp             EEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTT--CCEEECTTBCCC-EECTT-TTTTCTTCCEEE
T ss_pred             EEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCC--CeEEECCCCCcc-eecHh-hhhCCCCCCEEE
Confidence            4443322 11111111123455566666554222 1111111 2433  888888888888 44442 688888888888


Q ss_pred             cccccccccCCcccCCCcCcc-EEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEc
Q 046240          292 LSRNNFSGDIPATIGGLKDVQ-NISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNL  364 (763)
Q Consensus       292 Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  364 (763)
                      |++| ++.+.+.+|.++++|+ .|++.+ +++...+.+|.++++|+.|++++|+++.+.+.+|.++++|+.++.
T Consensus       257 l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          257 LPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             CCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            8887 7777788888888888 888888 677666788888888888888888888888888888888888764

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=1e-18  Score=178.96  Aligned_cols=163  Identities=23%  Similarity=0.330  Sum_probs=126.2

Q ss_pred             ccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCc
Q 046240          191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNS  270 (763)
Q Consensus       191 l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~  270 (763)
                      +.+|.+++..  .+..+. +|++|++++|+++. ++ .+..+++|++|+|++|+|++..|  +..+++  |++|+|++|+
T Consensus        26 l~~~~i~~~~--~~~~l~-~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~--L~~L~L~~N~   96 (263)
T 1xeu_A           26 LGKQSVTDLV--SQKELS-GVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTK--LEELSVNRNR   96 (263)
T ss_dssp             HTCSCTTSEE--CHHHHT-TCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSS--CCEEECCSSC
T ss_pred             hcCCCccccc--chhhcC-cCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCC--CCEEECCCCc
Confidence            4445444332  344454 78888888888874 44 67888888888888888885544  777766  8888888888


Q ss_pred             cccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccc
Q 046240          271 FSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL  350 (763)
Q Consensus       271 l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  350 (763)
                      +++ +|.   +.. ++|++|+|++|++++.  ..+..+++|+.|+|++|++++. + .+..+++|+.|+|++|++++.  
T Consensus        97 l~~-l~~---~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--  165 (263)
T 1xeu_A           97 LKN-LNG---IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--  165 (263)
T ss_dssp             CSC-CTT---CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--
T ss_pred             cCC-cCc---ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--
Confidence            884 554   223 8899999999999863  3588899999999999999854 4 688899999999999999986  


Q ss_pred             hhhhhhccCceEEcccccCCCCC
Q 046240          351 ISLEKLLYLKKLNLSFNKLEGEI  373 (763)
Q Consensus       351 ~~~~~l~~L~~L~l~~N~l~~~~  373 (763)
                      ..+..+++|+.|++++|++++.+
T Consensus       166 ~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          166 GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             HHhccCCCCCEEeCCCCcccCCc
Confidence            67888999999999999998764

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=2.6e-18  Score=167.95  Aligned_cols=154  Identities=19%  Similarity=0.288  Sum_probs=132.0

Q ss_pred             ccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccC
Q 046240          205 VNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNL  284 (763)
Q Consensus       205 ~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l  284 (763)
                      ..+. +|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++  |++|++++|++++..|.  .+..+
T Consensus        41 ~~l~-~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~--L~~L~l~~n~l~~~~~~--~l~~l  111 (197)
T 4ezg_A           41 AQMN-SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSN--LERLRIMGKDVTSDKIP--NLSGL  111 (197)
T ss_dssp             HHHH-TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTT--CCEEEEECTTCBGGGSC--CCTTC
T ss_pred             hhcC-CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCC--CCEEEeECCccCcccCh--hhcCC
Confidence            4555 8999999999999 555 6899999999999999876  3347888876  99999999999977777  78999


Q ss_pred             CcccEEEcccccccccCCcccCCCcCccEEEccCcc-ccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEE
Q 046240          285 KVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNR-LEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLN  363 (763)
Q Consensus       285 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  363 (763)
                      ++|++|+|++|++++..|..++.+++|+.|++++|+ ++ .+| .+..+++|+.|++++|+++++.  .+..+++|+.|+
T Consensus       112 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~  187 (197)
T 4ezg_A          112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLY  187 (197)
T ss_dssp             TTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEE
T ss_pred             CCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEE
Confidence            999999999999998889999999999999999998 66 555 6899999999999999999844  788999999999


Q ss_pred             cccccCCC
Q 046240          364 LSFNKLEG  371 (763)
Q Consensus       364 l~~N~l~~  371 (763)
                      +++|++.+
T Consensus       188 l~~N~i~~  195 (197)
T 4ezg_A          188 AFSQTIGG  195 (197)
T ss_dssp             ECBC----
T ss_pred             eeCcccCC
Confidence            99999864

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=1.3e-19  Score=212.22  Aligned_cols=186  Identities=22%  Similarity=0.240  Sum_probs=67.5

Q ss_pred             CCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCC
Q 046240          101 PSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLR  180 (763)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  180 (763)
                      +.++.|+|.+|.+.       .+|..+      |+.++|+.|.|++              ++++.|++. ..|+.|..++
T Consensus       173 ~~~~~l~L~~n~~~-------~~~~~~------l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~  224 (727)
T 4b8c_D          173 PLTPKIELFANGKD-------EANQAL------LQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQ  224 (727)
T ss_dssp             -----------------------------------------------------------------------------CCC
T ss_pred             CccceEEeeCCCCC-------cchhhH------hhcCccCcccccC--------------cccccccee-cChhhhccCC
Confidence            45677777777764       233222      4455555555442              233333333 3344444444


Q ss_pred             chhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCC
Q 046240          181 NIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSK  260 (763)
Q Consensus       181 ~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~  260 (763)
                      +|+.|+    |++|.+. .+|..++++. +|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|.++.+  
T Consensus       225 ~L~~L~----Ls~n~l~-~l~~~~~~l~-~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~--  294 (727)
T 4b8c_D          225 LWHALD----LSNLQIF-NISANIFKYD-FLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQ--  294 (727)
T ss_dssp             CCCEEE----CTTSCCS-CCCGGGGGCC-SCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTT--
T ss_pred             CCcEEE----CCCCCCC-CCChhhcCCC-CCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCC--
Confidence            444444    3334333 3333344443 5555555555555 44555555555555555555555 44555555544  


Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcC-ccEEEccCccccCcccc
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKD-VQNISLPYNRLEGPIPE  327 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~  327 (763)
                      |++|+|++|.|+ .+|.  .|.++++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus       295 L~~L~L~~N~l~-~lp~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~  359 (727)
T 4b8c_D          295 LKYFYFFDNMVT-TLPW--EFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH  359 (727)
T ss_dssp             CSEEECCSSCCC-CCCS--STTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred             CCEEECCCCCCC-ccCh--hhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence            555555555554 4444  4555555555555555555555554443321 12345555555555444

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.75  E-value=3e-19  Score=183.04  Aligned_cols=39  Identities=18%  Similarity=0.220  Sum_probs=17.1

Q ss_pred             cCCCccEEEcccccccccCCCcccCCCCCCeeeecCccccc
Q 046240          130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSG  170 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~  170 (763)
                      .+++|++|++++|.|+. +| .+..+++|++|+|++|+|++
T Consensus        39 ~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~   77 (263)
T 1xeu_A           39 ELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD   77 (263)
T ss_dssp             HHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC
T ss_pred             hcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC
Confidence            34444444444444442 22 34444444444444444443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.74  E-value=1.8e-18  Score=168.37  Aligned_cols=129  Identities=25%  Similarity=0.297  Sum_probs=70.3

Q ss_pred             cEEEeecCccccccccccCCccccceeecccccccCCCCc-cccccCCCCccEEEecCCccccCCCCccccccCCcccEE
Q 046240          212 ERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPV-TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEI  290 (763)
Q Consensus       212 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L  290 (763)
                      +++++++|+++ .+|..+..  +|++|+|++|+|++..+. .|..+++  |++|+|++|++++..|.  .|.++++|++|
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L   83 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPH--LVKLELKRNQLTGIEPN--AFEGASHIQEL   83 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTT--CCEEECCSSCCCCBCTT--TTTTCTTCCEE
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCC--CCEEECCCCCCCCcCHh--HcCCcccCCEE
Confidence            45666666665 34443322  556666666666544433 2555544  55555555555554454  45555555555


Q ss_pred             EcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCC
Q 046240          291 NLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       291 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      +|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|++.+
T Consensus        84 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            555555555555555555555555555555555555555555555555555555554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=4.3e-18  Score=166.43  Aligned_cols=150  Identities=15%  Similarity=0.263  Sum_probs=91.8

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.|++++|+++ .+| .+..+++|++|++++|.++       .++  .+..+++|++|+|++|.+++..+..|.+++
T Consensus        44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-------~~~--~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~  112 (197)
T 4ezg_A           44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-------NYN--PISGLSNLERLRIMGKDVTSDKIPNLSGLT  112 (197)
T ss_dssp             HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-------CCG--GGTTCTTCCEEEEECTTCBGGGSCCCTTCT
T ss_pred             CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-------cch--hhhcCCCCCEEEeECCccCcccChhhcCCC
Confidence            36777888888777 455 5777777888888777663       222  233677777777777777766677777777


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCc-cccccccccCCcccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCS-ITGNIPQVMGNLSIF  235 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~-l~~~~~~~~~~l~~L  235 (763)
                      +|++|+|++|++++..|..|+++++|+                             +|+|++|+ ++ .+| .+..+++|
T Consensus       113 ~L~~L~Ls~n~i~~~~~~~l~~l~~L~-----------------------------~L~L~~n~~i~-~~~-~l~~l~~L  161 (197)
T 4ezg_A          113 SLTLLDISHSAHDDSILTKINTLPKVN-----------------------------SIDLSYNGAIT-DIM-PLKTLPEL  161 (197)
T ss_dssp             TCCEEECCSSBCBGGGHHHHTTCSSCC-----------------------------EEECCSCTBCC-CCG-GGGGCSSC
T ss_pred             CCCEEEecCCccCcHhHHHHhhCCCCC-----------------------------EEEccCCCCcc-ccH-hhcCCCCC
Confidence            777777777777766666666665554                             55555554 33 223 35555555


Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccc
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS  272 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~  272 (763)
                      ++|++++|++++ ++ .+..+++  |++|++++|++.
T Consensus       162 ~~L~l~~n~i~~-~~-~l~~l~~--L~~L~l~~N~i~  194 (197)
T 4ezg_A          162 KSLNIQFDGVHD-YR-GIEDFPK--LNQLYAFSQTIG  194 (197)
T ss_dssp             CEEECTTBCCCC-CT-TGGGCSS--CCEEEECBC---
T ss_pred             CEEECCCCCCcC-hH-HhccCCC--CCEEEeeCcccC
Confidence            555555555553 22 4445543  566666665554

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=1.9e-18  Score=176.46  Aligned_cols=136  Identities=20%  Similarity=0.248  Sum_probs=105.5

Q ss_pred             cCcCceecccCCceEEEEEe-cCCce--EEEEEeehhhH------------------------HHHHHHHHHHHHHHhCC
Q 046240          477 FGRDNLIGIGSFGYVYKAEL-DDGIE--VAIKVFHQECA------------------------RAMKSFEVECEVMKNIR  529 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l~  529 (763)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++....                        .....+.+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999987 68889  99998753211                        11236788999999998


Q ss_pred             CCcc--ceEEeeeecCCceEEEEEccCC-C----ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEeCCC
Q 046240          530 HRNL--VKIISGCSNDDFKALVLEYMPN-G----SLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH-TTPIIHCDL  601 (763)
Q Consensus       530 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h-~~~ivH~dl  601 (763)
                      |+++  ..++++    +..++||||+.+ |    +|.++...    .+......++.|+++++.||   | +.+|+||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~l---H~~~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRL---YQEAELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHH---HHTSCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHH---HHHCCEEeCCC
Confidence            8764  344432    357899999942 4    56655432    12335678999999999999   6 889999999


Q ss_pred             CCCCEEecCCCcEEEeeecCceec
Q 046240          602 KSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       602 k~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      ||+|||++.  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999999764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=1.8e-17  Score=161.25  Aligned_cols=156  Identities=26%  Similarity=0.293  Sum_probs=119.9

Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEE
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS  315 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  315 (763)
                      +.+++++|+++ .+|..+..    ++++|++++|++++..+. ..+..+++|++|+|++|+|++..|..|.++++|+.|+
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~----~l~~L~l~~n~i~~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   84 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL----HTTELLLNDNELGRISSD-GLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ   84 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT----TCSEEECCSCCCCSBCCS-CSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CEEEcCCCCcC-cCccCCCC----CCCEEECCCCcCCccCCc-cccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence            67888888887 66765543    388899999988855543 1378888899999999999888888888889999999


Q ss_pred             ccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcccC
Q 046240          316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG  395 (763)
Q Consensus       316 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~  395 (763)
                      |++|+|++..+..|..+++|++|+|++|+|+++.|..|..+++|+.|+|++|++++..+...-...+....+.++...|+
T Consensus        85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~  164 (192)
T 1w8a_A           85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred             CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence            99999988777888888899999999999988888888888889999999998888765321111223334455556676


Q ss_pred             CC
Q 046240          396 LP  397 (763)
Q Consensus       396 ~p  397 (763)
                      .|
T Consensus       165 ~P  166 (192)
T 1w8a_A          165 AP  166 (192)
T ss_dssp             SS
T ss_pred             CC
Confidence            55

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.72  E-value=3.5e-20  Score=213.67  Aligned_cols=282  Identities=13%  Similarity=0.096  Sum_probs=143.8

Q ss_pred             CceEEEEecCC-CCCCc-CCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccc--cccc-CCCc
Q 046240           77 HRVTALNISSL-NLQGE-IPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNR--FSGT-IQSP  151 (763)
Q Consensus        77 ~~v~~L~L~~~-~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~--i~~~-~p~~  151 (763)
                      .++++|+|++| .++.. ++..+.++++|++|+|++|.+++...  ..+ ..+...+++|++|+|++|.  ++.. ++..
T Consensus       130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~--~~l-~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l  206 (594)
T 2p1m_B          130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSG--HWL-SHFPDTYTSLVSLNISCLASEVSFSALERL  206 (594)
T ss_dssp             TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCG--GGG-GGSCTTCCCCCEEECTTCCSCCCHHHHHHH
T ss_pred             CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcch--HHH-HHHhhcCCcCcEEEecccCCcCCHHHHHHH
Confidence            57888999888 55432 34445578889999998888752110  011 1222356788888888876  2211 1112


Q ss_pred             ccCCCCCCeeeecCc-ccccccccccCCCCchhhhhhhhh---------------------------ccCCcccccCCcc
Q 046240          152 ITNASKLTILELGGN-SFSGFIPNTIGNLRNIEWLGLVIG---------------------------LIGNPLNGILPSS  203 (763)
Q Consensus       152 ~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~~---------------------------l~~n~l~~~~p~~  203 (763)
                      +.++++|++|+|++| .+++ +|..+..+++|+.|++...                           +.+ ...+.++..
T Consensus       207 ~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~-~~~~~l~~~  284 (594)
T 2p1m_B          207 VTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD-AVPAYLPAV  284 (594)
T ss_dssp             HHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBT-CCGGGGGGG
T ss_pred             HHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcc-cchhhHHHH
Confidence            234578888888877 3333 5555556666665542100                           110 011123333


Q ss_pred             cccccccccEEEeecCccccccc-cccCCccccceeecccccccCC-CCccccccCCCCccEEEecC---------Cccc
Q 046240          204 IVNLSISLERLYISNCSITGNIP-QVMGNLSIFLLLDLELNKLTGP-IPVTFGRLQNSKLDTLSLCG---------NSFS  272 (763)
Q Consensus       204 ~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~~~L~~L~L~~---------N~l~  272 (763)
                      +..++ +|++|+|++|.+++... ..+..+++|++|++++| ++.. ++.....+++  |++|++++         |.++
T Consensus       285 ~~~~~-~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~--L~~L~L~~~~~~g~~~~~~l~  360 (594)
T 2p1m_B          285 YSVCS-RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKD--LRELRVFPSEPFVMEPNVALT  360 (594)
T ss_dssp             HHHHT-TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTT--CCEEEEECSCTTCSSCSSCCC
T ss_pred             HHhhC-CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCC--CCEEEEecCcccccccCCCCC
Confidence            33445 78888888888764332 23567788888888877 4321 1212223443  77776632         3333


Q ss_pred             cCCCCcccc-ccCCcccEEEcccccccccCCcccC-CCcCccEEEcc--C----ccccCc-----ccccccccccccEEe
Q 046240          273 GSIPSCIDI-GNLKVVVEINLSRNNFSGDIPATIG-GLKDVQNISLP--Y----NRLEGP-----IPESFGYLTSLEILD  339 (763)
Q Consensus       273 ~~~p~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~  339 (763)
                      +....  .+ .++++|++|+++.|++++..+..+. .+++|+.|+++  +    |.+++.     ++..+..+++|+.|+
T Consensus       361 ~~~l~--~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~  438 (594)
T 2p1m_B          361 EQGLV--SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLS  438 (594)
T ss_dssp             HHHHH--HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEE
T ss_pred             HHHHH--HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEe
Confidence            21111  11 1245555555555555544333333 35555555555  2    334311     111133444555555


Q ss_pred             CcCCccCCccchhhhh-hccCceEEcccccCC
Q 046240          340 LSNNKISGFILISLEK-LLYLKKLNLSFNKLE  370 (763)
Q Consensus       340 L~~N~l~~~~~~~~~~-l~~L~~L~l~~N~l~  370 (763)
                      |++ .+++..+..+.. +++|+.|+|++|.++
T Consensus       439 L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~  469 (594)
T 2p1m_B          439 LSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDS  469 (594)
T ss_dssp             CCS-SCCHHHHHHHHHHCTTCCEEEEESCCSS
T ss_pred             ecC-cccHHHHHHHHHhchhccEeeccCCCCc
Confidence            544 344333333333 444555555555543

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.72  E-value=6.3e-20  Score=211.54  Aligned_cols=298  Identities=13%  Similarity=0.078  Sum_probs=202.5

Q ss_pred             CceEEEEecCCCCCCcCCcccC-CCCCCCEEEcCCC-cccCCCccccCccccccccCCCccEEEcccccccccCCCccc-
Q 046240           77 HRVTALNISSLNLQGEIPHEIG-YLPSLTKLALGYN-SLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPIT-  153 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~-~l~~L~~L~L~~n-~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~-  153 (763)
                      .++++|+|++|.+++..+..+. .+++|++|+|++| .++      ..-...+..++++|++|+|++|.+++..+..+. 
T Consensus       105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~------~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~  178 (594)
T 2p1m_B          105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFS------TDGLAAIAATCRNLKELDLRESDVDDVSGHWLSH  178 (594)
T ss_dssp             TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEE------HHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGG
T ss_pred             CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCC------HHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHH
Confidence            5789999999988877777775 6889999999988 442      111223334789999999999998876554443 


Q ss_pred             ---CCCCCCeeeecCcc--ccc-ccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCc-------
Q 046240          154 ---NASKLTILELGGNS--FSG-FIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCS-------  220 (763)
Q Consensus       154 ---~l~~L~~L~L~~N~--l~~-~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~-------  220 (763)
                         .+++|++|+|++|.  ++. .++..+.++++|+.|+    +.+|...+.+|..+..++ +|++|+++.+.       
T Consensus       179 ~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~----L~~~~~~~~l~~~~~~~~-~L~~L~l~~~~~~~~~~~  253 (594)
T 2p1m_B          179 FPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLK----LNRAVPLEKLATLLQRAP-QLEELGTGGYTAEVRPDV  253 (594)
T ss_dssp             SCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEE----CCTTSCHHHHHHHHHHCT-TCSEEECSBCCCCCCHHH
T ss_pred             HhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEe----cCCCCcHHHHHHHHhcCC-cceEcccccccCccchhh
Confidence               66789999999997  321 1222234568888888    667633333666666666 88888765542       


Q ss_pred             -------------------ccc----ccccccCCccccceeecccccccCCCCc-cccccCCCCccEEEecCCccccC-C
Q 046240          221 -------------------ITG----NIPQVMGNLSIFLLLDLELNKLTGPIPV-TFGRLQNSKLDTLSLCGNSFSGS-I  275 (763)
Q Consensus       221 -------------------l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~~~L~~L~L~~N~l~~~-~  275 (763)
                                         +..    .++..+..+++|++|+|++|.+++.... .+..+++  |+.|++++| +... +
T Consensus       254 ~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~--L~~L~l~~~-~~~~~l  330 (594)
T 2p1m_B          254 YSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPK--LQRLWVLDY-IEDAGL  330 (594)
T ss_dssp             HHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTT--CCEEEEEGG-GHHHHH
T ss_pred             HHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCC--cCEEeCcCc-cCHHHH
Confidence                               111    2333344679999999999998743322 2456655  999999998 4421 2


Q ss_pred             CCccccccCCcccEEEcc---------cccccccCCcccC-CCcCccEEEccCccccCccccccc-ccccccEEeCc--C
Q 046240          276 PSCIDIGNLKVVVEINLS---------RNNFSGDIPATIG-GLKDVQNISLPYNRLEGPIPESFG-YLTSLEILDLS--N  342 (763)
Q Consensus       276 p~~~~~~~l~~L~~L~Ls---------~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~--~  342 (763)
                      +.  ....+++|++|+++         .|.++......+. ++++|+.|.++.|++++..+..+. .+++|+.|+|+  +
T Consensus       331 ~~--l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~  408 (594)
T 2p1m_B          331 EV--LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIE  408 (594)
T ss_dssp             HH--HHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESS
T ss_pred             HH--HHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeeccc
Confidence            22  23358899999994         3566544333343 489999999999999877666665 58999999999  5


Q ss_pred             ----CccCCc-----cchhhhhhccCceEEcccccCCCCCCCC-C-CccccccccccCCC
Q 046240          343 ----NKISGF-----ILISLEKLLYLKKLNLSFNKLEGEIPRG-G-PFANFTAKSFMGNE  391 (763)
Q Consensus       343 ----N~l~~~-----~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~-~~~~l~~~~~~~n~  391 (763)
                          |.++..     .+..+..+++|+.|+|++ .++...+.. . ..+++..+++.+|.
T Consensus       409 ~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~  467 (594)
T 2p1m_B          409 PKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAG  467 (594)
T ss_dssp             TTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCC
T ss_pred             CCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCC
Confidence                667743     233467789999999977 555432211 1 14567778887765

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.69  E-value=3.4e-17  Score=173.76  Aligned_cols=243  Identities=12%  Similarity=0.092  Sum_probs=184.5

Q ss_pred             CCceEEEEecCCCCC--------------------CcCCcccCC--------CCCCCEEEcCCCcccCCCccccCccccc
Q 046240           76 SHRVTALNISSLNLQ--------------------GEIPHEIGY--------LPSLTKLALGYNSLVGNNSLSGSLPSRI  127 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~--------------------~~~~~~~~~--------l~~L~~L~L~~n~l~~~~~~~~~lp~~~  127 (763)
                      ..+++.|||++|+|.                    .+.+..|.+        +++|++|+|.+ .++       .|++.+
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-------~I~~~a  119 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIK-------NIEDAA  119 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCC-------EECTTT
T ss_pred             hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-ccc-------chhHHH
Confidence            457999999999888                    233456778        99999999998 775       899999


Q ss_pred             cccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcc----cccccccccCCCCchh-hhhhhhhccCCcccccCCc
Q 046240          128 DLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNS----FSGFIPNTIGNLRNIE-WLGLVIGLIGNPLNGILPS  202 (763)
Q Consensus       128 ~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~----l~~~~p~~~~~l~~L~-~L~L~~~l~~n~l~~~~p~  202 (763)
                      |.++++|++|+|++|.++.+.+..|.++.++..+.+..+.    ...+...+|.++.+|+ .+.    +...   +.++.
T Consensus       120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~----~~~~---~~l~~  192 (329)
T 3sb4_A          120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQ----VGAM---GKLED  192 (329)
T ss_dssp             TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEE----ECTT---CCHHH
T ss_pred             hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEE----ecCC---CcHHH
Confidence            9999999999999999998999999999988888887743    2334556676777666 222    1111   11122


Q ss_pred             ccc----cccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCc
Q 046240          203 SIV----NLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSC  278 (763)
Q Consensus       203 ~~~----~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~  278 (763)
                      .++    ... ++..+.+.++-...........+++|+.|+|++|+++.+.+..|.++.+  |+.|+|.+| ++...+. 
T Consensus       193 ~~~~~~~~~~-~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~--L~~l~l~~n-i~~I~~~-  267 (329)
T 3sb4_A          193 EIMKAGLQPR-DINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY--LLKIKLPHN-LKTIGQR-  267 (329)
T ss_dssp             HHHHTTCCGG-GCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT--CCEEECCTT-CCEECTT-
T ss_pred             HHhhcccCcc-ccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC--CCEEECCcc-cceehHH-
Confidence            111    122 6777777766433222222224789999999999999777778998876  999999988 7644444 


Q ss_pred             cccccCCccc-EEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeC
Q 046240          279 IDIGNLKVVV-EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDL  340 (763)
Q Consensus       279 ~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  340 (763)
                       .|.++++|+ .|++.+ +++.+.+.+|.++++|+.|++++|+++...+.+|.++++|+.++.
T Consensus       268 -aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          268 -VFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             -TTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             -HhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence             789999999 999998 788788899999999999999999999777889999999999874

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.68  E-value=3.6e-17  Score=159.06  Aligned_cols=130  Identities=27%  Similarity=0.355  Sum_probs=96.0

Q ss_pred             ceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEE
Q 046240          236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNIS  315 (763)
Q Consensus       236 ~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  315 (763)
                      +.+++++|+++ .+|..+.    ++|++|+|++|+++ .+|.  .+.++++|++|+|++|+|++..+..|.++++|+.|+
T Consensus        13 ~~l~~~~~~l~-~ip~~~~----~~l~~L~L~~n~i~-~ip~--~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~   84 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP----RDVTELYLDGNQFT-LVPK--ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI   84 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC----TTCCEEECCSSCCC-SCCG--GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CEEEcCCCCCC-cCCCCCC----CCCCEEECCCCcCc-hhHH--HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEE
Confidence            35566666665 4454433    13777777777776 5665  677777888888888888877777788888888888


Q ss_pred             ccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCC
Q 046240          316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI  373 (763)
Q Consensus       316 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  373 (763)
                      |++|+|++..|..|..+++|++|+|++|+|+.+.+..|..+++|+.|+|++|++.+..
T Consensus        85 Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           85 LSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             CCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            8888888777777888888888888888888777777888888888888888887644

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.68  E-value=5.1e-16  Score=168.40  Aligned_cols=246  Identities=11%  Similarity=0.113  Sum_probs=183.6

Q ss_pred             CCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCC
Q 046240           99 YLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGN  178 (763)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  178 (763)
                      ....++.+.+..+ ++       .|+...|.+. +|+.++|..| ++.+...+|.+. +|+.+.|.+ .++.+.+.+|.+
T Consensus       111 ~~~~l~~i~ip~~-i~-------~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~  178 (401)
T 4fdw_A          111 ILKGYNEIILPNS-VK-------SIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYY  178 (401)
T ss_dssp             ECSSCSEEECCTT-CC-------EECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTT
T ss_pred             ecCCccEEEECCc-cC-------EehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhC
Confidence            3466777777643 32       6777777664 6888888766 676777777774 688888875 677677788888


Q ss_pred             CCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCC
Q 046240          179 LRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQN  258 (763)
Q Consensus       179 l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  258 (763)
                      +++|+.++    +.+|+++......|. .. +|+++.|.++ ++.+...+|.++++|+.+++..| ++.+....|.+ .+
T Consensus       179 c~~L~~l~----l~~n~l~~I~~~aF~-~~-~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~  249 (401)
T 4fdw_A          179 CYNLKKAD----LSKTKITKLPASTFV-YA-GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SG  249 (401)
T ss_dssp             CTTCCEEE----CTTSCCSEECTTTTT-TC-CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CC
T ss_pred             cccCCeee----cCCCcceEechhhEe-ec-ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CC
Confidence            88888887    667777755444444 44 8888888744 77677888888888999988875 55566667776 33


Q ss_pred             CCccEEEecCCccccCCCCccccccCCcccEEEccccccc-----ccCCcccCCCcCccEEEccCccccCcccccccccc
Q 046240          259 SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFS-----GDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLT  333 (763)
Q Consensus       259 ~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  333 (763)
                        |+.+.+. |.++...+.  .|.++++|+.+++.+|.+.     .+.+.+|.++++|+.+.|. |.++.....+|.+++
T Consensus       250 --L~~i~lp-~~i~~I~~~--aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~  323 (401)
T 4fdw_A          250 --ITTVKLP-NGVTNIASR--AFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNR  323 (401)
T ss_dssp             --CSEEEEE-TTCCEECTT--TTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCC
T ss_pred             --ccEEEeC-CCccEEChh--HhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCC
Confidence              8888884 456534344  7888888999998888765     4667888889999999998 457766677888889


Q ss_pred             cccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCC
Q 046240          334 SLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI  373 (763)
Q Consensus       334 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  373 (763)
                      +|+.++|.+| ++.+...+|.++ +|+.+++++|.+....
T Consensus       324 ~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~  361 (401)
T 4fdw_A          324 KVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVF  361 (401)
T ss_dssp             SCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCC
T ss_pred             CccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccc
Confidence            9999998555 777778888888 8999999988776543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=1.6e-16  Score=150.83  Aligned_cols=134  Identities=20%  Similarity=0.239  Sum_probs=84.7

Q ss_pred             cccEEEeecCccc-cccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCccc
Q 046240          210 SLERLYISNCSIT-GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV  288 (763)
Q Consensus       210 ~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~  288 (763)
                      +|++|+|++|+++ +.+|..+..+++|++|+|++|.+++.  .                            .+..+++|+
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~----------------------------~~~~l~~L~   74 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--S----------------------------NLPKLPKLK   74 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--S----------------------------SCCCCSSCC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--h----------------------------hhccCCCCC
Confidence            5555666655555 44454455555555555555555422  2                            455566666


Q ss_pred             EEEcccccccccCCcccCCCcCccEEEccCccccCccc-ccccccccccEEeCcCCccCCccc---hhhhhhccCceEEc
Q 046240          289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIP-ESFGYLTSLEILDLSNNKISGFIL---ISLEKLLYLKKLNL  364 (763)
Q Consensus       289 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l  364 (763)
                      +|+|++|++++.+|..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|++++..+   ..+..+++|+.|++
T Consensus        75 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l  154 (168)
T 2ell_A           75 KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDG  154 (168)
T ss_dssp             EEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETT
T ss_pred             EEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecC
Confidence            66666666665566666667777777777777764322 567777777777777777777555   46777778888888


Q ss_pred             ccccCCCCC
Q 046240          365 SFNKLEGEI  373 (763)
Q Consensus       365 ~~N~l~~~~  373 (763)
                      ++|.+...+
T Consensus       155 ~~n~~~~~~  163 (168)
T 2ell_A          155 YDREDQEAP  163 (168)
T ss_dssp             EETTSCBCC
T ss_pred             CCCChhhcc
Confidence            887776443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=2.1e-16  Score=150.12  Aligned_cols=134  Identities=18%  Similarity=0.184  Sum_probs=103.5

Q ss_pred             CCchhhhhhhhhccCCccc-ccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccC
Q 046240          179 LRNIEWLGLVIGLIGNPLN-GILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQ  257 (763)
Q Consensus       179 l~~L~~L~L~~~l~~n~l~-~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  257 (763)
                      .++|+.|+    +++|.++ +.+|..+..+. +|++|+|++|+|++.  ..|..+++|++|+|++|++++.+|..+..++
T Consensus        23 ~~~L~~L~----l~~n~l~~~~i~~~~~~l~-~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   95 (168)
T 2ell_A           23 PAAVRELV----LDNCKSNDGKIEGLTAEFV-NLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLP   95 (168)
T ss_dssp             TTSCSEEE----CCSCBCBTTBCSSCCGGGG-GCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCT
T ss_pred             cccCCEEE----CCCCCCChhhHHHHHHhCC-CCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCC
Confidence            36788888    8899998 78898888888 999999999999976  7899999999999999999977777777776


Q ss_pred             CCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCC---cccCCCcCccEEEccCcccc
Q 046240          258 NSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIP---ATIGGLKDVQNISLPYNRLE  322 (763)
Q Consensus       258 ~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~  322 (763)
                      +  |++|+|++|++++ +|....+..+++|++|++++|++++..+   ..+..+++|+.|++++|.+.
T Consensus        96 ~--L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A           96 N--LTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             T--CCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             C--CCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            5  8888888888874 3311156667777777777777765444   35666666666666666665

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.65  E-value=5.2e-16  Score=148.76  Aligned_cols=112  Identities=21%  Similarity=0.230  Sum_probs=70.9

Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeC
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDL  340 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  340 (763)
                      |++|++++|++++..+.  .+..+++|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|++|+|
T Consensus        30 l~~L~l~~n~l~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           30 ATRLELESNKLQSLPHG--VFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             CSEEECCSSCCCCCCTT--TTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CcEEEeCCCcccEeCHH--HhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            55566666665543333  4555666666666666666555555666666666666666666555555666666777777


Q ss_pred             cCCccCCccchhhhhhccCceEEcccccCCCCCC
Q 046240          341 SNNKISGFILISLEKLLYLKKLNLSFNKLEGEIP  374 (763)
Q Consensus       341 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  374 (763)
                      ++|+++++++..+..+++|+.|++++|++++.+|
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            7777666655556666677777777777666554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.64  E-value=4.7e-16  Score=151.15  Aligned_cols=127  Identities=24%  Similarity=0.281  Sum_probs=83.8

Q ss_pred             EEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCC
Q 046240           80 TALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLT  159 (763)
Q Consensus        80 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~  159 (763)
                      +.+++++|+|+ .+|..+.  ++|++|+|++|.|+       .+| ..+.++++|++|+|++|.|+++.+..|.++++|+
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-------~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~   81 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-------LVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL   81 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-------SCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-------hhH-HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCC
Confidence            35778888888 5665543  57777888777774       566 3445677777777777777766666777777777


Q ss_pred             eeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceee
Q 046240          160 ILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLD  239 (763)
Q Consensus       160 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  239 (763)
                      +|+|++|+|+++.|..|.+++                             +|++|+|++|+|+...+..|..+++|+.|+
T Consensus        82 ~L~Ls~N~l~~i~~~~f~~l~-----------------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  132 (193)
T 2wfh_A           82 TLILSYNRLRCIPPRTFDGLK-----------------------------SLRLLSLHGNDISVVPEGAFNDLSALSHLA  132 (193)
T ss_dssp             EEECCSSCCCBCCTTTTTTCT-----------------------------TCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred             EEECCCCccCEeCHHHhCCCC-----------------------------CCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence            777777777766666665555                             455555666666655555566666666666


Q ss_pred             ccccccc
Q 046240          240 LELNKLT  246 (763)
Q Consensus       240 L~~N~l~  246 (763)
                      |++|.+.
T Consensus       133 L~~N~~~  139 (193)
T 2wfh_A          133 IGANPLY  139 (193)
T ss_dssp             CCSSCEE
T ss_pred             eCCCCee
Confidence            6666655

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=3.4e-16  Score=145.39  Aligned_cols=128  Identities=20%  Similarity=0.205  Sum_probs=85.2

Q ss_pred             cccceeeccccccc-CCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCc
Q 046240          233 SIFLLLDLELNKLT-GPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDV  311 (763)
Q Consensus       233 ~~L~~L~L~~N~l~-~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  311 (763)
                      ++|+.|++++|.++ +.+|..+..+++  |++|++++|.+++.  .  .+..+++|++|+|++|++++.+|..+..+++|
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~--L~~L~l~~n~l~~~--~--~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L   90 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEE--LEFLSTINVGLTSI--A--NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL   90 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTT--CCEEECTTSCCCCC--T--TCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCC--CcEEECcCCCCCCc--h--hhhcCCCCCEEECCCCcccchHHHHhhhCCCC
Confidence            34444444444444 344444444433  55555555555533  2  46667777777777777776677777777888


Q ss_pred             cEEEccCccccCc-ccccccccccccEEeCcCCccCCccc---hhhhhhccCceEEccc
Q 046240          312 QNISLPYNRLEGP-IPESFGYLTSLEILDLSNNKISGFIL---ISLEKLLYLKKLNLSF  366 (763)
Q Consensus       312 ~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~  366 (763)
                      +.|++++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|+.|++++
T Consensus        91 ~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           91 THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            8888888888753 34678888888888888888887665   5788888888888763

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.63  E-value=3.6e-15  Score=161.75  Aligned_cols=264  Identities=12%  Similarity=0.117  Sum_probs=215.0

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      .++.+.+.+ +++.+-..+|.+. +|+.++|..| ++       .|+...|.+ .+|+.++|.. .++.+.+..|.++++
T Consensus       114 ~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~-------~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~  181 (401)
T 4fdw_A          114 GYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LK-------SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYN  181 (401)
T ss_dssp             SCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CC-------EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTT
T ss_pred             CccEEEECC-ccCEehHhhcccC-CccEEEeCCC-cc-------EECHHhcCC-CCceEEEeCC-CccEehHHHhhCccc
Confidence            344555544 4665666788885 7999999876 54       788888877 4799999986 778788889999999


Q ss_pred             CCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccce
Q 046240          158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL  237 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  237 (763)
                      |+.++|++|+++.+...+|. .++|+.+.    +. +++..+-...|.++. +|+.+++.+| ++.+...+|.+ .+|+.
T Consensus       182 L~~l~l~~n~l~~I~~~aF~-~~~L~~l~----lp-~~l~~I~~~aF~~~~-~L~~l~l~~~-l~~I~~~aF~~-~~L~~  252 (401)
T 4fdw_A          182 LKKADLSKTKITKLPASTFV-YAGIEEVL----LP-VTLKEIGSQAFLKTS-QLKTIEIPEN-VSTIGQEAFRE-SGITT  252 (401)
T ss_dssp             CCEEECTTSCCSEECTTTTT-TCCCSEEE----CC-TTCCEECTTTTTTCT-TCCCEECCTT-CCEECTTTTTT-CCCSE
T ss_pred             CCeeecCCCcceEechhhEe-ecccCEEE----eC-CchheehhhHhhCCC-CCCEEecCCC-ccCcccccccc-CCccE
Confidence            99999999999988888887 58898888    54 447767777788887 9999999875 67677888888 89999


Q ss_pred             eecccccccCCCCccccccCCCCccEEEecCCccc-----cCCCCccccccCCcccEEEcccccccccCCcccCCCcCcc
Q 046240          238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS-----GSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQ  312 (763)
Q Consensus       238 L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~-----~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  312 (763)
                      +.| .|.++...+..|.++.+  |+.+++.+|.+.     ...+.  .|.++++|+.++|. |.++.+...+|.++++|+
T Consensus       253 i~l-p~~i~~I~~~aF~~c~~--L~~l~l~~~~~~~~~~~~I~~~--aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~  326 (401)
T 4fdw_A          253 VKL-PNGVTNIASRAFYYCPE--LAEVTTYGSTFNDDPEAMIHPY--CLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT  326 (401)
T ss_dssp             EEE-ETTCCEECTTTTTTCTT--CCEEEEESSCCCCCTTCEECTT--TTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred             EEe-CCCccEEChhHhhCCCC--CCEEEeCCccccCCcccEECHH--HhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence            999 56677677888999977  999999988775     23333  78999999999999 568878889999999999


Q ss_pred             EEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhc-cCceEEcccccCC
Q 046240          313 NISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLL-YLKKLNLSFNKLE  370 (763)
Q Consensus       313 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~  370 (763)
                      .+.|..| ++...+.+|.++ +|+.+++++|.+..+.+..|.+++ .++.|++..|.+.
T Consensus       327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             EEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            9999665 776777899999 999999999999988888888884 7889998877654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=1.1e-15  Score=146.43  Aligned_cols=130  Identities=24%  Similarity=0.275  Sum_probs=83.6

Q ss_pred             EEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCe
Q 046240           81 ALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTI  160 (763)
Q Consensus        81 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  160 (763)
                      .+++++++++ .+|..+  .++|++|+|++|+++       .+|...+..+++|++|+|++|+|++..+..|.++++|++
T Consensus        11 ~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~-------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~   80 (177)
T 2o6r_A           11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-------SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTI   80 (177)
T ss_dssp             EEECCSSCCS-SCCTTC--CTTCSEEECCSSCCC-------CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             EEEecCCCCc-cCCCCC--CCCCcEEEeCCCccc-------EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCE
Confidence            3444556676 455433  367778888877774       566666667777777777777777666666677777777


Q ss_pred             eeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeec
Q 046240          161 LELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDL  240 (763)
Q Consensus       161 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  240 (763)
                      |+|++|+|++..+..|.+++                             +|++|+|++|+|++..+..|..+++|++|+|
T Consensus        81 L~l~~N~l~~~~~~~~~~l~-----------------------------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  131 (177)
T 2o6r_A           81 LYLHENKLQSLPNGVFDKLT-----------------------------QLKELALDTNQLKSVPDGIFDRLTSLQKIWL  131 (177)
T ss_dssp             EECCSSCCCCCCTTTTTTCT-----------------------------TCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             EECCCCCccccCHHHhhCCc-----------------------------ccCEEECcCCcceEeCHHHhcCCcccCEEEe
Confidence            77777777765555555544                             5556666666666555555566666666666


Q ss_pred             ccccccCCC
Q 046240          241 ELNKLTGPI  249 (763)
Q Consensus       241 ~~N~l~~~~  249 (763)
                      ++|.+++..
T Consensus       132 ~~N~~~~~~  140 (177)
T 2o6r_A          132 HTNPWDCSC  140 (177)
T ss_dssp             CSSCBCCCH
T ss_pred             cCCCeeccC
Confidence            666666433

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=3.7e-16  Score=145.14  Aligned_cols=127  Identities=19%  Similarity=0.237  Sum_probs=111.6

Q ss_pred             cccEEEeecCccc-cccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCccc
Q 046240          210 SLERLYISNCSIT-GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV  288 (763)
Q Consensus       210 ~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~  288 (763)
                      +|++|++++|.++ +.+|..+..+++|++|++++|++++.  ..+..+++  |++|++++|++++.+|.  .+..+++|+
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~--L~~L~Ls~n~i~~~~~~--~~~~l~~L~   91 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNK--LKKLELSDNRVSGGLEV--LAEKCPNLT   91 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTT--CCEEECCSSCCCSCTHH--HHHHCTTCC
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCC--CCEEECCCCcccchHHH--HhhhCCCCC
Confidence            8999999999998 78888899999999999999999965  77888876  99999999999976777  677799999


Q ss_pred             EEEccccccccc-CCcccCCCcCccEEEccCccccCccc---ccccccccccEEeCcC
Q 046240          289 EINLSRNNFSGD-IPATIGGLKDVQNISLPYNRLEGPIP---ESFGYLTSLEILDLSN  342 (763)
Q Consensus       289 ~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~  342 (763)
                      +|++++|++++. .+..+..+++|+.|++++|++++..+   ..+..+++|+.|++++
T Consensus        92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            999999999964 34889999999999999999997665   5789999999999874

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=4.5e-16  Score=164.76  Aligned_cols=137  Identities=13%  Similarity=0.150  Sum_probs=98.8

Q ss_pred             cCcCceecccCCceEEEEEecCCceEEEEEeehhhH------------------H----HHHHHHHHHHHHHhCCCCccc
Q 046240          477 FGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECA------------------R----AMKSFEVECEVMKNIRHRNLV  534 (763)
Q Consensus       477 ~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~e~~~l~~l~h~niv  534 (763)
                      |.+.+.||+|++|.||+|...+|+.||||+++....                  .    ......+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            888999999999999999999999999998752210                  0    011123466666666444332


Q ss_pred             eEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC--
Q 046240          535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM--  612 (763)
Q Consensus       535 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~--  612 (763)
                      ...-+..  ...++||||++|++|..+....       ....++.|++.++.+|   |+.+||||||||.|||+++++  
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~~-------~~~~l~~qll~~l~~l---H~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSVP-------DPASLYADLIALILRL---AKHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCCCS-------CHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEEEEECS
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhcccH-------HHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEEeCCCCc
Confidence            1111111  1237999999999887664321       2356789999999999   678999999999999998776  


Q ss_pred             --------cEEEeeecCceec
Q 046240          613 --------IAHLSDFGIAKLL  625 (763)
Q Consensus       613 --------~~kl~Dfgla~~~  625 (763)
                              .+.|+||+-+...
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEET
T ss_pred             ccccccccceEEEEeCCcccC
Confidence                    3899999977654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.56  E-value=5.3e-15  Score=141.51  Aligned_cols=134  Identities=19%  Similarity=0.167  Sum_probs=92.8

Q ss_pred             cCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCC
Q 046240          229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGL  308 (763)
Q Consensus       229 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  308 (763)
                      +..+++|+.|++++|+++. +|. +..+. ++|++|+|++|.+++.  .  .+..+++|++|+|++|+|++..+..|..+
T Consensus        15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~-~~L~~L~Ls~N~l~~~--~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l   87 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPV-IEN-LGATL-DQFDAIDFSDNEIRKL--D--GFPLLRRLKTLLVNNNRICRIGEGLDQAL   87 (176)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCC-GGGGT-TCCSEEECCSSCCCEE--C--CCCCCSSCCEEECCSSCCCEECSCHHHHC
T ss_pred             cCCcCCceEEEeeCCCCch-hHH-hhhcC-CCCCEEECCCCCCCcc--c--ccccCCCCCEEECCCCcccccCcchhhcC
Confidence            4455566666666666663 333 33332 1277777777777643  2  46777788888888888886555556788


Q ss_pred             cCccEEEccCccccCcccc--cccccccccEEeCcCCccCCccch---hhhhhccCceEEcccccCC
Q 046240          309 KDVQNISLPYNRLEGPIPE--SFGYLTSLEILDLSNNKISGFILI---SLEKLLYLKKLNLSFNKLE  370 (763)
Q Consensus       309 ~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~  370 (763)
                      ++|+.|+|++|+++ .+|.  .+..+++|+.|++++|+++...+.   .+..+++|+.||+++|.+.
T Consensus        88 ~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           88 PDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             TTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            88888888888886 4554  677888888888888888764333   4788888888888888765

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=8e-17  Score=157.50  Aligned_cols=151  Identities=22%  Similarity=0.234  Sum_probs=111.8

Q ss_pred             cccEEEeecCcccccccc------ccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCcccccc
Q 046240          210 SLERLYISNCSITGNIPQ------VMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGN  283 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~  283 (763)
                      +++.++++.|.+.+..|.      .|..+++|++|+|++|++++ +| .+.++++  |++|++++|.++ .+|.  .+..
T Consensus        19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~--L~~L~l~~n~l~-~l~~--~~~~   91 (198)
T 1ds9_A           19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMEN--LRILSLGRNLIK-KIEN--LDAV   91 (198)
T ss_dssp             CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTT--CCEEEEEEEEEC-SCSS--HHHH
T ss_pred             cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCC--CCEEECCCCCcc-cccc--hhhc
Confidence            555566666666655555      77778888888888888875 56 7777765  888888888887 5666  5666


Q ss_pred             CCcccEEEcccccccccCCcccCCCcCccEEEccCccccCccc-ccccccccccEEeCcCCccCCccch----------h
Q 046240          284 LKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIP-ESFGYLTSLEILDLSNNKISGFILI----------S  352 (763)
Q Consensus       284 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~----------~  352 (763)
                      +++|++|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|++++..|.          .
T Consensus        92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~  169 (198)
T 1ds9_A           92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV  169 (198)
T ss_dssp             HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred             CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence            7888888888888885 34 57788888888888888885433 4678888888888888888776554          3


Q ss_pred             hhhhccCceEEcccccCCC
Q 046240          353 LEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       353 ~~~l~~L~~L~l~~N~l~~  371 (763)
                      +..+++|+.||  +|+++.
T Consensus       170 ~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          170 VKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHHCSSCSEEC--CGGGTT
T ss_pred             HHhCCCcEEEC--CcccCH
Confidence            77888888876  666663

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.54  E-value=3.6e-15  Score=142.69  Aligned_cols=37  Identities=14%  Similarity=0.184  Sum_probs=17.6

Q ss_pred             CccEEEcccccccccCCCcccCCCCCCeeeecCcccccc
Q 046240          133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGF  171 (763)
Q Consensus       133 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~  171 (763)
                      +|++|+|++|.|++.  ..|.++++|++|+|++|+|+++
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~   79 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRI   79 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCccccc
Confidence            444444444444433  3444444555555555554433

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=2.6e-14  Score=135.74  Aligned_cols=108  Identities=22%  Similarity=0.276  Sum_probs=63.0

Q ss_pred             cEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCc
Q 046240          262 DTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLS  341 (763)
Q Consensus       262 ~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  341 (763)
                      +.+++++|+++ .+|.  .+  .++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus        12 ~~l~~s~n~l~-~ip~--~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPT--GI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             TEEECTTSCCS-SCCS--CC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CEEEeCCCCcC-ccCc--cC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            44555555555 3443  22  2455566666666665555566666666666666666665555555666666666666


Q ss_pred             CCccCCccchhhhhhccCceEEcccccCCCCCC
Q 046240          342 NNKISGFILISLEKLLYLKKLNLSFNKLEGEIP  374 (763)
Q Consensus       342 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p  374 (763)
                      +|+|+++.+..|..+++|+.|+|++|++++..+
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            666666555556666666666666666665544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.52  E-value=2e-16  Score=154.68  Aligned_cols=162  Identities=19%  Similarity=0.237  Sum_probs=120.6

Q ss_pred             ccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCC
Q 046240          152 ITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGN  231 (763)
Q Consensus       152 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~  231 (763)
                      +.....++.+++++|.+++..|. +   +                  .+|..+..+. +|++|+|++|++++ +| .+..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~-l---~------------------~l~~~~~~l~-~L~~L~ls~n~l~~-l~-~~~~   68 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPP-I---E------------------KMDATLSTLK-ACKHLALSTNNIEK-IS-SLSG   68 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTT-C---C------------------CCHHHHHHTT-TCSEEECSEEEESC-CC-CHHH
T ss_pred             HHhcccccCcchheeEeccccCc-H---h------------------hhhHHHhcCC-CCCEEECCCCCCcc-cc-cccc
Confidence            44556777777777777765443 1   1                  1222455555 78888888888885 55 7888


Q ss_pred             ccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCC-cccCCCcC
Q 046240          232 LSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIP-ATIGGLKD  310 (763)
Q Consensus       232 l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~  310 (763)
                      +++|++|+|++|+++ .+|..+..+++  |++|+|++|++++ +|   .+..+++|++|++++|++++..+ ..+..+++
T Consensus        69 l~~L~~L~l~~n~l~-~l~~~~~~~~~--L~~L~L~~N~l~~-l~---~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~  141 (198)
T 1ds9_A           69 MENLRILSLGRNLIK-KIENLDAVADT--LEELWISYNQIAS-LS---GIEKLVNLRVLYMSNNKITNWGEIDKLAALDK  141 (198)
T ss_dssp             HTTCCEEEEEEEEEC-SCSSHHHHHHH--CSEEEEEEEECCC-HH---HHHHHHHSSEEEESEEECCCHHHHHHHTTTTT
T ss_pred             CCCCCEEECCCCCcc-cccchhhcCCc--CCEEECcCCcCCc-CC---ccccCCCCCEEECCCCcCCchhHHHHHhcCCC
Confidence            888888888888888 56777766665  8888888888884 44   47788889999999999885433 57888999


Q ss_pred             ccEEEccCccccCccccc----------ccccccccEEeCcCCccCC
Q 046240          311 VQNISLPYNRLEGPIPES----------FGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       311 L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~L~~N~l~~  347 (763)
                      |+.|++++|.+++..|..          +..+++|+.||  +|.++.
T Consensus       142 L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          142 LEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             CSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             CCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            999999999998776653          78899999987  777765

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.50  E-value=5.9e-14  Score=133.71  Aligned_cols=89  Identities=22%  Similarity=0.249  Sum_probs=48.3

Q ss_pred             CcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEc
Q 046240          285 KVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNL  364 (763)
Q Consensus       285 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  364 (763)
                      ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|+++++..|..+++|+.|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            44555555555555554555555555555555555555444444555555555555555555544444555555555555


Q ss_pred             ccccCCCCC
Q 046240          365 SFNKLEGEI  373 (763)
Q Consensus       365 ~~N~l~~~~  373 (763)
                      ++|+|.+.+
T Consensus       113 ~~N~~~c~~  121 (174)
T 2r9u_A          113 YNNPWDCEC  121 (174)
T ss_dssp             CSSCBCTTB
T ss_pred             CCCCccccc
Confidence            555555443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.48  E-value=1.2e-13  Score=131.01  Aligned_cols=48  Identities=19%  Similarity=0.229  Sum_probs=25.3

Q ss_pred             CccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCC
Q 046240          133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLR  180 (763)
Q Consensus       133 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  180 (763)
                      +|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|.+++
T Consensus        31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~   78 (170)
T 3g39_A           31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLT   78 (170)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCC
Confidence            344555555555555555555555555555555555554444444444

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.46  E-value=1.9e-13  Score=130.17  Aligned_cols=48  Identities=15%  Similarity=0.176  Sum_probs=23.6

Q ss_pred             CccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCC
Q 046240          133 NVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLR  180 (763)
Q Consensus       133 ~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  180 (763)
                      +|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.+++
T Consensus        34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~   81 (174)
T 2r9u_A           34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLT   81 (174)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcc
Confidence            344444444444444455555555555555555555544443344333

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.43  E-value=1.9e-12  Score=140.68  Aligned_cols=264  Identities=14%  Similarity=0.083  Sum_probs=157.1

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccc-------------
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYN-------------  142 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N-------------  142 (763)
                      -.+++.+.|.. +++.+-..+|.++++|+.++|..+ ++       .|+...|.++++|+.+.+..+             
T Consensus        70 c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-------~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~  140 (394)
T 4fs7_A           70 CRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-------MIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCD  140 (394)
T ss_dssp             CTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-------EECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCC
T ss_pred             CCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-------EccchhhcccccchhhcccCceeeecceeeeccc
Confidence            35788898874 477666778999999999998755 32       344444444444444333222             


Q ss_pred             --------cccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCC-------------
Q 046240          143 --------RFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILP-------------  201 (763)
Q Consensus       143 --------~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p-------------  201 (763)
                              .+..+...+|.++++|+.+.+.++. ..+...+|.++++|+.+.+    ..| ++..-.             
T Consensus       141 ~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l----~~~-~~~I~~~~F~~~~~L~~i~  214 (394)
T 4fs7_A          141 FKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKL----PRN-LKIIRDYCFAECILLENME  214 (394)
T ss_dssp             CSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCC----CTT-CCEECTTTTTTCTTCCBCC
T ss_pred             ccccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEc----CCC-ceEeCchhhccccccceee
Confidence                    0111122334444444444444332 2233444444444444442    111 221112             


Q ss_pred             ---------cccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccc
Q 046240          202 ---------SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFS  272 (763)
Q Consensus       202 ---------~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~  272 (763)
                               ...+... +|+.+.+.++ ++......|..+..|+.+.+..+..+ .....|.....  ++.+....+.+.
T Consensus       215 ~~~~~~~i~~~~~~~~-~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~--l~~~~~~~~~i~  289 (394)
T 4fs7_A          215 FPNSLYYLGDFALSKT-GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSG--LKKVIYGSVIVP  289 (394)
T ss_dssp             CCTTCCEECTTTTTTC-CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTT--CCEEEECSSEEC
T ss_pred             cCCCceEeehhhcccC-CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccc--cceeccCceeec
Confidence                     2222222 5555555433 33345556677777777777766554 55556666654  666666655432


Q ss_pred             cCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchh
Q 046240          273 GSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILIS  352 (763)
Q Consensus       273 ~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  352 (763)
                          .. .|..+.+|+.+.+.++ ++.+...+|.++++|+.+++..+ ++.....+|.++++|+.++|..| ++.+...+
T Consensus       290 ----~~-~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a  361 (394)
T 4fs7_A          290 ----EK-TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANA  361 (394)
T ss_dssp             ----TT-TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             ----cc-cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHH
Confidence                21 5677788888888654 66666778888888888888654 66556678888888888888776 77777788


Q ss_pred             hhhhccCceEEcccc
Q 046240          353 LEKLLYLKKLNLSFN  367 (763)
Q Consensus       353 ~~~l~~L~~L~l~~N  367 (763)
                      |.++.+|+.+++..|
T Consensus       362 F~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          362 FQGCINLKKVELPKR  376 (394)
T ss_dssp             BTTCTTCCEEEEEGG
T ss_pred             hhCCCCCCEEEECCC
Confidence            888888888888654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.33  E-value=2.5e-14  Score=153.62  Aligned_cols=93  Identities=19%  Similarity=0.296  Sum_probs=49.9

Q ss_pred             ccEEEecCCccccC----CCCccccccCCcccEEEccccccccc----CCcccCCCcCccEEEccCccccCc----cccc
Q 046240          261 LDTLSLCGNSFSGS----IPSCIDIGNLKVVVEINLSRNNFSGD----IPATIGGLKDVQNISLPYNRLEGP----IPES  328 (763)
Q Consensus       261 L~~L~L~~N~l~~~----~p~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~  328 (763)
                      |++|+|++|.++..    ++.  .+...++|++|+|++|+|+..    ++..+...++|+.|+|++|.|+..    +...
T Consensus       157 L~~L~Ls~n~l~~~~~~~l~~--~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~  234 (372)
T 3un9_A          157 ITTLRLSNNPLTAAGVAVLME--GLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA  234 (372)
T ss_dssp             CCEEECCSSCCHHHHHHHHHH--HHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred             cceeeCCCCCCChHHHHHHHH--HHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence            55555555555421    111  234455566666666666532    234455556666666666666542    2233


Q ss_pred             ccccccccEEeCcCCccCCccchhhhh
Q 046240          329 FGYLTSLEILDLSNNKISGFILISLEK  355 (763)
Q Consensus       329 ~~~l~~L~~L~L~~N~l~~~~~~~~~~  355 (763)
                      +...++|++|+|++|.|+......+..
T Consensus       235 L~~~~~L~~L~Ls~N~i~~~g~~~L~~  261 (372)
T 3un9_A          235 AREHPSLELLHLYFNELSSEGRQVLRD  261 (372)
T ss_dssp             HHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred             HHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence            344566777777777766554444444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.31  E-value=1.5e-12  Score=139.01  Aligned_cols=133  Identities=16%  Similarity=0.081  Sum_probs=93.6

Q ss_pred             ceeecccc-cccCCCCccccccCCCCccEEEecC-CccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccE
Q 046240          236 LLLDLELN-KLTGPIPVTFGRLQNSKLDTLSLCG-NSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQN  313 (763)
Q Consensus       236 ~~L~L~~N-~l~~~~p~~~~~l~~~~L~~L~L~~-N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  313 (763)
                      ..++++++ +|+ .+|. +..+.+  |+.|+|++ |+|++..|.  .|.++++|+.|+|++|+|++..|..|.++++|+.
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~--L~~L~l~~~n~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~   84 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAEN--LTELYIENQQHLQHLELR--DLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSC--CSEEECCSCSSCCEECGG--GSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCC--eeEEEccCCCCCCCcChh--HhccccCCCEEECCCCccceeCHHHhcCCcCCCE
Confidence            35678887 788 4676 777765  88888885 888866656  6788888888888888888877888888888888


Q ss_pred             EEccCccccCcccccccccccccEEeCcCCccCCccc-hhhhhhccCceEEcccccCCCCCCC
Q 046240          314 ISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL-ISLEKLLYLKKLNLSFNKLEGEIPR  375 (763)
Q Consensus       314 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~  375 (763)
                      |+|++|+|++..+..|..++ |+.|+|++|++...-. ..|..+.......+..+.+++..|.
T Consensus        85 L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           85 LNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             EECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             EeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            88888888866666666665 8888888888775322 3344443344444555666655554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.30  E-value=5.9e-12  Score=134.34  Aligned_cols=90  Identities=21%  Similarity=0.299  Sum_probs=42.9

Q ss_pred             cccCCcccEEEccc-ccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccC
Q 046240          281 IGNLKVVVEINLSR-NNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYL  359 (763)
Q Consensus       281 ~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  359 (763)
                      +..+++|++|+|++ |+|++..+..|+++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+++++..|..++ |
T Consensus        27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L  105 (347)
T 2ifg_A           27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L  105 (347)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred             CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence            34444444555543 444444444444455555555555555444444444455555555555555444444443333 4


Q ss_pred             ceEEcccccCCC
Q 046240          360 KKLNLSFNKLEG  371 (763)
Q Consensus       360 ~~L~l~~N~l~~  371 (763)
                      +.|+|++|+|.+
T Consensus       106 ~~l~l~~N~~~c  117 (347)
T 2ifg_A          106 QELVLSGNPLHC  117 (347)
T ss_dssp             CEEECCSSCCCC
T ss_pred             eEEEeeCCCccC
Confidence            455555554444

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.30  E-value=1.4e-13  Score=147.78  Aligned_cols=158  Identities=19%  Similarity=0.177  Sum_probs=121.3

Q ss_pred             cccEEEeecCccccccccccCCc-----cccceeecccccccCCCCcccc-ccCCCCccEEEecCCccccCCCCcccc--
Q 046240          210 SLERLYISNCSITGNIPQVMGNL-----SIFLLLDLELNKLTGPIPVTFG-RLQNSKLDTLSLCGNSFSGSIPSCIDI--  281 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~-~l~~~~L~~L~L~~N~l~~~~p~~~~~--  281 (763)
                      +|++|+|++|.|+......+...     ++|++|+|++|.|+......+. .+.+  |+.|+|++|.++.....  .+  
T Consensus        73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~--L~~L~Ls~n~l~~~~~~--~L~~  148 (372)
T 3un9_A           73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR--ARKLGLQLNSLGPEACK--DLRD  148 (372)
T ss_dssp             TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHT--EEEEECCSSCCCHHHHH--HHHH
T ss_pred             hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHh--ccHhhcCCCCCCHHHHH--HHHH
Confidence            78999999999986555554443     7999999999999754333332 3444  99999999999743222  22  


Q ss_pred             ---ccCCcccEEEccccccccc----CCcccCCCcCccEEEccCccccCc----ccccccccccccEEeCcCCccCCcc-
Q 046240          282 ---GNLKVVVEINLSRNNFSGD----IPATIGGLKDVQNISLPYNRLEGP----IPESFGYLTSLEILDLSNNKISGFI-  349 (763)
Q Consensus       282 ---~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-  349 (763)
                         ...++|++|+|++|.|+..    ++..+..+++|++|+|++|+|+..    ++..+...++|++|+|++|.|+... 
T Consensus       149 ~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~  228 (372)
T 3un9_A          149 LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA  228 (372)
T ss_dssp             HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHH
T ss_pred             HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHH
Confidence               2457899999999999753    445567889999999999999854    3556777889999999999998753 


Q ss_pred             ---chhhhhhccCceEEcccccCCC
Q 046240          350 ---LISLEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       350 ---~~~~~~l~~L~~L~l~~N~l~~  371 (763)
                         ...+...++|++|+|++|+|+.
T Consensus       229 ~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          229 LALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             HHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             HHHHHHHHhCCCCCEEeccCCCCCH
Confidence               3445566899999999999874

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.26  E-value=1e-10  Score=126.92  Aligned_cols=265  Identities=9%  Similarity=0.103  Sum_probs=152.3

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCc---ccCCCccccCccccccccCCCccEEEcccccccccCCCcccC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNS---LVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITN  154 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~---l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~  154 (763)
                      .++.+.+..+ ++.+-..+|.++++|+.+.+..|.   ++       .|+...|.+..+|+.+.+..+ ++.+....|.+
T Consensus        65 ~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-------~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~  135 (394)
T 4gt6_A           65 VLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVK-------KIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH  135 (394)
T ss_dssp             CCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCC-------EECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred             cCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeee-------EechhhchhcccceeeccCCc-cceehhhhhhh
Confidence            3666777643 665566678888888888877653   32       667777777777777777654 45466667777


Q ss_pred             CCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccc
Q 046240          155 ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSI  234 (763)
Q Consensus       155 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~  234 (763)
                      +.+|+.+.+..+ +..+...+|.++.+|+.+.    +.. .++.+-...| ... +|+.+.+..+-.. ....+|..+.+
T Consensus       136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~----~~~-~~~~I~~~aF-~~~-~l~~i~ip~~~~~-i~~~af~~c~~  206 (394)
T 4gt6_A          136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVT----LPD-SVTAIEERAF-TGT-ALTQIHIPAKVTR-IGTNAFSECFA  206 (394)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCEEE----CCT-TCCEECTTTT-TTC-CCSEEEECTTCCE-ECTTTTTTCTT
T ss_pred             hcccccccccce-eeeecccceeccccccccc----ccc-eeeEeccccc-ccc-ceeEEEECCcccc-cccchhhhccc
Confidence            788888887644 3446667777777777766    322 2333333333 333 6777777655433 55666777766


Q ss_pred             cceeeccccccc------------------------------------CCCCccccccCCCCccEEEecCCccccCCCCc
Q 046240          235 FLLLDLELNKLT------------------------------------GPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSC  278 (763)
Q Consensus       235 L~~L~L~~N~l~------------------------------------~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~  278 (763)
                      |.......+...                                    ......|.+...  |+.+.+.++... .... 
T Consensus       207 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~--L~~i~lp~~~~~-I~~~-  282 (394)
T 4gt6_A          207 LSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAY--LASVKMPDSVVS-IGTG-  282 (394)
T ss_dssp             CCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSS--CCEEECCTTCCE-ECTT-
T ss_pred             cceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeeccc--ccEEecccccce-ecCc-
Confidence            666655443322                                    111223333333  555555443322 2222 


Q ss_pred             cccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhcc
Q 046240          279 IDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLY  358 (763)
Q Consensus       279 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  358 (763)
                       .|.+++.|+.+.+. +.++.+...+|.++.+|+.+.+..+ ++.....+|.++++|+.+.|..+ ++.+...+|.++++
T Consensus       283 -aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~  358 (394)
T 4gt6_A          283 -AFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA  358 (394)
T ss_dssp             -TTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred             -ccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence             45555556666554 3444445555666666666666543 44344455666666666666433 55555566666666


Q ss_pred             CceEEccccc
Q 046240          359 LKKLNLSFNK  368 (763)
Q Consensus       359 L~~L~l~~N~  368 (763)
                      |+.+++.+|.
T Consensus       359 L~~i~~~~~~  368 (394)
T 4gt6_A          359 LNNIEYSGSR  368 (394)
T ss_dssp             CCEEEESSCH
T ss_pred             CCEEEECCce
Confidence            6666665553

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.24  E-value=4.6e-11  Score=129.72  Aligned_cols=255  Identities=11%  Similarity=-0.001  Sum_probs=138.9

Q ss_pred             CCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcc
Q 046240           88 NLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNS  167 (763)
Q Consensus        88 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~  167 (763)
                      .++.+-..+|.++++|+++.|..+ ++       .|++.+|.++++|+.++|.+| ++.+....|.++.+|+.+.+..+ 
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~-------~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-  127 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VR-------EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-  127 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CC-------EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-cc-------CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-
Confidence            355566678999999999999754 64       899999999999999999866 77677889999999999887655 


Q ss_pred             cccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccC
Q 046240          168 FSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTG  247 (763)
Q Consensus       168 l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  247 (763)
                      +..+...+|.+...++...      .+.....-...|.++. +|+.+.+.++. ......+|.++++|+.+.+..| ++.
T Consensus       128 l~~i~~~aF~~~~~~~~~~------~~~~~~i~~~aF~~c~-~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~  198 (394)
T 4fs7_A          128 LKSIGVEAFKGCDFKEITI------PEGVTVIGDEAFATCE-SLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKI  198 (394)
T ss_dssp             CCEECTTTTTTCCCSEEEC------CTTCCEECTTTTTTCT-TCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCE
T ss_pred             eeeecceeeeccccccccc------CccccccchhhhcccC-CCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceE
Confidence            3334444444443322111      1112222223333333 44444444332 2233444444444444444433 221


Q ss_pred             CCCccccccCC--------------------CCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCc----
Q 046240          248 PIPVTFGRLQN--------------------SKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPA----  303 (763)
Q Consensus       248 ~~p~~~~~l~~--------------------~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~----  303 (763)
                      .....|.+...                    ..|+.+.+..+. +.....  .+.+...|+.+.+..+... +...    
T Consensus       199 I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~-~~i~~~--~f~~~~~l~~~~~~~~~~~-i~~~~F~~  274 (394)
T 4fs7_A          199 IRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKNIIIPDSF-TELGKS--VFYGCTDLESISIQNNKLR-IGGSLFYN  274 (394)
T ss_dssp             ECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEECTTC-CEECSS--TTTTCSSCCEEEECCTTCE-ECSCTTTT
T ss_pred             eCchhhccccccceeecCCCceEeehhhcccCCCceEEECCCc-eecccc--cccccccceeEEcCCCcce-eecccccc
Confidence            22222222211                    124444443221 111112  4556666666666655332 3333    


Q ss_pred             -----------------ccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEccc
Q 046240          304 -----------------TIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF  366 (763)
Q Consensus       304 -----------------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  366 (763)
                                       .|.++.+|+.+.+..+ ++.....+|.++++|+.++|.++ ++.+...+|.++.+|+.+++..
T Consensus       275 ~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~  352 (394)
T 4fs7_A          275 CSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPL  352 (394)
T ss_dssp             CTTCCEEEECSSEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCT
T ss_pred             ccccceeccCceeeccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECc
Confidence                             4445555555555443 44344455666666666666533 5555556666666666666654


Q ss_pred             c
Q 046240          367 N  367 (763)
Q Consensus       367 N  367 (763)
                      |
T Consensus       353 ~  353 (394)
T 4fs7_A          353 S  353 (394)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=4.2e-11  Score=122.28  Aligned_cols=147  Identities=14%  Similarity=0.087  Sum_probs=114.4

Q ss_pred             HHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEE
Q 046240          471 SRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       471 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  549 (763)
                      ...-+.|.....++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            334467877888888888999999765 6789999987532223346888999999984 67788999999888899999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR--------------------------------------  591 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~--------------------------------------  591 (763)
                      |||++|.++.+.....      .....++.++++++..||..                                      
T Consensus        89 ~e~i~G~~l~~~~~~~------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCTT------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCCc------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999999997764211      12346788999999999861                                      


Q ss_pred             ------------------CCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          592 ------------------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       592 ------------------h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                                        +...++|||++|.||+++++..+.|.||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                              114589999999999998766677999987654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.14  E-value=4.1e-10  Score=122.24  Aligned_cols=265  Identities=8%  Similarity=0.131  Sum_probs=178.2

Q ss_pred             CceEEEEecCCC---CCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCccc
Q 046240           77 HRVTALNISSLN---LQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPIT  153 (763)
Q Consensus        77 ~~v~~L~L~~~~---l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~  153 (763)
                      .+++.+.+..|.   ++.+-..+|.++.+|+.+.+..+ ++       .++...|.+..+|+.+.+..+ ++.+....|.
T Consensus        87 ~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-------~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~  157 (394)
T 4gt6_A           87 TSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-------EIDSEAFHHCEELDTVTIPEG-VTSVADGMFS  157 (394)
T ss_dssp             TTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-------EECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred             ccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-------eehhhhhhhhcccccccccce-eeeeccccee
Confidence            578888887653   66555678888888988887654 32       677888888888888888754 4446667788


Q ss_pred             CCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccc----------------------
Q 046240          154 NASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISL----------------------  211 (763)
Q Consensus       154 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L----------------------  211 (763)
                      ++.+|+.+.+.++ ++.+...+|.+ .+|+.+.+    .. .+.......+.+.. +|                      
T Consensus       158 ~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~i----p~-~~~~i~~~af~~c~-~l~~~~~~~~~~~~~~~~~~~~~~  229 (394)
T 4gt6_A          158 YCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHI----PA-KVTRIGTNAFSECF-ALSTITSDSESYPAIDNVLYEKSA  229 (394)
T ss_dssp             TCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEE----CT-TCCEECTTTTTTCT-TCCEEEECCSSSCBSSSCEEEECT
T ss_pred             cccccccccccce-eeEeccccccc-cceeEEEE----CC-cccccccchhhhcc-ccceecccccccccccceeecccc
Confidence            8888888888665 44455556654 34555542    11 11111111222221 22                      


Q ss_pred             ---------------cEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCC
Q 046240          212 ---------------ERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIP  276 (763)
Q Consensus       212 ---------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p  276 (763)
                                     ..+.+. +.++.....+|.++.+|+.+.+..+..+ .....|.+...  |+.+.+. +.++ .++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~--L~~i~l~-~~i~-~I~  303 (394)
T 4gt6_A          230 NGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPA--LQDIEFS-SRIT-ELP  303 (394)
T ss_dssp             TSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTT--CCEEECC-TTCC-EEC
T ss_pred             cccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccc--cccccCC-Cccc-ccC
Confidence                           222222 3344455678999999999999877665 67778888876  9999996 4565 344


Q ss_pred             CccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhh
Q 046240          277 SCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKL  356 (763)
Q Consensus       277 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  356 (763)
                      .. .|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.....+|.++++|+.+++.+|...   ...+...
T Consensus       304 ~~-aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~  377 (394)
T 4gt6_A          304 ES-VFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTD  377 (394)
T ss_dssp             TT-TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCC
T ss_pred             ce-eecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhcc
Confidence            42 7999999999999865 77778899999999999999765 77567789999999999999998653   2456677


Q ss_pred             ccCceEEcccccCC
Q 046240          357 LYLKKLNLSFNKLE  370 (763)
Q Consensus       357 ~~L~~L~l~~N~l~  370 (763)
                      ..|+.+.+..|.+.
T Consensus       378 ~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          378 SGLQNLPVAPGSID  391 (394)
T ss_dssp             CCC-----------
T ss_pred             CCCCEEEeCCCCEE
Confidence            88888888776543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=1.3e-10  Score=118.33  Aligned_cols=129  Identities=14%  Similarity=0.099  Sum_probs=97.3

Q ss_pred             cccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCc--cceEEeeeecCCceEEEEEccCCCChhhh
Q 046240          484 GIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN--LVKIISGCSNDDFKALVLEYMPNGSLDIF  561 (763)
Q Consensus       484 g~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  561 (763)
                      +.|..+.||++...+|..+++|+....   ....+.+|+.+++.+.+.+  +.+++++...++..++||||++|.++.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            355669999998877889999997643   2245678999999885444  556888888888899999999998884  


Q ss_pred             hccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------------
Q 046240          562 LYSSTCMLDIFQRLNIMIDVASALEYLNFRH-------------------------------------------------  592 (763)
Q Consensus       562 l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h-------------------------------------------------  592 (763)
                      ...    .+   ...++.++++.+..||...                                                 
T Consensus       104 ~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  176 (264)
T 1nd4_A          104 SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  176 (264)
T ss_dssp             TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence            211    11   2356778888888885421                                                 


Q ss_pred             ------CCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          593 ------TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       593 ------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                            ...++|||++|.||++++++.+.|.||+.+..
T Consensus       177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                  12299999999999998876677999998764

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.95  E-value=1.5e-08  Score=109.16  Aligned_cols=261  Identities=11%  Similarity=0.079  Sum_probs=141.4

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.+.+.. +++.+-..+|.++.+|+.++|..+ ++       .|+..+|.+. +|+.+.+..+ ++.+...+|.+. 
T Consensus        46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~-------~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-  113 (379)
T 4h09_A           46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VT-------SIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-  113 (379)
T ss_dssp             GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CC-------EECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-
T ss_pred             cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ce-------EechhhhcCC-CCceEECCce-eeEeccceeccC-
Confidence            3577777764 466566678888888888888654 53       6777777665 5777776644 554555566554 


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccc--------------
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT--------------  222 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~--------------  222 (763)
                      +|+.+.+.++- +.+...+|.+. +|+.+.     ..+.++..-...+.... +|+.+.+..+...              
T Consensus       114 ~L~~i~lp~~~-~~i~~~~F~~~-~l~~~~-----~~~~v~~i~~~~f~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~  185 (379)
T 4h09_A          114 DLDDFEFPGAT-TEIGNYIFYNS-SVKRIV-----IPKSVTTIKDGIGYKAE-NLEKIEVSSNNKNYVAENYVLYNKNKT  185 (379)
T ss_dssp             CCSEEECCTTC-CEECTTTTTTC-CCCEEE-----ECTTCCEECSCTTTTCT-TCCEEEECTTCSSEEEETTEEEETTSS
T ss_pred             CcccccCCCcc-ccccccccccc-eeeeee-----ccceeeccccchhcccc-cccccccccccceeecccceecccccc
Confidence            67777776553 32444455443 233222     11223323333333333 4444444332211              


Q ss_pred             ---------------------cccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCcccc
Q 046240          223 ---------------------GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDI  281 (763)
Q Consensus       223 ---------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~  281 (763)
                                           ......+....+|+.+.+..+ ++......|.+...  |+.+.+..+ ++..-..  .|
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~--L~~i~lp~~-v~~I~~~--aF  259 (379)
T 4h09_A          186 ILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKA--LDEIAIPKN-VTSIGSF--LL  259 (379)
T ss_dssp             EEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSS--CCEEEECTT-CCEECTT--TT
T ss_pred             eeccccccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCcc--ceEEEcCCC-ccEeCcc--cc
Confidence                                 122334444555555555443 22234444555544  666666544 3322222  45


Q ss_pred             ccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCce
Q 046240          282 GNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKK  361 (763)
Q Consensus       282 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  361 (763)
                      .+...|+.+.+..+ ++.+...+|.++++|+.+.+.++.++.....+|.++.+|+.+.|.++ ++.+...+|.++.+|+.
T Consensus       260 ~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~  337 (379)
T 4h09_A          260 QNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALST  337 (379)
T ss_dssp             TTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCC
T ss_pred             ceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCE
Confidence            55666666666433 44444556666666666666666665444556666666666666543 55555566666666666


Q ss_pred             EEcc
Q 046240          362 LNLS  365 (763)
Q Consensus       362 L~l~  365 (763)
                      +.+.
T Consensus       338 i~ip  341 (379)
T 4h09_A          338 ISYP  341 (379)
T ss_dssp             CCCC
T ss_pred             EEEC
Confidence            6553

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.93  E-value=3.4e-10  Score=120.37  Aligned_cols=211  Identities=15%  Similarity=0.175  Sum_probs=113.4

Q ss_pred             CCCccEEEcccccccc-c-------CCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCc
Q 046240          131 LPNVKALSLAYNRFSG-T-------IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPS  202 (763)
Q Consensus       131 l~~L~~L~L~~N~i~~-~-------~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~  202 (763)
                      +..++.|.+......+ .       +..++..+++|+.|.+.++.....   .+..+.                .+.++.
T Consensus       106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~---~is~~~----------------~~~L~~  166 (362)
T 2ra8_A          106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ---EISWIE----------------QVDLSP  166 (362)
T ss_dssp             GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTC---CGGGCB----------------CCBCHH
T ss_pred             chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhc---cccccc----------------ccCHHH
Confidence            4567788888665442 1       123355677888888876543210   000000                001111


Q ss_pred             ccccccccccEEEeecCc-cccccccccCCccccceeecccccccCCCCcccc--ccCCCCccEEEecC--CccccC---
Q 046240          203 SIVNLSISLERLYISNCS-ITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFG--RLQNSKLDTLSLCG--NSFSGS---  274 (763)
Q Consensus       203 ~~~~l~~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~~~L~~L~L~~--N~l~~~---  274 (763)
                      .+..++ +|++|+|++|. +.  ++. + .+++|++|+|..|.++......+.  .+++  |+.|+|+.  |...+.   
T Consensus       167 ll~~~P-~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~--L~~L~L~~~~~~~~~~~~~  239 (362)
T 2ra8_A          167 VLDAMP-LLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPN--LEKLVLYVGVEDYGFDGDM  239 (362)
T ss_dssp             HHHTCT-TCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTT--CCEEEEECBCGGGTCCSCG
T ss_pred             HHhcCC-CCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCC--CcEEEEeccccccccchhH
Confidence            122233 67777777663 22  222 3 267777777777776533333333  3443  77777643  221111   


Q ss_pred             --CCCccccccCCcccEEEcccccccccCCcccC---CCcCccEEEccCccccCc----ccccccccccccEEeCcCCcc
Q 046240          275 --IPSCIDIGNLKVVVEINLSRNNFSGDIPATIG---GLKDVQNISLPYNRLEGP----IPESFGYLTSLEILDLSNNKI  345 (763)
Q Consensus       275 --~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l  345 (763)
                        +........+++|++|+|++|.+....+..+.   .+++|+.|+|+.|.|++.    ++..+..+++|+.|+|++|.|
T Consensus       240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i  319 (362)
T 2ra8_A          240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL  319 (362)
T ss_dssp             GGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred             HHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence              00100113467788888888877643333332   467888888888887753    333445678888888888877


Q ss_pred             CCccchhhhhhccCceEEccccc
Q 046240          346 SGFILISLEKLLYLKKLNLSFNK  368 (763)
Q Consensus       346 ~~~~~~~~~~l~~L~~L~l~~N~  368 (763)
                      +......+...- ...+++++|+
T Consensus       320 ~d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          320 SDEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             CHHHHHHHHHHC-CSEEECCSBC
T ss_pred             CHHHHHHHHHHc-CCEEEecCCc
Confidence            754444444311 3567777776

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.85  E-value=7.8e-09  Score=110.59  Aligned_cols=142  Identities=13%  Similarity=0.155  Sum_probs=106.3

Q ss_pred             cCceecccCCceEEEEEecCCceEEEEEee--hhh-HHHHHHHHHHHHHHHhCC--CCccceEEeeeecC---CceEEEE
Q 046240          479 RDNLIGIGSFGYVYKAELDDGIEVAIKVFH--QEC-ARAMKSFEVECEVMKNIR--HRNLVKIISGCSND---DFKALVL  550 (763)
Q Consensus       479 ~~~~lg~G~~g~v~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  550 (763)
                      ..+.++.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..+.++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35678999999999998764 578888875  332 123456788999999996  45688899988776   4589999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH--------------------------------------  592 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h--------------------------------------  592 (763)
                      ||++|..+.+...   ..++..++..++.+++++|..||...                                      
T Consensus       121 e~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999988754221   13567788889999999999998621                                      


Q ss_pred             -----------------CCCeEeCCCCCCCEEecCCCc--EEEeeecCcee
Q 046240          593 -----------------TTPIIHCDLKSSNVLLDEDMI--AHLSDFGIAKL  624 (763)
Q Consensus       593 -----------------~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~  624 (763)
                                       ...++|||+++.||+++.++.  +.|.||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             256999999999999997653  68999999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.82  E-value=7.2e-10  Score=117.81  Aligned_cols=206  Identities=16%  Similarity=0.222  Sum_probs=116.5

Q ss_pred             CCCCCEEEcCCCcccCCCcc---ccCccccccccCCCccEEEccccccc---------ccCCCcccCCCCCCeeeecCcc
Q 046240          100 LPSLTKLALGYNSLVGNNSL---SGSLPSRIDLALPNVKALSLAYNRFS---------GTIQSPITNASKLTILELGGNS  167 (763)
Q Consensus       100 l~~L~~L~L~~n~l~~~~~~---~~~lp~~~~~~l~~L~~L~L~~N~i~---------~~~p~~~~~l~~L~~L~L~~N~  167 (763)
                      ++.++.|.+......+ +..   ...+...+ ..+++|+.|.+..+...         +.+...+..+++|+.|+|++|.
T Consensus       106 ~~~v~~L~lg~~~~~~-~~~~~~~~~L~~s~-~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~  183 (362)
T 2ra8_A          106 LPSLKQITIGXWGYEG-EDCSDIADGIVENK-EKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTN  183 (362)
T ss_dssp             GGGCSEEEECCCCSSS-CCSHHHHHHHHTTH-HHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCB
T ss_pred             chhcceEEEcccccCC-CcHHHHHHHHHHhh-hhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCC
Confidence            3567889888654321 000   00112222 26789999999776432         1133344566777777777662


Q ss_pred             -cccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccC--Cccccceeeccc--
Q 046240          168 -FSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMG--NLSIFLLLDLEL--  242 (763)
Q Consensus       168 -l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~--  242 (763)
                       ++  ++. +. ++                             +|++|+|..|.+.......+.  .+++|++|+|+.  
T Consensus       184 ~l~--l~~-~~-~~-----------------------------~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~  230 (362)
T 2ra8_A          184 NLS--IGK-KP-RP-----------------------------NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGV  230 (362)
T ss_dssp             TCB--CCS-CB-CT-----------------------------TCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBC
T ss_pred             Cce--ecc-cc-CC-----------------------------CCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccc
Confidence             11  111 11 22                             666777776666543333333  567777777643  


Q ss_pred             ccccCC-----CCcccc--ccCCCCccEEEecCCccccCCCCc-cccccCCcccEEEcccccccccC----CcccCCCcC
Q 046240          243 NKLTGP-----IPVTFG--RLQNSKLDTLSLCGNSFSGSIPSC-IDIGNLKVVVEINLSRNNFSGDI----PATIGGLKD  310 (763)
Q Consensus       243 N~l~~~-----~p~~~~--~l~~~~L~~L~L~~N~l~~~~p~~-~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~  310 (763)
                      |...+.     +...+.  .+  ++|++|+|.+|.+.+..+.. +....+++|++|+|+.|.|+...    +..+..+++
T Consensus       231 ~~~~~~~~~~~l~~~l~~~~~--p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~  308 (362)
T 2ra8_A          231 EDYGFDGDMNVFRPLFSKDRF--PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH  308 (362)
T ss_dssp             GGGTCCSCGGGTGGGSCTTTC--TTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTT
T ss_pred             cccccchhHHHHHHHHhcCCC--CCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCc
Confidence            221111     111121  23  34888888888876432220 01124788999999999988643    333455789


Q ss_pred             ccEEEccCccccCcccccccc-cccccEEeCcCCc
Q 046240          311 VQNISLPYNRLEGPIPESFGY-LTSLEILDLSNNK  344 (763)
Q Consensus       311 L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~  344 (763)
                      |+.|+|++|.|+...-..+.. +  ...+++++|+
T Consensus       309 L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          309 LKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             CSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred             ceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence            999999999887544444433 2  3668998887

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.81  E-value=1.9e-11  Score=123.21  Aligned_cols=24  Identities=17%  Similarity=0.022  Sum_probs=19.3

Q ss_pred             CCCcccceeecCCCCceEEEEecC
Q 046240           63 SVCNWIGITCDVNSHRVTALNISS   86 (763)
Q Consensus        63 ~~c~w~gv~c~~~~~~v~~L~L~~   86 (763)
                      ..|.|.|+.|+.+..+|+.+...+
T Consensus        76 ~l~~~~g~i~~~~~~ki~~~v~~~   99 (267)
T 3rw6_A           76 ALKAVNYKILDRENRRISIIINSS   99 (267)
T ss_dssp             HHHHTTSSCBCTTSCBCCCEEEEC
T ss_pred             HHHhcCcEEECCCCCEEEEEEecC
Confidence            479999999998877887776655

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.81  E-value=4.3e-09  Score=109.76  Aligned_cols=185  Identities=15%  Similarity=0.170  Sum_probs=122.0

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCc--cceEEeeeecCC---ceEEEEEcc
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRN--LVKIISGCSNDD---FKALVLEYM  553 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~  553 (763)
                      .+.++.|....||+..    ..+++|+....  .....+.+|..+++.+ .+..  +.++++.....+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568899999999864    56899986543  3356788899999888 3332  445555544333   458999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR------------------------------------------  591 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~------------------------------------------  591 (763)
                      +|.++......   .++..++..++.++++.++.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888653321   245666777888888888888741                                          


Q ss_pred             -------------CCCCeEeCCCCCCCEEecC--CCcEEEeeecCceecCCCCCccccccccccccc---cCccccCC--
Q 046240          592 -------------HTTPIIHCDLKSSNVLLDE--DMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY---MAPEYGIE--  651 (763)
Q Consensus       592 -------------h~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y---~aPE~~~~--  651 (763)
                                   ....++|+|++|.||++++  +..+.|.||+.+..-++...-      .....+   ..|+....  
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHHHHHH
Confidence                         1235899999999999998  556889999998764321100      000001   12221100  


Q ss_pred             ---CC---------CCcchhHHHHHHHHHHHHcCCCCCch
Q 046240          652 ---RK---------VSTRSDIYSYGIMLIETFTRKKPADK  679 (763)
Q Consensus       652 ---~~---------~~~~~Dv~slGv~l~elltg~~p~~~  679 (763)
                         +.         .....+.|++|.++|++.+|..+|-.
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence               01         11236899999999999999888644

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.81  E-value=9.6e-08  Score=102.85  Aligned_cols=257  Identities=9%  Similarity=0.047  Sum_probs=179.9

Q ss_pred             CceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCC
Q 046240           77 HRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNAS  156 (763)
Q Consensus        77 ~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~  156 (763)
                      .+++.++|..+ ++.+-..+|.+. +|+.+.+..+ ++       .++..+|.. .+|+.+.+..+ ++.+....|.+. 
T Consensus        69 ~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-------~I~~~aF~~-~~L~~i~lp~~-~~~i~~~~F~~~-  135 (379)
T 4h09_A           69 YNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-------KFGDYVFQG-TDLDDFEFPGA-TTEIGNYIFYNS-  135 (379)
T ss_dssp             TTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-------EECTTTTTT-CCCSEEECCTT-CCEECTTTTTTC-
T ss_pred             CCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-------Eeccceecc-CCcccccCCCc-cccccccccccc-
Confidence            57999999754 776666788886 6888888654 42       677778854 47899988765 333445555554 


Q ss_pred             CCCeeeecCcccccccccccCCCCchhhhhhhhh-------------------------------ccCCcccccCCcccc
Q 046240          157 KLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIG-------------------------------LIGNPLNGILPSSIV  205 (763)
Q Consensus       157 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~-------------------------------l~~n~l~~~~p~~~~  205 (763)
                      +|+.+.+..+ ++.+...+|.+..+|+.......                               ...+.........+.
T Consensus       136 ~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~  214 (379)
T 4h09_A          136 SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFS  214 (379)
T ss_dssp             CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTT
T ss_pred             eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeecccc
Confidence            4665555443 44455566666666655442100                               000011111222333


Q ss_pred             cccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCC
Q 046240          206 NLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLK  285 (763)
Q Consensus       206 ~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~  285 (763)
                      ... +|+.+.+..+ +......+|.++..|+.+.+..+ ++......|.+..+  |+.+.+..+ +. .++.. .|.+++
T Consensus       215 ~~~-~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~--l~~i~l~~~-i~-~i~~~-aF~~c~  286 (379)
T 4h09_A          215 YGK-NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTA--LKTLNFYAK-VK-TVPYL-LCSGCS  286 (379)
T ss_dssp             TCS-SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTT--CCEEEECCC-CS-EECTT-TTTTCT
T ss_pred             ccc-ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeeh--hcccccccc-ce-ecccc-cccccc
Confidence            344 7888888655 55577788999999999999876 66566778888876  999999765 54 33332 789999


Q ss_pred             cccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhc
Q 046240          286 VVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLL  357 (763)
Q Consensus       286 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  357 (763)
                      +|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.....+|.++++|+.+.+..+ ++.+...+|.+..
T Consensus       287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~  356 (379)
T 4h09_A          287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS  356 (379)
T ss_dssp             TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred             ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence            9999999999999888899999999999999865 76566789999999999999765 7777777786653

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.40  E-value=3.1e-08  Score=99.72  Aligned_cols=79  Identities=22%  Similarity=0.310  Sum_probs=41.8

Q ss_pred             cCCcccEEEcccccccc--cCCcccCCCcCccEEEccCccccCcccccccccc--cccEEeCcCCccCCccc-------h
Q 046240          283 NLKVVVEINLSRNNFSG--DIPATIGGLKDVQNISLPYNRLEGPIPESFGYLT--SLEILDLSNNKISGFIL-------I  351 (763)
Q Consensus       283 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~~-------~  351 (763)
                      ++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..++  +|++|+|++|.+++..|       .
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~  245 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA  245 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence            34555555555555554  2334445556666666666666543  2233333  66666666666654332       2


Q ss_pred             hhhhhccCceEE
Q 046240          352 SLEKLLYLKKLN  363 (763)
Q Consensus       352 ~~~~l~~L~~L~  363 (763)
                      .+..+++|+.||
T Consensus       246 il~~~P~L~~LD  257 (267)
T 3rw6_A          246 IRERFPKLLRLD  257 (267)
T ss_dssp             HHHHCTTCCEES
T ss_pred             HHHHCcccCeEC
Confidence            355566666554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.37  E-value=6.6e-08  Score=92.57  Aligned_cols=62  Identities=21%  Similarity=0.261  Sum_probs=29.5

Q ss_pred             cCccEEEccCccccCc----ccccccccccccEEeC--cCCccCCcc----chhhhhhccCceEEcccccCC
Q 046240          309 KDVQNISLPYNRLEGP----IPESFGYLTSLEILDL--SNNKISGFI----LISLEKLLYLKKLNLSFNKLE  370 (763)
Q Consensus       309 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~  370 (763)
                      ++|++|+|++|.|...    +...+...++|++|+|  ++|.|....    ...+...+.|++|+|++|.+.
T Consensus        93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            4444444444444432    2333444455555555  555555432    223333355666666655543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.37  E-value=2.9e-06  Score=86.50  Aligned_cols=135  Identities=18%  Similarity=0.115  Sum_probs=97.0

Q ss_pred             eecccCCc-eEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          482 LIGIGSFG-YVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       482 ~lg~G~~g-~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      .+..|..+ .||+.... ++..+++|+-...   ....+.+|..+|+.+. +--+.++++++...+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            44556555 68988665 5678999987643   3456778999998884 33467889999888999999999999887


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----------------------------------------------  591 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----------------------------------------------  591 (763)
                      .+......     .....++.++++.+..||..                                               
T Consensus       108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            76543221     12334566666666666631                                               


Q ss_pred             --------CCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          592 --------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       592 --------h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                              +...++|+|+.+.||++++++.+-|.||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    122378999999999999887778999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.33  E-value=4.3e-06  Score=86.88  Aligned_cols=136  Identities=15%  Similarity=0.112  Sum_probs=93.3

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCC---ccceEEeeee-cCCceEEEEEccCC
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHR---NLVKIISGCS-NDDFKALVLEYMPN  555 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  555 (763)
                      .+.++.|....||+.    |..+++|+-..  ......+.+|.++++.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356778888899987    57789998532  23356788999999999642   3566677764 45568899999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR--------------------------------------------  591 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~--------------------------------------------  591 (763)
                      ..+......   .++..+...++.++++.|..||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888653211   123334444455555555444432                                            


Q ss_pred             -------------CCCCeEeCCCCCCCEEecC---CCc-EEEeeecCcee
Q 046240          592 -------------HTTPIIHCDLKSSNVLLDE---DMI-AHLSDFGIAKL  624 (763)
Q Consensus       592 -------------h~~~ivH~dlk~~NIll~~---~~~-~kl~Dfgla~~  624 (763)
                                   ....++|+|++|.||+++.   ++. +.|.||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         3345799999999999987   345 58999998765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.24  E-value=9.8e-08  Score=91.36  Aligned_cols=66  Identities=12%  Similarity=0.118  Sum_probs=44.7

Q ss_pred             ccCCcccEEEccccccccc----CCcccCCCcCccEEEc--cCccccCc----ccccccccccccEEeCcCCccCC
Q 046240          282 GNLKVVVEINLSRNNFSGD----IPATIGGLKDVQNISL--PYNRLEGP----IPESFGYLTSLEILDLSNNKISG  347 (763)
Q Consensus       282 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  347 (763)
                      ...+.|++|+|++|.|+..    +...+...++|++|+|  ++|.|...    +...+...++|++|+|++|.+..
T Consensus        90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~  165 (185)
T 1io0_A           90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP  165 (185)
T ss_dssp             HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHH
T ss_pred             HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCCh
Confidence            3445666777777776642    3455666677888888  77888754    33445556889999999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.10  E-value=6e-06  Score=87.88  Aligned_cols=81  Identities=6%  Similarity=-0.027  Sum_probs=56.6

Q ss_pred             Ccee-cccCCceEEEEEec-------CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCC-C--CccceEEeeeecC--
Q 046240          480 DNLI-GIGSFGYVYKAELD-------DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIR-H--RNLVKIISGCSND--  543 (763)
Q Consensus       480 ~~~l-g~G~~g~v~~~~~~-------~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--  543 (763)
                      .+.| +.|....+|+....       +++.+++|+......   .....+.+|+.+++.+. +  -.+.++++++...  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999998664       267899998654320   01245678888888884 3  3567788887655  


Q ss_pred             -CceEEEEEccCCCChhh
Q 046240          544 -DFKALVLEYMPNGSLDI  560 (763)
Q Consensus       544 -~~~~lv~e~~~~g~L~~  560 (763)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35789999999977654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.88  E-value=7e-06  Score=76.56  Aligned_cols=81  Identities=21%  Similarity=0.171  Sum_probs=35.8

Q ss_pred             ccEEEcccccccccCCcccCCCcCccEEEccCcc-ccCccccccccc----ccccEEeCcCC-ccCCccchhhhhhccCc
Q 046240          287 VVEINLSRNNFSGDIPATIGGLKDVQNISLPYNR-LEGPIPESFGYL----TSLEILDLSNN-KISGFILISLEKLLYLK  360 (763)
Q Consensus       287 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N-~l~~~~~~~~~~l~~L~  360 (763)
                      |+.||++++.++...-..+.++++|+.|+|++|. |+..--..++.+    ++|++|+|++| +|+...-..+..+++|+
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~  142 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK  142 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence            4444444444443333334444455555555442 333222233332    24555555554 24444334444455555


Q ss_pred             eEEcccc
Q 046240          361 KLNLSFN  367 (763)
Q Consensus       361 ~L~l~~N  367 (763)
                      .|+|+++
T Consensus       143 ~L~L~~c  149 (176)
T 3e4g_A          143 YLFLSDL  149 (176)
T ss_dssp             EEEEESC
T ss_pred             EEECCCC
Confidence            5555554

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.77  E-value=5.8e-05  Score=81.50  Aligned_cols=75  Identities=13%  Similarity=0.188  Sum_probs=48.9

Q ss_pred             CceecccCCceEEEEEec-CCceEEEEEeehhhH-------HHHHHHHHHHHHHHhCCC--Cc-cceEEeeeecCCceEE
Q 046240          480 DNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA-------RAMKSFEVECEVMKNIRH--RN-LVKIISGCSNDDFKAL  548 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  548 (763)
                      .+.+|.|..+.||++... +++.|+||.......       .....+..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999754 468899997643211       112445778888887732  33 4455544  3445689


Q ss_pred             EEEccCCC
Q 046240          549 VLEYMPNG  556 (763)
Q Consensus       549 v~e~~~~g  556 (763)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.77  E-value=0.00014  Score=76.57  Aligned_cols=139  Identities=16%  Similarity=0.207  Sum_probs=78.7

Q ss_pred             ceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCC--CccceEEe------eeecCCceEEEEEc
Q 046240          481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRH--RNLVKIIS------GCSNDDFKALVLEY  552 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  552 (763)
                      +.++.|..+.||+....+| .+++|+.....    ..+..|..+++.+..  -.+.+++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3455567889999987655 58999887532    223345555554421  12333333      11245667899999


Q ss_pred             cCCCChhh--------------hhcc--CCC-----------CCCHHHHH------------------------------
Q 046240          553 MPNGSLDI--------------FLYS--STC-----------MLDIFQRL------------------------------  575 (763)
Q Consensus       553 ~~~g~L~~--------------~l~~--~~~-----------~~~~~~~~------------------------------  575 (763)
                      ++|..+..              .++.  ...           ...|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99875430              0111  000           11232110                              


Q ss_pred             -HHHHHHHHHHHHHHh----------cCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          576 -NIMIDVASALEYLNF----------RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       576 -~i~~~ia~~L~~Lh~----------~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                       .+...+.+++.+|+.          .....++|||+++.||+++.++.+.|.||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             011123345556642          1357899999999999998888999999997653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.73  E-value=0.00024  Score=73.49  Aligned_cols=75  Identities=12%  Similarity=0.122  Sum_probs=60.1

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC---CCccceEEeeeecCCceEEEEEccCCC
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR---HRNLVKIISGCSNDDFKALVLEYMPNG  556 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  556 (763)
                      .+.|+.|....+|+.... +..+++|+....   ....+..|...|+.+.   ...+.++++++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            456889999999999864 678899987643   2456788988888873   356888898888888899999999987


Q ss_pred             Ch
Q 046240          557 SL  558 (763)
Q Consensus       557 ~L  558 (763)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.65  E-value=7.6e-05  Score=76.65  Aligned_cols=79  Identities=14%  Similarity=0.151  Sum_probs=57.3

Q ss_pred             ccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-C--CccceEEeeeecCCceEEEEEc
Q 046240          476 RFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-H--RNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      +...++.+|.|..+.||+.+..||+.|++|+...........+..|+..|+.+. .  --+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            345567789999999999999999999999876443333446788999999884 2  1344555542    34789999


Q ss_pred             cCCCCh
Q 046240          553 MPNGSL  558 (763)
Q Consensus       553 ~~~g~L  558 (763)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.60  E-value=1.8e-05  Score=73.82  Aligned_cols=85  Identities=12%  Similarity=0.116  Sum_probs=62.4

Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEccccc-ccccCCcccCCC----cCccEEEccCcc-ccCccccccccccc
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNN-FSGDIPATIGGL----KDVQNISLPYNR-LEGPIPESFGYLTS  334 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~  334 (763)
                      |+.||++++.++..--.  .+.++++|++|+|++|. |+...-..++.+    ++|++|+|++|. |+..--..+..+++
T Consensus        63 L~~LDLs~~~Itd~GL~--~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFD--HMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             EEEEEEESCCCCGGGGG--GGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             EeEEeCcCCCccHHHHH--HhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            77777777776643333  56778888888888885 665444556654    479999999974 87665667788999


Q ss_pred             ccEEeCcCCc-cCC
Q 046240          335 LEILDLSNNK-ISG  347 (763)
Q Consensus       335 L~~L~L~~N~-l~~  347 (763)
                      |+.|+|+++. ++.
T Consensus       141 L~~L~L~~c~~Itd  154 (176)
T 3e4g_A          141 LKYLFLSDLPGVKE  154 (176)
T ss_dssp             CCEEEEESCTTCCC
T ss_pred             CCEEECCCCCCCCc
Confidence            9999999985 654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.37  E-value=0.0003  Score=76.38  Aligned_cols=79  Identities=14%  Similarity=0.140  Sum_probs=49.9

Q ss_pred             CCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccccccc--ccccccCccccCCC---CCCcchhHHHHHHH
Q 046240          592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL--ATIGYMAPEYGIER---KVSTRSDIYSYGIM  666 (763)
Q Consensus       592 h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~---~~~~~~Dv~slGv~  666 (763)
                      +...++|||++|.||+++.++ +++.||+.+..-++.-   ......  -...|++|+.....   ......++.+....
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQ  305 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHH
Confidence            567899999999999999876 9999999887532110   000001  12346666654321   11223556688888


Q ss_pred             HHHHHcCC
Q 046240          667 LIETFTRK  674 (763)
Q Consensus       667 l~elltg~  674 (763)
                      +|+.+++.
T Consensus       306 ~~~~y~~~  313 (420)
T 2pyw_A          306 TWNLFNKR  313 (420)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88877653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.34  E-value=0.00068  Score=70.59  Aligned_cols=157  Identities=13%  Similarity=0.141  Sum_probs=88.6

Q ss_pred             CChHHHHHHHhccCcC-----ceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCc--cceEE
Q 046240          465 LPYQDLSRATNRFGRD-----NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN--LVKII  537 (763)
Q Consensus       465 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~  537 (763)
                      ++.+++.....+|...     +.|+.|....+|+....+| .+++|+....  .....+..|..+++.+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4556666666667653     3466688889999987765 6889988652  12234556777777763212  23333


Q ss_pred             ee------eecCCceEEEEEccCCCChhhh--------------hccC--C--CC----C---CHHHHHH----------
Q 046240          538 SG------CSNDDFKALVLEYMPNGSLDIF--------------LYSS--T--CM----L---DIFQRLN----------  576 (763)
Q Consensus       538 ~~------~~~~~~~~lv~e~~~~g~L~~~--------------l~~~--~--~~----~---~~~~~~~----------  576 (763)
                      ..      ....+..+++++|++|..+...              ++..  .  ..    .   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      1223567899999998654210              1110  0  00    1   1222100          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          577 --IMIDVASALEYLNFR----HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       577 --i~~~ia~~L~~Lh~~----h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                        +...+.+.++++...    ....++|+|+++.||+++++..+.|.||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011234445555321    235689999999999999876668999987653

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.09  E-value=0.00065  Score=60.23  Aligned_cols=56  Identities=20%  Similarity=0.221  Sum_probs=30.6

Q ss_pred             EEEccCcccc-CcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCC
Q 046240          313 NISLPYNRLE-GPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE  370 (763)
Q Consensus       313 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  370 (763)
                      .++.+++.|+ ..+|..+  -++|+.|+|++|+|+.+.+..|..+++|+.|+|++|++.
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            4555555554 1233222  134666666666666666666666666666666555554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.05  E-value=0.0017  Score=67.98  Aligned_cols=139  Identities=12%  Similarity=0.083  Sum_probs=72.9

Q ss_pred             ceecccCCce-EEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-C-CccceEEeeeecCCceEEEEEccCCCC
Q 046240          481 NLIGIGSFGY-VYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-H-RNLVKIISGCSNDDFKALVLEYMPNGS  557 (763)
Q Consensus       481 ~~lg~G~~g~-v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~~g~  557 (763)
                      +.++.|+... +|+....+|+.+++|......   ...+..|+.+++.+. + -.+.+++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3455554443 677766546778888654321   123445677777663 2 23556676643333  78999997766


Q ss_pred             hhhhhccC---------------------C----CCCCHHHHH--------------------HHHHHHHHHHHHHH---
Q 046240          558 LDIFLYSS---------------------T----CMLDIFQRL--------------------NIMIDVASALEYLN---  589 (763)
Q Consensus       558 L~~~l~~~---------------------~----~~~~~~~~~--------------------~i~~~ia~~L~~Lh---  589 (763)
                      +.+++...                     .    ..++.....                    .....+.+.+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            54332110                     0    011111000                    00011111222221   


Q ss_pred             hcCCCCeEeCCCCCCCEEecCC----CcEEEeeecCcee
Q 046240          590 FRHTTPIIHCDLKSSNVLLDED----MIAHLSDFGIAKL  624 (763)
Q Consensus       590 ~~h~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~  624 (763)
                      ..+...++|||+.+.||+++.+    +.+.|.||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1245679999999999999874    6899999998865

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.02  E-value=0.0045  Score=64.49  Aligned_cols=156  Identities=12%  Similarity=0.117  Sum_probs=88.6

Q ss_pred             CChHHHHHHHhccCc-----CceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCC--ccceEE
Q 046240          465 LPYQDLSRATNRFGR-----DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHR--NLVKII  537 (763)
Q Consensus       465 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~  537 (763)
                      ++.+++...-..|..     ...++ |....||+....+|+.+++|+..... .....+..|..+++.+...  .+.+++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~   88 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV   88 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence            444555555455543     23466 77889999887778889999986331 1234556677777777421  234444


Q ss_pred             ee-----eecCCceEEEEEccCCCChhh-----h---------hcc--C------CCCCCHHHH----HHH---------
Q 046240          538 SG-----CSNDDFKALVLEYMPNGSLDI-----F---------LYS--S------TCMLDIFQR----LNI---------  577 (763)
Q Consensus       538 ~~-----~~~~~~~~lv~e~~~~g~L~~-----~---------l~~--~------~~~~~~~~~----~~i---------  577 (763)
                      ..     ....+..+++|||++|..+..     .         ++.  .      ....++...    ..+         
T Consensus        89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  168 (328)
T 1zyl_A           89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS  168 (328)
T ss_dssp             CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred             ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence            43     122445678999998865421     0         111  0      011222211    000         


Q ss_pred             ------HHHHHHHHHHHHhc----CCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          578 ------MIDVASALEYLNFR----HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       578 ------~~~ia~~L~~Lh~~----h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                            ...+.+.++.+...    ....++|||+++.||+++ + .+.+.||+.+..
T Consensus       169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                  11111223333211    345689999999999999 4 899999987754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.01  E-value=0.0017  Score=66.88  Aligned_cols=71  Identities=8%  Similarity=0.066  Sum_probs=45.2

Q ss_pred             CceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCcc-ceEEeeeecCCceEEEEEcc-CCCC
Q 046240          480 DNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL-VKIISGCSNDDFKALVLEYM-PNGS  557 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  557 (763)
                      .+.++.|....+|+.     ..+++|+....... .....+|+.+++.+....+ .+++++.  .+..++|+||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            678888999999998     56899987643211 1223567777777642222 4555543  33457899999 6655


Q ss_pred             h
Q 046240          558 L  558 (763)
Q Consensus       558 L  558 (763)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.00  E-value=0.0019  Score=68.50  Aligned_cols=140  Identities=14%  Similarity=0.161  Sum_probs=81.0

Q ss_pred             CceecccCCceEEEEEec--------CCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEE
Q 046240          480 DNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .+.+..|-...+|+....        +++.+++|+.... ........+|..+++.+. +.-..++++++..    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            355666778889998775        3578999986432 122345668988888874 3333567776654    2899


Q ss_pred             EccCCCChhhh-----------------hccC----CCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 046240          551 EYMPNGSLDIF-----------------LYSS----TCMLD--IFQRLNIMIDVA-------------------SALEYL  588 (763)
Q Consensus       551 e~~~~g~L~~~-----------------l~~~----~~~~~--~~~~~~i~~~ia-------------------~~L~~L  588 (763)
                      ||++|..+..-                 ++..    .....  +.+..++..++.                   +.+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665321                 1111    11122  223333332221                   112222


Q ss_pred             H----h-cCCCCeEeCCCCCCCEEecCC----CcEEEeeecCcee
Q 046240          589 N----F-RHTTPIIHCDLKSSNVLLDED----MIAHLSDFGIAKL  624 (763)
Q Consensus       589 h----~-~h~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~  624 (763)
                      .    . .....++|+|+.+.||+++.+    +.+.+.||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            1    1 133468999999999999876    6899999988764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.98  E-value=0.00098  Score=59.05  Aligned_cols=36  Identities=19%  Similarity=0.263  Sum_probs=18.8

Q ss_pred             ccEEEcccccccccCCCcccCCCCCCeeeecCcccc
Q 046240          134 VKALSLAYNRFSGTIQSPITNASKLTILELGGNSFS  169 (763)
Q Consensus       134 L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  169 (763)
                      |++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus        33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            444444444444444445555555555566665553

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.88  E-value=0.0021  Score=69.80  Aligned_cols=73  Identities=16%  Similarity=0.193  Sum_probs=49.2

Q ss_pred             CceecccCCceEEEEEecC--------CceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEE
Q 046240          480 DNLIGIGSFGYVYKAELDD--------GIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .+.|+.|....+|+....+        ++.+++|+.....  ....+.+|..+++.+. +.-..++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4567778889999998753        5789999884321  1134457888888874 3223567776543    3899


Q ss_pred             EccCCCCh
Q 046240          551 EYMPNGSL  558 (763)
Q Consensus       551 e~~~~g~L  558 (763)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.88  E-value=0.0003  Score=66.74  Aligned_cols=83  Identities=16%  Similarity=0.171  Sum_probs=37.6

Q ss_pred             CcccEEEcccccccccC----CcccCCCcCccEEEccCccccCc----ccccccccccccEEeCcCC---ccCCc----c
Q 046240          285 KVVVEINLSRNNFSGDI----PATIGGLKDVQNISLPYNRLEGP----IPESFGYLTSLEILDLSNN---KISGF----I  349 (763)
Q Consensus       285 ~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N---~l~~~----~  349 (763)
                      +.|+.|+|++|+|....    ...+..-+.|+.|+|++|.|...    +-+.+..-+.|++|+|++|   .+...    +
T Consensus        70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i  149 (197)
T 1pgv_A           70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM  149 (197)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred             CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence            34444444444444221    12222334555555555555532    2223334455666666644   22321    2


Q ss_pred             chhhhhhccCceEEcccc
Q 046240          350 LISLEKLLYLKKLNLSFN  367 (763)
Q Consensus       350 ~~~~~~l~~L~~L~l~~N  367 (763)
                      ...+..-+.|+.|+++.|
T Consensus       150 a~aL~~N~tL~~L~l~~~  167 (197)
T 1pgv_A          150 MMAIEENESLLRVGISFA  167 (197)
T ss_dssp             HHHHHHCSSCCEEECCCC
T ss_pred             HHHHHhCCCcCeEeccCC
Confidence            233444456666666544

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.84  E-value=0.00018  Score=68.35  Aligned_cols=113  Identities=11%  Similarity=0.057  Sum_probs=62.7

Q ss_pred             cccEEEeecC-ccccc----cccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccC
Q 046240          210 SLERLYISNC-SITGN----IPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNL  284 (763)
Q Consensus       210 ~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l  284 (763)
                      +|++|+|++| +|...    +.+++..-+.|+.|+|++|+|.......+..                        .+..-
T Consensus        42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~------------------------aL~~N   97 (197)
T 1pgv_A           42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIE------------------------LIETS   97 (197)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHH------------------------HHHHC
T ss_pred             CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHH------------------------HHhcC
Confidence            6777888775 66532    2334455566666666666665322222211                        22233


Q ss_pred             CcccEEEccccccccc----CCcccCCCcCccEEEccCc---cccC----cccccccccccccEEeCcCCccC
Q 046240          285 KVVVEINLSRNNFSGD----IPATIGGLKDVQNISLPYN---RLEG----PIPESFGYLTSLEILDLSNNKIS  346 (763)
Q Consensus       285 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~----~~p~~~~~l~~L~~L~L~~N~l~  346 (763)
                      +.|++|+|++|.|+..    +-.++..-+.|+.|+|++|   .+..    .+...+..-+.|+.|+++.|.+.
T Consensus        98 ~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A           98 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             CccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            4556666666666532    2234445566778888754   3332    13344556678888888887654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.68  E-value=0.0047  Score=67.32  Aligned_cols=74  Identities=16%  Similarity=0.151  Sum_probs=48.0

Q ss_pred             CceecccCCceEEEEEecC-CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCcc-ceEEeeeecCCceEEEEEccCCCC
Q 046240          480 DNLIGIGSFGYVYKAELDD-GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL-VKIISGCSNDDFKALVLEYMPNGS  557 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  557 (763)
                      .+.|+.|-...+|+....+ +..+++|+...... ..-+..+|..+++.+...++ .++++++.  +  .+|+||++|..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4567778889999998775 57899998753321 11122578888888864444 56777763  2  25999999855


Q ss_pred             h
Q 046240          558 L  558 (763)
Q Consensus       558 L  558 (763)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.62  E-value=0.0036  Score=66.53  Aligned_cols=74  Identities=14%  Similarity=0.218  Sum_probs=44.8

Q ss_pred             CceecccCCceEEEEEecC---------CceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCc-cceEEeeeecCCceEEE
Q 046240          480 DNLIGIGSFGYVYKAELDD---------GIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN-LVKIISGCSNDDFKALV  549 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  549 (763)
                      .+.++.|....+|+....+         +..+++|+....... ......|..+++.+...+ +.++++...    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            3457778888999997654         268899987643221 122356888888774323 446665542    3689


Q ss_pred             EEccCCCCh
Q 046240          550 LEYMPNGSL  558 (763)
Q Consensus       550 ~e~~~~g~L  558 (763)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.59  E-value=0.022  Score=54.30  Aligned_cols=168  Identities=11%  Similarity=0.024  Sum_probs=98.6

Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQT  635 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  635 (763)
                      -+|.+++...+.+++..+.+.++.|.+.+|.-+-..  +.-..+=..|..|++..+|.|...+ ..+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            378999988888999999999999999998776321  1111223456889999999887763 1110            


Q ss_pred             cccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccccH
Q 046240          636 QTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDF  715 (763)
Q Consensus       636 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~  715 (763)
                        .....+.|||... ...+.+.=|||+|+++|.-+--..|-+.            ...+++++..+++.|........ 
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e------------E~eLS~~LE~LL~~Mt~~~~d~~-  161 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE------------ERELSPPLEQLIDHMANTVEADG-  161 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE------------EECCCHHHHHHHHHHTTCCC----
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc------------chhhCHHHHHHHHHHHhcccccc-
Confidence              1122456888753 3556788999999999999874444222            34467788888888875522100 


Q ss_pred             HHHHHHH---HHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          716 AAKEQCV---LSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       716 ~~~~~~~---~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ...+..-   +.-.+ -..  ...+..|++.++|++.-...+.++
T Consensus       162 ~~DeG~~~~~eg~~d-~~~--~~~~~~~~sl~~Vi~~C~~hl~~p  203 (229)
T 2yle_A          162 SNDEGYEAAEEGLGD-EDE--KRKISAIRSYRDVMKLCAAHLPTE  203 (229)
T ss_dssp             ------------------C--CSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred             ccccccccccccccc-ccc--cccccCcCCHHHHHHHHHhhccCc
Confidence            0000000   00000 000  234667777888877777666654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.30  E-value=0.01  Score=62.15  Aligned_cols=31  Identities=23%  Similarity=0.358  Sum_probs=27.7

Q ss_pred             CCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       594 ~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      ..++|+|+.+.||++++++.+.+.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4689999999999999888899999988765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.17  E-value=0.029  Score=60.26  Aligned_cols=74  Identities=12%  Similarity=0.195  Sum_probs=47.6

Q ss_pred             CceecccCCceEEEEEecC--------CceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEE
Q 046240          480 DNLIGIGSFGYVYKAELDD--------GIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  550 (763)
                      .+.+..|-...+|+....+        ++.+++|+..... ...-+..+|..+++.+. +.-..++++.+.    -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3456667788999997763        5789999865332 11122356888888774 333445565432    36899


Q ss_pred             EccCCCCh
Q 046240          551 EYMPNGSL  558 (763)
Q Consensus       551 e~~~~g~L  558 (763)
                      ||++|..+
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.11  E-value=0.38  Score=51.27  Aligned_cols=29  Identities=31%  Similarity=0.425  Sum_probs=24.7

Q ss_pred             eEeCCCCCCCEEe------cCCCcEEEeeecCcee
Q 046240          596 IIHCDLKSSNVLL------DEDMIAHLSDFGIAKL  624 (763)
Q Consensus       596 ivH~dlk~~NIll------~~~~~~kl~Dfgla~~  624 (763)
                      ++|+|+.+.||++      +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567799999998764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.61  E-value=5.5  Score=37.76  Aligned_cols=120  Identities=13%  Similarity=0.146  Sum_probs=78.6

Q ss_pred             CCCccceEEeeeecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       529 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      .||+++.. ..-.+.+...+.++.-+  ....+-.-.  ..+...+++++..|+....++     ..-+|--+.|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik--~~~~~eKlr~l~ni~~l~~~~-----~~r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK--SFTKNEKLRYLLNIKNLEEVN-----RTRYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG--GSCHHHHHHHHHHGGGGGGGG-----GSSEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH--hcCHHHHHHHHHHHHHHHHHh-----cCceEEEEecceEEE
Confidence            58888866 45555666555555433  222222211  267788999999888876544     234677899999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFA  682 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~  682 (763)
                      +.++.+++.-.|+-..+.                   |.     ..++..=.-.+=|++..+++++..|+....
T Consensus       113 ~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~  162 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDALVE  162 (215)
T ss_dssp             CTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHH
T ss_pred             cCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHc
Confidence            999999998777643322                   21     112222344677889999999999876543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	763
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-53
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-50
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-49
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-28
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-05
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 4e-62
 Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRN 532
            +      IG GSFG VYK +     +VA+K+ +      + +++F+ E  V++  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           ++  + G S     A+V ++    SL   L+      ++ + ++I    A  ++YL   H
Sbjct: 66  ILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---H 121

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY---G 649
              IIH DLKS+N+ L ED+   + DFG+A + S    S    Q   +I +MAPE     
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS 709
            +   S +SD+Y++GI+L E  T + P   +   +  +     G L   L +V       
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------- 234

Query: 710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
                   +  C  ++  L  EC  +  ++R    
Sbjct: 235 --------RSNCPKAMKRLMAECLKKKRDERPLFP 261

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (493), Expect = 8e-57
 Identities = 69/312 (22%), Positives = 130/312 (41%), Gaps = 40/312 (12%)

Query: 467 YQDLSRATNRFGR---------DNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQE-CA 512
           ++D + A   F +         + +IG G FG V    L       I VAIK        
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 513 RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF 572
           +  + F  E  +M    H N++ +    +      ++ E+M NGSLD FL  +     + 
Sbjct: 69  KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128

Query: 573 QRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM 632
           Q + ++  +A+ ++YL        +H DL + N+L++ +++  +SDFG+++ L  +    
Sbjct: 129 QLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185

Query: 633 TQTQTL---ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKH 689
           T T  L     I + APE    RK ++ SD++SYGI++ E  +  +              
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER------------- 232

Query: 690 WVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV 749
               +    ++  + +    PP  D      C  ++  L ++C  +    R         
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPPPMD------CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 750 LCEQFVSNSSEL 761
           L ++ + N + L
Sbjct: 287 L-DKMIRNPNSL 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 4e-55
 Identities = 61/271 (22%), Positives = 118/271 (43%), Gaps = 26/271 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
                   +G G FG V+    +   +VA+K   Q  + +  +F  E  +MK ++H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-LDIFQRLNIMIDVASALEYLNFRHT 593
           ++       +   ++ EYM NGSL  FL + + + L I + L++   +A  + ++     
Sbjct: 72  RLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EE 127

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERK 653
              IH DL+++N+L+ + +   ++DFG+A+L+  +++   +      I + APE      
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 654 VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK 713
            + +SD++S+GI+L E  T  +           +++   G   V                
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR--------------- 231

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
                + C   ++ L   C  E PE R    
Sbjct: 232 ----PDNCPEELYQLMRLCWKERPEDRPTFD 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-53
 Identities = 70/297 (23%), Positives = 133/297 (44%), Gaps = 26/297 (8%)

Query: 465 LPYQDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEV 524
           L              +  +G G FG V+    +    VAIK        + ++F  E +V
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQV 65

Query: 525 MKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIF-QRLNIMIDVAS 583
           MK +RH  LV++ +  S +    +V EYM  GSL  FL   T       Q +++   +AS
Sbjct: 66  MKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124

Query: 584 ALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
            + Y+        +H DL+++N+L+ E+++  ++DFG+A+L+  +++   +      I +
Sbjct: 125 GMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 180

Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV 703
            APE  +  + + +SD++S+GI+L E  T+ +                 G++   +++ V
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-------------PYPGMVNREVLDQV 227

Query: 704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
            +    P   +      C  S+  L  +C  + PE+R   +     L + F S   +
Sbjct: 228 ERGYRMPCPPE------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-53
 Identities = 62/264 (23%), Positives = 117/264 (44%), Gaps = 24/264 (9%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
             +G G FG V   +     +VAIK+  +  + +   F  E +VM N+ H  LV++   C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
           +      ++ EYM NG L  +L          Q L +  DV  A+EYL    +   +H D
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 125

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+++  +  +SDFG+++ +  +D+  +   +   + +  PE  +  K S++SDI
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQ 720
           +++G+++ E ++  K   + F    + +H   GL                P         
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------RPHL------- 225

Query: 721 CVLSIFSLAMECTMELPEKRINAK 744
               ++++   C  E  ++R   K
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFK 249

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 8e-53
 Identities = 60/264 (22%), Positives = 110/264 (41%), Gaps = 24/264 (9%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
             IG G FG V+     +  +VAIK   +  A + + F  E EVM  + H  LV++   C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
                  LV E+M +G L  +L +   +      L + +DV   + YL       +IH D
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 126

Query: 601 LKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDI 660
           L + N L+ E+ +  +SDFG+ + +  +  + +   T   + + +PE     + S++SD+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKSDV 185

Query: 661 YSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQ 720
           +S+G+++ E F+  K                       ++E ++        +       
Sbjct: 186 WSFGVLMWEVFSEGKI-------------PYENRSNSEVVEDISTGFRLYKPRL------ 226

Query: 721 CVLSIFSLAMECTMELPEKRINAK 744
               ++ +   C  E PE R    
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFS 250

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-52
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 34/277 (12%)

Query: 479 RDNL------IGIGSFGYVYKAEL---DDGIEVAIKVFHQECARA-MKSFEVECEVMKNI 528
           RDNL      +G G+FG V +         I+VAIKV  Q   +A  +    E ++M  +
Sbjct: 7   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            +  +V++I G    +   LV+E    G L  FL      + +     ++  V+  ++YL
Sbjct: 67  DNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPE 647
                   +H DL + NVLL     A +SDFG++K L  +D   T        + + APE
Sbjct: 126 ---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL 707
               RK S+RSD++SYG+ + E  +  +                  +    +M  + +  
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKP-------------YKKMKGPEVMAFIEQGK 229

Query: 708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
                 +      C   +++L  +C +   E R +  
Sbjct: 230 RMECPPE------CPPELYALMSDCWIYKWEDRPDFL 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-51
 Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 14/283 (4%)

Query: 473 ATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKS-FEVECEVMKNIRH 530
             + F + + +G G+ G V+K      G+ +A K+ H E   A+++    E +V+     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             +V       +D   ++ +E+M  GSLD  L  +   +       + I V   L YL  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 122

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
           +H   I+H D+K SN+L++      L DFG++  L     SM  +    T  YM+PE   
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMSPERLQ 176

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP 710
               S +SDI+S G+ L+E    + P     A EL L  +   +   +            
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL-MFGCQVEGDAAETPPRPRTPGR 235

Query: 711 PEKDFAAKEQCVLSIFSLAMECTME----LPEKRINAKCCNFV 749
           P   +    +  ++IF L      E    LP    + +  +FV
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 278

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 6e-51
 Identities = 67/277 (24%), Positives = 120/277 (43%), Gaps = 29/277 (10%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDG-----IEVAIKVFHQECA-RAMKSFEVECEVMKNI 528
           +   R  +IG G FG VYK  L        + VAIK        +    F  E  +M   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 529 RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL 588
            H N++++    S      ++ EYM NG+LD FL        + Q + ++  +A+ ++Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY- 125

Query: 589 NFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPE 647
                   +H DL + N+L++ +++  +SDFG++++L    + + T +     I + APE
Sbjct: 126 --LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL 707
               RK ++ SD++S+GI++ E  T  +                  L    +M+ +N   
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAINDGF 230

Query: 708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
             P   D      C  +I+ L M+C  +   +R    
Sbjct: 231 RLPTPMD------CPSAIYQLMMQCWQQERARRPKFA 261

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 7e-51
 Identities = 67/287 (23%), Positives = 118/287 (41%), Gaps = 32/287 (11%)

Query: 467 YQDLSRATN---RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVEC 522
           Y+ ++R  N    +     +G G+FG VYKA+  +  +  A KV   +    ++ + VE 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 523 EVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
           +++ +  H N+VK++     ++   +++E+   G++D  +      L   Q   +     
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIG 642
            AL YL   H   IIH DLK+ N+L   D    L+DFG++   +   Q         T  
Sbjct: 121 DALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPY 175

Query: 643 YMAPEY-----GIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV 697
           +MAPE        +R    ++D++S GI LIE    + P  ++    + LK   +    +
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL 235

Query: 698 SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           +          S   KDF  K             C  +  + R    
Sbjct: 236 AQPSRW-----SSNFKDFLKK-------------CLEKNVDARWTTS 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 1e-50
 Identities = 68/278 (24%), Positives = 111/278 (39%), Gaps = 34/278 (12%)

Query: 476 RFGR-DNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHR 531
           RF + D  IG GSF  VYK    +  +EVA              + F+ E E++K ++H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 532 NLVKII----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           N+V+      S         LV E M +G+L  +L      + I    +    +   L++
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQF 127

Query: 588 LNFRHTTPIIHCDLKSSNVLL-DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAP 646
           L+   T PIIH DLK  N+ +        + D G+A L             + T  +MAP
Sbjct: 128 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182

Query: 647 EYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT 706
           E   E K     D+Y++G+ ++E  T + P  +   A    +   +G+ P S  +V    
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA--- 238

Query: 707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
              P  K+                 C  +  ++R + K
Sbjct: 239 --IPEVKEIIEG-------------CIRQNKDERYSIK 261

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 5e-50
 Identities = 60/287 (20%), Positives = 111/287 (38%), Gaps = 30/287 (10%)

Query: 480 DNLIGIGSFGYVYKAELDD---GIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLV 534
           D  +G G+FG V K           VA+K+   E            E  VM+ + +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
           ++I  C  + +  LV+E    G L+ +L  +   +     + ++  V+  ++YL     +
Sbjct: 72  RMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL---EES 126

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TIGYMAPEYGIERK 653
             +H DL + NVLL     A +SDFG++K L  ++            + + APE     K
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 654 VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK 713
            S++SD++S+G+++ E F+  +                 G+    +  ++ K        
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKP-------------YRGMKGSEVTAMLEKGERMGCPA 233

Query: 714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSSE 760
                  C   ++ L   C     E R         L   +    +E
Sbjct: 234 G------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 5e-50
 Identities = 68/280 (24%), Positives = 115/280 (41%), Gaps = 22/280 (7%)

Query: 483 IGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN 542
           IG G FG V++ +   G EVA+K+F     R+    E E      +RH N++  I+  + 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 543 DDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYL-----NFRHT 593
           D+       LV +Y  +GSL  +L   T  + +   + + +  AS L +L       +  
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT--QTQTLATIGYMAPEYGIE 651
             I H DLKS N+L+ ++    ++D G+A        ++       + T  YMAPE   +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 652 R------KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM-EVVN 704
                  +   R+DIY+ G++  E   R          +L     V     V  M +VV 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           +  L P   +     + +  +  +  EC       R+ A 
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (442), Expect = 8e-50
 Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 26/284 (9%)

Query: 463 RRLPYQDLSRATNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVE 521
               Y             + +G G +G VY+       + VA+K   ++    ++ F  E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63

Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-LDIFQRLNIMID 580
             VMK I+H NLV+++  C+ +    ++ E+M  G+L  +L       +     L +   
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 581 VASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
           ++SA+EYL        IH DL + N L+ E+ +  ++DFG+++L++G D           
Sbjct: 124 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFP 179

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
           I + APE     K S +SD++++G++L E  T                    G+    + 
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------PYPGIDLSQVY 226

Query: 701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           E++ K       +       C   ++ L   C    P  R +  
Sbjct: 227 ELLEKDYRMERPEG------CPEKVYELMRACWQWNPSDRPSFA 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-49
 Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 32/266 (12%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
             IG G FG V   +   G +VA+K    +     ++F  E  VM  +RH NLV+++   
Sbjct: 13  QTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 541 SNDDFK-ALVLEYMPNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
             +     +V EYM  GSL  +L S    +L     L   +DV  A+EYL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 126

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
            DL + NVL+ ED +A +SDFG+ K  S      TQ      + + APE   E+K ST+S
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTKS 181

Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK 718
           D++S+GI+L E ++  +        +  +     G                       A 
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------------DAP 222

Query: 719 EQCVLSIFSLAMECTMELPEKRINAK 744
           + C  +++ +   C       R +  
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFL 248

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 6e-49
 Identities = 72/309 (23%), Positives = 124/309 (40%), Gaps = 54/309 (17%)

Query: 467 YQDLSRATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFE 519
              L    N       IG G+FG V++A        +    VA+K+  +E  A     F+
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 520 VECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM----------- 568
            E  +M    + N+VK++  C+      L+ EYM  G L+ FL S +             
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 569 ------------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
                       L   ++L I   VA+ + YL        +H DL + N L+ E+M+  +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKI 181

Query: 617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           +DFG+++ +   D           I +M PE     + +T SD+++YG++L E F+    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 677 ADKMFAAELSLKHWVNGLLPVSLME-VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTME 735
                           G+    ++  V +  +L+ PE        C L +++L   C  +
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNILACPEN-------CPLELYNLMRLCWSK 281

Query: 736 LPEKRINAK 744
           LP  R +  
Sbjct: 282 LPADRPSFC 290

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (437), Expect = 8e-49
 Identities = 62/278 (22%), Positives = 101/278 (36%), Gaps = 36/278 (12%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIR 529
              F     IG GSFG VY A  + +   VAIK             +    E   ++ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H N ++       +    LV+EY    + D+        L   +   +       L YL 
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYL- 131

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEY- 648
             H+  +IH D+K+ N+LL E  +  L DFG A +++           + T  +MAPE  
Sbjct: 132 --HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVI 183

Query: 649 --GIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT 706
               E +   + D++S GI  IE   RK P   M A                L  +    
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNE 230

Query: 707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
             +     ++          +    C  ++P+ R  ++
Sbjct: 231 SPALQSGHWSE------YFRNFVDSCLQKIPQDRPTSE 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-48
 Identities = 62/273 (22%), Positives = 119/273 (43%), Gaps = 30/273 (10%)

Query: 480 DNLIGIGSFGYVYKAELDD----GIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLV 534
           + +IG G FG VY   L D     I  A+K  ++      +  F  E  +MK+  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 535 KIISGCSNDDFKA-LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
            ++  C   +    +VL YM +G L  F+ + T    +   +   + VA  +++     +
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF---LAS 148

Query: 594 TPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED--QSMTQTQTLATIGYMAPEYGIE 651
              +H DL + N +LDE     ++DFG+A+ +  ++      +T     + +MA E    
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP 711
           +K +T+SD++S+G++L E  TR  P       +++             + ++    L  P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDI--------TVYLLQGRRLLQP 256

Query: 712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           E        C   ++ + ++C     E R +  
Sbjct: 257 EY-------CPDPLYEVMLKCWHPKAEMRPSFS 282

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 5e-48
 Identities = 60/284 (21%), Positives = 100/284 (35%), Gaps = 33/284 (11%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA--RAMKSFEVECEVMKN 527
           SRA + +     IG GS+G   K     DG  +  K            +    E  +++ 
Sbjct: 1   SRAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 528 IRHRNLVKIISGC--SNDDFKALVLEYMPNGSLDIFLYSST---CMLDIFQRLNIMIDVA 582
           ++H N+V+         +    +V+EY   G L   +   T     LD    L +M  + 
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 583 SALEYLNFRHTT--PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLAT 640
            AL+  + R      ++H DLK +NV LD      L DFG+A++L+ +           T
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--T 177

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
             YM+PE       + +SDI+S G +L E      P       EL               
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------------AG 224

Query: 701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           ++        P +           +  +           R + +
Sbjct: 225 KIREGKFRRIPYR-------YSDELNEIITRMLNLKDYHRPSVE 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 7e-48
 Identities = 56/267 (20%), Positives = 97/267 (36%), Gaps = 25/267 (9%)

Query: 481 NLIGIGSFGYVYKAE-LDDGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIIS 538
             +G G++G V  A        VA+K+   +      ++ + E  + K + H N+VK   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 539 GCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIH 598
                + + L LEY   G L   +      +           + + + YL   H   I H
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYL---HGIGITH 126

Query: 599 CDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTR- 657
            D+K  N+LLDE     +SDFG+A +    ++     +   T+ Y+APE    R+     
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186

Query: 658 SDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAA 717
            D++S GI+L      + P D+   +      W      ++  + +              
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-----DSAPLALLH 241

Query: 718 KEQCVLSIFSLAMECTMELPEKRINAK 744
           K               +E P  RI   
Sbjct: 242 K-------------ILVENPSARITIP 255

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 9e-48
 Identities = 73/272 (26%), Positives = 112/272 (41%), Gaps = 26/272 (9%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN 532
             ++ R   IG G+ G VY A ++  G EVAI+  + +     +    E  VM+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +V  +      D   +V+EY+  GSL   +  +    D  Q   +  +   ALE+L   H
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFL---H 133

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           +  +IH D+KS N+LL  D    L+DFG    ++ E    +      T  +MAPE    +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRK 191

Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
               + DI+S GIM IE    + P               NG   +   E      LS   
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK-----LSAIF 246

Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           +DF  +             C     EKR +AK
Sbjct: 247 RDFLNR-------------CLDMDVEKRGSAK 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  170 bits (432), Expect = 9e-48
 Identities = 51/273 (18%), Positives = 92/273 (33%), Gaps = 26/273 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
           + +     +G G+FG V++  E   G   A K          ++   E + M  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           V +     +D+   ++ E+M  G L   +      +   + +  M  V   L ++   H 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HE 142

Query: 594 TPIIHCDLKSSNVLL--DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
              +H DLK  N++          L DFG+   L  +      T T     + APE    
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEG 199

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP 711
           + V   +D++S G++     +   P    F  E             +  E +        
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSP----FGGE-------------NDDETLRNVKSCDW 242

Query: 712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
             D +A             +  +  P  R+   
Sbjct: 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIH 275

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 9e-47
 Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 29/274 (10%)

Query: 477 FGRDNLIGIGSFGYVYKAELDD-----GIEVAIKVFHQE-CARAMKSFEVECEVMKNIRH 530
           F +  ++G G+FG VYK           I VAIK   +    +A K    E  VM ++ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
            ++ +++  C     + L+ + MP G L  ++      +     LN  + +A  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
           R    ++H DL + NVL+       ++DFG+AKLL  E++          I +MA E  +
Sbjct: 130 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP 710
            R  + +SD++SYG+ + E  T                   +G+    +  ++ K    P
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSK-------------PYDGIPASEISSILEKGERLP 233

Query: 711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
                     C + ++ + ++C M   + R   +
Sbjct: 234 QPPI------CTIDVYMIMVKCWMIDADSRPKFR 261

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-46
 Identities = 71/284 (25%), Positives = 109/284 (38%), Gaps = 35/284 (12%)

Query: 474 TNRFGRDNL-----IGIGSFGYVYKAELD----DGIEVAIKVFHQECA---RAMKSFEVE 521
           T   G  +L     +G GSFG V + E D      + VA+K    +      AM  F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 522 CEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDV 581
              M ++ HRNL+++         K +V E  P GSL   L        +       + V
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120

Query: 582 ASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLAT 640
           A  + YL    +   IH DL + N+LL    +  + DFG+ + L   +D  + Q      
Sbjct: 121 AEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 641 IGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLM 700
             + APE    R  S  SD + +G+ L E FT  +                 GL    ++
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------------GLNGSQIL 224

Query: 701 EVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
             ++K     P       E C   I+++ ++C    PE R    
Sbjct: 225 HKIDKEGERLPR-----PEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-46
 Identities = 59/300 (19%), Positives = 109/300 (36%), Gaps = 51/300 (17%)

Query: 475 NRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVFHQEC-ARAMKSFEVECEVMKN 527
                  ++G G+FG V  A      +    I+VA+K+  ++  +   ++   E ++M  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 528 I-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYS---------------------- 564
           +  H N+V ++  C+      L+ EY   G L  +L S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 565 STCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL 624
              +L     L     VA  +E+L        +H DL + NVL+    +  + DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAE 684
           +  +   + +      + +MAPE   E   + +SD++SYGI+L E F+           +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 685 LSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
            +    +            N   +  P             I+ +   C      KR +  
Sbjct: 274 ANFYKLIQ-----------NGFKMDQPFY-------ATEEIYIIMQSCWAFDSRKRPSFP 315

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 5e-46
 Identities = 59/283 (20%), Positives = 108/283 (38%), Gaps = 36/283 (12%)

Query: 481 NLIGIGSFGYVYKAEL-DDGIEVAIKVFHQ---ECARAMKSFEVECEVMKNIRHRNLVKI 536
             +G G FG VY A        +A+KV  +   E A        E E+  ++RH N++++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                +     L+LEY P G++   L   +   D  +    + ++A+AL Y    H+  +
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC---HSKRV 127

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           IH D+K  N+LL       ++DFG +       ++        T+ Y+ PE    R    
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIEGRMHDE 183

Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFA 716
           + D++S G++  E    K P +     E   K                   ++   +D  
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRISRVEFTFP-------DFVTEGARDLI 235

Query: 717 AKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSS 759
           ++                  P +R   +    VL   +++ +S
Sbjct: 236 SR-------------LLKHNPSQRPMLRE---VLEHPWITANS 262

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 5e-46
 Identities = 71/323 (21%), Positives = 120/323 (37%), Gaps = 52/323 (16%)

Query: 465 LPYQD---LSRATNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQE-CARA 514
           LPY       R    FG+   +G G+FG V +A        D  + VA+K+         
Sbjct: 12  LPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69

Query: 515 MKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSS-------- 565
            ++   E +V+  +  H N+V ++  C+      ++ EY   G L  FL           
Sbjct: 70  REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129

Query: 566 ---------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
                       LD+   L+    VA  + +L    +   IH DL + N+LL    I  +
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKI 186

Query: 617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
            DFG+A+ +  +   + +      + +MAPE       +  SD++SYGI L E F+    
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246

Query: 677 ADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMEL 736
                  +      +               +LSP        E     ++ +   C    
Sbjct: 247 PYPGMPVDSKFYKMIKEGFR----------MLSP--------EHAPAEMYDIMKTCWDAD 288

Query: 737 PEKRINAKCCNFVLCEQFVSNSS 759
           P KR   K    ++ E+ +S S+
Sbjct: 289 PLKRPTFKQIVQLI-EKQISEST 310

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 4e-45
 Identities = 69/257 (26%), Positives = 108/257 (42%), Gaps = 13/257 (5%)

Query: 472 RATNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECA---RAMKSFEVECEVMKN 527
           +    F    ++G GSF  V  A EL    E AIK+  +        +     E +VM  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           + H   VK+     +D+     L Y  NG L  ++       D         ++ SALEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           L   H   IIH DLK  N+LL+EDM   ++DFG AK+LS E +       + T  Y++PE
Sbjct: 124 L---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 648 YGIERKVSTRSDIYSYGIMLIETFTRKKP-----ADKMFAAELSLKHWVNGLLPVSLMEV 702
              E+     SD+++ G ++ +      P        +F   + L++           ++
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240

Query: 703 VNKTLLSPPEKDFAAKE 719
           V K L+    K    +E
Sbjct: 241 VEKLLVLDATKRLGCEE 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  158 bits (400), Expect = 3e-44
 Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 30/280 (10%)

Query: 471 SRATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECAR---AMKSFEVECEVMK 526
           S  ++R+    ++G G    V+ A  L    +VA+KV   + AR       F  E +   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 527 NIRHRNLVKIISGCSNDDFKA----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVA 582
            + H  +V +      +        +V+EY+   +L   +++    +   + + ++ D  
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADAC 121

Query: 583 SALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLA-TI 641
            AL + +      IIH D+K +N+++       + DFGIA+ ++    S+TQT  +  T 
Sbjct: 122 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 642 GYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME 701
            Y++PE      V  RSD+YS G +L E  T + P    F  +             S + 
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGD-------------SPVS 221

Query: 702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI 741
           V  + +   P    A  E     + ++ ++   + PE R 
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 261

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 4e-44
 Identities = 58/275 (21%), Positives = 109/275 (39%), Gaps = 29/275 (10%)

Query: 475 NRFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQECARAMKS-FEVECEVMKNIR 529
            R      IG G FG V++       +  + VAIK      + +++  F  E   M+   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           H ++VK+I G   ++   +++E    G L  FL      LD+   +     +++AL YL 
Sbjct: 67  HPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL- 124

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
              +   +H D+ + NVL+  +    L DFG+++ +            L  I +MAPE  
Sbjct: 125 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESI 181

Query: 650 IERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS 709
             R+ ++ SD++ +G+ + E                       G+    ++  +      
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVK-------------PFQGVKNNDVIGRIENGERL 228

Query: 710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           P   +      C  +++SL  +C    P +R    
Sbjct: 229 PMPPN------CPPTLYSLMTKCWAYDPSRRPRFT 257

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 4e-44
 Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 45/290 (15%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDG---IEVAIKVFHQECAR-AMKSFEVECEVMKNI-R 529
           N     ++IG G+FG V KA +      ++ AIK   +  ++   + F  E EV+  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 530 HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM---------------LDIFQR 574
           H N++ ++  C +  +  L +EY P+G+L  FL  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 575 LNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ 634
           L+   DVA  ++YL        IH DL + N+L+ E+ +A ++DFG+++   G++  + +
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL 694
           T     + +MA E       +T SD++SYG++L E  +                    G+
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------------PYCGM 230

Query: 695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
               L E + +        +      C   ++ L  +C  E P +R +  
Sbjct: 231 TCAELYEKLPQGYRLEKPLN------CDDEVYDLMRQCWREKPYERPSFA 274

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  159 bits (403), Expect = 1e-43
 Identities = 51/266 (19%), Positives = 97/266 (36%), Gaps = 26/266 (9%)

Query: 482 LIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGC 540
            +G G+FG V++  E   G     K  +        + + E  +M  + H  L+ +    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 541 SNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCD 600
            +     L+LE++  G L   + +    +   + +N M      L+++   H   I+H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLD 152

Query: 601 LKSSNVLLD--EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRS 658
           +K  N++ +  +     + DFG+A  L+ ++     T   AT  + APE      V   +
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYT 209

Query: 659 DIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAK 718
           D+++ G++     +   P    FA E               +E +        E D  A 
Sbjct: 210 DMWAIGVLGYVLLSGLSP----FAGE-------------DDLETLQNVKRCDWEFDEDAF 252

Query: 719 EQCVLSIFSLAMECTMELPEKRINAK 744
                           + P KR+   
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVH 278

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 62/286 (21%), Positives = 113/286 (39%), Gaps = 38/286 (13%)

Query: 475 NRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQECA-RAMKSFEVECEVMKN 527
            +      +G GSFG VY+         +    VAIK  ++  + R    F  E  VMK 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLY---------SSTCMLDIFQRLNIM 578
               ++V+++   S      +++E M  G L  +L                 + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTL 638
            ++A  + YLN       +H DL + N ++ ED    + DFG+ + +   D      + L
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 639 ATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS 698
             + +M+PE   +   +T SD++S+G++L E  T  +   +  + E  L+  + G     
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG----- 251

Query: 699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
                   LL  P+        C   +F L   C    P+ R +  
Sbjct: 252 -------GLLDKPDN-------CPDMLFELMRMCWQYNPKMRPSFL 283

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 4e-43
 Identities = 70/308 (22%), Positives = 128/308 (41%), Gaps = 52/308 (16%)

Query: 465 LPYQD---LSRATNRFGRDNLIGIGSFGYVYKAEL--------DDGIEVAIKVFHQECA- 512
           LP      L R  +R      +G G+FG V  AE         +   +VA+K+   +   
Sbjct: 2   LPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59

Query: 513 RAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCM--- 568
           + +     E E+MK I +H+N++ ++  C+ D    +++EY   G+L  +L +       
Sbjct: 60  KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119

Query: 569 ------------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
                       L     ++    VA  +EYL    +   IH DL + NVL+ ED +  +
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKI 176

Query: 617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
           +DFG+A+ +   D     T     + +MAPE   +R  + +SD++S+G++L E FT    
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236

Query: 677 ADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMEL 736
                           G+    L +++ +        +      C   ++ +  +C   +
Sbjct: 237 -------------PYPGVPVEELFKLLKEGHRMDKPSN------CTNELYMMMRDCWHAV 277

Query: 737 PEKRINAK 744
           P +R   K
Sbjct: 278 PSQRPTFK 285

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 5e-41
 Identities = 57/273 (20%), Positives = 99/273 (36%), Gaps = 23/273 (8%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAM-KSFEVECEVMKNIRHR 531
            + +   +++G G+F  V  AE       VAIK   ++       S E E  V+  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           N+V +     +     L+++ +  G L   +              ++  V  A++YL+  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
                           LDED    +SDFG++K+   ED     +    T GY+APE   +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP 711
           +  S   D +S G++         P    F  E             +  ++  + L +  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP----FYDE-------------NDAKLFEQILKAEY 226

Query: 712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           E D    +    S          + PEKR   +
Sbjct: 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 259

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 1e-40
 Identities = 47/256 (18%), Positives = 100/256 (39%), Gaps = 19/256 (7%)

Query: 476 RFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
           ++     +G G FG V++  E         K    +        + E  ++   RHRN++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNIL 64

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            +     + +   ++ E++    +   + +S   L+  + ++ +  V  AL++L   H+ 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSH 121

Query: 595 PIIHCDLKSSNVLLDEDMIAH--LSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
            I H D++  N++      +   + +FG A+ L   D             Y APE     
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQHD 178

Query: 653 KVSTRSDIYSYGIMLIETFTRKKP---------ADKMFAAELSLKHWVNGLLPVSLMEVV 703
            VST +D++S G ++    +   P          + +  AE +        + +  M+ V
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 704 NKTLLSPPEKDFAAKE 719
           ++ L+   +    A E
Sbjct: 239 DRLLVKERKSRMTASE 254

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (374), Expect = 3e-40
 Identities = 56/267 (20%), Positives = 104/267 (38%), Gaps = 34/267 (12%)

Query: 481 NLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKI 536
             +G GSFG V+      +G   A+KV  +E     + ++    E  ++  + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 537 ISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPI 596
                +     ++++Y+  G L   L   +             +V  ALEYL   H+  I
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELF-SLLRKSQRFPNPVAKFYAAEVCLALEYL---HSKDI 125

Query: 597 IHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVST 656
           I+ DLK  N+LLD++    ++DFG AK +     ++       T  Y+APE    +  + 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180

Query: 657 RSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFA 716
             D +S+GI++ E      P       +                +++N  L  PP  +  
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKT-------------YEKILNAELRFPPFFNED 227

Query: 717 AKEQCVLSIFSLAMECTMELPEKRINA 743
            K+        L          +R+  
Sbjct: 228 VKD--------LLSRLITRDLSQRLGN 246

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 4e-39
 Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 18/252 (7%)

Query: 481 NLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA---RAMKSFEVECEVM-KNIRHRNLVK 535
            ++G GSFG V+ AE        AIK   ++       ++   VE  V+     H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 536 IISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP 595
           +       +    V+EY+  G L   + S     D+ +      ++   L++L+ +    
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKG--- 123

Query: 596 IIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVS 655
           I++ DLK  N+LLD+D    ++DFG+ K     D          T  Y+APE  + +K +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEILLGQKYN 181

Query: 656 TRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNG------LLPVSLMEVVNKTLLS 709
              D +S+G++L E    + P       EL               L     +++ K  + 
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240

Query: 710 PPEKDFAAKEQC 721
            PEK    +   
Sbjct: 241 EPEKRLGVRGDI 252

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 55/286 (19%), Positives = 101/286 (35%), Gaps = 41/286 (14%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFH---------QECARAMKSFEVECEVM 525
            +    ++G G    V +        E A+K+           +E     ++   E +++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 526 KNIR-HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASA 584
           + +  H N++++      + F  LV + M  G L  +L      L   +   IM  +   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEV 122

Query: 585 LEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
           +  L   H   I+H DLK  N+LLD+DM   L+DFG +  L   D      +   T  Y+
Sbjct: 123 ICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYL 176

Query: 645 APEY------GIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVS 698
           APE                 D++S G+++        P    F                 
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR-------------K 219

Query: 699 LMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
            M ++   +    +      +    ++  L     +  P+KR  A+
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  143 bits (362), Expect = 4e-38
 Identities = 52/255 (20%), Positives = 92/255 (36%), Gaps = 24/255 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFH------QECARAMKSFEVECEVMKN 527
           N F    +IG G FG VY     D G   A+K         ++      +  +   ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
                +V +       D  + +L+ M  G L   L       +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE 647
           +   H   +++ DLK +N+LLDE     +SD G+A   S +    +      T GYMAPE
Sbjct: 123 M---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----THGYMAPE 175

Query: 648 YGIE-RKVSTRSDIYSYGIMLIETFTRKKPAD--------KMFAAELSLKHWVNGLLPVS 698
              +     + +D +S G ML +      P          ++    L++   +       
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235

Query: 699 LMEVVNKTLLSPPEK 713
           L  ++   L     +
Sbjct: 236 LRSLLEGLLQRDVNR 250

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 4e-38
 Identities = 54/282 (19%), Positives = 102/282 (36%), Gaps = 27/282 (9%)

Query: 472 RATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRH 530
           R  NR+     IG GSFG +Y    +  G EVAIK+   +         +E ++ K ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQG 61

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
              +  I  C  +    +++  +   SL+      +    +   L +   + S +EY+  
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI-- 119

Query: 591 RHTTPIIHCDLKSSNVL---LDEDMIAHLSDFGIAKLLSGED-----QSMTQTQTLATIG 642
            H+   IH D+K  N L     +  + ++ DFG+AK                     T  
Sbjct: 120 -HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 643 YMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV 702
           Y +    +  + S R D+ S G +L+       P   + AA    K+           E 
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-----------ER 227

Query: 703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           +++  +S P +     +       +    C     + + +  
Sbjct: 228 ISEKKMSTPIEVL--CKGYPSEFATYLNFCRSLRFDDKPDYS 267

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-38
 Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 19/287 (6%)

Query: 474 TNRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQ-ECARAMKSFEVECEVMKNIRHR 531
             R+   + IG G++G V  A +  + + VAIK     E     +    E +++   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLN 589
           N++ I         + +   Y+    +  D++    T  L        +  +   L+Y+ 
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI- 125

Query: 590 FRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL-SGEDQSMTQTQTLATIGYMAPEY 648
             H+  ++H DLK SN+LL+      + DFG+A++     D +   T+ +AT  Y APE 
Sbjct: 126 --HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 649 GIERKVSTRS-DIYSYGIMLIETFTRKKP------ADKMFAAELSLKHWVNGLLPVSLME 701
            +  K  T+S DI+S G +L E  + +         D++      L       L   +  
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMEL----PEKRINAK 744
                LLS P K+     +   +  S A++   ++    P KRI  +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 7e-38
 Identities = 58/308 (18%), Positives = 115/308 (37%), Gaps = 51/308 (16%)

Query: 465 LPYQ----DLSRATNRFGRDNLIGIGSFGYVYKA------ELDDGIEVAIKVFHQECARA 514
           LPY     +  R  +R      +G G+FG V +A      +      VA+K+  +    +
Sbjct: 1   LPYDASKWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 58

Query: 515 -MKSFEVECEVMKNIRHRNLVKIISGC--SNDDFKALVLEYMPNGSLDIFLYSSTCM--- 568
             ++   E +++ +I H   V  + G          +++E+   G+L  +L S       
Sbjct: 59  EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118

Query: 569 ------------LDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHL 616
                       L +   +     VA  +E+L    +   IH DL + N+LL E  +  +
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 175

Query: 617 SDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP 676
            DFG+A+ +  +   + +      + +MAPE   +R  + +SD++S+G++L E F+    
Sbjct: 176 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235

Query: 677 ADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMEL 736
                                 + E   + L           +     ++   ++C    
Sbjct: 236 PYPGV----------------KIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGE 277

Query: 737 PEKRINAK 744
           P +R    
Sbjct: 278 PSQRPTFS 285

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 67/295 (22%), Positives = 114/295 (38%), Gaps = 28/295 (9%)

Query: 470 LSRATNRFGRDNLIGIGSFGYVYKAE--LDDGIEVAIKVFHQECARAMKSFEVECEV--- 524
           L RA  ++     IG G++G V+KA    + G  VA+K    +            EV   
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 525 --MKNIRHRNLVKIISGCSNDDFKA-----LVLEYMPNGSLDIFLYSSTCMLDIFQRLNI 577
             ++   H N+V++   C+           LV E++               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 578 MIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
           M  +   L++L   H+  ++H DLK  N+L+       L+DFG+A++       M  T  
Sbjct: 122 MFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175

Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP- 696
           + T+ Y APE  ++   +T  D++S G +  E F RK         +   K      LP 
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 697 -------VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
                  V+L      +  + P + F            L ++C    P KRI+A 
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTD--IDELGKDLLLKCLTFNPAKRISAY 288

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-36
 Identities = 65/279 (23%), Positives = 109/279 (39%), Gaps = 22/279 (7%)

Query: 481 NLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMK-----SFEVECEVMKNIRHRNLV 534
           + +G G F  VYKA   +    VAIK          K     +   E ++++ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 535 KIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTT 594
            ++    +    +LV ++M        +  ++ +L        M+     LEYL   H  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQH 119

Query: 595 PIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE-YGIERK 653
            I+H DLK +N+LLDE+ +  L+DFG+AK       +   T  + T  Y APE     R 
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 654 VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK 713
                D+++ G +L E   R          +  L      L   +  +  +   L     
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 714 DFAAKEQCVLSIFSLAMECTMEL--------PEKRINAK 744
             +     +  IFS A +  ++L        P  RI A 
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 64/282 (22%), Positives = 112/282 (39%), Gaps = 19/282 (6%)

Query: 475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRN 532
            ++     IG G++G VYKA+ + G   A+K    E        +   E  ++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +VK+           LV E++ +  L   L      L+     + ++ + + + Y    H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC---H 117

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI-E 651
              ++H DLK  N+L++ +    ++DFG+A+           T  + T+ Y AP+  +  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP 711
           +K ST  DI+S G +  E          +  A+  L      L   +     N T L   
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY 234

Query: 712 EKDFAAKEQCVLSIF---------SLAMECTMELPEKRINAK 744
           + +F   E      F          L  +     P +RI AK
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-36
 Identities = 49/259 (18%), Positives = 93/259 (35%), Gaps = 25/259 (9%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECARAM------KSFEVECEVMKN 527
           +++    L+G G FG VY    + D + VAIK   ++               +E  ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 528 IR--HRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL 585
           +      +++++      D   L+LE            +    L      +    V  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYM 644
            + +      ++H D+K  N+L+D +     L DFG   LL         T    T  Y 
Sbjct: 124 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYS 176

Query: 645 APEYGIERKVSTRS-DIYSYGIMLIETFTRKKP---ADKMFAAELSLKHWVNGLLPVSLM 700
            PE+    +   RS  ++S GI+L +      P    +++   ++  +  V         
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV----SSECQ 232

Query: 701 EVVNKTLLSPPEKDFAAKE 719
            ++   L   P      +E
Sbjct: 233 HLIRWCLALRPSDRPTFEE 251

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  135 bits (340), Expect = 6e-36
 Identities = 41/281 (14%), Positives = 88/281 (31%), Gaps = 29/281 (10%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
             +     IG GSFG +++   L +  +VAIK   +           E    K +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62

Query: 534 VKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHT 593
           +  +     +    +++  +   SL+  L        +         + + ++ +   H 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HE 119

Query: 594 TPIIHCDLKSSNVLLDEDMIAH-----LSDFGIAKLLSGEDQS-----MTQTQTLATIGY 643
             +++ D+K  N L+      +     + DFG+ K               +     T  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV 703
           M+    + R+ S R D+ + G + +       P   + AA    K+           E +
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-----------ERI 228

Query: 704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
            +   S P ++  A        +           +   +  
Sbjct: 229 GEKKQSTPLRELCAG--FPEEFYKYMHYARNLAFDATPDYD 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 7e-36
 Identities = 60/281 (21%), Positives = 109/281 (38%), Gaps = 17/281 (6%)

Query: 476 RFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRN 532
            F +   IG G++G VYKA     G  VA+K    +        +   E  ++K + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 533 LVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRH 592
           +VK++     ++   LV E++          S+   + +    + +  +   L + +   
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 593 TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPE-YGIE 651
              ++H DLK  N+L++ +    L+DFG+A+      ++ T      T+ Y APE     
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 177

Query: 652 RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP 711
           +  ST  DI+S G +  E  TR+         +   + +     P  ++     ++    
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 712 EKDFAAKEQCVLSIFSLAMECTMEL--------PEKRINAK 744
                   Q    +     E    L        P KRI+AK
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-35
 Identities = 50/272 (18%), Positives = 96/272 (35%), Gaps = 32/272 (11%)

Query: 482 LIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKII--- 537
           ++G+G  G V +        + A+K+   +C +A +  E+     +  +  ++V+I+   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELH---WRASQCPHIVRIVDVY 74

Query: 538 -SGCSNDDFKALVLEYMPNGSLDIFLYSSTCM-LDIFQRLNIMIDVASALEYLNFRHTTP 595
            +  +      +V+E +  G L   +           +   IM  +  A++YL   H+  
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSIN 131

Query: 596 IIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIER 652
           I H D+K  N+L      + I  L+DFG AK  +  +   T      T  Y+APE     
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPE 188

Query: 653 KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE 712
           K     D++S G+++        P        +S        +          + +S   
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAK 744
           K                       P +R+   
Sbjct: 249 KMLIRN-------------LLKTEPTQRMTIT 267

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 4e-35
 Identities = 49/265 (18%), Positives = 96/265 (36%), Gaps = 27/265 (10%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFH------QECARAMKSFEVECEVMKN 527
           + +     +G G F  V K  E   G++ A K              + +  E E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 528 IRHRNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEY 587
           I+H N++ +     N     L+LE +  G L  FL     + +       +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-ATEFLKQILNGVYY 128

Query: 588 LNFRHTTPIIHCDLKSSNVLLDEDMIA----HLSDFGIAKLLSGEDQSMTQTQTLATIGY 643
               H+  I H DLK  N++L +  +      + DFG+A  +   D          T  +
Sbjct: 129 ---LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 644 MAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP---------ADKMFAAELSLKHWVNGL 694
           +APE      +   +D++S G++     +   P            + A     +      
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 695 LPVSLMEVVNKTLLSPPEKDFAAKE 719
                 + + + L+  P+K    ++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQD 267

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 6e-35
 Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 29/288 (10%)

Query: 476 RFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV 534
            +    +IG GSFG VY+A+L D G  VAIK   Q+     +    E ++M+ + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76

Query: 535 KIISGC------SNDDFKALVLEYMPNGSLDIFLYSSTCM--LDIFQRLNIMIDVASALE 586
           ++           ++ +  LVL+Y+P     +  + S     L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
           Y+   H+  I H D+K  N+LLD D  +  L DFG AK L   + +++    + +  Y A
Sbjct: 137 YI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRA 190

Query: 646 P-EYGIERKVSTRSDIYSYGIMLIETFTRKKP------ADKMFAAELSLKHWVNGLLPVS 698
           P         ++  D++S G +L E    +         D++      L       +   
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 699 LMEVVNKTLLSPPEKDFAAKEQCVLS--IFSLAMECTMELPEKRINAK 744
                           +    +        +L        P  R+   
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-34
 Identities = 61/300 (20%), Positives = 122/300 (40%), Gaps = 29/300 (9%)

Query: 470 LSRATNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECAR--AMKSFEVECEVMK 526
                +++ +   IG G+FG V+KA     G +VA+K    E  +     +   E ++++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 527 NIRHRNLVKIISGCSNDDFKA--------LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM 578
            ++H N+V +I  C               LV ++  +    +          + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123

Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQT- 637
             + + L Y++      I+H D+K++NVL+  D +  L+DFG+A+  S    S     T 
Sbjct: 124 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 638 -LATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKP-ADKMFAAELSLKHWVNGL 694
            + T+ Y  PE  + ER      D++  G ++ E +TR           +L+L   + G 
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 695 LPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFS----------LAMECTMELPEKRINAK 744
           +   +   V+   L    +    +++ V               L  +  +  P +RI++ 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 4e-34
 Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 15/248 (6%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARA---MKSFEVECEVMKNIRH 530
           N F    L+G G+FG V        G   A+K+  +E   A   +     E  V++N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             L  +       D    V+EY   G L   L S   +    +      ++ SALEY   
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY--- 120

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +++ D+K  N++LD+D    ++DFG+ K    +  +M       T  Y+APE   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL-----LPVSLMEVVNK 705
           +       D +  G+++ E    + P        L     +  +     L      ++  
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238

Query: 706 TLLSPPEK 713
            L   P++
Sbjct: 239 LLKKDPKQ 246

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 7e-34
 Identities = 57/283 (20%), Positives = 112/283 (39%), Gaps = 19/283 (6%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHR 531
            ++ +   IG G++G V+KA+  +    VA+K    +        S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 532 NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR 591
           N+V++     +D    LV E+        F   +  + D     + +  +   L +    
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFC--- 117

Query: 592 HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIE 651
           H+  ++H DLK  N+L++ +    L++FG+A+      +    +  + T+ Y  P+    
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFG 175

Query: 652 RKV-STRSDIYSYGIMLIETFTRKKP--ADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL 708
            K+ ST  D++S G +  E     +P         +L     + G         + K   
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 709 SPPEKDFAAKEQCVLSIFSLAMECTMEL-------PEKRINAK 744
             P   + A    V  +  L       L       P +RI+A+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 2e-32
 Identities = 50/251 (19%), Positives = 100/251 (39%), Gaps = 18/251 (7%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRH 530
           ++F R   +G GSFG V   +  + G   A+K+  ++     + ++    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 531 RNLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
             LVK+     ++    +V+EY+  G +   L                  +    EYL  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYL-- 157

Query: 591 RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGI 650
            H+  +I+ DLK  N+L+D+     ++DFG AK + G   ++       T   +APE  +
Sbjct: 158 -HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211

Query: 651 ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGL-----LPVSLMEVVNK 705
            +  +   D ++ G+++ E      P       ++  K     +         L +++  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

Query: 706 TLLSPPEKDFA 716
            L     K F 
Sbjct: 272 LLQVDLTKRFG 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 7e-32
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 21/232 (9%)

Query: 461 TKRRLPYQDLSRATNRFGRDN-----LIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC 511
            K  L   +L+    + G +N     ++G G++G V+        D G   A+KV  +  
Sbjct: 5   VKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 64

Query: 512 ----ARAMKSFEVECEVMKNIRHR-NLVKIISGCSNDDFKALVLEYMPNGSLDIFLYSST 566
               A+  +    E +V+++IR    LV +      +    L+L+Y+  G L   L    
Sbjct: 65  IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE 124

Query: 567 CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLS 626
              +      + I V   +  L   H   II+ D+K  N+LLD +    L+DFG++K   
Sbjct: 125 RFTE----HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180

Query: 627 GEDQSMTQTQTLATIGYMAPE--YGIERKVSTRSDIYSYGIMLIETFTRKKP 676
            ++          TI YMAP+   G +       D +S G+++ E  T   P
Sbjct: 181 ADETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 9e-31
 Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 31/290 (10%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHR 531
             +     +G G++G V  A +   G +VAIK  ++        K    E  ++K++RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 532 NLVKIISGCSNDDFKA------LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL 585
           N++ ++   + D+         LV+ +M      +  +     L   +   ++  +   L
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGL 134

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
            Y+   H   IIH DLK  N+ ++ED    + DFG+A+    E      T  + T  Y A
Sbjct: 135 RYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRA 186

Query: 646 PEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW-VNGLLPVSLMEVV 703
           PE  +   + +   DI+S G ++ E  T K         +   +   V G  P   ++ +
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246

Query: 704 NKTLLSPPEKDFAAKEQCVL-SIFSLAMECTMEL--------PEKRINAK 744
                    K     E+    SI + A    + L         E+R+ A 
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 54/293 (18%), Positives = 114/293 (38%), Gaps = 36/293 (12%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRN 532
           + +     +G G +  V++A  + +  +V +K+         K  + E ++++N+R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPN 91

Query: 533 LVKIISGCSNDDFK--ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNF 590
           ++ +     +   +  ALV E++ N        +    L  +     M ++  AL+Y   
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC-- 145

Query: 591 RHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYG 649
            H+  I+H D+K  NV++D E     L D+G+A+              +A+  +  PE  
Sbjct: 146 -HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL 201

Query: 650 IE-RKVSTRSDIYSYGIMLIETFTRKKP---------ADKMFAAELSLKHW------VNG 693
           ++ +      D++S G ML     RK+P              A  L  +         N 
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLS--IFSLAMECTMELPEKRINAK 744
            L     +++ +      E+   ++ Q ++S        +      + R+ A+
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 4e-28
 Identities = 57/285 (20%), Positives = 106/285 (37%), Gaps = 20/285 (7%)

Query: 475 NRFGRDNLIGIGSFGYVYKA-ELDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHR 531
            R+     IG G+ G V  A +      VAIK   +        K    E  +MK + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 532 NLVKIISGCSNDDFK------ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL 585
           N++ +++  +            LV+E M      +        LD  +   ++  +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGI 132

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
           ++L   H+  IIH DLK SN+++  D    + DFG+A+       S   T  + T  Y A
Sbjct: 133 KHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRA 186

Query: 646 PEYGIERKVSTRSDIYSYGIMLIETFTRKKP-ADKMFAAELSLKHWVNGLLPVSLMEVVN 704
           PE  +        DI+S G ++ E    K     + +  + +      G      M+ + 
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFV 749
            T+ +  E            +F  ++        K   ++  + +
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (284), Expect = 6e-28
 Identities = 58/314 (18%), Positives = 111/314 (35%), Gaps = 47/314 (14%)

Query: 475 NRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL 533
            R+     +G G F  V+ A+ + +   VA+K+   +     ++ E E ++++ +   + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADN 71

Query: 534 VKIISGCSNDDFK---------------ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIM 578
            K  S  +N   K                +V E +    L +        + +     I 
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 579 IDVASALEYLNFRHTTPIIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSGEDQSMTQTQT 637
             +   L+Y++ R    IIH D+K  NVL++  D   +L    IA L +        T +
Sbjct: 132 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 638 LATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKP-------ADKMFAAELSLKHW 690
           + T  Y +PE  +       +DI+S   ++ E  T           +       ++    
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 691 VNGLLPVSLMEVVNKT---------LLSPPEKDFAAKEQCVLSIFSLAMECTMEL----- 736
           + G LP  L+     T         L +  +  F   E  +   +  + +   E+     
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 737 ------PEKRINAK 744
                 P KR +A 
Sbjct: 310 PMLQLDPRKRADAG 323

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 9e-28
 Identities = 55/290 (18%), Positives = 109/290 (37%), Gaps = 29/290 (10%)

Query: 474 TNRFGRDNLIGIGSFGYVYKAE-LDDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRH 530
             R+   + +G G++G V  A     G+ VA+K   +        K    E  ++K+++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 531 RNLVKII-----SGCSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASAL 585
            N++ ++     +    +     ++ ++     D+        L       ++  +   L
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--DLNNIVKCQKLTDDHVQFLIYQILRGL 134

Query: 586 EYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMA 645
           +Y+   H+  IIH DLK SN+ ++ED    + DFG+A+    E           T  Y A
Sbjct: 135 KYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRA 186

Query: 646 PEYGIERK-VSTRSDIYSYGIMLIETFTRKKP---------ADKMFAAELSLKHWVNGLL 695
           PE  +     +   DI+S G ++ E  T +              +     +    +   +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246

Query: 696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIF-SLAMECTMELPEKRINAK 744
                    ++L   P+ +FA        +   L  +  +   +KRI A 
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  110 bits (274), Expect = 5e-27
 Identities = 80/317 (25%), Positives = 137/317 (43%), Gaps = 26/317 (8%)

Query: 34  TDQQALLALEAHISYDPTNLLAQNWTSNTSVCN--WIGITCDVNS--HRVTALNISSLNL 89
            D+QALL ++  +  +PT L   +W   T  CN  W+G+ CD ++  +RV  L++S LNL
Sbjct: 6   QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 90  QG--EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGT 147
                IP  +  LP L      +  + G N+L G +P      L  +  L + +   SG 
Sbjct: 63  PKPYPIPSSLANLPYLN-----FLYIGGINNLVGPIPP-AIAKLTQLHYLYITHTNVSGA 116

Query: 148 IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNL 207
           I   ++    L  L+   N+ SG +P +I +L N+      I   GN ++G +P S  + 
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG----ITFDGNRISGAIPDSYGSF 172

Query: 208 SISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLC 267
           S     + IS   +TG IP    NL++  +             +                
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT------QKI 226

Query: 268 GNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPE 327
             + +        +G  K +  ++L  N   G +P  +  LK + ++++ +N L G IP+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 328 SFGYLTSLEILDLSNNK 344
             G L   ++   +NNK
Sbjct: 287 -GGNLQRFDVSAYANNK 302

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 44.7 bits (104), Expect = 2e-05
 Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 8/80 (10%)

Query: 65  CNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLP 124
                +     S  +  L++ +  + G +P  +  L  L  L +        N+L G +P
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV------SFNNLCGEIP 285

Query: 125 SRIDLALPNVKALSLAYNRF 144
                 L      + A N+ 
Sbjct: 286 Q--GGNLQRFDVSAYANNKC 303

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.1 bits (220), Expect = 6e-21
 Identities = 33/204 (16%), Positives = 63/204 (30%), Gaps = 33/204 (16%)

Query: 481 NLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMK----------SFEVECEVMKNIRH 530
            L+G G    V+    +   E  +K          K           F V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 531 RNLVKIISGCSNDDF----KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALE 586
           R L K+        +     A+++E +               + +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117

Query: 587 YLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED-QSMTQTQTLATIGYMA 645
                +   I+H DL   NVL+ E+ I  + DF  +  +  E  + + +      I Y +
Sbjct: 118 KF---YHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 646 PEYGIERKVSTRSDIYSYGIMLIE 669
             Y  E       DI S    +++
Sbjct: 174 RTYRTE------KDINSAIDRILQ 191

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 80.4 bits (197), Expect = 1e-16
 Identities = 43/193 (22%), Positives = 74/193 (38%), Gaps = 33/193 (17%)

Query: 193 GNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVT 252
            N ++ I P  I+    +L+ L ++   +       + +L+    LDL  N+++   P++
Sbjct: 206 NNQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 260

Query: 253 FGRLQNSKLDTLSLCGNSFSGSIP------------------SCIDIGNLKVVVEINLSR 294
                 +KL  L L  N  S   P                      I NLK +  + L  
Sbjct: 261 ----GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316

Query: 295 NNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLE 354
           NN S   P  +  L  +Q +    N++      S   LT++  L   +N+IS   L  L 
Sbjct: 317 NNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISD--LTPLA 370

Query: 355 KLLYLKKLNLSFN 367
            L  + +L L+  
Sbjct: 371 NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 68.1 bits (165), Expect = 1e-12
 Identities = 59/338 (17%), Positives = 117/338 (34%), Gaps = 35/338 (10%)

Query: 54  LAQNWTSNTSVCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSL 113
           LA+   +     N        +  +VT L    L ++  I   + YL +LT++    N L
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQL 78

Query: 114 VGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIP 173
                L  +L   +D+ + N +   +        +       +++T ++   N  +    
Sbjct: 79  TDITPL-KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 137

Query: 174 NTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLS 233
               N  +       +  +     G   + +  L+       +   S   +   V+  L+
Sbjct: 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT 197

Query: 234 IFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS 293
               L    N+++   P+       + LD LSL GN     I +   + +L  + +++L+
Sbjct: 198 NLESLIATNNQISDITPLGI----LTNLDELSLNGNQLKD-IGT---LASLTNLTDLDLA 249

Query: 294 RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIP--------------------ESFGYLT 333
            N  S   P  + GL  +  + L  N++    P                         L 
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 334 SLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEG 371
           +L  L L  N IS   +  +  L  L++L  + NK+  
Sbjct: 308 NLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD 343

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 4e-06
 Identities = 15/85 (17%), Positives = 36/85 (42%), Gaps = 6/85 (7%)

Query: 283 NLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN 342
            L   ++  L + N +  +  +   L  V  +      ++    +   YL +L  ++ SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 343 NKISGFILISLEKLLYLKKLNLSFN 367
           N+++   +  L+ L  L  + ++ N
Sbjct: 76  NQLTD--ITPLKNLTKLVDILMNNN 98

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 8e-05
 Identities = 13/68 (19%), Positives = 24/68 (35%), Gaps = 4/68 (5%)

Query: 307 GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF 366
            L +     L    +   + ++   L  +  L      I    +  +E L  L ++N S 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75

Query: 367 NKLEGEIP 374
           N+L    P
Sbjct: 76  NQLTDITP 83

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.8 bits (190), Expect = 3e-16
 Identities = 48/280 (17%), Positives = 90/280 (32%), Gaps = 49/280 (17%)

Query: 122 SLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRN 181
            +P  +    P+   L L  N+ +        N   L  L L  N  S   P     L  
Sbjct: 24  KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80

Query: 182 IEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDL- 240
           +E L L      N L  +       +  +L+ L +    IT     V   L+  ++++L 
Sbjct: 81  LERLYLS----KNQLKELPEK----MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132

Query: 241 -ELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG 299
               K +G     F  ++   L  + +   + +      I  G    + E++L  N  + 
Sbjct: 133 TNPLKSSGIENGAFQGMKK--LSYIRIADTNIT-----TIPQGLPPSLTELHLDGNKITK 185

Query: 300 DIPATIGGLKDVQNISLPYNRLEGPI-----------------------PESFGYLTSLE 336
              A++ GL ++  + L +N +                           P        ++
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245

Query: 337 ILDLSNNKISGF------ILISLEKLLYLKKLNLSFNKLE 370
           ++ L NN IS              K      ++L  N ++
Sbjct: 246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 70.1 bits (170), Expect = 1e-13
 Identities = 53/218 (24%), Positives = 75/218 (34%), Gaps = 9/218 (4%)

Query: 191 LIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIP 250
           L  N +  I      NL  +L  L + N  I+   P     L     L L  N+L     
Sbjct: 38  LQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPE 96

Query: 251 VTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKD 310
                LQ      L +  N  +    S  +  N  +VVE+  +    SG       G+K 
Sbjct: 97  KMPKTLQE-----LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151

Query: 311 VQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLE 370
           +  I +    +   IP+      SL  L L  NKI+     SL+ L  L KL LSFN + 
Sbjct: 152 LSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208

Query: 371 GEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQT 408
                         +  + N KL  +P         Q 
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV 246

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 67.4 bits (163), Expect = 9e-13
 Identities = 40/214 (18%), Positives = 71/214 (33%), Gaps = 12/214 (5%)

Query: 206 NLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLS 265
           +L      L + N  IT        NL     L L  NK++   P  F  L    L+ L 
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK--LERLY 85

Query: 266 LCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLE--G 323
           L  N     +P  +         E+ +  N  +    +   GL  +  + L  N L+  G
Sbjct: 86  LSKNQLK-ELPEKMPKTL----QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140

Query: 324 PIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFT 383
               +F  +  L  + +++  I+    I       L +L+L  NK+           N  
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197

Query: 384 AKSFMGNEKLCGLPHLQVPQCKHQTRPKSSKKMI 417
           AK  +    +  + +  +    H      +   +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 65.1 bits (157), Expect = 6e-12
 Identities = 44/274 (16%), Positives = 82/274 (29%), Gaps = 29/274 (10%)

Query: 75  NSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNV 134
           N   +  L + +  +    P     L  L +L L  N L         LP ++   L  +
Sbjct: 53  NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-------KELPEKMPKTLQEL 105

Query: 135 KALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGN 194
           +       +   ++ + +     +  L       SG        ++ + ++ +    I  
Sbjct: 106 RVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164

Query: 195 PLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFG 254
              G+ P        SL  L++    IT      +  L+    L L  N ++     +  
Sbjct: 165 IPQGLPP--------SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 216

Query: 255 RLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSG------DIPATIGGL 308
                 L  L L  N          D   ++V   + L  NN S         P      
Sbjct: 217 --NTPHLRELHLNNNKLVKVPGGLADHKYIQV---VYLHNNNISAIGSNDFCPPGYNTKK 271

Query: 309 KDVQNISLPYNRLE--GPIPESFGYLTSLEILDL 340
                +SL  N ++     P +F  +     + L
Sbjct: 272 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 51.2 bits (121), Expect = 2e-07
 Identities = 21/132 (15%), Positives = 40/132 (30%), Gaps = 4/132 (3%)

Query: 267 CGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIP 326
           C +     +P  +          ++L  N  +         LK++  + L  N++    P
Sbjct: 17  CSDLGLEKVPKDLP----PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72

Query: 327 ESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKS 386
            +F  L  LE L LS N++        + L  L+       K+   +  G          
Sbjct: 73  GAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 132

Query: 387 FMGNEKLCGLPH 398
               +       
Sbjct: 133 TNPLKSSGIENG 144

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.0 bits (172), Expect = 5e-14
 Identities = 57/277 (20%), Positives = 91/277 (32%), Gaps = 16/277 (5%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
              L  ++P  I       + + L  NR S    +       LTIL L  N  +      
Sbjct: 20  QQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF 235
              L  +E     + L  N     +  +  +    L  L++  C +    P +   L+  
Sbjct: 76  FTGLALLEQ----LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN 295
             L L+ N L      TF  L N  L  L L GN  S           L  +  + L +N
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGN--LTHLFLHGNRISSVPERAFR--GLHSLDRLLLHQN 187

Query: 296 NFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEK 355
             +   P     L  +  + L  N L     E+   L +L+ L L++N            
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPL 246

Query: 356 LLYLKKLNLSFNKLEGEIP---RGGPFANFTAKSFMG 389
             +L+K   S +++   +P    G       A    G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.5 bits (137), Expect = 2e-09
 Identities = 49/240 (20%), Positives = 77/240 (32%), Gaps = 8/240 (3%)

Query: 158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
              + L GN  S     +    RN+      + L  N L  I  ++   L++  +     
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTI----LWLHSNVLARIDAAAFTGLALLEQLDLSD 89

Query: 218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPS 277
           N  +    P     L    L  L L++              + L  L L  N+       
Sbjct: 90  NAQLRSVDPATFHGL--GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 278 CIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEI 337
                +L  +  + L  N  S        GL  +  + L  NR+    P +F  L  L  
Sbjct: 148 TFR--DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 338 LDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP 397
           L L  N +S     +L  L  L+ L L+ N    +      +A         +E  C LP
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 2e-07
 Identities = 14/93 (15%), Positives = 35/93 (37%), Gaps = 13/93 (13%)

Query: 283 NLKVVVEINLSRNNFS-GDIPATIGGLKDVQNISLPYNRLEG----PIPESFGYLTSLEI 337
           +++    +++     S       +  L+  Q + L    L       I  +     +L  
Sbjct: 3   DIQ---SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 338 LDLSNNKISGFILISLEKLL-----YLKKLNLS 365
           L+L +N++    +  + + L      ++KL+L 
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 13/71 (18%), Positives = 27/71 (38%), Gaps = 5/71 (7%)

Query: 310 DVQNISLPYNRL-EGPIPESFGYLTSLEILDLSNNKISGFILISLEKLL----YLKKLNL 364
           D+Q++ +    L +    E    L   +++ L +  ++      +   L     L +LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 365 SFNKLEGEIPR 375
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 2e-05
 Identities = 14/73 (19%), Positives = 27/73 (36%), Gaps = 9/73 (12%)

Query: 312 QNISLPYNRLEG----PIPESFGYLTSLEILDLSNNKISGFILISLEKLL-----YLKKL 362
           + + L    +       +  +     SL  LDLSNN +    ++ L + +      L++L
Sbjct: 372 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQL 431

Query: 363 NLSFNKLEGEIPR 375
            L       E+  
Sbjct: 432 VLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 6e-04
 Identities = 15/81 (18%), Positives = 26/81 (32%), Gaps = 9/81 (11%)

Query: 289 EINLSRNNFSGD----IPATIGGLKDVQNISLPYNRLEGPIPESFG-----YLTSLEILD 339
            + L+  + S      + AT+     ++ + L  N L                  LE L 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 340 LSNNKISGFILISLEKLLYLK 360
           L +   S  +   L+ L   K
Sbjct: 433 LYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 12/89 (13%), Positives = 27/89 (30%), Gaps = 5/89 (5%)

Query: 238 LDLELNKLT-GPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCID--IGNLKVVVEINLSR 294
           LD++  +L+          LQ  +   + L     + +    I   +     + E+NL  
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQ--VVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64

Query: 295 NNFSGDIPATIGGLKDVQNISLPYNRLEG 323
           N         +       +  +    L+ 
Sbjct: 65  NELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 1e-06
 Identities = 36/186 (19%), Positives = 58/186 (31%), Gaps = 13/186 (6%)

Query: 158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS 217
            TIL L  N    F   T+     +  L L    +           +  L +S  +L   
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92

Query: 218 NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPS 277
                      + ++S   L  L L  L G   +              L GN      P 
Sbjct: 93  PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY----------LKGNELKTLPPG 142

Query: 278 CIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEI 337
            +         +++L+ NN +      + GL+++  + L  N L   IP+ F     L  
Sbjct: 143 LLTPTPKL--EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199

Query: 338 LDLSNN 343
             L  N
Sbjct: 200 AFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 1e-06
 Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 4/69 (5%)

Query: 276 PSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL 335
           P C ++  +   +E+N  + N +  +P  +   KD   + L  N L      +    T L
Sbjct: 2   PIC-EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRL 57

Query: 336 EILDLSNNK 344
             L+L   +
Sbjct: 58  TQLNLDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 3e-06
 Identities = 31/218 (14%), Positives = 64/218 (29%), Gaps = 16/218 (7%)

Query: 152 ITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISL 211
           ++  +    +     + +  +P  +   ++   L L      N L     ++++  +  L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLS----ENLLYTFSLATLMPYT-RL 57

Query: 212 ERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSF 271
            +L +    +T              L  L    L+     +   L  +      L  +  
Sbjct: 58  TQLNLDRAELTKLQVDGT-------LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFN 110

Query: 272 SGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGY 331
             +      +  L  + E+ L  N      P  +     ++ +SL  N L          
Sbjct: 111 RLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170

Query: 332 LTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL 369
           L +L+ L L  N +   I         L    L  N  
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 5e-04
 Identities = 37/202 (18%), Positives = 63/202 (31%), Gaps = 27/202 (13%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNS-------- 167
             +L+ +LP  +     +   L L+ N       + +   ++LT L L            
Sbjct: 19  KRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74

Query: 168 ---------FSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISN 218
                     S     ++  L        V+ +  N L  +   ++  L    E     N
Sbjct: 75  TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134

Query: 219 CSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSC 278
             +    P ++        L L  N LT         L+N  LDTL L  NS   +IP  
Sbjct: 135 E-LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN--LDTLLLQENSLY-TIPK- 189

Query: 279 IDIGNLKVVVEINLSRNNFSGD 300
                  ++    L  N +  +
Sbjct: 190 -GFFGSHLLPFAFLHGNPWLCN 210

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 2e-06
 Identities = 35/225 (15%), Positives = 66/225 (29%), Gaps = 23/225 (10%)

Query: 151 PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS 210
           P    +    +  G ++ +  +  T  +L  I  L       G  +  I    +  L+ +
Sbjct: 14  PDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSA----FGTGVTTI--EGVQYLN-N 64

Query: 211 LERLYISNCSI-----TGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLS 265
           L  L + +  I       N+ ++         L             T         D   
Sbjct: 65  LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124

Query: 266 LCGNSFSGSIPSCIDIGNLKVVVEI-----NLSRNNFSGDIPATIGGLKDVQNISLPYNR 320
           L G S    +   ++       +        LS  N        +  L  +  +    N+
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 321 LEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLS 365
           +    P     L +L  + L NN+IS   +  L     L  + L+
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 11/101 (10%), Positives = 27/101 (26%), Gaps = 4/101 (3%)

Query: 307 GLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF 366
            L +   I+   + +   + ++   L  +  L      ++   +  ++ L  L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 367 NKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQ 407
           N++    P          +      K               
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLD 113

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 4e-06
 Identities = 24/127 (18%), Positives = 41/127 (32%), Gaps = 10/127 (7%)

Query: 238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNF 297
           L L    LT        +L    +  L L  N      P+   +  L+V+   + +  N 
Sbjct: 3   LHLAHKDLTVLCH--LEQLLL--VTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 298 SGDIPATIGGLKDVQNISLPYNRLEG-PIPESFGYLTSLEILDLSNNKISGFILISLEKL 356
            G           +Q + L  NRL+     +       L +L+L  N +     I     
Sbjct: 59  DGVANL-----PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113

Query: 357 LYLKKLN 363
             L  ++
Sbjct: 114 EMLPSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 26/111 (23%), Positives = 41/111 (36%), Gaps = 8/111 (7%)

Query: 263 TLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLE 322
            L L     +  +     +  L +V  ++LS N      PA +  L+ ++ +    N   
Sbjct: 2   VLHLAHKDLT-VLCH---LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA-- 54

Query: 323 GPIPESFGYLTSLEILDLSNNKISGFILI-SLEKLLYLKKLNLSFNKLEGE 372
               +    L  L+ L L NN++     I  L     L  LNL  N L  E
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.8 bits (82), Expect = 0.003
 Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 2/70 (2%)

Query: 337 ILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGL 396
           +L L++  ++  +L  LE+LL +  L+LS N+L    P               N      
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 397 PHLQVPQCKH 406
               +P+ + 
Sbjct: 60  GVANLPRLQE 69

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 1e-05
 Identities = 27/159 (16%), Positives = 62/159 (38%), Gaps = 10/159 (6%)

Query: 239 DLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFS 298
           +L+  ++   + +   +  +     L L        + S  D+    + V +N   ++ +
Sbjct: 3   ELKPEQVEQ-LKLIMSKRYDGSQQALDLK------GLRSDPDLVAQNIDVVLNRR-SSMA 54

Query: 299 GDIPATIGGLKDVQNISLPYNRLEG--PIPESFGYLTSLEILDLSNNKISGFILISLEKL 356
             +      + ++ +++L  NRL     +        +L+IL+LS N++     +   K 
Sbjct: 55  ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKG 114

Query: 357 LYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG 395
           L L++L L  N L         + +   + F    +L G
Sbjct: 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (104), Expect = 2e-05
 Identities = 31/213 (14%), Positives = 63/213 (29%), Gaps = 5/213 (2%)

Query: 156 SKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLY 215
                L                   ++E + +    +   +   + S++  L        
Sbjct: 29  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88

Query: 216 ISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSI 275
            +   I     Q + NL   L+ +  +            ++ + +   L +  N    +I
Sbjct: 89  NNLLYINPEAFQNLPNLQYLLISNTGIKH-----LPDVHKIHSLQKVLLDIQDNINIHTI 143

Query: 276 PSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSL 335
                +G     V + L++N           G +  +      N LE    + F   +  
Sbjct: 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 203

Query: 336 EILDLSNNKISGFILISLEKLLYLKKLNLSFNK 368
            ILD+S  +I       LE L  L+  +    K
Sbjct: 204 VILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 31/229 (13%), Positives = 58/229 (25%), Gaps = 9/229 (3%)

Query: 116 NNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNT 175
            + ++  +PS +     N   L     +     +   +    L  +E+  N     I   
Sbjct: 17  ESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72

Query: 176 IGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIF 235
           + +          I +        +         +L+ L ISN  I         +    
Sbjct: 73  VFSNLPKLH---EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129

Query: 236 LLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN 295
           +LLD++ N     I        + +   L L  N               ++        N
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ--EIHNCAFNGTQLDELNLSDNN 187

Query: 296 NFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNK 344
           N          G      + +   R+          L  L      N K
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 2e-05
 Identities = 38/215 (17%), Positives = 72/215 (33%), Gaps = 25/215 (11%)

Query: 151 PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS 210
                ++     L   S +  +  T   L +I+ +        + +  +    I  L  +
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIA----NNSDIKSVQG--IQYLP-N 69

Query: 211 LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNS 270
           + +L+++   +T   P          L +L+              L + K        + 
Sbjct: 70  VTKLFLNGNKLTDIKP----------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119

Query: 271 FSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFG 330
               I     + +L  +  + L  N  +     +   L  +  +SL  N++   +P    
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LA 175

Query: 331 YLTSLEILDLSNNKISGFILISLEKLLYLKKLNLS 365
            LT L+ L LS N IS   L +L  L  L  L L 
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 37/234 (15%), Positives = 72/234 (30%), Gaps = 32/234 (13%)

Query: 114 VGNNSLSGSLPSRI-----DLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSF 168
           +G+ +++  +P+ I     D A       +L     +  +       + +  +    +  
Sbjct: 3   LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDI 58

Query: 169 SGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQV 228
                  I  L N+  L L     GN L  I P +      +L+ L              
Sbjct: 59  KSVQG--IQYLPNVTKLFL----NGNKLTDIKPLA------NLKNLGWLFLDENKVKDLS 106

Query: 229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV 288
                  L      +     I       Q              +  I     +  L  + 
Sbjct: 107 SLKDLKKLKSLSLEHNGISDINGLVHLPQLE-------SLYLGNNKITDITVLSRLTKLD 159

Query: 289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN 342
            ++L  N  S  +P  + GL  +QN+ L  N +      +   L +L++L+L +
Sbjct: 160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 2e-05
 Identities = 34/267 (12%), Positives = 74/267 (27%), Gaps = 18/267 (6%)

Query: 115 GNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSG-FIP 173
              +L   +  R  L    V A     +     + +   +  ++  ++L  +      + 
Sbjct: 8   TGKNLHPDVTGR--LLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLH 64

Query: 174 NTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC-----SITGNIPQV 228
             +     ++ L L        L+  + +++   S +L RL +S C          +   
Sbjct: 65  GILSQCSKLQNLSLEG----LRLSDPIVNTLAKNS-NLVRLNLSGCSGFSEFALQTLLSS 119

Query: 229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV 288
              L    L                   +      LS    +   S  S +      +V 
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 289 EINLSRNNFSGDIPATIGGLKDVQNISLPY-NRLEGPIPESFGYLTSLEILDLSNNKISG 347
                      D       L  +Q++SL     +        G + +L+ L +      G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 348 FILISLEKLLYLKKLNLSFNKLEGEIP 374
            + +  E    L  L ++ +       
Sbjct: 240 TLQLLKEA---LPHLQINCSHFTTIAR 263

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 17/118 (14%)

Query: 65  CNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLP 124
              +          +            EI       PSL +L +  N L           
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL----------- 296

Query: 125 SRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGF--IPNTIGNLR 180
             +    P ++ L  ++N  +   + P      L  L +  N    F  IP ++ +LR
Sbjct: 297 IELPALPPRLERLIASFNHLAEVPELP----QNLKQLHVEYNPLREFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.8 bits (91), Expect = 0.001
 Identities = 18/103 (17%), Positives = 34/103 (33%), Gaps = 19/103 (18%)

Query: 141 YNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGIL 200
            N  S  I+S       L  L +  N     +P     L  +           N L    
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI-------ASFNHL---- 316

Query: 201 PSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELN 243
            + +  L  +L++L++    +    P +  ++      DL +N
Sbjct: 317 -AEVPELPQNLKQLHVEYNPLRE-FPDIPESVE-----DLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.001
 Identities = 20/60 (33%), Positives = 26/60 (43%), Gaps = 7/60 (11%)

Query: 316 LPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLL-YLKKLNLSFNKLEGEIP 374
              N     I        SLE L++SNNK+       L  L   L++L  SFN L  E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLA-EVP 320

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.2 bits (97), Expect = 2e-04
 Identities = 14/50 (28%), Positives = 21/50 (42%), Gaps = 5/50 (10%)

Query: 328 SFGYLTSLEILDLSNNKISGFILISL-----EKLLYLKKLNLSFNKLEGE 372
           S      L+ L L  N+I    + +L     EK+  L  L L+ N+   E
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 9/75 (12%), Positives = 21/75 (28%), Gaps = 4/75 (5%)

Query: 324 PIPESFGYLTSLEILDLSNNKISG----FILISLEKLLYLKKLNLSFNKLEGEIPRGGPF 379
            +        S++ + LS N I      ++  ++     L+    S              
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 380 ANFTAKSFMGNEKLC 394
                ++ +   KL 
Sbjct: 82  LRLLLQALLKCPKLH 96

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 3e-04
 Identities = 17/101 (16%), Positives = 31/101 (30%), Gaps = 3/101 (2%)

Query: 308 LKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFN 367
               + + L   ++   I      L   + +D S+N+I    L     L  LK L ++ N
Sbjct: 17  AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73

Query: 368 KLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQT 408
           ++               +  + N  L  L  L         
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 114

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 39/213 (18%), Positives = 74/213 (34%), Gaps = 27/213 (12%)

Query: 151 PITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSIS 210
             T  ++     LG  + +  +  +  +L  +  L          +  I    +  L+ +
Sbjct: 13  TDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQA----DRLGIKSI--DGVEYLN-N 63

Query: 211 LERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNS 270
           L ++  SN  +T   P               L  LT  + +     Q + +  L+   N 
Sbjct: 64  LTQINFSNNQLTDITP---------------LKNLTKLVDILMNNNQIADITPLANLTNL 108

Query: 271 FSGSIPSCIDIGNLKVVVEINLSR-NNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESF 329
              ++ +        +    NL+R    S  I              L ++  +    +  
Sbjct: 109 TGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPL 168

Query: 330 GYLTSLEILDLSNNKISGFILISLEKLLYLKKL 362
             LT+LE LD+S+NK+S   +  L KL  L+ L
Sbjct: 169 ANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.3 bits (82), Expect = 0.004
 Identities = 19/130 (14%), Positives = 44/130 (33%), Gaps = 2/130 (1%)

Query: 289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNR-LEGPIPESFGYLTSLEILDLSNNKISG 347
            +  +R+    D    + G +++  + +   + L+         L  L  L +  + +  
Sbjct: 12  GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70

Query: 348 FILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCKHQ 407
               +      L +LNLSFN LE    +     +       GN   C      + + + +
Sbjct: 71  VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEE 130

Query: 408 TRPKSSKKMI 417
                 ++ +
Sbjct: 131 GLGGVPEQKL 140

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	763
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.94
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.68
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.57
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.55
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.51
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.51
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.46
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.46
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.39
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.35
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.33
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.29
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.36
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.33
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.99
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.54
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.4
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.25
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.9
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.68
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.64
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.45
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.09

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=408.94  Aligned_cols=262  Identities=27%  Similarity=0.398  Sum_probs=206.2

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|.+.+.||+|+||+||+|.+++  .||||+++..  .....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            4679999999999999999998753  5999998643  23456788999999999999999999998765 46899999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++|+|.+++......+++..+..++.|+|+||+||   |+++||||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999987666799999999999999999999   6789999999999999999999999999999877544333


Q ss_pred             cccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          632 MTQTQTLATIGYMAPEYGIE---RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .......||+.|||||++.+   ..++.++|||||||++|||+||+.||........             ....+.+...
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-------------~~~~~~~~~~  227 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-------------IIFMVGRGYL  227 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-------------HHHHHHHTSC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-------------HHHHHhcCCC
Confidence            34455679999999998754   4589999999999999999999999976432211             1112222111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      . +.. ......++.++.+++.+||+.+|++|||++||++.|+.+.+.
T Consensus       228 ~-p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         228 S-PDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             C-CCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             C-Ccc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            1 110 011123456789999999999999999999999999877654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=403.29  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=202.3

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      ++|+..+.||+|+||+||+|.+.+++.||||+++... ...+++.+|++++++++||||++++|+|..++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4688899999999999999999888999999997543 234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +|+|.+++......+++..+..++.|+|+||+||   |+++|+||||||+||++++++.+||+|||+++.+..... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            9999999987777789999999999999999999   778999999999999999999999999999987653332 223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcC-CCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....||+.|+|||++.+..++.++|||||||++|||+|+ .+|+.......              ..+.+........  
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--------------~~~~i~~~~~~~~--  223 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------------VVEDISTGFRLYK--  223 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--------------HHHHHHHTCCCCC--
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHhcCCCCC--
Confidence            345789999999999999999999999999999999995 55554422111              1111211111100  


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                          +..+..++.+++..||+.+|++||||+||++.|+++.+
T Consensus       224 ----p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         224 ----PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                01234568899999999999999999999999998765

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.9e-49  Score=408.91  Aligned_cols=260  Identities=24%  Similarity=0.435  Sum_probs=201.7

Q ss_pred             hccCcCceecccCCceEEEEEec-CC---ceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DG---IEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|++.+.||+|+||+||+|... ++   ..||||++... .....+.+.+|++++++++|||||+++|++..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34566789999999999999764 33   35899988654 344567899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++|+|.+++......+++.++..++.|||+||+||   |+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999999999887766799999999999999999999   67899999999999999999999999999998875432


Q ss_pred             Ccc---ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          630 QSM---TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       630 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      ...   ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.......              ..+.+..
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--------------~~~~i~~  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------------VINAIEQ  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------------HHHHHHT
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHc
Confidence            221   2223467999999999999999999999999999999998 899987643221              1111211


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      ......      ...++..+.+++.+||+.+|++|||++||++.|+++++.+
T Consensus       249 ~~~~~~------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         249 DYRLPP------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             TCCCCC------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CCCCCC------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence            111111      1124567899999999999999999999999999988763

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=405.52  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=204.6

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5799999999999999999976 478999999987543 23446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +++|+|.+++.... .+++..+..++.|+++||+||   |+++|+||||||+|||+++++.+||+|||+|+.+.......
T Consensus        85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            99999999997543 689999999999999999999   77899999999999999999999999999999875444333


Q ss_pred             ccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||............+.            .......+
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~------------~~~~~~~~  228 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------EKKTYLNP  228 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH------------TTCTTSTT
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh------------cCCCCCCc
Confidence            4456789999999999988776 5789999999999999999999976432221111111            11111111


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .      .....++.+++.+|++.||++|||++|+++
T Consensus       229 ~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 W------KKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             G------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1      112345789999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=402.44  Aligned_cols=249  Identities=27%  Similarity=0.325  Sum_probs=207.9

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      ++|+..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            5799999999999999999976 579999999998665445677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++|+|.+++...  .++...+..++.|++.||+||   |+++|+||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence            999999988764  489999999999999999999   788999999999999999999999999999998753332  3


Q ss_pred             cccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          634 QTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      .....||+.|+|||++.+..++.++||||+||++|||+||+.||........             ...++.... .... 
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~~~~~~~~-~~~~-  237 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------------LYLIATNGT-PELQ-  237 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------------HHHHHHHCS-CCCS-
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-------------HHHHHhCCC-CCCC-
Confidence            3456799999999999999999999999999999999999999976432211             111111110 0010 


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         ....+...+.+++.+||+.||++|||++|+++
T Consensus       238 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ---SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               01123556889999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.6e-49  Score=406.01  Aligned_cols=263  Identities=24%  Similarity=0.394  Sum_probs=215.3

Q ss_pred             HHHhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          472 RATNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       472 ~~~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ...++|++.+.||+|+||+||+|.+. +|+.||||+++... ...+++.+|++++++++|||||+++++|.+++..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            34578999999999999999999775 68899999997553 23567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSS-TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      ||+++|+|..++... ...+++..+..++.|+++||+||   |+++|+||||||+|||+++++.+||+|||+|+......
T Consensus        93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999998753 44789999999999999999999   67899999999999999999999999999998765332


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                       ........|++.|+|||++.+..++.++|||||||++|||++|..|+.......             ...+.+......
T Consensus       170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-------------~~~~~i~~~~~~  235 (287)
T d1opja_         170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------QVYELLEKDYRM  235 (287)
T ss_dssp             -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------------HHHHHHHTTCCC
T ss_pred             -ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-------------HHHHHHhcCCCC
Confidence             223344568999999999999999999999999999999999777654322111             112222222111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                      ..      .+.++.++.+++..||+.||++|||++||++.|+.+.++.+
T Consensus       236 ~~------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~  278 (287)
T d1opja_         236 ER------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  278 (287)
T ss_dssp             CC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred             CC------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence            10      11235678999999999999999999999999998877653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=391.92  Aligned_cols=253  Identities=24%  Similarity=0.400  Sum_probs=213.6

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMP  554 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  554 (763)
                      ++|+..+.||+|+||+||+|.+++++.||||+++.... ..+++.+|++++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57899999999999999999999889999999976432 34678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcccc
Q 046240          555 NGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQ  634 (763)
Q Consensus       555 ~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  634 (763)
                      +|++..++......+++..+..++.|+++||+||   |+.+|+||||||+||++++++.+||+|||+++.+..... ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eee
Confidence            9999999877767789999999999999999999   678999999999999999999999999999987654332 233


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.              ...+........  
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--------------~~~i~~~~~~~~--  222 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------------AEHIAQGLRLYR--  222 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--------------HHHHHTTCCCCC--
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--------------HHHHHhCCCCCC--
Confidence            45678999999999999999999999999999999998 8999987543321              111111111110  


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                          ++.+..++.+++.+||+.+|++|||++++++.|.+
T Consensus       223 ----p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         223 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                11235678999999999999999999999998865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=401.29  Aligned_cols=257  Identities=24%  Similarity=0.410  Sum_probs=207.8

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|++.+.||+|+||+||+|.+++++.||||+++... ...+.+.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46889999999999999999999888999999997543 234678999999999999999999998865 5679999999


Q ss_pred             CCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSSTC-MLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++|+|.+++..... .+++..+..|+.||++||.||   |+++|+||||||+|||+++++.+||+|||+|+.+.... ..
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence            99999988765432 589999999999999999999   67899999999999999999999999999999875332 22


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+........             ..+.+.....  +.
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-------------~~~~i~~~~~--~~  230 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------------VIQNLERGYR--MV  230 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------------HHHHHHTTCC--CC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-------------HHHHHHhcCC--CC
Confidence            33456789999999999989999999999999999999996655433211111             1111111111  00


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      .    ++.++.++.+++.+||+.+|++||||++|++.|++.+.
T Consensus       231 ~----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         231 R----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            0    11235568999999999999999999999999987653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=402.09  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=210.2

Q ss_pred             hccCcCce-ecccCCceEEEEEec---CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNL-IGIGSFGYVYKAELD---DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~-lg~G~~g~v~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||+++... ....+.+.+|++++++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666674 999999999999764   45579999997543 3456789999999999999999999999865 468999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++|+|.+++...+..+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+++.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999999877666799999999999999999999   67899999999999999999999999999999875443


Q ss_pred             Cc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          630 QS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       630 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+              +...+.+..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------------~~~~i~~~~  229 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGK  229 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------------HHHHHHTTC
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHcCC
Confidence            22 22334568999999999998999999999999999999998 999997643221              111111111


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      .  +.    .+..++.++.+++.+||+.+|++|||+.+|.+.|++....
T Consensus       230 ~--~~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         230 R--ME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             C--CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C--CC----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            0  11    1112456789999999999999999999999999876654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=392.81  Aligned_cols=245  Identities=23%  Similarity=0.300  Sum_probs=204.9

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|... +|+.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999764 689999999975432   23567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++.... .+++..+..++.||++||+||   |+++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999987644 589999999999999999999   7889999999999999999999999999999876432  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......||+.|||||++.+..++.++|||||||++|||++|+.||........ ...            +    ....
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~------------i----~~~~  220 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKR------------I----SRVE  220 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH------------H----HTTC
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-HHH------------H----HcCC
Confidence              22345799999999999999999999999999999999999999976432211 111            1    1111


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +...    +.+..++.+++.+|++.||++|||++|+++
T Consensus       221 ~~~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 FTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1100    112456789999999999999999999985

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=396.22  Aligned_cols=260  Identities=26%  Similarity=0.446  Sum_probs=204.1

Q ss_pred             hccCcCceecccCCceEEEEEecCC-----ceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDG-----IEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|+..++||+|+||+||+|.+.++     ..||||+++... ......+.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688899999999999999976532     469999997543 3445678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+.++++.+++......+++..+..++.|++.||+||   |+++|+||||||+|||++.++.+||+|||+++.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhc---cccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999998887777899999999999999999999   7789999999999999999999999999999887543


Q ss_pred             CC-ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQ-SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .. ........||+.|+|||++.++.++.++|||||||++|||++|..|+.......             ...+.+....
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-------------~~~~~i~~~~  230 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------------EVMKAINDGF  230 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------------HHHHHHHTTC
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-------------HHHHHHhccC
Confidence            22 223344568999999999999999999999999999999999766654321111             1112222211


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      ....      ...++.++.+++.+||+.+|++||+|.||++.|+++.+.
T Consensus       231 ~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         231 RLPT------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCC------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCC------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            1111      112456789999999999999999999999999887765

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=403.35  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=206.4

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      +.|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4688999999999999999976 478999999998665556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCccc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSMT  633 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  633 (763)
                      ++|+|.+++......+++..+..++.|+++||.||   |+++|+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            99999999876656799999999999999999999   7789999999999999999999999999999865321  112


Q ss_pred             cccccccccccCccccC-----CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          634 QTQTLATIGYMAPEYGI-----ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       634 ~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .....||+.|+|||++.     +..|+.++|||||||++|||+||+.||........ +            ..+..... 
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~------------~~i~~~~~-  232 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-L------------LKIAKSEP-  232 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H------------HHHHHSCC-
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-H------------HHHHcCCC-
Confidence            34567999999999873     56689999999999999999999999976432221 1            11111110 


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                        +..  .....+..++.+++.+||+.||++|||++|+++
T Consensus       233 --~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 --PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000  001123556889999999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=394.62  Aligned_cols=248  Identities=26%  Similarity=0.334  Sum_probs=202.7

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.....   ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999976 5789999999975532   23467899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+||   |+++|+||||||+||++++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887654 589999999999999999999   788999999999999999999999999999998764443


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||........ .            ..+.    ...
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~------------~~i~----~~~  226 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-F------------QKII----KLE  226 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHH----TTC
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-H------------HHHH----cCC
Confidence            3344556799999999999999999999999999999999999999976332211 1            1111    111


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCN  747 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~  747 (763)
                      +...    +....++.+++.+|++.||++|||++|++
T Consensus       227 ~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 YDFP----EKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            1110    11245678999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=399.96  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=207.7

Q ss_pred             HhccCcCceecccCCceEEEEEecC-C-----ceEEEEEeehh-hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD-G-----IEVAIKVFHQE-CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  545 (763)
                      .++|++.+.||+|+||+||+|.... +     ..||+|++... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3679999999999999999997642 2     36999998654 334566789999999998 89999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCC
Q 046240          546 KALVLEYMPNGSLDIFLYSST----------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKS  603 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~  603 (763)
                      .++||||+++|+|.+++....                      ..+++..+..++.|+++||+||   |+++||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL---H~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH---HHTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCch
Confidence            999999999999999997543                      2478899999999999999999   678999999999


Q ss_pred             CCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhh
Q 046240          604 SNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFA  682 (763)
Q Consensus       604 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~  682 (763)
                      +||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987754444333445678999999999999999999999999999999998 8999976322


Q ss_pred             hhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhh
Q 046240          683 AELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCE  752 (763)
Q Consensus       683 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~  752 (763)
                      ..             .+.+++........      +..+..++.+++.+||+.+|++|||++||++.|..
T Consensus       273 ~~-------------~~~~~~~~~~~~~~------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         273 DA-------------NFYKLIQNGFKMDQ------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             SH-------------HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH-------------HHHHHHhcCCCCCC------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            11             12222222211111      11235678999999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=391.12  Aligned_cols=252  Identities=22%  Similarity=0.271  Sum_probs=192.8

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeec--CCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSN--DDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  549 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++..  .....+.+.+|++++++++||||+++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6799999999999999999966 47899999998754  23446778999999999999999999999865  4568999


Q ss_pred             EEccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          550 LEYMPNGSLDIFLYS---STCMLDIFQRLNIMIDVASALEYLNFRH--TTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~ia~~L~~Lh~~h--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      |||+++|+|.+++..   ....+++..+..++.|+++||.|||...  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   2346899999999999999999996543  24599999999999999999999999999988


Q ss_pred             cCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      +.....  ......||+.|||||++.+..++.++|||||||++|||+||+.||........             ...+..
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------------~~~i~~  228 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------------AGKIRE  228 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------------HHHHHH
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------------HHHHHc
Confidence            753222  23446799999999999999999999999999999999999999976432211             111111


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......+.       .+..++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~-------~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         229 GKFRRIPY-------RYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             TCCCCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCc-------ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11111111       12456889999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=393.14  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=201.2

Q ss_pred             ceecccCCceEEEEEec---CCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEccCC
Q 046240          481 NLIGIGSFGYVYKAELD---DGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYMPN  555 (763)
Q Consensus       481 ~~lg~G~~g~v~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  555 (763)
                      +.||+|+||+||+|.++   .++.||||+++...  ....+.+.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999764   34689999996542  2345679999999999999999999999965 467899999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc-ccc
Q 046240          556 GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS-MTQ  634 (763)
Q Consensus       556 g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~  634 (763)
                      |+|.+++.... .+++..+..++.||++||+||   |+++|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999987654 589999999999999999999   6789999999999999999999999999999987543322 223


Q ss_pred             ccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCccc
Q 046240          635 TQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPEK  713 (763)
Q Consensus       635 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~  713 (763)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+              ....+.+...  +. 
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--------------~~~~i~~~~~--~~-  230 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGER--MG-  230 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------HHHHHHTTCC--CC-
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--------------HHHHHHcCCC--CC-
Confidence            44578999999999999999999999999999999998 899997643221              1111221110  11 


Q ss_pred             cHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          714 DFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       714 ~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                         .+..++.++.+++.+||+.||++|||+++|.+.|++.+.+
T Consensus       231 ---~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         231 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence               1122456789999999999999999999999998876644

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.2e-47  Score=401.95  Aligned_cols=251  Identities=20%  Similarity=0.247  Sum_probs=209.1

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5899999999999999999976 579999999997665556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC--CCcEEEeeecCceecCCCCCc
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE--DMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      ++|+|.+++......+++..+..++.||+.||+||   |+++||||||||+|||++.  ++.+||+|||+|+.+....  
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--  180 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  180 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence            99999999976666799999999999999999999   7889999999999999964  5789999999999875333  


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       ......||+.|||||++.+..++.++||||+||++|||++|+.||......+. +            ..+....... +
T Consensus       181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~------------~~i~~~~~~~-~  245 (350)
T d1koaa2         181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-L------------RNVKSCDWNM-D  245 (350)
T ss_dssp             -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHTCCCS-C
T ss_pred             -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-H------------HHHHhCCCCC-C
Confidence             23446789999999999999999999999999999999999999976432211 1            1111111111 1


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   .......++.+++.+|+..||++|||++|+++
T Consensus       246 ~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         246 DS---AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CG---GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cc---cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11   11122456889999999999999999999987

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-47  Score=395.73  Aligned_cols=251  Identities=24%  Similarity=0.282  Sum_probs=190.3

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999764 68999999997543 2334567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec---CCCcEEEeeecCceecCCC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD---EDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~  628 (763)
                      |++||+|.+++...+ .+++.....++.|++.||+||   |+++|+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999997644 689999999999999999999   788999999999999994   5789999999999876432


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                      .   ......||+.|||||++.+..++.++||||+||++|||++|+.||........                 ....+.
T Consensus       164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----------------~~~i~~  223 (307)
T d1a06a_         164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-----------------FEQILK  223 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------------HHHHHT
T ss_pred             C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-----------------HHHHhc
Confidence            2   22346799999999999999999999999999999999999999976432221                 111111


Q ss_pred             CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...............++.+++.+|++.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111111111123456889999999999999999999987

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=402.24  Aligned_cols=266  Identities=26%  Similarity=0.342  Sum_probs=207.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|++.+.||+|+||+||+|.. .+|+.||+|+++... ....+.+.+|+.++++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57899999999999999999976 478999999987542 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+++|+|.+++...+ .+++..+..++.|+++||.|||.  ..+|+||||||+|||++.++.+||+|||+|+.+...   
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence            999999999997654 58999999999999999999952  248999999999999999999999999999876421   


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh--hcc----------------
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW--VNG----------------  693 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~--~~~----------------  693 (763)
                       .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.............  ..+                
T Consensus       159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence             2234689999999999999999999999999999999999999997533221111100  000                


Q ss_pred             -------cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          694 -------LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       694 -------~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                             ..+....+..+......+...+.  .....++.+++.+|+..||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccchhHHHHHhhhhccCCccCcc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                   00111222222222222111110  012356889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-46  Score=399.90  Aligned_cols=252  Identities=19%  Similarity=0.243  Sum_probs=209.2

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999976 57999999999866555567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec--CCCcEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD--EDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      +++|+|.+++......+++..+..++.||++||+||   |+++|+||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            999999988877666799999999999999999999   788999999999999998  57899999999999875432 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......||+.|+|||++.+..++.++||||+||++|||+||+.||........ +..            +..... ..
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~------------i~~~~~-~~  247 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQN------------VKRCDW-EF  247 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHH------------HHHCCC-CC
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHH------------HHhCCC-CC
Confidence              23445789999999999999999999999999999999999999976432221 111            111111 11


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +...   ......++.+++.+|++.||++|||++|+++
T Consensus       248 ~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         248 DEDA---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CSST---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             Cccc---ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1110   0112456789999999999999999999976

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=383.08  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=194.5

Q ss_pred             CcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeec----CCceEEEE
Q 046240          478 GRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSN----DDFKALVL  550 (763)
Q Consensus       478 ~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  550 (763)
                      +..+.||+|+||+||+|... +++.||+|++...  .....+.+.+|++++++++||||+++++++..    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45678999999999999764 6889999998754  23456778999999999999999999999864    34679999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeCCCCCCCEEec-CCCcEEEeeecCceecCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTP--IIHCDLKSSNVLLD-EDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~  627 (763)
                      ||+++|+|.+++.... .+++..+..++.||++||+||   |+++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999997643 589999999999999999999   5655  99999999999996 578999999999986432


Q ss_pred             CCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .    ......||+.|||||++.+ .++.++|||||||++|||++|+.||...............+..+           
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~-----------  231 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-----------  231 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-----------
Confidence            2    2234679999999998865 69999999999999999999999997533222111111111111           


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                           .  ........++.+++.+||+.||++|||++|+++
T Consensus       232 -----~--~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 -----A--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----G--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----c--ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 0  011122446889999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=390.97  Aligned_cols=259  Identities=26%  Similarity=0.435  Sum_probs=204.3

Q ss_pred             HhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEcc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEYM  553 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  553 (763)
                      .++|++++.||+|+||+||+|.+++++.||||+++... ...+.+.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            36799999999999999999999888899999997553 234678999999999999999999999865 5678999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++|++..++.... ..+++.+++.++.||++||+||   |+.+|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHH---hhhheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            9999998887532 3589999999999999999999   678999999999999999999999999999987643322 2


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCcc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPPE  712 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~  712 (763)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+........             ..+.+.+....  .
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-------------~~~~i~~~~~~--~  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------------VLDQVERGYRM--P  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------------HHHHHHTTCCC--C
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-------------HHHHHHhcCCC--C
Confidence            33446789999999999999999999999999999999997666544221111             11112211111  1


Q ss_pred             ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          713 KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       713 ~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .    ...+..++.+++.+||+.+|++||++++|+++|++.+...
T Consensus       235 ~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         235 C----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             C----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            1    1123567899999999999999999999999999877553

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=391.49  Aligned_cols=280  Identities=23%  Similarity=0.276  Sum_probs=208.1

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC----ceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD----FKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  550 (763)
                      ++|...+.||+|+||.||+|++ +|+.||||+++..... ....+.|+..+.+++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            5678889999999999999987 4889999999755322 222344556666789999999999997653    578999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      ||+++|+|.++++..  .++|..+..++.++|.||+|+|..     |.++|+||||||+||||+.++.+||+|||+++.+
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999865  489999999999999999999743     5689999999999999999999999999999987


Q ss_pred             CCCCCc--cccccccccccccCccccCCC------CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCC-
Q 046240          626 SGEDQS--MTQTQTLATIGYMAPEYGIER------KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLP-  696 (763)
Q Consensus       626 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-  696 (763)
                      ......  .......||+.|+|||++.+.      .++.++|||||||++|||+||..|+................... 
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            543322  223456799999999987654      36779999999999999999998876532222111111111111 


Q ss_pred             hhHHHHHHh-hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCcc
Q 046240          697 VSLMEVVNK-TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNSS  759 (763)
Q Consensus       697 ~~~~~~i~~-~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~~  759 (763)
                      ....+.+.. ........+ .....+...+.+++.+||+.||++|||+.||++.|+++.+..+-
T Consensus       239 ~~~~~~~~~~~~~p~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~  301 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGG-GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHhccccCCCCCcc-cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence            122222221 111111111 11223467799999999999999999999999999988766543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-46  Score=391.34  Aligned_cols=246  Identities=25%  Similarity=0.331  Sum_probs=201.1

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      .+.|+..+.||+|+||+||+|.. .+|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            35699999999999999999965 578999999987442   33456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      ||||++|++..++... ..+++..+..++.||++||.||   |+++|+||||||+|||++.++.+||+|||+|+....  
T Consensus        94 ~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             EECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            9999999998766544 3689999999999999999999   778999999999999999999999999999987532  


Q ss_pred             CccccccccccccccCccccCC---CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          630 QSMTQTQTLATIGYMAPEYGIE---RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                          .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||........ +            ..++...
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~------------~~i~~~~  230 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-L------------YHIAQNE  230 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-H------------HHHHHSC
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-H------------HHHHhCC
Confidence                234579999999998753   5689999999999999999999999976432211 1            1111111


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .   +....   ..+...+.+++.+||+.||++|||++|+++
T Consensus       231 ~---~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 S---PALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C---CCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C---CCCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1   11100   112456889999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.9e-47  Score=394.62  Aligned_cols=260  Identities=28%  Similarity=0.439  Sum_probs=211.2

Q ss_pred             HHhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCc
Q 046240          473 ATNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDF  545 (763)
Q Consensus       473 ~~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  545 (763)
                      ..++|++.+.||+|+||+||+|...      +++.||||+++... ....+.+.+|++++++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4578999999999999999999764      45789999997553 3346779999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCC
Q 046240          546 KALVLEYMPNGSLDIFLYSST-----------------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLK  602 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk  602 (763)
                      .++||||+++|+|.+++....                       ..+++..+..|+.|++.||+||   |+++|||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl---H~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc---ccCCeEeeEEc
Confidence            999999999999999986422                       2478889999999999999999   78899999999


Q ss_pred             CCCEEecCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCC-CCCchhh
Q 046240          603 SSNVLLDEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK-KPADKMF  681 (763)
Q Consensus       603 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~  681 (763)
                      |+|||+|.++.+||+|||+|+.+.............+++.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999998775444444445567899999999999999999999999999999999985 5666533


Q ss_pred             hhhhhhhhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          682 AAELSLKHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       682 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      ..+.              ...+.+...  +.    .++.++.++.+++..||+.+|++||||.||+++|+++.+
T Consensus       248 ~~e~--------------~~~v~~~~~--~~----~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         248 HEEV--------------IYYVRDGNI--LA----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHH--------------HHHHHTTCC--CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHH--------------HHHHHcCCC--CC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2221              111111110  00    011235568999999999999999999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-46  Score=386.10  Aligned_cols=251  Identities=20%  Similarity=0.253  Sum_probs=207.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH------HHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA------RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++....      ...+.+.+|++++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46899999999999999999976 5789999999864321      1356789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC----cEEEeeecCc
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM----IAHLSDFGIA  622 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla  622 (763)
                      |+||||+++|+|.+++...+ .+++..+..++.|++.||+||   |+.+|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999987654 589999999999999999999   788999999999999998776    5999999999


Q ss_pred             eecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          623 KLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       623 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      +......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||........                 
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----------------  224 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----------------  224 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-----------------
Confidence            8875332   22345789999999999999999999999999999999999999976432221                 


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      +.................+...+.+++.+||+.||++|||++|+++
T Consensus       225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111111111112222233556889999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=385.82  Aligned_cols=259  Identities=22%  Similarity=0.340  Sum_probs=201.2

Q ss_pred             HhccCcCceecccCCceEEEEEecC----CceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELDD----GIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      .++|++.+.||+|+||.||+|.+..    +..||||+++.. .....+.+.+|++++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999997642    456899988644 3344677899999999999999999999996 467899


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ||||+++|++.+++......+++..+..++.|+++||+||   |+++|+||||||+||+++.++.+||+|||+|+.+...
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998877777799999999999999999999   7889999999999999999999999999999876533


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      .. .......||+.|+|||++.+..++.++|||||||++|||+| |.+||......+.              .+.+....
T Consensus       162 ~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--------------~~~i~~~~  226 (273)
T d1mp8a_         162 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------------IGRIENGE  226 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------------HHHHHTTC
T ss_pred             cc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--------------HHHHHcCC
Confidence            22 23344568999999999999999999999999999999998 8999876433221              11111110


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      .  +..    ...++.++.+++.+||+.||++|||+.||++.|++++++.
T Consensus       227 ~--~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         227 R--LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             C--CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C--CCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            0  000    1123567899999999999999999999999999888764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=393.60  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=204.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCc----eEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGI----EVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  548 (763)
                      ++|++.+.||+|+||+||+|.+. +|+    +||+|+++... ....+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999764 444    68999886442 33467899999999999999999999999875 5678


Q ss_pred             EEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCC
Q 046240          549 VLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGE  628 (763)
Q Consensus       549 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~  628 (763)
                      ++||+.+|+|.+++......+++..+..++.|||+||+||   |+++|+||||||+||+++.++.+||+|||+|+.+...
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8999999999999888777899999999999999999999   6789999999999999999999999999999987654


Q ss_pred             CCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhc
Q 046240          629 DQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       629 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  707 (763)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |..||......              .+...+....
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------------~~~~~i~~~~  230 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------------EISSILEKGE  230 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------------GHHHHHHHTC
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------------HHHHHHHcCC
Confidence            44444455678999999999999999999999999999999999 78888764322              1222222221


Q ss_pred             CCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          708 LSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       708 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                      .. +.     ++.+...+.+++.+||+.||++|||+.||++.+.++..
T Consensus       231 ~~-~~-----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         231 RL-PQ-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CC-CC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-CC-----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            11 10     11235678999999999999999999999998876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=385.14  Aligned_cols=262  Identities=22%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC-C
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND-D  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  544 (763)
                      .++|++.+.||+|+||+||+|...      +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+. .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            468999999999999999999753      34689999987543 33456677888888877 689999999988665 4


Q ss_pred             ceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEec
Q 046240          545 FKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLD  609 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~  609 (763)
                      ..++||||+++|+|.+++....               ..+++..+..++.||++||+||   |+++|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH---HhCCCcCCcCCccceeEC
Confidence            6899999999999999986532               2478999999999999999999   778999999999999999


Q ss_pred             CCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCC-CCCchhhhhhhhhh
Q 046240          610 EDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK-KPADKMFAAELSLK  688 (763)
Q Consensus       610 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~  688 (763)
                      +++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||.......    
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----  244 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----  244 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence            99999999999998775444444445567999999999999999999999999999999999974 5776532211    


Q ss_pred             hhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          689 HWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       689 ~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                               .....+........      ++.+..++.+++.+||+.||++|||++||++.|+++++.+
T Consensus       245 ---------~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         245 ---------EFCRRLKEGTRMRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             ---------HHHHHHHHTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------HHHHHHhcCCCCCC------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence                     12222222111110      1123456899999999999999999999999999988754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-46  Score=380.36  Aligned_cols=256  Identities=27%  Similarity=0.397  Sum_probs=198.2

Q ss_pred             hccCcCceecccCCceEEEEEec--CC--ceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD--DG--IEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      ++|++.+.||+|+||.||+|...  ++  ..||||++....   ....+.+.+|+.++++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            57999999999999999999754  22  368999987542   2345678999999999999999999999976 4678


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||+++|++.+++......+++..+..++.|+|+||.||   |+++|+||||||+||+++.++.+||+|||+++.+..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999998877666799999999999999999999   678999999999999999999999999999998754


Q ss_pred             CCCc-cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHh
Q 046240          628 EDQS-MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNK  705 (763)
Q Consensus       628 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  705 (763)
                      .... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+..              ..+.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~--------------~~i~~  229 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL--------------HKIDK  229 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--------------HHHHT
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH--------------HHHHh
Confidence            4332 23344567889999999999999999999999999999998 89999764332211              11111


Q ss_pred             hcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          706 TLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       706 ~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .-.+.+     ....++..+.+++.+||+.||++|||+.+|.+.|++.
T Consensus       230 ~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 EGERLP-----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             SCCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCC-----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111111     1112355789999999999999999999999998864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=384.35  Aligned_cols=263  Identities=24%  Similarity=0.391  Sum_probs=216.8

Q ss_pred             HhccCcCceecccCCceEEEEEe------cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL------DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  545 (763)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++... ......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46888999999999999999975      246789999997543 34556789999999999 69999999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          546 KALVLEYMPNGSLDIFLYSST-----------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      .++||||+++|+|.++++...                 ..+++..+..++.||++|++||   |+++++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L---H~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccccccccc
Confidence            999999999999999986532                 2578899999999999999999   78899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcC-CCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTR-KKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg-~~p~~~~~~~~~~~  687 (763)
                      +.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|+ .+|+......    
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~----  254 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----  254 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH----
Confidence            99999999999999987655555555667899999999999999999999999999999999994 5555442211    


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                               +.+.+++.........      +.+...+.+++.+||++||++||||++|+++|++++.+.+
T Consensus       255 ---------~~~~~~i~~~~~~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         255 ---------SKFYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             ---------HHHHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             ---------HHHHHHHhcCCCCCCc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence                     1223333333221111      1234568999999999999999999999999998877654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=380.68  Aligned_cols=248  Identities=30%  Similarity=0.425  Sum_probs=196.5

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeec-CCceEEEEEcc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSN-DDFKALVLEYM  553 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  553 (763)
                      ++|++.+.||+|+||.||+|.+. |+.||||+++...  ..+.+.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            57888999999999999999985 7899999997543  34678999999999999999999999865 45689999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          554 PNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       554 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++|+|.+++...+ ..+++..++.|+.||++||.||   |+.+|+||||||+||+++.++.+|++|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhheecCCCCEeecccccceecCCC----
Confidence            9999999997543 2589999999999999999999   6789999999999999999999999999999875422    


Q ss_pred             ccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          633 TQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                       .....++..|+|||++.++.++.++|||||||++|||+| |+.||.......              +.+.+....  .+
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--------------~~~~i~~~~--~~  219 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------VVPRVEKGY--KM  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------------HHHHHTTTC--CC
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHcCC--CC
Confidence             223457889999999999999999999999999999999 677776532221              111121111  11


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhc
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQ  753 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~  753 (763)
                      .    ....+..++.+++.+||+.||++||||.+++++|+++
T Consensus       220 ~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         220 D----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1    1112345688999999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-45  Score=380.02  Aligned_cols=259  Identities=21%  Similarity=0.335  Sum_probs=201.7

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC----c
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD----F  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  545 (763)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++...   ....+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46899999999999999999965 579999999997542   334567899999999999999999999987543    4


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .|+||||++|++|..++...+ .+++.++..++.|+++||+||   |+++|+||||||+||+++.++..+++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999886654 589999999999999999999   7889999999999999999999999999998765


Q ss_pred             CCCCC-ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          626 SGEDQ-SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       626 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..........                 
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-----------------  224 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-----------------  224 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----------------
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH-----------------
Confidence            43222 223345679999999999999999999999999999999999999997643322111                 


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCC-CHHHHHHHHhhc
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRI-NAKCCNFVLCEQ  753 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-s~~~v~~~L~~~  753 (763)
                      +.+...+.........++.++.+++.+|++.||++|| |++++.+.|.++
T Consensus       225 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            1111111110011112345688999999999999999 899999988765

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-45  Score=382.40  Aligned_cols=247  Identities=24%  Similarity=0.314  Sum_probs=204.6

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++++...   ...+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999976 5799999999986532   23567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+++|+|.+++...+ .++......++.|++.||+||   |+++|+||||||+|||++++|.+||+|||+|+.......
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            9999999999987654 578888999999999999999   789999999999999999999999999999987643222


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||........ ...            +..... ..
T Consensus       161 --~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~------------i~~~~~-~~  224 (337)
T d1o6la_         161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FEL------------ILMEEI-RF  224 (337)
T ss_dssp             --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH------------HHHCCC-CC
T ss_pred             --ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-HHH------------HhcCCC-CC
Confidence              33456899999999999999999999999999999999999999987433221 111            111111 11


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                      |.       .+..++.+++.+|++.||++||+     +.|+++
T Consensus       225 p~-------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 PR-------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CT-------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             Cc-------cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            11       12445789999999999999995     677764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=381.61  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=205.9

Q ss_pred             CceecccCCceEEEEEecCC----ceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeec-CCceEEEEEcc
Q 046240          480 DNLIGIGSFGYVYKAELDDG----IEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSN-DDFKALVLEYM  553 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  553 (763)
                      .++||+|+||+||+|.+.++    ..||||+++.. .....+++.+|++++++++||||++++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999976432    36899998743 34556889999999999999999999999865 45789999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc--
Q 046240          554 PNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS--  631 (763)
Q Consensus       554 ~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--  631 (763)
                      ++|+|.+++.......++..+..++.|+++||.|+   |+.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999988777788999999999999999999   7889999999999999999999999999999887543222  


Q ss_pred             cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCCc
Q 046240          632 MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSPP  711 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~~  711 (763)
                      .......||+.|+|||.+.+..++.++||||||+++|||+||..||...........            .+....-...|
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~------------~i~~g~~~~~p  256 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV------------YLLQGRRLLQP  256 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH------------HHHTTCCCCCC
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH------------HHHcCCCCCCc
Confidence            223345789999999999999999999999999999999998888765322111111            11110000011


Q ss_pred             cccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          712 EKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       712 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                             ..+...+.+++.+||+.||++||+|.||++.|++++.+..
T Consensus       257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence                   1235568899999999999999999999999998887643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-45  Score=380.63  Aligned_cols=251  Identities=18%  Similarity=0.239  Sum_probs=206.7

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      .++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+|++++++++||||+++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999764 788999999976533 345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC--CcEEEeeecCceecCCCCC
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED--MIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~~  630 (763)
                      |+||+|.+++...+..+++.+...++.||++||+||   |+.+|+||||||+|||++.+  +.+||+|||+++...... 
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            999999999987766799999999999999999999   78899999999999999854  589999999998764322 


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                        ......+++.|+|||...+..++.++||||+||++|||++|+.||........             ...+....    
T Consensus       159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-------------~~~i~~~~----  219 (321)
T d1tkia_         159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------------IENIMNAE----  219 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHTC----
T ss_pred             --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhCC----
Confidence              23345789999999999999999999999999999999999999976432211             11111111    


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..........+..++.+++.+|+..||++|||+.|+++
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111123456889999999999999999999987

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-44  Score=377.76  Aligned_cols=244  Identities=23%  Similarity=0.298  Sum_probs=203.3

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++....   ...+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999976 5799999999986532   23567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||++||++..++.... .++......++.|++.||+||   |+++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999887654 578888889999999999999   8899999999999999999999999999999986432  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                         .....||+.|||||++.+..++.++||||+||++|||+||+.||........             ...+....... 
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~~i~~~~~~~-  220 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------------YEKILNAELRF-  220 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHCCCCC-
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------------HHHHHcCCCCC-
Confidence               2346799999999999999999999999999999999999999976432211             11111111111 


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      |.       ....++.+++.+|+..||++||     +++++++
T Consensus       221 p~-------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         221 PP-------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CT-------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC-------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            11       1234578999999999999996     8888874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=379.09  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=208.3

Q ss_pred             HhccCcCceecccCCceEEEEEec--------CCceEEEEEeehhh-HHHHHHHHHHHHHHHhC-CCCccceEEeeeecC
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD--------DGIEVAIKVFHQEC-ARAMKSFEVECEVMKNI-RHRNLVKIISGCSND  543 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  543 (763)
                      .++|.+.+.||+|+||.||+|+..        ++..||||+++... ......+.+|...+.++ +||||++++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            468999999999999999999653        23479999997654 34457788899999888 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEe
Q 046240          544 DFKALVLEYMPNGSLDIFLYSST---------------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLL  608 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll  608 (763)
                      +..++||||+++|+|.+++....               ..+++.+++.++.|++.||+||   |+.+||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl---H~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh---hhCCEEeeeecccceee
Confidence            99999999999999999996543               3479999999999999999999   78899999999999999


Q ss_pred             cCCCcEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHc-CCCCCchhhhhhhhh
Q 046240          609 DEDMIAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFT-RKKPADKMFAAELSL  687 (763)
Q Consensus       609 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ellt-g~~p~~~~~~~~~~~  687 (763)
                      +.++.+||+|||+++...............+++.|+|||.+.++.|+.++|||||||++|||++ |.+||.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999998765544444556778999999999999999999999999999999998 688887533221   


Q ss_pred             hhhhcccCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccc
Q 046240          688 KHWVNGLLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFV  755 (763)
Q Consensus       688 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~  755 (763)
                                 ..+.+.....  +..    +..+...+.+++.+||+.+|++|||+.||+++|++++.
T Consensus       246 -----------~~~~i~~~~~--~~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 -----------LFKLLKEGHR--MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -----------HHHHHHTTCC--CCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------HHHHHHcCCC--CCC----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                       1112221111  110    11234568999999999999999999999999988764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.2e-45  Score=372.59  Aligned_cols=250  Identities=21%  Similarity=0.287  Sum_probs=204.4

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh---------HHHHHHHHHHHHHHHhCC-CCccceEEeeeecC
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC---------ARAMKSFEVECEVMKNIR-HRNLVKIISGCSND  543 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  543 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...         ....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999976 579999999986431         223456889999999997 99999999999999


Q ss_pred             CceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCce
Q 046240          544 DFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAK  623 (763)
Q Consensus       544 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~  623 (763)
                      +..|+||||+++|+|.+++...+ .+++.++..++.||++||+||   |+++|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997654 689999999999999999999   77899999999999999999999999999999


Q ss_pred             ecCCCCCccccccccccccccCccccC------CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCCh
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGI------ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPV  697 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  697 (763)
                      .+....   ......||+.|+|||++.      ...++.++||||+||++|||++|+.||........            
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------------  223 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------------  223 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------------
Confidence            875432   234467999999999864      34578899999999999999999999986432221            


Q ss_pred             hHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 SLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ...+...... .+...   ...+..++.+++.+|++++|++|||++||++
T Consensus       224 -~~~i~~~~~~-~~~~~---~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 -LRMIMSGNYQ-FGSPE---WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -HHHHHHTCCC-CCTTT---GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHHHhCCCC-CCCcc---cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             1111211111 11111   1123557889999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-45  Score=381.02  Aligned_cols=261  Identities=24%  Similarity=0.382  Sum_probs=214.1

Q ss_pred             HhccCcCceecccCCceEEEEEec------CCceEEEEEeehh-hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCCce
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD------DGIEVAIKVFHQE-CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFK  546 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  546 (763)
                      .++|...+.||+|+||+||+|.+.      +++.||||+++.. .......+.+|++++++++||||+++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            478899999999999999999763      3578999999754 334556789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEe
Q 046240          547 ALVLEYMPNGSLDIFLYSST---------CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLS  617 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~  617 (763)
                      ++||||+++|+|.+++....         ..+++..+..++.|+|+||.||   |+++|+||||||+|||+++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999886421         2468899999999999999999   67899999999999999999999999


Q ss_pred             eecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCC-CCCchhhhhhhhhhhhhcccCC
Q 046240          618 DFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK-KPADKMFAAELSLKHWVNGLLP  696 (763)
Q Consensus       618 Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~  696 (763)
                      |||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||+||. .||......+.           
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~-----------  244 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----------  244 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-----------
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH-----------
Confidence            999998775444444445567899999999999999999999999999999999984 66655322211           


Q ss_pred             hhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          697 VSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                        ...+.+......+       ..+...+.+++.+||+.+|++|||+++|++.|++.++..
T Consensus       245 --~~~i~~~~~~~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         245 --LRFVMEGGLLDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             --HHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             --HHHHHhCCCCCCc-------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence              1111111111111       123557899999999999999999999999999988765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-45  Score=380.86  Aligned_cols=258  Identities=29%  Similarity=0.448  Sum_probs=204.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCc--eEEEEEeehh-hHHHHHHHHHHHHHHHhC-CCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGI--EVAIKVFHQE-CARAMKSFEVECEVMKNI-RHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|++.+.||+|+||+||+|.+. +|.  .||||+++.. .....+.+.+|+++++++ +||||++++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67888999999999999999775 444  4788887643 333556789999999998 799999999999999999999


Q ss_pred             EEccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcE
Q 046240          550 LEYMPNGSLDIFLYSS---------------TCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIA  614 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~  614 (763)
                      |||+++|+|.++++..               ...+++..+..++.|||+||.|+   |+++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcCCccccccccceEEEcCCCce
Confidence            9999999999998643               24689999999999999999999   78899999999999999999999


Q ss_pred             EEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCC-CCCchhhhhhhhhhhhhcc
Q 046240          615 HLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRK-KPADKMFAAELSLKHWVNG  693 (763)
Q Consensus       615 kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~-~p~~~~~~~~~~~~~~~~~  693 (763)
                      ||+|||+++.....   .......||..|+|||.+.+..++.++|||||||++|||++|. +||.......         
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---------  234 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------  234 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---------
Confidence            99999999865321   1223456899999999999999999999999999999999975 5665532221         


Q ss_pred             cCChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccCc
Q 046240          694 LLPVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSNS  758 (763)
Q Consensus       694 ~~~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~~  758 (763)
                           +.+.+.+..  .+..    ...+..++.+++.+||+.||++||||+||++.|++++++.+
T Consensus       235 -----~~~~i~~~~--~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         235 -----LYEKLPQGY--RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             -----HHHHGGGTC--CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             -----HHHHHHhcC--CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence                 111111110  1111    11235678999999999999999999999999998887653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-44  Score=377.87  Aligned_cols=250  Identities=20%  Similarity=0.236  Sum_probs=197.7

Q ss_pred             hccCcCc-eecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhC-CCCccceEEeeeec----CCceE
Q 046240          475 NRFGRDN-LIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNI-RHRNLVKIISGCSN----DDFKA  547 (763)
Q Consensus       475 ~~~~~~~-~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~  547 (763)
                      ++|.+.. .||+|+||+||+|.. .+|+.||||+++..     ..+.+|++++.++ +||||++++++|.+    ....|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788764 699999999999965 57899999999643     3467799887655 89999999999864    45789


Q ss_pred             EEEEccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecCce
Q 046240          548 LVLEYMPNGSLDIFLYSST-CMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAK  623 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~  623 (763)
                      +|||||+||+|.+++...+ ..+++..+..++.|+++||+||   |+++|+||||||+|||++.   ++.+||+|||+|+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH---HHcCCccccccccccccccccccccccccccceee
Confidence            9999999999999997643 4689999999999999999999   7889999999999999985   5679999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      ......   ......||+.|+|||++.+..|+.++|||||||++|||+||+.||.........             ..+.
T Consensus       163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-------------~~~~  226 (335)
T d2ozaa1         163 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------PGMK  226 (335)
T ss_dssp             ECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------
T ss_pred             eccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-------------HHHH
Confidence            865333   234467999999999999999999999999999999999999999764321110             0011


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .................+..++.+++.+|++.||++|||+.|+++
T Consensus       227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111111111111122334667899999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.6e-44  Score=377.03  Aligned_cols=244  Identities=20%  Similarity=0.279  Sum_probs=204.0

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH---HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA---RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++....   ...+.+.+|+++++.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5899999999999999999976 4799999999975432   23467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQ  630 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  630 (763)
                      ||+.+|+|..++...+ .++...+..++.||+.||.||   |+++||||||||+|||++.++.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999987654 589999999999999999999   7889999999999999999999999999999987532  


Q ss_pred             ccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCCC
Q 046240          631 SMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLSP  710 (763)
Q Consensus       631 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  710 (763)
                         .....||+.|||||++.+..++.++|||||||++|||+||+.||........ .            ..+..... ..
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~------------~~i~~~~~-~~  257 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-Y------------EKIVSGKV-RF  257 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHCCC-CC
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-H------------HHHhcCCC-CC
Confidence               2345799999999999999999999999999999999999999976332111 1            11111111 11


Q ss_pred             ccccHHHHHHHHHHHHHHHHHccccCcCCCC-----CHHHHHH
Q 046240          711 PEKDFAAKEQCVLSIFSLAMECTMELPEKRI-----NAKCCNF  748 (763)
Q Consensus       711 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rp-----s~~~v~~  748 (763)
                      +.       .+..++.+++.+|+..||++|+     +++++++
T Consensus       258 p~-------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 PS-------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CT-------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             Cc-------cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            11       1245688999999999999994     8899875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=375.11  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=200.6

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhh---HHHHHHHHHHHHHHH-hCCCCccceEEeeeecCCceEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQEC---ARAMKSFEVECEVMK-NIRHRNLVKIISGCSNDDFKALV  549 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  549 (763)
                      ++|++.+.||+|+||+||+|... +|+.||||++++..   ....+.+..|+.++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999664 79999999998653   223455667777765 68999999999999999999999


Q ss_pred             EEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCC
Q 046240          550 LEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       550 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  629 (763)
                      |||+++|+|.+++.... .++...+..++.||+.||+||   |+++|+||||||+|||+++++.+||+|||+++......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999997654 588899999999999999999   77899999999999999999999999999998764322


Q ss_pred             CccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcCC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLLS  709 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  709 (763)
                        .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+......                 ..+....
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-----------------~~~i~~~  218 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----------------FHSIRMD  218 (320)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------------HHHHHHC
T ss_pred             --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-----------------HHHHHcC
Confidence              233456799999999999999999999999999999999999999976432221                 1111111


Q ss_pred             CccccHHHHHHHHHHHHHHHHHccccCcCCCCCHH-HHH
Q 046240          710 PPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAK-CCN  747 (763)
Q Consensus       710 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~-~v~  747 (763)
                      .+...    ..+..++.+++.+|+..+|++||++. +++
T Consensus       219 ~~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         219 NPFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             CCCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            11111    11245678999999999999999985 664

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-43  Score=378.25  Aligned_cols=248  Identities=23%  Similarity=0.261  Sum_probs=197.4

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehhhH---HHHHHHHH---HHHHHHhCCCCccceEEeeeecCCceE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECA---RAMKSFEV---ECEVMKNIRHRNLVKIISGCSNDDFKA  547 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~  547 (763)
                      ++|++.+.||+|+||+||+|... +|+.||||++.....   .....+.+   |+.+++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999764 799999999975421   11223333   466677778999999999999999999


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      +||||+++|+|.+++.... .+++..+..++.||+.||.||   |+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999997654 578889999999999999999   789999999999999999999999999999997753


Q ss_pred             CCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhh
Q 046240          628 EDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKT  706 (763)
Q Consensus       628 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  706 (763)
                      ..    .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.......              ..++....
T Consensus       160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------------~~~~~~~~  221 (364)
T d1omwa3         160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--------------KHEIDRMT  221 (364)
T ss_dssp             SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--------------HHHHHHHS
T ss_pred             Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHHhc
Confidence            32    234579999999999864 568999999999999999999999997632211              11122222


Q ss_pred             cCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          707 LLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       707 l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                      ....+...    ..+..++.+++.+|++.||++|||     ++|+++
T Consensus       222 ~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         222 LTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSCCCCCC----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ccCCCCCC----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            22111111    112456889999999999999999     577763

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=8e-43  Score=367.04  Aligned_cols=304  Identities=35%  Similarity=0.637  Sum_probs=205.0

Q ss_pred             CChhhHHHHHHHHHhccCCCCcccccCCCCCCCCC--cccceeecCCC--CceEEEEecCCCCCC--cCCcccCCCCCCC
Q 046240           31 NITTDQQALLALEAHISYDPTNLLAQNWTSNTSVC--NWIGITCDVNS--HRVTALNISSLNLQG--EIPHEIGYLPSLT  104 (763)
Q Consensus        31 ~~~~~~~~l~~~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~~--~~v~~L~L~~~~l~~--~~~~~~~~l~~L~  104 (763)
                      +.++|++||++||++++ ||. .++ +|..++|||  +|.||+|+...  .||++|+|+++++.|  .+|+++++|++|+
T Consensus         3 c~~~e~~aLl~~k~~~~-~~~-~l~-sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~   79 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLG-NPT-TLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             SCHHHHHHHHHHHHHTT-CCG-GGT-TCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCHHHHHHHHHHHHHCC-CCC-cCC-CCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence            57899999999999997 453 465 899889999  59999998754  489999999999987  4677777777777


Q ss_pred             EEEcCC-CcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchh
Q 046240          105 KLALGY-NSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIE  183 (763)
Q Consensus       105 ~L~L~~-n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  183 (763)
                      +|+|++ |.++      |.+|+.+. ++++|++|+|++|+|++..+..+..+.+|+.+++++|++.+.+|..|+      
T Consensus        80 ~L~Ls~~N~l~------g~iP~~i~-~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~------  146 (313)
T d1ogqa_          80 FLYIGGINNLV------GPIPPAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS------  146 (313)
T ss_dssp             EEEEEEETTEE------SCCCGGGG-GCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG------
T ss_pred             ccccccccccc------cccccccc-cccccchhhhccccccccccccccchhhhcccccccccccccCchhhc------
Confidence            777764 4443      34544433 444444444444444444444444444444444444444433333322      


Q ss_pred             hhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccE
Q 046240          184 WLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDT  263 (763)
Q Consensus       184 ~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~  263 (763)
                                            +++ +|+++++++|.+++.+|..+..+..+                         ++.
T Consensus       147 ----------------------~l~-~L~~l~l~~n~l~~~ip~~~~~l~~l-------------------------~~~  178 (313)
T d1ogqa_         147 ----------------------SLP-NLVGITFDGNRISGAIPDSYGSFSKL-------------------------FTS  178 (313)
T ss_dssp             ----------------------GCT-TCCEEECCSSCCEEECCGGGGCCCTT-------------------------CCE
T ss_pred             ----------------------cCc-ccceeecccccccccccccccccccc-------------------------ccc
Confidence                                  222 45555555555555555555444443                         244


Q ss_pred             EEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCC
Q 046240          264 LSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNN  343 (763)
Q Consensus       264 L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  343 (763)
                      +++++|++++..|.  .+..+.. ..+++++|.+.+.+|..+..+++|+.+++++|.+.+.+| .++.+++|+.|+|++|
T Consensus       179 l~~~~n~l~~~~~~--~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N  254 (313)
T d1ogqa_         179 MTISRNRLTGKIPP--TFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN  254 (313)
T ss_dssp             EECCSSEEEEECCG--GGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSS
T ss_pred             cccccccccccccc--ccccccc-ccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccC
Confidence            55555555544444  3444433 356666666666677777777777777777777776544 5777788888888888


Q ss_pred             ccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcccCCCCCCCCCCC
Q 046240          344 KISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPHLQVPQCK  405 (763)
Q Consensus       344 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p~~~~~~c~  405 (763)
                      ++++.+|..+.++++|++|+|++|+|+|.+|..+.+..+..+++.+|+.+||.|   +|+|.
T Consensus       255 ~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p---lp~c~  313 (313)
T d1ogqa_         255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPACT  313 (313)
T ss_dssp             CCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---SSCCC
T ss_pred             eecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC---CCCCC
Confidence            888878888888888888888888888888887778888899999999999987   67773

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=370.13  Aligned_cols=269  Identities=24%  Similarity=0.271  Sum_probs=202.0

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH--HHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA--RAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++....  ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999976 5799999999965432  235778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      |+.++.+..........+++..+..++.|++.||+||   |+++||||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-  157 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  157 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence            9987666555555555799999999999999999999   788999999999999999999999999999987643322 


Q ss_pred             cccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc-ccCCh-hHHHHHH--hh
Q 046240          632 MTQTQTLATIGYMAPEYGIERK-VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN-GLLPV-SLMEVVN--KT  706 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~-~~~~~i~--~~  706 (763)
                       ......||+.|+|||...... ++.++||||+||++|||++|+.||............... +...+ ....+..  ..
T Consensus       158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence             334567999999999876655 578999999999999999999999764332221111100 00000 0000000  00


Q ss_pred             cC---CCcccc-HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          707 LL---SPPEKD-FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       707 l~---~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   ...... .........++.+++.+|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00   000000 0011122356889999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=366.80  Aligned_cols=264  Identities=23%  Similarity=0.263  Sum_probs=194.2

Q ss_pred             cCceecccCCceEEEEEec-CCceEEEEEeehhhHH-----HHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          479 RDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECAR-----AMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       479 ~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ..++||+|+||+||+|... +|+.||||+++.....     ..+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999764 6899999998644221     235688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      ++++++..+... ...++...+..++.||++||+||   |+++|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            999877766654 34678888999999999999999   789999999999999999999999999999987643322  


Q ss_pred             ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhHHHHH---H-h
Q 046240          633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSLMEVV---N-K  705 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~i---~-~  705 (763)
                      ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+..  ..............+..   . .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            2334579999999998765 46799999999999999999999999764332211  00100000000000000   0 0


Q ss_pred             hcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          706 TLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       706 ~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      .....+..... .......++.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000111000 00112456889999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=362.07  Aligned_cols=244  Identities=20%  Similarity=0.261  Sum_probs=196.8

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhH------HHHHHHHHHHHHHHhCC--CCccceEEeeeecCCc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECA------RAMKSFEVECEVMKNIR--HRNLVKIISGCSNDDF  545 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~  545 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.....      .....+.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999966 5789999999975421      11234568999999986  8999999999999999


Q ss_pred             eEEEEEccCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCC-CcEEEeeecCce
Q 046240          546 KALVLEYMPN-GSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDED-MIAHLSDFGIAK  623 (763)
Q Consensus       546 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~  623 (763)
                      .++||||+.+ +++.+++.... .+++..+..++.|+++||+||   |+++|+||||||+||+++.+ +.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 56777765543 589999999999999999999   78999999999999999854 799999999998


Q ss_pred             ecCCCCCccccccccccccccCccccCCCCC-CcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHH
Q 046240          624 LLSGEDQSMTQTQTLATIGYMAPEYGIERKV-STRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEV  702 (763)
Q Consensus       624 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  702 (763)
                      .....    ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....                   +
T Consensus       160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------------i  216 (273)
T d1xwsa_         160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------------I  216 (273)
T ss_dssp             ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------------H
T ss_pred             ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------------H
Confidence            75422    2234679999999999887665 5679999999999999999999976321                   1


Q ss_pred             HHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH--HHhhc
Q 046240          703 VNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF--VLCEQ  753 (763)
Q Consensus       703 i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~--~L~~~  753 (763)
                      ........+.        ...++.+++.+|++.||++|||++|+++  .+++.
T Consensus       217 ~~~~~~~~~~--------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         217 IRGQVFFRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHCCCCCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             hhcccCCCCC--------CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            1111111111        2345789999999999999999999986  35443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.8e-43  Score=365.01  Aligned_cols=268  Identities=21%  Similarity=0.258  Sum_probs=200.4

Q ss_pred             hccCcCceecccCCceEEEEEecCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|++.+.||+|+||+||+|...+|+.||||+++...  ....+.+.+|+.++++++||||+++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999998899999999996542  23357889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCcc
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQSM  632 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  632 (763)
                      +.++.+..+.... ..++...+..++.||+.||+||   |+.+||||||||+|||++.++.+|++|||.+........  
T Consensus        82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence            9887776665544 4699999999999999999999   678999999999999999999999999999987643322  


Q ss_pred             ccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh--hcccCChhHHHHHH-----
Q 046240          633 TQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW--VNGLLPVSLMEVVN-----  704 (763)
Q Consensus       633 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~i~-----  704 (763)
                      ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||............+  ..............     
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            2344568999999998865 456899999999999999999999997643322211111  00000000000000     


Q ss_pred             -hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          705 -KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       705 -~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                       ......+.............+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00000010000111122446789999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-43  Score=365.90  Aligned_cols=269  Identities=22%  Similarity=0.261  Sum_probs=198.0

Q ss_pred             HhccCcCceecccCCceEEEEEe-cC-CceEEEEEeehhhH--HHHHHHHHHHHHHHhC---CCCccceEEeeeec----
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DD-GIEVAIKVFHQECA--RAMKSFEVECEVMKNI---RHRNLVKIISGCSN----  542 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  542 (763)
                      .++|++.+.||+|+||+||+|.. .+ ++.||||+++....  .....+.+|+++++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999976 34 66799999864421  2233456777777665   79999999999853    


Q ss_pred             -CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecC
Q 046240          543 -DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGI  621 (763)
Q Consensus       543 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgl  621 (763)
                       ....+++|||++++.+..........+++.....++.|++.||+||   |+++|+||||||+|||++.++.+||+|||.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             3468899999999888766666666789999999999999999999   788999999999999999999999999999


Q ss_pred             ceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcccCChhH
Q 046240          622 AKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNGLLPVSL  699 (763)
Q Consensus       622 a~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~  699 (763)
                      ++....   ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.........  .............
T Consensus       163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            886532   22345567999999999999999999999999999999999999999764332211  0111000000000


Q ss_pred             HH---HHHhhcC-CCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          700 ME---VVNKTLL-SPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       700 ~~---~i~~~l~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ..   ....... ................+.+++.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00   0000000 0000000001112446789999999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-42  Score=356.74  Aligned_cols=263  Identities=21%  Similarity=0.244  Sum_probs=201.3

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccc-eEEeeeecCCceEEEEEc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLV-KIISGCSNDDFKALVLEY  552 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~  552 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++....  ..+.+.+|+++++.++|+|++ .+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999965 578999999887543  234578899999999876654 555666778889999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC---CCcEEEeeecCceecCCCC
Q 046240          553 MPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE---DMIAHLSDFGIAKLLSGED  629 (763)
Q Consensus       553 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~  629 (763)
                      +. +++...+......+++..+..++.|+++||+||   |+++|+||||||+||+++.   +..+|++|||+|+.+....
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 LG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             CC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             cC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            95 566666665556799999999999999999999   7789999999999999864   5579999999999875433


Q ss_pred             Cc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHH
Q 046240          630 QS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVN  704 (763)
Q Consensus       630 ~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  704 (763)
                      ..     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...........          ......
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~----------~~~~~~  230 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK----------YERISE  230 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------------HHHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH----------HHHhhc
Confidence            21     123455799999999999999999999999999999999999999976432211100          011111


Q ss_pred             hhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhcccc
Q 046240          705 KTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVS  756 (763)
Q Consensus       705 ~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~  756 (763)
                      .......   ......++.++.+++..||+.+|++||+++++.+.|++.+.+
T Consensus       231 ~~~~~~~---~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         231 KKMSTPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHSCH---HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCCCCh---hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            1111100   011122456789999999999999999999999998887654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-41  Score=357.91  Aligned_cols=270  Identities=20%  Similarity=0.192  Sum_probs=198.1

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh-HHHHHHHHHHHHHHHhCCCCccceEEeeeecCC----ceE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC-ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD----FKA  547 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  547 (763)
                      +++|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999965 589999999997442 345667889999999999999999999986553    234


Q ss_pred             EEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCC
Q 046240          548 LVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSG  627 (763)
Q Consensus       548 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~  627 (763)
                      ++++|+.+|+|.+++...  .+++..+..++.|+++||+||   |+++||||||||+|||++.++.+||+|||+++....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555667799999999765  489999999999999999999   778999999999999999999999999999987643


Q ss_pred             CCCc-cccccccccccccCccccC-CCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh-hcccC---------
Q 046240          628 EDQS-MTQTQTLATIGYMAPEYGI-ERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW-VNGLL---------  695 (763)
Q Consensus       628 ~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~---------  695 (763)
                      .... .......||+.|+|||++. +..++.++||||+||++|||++|+.||............. .....         
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            3222 2234567999999999875 4567899999999999999999999997643222111110 00101         


Q ss_pred             ChhHHHHHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          696 PVSLMEVVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       696 ~~~~~~~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...........-...+..-.........++.+++.+|++.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111111111110000000112346789999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-41  Score=350.83  Aligned_cols=265  Identities=15%  Similarity=0.148  Sum_probs=209.2

Q ss_pred             HhccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCC-CccceEEeeeecCCceEEEEE
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRH-RNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  551 (763)
                      .++|++.+.||+|+||+||+|... +|+.||||++....  ....+.+|+++++.+.| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999754 78999999986542  23456789999999965 899999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecC-----CCcEEEeeecCceecC
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDE-----DMIAHLSDFGIAKLLS  626 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~  626 (763)
                      |+ +++|.+++......++......++.|++.||+||   |+++|+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            98 6799999887776799999999999999999999   8899999999999999974     5789999999999875


Q ss_pred             CCCCc-----cccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHH
Q 046240          627 GEDQS-----MTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLME  701 (763)
Q Consensus       627 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  701 (763)
                      .....     .......||+.|||||++.+..++.++|||||||++|||+||+.||..........          ....
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~----------~~~~  227 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ----------KYER  227 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH----------HHHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH----------HHHH
Confidence            33211     12334579999999999999999999999999999999999999997532211100          0011


Q ss_pred             HHHhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHHHHhhccccC
Q 046240          702 VVNKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNFVLCEQFVSN  757 (763)
Q Consensus       702 ~i~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~~L~~~~~~~  757 (763)
                      +........+   ......++.++.+++..|++.+|++||+++.+.+.+++++++.
T Consensus       228 i~~~~~~~~~---~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         228 IGEKKQSTPL---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHSCH---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhccCCCCh---HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            1111110000   0011123456899999999999999999999999988877653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-41  Score=358.04  Aligned_cols=264  Identities=25%  Similarity=0.272  Sum_probs=195.2

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeecCC------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSNDD------  544 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  544 (763)
                      .++|++++.||+|+||+||+|.. .+|+.||||+++..  .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999975 57999999999743  2344677889999999999999999999997654      


Q ss_pred             ceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          545 FKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       545 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                      +.|+||||+ +.+|..+....  .+++..+..++.|++.||+||   |+++|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 56777777554  489999999999999999999   788999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhh-hhhhcccCCh-----
Q 046240          625 LSGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSL-KHWVNGLLPV-----  697 (763)
Q Consensus       625 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~-----  697 (763)
                      ....     .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......... .....+..+.     
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            6422     244679999999998765 456899999999999999999999997643222111 0111111111     


Q ss_pred             ---hHHHHHHhhcCCCccccHH-HHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 ---SLMEVVNKTLLSPPEKDFA-AKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 ---~~~~~i~~~l~~~~~~~~~-~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                         ....-....+......... ........+.+++.+|+..||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               1111111122111111110 00112345789999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-41  Score=351.68  Aligned_cols=271  Identities=21%  Similarity=0.281  Sum_probs=195.9

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeec--------
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSN--------  542 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  542 (763)
                      -++|++.+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            37899999999999999999976 579999999986442  2345678899999999999999999998855        


Q ss_pred             CCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCc
Q 046240          543 DDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIA  622 (763)
Q Consensus       543 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla  622 (763)
                      .+..++||||+.++.+...... ...++......++.|+++||.||   |+.+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHh---ccCCEEecCcCchheeecCCCcEEeeeccee
Confidence            3467999999988777655443 34688889999999999999999   7889999999999999999999999999999


Q ss_pred             eecCCCCCc--cccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhh--hhhhhhcccCCh
Q 046240          623 KLLSGEDQS--MTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAEL--SLKHWVNGLLPV  697 (763)
Q Consensus       623 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~  697 (763)
                      +.+......  .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........  ..........++
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            877543322  122345799999999988754 689999999999999999999999975432221  111111111110


Q ss_pred             --------hHHHHHHhhcCCCccccH-HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          698 --------SLMEVVNKTLLSPPEKDF-AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       698 --------~~~~~i~~~l~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                              .....+............ .........+.+++.+|++.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                    111111100000000000 001112345678999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.5e-40  Score=348.67  Aligned_cols=261  Identities=20%  Similarity=0.253  Sum_probs=196.8

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecC--CceEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSND--DFKALVL  550 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  550 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...   .+.+.+|++++++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6899999999999999999976 578999999997542   356788999999995 99999999998743  5689999


Q ss_pred             EccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeecCceecCCCC
Q 046240          551 EYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLLSGED  629 (763)
Q Consensus       551 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  629 (763)
                      ||+++++|..+..    .++...+..++.||+.||+||   |+++|+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHH---hhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999977643    488999999999999999999   788999999999999998654 69999999998865332


Q ss_pred             CccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHHHhhcC
Q 046240          630 QSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVVNKTLL  708 (763)
Q Consensus       630 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  708 (763)
                         ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..................++...+.....-.
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence               23456789999999987764 57999999999999999999999986533221111111111111111111111100


Q ss_pred             -----------CCcccc------HHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          709 -----------SPPEKD------FAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       709 -----------~~~~~~------~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                                 ..+...      .........++.+++.+|+..||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       000000      0011123456889999999999999999999976

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=353.88  Aligned_cols=262  Identities=24%  Similarity=0.311  Sum_probs=192.6

Q ss_pred             ccCcCceecccCCceEEEEEec-CCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCccceEEeeeecC------CceEE
Q 046240          476 RFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNLVKIISGCSND------DFKAL  548 (763)
Q Consensus       476 ~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  548 (763)
                      +|...++||+|+||+||+|... +|+.||||++....    ....+|++++++++||||+++++++...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888999999999999999764 79999999997542    2234799999999999999999998532      35789


Q ss_pred             EEEccCCCChhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC-cEEEeeecCceec
Q 046240          549 VLEYMPNGSLDIFLY--SSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM-IAHLSDFGIAKLL  625 (763)
Q Consensus       549 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~  625 (763)
                      ||||++++.+..+..  .....+++..+..++.|++.||+||   |+++|+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998775544432  2334689999999999999999999   789999999999999999775 8999999999887


Q ss_pred             CCCCCccccccccccccccCccccCC-CCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhc--ccCCh-hHHH
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIE-RKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVN--GLLPV-SLME  701 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~--~~~~~-~~~~  701 (763)
                      .....   .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........ +.....  +..+. ....
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhh
Confidence            53332   234579999999998764 5789999999999999999999999976433221 111111  11111 1111


Q ss_pred             HHHhhcCCC-cc---ccH--HHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          702 VVNKTLLSP-PE---KDF--AAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       702 ~i~~~l~~~-~~---~~~--~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ......... +.   ...  ........++.+++.+|+..||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110000000 00   000  000112446789999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-41  Score=347.93  Aligned_cols=267  Identities=20%  Similarity=0.216  Sum_probs=202.3

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecCCceEEEEE
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSNDDFKALVLE  551 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  551 (763)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|+.+++.++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999976 578999999986442  2346788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceecCCCCCc
Q 046240          552 YMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLLSGEDQS  631 (763)
Q Consensus       552 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  631 (763)
                      ++.++++..++... +.+++..+..++.|+++||+||   |+++|+||||||+|||++.++.+||+|||.++....... 
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99999988877654 4678899999999999999999   778999999999999999999999999999998753332 


Q ss_pred             cccccccccccccCccccCCCC-CCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhh---hcccCChhHHHHHHhhc
Q 046240          632 MTQTQTLATIGYMAPEYGIERK-VSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHW---VNGLLPVSLMEVVNKTL  707 (763)
Q Consensus       632 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l  707 (763)
                       ......++..|+|||.+.+.. ++.++||||+||++|||++|+.||.............   ............ .+..
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  234 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM-TKLP  234 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG-GGST
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh-hhcc
Confidence             233456788999999887654 6899999999999999999999975422222111111   111000000000 0000


Q ss_pred             CCC-------ccccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          708 LSP-------PEKDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       708 ~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ...       ..............+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000       00000011122345789999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-40  Score=351.24  Aligned_cols=264  Identities=22%  Similarity=0.194  Sum_probs=192.0

Q ss_pred             hccCcCceecccCCceEEEEEec-CCceEEEEEeehh--hHHHHHHHHHHHHHHHhCCCCccceEEeeeec------CCc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAELD-DGIEVAIKVFHQE--CARAMKSFEVECEVMKNIRHRNLVKIISGCSN------DDF  545 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  545 (763)
                      ++|++.+.||+|+||+||+|... +|+.||||++...  .....+.+.+|+.++++++||||+++++++..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999764 7999999999754  23445678899999999999999999999853      368


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .|+||||+.++.+..+.    ..+++..+..++.|++.||+||   |+.||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHh---hhcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999876665442    2478999999999999999999   7889999999999999999999999999998865


Q ss_pred             CCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhcc-------cCC
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVNG-------LLP  696 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~~-------~~~  696 (763)
                      ...   .......+|+.|+|||++.+..+++++||||+||+++||++|+.||.........  .......       ...
T Consensus       170 ~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         170 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            422   2334557899999999999999999999999999999999999999653221110  1000000       011


Q ss_pred             hhHHHHHHhhcCCCcc------------ccHHHHHHHHHHHHHHHHHccccCcCCCCCHHHHHH
Q 046240          697 VSLMEVVNKTLLSPPE------------KDFAAKEQCVLSIFSLAMECTMELPEKRINAKCCNF  748 (763)
Q Consensus       697 ~~~~~~i~~~l~~~~~------------~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~  748 (763)
                      ....+...........            ............+.+++.+|+..||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1222222222111100            011122334667899999999999999999999984

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=347.66  Aligned_cols=252  Identities=25%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             hccCcCceecccCCceEEEEEe----cCCceEEEEEeehhh----HHHHHHHHHHHHHHHhCCC-CccceEEeeeecCCc
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL----DDGIEVAIKVFHQEC----ARAMKSFEVECEVMKNIRH-RNLVKIISGCSNDDF  545 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  545 (763)
                      ++|++.+.||+|+||+||+|..    .+|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999965    258899999986431    1234567889999999976 899999999999999


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .++||||+.+|+|.+++...+ .+.......++.|++.||+|+   |+.+|+||||||+||+++.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999987655 466788888999999999999   7889999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccccCccccCCC--CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhhhhhhhcccCChhHHHHH
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIER--KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELSLKHWVNGLLPVSLMEVV  703 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  703 (763)
                      ..... .......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||........             ...+.
T Consensus       180 ~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-------------~~~i~  245 (322)
T d1vzoa_         180 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-------------QAEIS  245 (322)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-------------HHHHH
T ss_pred             ccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHH
Confidence            43322 223446799999999988654  468899999999999999999999976432211             11111


Q ss_pred             HhhcCCCccccHHHHHHHHHHHHHHHHHccccCcCCCCC-----HHHHHH
Q 046240          704 NKTLLSPPEKDFAAKEQCVLSIFSLAMECTMELPEKRIN-----AKCCNF  748 (763)
Q Consensus       704 ~~~l~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~Rps-----~~~v~~  748 (763)
                      .......+...    ..+..++.+++.+|++++|++|||     ++|+++
T Consensus       246 ~~~~~~~~~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 RRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HhcccCCCCCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            11111111110    113567899999999999999995     778764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=347.53  Aligned_cols=269  Identities=22%  Similarity=0.256  Sum_probs=199.7

Q ss_pred             HhccCcCceecccCCceEEEEEe-cCCceEEEEEeehhh--HHHHHHHHHHHHHHHhCCCCccceEEeeeecC-----Cc
Q 046240          474 TNRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQEC--ARAMKSFEVECEVMKNIRHRNLVKIISGCSND-----DF  545 (763)
Q Consensus       474 ~~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  545 (763)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|++++++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999999965 579999999997542  34456788999999999999999999998643     34


Q ss_pred             eEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeeecCceec
Q 046240          546 KALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKLL  625 (763)
Q Consensus       546 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~  625 (763)
                      .+++++|+.+|+|.+++..+  .++...+..++.||+.||+||   |+++|+||||||+|||++.++.+|++|||.+...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHH---HhCCCcccccCCccccccccccccccccchhccc
Confidence            46777888899999998654  489999999999999999999   7889999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccccCccccCCC-CCCcchhHHHHHHHHHHHHcCCCCCchhhhhhhh--hhhhhc--------cc
Q 046240          626 SGEDQSMTQTQTLATIGYMAPEYGIER-KVSTRSDIYSYGIMLIETFTRKKPADKMFAAELS--LKHWVN--------GL  694 (763)
Q Consensus       626 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~elltg~~p~~~~~~~~~~--~~~~~~--------~~  694 (763)
                      ..     ......|++.|+|||...+. .++.++||||+||++|||++|+.||.........  ......        ..
T Consensus       172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            31     23446789999999986664 5688999999999999999999999753322111  111000        00


Q ss_pred             CChhHHHHHHhhcCCCccccHHH-HHHHHHHHHHHHHHccccCcCCCCCHHHHHH--HHhhc
Q 046240          695 LPVSLMEVVNKTLLSPPEKDFAA-KEQCVLSIFSLAMECTMELPEKRINAKCCNF--VLCEQ  753 (763)
Q Consensus       695 ~~~~~~~~i~~~l~~~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~Rps~~~v~~--~L~~~  753 (763)
                      ........ ...+...+...... .......+.+++.+|++.||++|||++|+++  .+++.
T Consensus       247 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         247 SSESARNY-IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CCHHHHHH-HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             cchhhhhh-hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            11111111 12222222222111 1123456789999999999999999999987  45543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-35  Score=312.45  Aligned_cols=266  Identities=18%  Similarity=0.198  Sum_probs=186.9

Q ss_pred             hccCcCceecccCCceEEEEEe-cCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-----------CCccceEEeeeec
Q 046240          475 NRFGRDNLIGIGSFGYVYKAEL-DDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-----------HRNLVKIISGCSN  542 (763)
Q Consensus       475 ~~~~~~~~lg~G~~g~v~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  542 (763)
                      .+|++++.||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999976 5799999999976532 3456678888888775           5789999988864


Q ss_pred             C--CceEEEEEccCCCCh--hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCC------
Q 046240          543 D--DFKALVLEYMPNGSL--DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDM------  612 (763)
Q Consensus       543 ~--~~~~lv~e~~~~g~L--~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~------  612 (763)
                      .  ...+++++++..+..  ..........++...+..++.|++.||+|||  +..+|+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh--hhcCcccccCChhHeeeeccCcccccc
Confidence            3  455666666555432  2222334446888899999999999999996  358999999999999998654      


Q ss_pred             cEEEeeecCceecCCCCCccccccccccccccCccccCCCCCCcchhHHHHHHHHHHHHcCCCCCchhhhh-----hhhh
Q 046240          613 IAHLSDFGIAKLLSGEDQSMTQTQTLATIGYMAPEYGIERKVSTRSDIYSYGIMLIETFTRKKPADKMFAA-----ELSL  687 (763)
Q Consensus       613 ~~kl~Dfgla~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slGv~l~elltg~~p~~~~~~~-----~~~~  687 (763)
                      .++++|||.+.....     ......||+.|+|||++.+..++.++||||+||+++||++|+.||......     ....
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            399999999986532     223457999999999999999999999999999999999999999753211     0011


Q ss_pred             hh--hhcccCChhHHHH---HHhhc------CCCccc-----------cHHHHHHHHHHHHHHHHHccccCcCCCCCHHH
Q 046240          688 KH--WVNGLLPVSLMEV---VNKTL------LSPPEK-----------DFAAKEQCVLSIFSLAMECTMELPEKRINAKC  745 (763)
Q Consensus       688 ~~--~~~~~~~~~~~~~---i~~~l------~~~~~~-----------~~~~~~~~~~~l~~l~~~cl~~~P~~Rps~~~  745 (763)
                      ..  ..-+..+......   .....      ......           .....+.....+.+++.+|++.||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            11  1111111111000   00000      000000           00011234667899999999999999999999


Q ss_pred             HHH
Q 046240          746 CNF  748 (763)
Q Consensus       746 v~~  748 (763)
                      +++
T Consensus       325 ~L~  327 (362)
T d1q8ya_         325 LVN  327 (362)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            986

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=2.7e-27  Score=246.76  Aligned_cols=262  Identities=19%  Similarity=0.236  Sum_probs=191.0

Q ss_pred             EecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeee
Q 046240           83 NISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILE  162 (763)
Q Consensus        83 ~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~  162 (763)
                      |-++++++ .+|..+.  +++++|+|++|+|+       .+|+..|.++++|++|++++|.++.+.|..|.++++|++|+
T Consensus        16 ~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-------~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~   85 (305)
T d1xkua_          16 QCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-------EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY   85 (305)
T ss_dssp             ECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-------CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             EecCCCCC-ccCCCCC--CCCCEEECcCCcCC-------CcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence            33456677 5677664  68999999999996       89988888999999999999999988888999999999999


Q ss_pred             ecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccc--cccccccCCccccceeec
Q 046240          163 LGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT--GNIPQVMGNLSIFLLLDL  240 (763)
Q Consensus       163 L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L  240 (763)
                      +++|+|+.+....+.   .|+.|+    +..|.+.+..+..+.... .+..++...|...  ...+..|..+++|+.+++
T Consensus        86 l~~n~l~~l~~~~~~---~l~~L~----~~~n~l~~l~~~~~~~~~-~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l  157 (305)
T d1xkua_          86 LSKNQLKELPEKMPK---TLQELR----VHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI  157 (305)
T ss_dssp             CCSSCCSBCCSSCCT---TCCEEE----CCSSCCCBBCHHHHTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred             ccCCccCcCccchhh---hhhhhh----ccccchhhhhhhhhhccc-cccccccccccccccCCCccccccccccCcccc
Confidence            999999865444333   344444    667777665444444444 6777777777543  344556777778888888


Q ss_pred             ccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCcc
Q 046240          241 ELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNR  320 (763)
Q Consensus       241 ~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  320 (763)
                      ++|.++ .+|..+  .+  +|+.|++++|..++..+.  .+.+++.++.|++++|.+++..+..|.++++|++|+|++|+
T Consensus       158 ~~n~l~-~l~~~~--~~--~L~~L~l~~n~~~~~~~~--~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~  230 (305)
T d1xkua_         158 ADTNIT-TIPQGL--PP--SLTELHLDGNKITKVDAA--SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK  230 (305)
T ss_dssp             CSSCCC-SCCSSC--CT--TCSEEECTTSCCCEECTG--GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred             ccCCcc-ccCccc--CC--ccCEEECCCCcCCCCChh--Hhhccccccccccccccccccccccccccccceeeeccccc
Confidence            888777 344433  22  377788888877766666  67777778888888888877777777778888888888888


Q ss_pred             ccCcccccccccccccEEeCcCCccCCccchhh------hhhccCceEEcccccCC
Q 046240          321 LEGPIPESFGYLTSLEILDLSNNKISGFILISL------EKLLYLKKLNLSFNKLE  370 (763)
Q Consensus       321 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~l~~N~l~  370 (763)
                      |+ .+|..|..+++|++|+|++|+|+.+....|      ..+.+|+.|+|++|+++
T Consensus       231 L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         231 LV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             cc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            77 456677778888888888888777644443      34566777777777765

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.4e-27  Score=246.07  Aligned_cols=265  Identities=22%  Similarity=0.238  Sum_probs=174.9

Q ss_pred             CCcccceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccc
Q 046240           64 VCNWIGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNR  143 (763)
Q Consensus        64 ~c~w~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~  143 (763)
                      +|. .++.|.....  ..++.++++++ .+|..+.  +.+++|+|++|+|+       .+|...|.++++|++|++++|+
T Consensus         1 ~cp-~~C~C~~~~~--~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~-------~i~~~~f~~l~~L~~L~ls~n~   67 (284)
T d1ozna_           1 PCP-GACVCYNEPK--VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRIS-------HVPAASFRACRNLTILWLHSNV   67 (284)
T ss_dssp             CCC-TTCEEECSSS--CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCC-------EECTTTTTTCTTCCEEECCSSC
T ss_pred             CcC-CCCEEcCCCC--eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCC-------CCCHHHhhcccccccccccccc
Confidence            354 2777854332  34567788887 5665543  45677777777774       6666666666667777777776


Q ss_pred             ccccCCCcccCCCCCCeeee-cCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccc
Q 046240          144 FSGTIQSPITNASKLTILEL-GGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSIT  222 (763)
Q Consensus       144 i~~~~p~~~~~l~~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~  222 (763)
                      |..+.+..+.++..++.++. ..|.++.+.+..|++++                             +|++|++++|.+.
T Consensus        68 l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~-----------------------------~L~~L~l~~n~~~  118 (284)
T d1ozna_          68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG-----------------------------RLHTLHLDRCGLQ  118 (284)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCT-----------------------------TCCEEECTTSCCC
T ss_pred             ccccccccccccccccccccccccccccccchhhcccc-----------------------------cCCEEecCCcccc
Confidence            66666666666666666654 34455555555555555                             5666666666666


Q ss_pred             cccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCC
Q 046240          223 GNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIP  302 (763)
Q Consensus       223 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p  302 (763)
                      ...+..+..+++|+.+++++|+|++..+..|..+++  |+.|++++|++++..+.  .|.++++|+.+++++|++++..|
T Consensus       119 ~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~--L~~L~l~~N~l~~l~~~--~f~~l~~L~~l~l~~N~l~~i~~  194 (284)
T d1ozna_         119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN--LTHLFLHGNRISSVPER--AFRGLHSLDRLLLHQNRVAHVHP  194 (284)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT--CCEEECCSSCCCEECTT--TTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccchhcccchhhhccccccccChhHhccccc--hhhcccccCcccccchh--hhccccccchhhhhhccccccCh
Confidence            555666666667777777777776555566666654  77777777777755555  66777777788888888877777


Q ss_pred             cccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCC
Q 046240          303 ATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPR  375 (763)
Q Consensus       303 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  375 (763)
                      ..|.++++|++|++++|++.+..+..|+.+++|++|+|++|++...-+ .-.-...++.+....+++.+..|.
T Consensus       195 ~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESG
T ss_pred             hHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCch
Confidence            778888888888888888887777777788888888888887775322 112233455666666777766554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.5e-26  Score=241.04  Aligned_cols=276  Identities=20%  Similarity=0.236  Sum_probs=229.3

Q ss_pred             CcccceeecCC---------CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCcc
Q 046240           65 CNWIGITCDVN---------SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVK  135 (763)
Q Consensus        65 c~w~gv~c~~~---------~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~  135 (763)
                      |.|.+|.|...         +..+++|+|++|+|+...+..|.++++|++|++++|.+.       .+++..|.++++|+
T Consensus        10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-------~i~~~~f~~l~~L~   82 (305)
T d1xkua_          10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-------KISPGAFAPLVKLE   82 (305)
T ss_dssp             EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-------CBCTTTTTTCTTCC
T ss_pred             ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhcccccccccccccccc-------ccchhhhhCCCccC
Confidence            78999999652         257999999999999666668999999999999999996       78788888999999


Q ss_pred             EEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCc--ccccCCcccccccccccE
Q 046240          136 ALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNP--LNGILPSSIVNLSISLER  213 (763)
Q Consensus       136 ~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~--l~~~~p~~~~~l~~~L~~  213 (763)
                      +|++++|+|+. +|..+  ...|..|++++|.+.++.+..+.....+..++    ...|.  .....+..+..+. +|+.
T Consensus        83 ~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~----~~~n~~~~~~~~~~~~~~l~-~L~~  154 (305)
T d1xkua_          83 RLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVE----LGTNPLKSSGIENGAFQGMK-KLSY  154 (305)
T ss_dssp             EEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEE----CCSSCCCGGGBCTTGGGGCT-TCCE
T ss_pred             EecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccc----cccccccccCCCcccccccc-ccCc
Confidence            99999999995 44433  35799999999999988888888888777776    55553  3444566777777 9999


Q ss_pred             EEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcc
Q 046240          214 LYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLS  293 (763)
Q Consensus       214 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls  293 (763)
                      +++++|.++. +|..+  +++|+.|++++|.+++..+..|.+++.  ++.|++++|.+++..+.  .+.++++|++|+|+
T Consensus       155 l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~--l~~L~~s~n~l~~~~~~--~~~~l~~L~~L~L~  227 (305)
T d1xkua_         155 IRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNN--LAKLGLSFNSISAVDNG--SLANTPHLRELHLN  227 (305)
T ss_dssp             EECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTT--CCEEECCSSCCCEECTT--TGGGSTTCCEEECC
T ss_pred             cccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccc--ccccccccccccccccc--cccccccceeeecc
Confidence            9999999984 45443  589999999999999999999999976  99999999999977777  78999999999999


Q ss_pred             cccccccCCcccCCCcCccEEEccCccccCcccccc------cccccccEEeCcCCccC--CccchhhhhhccCceEE
Q 046240          294 RNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESF------GYLTSLEILDLSNNKIS--GFILISLEKLLYLKKLN  363 (763)
Q Consensus       294 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~  363 (763)
                      +|+|+ .+|.+|..+++|+.|+|++|+|+......|      ..+.+|+.|+|++|++.  .+.|..|.-+.....++
T Consensus       228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~~  304 (305)
T d1xkua_         228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ  304 (305)
T ss_dssp             SSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred             ccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCcccc
Confidence            99999 568899999999999999999996544443      46789999999999986  45677776655444443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.94  E-value=7.9e-28  Score=251.77  Aligned_cols=227  Identities=28%  Similarity=0.456  Sum_probs=166.3

Q ss_pred             CCceEEEEecC-CCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccC
Q 046240           76 SHRVTALNISS-LNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITN  154 (763)
Q Consensus        76 ~~~v~~L~L~~-~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~  154 (763)
                      ..++++|+|++ |+++|.+|++|++|++|++|+|++|++.       .++...+..+++|+.+++++|.+.+.+|..|.+
T Consensus        75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~-------~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~  147 (313)
T d1ogqa_          75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS-------GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS  147 (313)
T ss_dssp             CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCE-------EECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred             Cccccccccccccccccccccccccccccchhhhcccccc-------ccccccccchhhhcccccccccccccCchhhcc
Confidence            46899999997 8999999999999999999999999996       566666679999999999999999999999999


Q ss_pred             CCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccc
Q 046240          155 ASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSI  234 (763)
Q Consensus       155 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~  234 (763)
                      +++|+++++++|++++.+|..+..+.++                            ++.+++++|++++..|..+..+..
T Consensus       148 l~~L~~l~l~~n~l~~~ip~~~~~l~~l----------------------------~~~l~~~~n~l~~~~~~~~~~l~~  199 (313)
T d1ogqa_         148 LPNLVGITFDGNRISGAIPDSYGSFSKL----------------------------FTSMTISRNRLTGKIPPTFANLNL  199 (313)
T ss_dssp             CTTCCEEECCSSCCEEECCGGGGCCCTT----------------------------CCEEECCSSEEEEECCGGGGGCCC
T ss_pred             Ccccceeecccccccccccccccccccc----------------------------cccccccccccccccccccccccc
Confidence            9999999999999999888888776653                            345556666666655555555443


Q ss_pred             cceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEE
Q 046240          235 FLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNI  314 (763)
Q Consensus       235 L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  314 (763)
                      + .+++++|.+.+.+|..+..+.+  ++.+++++|.+.+.+|   .+..+++|+.|+|++|++++.+|..|+++++|++|
T Consensus       200 ~-~l~l~~~~~~~~~~~~~~~~~~--l~~l~~~~~~l~~~~~---~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L  273 (313)
T d1ogqa_         200 A-FVDLSRNMLEGDASVLFGSDKN--TQKIHLAKNSLAFDLG---KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL  273 (313)
T ss_dssp             S-EEECCSSEEEECCGGGCCTTSC--CSEEECCSSEECCBGG---GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEE
T ss_pred             c-cccccccccccccccccccccc--cccccccccccccccc---ccccccccccccCccCeecccCChHHhCCCCCCEE
Confidence            3 4556666665555555555544  6666666666654443   24555666666666666666666666666666666


Q ss_pred             EccCccccCcccccccccccccEEeCcCCc
Q 046240          315 SLPYNRLEGPIPESFGYLTSLEILDLSNNK  344 (763)
Q Consensus       315 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  344 (763)
                      +|++|+|+|.+|. ++.+++|+.+++++|+
T Consensus       274 ~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         274 NVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             ECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             ECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            6666666666653 4556666666666665

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6e-27  Score=241.29  Aligned_cols=251  Identities=23%  Similarity=0.219  Sum_probs=205.2

Q ss_pred             CEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchh
Q 046240          104 TKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIE  183 (763)
Q Consensus       104 ~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  183 (763)
                      ..++.++++++       ++|..++   +++++|+|++|+|+++.+..|.++++|++|++++|+|..+.+..+.+++.  
T Consensus        14 ~~v~c~~~~L~-------~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~--   81 (284)
T d1ozna_          14 VTTSCPQQGLQ-------AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL--   81 (284)
T ss_dssp             CEEECCSSCCS-------SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT--
T ss_pred             eEEEcCCCCCC-------ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccc--
Confidence            34566666665       7777664   46788888888888777778888888888888888888777766665553  


Q ss_pred             hhhhhhhccCCcccccCCcccccccccccEEEe-ecCccccccccccCCccccceeecccccccCCCCccccccCCCCcc
Q 046240          184 WLGLVIGLIGNPLNGILPSSIVNLSISLERLYI-SNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLD  262 (763)
Q Consensus       184 ~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L-~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~  262 (763)
                                                 +..++. ..|.++...+..|+++++|++|++++|.+....+..+....+  |+
T Consensus        82 ---------------------------~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~--L~  132 (284)
T d1ozna_          82 ---------------------------LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA--LQ  132 (284)
T ss_dssp             ---------------------------CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT--CC
T ss_pred             ---------------------------ccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcc--cc
Confidence                                       444443 456677777889999999999999999999777777887766  99


Q ss_pred             EEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcC
Q 046240          263 TLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN  342 (763)
Q Consensus       263 ~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  342 (763)
                      .+++++|++++..+.  .|..+++|++|++++|++++..+.+|.++++|+.+++++|++++..|..|..+++|++|++++
T Consensus       133 ~l~l~~N~l~~i~~~--~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~  210 (284)
T d1ozna_         133 YLYLQDNALQALPDD--TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA  210 (284)
T ss_dssp             EEECCSSCCCCCCTT--TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             hhhhccccccccChh--HhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccc
Confidence            999999999966666  688999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCCCcccCCC
Q 046240          343 NKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       343 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      |++.++.+..|..+++|++|+|++|++.+..+...-...+.......+...|..|
T Consensus       211 N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p  265 (284)
T d1ozna_         211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP  265 (284)
T ss_dssp             SCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred             cccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCc
Confidence            9999999999999999999999999999876543222234444445555666544

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.94  E-value=4.5e-26  Score=245.36  Aligned_cols=278  Identities=24%  Similarity=0.356  Sum_probs=195.9

Q ss_pred             CCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCC
Q 046240           76 SHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNA  155 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l  155 (763)
                      ..++++|++++++|+. + +.+..|++|++|+|++|+|+       .+|+  +.++++|++|++++|+|++..  .++++
T Consensus        43 l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~-------~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l  109 (384)
T d2omza2          43 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLT-------DITP--LKNLTKLVDILMNNNQIADIT--PLANL  109 (384)
T ss_dssp             HTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCC-------CCGG--GTTCTTCCEEECCSSCCCCCG--GGTTC
T ss_pred             hCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCC-------CCcc--ccCCccccccccccccccccc--ccccc
Confidence            3578999999999985 3 46888999999999999986       5554  558999999999999998654  38899


Q ss_pred             CCCCeeeecCccccccccc-------------------------------------------------------------
Q 046240          156 SKLTILELGGNSFSGFIPN-------------------------------------------------------------  174 (763)
Q Consensus       156 ~~L~~L~L~~N~l~~~~p~-------------------------------------------------------------  174 (763)
                      ++|+.|++++|.+++..+.                                                             
T Consensus       110 ~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (384)
T d2omza2         110 TNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD  189 (384)
T ss_dssp             TTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccc
Confidence            9999999999888753321                                                             


Q ss_pred             --ccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCcc
Q 046240          175 --TIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVT  252 (763)
Q Consensus       175 --~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  252 (763)
                        .+..+++++.|+    +++|.+++..|.  .... +|++|++++|+++..  +.+..+++|+.|++++|++++..+  
T Consensus       190 ~~~~~~l~~~~~l~----l~~n~i~~~~~~--~~~~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--  258 (384)
T d2omza2         190 ISVLAKLTNLESLI----ATNNQISDITPL--GILT-NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--  258 (384)
T ss_dssp             CGGGGGCTTCSEEE----CCSSCCCCCGGG--GGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred             ccccccccccceee----ccCCccCCCCcc--cccC-CCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--
Confidence              233334444444    556666654432  2233 677777777777642  246667777777777777775433  


Q ss_pred             ccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCccccccccc
Q 046240          253 FGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYL  332 (763)
Q Consensus       253 ~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  332 (763)
                      +..+++  |+.|++++|++++ ++   .+..++.++.+++++|++++  ...+..+++++.|++++|++++..  .+..+
T Consensus       259 ~~~~~~--L~~L~l~~~~l~~-~~---~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l  328 (384)
T d2omza2         259 LSGLTK--LTELKLGANQISN-IS---PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSL  328 (384)
T ss_dssp             GTTCTT--CSEEECCSSCCCC-CG---GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGC
T ss_pred             cccccc--CCEeeccCcccCC-CC---cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccC
Confidence            555544  7777777777763 22   25566677777777777764  334777788888888888888643  27778


Q ss_pred             ccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCCCCCCCccccccccccCC
Q 046240          333 TSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEIPRGGPFANFTAKSFMGN  390 (763)
Q Consensus       333 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n  390 (763)
                      ++|++|++++|+|+++ + .+.++++|++|++++|++++.+| ...+++++.+++.+|
T Consensus       329 ~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         329 TKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             TTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            8888888888888863 2 57888888888888888887665 445667777777665

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.92  E-value=1.3e-24  Score=233.88  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=217.8

Q ss_pred             cceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccccccc
Q 046240           68 IGITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGT  147 (763)
Q Consensus        68 ~gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~  147 (763)
                      +|+..   ..++++|+|++|+|++. | .|+++++|++|++++|.++       .+++  +.++++|+.|++++|.+++.
T Consensus        60 ~gl~~---L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~-------~i~~--l~~l~~L~~L~~~~~~~~~~  125 (384)
T d2omza2          60 DGVEY---LNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA-------DITP--LANLTNLTGLTLFNNQITDI  125 (384)
T ss_dssp             TTGGG---CTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-------CCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred             ccccc---CCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccc-------cccc--cccccccccccccccccccc
Confidence            45543   46899999999999964 4 3999999999999999996       4443  34899999999999887642


Q ss_pred             C---------------------------------------------------------------CCcccCCCCCCeeeec
Q 046240          148 I---------------------------------------------------------------QSPITNASKLTILELG  164 (763)
Q Consensus       148 ~---------------------------------------------------------------p~~~~~l~~L~~L~L~  164 (763)
                      .                                                               ...+..+++++.|+++
T Consensus       126 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~  205 (384)
T d2omza2         126 DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIAT  205 (384)
T ss_dssp             GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeecc
Confidence            1                                                               1245667889999999


Q ss_pred             CcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeeccccc
Q 046240          165 GNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNK  244 (763)
Q Consensus       165 ~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  244 (763)
                      +|++++..|  +...++|+.|+    +.+|.++..  ..+..+. +|+.|++++|++++..+  ++.+++|++|++++|+
T Consensus       206 ~n~i~~~~~--~~~~~~L~~L~----l~~n~l~~~--~~l~~l~-~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~  274 (384)
T d2omza2         206 NNQISDITP--LGILTNLDELS----LNGNQLKDI--GTLASLT-NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ  274 (384)
T ss_dssp             SSCCCCCGG--GGGCTTCCEEE----CCSSCCCCC--GGGGGCT-TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred             CCccCCCCc--ccccCCCCEEE----CCCCCCCCc--chhhccc-ccchhccccCccCCCCc--ccccccCCEeeccCcc
Confidence            999998765  56678899988    889998863  4677777 99999999999997654  8889999999999999


Q ss_pred             ccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCc
Q 046240          245 LTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGP  324 (763)
Q Consensus       245 l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  324 (763)
                      +++..+  +..+..  ++.+++++|++++ ++   .+..+++++.|++++|++++..  .+..+++|++|++++|+|++ 
T Consensus       275 l~~~~~--~~~~~~--l~~l~~~~n~l~~-~~---~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-  343 (384)
T d2omza2         275 ISNISP--LAGLTA--LTNLELNENQLED-IS---PISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-  343 (384)
T ss_dssp             CCCCGG--GTTCTT--CSEEECCSSCCSC-CG---GGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-
T ss_pred             cCCCCc--cccccc--ccccccccccccc-cc---ccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-
Confidence            996443  666665  9999999999984 33   4788999999999999999754  38899999999999999985 


Q ss_pred             ccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccc
Q 046240          325 IPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFN  367 (763)
Q Consensus       325 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  367 (763)
                      ++ .+..+++|++|++++|+|+++.|  +.++++|+.|+|++|
T Consensus       344 l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         344 VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            44 58999999999999999999765  899999999999998

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.3e-24  Score=216.06  Aligned_cols=201  Identities=20%  Similarity=0.196  Sum_probs=114.3

Q ss_pred             cCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccc
Q 046240          130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSI  209 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~  209 (763)
                      +..++.+++.+++.|+. +|..+.  ++|++|+|++|+|+++.+.+|.+++                             
T Consensus         8 ~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~-----------------------------   55 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYT-----------------------------   55 (266)
T ss_dssp             CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCT-----------------------------
T ss_pred             ccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccc-----------------------------
Confidence            44556666777777773 455443  4567777777777655555555544                             


Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +|++|+|++|+|+.. | .++.+++|++|+|++|+++ ..+..+.++++  |+.|++++|.+.+..+.  .+..+.++++
T Consensus        56 ~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~--L~~L~l~~~~~~~~~~~--~~~~l~~l~~  128 (266)
T d1p9ag_          56 RLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA--LTVLDVSFNRLTSLPLG--ALRGLGELQE  128 (266)
T ss_dssp             TCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTT--CCEEECCSSCCCCCCSS--TTTTCTTCCE
T ss_pred             ccccccccccccccc-c-ccccccccccccccccccc-ccccccccccc--cccccccccccceeecc--cccccccccc
Confidence            455555666666532 2 2456667777777777766 34555555544  66666666666543333  4555555666


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccC
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKL  369 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  369 (763)
                      |++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+. +|..+..+++|+.|+|++|++
T Consensus       129 L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~-lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCCCSEEECCSCCB
T ss_pred             ccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcc-cChhHCCCCCCCEEEecCCCC
Confidence            6666666655555555555555555555555555555555555555555555555553 344444455555555544444


Q ss_pred             C
Q 046240          370 E  370 (763)
Q Consensus       370 ~  370 (763)
                      .
T Consensus       208 ~  208 (266)
T d1p9ag_         208 L  208 (266)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1e-23  Score=214.41  Aligned_cols=203  Identities=22%  Similarity=0.267  Sum_probs=159.0

Q ss_pred             cCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCccccccccccc
Q 046240           97 IGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTI  176 (763)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  176 (763)
                      ..+...+.+.+.+++.++       .||+++.   ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+ | .+
T Consensus         6 ~~~~~~~~~v~C~~~~L~-------~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~   73 (266)
T d1p9ag_           6 VSKVASHLEVNCDKRNLT-------ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VD   73 (266)
T ss_dssp             EECSTTCCEEECTTSCCS-------SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CC
T ss_pred             EcccCCCeEEEccCCCCC-------eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cc
Confidence            345667777888888886       6777664   5788888888888877778888888888888888888743 2 12


Q ss_pred             CCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCcccccc
Q 046240          177 GNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRL  256 (763)
Q Consensus       177 ~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  256 (763)
                      +.++                             +|++|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+
T Consensus        74 ~~l~-----------------------------~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l  123 (266)
T d1p9ag_          74 GTLP-----------------------------VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL  123 (266)
T ss_dssp             SCCT-----------------------------TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTC
T ss_pred             cccc-----------------------------ccccccccccccc-ccccccccccccccccccccccceeeccccccc
Confidence            2222                             6777888888887 456678888888888888888887777777777


Q ss_pred             CCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCccccccccccccc
Q 046240          257 QNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLE  336 (763)
Q Consensus       257 ~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  336 (763)
                      .+  +++|++++|.++...+.  .+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+
T Consensus       124 ~~--l~~L~l~~n~l~~l~~~--~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~  198 (266)
T d1p9ag_         124 GE--LQELYLKGNELKTLPPG--LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP  198 (266)
T ss_dssp             TT--CCEEECTTSCCCCCCTT--TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCS
T ss_pred             cc--cccccccccccceeccc--cccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCC
Confidence            66  88888888888855555  6777888888888888888877788888888888888888888 6777777888888


Q ss_pred             EEeCcCCccC
Q 046240          337 ILDLSNNKIS  346 (763)
Q Consensus       337 ~L~L~~N~l~  346 (763)
                      .|+|++|++.
T Consensus       199 ~L~L~~Np~~  208 (266)
T d1p9ag_         199 FAFLHGNPWL  208 (266)
T ss_dssp             EEECCSCCBC
T ss_pred             EEEecCCCCC
Confidence            8888888876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=4.3e-22  Score=191.47  Aligned_cols=163  Identities=18%  Similarity=0.161  Sum_probs=120.3

Q ss_pred             CcCceecccCCceEEEEEecCCceEEEEEeehhh------------------HHHHHHHHHHHHHHHhCCCCccceEEee
Q 046240          478 GRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQEC------------------ARAMKSFEVECEVMKNIRHRNLVKIISG  539 (763)
Q Consensus       478 ~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~l~~~  539 (763)
                      .+++.||+|+||+||+|...+|+.||||+++...                  ........+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4578999999999999988889999999875211                  1112345678899999999999988866


Q ss_pred             eecCCceEEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeCCCCCCCEEecCCCcEEEeee
Q 046240          540 CSNDDFKALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFRHTTPIIHCDLKSSNVLLDEDMIAHLSDF  619 (763)
Q Consensus       540 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~dlk~~NIll~~~~~~kl~Df  619 (763)
                      ..    .+++|||++++.+..+        +......++.|++++++||   |+.+|+||||||+|||++++ .++|+||
T Consensus        83 ~~----~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCC-CEEEEEC
Confidence            32    3799999998766443        2223457899999999999   77899999999999999975 5899999


Q ss_pred             cCceecCCCCCccccccccccccccC------ccccCCCCCCcchhHHHHHHHH
Q 046240          620 GIAKLLSGEDQSMTQTQTLATIGYMA------PEYGIERKVSTRSDIYSYGIML  667 (763)
Q Consensus       620 gla~~~~~~~~~~~~~~~~g~~~y~a------PE~~~~~~~~~~~Dv~slGv~l  667 (763)
                      |.|.........          .|..      .| ...+.|+.++|+||..--+
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence            999875422110          1111      01 1246678899999976544

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=6e-20  Score=183.60  Aligned_cols=219  Identities=17%  Similarity=0.126  Sum_probs=128.3

Q ss_pred             EEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccC-CCcccCCCCCC
Q 046240           81 ALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTI-QSPITNASKLT  159 (763)
Q Consensus        81 ~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~-p~~~~~l~~L~  159 (763)
                      .++.++++++ .+|+.+.  +++++|+|++|+|+       .+|...|.++++|++|+|++|.+...+ +..|.++++++
T Consensus        12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-------~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~   81 (242)
T d1xwdc1          12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-------VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLH   81 (242)
T ss_dssp             EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-------EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCC
T ss_pred             EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-------ccChhHhhccchhhhhhhccccccceeeccccccccccc
Confidence            4556667777 5665553  46778888887774       677777777777777777777776543 44667777777


Q ss_pred             eeeecC-cccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcccccccc-ccCCccccce
Q 046240          160 ILELGG-NSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQ-VMGNLSIFLL  237 (763)
Q Consensus       160 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~  237 (763)
                      +|++.. |++....+..|.++++|+.|                             ++++|++....+. .+..+..+..
T Consensus        82 ~l~~~~~n~l~~~~~~~~~~l~~L~~l-----------------------------~l~~~~l~~~~~~~~~~~l~~l~~  132 (242)
T d1xwdc1          82 EIRIEKANNLLYINPEAFQNLPNLQYL-----------------------------LISNTGIKHLPDVHKIHSLQKVLL  132 (242)
T ss_dssp             EEEEECCTTCCEECTTSEECCTTCCEE-----------------------------EEESCCCCSCCCCTTTCBSSCEEE
T ss_pred             ccccccccccccccccccccccccccc-----------------------------ccchhhhccccccccccccccccc
Confidence            777653 56666666666666655544                             4444444422221 1233344444


Q ss_pred             eecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE-EEcccccccccCCcccCCCcCccEEEc
Q 046240          238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE-INLSRNNFSGDIPATIGGLKDVQNISL  316 (763)
Q Consensus       238 L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L  316 (763)
                      +..+++.+....+..|.++. ..++.|++++|+++...+.  .+ ...++++ +++++|+++.+.+..|.++++|++|+|
T Consensus       133 ~~~~n~~l~~i~~~~~~~~~-~~l~~L~l~~n~l~~i~~~--~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~L  208 (242)
T d1xwdc1         133 DIQDNINIHTIERNSFVGLS-FESVILWLNKNGIQEIHNC--AF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI  208 (242)
T ss_dssp             EEESCTTCCEECTTSSTTSB-SSCEEEECCSSCCCEECTT--TT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEEC
T ss_pred             cccccccccccccccccccc-ccceeeecccccccccccc--cc-cchhhhccccccccccccccHHHhcCCCCCCEEEC
Confidence            44444455444444444433 1356666666666633222  22 2333333 345666676555556777777777777


Q ss_pred             cCccccCcccccccccccccEEeCcC
Q 046240          317 PYNRLEGPIPESFGYLTSLEILDLSN  342 (763)
Q Consensus       317 s~N~l~~~~p~~~~~l~~L~~L~L~~  342 (763)
                      ++|+|+...+..|..+++|+.|++.+
T Consensus       209 s~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         209 SRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             TTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             CCCcCCccCHHHHcCCcccccCcCCC
Confidence            77777755555677777777666543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=7.2e-20  Score=183.00  Aligned_cols=220  Identities=17%  Similarity=0.124  Sum_probs=163.4

Q ss_pred             CEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCccccccc-ccccCCCCch
Q 046240          104 TKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFI-PNTIGNLRNI  182 (763)
Q Consensus       104 ~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L  182 (763)
                      +.++.+++.++       .+|.+++   +++++|+|++|+|+.+.+..|.++++|++|+|++|.+...+ +.+|.+++  
T Consensus        11 ~~i~c~~~~l~-------~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~--   78 (242)
T d1xwdc1          11 RVFLCQESKVT-------EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP--   78 (242)
T ss_dssp             SEEEEESCSCS-------SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCT--
T ss_pred             CEEEEeCCCCC-------CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccc--
Confidence            46677766664       6777664   46788888888887666667788888888888888776543 33455544  


Q ss_pred             hhhhhhhhccCCcccccCCcccccccccccEEEee-cCccccccccccCCccccceeecccccccCCCCcc-ccccCCCC
Q 046240          183 EWLGLVIGLIGNPLNGILPSSIVNLSISLERLYIS-NCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVT-FGRLQNSK  260 (763)
Q Consensus       183 ~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~~~  260 (763)
                                                 +++++.+. .|.+....+..|.++++|++|++++|+++...+.. +..++.  
T Consensus        79 ---------------------------~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~--  129 (242)
T d1xwdc1          79 ---------------------------KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK--  129 (242)
T ss_dssp             ---------------------------TCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSC--
T ss_pred             ---------------------------ccccccccccccccccccccccccccccccccchhhhcccccccccccccc--
Confidence                                       56666655 46777788889999999999999999998543332 334443  


Q ss_pred             ccEEEecCCccccCCCCccccccCC-cccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEe
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLK-VVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILD  339 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  339 (763)
                      +..+..+++.+....+.  .+.+++ .++.|++++|+++...+..+....-++.+++++|+++...+..|.++++|++|+
T Consensus       130 l~~~~~~n~~l~~i~~~--~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~  207 (242)
T d1xwdc1         130 VLLDIQDNINIHTIERN--SFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD  207 (242)
T ss_dssp             EEEEEESCTTCCEECTT--SSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEE
T ss_pred             ccccccccccccccccc--ccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEE
Confidence            77778888888854444  555554 789999999999966665555443344556888999966667799999999999


Q ss_pred             CcCCccCCccchhhhhhccCceEEccc
Q 046240          340 LSNNKISGFILISLEKLLYLKKLNLSF  366 (763)
Q Consensus       340 L~~N~l~~~~~~~~~~l~~L~~L~l~~  366 (763)
                      |++|+|+.+++..|.++++|+.+++.+
T Consensus       208 Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         208 ISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             CCCCcCCccCHHHHcCCcccccCcCCC
Confidence            999999998888899998888877754

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=8.2e-20  Score=175.42  Aligned_cols=179  Identities=23%  Similarity=0.295  Sum_probs=120.4

Q ss_pred             ceeecCCCCceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccC
Q 046240           69 GITCDVNSHRVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTI  148 (763)
Q Consensus        69 gv~c~~~~~~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~  148 (763)
                      |++|..     +.++.++++++ .+|..+.  +++++|+|++|+|+      +.++...|.++++|++|+|++|.+++..
T Consensus         5 ~C~C~~-----~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~------~~~~~~~f~~l~~L~~L~L~~N~i~~~~   70 (192)
T d1w8aa_           5 MCHCEG-----TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELG------RISSDGLFGRLPHLVKLELKRNQLTGIE   70 (192)
T ss_dssp             TSEEET-----TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCC------SBCCSCSGGGCTTCCEEECCSSCCCCBC
T ss_pred             CCEEcC-----CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCc------ccccccccCCCceEeeeecccccccccc
Confidence            555642     35778888888 6777664  68999999999886      3577888888999999999999999888


Q ss_pred             CCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccc
Q 046240          149 QSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQV  228 (763)
Q Consensus       149 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~  228 (763)
                      +..|..+++|++|+|++|+|+.+.|++|.++++                             |++|+|++|+|++..+++
T Consensus        71 ~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~-----------------------------L~~L~L~~N~l~~i~~~~  121 (192)
T d1w8aa_          71 PNAFEGASHIQELQLGENKIKEISNKMFLGLHQ-----------------------------LKTLNLYDNQISCVMPGS  121 (192)
T ss_dssp             TTTTTTCTTCCEEECCSCCCCEECSSSSTTCTT-----------------------------CCEEECCSSCCCEECTTS
T ss_pred             ccccccccccceeeeccccccccCHHHHhCCCc-----------------------------ccccccCCccccccCHHH
Confidence            889999999999999999999888888887775                             455555555555555555


Q ss_pred             cCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEccccccc
Q 046240          229 MGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFS  298 (763)
Q Consensus       229 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~  298 (763)
                      |..+++|++|+|++|.+....+..+. ...  ++.+.+..|.++...|.  .   +..++.++|+.|.++
T Consensus       122 f~~l~~L~~l~L~~N~~~~~~~~~~~-~~~--l~~~~l~~~~~~c~~p~--~---l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         122 FEHLNSLTSLNLASNPFNCNCHLAWF-AEW--LRKKSLNGGAARCGAPS--K---VRDVQIKDLPHSEFK  183 (192)
T ss_dssp             STTCTTCCEEECTTCCBCCSGGGHHH-HHH--HHHHCCSGGGCBBCSST--T---TTTSBGGGSCTTTCC
T ss_pred             hcCCcccccccccccccccccchHHH-hhh--hhhhcccCCCeEeCCCh--h---hcCCEeeecCHhhCc
Confidence            55666666666666655532221110 111  44445555555544443  2   333444566666665

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.78  E-value=6.9e-18  Score=178.05  Aligned_cols=96  Identities=23%  Similarity=0.381  Sum_probs=71.0

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      ++++|||++++|+ .+|+.   +++|++|+|++|+|+       .+|..    +.+|+.|++++|+++. ++..   .+.
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-------~lp~~----~~~L~~L~l~~n~l~~-l~~l---p~~   99 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-------ELPEL----PQSLKSLLVDNNNLKA-LSDL---PPL   99 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-------SCCCC----CTTCCEEECCSSCCSC-CCSC---CTT
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-------ccccc----hhhhhhhhhhhcccch-hhhh---ccc
Confidence            5788999999988 56753   568889999999886       67753    4578888999988873 3321   245


Q ss_pred             CCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccc
Q 046240          158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNG  198 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~  198 (763)
                      |++|++++|+|+. +|. ++.+++|+.|+    +.+|.+..
T Consensus       100 L~~L~L~~n~l~~-lp~-~~~l~~L~~L~----l~~~~~~~  134 (353)
T d1jl5a_         100 LEYLGVSNNQLEK-LPE-LQNSSFLKIID----VDNNSLKK  134 (353)
T ss_dssp             CCEEECCSSCCSS-CCC-CTTCTTCCEEE----CCSSCCSC
T ss_pred             ccccccccccccc-ccc-hhhhccceeec----cccccccc
Confidence            8889999998884 453 67888888888    66666553

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=1.4e-19  Score=178.94  Aligned_cols=188  Identities=21%  Similarity=0.281  Sum_probs=132.3

Q ss_pred             cCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccc
Q 046240          130 ALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSI  209 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~  209 (763)
                      .+.+|++|++.+|.|+..  ..+.++++|++|++++|+|++..|  |.                            ++. 
T Consensus        39 ~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~----------------------------~l~-   85 (227)
T d1h6ua2          39 DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LK----------------------------NLT-   85 (227)
T ss_dssp             HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GT----------------------------TCC-
T ss_pred             HcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cc----------------------------ccc-
Confidence            455566666666666532  235666666666666666654322  33                            333 


Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +|+++++++|.++. ++ .+.++++|+.+++++|...+..+  +.....  +..+.++++.+....    .+.+.++|++
T Consensus        86 ~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~--~~~l~~~~~~~~~~~----~~~~~~~L~~  155 (227)
T d1h6ua2          86 KITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSN--LQVLYLDLNQITNIS----PLAGLTNLQY  155 (227)
T ss_dssp             SCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGG--GTTCTT--CCEEECCSSCCCCCG----GGGGCTTCCE
T ss_pred             cccccccccccccc-cc-cccccccccccccccccccccch--hccccc--hhhhhchhhhhchhh----hhcccccccc
Confidence            67777777777763 22 46778888888888888774332  344433  888888888876322    4677888999


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEccc
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF  366 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  366 (763)
                      |++++|.++..  ..++++++|+.|+|++|++++ ++ .++.+++|++|+|++|+|+++.|  +.++++|+.|++++
T Consensus       156 L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         156 LSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             ccccccccccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence            99999988743  348889999999999999985 33 37889999999999999998643  78899999999874

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=7.4e-19  Score=168.67  Aligned_cols=178  Identities=22%  Similarity=0.225  Sum_probs=136.8

Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCC-CCccccccCCCCccEEEecCCccccCCCCccccccCCccc
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGP-IPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV  288 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~  288 (763)
                      +.++++.++|+++ .+|..+.  +++++|+|++|+|++. .+..|.++++  |++|+|++|++.+..+.  .+..+++|+
T Consensus         9 ~~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~--L~~L~L~~N~i~~~~~~--~~~~~~~L~   81 (192)
T d1w8aa_           9 EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPH--LVKLELKRNQLTGIEPN--AFEGASHIQ   81 (192)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTT--CCEEECCSSCCCCBCTT--TTTTCTTCC
T ss_pred             cCCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCce--Eeeeecccccccccccc--ccccccccc
Confidence            3457888888888 4555443  6788888888888753 4556777866  88888888888877776  788888999


Q ss_pred             EEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEccccc
Q 046240          289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNK  368 (763)
Q Consensus       289 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  368 (763)
                      +|+|++|+|+++.|.+|.++++|++|+|++|+|++..++.|..+++|++|+|++|.+...... ..-...++.+.+..|.
T Consensus        82 ~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~  160 (192)
T d1w8aa_          82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGA  160 (192)
T ss_dssp             EEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGG
T ss_pred             eeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCC
Confidence            999999999988888899999999999999999987888889999999999999988764322 2223446677788888


Q ss_pred             CCCCCCCCCCccccccccccCCCcccCCC
Q 046240          369 LEGEIPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       369 l~~~~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      +++..|..  +..+...++..|...|..+
T Consensus       161 ~~c~~p~~--l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         161 ARCGAPSK--VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             CBBCSSTT--TTTSBGGGSCTTTCCCCCC
T ss_pred             eEeCCChh--hcCCEeeecCHhhCcCCCC
Confidence            88776643  4556667777887777665

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=2.4e-18  Score=169.91  Aligned_cols=207  Identities=23%  Similarity=0.328  Sum_probs=140.7

Q ss_pred             ceEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCC
Q 046240           78 RVTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASK  157 (763)
Q Consensus        78 ~v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~  157 (763)
                      ++..++++.+++++.+  .+..|.+|++|++.+|.|+       .++ + +..+++|++|++++|+|++..|  +.++++
T Consensus        20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-------~l~-~-l~~l~~L~~L~ls~n~i~~~~~--l~~l~~   86 (227)
T d1h6ua2          20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-------TIE-G-VQYLNNLIGLELKDNQITDLAP--LKNLTK   86 (227)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-------CCT-T-GGGCTTCCEEECCSSCCCCCGG--GTTCCS
T ss_pred             HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-------cch-h-HhcCCCCcEeecCCceeecccc--cccccc
Confidence            4455667777777644  4677899999999999996       553 3 3589999999999999997654  899999


Q ss_pred             CCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccce
Q 046240          158 LTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLL  237 (763)
Q Consensus       158 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  237 (763)
                      |++|++++|.++.+ + .|.++++|+                             ++++++|...+..  .+...+.+..
T Consensus        87 l~~l~~~~n~~~~i-~-~l~~l~~L~-----------------------------~l~l~~~~~~~~~--~~~~~~~~~~  133 (227)
T d1h6ua2          87 ITELELSGNPLKNV-S-AIAGLQSIK-----------------------------TLDLTSTQITDVT--PLAGLSNLQV  133 (227)
T ss_dssp             CCEEECCSCCCSCC-G-GGTTCTTCC-----------------------------EEECTTSCCCCCG--GGTTCTTCCE
T ss_pred             cccccccccccccc-c-ccccccccc-----------------------------ccccccccccccc--hhccccchhh
Confidence            99999999998843 2 355555444                             4455555444222  2444556666


Q ss_pred             eecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEcc
Q 046240          238 LDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLP  317 (763)
Q Consensus       238 L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  317 (763)
                      +.++.+.+....  .+.+.++  |++|++++|.+.+ .+   .+.++++|++|+|++|++++. + .++++++|++|+|+
T Consensus       134 l~~~~~~~~~~~--~~~~~~~--L~~L~l~~n~~~~-~~---~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls  203 (227)
T d1h6ua2         134 LYLDLNQITNIS--PLAGLTN--LQYLSIGNAQVSD-LT---PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLK  203 (227)
T ss_dssp             EECCSSCCCCCG--GGGGCTT--CCEEECCSSCCCC-CG---GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECT
T ss_pred             hhchhhhhchhh--hhccccc--ccccccccccccc-ch---hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECc
Confidence            666666665322  2444443  6777777776652 22   356677777777777777743 2 36777788888888


Q ss_pred             CccccCcccccccccccccEEeCcC
Q 046240          318 YNRLEGPIPESFGYLTSLEILDLSN  342 (763)
Q Consensus       318 ~N~l~~~~p~~~~~l~~L~~L~L~~  342 (763)
                      +|++++..|  ++.+++|+.|+|++
T Consensus       204 ~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         204 NNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             TSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             CCcCCCCcc--cccCCCCCEEEeeC
Confidence            887774332  67778888887763

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=6.9e-18  Score=164.21  Aligned_cols=141  Identities=27%  Similarity=0.352  Sum_probs=89.4

Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +|++|+|++|+|++..+  ++.+++|++|++++|+|++ +| .+.++++  |+.|++++|.+. .++   .+..++.|+.
T Consensus        69 ~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~--L~~L~l~~~~~~-~~~---~l~~l~~l~~  138 (210)
T d1h6ta2          69 NVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKK--LKSLSLEHNGIS-DIN---GLVHLPQLES  138 (210)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTT--CCEEECTTSCCC-CCG---GGGGCTTCCE
T ss_pred             CCCEEeCCCccccCccc--cccCccccccccccccccc-cc-ccccccc--cccccccccccc-ccc---cccccccccc
Confidence            55555666666554332  4556666666666666653 33 3555544  666666666665 333   3566677777


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceEEccc
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSF  366 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  366 (763)
                      +++++|.+++  +..+..+++|+.+++++|++++. + .+..+++|++|+|++|+|+.+ + .+.++++|++|+|++
T Consensus       139 l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         139 LYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             EECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred             cccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence            7777777763  33466677777777777777743 3 267777788888888877763 3 477777888887764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=3.2e-18  Score=165.19  Aligned_cols=182  Identities=26%  Similarity=0.391  Sum_probs=117.8

Q ss_pred             CCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccc
Q 046240          132 PNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISL  211 (763)
Q Consensus       132 ~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L  211 (763)
                      +++..+.++.+.+++.++  ...+.+|++|++++|.|+.+ + .+..                            ++ +|
T Consensus        18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l-~-~l~~----------------------------l~-nL   64 (199)
T d2omxa2          18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-D-GVEY----------------------------LN-NL   64 (199)
T ss_dssp             HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC-T-TGGG----------------------------CT-TC
T ss_pred             HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc-c-cccc----------------------------CC-Cc
Confidence            344455666666665432  24566777777777776632 1 1222                            22 67


Q ss_pred             cEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEE
Q 046240          212 ERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEIN  291 (763)
Q Consensus       212 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~  291 (763)
                      ++|+|++|++++..|  ++++++|++|++++|.+.. ++ .+.+++.  |+.|++++|.+.. ++   .+..+++|+.|+
T Consensus        65 ~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~--L~~L~l~~~~~~~-~~---~~~~l~~L~~L~  134 (199)
T d2omxa2          65 TQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTN--LTGLTLFNNQITD-ID---PLKNLTNLNRLE  134 (199)
T ss_dssp             CEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTT--CSEEECCSSCCCC-CG---GGTTCTTCSEEE
T ss_pred             CcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccc--ccccccccccccc-cc---ccchhhhhHHhh
Confidence            777777777775443  7777777777777777763 33 3666655  7777777777763 22   356677777888


Q ss_pred             cccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccchhhhhhccCceE
Q 046240          292 LSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKL  362 (763)
Q Consensus       292 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  362 (763)
                      +++|++.. + ..+..+++|+.|++++|++++. + .++.+++|++|++++|+++++  +.+.++++|+.|
T Consensus       135 l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L  199 (199)
T d2omxa2         135 LSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL  199 (199)
T ss_dssp             CCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             hhhhhhcc-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence            88887763 2 3577777888888888877743 2 367778888888888887763  246677777664

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=2.1e-17  Score=160.67  Aligned_cols=119  Identities=24%  Similarity=0.390  Sum_probs=77.4

Q ss_pred             cccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccE
Q 046240          210 SLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVE  289 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~  289 (763)
                      +|++|++++|+|++ +| .+..+++|+.|++++|.+.. + ..+..++.  ++.+++++|.+++ .+   .+..+++|+.
T Consensus        91 ~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~--l~~l~~~~n~l~~-~~---~~~~l~~L~~  160 (210)
T d1h6ta2          91 NLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQ--LESLYLGNNKITD-IT---VLSRLTKLDT  160 (210)
T ss_dssp             TCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTT--CCEEECCSSCCCC-CG---GGGGCTTCSE
T ss_pred             cccccccccccccc-cc-cccccccccccccccccccc-c-cccccccc--ccccccccccccc-cc---cccccccccc
Confidence            55566666666653 22 35666666666666666652 2 23555544  7777777777663 22   3566777788


Q ss_pred             EEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcC
Q 046240          290 INLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN  342 (763)
Q Consensus       290 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  342 (763)
                      +++++|++++. + .+.++++|+.|+|++|+|+. ++ .+..+++|++|+|++
T Consensus       161 l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         161 LSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             EECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             ccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            88888877743 2 37778888888888888873 44 477788888888764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=6.6e-18  Score=162.92  Aligned_cols=183  Identities=23%  Similarity=0.343  Sum_probs=125.1

Q ss_pred             CCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCC
Q 046240          100 LPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNL  179 (763)
Q Consensus       100 l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  179 (763)
                      +.++..+.++.+.++      +.++.   ..+++|++|++++|.|+..  +.+..+++|++|+|++|+|++..|  |+++
T Consensus        17 l~~~i~~~l~~~~~~------~~~~~---~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l   83 (199)
T d2omxa2          17 LAEKMKTVLGKTNVT------DTVSQ---TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNL   83 (199)
T ss_dssp             HHHHHHHHTTCSSTT------SEECH---HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTC
T ss_pred             HHHHHHHHhCCCCCC------CccCH---HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCC
Confidence            334445667777665      22221   2578999999999999854  358899999999999999996543  6666


Q ss_pred             CchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCC
Q 046240          180 RNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNS  259 (763)
Q Consensus       180 ~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~  259 (763)
                      +                             +|++|++++|.+... + .++++++|+.|++++|.+...  ..+..+++ 
T Consensus        84 ~-----------------------------~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~-  129 (199)
T d2omxa2          84 T-----------------------------KLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTN-  129 (199)
T ss_dssp             T-----------------------------TCCEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTT-
T ss_pred             c-----------------------------ccccccccccccccc-c-ccccccccccccccccccccc--cccchhhh-
Confidence            5                             455555666655532 2 266667777777777766632  23555554 


Q ss_pred             CccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEE
Q 046240          260 KLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEIL  338 (763)
Q Consensus       260 ~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  338 (763)
                       |+.|++++|++. .++   .+..+++|+.|++++|++++.  ..++++++|+.|++++|++++ ++ .++.+++|+.|
T Consensus       130 -L~~L~l~~n~l~-~~~---~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         130 -LNRLELSSNTIS-DIS---ALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             -CSEEECCSSCCC-CCG---GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             -hHHhhhhhhhhc-ccc---cccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence             777777777776 333   366777888888888888753  247788888888888888874 33 46777777765

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.68  E-value=1.7e-15  Score=159.40  Aligned_cols=251  Identities=23%  Similarity=0.280  Sum_probs=150.5

Q ss_pred             CCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCcccccccccccCCCC
Q 046240          101 PSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSGFIPNTIGNLR  180 (763)
Q Consensus       101 ~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  180 (763)
                      .+|++|||++|.++       ++|+    .+++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++. ++...   +
T Consensus        38 ~~l~~LdLs~~~L~-------~lp~----~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~lp---~   98 (353)
T d1jl5a_          38 RQAHELELNNLGLS-------SLPE----LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDLP---P   98 (353)
T ss_dssp             HTCSEEECTTSCCS-------CCCS----CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSCC---T
T ss_pred             cCCCEEEeCCCCCC-------CCCC----CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhhc---c
Confidence            36899999999996       7885    3578999999999999 567654   579999999999984 33321   3


Q ss_pred             chhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccc------------------cccCCccccceeeccc
Q 046240          181 NIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIP------------------QVMGNLSIFLLLDLEL  242 (763)
Q Consensus       181 ~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~------------------~~~~~l~~L~~L~L~~  242 (763)
                      +|++|+    +++|.+.. +|. +..+. +|++|++++|.+.....                  ..+..++.++.|++++
T Consensus        99 ~L~~L~----L~~n~l~~-lp~-~~~l~-~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~  171 (353)
T d1jl5a_          99 LLEYLG----VSNNQLEK-LPE-LQNSS-FLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADN  171 (353)
T ss_dssp             TCCEEE----CCSSCCSS-CCC-CTTCT-TCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCS
T ss_pred             cccccc----cccccccc-ccc-hhhhc-cceeeccccccccccccccccccchhhccccccccccccccccceeccccc
Confidence            588888    88999885 453 56777 99999999998874332                  2244556666677776


Q ss_pred             ccccCCCCc------------------cccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcc
Q 046240          243 NKLTGPIPV------------------TFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPAT  304 (763)
Q Consensus       243 N~l~~~~p~------------------~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  304 (763)
                      |.+......                  .+..++.  |+.+++++|... .+|.     ...++..+.+.+|.+.. .+..
T Consensus       172 n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~--L~~l~l~~n~~~-~~~~-----~~~~l~~~~~~~~~~~~-~~~~  242 (353)
T d1jl5a_         172 NSLKKLPDLPLSLESIVAGNNILEELPELQNLPF--LTTIYADNNLLK-TLPD-----LPPSLEALNVRDNYLTD-LPEL  242 (353)
T ss_dssp             SCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTT--CCEEECCSSCCS-SCCS-----CCTTCCEEECCSSCCSC-CCCC
T ss_pred             cccccccccccccccccccccccccccccccccc--cccccccccccc-cccc-----ccccccccccccccccc-cccc
Confidence            666532110                  1111221  444444444433 1221     11223333333333331 1111


Q ss_pred             cCCCcCccEEEccCccccCc----------------ccccccccccccEEeCcCCccCCccchhhhhhccCceEEccccc
Q 046240          305 IGGLKDVQNISLPYNRLEGP----------------IPESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNK  368 (763)
Q Consensus       305 ~~~l~~L~~L~Ls~N~l~~~----------------~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  368 (763)
                         ...+..+++..|.+.+.                ++.....+++|++|+|++|+|+.+ |.   .+++|+.|+|++|+
T Consensus       243 ---~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~l-p~---~~~~L~~L~L~~N~  315 (353)
T d1jl5a_         243 ---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL-PA---LPPRLERLIASFNH  315 (353)
T ss_dssp             ---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSC
T ss_pred             ---cccccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccCcc-cc---ccCCCCEEECCCCc
Confidence               12222333322222210                111112356888888888888864 43   35678888888888


Q ss_pred             CCCCCCCCCCccccccccccCCCcccCCC
Q 046240          369 LEGEIPRGGPFANFTAKSFMGNEKLCGLP  397 (763)
Q Consensus       369 l~~~~p~~~~~~~l~~~~~~~n~~~c~~p  397 (763)
                      |+. +|..  ..+++.+++.+|+ +-..|
T Consensus       316 L~~-l~~~--~~~L~~L~L~~N~-L~~lp  340 (353)
T d1jl5a_         316 LAE-VPEL--PQNLKQLHVEYNP-LREFP  340 (353)
T ss_dssp             CSC-CCCC--CTTCCEEECCSSC-CSSCC
T ss_pred             CCc-cccc--cCCCCEEECcCCc-CCCCC
Confidence            884 4432  3567778888887 33444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=1.6e-17  Score=181.84  Aligned_cols=160  Identities=19%  Similarity=0.163  Sum_probs=81.6

Q ss_pred             cccEEEeecCcccc-----ccccccCCccccceeecccccccCCC----CccccccCCCCccEEEecCCccccCCCCcc-
Q 046240          210 SLERLYISNCSITG-----NIPQVMGNLSIFLLLDLELNKLTGPI----PVTFGRLQNSKLDTLSLCGNSFSGSIPSCI-  279 (763)
Q Consensus       210 ~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~-  279 (763)
                      .++.+++++|++..     ..+..+.....|+.|++++|.+....    ...+...+.  ++.+++++|.++....... 
T Consensus       227 ~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~--l~~l~l~~n~i~~~~~~~l~  304 (460)
T d1z7xw1         227 SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES--LKELSLAGNELGDEGARLLC  304 (460)
T ss_dssp             TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTT--CCEEECTTCCCHHHHHHHHH
T ss_pred             cccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccc--ccccccccccccccccchhh
Confidence            34555555554431     12223334455666666666554221    112222322  6666666666542111100 


Q ss_pred             --ccccCCcccEEEcccccccccCCcc----cCCCcCccEEEccCccccCc----cccccc-ccccccEEeCcCCccCCc
Q 046240          280 --DIGNLKVVVEINLSRNNFSGDIPAT----IGGLKDVQNISLPYNRLEGP----IPESFG-YLTSLEILDLSNNKISGF  348 (763)
Q Consensus       280 --~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~  348 (763)
                        .......|+.+++++|.++......    +...++|++|+|++|+++..    ++..+. ..+.|++|+|++|+|+..
T Consensus       305 ~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~  384 (460)
T d1z7xw1         305 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS  384 (460)
T ss_dssp             HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred             ccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence              0112345677777777766443222    23445677777777777542    222222 345677777777777643


Q ss_pred             ----cchhhhhhccCceEEcccccCCC
Q 046240          349 ----ILISLEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       349 ----~~~~~~~l~~L~~L~l~~N~l~~  371 (763)
                          +.+.+...++|++|+|++|+++.
T Consensus       385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         385 SCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             HHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence                23344555777777777777753

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=4.9e-17  Score=177.80  Aligned_cols=162  Identities=20%  Similarity=0.178  Sum_probs=116.1

Q ss_pred             cccEEEeecCcccccc----ccccCCccccceeecccccccCCCCccccc---cCCCCccEEEecCCccccCCCCc--cc
Q 046240          210 SLERLYISNCSITGNI----PQVMGNLSIFLLLDLELNKLTGPIPVTFGR---LQNSKLDTLSLCGNSFSGSIPSC--ID  280 (763)
Q Consensus       210 ~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---l~~~~L~~L~L~~N~l~~~~p~~--~~  280 (763)
                      +|+.|++++|.+....    ...+...+.++.+++++|.++......+..   .....|+.+++++|.++......  ..
T Consensus       256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~  335 (460)
T d1z7xw1         256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV  335 (460)
T ss_dssp             CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccc
Confidence            7999999999987433    334567889999999999997433222211   01124999999999987432220  02


Q ss_pred             cccCCcccEEEccccccccc----CCcccC-CCcCccEEEccCccccCc----ccccccccccccEEeCcCCccCCccch
Q 046240          281 IGNLKVVVEINLSRNNFSGD----IPATIG-GLKDVQNISLPYNRLEGP----IPESFGYLTSLEILDLSNNKISGFILI  351 (763)
Q Consensus       281 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~  351 (763)
                      +...++|++|+|++|+|+..    ++..+. ..+.|+.|+|++|+|+..    +...+..+++|++|+|++|+|+.....
T Consensus       336 ~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~  415 (460)
T d1z7xw1         336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL  415 (460)
T ss_dssp             HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHH
T ss_pred             cccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHH
Confidence            34556899999999999753    333343 467899999999999853    445566789999999999999875444


Q ss_pred             hhh-----hhccCceEEcccccCCC
Q 046240          352 SLE-----KLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       352 ~~~-----~l~~L~~L~l~~N~l~~  371 (763)
                      .+.     +...|+.|++++|.+..
T Consensus       416 ~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         416 QLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             HHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             HHHHHHHhCCCccCEEECCCCCCCH
Confidence            443     23479999999999874

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=4.1e-15  Score=137.34  Aligned_cols=127  Identities=19%  Similarity=0.152  Sum_probs=78.1

Q ss_pred             CCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCc
Q 046240          230 GNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLK  309 (763)
Q Consensus       230 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  309 (763)
                      .+..+|++|+|++|+|+ .+|..+..+++  |+.|+|++|+|+ .++   .+..+++|++|++++|+++...+..+..++
T Consensus        15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~--L~~L~Ls~N~i~-~l~---~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~   87 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIP-VIENLGATLDQ--FDAIDFSDNEIR-KLD---GFPLLRRLKTLLVNNNRICRIGEGLDQALP   87 (162)
T ss_dssp             ECTTSCEEEECTTSCCC-SCCCGGGGTTC--CSEEECCSSCCC-EEC---CCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             cCcCcCcEEECCCCCCC-ccCcccccccc--CCEEECCCCCCC-ccC---CcccCcchhhhhcccccccCCCcccccccc
Confidence            34445555555555555 33444444443  666666666665 333   356666777777777777755555566677


Q ss_pred             CccEEEccCccccCccc-ccccccccccEEeCcCCccCCcc---chhhhhhccCceEE
Q 046240          310 DVQNISLPYNRLEGPIP-ESFGYLTSLEILDLSNNKISGFI---LISLEKLLYLKKLN  363 (763)
Q Consensus       310 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~  363 (763)
                      +|+.|++++|+|+.... ..+..+++|++|++++|+++...   +..+..+++|+.||
T Consensus        88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            77777777777764322 35677777888888888776643   23566777777776

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=2.8e-15  Score=152.73  Aligned_cols=208  Identities=19%  Similarity=0.247  Sum_probs=117.6

Q ss_pred             cCCCccEEEccccccccc-CCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCccccccc
Q 046240          130 ALPNVKALSLAYNRFSGT-IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLS  208 (763)
Q Consensus       130 ~l~~L~~L~L~~N~i~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~  208 (763)
                      ...+|++|||++|.++.. ++..+.++++|++|+|++|++++..+..++.++                            
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~----------------------------   95 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS----------------------------   95 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCT----------------------------
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCC----------------------------
Confidence            344566666666665533 233445566666666666665544444444444                            


Q ss_pred             ccccEEEeecC-ccccc-cccccCCccccceeecccc-cccCC-CCccccccCCCCccEEEecCCc--cccC-CCCcccc
Q 046240          209 ISLERLYISNC-SITGN-IPQVMGNLSIFLLLDLELN-KLTGP-IPVTFGRLQNSKLDTLSLCGNS--FSGS-IPSCIDI  281 (763)
Q Consensus       209 ~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~~~L~~L~L~~N~--l~~~-~p~~~~~  281 (763)
                       +|++|+|+++ .++.. +...+.++++|++|+++++ .++.. +...+.... +.|+.|+++++.  ++.. +..  ..
T Consensus        96 -~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~-~~L~~L~l~~~~~~i~~~~l~~--l~  171 (284)
T d2astb2          96 -NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS-ETITQLNLSGYRKNLQKSDLST--LV  171 (284)
T ss_dssp             -TCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSC-TTCCEEECCSCGGGSCHHHHHH--HH
T ss_pred             -CCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccc-cccchhhhcccccccccccccc--cc
Confidence             5555555553 34321 1122345667777777664 33311 111222221 237777777642  3211 111  23


Q ss_pred             ccCCcccEEEcccc-cccccCCcccCCCcCccEEEccC-ccccCcccccccccccccEEeCcCCccCC-ccchhhhhhcc
Q 046240          282 GNLKVVVEINLSRN-NFSGDIPATIGGLKDVQNISLPY-NRLEGPIPESFGYLTSLEILDLSNNKISG-FILISLEKLLY  358 (763)
Q Consensus       282 ~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~  358 (763)
                      .++++|++|++++| .+++.....+..+++|++|+|++ +.+++.....++.+++|+.|+++++ ++. ..+.....+++
T Consensus       172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~  250 (284)
T d2astb2         172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPH  250 (284)
T ss_dssp             HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTT
T ss_pred             cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcc
Confidence            45678888888876 46766777788888888888888 4677666667788888888888887 332 22222233444


Q ss_pred             CceEEcccccCCCCC
Q 046240          359 LKKLNLSFNKLEGEI  373 (763)
Q Consensus       359 L~~L~l~~N~l~~~~  373 (763)
                         |.+..++++...
T Consensus       251 ---L~i~~~~ls~~~  262 (284)
T d2astb2         251 ---LQINCSHFTTIA  262 (284)
T ss_dssp             ---SEESCCCSCCTT
T ss_pred             ---ccccCccCCCCC
Confidence               445667776543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=4.4e-15  Score=137.15  Aligned_cols=64  Identities=13%  Similarity=0.103  Sum_probs=28.8

Q ss_pred             cCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCeeeecCccccc
Q 046240           97 IGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTILELGGNSFSG  170 (763)
Q Consensus        97 ~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~  170 (763)
                      |.+...|++|+|++|+|+       .+| ..+..+++|+.|+|++|+|+..  +.|..+++|++|++++|+|+.
T Consensus        14 ~~n~~~lr~L~L~~n~I~-------~i~-~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~   77 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-------VIE-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR   77 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-------SCC-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE
T ss_pred             ccCcCcCcEEECCCCCCC-------ccC-ccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccC
Confidence            334444455555555443       333 2223444455555555544432  124444455555555555543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=2.6e-14  Score=125.40  Aligned_cols=101  Identities=25%  Similarity=0.318  Sum_probs=50.5

Q ss_pred             EEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEccCccccCcccccccccccccEEeCcC
Q 046240          263 TLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSN  342 (763)
Q Consensus       263 ~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  342 (763)
                      .|+|++|+++ .++.   +..+++|++|++++|+|+ .+|..|+.+++|+.|++++|+|++ +| .+..+++|++|++++
T Consensus         2 ~L~Ls~n~l~-~l~~---l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~   74 (124)
T d1dcea3           2 VLHLAHKDLT-VLCH---LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN   74 (124)
T ss_dssp             EEECTTSCCS-SCCC---GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred             EEEcCCCCCC-CCcc---cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCC
Confidence            3444445444 3332   444555555555555554 334445555555555555555552 22 245555555555555


Q ss_pred             CccCCccc-hhhhhhccCceEEcccccCC
Q 046240          343 NKISGFIL-ISLEKLLYLKKLNLSFNKLE  370 (763)
Q Consensus       343 N~l~~~~~-~~~~~l~~L~~L~l~~N~l~  370 (763)
                      |+|+.+.. ..+..+++|+.|++++|+++
T Consensus        75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            55554322 34455555555555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=4.3e-14  Score=123.97  Aligned_cols=117  Identities=21%  Similarity=0.280  Sum_probs=69.1

Q ss_pred             eeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCcccEEEcccccccccCCcccCCCcCccEEEc
Q 046240          237 LLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRNNFSGDIPATIGGLKDVQNISL  316 (763)
Q Consensus       237 ~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  316 (763)
                      .|+|++|+|+ .++ .+..+..  |++|++++|+|+ .+|.  .++.+++|+.|++++|+|+. +| .+..+++|+.|++
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~--L~~L~ls~N~l~-~lp~--~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l   72 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLL--VTHLDLSHNRLR-ALPP--ALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLL   72 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTT--CCEEECCSSCCC-CCCG--GGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred             EEEcCCCCCC-CCc-ccccCCC--CCEEECCCCccC-cchh--hhhhhhcccccccccccccc-cC-ccccccccCeEEC
Confidence            4555555555 233 2455544  555566555555 4444  45666666666666666663 23 3666777777777


Q ss_pred             cCccccCccc-ccccccccccEEeCcCCccCCc---cchhhhhhccCceE
Q 046240          317 PYNRLEGPIP-ESFGYLTSLEILDLSNNKISGF---ILISLEKLLYLKKL  362 (763)
Q Consensus       317 s~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L  362 (763)
                      ++|+|+.... ..+..+++|+.|++++|+++..   .......+++|+.|
T Consensus        73 ~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            7777764332 4567777777777777777643   23344556666654

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.46  E-value=2.8e-15  Score=157.51  Aligned_cols=247  Identities=15%  Similarity=0.133  Sum_probs=150.6

Q ss_pred             CCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEccccccccc----------CCCcccCCCCCCeee
Q 046240           93 IPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGT----------IQSPITNASKLTILE  162 (763)
Q Consensus        93 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~----------~p~~~~~l~~L~~L~  162 (763)
                      +...+.+.+.|+.|+|++|.|...  ....+... ....++|+.|+++++.+...          +...+...++|+.|+
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~--~~~~l~~~-l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~   99 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTE--AARWLSEN-IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVR   99 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHH--HHHHHHHT-TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEE
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHH--HHHHHHHH-HHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccc
Confidence            445677788899999998877410  00011111 23567888888887755422          112344567788888


Q ss_pred             ecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCccccccccc-------------c
Q 046240          163 LGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSITGNIPQV-------------M  229 (763)
Q Consensus       163 L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~~~~-------------~  229 (763)
                      |++|.++......+.                        ..+...+ +|++|++++|.+.......             .
T Consensus       100 L~~n~i~~~~~~~l~------------------------~~l~~~~-~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~  154 (344)
T d2ca6a1         100 LSDNAFGPTAQEPLI------------------------DFLSKHT-PLEHLYLHNNGLGPQAGAKIARALQELAVNKKA  154 (344)
T ss_dssp             CCSCCCCTTTHHHHH------------------------HHHHHCT-TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccchh------------------------hhhcccc-cchheeccccccccccccccccccccccccccc
Confidence            888877642111111                        1111222 6667777777654221111             1


Q ss_pred             CCccccceeecccccccCCC----CccccccCCCCccEEEecCCccccC-----CCCccccccCCcccEEEccccccccc
Q 046240          230 GNLSIFLLLDLELNKLTGPI----PVTFGRLQNSKLDTLSLCGNSFSGS-----IPSCIDIGNLKVVVEINLSRNNFSGD  300 (763)
Q Consensus       230 ~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~~~L~~L~L~~N~l~~~-----~p~~~~~~~l~~L~~L~Ls~N~l~~~  300 (763)
                      ...+.|+.|++++|.++...    ...+.....  |+.|+|++|+++..     +..  .+...++|+.|+|++|.++..
T Consensus       155 ~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~--L~~L~L~~n~i~~~g~~~~l~~--~l~~~~~L~~L~Ls~N~i~~~  230 (344)
T d2ca6a1         155 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL--LHTVKMVQNGIRPEGIEHLLLE--GLAYCQELKVLDLQDNTFTHL  230 (344)
T ss_dssp             HTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT--CCEEECCSSCCCHHHHHHHHHT--TGGGCTTCCEEECCSSCCHHH
T ss_pred             ccCcccceeecccccccccccccccchhhhhhh--hcccccccccccccccccchhh--hhcchhhhccccccccccccc
Confidence            23456777888887776322    222333433  88888888877531     122  456778888899998888643


Q ss_pred             ----CCcccCCCcCccEEEccCccccCcccccc----c--ccccccEEeCcCCccCCcc----chhhh-hhccCceEEcc
Q 046240          301 ----IPATIGGLKDVQNISLPYNRLEGPIPESF----G--YLTSLEILDLSNNKISGFI----LISLE-KLLYLKKLNLS  365 (763)
Q Consensus       301 ----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~--~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~l~  365 (763)
                          +...+..+++|++|+|++|.|++.....+    .  ..+.|++|++++|+|+...    ...+. ++++|+.|+|+
T Consensus       231 g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~  310 (344)
T d2ca6a1         231 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN  310 (344)
T ss_dssp             HHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECT
T ss_pred             ccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECC
Confidence                34556778889999999998875433333    2  2367899999999887542    23332 46789999999


Q ss_pred             cccCCC
Q 046240          366 FNKLEG  371 (763)
Q Consensus       366 ~N~l~~  371 (763)
                      +|++..
T Consensus       311 ~N~~~~  316 (344)
T d2ca6a1         311 GNRFSE  316 (344)
T ss_dssp             TSBSCT
T ss_pred             CCcCCC
Confidence            999864

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=2.6e-15  Score=152.89  Aligned_cols=232  Identities=17%  Similarity=0.190  Sum_probs=140.9

Q ss_pred             eEEEEecCCCCCCcCCcccCCCCCCCEEEcCCCcccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCC
Q 046240           79 VTALNISSLNLQGEIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKL  158 (763)
Q Consensus        79 v~~L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L  158 (763)
                      +..+.+.+..+.... .......+|++|||++|.++      ......++..+++|++|+|++|.+++..+..+..+++|
T Consensus        25 ~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~------~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L   97 (284)
T d2astb2          25 VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIE------VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL   97 (284)
T ss_dssp             CSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEEC------HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTC
T ss_pred             ceEeeccccccccch-hhhccCCCCCEEECCCCccC------HHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCC
Confidence            345556555554322 33445678999999999875      23344566789999999999999998888889999999


Q ss_pred             CeeeecCc-cccccc-ccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecC-ccccc-cccccCC-cc
Q 046240          159 TILELGGN-SFSGFI-PNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNC-SITGN-IPQVMGN-LS  233 (763)
Q Consensus       159 ~~L~L~~N-~l~~~~-p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N-~l~~~-~~~~~~~-l~  233 (763)
                      ++|+|+++ .++... ...+.+++                             +|++|+++++ .++.. +...+.. .+
T Consensus        98 ~~L~Ls~c~~itd~~l~~l~~~~~-----------------------------~L~~L~ls~c~~~~~~~~~~~~~~~~~  148 (284)
T d2astb2          98 VRLNLSGCSGFSEFALQTLLSSCS-----------------------------RLDELNLSWCFDFTEKHVQVAVAHVSE  148 (284)
T ss_dssp             SEEECTTCBSCCHHHHHHHHHHCT-----------------------------TCCEEECCCCTTCCHHHHHHHHHHSCT
T ss_pred             cCccccccccccccccchhhHHHH-----------------------------hccccccccccccccccchhhhccccc
Confidence            99999995 555211 11122334                             5555555553 23211 1112222 24


Q ss_pred             ccceeecccc--cccCC-CCccccccCCCCccEEEecCC-ccccCCCCccccccCCcccEEEcccc-cccccCCcccCCC
Q 046240          234 IFLLLDLELN--KLTGP-IPVTFGRLQNSKLDTLSLCGN-SFSGSIPSCIDIGNLKVVVEINLSRN-NFSGDIPATIGGL  308 (763)
Q Consensus       234 ~L~~L~L~~N--~l~~~-~p~~~~~l~~~~L~~L~L~~N-~l~~~~p~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l  308 (763)
                      +|+.|+++++  .++.. +.....++++  |++|++++| .+++....  .+.++++|++|+|++| .++......++.+
T Consensus       149 ~L~~L~l~~~~~~i~~~~l~~l~~~~~~--L~~L~L~~~~~itd~~~~--~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~  224 (284)
T d2astb2         149 TITQLNLSGYRKNLQKSDLSTLVRRCPN--LVHLDLSDSVMLKNDCFQ--EFFQLNYLQHLSLSRCYDIIPETLLELGEI  224 (284)
T ss_dssp             TCCEEECCSCGGGSCHHHHHHHHHHCTT--CSEEECTTCTTCCGGGGG--GGGGCTTCCEEECTTCTTCCGGGGGGGGGC
T ss_pred             ccchhhhccccccccccccccccccccc--ccccccccccCCCchhhh--hhcccCcCCEEECCCCCCCChHHHHHHhcC
Confidence            5666666653  23211 1122233443  777777765 35544444  5677788888888884 6766666677788


Q ss_pred             cCccEEEccCccccC-cccccccccccccEEeCcCCccCCccchhhh
Q 046240          309 KDVQNISLPYNRLEG-PIPESFGYLTSLEILDLSNNKISGFILISLE  354 (763)
Q Consensus       309 ~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  354 (763)
                      ++|+.|+++++ ++. .++.....+++   |.++.++++.+.++.++
T Consensus       225 ~~L~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~~~~  267 (284)
T d2astb2         225 PTLKTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFTTIARPTIG  267 (284)
T ss_dssp             TTCCEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSCCTTCSSCS
T ss_pred             CCCCEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCCCCCCCccC
Confidence            88888888877 331 12222223444   44567777776554443

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.45  E-value=3.7e-15  Score=156.54  Aligned_cols=249  Identities=16%  Similarity=0.195  Sum_probs=168.2

Q ss_pred             CCceEEEEecCCCCCC----cCCcccCCCCCCCEEEcCCCcccCCCccccCcccc------ccccCCCccEEEccccccc
Q 046240           76 SHRVTALNISSLNLQG----EIPHEIGYLPSLTKLALGYNSLVGNNSLSGSLPSR------IDLALPNVKALSLAYNRFS  145 (763)
Q Consensus        76 ~~~v~~L~L~~~~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~lp~~------~~~~l~~L~~L~L~~N~i~  145 (763)
                      ...+++|+|++|.+..    .+...+...++|+.|+++++....   .....|..      .....++|++|+|++|.++
T Consensus        30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~---~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  106 (344)
T d2ca6a1          30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR---VKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG  106 (344)
T ss_dssp             CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTS---CGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCC
T ss_pred             CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccc---cccccchHHHHHHHHHhhCCCcccccccccccc
Confidence            3579999999998854    244567889999999999886631   11111211      1235789999999999998


Q ss_pred             cc----CCCcccCCCCCCeeeecCcccccccccccCCCCchhhhhhhhhccCCcccccCCcccccccccccEEEeecCcc
Q 046240          146 GT----IQSPITNASKLTILELGGNSFSGFIPNTIGNLRNIEWLGLVIGLIGNPLNGILPSSIVNLSISLERLYISNCSI  221 (763)
Q Consensus       146 ~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~~l~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l  221 (763)
                      ..    +...+...++|++|++++|.++......++  ..|..+....             ...... .|+.|++++|++
T Consensus       107 ~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~~-------------~~~~~~-~L~~l~l~~n~i  170 (344)
T d2ca6a1         107 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVNK-------------KAKNAP-PLRSIICGRNRL  170 (344)
T ss_dssp             TTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHHH-------------HHHTCC-CCCEEECCSSCC
T ss_pred             cccccchhhhhcccccchheeccccccccccccccc--cccccccccc-------------ccccCc-ccceeecccccc
Confidence            64    333455678999999999998632222221  1122222110             001122 788899999988


Q ss_pred             ccc----cccccCCccccceeecccccccCC-----CCccccccCCCCccEEEecCCccccC----CCCccccccCCccc
Q 046240          222 TGN----IPQVMGNLSIFLLLDLELNKLTGP-----IPVTFGRLQNSKLDTLSLCGNSFSGS----IPSCIDIGNLKVVV  288 (763)
Q Consensus       222 ~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~~~L~~L~L~~N~l~~~----~p~~~~~~~l~~L~  288 (763)
                      +..    +...+...+.|+.|+|++|+++..     +...+...+.  |+.|+|++|.++..    +..  .+...++|+
T Consensus       171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~--L~~L~Ls~N~i~~~g~~~L~~--~l~~~~~L~  246 (344)
T d2ca6a1         171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE--LKVLDLQDNTFTHLGSSALAI--ALKSWPNLR  246 (344)
T ss_dssp             TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTT--CCEEECCSSCCHHHHHHHHHH--HGGGCTTCC
T ss_pred             cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhh--hcccccccccccccccccccc--cccccccch
Confidence            633    333456678899999999988732     2334555554  99999999988632    222  467788999


Q ss_pred             EEEcccccccccCCccc----C--CCcCccEEEccCccccCcc----ccccc-ccccccEEeCcCCccCC
Q 046240          289 EINLSRNNFSGDIPATI----G--GLKDVQNISLPYNRLEGPI----PESFG-YLTSLEILDLSNNKISG  347 (763)
Q Consensus       289 ~L~Ls~N~l~~~~p~~~----~--~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~L~~N~l~~  347 (763)
                      +|+|++|+|+......+    .  ..+.|+.|++++|+|+...    ...+. .+++|+.|+|++|++..
T Consensus       247 ~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             hhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            99999999986433333    2  2467999999999987532    33332 57899999999999976

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.39  E-value=7e-15  Score=140.74  Aligned_cols=143  Identities=22%  Similarity=0.246  Sum_probs=87.8

Q ss_pred             ccEEEeecC--ccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccCCccc
Q 046240          211 LERLYISNC--SITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNLKVVV  288 (763)
Q Consensus       211 L~~L~L~~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l~~L~  288 (763)
                      ++.+++.++  .++ .++..++.+++|++|+|++|+|+ .++ .+..+++  |+.|+|++|.++ .+|.  ....+++|+
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~--L~~L~Ls~N~i~-~i~~--~~~~~~~L~   96 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMEN--LRILSLGRNLIK-KIEN--LDAVADTLE   96 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTT--CCEEECCEEEEC-SCSS--HHHHHHHCC
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCcc--ccChhhcccccc-cccc--ccccccccc
Confidence            444444433  233 34556677777777777777777 333 4666655  777777777776 4554  334455677


Q ss_pred             EEEcccccccccCCcccCCCcCccEEEccCccccCccc-ccccccccccEEeCcCCccCCccchh----------hhhhc
Q 046240          289 EINLSRNNFSGDIPATIGGLKDVQNISLPYNRLEGPIP-ESFGYLTSLEILDLSNNKISGFILIS----------LEKLL  357 (763)
Q Consensus       289 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~  357 (763)
                      .|++++|+|+..  ..+..+++|+.|++++|+++.... ..+..+++|+.|+|++|++....+..          +..++
T Consensus        97 ~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp  174 (198)
T d1m9la_          97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP  174 (198)
T ss_dssp             EEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCS
T ss_pred             cccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCC
Confidence            777777777643  346667777777777777764322 35667777777777777765543321          45566


Q ss_pred             cCceEE
Q 046240          358 YLKKLN  363 (763)
Q Consensus       358 ~L~~L~  363 (763)
                      +|+.||
T Consensus       175 ~L~~LD  180 (198)
T d1m9la_         175 NLKKLD  180 (198)
T ss_dssp             SCCEES
T ss_pred             CcCEeC
Confidence            777665

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=1e-12  Score=120.16  Aligned_cols=107  Identities=19%  Similarity=0.230  Sum_probs=76.3

Q ss_pred             ccEEEecCCccccCCCCccccccCCcccEEEcccc-cccccCCcccCCCcCccEEEccCccccCcccccccccccccEEe
Q 046240          261 LDTLSLCGNSFSGSIPSCIDIGNLKVVVEINLSRN-NFSGDIPATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILD  339 (763)
Q Consensus       261 L~~L~L~~N~l~~~~p~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  339 (763)
                      .+.++.+++.+. ..|.  .+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+...+.+|..+++|++|+
T Consensus        10 ~~~l~c~~~~~~-~~p~--~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLH--HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSCEECCSSCCC-TTTT--TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCeEEecCCCCc-cCcc--cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            456777777777 4555  5677777777777655 47766667777777777777777777766677777777777777


Q ss_pred             CcCCccCCccchhhhhhccCceEEcccccCCC
Q 046240          340 LSNNKISGFILISLEKLLYLKKLNLSFNKLEG  371 (763)
Q Consensus       340 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  371 (763)
                      |++|+|+.+.+..|..+ .|+.|+|++|+|.+
T Consensus        87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C  117 (156)
T d2ifga3          87 LSFNALESLSWKTVQGL-SLQELVLSGNPLHC  117 (156)
T ss_dssp             CCSSCCSCCCSTTTCSC-CCCEEECCSSCCCC
T ss_pred             ccCCCCcccChhhhccc-cccccccCCCcccC
Confidence            77777777666665544 57777777777754

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=1.1e-12  Score=119.82  Aligned_cols=96  Identities=18%  Similarity=0.148  Sum_probs=74.9

Q ss_pred             EEecCCCCCCcCCcccCCCCCCCEEEcCCC-cccCCCccccCccccccccCCCccEEEcccccccccCCCcccCCCCCCe
Q 046240           82 LNISSLNLQGEIPHEIGYLPSLTKLALGYN-SLVGNNSLSGSLPSRIDLALPNVKALSLAYNRFSGTIQSPITNASKLTI  160 (763)
Q Consensus        82 L~L~~~~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~lp~~~~~~l~~L~~L~L~~N~i~~~~p~~~~~l~~L~~  160 (763)
                      ++.+++++. ..|..+..+++|++|++++| .|+       .++...|.++++|+.|+|++|+|+.+.|..|.++++|++
T Consensus        13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-------~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~   84 (156)
T d2ifga3          13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQ-------HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (156)
T ss_dssp             EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-------EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             EEecCCCCc-cCcccccCccccCeeecCCCcccc-------ccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence            444556666 56778888999999999766 474       788888888999999999999999888888999999999


Q ss_pred             eeecCcccccccccccCCCCchhhhh
Q 046240          161 LELGGNSFSGFIPNTIGNLRNIEWLG  186 (763)
Q Consensus       161 L~L~~N~l~~~~p~~~~~l~~L~~L~  186 (763)
                      |+|++|+|+.+.+..|..+ +|+.|+
T Consensus        85 L~Ls~N~l~~l~~~~~~~~-~l~~L~  109 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQGL-SLQELV  109 (156)
T ss_dssp             EECCSSCCSCCCSTTTCSC-CCCEEE
T ss_pred             eeccCCCCcccChhhhccc-cccccc
Confidence            9999999986655555443 344444

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.29  E-value=2.5e-14  Score=136.80  Aligned_cols=133  Identities=20%  Similarity=0.239  Sum_probs=100.2

Q ss_pred             cccccccccccEEEeecCccccccccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCcccc
Q 046240          202 SSIVNLSISLERLYISNCSITGNIPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDI  281 (763)
Q Consensus       202 ~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~  281 (763)
                      .++..+. +|++|+|++|+|+. ++ .|.++++|++|+|++|+|+ .+|..+..++.  |++|++++|+++ .++   .+
T Consensus        42 ~sl~~L~-~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~--L~~L~l~~N~i~-~l~---~~  111 (198)
T d1m9la_          42 ATLSTLK-ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT--LEELWISYNQIA-SLS---GI  111 (198)
T ss_dssp             HHHHHTT-TCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHH--CCEEECSEEECC-CHH---HH
T ss_pred             hHHhccc-ccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccc--cccccccccccc-ccc---cc
Confidence            3444555 88888888888884 33 4888889999999999888 55655555544  889999999988 343   47


Q ss_pred             ccCCcccEEEcccccccccCC-cccCCCcCccEEEccCccccCccccc----------ccccccccEEeCcCCccC
Q 046240          282 GNLKVVVEINLSRNNFSGDIP-ATIGGLKDVQNISLPYNRLEGPIPES----------FGYLTSLEILDLSNNKIS  346 (763)
Q Consensus       282 ~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~L~~N~l~  346 (763)
                      ..+++|+.|++++|+|+.... ..+..+++|+.|+|++|++....+..          +..+++|+.||  +..++
T Consensus       112 ~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred             cccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence            788899999999999985432 56889999999999999987554432          56789999987  55554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=3.6e-07  Score=90.29  Aligned_cols=150  Identities=14%  Similarity=0.105  Sum_probs=102.5

Q ss_pred             HHHHHHHhccCcCceecccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCce
Q 046240          468 QDLSRATNRFGRDNLIGIGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFK  546 (763)
Q Consensus       468 ~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~  546 (763)
                      .++...-..|+..+..+-++.+.||+...+ ++.+++|+...........+.+|...+..+. +--+.+++++...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            355555566766655444455789998754 5667888876554444455678888888774 43467788888888889


Q ss_pred             EEEEEccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 046240          547 ALVLEYMPNGSLDIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----------------------------------  591 (763)
Q Consensus       547 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----------------------------------  591 (763)
                      ++||++++|.++........      ....++.++++.+..||..                                   
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999988765443211      1233455555556655521                                   


Q ss_pred             ---------------------CCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          592 ---------------------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       592 ---------------------h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                                           ....++|+|+.|.||++++++.+-|.||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 122378999999999999877777999988764

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.36  E-value=6.1e-09  Score=95.16  Aligned_cols=70  Identities=24%  Similarity=0.206  Sum_probs=38.9

Q ss_pred             ccCCCcCccEEEccCccccCcc--cccccccccccEEeCcCCccCCccchhhhhhccCceEEcccccCCCCC
Q 046240          304 TIGGLKDVQNISLPYNRLEGPI--PESFGYLTSLEILDLSNNKISGFILISLEKLLYLKKLNLSFNKLEGEI  373 (763)
Q Consensus       304 ~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  373 (763)
                      .+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+.+.+-.+....+|+.|++++|+++...
T Consensus        60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~  131 (162)
T d1koha1          60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF  131 (162)
T ss_dssp             HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred             HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence            3344556666666666665432  234455666666666666666644434444445666666666665443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.33  E-value=1.4e-08  Score=92.76  Aligned_cols=85  Identities=21%  Similarity=0.148  Sum_probs=50.1

Q ss_pred             cCCcccEEEcccccccccC--CcccCCCcCccEEEccCccccCcccccccccccccEEeCcCCccCCccc-------hhh
Q 046240          283 NLKVVVEINLSRNNFSGDI--PATIGGLKDVQNISLPYNRLEGPIPESFGYLTSLEILDLSNNKISGFIL-------ISL  353 (763)
Q Consensus       283 ~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-------~~~  353 (763)
                      .++.|++|+|++|+|+...  +..+..+++|+.|+|++|+|+...+-.+....+|+.|++++|+++....       ..+
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~  142 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR  142 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence            4555666666666665432  2345566777777777777774333233344567777777777765432       235


Q ss_pred             hhhccCceEEcccccC
Q 046240          354 EKLLYLKKLNLSFNKL  369 (763)
Q Consensus       354 ~~l~~L~~L~l~~N~l  369 (763)
                      ..+++|+.||  ++++
T Consensus       143 ~~~P~L~~LD--g~~v  156 (162)
T d1koha1         143 ERFPKLLRLD--GHEL  156 (162)
T ss_dssp             TTSTTCCEET--TEEC
T ss_pred             HHCCCCCEEC--cCCC
Confidence            5677787765  4444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.99  E-value=1.1e-05  Score=78.92  Aligned_cols=131  Identities=13%  Similarity=0.108  Sum_probs=87.0

Q ss_pred             eecccCC-ceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCC--CCccceEEeeeecCCceEEEEEccCCCCh
Q 046240          482 LIGIGSF-GYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIR--HRNLVKIISGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       482 ~lg~G~~-g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      .+..|.. +.||+....++..+++|......   ...+..|...++.+.  .-.+.+++++..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455543 67899998888889999865432   234567888887763  23366788888888889999999998766


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 046240          559 DIFLYSSTCMLDIFQRLNIMIDVASALEYLNFR-----------------------------------------------  591 (763)
Q Consensus       559 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~~Lh~~-----------------------------------------------  591 (763)
                      .....      .   ....+.++++.+.-||..                                               
T Consensus        94 ~~~~~------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSHL------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSCC------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccccc------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            43211      0   011122333333333310                                               


Q ss_pred             --------CCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          592 --------HTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       592 --------h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                              ....++|+|+.|.||+++++..+-|.||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                    122379999999999999877778999987654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.54  E-value=1.5e-05  Score=72.21  Aligned_cols=85  Identities=18%  Similarity=0.205  Sum_probs=42.0

Q ss_pred             cCCcccEEEccccccccc----CCcccCCCcCccEEEccCccccCc----ccccccccccccEEeCcCCccCCc------
Q 046240          283 NLKVVVEINLSRNNFSGD----IPATIGGLKDVQNISLPYNRLEGP----IPESFGYLTSLEILDLSNNKISGF------  348 (763)
Q Consensus       283 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~------  348 (763)
                      ..+.|++|+|++|.+...    +...+...+.|+.|+|++|.++..    +-..+...++|++|+|++|.+..+      
T Consensus        42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~  121 (167)
T d1pgva_          42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM  121 (167)
T ss_dssp             TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred             hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence            334455555555554421    112233345566666666665532    122344456666666666654432      


Q ss_pred             -cchhhhhhccCceEEcccc
Q 046240          349 -ILISLEKLLYLKKLNLSFN  367 (763)
Q Consensus       349 -~~~~~~~l~~L~~L~l~~N  367 (763)
                       +...+..-+.|+.|+++.+
T Consensus       122 ~l~~~L~~n~sL~~l~l~~~  141 (167)
T d1pgva_         122 DMMMAIEENESLLRVGISFA  141 (167)
T ss_dssp             HHHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHHHhCCCccEeeCcCC
Confidence             2333444456666666544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.40  E-value=1.6e-05  Score=72.12  Aligned_cols=112  Identities=11%  Similarity=0.047  Sum_probs=62.1

Q ss_pred             cccEEEeecC-ccccc----cccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccC
Q 046240          210 SLERLYISNC-SITGN----IPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNL  284 (763)
Q Consensus       210 ~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l  284 (763)
                      +|++|+|+++ .++..    +-..+...+.|++|+|++|.++......+..                        .+...
T Consensus        16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~------------------------~L~~n   71 (167)
T d1pgva_          16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIE------------------------LIETS   71 (167)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHH------------------------HHHHC
T ss_pred             CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhh------------------------hhhhc
Confidence            6777777763 35422    2233445556666666666655221111111                        22334


Q ss_pred             CcccEEEccccccccc----CCcccCCCcCccEEEccCccccCc-------ccccccccccccEEeCcCCcc
Q 046240          285 KVVVEINLSRNNFSGD----IPATIGGLKDVQNISLPYNRLEGP-------IPESFGYLTSLEILDLSNNKI  345 (763)
Q Consensus       285 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~L~~N~l  345 (763)
                      +.|++|+|++|.|+..    +-.++...++|++|+|++|.+...       +...+...++|+.|+++.+..
T Consensus        72 ~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          72 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             ccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            5566666666666532    223455567777788877765422       334455578888888887754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.25  E-value=0.00039  Score=72.02  Aligned_cols=76  Identities=14%  Similarity=0.211  Sum_probs=47.9

Q ss_pred             CceecccCCceEEEEEecC-CceEEEEEeehhh-------HHHHHHHHHHHHHHHhCC-C--CccceEEeeeecCCceEE
Q 046240          480 DNLIGIGSFGYVYKAELDD-GIEVAIKVFHQEC-------ARAMKSFEVECEVMKNIR-H--RNLVKIISGCSNDDFKAL  548 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l  548 (763)
                      .+.||.|....||+....+ ++.|+||.-....       .....+...|.+.++.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999997754 6789999654221       011234556888887762 2  345556654  3445679


Q ss_pred             EEEccCCCC
Q 046240          549 VLEYMPNGS  557 (763)
Q Consensus       549 v~e~~~~g~  557 (763)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997754

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.90  E-value=5.5e-05  Score=68.35  Aligned_cols=60  Identities=23%  Similarity=0.263  Sum_probs=27.4

Q ss_pred             CcCccEEEccCccccCc----ccccccccccccEEeC--cCCccCCc----cchhhhhhccCceEEcccc
Q 046240          308 LKDVQNISLPYNRLEGP----IPESFGYLTSLEILDL--SNNKISGF----ILISLEKLLYLKKLNLSFN  367 (763)
Q Consensus       308 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~l~~N  367 (763)
                      .++++.+++++|.+...    +...+...++|+.++|  ++|++...    +...+...+.|+.|+++.|
T Consensus        73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_          73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred             cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence            34444555555444322    2233444555554333  34444432    2333445556666666544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.68  E-value=0.0025  Score=63.89  Aligned_cols=69  Identities=12%  Similarity=0.153  Sum_probs=45.5

Q ss_pred             ceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCcc--ceEE-----eeeecCCceEEEEEccCCCCh
Q 046240          489 GYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRNL--VKII-----SGCSNDDFKALVLEYMPNGSL  558 (763)
Q Consensus       489 g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L  558 (763)
                      -.||++...+|+.|++|+.+... ...+++..|...+..+....+  +..+     ..+...+..+.++++++|..+
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            58999999999999999986542 224556778888877742221  1111     122345567889999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.64  E-value=0.0028  Score=63.14  Aligned_cols=158  Identities=12%  Similarity=0.063  Sum_probs=85.9

Q ss_pred             CCChHHHHHHHhccCcCceec-----ccCCceEEEEEecCCceEEEEEeehhhHHHHHHHHHHHHHHHhCCCCc--cceE
Q 046240          464 RLPYQDLSRATNRFGRDNLIG-----IGSFGYVYKAELDDGIEVAIKVFHQECARAMKSFEVECEVMKNIRHRN--LVKI  536 (763)
Q Consensus       464 ~~~~~~~~~~~~~~~~~~~lg-----~G~~g~v~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l  536 (763)
                      .++.++++....+|..++...     .|---+.|+....+| .+++|++....  ..+.+..|++++..+...+  +...
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            356788888888898766543     455567899988765 58999986432  2345566777777764222  1111


Q ss_pred             Ee------eeecCCceEEEEEccCCCChhhhh--------------c----cC----CCCCCHH----------------
Q 046240          537 IS------GCSNDDFKALVLEYMPNGSLDIFL--------------Y----SS----TCMLDIF----------------  572 (763)
Q Consensus       537 ~~------~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~~----~~~~~~~----------------  572 (763)
                      +.      +.........++.++.+......-              +    ..    .......                
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11      112234556667777664332110              0    00    0000000                


Q ss_pred             --HHHHHHHHHHHHHHHHHh-cCCCCeEeCCCCCCCEEecCCCcEEEeeecCcee
Q 046240          573 --QRLNIMIDVASALEYLNF-RHTTPIIHCDLKSSNVLLDEDMIAHLSDFGIAKL  624 (763)
Q Consensus       573 --~~~~i~~~ia~~L~~Lh~-~h~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~  624 (763)
                        .....+......+..... ....++||+|+.++||+++.+...-|.||+.+..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence              011111122222222211 1346799999999999999887778999998753

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.45  E-value=0.00016  Score=65.20  Aligned_cols=113  Identities=12%  Similarity=0.159  Sum_probs=62.0

Q ss_pred             cccEEEeec-Cccccc----cccccCCccccceeecccccccCCCCccccccCCCCccEEEecCCccccCCCCccccccC
Q 046240          210 SLERLYISN-CSITGN----IPQVMGNLSIFLLLDLELNKLTGPIPVTFGRLQNSKLDTLSLCGNSFSGSIPSCIDIGNL  284 (763)
Q Consensus       210 ~L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~L~~L~L~~N~l~~~~p~~~~~~~l  284 (763)
                      +|++|+|++ +.++..    +-.++...+.|++|+|++|.++......+..                        .+...
T Consensus        18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~------------------------~l~~~   73 (166)
T d1io0a_          18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAE------------------------MLKVN   73 (166)
T ss_dssp             TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHH------------------------HHHHC
T ss_pred             CCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHH------------------------HHhhc
Confidence            677777776 445422    2333445666666666666665322111111                        23334


Q ss_pred             CcccEEEccccccccc----CCcccCCCcCccEEEc--cCccccC----cccccccccccccEEeCcCCccC
Q 046240          285 KVVVEINLSRNNFSGD----IPATIGGLKDVQNISL--PYNRLEG----PIPESFGYLTSLEILDLSNNKIS  346 (763)
Q Consensus       285 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~  346 (763)
                      +.++.|++++|.++..    +...+...++|+.++|  ++|.+..    .+...+...++|+.|+++.|...
T Consensus        74 ~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          74 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             ccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence            5566666666665432    2244556667776444  4566653    23445567788888888877643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.09  E-value=0.009  Score=61.43  Aligned_cols=73  Identities=16%  Similarity=0.207  Sum_probs=48.5

Q ss_pred             CceecccCCceEEEEEecC--------CceEEEEEeehhhHHHHHHHHHHHHHHHhCC-CCccceEEeeeecCCceEEEE
Q 046240          480 DNLIGIGSFGYVYKAELDD--------GIEVAIKVFHQECARAMKSFEVECEVMKNIR-HRNLVKIISGCSNDDFKALVL  550 (763)
Q Consensus       480 ~~~lg~G~~g~v~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  550 (763)
                      ++.|+.|-.-.+|++...+        .+.|.+++.... . ......+|..+++.+. +.-..++++++..    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4567778888999997653        345777765422 1 2234567888888874 4434577777753    5889


Q ss_pred             EccCCCCh
Q 046240          551 EYMPNGSL  558 (763)
Q Consensus       551 e~~~~g~L  558 (763)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99988654